FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Suy, A
   Sulleiro, E
   Rodo, C
   Vazquez, E
   Bocanegra, C
   Molina, I
   Esperalba, J
   Sanchez-Seco, MP
   Boix, H
   Pumarola, T
   Carreras, E
AF Suy, Anna
   Sulleiro, Elena
   Rodo, Carlota
   Vazquez, Elida
   Bocanegra, Cristina
   Molina, Israel
   Esperalba, Juliana
   Sanchez-Seco, Maria P.
   Boix, Hector
   Pumarola, Tomas
   Carreras, Elena
TI Prolonged Zika Virus Viremia during Pregnancy
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Suy, Anna; Vazquez, Elida; Bocanegra, Cristina; Molina, Israel; Esperalba, Juliana; Boix, Hector; Pumarola, Tomas; Carreras, Elena] Hosp Valle De Hebron, Barcelona, Spain.
   [Sulleiro, Elena; Rodo, Carlota] Univ Autonoma Barcelona, Barcelona, Spain.
   [Sanchez-Seco, Maria P.] Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Madrid, Spain.
RP Suy, A (corresponding author), Hosp Valle De Hebron, Barcelona, Spain.
EM asuy@vhebron.net
RI Boix, Hector/G-5390-2018; Boix, Hector/N-6800-2019; Pumarola,
   Tomas/AAB-5532-2019; Sune, Tomas Pumarola/F-7583-2017; RODO,
   CARLOTA/K-9179-2017
OI Boix, Hector/0000-0002-8613-1401; Boix, Hector/0000-0002-8613-1401;
   Pumarola, Tomas/0000-0002-5171-7461; Sune, Tomas
   Pumarola/0000-0002-5171-7461; RODO, CARLOTA/0000-0001-8801-5677; Suy
   Franch, Anna/0000-0003-2987-6105; Sulleiro, Elena/0000-0002-9783-6060;
   Molina Romero, Israel/0000-0001-6642-7515; Esperalba,
   Juliana/0000-0003-1326-1341; SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704
CR Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
NR 3
TC 66
Z9 66
U1 0
U2 13
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 29
PY 2016
VL 375
IS 26
BP 2611
EP 2613
DI 10.1056/NEJMc1607580
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG6SC
UT WOS:000391175300035
PM 27959695
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI First Inactivated Zika Vaccine Trial
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 102
Z9 102
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD DEC 27
PY 2016
VL 316
IS 24
BP 2588
EP 2588
DI 10.1001/jama.2016.19328
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EL9VN
UT WOS:000394968300002
PM 28027353
DA 2020-07-08
ER

PT J
AU Richardson, E
AF Richardson, Emma
TI Zika Travel Policies May Reduce Women's Leadership in Global Health
SO GLOBAL HEALTH-SCIENCE AND PRACTICE
LA English
DT Letter
C1 [Richardson, Emma] McMaster Univ, Hamilton, ON L8S 4L8, Canada.
RP Richardson, E (corresponding author), McMaster Univ, Hamilton, ON L8S 4L8, Canada.
EM richardsone@smh.ca
CR Downs JA, 2014, ACAD MED, V89, P1103, DOI 10.1097/ACM.0000000000000369
   FindLaw, 2013, ILL INT QUEST FEM AP
   Ibarra Alicia Barcena, 2016, LATIN AM IS WORLDS M
   U.S. Agency for International Development (USAID), 2016, LAT AM CAR IMPR SEC
   U.S. Centers for Disease Control and Prevention (CDC), 2016, CDC ISS INT TRAV GUI
   U.S. Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR WOM TRYING B
   UN News Centre, 2016, NO LONG INT PUBL HLT
   Vaidya A, 2016, WHO ZIKA NO LONGER P
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 9
TC 2
Z9 2
U1 0
U2 2
PU US AGENCY INT DEVELOPMENT-USAID
PI BALTIMORE
PA US AGENCY INT DEVELOPMENT-USAID, BALTIMORE, MD 00000 USA
SN 2169-575X
J9 GLOB HEALTH-SCI PRAC
JI Glob. Health
PD DEC 23
PY 2016
VL 4
IS 4
BP 696
EP 697
DI 10.9745/GHSP-D-16-00282
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EG6XQ
UT WOS:000391190000018
PM 28031307
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, ZZ
   Li, Y
   Loh, YR
   Phoo, WW
   Hung, AW
   Kang, CB
   Luo, DH
AF Zhang, Zhenzhen
   Li, Yan
   Loh, Ying Ru
   Phoo, Wint Wint
   Hung, Alvin W.
   Kang, CongBao
   Luo, Dahai
TI Crystal structure of unlinked NS2B-NS3 protease from Zika virus
SO SCIENCE
LA English
DT Article
ID WEST-NILE-VIRUS; DENGUE VIRUS; NS3 PROTEASE; NMR ANALYSIS; INHIBITORS;
   COFACTOR; CONFORMATION; HELICASE; BINDING; COMPLEX
AB Zika virus (ZIKV) has rapidly emerged as a global public health concern. Viral NS2B-NS3 protease processes viral polyprotein and is essential for the virus replication, making it an attractive antiviral drug target. We report crystal structures at 1.58-angstrom resolution of the unlinked NS2B-NS3 protease from ZIKV as free enzyme and bound to a peptide reversely oriented at the active site. The unlinked NS2B-NS3 protease adopts a closed conformation in which NS2B engages NS3 to form an empty substrate-binding site. A second protease in the same crystal binds to the residues K14K15G16E17 from the neighboring NS3 in reverse orientation, resisting proteolysis. These features of ZIKV NS2B-NS3 protease may accelerate the discovery of structure-based antiviral drugs against ZIKV and related pathogenic flaviviruses.
C1 [Zhang, Zhenzhen; Phoo, Wint Wint; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, Expt Med Bldg 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Zhang, Zhenzhen; Phoo, Wint Wint; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, Expt Med Bldg 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
   [Li, Yan; Loh, Ying Ru; Hung, Alvin W.; Kang, CongBao] ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,Nanos 03-01, Singapore 0301, Singapore.
   [Phoo, Wint Wint] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
RP Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Expt Med Bldg 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, Expt Med Bldg 06-01,59 Nanyang Dr, Singapore 636921, Singapore.; Kang, CB (corresponding author), ASTAR, Ctr Expt Therapeut, 31 Biopolis Way,Nanos 03-01, Singapore 0301, Singapore.
EM cbkang@etc.a-star.edu.sg; luodahai@ntu.edu.sg
RI Kang, Congbao/AAP-7572-2020; Li, Yan/G-4642-2013; Luo, Dahai/J-6022-2012
OI Kang, Congbao/0000-0002-9886-9374; Li, Yan/0000-0003-1963-839X; Luo,
   Dahai/0000-0001-7637-7275
FU Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; National Medical Research
   CouncilMedical Research Council UK (MRC) [CBRG15May045]; A*STAR Joint
   Council OfficeAgency for Science Technology & Research (ASTAR)
   [1431AFG102/1331A028]
FX We thank W. Bin, E. Abbas, C. Liew (Nanyang Technological University),
   and scientists from the Australian Light Source MX beamline and the
   Swiss Light Source X06DA (PXIII) beamline for their help with
   diffraction data collection. We thank S. Liu for technical support for
   fragment screening. We thank A. Matter and T. H. Keller for critical
   reading of this manuscript. The data presented in this manuscript are
   tabulated in the main paper and the supplementary materials. The
   corresponding coordinates and structure factors are available from the
   PDB under accession codes 5GPI for bZiPro and 5H4I for its complex with
   EN300. Assignments of protease in the absence and presence of AcKR have
   been deposited in the Biological Magnetic Resonance Data Bank with
   accession numbers 26928 and 26927, respectively. This work was supported
   by (i) a start-up grant from Lee Kong Chian School of Medicine, Nanyang
   Technological University; (ii) National Medical Research Council grant
   CBRG15May045 to D.L.'s laboratory; and (iii) A*STAR Joint Council Office
   grant 1431AFG102/1331A028 to C.K. The authors declare no competing
   financial interests.
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Lindenbach B.D., 2013, FIELDS VIROLOGY, P712
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 27
TC 65
Z9 72
U1 4
U2 71
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD DEC 23
PY 2016
VL 354
IS 6319
BP 1597
EP 1600
DI 10.1126/science.aai9309
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EF3VZ
UT WOS:000390254300056
PM 27940580
DA 2020-07-08
ER

PT J
AU Souza, BSF
   Sampaio, GLA
   Pereira, CS
   Campos, GS
   Sardi, SI
   Freitas, LAR
   Figueira, CP
   Paredes, BD
   Nonaka, CKV
   Azevedo, CM
   Rocha, VPC
   Bandeira, AC
   Mendez-Otero, R
   dos Santos, RR
   Soares, MBP
AF Souza, Bruno S. F.
   Sampaio, Gabriela L. A.
   Pereira, Ciro S.
   Campos, Gubio S.
   Sardi, Silvia I.
   Freitas, Luiz A. R.
   Figueira, Claudio P.
   Paredes, Bruno D.
   Nonaka, Carolina K. V.
   Azevedo, Carine M.
   Rocha, Vinicius P. C.
   Bandeira, Antonio C.
   Mendez-Otero, Rosalia
   dos Santos, Ricardo Ribeiro
   Soares, Milena B. P.
TI Zika virus infection induces mitosis abnormalities and apoptotic cell
   death of human neural progenitor cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID STEM-CELLS; BRAIN; MICRONESIA; ORGANOIDS; AUTOPHAGY; OUTBREAK; BRAZIL;
   MODEL
AB Zika virus (ZIKV) infection has been associated with severe complications both in the developing and adult nervous system. To investigate the deleterious effects of ZIKV infection, we used human neural progenitor cells (NPC), derived from induced pluripotent stem cells (iPSC). We found that NPC are highly susceptible to ZIKV and the infection results in cell death. ZIKV infection led to a marked reduction in cell proliferation, ultrastructural alterations and induction of autophagy. Induction of apoptosis of Sox2(+) cells was demonstrated by activation of caspases 3/7, 8 and 9, and by ultrastructural and flow cytometry analyses. ZIKV-induced death of Sox2+ cells was prevented by incubation with the pan-caspase inhibitor, Z-VAD-FMK. By confocal microscopy analysis we found an increased number of cells with supernumerary centrosomes. Live imaging showed a significant increase in mitosis abnormalities, including multipolar spindle, chromosome laggards, micronuclei and death of progeny after cell division. FISH analysis for chromosomes 12 and 17 showed increased frequency of aneuploidy, such as monosomy, trisomy and polyploidy. Our study reinforces the link between ZIKV and abnormalities in the developing human brain, including microcephaly.
C1 [Souza, Bruno S. F.; Pereira, Ciro S.; Freitas, Luiz A. R.; Figueira, Claudio P.; Nonaka, Carolina K. V.; Azevedo, Carine M.; Rocha, Vinicius P. C.; Soares, Milena B. P.] Fiocruz MS, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.
   [Souza, Bruno S. F.; Sampaio, Gabriela L. A.; Paredes, Bruno D.; Nonaka, Carolina K. V.; Azevedo, Carine M.; Rocha, Vinicius P. C.; dos Santos, Ricardo Ribeiro; Soares, Milena B. P.] Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, BR-41253190 Salvador, BA, Brazil.
   [Campos, Gubio S.; Sardi, Silvia I.] Univ Fed Bahia, Virol Lab, BR-40110100 Salvador, BA, Brazil.
   [Freitas, Luiz A. R.] Fed Univ Bahia Salvador, Dept Pathol, BR-40110100 Salvador, BA, Brazil.
   [Bandeira, Antonio C.] Hosp Couto Maia, BR-40425060 Salvador, BA, Brazil.
   [Mendez-Otero, Rosalia] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Souza, BSF; Soares, MBP (corresponding author), Fiocruz MS, Goncalo Moniz Inst, BR-40296710 Salvador, BA, Brazil.; Souza, BSF; Soares, MBP (corresponding author), Sao Rafael Hosp, Ctr Biotechnol & Cell Therapy, BR-41253190 Salvador, BA, Brazil.
EM bruno.souza@bahia.fiocruz.br; milena@bahia.fiocruz.br
RI Mendez-Otero, Rosalia/AAL-7551-2020; Freitas, Luis/AAA-1784-2019; sardi,
   silvia ines/P-9349-2016
OI Mendez-Otero, Rosalia/0000-0002-1798-9930; sardi, silvia
   ines/0000-0002-2002-8436; Sampaio, Gabriela/0000-0002-9955-258X
FU Brazilian government through CAPES (Zika FastTrack); FINEPCiencia
   Tecnologia e Inovacao (FINEP); FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); FAPESB;
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX The authors wish to thank Dr. Cecilia Laterza for helpful comments on
   the manuscript. This study was supported by funds from the Brazilian
   government, through CAPES (Zika FastTrack), FINEP, FAPERJ and FAPESB.
   Milena B. P. Soares, Rosalia Mendez-Otero and Ricardo Ribeiro dos Santos
   are recipients of CNPq fellowships.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Chung KM, 2013, BMB REP, V46, P383, DOI 10.5483/BMBRep.2013.46.8.164
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]
   Pan American Health Organization/ World Health Organization, 2016, ZIK EP UPD 17 MARCH
   Salonen A, 2005, CURR TOP MICROBIOL, V285, P139
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 37
TC 71
Z9 71
U1 2
U2 32
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 23
PY 2016
VL 6
AR 39775
DI 10.1038/srep39775
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG0XV
UT WOS:000390756600004
PM 28008958
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cao, B
   Macones, C
   Mysorekar, IU
AF Cao, Bin
   Macones, Colin
   Mysorekar, Indira U.
TI ATG16L1 governs placental infection risk and preterm birth in mice and
   women
SO JCI INSIGHT
LA English
DT Article
ID AUTOPHAGY GENE ATG16L1; ZIKA VIRUS-INFECTION; DEFICIENCY; PREGNANCY;
   FETAL; COLI; INFLAMMATION; EXPRESSION; PROTECTION; BACTERIA
AB The placenta is a barrier against maternal-fetal transmission of pathogens. Placental infections can cause several adverse pregnancy outcomes, including preterm birth (PTB). Yet, we have limited knowledge regarding the mechanisms the placenta uses to control infections. Here, we show that autophagy, a cellular recycling pathway important for host defense against pathogens, and the autophagy gene Atg16L1 play a key role in placental defense and are negatively associated with PTB in pregnant women. First, we demonstrate that placentas from women who delivered preterm exhibit reduced autophagy activity and are associated with higher infection indicators. Second, we identify the cellular location of the autophagy activity as being in syncytial trophoblasts. Third, we demonstrate that higher levels of autophagy and ATG16L1 in human trophoblasts were associated with increased resistance to infection. Accordingly, loss of autophagy or ATG16L1 impaired trophoblast antibacterial defenses. Fourth, we show that Atg16l1-deficient mice gave birth prematurely upon an inflammatory stimulus and their placentas were significantly less able to withstand infection. Finally, global induction of autophagy in both mouse placentas and human trophoblasts increased infection resistance. Our study has significant implications for understanding the etiology of placental infections and prematurity and developing strategies to mitigate placental infection-induced PTB.
C1 [Cao, Bin; Macones, Colin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave, St Louis, MO 63110 USA.
   [Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.
RP Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 South Euclid Ave, St Louis, MO 63110 USA.; Mysorekar, IU (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, 660 South Euclid Ave, St Louis, MO 63110 USA.
EM indira@wustl.edu
FU March of DimesMarch of Dimes; Burroughs Wellcome FundBurroughs Wellcome
   Fund
FX We thank Herbert "Skip" Virgin for kindly providing the
   Atg16l1<SUP>HM</SUP> mice; George Macones, Jason Mills, and Deborah
   Frank for comments on the manuscript; and the Women and Infants' Health
   Specimen Consortium at Washington University for sample collection. This
   work was supported by a Preventing Prematurity Initiative grant from the
   Burroughs Wellcome Fund and a Prematurity Research Initiative
   Investigator award from the March of Dimes (to IUM).
CR Agrawal V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09410
   Bauckman KA, 2016, AUTOPHAGY, V12, P850, DOI 10.1080/15548627.2016.1160176
   Bauckman KA, 2015, METHODS, V75, P120, DOI 10.1016/j.ymeth.2014.12.005
   Bildirici I, 2012, PLACENTA, V33, P591, DOI 10.1016/j.placenta.2012.04.011
   Broz P, 2011, IMMUNOL REV, V243, P174, DOI 10.1111/j.1600-065X.2011.01041.x
   Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416
   Campbell MK, 2005, J CLIN EPIDEMIOL, V58, P304, DOI 10.1016/j.jclinepi.2004.06.015
   Cao B, 2014, PLACENTA, V35, P139, DOI 10.1016/j.placenta.2013.12.007
   Carcopino X, 2009, ANN NY ACAD SCI, V1166, P79, DOI 10.1111/j.1749-6632.2009.04519.x
   Cemma M, 2012, CURR BIOL, V22, pR540, DOI 10.1016/j.cub.2012.06.001
   Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Doulaveris G, 2013, J PERINAT MED, V41, P411, DOI 10.1515/jpm-2012-0278
   Drewlo Sascha, 2008, V475, P363, DOI 10.1007/978-1-59745-250-2_21
   Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009
   Gawriluk TR, 2014, P NATL ACAD SCI USA, V111, pE4194, DOI 10.1073/pnas.1409323111
   Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108
   Hung TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083475
   Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957
   Huppertz B, 2008, J CLIN PATHOL, V61, P1296, DOI 10.1136/jcp.2008.055277
   Khan MY, 2001, CLIN INFECT DIS, V32, P1172, DOI 10.1086/319758
   KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567
   Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496
   Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013
   Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159
   Pontillo A, 2013, REPROD SCI, V20, P563, DOI 10.1177/1933719112459240
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Stout MJ, 2015, J MATERN-FETAL NEO M, V28, P454, DOI 10.3109/14767058.2014.921152
   Symington JW, 2015, MUCOSAL IMMUNOL, V8, P1388, DOI 10.1038/mi.2015.7
   Wang CH, 2012, P NATL ACAD SCI USA, V109, P11008, DOI 10.1073/pnas.1203952109
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
   Zeldovich VB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002804
   Zeldovich VB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002005
NR 39
TC 21
Z9 23
U1 2
U2 19
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD DEC 22
PY 2016
VL 1
IS 21
AR e86654
DI 10.1172/jci.insight.86654
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA EJ1IL
UT WOS:000392963700001
PM 28018968
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Butler, D
AF Butler, Declan
TI ZIKA DETECTIVE
SO NATURE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD DEC 22
PY 2016
VL 540
IS 7634
BP 511
EP 511
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EG6XV
UT WOS:000391190500023
DA 2020-07-08
ER

PT J
AU Langerak, T
   Yang, H
   Baptista, M
   Doornekamp, L
   Kerkman, T
   Codrington, J
   Roosblad, J
   Vreden, SGS
   De Bruin, E
   Mogling, R
   Jacobs, BC
   Pas, SD
   GeurtsvanKessel, CH
   Reusken, CBEM
   Koopmans, MP
   Van Gorp, ECM
   Alberga, H
AF Langerak, Thomas
   Yang, Harvey
   Baptista, Mark
   Doornekamp, Laura
   Kerkman, Tessa
   Codrington, John
   Roosblad, Jimmy
   Vreden, Stephen G. S.
   De Bruin, Erwin
   Mogling, Ramona
   Jacobs, Bart C.
   Pas, Suzan D.
   GeurtsvanKessel, Corine H.
   Reusken, Chantal B. E. M.
   Koopmans, Marion P.
   Van Gorp, Eric C. M.
   Alberga, Henk
TI Zika Virus Infection and Guillain-Barre Syndrome in Three Patients from
   Suriname
SO FRONTIERS IN NEUROLOGY
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome; Flavivirus infections; acute
   flaccid paralysis; emerging infectious disease
ID VALIDATION
AB We present three patients from Suriname who were diagnosed with Guillain-Barre syndrome (GBS) during the Zika virus (ZIKV) outbreak in this country. One patient had a positive ZIKV urine real-time RT-PCR (qRT-PCR) result. The other two patients had a negative ZIKV urine qRT-PCR but a positive virus neutralization test and presence of IgG antibodies against ZIKV in the serum. Considering the evidence of a past ZIKV infection and absence of evidence for recent infections with the most common preceding infections of GBS, it is very likely that these GBS cases were triggered by ZIKV.
C1 [Langerak, Thomas; Doornekamp, Laura; Kerkman, Tessa; De Bruin, Erwin; Mogling, Ramona; Pas, Suzan D.; GeurtsvanKessel, Corine H.; Reusken, Chantal B. E. M.; Koopmans, Marion P.; Van Gorp, Eric C. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Yang, Harvey; Alberga, Henk] Acad Hosp Paramaribo, Dept Neurol, Paramaribo, Suriname.
   [Baptista, Mark] St Vincentius Hosp, Dept Neurol, Paramaribo, Suriname.
   [Codrington, John; Roosblad, Jimmy] Acad Hosp Paramaribo, Diagnost Lab, Paramaribo, Suriname.
   [Vreden, Stephen G. S.] Acad Hosp Paramaribo, Dept Internal Med, Paramaribo, Suriname.
   [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
RP Langerak, T (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
EM thomas.langerak@erasmusmc.nl
RI Pas, Suzan D/M-9863-2013; Koopmans, Marion/Y-9170-2019
OI Pas, Suzan D/0000-0003-1943-1217; Koopmans, Marion/0000-0002-5204-2312
CR Bensa S, 2000, EUR J NEUROL, V7, P423, DOI 10.1046/j.1468-1331.2000.00096.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   ECDC, 2016, RAP RISK ASS ZIK VIR
   Euroimmun, 2016, EUR TEST SYST DIAGN
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Kuijf ML, 2005, J NEUROL SCI, V239, P37, DOI 10.1016/j.jns.2005.07.009
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Preston D. C., 2013, ELECTROMYOGRAPHY NEU
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   van Doorn PA, 2016, BRAIN, V139, P1622, DOI 10.1093/brain/aww078
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 20
TC 11
Z9 13
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD DEC 22
PY 2016
VL 7
AR 233
DI 10.3389/fneur.2016.00233
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EF3ZH
UT WOS:000390263400001
PM 28066317
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stephen, P
   Baz, M
   Boivin, G
   Lin, SX
AF Stephen, Preyesh
   Baz, Mariana
   Boivin, Guy
   Lin, Sheng-Xiang
TI Structural Insight into NS5 of Zika Virus Leading to the Discovery of
   MTase Inhibitors
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID IDENTIFICATION; POLYMERASE; INFECTION; BRAZIL
AB Zika virus (ZIKV) is an emerging mosquito-borne virus recently linked to intrauterine growth restriction including abnormal fetal brain development. The recent outbreak of ZIKV reached pandemic level resulting in an alarming public health emergency. At present, there is limited understanding of the infectious mechanism and no approved therapy. Nonstructural protein 5 is essential for capping and replication of viral RNA and comprises a methyltransferase (MTase) and RNA dependent RNA polymerase domain. Here we used molecular modeling to obtain the structure of ZIKV MTase and molecular docking to identify the additional hydrophobic region uniquely conserved in flavivirus MTase that can be used as a druggable site. Subsequently, a virtual screening with a library of 28 341 compounds identified 10 best hits showing decisive contacts with the MTase. In vitro efficacy analysis of these compounds against ZIKV, by plaque reduction assay, has confirmed four of the top scored ligands (Life Chemicals ID: F3043-0013, F0922-0796, F1609-0442, and F1750-0048) having EC50 (50% effective concentration) values of 4.8 +/- 2.3, 12.5 +/- 7.4, 17.5 +/- 8.4, and 17.6 +/- 3.1 mu M respectively, identifying lead compounds for anti-ZIKV drug development.
C1 [Stephen, Preyesh; Lin, Sheng-Xiang] Univ Laval, Axe Mol Endocrinol & Nephrol, CHU Res Ctr, Quebec City, PQ G1V 4G2, Canada.
   [Stephen, Preyesh; Lin, Sheng-Xiang] Univ Laval, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada.
   [Baz, Mariana; Boivin, Guy] CHU Res Ctr, Axe Infect Dis, Quebec City, PQ G1V 4G2, Canada.
   [Baz, Mariana; Boivin, Guy] Univ Laval, Quebec City, PQ G1V 4G2, Canada.
RP Lin, SX (corresponding author), Univ Laval, Axe Mol Endocrinol & Nephrol, CHU Res Ctr, Quebec City, PQ G1V 4G2, Canada.; Lin, SX (corresponding author), Univ Laval, Dept Mol Med, Quebec City, PQ G1V 4G2, Canada.
EM sxlin@crchul.ulaval.ca
RI Stephen, Preyesh/L-1010-2019
OI Stephen, Preyesh/0000-0003-2889-2701; Lin,
   Sheng-Xiang/0000-0001-9149-375X
FU Quebec CHU Foundation [2759]; CIHR FoundationCanadian Institutes of
   Health Research (CIHR) [148361]
FX S.-X.L. acknowledges financial support from Quebec CHU Foundation (No.
   2759) and CIHR Foundation. G.B. acknowledges financial support from CIHR
   Foundation (No. 148361).
CR Baez CF, 2017, MOL BIOSYST, V13, P122, DOI 10.1039/c6mb00645k
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen NM, 2013, J INFECT DIS, V207, P1442, DOI 10.1093/infdis/jis470
   Nulf CJ, 2004, NUCLEIC ACIDS RES, V32, P3792, DOI 10.1093/nar/gkh706
   Smith TM, 2015, J BIOMOL SCREEN, V20, P153, DOI 10.1177/1087057114551141
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Xu HT, 2016, ANTIMICROB AGENTS CH, V60, P600, DOI 10.1128/AAC.02203-15
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhao YQ, 2015, J VIROL, V89, P10717, DOI 10.1128/JVI.01239-15
NR 21
TC 36
Z9 36
U1 2
U2 32
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 21
PY 2016
VL 138
IS 50
BP 16212
EP 16215
DI 10.1021/jacs.6b10399
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA EG0NM
UT WOS:000390729500008
PM 27998085
DA 2020-07-08
ER

PT J
AU Lee, D
   Shin, Y
   Chung, S
   Hwang, KS
   Yoon, DS
   Lee, JH
AF Lee, Dohwan
   Shin, Yong
   Chung, Seok
   Hwang, Kyo Seon
   Yoon, Dae Sung
   Lee, Jeong Hoon
TI Simple and Highly Sensitive Molecular Diagnosis of Zika Virus by Lateral
   Flow Assays
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID MEDIATED ISOTHERMAL AMPLIFICATION; PCR; INFECTION; BRAZIL
AB We have developed a simple, user-friendly, and highly sensitive Zika virus (ZIKV) detection method by incorporating optimized reverse transcription loop-mediated isothermal amplification (RT-LAMP) and a lateral flow assay (LFA). The optimized RT-LAMP reaction was carried out using Bst 3.0 polymerase, which has robust and fast isothermal amplification performance even in the presence of high concentrations of inhibitors; this permitted the amplification of ZIKV RNA in pure water and human whole blood. In addition, the strong reverse transcription activity of Bst 3.0 polymerase enabled specific ZIKV RNA amplification without extra addition of reverse transcriptase. The RT-LAMP condition was optimized by adjusting the Mg2+ and dNTP mix concentration to extirpate nontarget amplification, which is caused by nonspecific primer dimers amplification. After 30 min of RT-LAMP reaction, the resultant amplicons were simply and rapidly analyzed by the LFA test in less than 5 min. The optimized RT-LAMP combined with the LFA allowed specific ZIKV RNA detection down to the single copy level within 35 min.
C1 [Lee, Dohwan; Lee, Jeong Hoon] Kwangwoon Univ, Dept Elect Engn, 447-1 Wolgye, Seoul 01897, South Korea.
   [Shin, Yong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Ulsan, South Korea.
   [Shin, Yong] Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, 88 Olympicro 43Gil, Seoul, South Korea.
   [Chung, Seok] Korea Univ, Sch Mech Engn, Seoul 136703, South Korea.
   [Yoon, Dae Sung] Korea Univ, Sch Biomed Engn, Seoul 136703, South Korea.
   [Hwang, Kyo Seon] Korea Inst Sci & Technol, Ctr BioMicrosyst, Seoul 136791, South Korea.
RP Lee, JH (corresponding author), Kwangwoon Univ, Dept Elect Engn, 447-1 Wolgye, Seoul 01897, South Korea.; Yoon, DS (corresponding author), Korea Univ, Sch Biomed Engn, Seoul 136703, South Korea.
EM dsyoon@korea.ac.kr; jhlee@kw.ac.kr
RI Lee, Jeong Hoon/J-5534-2019; Hwang, Kyo Seon/AAI-1018-2020
OI Lee, Jeong Hoon/0000-0001-7344-6060; 
FU National Research Foundation of Korea - Korean Government (MEST)Ministry
   of Education, Science and Technology, Republic of KoreaNational Research
   Foundation of KoreaKorean Government [NRF-2015R1D1A1A01059806,
   NRF-2015R1A5A7037674]; Korea Health Technology R&D Project through the
   Korea Health Industry Development Institute (KHIDI) - Ministry of Health
   and Welfare, Republic of Korea [HI16C0272]; Kwangwoon University
FX This work was supported by the National Research Foundation of Korea
   Grant funded by the Korean Government (MEST; NRF-2015R1D1A1A01059806 and
   NRF-2015R1A5A7037674) and by a Grant of the Korea Health Technology R&D
   Project through the Korea Health Industry Development Institute (KHIDI),
   funded by the Ministry of Health and Welfare, Republic of Korea (Grant
   No.: HI16C0272). J.H.L. was also supported by a Research Grant from
   Kwangwoon University in 2016.
CR Alaeddini R, 2012, FORENSIC SCI INT-GEN, V6, P297, DOI 10.1016/j.fsigen.2011.08.006
   [Anonymous], 2005, WHO STAT 1 M INT HLT
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang CC, 2012, SENSORS-BASEL, V12, P8319, DOI 10.3390/s120608319
   COMPTON J, 1991, NATURE, V350, P91, DOI 10.1038/350091a0
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Jung JH, 2015, ANAL CHIM ACTA, V853, P541, DOI 10.1016/j.aca.2014.10.020
   KHAN G, 1991, J CLIN PATHOL, V44, P360, DOI 10.1136/jcp.44.5.360
   Lee D, 2016, BIOSENS BIOELECTRON, V79, P273, DOI 10.1016/j.bios.2015.12.044
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu J., 2013, BIOMED RES INT, V2013, P1, DOI DOI 10.1109/BSN.2013.6575474
   Nie K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052486
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Nyan DC, 2014, CLIN INFECT DIS, V59, P16, DOI 10.1093/cid/ciu210
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Qui XH, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-318
   Roux Kenneth H, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip66
   Safavieh M, 2016, ACS BIOMATER SCI ENG, V2, P278, DOI 10.1021/acsbiomaterials.5b00449
   Sajid M, 2015, J SAUDI CHEM SOC, V19, P689, DOI 10.1016/j.jscs.2014.09.001
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Senarath KD, 2014, J TUBERCULOSIS RES, V2, P168
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Su YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23994
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vincent M, 2004, EMBO REP, V5, P795, DOI 10.1038/sj.embor.7400200
   Wang DG, 2015, MOLECULES, V20, P6048, DOI 10.3390/molecules20046048
   Waterfall CM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e119
   Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428
NR 37
TC 32
Z9 32
U1 9
U2 58
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD DEC 20
PY 2016
VL 88
IS 24
BP 12272
EP 12278
DI 10.1021/acs.analchem.6b03460
PG 7
WC Chemistry, Analytical
SC Chemistry
GA EF8ZR
UT WOS:000390621000043
PM 28193014
DA 2020-07-08
ER

PT J
AU Tang, WW
   Young, MP
   Mamidi, A
   Regla-Nava, JA
   Kim, K
   Shresta, S
AF Tang, William Weihao
   Young, Matthew Perry
   Mamidi, Anila
   Regla-Nava, Jose Angel
   Kim, Kenneth
   Shresta, Sujan
TI A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral
   Replication
SO CELL REPORTS
LA English
DT Article
ID FEMALE GENITAL-TRACT; UNITED-STATES; SEMEN; INFECTION; MACROPHAGES;
   PERSISTENCE; LOAD; MICE
AB Case reports of Zika virus (ZIKV) sexual transmission and genital persistence are mounting. Venereal transmission and genital persistence threaten public health within and beyond the range of ZIKV's mosquito vectors. In this study, we administered ZIKV into the vaginas of AG129 mice and LysMCre(+) IFNAR(fl/fl) C57BL/6 mice after hormonal treatments. Mice infected during estrus-like phase were resistant to vaginal infection. In contrast, when infected during diestrus-like phase, AG129 mice succumbed to infection, whereas LysMCre(+) IFNAR(fl/fl) mice experienced transient illness. Patency of transgenital transmission (TGT) in diestrus-like mice was demonstrated by detection of viremia and ZIKV replication in spleen and brain, and viral RNA persisted in vaginal washes as late as 10 days post-infection. In these lethal and sublethal mouse models, this study indicates that intravaginal deposition of ZIKV can cause TGT, hormonal changes in the female reproductive tract (FRT) influence transmission, and ZIKV replication persists in the FRT for several days.
C1 [Tang, William Weihao; Young, Matthew Perry; Mamidi, Anila; Regla-Nava, Jose Angel; Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.
RP Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.
EM sujan@lji.org
OI Regla-Nava, Jose Angel/0000-0002-5438-1369
FU NIAID/NIH grant [1R01 AI116813]; La Jolla Institute for Allergy
   Immunology
FX We thank Anh-Thy Huynh for assistance with immunohistochemistry, Dr.
   Jinsheng Wen and Karla Viramontes for assistance with harvesting of
   samples, and Chris Lena for assistance with reagents. We also thank
   Genetex for antibody samples. This research was funded by NIAID/NIH
   grant 1R01 AI116813 and the La Jolla Institute for Allergy & Immunology
   institutional support.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bielanski A, 2013, THERIOGENOLOGY, V80, P451, DOI 10.1016/j.theriogenology.2013.04.028
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Braun U, 2015, RES VET SCI, V100, P297, DOI 10.1016/j.rvsc.2015.03.027
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Burke SA, 2004, IMMUNOL CELL BIOL, V82, P174, DOI 10.1046/j.0818-9641.2004.01239.x
   Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538
   Caligioni Claudia S, 2009, Curr Protoc Neurosci, VAppendix 4, p4I, DOI 10.1002/0471142301.nsa04is48
   Chen JC, 2016, INT J INFECT DIS, V51, P139, DOI 10.1016/j.ijid.2016.07.015
   Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daniels Kimberly, 2015, Natl Health Stat Report, P1
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Floegel G, 2000, VET MICROBIOL, V77, P109, DOI 10.1016/S0378-1135(00)00267-4
   Fourcade C, 2016, J CLIN VIROL, V82, P1, DOI 10.1016/j.jcv.2016.06.011
   Freour T., 2016, EUROSURVEILLANCE, V21
   Habu A, 1977, Uirusu, V27, P21
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4298
   Morrison CS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001778
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Tavernise S., 2016, NY TIMES, pA17
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 39
TC 74
Z9 74
U1 2
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD DEC 20
PY 2016
VL 17
IS 12
BP 3091
EP 3098
DI 10.1016/j.celrep.2016.11.070
PG 8
WC Cell Biology
SC Cell Biology
GA EG2SY
UT WOS:000390895600001
PM 28009279
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Douris, V
   Steinbach, D
   Panteleri, R
   Livadaras, I
   Pickett, JA
   Van Leeuwen, T
   Nauen, R
   Vontas, J
AF Douris, Vassilis
   Steinbach, Denise
   Panteleri, Rafaela
   Livadaras, Ioannis
   Pickett, John Anthony
   Van Leeuwen, Thomas
   Nauen, Ralf
   Vontas, John
TI Resistance mutation conserved between insects and mites unravels the
   benzoylurea insecticide mode of action on chitin biosynthesis
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE insecticide resistance; benzoylureas; CRISPR/Cas9; resistance
   management; mosquito control
ID DIAMIDE INSECTICIDES; DIAMONDBACK MOTH; DROSOPHILA-MELANOGASTER;
   RYANODINE RECEPTOR; FUNCTIONAL-CHARACTERIZATION; SYNTHESIS INHIBITORS;
   TETRANYCHUS-URTICAE; PLUTELLA-XYLOSTELLA; MALARIA CONTROL; TARGET-SITE
AB Despite the major role of chitin biosynthesis inhibitors such as benzoylureas (BPUs) in the control of pests in agricultural and public health for almost four decades, their molecular mode of action (MoA) has in most cases remained elusive. BPUs interfere with chitin biosynthesis and were thought to interact with sulfonylurea receptors that mediate chitin vesicle transport. Here, we uncover a mutation (I1042M) in the chitin synthase 1 (CHS1) gene of BPU-resistant Plutella xylostella at the same position as the I1017F mutation reported in spider mites that confers etoxazole resistance. Using a genome-editing CRISPR/Cas9 approach coupled with homology-directed repair (HDR) in Drosophila melanogaster, we introduced both substitutions (I1056M/F) in the corresponding fly CHS1 gene (kkv). Homozygous lines bearing either of these mutations were highly resistant to etoxazole and all tested BPUs, as well as buprofezin-an important hemipteran chitin biosynthesis inhibitor. This provides compelling evidence that BPUs, etoxazole, and buprofezin share in fact the same molecular MoA and directly interact with CHS. This finding has immediate effects on resistance management strategies of major agricultural pests but also on mosquito vectors of serious human diseases such as Dengue and Zika, as diflubenzuron, the standard BPU, is one of the few effective larvicides in use. The study elaborates on how genome editing can directly, rapidly, and convincingly elucidate the MoA of bioactive molecules, especially when target sites are complex and hard to reconstitute in vitro.
C1 [Douris, Vassilis; Panteleri, Rafaela; Livadaras, Ioannis; Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, GR-70013 Iraklion, Crete, Greece.
   [Douris, Vassilis; Panteleri, Rafaela] Univ Crete, Dept Biol, Lab Mol Entomol, GR-70013 Iraklion, Crete, Greece.
   [Steinbach, Denise; Nauen, Ralf] Bayer CropSci AG, R&D Pest Control Biol, D-40789 Mannheim, Germany.
   [Steinbach, Denise] Martin Luther Univ Halle Wittenberg, Dept Biol, Dev Biol, D-06120 Halle, Germany.
   [Pickett, John Anthony] Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England.
   [Van Leeuwen, Thomas] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1098 XH Amsterdam, Netherlands.
   [Van Leeuwen, Thomas] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, B-9000 Ghent, Belgium.
   [Vontas, John] Agr Univ Athens, Dept Crop Sci, Lab Pesticide Sci, GR-11855 Athens, Greece.
RP Vontas, J (corresponding author), Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, GR-70013 Iraklion, Crete, Greece.; Nauen, R (corresponding author), Bayer CropSci AG, R&D Pest Control Biol, D-40789 Mannheim, Germany.; Pickett, JA (corresponding author), Rothamsted Res, Dept Biol Chem & Crop Protect, Harpenden AL5 2JQ, Herts, England.; Vontas, J (corresponding author), Agr Univ Athens, Dept Crop Sci, Lab Pesticide Sci, GR-11855 Athens, Greece.
EM john.pickett@rothamsted.ac.uk; ralf.nauen@bayer.com;
   vontas@imbb.forth.gr
RI Douris, Vassilis/AAG-9423-2020; Nauen, Ralf/AAG-5840-2019; Steinbach,
   Denise/I-9159-2019
OI Douris, Vassilis/0000-0003-4608-7482; Nauen, Ralf/0000-0002-7525-8589;
   Van Leeuwen, Thomas/0000-0003-4651-830X; Vontas,
   John/0000-0002-8704-2574
FU Fund for Scientific Research Flanders (FWO)FWO [G009312N, G053815N];
   Biotechnology and Biological Sciences Research Council of the United
   KingdomBiotechnology and Biological Sciences Research Council (BBSRC);
   Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BBS/E/C/00004944,
   BBS/E/C/00005194]
FX We thank Athanasia Zampouka (University of Crete) for her help with
   Drosophila bioassays and cloning, Dr. Maria Riga (University of Crete)
   for valuable discussions regarding Drosophila life table experiments,
   and Prof. Christos Delidakis (Institute of Molecular Biology and
   Biotechnology, Foundation for Research and Technology and University of
   Crete) for providing fly stocks and very helpful advice. T.V.L. is
   supported by Fund for Scientific Research Flanders (FWO) Grants G009312N
   and G053815N. Rothamsted Research receives grant-aided support from the
   Biotechnology and Biological Sciences Research Council of the United
   Kingdom.
CR Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   COHEN E, 1980, PESTIC BIOCHEM PHYS, V13, P121, DOI 10.1016/0048-3575(80)90063-2
   Cohen E, 2010, ADV INSECT PHYSIOL, V38, P5, DOI 10.1016/S0065-2806(10)38005-2
   DECOCK A, 1991, TISSUE CELL, V23, P755, DOI 10.1016/0040-8166(91)90028-R
   Demaeght P, 2014, INSECT BIOCHEM MOLEC, V51, P52, DOI 10.1016/j.ibmb.2014.05.004
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Food and Agriculture Organization of the United Nations, 2010, FEED WORLD 2050
   Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002
   Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713
   Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710
   Heckel DG, 2003, ANNU REV ENTOMOL, V48, P235, DOI 10.1146/annurev.ento.48.091801.112624
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Matsumura F, 2010, PESTIC BIOCHEM PHYS, V97, P133, DOI 10.1016/j.pestbp.2009.10.001
   Maue L, 2009, INSECT BIOCHEM MOLEC, V39, P654, DOI 10.1016/j.ibmb.2009.06.005
   Merzendorfer H, 2013, INSECT SCI, V20, P121, DOI 10.1111/j.1744-7917.2012.01535.x
   Meyer F, 2013, PEST MANAG SCI, V69, P1136, DOI 10.1002/ps.3476
   Nauen R, 2006, PEST MANAG SCI, V62, P379, DOI 10.1002/ps.1192
   Nauen R, 2015, PESTIC BIOCHEM PHYS, V121, P3, DOI 10.1016/j.pestbp.2014.12.023
   O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925
   Organization W. H, 2016, WORLD MAL REP 2015
   Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111
   Ren XJ, 2014, CELL REP, V9, P1151, DOI 10.1016/j.celrep.2014.09.044
   Riga M, 2015, INSECT BIOCHEM MOLEC, V65, P91, DOI 10.1016/j.ibmb.2015.09.004
   Ruiz-Herrera J., 2003, Current Drug Targets - Infectious Disorders, V3, P77, DOI 10.2174/1568005033342064
   Somers J, 2015, INSECT BIOCHEM MOLEC, V64, P116, DOI 10.1016/j.ibmb.2015.01.018
   Sparks TC, 2015, PESTIC BIOCHEM PHYS, V121, P122, DOI 10.1016/j.pestbp.2014.11.014
   Steinbach D, 2015, INSECT BIOCHEM MOLEC, V63, P14, DOI 10.1016/j.ibmb.2015.05.001
   STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325
   Sun RF, 2015, J AGR FOOD CHEM, V63, P6847, DOI 10.1021/acs.jafc.5b02460
   TALEKAR NS, 1993, ANNU REV ENTOMOL, V38, P275, DOI 10.1146/annurev.en.38.010193.001423
   Teixeira LA, 2013, PESTIC BIOCHEM PHYS, V106, P76, DOI 10.1016/j.pestbp.2013.01.010
   Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001
   Troczka BJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14680
   UCHIDA M, 1985, AGR BIOL CHEM TOKYO, V49, P1233, DOI 10.1080/00021369.1985.10866885
   Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109
   Zhang D, 1999, CURR PHARM DESIGN, V5, P73
   Zimmer CT, 2016, INSECT BIOCHEM MOLEC, V73, P62, DOI 10.1016/j.ibmb.2016.04.007
NR 40
TC 50
Z9 52
U1 4
U2 63
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 20
PY 2016
VL 113
IS 51
BP 14692
EP 14697
DI 10.1073/pnas.1618258113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EF0VR
UT WOS:000390044900055
PM 27930336
OA Bronze, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Rojek, AM
   Horby, PW
AF Rojek, Amanda M.
   Horby, Peter W.
TI Modernising epidemic science: enabling patient-centred research during
   epidemics
SO BMC MEDICINE
LA English
DT Article
DE Epidemic; Pandemic; Outbreak; Clinical research; Clinical trial; Ebola;
   Zika
ID CRITICALLY-ILL PATIENTS; 2009 INFLUENZA A(H1N1); RESPIRATORY SYNDROME;
   INFECTION; METAANALYSIS; FEASIBILITY; OSELTAMIVIR; MORTALITY; CHILDREN;
   ADULTS
AB Background: Emerging and epidemic infectious disease outbreaks are a significant public health problem and global health security threat. As an outbreak begins, epidemiological investigations and traditional public health responses are generally mounted very quickly. However, patient-centred research is usually not prioritised when planning and enacting the response. Instead, the clinical research response occurs subsequent to and separate from the public health response, and is inadequate for evidence-based decision-making at the bedside or in the offices of public health policymakers.
   Discussion: The deficiencies of the clinical research response to severe acute respiratory syndrome, pandemic influenza, Middle East respiratory syndrome coronavirus and Ebola virus demonstrate that current research models do not adequately inform and improve the quality of clinical care or public health response. Three suggestions for improvements are made. First, integrate the data and sample collection needs for clinical and public health decision-making within a unified framework, combined with a risk-based, rather than a discipline-based, approach to ethical review and consent. Second, develop clinical study methods and tools that are specifically designed to meet the epidemiological and contextual challenges of emerging and epidemic infectious diseases. Third, invest in investigator-led clinical research networks that are primed and incentivised to respond to outbreak infections, and which can call on the support and resources of a central centre of excellence.
   Conclusions: It is crucial that the field of epidemic science matures to place patients at the heart of the response. This can only be achieved when patient-centred research is integrated in the outbreak response from day one and practical steps are taken to reduce the barriers to the generation of reliable and useful evidence.
C1 [Rojek, Amanda M.; Horby, Peter W.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Old Rd Campus,Roosevelt Dr, Oxford OX3 7FZ, England.
   [Horby, Peter W.] Univ Oxford, Int Severe Acute Resp & Emerging Infect Consortiu, Oxford, England.
RP Horby, PW (corresponding author), Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Old Rd Campus,Roosevelt Dr, Oxford OX3 7FZ, England.; Horby, PW (corresponding author), Univ Oxford, Int Severe Acute Resp & Emerging Infect Consortiu, Oxford, England.
EM peter.horby@ndm.ox.ac.uk
OI Horby, Peter/0000-0002-9822-1586; Rojek, Amanda/0000-0002-3948-0756
FU Wellcome Trust of Great BritainWellcome Trust [107834/Z/15/Z,
   106491/Z/14/Z]; EU FP7 project PREPARE [602525]; Medical Research
   Council UKMedical Research Council UK (MRC) [MC_PC_15001]; Bill and
   Melinda Gates FoundationGates Foundation [OPP1116588]; Rhodes
   Scholarship
FX This work was supported by the Wellcome Trust of Great Britain (grant
   numbers 107834/Z/15/Z and106491/Z/14/Z), EU FP7 project PREPARE
   (602525), Medical Research Council UK (MC_PC_15001), and the Bill and
   Melinda Gates Foundation (OPP1116588). AR is funded by a Rhodes
   Scholarship.
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P133
   [Anonymous], 2015, ETH EP EM DIS RES SU
   Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9
   Arabi YM, 2016, EMERG INFECT DIS, V22, P1554, DOI 10.3201/eid2209.151164
   Arabi YM, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0198-x
   Arabi YM, 2016, J INFECT PUBLIC HEAL, V9, P213, DOI 10.1016/j.jiph.2016.03.004
   Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486
   Bausch DG, 2007, J INFECT DIS, V196, pS136, DOI 10.1086/520542
   Carson SS, 2015, AM J RESP CRIT CARE, V191, P728, DOI 10.1164/rccm.201412-2272ED
   Centers for Disease Control and Prevention, 2014, CAS DEF EB VIR DES E
   Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB HLTH S
   Cooper B, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001815
   Davies GE, 2011, J TRAUMA, V70, pE75, DOI 10.1097/TA.0b013e3181f6f72f
   Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1
   Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536
   Dunning J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162199
   Dunning J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001997
   Dunning J, 2014, LANCET INFECT DIS, V14, P1259, DOI 10.1016/S1473-3099(14)70821-7
   Dunning JW, 2014, LANCET INFECT DIS, V14, P8, DOI 10.1016/S1473-3099(13)70327-X
   Dye C, 2015, NEW ENGL J MED, V372, P189, DOI 10.1056/NEJMc1413884
   Fischer A, 2005, PLOS MED, V2, P845, DOI 10.1371/journal.pmed.0020243
   Fleming DM, 1999, EUR J EPIDEMIOL, V15, P467, DOI 10.1023/A:1007525402861
   Gobat NH, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1110-6
   Henao-Restrepo AM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3740
   Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545
   Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496
   Langan NR, 2014, JAMA SURG, V149, P904, DOI 10.1001/jamasurg.2014.940
   Leong HN, 2004, TROP MED INT HEALTH, V9, P923, DOI 10.1111/j.1365-3156.2004.01281.x
   Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Publich Health England, 2015, TREATM MERS COV INF
   Senga M, 2017, J INFECT PUBLIC HEAL, V10, P191, DOI 10.1016/j.jiph.2016.04.008
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
   Stiell IG, 2007, NEW ENGL J MED, V356, P2156, DOI 10.1056/NEJMoa060334
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812
   Watson R, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d652
   Wertheim HFL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000231
   WHO, 2016, MIDDL E RESP SYNDR C
   WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992
   Wong JY, 2015, AM J EPIDEMIOL, V182, P294, DOI 10.1093/aje/kwv054
   World Health Organization, 2014, CAS DEF REC EB MARB
   World Health Organization, 2016, EM DIS SURV RESP AV
   Zumla A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0686-3
NR 46
TC 13
Z9 13
U1 2
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD DEC 19
PY 2016
VL 14
AR 212
DI 10.1186/s12916-016-0760-x
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG5FV
UT WOS:000391069900001
PM 27989237
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Best, SM
AF Best, Sonja M.
TI Flaviviruses
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID ZIKA VIRUS
C1 [Best, Sonja M.] NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
RP Best, SM (corresponding author), NIAID, Virol Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.
EM sbest@niaid.nih.gov
CR Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tabachnick W. J., 2016, ANN REV VIROL
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 9
TC 4
Z9 4
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD DEC 19
PY 2016
VL 26
IS 24
BP R1258
EP R1260
DI 10.1016/j.cub.2016.09.029
PG 4
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA EF9RB
UT WOS:000390666200004
PM 27997831
OA Bronze
DA 2020-07-08
ER

PT J
AU Atieh, T
   Baronti, C
   de Lamballerie, X
   Nougairede, A
AF Atieh, Therese
   Baronti, Cecile
   de Lamballerie, Xavier
   Nougairede, Antoine
TI Simple reverse genetics systems for Asian and African Zika viruses
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SEXUAL TRANSMISSION; MICRONESIA; DENGUE; BRAZIL
AB Zika virus (ZIKV), a typical example of a re-emerging pathogen, recently caused large outbreaks in Pacific islands and the Americas, associated with congenital diseases and neurological complications. Deciphering the natural history, ecology and pathophysiology of this mosquito-borne pathogen requires effective reverse genetics tools. In the current study, using the bacterium-free 'Infectious Subgenomic Amplicons' (ISA) method, we generated and made available to the scientific community via the non-profit European Virus Archive collection, two simple and performing reverse genetics systems for ZIKV. One is based on an Asian ZIKV strain belonging to the outbreak lineage (French Polynesia 2013). The second was designed from the sequence of a low-passaged ZIKV African strain (Dakar 1984). Using the ISA procedure, we derived wild-type and a variety of specifically engineered ZIKVs in days (intra-and inter-lineage chimeras). Since they are based on low-passaged ZIKV strains, these engineered viruses provide ideal tools to study the effect of genetic changes observed in different evolutionary time-scales of ZIKV as well as pathophysiology of ZIKV infections.
C1 [Atieh, Therese; Baronti, Cecile; de Lamballerie, Xavier; Nougairede, Antoine] EPV Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, Inserm 1207,EHESP, F-13385 Marseille, France.
   [de Lamballerie, Xavier; Nougairede, Antoine] Inst Hosp Univ Mediterranee Infect, F-13385 Marseille, France.
RP Nougairede, A (corresponding author), EPV Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, Inserm 1207,EHESP, F-13385 Marseille, France.; Nougairede, A (corresponding author), Inst Hosp Univ Mediterranee Infect, F-13385 Marseille, France.
EM antoine.nougairede@univ-amu.fr
FU Zikalliance project (European Union - Horizon programme) [734548];
   French "Agence Nationale de la Recherche"French National Research Agency
   (ANR) [ANR-14-CE14-0001]; PREDEMICS programme (European Union Seventh
   Framework programme) [278433]; European Virus Archive goes global
   project (EVAg; European Union - Horizon programme) [653316]
FX We thank Ludivine Molina and Charlotte Pariente from the
   UMR190-Emergence des Pathologies Virales (Marseille, France) for their
   technical contribution. We thank Ernest A Gould from the
   UMR190-Emergence des Pathologies Virales (Marseille, France) for his
   valuable review of the manuscript. This work was supported by the
   Zikalliance project (European Union - Horizon 2020 programme under grant
   agreement no. 734548), the French "Agence Nationale de la Recherche"
   (grant agreement no. ANR-14-CE14-0001), the PREDEMICS programme
   (European Union Seventh Framework programme under grant agreement no.
   278433) and the European Virus Archive goes global project (EVAg;
   European Union - Horizon 2020 programme under grant agreement no.
   653316; http://www.european-virus-archive.com/).
CR Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Fabritus L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159564
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nougairede A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003172
   Pettersson J. H., 2016, MBIO IN PRESS
   Piorkowski G., 2016, New Microbes and New Infections, V11, P52, DOI 10.1016/j.nmni.2016.02.013
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 30
TC 28
Z9 28
U1 4
U2 34
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 19
PY 2016
VL 6
AR 39384
DI 10.1038/srep39384
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE8LM
UT WOS:000389877100001
PM 27991555
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Koide, F
   Goebel, S
   Snyder, B
   Walters, KB
   Gast, A
   Hagelin, K
   Kalkeri, R
   Rayner, J
AF Koide, Fusataka
   Goebel, Scott
   Snyder, Beth
   Walters, Kevin B.
   Gast, Alison
   Hagelin, Kimberly
   Kalkeri, Raj
   Rayner, Jonathan
TI Development of a Zika Virus Infection Model in Cynomolgus Macaques
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; cynomolgus macaque; non-human primate; flavivirus; arbovirus
ID ASIAN-LINEAGE; DENGUE VIRUS; RHESUS; BRAZIL; PATHOGENESIS; OUTBREAK;
   AMERICA; GENOME
AB Limited availability of Indian rhesus macaques (IRM) is a bottleneck to study Zika virus (ZIKV) pathogenesis and evaluation of appropriate control measures in non-human primates. To address these issues, we report here the Mauritian cynomolgus macaque (MCM) model for ZIKV infection. In brief, six MCMs (seronegative for Dengue and ZIKV) were subdivided into three cohorts with a male and female each and challenged with different doses of Asian [PRVABC59 (Puerto Rico) or FSS13025 (Cambodia)] or African (IBH30656) lineage ZIKV isolates. Clinical signs were monitored; and biological fluids (serum, saliva, and urine) and tissues (testes and brain) were assessed for viral load by quantitative reverse transcription polymerase chain reaction and neutralizing antibodies (Nab) by 50% Plaque Reduction Neutralization Test (PRNT50) at various times post infection (p.i). PRVABC59 induced viremia detectable up to day 10, with peak viral load at 2-3 days p.i. An intermittent viremia spike was observed on day 30 with titers reaching 2.5 x 10(3) genomes/mL. Moderate viral load was observed in testes, urine and saliva. In contrast, FSS13025 induced viremia lasting only up to 6 days and detectable viral loads in testes but not in urine and saliva. Recurrent viremia was detected but at lower titers compare to PRVABC59. Challenge with either PRVABC59 or FSS13025 resulted in 100% seroconversion; with mean PRNT50 titers ranging from 597 to 5179. IBH30656 failed to establish infection in MCM suggesting that MCM are susceptible to infection with ZIKV isolates of the Asian lineage but not from Africa. Due to the similarity of biphasic viremia and Nab responses between MCM and IRM models, MCM could be a suitable alternative for evaluation of ZIKV vaccine and therapeutic candidates.
C1 [Koide, Fusataka; Goebel, Scott; Snyder, Beth; Walters, Kevin B.; Gast, Alison; Hagelin, Kimberly; Kalkeri, Raj] Southern Res Inst, Drug Dev, Dept Infect Dis Res, Frederick, MD USA.
   [Rayner, Jonathan] Southern Res Inst, Drug Dev, Dept Infect Dis Res, Birmingham, AL 35205 USA.
RP Rayner, J (corresponding author), Southern Res Inst, Drug Dev, Dept Infect Dis Res, Birmingham, AL 35205 USA.
EM jrayner@southresearch.org
OI Rayner, Jonathan/0000-0002-2091-7604
FU Southern Research
FX This work was performed with the internal funds from Southern Research.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Andrade MCR, 2004, MEM I OSWALDO CRUZ, V99, P581, DOI 10.1590/S0074-02762004000600009
   Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Spearman P, 2006, CURR PHARM DESIGN, V12, P1147, DOI 10.2174/138161206776055859
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 38
TC 54
Z9 55
U1 0
U2 27
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD DEC 19
PY 2016
VL 7
AR 2028
DI 10.3389/fmicb.2016.02028
PG 8
WC Microbiology
SC Microbiology
GA EE9NH
UT WOS:000389952900003
PM 28066354
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cuevas, EL
   Tong, VT
   Rozo, N
   Valencia, D
   Pacheco, O
   Gilboa, SM
   Mercado, M
   Renquist, CM
   Gonzalez, M
   Ailes, EC
   Duarte, C
   Godoshian, V
   Sancken, CL
   Turca, AMR
   Galles, DL
   Ayala, M
   Morgan, P
   Perez, ENT
   Bonilla, HQ
   Gomez, RC
   Estupinan, AC
   Gunturiz, ML
   Meaney-Delman, D
   Jamieson, DJ
   Honein, MA
   Martinez, MLO
AF Liliana Cuevas, Esther
   Tong, Van T.
   Rozo, Nathaly
   Valencia, Diana
   Pacheco, Oscar
   Gilboa, Suzanne M.
   Mercado, Marcela
   Renquist, Christina M.
   Gonzalez, Maritza
   Ailes, Elizabeth C.
   Duarte, Carolina
   Godoshian, Valerie
   Sancken, Christina L.
   Rico Turca, Angelica Maria
   Galles, Dinorah L.
   Ayala, Martha
   Morgan, Paula
   Tolosa Perez, Erika Natalia
   Quijada Bonilla, Hernan
   Caceres Gomez, Ruben
   Carolina Estupinan, Ana
   Luz Gunturiz, Maria
   Meaney-Delman, Dana
   Jamieson, Denise J.
   Honein, Margaret A.
   Ospina Martinez, Martha Lucia
TI Preliminary Report of Microcephaly Potentially Associated with Zika
   Virus Infection During Pregnancy - Colombia, January-November 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID BIRTH
C1 [Liliana Cuevas, Esther; Rozo, Nathaly; Pacheco, Oscar; Mercado, Marcela; Gonzalez, Maritza; Duarte, Carolina; Rico Turca, Angelica Maria; Ayala, Martha; Tolosa Perez, Erika Natalia; Quijada Bonilla, Hernan; Caceres Gomez, Ruben; Luz Gunturiz, Maria; Ospina Martinez, Martha Lucia] Inst Nacl Salud, Bogota, Colombia.
   [Tong, Van T.; Valencia, Diana; Gilboa, Suzanne M.; Renquist, Christina M.; Ailes, Elizabeth C.; Godoshian, Valerie; Sancken, Christina L.; Galles, Dinorah L.; Morgan, Paula; Meaney-Delman, Dana; Jamieson, Denise J.; Honein, Margaret A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Carolina Estupinan, Ana] Minist Salud & Protecc Social, Bogota, Colombia.
RP Honein, MA (corresponding author), CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
OI Ayala Sotelo, Martha Stella/0000-0002-6804-0581; Sancken,
   Christina/0000-0002-4795-4675; Pacheco Garcia, Oscar
   Eduardo/0000-0001-5939-6407; Jamieson, Denise/0000-0003-2597-1201;
   GUNTURIZ, MARIA LUZ/0000-0001-9803-7909
CR Anderka M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2223-2
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Departamento Administrativo Nacional de Estadistica, NAC EST NAC AR OC SE
   Duke CW, 2007, PUBLIC HEALTH REP, V122, P664, DOI 10.1177/003335490712200514
   Instituto Nacional de Salud, 2016, EP WEEK 45 BOG
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Pacheco O, 2016, N ENGL J MED
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 10
TC 60
Z9 61
U1 0
U2 12
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD DEC 16
PY 2016
VL 65
IS 49
BP 1409
EP 1413
DI 10.15585/mmwr.mm6549e1
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EF8YJ
UT WOS:000390617600005
PM 27977645
OA Bronze
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Data mount linking Zika, birth defects
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 12
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD DEC 16
PY 2016
VL 354
IS 6318
BP 1356
EP 1356
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EF3YN
UT WOS:000390261300002
DA 2020-07-08
ER

PT J
AU Escobar, LE
   Romero-Alvarez, D
   Leon, R
   Lepe-Lopez, MA
   Craft, ME
   Borbor-Cordova, MJ
   Svenning, JC
AF Escobar, Luis E.
   Romero-Alvarez, Daniel
   Leon, Renato
   Lepe-Lopez, Manuel A.
   Craft, Meggan E.
   Borbor-Cordova, Mercy J.
   Svenning, Jens-Christian
TI Declining Prevalence of Disease Vectors Under Climate Change
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ECOLOGICAL NICHE MODELS; GEOGRAPHIC DISTRIBUTIONS; SPECIES
   DISTRIBUTIONS; PUERTO-RICO; DENGUE; TRANSMISSION; BIOGEOGRAPHY;
   EMISSIONS; FRAMEWORK; DYNAMICS
AB More than half of the world population is at risk of vector-borne diseases including dengue fever, chikungunya, zika, yellow fever, leishmaniasis, chagas disease, and malaria, with highest incidences in tropical regions. In Ecuador, vector-borne diseases are present from coastal and Amazonian regions to the Andes Mountains; however, a detailed characterization of the distribution of their vectors has never been carried out. We estimate the distribution of 14 vectors of the above vector-borne diseases under present-day and future climates. Our results consistently suggest that climate warming is likely threatening some vector species with extinction, locally or completely. These results suggest that climate change could reduce the burden of specific vector species. Other vector species are likely to shift and constrain their geographic range to the highlands in Ecuador potentially affecting novel areas and populations. These forecasts show the need for development of early prevention strategies for vector species currently absent in areas projected as suitable under future climate conditions. Informed interventions could reduce the risk of human exposure to vector species with distributional shifts, in response to current and future climate changes. Based on the mixed effects of future climate on human exposure to disease vectors, we argue that research on vector-borne diseases should be cross-scale and include climatic, demographic, and landscape factors, as well as forces facilitating disease transmission at fine scales.
C1 [Escobar, Luis E.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.
   [Escobar, Luis E.; Craft, Meggan E.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.
   [Escobar, Luis E.; Lepe-Lopez, Manuel A.] Univ San Carlos, Fac Med Vet & Zootecnia, Guatemala City, Guatemala.
   [Romero-Alvarez, Daniel] Univ Cent Ecuador, Sch Med, Unit Mol Parasitol & Trop Med, Ctr Biomed, Quito, Ecuador.
   [Leon, Renato] Univ San Francisco Quito, Lab Entomol Med & Med Trop, Quito, Ecuador.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral, Fac Marine Sci Biol Ocean Sci & Nat Resource, Guayaquil, Ecuador.
   [Svenning, Jens-Christian] Aarhus Univ, Sect Ecoinformat & Biodivers, Dept Biosci, DK-8000 Aarhus C, Denmark.
RP Escobar, LE (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.; Escobar, LE (corresponding author), Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA.; Escobar, LE (corresponding author), Univ San Carlos, Fac Med Vet & Zootecnia, Guatemala City, Guatemala.
EM lescobar@umn.edu
RI Svenning, Jens-Christian/Y-3318-2019; Romero-Alvarez, Daniel/K-2270-2019
OI Svenning, Jens-Christian/0000-0002-3415-0862; Borbor,
   Mercy/0000-0002-7418-141X; Escobar, Luis E./0000-0001-5735-2750
FU Minnesota Environment and Natural Resources Trust Fund; Minnesota
   Aquatic Invasive Species Research Center; Clean Water Land and Legacy;
   AU IDEAS program via Center for Informatics Research on Complexity in
   Ecology (CIRCE)
FX L.E.E. was supported by the Minnesota Environment and Natural Resources
   Trust Fund, the Minnesota Aquatic Invasive Species Research Center, and
   the Clean Water Land and Legacy. J.-C.S. was supported by the AU IDEAS
   program via Center for Informatics Research on Complexity in Ecology
   (CIRCE).
CR Anderson R. P., 2016, J BIOGEOGR IN PRESS
   Anderson RP, 2013, ANN NY ACAD SCI, V1297, P8, DOI 10.1111/nyas.12264
   Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Boucau S., 2014, EUROSURVEILLANCE, V19, P1
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Colon-Gonzalez FJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002503
   Escobar LE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01174
   Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P1830, DOI 10.1111/j.1365-2486.2009.02085.x
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Hengl T., 2015, WORLDGRIDS PUBLIC RE
   Hurtado LA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.27
   Johansson MA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000382
   Kellermann V, 2012, P NATL ACAD SCI USA, V109, P16228, DOI 10.1073/pnas.1207553109
   Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x
   LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Manning MR, 2010, NAT GEOSCI, V3, P376, DOI 10.1038/ngeo880
   McMichael T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1359
   Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Ministerio de Salud Publica, 2015, AN EP 1994 2014
   Murdock CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27771
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534
   New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2
   Oak Ridge National Laboratory, 2011, LANDSCAN GLOB POP DA
   Owens HL, 2013, ECOL MODEL, V263, P10, DOI 10.1016/j.ecolmodel.2013.04.011
   Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x
   Peterson A.T., 2011, ECOLOGICAL NICHES GE
   Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5
   Peterson AT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-59
   Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8
   Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265
   Peterson AT, 2014, MAPPING DISEASE TRANSMISSION RISK: ENRICHING MODELS USING BIOGEOGRAPHY AND ECOLOGY, P1
   Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a
   Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026
   Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843
   Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104
   Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y
   Ryan SJ, 2015, VECTOR-BORNE ZOONOT, V15, P718, DOI 10.1089/vbz.2015.1822
   Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325
   Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121
   Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 44
TC 11
Z9 11
U1 0
U2 63
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 16
PY 2016
VL 6
AR 39150
DI 10.1038/srep39150
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE8PO
UT WOS:000389888300001
PM 27982119
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Johnson, BW
   Russell, BJ
   Goodman, CH
AF Johnson, Barbara W.
   Russell, Brandy J.
   Goodman, Christin H.
TI Laboratory Diagnosis of Chikungunya Virus Infections and Commercial
   Sources for Diagnostic Assays
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Chikungunya virus; arbovirus diagnostic testing; real-time RT-PCR; IgM
   antibody capture enzyme-linked immunosorbent assay (MAC-ELISA)
ID DENGUE; FEVER; TESTS; ZIKA
AB Detection of chikungunya virus (CHIKV) or viral RNA is the primary laboratory test used to diagnose infection in serum collected <6 days after onset of illness. Two real-time reverse transcription-polymerase chain reaction (RT-PCR) kits are available commercially, but validity data are limited. There are 2 commercial sources of inactivated positive-control CHIKV RNA to be used with purchased primers. The Centers for Disease Control and Prevention provides viral RNA-positive controls and primer and probe nucleotide sequences for real-time RT-PCR testing. Detection of CHIKV-specific immunoglobulin M (IgM) antibody becomes a sensitive test for samples collected approximately >5 days of illness. Commercially available CHIKV IgM-detection assays include lateral flow rapid tests, IgM antibody capture enzyme-linked immunosorbent assays (MAC-ELISAs), and indirect immunofluorescence tests. Nine commercial CHIKV IgM detection assays were evaluated at 3 reference laboratories to provide guidance to public health diagnostic laboratories on their performance parameters. Sensitivity of the rapid tests and 3MAC-ELISAs was <50%, and thus these assays are not recommended. Three of the MAC-ELISA kits and 1 indirect immunofluorescence kit had comparable performance to the reference assays. In summary, commercial assays with performance comparable to reference assays are available for molecular and serological diagnosis of CHIKV infections.
C1 [Johnson, Barbara W.; Russell, Brandy J.; Goodman, Christin H.] Ctr Dis Control & Prevent, Diagnost & Reference Lab, Arboviral Dis Branch, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
RP Johnson, BW (corresponding author), Ctr Dis Control & Prevent, Diagnost & Reference Lab, Arboviral Dis Branch, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM bfj9@cdc.gov
FU Intramural CDC HHS [CC999999]
CR Beaty B, 1995, DIAGNOSTIC PROCEDURE, P189
   Blacksell SD, 2011, CLIN VACCINE IMMUNOL, V18, P1773, DOI 10.1128/CVI.05288-11
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cassadou S, 2013, EUROSURVEILLANCE, V19, P13
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Kosasih H, 2012, SE ASIAN J TROP MED, V43, P55
   Kuno G, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004101
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   LEPINIEC L, 1994, J GEN VIROL, V75, P417, DOI 10.1099/0022-1317-75-2-417
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Martin DA, 2004, CLIN DIAGN LAB IMMUN, V11, P1130, DOI 10.1128/CDLI.11.6.1130-1133.2004
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Panning M, 2009, J CLIN MICROBIOL, V47, P3014, DOI 10.1128/JCM.01024-09
   Powers AM, 2011, METHODS MOL BIOL, V665, P17, DOI 10.1007/978-1-60761-817-1_2
   Powers AM, 2010, CLIN LAB MED, V30, P209, DOI 10.1016/j.cll.2009.10.003
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Rianthavorn P, 2010, SE ASIAN J TROP MED, V41, P92
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 23
TC 33
Z9 35
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2016
VL 214
SU 5
BP S471
EP S474
DI 10.1093/infdis/jiw274
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FK9EZ
UT WOS:000413815700010
PM 27920176
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Cordeiro, MT
   Brito, CAA
   Pena, LJ
   Castanha, PMS
   Gil, LHVG
   Lopes, KGS
   Dhalia, R
   Meneses, JA
   Ishigami, AC
   Mello, LM
   Alencar, LXE
   Guarines, KM
   Rodrigues, LC
   Marques, ETA
AF Cordeiro, Marli T.
   Brito, Carlos A. A.
   Pena, Lindomar J.
   Castanha, Priscila M. S.
   Gil, Laura H. V. G.
   Lopes, Kennya G. S.
   Dhalia, Rafael
   Meneses, Jucille A.
   Ishigami, Ana C.
   Mello, Luisa M.
   Alencar, Liciana X. E.
   Guarines, Klarissa M.
   Rodrigues, Laura C.
   Marques, Ernesto T. A.
TI Results of a Zika Virus (ZIKV) Immunoglobulin M-Specific Diagnostic
   Assay Are Highly Correlated With Detection of Neutralizing Anti-ZIKV
   Antibodies in Neonates With Congenital Disease
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; microcephaly; congenital Zika; anti-ZIKV IgM; ZIKV
   antibodies
ID INFECTION; DENGUE; BRAZIL
AB Background. Usually, immunoglobulin M (IgM) serologic analysis is not sufficiently specific to confirm Zika virus (ZIKV) infection. However, since IgM does not cross the placenta, it may be a good marker of infection in neonates.
   Methods. We tested blood from 42 mothers and neonates with microcephaly and collected cerebrospinal fluid (CSF) specimens from 30 neonates. Molecular assays were performed for detection of ZIKV, dengue virus, and chikungunya virus; IgM enzyme-linked immunosorbent assays and plaque-reduction neutralization tests (PRNTs) were performed to detect ZIKV and dengue virus. No control neonates without microcephaly were evaluated.
   Results. Among neonates, all 42 tested positive for ZIKV IgM: 38 of 42 serum specimens (90.5%) were positive, whereas 30 of 30 CSF specimens (100%) were positive. ZIKV IgM-specific ELISA ratios, calculated as the mean optical density (OD) of the test sample when reacted on viral antigen divided by the mean OD of the negative control when reacted with viral antigen, were higher in CSF specimens (median, 14.9 [range, 9.3-16.4]) than in serum (median, 8.9 [range, 2.1-20.6]; P =.0003). All ZIKV IgM-positive results among the neonates were confirmed by the detection of neutralizing antibodies. Mother/neonate pairs with primary ZIKV infection had neutralizing antibodies to ZIKV only, and mother/neonate pairs with ZIKV virus infection secondary to infection with another flavivirus had high titers of neutralizing antibodies to ZIKV. Among secondary infections, median titers in serum were 2072 (range, 232-12 980) for mothers and 2730 (range, 398-12 980) for neonates (P < .0001), and the median titer in CSF was 93 (range, 40-578) among neonates (P < .0001).
   Conclusions. Among neonates, detection of ZIKV IgM in serum is confirmatory of congenital ZIKV infection, and detection of ZIKV IgM in CSF is confirmatory of neurologic infection. Therefore, we recommend testing for ZIKV IgM in neonates suspected of having congenital ZIKV infection and performance of PRNTs in equivocal cases.
C1 [Cordeiro, Marli T.; Pena, Lindomar J.; Castanha, Priscila M. S.; Gil, Laura H. V. G.; Lopes, Kennya G. S.; Dhalia, Rafael; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Res Ctr, Dept Virol, Recife, PE, Brazil.
   [Brito, Carlos A. A.] Univ Fed Pernambuco, Dept Clin Med, Recife, PE, Brazil.
   [Meneses, Jucille A.; Ishigami, Ana C.; Mello, Luisa M.] Inst Med Integral Prof Fernando Figueira, Dept Pediat, Recife, PE, Brazil.
   [Alencar, Liciana X. E.; Guarines, Klarissa M.] Secretaria Saude Estado Pernambuco, Cent Publ Hlth Lab, Recife, PE, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
RP Marques, ETA (corresponding author), FIOCRUZ PE, Dept Virol, Ctr Pesquisas Aggeu Magalhaes CPqAM, Av Prof Moraes Rego SN,Campus UFPE,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM marques@pitt.edu
RI Marques, Ernesto T. A/L-4967-2013; Dhalia, Rafael/AAD-5432-2020;
   CASTANHA, PRISCILA/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; CASTANHA,
   PRISCILA/0000-0002-1220-5308
FU Brazilian government "Programa de pesquisas para o SUS / Fundacao de
   amparo a ciencia e tecnologia de PE" (PPSUS/FACEPE) [APQ: 0302-4.01/13]
FX This study was supported by the Brazilian government "Programa de
   pesquisas para o SUS / Fundacao de amparo a ciencia e tecnologia de PE"
   (PPSUS/FACEPE - grant APQ: 0302-4.01/13).
CR Brasil P, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa160241412, DOI 10.1056/NEJMOA160241412]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128
   de Paula Freitas B, 2016, JAMA OPHTHALMOL, DOI [10.1001/jamaophthlmol.2016.0267, DOI 10.1001/JAMAOPHTHLMOL.2016.0267]
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   World Health Organization (WHO), INT HLTH REG EM COMM
NR 23
TC 27
Z9 27
U1 0
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 15
PY 2016
VL 214
IS 12
BP 1897
EP 1904
DI 10.1093/infdis/jiw477
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EJ3RT
UT WOS:000393130000018
PM 27923950
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Hilgenfeld, R
AF Hilgenfeld, Rolf
TI Zika virus NS1, a pathogenicity factor with many faces
SO EMBO JOURNAL
LA English
DT Editorial Material
ID SPECIFICITY
AB Recent publications in The EMBO Journal (Xu et al, 2016) and in Nature Structural & Molecular Biology (Brown et al, 2016) report crystal structures of the Zika virus (ZIKV) NS1 protein. The structures reveal unique surface properties that help explain the specificity of anti-ZIKV NS1 antibodies. Possible functions of this multifaceted pathogenicity factor are discussed here on the basis of the structures and cautious extrapolation from other flaviviruses.
C1 [Hilgenfeld, Rolf] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, Lubeck, Germany.
   [Hilgenfeld, Rolf] Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
RP Hilgenfeld, R (corresponding author), Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, Lubeck, Germany.; Hilgenfeld, R (corresponding author), Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, Lubeck, Germany.
EM hilgenfeld@biochem.uni-luebeck.de
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
NR 13
TC 18
Z9 20
U1 2
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD DEC 15
PY 2016
VL 35
IS 24
BP 2631
EP 2633
DI 10.15252/embj.201695871
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EG3ML
UT WOS:000390948700005
PM 27789523
OA Green Published
DA 2020-07-08
ER

PT J
AU Honein, MA
   Jamieson, DJ
AF Honein, Margaret A.
   Jamieson, Denise J.
TI Monitoring and Preventing Congenital Zika Syndrome
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID UNITED-STATES
C1 [Honein, Margaret A.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
RP Honein, MA (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.
OI Jamieson, Denise/0000-0003-2597-1201
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Grant GB, 2015, MMWR-MORBID MORTAL W, V64, P1052, DOI 10.15585/mmwr.mm6437a5
   HOLTZMAN NA, 1986, ANNU REV PUBL HEALTH, V7, P237, DOI 10.1146/annurev.pu.07.050186.001321
   KALLEN B, 1968, PEDIATRICS, V41, P765
   Melo AS, 2016, JAMA NEUROL
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1
   van der Linden V, 2016, MMWR MORB MORTAL WKL
   Williams J, 2015, MMWR-MORBID MORTAL W, V64, P1
NR 11
TC 4
Z9 5
U1 0
U2 5
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 15
PY 2016
VL 375
IS 24
BP 2393
EP 2394
DI 10.1056/NEJMe1613368
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF0SO
UT WOS:000390036500013
PM 27960068
DA 2020-07-08
ER

PT J
AU Waggoner, JJ
   Gresh, L
   Vargas, MJ
   Ballesteros, G
   Tellez, Y
   Soda, KJ
   Sahoo, MK
   Nunez, A
   Balmaseda, A
   Harris, E
   Pinsky, BA
AF Waggoner, Jesse J.
   Gresh, Lionel
   Jose Vargas, Maria
   Ballesteros, Gabriela
   Tellez, Yolanda
   Soda, K. James
   Sahoo, Malaya K.
   Nunez, Andrea
   Balmaseda, Angel
   Harris, Eva
   Pinsky, Benjamin A.
TI Viremia and Clinical Presentation in Nicaraguan Patients Infected With
   Zika Virus, Chikungunya Virus, and Dengue Virus
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE dengue virus; chikungunya virus; Zika virus; coinfection; viremia
ID REVERSE TRANSCRIPTION-PCR; TIME RT-PCR; SINGLE-REACTION; EPIDEMIC;
   ASSAY; COINFECTION; MULTIPLEX; CORRELATE; SEVERITY; CHILDREN
AB Background. Zika virus (ZIKV), chikungunya virus (CHIKV), and dengue virus (DENV) cocirculate in Nicaragua. In this study, we sought to compare the quantified viremia and clinical presentation of patients infected with 1 or more of these viruses.
   Methods. Acute-phase serum samples from 346 patients with a suspected arboviral illness were tested using a multiplex realtime reverse-transcription polymerase chain reaction for ZIKV, CHIKV, and DENV. Viremia was quantitated for each detected virus, and clinical information from request forms submitted with each sample was recorded.
   Results. A total of 263 patients tested positive for 1 or more viruses: 192 patients tested positive for a single virus (monoinfections) and 71 patients tested positive for 2 or all 3 viruses (coinfections). Quantifiable viremia was lower in ZIKV infections compared with CHIKV or DENV (mean 4.70 vs 6.42 and 5.84 log(10) copies/mL serum, respectively; P<.001 for both comparisons), and for each virus, mean viremia was significantly lower in coinfections than in monoinfections. Compared with patients with CHIKV or DENV, ZIKV patients were more likely to have a rash (P<.001) and less likely to be febrile (P<.05) or require hospitalization (P<.001). Among all patients, hospitalized cases had higher viremia than those who did not require hospitalization (7.1 vs 4.1 log(10) copies/mL serum, respectively; P<.001).
   Conclusions. ZIKV, CHIKV, and DENV result in similar clinical presentations, and coinfections may be relatively common. Our findings illustrate the need for accurate, multiplex diagnostics for patient care and epidemiologic surveillance.
C1 [Waggoner, Jesse J.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Dept Med, Stanford, CA 94305 USA.
   [Gresh, Lionel] Minist Hlth, Sustainable Sci Inst, Managua, Nicaragua.
   [Jose Vargas, Maria; Ballesteros, Gabriela; Tellez, Yolanda; Nunez, Andrea; Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Natl Virol Lab, Managua, Nicaragua.
   [Soda, K. James] Florida State Univ, Dept Sci Comp, Tallahassee, FL 32306 USA.
   [Sahoo, Malaya K.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Waggoner, Jesse J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
RP Pinsky, BA (corresponding author), 3375 Hillview Ave,Rm 2913, Palo Alto, CA 94304 USA.
EM bpinsky@stanford.edu
OI Pinsky, Benjamin/0000-0001-8751-4810; Sahoo, Malaya/0000-0001-9837-4032;
   Gresh, Lionel/0000-0002-2333-1748
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [K08AI110528]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI099631, U54AI65359]
FX This work was supported by National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health (NIH) (K08AI110528; J. J.
   W.). Studies in Nicaragua were supported by NIH (R01AI099631; A. B. and
   U54AI65359; A. B.).
CR Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Chursi S, 2014, AM J TROP MED HYG, V90, P410, DOI 10.4269/ajtmh.12-0681
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002
   KOURI G, 1991, REV I MED TROP, V33, P365, DOI 10.1590/S0036-46651991000500005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Pozo-Aguilar JO, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0590-7
   Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Tricou V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001309
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 30
TC 100
Z9 103
U1 0
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 15
PY 2016
VL 63
IS 12
BP 1584
EP 1590
DI 10.1093/cid/ciw589
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EI7WW
UT WOS:000392716100008
PM 27578819
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU de Souza, AS
   Dias, CM
   Braga, FDB
   Terzian, ACB
   Estofolete, CF
   Oliani, AH
   Oliveira, GH
   de Mattos, CCB
   de Mattos, LC
   Nogueira, ML
   Vaz-Oliani, DCM
AF de Souza, Antonio Soares
   Dias, Cristiane Moraes
   Braojos Braga, Fernanda Del Campo
   Bernardes Terzian, Ana Carolina
   Estofolete, Cassia Fernanda
   Oliani, Antonio Helio
   Oliveira, Gustavo Henrique
   Brandao de Mattos, Cinara Cassia
   de Mattos, Luiz Carlos
   Nogueira, Mauricio Lacerda
   Mos Vaz-Oliani, Denise Cristina
TI Fetal Infection by Zika Virus in the Third Trimester: Report of 2 Cases
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus infection; infection/ congenital; ultrasonography; central
   nervous system cysts; lenticulostriate vasculopathy
ID LENTICULOSTRIATE VASCULOPATHY; SUBEPENDYMAL PSEUDOCYSTS; NEWBORNS;
   BRAZIL
AB Zika virus (ZIKV) infection acquired during pregnancy is associated with congenital microcephaly. We describe 2 cases of ZIKV infection in women in their 36th week of pregnancy whose fetuses had preserved head circumference at birth and findings of subependymal cysts and lenticulostriate vasculopathy in postnatal imaging. These represent the first signs of congenital brain injury acquired due to ZIKV in the third trimester.
C1 [de Souza, Antonio Soares] Fac Med Sao Jose Do Rio Preto FAMERP, Dept Radiol, Sao Jose Do Rio Preto, SP, Brazil.
   [de Souza, Antonio Soares; Dias, Cristiane Moraes; Braojos Braga, Fernanda Del Campo; Oliveira, Gustavo Henrique; Mos Vaz-Oliani, Denise Cristina] Hosp Crianca & Maternidade, Sao Jose Do Rio Preto, SP, Brazil.
   [Bernardes Terzian, Ana Carolina; Estofolete, Cassia Fernanda; Nogueira, Mauricio Lacerda] FAMERP, Dept Infect & Dermatol Dis, Lab Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [Oliani, Antonio Helio; Mos Vaz-Oliani, Denise Cristina] FAMERP, Dept Obstet & Gynecol, Sao Jose Do Rio Preto, SP, Brazil.
   [Brandao de Mattos, Cinara Cassia; de Mattos, Luiz Carlos] FAMERP, Immunogenet Lab, Dept Mol Biol, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Fac Med Sao Jose Do Rio Preto, Virol Lab, Ave Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Estofolete, Cassia/N-6673-2019; Nogueira, Mauricio L/B-7599-2012; de
   Mattos, Luiz Carlos/P-4005-2019; de Mattos, Cinara Brandao/B-3650-2008;
   OLIANI, ANTONIO/O-1673-2019; de Mattos, Luiz Carlos/P-3574-2019
OI Estofolete, Cassia/0000-0001-7324-1591; Nogueira, Mauricio
   L/0000-0003-1102-2419; de Mattos, Luiz Carlos/0000-0002-8572-8177; de
   Mattos, Cinara Brandao/0000-0002-4836-3113; Oliani, Antonio
   Helio/0000-0003-1242-4364
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2015/12295-0, 2016/05115-9];
   CNPqNational Council for Scientific and Technological Development (CNPq)
FX This work was supported by the Sao Paulo Research Foundation (FAPESP
   numbers 2013/21719-3 to M. L. N.; 2015/12295-0 to A. C. B. T.; and
   2016/05115-9 to L. C. M.). M. L. N. is supported by a CNPq Fellowship.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cantey JB, 2015, EARLY HUM DEV, V91, P427, DOI 10.1016/j.earlhumdev.2015.04.005
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cevey-Macherel M, 2013, ARCH DIS CHILD, V98, P497, DOI 10.1136/archdischild-2012-303223
   El Ayoubi M, 2003, PEDIATR RADIOL, V33, P697, DOI 10.1007/s00247-003-0948-z
   Esteban H, 2015, ULTRASOUND OBST GYN, V46, P678, DOI 10.1002/uog.14820
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fink KR, 2010, RADIOGRAPHICS, V30, P1779, DOI 10.1148/rg.307105043
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ong CW, 2016, INTERN MED J, V46, P525, DOI 10.1111/imj.13059
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sisman J, 2015, EARLY HUM DEV, V91, P423, DOI 10.1016/j.earlhumdev.2015.04.004
   van der Weiden S, 2010, EARLY HUM DEV, V86, P203, DOI 10.1016/j.earlhumdev.2010.02.009
NR 17
TC 34
Z9 34
U1 0
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD DEC 15
PY 2016
VL 63
IS 12
BP 1622
EP 1625
DI 10.1093/cid/ciw613
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EI7WW
UT WOS:000392716100015
PM 27601223
OA Bronze
DA 2020-07-08
ER

PT J
AU Steinhagen, K
   Probst, C
   Radzimski, C
   Schmidt-Chanasit, J
   Emmerich, P
   van Esbroeck, M
   Schinkel, J
   Grobusch, MP
   Goorhuls, A
   Warnecke, JM
   Lattwein, E
   Komorowski, L
   Deerberg, A
   Saschenbrecker, S
   Stocker, W
   Schlumberger, W
AF Steinhagen, K.
   Probst, C.
   Radzimski, C.
   Schmidt-Chanasit, J.
   Emmerich, P.
   van Esbroeck, M.
   Schinkel, J.
   Grobusch, M. P.
   Goorhuls, A.
   Warnecke, J. M.
   Lattwein, E.
   Komorowski, L.
   Deerberg, A.
   Saschenbrecker, S.
   Stoecker, W.
   Schlumberger, W.
TI Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA
   devoid of cross-reactivity with dengue virus antibodies: a multicohort
   study of assay performance, 2015 to 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID NONSTRUCTURAL GLYCOPROTEIN NS1; PROTEIN NS1; ACUTE-PHASE; SPECIFICITY;
   DISEASE; ANTIGEN; RNA; RESPONSES; BIOLOGY; CELLS
AB Serological diagnosis of Zika virus (ZIKV) infections is challenging due to high cross-reactivity between flaviviruses. We evaluated the diagnostic performance of a novel anti-ZIKV ELISA based on recombinant ZIKV non-structural protein 1 (NS1). Assay sensitivity was examined using sera from 27 patients with reverse transcription (RT)-PCR-confirmed and 85 with suspected ZIKV infection. Specificity was analysed using sera from 1,015 healthy individuals. Samples from 252 patients with dengue virus (n = 93), West Nile virus (n = 34), Japanese encephalitis virus (n = 25), chikungunya virus (n = 19) or Plasmodium spp. (n = 69) infections and from 12 yellow fever-vaccinated individuals were also examined. In confirmed ZIKV specimens collected = 6 days after symptom onset, ELISA sensitivity was 58.8% (95% confidence interval (CI): 36.0-78.4) for IgM, 88.2% (95% CI: 64.4-98.0) for IgG, and 100% (95% CI: 78.4-100) for IgM/IgG, at 99.8% (95% CI: 99.2-100) specificity. Cross-reactivity with high-level dengue virus antibodies was not detected. Among patients with potentially cross-reactive antibodies anti-ZIKV positive rates were 0.8% (95% CI: 0-3.0) and 0.4% (95% CI: 0-2.4) for IgM and IgG, respectively. Providing high specificity and low cross-reactivity, the NS1-based ELISA has the potential to aid in counselling patients, pregnant women and travellers after returning from ZIKV-endemic areas.
C1 [Steinhagen, K.; Probst, C.; Radzimski, C.; Warnecke, J. M.; Lattwein, E.; Komorowski, L.; Deerberg, A.; Saschenbrecker, S.; Stoecker, W.; Schlumberger, W.] EUROIMMUN AG, Inst Expt Immunol, Lubeck, Germany.
   [Schmidt-Chanasit, J.; Emmerich, P.] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Schmidt-Chanasit, J.] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel, Hamburg, Germany.
   [van Esbroeck, M.] Inst Trop Med, Dept Clin Sci, Natl Reference Ctr Arboviruses, Antwerp, Belgium.
   [Schinkel, J.] Acad Med Ctr, Sect Clin Virol, Dept Med Microbiol, Publ Hlth Serv, Amsterdam, Netherlands.
   [Grobusch, M. P.; Goorhuls, A.] Univ Amsterdam, Ctr Trop Med & Travel Med, Dept Infect Dis, Div Internal Med,Acad Med Ctr, Amsterdam, Netherlands.
   [Grobusch, M. P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany.
RP Schlumberger, W (corresponding author), EUROIMMUN AG, Inst Expt Immunol, Lubeck, Germany.
EM w.schlumberger@euroimmun.de
RI amsalu, ribka/G-8780-2019; Schinkel, Janke/I-3099-2012
OI Schinkel, Janke/0000-0002-1112-0644; Van Esbroeck,
   Marjan/0000-0002-7294-6319
FU EUROIMMUN
FX This study was sponsored and funded by EUROIMMUN. Company staff were
   involved in study design, data collection, data analysis, data
   interpretation, and writing of the report. However, the contributions of
   EUROIMMUN employees and board members were based exclusively on
   scientific grounds and transparent to and reviewable by all co-authors.
   The corresponding author had full access to all the data in the study
   and had final responsibility for the decision to submit for publication.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5527
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR OUTBR AM PAC
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEE JM, 1989, J GEN VIROL, V70, P335, DOI 10.1099/0022-1317-70-2-335
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV AM
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4
   Zentrale Ethikkommission bei der Bundesarztekammer, 2003, WEIT VERW MENSCHL KO
NR 36
TC 67
Z9 69
U1 1
U2 25
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD DEC 15
PY 2016
VL 21
IS 50
BP 13
EP 28
AR 30426
DI 10.2807/1560-7917.ES.2016.21.50.30426
PG 16
WC Infectious Diseases
SC Infectious Diseases
GA EG8BI
UT WOS:000391280200003
PM 28006649
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Govero, J
   Esakky, P
   Scheaffer, SM
   Fernandez, E
   Drury, A
   Platt, DJ
   Gorman, MJ
   Richner, JM
   Caine, EA
   Salazar, V
   Moley, KH
   Diamond, MS
AF Govero, Jennifer
   Esakky, Prabagaran
   Scheaffer, Suzanne M.
   Fernandez, Estefania
   Drury, Andrea
   Platt, Derek J.
   Gorman, Matthew J.
   Richner, Justin M.
   Caine, Elizabeth A.
   Salazar, Vanessa
   Moley, Kelle H.
   Diamond, Michael S.
TI Zika virus infection damages the testes in mice
SO NATURE
LA English
DT Article
ID SEXUAL TRANSMISSION; TYRO-3 FAMILY; LEYDIG-CELLS; MOUSE; SEMEN;
   SPERMATOGENESIS; RECEPTOR; PROTECTION
AB Infection of pregnant women with Zika virus (ZIKV) can cause congenital malformations including microcephaly, which has focused global attention on this emerging pathogen(1). In addition to transmission by mosquitoes, ZIKV can be detected in the seminal fluid of affected males for extended periods of time and transmitted sexually(2). Here, using a mouse-adapted African ZIKV strain (Dakar 41519), we evaluated the consequences of infection in the male reproductive tract of mice. We observed persistence of ZIKV, but not the closely related dengue virus (DENV), in the testis and epididymis of male mice, and this was associated with tissue injury that caused diminished testosterone and inhibin B levels and oligospermia. ZIKV preferentially infected spermatogonia, primary spermatocytes and Sertoli cells in the testis, resulting in cell death and destruction of the seminiferous tubules. Less damage was caused by a contemporary Asian ZIKV strain (H/PF/2013), in part because this virus replicates less efficiently in mice. The extent to which these observations in mice translate to humans remains unclear, but longitudinal studies of sperm function and viability in ZIKV-infected humans seem warranted.
C1 [Govero, Jennifer; Richner, Justin M.; Caine, Elizabeth A.; Salazar, Vanessa; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Esakky, Prabagaran; Scheaffer, Suzanne M.; Drury, Andrea; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Fernandez, Estefania; Gorman, Matthew J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Moley, Kelle H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
EM moleyk@wustl.edu; diamond@wusm.wustl.edu
RI amsalu, ribka/G-8780-2019; Diamond, Michael/AAH-1733-2019
OI Diamond, Michael/0000-0002-8791-3165; Richner,
   Justin/0000-0002-5344-118X; Salazar, Vanessa/0000-0002-1947-6039;
   PEREZ-ALBELA FERNANDEZ, EDUARDO/0000-0002-1428-6041; ESAKKY,
   PRABAGARAN/0000-0003-4688-2427; Platt, Derek/0000-0003-0766-4590
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972, R01
   HD065435, R01HD083895, T32 AI007163]; Washington University Institute of
   Clinical and Translational Sciences from the National Center for
   Advancing Translational Sciences [UL1 TR000448]; Washington University
   Institute of Clinical and Translational Sciences from the National
   Institute of General Medical Sciences [P41 GM103422-35]; Veteran Affairs
   Office of Research and Development [IO1BX007080]; Eunice Kennedy Shriver
   NICHD/NIH (NCTRI) [P50-HD28934]
FX NIH grants (R01 AI073755 and R01 AI104972 to M.S.D., R01 HD065435 and
   R01HD083895 to K.H.M., and T32 AI007163 (E.F.)) supported this work.
   This work was supported by the Washington University Institute of
   Clinical and Translational Sciences (UL1 TR000448 from the National
   Center for Advancing Translational Sciences and P41 GM103422-35 from the
   National Institute of General Medical Sciences to K.H.M.), as well as a
   grant from the Veteran Affairs Office of Research and Development
   IO1BX007080 to K.H.M.). The authors thank J. Miner, T. Pierson, P.A.
   Felder and J. Halabi for technical assistance, manuscript review and
   data analysis. The testosterone and inhibin B assays were processed by
   the University of Virginia Center for Research in Reproduction Ligand
   Assay and Analysis Core, which is supported by the Eunice Kennedy
   Shriver NICHD/NIH (NCTRI) Grant P50-HD28934.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612
   Esakky P, 2013, REPROD SCI, V20, P238, DOI 10.1177/1933719112452939
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Goffic R, 2003, J VIROL, V77, P3297, DOI 10.1128/JVI.77.5.3297-3300.2003
   Liu S., 2016, CIRC RES, V116
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrow CMK, 2007, ANN NY ACAD SCI, V1120, P144, DOI 10.1196/annals.1411.005
   Mullen TE, 2003, AIDS RES HUM RETROV, V19, P235, DOI 10.1089/088922203763315740
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 35
TC 257
Z9 266
U1 3
U2 79
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD DEC 15
PY 2016
VL 540
IS 7633
BP 438
EP +
DI 10.1038/nature20556
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE6JR
UT WOS:000389716800043
PM 27798603
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Sapparapu, G
   Fernandez, E
   Kose, N
   Cao, B
   Fox, JM
   Bombardi, RG
   Zhao, HY
   Nelson, CA
   Bryan, AL
   Barnes, T
   Davidson, E
   Mysorekar, IU
   Fremont, DH
   Doranz, BJ
   Diamond, MS
   Crowe, JE
AF Sapparapu, Gopal
   Fernandez, Estefania
   Kose, Nurgun
   Cao, Bin
   Fox, Julie M.
   Bombardi, Robin G.
   Zhao, Haiyan
   Nelson, Christopher A.
   Bryan, Aubrey L.
   Barnes, Trevor
   Davidson, Edgar
   Mysorekar, Indira U.
   Fremont, Daved H.
   Doranz, Benjamin J.
   Diamond, Michael S.
   Crowe, James E., Jr.
TI Neutralizing human antibodies prevent Zika virus replication and fetal
   disease in mice
SO NATURE
LA English
DT Article
ID WEST-NILE-VIRUS; MONOCLONAL-ANTIBODIES; CROSS-REACTIVITY; INFECTION;
   PREGNANCY; ENHANCEMENT; PROTECTION; EXPOSURE
AB Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that can cause severe disease, including congenital birth defects during pregnancy(1). To develop candidate therapeutic agents against ZIKV, we isolated a panel of human monoclonal antibodies from subjects that were previously infected with ZIKV. We show that a subset of antibodies recognize diverse epitopes on the envelope (E) protein and exhibit potent neutralizing activity. One of the most inhibitory antibodies, ZIKV-117, broadly neutralized infection of ZIKV strains corresponding to African and Asian-American lineages. Epitope mapping studies revealed that ZIKV-117 recognized a unique quaternary epitope on the E protein dimer-dimer interface. We evaluated the therapeutic efficacy of ZIKV-117 in pregnant and non-pregnant mice. Monoclonal antibody treatment markedly reduced tissue pathology, placental and fetal infection, and mortality in mice. Thus, neutralizing human antibodies can protect against maternal-fetal transmission, infection and disease, and reveal important determinants for structure-based rational vaccine design efforts.
C1 [Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.
   [Sapparapu, Gopal; Kose, Nurgun; Bombardi, Robin G.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.
   [Fernandez, Estefania; Zhao, Haiyan; Nelson, Christopher A.; Mysorekar, Indira U.; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
   [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Fox, Julie M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Bryan, Aubrey L.; Barnes, Trevor; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol, Philadelphia, PA USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
EM diamond@wusm.wustl.edu; james.crowe@vanderbilt.edu
RI Diamond, Michael/AAH-1733-2019; Crowe, James E./B-5549-2009
OI Diamond, Michael/0000-0002-8791-3165; Crowe, James
   E./0000-0002-0049-1079; Fox, Julie/0000-0003-0567-738X; Sapparapu,
   Gopal/0000-0001-9670-1757; PEREZ-ALBELA FERNANDEZ,
   EDUARDO/0000-0002-1428-6041
FU US N.I.H.United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI073755, R01 AI104972,
   HHSN272201400024C, HHSN272201400058C, HHSN272201400018C,
   HHSN272201200026C]; Preventing Prematurity Initiative grant from the
   Burroughs Wellcome Fund; March of DimesMarch of Dimes; N.I.H.United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [T32 AI007163]
FX We thank N. Murphy, J. Govero, M. Gorman, J. Miner, R. Fong and S. Reddy
   for technical help and advice on experiments. This work was supported by
   US N.I.H. grants R01 AI073755 (to M.S.D., D.H.F and J.E.C.), R01
   AI104972 (to M.S.D.), US N.I.H. contracts HHSN272201400024C (to J.E.C.),
   HHSN272201400058C (to B.J.D.), HHSN272201400018C (to D.H.F, M.S.D, and
   J.E.C) and HHSN272201200026C (CSGID; to D.H.F), and by a Preventing
   Prematurity Initiative grant from the Burroughs Wellcome Fund and an
   Investigator award from the March of Dimes (to I.U.M.). E.F. was
   supported by an N.I.H. Pre-doctoral training grant award (T32 AI007163).
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316
   Charles A. S., 2016, PLOS CURR, V8, P1
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nelson CA, 2014, METHODS MOL BIOL, V1140, P145, DOI 10.1007/978-1-4939-0354-2_11
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Thornburg NJ, 2016, J CLIN INVEST, V126, P1482, DOI 10.1172/JCI85317
   Thornburg NJ, 2013, J CLIN INVEST, V123, P4405, DOI 10.1172/JCI69377
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 33
TC 211
Z9 212
U1 1
U2 87
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD DEC 15
PY 2016
VL 540
IS 7633
BP 443
EP +
DI 10.1038/nature20564
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE6JR
UT WOS:000389716800044
PM 27819683
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Brasil, P
   Pereira, JP
   Moreira, ME
   Nogueira, RMR
   Damasceno, L
   Wakimoto, M
   Rabello, RS
   Valderramos, SG
   Halai, UA
   Salles, TS
   Zin, AA
   Horovitz, D
   Daltro, P
   Boechat, M
   Gabaglia, CR
   de Sequeira, PC
   Pilotto, JH
   Medialdea-Carrera, R
   da Cunha, DC
   de Carvalho, LMA
   Pone, M
   Siqueira, AM
   Calvet, GA
   Baiao, AER
   Neves, ES
   de Carvalho, PRN
   Hasue, RH
   Marschik, PB
   Einspieler, C
   Janzen, C
   Cherry, JD
   de Filippis, AMB
   Nielsen-Saines, K
AF Brasil, P.
   Pereira, J. P., Jr.
   Moreira, M. E.
   Ribeiro Nogueira, R. M.
   Damasceno, L.
   Wakimoto, M.
   Rabello, R. S.
   Valderramos, S. G.
   Halai, U. -A.
   Salles, T. S.
   Zin, A. A.
   Horovitz, D.
   Daltro, P.
   Boechat, M.
   Gabaglia, C. Raja
   Carvalho de Sequeira, P.
   Pilotto, J. H.
   Medialdea-Carrera, R.
   Cotrim da Cunha, D.
   Abreu de Carvalho, L. M.
   Pone, M.
   Machado Siqueira, A.
   Calvet, G. A.
   Rodrigues Baiao, A. E.
   Neves, E. S.
   Nassar de Carvalho, P. R.
   Hasue, R. H.
   Marschik, P. B.
   Einspieler, C.
   Janzen, C.
   Cherry, J. D.
   Bispo de Filippis, A. M.
   Nielsen-Saines, K.
TI Zika Virus Infection in Pregnant Women in Rio de Janeiro
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID BRAZIL; TRANSMISSION; RUBELLA
AB BACKGROUND
   Zika virus (ZIKV) has been linked to central nervous system malformations in fetuses. To characterize the spectrum of ZIKV disease in pregnant women and infants, we followed patients in Rio de Janeiro to describe clinical manifestations in mothers and repercussions of acute ZIKV infection in infants.
   METHODS
   We enrolled pregnant women in whom a rash had developed within the previous 5 days and tested blood and urine specimens for ZIKV by reverse-transcriptase-polymerase-chain-reaction assays. We followed women prospectively to obtain data on pregnancy and infant outcomes.
   RESULTS
   A total of 345 women were enrolled from September 2015 through May 2016; of these, 182 women (53%) tested positive for ZIKV in blood, urine, or both. The timing of acute ZIKV infection ranged from 6 to 39 weeks of gestation. Predominant maternal clinical features included a pruritic descending macular or maculopapular rash, arthralgias, conjunctival injection, and headache; 27% had fever (short-term and low-grade). By July 2016, a total of 134 ZIKV-affected pregnancies and 73 ZIKV-unaffected pregnancies had reached completion, with outcomes known for 125 ZIKV-affected and 61 ZIKV-unaffected pregnancies. Infection with chikungunya virus was identified in 42% of women without ZIKV infection versus 3% of women with ZIKV infection (P<0.001). Rates of fetal death were 7% in both groups; overall adverse outcomes were 46% among offspring of ZIKV-positive women versus 11.5% among offspring of ZIKV-negative women (P<0.001). Among 117 live infants born to 116 ZIKV-positive women, 42% were found to have grossly abnormal clinical or brain imaging findings or both, including 4 infants with microcephaly. Adverse outcomes were noted regardless of the trimester during which the women were infected with ZIKV (55% of pregnancies had adverse outcomes after maternal infection in the first trimester, 52% after infection in the second trimester, and 29% after infection in the third trimester).
   CONCLUSIONS
   Despite mild clinical symptoms in the mother, ZIKV infection during pregnancy is deleterious to the fetus and is associated with fetal death, fetal growth restriction, and a spectrum of central nervous system abnormalities. (Funded by Ministerio da Saude do Brasil and others.)
C1 [Brasil, P.; Pereira, J. P., Jr.; Moreira, M. E.; Ribeiro Nogueira, R. M.; Damasceno, L.; Wakimoto, M.; Rabello, R. S.; Salles, T. S.; Zin, A. A.; Horovitz, D.; Boechat, M.; Carvalho de Sequeira, P.; Pilotto, J. H.; Medialdea-Carrera, R.; Cotrim da Cunha, D.; Abreu de Carvalho, L. M.; Pone, M.; Machado Siqueira, A.; Calvet, G. A.; Rodrigues Baiao, A. E.; Neves, E. S.; Nassar de Carvalho, P. R.; Bispo de Filippis, A. M.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Daltro, P.] Clin Diagnost Imagem, Rio De Janeiro, Brazil.
   [Valderramos, S. G.; Halai, U. -A.; Janzen, C.; Cherry, J. D.; Nielsen-Saines, K.] David Geffen UCLA Sch Med, Los Angeles, CA USA.
   [Gabaglia, C. Raja] Biomed Res Inst Southern Calif, Oceanside, CA USA.
   [Hasue, R. H.] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil.
   [Marschik, P. B.; Einspieler, C.] Med Univ Graz, Graz, Austria.
   [Marschik, P. B.] Karolinska Inst, Stockholm, Sweden.
RP Brasil, P (corresponding author), Fiocruz MS, INI, Lab Doencas Febris Agudas, 4365 Av Brasil, BR-21040900 Rio De Janeiro, RJ, Brazil.; Nielsen-Saines, K (corresponding author), UCLA, David Geffen Sch Med, Div Pediat Infectious Dis, MDCC 22-442,10833 LeConte Ave, Los Angeles, CA 90095 USA.
EM patricia.brasil33@gmail.com; knielsen@mednet.ucla.edu
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Hasue, Renata/B-2328-2013;
   Siqueira, Andre M/G-1340-2010; Pilotto, Jose Henrique/AAD-9773-2019;
   Gaw, Stephanie/K-4592-2019; Calvet, Guilherme/G-6959-2013; Marschik,
   Peter B/F-8195-2011
OI Siqueira, Andre M/0000-0003-2208-0294; Pilotto, Jose
   Henrique/0000-0003-0521-8597; Gaw, Stephanie/0000-0003-0891-6964; da
   Silva Pone, Marcos Vinicius/0000-0002-5152-2242; Calvet,
   Guilherme/0000-0002-3545-5238; Marschik, Peter B/0000-0001-8932-0980;
   Medialdea-Carrera, Raquel/0000-0002-0371-5138
FU Ministerio da Saude do Brasil; Medical Research CouncilMedical Research
   Council UK (MRC) [MC_PC_15101]; Bill & Melinda Gates Foundation - Grand
   Challenges Explorations Initiative [OPP1128871]
FX Funded by Ministerio da Saude do Brasil and others.
CR [Anonymous], 2015, EP AL NEUR SYNDR CON
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Cherry JD, 2014, FEIGIN CHERRYS TXB P, P741
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088
   GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NAEYE RL, 1965, J AMER MED ASSOC, V194, P1277, DOI 10.1001/jama.194.12.1277
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   PLOTKIN SA, 1965, AM J EPIDEMIOL, V81, P71, DOI 10.1093/oxfordjournals.aje.a120499
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SEVER JL, 1964, OBSTET GYNECOL, V23, P153
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 767
Z9 786
U1 8
U2 200
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD DEC 15
PY 2016
VL 375
IS 24
BP 2321
EP 2334
DI 10.1056/NEJMoa1602412
PG 14
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF0SO
UT WOS:000390036500004
PM 26943629
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Tian, B
   Qiu, Z
   Ma, J
   de la Torre, TZG
   Johansson, C
   Svedlindh, P
   Stromberg, M
AF Tian, Bo
   Qiu, Zhen
   Ma, Jing
   de la Torre, Teresa Zardan Gomez
   Johansson, Christer
   Svedlindh, Peter
   Stromberg, Mattias
TI Attomolar Zika virus oligonucleotide detection based on loop-mediated
   isothermal amplification and AC susceptometry
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Zika virus; Loop-mediated isothermal amplification; Magnetic
   nanoparticles; Brownian relaxation; AC susceptometer
ID ARBOVIRUS THREAT; OUTBREAK; INFECTION; BRAZIL; TRANSMISSION; DYNAMICS;
   AMERICA; SALIVA; PCR
AB Because of the serological cross-reactivity among the flaviviruses, molecular detection methods, such as reverse-transcription polymerase chain reaction (RT-PCR), play an important role in the recent Zika outbreak. However, due to the limited sensitivity, the detection window of RT-PCR for Zika viremia is only about one week after symptom onset. By combining loop-mediated isothermal amplification (LAMP) and AC susceptometry, we demonstrate a rapid and homogeneous detection system for the Zika virus oligonucleotide. Streptavidin-magnetic nanoparticles (streptavidin-MNPs) are premixed with LAMP reagents including the analyte and biotinylated primers, and their hydrodynamic volumes are dramatically increased after a successful LAMP reaction. Analyzed by a portable AC susceptometer, the changes of the hydrodynamic volume are probed as Brownian relaxation frequency shifts, which can be used to quantify the Zika virus oligonucleotide. The proposed detection system can recognize 1 aM synthetic Zika virus oligonucleotide in 20% serum with a total assay time of 27 min, which can hopefully widen the detection window for Zika viremia and is therefore promising in worldwide Zika fever control. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Tian, Bo; Qiu, Zhen; de la Torre, Teresa Zardan Gomez; Svedlindh, Peter; Stromberg, Mattias] Uppsala Univ, Dept Engn Sci, Angstrom Lab, Box 534, SE-75121 Uppsala, Sweden.
   [Ma, Jing] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden.
   [Johansson, Christer] Acreo Swedish ICT AB, Arvid Hedvalls Backe 4, SE-41133 Gothenburg, Sweden.
RP Stromberg, M (corresponding author), Uppsala Univ, Dept Engn Sci, Angstrom Lab, Box 534, SE-75121 Uppsala, Sweden.
EM mattias.stromberg@angstrom.uu.se
RI Johansson, Christer/Y-6654-2019; Tian, Bo/K-1774-2019; Svedlindh,
   Peter/K-2702-2012
OI Johansson, Christer/0000-0002-6662-8023; Tian, Bo/0000-0002-5249-4415;
   Svedlindh, Peter/0000-0002-3049-6831
FU Swedish Research Council FormasSwedish Research CouncilSwedish Research
   Council Formas [221-2012-444, 221-2014-574, 2011-1692]
FX This work was financially supported by Swedish Research Council Formas
   (Project nos. 221-2012-444, 221-2014-574 and 2011-1692).
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Astalan AP, 2004, BIOSENS BIOELECTRON, V19, P945, DOI 10.1016/j.bios.2003.09.005
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   Brasil P, 2016, N ENGL J MED
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, N ENGL J MED
   de la Torre TZG, 2011, BIOSENS BIOELECTRON, V29, P195, DOI 10.1016/j.bios.2011.08.019
   Donolato M, 2015, ANAL CHEM, V87, P1622, DOI 10.1021/ac503191v
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goeijenbier M, 2016, NETH J MED, V74, P104
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haug CJ, 2016, N ENGL J MED
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Tian B., 2016, UNPUB
   Tian B, 2016, BIOSENS BIOELECTRON, V77, P32, DOI 10.1016/j.bios.2015.08.070
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 39
TC 41
Z9 44
U1 4
U2 144
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD DEC 15
PY 2016
VL 86
BP 420
EP 425
DI 10.1016/j.bios.2016.06.085
PG 6
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA DY1KG
UT WOS:000384853300057
PM 27423039
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Wang, QH
   Yang, HB
   Liu, XQ
   Dai, LP
   Ma, T
   Qi, JX
   Wong, G
   Peng, RC
   Liu, S
   Li, JF
   Li, SH
   Song, J
   Liu, JY
   He, JH
   Yuan, H
   Xiong, Y
   Liao, Y
   Li, JH
   Yang, JP
   Tong, Z
   Griffin, BD
   Bi, YH
   Liang, MF
   Xu, XN
   Qin, C
   Cheng, G
   Zhang, XZ
   Wang, PY
   Qiu, XG
   Kobinger, G
   Shi, Y
   Yan, JH
   Gao, GF
AF Wang, Qihui
   Yang, Huabing
   Liu, Xiaoqing
   Dai, Lianpan
   Ma, Tong
   Qi, Jianxun
   Wong, Gary
   Peng, Ruchao
   Liu, Sheng
   Li, Junfu
   Li, Shihua
   Song, Jian
   Liu, Jianying
   He, Jianhua
   Yuan, Hui
   Xiong, Ying
   Liao, Yong
   Li, Jianhua
   Yang, Jianping
   Tong, Zhou
   Griffin, Bryan D.
   Bi, Yuhai
   Liang, Mifang
   Xu, Xiaoning
   Qin, Chuan
   Cheng, Gong
   Zhang, Xinzheng
   Wang, Peiyi
   Qiu, Xiangguo
   Kobinger, Gary
   Shi, Yi
   Yan, Jinghua
   Gao, George F.
TI Molecular determinants of human neutralizing antibodies isolated from a
   patient infected with Zika virus
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID DENGUE VIRUS; CROSS-REACTIVITY; STRUCTURAL BASIS; DOMAIN-III;
   TRANSMISSION; VECTOR
AB The 2015-2016 outbreak of Zika virus (ZIKV) disease has affected many countries and is a major public health concern. ZIKV is associated with fetal microcephaly and neurological complications, and countermeasures are needed to treat and prevent ZIKV infection. We report the isolation of 13 specific human monoclonal antibodies from a single patient infected with ZIKV. Two of the isolated antibodies (Z23 and Z3L1) demonstrated potent ZIKV-specific neutralization in vitro without binding or neutralizing activity against strains 1 to 4 of dengue virus, the closest relative to ZIKV. These two antibodies provided postexposure protection to mice in vivo. Structural studies revealed that Z23 and Z3L1 bound to tertiary epitopes in envelope protein domain I, II, or III, indicating potential targets for ZIKV-specific therapy. Our results suggest the potential of antibody-based therapeutics and provide a structure-based rationale for the design of future ZIKV-specific vaccines.
C1 [Wang, Qihui; Yang, Huabing; Ma, Tong; Li, Junfu; Tong, Zhou; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing 100101, Peoples R China.
   [Wang, Qihui; Wong, Gary; Tong, Zhou; Bi, Yuhai; Shi, Yi; Yan, Jinghua; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.
   [Yang, Huabing; Ma, Tong; Yan, Jinghua] Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China.
   [Liu, Xiaoqing; Yuan, Hui; Xiong, Ying] Jiangxi Prov Ctr Dis Control & Prevent, Nanchang 330029, Jiangxi, Peoples R China.
   [Dai, Lianpan; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China.
   [Qi, Jianxun; Wong, Gary; Peng, Ruchao; Liu, Sheng; Li, Shihua; Song, Jian; Tong, Zhou; Bi, Yuhai; Shi, Yi; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Wong, Gary; Bi, Yuhai; Gao, George F.] Chinese Acad Sci, CAS Ctr Influenza Res & Early Warning, Beijing 100101, Peoples R China.
   [Liu, Sheng; Gao, George F.] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China.
   [Liu, Jianying] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.
   [He, Jianhua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China.
   [Liao, Yong; Li, Jianhua; Yang, Jianping] Ganzhou Prefecture Ctr Dis Control & Prevent, Ganzhou 331000, Peoples R China.
   [Griffin, Bryan D.; Qiu, Xiangguo; Kobinger, Gary] Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada.
   [Griffin, Bryan D.; Qiu, Xiangguo] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada.
   [Liang, Mifang; Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Xu, Xiaoning] Univ Oxford, Human Immunol Unit, MRC, Oxford OX3 9DS, England.
   [Qin, Chuan] Chinese Acad Med Sci, Inst Med Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China.
   [Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.
   [Zhang, Xinzheng] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Ctr Biol Imaging, Beijing 100101, Peoples R China.
   [Wang, Peiyi] Univ Leeds, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England.
   [Yan, Jinghua] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.
   [Gao, George F.] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.
   [Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
RP Yan, JH (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing 100101, Peoples R China.; Yan, JH; Gao, GF (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen 518112, Peoples R China.; Yan, JH (corresponding author), Anhui Univ, Sch Life Sci, Hefei 230039, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100101, Peoples R China.; Yan, JH; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, CAS Ctr Influenza Res & Early Warning, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.; Yan, JH (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.; Gao, GF (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
EM yanjh@im.ac.cn; gaof@im.ac.cn
RI zhang, xinzheng/L-6254-2019
FU State Key Research Development Program of ChinaState Key Development
   Program for Basic Research of China [2016YFC1200300]; Zika Special
   Project of the Ministry of Science and Technology Reform and Development
   Project; Public Health Agency of Canada; Banting Postdoctoral Fellowship
   from the Canadian Institutes of Health ResearchCanadian Institutes of
   Health Research (CIHR); President's International Fellowship Initiative
   from the CAS; National Natural Science Foundation of China
   (NSFC)National Natural Science Foundation of China [81422028, 81571975];
   Excellent Young Scientist Program of CAS; Youth Innovation Promotion
   Association of CAS [2015078]; Young Elite Scientist Sponsorship Program
   by China Association for Science and Technology; NSFC Innovative
   Research Group [81321063]; Academy of Medical Sciences (AMS)Academy of
   Medical Sciences (AMS) [AMS-NAF1-Cheng]
FX This work was supported by the State Key Research Development Program of
   China (grant no. 2016YFC1200300) and the Zika Special Project of the
   Ministry of Science and Technology Reform and Development Project.
   B.D.G., X.Q., and G.K. were partially supported by the Public Health
   Agency of Canada. G.W. is the recipient of a Banting Postdoctoral
   Fellowship from the Canadian Institutes of Health Research and the
   President's International Fellowship Initiative from the CAS. G.C. is
   supported by the National Natural Science Foundation of China (NSFC;
   grant nos. 81422028 and 81571975). Y.S. is supported by the Excellent
   Young Scientist Program of CAS and the Youth Innovation Promotion
   Association of CAS (grant no. 2015078). Q.W. is supported by Young Elite
   Scientist Sponsorship Program by China Association for Science and
   Technology. G.F.G. is a leading principal investigator of the NSFC
   Innovative Research Group (grant no. 81321063).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P785, DOI 10.1038/ni0715-785a
   Deng Y, 2011, CONTROL THEORY APPL, V6, P6, DOI DOI 10.1371/J0URNAL.P0NE.0016059
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Qiu XG, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9875
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009
   van der Burg M, 2001, BLOOD, V97, P1001, DOI 10.1182/blood.V97.4.1001
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Wang QH, 2014, CELL HOST MICROBE, V16, P328, DOI 10.1016/j.chom.2014.08.009
   World Health Organization, 2016, ZIK VIR COMPL
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 54
TC 113
Z9 121
U1 3
U2 57
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD DEC 14
PY 2016
VL 8
IS 369
AR 369ra179
DI 10.1126/scitranslmed.aai8336
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA EG5UL
UT WOS:000391110000005
PM 27974667
DA 2020-07-08
ER

PT J
AU Retallack, H
   Di Lullo, E
   Arias, C
   Knopp, KA
   Laurie, MT
   Sandoval-Espinosa, C
   Leon, WRM
   Krencik, R
   Ullian, EM
   Spatazza, J
   Pollen, AA
   Mandel-Brehm, C
   Nowakowski, TJ
   Kriegstein, AR
   DeRisi, JL
AF Retallack, Hanna
   Di Lullo, Elizabeth
   Arias, Carolina
   Knopp, Kristeene A.
   Laurie, Matthew T.
   Sandoval-Espinosa, Carmen
   Leon, Walter R. Mancia
   Krencik, Robert
   Ullian, Erik M.
   Spatazza, Julien
   Pollen, Alex A.
   Mandel-Brehm, Caleigh
   Nowakowski, Tomasz J.
   Kriegstein, Arnold R.
   DeRisi, Joseph L.
TI Zika virus cell tropism in the developing human brain and inhibition by
   azithromycin
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; cortical development; azithromycin; microcephaly
ID INFECTION
AB The rapid spread of Zika virus (ZIKV) and its association with abnormal brain development constitute a global health emergency. Congenital ZIKV infection produces a range of mild to severe pathologies, including microcephaly. To understand the pathophysiology of ZIKV infection, we used models of the developing brain that faithfully recapitulate the tissue architecture in early to midgestation. We identify the brain cell populations that are most susceptible to ZIKV infection in primary human tissue, provide evidence for a mechanism of viral entry, and show that a commonly used antibiotic protects cultured brain cells by reducing viral proliferation. In the brain, ZIKV preferentially infected neural stem cells, astrocytes, oligodendrocyte precursor cells, and microglia, whereas neurons were less susceptible to infection. These findings suggest mechanisms for microcephaly and other pathologic features of infants with congenital ZIKV infection that are not explained by neural stem cell infection alone, such as calcifications in the cortical plate. Furthermore, we find that blocking the glia-enriched putative viral entry receptor AXL reduced ZIKV infection of astrocytes in vitro, and genetic knockdown of AXL in a glial cell line nearly abolished infection. Finally, we evaluate 2,177 compounds, focusing on drugs safe in pregnancy. We show that the macrolide antibiotic azithromycin reduced viral proliferation and virus-induced cytopathic effects in glial cell lines and human astrocytes. Our characterization of infection in the developing human brain clarifies the pathogenesis of congenital ZIKV infection and provides the basis for investigating possible therapeutic strategies to safely alleviate or prevent the most severe consequences of the epidemic.
C1 [Retallack, Hanna; Arias, Carolina; Knopp, Kristeene A.; Laurie, Matthew T.; Mandel-Brehm, Caleigh; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.
   [Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Leon, Walter R. Mancia; Spatazza, Julien; Pollen, Alex A.; Nowakowski, Tomasz J.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.
   [Di Lullo, Elizabeth; Sandoval-Espinosa, Carmen; Leon, Walter R. Mancia; Pollen, Alex A.; Nowakowski, Tomasz J.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.
   [Arias, Carolina] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.
   [Krencik, Robert; Ullian, Erik M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94122 USA.
   [Krencik, Robert] Houston Methodist Res Inst, Ctr Neuroregenerat, Dept Neurosurg, Houston, TX 77030 USA.
   [Spatazza, Julien] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.
RP DeRisi, JL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.; Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Kriegstein, AR (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.
EM kriegsteina@stemcell.ucsf.edu; joe@derisilab.ucsf.edu
OI Krencik, Robert/0000-0002-2968-3162
FU NIH/NINDSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS075998, U01 MH105989]; Howard Hughes
   Medical InstituteHoward Hughes Medical Institute; NIMHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [R01MH099595-01];
   Paul G. Allen Family Foundation; Damon Runyon Cancer Research Foundation
   [DRG-2166-13]
FX We thank Marc and Lynne Benioff for their financial support of these
   studies. We also thank Susan Fisher (UCSF), Robert Tesh (UTMB), Nikos
   Vasilakis (UTMB), Julio Rodriguez-Andres (CSIRO), Graham Simmons (BSRI),
   Charles Chiu (UCSF), Dan Lim (UCSF), John Liu (UCSF), Max Horlbeck
   (UCSF), Shaohui Wang (UCSF), Diego Acosta-Alvear (UCSF), and the Small
   Molecule Discovery Center at UCSF for providing reagents and advice.
   This work was supported by NIH/NINDS Grants R01NS075998 and U01 MH105989
   as well as a gift from Bernard Osher (to A.R.K.), Howard Hughes Medical
   Institute (J.L.D.), NIMH Grant R01MH099595-01 and Paul G. Allen Family
   Foundation Distinguished Investigator Award (to E.M.U.), and Damon
   Runyon Cancer Research Foundation Postdoctoral Fellowship DRG-2166-13
   (to A.A.P.).
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DHHS Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2016, GUID PREV TREATM OPP
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Jaruratanasirikul S, 1996, ANTIMICROB AGENTS CH, V40, P825, DOI 10.1128/AAC.40.3.825
   Kemp MW, 2014, ANTIMICROB AGENTS CH, V58, P6581, DOI 10.1128/AAC.03721-14
   Krencik R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5645
   Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lin KJ, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.12.023
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu SJ, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0932-1
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramsey PS, 2003, AM J OBSTET GYNECOL, V188, P714, DOI 10.1067/mob.2003.141
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Sacramento CQ, 2016, BIORXIV
   Sarkar Moumita, 2006, BMC Pregnancy Childbirth, V6, P18, DOI 10.1186/1471-2393-6-18
   Stenglein MD, 2014, MBIO, V5, DOI 10.1128/mBio.01484-14
   Sutton AL, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Workowski KA, 2015, MMWR RECOMM REP, V64, P1
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 32
TC 169
Z9 171
U1 2
U2 53
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 13
PY 2016
VL 113
IS 50
BP 14408
EP 14413
DI 10.1073/pnas.1618029113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE6CQ
UT WOS:000389696700070
PM 27911847
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Saad-Roy, CM
   van den Driessche, P
   Ma, JL
AF Saad-Roy, C. M.
   van den Driessche, P.
   Ma, Junling
TI Estimation of Zika virus prevalence by appearance of microcephaly
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika prevalence; Microcephaly; Vector transmission; Sexual transmission;
   Mathematical model; Contact network
ID SEXUAL TRANSMISSION; OUTBREAK; CHIKUNGUNYA; INFECTION; EMERGENCE;
   DENGUE; STATES
AB Background: There currently is a severe Zika Virus (ZIKV) epidemic in Brazil and other South American countries. Due to international travel, this poses severe public health risk of ZIKV importation to other countries. We estimate the prevalence of ZIKV in an import region by the time a microcephaly case is detected, since microcephaly is presently the most significant indication of ZIKV presence.
   Methods: We establish a mathematical model to describe ZIKV spread from a source region to an import region. This model incorporates both vector transmission (between humans and mosquitoes) and sexual transmission (from males to females). We take account of population structure through a contact network for sexually active individuals. Parameter values of our model are either taken from the literature or estimated from travel data.
   Results: This model gives us the probability distribution of time until detection of the first microcephaly case. Based on current field observations, our results also indicate that the percentage of infected pregnant women that results in fetal abnormalities is more likely to be on the smaller end of the 1%-30% spectrum that is currently hypothesized. Our model predicts that for import regions with at least 250,000 people, on average 1,000-12,000 will have been infected by the time of the first detection of microcephaly, and on average 200-1,500 will be infectious at this time. Larger population sizes do not significantly change our predictions.
   Conclusions: By the first detection of a microcephaly case, a sizable fraction of the population will have been infected by ZIKV. It is thus clear that adequate surveillance, isolation, and quarantine are needed in susceptible import regions to stop the dissemination of a Zika epidemic.
C1 [Saad-Roy, C. M.; van den Driessche, P.; Ma, Junling] Univ Victoria, Dept Math & Stat, Victoria, BC V8W 2Y2, Canada.
RP Ma, JL (corresponding author), Univ Victoria, Dept Math & Stat, Victoria, BC V8W 2Y2, Canada.
EM junlingm@uvic.ca
FU NSERC, through NSERC Discovery Grants; NSERC-USRANatural Sciences and
   Engineering Research Council of Canada
FX This research is supported by NSERC, through NSERC Discovery Grants (J.
   M. and P. vdD.) and NSERC-USRA (C. M. S.- R.).
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson N, 2016, COUNTERING ZIKA LATI, DOI [10.1126/science.aag0219, DOI 10.1126/SCIENCE.AAG0219]
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MacFadden DR, 2016, CAN MED ASSOC J, V188, P367, DOI 10.1503/cmaj.151486
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PAHO, 2016, TECHNICAL REPORT
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rasmussen SA, 2007, NEW ENGL J MED, V374, P1981
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Riker D, 2013, J INT COMMERCE EC, V5, P1
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   World Health Organization W, 2016, TECHNICAL REPORT
NR 31
TC 8
Z9 8
U1 1
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD DEC 12
PY 2016
VL 16
AR 754
DI 10.1186/s12879-016-2076-z
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA EF4DW
UT WOS:000390276000008
PM 27955630
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Everts, S
AF Everts, Sarah
TI Progress on Zika
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
OI Everts, Sarah/0000-0001-8898-0581
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD DEC 12
PY 2016
VL 94
IS 49
BP 35
EP 35
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA EF2WA
UT WOS:000390185100059
DA 2020-07-08
ER

PT J
AU Chan, K
   Weaver, SC
   Wong, PY
   Lie, S
   Wang, E
   Guerbois, M
   Vayugundla, SP
   Wong, S
AF Chan, Kamfai
   Weaver, Scott C.
   Wong, Pui-Yan
   Lie, Sherly
   Wang, Eryu
   Guerbois, Mathilde
   Vayugundla, Siva Praneeth
   Wong, Season
TI Rapid, Affordable and Portable Medium-Throughput Molecular Device for
   Zika Virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID RECOMBINASE POLYMERASE AMPLIFICATION; CHAIN-REACTION; DNA; ASSAY; PCR;
   URINE
AB Zika virus (ZIKV) has gained global attention as an etiologic agent of fetal microcephaly and Guillain-Barre syndrome. Existing immuno-based rapid tests often fail to distinguish between Zika and related flaviviruses that are common in affected regions of Central and South Americas and the Caribbean. The US CDC and qualified state health department laboratories can perform the reverse transcription polymerase chain reaction (RT-PCR) ZIKV test using highly sophisticated instruments with long turnaround times. The preliminary results of a portable and low-cost molecular diagnostics system for ZIKV infection are reported here. In less than 15 minutes, this low-cost platform can automatically perform high quality RNA extraction from up to 12 ZIKV-spiked urine samples simultaneously. It can also perform reverse transcription recombinase polymerase amplification reaction (RT-RPA) in <= 15 minutes. The fluorescent signal produced from probe-based RT-RPA or RT-PCR assays can be monitored using LEDs and a smartphone camera. In addition, the RT-RPA and RT-PCR assays do not cross-react with dengue and chikungunya viral RNA. This low-cost system lacks complicated, sensitive and high cost components, making it suitable for resource-limited settings. It has the potential to offer simple sample-to-answer molecular diagnostics and can inform healthcare workers of patients' diagnosis promptly.
C1 [Chan, Kamfai; Wong, Pui-Yan; Lie, Sherly; Vayugundla, Siva Praneeth; Wong, Season] AI Biosci Inc, College Stn, TX 77845 USA.
   [Weaver, Scott C.; Wang, Eryu; Guerbois, Mathilde] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Wang, Eryu; Guerbois, Mathilde] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Weaver, Scott C.; Wang, Eryu; Guerbois, Mathilde] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Wong, S (corresponding author), AI Biosci Inc, College Stn, TX 77845 USA.
EM season.wong@aibiosciences.com
FU US National Institutes of Health (NIH) through the Small Business
   Innovative Research (SBIR) program (NIH grant) [1R43EB018641,
   1R43AI107984]; US NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI120942]
FX Some early concepts of the work were conceived based on work done under
   grants from the US National Institutes of Health (NIH) through the Small
   Business Innovative Research (SBIR) program (NIH grant no. 1R43EB018641
   and 1R43AI107984). S.C.W. would like to acknowledge funding by the US
   NIH (Grant no. AI120942). The content is solely the responsibility of
   the authors and does not necessarily represent or reflect views of the
   NIH, or the Federal Government.
CR Abd El Wahed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129682
   Abd El Wahed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071642
   Agrawal N, 2007, ANGEW CHEM INT EDIT, V46, P4316, DOI 10.1002/anie.200700306
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Boyle DS, 2013, MBIO, V4, DOI 10.1128/mBio.00135-13
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan K., 2016, PLOS ONE IN PRESS
   Chan KF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149150
   Crannell ZA, 2014, ANAL CHEM, V86, P5615, DOI 10.1021/ac5011298
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2015, EURO SURVEILL, V20
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Jiang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04137
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Levene H., 1960, CONTRIBUTIONS PROBAB, P278
   Lillis L, 2016, MOL CELL PROBE, V30, P74, DOI 10.1016/j.mcp.2016.01.009
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Priye A, 2016, ANAL CHEM, V88, P4651, DOI 10.1021/acs.analchem.5b04153
   Rodriguez-Manzano J, 2016, ACS NANO, V10, P3102, DOI 10.1021/acsnano.5b07338
   Rohrman B, 2015, ANAL CHEM, V87, P1963, DOI 10.1021/ac504365v
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wong G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131701
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yan L, 2014, MOL BIOSYST, V10, P970, DOI 10.1039/c3mb70304e
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 46
TC 29
Z9 29
U1 2
U2 37
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 9
PY 2016
VL 6
AR 38223
DI 10.1038/srep38223
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE7PO
UT WOS:000389815500001
PM 27934884
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mirza, MU
   Rafique, S
   Ali, A
   Munir, M
   Ikram, N
   Manan, A
   Salo-Ahen, OMH
   Idrees, M
AF Mirza, Muhammad Usman
   Rafique, Shazia
   Ali, Amjad
   Munir, Mobeen
   Ikram, Nazia
   Manan, Abdul
   Salo-Ahen, Outi M. H.
   Idrees, Muhammad
TI Towards peptide vaccines against Zika virus: Immunoinformatics combined
   with molecular dynamics simulations to predict antigenic epitopes of
   Zika viral proteins
SO SCIENTIFIC REPORTS
LA English
DT Article
ID FAST INTERACTION REFINEMENT; CLASS-I MOLECULES; DENGUE-FEVER;
   FORCE-FIELD; DRUG DESIGN; DETERMINANTS; DOCKING; FLAVIVIRUSES;
   SPECIFICITY; ANTIBODIES
AB The recent outbreak of Zika virus (ZIKV) infection in Brazil has developed to a global health concern due to its likely association with birth defects (primary microcephaly) and neurological complications. Consequently, there is an urgent need to develop a vaccine to prevent or a medicine to treat the infection. In this study, immunoinformatics approach was employed to predict antigenic epitopes of Zika viral proteins to aid in development of a peptide vaccine against ZIKV. Both linear and conformational B-cell epitopes as well as cytotoxic T-lymphocyte (CTL) epitopes were predicted for ZIKV Envelope (E), NS3 and NS5 proteins. We further investigated the binding interactions of altogether 15 antigenic CTL epitopes with three class I major histocompatibility complex (MHC I) proteins after docking the peptides to the binding groove of the MHC I proteins. The stability of the resulting peptide-MHC I complexes was further studied by molecular dynamics simulations. The simulation results highlight the limits of rigid-body docking methods. Some of the antigenic epitopes predicted and analyzed in this work might present a preliminary set of peptides for future vaccine development against ZIKV.
C1 [Mirza, Muhammad Usman] Univ Lahore, Ctr Res Mol Med CRiMM, Lahore, Pakistan.
   [Rafique, Shazia; Ali, Amjad; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, Lahore, Pakistan.
   [Munir, Mobeen] Univ Educ Lahore, Div Sci & Technol, Lahore, Pakistan.
   [Ikram, Nazia; Manan, Abdul] Univ Lahore, IMBB, Lahore, Pakistan.
   [Salo-Ahen, Outi M. H.] Abo Akad Univ, Struct Bioinformat Lab, Fac Sci & Engn, Biochem, Turku, Finland.
   [Salo-Ahen, Outi M. H.] Abo Akad Univ, Pharmaceut Sci Lab, Fac Sci & Engn, Pharm, Turku, Finland.
   [Idrees, Muhammad] Vice Chancellor Hazara Univ, Mansehra, Pakistan.
RP Idrees, M (corresponding author), Univ Punjab, Ctr Appl Mol Biol, Lahore, Pakistan.; Idrees, M (corresponding author), Vice Chancellor Hazara Univ, Mansehra, Pakistan.
EM idrees.camb@pu.edu.pk
RI Mirza, Muhammad Usman/I-5970-2019; Mirza, Muhammad Usman/F-4150-2015;
   Manan, Abdul/M-5084-2019; Idrees, Muhammad/K-6032-2012; Salo-Ahen, Outi
   M. H./J-9901-2019
OI Mirza, Muhammad Usman/0000-0001-9120-2414; Mirza, Muhammad
   Usman/0000-0001-9120-2414; Idrees, Muhammad/0000-0002-3081-7631;
   Salo-Ahen, Outi M. H./0000-0003-0725-126X; munirahmed,
   mobeenmunir/0000-0002-6719-7376
CR Abualrous ET, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135421
   Alam A., 2016, IMMUNOLOGY
   Alberts B, 2015, MOLECULAR BIOLOGY OF THE CELL, SIXTH EDITION, P1
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495
   Ashfaq UA, 2016, VIRAL IMMUNOL, V29, P436, DOI 10.1089/vim.2016.0033
   Backert L, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0245-0
   Badawy MEI, 2016, J CHITIN CHITOSAN SC, V4, P46, DOI 10.1166/jcc.2016.1097
   BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brusic Vladimir, 2005, Expert Rev Clin Immunol, V1, P145, DOI 10.1586/1744666X.1.1.145
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Case D.A., 2012, AMBER 12
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010
   De Gregorio E, 2012, MICROB BIOTECHNOL, V5, P149, DOI 10.1111/j.1751-7915.2011.00276.x
   De Groot Anne S, 2004, Expert Rev Vaccines, V3, P59
   Delano W.L., 2002, PYMOL MOL GRAPHICS S
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Duhovny D., 2002, ALG BIOINF 2 INT WOR
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985
   Fan PH, 2015, VIRUSES-BASEL, V7, P1558, DOI 10.3390/v7041558
   FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568
   Fleischmann G, 2015, J IMMUNOL, V195, P4503, DOI 10.4049/jimmunol.1501515
   Florea L, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P17, DOI 10.1109/CSB.2003.1227293
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000
   Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009
   Gupta P., 2014, AUSTIN J BIOTECHNOL, V1, P2
   Homan J., 2016, BIORXIV
   Ip PP, 2015, VACCINES-BASEL, V3, P203, DOI 10.3390/vaccines3020203
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186
   Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nair DT, 2002, J IMMUNOL, V168, P2371, DOI 10.4049/jimmunol.168.5.2371
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Rappuoli R, 2000, CURR OPIN MICROBIOL, V3, P445, DOI 10.1016/S1369-5274(00)00119-3
   Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397
   Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009
   Sieker F, 2009, CURR PROTEIN PEPT SC, V10, P286, DOI 10.2174/138920309788452191
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Taebi S., 2016, 2 INT 14 IR GEN C IR
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   TAYLOR WR, 1983, J MOL GRAPHICS, V1, P30
   THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x
   Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054
   Venable RM, 2014, BIOPHYS J, V107, P134, DOI 10.1016/j.bpj.2014.05.034
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1
   Weltman J., 2016, J MED MICROB DIAGN, V5
   Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602
NR 71
TC 36
Z9 37
U1 0
U2 31
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 9
PY 2016
VL 6
AR 37313
DI 10.1038/srep37313
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE7OS
UT WOS:000389813300001
PM 27934901
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, HD
   Saucedo-Cuevas, L
   Shresta, S
   Gleeson, JG
AF Li, Hongda
   Saucedo-Cuevas, Laura
   Shresta, Sujan
   Gleeson, Joseph G.
TI The Neurobiology of Zika Virus
SO NEURON
LA English
DT Review
ID WEST-NILE-VIRUS; CONGENITAL CYTOMEGALOVIRUS-INFECTION;
   CENTRAL-NERVOUS-SYSTEM; DENGUE VIRUS; NEURAL PROGENITORS; VERTICAL
   TRANSMISSION; FLACCID PARALYSIS; CROSS-REACTIVITY; STEM-CELLS; BRAIN
AB Zika virus (ZIVK) represents a new threat to global health, with particular relevance to neuroscientists, due to associated newborn and adult neurological disease. Consequences of vertical infection include microcephaly with brain and eye anomalies, and consequences of adult infection include Guillain-Barre syndrome (GBS) and meningoencephalitis. Recent data suggest specific vulnerability of neural progenitors to infection, leading to cell death and brain calcification, reminiscent of other viral syndromes. Prevailing models suggest entry into neuronal stem cells through transmembrane receptors, hijacking cellular signaling to interfere with neurogenesis and cell survival. Mechanisms of adult neurological disease are unknown, but recent evidence suggests propensity for infection of adult neural stem cells. Efforts focused on mechanisms of pathogenesis, vulnerabilities, and treatments are urgently needed.
C1 [Li, Hongda; Saucedo-Cuevas, Laura; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA.
   [Li, Hongda; Saucedo-Cuevas, Laura; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, La Jolla, CA 92093 USA.
   [Shresta, Sujan] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.
RP Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10065 USA.; Gleeson, JG (corresponding author), Univ Calif San Diego, Dept Neurosci, Howard Hughes Med Inst, Rady Childrens Inst Genom Med, La Jolla, CA 92093 USA.
EM jogleeson@ucsd.edu
RI Li, Hongda/F-3034-2017
OI Li, Hongda/0000-0001-6754-5150
FU New York Stem Cell Foundation [NYSCF-D-F47]
FX We thank Stephen Spector, Deborah Spector, and Tariq Rana for
   discussions. H.L. is supported by a Druckenmiller Fellowship from New
   York Stem Cell Foundation (NYSCF-D-F47). J.G.G. is an Investigator with
   the Howard Hughes Medical Institute.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Araujo F, 2012, EMERG INFECT DIS, V18, P677, DOI [10.3201/eid1804.111552, 10.3201/eid1804.111522]
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592
   Chen JC, 2002, BLOOD, V99, P561, DOI 10.1182/blood.V99.2.561
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   IBANEZ CE, 1991, J VIROL, V65, P6581, DOI 10.1128/JVI.65.12.6581-6588.1991
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   JONES CA, 1995, J PAEDIATR CHILD H, V31, P70, DOI 10.1111/j.1440-1754.1995.tb00749.x
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li J, 2003, ANN NEUROL, V53, P703, DOI 10.1002/ana.10575
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Michaels MG, 2003, PEDIATR INFECT DIS J, V22, P504, DOI 10.1097/00006454-200306000-00005
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schwartz D.A., 2016, ARCH PATHOL LAB MED
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
NR 72
TC 60
Z9 60
U1 0
U2 55
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD DEC 7
PY 2016
VL 92
IS 5
BP 949
EP 958
DI 10.1016/j.neuron.2016.11.031
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA EG7VJ
UT WOS:000391264200007
PM 27930910
OA Bronze
DA 2020-07-08
ER

PT J
AU Rochlin, I
   Faraji, A
   Ninivaggi, DV
   Barker, CM
   Kilpatrick, AM
AF Rochlin, Ilia
   Faraji, Ary
   Ninivaggi, Dominick V.
   Barker, Christopher M.
   Kilpatrick, A. Marm
TI Anthropogenic impacts on mosquito populations in North America over the
   past century
SO NATURE COMMUNICATIONS
LA English
DT Article
ID WEST-NILE; CLIMATE-CHANGE; LAND-USE; DISEASE; RANGE; URBANIZATION;
   TRANSMISSION; CONTAMINANTS; DENSITY; SHIFTS
AB The recent emergence and spread of vector-borne viruses including Zika, chikungunya and dengue has raised concerns that climate change may cause mosquito vectors of these diseases to expand into more temperate regions. However, the long-term impact of other anthropogenic factors on mosquito abundance and distributions is less studied. Here, we show that anthropogenic chemical use (DDT; dichlorodiphenyltrichloroethane) and increasing urbanization were the strongest drivers of changes in mosquito populations over the last eight decades in areas on both coasts of North America. Mosquito populations have increased as much as tenfold, and mosquito communities have become two-to fourfold richer over the last five decades. These increases are correlated with the decay in residual environmental DDT concentrations and growing human populations, but not with temperature. These results illustrate the far-reaching impacts of multiple anthropogenic disturbances on animal communities and suggest that interactions between land use and chemical use may have unforeseen consequences on ecosystems.
C1 [Rochlin, Ilia; Ninivaggi, Dominick V.] Suffolk Cty Vector Control, 335 Yaphank Ave, Yaphank, NY 11980 USA.
   [Rochlin, Ilia; Faraji, Ary] Rutgers State Univ, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ 08901 USA.
   [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, 2020 North Redwood Rd, Salt Lake City, UT 84116 USA.
   [Barker, Christopher M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.
   [Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA.
RP Kilpatrick, AM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, 1156 High St, Santa Cruz, CA 95064 USA.
EM akilpatr@ucsc.edu
RI Barker, Christopher/K-1415-2018
OI Barker, Christopher/0000-0002-7941-346X
FU National Science FoundationNational Science Foundation (NSF)
   [EF-0914866, DEB-1115895, DEB-1336290, DEB-1115069]; National Institute
   of HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R01AI090159]; Suffolk County; Mercer
   County; Research and Policy for Infectious Disease Dynamics (RAPIDD)
   programme of the Science and Technology Directorate; Department of
   Homeland Security, National Institutes of Health; Fogarty International
   Center, National Institutes of HealthUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty
   International Center (FIC)
FX We are greatly indebted to the following individuals: Rich Candeletti
   and the staff of Ocean County Mosquito Extermination Commission for
   mosquito data; Michael Kimball and Debra Lemenager from the Sutter-Yuba
   Mosquito and Vector Control District; the Suffolk County Department of
   Health Services and James Dantonio for mosquito data collection and
   record keeping; Barbara Mahler and Peter Van Metre (USGS) for DDT data
   and advice; the Kilpatrick lab, Jonathan Day, Bill Reisen and Dina
   Fonseca for comments; and Malgorzata Kawalkowski for data processing.
   Funding support was provided by National Science Foundation Grants
   EF-0914866, DEB-1115895, DEB-1336290 and DEB-1115069, National Institute
   of Health Grant 1R01AI090159 and by the taxpayers of Suffolk and Mercer
   Counties. C.M.B. acknowledges financial support from the Research and
   Policy for Infectious Disease Dynamics (RAPIDD) programme of the Science
   and Technology Directorate, Department of Homeland Security and Fogarty
   International Center, National Institutes of Health. The opinions
   expressed are those of the authors and not the funding or governmental
   agencies.
CR Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367
   Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/NCLIMATE1990, 10.1038/nclimate1990]
   Breed GA, 2013, NAT CLIM CHANGE, V3, P142, DOI [10.1038/NCLIMATE1663, 10.1038/nclimate1663]
   Burnham K. P., 2002, MODEL SELECTION MULT
   Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432
   Crawley MJ, 2007, R BOOK, P323, DOI DOI 10.1002/9780470515075
   Darsie R.F. Jr, 1981, Mosquito Systematics Supplement, V1, P1
   Fox R, 2013, INSECT CONSERV DIVER, V6, P5, DOI 10.1111/j.1752-4598.2012.00186.x
   GOTTMANN J, 1957, ECON GEOGR, V33, P189, DOI 10.2307/142307
   Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069
   Henny CJ, 2010, J TOXICOL ENV HEAL B, V13, P579, DOI 10.1080/10937404.2010.538658
   HERMAN SG, 1979, WILDLIFE MONOGR, P6
   Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x
   Hoffmann CH, 1949, SCI MON, V69, P104
   Jetten TH, 1997, AM J TROP MED HYG, V57, P285, DOI 10.4269/ajtmh.1997.57.285
   Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364
   Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x
   Long GR, 2003, 024272 US GEOL SURV
   MULHERN TD, 1985, J AM MOSQUITO CONTR, V1, P411
   NEWSOM LD, 1967, ANNU REV ENTOMOL, V12, P257, DOI 10.1146/annurev.en.12.010167.001353
   Nocera JJ, 2012, P ROY SOC B-BIOL SCI, V279, P3114, DOI 10.1098/rspb.2012.0445
   Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016
   Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286
   Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181
   Prior KM, 2013, ECOLOGY, V94, P1015, DOI 10.1890/12-1710.1
   R Development Core Team, 2012, R LANG ENV STAT COMP
   Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x
   Rochlin I, 2008, J MED ENTOMOL, V45, P563, DOI 10.1603/0022-2585(2008)45[563:CAODAA]2.0.CO;2
   Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6
   SANDERS G, 1992, ENVIRON SCI TECHNOL, V26, P1815, DOI 10.1021/es00033a016
   Siraj AS, 2014, SCIENCE, V343, P1154, DOI 10.1126/science.1244325
   Therneau T.M., 2013, INTRO RECURSIVE PART
   Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007
   United Nations Department of Economic and Social Affairs Population Division, 2014, STESASERA352 UN
   US Environmental Protection Agency, 1975, EPA540175022
   Van Metre P.C., 2004, 20045184 US GEOL SUR
   Van Metre PC, 2005, ENVIRON SCI TECHNOL, V39, P5567, DOI 10.1021/es0503175
   Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WOODWELL GM, 1971, SCIENCE, V174, P1101, DOI 10.1126/science.174.4014.1101
   Zuur Alain F., 2009, P1
NR 44
TC 15
Z9 15
U1 2
U2 43
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD DEC 6
PY 2016
VL 7
AR 13604
DI 10.1038/ncomms13604
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE0LX
UT WOS:000389267700001
PM 27922001
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jarvis, L
AF Jarvis, Lisa
TI Zika response in full gear
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD DEC 5
PY 2016
VL 94
IS 48
BP 38
EP 38
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA EE2FC
UT WOS:000389398100044
DA 2020-07-08
ER

PT J
AU Escadafal, C
   Gaayeb, L
   Riccardo, F
   Perez-Ramirez, E
   Picard, M
   Dente, MG
   Fernandez-Pinero, J
   Manuguerra, JC
   Jimenez-Clavero, MA
   Declich, S
   Victoir, K
   Robert, V
AF Escadafal, Camille
   Gaayeb, Lobna
   Riccardo, Flavia
   Perez-Ramirez, Elisa
   Picard, Marie
   Dente, Maria Grazia
   Fernandez-Pinero, Jovita
   Manuguerra, Jean-Claude
   Jimenez-Clavero, Miguel-Angel
   Declich, Silvia
   Victoir, Kathleen
   Robert, Vincent
TI Risk of Zika virus transmission in the Euro-Mediterranean area and the
   added value of building preparedness to arboviral threats from a One
   Health perspective
SO BMC PUBLIC HEALTH
LA English
DT Article
DE MediLabSecure; Laboratory network; Euro-Mediterranean area; One Health;
   Arboviruses; Zika virus; Aedes mosquito; Preparedness;
   Capacity-building; Risk assessment
AB In the alarming context of risk of Zika virus (ZIKV) transmission in the Euro-Mediterranean area, there is a need to examine whether capacities to detect, diagnose and notify ZIKV infections in the region are in place and whether ongoing capacity-building initiatives are filling existing gaps.
   The MediLabSecure network, created in 2014, comprises 55 laboratories of virology and medical entomology and 19 public health institutions in 19 countries in the Balkans, North-Africa, the Middle-East and the Black Sea regions. It aims to set up awareness, risk assessment, monitoring and control of emerging and re-emerging vector-borne viruses. We here examine the actions and strategies that MediLabSecure has been implementing and how they will contribute to the prevention and control of the ZIKV threat in the Euro-Mediterranean area.
   Capacity-building for arbovirus diagnostics is a major objective of the project and follows a methodological rather than disease-driven approach. This enables the implementation of laboratory trainings on techniques that are common to several arboviruses, including ZIKV, and putting into action appropriate diagnostic tools in the target region.
   Moreover, by its One Health approach and the interaction of its four sub-networks in human virology, animal virology, medical entomology and public health, MediLabSecure is fostering intersectoral collaboration, expertise and sharing of information. The resulting exchanges (methodological, communication and operational) across disciplines and across countries, dedicated research on intersectoral collaboration and increasing diagnostic capacities are providing new paths and tools to public health professionals to face emerging viral threats such as a ZIKV epidemic in the Euro-Mediterranean region.
C1 [Escadafal, Camille; Gaayeb, Lobna; Manuguerra, Jean-Claude; Victoir, Kathleen] Inst Pasteur, Paris, France.
   [Riccardo, Flavia; Dente, Maria Grazia; Declich, Silvia] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Rome, Italy.
   [Perez-Ramirez, Elisa; Fernandez-Pinero, Jovita; Jimenez-Clavero, Miguel-Angel] Inst Nacl Invest & Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim INIA CISA, Madrid, Spain.
   [Jimenez-Clavero, Miguel-Angel] CIBERESP, Madrid, Spain.
   [Robert, Vincent] UM, CNRS 5290, IRD 224, MIVEGEC Unit,Inst Rech Dev, Montpellier, France.
RP Victoir, K (corresponding author), Inst Pasteur, Paris, France.
EM kathleen.victoir@pasteur.fr
RI Fernandez-Pinero, Jovita/H-4515-2015; Jimenez-Clavero, Miguel
   Angel/E-3048-2010; Riccardo, Flavia/K-5215-2016
OI Fernandez-Pinero, Jovita/0000-0001-9919-0112; Jimenez-Clavero, Miguel
   Angel/0000-0003-2125-9743; Declich, Silvia/0000-0002-5916-3889; Dente,
   Maria Grazia/0000-0002-0782-6564; Riccardo, Flavia/0000-0002-1582-6329
FU European UnionEuropean Union (EU) [DEVCO: IFS/21010/23/-194]
FX MediLabSecure Project is supported by the European Union (DEVCO:
   IFS/21010/23/-194).
CR Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Braks M, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-192
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dente MG, 2009, EUROSURVEILLANCE, V14
   Dente MG, 2016, QUADERNI SOC ITALIAN
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Health Forum Gastein, EUR HLTH AW 2014
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gnesotto R, 122010 EPISOUTH PROJ
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Hadjichristodoulou C, 2013, EPISOUTH PLUS PROJEC
   Hasler B, 2013, CURR TOP MICROBIOL, V365, P127, DOI 10.1007/82_2012_239
   Kading RC, 2016, AM J TROP MED HYG, V95, P993, DOI 10.4269/ajtmh.16-0625
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rabaan AA, 2016, J INFECT PUBLIC HLTH
   VectorNet, 2016, ECDC EFSA MOSQ MAPS
NR 20
TC 5
Z9 5
U1 0
U2 18
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD DEC 3
PY 2016
VL 16
AR 1219
DI 10.1186/s12889-016-3831-1
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EE2BG
UT WOS:000389388100004
PM 27914465
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schmidt, T
   Kuehnel, D
   Mueller, S
   Pichotta, A
   Radomski, KU
   Volk, A
   Knaub, S
AF Schmidt, Torben
   Kuehnel, Denis
   Mueller, Sebastian
   Pichotta, Alexander
   Radomski, Kai Uwe
   Volk, Andreas
   Knaub, Sigurd
TI Inactivation of Zika Virus By Solvent/Detergent Treatment or
   Pasteurization
SO BLOOD
LA English
DT Meeting Abstract
CT 58th Annual Meeting and Exposition of the American-Society-of-Hematology
   (ASH)
CY DEC 03-06, 2016
CL San Diego, CA
SP Amer Soc Hematol
C1 [Schmidt, Torben; Kuehnel, Denis; Mueller, Sebastian; Pichotta, Alexander; Radomski, Kai Uwe; Volk, Andreas] Octapharma Biopharmaceut GmbH, Frankfurt, Germany.
   [Knaub, Sigurd] Octapharma AG, Lachen, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD DEC 2
PY 2016
VL 128
IS 22
MA 2630
DI 10.1182/blood.V128.22.2630.2630
PG 5
WC Hematology
SC Hematology
GA EL2LX
UT WOS:000394452302047
DA 2020-07-08
ER

PT J
AU Vogel, G
AF Vogel, Gretchen
TI INFECTIOUS DISEASE One year later, Zika scientists prepare for a long
   war
SO SCIENCE
LA English
DT News Item
NR 0
TC 6
Z9 6
U1 0
U2 5
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD DEC 2
PY 2016
VL 354
IS 6316
BP 1088
EP 1089
DI 10.1126/science.354.6316.1088
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ED5TY
UT WOS:000388916400012
PM 27934714
DA 2020-07-08
ER

PT J
AU van der Linden, V
   Pessoa, A
   Dobyns, W
   Barkovich, AJ
   van der Linden, H
   Rolim, EL
   Ribeiro, EM
   Leal, MD
   Coimbra, PPDA
   Araglo, MDVV
   Vercosa, I
   Ventura, C
   Ramos, RC
   Cruz, DDCS
   Cordeiro, MT
   Mota, VMR
   Dott, M
   Hillard, C
   Moore, CA
AF van der Linden, Vanessa
   Pessoa, Andre
   Dobyns, William
   Barkovich, A. James
   van der Linden, Helio, Jr.
   Rolim Filho, Epitacio Leite
   Ribeiro, Erlane Marques
   Leal, Mariana de Carvalho
   de Aratijo Coimbra, Pablo Picasso
   Viana Vasco Araglo, Maria de Fatima
   Vercosa, Islane
   Ventura, Camila
   Ramos, Regina Coeli
   Sousa Cruz, Danielle Di Cavalcanti
   Cordeiro, Marli Tenorio
   Ribeiro Mota, Vivian Maria
   Dott, Mary
   Hillard, Christina
   Moore, Cynthia A.
TI Description of 13 Infants Born During October 2015-January 2016 With
   Congenital Zika Virus Infection Without Microcephaly at Birth - Brazil
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [van der Linden, Vanessa; Rolim Filho, Epitacio Leite] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [Pessoa, Andre; Ribeiro, Erlane Marques] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Dobyns, William] Univ Washington, Seattle, WA 98195 USA.
   [Dobyns, William] Seattle Childrens Res Inst, Seattle, WA USA.
   [Barkovich, A. James] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [van der Linden, Helio, Jr.] Dr Henrique Santillo Rehabil Ctr, Goiania, Go, Brazil.
   [Rolim Filho, Epitacio Leite; Leal, Mariana de Carvalho] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Leal, Mariana de Carvalho] Agamenon Magalhaes Hosp HAM, Recife, PE, Brazil.
   [de Aratijo Coimbra, Pablo Picasso] Uniclin Diagnost Imagem, Fortaleza, Ceara, Brazil.
   [Viana Vasco Araglo, Maria de Fatima] Ctr Diagnost Multimagem, Recife, PE, Brazil.
   [Viana Vasco Araglo, Maria de Fatima] Mauricio de Nassau Univ, Recife, PE, Brazil.
   [Vercosa, Islane] Caviver Clin, Fortaleza, Ceara, Brazil.
   [Ventura, Camila; Ramos, Regina Coeli] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila; Sousa Cruz, Danielle Di Cavalcanti] Pernambucos Eye Hosp, Recife, PE, Brazil.
   [Ventura, Camila; Ramos, Regina Coeli] Oswaldo Cruz Univ Hosp, Recife, PE, Brazil.
   [Ventura, Camila; Sousa Cruz, Danielle Di Cavalcanti] Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil.
   [Cordeiro, Marli Tenorio] Fiocruz MS, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil.
   [Ribeiro Mota, Vivian Maria] Univ Fortaleza, Fortaleza, Ceara, Brazil.
   [Dott, Mary] CDC, Ctr Surveillance Epidemiol & Lab Serv, Atlanta, GA 30333 USA.
   [Hillard, Christina; Moore, Cynthia A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
RP Moore, CA (corresponding author), CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
RI Ventura, Camila V/N-2654-2018; Dobyns, William/AAI-2768-2020
OI Ventura, Camila V/0000-0002-2927-4684; Dobyns,
   William/0000-0002-7681-2844; VAN DER LINDEN JUNIOR,
   HELIO/0000-0002-3123-2264
CR Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Moore CA, 2016, JAMA PEDIAT
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Rodrigues LC, 2016, LANCET INFECT DIS
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Wimalasundera Neil, 2016, Pract Neurol, V16, P184, DOI 10.1136/practneurol-2015-001184
NR 10
TC 177
Z9 179
U1 2
U2 18
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD DEC 2
PY 2016
VL 65
IS 47
BP 1343
EP 1348
DI 10.15585/mmwr.mm6547e2
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EE4GX
UT WOS:000389561400004
PM 27906905
OA Bronze
DA 2020-07-08
ER

PT J
AU Akiyama, BM
   Laurence, HM
   Massey, AR
   Costantino, DA
   Xie, XP
   Yang, YJ
   Shi, PY
   Nix, JC
   Beckham, JD
   Kieft, JS
AF Akiyama, Benjamin M.
   Laurence, Hannah M.
   Massey, Aaron R.
   Costantino, David A.
   Xie, Xuping
   Yang, Yujiao
   Shi, Pei-Yong
   Nix, Jay C.
   Beckham, J. David
   Kieft, Jeffrey S.
TI Zika virus produces noncoding RNAs using a multi-pseudoknot structure
   that confounds a cellular exonuclease
SO SCIENCE
LA English
DT Article
ID SUBGENOMIC FLAVIVIRUS RNA; WEST-NILE; JAPANESE ENCEPHALITIS;
   EXORIBONUCLEASE XRN1; HOST ADAPTATION; INTERFERON; CELLS; BINDS
AB A specialized bone marrow microenvironment (niche) regulates hematopoietic stem cell (HSC) self-renewal and commitment. For successful donor-HSC engraftment, the niche must be emptied via myeloablative irradiation or chemotherapy. However, myeloablation can cause severe complications and even mortality. Here we report that the essential amino acid valine is indispensable for the proliferation and maintenance of HSCs. Both mouse and human HSCs failed to proliferate when cultured in valine-depleted conditions. In mice fed a valine-restricted diet, HSC frequency fell dramatically within 1 week. Furthermore, dietary valine restriction emptied the mouse bone marrow niche and afforded donor-HSC engraftment without chemoirradiative myeloablation. These findings indicate a critical role for valine in HSC maintenance and suggest that dietary valine restriction may reduce iatrogenic complications in HSC transplantation.
C1 [Akiyama, Benjamin M.; Laurence, Hannah M.; Costantino, David A.; Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.
   [Laurence, Hannah M.] Univ Colorado Denver, HHMI, Sch Med, Aurora, CO 80045 USA.
   [Laurence, Hannah M.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA.
   [Massey, Aaron R.; Beckham, J. David] Univ Colorado Denver, Sch Med, Dept Med, Aurora, CO 80045 USA.
   [Xie, Xuping; Yang, Yujiao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Nix, Jay C.] Lawrence Berkeley Natl Lab, Adv Light Source, Mol Biol Consortium, Berkeley, CA 94720 USA.
   [Kieft, Jeffrey S.] Univ Colorado Denver, Sch Med, RNA BioSci Initiat, Aurora, CO 80045 USA.
RP Kieft, JS (corresponding author), Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.; Kieft, JS (corresponding author), Univ Colorado Denver, Sch Med, RNA BioSci Initiat, Aurora, CO 80045 USA.
EM jeffrey.kieft@ucdenver.edu
RI Xie, Xuping/AAD-7406-2019; Beckham, John/AAE-6694-2020
OI Beckham, John/0000-0001-9305-2683; Massey, Aaron/0000-0002-8747-0114
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [F32GM117730, R35GM118070, R01GM081346,
   R01AI087856, S10OD012033]; HHMIHoward Hughes Medical Institute;
   HHMI-Burroughs Wellcome Fund medical research fellowship; University of
   Colorado School of Medicine; University of Colorado Department of
   Medicine; Novartis Institutes for BioMedical Research; University of
   Texas Medical Branch; University of Texas; UC Cancer Center
   [P30CA046934]; Office of Science, Office of Basic Energy Sciences, of
   the U.S. Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC02-05CH11231]
FX We thank the members of the Kieft lab for discussions; C. Musselman and
   M. Stone for critical reading of this manuscript; and R. Soto from the
   M. Garcia-Blanco and S. Bradrick laboratories for sharing their protocol
   for sfRNA blots. Supported by NIH fellowship F32GM117730 (B.M.A.); an
   HHMI Early Career Scientist award and NIH grants R35GM118070 and
   R01GM081346 (J.S.K.); a HHMI-Burroughs Wellcome Fund medical research
   fellowship (H.M.L.); University of Colorado School of Medicine and
   Department of Medicine institutional pilot funds (A.R.M. and J.D.B.); a
   postdoctoral fellowship from Novartis Institutes for BioMedical Research
   (X.X.); and a University of Texas Medical Branch startup award, a
   University of Texas STARs award, and NIH grant R01AI087856 (P.-Y.S.).
   The UC Denver X-ray Facility is supported by UC Cancer Center support
   grant P30CA046934 and NIH grant S10OD012033. The Advanced Light Source
   is supported by the Office of Science, Office of Basic Energy Sciences,
   of the U.S. Department of Energy under contract DE-AC02-05CH11231. The
   data presented in this manuscript are tabulated in the main paper and in
   the supplementary materials. Coordinates and structure factors have been
   deposited with PDB accession code 5TPY.
CR Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Durbin AP, 2005, J INFECT DIS, V191, P710, DOI 10.1086/427780
   Emara MM, 2008, J VIROL, V82, P10657, DOI 10.1128/JVI.00991-08
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Jinek M, 2011, MOL CELL, V41, P600, DOI 10.1016/j.molcel.2011.02.004
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Leontis N.B., 2001, NUCLEIC ACIDS RES, V7, P499
   LEVITT M, 1969, NATURE, V224, P759, DOI 10.1038/224759a0
   Lindenbach B. D., 2007, FIELDS VIROLOGY
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sherlin LD, 2000, J MOL BIOL, V299, P431, DOI 10.1006/jmbi.2000.3749
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
NR 30
TC 77
Z9 78
U1 0
U2 36
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD DEC 2
PY 2016
VL 354
IS 6316
BP 1148
EP 1152
DI 10.1126/science.aah3963
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ED5TY
UT WOS:000388916400042
PM 27934765
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Byler, KG
   Setzer, WN
AF Byler, K. G.
   Setzer, W. N.
TI In-silico screening for anti-zika virus phytochemicals
SO PLANTA MEDICA
LA English
DT Meeting Abstract
CT 9th Joint Meeting of AFERP, ASP, GA, JSP, PSE and SIF
CY JUL 24-27, 2016
CL Copenhagen, DENMARK
SP AFERP, ASP, GA, JSP, PSE, SIF
C1 [Byler, K. G.; Setzer, W. N.] Univ Alabama, Dept Chem, Huntsville, AL 35899 USA.
RI Byler, Kendall/X-7084-2019
CR Molecular Operating Environment (MOE), 2016, MOL OPERATING ENV
   Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e
NR 2
TC 1
Z9 1
U1 0
U2 1
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0032-0943
EI 1439-0221
J9 PLANTA MED
JI Planta Med.
PD DEC
PY 2016
VL 82
SU 1
MA P105
DI 10.1055/s-0036-1596272
PG 1
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA FI2RE
UT WOS:000411789300096
DA 2020-07-08
ER

PT J
AU Brito, MB
   Fraser, IS
AF Brito, Milena Bastos
   Fraser, Ian S.
TI Zika Virus Outbreak and the Poor Brazilian Family Planning Program
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Editorial Material
ID HEALTH; CONTRACEPTION
C1 [Brito, Milena Bastos] Escola Bahiana Med & Saude Publ, Salvador, BA, Brazil.
   [Fraser, Ian S.] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.
   [Fraser, Ian S.] Univ New South Wales, Royal Hosp Women, Sydney, NSW, Australia.
RP Brito, MB (corresponding author), Av D Joao 6,275, Salvador, BA, Brazil.
EM milenabrito@bahiana.edu.br
RI BRITO, MILENA B/K-9457-2018
OI BRITO, MILENA B/0000-0002-2397-4145
CR Brasil, 2016, MON CAS DENG FEBR CH, V47
   Brasil. Ministerio da Saude, 2013, SAUD SEX SAUD REPR, V26
   Brasil. Ministerio da Saude, 2016, REC TECN
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Franca GV, 2016, LANCET S
   Mavranezouli I, 2008, HUM REPROD, V23, P1338, DOI 10.1093/humrep/den091
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855
   World Health Organization, 2016, 69 WORLD HLTH ASS OP
NR 11
TC 2
Z9 2
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD DEC
PY 2016
VL 38
IS 12
BP 583
EP 584
DI 10.1055/s-0036-1593411
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4QW
UT WOS:000410251400001
PM 27741537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Insect Repellants During Pregnancy in the Era of the Zika Virus
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
ID REPELLENT
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Achee NL, 2009, J AM MOSQUITO CONTR, V25, P156, DOI 10.2987/08-5831.1
   Lindsay SW, 1998, MED VET ENTOMOL, V12, P295, DOI 10.1046/j.1365-2915.1998.00115.x
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
NR 3
TC 0
Z9 0
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD DEC
PY 2016
VL 128
IS 6
BP 1446
EP 1447
DI 10.1097/AOG.0000000000001790
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EQ1KW
UT WOS:000397830000021
PM 27875460
DA 2020-07-08
ER

PT J
AU Wylie, B
   Hauptman, M
   Woolf, AD
   Goldman, RH
AF Wylie, Blair
   Hauptman, Marissa
   Woolf, Alan D.
   Goldman, Rose H.
TI Insect Repellants During Pregnancy in the Era of the Zika Virus Reply
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Wylie, Blair] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Boston, MA 02114 USA.
   [Hauptman, Marissa] Boston Childrens Hosp, Boston, MA 02115 USA.
   [Woolf, Alan D.; Goldman, Rose H.] Boston Childrens Hosp, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
RP Wylie, B (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, Boston, MA 02114 USA.
CR Centers for Disease Control and Prevention, ZIK VIR PREGN
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
NR 2
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD DEC
PY 2016
VL 128
IS 6
BP 1447
EP 1447
DI 10.1097/AOG.0000000000001791
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EQ1KW
UT WOS:000397830000022
PM 27875461
DA 2020-07-08
ER

PT J
AU Martinez-Palomo, A
AF Martinez-Palomo, Adolfo
TI Zika the Emerging Epidemic
SO JOURNAL OF PUBLIC HEALTH POLICY
LA English
DT Book Review
EM amartine@cinvestav.mx
CR McNeil D., 2016, ZIKA EMERGING EPIDEM
NR 1
TC 0
Z9 0
U1 0
U2 2
PU PALGRAVE MACMILLAN LTD
PI BASINGSTOKE
PA BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND
SN 0197-5897
EI 1745-655X
J9 J PUBLIC HEALTH POL
JI J. Public Health Policy
PD DEC
PY 2016
VL 37
IS 4
BP 543
EP 546
DI 10.1057/s41271-016-0044-x
PG 4
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA EL3MY
UT WOS:000394524500012
OA Bronze
DA 2020-07-08
ER

PT J
AU Adilah-Amrannudin, N
   Hamsidi, M
   Ismail, NA
   Ismail, R
   Dom, NC
   Ahmad, A
   Mastuki, MF
   Tengku, TSA
   Basri, A
   Khalid, A
   Muslim, M
   Daud, NAA
   Camalxaman, SN
AF Adilah-Amrannudin, Nurul
   Hamsidi, Mayamin
   Ismail, Nurul-Ain
   Ismail, Rodziah
   Dom, Nazri Che
   Ahmad, Abu Hassan
   Mastuki, Mohd Fahmi
   Tengku, Tengku Shahrul Anuar
   Basri, Ahmad
   Khalid, Adira
   Muslim, Mohammad
   Daud, Nurul Amalina Ahmad
   Camalxaman, Siti Nazrina
TI GENETIC POLYMORPHISM OF AEDES ALBOPICTUS POPULATION INFERRED FROM ND5
   GENE VARIABILITIES IN SUBANG JAYA, MALAYSIA
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes albopictus; genetic variation; haplotype; nicotinamide adenine
   dinucleotide dehydrogenase 5 subunit; phylogenetic tree
ID DIPTERA-CULICIDAE; ADAPTIVE EVOLUTION; INVASIVE MOSQUITOS; VECTOR
   COMPETENCE; MITOCHONDRIAL ND5; ZIKA VIRUS; DENGUE; CHIKUNGUNYA; AEGYPTI;
   DIFFERENTIATION
AB This study was performed to establish the genetic variability of Aedes albopictus within Subang Jaya, Selangor, Malaysia, by using the nicotinamide adenine dinucleotide dehydrogenase 5 subunit (ND5) mitochondrial DNA (mtDNA) marker. A total of 90 samples were collected from 9 localities within an area of the Subang Jaya Municipality. Genetic variability was determined through the amplification and sequencing of a fragment of the ND5 gene. Eight distinct mtDNA haplotypes were identified. The evolutionary relationship of the local haplotypes alongside 28 reference strains was used to construct a phylogram, the analysis of which revealed low genetic differentiation in terms of both nucleotide and haplotype diversity. Bayesian method was used to infer the phylogenetic tree, revealing a unique relationship between local isolates. The study corroborates the reliability of ND5 to identify distinct lineages for polymorphism-based studies and supplements the existing body of knowledge regarding its genetic diversity. This in turn could potentially aid existing vector control strategies to help mitigate the risk and spread of the dengue virus.
C1 [Adilah-Amrannudin, Nurul; Hamsidi, Mayamin; Ismail, Nurul-Ain; Ismail, Rodziah; Dom, Nazri Che; Mastuki, Mohd Fahmi; Tengku, Tengku Shahrul Anuar; Basri, Ahmad; Khalid, Adira; Muslim, Mohammad; Daud, Nurul Amalina Ahmad; Camalxaman, Siti Nazrina] Univ Teknol MARA, Fac Hlth Sci, Puncak Alam 42300, Selangor, Malaysia.
   [Ahmad, Abu Hassan] Univ Sains Malaysia, Sch Biol Sci, George Town 11800, Malaysia.
RP Camalxaman, SN (corresponding author), Univ Teknol MARA, Fac Hlth Sci, Puncak Alam 42300, Selangor, Malaysia.
RI Dom, Nazri Che/AAO-9787-2020; Che Dom, Nazri/G-3268-2017
OI Che Dom, Nazri/0000-0002-9500-7453
FU Ministry of Education, Malaysia [FRGS/1/2014/SKK10/UITM/03/1]
FX The authors thank the Ministry of Education, Malaysia for providing
   financial support under the Fundamental Research Grant Scheme
   (FRGS/1/2014/SKK10/UITM/03/1) and the General Director of Subang Jaya
   Municipal Council for granting permission to collect samples in
   specified localities. In addition, the authors thank the Faculty of
   Health Sciences, Universiti Teknologi MARA for providing research
   facilities, and Universiti Sains Malaysia for the laboratory strain.
CR Ayres CFJ, 2003, J MED ENTOMOL, V40, P430, DOI 10.1603/0022-2585-40.4.430
   BALLINGERCRABTREE ME, 1992, AM J TROP MED HYG, V47, P893, DOI 10.4269/ajtmh.1992.47.893
   Banu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089440
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brelsfoard CL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-80
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, 2012, DENG AED ALB MOSQ
   de Jong MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021385
   de Oliveira RL, 2003, AM J TROP MED HYG, V69, P105, DOI 10.4269/ajtmh.2003.69.105
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026
   Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790
   Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x
   DOM NC, 2013, ASIAN PAC J TROP DIS, V3, P352, DOI DOI 10.1016/S2222-1808(13)60084-5
   Gerberg EJ, 1970, BULLETIN, V5
   Gerhardt RR, 2001, EMERG INFECT DIS, V7, P807
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   HEWITT G, 1983, TUATARA, V26, P73
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Ismail NA, 2015, J AM MOSQUITO CONTR, V31, P305, DOI 10.2987/moco-31-04-305-312.1
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581
   Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Navarro Juan-Carlos, 2013, Journal of Entomology and Zoology Studies, V1, P32
   NEI M, 1990, GENETICS, V125, P873
   Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004
   Raharimalala FN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-56
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Rodrigues MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0703-y
   Rodriguez-Barraquer I, 2011, PLOS NEGLECT TROP D, V5, P1, DOI DOI 10.1371/journal.pntd.0001370
   Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17
   Sardelis MR, 2002, J AM MOSQUITO CONTR, V18, P284
   Saxton-Shaw KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128712
   Stojanoyich CJ, 1965, ILLUSTRATED KEY MOSQ
   Stout JC, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plu087
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, P3
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zawani MKN, 2014, GENET MOL RES, V13, P8184, DOI 10.4238/2014.October.7.13
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
   Zitko T, 2011, EUR J ENTOMOL, V108, P501, DOI 10.14411/eje.2011.065
NR 64
TC 1
Z9 1
U1 1
U2 7
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD DEC
PY 2016
VL 32
IS 4
BP 265
EP 272
PG 8
WC Entomology
SC Entomology
GA EM0ZY
UT WOS:000395048200001
PM 28206858
DA 2020-07-08
ER

PT J
AU Klobucar, A
   Benic, N
   Krajcar, D
   Kosanovic-Licina, ML
   Tesic, V
   Merdic, E
   Vrucina, I
   Savic, V
   Barbic, L
   Stevanovic, V
   Pem-Novosel, I
   Vilibic-Cavlek, T
AF Klobucar, Ana
   Benic, Nikola
   Krajcar, Darko
   Kosanovic-Licina, Mirjana Lana
   Tesic, Vanja
   Merdic, Enrih
   Vrucina, Ivana
   Savic, Vladimir
   Barbic, Ljubo
   Stevanovic, Vladimir
   Pem-Novosel, Iva
   Vilibic-Cavlek, Tatjana
TI An overview of mosquitoes and emerging arboviral infections in the
   Zagreb area, Croatia
SO JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
LA English
DT Review
DE mosquito species; vectors; arboviruses; Zagreb; Croatia
ID WEST-NILE-VIRUS; USUTU VIRUS; AEDES-ALBOPICTUS; CHIKUNGUNYA VIRUS; ZIKA
   VIRUS; NEUROINVASIVE INFECTION; INVASIVE MOSQUITOS; OUTBREAK; DENGUE;
   DISEASE
AB Mosquito control in the Zagreb area has been conducted for many years, whereas the fauna has only been investigated in the last 20 years. So far 30 mosquito species have been detected in the city area. Culex pipiens form molestus is the dominant mosquito species in indoor breeding sites. In forested areas and areas exposed to flooding, the active period is early spring and the dominant species are Ochlerotatus sticticus, Ochlerotatus cantans, Ochlerotatus geniculatus and Aedes vexans. The eudominant mosquito species found in the artificial breeding sites are Culex pipiens and the Asian tiger mosquito, Aedes albopictus. Invasive Ae. albopictus, present in the Zagreb area since 2004, has expanded to a larger area of the city during the last three years. The recent emergence of the human West Nile virus and Usutu virus neuroinvasive disease in Zagreb and its surroundings highlighted the role of mosquitoes as vectors of emerging arboviruses.
   The paper focuses on mosquito species and arboviral infections detected in humans and animals in the Zagreb area, Croatia.
C1 [Klobucar, Ana; Benic, Nikola; Krajcar, Darko; Kosanovic-Licina, Mirjana Lana; Tesic, Vanja] Andrija Stampar Teaching Inst Publ Hlth, Dept Epidemiol, Mirogojska 16, Zagreb 10000, Croatia.
   [Merdic, Enrih; Vrucina, Ivana] Josip Juraj Strossmayer Univ Osijek, Dept Biol, Osijek, Croatia.
   [Savic, Vladimir] Croatian Vet Inst, Poultry Ctr, Zagreb, Croatia.
   [Barbic, Ljubo; Stevanovic, Vladimir] Univ Zagreb, Fac Vet Med, Dept Microbiol & Infect Dis Clin, Zagreb, Croatia.
   [Pem-Novosel, Iva] Croatian Natl Inst Publ Hlth, Dept Epidemiol, Zagreb, Croatia.
   [Vilibic-Cavlek, Tatjana] Croatian Natl Inst Publ Hlth, Dept Virol, Zagreb, Croatia.
   [Vilibic-Cavlek, Tatjana] Univ Zagreb, Sch Med, Zagreb, Croatia.
RP Klobucar, A (corresponding author), Andrija Stampar Teaching Inst Publ Hlth, Dept Epidemiol, Mirogojska 16, Zagreb 10000, Croatia.
EM ana.klobucar@stampar.hr
RI Vilibic-Cavlek, Tatjana/AAI-2010-2019
OI Savic, Vladimir/0000-0003-0398-5346
FU Zagreb City Office for Health
FX The research carried out in the Maksimir Park was partly funded by
   Zagreb City Office for Health.
CR Angelini P, 2010, EUROSURVEILLANCE, V15, P11
   Barbic L, 2015, CROATIAN J INFECT, V35, P61
   Barbic L, 2013, VECTOR-BORNE ZOONOT, V13, P772, DOI 10.1089/vbz.2012.1236
   Barbic L, 2012, VET MICROBIOL, V159, P504, DOI 10.1016/j.vetmic.2012.04.038
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Benic N, 2008, P SEM DIS DIS DER PR, P141
   Berlot J, 1983, I DAYS, P53
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Cantile C, 2000, EQUINE VET J, V32, P31, DOI 10.2746/042516400777612080
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Cotteaux-Lautard C, 2013, J AM MOSQUITO CONTR, V29, P81, DOI 10.2987/12-6288R.1
   Di Sabatino D, 2014, BIOMED RES INT, DOI 10.1155/2014/907852
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, W NIL FEV MAPS
   European Centre for Disease Prevention and Control, 2012, GUID SERV INV MOSQ E
   Fritz ML, 2015, MED VET ENTOMOL, V29, P115, DOI 10.1111/mve.12096
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Goenaga S, 2012, VECTOR-BORNE ZOONOT, V12, P986, DOI 10.1089/vbz.2011.0730
   Golubic D., 2012, Croatian Journal of Infection, V32, P153
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Hadzi J, 1918, LIJECNICKI VIJESNIK, V40, P309
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Jost H, 2011, AM J TROP MED HYG, V85, P551, DOI 10.4269/ajtmh.2011.11-0248
   Kampen H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-59
   Klobucar A, 2006, J AM MOSQUITO CONTR, V22, P147, DOI 10.2987/8756-971X(2006)22[147:FROAAI]2.0.CO;2
   Klobucar A, 2015, 7 EUR MOSQ CONTR ASS, P123
   Klobucar A, 2010, P SEM DIS DIS DER PR, P195
   Klobucar A, 2007, THESIS
   KNUDSEN AB, 1995, EUR J EPIDEMIOL, V11, P345, DOI 10.1007/BF01719441
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Langhoffer A, 1930, AGRONOMSKI GLASNIK, V1, P107
   Langhoffer A, 1916, LIJECNICKI VIJESNIK, V38, P321
   Madic J, 2007, VET REC, V160, P772, DOI 10.1136/vr.160.22.772
   MADIC J, 1993, J WILDLIFE DIS, V29, P572, DOI 10.7589/0090-3558-29.4.572
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Merdic Enrih, 2004, European Mosquito Bulletin, V17, P8
   Merdic Enrih, 2005, Entomologia Croatica, V9, P71
   Merdic Enrih, 2002, Entomologia Croatica, V6, P51
   Merdic Enrih, 2014, Coll Antropol, V38, P423
   Murgue B, 2001, EMERG INFECT DIS, V7, P692
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   PAVISIC V, 1951, Hig Cas Hig Mikrobiol Epidemiol Sanit Teh, V3, P183
   PAVISIC V, 1949, Hig Cas Hig Mikrobiol Epidemiol Sanit Teh, V1, P253
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Pem-Novosel I, 2015, NEW MICROBIOL, V38, P97
   Pem-Novosel I, 2014, VECTOR-BORNE ZOONOT, V14, P82, DOI 10.1089/vbz.2012.1295
   Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118
   Pradier S, 2012, REV SCI TECH OIE, V31, P829
   Reinert JF, 2004, ZOOL J LINN SOC-LOND, V142, P289, DOI 10.1111/j.1096-3642.2004.00144.x
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098
   Ropac D, 1988, Lijec Vjesn, V110, P177
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Stevanovic V, 2014, EMERGING REEMERGING, P36
   Straetemans M., 2008, Eurosurveillance, V13, P8040
   Tber Abdelhaq A, 1996, B OIE, P867
   Triki H, 2001, Med Trop (Mars), V61, P487
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Vesenjak-Hirjan J, 1980, ARBOVIRUSES MEDITERR, P311
   Vilibic-Cavlek T, 2014, INFECTION, V42, P689, DOI 10.1007/s15010-014-0625-1
   Vilibic-Cavlek T, 2015, 3 CROAT EP C SIB, P112
   Vilibic-Cavlek T, 2015, ACTA MICROBIOL IMM H, V62, P199, DOI 10.1556/030.62.2015.2.9
   Vinogradova E. B., 2000, CULEX PIPIENS PIPIEN
   Weissenbock H, 2013, EMERG INFECT DIS, V19, P274, DOI 10.3201/eid1902.121191
   Weissenbock H, 2007, ECOL CONT VECTOR-BOR, V1, P153
   Zagreb City Office, 2010, ENV PROT PROGR
   Zagreb City Office for Health, 2015, ZAGREB OFFICIAL GAZE, V2, P27
   Zaninovic K, 2008, CLIMATE ATLAS CROATI, P1971
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zitko T, 2014, J MED ENTOMOL, V51, P760, DOI 10.1603/ME13071
   Zitko Toni, 2006, European Mosquito Bulletin, V21, P11
NR 80
TC 3
Z9 3
U1 0
U2 11
PU J INFECTION DEVELOPING COUNTRIES
PI TRAMANIGLIO
PA JIDC CENT OFF PORTO CONTE RICERCHE RES CTR, S P 55, PORTO CONTE CAPO
   CACCIA KM 8.400 LOC, TRAMANIGLIO, 07041, ITALY
SN 1972-2680
J9 J INFECT DEV COUNTR
JI J. Infect. Dev. Ctries.
PD DEC
PY 2016
VL 10
IS 12
BP 1286
EP 1293
DI 10.3855/jidc.7988
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA EO1YF
UT WOS:000396493100002
PM 28036307
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Green, R
   Wilkins, C
   Thomas, S
   Sekine, A
   Ireton, RC
   Ferris, MT
   Hendrick, DM
   Voss, K
   de Villena, FPM
   Baric, R
   Heise, M
   Gale, M
AF Green, Richard
   Wilkins, Courtney
   Thomas, Sunil
   Sekine, Aimee
   Ireton, Renee C.
   Ferris, Martin T.
   Hendrick, Duncan M.
   Voss, Kathleen
   de Villena, Fernando Pardo-Manuel
   Baric, Ralph
   Heise, Mark
   Gale, Michael, Jr.
TI Identifying protective host gene expression signatures within the spleen
   during West Nile virus infection in the collaborative cross model
SO GENOMICS DATA
LA English
DT Article
DE Collaborative cross; Flaviviruses; Nanostring; West Nile virus; Spleen
ID BIOCONDUCTOR
AB Flaviviruses are hematophagous arthropod-viruses that pose global challenges to human health. Like Zika virus, West Nile Virus (WNV) is a flavivirus for which no approved vaccine exists [1]. The role host genetics play in early detection and response to WNV still remains largely unexplained. In order to capture the impact of genetic variation on innate immune responses, we studied gene expression following WNV infection using the collaborative cross (CC). The CC is a mouse genetics resource composed of hundreds of independently bred, octo-parental recombinant inbred mouse lines [2]. To accurately capture the host immune gene expression signatures of West Nile infection, we used the nanostring platform to evaluate expression in spleen tissue isolated from CC mice infected with WNV over a time course of 4, 7, and 12 days' post-infection [3]. Nanostring is a non-amplification based digital method to quantitate gene expression that uses color-coded molecular barcodes to detect hundreds of transcripts in a sample. Using this approach, we identified unique gene signatures in spleen tissue at days 4, 7, and 12 following WNV infection, which delineated distinct differences between asymptomatic and symptomatic CC lines. We also identified novel immune genes. Data was deposited into the Gene Expression Omnibus under accession GSE86000. Published by Elsevier Inc.
C1 [Green, Richard; Wilkins, Courtney; Thomas, Sunil; Sekine, Aimee; Ireton, Renee C.; Hendrick, Duncan M.; Voss, Kathleen; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Ferris, Martin T.; de Villena, Fernando Pardo-Manuel; Baric, Ralph; Heise, Mark] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA.
RP Green, R (corresponding author), Univ Washington, Dept Immunol, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
EM greener@uw.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI100625, R01AI104002, U19AI083019]
FX We would like to thank Rob Kleinhanz, Karen Krantz, Nathan Elliott and
   Andrew White from Nanostring for their advice and assistance. We
   acknowledge the support of NIH grants U19AI100625, R01AI104002, and
   U19AI083019.
CR Bottomly D, 2014, R J, V6, P159
   Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120
   Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639
   Loraine AE, 2015, METHODS MOL BIOL, V1284, P481, DOI 10.1007/978-1-4939-2444-8_24
   Rasmussen AL, 2014, SCIENCE, V346, P987, DOI 10.1126/science.1259595
   Smyth G. K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027
NR 10
TC 7
Z9 7
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2213-5960
J9 GENOM DATA
JI Genom. Data
PD DEC
PY 2016
VL 10
BP 114
EP 117
DI 10.1016/j.gdata.2016.10.006
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA EM4ZA
UT WOS:000395320500028
PM 27843766
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mota, MTD
   Terzian, AC
   Silva, MLCR
   Estofolete, C
   Nogueira, ML
AF de Oliveira Mota, Manlio Tasso
   Terzian, Ana Carolina
   Cristiny Rodrigues Silva, Maria Luana
   Estofolete, Cassia
   Nogueira, Mauricio Lacerda
TI Mosquito-transmitted viruses - the great Brazilian challenge
SO BRAZILIAN JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Arboviruses; Dengue; Chikungunya; Mayaro; Zikaa
ID RIO-DE-JANEIRO; DENGUE HEMORRHAGIC-FEVER; ZIKA VIRUS; CHIKUNGUNYA-VIRUS;
   MAYARO-VIRUS; RISK-FACTORS; CO-CIRCULATION; SEROTYPE 4; VIROLOGICAL
   FINDINGS; POPULATION-DYNAMICS
AB Arboviruses pose a serious threat to public health worldwide, overloading the healthcare system and causing economic losses. These viruses form a very diverse group, and in Brazil, arboviruses belonging to the families Flaviviridae and Togaviridae are predominant. Unfortunately, the number of arboviruses increases in proportion with factors such as deforestation, poor sanitation, climate changes, and introduction of new viruses like Chikungunya virus and Zika virus.
   In Brazil, dengue is endemic, along with the presence of other arboviruses. The situation is complicated by the scarcity of diagnostic infrastructure and the absence of approved vaccines for these diseases. Disease control, thus, relies solely on vector control. Therefore, enhanced clinical knowledge and improved general awareness about these arboviruses are indispensable to tackle diagnostic inadequacies. (C) 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda.
C1 [de Oliveira Mota, Manlio Tasso; Terzian, Ana Carolina; Cristiny Rodrigues Silva, Maria Luana; Estofolete, Cassia; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Fac Med Sao Jose do Rio Preto FAMERP, Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Nogueira, Mauricio L/B-7599-2012; Estofolete, Cassia/N-6673-2019; de
   Oliveira Mota, Manlio Tasso/E-2619-2013
OI Nogueira, Mauricio L/0000-0003-1102-2419; Estofolete,
   Cassia/0000-0001-7324-1591; Silva, Maria Luana Cristiny
   Rodrigues/0000-0002-1367-3816
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320
   [Anonymous], 1998, Wkly Epidemiol Rec, V73, P182
   [Anonymous], 2016, ZIKA INFECT MAY BE W
   Assuncao-Miranda I, 2013, BIOMED RES INT, DOI 10.1155/2013/973516
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Back AT, 2013, INFECT ECOL EPIDEMIO, V3
   Bastos MD, 2012, REV SOC BRAS MED TRO, V45, P393, DOI 10.1590/S0037-86822012000300022
   Bhavana K, 2008, INT J PEDIATR OTORHI, V72, P257, DOI 10.1016/j.ijporl.2007.09.022
   Bodenmann P, 2006, LANCET, V368, P258, DOI 10.1016/S0140-6736(06)69046-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Brasil P, 2016, N ENGL J MED, V4
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   BRIGHTON SW, 1983, S AFR MED J, V63, P313
   Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005
   Calvet G., 2016, LANCET INFECT DIS
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RD, 2013, J CLIN VIROL, V56, P86, DOI 10.1016/j.jcv.2012.10.006
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   Control ECfDPa, 2015, RAP RISK ASS ZIK VIR
   Cruz ACR, 2010, REV PAN AM SAUDE, V1, P25
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MD, 2016, INFECT GENET EVOL, V43, P130, DOI 10.1016/j.meegid.2016.05.021
   D'Ortenzio E, 2016, N ENGL J MED, V13
   da Rocha LA, 2009, REV SOC BRAS MED TRO, V42, P18, DOI 10.1590/S0037-86822009000100005
   Heinen LBD, 2015, REV INST MED TROP SP, V57, P489, DOI 10.1590/S0036-46652015000600005
   Vieira CJDP, 2015, ACTA TROP, V147, P12, DOI 10.1016/j.actatropica.2015.03.020
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Mota MTD, 2015, FUTURE VIROL, V10, P1109, DOI 10.2217/fvl.15.76
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Dejnirattisai W, 2016, NAT IMMUNOL, V23
   DELLER JJ, 1968, AM J TROP MED HYG, V17, P107
   DESOUZA RV, 1995, MEM I OSWALDO CRUZ, V90, P345, DOI 10.1590/S0074-02761995000300006
   Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11, DOI 10.1590/S0036-46652003000100003
   Drumond BP, 2016, BRAZ J MICROBIOL, V47, P251, DOI 10.1016/j.bjm.2015.11.016
   Drumond BP, 2012, ARCH VIROL, V157, P2061, DOI 10.1007/s00705-012-1393-9
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Favoretto S, 2016, BIORXIV
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fiocru Z., 2016, FIOCRUZ MINAS CRIA B
   Fiocru Z., 2016, FIOCRUZ BAHIA MOSTRA
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Franca GV, 2016, LANCET
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   de Araujo JMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001784
   de Araujo JMG, 2009, MEM I OSWALDO CRUZ, V104, P526, DOI 10.1590/S0074-02762009000300021
   de Figueiredo MLG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-60
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   HALSTEAD SB, 1969, AM J TROP MED HYG, V18, P972, DOI 10.4269/ajtmh.1969.18.972
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hanafusa Shigeki, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P252
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Heymann DL, 2016, LANCET, V11
   HOCH AL, 1981, AM J TROP MED HYG, V30, P689, DOI 10.4269/ajtmh.1981.30.689
   Huang YH, 1997, CLIN EXP IMMUNOL, V110, P35, DOI 10.1111/j.1365-2249.1997.499-ce1398.x
   Jaenisch T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1440-3
   Jain M, 2008, TROP DOCT, V38, P70, DOI 10.1258/td.2007.070019
   Jhanjee Anurag, 2011, Ind Psychiatry J, V20, P56, DOI 10.4103/0972-6748.98418
   Jimenez Corona ME, 2016, PLOS CURR, V8
   Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673
   King AMQ, 2011, 9 INT COMM TAX VIR, P1103
   Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65
   Larocca RA, 2016, NATURE, V28
   Laurent P, 2007, CLIN CHEM, V53, P1408, DOI 10.1373/clinchem.2007.086595
   Lavergne A, 2006, VIRUS RES, V117, P283, DOI 10.1016/j.virusres.2005.11.006
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Pessanha JEM, 2011, REV SOC BRAS MED TRO, V44
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martins VCA, 2014, PLOS ONE, V9
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohan A, 2006, INDIAN J MED RES, V124, P471
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Mota MT, 2015, GENOME ANNOUN, V3
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naveca FG, 2012, J VIROL, V86, P1897, DOI 10.1128/JVI.06731-11
   Neumayr A, 2012, EMERG INFECT DIS, V18, P695, DOI 10.3201/eid1804.111717
   Nilsson J, 2005, SCAND J INFECT DIS, V37, P776, DOI 10.1080/00365540410020992
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Nishiura H, 2016, TRAVEL MED INFECT DI, V7
   Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nogueira RMR, 2001, MEM I OSWALDO CRUZ, V96, P925, DOI 10.1590/S0074-02762001000700007
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Oliveira MF, 2010, EMERG INFECT DIS, V16, P576, DOI 10.3201/eid1603.090996
   Osanai C H, 1983, Rev Inst Med Trop Sao Paulo, V25, P53
   Paul L., 2016, BIORXIV
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Picone O, 2016, J GYNECOL OBSTET BIO, V11
   Pinheiro F.P., 1986, ARBOVIRUSES EPIDEMIO, P137
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Pinheiro FP, 1981, CRC HDB SERIES ZOONO, V1, P159
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Queyriaux B, 2008, LANCET, V371, P723, DOI 10.1016/S0140-6736(08)60337-2
   Raghwani J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002064
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Rapp C, 2002, PRESSE MED, V31, P1704
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Reuters, 2016, REUTERS
   Nogueira RMR, 2007, REV PANAM SALUD PUBL, V22, P358, DOI 10.1590/S1020-49892007001000009
   Rigau-Perez JG, 2006, LANCET INFECT DIS, V6, P297, DOI 10.1016/S1473-3099(06)70465-0
   Rigau-Perez JG, 1998, AM J TROP MED HYG, V59, P272, DOI 10.4269/ajtmh.1998.59.272
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Roby JA, 2012, FLAVIVIRUSES
   Rocco Iray Maria, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P151, DOI 10.1590/S0036-46651998000300004
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Salvador FS, 2015, GENOME ANNOUN, V3
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Saude SdVeSMd, 2016, B EPIDEMIOLOGICO, P2358
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039
   Simmonds P., 2011, VIRUS TAXONOMY, P1003, DOI DOI 10.1016/J.BJID.2014.12.003
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Solanki BS, 2007, INT J CLIN PRACT, V61, P1941, DOI 10.1111/j.1742-1241.2007.01329.x
   Srikiatkhachorn A, 2011, CLIN INFECT DIS, V53, P563, DOI 10.1093/cid/cir451
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Taubitz W, 2007, CLIN INFECT DIS, V45, pE1, DOI 10.1086/518701
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vasconcelos Pedro F. Da C., 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P253
   Vasconcelos PFC, 1998, OVERVIEW ARBOVIROLOG, P72
   Venturi G, 2016, EURO SURVEILL, V21
   Vilela APP, 2010, EMERG INFECT DIS, V16, P989, DOI 10.3201/eid1606.091000
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063496
   Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   WHO, 2009, DENG GUID DIAGN TREA, P160
   WHO, 2016, ZIK POT COMPL ZIK SI
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Witayathawornwong Prasonk, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P896
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
   ZAGNE SMO, 1994, T ROY SOC TROP MED H, V88, P677, DOI 10.1016/0035-9203(94)90225-9
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 192
TC 18
Z9 18
U1 0
U2 16
PU SOC BRASILEIRA MICROBIOLOGIA
PI SAO PAULO
PA AV PROF LINEU PRESTES,1374, 05508 SAO PAULO, BRAZIL
SN 1517-8382
EI 1678-4405
J9 BRAZ J MICROBIOL
JI Braz. J. Microbiol.
PD DEC
PY 2016
VL 47
SU 1
BP 38
EP 50
DI 10.1016/j.bjm.2016.10.008
PG 13
WC Microbiology
SC Microbiology
GA EK6PW
UT WOS:000394047600004
PM 27818091
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chan, JFW
   Zhang, AJ
   Chan, CCS
   Yip, CCY
   Mak, WWN
   Zhu, HS
   Poon, VKM
   Tee, KM
   Zhu, Z
   Cai, JP
   Tsang, JOL
   Chik, KKH
   Yin, FF
   Chan, KH
   Kok, KH
   Jin, DY
   Au-Yeung, RKH
   Yuen, KY
AF Chan, Jasper Fuk-Woo
   Zhang, Anna Jinxia
   Chan, Chris Chung-Sing
   Yip, Cyril Chik-Yan
   Mak, Winger Wing-Nga
   Zhu, Houshun
   Poon, Vincent Kwok-Man
   Tee, Kah-Meng
   Zhu, Zheng
   Cai, Jian-Piao
   Tsang, Jessica Oi-Ling
   Chik, Kenn Ka-Heng
   Yin, Feifei
   Chan, Kwok-Hung
   Kok, Kin-Hang
   Jin, Dong-Yan
   Au-Yeung, Rex Kwok-Him
   Yuen, Kwok-Yung
TI Zika Virus Infection in Dexamethasone-immunosuppressed Mice
   Demonstrating Disseminated Infection with Multi-organ Involvement
   Including Orchitis Effectively Treated by Recombinant Type I Interferons
SO EBIOMEDICINE
LA English
DT Article
DE Zika; Flavivirus; Mouse; Animal; Model; Testis; Orchitis; Steroid;
   Treatment; Interferon
ID MODEL; IMMUNOPATHOLOGY; TRANSMISSION; REPLICATION; RECEPTOR; DISEASE;
   FEVER
AB Background: Disseminated or fatal Zika virus (ZIKV) infections were reported in immunosuppressed patients. Existing interferon-signaling/receptor-deficient mouse models may not be suitable for evaluating treatment effects of recombinant interferons.
   Methods: We developed a novel mouse model for ZIKV infection by immunosuppressing BALB/c mice with dexamethasone.
   Results: Dexamethasone-immunosuppressed male mice (68 weeks) developed disseminated infection as evidenced by the detection of ZIKV-NS1 protein expression and high viral loads in multiple organs. They had ?10% weight loss and high clinical scores soon after dexamethasone withdrawal (10 dpi), which warranted euthanasia at 12 dpi. Viral loads in blood and most tissues at 5 dpi were significantly higher than those at 12 dpi (P < 0.05). Histological examination revealed prominent inflammatory infiltrates in multiple organs, and CD45+ and CD8+ inflammatory cells were seen in the testis. These findings suggested that clinical deterioration occurred during viral clearance by host immune response. Type I interferon treatments improved clinical outcome of mice (100% vs 0% survival).
   Conclusions: Besides virus dissemination, inflammation of various tissues, especially orchitis, may be potential complications of ZIKV infection with significant implications on disease transmission and male fertility. Interferon treatment should be considered in patients at high risks for ZIKV-associated complications when the potential benefits outweigh the side effects of treatment. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Zhang, Anna Jinxia; Chan, Chris Chung-Sing; Yip, Cyril Chik-Yan; Mak, Winger Wing-Nga; Zhu, Houshun; Poon, Vincent Kwok-Man; Tee, Kah-Meng; Zhu, Zheng; Cai, Jian-Piao; Tsang, Jessica Oi-Ling; Chik, Kenn Ka-Heng; Chan, Kwok-Hung; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Kok, Kin-Hang; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immunol, Hong Kong, Hong Kong, Peoples R China.
   [Chan, Jasper Fuk-Woo; Yuen, Kwok-Yung] Univ Hong Kong, Carol Yu Ctr Infect, Hong Kong, Hong Kong, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Dept Pathogen Biol, Haikou 571101, Hainan, Peoples R China.
   [Jin, Dong-Yan] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China.
   [Au-Yeung, Rex Kwok-Him] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.
   [Yuen, Kwok-Yung] Univ Hong Kong, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hong Kong, Hong Kong, Peoples R China.
RP Chan, JFW; Yuen, KY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Carol Yu Ctr Infect, Dept Microbiol,State Key Lab Emerging Infect Dis, 102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
EM jfwchan@hku.hk; kyyuen@hku.hk
RI Kok, Kin-Hang/C-4184-2009; Yeung, Kwok Him Rex Au/A-2476-2019; Chan,
   Jasper F. W./D-8007-2013; ZHU, ZHENG/P-2173-2016; Zhang,
   Jinxia/C-4470-2009
OI Yeung, Kwok Him Rex Au/0000-0002-3137-0886; Chan, Jasper F.
   W./0000-0001-6336-6657; ZHU, ZHENG/0000-0002-2035-0804; Zhang,
   Jinxia/0000-0002-5087-3614; /0000-0003-3426-332X; Yuen,
   Kwok-yung/0000-0002-2083-1552
FU ChowSin Lan Charity Fund Limited; Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Diseases of the
   Department of Health, Hong Kong Special Administrative Region; Committee
   for Research and Conference Grant, The University of Hong KongUniversity
   of Hong Kong; Collaborative Innovation Center for Diagnosis and
   Treatment of Infectious Diseases, the Ministry of Education of
   ChinaMinistry of Education, China
FX We are grateful to Can Li, Andrew Chak-Yiu Lee, and Shuofeng Yuan for
   their facilitation of the study. This work was partly supported by the
   donations of Larry Chi-Kin Yung, and Hui Hoy and ChowSin Lan Charity
   Fund Limited; and funding from the Consultancy Service for Enhancing
   Laboratory Surveillance of Emerging Infectious Diseases of the
   Department of Health, Hong Kong Special Administrative Region; and the
   Committee for Research and Conference Grant, The University of Hong
   Kong; and the Collaborative Innovation Center for Diagnosis and
   Treatment of Infectious Diseases, the Ministry of Education of China.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bhagat M, 2012, PAEDIATR INT CHILD H, V32, P161, DOI 10.1179/2046905512Y.0000000001
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392
   Chan JFW, 2015, J CLIN MICROBIOL, V53, P2722, DOI 10.1128/JCM.01224-15
   Chatterjee Nandini, 2014, J Assoc Physicians India, V62, P224
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2016, INFECTION
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Govero J, 2016, NATURE
   Graham JB, 2015, MBIO, V6, DOI 10.1128/mBio.00493-15
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Khorsandi L, 2013, PHARM BIOL, V51, P206, DOI 10.3109/13880209.2012.716854
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mercado M., 2016, EUR SURG, V21
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON, P1
   Prazeres J., 2016, JAMA OPHTHALMOL
   Quaresma JAS, 2013, REV MED VIROL, V23, P305, DOI 10.1002/rmv.1752
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2
   Tian YJ, 2012, J VIROL, V86, P1904, DOI 10.1128/JVI.06707-11
   Torres J R, 2000, Clin Infect Dis, V31, pE28, DOI 10.1086/317454
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   World Health Organization, 2016, ZIK SIT REP
   Zhang AJX, 2014, CLIN VACCINE IMMUNOL, V21, P570, DOI 10.1128/CVI.00816-13
   Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105
   Zhou J, 2014, J INFECT DIS, V209, P1331, DOI 10.1093/infdis/jit504
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 58
TC 47
Z9 50
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD DEC
PY 2016
VL 14
BP 112
EP 122
DI 10.1016/j.ebiom.2016.11.017
PG 11
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EM4AP
UT WOS:000395256000017
PM 27884655
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cao, XC
   Li, YJ
   Jin, XY
   Li, YL
   Guo, F
   Jin, TC
AF Cao, Xiaocong
   Li, Yajuan
   Jin, Xiangyu
   Li, Yuelong
   Guo, Feng
   Jin, Tengchuan
TI Molecular mechanism of divalent-metal-induced activation of NS3 helicase
   and insights into Zika virus inhibitor design
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MUTATIONAL ANALYSIS; RNA TRANSLOCATION; CRYSTAL-STRUCTURE; ATP
   HYDROLYSIS; PROTEIN
AB Zika virus has attracted increasing attention because of its potential for causing human neural disorders, including microcephaly in infants and Guillain-Barre syndrome. Its NS3 helicase domain plays critical roles in NTP-dependent RNA unwinding and translocation during viral replication. Our structural analysis revealed a pre-activation state of NS3 helicase in complex with GTP gamma S, in which the triphosphate adopts a compact conformation in the absence of any divalent metal ions. In contrast, in the presence of a divalent cation, GTP gamma S adopts an extended conformation, and the Walker A motif undergoes substantial conformational changes. Both features contribute to more extensive interactions between the GTP gamma S and the enzyme. Thus, this study provides structural evidence on the allosteric modulation of MgNTP2-on the NS3 helicase activity. Furthermore, the compact conformation of inhibitory NTP identified in this study provides precise information for the rational drug design of small molecule inhibitors for the treatment of ZIKV infection.
C1 [Cao, Xiaocong; Li, Yajuan; Jin, Xiangyu; Li, Yuelong; Jin, Tengchuan] Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, CAS Ctr Excellence Mol Cell Sci, Lab Struct Immunol,Sch Life Sci, Hefei 230027, Anhui, Peoples R China.
   [Cao, Xiaocong; Li, Yajuan; Jin, Xiangyu; Li, Yuelong; Jin, Tengchuan] Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China.
   [Guo, Feng] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
RP Li, YJ; Jin, TC (corresponding author), Univ Sci & Technol China, CAS Key Lab Innate Immun & Chron Dis, CAS Ctr Excellence Mol Cell Sci, Lab Struct Immunol,Sch Life Sci, Hefei 230027, Anhui, Peoples R China.; Li, YJ; Jin, TC (corresponding author), Univ Sci & Technol China, Med Ctr, Hefei 230027, Anhui, Peoples R China.
EM lyj106@mail.ustc.edu.cn; jint@ustc.edu.cn
RI Jin, Tengchuan/B-5883-2014; li, yue long/G-6811-2018
OI Jin, Tengchuan/0000-0002-1395-188X; li, yue long/0000-0001-5466-779X
FU Task Force of Zika Virus Research from the Chinese Academy of Sciences
   (CAS); Fundamental Research Funds for the Central
   UniversitiesFundamental Research Funds for the Central Universities; 100
   Talents Program of CASChinese Academy of Sciences; China Postdoctoral
   Science FoundationChina Postdoctoral Science Foundation [2015M582007];
   CAS Key Laboratory of Innate Immunity and Chronic Diseases
FX Task Force of Zika Virus Research from the Chinese Academy of Sciences
   (CAS); Fundamental Research Funds for the Central Universities and the
   100 Talents Program of CAS (to T.J.); China Postdoctoral Science
   Foundation [2015M582007 to Y.J.L.]; CAS Key Laboratory of Innate
   Immunity and Chronic Diseases (to F.G.). Funding for open access charge:
   The author.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Belon CA, 2009, J MOL BIOL, V388, P851, DOI 10.1016/j.jmb.2009.03.059
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097
   Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331
   Frick DN, 2007, J MOL BIOL, V365, P1017, DOI 10.1016/j.jmb.2006.10.023
   Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60
   Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859
   Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lu SY, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003831
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rawling DC, 2015, ELIFE, V4, DOI 10.7554/eLife.09391
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Salonen A, 2005, CURR TOP MICROBIOL, V285, P139
   Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05
   Tai CL, 2001, J VIROL, V75, P8289, DOI 10.1128/JVI.75.17.8289-8297.2001
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Yamashita T, 2008, VIROLOGY, V373, P426, DOI 10.1016/j.virol.2007.12.018
   Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419
   Zheng WJ, 2007, PROTEINS, V67, P886, DOI 10.1002/prot.21326
NR 38
TC 24
Z9 25
U1 0
U2 24
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD DEC
PY 2016
VL 44
IS 21
BP 10505
EP 10514
DI 10.1093/nar/gkw941
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EK5PX
UT WOS:000393979400042
PM 27915293
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moran, KR
   Fairchild, G
   Generous, N
   Hickmann, K
   Osthus, D
   Priedhorsky, R
   Hyman, J
   Del Valle, SY
AF Moran, Kelly R.
   Fairchild, Geoffrey
   Generous, Nicholas
   Hickmann, Kyle
   Osthus, Dave
   Priedhorsky, Reid
   Hyman, James
   Del Valle, Sara Y.
TI Epidemic Forecasting is Messier Than Weather Forecasting: The Role of
   Human Behavior and Internet Data Streams in Epidemic Forecast
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE disease; weather; forecasting; Internet data; modeling
ID BIG DATA; INFLUENZA; SURVEILLANCE
AB Mathematical models, such as those that forecast the spread of epidemics or predict the weather, must overcome the challenges of integrating incomplete and inaccurate data in computer simulations, estimating the probability of multiple possible scenarios, incorporating changes in human behavior and/or the pathogen, and environmental factors. In the past 3 decades, the weather forecasting community has made significant advances in data collection, assimilating heterogeneous data steams into models and communicating the uncertainty of their predictions to the general public. Epidemic modelers are struggling with these same issues in forecasting the spread of emerging diseases, such as Zika virus infection and Ebola virus disease. While weather models rely on physical systems, data from satellites, and weather stations, epidemic models rely on human interactions, multiple data sources such as clinical surveillance and Internet data, and environmental or biological factors that can change the pathogen dynamics. We describe some of similarities and differences between these 2 fields and how the epidemic modeling community is rising to the challenges posed by forecasting to help anticipate and guide the mitigation of epidemics. We conclude that some of the fundamental differences between these 2 fields, such as human behavior, make disease forecasting more challenging than weather forecasting.
C1 [Moran, Kelly R.; Fairchild, Geoffrey; Generous, Nicholas; Del Valle, Sara Y.] Los Alamos Natl Lab, Analyt Intelligence & Technol Div, Los Alamos, NM USA.
   [Hickmann, Kyle; Hyman, James] Los Alamos Natl Lab, Theoret Div, Los Alamos, NM USA.
   [Osthus, Dave] Los Alamos Natl Lab, Comp Computat & Stat Sci Div, Los Alamos, NM USA.
   [Priedhorsky, Reid] Los Alamos Natl Lab, High Performance Comp Div, Los Alamos, NM USA.
   [Hyman, James] Tulane Univ, Dept Math, New Orleans, LA 70118 USA.
RP Del Valle, SY (corresponding author), Los Alamos Natl Lab, Analyt Intelligence & Technol, POB 1663,MS F609, Los Alamos, NM 87545 USA.
EM sdelvall@lanl.gov
RI Hyman, James M/AAF-7389-2020
OI Hyman, James M/0000-0001-5247-5794
FU National Institute of General Medical Sciences, National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U01-GM097658-01]; Department of EnergyUnited
   States Department of Energy (DOE) [DE-AC52-06NA25396]
FX This work was supported by the Models of Infectious Disease Agent Study,
   National Institute of General Medical Sciences, National Institutes of
   Health (grant U01-GM097658-01). Los Alamos National Laboratory is
   operated by Los Alamos National Security, for the Department of Energy,
   under contract DE-AC52-06NA25396.
CR Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0
   Araz OM, 2014, AM J EMERG MED, V32, P1016, DOI 10.1016/j.ajem.2014.05.052
   Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826
   Culotta A, 2013, LANG RESOUR EVAL, V47, P217, DOI 10.1007/s10579-012-9185-0
   Davidson MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08154
   Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006
   Digital Content Next, 2012, OPA STUDY DEFINES TO
   Dole R., 2009, FUTURE FORECASTS
   Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892
   George D., 2015, BACK FUTURE USING HI
   Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103
   Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634
   Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x
   Hamill TM, 2006, Q J ROY METEOR SOC, V132, P2905, DOI 10.1256/qj.06.25
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Jajosky RA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-29
   Jia-xing B, 2013, 2013 INT C MAN SCI E
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   Lott J. N., 2002, 13 S GLOB CHANG CLIM
   Lynch P, 2008, J COMPUT PHYS, V227, P3431, DOI 10.1016/j.jcp.2007.02.034
   McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581
   National Oceanographic and Atmospheric Administration, FY 2015 BUDG SUMM
   POLGREEN PM, 2006, MICROBE, V1, P459
   Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199
   Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212
   *WHO, WHO REP GLOB SURV EP
   World Meteorological Association, STAND TECHN REG
NR 29
TC 19
Z9 19
U1 1
U2 11
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD DEC 1
PY 2016
VL 214
SU 4
BP S404
EP S408
DI 10.1093/infdis/jiw375
PG 5
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EJ3RW
UT WOS:000393130300006
PM 28830111
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Butt, AM
   Siddique, S
   Gardner, LM
   Sarkar, S
   Lancelot, R
   Qamar, R
AF Butt, Azeem Mehmood
   Siddique, Shafiqa
   Gardner, Lauren M.
   Sarkar, Sahotra
   Lancelot, Renaud
   Qamar, Raheel
TI Zika virus in Pakistan: the tip of the iceberg?
SO LANCET GLOBAL HEALTH
LA English
DT Letter
C1 [Butt, Azeem Mehmood; Qamar, Raheel] COMSATS Inst Informat Technol, Translat Genom Lab, Dept Biosci, Islamabad, Pakistan.
   [Siddique, Shafiqa] Holy Family Hosp, Rawalpindi Med Coll, Rawalpindi, Pakistan.
   [Gardner, Lauren M.] Univ New South Wales Australia, Sch Civil & Environm Engn, Sydney, NSW, Australia.
   [Sarkar, Sahotra] Univ Texas Austin, Dept Philosophy, Austin, TX 78712 USA.
   [Sarkar, Sahotra] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.
   [Lancelot, Renaud] INRA, CIRAD, Montpellier, France.
RP Butt, AM (corresponding author), COMSATS Inst Informat Technol, Translat Genom Lab, Dept Biosci, Islamabad, Pakistan.
EM azeem.butt@comsats.edu.pk
RI Butt, Azeem Mehmood/B-6249-2014
OI Butt, Azeem Mehmood/0000-0001-5897-6848
CR Afzal MF, 2015, MERIT RES J MED MED, V3, P69
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Fatima SH, 2016, TROP MED INT HEALTH, V21, P427, DOI 10.1111/tmi.12664
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Qasim M., INCIDENCE PARALYSIS
NR 5
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD DEC
PY 2016
VL 4
IS 12
BP E913
EP E914
DI 10.1016/S2214-109X(16)30246-7
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EJ2FV
UT WOS:000393026400023
PM 27815146
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Smith, DE
   Beckham, JD
   Tyler, KL
   Pastula, DM
AF Smith, Daniel E.
   Beckham, J. David
   Tyler, Kenneth L.
   Pastula, Daniel M.
TI Zika virus disease for neurologists
SO NEUROLOGY-CLINICAL PRACTICE
LA English
DT Review
ID SEXUAL TRANSMISSION; BREAST-MILK; INFECTION; BRAZIL; TRANSFUSION;
   OUTBREAK; NIGERIA; FEVER
AB Purpose of review: Zika virus (ZIKV) was not initially thought to be an important cause of neurologic disease, but with the recent epidemic in the Western Hemisphere, there is a growing body of evidence for possible neurologic complications. This review discusses these in addition to what is known about modes of transmission, testing for the virus, as well as future directions. Recent findings: ZIKV disease has been associated with microcephaly and congenital eye disease in infants, as well as with Guillain-Barre syndrome, uveitis, myelitis, and meningoencephalitis in adults. Summary: Even though most infections are asymptomatic, there are important possible neurologic complications of ZIKV disease in both children and adults of which neurologists should be aware.
C1 [Pastula, Daniel M.] Univ Colorado, Dept Neurol, Neuroinfect Dis Grp, Denver, CO 80202 USA.
   Univ Colorado, Div Infect Dis, Denver, CO 80202 USA.
RP Pastula, DM (corresponding author), Univ Colorado, Dept Neurol, Neuroinfect Dis Grp, Denver, CO 80202 USA.
EM Daniel.Pastula@ucdenver.edu
RI Pastula, Daniel M./M-1325-2019; Tyler, Kenneth L./J-2420-2019
OI Pastula, Daniel M./0000-0001-9342-4459; Tyler, Kenneth
   L./0000-0003-3294-5888
CR [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Besnard M, 2014, EURO SURVEILL, V19
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CDC, ZIK VIR ZIK SEX TRAN
   CDC, 2016, ADV PEOPL LIV TRAV S
   CDC, GUID TRAV VIS FRIEND
   CDC, 2016, CAS COUNTS US
   CDC, ZIK VIR DIAGN TEST
   CDC, ZIK VIR CLIN EV DIS
   CDC, ZIA VIR AR ZIK
   CDC, ZIK VIR TRANSM RISKS
   CDC, ZIK VIR WOM THEIR PA
   CDC, ZIK VIR DIS US 2015
   CDC, 2016, OUTC PREGN LAB EV PO
   CDC, ZIK VIR SYMPT DIAGN
   CDC, ZIK VIR PREV
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Paula Freitas B, JAMA OPHTHALMOL 0209
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eunjung Cha A, 2016, WASHINGTON POST 0620
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO, ZIK CUM CAS
   PAHO, TIM EM ZIK VIR AM
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Styczynski AMJ, 2016, 65 EIS C
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 61
TC 5
Z9 5
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2163-0402
EI 2163-0933
J9 NEUROL-CLIN PRACT
JI Neurol.-Clin. Pract.
PD DEC
PY 2016
VL 6
IS 6
BP 515
EP 522
DI 10.1212/CPJ.0000000000000307
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA EJ3HD
UT WOS:000393102300012
PM 28058206
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ahmed, QA
   Kattan, RF
   Memish, ZA
AF Ahmed, Qanta A.
   Kattan, Rana F.
   Memish, Ziad A.
TI Hajj 2016: Under the shadow of global Zika spread
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Editorial Material
ID VIRUS
C1 [Ahmed, Qanta A.] Winthrop Univ Hosp, Dept Med, Div Pulm Dis & Crit Care Med, Mineola, NY 11501 USA.
   [Ahmed, Qanta A.] SUNY Stony Brook, Stony Brook, NY 11794 USA.
   [Kattan, Rana F.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Specialized Children Hosp, Dept Pediat, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Minist Hlth, Riyadh, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia.
RP Memish, ZA (corresponding author), POB 54146, Riyadh 11514, Saudi Arabia.
EM zmemish@yahoo.com
CR Aziz Al Thabiany, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P849, DOI 10.1016/S2221-1691(12)60242-1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Minh NNT, 2016, E MEDITERR HEALTH J, V22, P350
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
NR 7
TC 3
Z9 3
U1 0
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD DEC 1
PY 2016
VL 44
IS 12
BP 1449
EP 1450
DI 10.1016/j.ajic.2016.09.002
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EI6SH
UT WOS:000392626300004
PM 27751616
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika live Twitter chat
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Letter
ID VIRUS
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok 10330, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok 10330, Thailand.
EM beuyjoob@hotmail.com
CR Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Goff DA, 2015, CLIN INFECT DIS, V60, P1533, DOI 10.1093/cid/civ071
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Schwartz J, 2016, HEALTH COMMUN, P1
   Venkatraman A, 2016, TRAVEL MED INFECT DI, V14, P421, DOI 10.1016/j.tmaid.2016.05.018
NR 5
TC 2
Z9 2
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD DEC 1
PY 2016
VL 44
IS 12
BP 1756
EP 1757
DI 10.1016/j.ajic.2016.08.019
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EI6SH
UT WOS:000392626300076
PM 27751615
OA Bronze
DA 2020-07-08
ER

PT J
AU Reegan, AD
   Ceasar, SA
   Paulraj, MG
   Ignacimuthu, S
   Al-Dhabi, NA
AF Reegan, Appadurai Daniel
   Ceasar, Stanislaus Antony
   Paulraj, Michael Gabriel
   Ignacimuthu, Savarimuthu
   Al-Dhabi, Naif Abdullah
TI Current status of genome editing in vector mosquitoes: A review
SO BioScience Trends
LA English
DT Review
DE Gene alteration; mosquito borne disease control; zinc finger nuclease
   (ZFN); transcription activator-like effector nuclease (TALEN); clustered
   regulatory interspaced short palindromic repeats (CRISPR)/CRISPR
   associated protein 9 (Cas9)
ID ZINC-FINGER NUCLEASES; YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; GENE DRIVE;
   GERMLINE TRANSFORMATION; ANOPHELES-STEPHENSI; MALARIA VECTOR;
   HUMAN-CELLS; CRISPR-CAS9; CAS9
AB Mosquitoes pose a major threat to human health as they spread many deadly diseases like malaria, dengue, chikungunya, filariasis, Japanese encephalitis and Zika. Identification and use of novel molecular tools are essential to combat the spread of vector borne diseases. Genome editing tools have been used for the precise alterations of the gene of interest for producing the desirable trait in mosquitoes. Deletion of functional genes or insertion of toxic genes in vector mosquitoes will produce either knock-out or knock-in mutants that will check the spread of vector-borne diseases. Presently, three types of genome editing tools viz., zinc finger nuclease (ZFN), transcription activator-like effector nucleases (TALEN) and clustered regulatory interspaced short palindromic repeats (CRISPR) and CRISPR associated protein 9 (Cas9) are widely used for the editing of the genomes of diverse organisms. These tools are also applied in vector mosquitoes to control the spread of vector-borne diseases. A few studies have been carried out on genome editing to control the diseases spread by vector mosquitoes and more studies need to be performed with the utilization of more recently invented tools like CRISPR/Cas9 to combat the spread of deadly diseases by vector mosquitoes. The high specificity and flexibility of CRISPR/Cas9 system may offer possibilities for novel genome editing for the control of important diseases spread by vector mosquitoes. In this review, we present the current status of genome editing research on vector mosquitoes and also discuss the future applications of vector mosquito genome editing to control the spread of vectorborne diseases.
C1 [Reegan, Appadurai Daniel; Paulraj, Michael Gabriel; Ignacimuthu, Savarimuthu] Entomol Res Inst, Loyola Coll, Div Vector Control, Madras 600034, Tamil Nadu, India.
   [Reegan, Appadurai Daniel] Madras Christian Coll, Dept Zool, Madras, Tamil Nadu, India.
   [Ceasar, Stanislaus Antony; Ignacimuthu, Savarimuthu] Entomol Res Inst, Loyola Coll, Div Mol Biol, Madras, Tamil Nadu, India.
   [Ignacimuthu, Savarimuthu] King Saud Univ, Int Sci Partnership Program, Res, Riyadh 11451, Saudi Arabia.
   [Al-Dhabi, Naif Abdullah] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Addiriyah Chair Environm Studies, Riyadh 11451, Saudi Arabia.
RP Ignacimuthu, S (corresponding author), Entomol Res Inst, Loyola Coll, Div Vector Control, Madras 600034, Tamil Nadu, India.
EM eriloyola@hotmail.com
RI Stanislaus, Antony Ceasar/P-2479-2017
OI Stanislaus, Antony Ceasar/0000-0003-4106-1531
FU International Scientific Partnership Program (ISPP); Deanship of
   research, King Saudi University Riyadh, Saudi Arabia through ISPP [0020]
FX The authors extend their appreciation to the International Scientific
   Partnership Program (ISPP), Deanship of research, King Saudi University
   Riyadh, Saudi Arabia for funding this research work through ISPP#0020.
   The authors are grateful to Mr. S. Sylvester Darvin, Senior Research
   Fellow, Entomology Research Institute for his assistance and
   contribution in preparing the figures.
CR Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Alphey L, 2016, NAT BIOTECHNOL, V34, P149, DOI 10.1038/nbt.3473
   Aryan A, 2014, METHODS, V69, P38, DOI 10.1016/j.ymeth.2014.02.008
   Aryan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060082
   Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659
   Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112
   Bayen S, 2012, ENVIRON INT, V48, P84, DOI 10.1016/j.envint.2012.07.008
   Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001
   Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512
   Bibikova M, 2002, GENETICS, V161, P1169
   Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936
   Briese DT, 2004, AUST J ENTOMOL, V43, P304, DOI 10.1111/j.1326-6756.2004.00442.x
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Buzzkill Chakradhar S., 2016, NAT MED, V21, P416
   Callaway Ewen, 2015, NATURE
   Carlson DF, 2012, P NATL ACAD SCI USA, V109, P17382, DOI 10.1073/pnas.1211446109
   Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433
   Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096
   Ceasar SA, 2016, BBA-MOL CELL RES, V1863, P2333, DOI 10.1016/j.bbamcr.2016.06.009
   Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748
   Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714
   Criscione F, 2015, CURR OPIN INSECT SCI, V10, P90, DOI 10.1016/j.cois.2015.04.012
   Curtin SJ, 2011, PLANT PHYSIOL, V156, P466, DOI 10.1104/pp.111.172981
   DeFrancesco L., 2012, NAT BIOTECHNOL, V29, P681
   DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401
   Franz Alexander W E, 2014, Curr Trop Med Rep, V1, P21
   Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623
   Gabrieli P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0535-7
   Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004
   Galizi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31139
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172
   Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647
   Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/NMETH.3284, 10.1038/nmeth.3284]
   Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526
   KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459
   Ledford H, 2015, NATURE
   Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a
   Liesch J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002486
   Madhu SK, 2010, ACTA TROP, V113, P7, DOI 10.1016/j.actatropica.2009.08.023
   Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x
   Mussolino C, 2012, CURR OPIN BIOTECH, V23, P644, DOI 10.1016/j.copbio.2012.01.013
   Overcash JM, 2015, CHROMOSOME RES, V23, P31, DOI 10.1007/s10577-014-9450-8
   Oye KA, 2014, SCIENCE, V345, P626, DOI 10.1126/science.1254287
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Paulraj MG, 2016, INDIAN J NAT PROD RE, V7, P193
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Reegan AD, 2014, ACTA TROP, V139, P67, DOI 10.1016/j.actatropica.2014.07.002
   Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170
   Sakuma T, 2014, DEV GROWTH DIFFER, V56, P2, DOI 10.1111/dgd.12111
   Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542
   Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992
   Smidler AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074511
   Tikar SN, 2009, PARASITOL RES, V105, P57, DOI 10.1007/s00436-009-1362-8
   Vogel G. U. K., SCI NEWS
   Webber BL, 2015, P NATL ACAD SCI USA, V112, P10565, DOI 10.1073/pnas.1514258112
   WHO, WHO DIR GEN SUMM OUT
   WHO, WORLD MALARIA REPORT
   Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183
NR 74
TC 9
Z9 9
U1 1
U2 43
PU IRCA-BSSA
PI TOKYO
PA PEARL CITY KOISHIKAWA 603, 2-4-5 KASUGA, BUNKYO-KU, TOKYO, 112-0003,
   JAPAN
SN 1881-7815
EI 1881-7823
J9 BIOSCI TRENDS
JI BioSci. Trends
PD DEC
PY 2016
VL 10
IS 6
BP 424
EP 432
DI 10.5582/bst.2016.01180
PG 9
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EI9FS
UT WOS:000392813900001
PM 27990003
OA Bronze
DA 2020-07-08
ER

PT J
AU Maynard, AD
   Bowman, DM
   Hodge, JG
AF Maynard, Andrew D.
   Bowman, Diana M.
   Hodge, James G., Jr.
TI Mitigating Risks to Pregnant Teens from Zika Virus
SO JOURNAL OF LAW MEDICINE & ETHICS
LA English
DT Article
ID UNITED-STATES; UNINTENDED PREGNANCY
C1 [Maynard, Andrew D.] Arizona State Univ, Risk Innovat Lab, Tempe, AZ 85287 USA.
   [Maynard, Andrew D.] Arizona State Univ, Master Sci & Technol Policy, Tempe, AZ 85287 USA.
   [Maynard, Andrew D.] Arizona State Univ, Sch Future Innovat Soc, Tempe, AZ 85287 USA.
   [Bowman, Diana M.] ASU, Sandra Day OConnor Coll Law, Phoenix, AZ USA.
   [Bowman, Diana M.] ASU, Sch Future Innovat Soc, Phoenix, AZ USA.
   [Hodge, James G., Jr.] ASU, Sandra Day OConnor Coll Law, Publ Hlth Law & Eth, Phoenix, AZ USA.
   [Hodge, James G., Jr.] ASU, Sandra Day OConnor Coll Law, Publ Hlth Law & Policy Program, Phoenix, AZ USA.
RP Maynard, AD (corresponding author), Arizona State Univ, Risk Innovat Lab, Tempe, AZ 85287 USA.; Maynard, AD (corresponding author), Arizona State Univ, Master Sci & Technol Policy, Tempe, AZ 85287 USA.; Maynard, AD (corresponding author), Arizona State Univ, Sch Future Innovat Soc, Tempe, AZ 85287 USA.
OI Maynard, Andrew/0000-0003-2117-5128
CR Centers for Disease Control and Pre-vention, 2016, ZIK VIR PREGN WOM PR
   Centers for Disease Control and Pre-vention, ZIK VIR ADV PEOPL LI
   Centers for Disease Control and Pre-vention, ZIK VIR WOM TRYING B
   Centers for Disease Control and Pre-vention, ZIK VIR PROT YOUR DU
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013
   Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2
   Hodge Jr J.G., 2016, US NEWS WORLD REPORT
   Johansson MA, 2016, NEW ENGL J MED, V375
   Kennedy K., 2016, WASHINGTON POST
   Kost K., 2016, U S TEEN PREGNANCIES
   Mansuy J. M., 2016, LANCET INFECT DIS, V16
   Monaghan A, 2016, PLOS CURRENTS OUTBRE
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Tavernise S, 2016, NY TIMES
   WHO, 2016, ZIK VIR FACT SHEET
NR 16
TC 0
Z9 0
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1073-1105
EI 1748-720X
J9 J LAW MED ETHICS
JI J. Law Med. Ethics
PD DEC
PY 2016
VL 44
IS 4
BP 657
EP 659
DI 10.1177/1073110516684814
PG 3
WC Ethics; Law; Medical Ethics; Medicine, Legal
SC Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal
   Medicine
GA EI9PS
UT WOS:000392841400018
PM 28661244
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika Virus Infection: Don't Miss It
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Letter
ID DENGUE
C1 [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok, Thailand.
CR Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Wiwanitkit S, 2016, ASIAN PAC J IN PRESS
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 5
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD DEC
PY 2016
VL 129
IS 12
DI 10.1016/j.amjmed.2016.03.017
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EI6QB
UT WOS:000392619500015
PM 27866593
OA Bronze
DA 2020-07-08
ER

PT J
AU Gyawali, N
   Bradbury, RS
   Taylor-Robinson, AW
AF Gyawali, Narayan
   Bradbury, Richard S.
   Taylor-Robinson, Andrew W.
TI Do neglected Australian arboviruses pose a global epidemic threat?
SO AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH
LA English
DT Letter
ID MOSQUITOS DIPTERA; ZIKA VIRUS; INFECTION; CULICIDAE
C1 [Gyawali, Narayan; Bradbury, Richard S.; Taylor-Robinson, Andrew W.] Cent Queensland Univ, Sch Med & Appl Sci, Rockhampton, Qld, Australia.
RP Taylor-Robinson, AW (corresponding author), Cent Queensland Univ, Sch Med & Appl Sci, Infect Dis Res Grp, Rockhampton, Qld 4702, Australia.
EM a.taylor-robinson@cqu.edu.au
RI Bradbury, Richard S/A-2094-2019
OI Bradbury, Richard S/0000-0002-5524-506X; Taylor-Robinson, Andrew
   W./0000-0001-7342-8348
CR AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DOHERTY RL, 1977, AUST J EXP BIOL MED, V55, P103, DOI 10.1038/icb.1977.9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   KAY BH, 1979, J MED ENTOMOL, V16, P59, DOI 10.1093/jmedent/16.1.59
   Russell RC, 2000, MICROBES INFECT, V2, P1693, DOI 10.1016/S1286-4579(00)01324-1
   Smith DW, 2011, TRAVEL MED INFECT DI, V9, P113, DOI 10.1016/j.tmaid.2010.05.005
   TESH RB, 1981, T ROY SOC TROP MED H, V75, P426, DOI 10.1016/0035-9203(81)90112-7
NR 8
TC 4
Z9 4
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1326-0200
EI 1753-6405
J9 AUST NZ J PUBL HEAL
JI Aust. N. Z. Publ. Health
PD DEC
PY 2016
VL 40
IS 6
BP 596
EP 596
DI 10.1111/1753-6405.12582
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EI7DB
UT WOS:000392656600020
PM 27774685
DA 2020-07-08
ER

PT J
AU Ahmed, Q
   Memish, Z
AF Ahmed, Qanta A.
   Memish, Ziad A.
TI Yellow fever and Hajj: with all eyes on Zika, a familiar flavivirus
   remains a threat
SO FRONTIERS OF MEDICINE
LA English
DT Editorial Material
DE yellow fever; mass gathering; Saudi Arabia; Hajj; Zika virus
AB Hajj is among the world's largest mass gatherings, drawing between 2 and 3.5 million Muslims from 183 nations annually to perform pilgrimage in Mecca, Saudi Arabia. Infectious disease outbreaks can be imported both into the Hajj population and exported internationally by returning pilgrims. The domestic Saudi population can also be at risk of outbreaks traveling amid this mass migration. With yellow fever reported for the first time in China following the infection of expatriate Chinese workers in Angola and a full blown outbreak underway in wider West Africa, the prospect of yellow fever outbreaks in Asia threatens to impact Saudi Arabia, both during and beyond the Hajj season. With global focus trained on Zika, the rising threat of yellow fever cannot be overlooked. Strategies to mitigate risk to Saudi Arabia and the global population are thereby suggested.
C1 [Ahmed, Qanta A.] SUNY Stony Brook, Winthrop Univ Hosp, Dept Med, Div Pulm Dis & Crit Care Med, Stony Brook, NY 11790 USA.
   [Memish, Ziad A.] Minist Hlth, Riyadh 11514, Saudi Arabia.
   [Memish, Ziad A.] Alfaisal Univ, Coll Med, Riyadh 11533, Saudi Arabia.
RP Memish, ZA (corresponding author), Minist Hlth, Riyadh 11514, Saudi Arabia.; Memish, ZA (corresponding author), Alfaisal Univ, Coll Med, Riyadh 11533, Saudi Arabia.
EM Zmemish@yahoo.com
CR [Anonymous], 2016, Wkly Epidemiol Rec, V91, P331
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Burki T, 2016, LANCET INFECT DIS, V16, P896, DOI 10.1016/S1473-3099(16)30224-9
   Elachola H, 2016, LANCET, V388, P1155, DOI 10.1016/S0140-6736(16)31546-X
   Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4756
   Jamie A., YELLOW FEVER SPREADS
   Kupferschmidt K, 2016, SCIENCE, V352, P128, DOI 10.1126/science.352.6282.128
   Maguire HCF, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3764
   Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Wang LF, 2016, J INFECTION, V73, P377, DOI 10.1016/j.jinf.2016.07.003
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
NR 13
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 2095-0217
EI 2095-0225
J9 FRONT MED-PRC
JI Front. Med.
PD DEC
PY 2016
VL 10
IS 4
BP 527
EP 530
DI 10.1007/s11684-016-0487-2
PG 4
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA EI5BL
UT WOS:000392508300020
PM 27757795
OA Bronze
DA 2020-07-08
ER

PT J
AU Althouse, BM
   Vasilakis, N
   Sall, AA
   Diallo, M
   Weaver, SC
   Hanley, KA
AF Althouse, Benjamin M.
   Vasilakis, Nikos
   Sall, Amadou A.
   Diallo, Mawlouth
   Weaver, Scott C.
   Hanley, Kathryn A.
TI Potential for Zika Virus to Establish a Sylvatic Transmission Cycle in
   the Americas
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID YELLOW-FEVER VIRUS; DENGUE VIRUS; NONHUMAN-PRIMATES; AEDES-AEGYPTI;
   BRAZIL; INFECTION; INDONESIA; MOSQUITOS; SENEGAL; FLAVIVIRUSES
AB Zika virus (ZIKV) originated and continues to circulate in a sylvatic transmission cycle between non-human primate hosts and arboreal mosquitoes in tropical Africa. Recently ZIKV invaded the Americas, where it poses a threat to human health, especially to pregnant women and their infants. Here we examine the risk that ZIKV will establish a sylvatic cycle in the Americas, focusing on Brazil. We review the natural history of sylvatic ZIKV and present a mathematical dynamic transmission model to assess the probability of establishment of a sylvatic ZIKV transmission cycle in non-human primates and/or other mammals and arboreal mosquito vectors in Brazil. Brazil is home to multiple species of primates and mosquitoes potentially capable of ZIKV transmission, though direct assessment of host competence (ability to mount viremia sufficient to infect a feeding mosquito) and vector competence (ability to become infected with ZIKV and disseminate and transmit upon subsequent feedings) of New World species is lacking. Modeling reveals a high probability of establishment of sylvatic ZIKV across a large range of biologically plausible parameters. Probability of establishment is dependent on host and vector population sizes, host birthrates, and ZIKV force of infection. Research on the host competence of New World monkeys or other small mammals to ZIKV, on vector competence of New World Aedes, Sabethes, and Haemagogus mosquitoes for ZIKV, and on the geographic range of potential New World hosts and vectors is urgently needed. A sylvatic cycle of ZIKV would make future elimination efforts in the Americas practically impossible, and paints a dire picture for the epidemiology of ZIKV and our ability to end the ongoing outbreak of congenital Zika syndrome.
C1 [Althouse, Benjamin M.] Inst Dis Modeling, Bellevue, WA 98005 USA.
   [Althouse, Benjamin M.] Santa Fe Inst, Santa Fe, NM 87501 USA.
   [Althouse, Benjamin M.] Univ Washington, Informat Sch, Seattle, WA 98195 USA.
   [Althouse, Benjamin M.; Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodefense & Emerging Infect Dis, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Sall, Amadou A.; Diallo, Mawlouth] Inst Pasteur, Dakar, Senegal.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Immunol, Galveston, TX 77555 USA.
RP Althouse, BM (corresponding author), Inst Dis Modeling, Bellevue, WA 98005 USA.; Althouse, BM (corresponding author), Santa Fe Inst, Santa Fe, NM 87501 USA.; Althouse, BM (corresponding author), Univ Washington, Informat Sch, Seattle, WA 98195 USA.; Althouse, BM (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
EM balthouse@idmod.org
RI amsalu, ribka/G-8780-2019
FU U.S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [1R15A1113628-01, RO1A1069145, R24AI120942, 1U01AI115577-01]; Bill and
   Melinda Gates; Global Good Fund
FX We gratefully acknowledge the impetus for this work provided by the
   NSF-RCN on Infectious Disease Evolution Across Scales (RCN-IDEAS)
   program. This work was supported by grants 1R15A1113628-01 (KAH),
   RO1A1069145 (BMA, SCW, KAH), R24AI120942 (NV, SCW), 1U01AI115577-01 (NV,
   SCW, KAH) from the U.S. National Institutes of Health. BMA thanks Bill
   and Melinda Gates for their active support of this work and their
   sponsorship through the Global Good Fund. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alberts SC, 2013, P NATL ACAD SCI USA, V110, P13440, DOI 10.1073/pnas.1311857110
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Althouse BM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0299
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Althouse BM, 2014, VIROLOGY, V452, P237, DOI 10.1016/j.virol.2014.01.015
   Althouse BM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001928
   Althouse BM, 2016, BIORXIV
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camara FP, 2013, T ROY SOC TROP MED H, V107, P324, DOI 10.1093/trstmh/trt014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P209
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Codeco CT, 2004, T ROY SOC TROP MED H, V98, P702, DOI 10.1016/j.trstmh.2003.12.019
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2013, T ROY SOC TROP MED H, V107, P200, DOI 10.1093/trstmh/trs095
   Ernest SKM, 2003, ECOLOGY, V84, P3402, DOI 10.1890/02-9002
   Fagbami A, 1985, AFRICAN J MED MED SC, V15, P103
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4
   Jones JH, 2011, CURR BIOL, V21, pR708, DOI 10.1016/j.cub.2011.08.025
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Romano APM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002740
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreno ES, 2013, REV INST MED TROP SP, V55, P45, DOI 10.1590/S0036-46652013000100008
   Moreno ES, 2011, REV INST MED TROP SP, V53, P335, DOI 10.1590/S0036-46652011000600007
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tranquilin MV, 2013, REV SOC BRAS MED TRO, V46, P522, DOI 10.1590/0037-8682-0106-2013
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 68
TC 43
Z9 43
U1 1
U2 19
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005055
DI 10.1371/journal.pntd.0005055
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100009
PM 27977671
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bueno, MG
   Martinez, N
   Abdalla, L
   dos Santos, CND
   Chame, M
AF Bueno, Marina Galvao
   Martinez, Nadia
   Abdalla, Livia
   Duarte dos Santos, Claudia Nunes
   Chame, Marcia
TI Animals in the Zika Virus Life Cycle: What to Expect from Megadiverse
   Latin American Countries
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID YELLOW-FEVER; TRANSMISSION; ARBOVIRUSES; WILD; EPIDEMIOLOGY; ISOLATIONS;
   PRIMATES; SPREAD; DENGUE
AB Zika virus (ZIKV) was first isolated in 1947 in primates in Uganda, West Africa. The virus remained confined to the equatorial regions of Africa and Asia, cycling between infecting monkeys, arboreal mosquitoes, and occasionally humans. The ZIKV Asiatic strain was probably introduced into Brazil in or around late 2013. Presently, ZIKV is in contact with the rich biodiversity in all Brazilian biomes, bordering on other Latin American countries. Infections in Brazilian primates have been reported recently, but the overall impact of this virus on wildlife in the Americas is still unknown. The current epidemic in the Americas requires knowledge on the role of mammals, especially nonhuman primates (NHPs), in ZIKV transmission to humans. The article discusses the available data on ZIKV in host animals and issues of biodiversity, rapid environmental change, and impact on human health in megadiverse Latin American countries. The authors reviewed scientific articles and recent news stories on ZIKV in animals, showing that 47 animal species from three orders (mammals, reptiles, and birds) have been investigated for the potential to establish a sylvatic cycle. The review aims to contribute to epidemiological studies and the knowledge on the natural history of ZIKV. The article concludes with questions that require urgent attention in epidemiological studies involving wildlife in order to understand their role as ZIKV hosts and to effectively control the epidemic.
C1 [Bueno, Marina Galvao; Martinez, Nadia; Abdalla, Livia; Chame, Marcia] Fundacao Oswaldo Cruz, Programa Inst Biodiversidade & Saude, Rio De Janeiro, Brazil.
   [Duarte dos Santos, Claudia Nunes] Fundacao Oswaldo Cruz, Inst Carlos Chagas, Lab Virol Mol, Curitiba, Parana, Brazil.
RP Bueno, MG; Chame, M (corresponding author), Fundacao Oswaldo Cruz, Programa Inst Biodiversidade & Saude, Rio De Janeiro, Brazil.
EM buenomg@gmail.com; mchame@fiocruz.br
RI Duarte dos Santos, Claudia/E-1857-2018; Santos, Claudia Duarte
   dos/P-4868-2019
OI Duarte dos Santos, Claudia/0000-0001-8707-6638; Santos, Claudia Duarte
   dos/0000-0001-8707-6638
CR Albuquerque C, 2016, PORTAL FIOCRUZ  0525
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Althouse BM, 2016, POTENTIAL Z IN PRESS
   Barr KL, 2016, WORKING ZIK IN PRESS
   Bohrer CBA, 2012, GUIA HIST NATURAL RI, P138
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284
   Di Gennaro A, 2014, CLIN VACCINE IMMUNOL, V21, P1460, DOI 10.1128/CVI.00426-14
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Faria NR, 2016, SCIENCE, V351, P1371
   Favoretto S, 2016, 1 DETECTION IN PRESS
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gillespie TR, 2008, AM J PRIMATOL, V70, P222, DOI 10.1002/ajp.20475
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haviland WA, 2014, LIVING PRIMATES
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Henderson BE, 1968, VIRUS RES I ANN REPO, P48
   International comittee on taxonomy of viruses, 2014, VIRUS TAXONOMY
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JOHNSON BK, 1977, T ROY SOC TROP MED H, V71, P512, DOI 10.1016/0035-9203(77)90146-8
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Karesh WB, 2015, CONNECTING GLOBAL PR
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   MARSH LK, 2003, PRIMATES FRAGMENTS E
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mittermeier R, 1999, BIODIVERSITY, P521
   MONATH TP, 1973, TROP GEOGR MED, V25, P28
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OSOFSKY SA, 2005, FRIENDS LIFE NEW PAR, P65
   Pedersen AB, 2009, ECOHEALTH, V6, P496, DOI 10.1007/s10393-010-0284-3
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Rabe IB, 2016, MMWR MORB MORTAL WKL, V65
   REAGAN REGINALD L., 1955, TRANS AMER MICROSC SOC, V74, P77, DOI 10.2307/3223847
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Unwin Steve, 2011, P147
   Vasconcelos PFC, 2001, J MED VIROL, V65, P598, DOI 10.1002/jmv.2078
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vogel G, 2016, SCIENCE
   Wardeh M, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.49
   Wolfe ND, 1998, EMERG INFECT DIS, V4, P149, DOI 10.3201/eid0402.980202
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2015, EP UPD ZIK VIR INF
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 57
TC 21
Z9 23
U1 0
U2 17
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005073
DI 10.1371/journal.pntd.0005073
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100012
PM 28005902
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chandel, K
   Suman, DS
   Wang, Y
   Unlu, I
   Williges, E
   Williams, GM
   Gaugler, R
AF Chandel, Kshitij
   Suman, Devi Shankar
   Wang, Yi
   Unlu, Isik
   Williges, Eric
   Williams, Gregory M.
   Gaugler, Randy
TI Targeting a Hidden Enemy: Pyriproxyfen Autodissemination Strategy for
   the Control of the Container Mosquito Aedes albopictus in Cryptic
   Habitats
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID INSECT GROWTH-REGULATOR; ASIAN TIGER MOSQUITO; DIPTERA-CULICIDAE;
   OVIPOSITION SITES; SOURCE REDUCTION; LARVAL HABITATS; FIELD; AEGYPTI;
   STATION; VECTOR
AB Background
   The Asian tiger mosquito, Aedes albopictus, is a vector of dengue, Chikungunya, and Zika viruses. This mosquito inhabits a wide range of artificial water-holding containers in urban and suburban areas making it difficult to control. We tested the hypothesis that femaledriven autodissemination of an insect growth regulator could penetrate cryptic oviposition habitats difficult to treat with conventional insecticidal sprays.
   Methodology
   Oviposition preferences of Ae. albopictus females for open and cryptic cups were tested in semi-field experiments. Two conventional larvicidal sprayers were tested to determine droplet penetration and larvicidal efficacy in open and cryptic habitats using Bacillus thuringiensis var. israelensis (Bti) in the field. Finally, the efficacy of pyriproxyfen autodissemination stations was assessed in cryptic and open cups in residential areas during 2013 and 2014.
   Principal Findings
   Gravid females strongly preferred cryptic (53.1 +/- 12.9 eggs/cup) over open (10.3 +/- 4.3 eggs/cup) cups for oviposition. Cryptic cups showed limited droplet penetration and produced 0.1-0.3% larval mortality with a conventional backpack and low-volume sprays of Bti. The autodissemination stations effectively contaminated these cryptic cups (59.3-84.6%) and produced 29.7-40.8% pupal mortality during 2013-2014. Significant pupal mortality was also observed in open cups.
   Conclusions
   The autodissemination station effectively exploits the oviposition behavior of wild gravid females to deliver pyriproxyfen to targeted oviposition habitats. Although the pupal mortality in cryptic cups was relatively lower than expected for the effective vector control. Autodissemination approach may be a suitable supporting tool to manage Ae. albopictus immatures in the cryptic habitats those are less accessible to conventional larvicidal sprays.
C1 [Chandel, Kshitij; Suman, Devi Shankar; Wang, Yi; Unlu, Isik; Gaugler, Randy] Rutgers State Univ, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ USA.
   [Unlu, Isik] Mercer Cty Mosquito Control, West Trenton, NJ USA.
   [Williges, Eric] Essex Cty Div Environm Affairs, Cedar Grove, NJ USA.
   [Williams, Gregory M.] Hudson Reg Hlth Commiss, 595 Cty Ave, Secaucus, NJ USA.
RP Chandel, K (corresponding author), Rutgers State Univ, Ctr Vector Biol, 180 Jones Ave, New Brunswick, NJ USA.
EM chandelkc@gmail.com
OI Williams, Gregory/0000-0001-9760-6831
FU SpringStar Inc.; National Institute of Allergy and Infectious Diseases
   (NIAID), National Institute of Health (NIH) [5R44AI096563-03]; US
   Department of AgricultureUnited States Department of Agriculture (USDA)
   [ARS-58-0208-0-066]; Deployed War Fighter Protection Research Program
   (DWFP), US Department of Defense [4-32131]
FX Funding was provided by SpringStar Inc., as a sub-award from Small
   Business Innovation Research (SBIR) grant from the National Institute of
   Allergy and Infectious Diseases (NIAID), National Institute of Health
   (NIH) under grant number 5R44AI096563-03. Partial funding from
   Multistate Research Project from US Department of Agriculture (Grand No.
   ARS-58-0208-0-066) and Deployed War Fighter Protection Research Program
   (DWFP), US Department of Defense (Grant No. 4-32131) is gratefully
   acknowledged. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   ABBOTT WS, 1987, J AM MOSQUITO CONTR, V3, P302
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alimi TO, 2013, J AM MOSQUITO CONTR, V29, P49, DOI 10.2987/12-6295R.1
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Davis TJ, 2016, J MED ENTOMOL, V53, P31, DOI 10.1093/jme/tjv170
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Farajollahi A, 2013, J AM MOSQUITO CONTR, V29, P385, DOI 10.2987/13-6332.1
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gumus A, 2015, J INVERTEBR PATHOL, V130, P56, DOI 10.1016/j.jip.2015.07.002
   Hahn M. B., 2016, J MED ENTOMOL
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   IWANAGA K, 1988, APPL ENTOMOL ZOOL, V23, P186, DOI 10.1303/aez.23.186
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Mbare O, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-280
   Moore CG, 1999, J AM MOSQUITO CONTR, V15, P221
   Qualls WA, 2006, J AM MOSQUITO CONTR, V22, P601, DOI 10.2987/8756-971X(2006)22[601:LSOTMI]2.0.CO;2
   Richards SL, 2008, J MED ENTOMOL, V45, P617, DOI 10.1603/0022-2585(2008)45[617:IOSROT]2.0.CO;2
   Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200
   Suman DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130499
   Suman DS, 2014, ACTA TROP, V135, P96, DOI 10.1016/j.actatropica.2014.03.026
   Suman DS, 2013, ACTA TROP, V128, P103, DOI 10.1016/j.actatropica.2013.06.025
   Suman DS, 2013, J MED ENTOMOL, V50, P1261, DOI 10.1603/ME13068
   Sun DB, 2014, J AM MOSQUITO CONTR, V30, P99, DOI 10.2987/13-6394.1
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139
   Wang Y, 2014, PEST MANAG SCI, V70, P1299, DOI 10.1002/ps.3702
   Williams GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110035
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 33
TC 16
Z9 16
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005235
DI 10.1371/journal.pntd.0005235
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100078
PM 28033379
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gudo, ES
   Falk, KI
   Ali, S
   Muianga, AF
   Monteiro, V
   Cliff, J
AF Gudo, Eduardo Samo
   Falk, Kerstin I.
   Ali, Sadia
   Muianga, Argentina Felisbela
   Monteiro, Vanessa
   Cliff, Julie
TI A Historic Report of Zika in Mozambique: Implications for Assessing
   Current Risk
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEXUAL TRANSMISSION; AEDES-ALBOPICTUS; YELLOW-FEVER; SOUTH-AFRICA;
   VIRUS; OUTBREAK; DENGUE; INFECTIONS; ISOLATIONS; VECTORS
C1 [Gudo, Eduardo Samo; Ali, Sadia; Muianga, Argentina Felisbela; Monteiro, Vanessa] Minist Hlth, Natl Inst Hlth, Virus Isolat Lab, Maputo, Mozambique.
   [Falk, Kerstin I.] Publ Hlth Agcy Sweden, Dept Microbiol, Solna, Sweden.
   [Falk, Kerstin I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden.
   [Cliff, Julie] Eduardo Mondlane Univ, Dept Community Hlth, Fac Med, Maputo, Mozambique.
RP Gudo, ES (corresponding author), Minist Hlth, Natl Inst Hlth, Virus Isolat Lab, Maputo, Mozambique.
EM esamogudojr@gmail.com
FU European Foundation Initiative for African Research into Neglected
   Tropical Diseases [91488]
FX ESG is a recipient of a post-doctoral grant from the European Foundation
   Initiative for African Research into Neglected Tropical Diseases, grant
   # 91488, http://www.ntd-africa.net. This body had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   [Anonymous], 2016, ZIKA STRAT RESP FRAM
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, COUNTR HAV CURR EV Z
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   Frank C, 2016, EURO SURVEILL, V21
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280
   Gudo ES, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004146
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JUPP PG, 1993, T ROY SOC TROP MED H, V87, P639, DOI 10.1016/0035-9203(93)90271-Q
   Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4
   KOKERNOT R. H., 1960, AN INST MED TROP, V17, P201
   KOKERNOT RH, 1962, AM J TROP MED HYG, V11, P678, DOI 10.4269/ajtmh.1962.11.678
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x
   Masaninga F, 2014, ASIAN PAC J TROP MED, V7, pS88, DOI 10.1016/S1995-7645(14)60210-8
   Massangaie M, 2016, AM J TROP MED HYG, V94, P413, DOI 10.4269/ajtmh.15-0543
   Mboera LEG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004313
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Mweya CN, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.25929
   SaUde INd Estatistica INd Macro I., 2010, INQ NAC PREV RISC CO
   Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326
   (UNAIDS) UNPOH, 2013, UNAIDS REP GLOB AIDS
   van Vuren PJ, 2016, SAMJ S AFR MED J, V106, P232, DOI [10.7196/SAMJ.2016.v106i3.10615, 10.7196/samj.2016.v106i3.10615]
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2015, ZIK VIR INF CAP VERD
   World Health Organization ROfA, 2016, ZIK VIR RISK ASS WHO
   WORTH C. BROOKE, 1960, AN INST MED TROP, V17, P231
NR 48
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005052
DI 10.1371/journal.pntd.0005052
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100007
PM 27930650
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kumar, M
   Ching, L
   Astern, J
   Lim, E
   Stokes, AJ
   Melish, M
   Nerurkar, VR
AF Kumar, Mukesh
   Ching, Lauren
   Astern, Joshua
   Lim, Eunjung
   Stokes, Alexander J.
   Melish, Marian
   Nerurkar, Vivek R.
TI Prevalence of Antibodies to Zika Virus in Mothers from Hawaii Who
   Delivered Babies with and without Microcephaly between 2009-2012
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID STATES; TRANSMISSION; DISEASE
AB Zika virus (ZIKV) is an emerging mosquito-borne pathogen. ZIKV infection is linked to the development of severe fetal abnormalities that include spontaneous abortion, stillbirth, hydranencephaly, and microcephaly. ZIKV outbreaks have been recorded in the United States. We recently demonstrated the first congenital ZIKV infection in the United States. In this study, we investigated archived blood samples from six mothers who gave birth to babies with microcephaly and 12 mothers who gave birth to healthy babies in Hawaii between 2009 and 2012. We tested maternal blood for the presence of ZIKV IgM and IgG antibodies using commercially available human ZIKV IgM and IgG ELISA kits. Blood from one mother who delivered babies with microcephaly tested positive for ZIKV IgM antibody (16.6%) and blood from three mothers tested positive for ZIKV IgG antibody (50%). ZIKV showed a trend toward significance with microcephaly. ZIKV IgG antibody positive mothers were more likely to deliver babies with microcephaly than mothers who were negative for ZIKV IgG antibodies (Odds ratio [OR] = 11.0, 95% confidence interval [CI] = 0.8-147.9, p = 0.083). Similarly, ZIKV IgM antibody positive mothers were also more likely to deliver babies with microcephaly than mothers who were negative for ZIKV IgM antibody (OR = 6.8, 95% CI = 0.2-195.1). These data provide further evidence of a link between ZIKV infection and microcephaly and suggests presence of ZIKV positive cases and associated microcephaly in the United States as early as 2009.
C1 [Kumar, Mukesh; Ching, Lauren; Lim, Eunjung; Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Kumar, Mukesh; Ching, Lauren; Melish, Marian; Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
   [Astern, Joshua; Stokes, Alexander J.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA.
   [Lim, Eunjung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Off Biostat & Quantitat Hlth Sci, Honolulu, HI 96822 USA.
   [Melish, Marian] Univ Hawaii Manoa, John A Burns Sch Med, Dept Pediat, Honolulu, HI 96822 USA.
RP Nerurkar, VR (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.; Nerurkar, VR (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Pacific Ctr Emerging Infect Dis Res, Honolulu, HI 96822 USA.
EM nerurkar@hawaii.edu
RI Nerurkar, Vivek R/F-5533-2011; Lim, Eunjung/G-9969-2016; Kumar,
   Mukesh/N-8814-2015; Stokes, Alexander/B-1086-2015; Kumar,
   Mukesh/AAI-1046-2019
OI Kumar, Mukesh/0000-0003-0970-4875; Stokes,
   Alexander/0000-0002-3526-4685; Kumar, Mukesh/0000-0003-0970-4875
FU Centers of Biomedical Research Excellence, National Institute of General
   Medical Sciences [P30GM114737]; National Institute on Minority Health
   and Health Disparities (NIMHD), National Institutes of Health
   [U54MD007584, G12MD007601]
FX This work was supported by a grant (P30GM114737) from the Centers of
   Biomedical Research Excellence, National Institute of General Medical
   Sciences, grants (U54MD007584, G12MD007601) from the National Institute
   on Minority Health and Health Disparities (NIMHD), National Institutes
   of Health, and Institutional funds. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Hendel-Paterson B, 2011, TRAVEL MED INFECT DI, V9, P192, DOI 10.1016/j.tmaid.2010.09.007
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Huzly D, 2016, EURO SURVEILLANCE, V21
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
NR 16
TC 4
Z9 4
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005262
DI 10.1371/journal.pntd.0005262
PG 8
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100088
PM 27997547
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Osamor, PE
   Grady, C
AF Osamor, Pauline E.
   Grady, Christine
TI Zika Virus: Promoting Male Involvement in the Health of Women and
   Families
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
C1 [Osamor, Pauline E.; Grady, Christine] NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.
RP Osamor, PE (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.
EM pauline.osamor@nih.gov
OI osamor, pauline/0000-0001-7026-4771
CR Abass K, INT J ASIAN SOCIAL S, V2, P2009
   Araujo AQ, 2016, BRAIN
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P15, DOI 10.2307/2991915
   Centers for Disease Control and Prevention, 2016, ZIK VIR CDC
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hills SL, 2016, MMWR-MORBID MORTAL W, P65
   Lindgren T, 2005, WOMEN HEALTH, V41, P69, DOI 10.1300/J013v41n01_05
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mohiddin A, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-1
   Moreira J, 2016, CLIN INFECT DIS
   Nations U., 1995, REP INT C POP DEV, P193
   World Health Organization, 2016, WHOZIKVMOC161
   World Health Organization, 2016, WHO ZIK VIR
NR 14
TC 4
Z9 4
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005127
DI 10.1371/journal.pntd.0005127
PG 5
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100020
PM 28033340
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Webb, CE
   Doggett, SL
AF Webb, Cameron E.
   Doggett, Stephen L.
TI Exotic mosquito threats require strategic surveillance and response
   planning
SO PUBLIC HEALTH RESEARCH & PRACTICE
LA English
DT Article
ID AEDES; AUSTRALIA
AB Mosquito-borne diseases caused by endemic pathogens such as Ross River, Barmah Forest and Murray Valley encephalitis viruses are an annual concern in New South Wales (NSW), Australia. More than a dozen mosquito species have been implicated in the transmission of these pathogens, with each mosquito occupying a specialised ecological niche that influences their habitat associations, host feeding preferences and the environmental drivers of their abundance.
   The NSW Arbovirus Surveillance and Mosquito Monitoring Program provides an early warning system for potential outbreaks of mosquito-borne disease by tracking annual activity of these mosquitoes and their associated pathogens. Although the program will effectively track changes in local mosquito populations that may increase with a changing climate, urbanisation and wetland rehabilitation, it will be less effective with current surveillance methodologies at detecting or monitoring changes in exotic mosquito threats, where different surveillance strategies need to be used.
   Exotic container-inhabiting mosquitoes such as Aedes aegypti and Ae. albopictus pose a threat to NSW because they are nuisance-biting pests and vectors of pathogens such as dengue, chikungunya and Zika viruses. International movement of humans and their belongings have spread these mosquitoes to many regions of the world. In recent years, these two mosquitoes have been detected by the Australian Government Department of Agriculture and Water Resources at local airports and seaports. To target the detection of these exotic mosquitoes, new trapping technologies and networks of surveillance locations are required. Additionally, incursions of these mosquitoes into urban areas of the state will require strategic responses to minimise substantial public health and economic burdens to local communities.
C1 [Webb, Cameron E.; Doggett, Stephen L.] Westmead Hosp, NSW Hlth Pathol, Med Entomol, Sydney, NSW, Australia.
   [Webb, Cameron E.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.
RP Webb, CE (corresponding author), Westmead Hosp, NSW Hlth Pathol, Med Entomol, Sydney, NSW, Australia.; Webb, CE (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.
EM cameron.webb@health.nsw.gov.au
OI Webb, Cameron/0000-0003-1029-5140
FU NSW Ministry of Health; Marie Bashir Institute for Infectious Diseases
   and Biosecurity; National Health and Medical Research Council Centre of
   Research Excellence in Emerging Infectious Diseases
FX The Department of Medical Entomology, NSW Health Pathology, receives
   funding from the NSW Ministry of Health to coordinate the NSW ASMMP.
   This manuscript was prepared with the support of the Marie Bashir
   Institute for Infectious Diseases and Biosecurity, and the National
   Health and Medical Research Council Centre of Research Excellence in
   Emerging Infectious Diseases.
CR Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Claflin SB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005070
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Doggett SL, 1999, J MED ENTOMOL, V36, P861, DOI 10.1093/jmedent/36.6.861
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Hill MP, 2014, AUSTRAL ECOL, V39, P469, DOI 10.1111/aec.12105
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Knope K., 2012, COMMUNICABLE DIS INT, V37, P55
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   NSW Health, 2016, NSW ARB SURV MOSQ MO
   Queensland Health, 2015, QUEENSL DENG MAN PLA
   Rohe D.L., 1979, Bulletin of the Society of Vector Ecologists, V4, P24
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Webb C, 2016, GUIDE MOSQUITOES AUS
   Webb CE, 2015, MED J AUSTRALIA, V202, P128, DOI 10.5694/mja14.01237
NR 17
TC 1
Z9 1
U1 1
U2 19
PU SAX INST
PI ULTIMO
PA LEVEL 13, BUILDING 10, 235 JONES ST, ULTIMO, NSW 2007, AUSTRALIA
SN 2204-2091
J9 PUBLIC HEALTH RES PR
JI Public Health Res. Pract.
PD DEC
PY 2016
VL 26
IS 5
AR e2651656
DI 10.17061/phrp2651656
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EH1SU
UT WOS:000391548300004
PM 27997935
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Webb, CE
   Hess, IMR
AF Webb, Cameron E.
   Hess, Isabel M. R.
TI A review of recommendations on the safe and effective use of topical
   mosquito repellents
SO PUBLIC HEALTH RESEARCH & PRACTICE
LA English
DT Article
ID INSECT REPELLENTS; FIELD-EVALUATION; DEET; PICARIDIN; AUSTRALIA;
   TOXICITY; FORMULATIONS; OIL
AB Mosquito-borne disease is an annual problem in Australia, with endemic pathogens such as Ross River virus infecting thousands of people each year. The recent emergence of Zika virus in South America and the Pacific, together with ongoing outbreaks of dengue viruses in Southeast Asia, generated great community interest in the most effective strategies to avoid mosquito bites. Large-scale mosquito control programs are not common in Australia and are limited in New South Wales (NSW).
   The use of topical insect repellents is a key recommendation by health authorities to prevent mosquito-borne disease. All products sold in Australia purporting to repel mosquitoes must be registered with the Australian Pesticides and Veterinary Medicines Authority. Despite around 100 commercial products registered as repelling mosquitoes, there are relatively few active ingredients used across these formulations. The most common are diethyltoluamide (DEET), picaridin, p-menthane-3,8-diol (PMD) and a range of plant-derived products (e.g. melaleuca, eucalyptus, citronella oils). Research has shown that each of these active ingredients varies in the duration of protection provided against biting mosquitoes.
   Recommendations by health authorities are informed by this research, but inconsistencies between recommendations and available repellent formulations and their concentration of active ingredients can cause confusion in the community. There are conflicts between the data resulting from scholarly research, marketing promotion by manufacturers and recommendations provided by overseas health authorities. A review was undertaken of NSW Health's current recommendations on choosing and using insect repellents, taking into consideration recent research and currently registered topical repellents.
C1 [Webb, Cameron E.] Westmead Hosp, NSW Hlth Pathol, Med Entomol, Sydney, NSW, Australia.
   [Webb, Cameron E.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.
   [Hess, Isabel M. R.] NSW Hlth, Hlth Protect NSW, Hlth Risk Policy Unit, Sydney, NSW, Australia.
RP Webb, CE (corresponding author), Westmead Hosp, NSW Hlth Pathol, Med Entomol, Sydney, NSW, Australia.; Webb, CE (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.
EM cameron.webb@health.nsw.gov.au
OI Webb, Cameron/0000-0003-1029-5140
FU Marie Bashir Institute for Infectious Diseases and Biosecurity; National
   Health and Medical Research Council Centre of Research Excellence in
   Emerging Infectious Diseases
FX This manuscript was prepared with the support of the Marie Bashir
   Institute for Infectious Diseases and Biosecurity and the National
   Health and Medical Research Council Centre of Research Excellence in
   Emerging Infectious Diseases.
CR Antwi FB, 2008, REGUL TOXICOL PHARM, V51, P31, DOI 10.1016/j.yrtph.2008.03.002
   [Australian Government Department of Health National Notifiable Diseases Surveillance System], 2016, NUMB NOT ROSS RIV VI
   Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2
   Centers for Disease Control and Prevention (CDC), 2016, CDC 24 7 SAV LIV PRO
   Charlton NP, 2016, CLIN TOXICOL, V54, P655, DOI 10.1080/15563650.2016.1186806
   Claflin SB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005070
   Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x
   EPA, 2016, REP AW GRAPH
   Frances SP, 2014, J AM MOSQUITO CONTR, V30, P65, DOI 10.2987/13-6366.1
   Frances SP, 2004, J MED ENTOMOL, V41, P414, DOI 10.1603/0022-2585-41.3.414
   Goodyer L, 1998, AM J TROP MED HYG, V59, P323, DOI 10.4269/ajtmh.1998.59.323
   Goodyer LI, 2010, J TRAVEL MED, V17, P182, DOI 10.1111/j.1708-8305.2010.00402.x
   Hammer KA, 2006, FOOD CHEM TOXICOL, V44, P616, DOI 10.1016/j.fct.2005.09.001
   Jacups SP, 2008, VECTOR-BORNE ZOONOT, V8, P283, DOI 10.1089/vbz.2007.0152
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   NSW Government, 2015, MOSQ AR A HLTH HAZ
   Trigg JK, 1996, PHYTOTHER RES, V10, P313, DOI 10.1002/(SICI)1099-1573(199606)10:4&lt;313::AID-PTR854&gt;3.0.CO;2-O
   Webb C, 2016, GUIDE MOSQUITOES AUS
   Webb CE, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P213
   Webb CE, 2015, MED J AUSTRALIA, V202, P128, DOI 10.5694/mja14.01237
NR 20
TC 3
Z9 4
U1 0
U2 12
PU SAX INST
PI ULTIMO
PA LEVEL 13, BUILDING 10, 235 JONES ST, ULTIMO, NSW 2007, AUSTRALIA
SN 2204-2091
J9 PUBLIC HEALTH RES PR
JI Public Health Res. Pract.
PD DEC
PY 2016
VL 26
IS 5
AR e2651657
DI 10.17061/phrp2651657
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EH1SU
UT WOS:000391548300005
PM 27997936
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Estallo, EL
   Benitez, EM
   Lanfri, MA
   Scavuzzo, CM
   Almiron, WR
AF Lilia Estallo, Elizabet
   Benitez, Elisabet M.
   Alberto Lanfri, Mario
   Marcelo Scavuzzo, Carlos
   Almiron, Walter R.
TI MODIS Environmental Data to Assess Chikungunya, Dengue, and Zika
   Diseases Through Aedes (Stegomia) aegypti Oviposition Activity
   Estimation
SO IEEE JOURNAL OF SELECTED TOPICS IN APPLIED EARTH OBSERVATIONS AND REMOTE
   SENSING
LA English
DT Article
DE Diseases; environmental factors; epidemiology; forecasting; image
   processing; image sensors
ID LIFE TABLE MODEL; INFECTIOUS-DISEASES; ARGENTINA; CLIMATE; DIPTERA;
   FEVER; NDVI; FLUCTUATIONS; EPIDEMIOLOGY; POPULATION
AB Aedes aegypti is the main vector for Chikungunya, Dengue, and Zika viruses in Latin America and it represents a main threat for our region. Taking into account this situation, several efforts have been done to use remote sensing to support public health decision making. Moderate resolution imaging spectrora-diometer (MODIS) sensor provides moderate-resolution remote sensing products; therefore, we explore the application of MODIS products to vector-borne disease problems in Argentina. We develop temporal forecasting models of Ae. aegypti oviposition, and we include its validation and its application to the 2016 Dengue outbreak. Temporal series (10/2005 to 09/2007) from MODIS products of normalized difference vegetation index and diurnal land surface temperature were built. Two linear regression models were developed: model 1 which uses environmental variables with time lag and model 2 uses environmental variables without time lags. Model 2 was the best model (AIC = 112) with high correlation (r = 0.88, p < 0.05) between observed and predicted data. We can suggest that MODIS products could be a good tool for estimating both Ae. aegypti oviposition activity and risks for Ae. aegypti-borne diseases. That statement is also supported by model results for 2016 when a dengue outbreak that started unusually earlier this season. If such activity could be forecast by a model based on remote sensing data, then a potential outbreak could be predicted.
C1 [Lilia Estallo, Elizabet; Benitez, Elisabet M.; Almiron, Walter R.] Univ Nacl Cordoba, Ctr Invest Entomol CIEC, IIBYT, CONICET,FCEFyN, Ave Velez Sarsfield 1611, RA-5016 Cordoba, Argentina.
   [Alberto Lanfri, Mario; Marcelo Scavuzzo, Carlos] Comis Nacl Actividades Espaciales, Inst Mario Gulich, RA-5100 Cordoba, Argentina.
RP Estallo, EL (corresponding author), Univ Nacl Cordoba, Ctr Invest Entomol CIEC, IIBYT, CONICET,FCEFyN, Ave Velez Sarsfield 1611, RA-5016 Cordoba, Argentina.
EM eelizabet@gmail.com; elisabet.benitez@gmail.com; lamfri@conae.gov.ar;
   scavuzzo@conae.gov.ar; ralmiron@efn.uncor.edu
FU Ministerio de Salud de la Nacion (National Health Ministry)
FX The authors would like to thank the Ministerio de Salud de la Nacion
   (National Health Ministry) for all their support, especially to Phy. M.
   Zaidenberg, Biol. V. Introini, B. Carrazan, and N. Bianconi from the
   Coordinacion Nacional de Control de Vectores. They also thank Dr. J.
   Beier of Miami University, Miller School of Medicine. USA, for editorial
   assistance.
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   ALMEIDA FFL, 1995, MEM I OSWALDO CRUZ, V90, P463, DOI 10.1590/S0074-02761995000400006
   Andreo V, 2009, AUSTRAL ECOL, V34, P132, DOI 10.1111/j.1442-9993.2008.01889.x
   Arroyo E. R., 2004, DIAGN PROD DEP OR, P13
   Batallan GP, 2015, ACTA TROP, V146, P53, DOI 10.1016/j.actatropica.2015.03.009
   Butt B, 2011, REMOTE SENS ENVIRON, V115, P3367, DOI 10.1016/j.rse.2011.08.001
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Juri MJD, 2015, J VECTOR ECOL, V40, P36, DOI 10.1111/jvec.12130
   Dominguez Martha C., 2000, Revista de la Sociedad Entomologica Argentina, V59, P41
   ENVI, 2004, ENV VIS IM RES SYST
   Estallo EL, 2008, J AM MOSQUITO CONTR, V24, P368, DOI 10.2987/5705.1
   Estallo EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127820
   Estallo EL, 2011, VECTOR-BORNE ZOONOT, V11, P543, DOI 10.1089/vbz.2009.0165
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   Gong Z, 2015, SOLID EARTH, V6, P1185, DOI 10.5194/se-6-1185-2015
   Gubler D. J., 1998, ARBOVIRUSES EPIDEMIO
   Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P204, DOI 10.1590/S1020-49892006000300015
   Hay SI, 1997, INT J REMOTE SENS, V18, P2899, DOI 10.1080/014311697217125
   Hay SI, 2000, ADV PARASIT, V47, P1, DOI 10.1016/S0065-308X(00)47005-3
   Hopp MJ, 2003, CLIM RES, V25, P85, DOI 10.3354/cr025085
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   INDEC (Instituto Nacional de Estadisticas y Censos), 2010, CENS NAC POBL HOG VI
   Justice CO, 2002, REMOTE SENS ENVIRON, V83, P3, DOI 10.1016/S0034-4257(02)00084-6
   Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116
   Estallo EL, 2012, INT J REMOTE SENS, V33, P4254, DOI 10.1080/01431161.2011.640962
   Micieli MV, 2003, MEM I OSWALDO CRUZ, V98, P659, DOI 10.1590/S0074-02762003000500013
   Modis Reprojection Tool, 2005, MOD REPR TOOL
   Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009
   Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217
   Porcasi X, 2006, J MED ENTOMOL, V43, P1060, DOI 10.1603/0022-2585(2006)43[1060:IORHBT]2.0.CO;2
   Porcasi X, 2012, GEOSPATIAL HEALTH, V6, pS31
   R Core Team, 2014, R LANG ENV STAT COMP
   Rai P.K, 2012, HLTH SCI J, V6, P731
   Reiter P, 2001, GUIDELINES ASSESSING
   Reiter Paul, 1997, P425
   RITCHIE SA, 1984, MOSQ NEWS, V44, P77
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   SERVICE MW, 1993, MOSQUITO ECOLOGY FIE
   Tatem Andrew J, 2004, Int J Appl Earth Obs Geoinf, V6, P33, DOI 10.1016/j.jag.2004.07.001
   Cid CV, 2013, ACTA TROP, V125, P303, DOI 10.1016/j.actatropica.2012.12.005
   Wang L, 2007, INT J REMOTE SENS, V28, P1413, DOI 10.1080/01431160601075525
   WHO, 2016, ZIK VIR FACT SHEET J
   WHO, 2016, CONTR STRAT
NR 44
TC 8
Z9 8
U1 2
U2 19
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1939-1404
EI 2151-1535
J9 IEEE J-STARS
JI IEEE J. Sel. Top. Appl. Earth Observ. Remote Sens.
PD DEC
PY 2016
VL 9
IS 12
SI SI
BP 5461
EP 5466
DI 10.1109/JSTARS.2016.2604577
PN 1
PG 6
WC Engineering, Electrical & Electronic; Geography, Physical; Remote
   Sensing; Imaging Science & Photographic Technology
SC Engineering; Physical Geography; Remote Sensing; Imaging Science &
   Photographic Technology
GA EH0QF
UT WOS:000391468100017
DA 2020-07-08
ER

PT J
AU Welfare, W
   Wright, E
AF Welfare, William
   Wright, Edward
TI Planning for the unexpected: Ebola virus, Zika virus, what's next?
SO BRITISH JOURNAL OF HOSPITAL MEDICINE
LA English
DT Review
AB Since 2000 we have witnessed global pandemics and public health emergencies of international concern. This review details which viruses are likely to caused further outbreaks and looks at the strategies and tools available to UK medical professionals to mitigate the threat posed.
C1 [Welfare, William] Publ Hlth England North West, Hlth Protect Team, Manchester, Lancs, England.
   [Welfare, William] Univ Manchester, Manchester, Lancs, England.
   [Wright, Edward] Univ Westminster, Fac Sci & Technol, Viral Pseudotype Unit, London W1W 6UW, England.
RP Wright, E (corresponding author), Univ Westminster, Fac Sci & Technol, Viral Pseudotype Unit, London W1W 6UW, England.
EM wrighte@westminster.ac.uk
OI Wright, Edward/0000-0001-7041-5138; Welfare, William/0000-0002-8304-1048
FU BBSRCBiotechnology and Biological Sciences Research Council (BBSRC);
   Wellcome TrustWellcome Trust; Department for International Development
   and Innovate UK
FX Dr W Welfare is employed by Public Health England and holds honorary
   positions at University of Manchester and University of Liverpool. Dr E
   Wright has received funding from the BBSRC, Wellcome Trust, Department
   for International Development and Innovate UK for studies on emerging
   viruses.
CR Amman BR, 2014, EMERG INFECT DIS, V20, P1761, DOI 10.3201/eid2010.140696
   [Anonymous], 2016, INT HLTH REG
   Hill AVS, 2016, OXFORD LONDON LECT 2
   Human Animal Infections and Risk Surveillance, 2016, QUAL ASS RISK ZIK VI
   Human Animal Infections and Risk Surveillance, 2013, PROC RISK ASS UND HU
   Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022
   National Academy of Medicine, 2016, NEGL DIM GLOB SEC FR
   To KKW, 2015, MICROBES INFECT, V17, P84, DOI 10.1016/j.micinf.2014.11.007
   Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150
   WHO, 2015, BLUEPR R D PREP RESP
NR 10
TC 3
Z9 3
U1 0
U2 4
PU MA HEALTHCARE LTD
PI LONDON
PA ST JUDES CHURCH, DULWICH ROAD, LONDON SE24 0PB, ENGLAND
SN 1750-8460
EI 1759-7390
J9 BRIT J HOSP MED
JI Br. J. Hosp. Med.
PD DEC
PY 2016
VL 77
IS 12
BP 704
EP 707
DI 10.12968/hmed.2016.77.12.704
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG6AS
UT WOS:000391126700017
PM 27937012
OA Green Accepted
DA 2020-07-08
ER

PT J
AU de Albuquerque, MDPM
   de Souza, WV
   Mendes, ADG
   Lyra, TM
   Ximenes, RAA
   Araujo, TVB
   Braga, C
   Miranda, DB
   Martelli, CMT
   Rodrigues, LC
AF Militao de Albuquerque, Maria de Fatima P.
   de Souza, Wayner V.
   Mendes, Antnio da Cruz G.
   Lyra, Tereza M.
   Ximenes, Ricardo A. A.
   Araujo, Thalia V. B.
   Braga, Cynthia
   Miranda-Filho, Democrito B.
   Martelli, Celina M. T.
   Rodrigues, Laura C.
TI Pyriproxyfen and the microcephaly epidemic in Brazil - an ecological
   approach to explore the hypothesis of their association
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika virus; microcephaly; pyriproxyfen larvicide
AB The microcephaly epidemic in Brazil generated intense debate regarding its causality, and one hypothesised cause of this epidemic, now recognised as congenital Zika virus syndrome, was the treatment of drinking water tanks with pyriproxyfen to control Aedes aegypti larvae. We present the results of a geographical analysis of the association between the prevalence of microcephaly confirmed by Fenton growth charts and the type of larvicide used in the municipalities that were home to the mothers of the affected newborns in the metropolitan region of Recife in Pernambuco, the state in Brazil where the epidemic was first detected. The overall prevalence of microcephaly was 82 per 10,000 live births in the three municipalities that used the larvicide Bti (Bacillus thuringiensis israelensis) instead of pyriproxyfen, and 69 per 10,000 live births in the eleven municipalities that used pyriproxyfen. The difference was not statistically significant. Our results show that the prevalence of microcephaly was not higher in the areas in which pyriproxyfen was used. In this ecological approach, there was no evidence of a correlation between the use of pyriproxyfen in the municipalities and the microcephaly epidemic.
C1 [Militao de Albuquerque, Maria de Fatima P.; de Souza, Wayner V.; Mendes, Antnio da Cruz G.; Lyra, Tereza M.; Braga, Cynthia; Martelli, Celina M. T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Aggeu Magalhaes, Dept Saude Colet, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.; Araujo, Thalia V. B.; Miranda-Filho, Democrito B.] Univ Pernambuco, Recife, PE, Brazil.
   [Rodrigues, Laura C.] London Sch Hyg & Trop Med, London, England.
RP Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, London, England.
EM laura.rodrigues@lshtm.ac.uk
RI Braga, Maria Cynthia/A-8204-2013; Souza, Wayner V/H-3798-2013
OI Braga, Maria Cynthia/0000-0002-7862-6455; Turchi Martelli, Celina
   Maria/0000-0002-2491-0688; Souza, Wayner/0000-0002-0939-9332
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
CR Abrasco, 2016, NOT TECN MICR DOENC
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Bar-Yam Y ED, 2016, IS ZIKA CAUSE MICROC
   Brasil-Ministerio da Saude do Brasil, 2016, MICR MIN SAUD CONF 1
   CES-Conselho Estadual de Saude de Pernambuco, 2016, GRUP TRAB SE REUN DI
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   EBC-Empresa Brasil de Comunicacao S/ A-Agencia Brasil, 2016, RS SUSP US LARV PYR
   Evans D, 2016, 048538V1 BIORXIV
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Regis LN, 2014, ACTA TROP, V137, P80, DOI 10.1016/j.actatropica.2014.04.010
   SWETOX-Swedish Toxicology Science Research Center, 2016, PYR MICR INV POT TIE
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   *WHO, 2008, GUID DRINK WAT QUAL
   WHO-World Health Organization, 2006, SPEC PUBL HLTH PEST
NR 14
TC 15
Z9 15
U1 0
U2 11
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD DEC
PY 2016
VL 111
IS 12
BP 774
EP 776
DI 10.1590/0074-02760160291
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EH0FD
UT WOS:000391437500009
PM 27812601
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Schaub, B
   Monthieux, A
   Najihoullah, F
   Harte, C
   Cesaire, R
   Jolivet, E
   Volumenie, JL
AF Schaub, Bruno
   Monthieux, Alice
   Najihoullah, Fatiha
   Harte, Caroline
   Cesaire, Raymond
   Jolivet, Eugenie
   Volumenie, Jean-Luc
TI Late miscarriage: another Zika concern?
SO EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
LA English
DT Letter
ID VIRUS; INFECTION
C1 [Schaub, Bruno; Jolivet, Eugenie; Volumenie, Jean-Luc] Ctr Hosp & Univ Martinique, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, Fort De France, Martinique, France.
   [Schaub, Bruno; Monthieux, Alice; Harte, Caroline; Jolivet, Eugenie; Volumenie, Jean-Luc] Ctr Hosp Univ Martinique, Maison Femme Mere & Enfant, Serv Gynecol Obstet, Fort De France, Martinique, France.
   [Najihoullah, Fatiha; Cesaire, Raymond] Ctr Hosp Univ Martinique, Serv Virol, Fort De France, Martinique, France.
RP Schaub, B (corresponding author), Ctr Hosp & Univ Martinique, Maison Femme Mere & Enfant, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, BP 632, Fort De France 97261, Martinique, France.
EM bruno.schaub@chu-fortdefrance.fr
CR Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
NR 5
TC 13
Z9 13
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-2115
EI 1872-7654
J9 EUR J OBSTET GYN R B
JI Eur. J. Obstet. Gynecol. Reprod. Biol.
PD DEC
PY 2016
VL 207
BP 240
EP +
DI 10.1016/j.ejogrb.2016.10.041
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA EG5IG
UT WOS:000391076900049
PM 27837933
DA 2020-07-08
ER

PT J
AU Passi, GR
AF Passi, Gouri Rao
TI FIGHTING THE ZIKA VIRUS
SO INDIAN PEDIATRICS
LA English
DT News Item
EM gouripassi@hotmail.com
RI Passi, Gouri/AAE-5210-2019
OI Passi, Gouri/0000-0003-0327-9644
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-6061
EI 0974-7559
J9 INDIAN PEDIATR
JI Indian Pediatrics
PD DEC
PY 2016
VL 53
IS 12
BP 1119
EP 1119
PG 1
WC Pediatrics
SC Pediatrics
GA EG3VK
UT WOS:000390972600026
DA 2020-07-08
ER

PT J
AU Wilson, M
   Tyler, KL
AF Wilson, Michael
   Tyler, Kenneth L.
TI Emerging Diagnostic and Therapeutic Tools for Central Nervous System
   Infections
SO JAMA NEUROLOGY
LA English
DT Editorial Material
ID ZIKA VIRUS; ENCEPHALITIS; DISEASES
C1 [Wilson, Michael] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA.
   [Tyler, Kenneth L.] Univ Colorado, Sch Med, Dept Neurol, Res Complex 2,12700 E 19th Ave, Aurora, CO 80045 USA.
   [Tyler, Kenneth L.] Univ Colorado, Sch Med, Dept Med, Res Complex 2,12700 E 19th Ave, Aurora, CO 80045 USA.
   [Tyler, Kenneth L.] Univ Colorado, Sch Med, Dept Immunol Microbiol, Res Complex 2,12700 E 19th Ave, Aurora, CO 80045 USA.
RP Tyler, KL (corresponding author), Univ Colorado, Sch Med, Neurol B182, Res Complex 2,12700 E 19th Ave, Aurora, CO 80045 USA.
EM ken.tyler@ucdenver.edu
RI Tyler, Kenneth L./J-2420-2019
OI Tyler, Kenneth L./0000-0003-3294-5888; Wilson,
   Michael/0000-0002-8705-5084
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R33 AI101064]
CR Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841
   Granerod J, 2010, NEUROLOGY, V75, P924, DOI 10.1212/WNL.0b013e3181f11d65
   Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912
   Nath A, 2015, JAMA NEUROL, V72, P143, DOI 10.1001/jamaneurol.2014.3442
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Roehm PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep23146
   Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Wollebo HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136046
NR 10
TC 4
Z9 4
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 1
PY 2016
VL 73
IS 12
BP 1389
EP 1390
DI 10.1001/jamaneurol.2016.3617
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EG5ZB
UT WOS:000391122200001
PM 27695862
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Roos, RP
AF Roos, Raymond P.
TI Zika Virus-A Public Health Emergency of International Concern
SO JAMA NEUROLOGY
LA English
DT Editorial Material
C1 [Roos, Raymond P.] Univ Chicago, Dept Neurol, 5841 S Maryland Ave,MC2030, Chicago, IL 60637 USA.
RP Roos, RP (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave,MC2030, Chicago, IL 60637 USA.
EM rroos@neurology.bsd.uchicago.edu
CR Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Johnson RT, 1982, VIRAL INFECTIONS NER
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Poe EA, MASQUE RED DEATH
   WHO, ZIK VIR
   World Health Organization, WHO DIR GEN BRIEFS E
   World Health Organization, CURR ZIK PROD PIP
NR 12
TC 9
Z9 9
U1 1
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 1
PY 2016
VL 73
IS 12
BP 1395
EP 1396
DI 10.1001/jamaneurol.2016.3677
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EG5ZB
UT WOS:000391122200004
PM 27695847
DA 2020-07-08
ER

PT J
AU Khan, S
   Woodruff, EM
   Trapecar, M
   Fontaine, KA
   Ezaki, A
   Borbet, TC
   Ott, M
   Sanjabi, S
AF Khan, Shahzada
   Woodruff, Erik M.
   Trapecar, Martin
   Fontaine, Krystal A.
   Ezaki, Ashley
   Borbet, Timothy C.
   Ott, Melanie
   Sanjabi, Shomyseh
TI Dampened antiviral immunity to intravaginal exposure to RNA viral
   pathogens allows enhanced viral replication
SO JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Article
ID LYMPHOCYTIC CHORIOMENINGITIS VIRUS; T-CELL-ACTIVATION; SEXUAL
   TRANSMISSION; ZIKA VIRUS; INFECTION; MUCOSAL; RECEPTORS; RESPONSES;
   DIFFERENTIATION; MECHANISMS
AB Understanding the host immune response to vaginal exposure to RNA viruses is required to combat sexual transmission of this class of pathogens. In this study, using lymphocytic choriomeningitis virus (LCMV) and Zika virus (ZIKV) in wild-type mice, we show that these viruses replicate in the vaginal mucosa with minimal induction of antiviral interferon and inflammatory response, causing dampened innate-mediated control of viral replication and a failure to mature local antigen-presenting cells (APCs). Enhancement of innate-mediated inflammation in the vaginal mucosa rescues this phenotype and completely inhibits ZIKV replication. To gain a better understanding of how this dampened innate immune activation in the lower female reproductive tract may also affect adaptive immunity, we modeled CD8 T cell responses using vaginal LCMV infection. We show that the lack of APC maturation in the vaginal mucosa leads to a delay in CD8 T cell activation in the draining lymph node and hinders the timely appearance of effector CD8 T cells in vaginal mucosa, thus further delaying viral control in this tissue. Our study demonstrates that vaginal tissue is exceptionally vulnerable to infection by RNA viruses and provides a conceptual framework for the male to female sexual transmission observed during ZIKV infection.
C1 [Khan, Shahzada; Woodruff, Erik M.; Trapecar, Martin; Fontaine, Krystal A.; Ezaki, Ashley; Borbet, Timothy C.; Ott, Melanie; Sanjabi, Shomyseh] Gladstone Inst, Virol & Immunol, San Francisco, CA 94158 USA.
   [Ott, Melanie] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.
   [Sanjabi, Shomyseh] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
   [Borbet, Timothy C.] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY 10016 USA.
RP Sanjabi, S (corresponding author), Gladstone Inst, Virol & Immunol, San Francisco, CA 94158 USA.; Sanjabi, S (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.
EM shomyseh.sanjabi@gladstone.ucsf.edu
RI Trapecar, Martin/AAL-5800-2020
OI Trapecar, Martin/0000-0002-0860-8948; Sanjabi,
   Shomyseh/0000-0002-3097-9665; khan, shahzada/0000-0003-2975-6621
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [DP2 AI112244];
   University of California Hellman Award; Center for AIDS Research (CFAR)
   Pilot Award [P30 AI027763, CNIHR P30 AI027767]; California Institute for
   Regenerative Medicine/Gladstone Institutes Fellowship [TG2-01160]; CFAR
   Mentored Scientist Award [P30 AI027763]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [P30
   AI027763, R01 AI097552]; National Center for Research Resources
   grantUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [RR18928]
FX This work was supported by grants from the National Institutes of Health
   (NIH; DP2 AI112244), a University of California Hellman Award, a Center
   for AIDS Research (CFAR) Pilot Award (P30 AI027763 and CNIHR P30
   AI027767 to S. Sanjabi), a California Institute for Regenerative
   Medicine/Gladstone Institutes Fellowship (TG2-01160), a CFAR Mentored
   Scientist Award (P30 AI027763 to S. Khan), and a grant from the NIH (R01
   AI097552 to M. Ott).; We thank M. Matloubian for LCMV<INF>Arm</INF>
   stock and propagation protocols, J. Luong for help with maintaining the
   mouse colonies, and F. Wu for technical assistance. We are grateful to
   J. Cyster (University of California, San Francisco [UCSF]), M.
   Matloubian (UCSF), W. Greene (Gladstone Institute of Virology and
   Immunology/UCSF), and M. R. Jakobsen (Aarhus University) for critical
   reading of the manuscript and to G. Howard and C. Herron (Gladstone) for
   editorial assistance. This publication was made possible with help from
   the UCSF-Gladstone Institutes CFAR, an NIH-funded program (P30 AI027763)
   supporting Gladstone's flow core. The Gladstone Institutes received
   support for its animal care facility from a National Center for Research
   Resources grant (RR18928).
CR Ashkar AA, 2004, J INFECT DIS, V190, P1841, DOI 10.1086/425079
   Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021
   Barton LL, 2002, AM J OBSTET GYNECOL, V187, P1715, DOI 10.1067/mob.2002.126297
   Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604
   Black CA, 2000, J IMMUNOL, V165, P5077, DOI 10.4049/jimmunol.165.9.5077
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538
   Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402
   Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361
   Fukao T, 2000, EUR J IMMUNOL, V30, P1453, DOI 10.1002/(SICI)1521-4141(200005)30:5<1453::AID-IMMU1453>3.0.CO;2-W
   FUNGLEUNG WP, 1991, CELL, V65, P443, DOI 10.1016/0092-8674(91)90462-8
   Gill N, 2006, J VIROL, V80, P9943, DOI 10.1128/JVI.01036-06
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Granucci F, 2002, TRENDS IMMUNOL, V23, P169, DOI 10.1016/S1471-4906(02)02187-7
   Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Herbst-Kralovetz MM, 2006, J VIROL, V80, P9988, DOI 10.1128/JVI.01099-06
   Hsia E, 2008, J INVEST DERMATOL, V128, P125, DOI 10.1038/sj.jid.5700968
   Iversen MB, 2016, NAT IMMUNOL, V17, P150, DOI 10.1038/ni.3319
   Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634
   Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123
   Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836
   Kumamoto Y, 2012, CURR OPIN IMMUNOL, V24, P411, DOI 10.1016/j.coi.2012.05.006
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li PL, 2016, NAT MED, V22, P807, DOI 10.1038/nm.4124
   Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338
   Mahlakoiv T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004782
   Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179
   McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025
   Moldenhauer LM, 2009, J IMMUNOL, V182, P8080, DOI 10.4049/jimmunol.0804018
   MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G
   Munoz-Suano A, 2011, IMMUNOL REV, V241, P20, DOI 10.1111/j.1600-065X.2011.01002.x
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nurkkala M, 2007, J REPROD IMMUNOL, V73, P148, DOI 10.1016/j.jri.2006.09.001
   Ochiel DO, 2010, J LEUKOCYTE BIOL, V88, P435, DOI 10.1189/jlb.1009700
   Oh JE, 2016, P NATL ACAD SCI USA, V113, pE762, DOI 10.1073/pnas.1518589113
   Olson MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003054
   Perez-Lopez A, 2016, NAT REV IMMUNOL, V16, P135, DOI 10.1038/nri.2015.17
   PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4
   Schenkel JM, 2013, NAT IMMUNOL, V14, P509, DOI 10.1038/ni.2568
   Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205
   Suvas PK, 2007, J IMMUNOL, V179, P8122, DOI 10.4049/jimmunol.179.12.8122
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664
   Turmel J. M., 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9
   Warning JC, 2011, REPRODUCTION, V141, P715, DOI 10.1530/REP-10-0360
   Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819
   Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365
   Yiu ZZN, 2015, J DERMATOL TREAT, V26, P329, DOI 10.3109/09546634.2014.991673
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109
   Zhou X, 2012, VIRUSES-BASEL, V4, P2650, DOI 10.3390/v4112650
NR 58
TC 25
Z9 25
U1 0
U2 6
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0022-1007
EI 1540-9538
J9 J EXP MED
JI J. Exp. Med.
PD DEC
PY 2016
VL 213
IS 13
BP 2913
EP 2929
DI 10.1084/jem.20161289
PG 17
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA EG5ZG
UT WOS:000391122900009
PM 27852793
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Rajaganesh, R
   Murugan, K
   Panneerselvam, C
   Jayashanthini, S
   Aziz, A
   Roni, M
   Suresh, U
   Trivedi, S
   Rehman, H
   Higuchi, A
   Nicoletti, M
   Benelli, G
AF Rajaganesh, Rajapandian
   Murugan, Kadarkarai
   Panneerselvam, Chellasamy
   Jayashanthini, Sudalaimani
   Aziz, Al Thbiani
   Roni, Mathath
   Suresh, Udaiyan
   Trivedi, Subrata
   Rehman, Hasibur
   Higuchi, Akon
   Nicoletti, Marcello
   Benelli, Giovanni
TI Fern-synthesized silver nanocrystals: Towards a new class of mosquito
   oviposition deterrents?
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE Aedes aegypti; Dengue; Dicranopteris linearis; Larvicides; Silver
   nanoparticles; Ovicides
ID ECO-FRIENDLY LARVICIDES; VECTOR ANOPHELES-STEPHENSI;
   CULEX-QUINQUEFASCIATUS; MALARIAL VECTOR; ESSENTIAL OIL; ZIKA VIRUS;
   PREDATION EFFICIENCY; GOLD NANOPARTICLES; AEDES-AEGYPTI; LEAF EXTRACT
AB Mosquitoes act as vectors of devastating pathogens and parasites, representing a key threat for millions of humans and animals worldwide. Eco-friendly control tools are urgently required. We proposed a novel method of fern-mediated biosynthesis of silver nanoparticles (AgNP) using Dicranopteris linearis, acting as a reducing and capping agent. AgNP were characterized by UV-vis spectroscopy, Fourier transform infrared (FTIR) spectroscopy, scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX), X-ray diffraction (XRD), zeta potential and particle size analysis. In mosquitocidal assays, the LC50 of D. linearis extract against Aedes aegypti ranged from 165213 (larva I) to 255.055 ppm (pupa). LC50 of D. linearis-synthesized AgNP ranged from 18.905 (larva I) to 29.328 ppm (pupa). In the field, the application of D. linearis extract and AgNP (10 x LC50) led to 100% larval reduction after 72 h. Smoke toxicity experiments conducted against A. aegypti adults showed that D. linearis leaf-, stem- and root-based coils evoked mortality rates comparable to the permethrin-based positive control (58%, 47%, 34%, and 48% respectively). In ovicidal experiments, egg hatchability was reduced by 100% after treatment with 25 ppm of AgNP and 300 ppm of D. linearis extract. Interestingly, oviposition deterrent assays highlighted that 100 ppm of fern extract reduced oviposition rates of more than 65%, while 10 ppm of fern fabricated AgNP reduced oviposition rates of more than 70% in A. aegypti (OAI were -0.52 and -0.55, respectively). Overall, our results highlighted that D. linearis-synthesized AgNP could be useful candidates to develop nano-formulated oviposition deterrents effective against dengue vectors. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Rajaganesh, Rajapandian; Murugan, Kadarkarai; Jayashanthini, Sudalaimani; Roni, Mathath; Suresh, Udaiyan] Bharathiar Univ, Sch Life Sci, Dept Zool, Div Entomol, Coimbatore 641046, Tamil Nadu, India.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Vellore 632115, Tamil Nadu, India.
   [Panneerselvam, Chellasamy; Aziz, Al Thbiani; Trivedi, Subrata; Rehman, Hasibur] Univ Tabuk, Fac Sci, Dept Biol, Tabuk, Saudi Arabia.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, 300 Jhongli, Taoyuan 32001, Taiwan.
   [Nicoletti, Marcello] Univ Roma La Sapienza, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Higuchi, Akon/AAA-9711-2019; Murugan, Kadarkarai/AAP-3937-2020; Rehman,
   Hasibur/K-5224-2019; Benelli, Giovanni/A-9100-2013
OI Rehman, Hasibur/0000-0003-1551-6520; Benelli,
   Giovanni/0000-0001-8971-6010; Panneerselvam,
   Chellasamy/0000-0003-3994-8141
FU King Saud University, through Vice Deanship of Research Chairs;
   UGC-NON-SAP-RFSMS, New Delhi India (NON-SAP RFSMS ZOOLOGY)
   [G2/11753/UGC]; PROAPI (PRAF); University of Pisa, Department of
   Agriculture, Food and Environment [COFIN2015_22]
FX Prof. P. Pasquali and the anonymous reviewers improved an earlier
   version of the manuscript. The authors would like to thank the financial
   support rendered by King Saud University, through the Vice Deanship of
   Research Chairs. The authors gratefully acknowledge the
   UGC-NON-SAP-RFSMS, New Delhi India (grant no. G2/11753/UGC NON-SAP RFSMS
   ZOOLOGY 2011). Dr. G. Benelli is sponsored by PROAPI (PRAF 2015) and
   University of Pisa, Department of Agriculture, Food and Environment
   (Grant ID: COFIN2015_22). Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aarthi N., 2010, Journal of Phytology, V2, P61
   Abirami D, 2011, J PHYTOL, V3, P60
   Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Amerasan D., 2015, J PEST SCI
   Anbu P., 2015, NAT PROD RES
   Assis LM, 2003, VET PARASITOL, V117, P43, DOI 10.1016/j.vetpar.2003.07.021
   Benelli G., 2016, ENZYM MICROB TECHNOL
   Benelli G., 2016, PARASITOL RES
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Benelli G, 2014, PARASITOL RES, V113, P933, DOI 10.1007/s00436-013-3725-4
   Chandramohan B., 2015, NANOPARTICLES FIGHT
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chenniappan Kuppusamy, 2008, Entomological Research, V38, P119, DOI 10.1111/j.1748-5967.2008.00147.x
   Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012
   Dhoondia ZH, 2012, NANOMATER NANOTECHNO, V2, DOI 10.5772/55741
   Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Dixit R.D., 1974, J RES INDIAN MED, V9, P59
   Dragieva I, 1999, NANOSTRUCT MATER, V12, P267, DOI 10.1016/S0965-9773(99)00114-2
   Dwivedi AD, 2010, COLLOID SURFACE A, V369, P27, DOI 10.1016/j.colsurfa.2010.07.020
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fayaz AM, 2010, NANOMED-NANOTECHNOL, V6, P103, DOI 10.1016/j.nano.2009.04.006
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Govindarajan M, 2011, PARASITOL RES, V109, P353, DOI 10.1007/s00436-011-2263-1
   Govindarajan M., 2016, COMB CHEM HIGH THROU
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Hamouda T, 2000, J APPL MICROBIOL, V89, P397, DOI 10.1046/j.1365-2672.2000.01127.x
   HOBBS JH, 1983, MOSQ NEWS, V43, P456
   Hussaini J., 2012, SCI RES ESSAYS, V7, P1761, DOI [10.5897/SRE11.775, DOI 10.5897/SRE11.775]
   Jeyabalan D, 2003, BIORESOURCE TECHNOL, V89, P185, DOI 10.1016/S0960-8524(03)00036-1
   Johnny L., 2010, Journal of Applied Biosciences, V34, P2218
   Josephrajkumar A, 2000, INT J TROPIC INSECT, V20, P295
   Kalwar NH, 2013, APPL CATAL A-GEN, V453, P54, DOI 10.1016/j.apcata.2012.12.005
   Kamisan FH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-123
   Kammi S., 2007, ETHNOBOTANICAL LEAFL, V11, P164
   Kasthuri J, 2009, J NANOPART RES, V11, P1075, DOI 10.1007/s11051-008-9494-9
   Kaviya S, 2011, SPECTROCHIM ACTA A, V79, P594, DOI 10.1016/j.saa.2011.03.040
   Kotakadi VS, 2013, COLLOID SURFACE B, V105, P194, DOI 10.1016/j.colsurfb.2013.01.003
   Kovendan K, 2013, PARASITOL RES, V112, P1205, DOI 10.1007/s00436-012-3252-8
   Kulkarni N, 2014, J NANOTECHNOL, V2014, DOI 10.1155/2014/510246
   Lai HowYee, 2011, International Journal of Environmental Science and Development, V2, P442
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Madhiyazhagan P., 2015, PARASITOL RES
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   MANNAR MANNAN M., 2008, ETHNOBOTANICAL LEAFL, V12, P281
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 1999, CURR SCI INDIA, V76, P631
   Murugan K., 1996, Journal of Entomological Research (New Delhi), V20, P137
   Murugan K, 2003, ANN MED ENTOMOL, V12, P11
   Murugan K., 2007, BIORESOUR TECHNOL, V98
   Murugan K., 2016, ENV SCI POLLUT RES
   Murugan K., 2015, PARASITOL RES
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4087, DOI 10.1007/s00436-015-4638-1
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Njagi EC, 2011, LANGMUIR, V27, P264, DOI 10.1021/la103190n
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P847, DOI 10.1016/S1995-7645(13)60151-0
   Panneerselvam C, 2013, PARASITOL RES, V112, P679, DOI 10.1007/s00436-012-3185-2
   Pavela R., 2016, EXP PARASITOL
   Pavela R., 2016, PARASITOL RES
   Pavela R., 2016, S AFR J BOT
   Perry L.M., 1980, MED PLANTS E S E ASI
   Ponnusamy Y., 2013, J NAT PROD PLANT RES, V3, P14
   Poopathi S, 2015, ENVIRON SCI POLLUT R, V22, P2956, DOI 10.1007/s11356-014-3560-x
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   RAJA DP, 1995, CHEM PHARM BULL, V43, P1800, DOI 10.1248/cpb.43.1800
   RAJENDRAN R, 1991, MED VET ENTOMOL, V5, P299, DOI 10.1111/j.1365-2915.1991.tb00556.x
   Rajkumar S, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.15
   Reegan Appadurai Daniel, 2015, Osong Public Health Res Perspect, V6, P64, DOI 10.1016/j.phrp.2014.08.009
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Sathyavathi R, 2010, ADV SCI LETT, V3, P138, DOI 10.1166/asl.2010.1099
   Satyavani K, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-43
   Schmid G., 1995, COLLOIDS CLUSTERS
   Shameli K, 2010, INT J NANOMED, V5, P743, DOI 10.2147/IJN.S13227
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Singh S., 2005, FERNS FERN ALLIES AR, VI-II
   Stuart B., 2002, POLYM ANAL
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Subramaniam J., 2016, ENV SCI POLLUT RES
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Vahitha R, 2002, BIORESOURCE TECHNOL, V82, P203, DOI 10.1016/S0960-8524(01)00175-4
   Wei ZG, 2005, BIOL TRACE ELEM RES, V106, P279, DOI 10.1385/BTER:106:3:279
   World Health Organization, 2012, HDB INT VECT MAN
   Yang W, 2009, TALANTA, V78, P557, DOI 10.1016/j.talanta.2008.12.009
   Zakaria Z. A., 2008, E PHARMANEXUS, V1, P10
   ZAKARIA ZA, 2007, J PHARM THER, V6, P87
   ZEBITZ CPW, 1984, ENTOMOL EXP APPL, V35, P11, DOI 10.1007/BF00343450
NR 103
TC 22
Z9 22
U1 1
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD DEC
PY 2016
VL 109
BP 40
EP 51
DI 10.1016/j.rvsc.2016.09.012
PG 12
WC Veterinary Sciences
SC Veterinary Sciences
GA EG0QL
UT WOS:000390737200006
PM 27892872
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus and maxillofacial surgery
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Osun State, Nigeria.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Shakib K, 2016, BR J ORAL MAXILLOFAC
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 1
Z9 1
U1 0
U2 1
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
EI 1532-1940
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD DEC
PY 2016
VL 54
IS 10
BP 1145
EP 1145
DI 10.1016/j.bjoms.2016.04.001
PG 1
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA EF7UN
UT WOS:000390534800027
PM 27094497
DA 2020-07-08
ER

PT J
AU Patel, S
AF Patel, Seema
TI In silico analysis of Hepatitis C virus (HCV) polyprotein domains and
   their comparison with other pathogens and allergens to gain insight on
   pathogenicity mechanisms
SO COMPUTATIONAL BIOLOGY AND CHEMISTRY
LA English
DT Article
DE Hepatitis C; Polyprotein domains; Genomic comparison; Pathogenesis;
   Phylogenetic conservation
ID LEUCINE-ZIPPER TRANSCRIPTION; ACTIN-BINDING DOMAIN; ATP-CITRATE LYASE;
   TERMINAL-DOMAIN; PROTEOLIPID PROTEIN; CRYSTAL-STRUCTURE; BASIC REGION;
   EXTRACELLULAR DOMAIN; CYSTINE KNOT; GENE
AB Hepatitis C (HCV) is a deadly virus from family Flaviviridae, causing acute or chronic liver inflammation. Given its lethality and no known vaccine to curb it, understanding its pathogenic mechanism is critical. By analyzing the domains in its protein sequence, a plethora can be learnt about its immune manipulation strategies. In this regard, current in silico study compares publicly-available HCV polyprotein sequences and their domain profiles. Apart from using UniProt sequences and SMART (Simple modular architecture research tool) platform for domain profiling, a set of customized scripts were developed to extract the patterns of protein domain distribution. Also, the total domain set in representative HCV polyprotein sequences were compared with that of other viral pathogens (Ebola, HIV, Dengue, Zika) and allergens (plant pollen, cockroach allergens) to find the conserved domains of key role in pathogenesis. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Patel, Seema] San Diego State Univ, Bioinformat & Med Informat Res Ctr, 5500 Campanile Dr, San Diego, CA 92182 USA.
RP Patel, S (corresponding author), San Diego State Univ, Bioinformat & Med Informat Res Ctr, 5500 Campanile Dr, San Diego, CA 92182 USA.
EM seemabiotech83@gmail.com
CR Abreu-Velez AM, 2012, N AM J MED SCI, V4, P1, DOI 10.4103/1947-2714.92892
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anand S, 2010, NUCLEIC ACIDS RES, V38, pW487, DOI 10.1093/nar/gkq340
   Anderson D, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv110
   Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359
   Arvanitis DN, 2002, J NEUROSCI RES, V70, P8, DOI 10.1002/jnr.10383
   Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895
   Baker LJ, 2001, STRUCTURE, V9, P539, DOI 10.1016/S0969-2126(01)00615-3
   Bernsel A, 2005, PROTEIN SCI, V14, P1723, DOI 10.1110/ps.051395305
   Berton A, 2007, FEBS J, V274, P6011, DOI 10.1111/j.1742-4658.2007.06123.x
   Blackard JT, 2008, HEPATOLOGY, V47, P321, DOI 10.1002/hep.21902
   Boman AL, 2002, MOL BIOL CELL, V13, P3078, DOI 10.1091/mbc.E02-02-0078
   Bonnett SA, 2013, CHEM BIOL, V20, P772, DOI 10.1016/j.chembiol.2013.04.014
   Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001
   Callebaut I, 2001, TRENDS BIOCHEM SCI, V26, P79, DOI 10.1016/S0968-0004(00)01730-8
   Cane DE, 2010, J BIOL CHEM, V285, P27517, DOI 10.1074/jbc.R110.144618
   Canis M, 2012, AM J RHINOL ALLERGY, V26, P31, DOI 10.2500/ajra.2012.26.3698
   Cao SS, 2015, J BACTERIOL, V197, P1185, DOI 10.1128/JB.02555-14
   Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003
   Chalmers IW, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-89
   Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006
   Chen JG, 2008, PLANT SIGNAL BEHAV, V3, P307, DOI 10.4161/psb.3.5.5292
   Chin CY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1692-0
   Ciccarelli FD, 2005, BIOINFORMATICS, V21, P1304, DOI 10.1093/bioinformatics/bti221
   D'Souza R, 2004, J ROY SOC MED, V97, P223, DOI 10.1258/jrsm.97.5.223
   Dartois V, 1996, J BACTERIOL, V178, P1178, DOI 10.1128/jb.178.4.1178-1186.1996
   de Bree FM, 1998, CELL MOL NEUROBIOL, V18, P173, DOI 10.1023/A:1022564803093
   Andrade LJD, 2009, J GLOB INFECT DIS, V1, P33, DOI 10.4103/0974-777X.52979
   De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003
   Deng GM, 2007, BIODRUGS, V21, P23, DOI 10.2165/00063030-200721010-00004
   Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13
   Di Cera E, 2009, IUBMB LIFE, V61, P510, DOI 10.1002/iub.186
   Diekmann Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002217
   Echeverria N, 2015, WORLD J HEPATOL, V7, P831, DOI 10.4254/wjh.v7.i6.831
   Elhiti M, 2009, PLANT SIGNAL BEHAV, V4, P86, DOI 10.4161/psb.4.2.7692
   Elphick MR, 2009, J EXP BIOL, V212, P1067, DOI 10.1242/jeb.027599
   Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698
   Fujisawa T, 2009, BIOCHEM BIOPH RES CO, V385, P215, DOI 10.1016/j.bbrc.2009.05.041
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Garbern JY, 1997, NEURON, V19, P205, DOI 10.1016/S0896-6273(00)80360-8
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015
   Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001
   Gracy J, 2008, NUCLEIC ACIDS RES, V36, pD314, DOI 10.1093/nar/gkm939
   Gu LC, 2009, NATURE, V459, P731, DOI 10.1038/nature07870
   Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y
   Gupta SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042578
   Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3
   Herzig V, 2015, TOXINS, V7, P4366, DOI 10.3390/toxins7104366
   Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200
   Huang X, 2003, DEVELOPMENT, V130, P3147, DOI 10.1242/dev.00518
   Huang XL, 2015, J BACTERIOL, V197, P2517, DOI 10.1128/JB.00176-15
   Huitema E, 2005, MOL PLANT MICROBE IN, V18, P183, DOI 10.1094/MPMI-18-0183
   Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33
   James PD, 2011, GENET MED, V13, P365, DOI 10.1097/GIM.0b013e3182035931
   Jaspard E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109570
   Jiraskova-Vanickova J, 2011, CURR DRUG TARGETS, V12, P1037, DOI 10.2174/138945011795677755
   Kishii R, 2007, J BIOL CHEM, V282, P26401, DOI 10.1074/jbc.M701342200
   Klaavuniemi T, 2004, J BIOL CHEM, V279, P26402, DOI 10.1074/jbc.M401871200
   Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/S0969-2126(04)00117-0
   Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085
   Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005
   Krammer C, 2008, PRION, V2, P99, DOI 10.4161/pri.2.3.7147
   Kruljac-Letunic A, 2003, J BIOL CHEM, V278, P29560, DOI 10.1074/jbc.M302278200
   Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7
   Kupfer L, 2009, CURR MOL MED, V9, P826, DOI 10.2174/156652409789105543
   Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018
   Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397
   Latefi NS, 2009, DEV NEUROBIOL, V69, P518, DOI 10.1002/dneu.20718
   Lavin JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-397
   Lerksuthirat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118547
   Lin RT, 2013, MOL CELL, V51, P506, DOI 10.1016/j.molcel.2013.07.002
   Lin XY, 2014, J BIOL CHEM, V289, P13615, DOI 10.1074/jbc.M114.550418
   Lucas-Lledo JI, 2011, MOL BIOL EVOL, V28, P1307, DOI 10.1093/molbev/msq318
   Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221
   Martinelli VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092259
   Mayer H, 2001, CYTOGENET CELL GENET, V93, P100, DOI 10.1159/000056958
   Mayr JA, 2011, AM J HUM GENET, V89, P806, DOI 10.1016/j.ajhg.2011.11.007
   Mehta P, 2004, PROTEIN SCI, V13, P295, DOI 10.1110/ps.03115604
   Merloni A, 2014, BBA-PROTEINS PROTEOM, V1844, P1662, DOI 10.1016/j.bbapap.2014.06.016
   Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Meyer M, 1997, J MOL BIOL, V269, P719, DOI 10.1006/jmbi.1997.1076
   Miertzschke M, 2011, EMBO J, V30, P4185, DOI 10.1038/emboj.2011.291
   Miller M, 2009, CURR PROTEIN PEPT SC, V10, P244, DOI 10.2174/138920309788452164
   Miller MJ, 2009, J NEUROSCI RES, V87, P2842, DOI 10.1002/jnr.22121
   Millhouse S, 2005, MOL CELL BIOL, V25, P533, DOI 10.1128/MCB.25.2.533-544.2005
   Muszewska A, 2011, MOL BIOL EVOL, V28, P3395, DOI 10.1093/molbev/msr176
   Nakamura M, 2016, WORLD J HEPATOL, V8, P183, DOI 10.4254/wjh.v8.i3.183
   Nolde SB, 2011, J BIOL CHEM, V286, P25145, DOI 10.1074/jbc.M110.200378
   Okay S, 2012, ACTA MICROBIOL IMM H, V59, P485, DOI 10.1556/AMicr.59.2012.4.6
   Oldenburg J, 2006, ANTIOXID REDOX SIGN, V8, P347, DOI 10.1089/ars.2006.8.347
   Park YH, 2014, BIOCHEM BIOPH RES CO, V443, P1155, DOI 10.1016/j.bbrc.2013.12.068
   Patel Manishha, 2013, Commun Integr Biol, V6, pe24298, DOI 10.4161/cib.24298
   Perin PM, 2016, HEPATOLOGY, V63, P49, DOI 10.1002/hep.28111
   Philip N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044617
   Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x
   Ponting CP, 2002, NUCLEIC ACIDS RES, V30, P3643, DOI 10.1093/nar/gkf498
   Ponting CP, 1999, NUCLEIC ACIDS RES, V27, P229, DOI 10.1093/nar/27.1.229
   Prigozhina NL, 2001, MOL BIOL CELL, V12, P3161, DOI 10.1091/mbc.12.10.3161
   Pupaibool J, 2006, EMERG INFECT DIS, V12, P517, DOI 10.3201/eid1203.051044
   Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057
   Ramadori G, 2008, J PHYSIOL PHARMACOL, V59, P107
   REDEKER V, 1992, FEBS LETT, V313, P185, DOI 10.1016/0014-5793(92)81441-N
   Reines A, 2012, J NEUROSCI, V32, P6323, DOI 10.1523/JNEUROSCI.0916-12.2012
   Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5
   Riquelme MA, 2013, NEUROPHARMACOLOGY, V75, P525, DOI 10.1016/j.neuropharm.2013.02.021
   Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659
   Scharfenberg F, 2015, J MOL BIOL, V427, P910, DOI 10.1016/j.jmb.2014.12.024
   Schreieck A, 2014, NAT STRUCT MOL BIOL, V21, P175, DOI 10.1038/nsmb.2753
   Searle MS, 2012, BIOCHEM SOC T, V40, P404, DOI 10.1042/BST20110729
   Shi Q, 2016, VIROLOGY, V490, P99, DOI 10.1016/j.virol.2016.01.012
   Shin JL, 2001, CELL COMMUN ADHES, V8, P271, DOI 10.3109/15419060109080736
   Shoseyov O, 2006, MICROBIOL MOL BIOL R, V70, P283, DOI 10.1128/MMBR.00028-05
   Shvetsov A, 2009, CELL MOTIL CYTOSKEL, V66, P90, DOI 10.1002/cm.20328
   SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107
   Sise ME, 2016, HEPATOLOGY, V63, P408, DOI 10.1002/hep.28297
   Smith AM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00006
   Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744
   Song HK, 2001, J BIOL CHEM, V276, P49359, DOI 10.1074/jbc.M108619200
   Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728
   Strich R, 2014, MICROB CELL, V1, P318, DOI 10.15698/mic2014.10.169
   Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9
   Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007
   Tamburstuen MV, 2010, EUR J ORAL SCI, V118, P451, DOI 10.1111/j.1600-0722.2010.00760.x
   Thauerer B, 2014, CURR NEUROPHARMACOL, V12, P213, DOI 10.2174/1570159X11666131225000518
   Thiel G, 2005, J NEUROCHEM, V92, P321, DOI 10.1111/j.1471-4159.2004.02882.x
   Torocsik B, 2002, J NEUROSCI, V22, P8971
   Tripathi LP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-549
   Uhlikova H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00059
   VANKESTEREN RE, 1995, J NEUROSCI, V15, P5989
   Veluchamy A, 2009, BIOINFORMATION, V4, P80, DOI 10.6026/97320630004080
   Wang Q, 2014, J VIROL, V88, P4853, DOI 10.1128/JVI.02923-13
   Wilton BA, 2008, VIROLOGY, V374, P82, DOI 10.1016/j.virol.2007.11.036
   Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0
   Wuichet K, 2015, GENOME BIOL EVOL, V7, P57, DOI 10.1093/gbe/evu264
   Xiao J, 2011, ARTERIOSCL THROM VAS, V31, P2261, DOI 10.1161/ATVBAHA.111.229609
   Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027
   Xie XQ, 2016, BIOCHEMISTRY-US, V55, P1179, DOI 10.1021/acs.biochem.6b00024
   Ying MY, 2012, DEV GROWTH DIFFER, V54, P32, DOI 10.1111/j.1440-169X.2011.01308.x
   Yoon H, 2011, TOHOKU J EXP MED, V224, P41, DOI 10.1620/tjem.224.41
   Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112
   Zhang JL, 2007, J BIOL CHEM, V282, P20002, DOI 10.1074/jbc.M700456200
   Zhao WD, 1999, J VIROL, V73, P1546, DOI 10.1128/JVI.73.2.1546-1554.1999
   Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85
NR 145
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1476-9271
EI 1476-928X
J9 COMPUT BIOL CHEM
JI Comput. Biol. Chem.
PD DEC
PY 2016
VL 65
BP 91
EP 102
DI 10.1016/j.compbiolchem.2016.10.006
PG 12
WC Biology; Computer Science, Interdisciplinary Applications
SC Life Sciences & Biomedicine - Other Topics; Computer Science
GA EF7GL
UT WOS:000390498000012
PM 27788396
DA 2020-07-08
ER

PT J
AU Wichit, S
   Ferraris, P
   Choumet, V
   Misse, D
AF Wichit, Sineewanlaya
   Ferraris, Pauline
   Choumet, Valerie
   Misse, Dorothee
TI The effects of mosquito saliva on dengue virus infectivity in humans
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID ADULT FEMALE MOSQUITO; AEDES-AEGYPTI; DENDRITIC CELLS; IMMUNE-RESPONSE;
   MAST-CELLS; HUMAN KERATINOCYTES; GLOBAL DISTRIBUTION; RIG-I; PROTEIN;
   REPLICATION
AB Arboviruses such as Dengue, Chikungunya, and Zika viruses represent a major public health problem due to globalization and propagation of susceptible vectors worldwide. Arthropod vector-derived salivary factors have the capacity to modulate human cells function by enhancing or suppressing viral replication and, therefore, modify the establishment of local and systemic viral infection. Here, we discuss how mosquito saliva may interfere with Dengue virus (DENV) infection in humans. Identification of saliva factors that enhance infectivity will allow the production of vector-based vaccines and therapeutics that would interfere with viral transmission by targeting arthropod saliva components. Understanding the role of salivary proteins in DENV transmission will provide tools to control not only Dengue but also other arboviral diseases transmitted by the same vectors.
C1 [Wichit, Sineewanlaya; Ferraris, Pauline; Misse, Dorothee] UMR 224 IRD CNRS UM1, Lab MIVEGEC, Montpellier, France.
   [Choumet, Valerie] Inst Pasteur, Environm & Infect Risks Unit, Paris, France.
RP Misse, D (corresponding author), UMR 224 IRD CNRS UM1, Lab MIVEGEC, Montpellier, France.
EM dorothee.misse@ird.fr
RI Ferraris, Pauline/F-9077-2017
OI Ferraris, Pauline/0000-0002-8796-3074
FU Agence Nationale de la Recherche FranceFrench National Research Agency
   (ANR) [ANR-12-BSV3-0004-01, ANR-14-CE14-0029]; Infectiopole Sud
   foundation
FX We thank Dr Hans Yssel for critical discussions and Thanyakorn Rongsawat
   for technical assistance. This work was supported by grants from the
   Agence Nationale de la Recherche France (grants ANR-12-BSV3-0004-01 and
   ANR-14-CE14-0029). Sineewanlaya Wichit was supported by a fellowship
   from the Infectiopole Sud foundation.
CR Abraham SN, 1997, INFECT IMMUN, V65, P3501, DOI 10.1128/IAI.65.9.3501-3508.1997
   Ader DB, 2004, VIRAL IMMUNOL, V17, P252, DOI 10.1089/0882824041310496
   Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042
   Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BISSONNETTE EY, 1993, PARASITE IMMUNOL, V15, P27, DOI 10.1111/j.1365-3024.1993.tb00569.x
   Bizzarro B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-329
   Boppana VD, 2009, PARASITE IMMUNOL, V31, P287, DOI 10.1111/j.1365-3024.2009.01096.x
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Brown MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034055
   Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420
   Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200
   Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200
   Chagas AC, 2014, P NATL ACAD SCI USA, V111, P6946, DOI 10.1073/pnas.1404179111
   Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   da Silva-Voorham Julia M, 2009, Ned Tijdschr Geneeskd, V153, pA778
   Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Henz BM, 2001, EXP DERMATOL, V10, P1, DOI 10.1034/j.1600-0625.2001.100101.x
   Juhn J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-1
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Le Coupanec A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002237
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x
   McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14
   Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024
   Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704
   Shresta S, 2004, VIROLOGY, V319, P262, DOI 10.1016/j.virol.2003.09.048
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Sun DF, 2006, PLATELETS, V17, P178, DOI 10.1080/09537100500460234
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Surasombatpattana P, 2012, J INVEST DERMATOL, V132, P2103, DOI 10.1038/jid.2012.76
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1199, DOI 10.1016/S0965-1748(02)00083-8
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x
   Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x
NR 56
TC 11
Z9 11
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD DEC
PY 2016
VL 21
BP 139
EP 145
DI 10.1016/j.coviro.2016.10.001
PG 7
WC Virology
SC Virology
GA EF7MA
UT WOS:000390512500022
PM 27770704
DA 2020-07-08
ER

PT J
AU Rifkin, LM
   Duker, JS
AF Rifkin, Lana M.
   Duker, Jay S.
TI Use of Retinal Optical Coherence Tomography to Detect Congenital Zika
   Syndrome
SO JAMA OPHTHALMOLOGY
LA English
DT Editorial Material
ID VIRUS-INFECTION
C1 [Rifkin, Lana M.; Duker, Jay S.] Tufts Univ, Sch Med, Tufts Med Ctr, New England Eye Ctr,Dept Ophthalmol, 800 Washington St,POB 450, Boston, MA 02111 USA.
RP Duker, JS (corresponding author), Tufts Univ, Sch Med, Tufts Med Ctr, New England Eye Ctr,Dept Ophthalmol, 800 Washington St,POB 450, Boston, MA 02111 USA.
EM jduker@tuftsmedicalcenter.org
CR Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
NR 6
TC 2
Z9 2
U1 0
U2 11
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD DEC 1
PY 2016
VL 134
IS 12
BP 1427
EP 1428
DI 10.1001/jamaophthalmol.2016.4299
PG 2
WC Ophthalmology
SC Ophthalmology
GA EF8SR
UT WOS:000390600300021
PM 27832245
OA Bronze
DA 2020-07-08
ER

PT J
AU Vorona, GA
   Lanni, SM
AF Vorona, Gregory A.
   Lanni, Susan M.
TI Fetal Magnetic Resonance Imaging Evaluation of a 21-Week Fetus With Zika
   Virus Infection
SO PEDIATRIC NEUROLOGY
LA English
DT Editorial Material
C1 [Vorona, Gregory A.] Virginia Commonwealth Univ, Pediat Radiol, Childrens Hosp Richmond, Med Coll Virginia Campus, Richmond, VA 23298 USA.
   [Lanni, Susan M.] Virginia Commonwealth Univ, Labor & Delivery, Maternal Fetal Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.
RP Vorona, GA (corresponding author), Virginia Commonwealth Univ, Pediat Radiol, Childrens Hosp Richmond, Main Hosp, Room 3-406,1250 East Marshall St,POB 980615, Richmond, VA 23298 USA.
EM gregory.vorona@vcuhealth.org
CR Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 4
TC 3
Z9 3
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0887-8994
EI 1873-5150
J9 PEDIATR NEUROL
JI Pediatr. Neurol.
PD DEC
PY 2016
VL 65
BP 98
EP 99
DI 10.1016/j.pediatrneurol.2016.07.014
PG 2
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA EF8YL
UT WOS:000390617800016
PM 27743747
DA 2020-07-08
ER

PT J
AU Musso, D
   Gould, E
   Lanteri, MC
AF Musso, Didier
   Gould, Ernest
   Lanteri, Marion C.
TI Documentation of transfusion-transmitted arbovirus infections in endemic
   areas
SO TRANSFUSION
LA English
DT Letter
ID ZIKA VIRUS
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
   [Gould, Ernest] INSERM 1207, UMR Emergence Pathol Virales, Marseille, France.
   [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, Blood Syst Res Inst, San Francisco, CA 94143 USA.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
EM dmusso@ilm.pf
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grinev A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004717
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Petersen LR, 2010, VOX SANG, V98, P495, DOI 10.1111/j.1423-0410.2009.01286.x
NR 5
TC 3
Z9 3
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD DEC
PY 2016
VL 56
IS 12
BP 3143
EP 3144
DI 10.1111/trf.13861
PG 2
WC Hematology
SC Hematology
GA EF8KS
UT WOS:000390578300036
PM 27933623
DA 2020-07-08
ER

PT J
AU Corman, VM
   Rasche, A
   Baronti, C
   Aldabbagh, S
   Cadar, D
   Reusken, CBEM
   Pas, SD
   Goorhuis, A
   Schinkel, J
   Molenkamp, R
   Kummerer, BM
   Bleicker, T
   Brunink, S
   Eschbach-Bludau, M
   Eis-Hubinger, AM
   Koopmans, MP
   Schmidt-Chanasit, J
   Grobusch, MP
   de Lamballerie, X
   Drosten, C
   Drexler, JF
AF Corman, Victor M.
   Rasche, Andrea
   Baronti, Cecile
   Aldabbagh, Souhaib
   Cadar, Daniel
   Reusken, Chantal B. E. M.
   Pas, Suzan D.
   Goorhuis, Abraham
   Schinkel, Janke
   Molenkamp, Richard
   Kuemmerer, Beate M.
   Bleicker, Tobias
   Bruenink, Sebastian
   Eschbach-Bludau, Monika
   Eis-Huebinger, Anna M.
   Koopmans, Marion P.
   Schmidt-Chanasit, Jonas
   Grobusch, Martin P.
   de Lamballerie, Xavier
   Drosten, Christian
   Drexler, Jan Felix
TI Assay optimization for molecular detection of Zika virus
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID REVERSE TRANSCRIPTION-PCR; POLYMERASE-CHAIN-REACTION; REAL-TIME PCR;
   VIRAL LOAD; INFECTION; BRAZIL; RNA; TRANSMISSION; MICRONESIA; EPIDEMIC
AB Objective To examine the diagnostic performance of real-time reverse transcription (RT)-polymerase chain reaction (PCR) assays for Zika virus detection.
   Methods We compared seven published real-time RT PCR assays and two new assays that we have developed. To determine the analytical sensitivity of each assay, we constructed a synthetic universal control ribonucleic acid (uncRNA) containing all of the assays' target regions, on one RNA strand and spiked human blood or urine with known quantities of African or Asian Zika virus strains. Viral loads in 33 samples from Zika virus-infected patients were determined by using one of the new assays.
   Findings Oligonucleotides of the published real-time RT PCR assays, showed up to 10 potential mismatches with the Asian lineage causing the current outbreak, compared with 0 to 4 mismatches for the new assays. The 95% lower detection limit of the seven most sensitive assays ranged from 2.1 to 12.1 uncRNA copies/reaction. Two assays had lower sensitivities of 17.0 and 1373.3 uncRNA copies/reaction and showed a similar sensitivity when using spiked samples.The mean viral loads in samples from Zika virus-infected patients were 5 x 10(4) RNA copies/mL of blood and 2 x 10(4) RNA copies/mL of urine.
   Conclusion We provide reagents and updated protocols for Zika virus detection suitable for the current outbreak strains. Some published assays might be unsuitable for Zika virus detection, due to the limited sensitivity and potential incompatibility with some strains. Viral concentrations in the clinical samples were close to the technical detection limit, suggesting that the use of insensitive assays will cause false-negative results.
C1 [Corman, Victor M.; Rasche, Andrea; Aldabbagh, Souhaib; Kuemmerer, Beate M.; Bleicker, Tobias; Bruenink, Sebastian; Eschbach-Bludau, Monika; Eis-Huebinger, Anna M.; Drosten, Christian; Drexler, Jan Felix] Univ Bonn, Med Ctr, Inst Virol, Sigmund Freud Str 25, D-53127 Bonn, Germany.
   [Baronti, Cecile; de Lamballerie, Xavier] Aix Marseille Univ, EPV, UMR, Marseille, France.
   [Cadar, Daniel; Schmidt-Chanasit, Jonas] WHO Collaborating Ctr Arbovirus & Hemorrhag Fever, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Reusken, Chantal B. E. M.; Pas, Suzan D.; Koopmans, Marion P.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Goorhuis, Abraham; Grobusch, Martin P.] Univ Amsterdam, Dept Infect Dis, Amsterdam, Netherlands.
   [Schinkel, Janke; Molenkamp, Richard] Univ Amsterdam, Clin Virol Lab, Amsterdam, Netherlands.
RP Drexler, JF (corresponding author), Univ Bonn, Med Ctr, Inst Virol, Sigmund Freud Str 25, D-53127 Bonn, Germany.
EM drexler@virology-bonn.de
RI Corman, Victor Max/K-1319-2019; Pas, Suzan D/M-9863-2013; Koopmans,
   Marion/Y-9170-2019
OI Corman, Victor Max/0000-0002-3605-0136; Pas, Suzan
   D/0000-0003-1943-1217; Koopmans, Marion/0000-0002-5204-2312; Cadar,
   Daniel/0000-0002-8063-2766; Rasche, Andrea/0000-0001-6693-1180; Drexler,
   Jan Felix/0000-0002-3509-0232
FU European CommissionEuropean Commission Joint Research Centre [653316,
   602525]
FX This study was supported by funding from the European Commission through
   the Horizon 2020 project EVAg (European Virus Archive goes global),
   grant agreement number 653316 and the framework program (FP)7 project
   PREPARE (Platform for European Preparedness Against (Re-emerging
   Epidemics), grant agreement number 602525.
CR [Anonymous], 2015, CUM ZIK SUSP CONF CA
   [Anonymous], 2016, WHOZIKVHS161
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Corman VM, 2012, EUROSURVEILLANCE, V17, P3
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Donald CE, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-15
   Drexler JF, 2007, J CLIN MICROBIOL, V45, P2061, DOI 10.1128/JCM.00136-07
   Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031
   Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498
   Drosten C, 2004, EMERG INFECT DIS, V10, P2200, DOI 10.3201/eid1012.040416
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duh D, 2007, EMERG INFECT DIS, V13, P1769, DOI 10.3201/eid1311.070222
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Kitchen A, 2011, P NATL ACAD SCI USA, V108, P238, DOI 10.1073/pnas.1011090108
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Panning M, 2009, EMERG INFECT DIS, V15, P469, DOI 10.3201/eid1503.081104
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simmonds Peter, 2012, BMC Res Notes, V5, P50, DOI 10.1186/1756-0500-5-50
   Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
NR 44
TC 63
Z9 65
U1 5
U2 30
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD DEC
PY 2016
VL 94
IS 12
BP 880
EP 892
DI 10.2471/BLT.16.175950
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EF1KN
UT WOS:000390083800007
PM 27994281
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
   Al-Abdely, HM
AF Yasri, Sora
   Wiwanitkit, Viroj
   Al-Abdely, Hail M.
TI Emerging Zika virus
SO SAUDI MEDICAL JOURNAL
LA English
DT Letter
ID INFECTION
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
   [Al-Abdely, Hail M.] Minist Hlth, Gen Directorate Infect Prevent & Control, Riyadh, Saudi Arabia.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
CR Al-Abdely HM, 2016, SAUDI MED J, V37, P831, DOI 10.15537/smj.2016.8.15676
   Porrino P, 2016, TROP DOCT, V46, P159, DOI 10.1177/0049475516656101
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   Wiwwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P513
NR 5
TC 0
Z9 0
U1 0
U2 4
PU SAUDI MED J
PI RIYADH
PA ARMED FORCES HOSPITAL, PO BOX 7897,, RIYADH 11159, SAUDI ARABIA
SN 0379-5284
J9 SAUDI MED J
JI Saudi Med. J.
PD DEC
PY 2016
VL 37
IS 12
BP 1417
EP 1417
DI 10.15537/smj.2016.12.16037
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF3MH
UT WOS:000390228000019
PM 27874162
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goldfarb, IT
   Naqvi, M
   Riley, LE
AF Goldfarb, I. T.
   Naqvi, M.
   Riley, L. E.
TI Initial impact of Zika exposure management in pregnancy
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 43rd Annual Meeting of the
   Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (ISDOG)
CY AUG 11-13, 2016
CL Annapolis, MD
SP Infect Dis Soc Obstet & Gynecol
C1 [Goldfarb, I. T.; Naqvi, M.; Riley, L. E.] Massachusetts Gen Hosp, Boston, MA 02114 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD DEC
PY 2016
VL 215
IS 6
MA 19
BP 822
EP 823
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EE3RM
UT WOS:000389514400071
DA 2020-07-08
ER

PT J
AU Gulland, A
AF Gulland, Anne
TI First case of Zika virus spread through sexual contact is detected in UK
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
NR 0
TC 3
Z9 3
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD DEC 1
PY 2016
VL 355
AR i6500
DI 10.1136/bmj.i6500
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EE0ZO
UT WOS:000389309800017
PM 27908879
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Mehrjardi, MZ
   Keshavarz, E
   Poretti, A
   Hazin, AN
AF Mehrjardi, Mohammad Zare
   Keshavarz, Elham
   Poretti, Andrea
   Hazin, Adriano N.
TI Neuroimaging findings of Zika virus infection: a review article
SO JAPANESE JOURNAL OF RADIOLOGY
LA English
DT Review
DE Zika virus (ZIKV); Neuroimaging; Magnetic resonance imaging (MRI);
   Computed tomography (CT); Ultrasound
ID ACUTE DISSEMINATED ENCEPHALOMYELITIS; EMERGENCE
AB Zika virus (ZIKV) is an arbovirus from the Flaviviridae family. It is usually transmitted by mosquito bite. There have been no reports of severe symptoms caused by ZIKV infection up until the last few years. In October 2013 an outbreak was reported in French Polynesia with severe neurological complications in some affected cases. In November 2015, the Ministry of Health of Brazil attributed the increased number of neonatal microcephaly cases in northeastern Brazil to congenital ZIKV infection. The rapid spread of the virus convinced the World Health Organization to announce ZIKV infection as a "Public Health Emergency of International Concern" in February 2016. The main neuroimaging findings in congenital ZIKV infection include microcephaly which is the hallmark of the disease, other malformations of cortical development (e.g., lissencephaly, heterotopia, etc.), parenchymal calcifications, unilateral or bilateral ventriculomegaly, enlarged extra-axial CSF spaces, dysgenesis of the corpus callosum, agenesis of the cavum septum pellucidum, cerebellar and brainstem hypoplasia, and ocular abnormalities. ZIKV infection may also cause Guillain-Barr, syndrome and acute disseminated encephalomyelitis in adults. Familiarity with neuroimaging findings of congenital and acquired ZIKV infection is crucial to suspect this disease in residents of endemic regions and travelers to these areas.
C1 [Mehrjardi, Mohammad Zare] Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
   [Keshavarz, Elham] Shahid Beheshti Univ Med Sci, Mahdieh Womens Hosp, Dept Radiol, Tehran, Iran.
   [Poretti, Andrea] Johns Hopkins Univ, Sch Med, Div Pediat Radiol, Sect Pediat Neuroradiol,Russell H Morgan Dept Rad, Baltimore, MD USA.
   [Hazin, Adriano N.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
RP Mehrjardi, MZ (corresponding author), Shahid Beheshti Univ Med Sci, Shohada Tajrish Hosp, Dept Radiol, Tehran, Iran.
EM zare@sbmu.ac.ir; elhamkeshavarz@yahoo.com; aporett1@jhmi.edu;
   adrianohazin@hotmail.com
RI Mehrjardi, Mohammad Zare/G-8980-2017
OI Mehrjardi, Mohammad Zare/0000-0001-5793-5323
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Baptista T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2194
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chibueze EC, 2016, B WHO
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fontes C. A., 2016, NEURORADIOLOGY
   Franca GV, 2016, LANCET
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hynson JL, 2001, NEUROLOGY, V56, P1308, DOI 10.1212/WNL.56.10.1308
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kornienko V. N., 2009, DIAGNOSTIC NEURORADI
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, N ENGL J MED, V374, P951
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Silva ACSE, 2016, NEUROPSYCH DIS TREAT, V12, P1747, DOI 10.2147/NDT.S113037
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   Tong A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-181
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Young NP, 2008, SEMIN NEUROL, V28, P84, DOI 10.1055/s-2007-1019130
NR 36
TC 25
Z9 27
U1 0
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1867-1071
EI 1867-108X
J9 JPN J RADIOL
JI Jpn. J. Radiol.
PD DEC
PY 2016
VL 34
IS 12
BP 765
EP 770
DI 10.1007/s11604-016-0588-5
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EE8SZ
UT WOS:000389897500002
PM 27714487
OA Bronze
DA 2020-07-08
ER

PT J
AU Lee, KM
   Chiu, KB
   Sansing, HA
   Didier, PJ
   Lackner, AA
   MacLean, AG
AF Lee, Kim M.
   Chiu, Kevin B.
   Sansing, Hope A.
   Didier, Peter J.
   Lackner, Andrew A.
   MacLean, Andrew G.
TI The flavivirus dengue induces hypertrophy of white matter astrocytes
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Flavivirus; Neuropathogenesis; Astrocyte; Glia; Hypertrophy
ID IMMUNE DYSFUNCTION; VIRUS-INFECTION; ANIMAL-MODELS; BRAIN; ENCEPHALITIS;
   MACAQUES
AB Flaviviruses, including Zika and dengue (DENV), pose a serious global threat to human health. Of the 50+ million humans infected with DENV annually, approximately 1-3 % progress to severe disease manifestations, dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Several factors are suspected to mediate the course of infection and pathogenesis of DENV infection. DHF and DSS are associated with vascular leakage and neurological sequelae. Our hypothesis was that altered astrocyte activation and morphology would alter the dynamics of the extracellular space and hence, neuronal and vascular function. We investigated the mechanisms of neuropathogenesis DENV infection in rhesus macaques. There were decreased numbers of GFAP immunopositive astrocytes per unit area, although those that remained had increased arbor length and complexity. This was combined with structural hypertrophy of white matter astrocytes in the absence of increased vascular leakage. Combined, these studies show how even low-grade infection with DENV induces measurable changes within the parenchyma of infected individuals.
C1 [Lee, Kim M.; Lackner, Andrew A.; MacLean, Andrew G.] Tulane Med Sch, Program Biomed Sci, New Orleans, LA 70112 USA.
   [Lee, Kim M.; Chiu, Kevin B.; Sansing, Hope A.; Didier, Peter J.; Lackner, Andrew A.; MacLean, Andrew G.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.
   [Chiu, Kevin B.] Dept Biomed Engn, Covington, LA USA.
   [Lackner, Andrew A.; MacLean, Andrew G.] Tulane Med Sch, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.
RP MacLean, AG (corresponding author), Tulane Med Sch, Program Biomed Sci, New Orleans, LA 70112 USA.; MacLean, AG (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.; MacLean, AG (corresponding author), Tulane Med Sch, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.
EM amaclean@tulane.edu
RI MacLean, Andrew/R-9906-2019
FU Tulane University School of Medicine; Tulane Program in Neuroscience;
   PHS grant [OD11104]
FX We thank the pathology faculty and staff at Tulane National Primate
   Research Center for expertly collecting and archiving samples. This work
   was supported in part through grants to Dr. MacLean from Tulane
   University School of Medicine and the Tulane Program in Neuroscience.
   Ms. Lee was the inaugural TNPRC postgraduate research fellow. PHS grant
   OD11104, formerly RR00164, was essential for animal husbandry and
   archiving the tissues for 50 years.
CR Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045
   Clarke P, 2014, MBIO, V5, DOI 10.1128/mBio.00902-14
   Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13
   Crompton D.W.T., 2010, WORKING OVERCOME GLO
   Freria CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-240
   Howard V., 1998, UNBIASED STEREOLOGY
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Lee KM, 2015, BRAIN BEHAV IMMUN, V50, P288, DOI 10.1016/j.bbi.2015.07.017
   Lee KM, 2014, J NEUROVIROL, V20, P474, DOI 10.1007/s13365-014-0267-1
   Lee KM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00086
   Lee KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069980
   Luabeya MK, 2000, NEUROPATH APPL NEURO, V26, P454, DOI 10.1046/j.1365-2990.2000.00275.x
   Maximova OA, 2008, J VIROL, V82, P5255, DOI 10.1128/JVI.00172-08
   Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Ramos C, 1998, J NEUROVIROL, V4, P465, DOI 10.3109/13550289809114548
   Renner NA, 2012, NEUROPATH APPL NEURO, V38, P162, DOI 10.1111/j.1365-2990.2011.01200.x
   Renner NA, 2013, J CELL PHYSIOL, V228, P1284, DOI 10.1002/jcp.24283
   Robillard K. N., 2016, BRAIN BEHAV IMMUN
   Snook E.R., 2013, AM J PATHOL
   Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0
   Torres-Platas SG, 2011, NEUROPSYCHOPHARMACOL, V36, P2650, DOI 10.1038/npp.2011.154
   Velandia-Romero ML, 2012, J NEUROVIROL, V18, P374, DOI 10.1007/s13365-012-0117-y
   ZLOTNIK I, 1968, BRIT J EXP PATHOL, V49, P555
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 25
TC 5
Z9 5
U1 0
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD DEC
PY 2016
VL 22
IS 6
BP 831
EP 839
DI 10.1007/s13365-016-0461-4
PG 9
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA EE1LK
UT WOS:000389342900012
PM 27273075
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Bordon, Y
AF Bordon, Yvonne
TI Zika virus: end of transmission?
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT News Item
OI Bordon, Yvonne/0000-0002-9728-012X
NR 0
TC 1
Z9 1
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
EI 1474-1741
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD DEC
PY 2016
VL 16
IS 12
BP 718
EP 718
DI 10.1038/nri.2016.131
PG 1
WC Immunology
SC Immunology
GA ED8PX
UT WOS:000389134500002
PM 27885280
DA 2020-07-08
ER

PT J
AU Diaz, JH
AF Diaz, James H.
TI Preparing the United States for Zika Virus: Pre-emptive Vector Control
   and Personal Protection
SO WILDERNESS & ENVIRONMENTAL MEDICINE
LA English
DT Editorial Material
DE Zika virus; arboviruses; mosquito-borne infectious diseases; Aedes
   aegypti; Aedes albopictus
AB Discovered in 1947 in a monkey in the Zika forest of Uganda, Zika virus was dismissed as a cause of a mild illness that was confined to Africa and Southeast Asia and transmitted by Aedes mosquitoes. In 2007, Zika virus appeared outside of its endemic borders in an outbreak on the South Pacific Island of Yap. In 2013, Zika virus was associated with a major neurological complication, Guillain-Barre syndrome, in a larger outbreak in the French Polynesian Islands. From the South Pacific, Zika invaded Brazil in 2015 and caused another severe neurological complication, fetal microcephaly. The mosquito borne transmission of Zika virus can be propagated by sexual transmission and, possibly, by blood transfusions, close personal contacts, and organ transplants, like other fiaviviruses. Since these combined mechanisms of infectious disease transmission could result in catastrophic incidences of severe neurological diseases in adults and children, the public should know what to expect from Zika virus, how to prevent infection, and what the most likely failures in preventive measures Will be. With federal research funding stalled, a Zika vaccine is far away. The only national strategies to prepare the United States for Zika virus invasion now are effective vector control measures and personal protection from mosquito bites. In addition to a basic knowledge of Aedes mosquito vectors and their biting behaviors, an understanding of simple household vector control measures, and the selection of the best chemical and physical mosquito repellents will be required to repel the Zika threat.
C1 [Diaz, James H.] Louisiana State Univ, Hlth Sci Ctr, Program Environm & Occupat Hlth Sci, Sch Publ Hlth, New Orleans, LA USA.
RP Diaz, JH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Environm & Occupat Hlth Sci, Sch Publ Hlth, 2020 Gravier St,Third Floor, New Orleans, LA 70112 USA.
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diaz JH, 2016, WILD ENVIRON MED, V27, P153, DOI 10.1016/j.wem.2015.11.007
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
NR 10
TC 1
Z9 1
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1080-6032
EI 1545-1534
J9 WILD ENVIRON MED
JI Wildern. Environ. Med.
PD DEC
PY 2016
VL 27
IS 4
BP 450
EP 457
DI 10.1016/j.wem.2016.07.006
PG 8
WC Public, Environmental & Occupational Health; Sport Sciences
SC Public, Environmental & Occupational Health; Sport Sciences
GA EE6QH
UT WOS:000389736800002
PM 28340908
OA Bronze
DA 2020-07-08
ER

PT J
AU Ming, GL
   Tang, HL
   Song, HJ
AF Ming, Guo-li
   Tang, Hengli
   Song, Hongjun
TI Advances in Zika Virus Research: Stem Cell Models, Challenges, and
   Opportunities
SO CELL STEM CELL
LA English
DT Review
ID BORNE ENCEPHALITIS-VIRUS; NEURAL CREST CELLS; BINDING KINASE 1; DENGUE
   VIRUS; CEREBRAL ORGANOIDS; ENDOTHELIAL-CELLS; INFECTION; RNA; BRAIN;
   ACTIVATION
AB The re-emergence of Zika virus (ZIKV) and its suspected link with various disorders in newborns and adults led the World Health Organization to declare a global health emergency. In response, the stem cell field quickly established platforms for modeling ZIKV exposure using human pluripotent stem cell-derived neural progenitors and brain organoids, fetal tissues, and animal models. These efforts provided significant insight into cellular targets, pathogenesis, and underlying biological mechanisms of ZIKV infection as well as platforms for drug testing. Here we review the remarkable progress in stem cell-based ZIKV research and discuss current challenges and future opportunities.
C1 [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
RP Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
EM gming1@jhmi.edu; shongju1@jhmi.edu
OI Ming, Guo-li/0000-0002-2517-6075
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01MH105128, R21MH110160, R35NS097370,
   R21AI119530, R37NS047344, U19MH106434, P01NS097206, R21HD086820,
   RM1HG008935]; Maryland Stem Cell Research Fund; Foundation for
   Prader-Willi Research; ZIKV from Florida State University
FX We apologize for not citing many original papers due to the space limit.
   We thank Kimberly M. Christian for comments. The research in the
   authors' laboratories was supported by grants from the NIH (R01MH105128,
   R21MH110160, and R35NS097370 to G.-l.M.; R21AI119530 to H.T.; and
   R37NS047344, U19MH106434, P01NS097206, R21HD086820, and RM1HG008935 to
   H.S.), Maryland Stem Cell Research Fund (G.-l.M. and H.S.), and
   Foundation for Prader-Willi Research (G.-l.M.), and ZIKV seed funding
   from Florida State University (H.T.).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akiyama B. M., 2016, SCIENCE
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L., 2016, EURO SURVEILL, V21
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bond AM, 2015, CELL STEM CELL, V17, P385, DOI 10.1016/j.stem.2015.09.003
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Burdette DL, 2013, NAT IMMUNOL, V14, P19, DOI 10.1038/ni.2491
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Etzrodt M, 2014, CELL STEM CELL, V15, P546, DOI 10.1016/j.stem.2014.10.015
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726
   Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar A., 2016, EMBO REP
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365
   Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030
   Luo Y, 2016, NAT MICROBIOL, V1, DOI 10.1038/NMICROBIOL.2016.68
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Melo AS, 2016, JAMA NEUROL
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mounce BC, 2016, J VIROL, V90, P9683, DOI 10.1128/JVI.01347-16
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Osuna CE, 2016, NAT MED
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rowe RG, 2016, CELL STEM CELL, V18, P707, DOI 10.1016/j.stem.2016.05.016
   Sapparapu G, 2016, NATURE
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013
   Shin J, 2014, NAT NEUROSCI, V17, P1463, DOI 10.1038/nn.3814
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yao B, 2016, NAT REV NEUROSCI, V17, P537, DOI 10.1038/nrn.2016.70
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 128
TC 50
Z9 51
U1 2
U2 64
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD DEC 1
PY 2016
VL 19
IS 6
BP 690
EP 702
DI 10.1016/j.stem.2016.11.014
PG 13
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EE3GD
UT WOS:000389474900008
PM 27912090
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Maharajan, MK
   Ranjan, A
   Chu, JF
   Foo, WL
   Chai, ZX
   Lau, EY
   Ye, HM
   Theam, XJ
   Lok, YL
AF Maharajan, Mari Kannan
   Ranjan, Aruna
   Chu, Jian Feng
   Foo, Wei Lim
   Chai, Zhi Xin
   Lau, Eileen YinYien
   Ye, Heuy Mien
   Theam, Xi Jin
   Lok, Yen Ling
TI Zika Virus Infection: Current Concerns and Perspectives
SO CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
LA English
DT Review
DE Zika virus; Diagnosis; Cytokines; Transmission; Management
ID SEROTYPE-SPECIFIC DIFFERENCES; WEST-NILE-VIRUS; FRENCH-POLYNESIA;
   UNITED-STATES; SEXUAL TRANSMISSION; DECEMBER 2013; OUTBREAK; TRAVELERS;
   FEVER; MECHANISMS
AB The Zika virus outbreaks highlight the growing importance need for a reliable, specific and rapid diagnostic device to detect Zika virus, as it is often recognized as a mild disease without being identified. Many Zika virus infection cases have been misdiagnosed or underreported because of the non-specific clinical presentation. The aim of this review was to provide a critical and comprehensive overview of the published peeraEuroreviewed evidence related to clinical presentations, various diagnostic methods and modes of transmission of Zika virus infection, as well as potential therapeutic targets to combat microcephaly. Zika virus is mainly transmitted through bites from Aedes aegypti mosquito. It can also be transmitted through blood, perinatally and sexually. Pregnant women are advised to postpone or avoid travelling to areas where active Zika virus transmission is reported, as this infection is directly linked to foetal microcephaly. Due to the high prevalence of Guillain-Barre syndrome and microcephaly in the endemic area, it is vital to confirm the diagnosis of Zika virus. Zika virus infection had been declared as a public health emergency and of international concern by the World Health Organisation. Governments and agencies should play an important role in terms of investing time and resources to fundamentally understand this infection so that a vaccine can be developed besides raising awareness.
C1 [Maharajan, Mari Kannan; Ranjan, Aruna; Chu, Jian Feng; Foo, Wei Lim; Chai, Zhi Xin; Lau, Eileen YinYien; Ye, Heuy Mien; Theam, Xi Jin; Lok, Yen Ling] Int Med Univ, Sch Pharm, Dept Pharm Practice, Kuala Lumpur 57000, Malaysia.
RP Maharajan, MK (corresponding author), Int Med Univ, Sch Pharm, Dept Pharm Practice, Kuala Lumpur 57000, Malaysia.
EM kanpharm2002@gmail.com
RI Maharajan, MariKannan/F-6660-2017; amsalu, ribka/G-8780-2019
OI Maharajan, MariKannan/0000-0001-6812-0533; 
CR [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   [Anonymous], 2016, ZIK VIR POT COMPL
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atkinson B, 2016, EMERG INFECT DIS
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC Health Alert Network, 2016, EM PREP RESP REC MAN
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Centers for Disease Control and Prevention, ZIK VIR DIS US 2015
   Chuang Vivien W. M., 2008, Hong Kong Medical Journal, V14, P170
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hans Rekha, 2014, Asian J Transfus Sci, V8, P2, DOI 10.4103/0973-6247.126679
   Hayer EB, 2009, ZIKA VIRUS OUTSIDE A, V15, P1347
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Heymann DL, 2016, NEW ENGL J MED, V374, P1504, DOI 10.1056/NEJMp1602278
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229
   Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kindhauser MK, 2016, B WHO
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Ledermann JP, 2011, CLIN VACCINE IMMUNOL, V18, P580, DOI 10.1128/CVI.00201-10
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morens DM, 2010, EMERG INFECT DIS, V16, P1023, DOI 10.3201/eid1606.100453
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Shapshak P, 2015, GLOBAL VIROLOGY 1 ID
   Shawan M. M. A. K., 2015, NAT SCI, V13, P37, DOI DOI 10.1017/CBO9781107415324.004
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Snyder EL, 2015, NEW ENGL J MED, V372, P1882, DOI 10.1056/NEJMp1500154
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   World Health Organization, 2016, ZIK SIT REP 19 FEBR
   World Health Organization (WHO), 1993, BREASTF COUNS TRAIN
   Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika Virus Infection and Pregnancy Information for Healthcare Professionals, 2016, INT RCOG RCM PHE HPS
NR 94
TC 19
Z9 20
U1 0
U2 38
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1080-0549
EI 1559-0267
J9 CLIN REV ALLERG IMMU
JI Clin. Rev. Allergy Immunol.
PD DEC
PY 2016
VL 51
IS 3
BP 383
EP 394
DI 10.1007/s12016-016-8554-7
PG 12
WC Allergy; Immunology
SC Allergy; Immunology
GA ED6DU
UT WOS:000388946300010
PM 27236440
OA Bronze
DA 2020-07-08
ER

PT J
AU Gonzalez-Barreto, W
   Rodriguez-Vega, G
   Rodriguez-Vazquez, J
AF Gonzalez-Barreto, Wilma
   Rodriguez-Vega, Gloria
   Rodriguez-Vazquez, Jose
CA GBS Passive Surveillance Syst
TI ZIKA VIRUS OUTBREAK AND GUILLAIN-BARRE SYNDROME IN PUERTO RICO: 2016
SO CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
CT 46th Critical Care Congress of the Society-of-Critical-Care-Medicine
CY JAN 21-25, 2017
CL Honolulu, HI
SP Soc Crit Care Med
NR 0
TC 1
Z9 1
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0090-3493
EI 1530-0293
J9 CRIT CARE MED
JI Crit. Care Med.
PD DEC
PY 2016
VL 44
IS 12
SU S
MA 1807
PG 1
WC Critical Care Medicine
SC General & Internal Medicine
GA ED5RO
UT WOS:000388910202332
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Hoti, SL
   Benelli, G
AF Govindarajan, Marimuthu
   Hoti, S. L.
   Benelli, Giovanni
TI Facile fabrication of eco-friendly nano-mosquitocides: Biophysical
   characterization and effectiveness on neglected tropical mosquito
   vectors
SO ENZYME AND MICROBIAL TECHNOLOGY
LA English
DT Article
DE Aedes albopictus; Anopheles subpictus; Culex tritaeniorhynchus; Green
   synthesis; Nanotechnology; Plant-borne larvicides
ID SILVER NANOPARTICLES; GREEN SYNTHESIS; LEAF EXTRACT; VETERINARY
   IMPORTANCE; FRUIT EXTRACT; BIOSYNTHESIS; PREDATORS; MALARIA; DENGUE;
   ORGANISMS
AB Mosquito (Diptera: Culicidae) vectors are solely responsible for transmitting important diseases such as malaria, dengue, chikungunya, Japanese encephalitis, lymphatic filariasis and Zika virus. Eco-friendly control tools of Culicidae vectors are a priority. In this study, we proposed a facile fabrication process of poly-disperse and stable silver nanoparticles (Ag NPs) using a cheap leaf extract of Ichnoccupus frutescens (Apocyanaceae). Bio-reduced AgNPs were characterized by UV-vis spectrophotometry, Fourier transform infrared spectroscopy (FTIR), X-ray diffraction analysis (XRD), atomic force microscopy (AFM), scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The acute toxicity of I. frutescens leaf extract and green-synthesized Ag NPs was evaluated against larvae of the malaria vector Anopheles subpictus, the dengue vector Aedes albopictus and the Japanese encephalitis vector Culex tritaeniorhynchus. Compared to the leaf aqueous extract, Ag NPs showed higher toxicity against A. subpictus, A. albopictus, and C. tritaeniorhynchus with LC50 values of 14.22, 15.84 and 17.26 mu g/mL, respectively. Ag NPs were found safer to non-target mosquito predators Anisops bouvieri, Diplonychus indicus and Gambusia affinis, with LC50 values ranging from 636.61 to 2098.61 mu g/mL. Overall, this research firstly shed light on the mosquitocidal potential of I. frutescens, a potential bio-resource for rapid, cheap and effective synthesis of poly-disperse and highly stable silver nanocrystals. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Hoti, S. L.] Reg Med Res Ctr, Belgaum 590010, Karnataka, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; g.benelli@sssup.it
RI GOVINDARAJAN, MARIMUTHU/A-8070-2019; Benelli, Giovanni/A-9100-2013
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Benelli,
   Giovanni/0000-0001-8971-6010
CR Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Benelli G, 2016, PARASITOL RES MG, V8, P155, DOI 10.1007/978-3-319-25292-6_8
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   Deo PG, 1998, INT PEST CONTROL, V30, P118
   Finney D. J., 1997, PROBIT ANAL, P68
   Geethalakshmi R, 2010, INT J ENG SCI TECHNO, V2, P976
   Govindarajan M., 2013, PARASITOL RES
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Govindarajan M, 2016, PARASITOL RES, V115, P723, DOI 10.1007/s00436-015-4794-3
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Khan M.S.Y., 1997, BR J INDIAN CHEM, V72, P65
   Kirtikar K. R, 1998, INDIAN MED PLANTS, P1590
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Kumarappan C. T., 2007, Experimental Oncology, V29, P94
   Lakshmi DKM, 1985, INDIAN DRUGS, V22, P552
   Li SK, 2007, GREEN CHEM, V9, P852, DOI 10.1039/b615357g
   Magudapathy P, 2001, PHYSICA B, V299, P142, DOI 10.1016/S0921-4526(00)00580-9
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Nadkarni K. M., 1982, INDIAN MAT MED, P674
   PANDURANGAN A., 2008, PHARM ONLINE, V1, P392
   Pavela R., 2016, J PEST SCI
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   Prakash P, 2013, COLLOID SURFACE B, V108, P255, DOI 10.1016/j.colsurfb.2013.03.017
   SALAM HA, 2012, INT RES J BIOL SCI, V1, P85
   Shaalan EAS, 2009, TROP BIOMED, V26, P223
   Shanmugam N, 2014, APPL NANOSCI, V4, P881, DOI 10.1007/s13204-013-0271-4
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Subash-Babu P, 2008, CHEM-BIOL INTERACT, V172, P159, DOI 10.1016/j.cbi.2007.12.004
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Vignesh V, 2013, COLLOID SURFACE A, V439, P184, DOI 10.1016/j.colsurfa.2013.04.011
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Yugandhar P, 2016, APPL NANOSCI, V6, P223, DOI 10.1007/s13204-015-0428-4
NR 40
TC 21
Z9 21
U1 3
U2 18
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0141-0229
EI 1879-0909
J9 ENZYME MICROB TECH
JI Enzyme Microb. Technol.
PD DEC
PY 2016
VL 95
SI SI
BP 155
EP 163
DI 10.1016/j.enzmictec.2016.05.005
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA ED9AD
UT WOS:000389161400018
PM 27866611
DA 2020-07-08
ER

PT J
AU Caragata, EP
   Dutra, HLC
   O'Neill, SL
   Moreira, LA
AF Caragata, Eric P.
   Dutra, Heverton L. C.
   O'Neill, Scott L.
   Moreira, Luciano A.
TI Zika control through the bacterium Wolbachia pipientis
SO FUTURE MICROBIOLOGY
LA English
DT Editorial Material
ID AEDES-AEGYPTI POPULATIONS; MOSQUITO; VIRUS; INFECTION; VECTOR; DENGUE;
   STRAIN; BRAZIL
C1 [Caragata, Eric P.; Dutra, Heverton L. C.; Moreira, Luciano A.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
   [O'Neill, Scott L.] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia.
RP Moreira, LA (corresponding author), Fiocruz MS, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.
EM luciano@cpqrr.fiocruz.br
RI O'Neill, Scott/R-9560-2019; O'Neill, Scott L/B-3568-2009; Dutra,
   Heverton Leandro Carneiro/V-7517-2019
OI O'Neill, Scott/0000-0002-4131-3615; O'Neill, Scott
   L/0000-0002-4131-3615; Dutra, Heverton Leandro
   Carneiro/0000-0002-0917-4512
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Atyame CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001440
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 18
TC 6
Z9 6
U1 0
U2 35
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD DEC
PY 2016
VL 11
IS 12
BP 1499
EP 1502
DI 10.2217/fmb-2016-0177
PG 4
WC Microbiology
SC Microbiology
GA ED2LM
UT WOS:000388676400002
PM 27831765
DA 2020-07-08
ER

PT J
AU Duijster, JW
   Goorhuis, A
   van Genderen, PJJ
   Visser, LG
   Koopmans, MP
   Reimerink, JH
   Grobusch, MP
   van der Eijk, AA
   van den Kerkhof, JHCT
   Reusken, CB
   Hahne, SJM
AF Duijster, Janneke W.
   Goorhuis, Abraham
   van Genderen, Perry J. J.
   Visser, Leo G.
   Koopmans, Marion P.
   Reimerink, Johan H.
   Grobusch, Martin P.
   van der Eijk, Annemiek A.
   van den Kerkhof, Johannes H. C. T.
   Reusken, Chantal B.
   Hahne, Susan J. M.
CA Dutch ZIKV Study Team
TI Zika virus infection in 18 travellers returning from Surinam and the
   Dominican Republic, The Netherlands, November 2015-March 2016
SO INFECTION
LA English
DT Article
DE Imported viral diseases; Netherlands; Zika virus; Travel; Surinam;
   Dominican Republic
ID EUROPE
AB Purpose We report 18 cases of confirmed Zika virus (ZIKV) infection in travellers returning to the Netherlands from Surinam (South America, bordering northern Brazil) and the Dominican Republic.
   Methods In a multi-centre study, we collected epidemiological, virological and clinical characteristics, as well as data on travel history, underlying illness and laboratory results of the 18 imported ZIKV infection cases using a standardised form.
   Results Most cases had a self-limiting course of disease, two patients developed complications, one had Guillain-Barre and another had severe thrombocytopenia. Four patients had underlying illness. One of the reported cases was pregnant. Three of 13 patients tested had a weak-positive result for dengue IgM. The majority of patients were born in Suriname and/or visiting friends and relatives (VFR).
   Conclusions Providing pre-travel advice among travellers, especially VFR travellers, is needed to enhance the use of preventive measures against ZIKV infection. Further evidence on health risks associated with ZIKV infection is urgently needed.
C1 [Duijster, Janneke W.; Reimerink, Johan H.; van den Kerkhof, Johannes H. C. T.; Hahne, Susan J. M.] Natl Inst Publ Hlth & Environm RIVM Bilthoven, Ctr Infect Dis Control, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands.
   [Goorhuis, Abraham; Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Div Internal Med,Dept Infect Dis, Meibergdreef 9,A01-330, NL-1105 AZ Amsterdam, Netherlands.
   [van Genderen, Perry J. J.] Harbour Hosp, Inst Trop Dis, Haringvliet 72, NL-3011 TG Rotterdam, Netherlands.
   [Visser, Leo G.] Leiden Univ, Med Ctr, Dept Infect Dis, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.
   [Koopmans, Marion P.; van der Eijk, Annemiek A.; Reusken, Chantal B.] Erasmus MC, Dept Virosci, WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Wytemaweg 80,Ee 1726, NL-3015 CN Rotterdam, Netherlands.
RP Duijster, JW (corresponding author), Natl Inst Publ Hlth & Environm RIVM Bilthoven, Ctr Infect Dis Control, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands.
EM janneke.duijster@rivm.nl
RI Koopmans, Marion/Y-9170-2019; amsalu, ribka/G-8780-2019
OI Koopmans, Marion/0000-0002-5204-2312; 
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2012, HLTH INF INT TRAVEL, P547
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   European Centre for Disease Prevention and Control, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, COUNTR TERR LOC ZIK
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Hendel-Paterson B, 2011, TRAVEL MED INFECT DI, V9, P192, DOI 10.1016/j.tmaid.2010.09.007
   Hills S, 2016, MMWR MORB MORTAL WKL
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kramer MA, 2008, SEX TRANSM INFECT, V84, P554, DOI 10.1136/sti.2008.032094
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Von Eije KJ, 2016, NED TIJDSCHR GENEES, V160, pC2895
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 19
TC 17
Z9 19
U1 0
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-8126
EI 1439-0973
J9 INFECTION
JI Infection
PD DEC
PY 2016
VL 44
IS 6
BP 797
EP 802
DI 10.1007/s15010-016-0906-y
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA ED4NY
UT WOS:000388827600014
PM 27209175
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Valentine, G
   Marquez, L
   Pammi, M
AF Valentine, Gregory
   Marquez, Lucila
   Pammi, Mohan
TI Zika virus epidemic: an update
SO EXPERT REVIEW OF ANTI-INFECTIVE THERAPY
LA English
DT Review
DE Zika virus; global health; vaccine; arbovirus; congenital infection
ID UNITED-STATES; SEXUAL TRANSMISSION; INTERIM GUIDELINES;
   FRENCH-POLYNESIA; PREGNANT-WOMEN; INFECTION; INFANTS; OUTBREAK; BRAZIL;
   PERSISTENCE
AB Introduction: Zika Virus (ZIKV), previously the cause of only rare and sporadic human infections, is now considered a Public Health Emergency of International Concern. Over the past two years, ZIKV has become a pandemic encompassing much of the Americas. ZIKV is now proven to cause microcephaly and ophthalmic anomalies in the newborn. Hydrops fetalis, developmental delay, and other anomalies are increasingly being attributed to ZIKV infection in fetuses and neonates. Sequelae of congenital infection and rapid spread of ZIKV throughout the Americas has catapulted Zika virus concerns to the forefront of the medical community.Areas covered: This review seeks to consolidate ZIKV epidemiology, diagnostic testing methods, CDC screening recommendations, and preventive strategies including potential vaccines.Expert commentary: Many unknowns still exist regarding ZIKV infections and its long-term effects in neonates. In addition, further studies need to evaluate if genomic differences that have occurred from the African to the Asian lineage of the virus have led to increased virulence of the virus. The authors believe that all pregnant women with fetuses showing microcephaly and/or intracranial calcifications should be tested for ZIKV infection if they cannot recall their sexual partner travel history. This change from the current CDCs recommendations could increase substantially the number of pregnant women and neonates, screened for ZIKV.
C1 [Valentine, Gregory] Dept Pediat, One Baylor Plaza, Houston, TX USA.
   [Marquez, Lucila] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA.
   [Pammi, Mohan] Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA.
RP Pammi, M (corresponding author), Baylor Coll Med, Dept Pediat, Sect Neonatol, Houston, TX 77030 USA.
EM mohanv@bcm.edu
OI Valentine, Gregory/0000-0002-3055-2987
CR AAP, 2016, 2016 SUMM SAF TIPS
   ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2016, ADV PEOPL LIV TRAV S
   CDC, 2016, ADD AR ACT ZIK TRANS
   CDC, 2016, CDC ASS UT INV ZIK V
   CDC, 2016, DENG DENG HEM FEV
   CDC, 2016, DIAGN TEST
   CDC, 2016, PREGN WOM AN LAB EV
   CDC, 2016, OUTC PREGN LAB EV PO
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GESER A, 1970, Bulletin of the World Health Organization, V43, P539
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1086
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mizumoto K, 2014, J VECTOR DIS, V51, P153
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   NIAID, 2016, ZIK VIR VACC RES
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sencer DJ, 2006, EMERG INFECT DIS, V12, P29
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Twatchman G, 2016, ZIKA VACCINE DEV GET
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   WHO, 2016, ZIK VIR INF CHIL
   WHO, 2016, ZIK OR SPREAD MOSQ B
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization [WHO], 2016, MOSQ CONTR CAN IT ST
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 86
TC 7
Z9 7
U1 1
U2 24
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1478-7210
EI 1744-8336
J9 EXPERT REV ANTI-INFE
JI Expert Rev. Anti-Infect. Ther.
PD DEC
PY 2016
VL 14
IS 12
BP 1127
EP 1138
DI 10.1080/14787210.2016.1245614
PG 12
WC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
SC Infectious Diseases; Microbiology; Pharmacology & Pharmacy
GA ED1EH
UT WOS:000388586800003
PM 27712118
DA 2020-07-08
ER

PT J
AU Goebel, S
   Snyder, B
   Sellati, T
   Saeed, M
   Ptak, R
   Murray, M
   Bostwick, R
   Rayner, J
   Koide, F
   Kalkeri, R
AF Goebel, Scott
   Snyder, Beth
   Sellati, Timothy
   Saeed, Mohammad
   Ptak, Roger
   Murray, Michael
   Bostwick, Robert
   Rayner, Jonathan
   Koide, Fusataka
   Kalkeri, Raj
TI A sensitive virus yield assay for evaluation of Antivirals against Zika
   Virus
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika virus; Quantitative RT-PCR; CP assay; Virus yield assay
ID REAL-TIME PCR; RT-PCR; INHIBITORS; MOSQUITOS; DRUGS; STEP
AB Despite the rapid spread of Zika virus (ZIKV) infection and associated neurological complications in the America's, prophylactic or therapeutic countermeasures are not currently available. This is mostly due to the fact that until recently there was no presumed need for medical intervention since there was no association between ZIKV infection and significant human morbidity. Consequently, there are currently no tools due mostly to the lack of sensitive cell based assays amenable for identification of ZIKV inhibitors. To address this unmet need we have developed a cell based virus yield assay suitable for testing antivirals against Zika virus.
   Using bioinformatics, several isolates of ZIKV from the Americas, Africa, and Asia were analyzed for sequence similarity. The alignment data were then used to design primers targeting a ZIKV genomic region that was highly conserved among all the ZIKV isolates. Subsequently, primers were used in a sensitive, quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay to detect ZIKV RNA. The qRT-PCR assay was found to be highly sensitive (lower limit of detection between-10-100 copies) and reproducible. Evaluation of the primers and probes used for ZIKV against another flavivirus (Dengue virus) demonstrated specificity of detection. To evaluate potential of qRT-PCR assay as an antiviral screening tool against ZIKV, Vero cells pretreated with Type I Interferons (IFN a) were infected with virus, followed by measurement of ZIKV RNA found in the cell culture supernatants using qRT-PCR assay. Dose-dependent antiviral activity of Type I Interferons and mycophenolic acid (MPA) against Zika virus in this cell culture system was confirmed using qRT-PCR. Due to reproducible assay performance, qPCR associated higher sensitivity and short duration of the assay time, this novel cell based assay will be very useful for confirming the activity of antivirals against ZIKV. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Goebel, Scott; Snyder, Beth; Ptak, Roger; Murray, Michael; Koide, Fusataka; Kalkeri, Raj] Dept Infect Dis Res, Drug Dev, Southern Res, Frederick, MD USA.
   [Sellati, Timothy; Saeed, Mohammad; Bostwick, Robert] Dept Infect Dis, Drug Discovery Div, Southern Res, Birmingham, AL USA.
   [Rayner, Jonathan] Dept Infect Dis Res, Drug Dev, Southern Res, Birmingham, AL USA.
RP Kalkeri, R (corresponding author), Dept Infect Dis Res, Vitro Antiviral Drug Dev, Southern Res, 431 Aviat Way, Frederick, MD 21701 USA.
EM rkalkeri@southernresearch.org
OI Rayner, Jonathan/0000-0002-2091-7604
CR Adelman ZN, 2012, INSECT MOL BIOL, V21, P357, DOI 10.1111/j.1365-2583.2012.01141.x
   Al-Siyabi T, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-184
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Contreras D., 2016, JOVE
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Klebe RJ, 1996, BIOTECHNIQUES, V21, P1094
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Longdon B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004395
   Lucchese G, 2016, AUTOIMMUN REV
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nunes ML, 2016, J PEDIAT RIO J
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Song H., 2016, NAT STRUCT MOLE BIOL
   THOMSON D, 1995, J VIROL METHODS, V54, P85, DOI 10.1016/0166-0934(95)00022-M
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00991
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 32
TC 27
Z9 27
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD DEC
PY 2016
VL 238
BP 13
EP 20
DI 10.1016/j.jviromet.2016.09.015
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA ED8AJ
UT WOS:000389093800003
PM 27678028
DA 2020-07-08
ER

PT J
AU Wang, X
   Yin, FG
   Bi, YH
   Cheng, G
   Li, J
   Hou, LD
   Li, YL
   Yang, BZ
   Liu, WJ
   Yang, LM
AF Wang, Xuan
   Yin, Fenggui
   Bi, Yuhai
   Cheng, Gong
   Li, Jing
   Hou, Lidan
   Li, Yunlong
   Yang, Baozhi
   Liu, Wenjun
   Yang, Limin
TI Rapid and sensitive detection of Zika virus by reverse transcription
   loop-mediated isothermal amplification
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zikv; Rt-lamp; Rapid detection; Poct
ID MASS GATHERINGS; URINE; FLAVIVIRUSES; PREPAREDNESS; MOSQUITOS; SALIVA;
   BRAZIL; LAMP; PCR; RNA
AB Background: Zika virus (ZIKV) is an arbovirus that recently emerged and has expanded worldwide, causing a global threat and raising international concerns. Current molecular diagnostics, e.g., real-time PCR and reverse transcription PCR (RT-PCR), are time consuming, expensive, and can only be deployed in a laboratory instead of for field diagnostics.
   Objectives: This study aimed to develop a one-step reverse transcription loop-mediated isothermal amplification (RT-LAMP) platform showing sensitivity, specificity, and more convenience than previous methods, being easily distributed and implemented.
   Methods: Specific primers were designed and screened to target the entire ZIKV genome. The analytical sensitivity and specificity of the assay were evaluated and compared with traditional PCR and quantitative real-time PCR. Three different simulated clinical sample quick preparation protocols were evaluated to establish a rapid and straightforward treatment procedure for clinical specimens in open field detection.
   Results: The RT-LAMP assay for detection of ZIKV demonstrated superior specificity and sensitivity compared to traditional PCR at the optimum reaction temperature. For the ZIKV RNA standard, the limit of detection was 20 copies/test. For the simulated ZIKV clinical samples, the limit of detection was 0.02 pfu/test, which was one order of magnitude higher than RT-PCR and similar to real-time PCR. The detection limit of simulated ZIKV specimens prepared using a protease quick processing method was consistent with that of samples prepared using commercial nucleic acid extraction kits, indicating that our ZIKV detection method could be used in point-of-care testing.
   Conclusions: The RT-LAMP assay had excellent sensitivity and specificity for detecting ZIKV and can be deployed together with a rapid specimen processing method, offering the possibility for ZIKV diagnosis outside of the laboratory. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Wang, Xuan; Bi, Yuhai; Li, Jing; Li, Yunlong; Liu, Wenjun; Yang, Limin] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 West Beichen Rd, Beijing 100101, Peoples R China.
   [Wang, Xuan; Yin, Fenggui; Bi, Yuhai; Cheng, Gong; Li, Jing; Hou, Lidan; Li, Yunlong; Yang, Baozhi; Liu, Wenjun; Yang, Limin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Cheng, Gong] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.
   [Hou, Lidan; Liu, Wenjun] China Inst Vet Drug Control, Beijing 100081, Peoples R China.
   [Yin, Fenggui; Yang, Baozhi] Guangxi Univ, Coll Anim Sci & Vet Med, Nanning 530004, Peoples R China.
RP Yang, LM (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, 1 West Beichen Rd, Beijing 100101, Peoples R China.
EM lmyang@im.ac.cn
RI yang, lm/AAE-3827-2019
OI yang, li min/0000-0002-1158-0800
FU National Key Program for Infectious Disease of China
   [2016ZX10004222-006]; National Key Technology R&D Program of
   ChinaNational Key Technology R&D Program [2016YFC1201001]; Key Research
   Program of the Chinese Academy of SciencesChinese Academy of Sciences
   [ZDRW-ZS-2016-4-4]
FX This work was supported by the National Key Program for Infectious
   Disease of China (2016ZX10004222-006), the National Key Technology R&D
   Program of China (2016YFC1201001) and the Key Research Program of the
   Chinese Academy of Sciences (ZDRW-ZS-2016-4-4).
CR Barzon L., 2016, EURO SURVEILL, V21
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Ibrahim NK, 2016, PAK J MED SCI, V32, P1038, DOI 10.12669/pjms.324.10038
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kurosaki Y, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004472
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0271-x
   Liu W, 2012, J CLIN MICROBIOL, V50, P1580, DOI 10.1128/JCM.06647-11
   Livingstone DM, 2016, J CLIN VIROL, V75, P37, DOI 10.1016/j.jcv.2016.01.002
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nemoto M, 2010, J VET MED SCI, V72, P823, DOI 10.1292/jvms.09-0446
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   World Health Organization, 2016, SAUDI MED J, V37, P332
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 36
TC 33
Z9 35
U1 5
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD DEC
PY 2016
VL 238
BP 86
EP 93
DI 10.1016/j.jviromet.2016.10.010
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA ED8AJ
UT WOS:000389093800014
PM 27793644
DA 2020-07-08
ER

PT J
AU Brosco, JH
   Brosco, JP
AF Hordatt Brosco, Joia
   Brosco, Jeffrey P.
TI Zika as a Catalyst for Social Change
SO PEDIATRICS
LA English
DT Editorial Material
C1 [Hordatt Brosco, Joia] Univ Penn, Philadelphia, PA 19104 USA.
   [Brosco, Jeffrey P.] Univ Miami, Miami, FL USA.
RP Brosco, JP (corresponding author), Univ Miami, Inst Bioeth & Hlth Policy, Dept Pediat, Leonard M Miller Sch Med, Miami, FL 33136 USA.
EM jbrosco@miami.edu
CR Amnesty International, 0133882016 AMR
   Centers for Disease Control and Prevention, PREV ZIK VIR
   Petchesky RP, 1984, ABORTION WOMANS CHOI, P101
   PEW RESEARCH CENTER, REL LAT AM WID CHANG
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reagan L. J., 2012, DANGEROUS PREGNANCIE
   Somashekhar S., 2016, WASHINGTON POST
   United Nations Office of the High Commissioner for Human Rights, 2016, UPH WOM HUM RIGHTS E
   World Bank, DIS INCL DEV LAT AM
NR 9
TC 2
Z9 2
U1 0
U2 1
PU AMER ACAD PEDIATRICS
PI ELK GROVE VILLAGE
PA 141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA
SN 0031-4005
EI 1098-4275
J9 PEDIATRICS
JI Pediatrics
PD DEC
PY 2016
VL 138
IS 6
AR e20162095
DI 10.1542/peds.2016-2095
PG 2
WC Pediatrics
SC Pediatrics
GA ED5WX
UT WOS:000388924800046
OA Bronze
DA 2020-07-08
ER

PT J
AU Pavela, R
   Maggi, F
   Mbuntcha, H
   Woguem, V
   Fogang, HPD
   Womeni, HM
   Tapondjou, LA
   Barboni, L
   Nicoletti, M
   Canale, A
   Benelli, G
AF Pavela, Roman
   Maggi, Filippo
   Mbuntcha, Helene
   Woguem, Verlaine
   Fogang, Hervet Paulin Dongmo
   Womeni, Hilaire Macaire
   Tapondjou, Leon Azefack
   Barboni, Luciano
   Nicoletti, Marcello
   Canale, Angelo
   Benelli, Giovanni
TI Traditional herbal remedies and dietary spices from Cameroon as novel
   sources of larvicides against filariasis mosquitoes?
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Aframomum daniellii; Dichrostachys cinerea; Echinops giganteus;
   Essential oil; Culex quinquefasciatus; Rift Valley fever; West Nile
   virus
ID ECO-FRIENDLY LARVICIDES; ESSENTIAL OILS; AEDES-ALBOPICTUS;
   CULEX-QUINQUEFASCIATUS; VETERINARY IMPORTANCE; TERPENE DERIVATIVES;
   ANOPHELES-SUBPICTUS; ZIKA VIRUS; IN-VITRO; DIPTERA
AB In Cameroon, many dietary spices are used by traditional healers to cure several diseases such as cancer and microbial infections. Aframomum daniellii, Dichrostachys cinerea and Echinops giganteus are Cameroonian spices widely used as flavourings and as food additives. Moreover, they are traditionally herbal remedies employed to treat several diseases, as well as to control populations of insect pests. In this research, we analysed the chemical composition of A. daniellii, D. cinerea and E. giganteus essential oils and we evaluated their larvicidal potential against larvae of the filariasis and West Nile virus vector Culex quinquefasciatus. The essential oils were obtained from different plant parts by hydrodistillation and their composition was analysed by GC-MS. The three spices exhibited different volatile chemical profiles, being characterized by 1,8-cineole, sabinene and beta-pinene (A. daniellii), geraniol and terpinen-4-ol (D. cinerea), and silphiperfol-6-ene and presilphiperfolan-8-ol (E. giganteus). Results showed that the highest larvicidal toxicity on Cx. quinquefasciatus was exerted by D. cinerea essential oil (LC50 = 39.1 mu L L-1), followed by A. daniellii (pericarp essential oil: LC50 = 65.5 mu L L-1; leaves: LC50 = 65.5 mu L L-1; seeds: LC50 = 106.5 mu L L-1) and E. giganteus (LC50 = 227.4 mu L L-1). Overall, the chance to use the D. cinerea essential oil against Cx. quinquefasciatus young instars seems promising, since it is effective at moderate doses and could be an advantageous alternative to build newer mosquito control tools.
C1 [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Maggi, Filippo] Univ Camerino, Sch Pharm, Camerino, Italy.
   [Mbuntcha, Helene; Woguem, Verlaine; Fogang, Hervet Paulin Dongmo; Tapondjou, Leon Azefack] Univ Dschang, Lab Environm & Appl Chem, Fac Sci, Dschang, Cameroon.
   [Mbuntcha, Helene; Woguem, Verlaine; Fogang, Hervet Paulin Dongmo; Womeni, Hilaire Macaire] Univ Dschang, Lab Biochem Med Plants Food Sci & Nutr, Fac Sci, Dschang, Cameroon.
   [Barboni, Luciano] Univ Camerino, Sch Sci & Technol, Camerino, Italy.
   [Nicoletti, Marcello] Sapienza Univ Rome, Dept Environm Biol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Pavela, Roman/Q-8647-2016; Benelli, Giovanni/A-9100-2013; Barboni,
   Luciano/O-9171-2014
OI Benelli, Giovanni/0000-0001-8971-6010; Barboni,
   Luciano/0000-0001-5594-4752; Pavela, Roman/0000-0001-7866-4278
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]; Technology Agency of the Czech Republic
   [TA04020103]
FX G. Benelli is sponsored by PROAPI (PRAF 2015) "Valutazione della qualita
   organolettica del polline d'api fresco sottoposto a differenti
   trattamenti di condizionamento" and University of Pisa, Department of
   Agriculture, Food and Environment (Grant ID: COFIN2015_22). R. Pavela
   would like to thank the Technology Agency of the Czech Republic for its
   financial support concerning botanical pesticide research (Project no.
   TA04020103). Funders had no role in the study design, data collection
   and analysis, decision to publish or preparation of the manuscript.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Adebayo T.A., 1999, NIGER J NAT PROD MED, V3, P74
   Adegoke GO, 1998, FLAVOUR FRAG J, V13, P349, DOI [10.1002/(SICI)1099-1026(1998090)13:5<349::AID-FFJ758>3.0.CO;2-O, 10.1002/(SICI)1099-1026(1998090)13:5&lt;349::AID-FFJ758&gt;3.0.CO;2-O]
   Ahua KM, 2007, J ETHNOPHARMACOL, V110, P99, DOI 10.1016/j.jep.2006.09.030
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   [Anonymous], 2012, 2 FFNSC SHIM CORPS
   [Anonymous], 2008, 08 NIST
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   BOHLMANN F, 1981, PHYTOCHEMISTRY, V20, P2239, DOI 10.1016/0031-9422(81)80121-5
   BOHLMANN F, 1980, PHYTOCHEMISTRY, V19, P259, DOI 10.1016/S0031-9422(00)81970-6
   Bouba A A., 2010, Agriculture and Biology Journal of North America, V1, P213, DOI 10.5251/abjna.2010.1.3.213.224
   Bouquet A., 1969, FETICHEURS MED TRADI
   Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365
   Chen W, 2010, S AFR J BOT, V76, P643, DOI 10.1016/j.sajb.2010.05.008
   Chuaycharoensuk T, 2012, PARASITE, V19, P427, DOI 10.1051/parasite/2012194427
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   Conti B, 2012, PARASITOL RES, V110, P2013, DOI 10.1007/s00436-011-2730-8
   Deniz IV, 2009, THESIS, P136
   Dzoyem JP, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-58
   El-Sayed AM, 2016, PHEROBASE DATABASE P
   Fankam AG, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-104
   Fasoyiro SB, 2007, AFR J BIOTECHNOL, V6, P235
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Fogang HPD, 2014, CHEM BIODIVERS, V11, P161, DOI 10.1002/cbdv.201300237
   Fogang HPD, 2012, FLAVOUR FRAG J, V27, P171, DOI 10.1002/ffj.3083
   Foster WA, 2002, MED ENTOMOL, P245
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Jeon JH, 2009, J FOOD PROTECT, V72, P1468, DOI 10.4315/0362-028X-72.7.1468
   Karunamoorthi K, 2014, J ETHNOBIOL ETHNOMED, V10, DOI 10.1186/1746-4269-10-22
   Khallaayoune K, 2009, PARASITE, V16, P223, DOI 10.1051/parasite/2009163223
   Kuete V, 2013, J ETHNOPHARMACOL, V149, P245, DOI 10.1016/j.jep.2013.06.029
   Kuete V, 2011, J ETHNOPHARMACOL, V134, P803, DOI 10.1016/j.jep.2011.01.035
   Lahlou M, 2004, PHYTOTHER RES, V18, P435, DOI 10.1002/ptr.1465
   MENUT C, 1991, Flavour and Fragrance Journal, V6, P183, DOI 10.1002/ffj.2730060304
   Menut C., 1997, Flavour and Fragrance Journal, V12, P415, DOI 10.1002/(SICI)1099-1026(199711/12)12:6&lt;415::AID-FFJ666&gt;3.0.CO;2-T
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nicoletti M, 2016, CURR ORG CHEM, V20, P2681, DOI 10.2174/1385272820666160218233923
   Odukoya OA, 1999, PHYTOMEDICINE, V6, P251, DOI 10.1016/S0944-7113(99)80017-8
   Pavela R, 2017, S AFR J BOT, V108, P359, DOI 10.1016/j.sajb.2016.08.017
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Taber DF, 2011, J ORG CHEM, V76, P1874, DOI 10.1021/jo200075v
   Tchiegang C., 2005, Tropicultura, V23, P193
   Tekwu EM, 2012, J ETHNOPHARMACOL, V142, P374, DOI 10.1016/j.jep.2012.05.003
   Tene M, 2004, PHYTOCHEMISTRY, V65, P2101, DOI 10.1016/j.phytochem.2004.05.014
   WHO, 1996, CTDWHOPESIC961
   Woguem V, 2014, FOOD CHEM, V149, P183, DOI 10.1016/j.foodchem.2013.10.093
NR 57
TC 4
Z9 5
U1 0
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD DEC
PY 2016
VL 115
IS 12
BP 4617
EP 4626
DI 10.1007/s00436-016-5254-4
PG 10
WC Parasitology
SC Parasitology
GA EC5QP
UT WOS:000388191400019
PM 27679452
OA Bronze
DA 2020-07-08
ER

PT J
AU Frenkel, LD
AF Frenkel, Lawrence D.
TI COMPARING CONGENITAL ZIKA AND CYTOMEGALOVIRUS AFFLICTION
SO PEDIATRIC INFECTIOUS DISEASE JOURNAL
LA English
DT Editorial Material
ID INFECTION
C1 [Frenkel, Lawrence D.] Univ Illinois, Dept Pediat, Coll Med, New Brunswick, NJ USA.
   [Frenkel, Lawrence D.] Univ Illinois, Dept Microbiol, Coll Med, New Brunswick, NJ USA.
   [Frenkel, Lawrence D.] St Peters Univ Hosp, Div Immunol Allergy & Infect Dis, Dept Pediat, Childrens Hosp, New Brunswick, NJ USA.
RP Frenkel, LD (corresponding author), 108 Stone Manor Dr, Somerset, NJ 08873 USA.
EM lfrenkel@uic.edu
CR D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Paula Freitas B, 2016, JAMA OPHTHAMOL
   Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8
   FRENKEL LD, 1980, PEDIATRICS, V66, P763
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROLAPLESZCZYNSKI M, 1977, J INFECT DIS, V135, P386, DOI 10.1093/infdis/135.3.386
   SABAHI F, 1995, AM J REPROD IMMUNOL, V33, P381, DOI 10.1111/j.1600-0897.1995.tb00907.x
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
NR 10
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0891-3668
EI 1532-0987
J9 PEDIATR INFECT DIS J
JI Pediatr. Infect. Dis. J.
PD DEC
PY 2016
VL 35
IS 12
BP 1371
EP 1372
DI 10.1097/INF.0000000000001273
PG 2
WC Immunology; Infectious Diseases; Pediatrics
SC Immunology; Infectious Diseases; Pediatrics
GA EC6AH
UT WOS:000388217900032
PM 27286563
DA 2020-07-08
ER

PT J
AU Oliveira, SJGD
   de Melo, ES
   Reinheimer, DM
   Gurgel, RQ
   Santos, VS
   Martins, PRS
AF Gomes dos Santos Oliveira, Sheila Jaqueline
   de Melo, Emanuela Santos
   Reinheimer, Daniele Machado
   Gurgel, Ricardo Queiroz
   Santos, Victor Santana
   Saquete Martins-Filho, Paulo Ricardo
TI Anxiety, depression, and quality of life in mothers of newborns with
   microcephaly and presumed congenital Zika virus infection
SO ARCHIVES OF WOMENS MENTAL HEALTH
LA English
DT Article
C1 [Gomes dos Santos Oliveira, Sheila Jaqueline; Reinheimer, Daniele Machado; Gurgel, Ricardo Queiroz; Santos, Victor Santana; Saquete Martins-Filho, Paulo Ricardo] Univ Fed Sergipe, Aracaju, Sergipe, Brazil.
   [de Melo, Emanuela Santos] Univ Tiradentes, Aracaju, Sergipe, Brazil.
   [Saquete Martins-Filho, Paulo Ricardo] Univ Fed Sergipe, Univ Hosp, Lab Patol Invest, Rua Claudio Batista S-N, BR-49060100 Aracaju, Sergipe, Brazil.
RP Martins, PRS (corresponding author), Univ Fed Sergipe, Aracaju, Sergipe, Brazil.; Martins, PRS (corresponding author), Univ Fed Sergipe, Univ Hosp, Lab Patol Invest, Rua Claudio Batista S-N, BR-49060100 Aracaju, Sergipe, Brazil.
EM martins-filho@ufs.br
RI Santos, Victor/M-5710-2019; Santos, Victor S/B-8738-2014; Gurgel,
   RQ/N-5105-2018; Martins-Filho, Paulo/AAC-4773-2019
OI Santos, Victor/0000-0003-0194-7397; Santos, Victor
   S/0000-0003-0194-7397; Gurgel, RQ/0000-0001-9651-3713; Martins-Filho,
   Paulo Ricardo/0000-0001-8779-0727
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Barlow J., 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002020.PUB2
   BRAZIL, 2016, 31 MIN SAUD
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 11
TC 11
Z9 11
U1 0
U2 6
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 1434-1816
EI 1435-1102
J9 ARCH WOMEN MENT HLTH
JI Arch. Womens Ment. Health
PD DEC
PY 2016
VL 19
IS 6
BP 1149
EP 1151
DI 10.1007/s00737-016-0654-0
PG 3
WC Psychiatry
SC Psychiatry
GA EB8QT
UT WOS:000387656600023
PM 27538400
OA Bronze
DA 2020-07-08
ER

PT J
AU Goldthwaite, LM
   Velasquez, G
AF Goldthwaite, Lisa M.
   Velasquez, Griselda
TI Family planning and the Zika era
SO CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
LA English
DT Review
DE abortion; contraception; family planning; microcephaly; Zika virus
ID VIRUS OUTBREAK; INFECTION; ABORTION; STATES; WOMEN
AB Purpose of review
   To review the current evidence regarding the impact of the Zika virus epidemic on pregnancy and the implications for family planning and reproductive health services for women in affected countries.
   Recent findings
   In the past 2 years, over the course of the Zika epidemic, much has been learned about the virus. Specifically in regard to pregnancy, a causative relationship has been established between the Zika virus and adverse fetal outcomes, and sexual transmission of the virus has been documented. Broad recommendations by government agencies and public health officials regarding avoidance of pregnancy for women at risk of acquiring the Zika virus have theoretical and documented implications for abortion and contraception demand and access.
   Summary
   Additional research is needed to better understand the impact of Zika virus health recommendations and advisories on women's decision making around pregnancy, as well as their impact on demand, access and safety of family planning services.
C1 [Goldthwaite, Lisa M.; Velasquez, Griselda] Stanford Univ, Sch Med, Stanford, CA 94305 USA.
RP Goldthwaite, LM (corresponding author), 300 Pasteur Dr, Stanford, CA 94305 USA.
EM lgoldthw@stanford.edu
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   [Anonymous], 2016, FACT SHEET AB LAT AM
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Collucci C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4657
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McNeil Jr Donald G., 2016, NY TIMES
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Pan American Health Organization / World Health Organization, 2015, EP AL INCR MICR NE B
   Pan American Health Organization/World Health Organization, 2016, ZIK EP UPD
   Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   WiIdCRU, 2016, TIME MAGAZINE
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
NR 31
TC 4
Z9 4
U1 0
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1040-872X
EI 1473-656X
J9 CURR OPIN OBSTET GYN
JI Curr. Opin. Obstet. Gynecol.
PD DEC
PY 2016
VL 28
IS 6
BP 499
EP 503
DI 10.1097/GCO.0000000000000323
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EC3DD
UT WOS:000388004100007
PM 27787288
DA 2020-07-08
ER

PT J
AU Leo, YS
   Chow, A
AF Leo, Yee-Sin
   Chow, Angela
TI Zika virus has arrived in Singapore
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID INFECTION
C1 [Leo, Yee-Sin; Chow, Angela] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore 308433, Singapore.
RP Leo, YS (corresponding author), Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore 308433, Singapore.
EM yee_sin_leo@ttsh.com.sg
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Min C. H., 2016, STRAITS TIMES
   Ministry of Health Singapore, 2016, WORK TOG ADDR ZIK OU
   Ministry of Health Singapore, 2016, CESS IS MOH SUBS ZIK
   Ministry of Health Singapore, 2016, 1 CAS LOC TRANSM ZIK
   Mohandas V., 2016, CHANNEL NEWS AS 0923
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
NR 12
TC 10
Z9 12
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1317
EP 1319
DI 10.1016/S1473-3099(16)30448-0
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800010
PM 27998580
OA Bronze
DA 2020-07-08
ER

PT J
AU Vouga, M
   Musso, D
   Panchaud, A
   Baud, D
AF Vouga, M.
   Musso, D.
   Panchaud, A.
   Baud, D.
TI Clinical management of pregnant women exposed to Zika virus (vol 16, pg
   773, 2016)
SO LANCET INFECTIOUS DISEASES
LA English
DT Correction
RI Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971
CR Vouga M, 2016, LANCET INFECT DIS, V16, P773, DOI 10.1016/S1473-3099(16)30083-4
NR 1
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1324
EP 1324
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800015
DA 2020-07-08
ER

PT J
AU Lover, AA
AF Lover, Andrew A.
TI Zika virus and microcephaly
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Lover, Andrew A.] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.
RP Lover, AA (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.
EM andrew.lover@ucsf.edu
CR Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475
   Coveney J., 2015, FIRTHLOGIT STATA MOD
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165
   Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687
   Li XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097775
   Pandeya N, 2009, AUST NZ J PUBL HEAL, V33, P312, DOI 10.1111/j.1753-6405.2009.00401.x
NR 9
TC 4
Z9 4
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1331
EP 1332
DI 10.1016/S1473-3099(16)30462-5
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800027
PM 27998594
OA Bronze
DA 2020-07-08
ER

PT J
AU de Araujo, TVB
   Martelli, CT
   de Souza, WV
   Rodrigues, LC
AF de Araujo, Thalia V. B.
   Martelli, Celina T.
   de Souza, Wayner V.
   Rodrigues, Laura-C
TI Zika virus and microcephaly Reply
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [de Araujo, Thalia V. B.] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [de Araujo, Thalia V. B.] Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
   [Martelli, Celina T.] Univ Fed Goias, Dept Community Hlth, Goiania, Go, Brazil.
   [de Souza, Wayner V.] Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [de Souza, Wayner V.] Oswaldo Cruz Fdn Fiocruz, Recife, PE, Brazil.
   [Rodrigues, Laura-C] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP de Araujo, TVB (corresponding author), Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.; de Araujo, TVB (corresponding author), Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
EM thalia@ufpe.br
RI Souza, Wayner V/H-3798-2013
OI Turchi Martelli, Celina Maria/0000-0002-2491-0688; Souza,
   Wayner/0000-0002-0939-9332
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15088]
CR de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687
NR 2
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1332
EP 1332
DI 10.1016/S1473-3099(16)30457-1
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800028
PM 27998595
OA Bronze
DA 2020-07-08
ER

PT J
AU Fu, KW
   Liang, H
   Saroha, N
   Tse, ZTH
   Ip, P
   Fung, ICH
AF Fu, King-Wa
   Liang, Hai
   Saroha, Nitin
   Tse, Zion Tsz Ho
   Ip, Patrick
   Fung, Isaac Chun-Hai
TI How people react to Zika virus outbreaks on Twitter? A computational
   content analysis
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Health communication; public response; social media; Zika virus disease;
   pregnancy complications
AB Zika-related Twitter incidence peaked after the World Health Organization declared an emergency. Five themes were identified from Zika-related Twitter content: (1) societal impact of the outbreak; (2) government, public and private sector, and general public responses to the outbreak; (3) pregnancy and microcephaly: negative health consequences related to pregnant women and babies; (4) transmission routes; and (5) case reports. User-generated contents sites were preferred direct information channels rather than those of the government authorities. (C) 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Fu, King-Wa; Liang, Hai] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.
   [Saroha, Nitin] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA.
   [Tse, Zion Tsz Ho] Univ Georgia, Coll Engn, Athens, GA 30602 USA.
   [Ip, Patrick] Univ Hong Kong, Li Ka Shing Fac Med, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.
   [Fung, Isaac Chun-Hai] Georgia Southern Univ, Jiann Ping Hsu Coll Publ Hlth, Dept Epidemiol, Statesboro, GA USA.
RP Fung, ICH (corresponding author), Georgia Southern Univ, Jiann Ping Hsu Coll Publ Hlth, POB 8015, Statesboro, GA 30460 USA.
EM cfung@georgiasouthern.edu
RI Liang, Hai/AAB-2150-2020; Liang, Hai/F-3797-2015; Fu,
   King-wa/A-2385-2010
OI Liang, Hai/0000-0003-1779-9552; Liang, Hai/0000-0003-1779-9552; Fu,
   King-wa/0000-0001-8157-5276; Fung, Isaac Chun-Hai/0000-0001-5496-2529;
   Tse, Zion/0000-0001-9741-1137
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [15IPA1509134, 16IPA1619505]
FX I.C.-H.F. and Z.T.H.T. received salary support from the Centers for
   Disease Control and Prevention (15IPA1509134 and 16IPA1619505).
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   WHO, 2016, ZIK VIR FACT SHEET
NR 6
TC 34
Z9 35
U1 4
U2 20
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD DEC 1
PY 2016
VL 44
IS 12
BP 1700
EP 1702
DI 10.1016/j.ajic.2016.04.253
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EI6SH
UT WOS:000392626300055
PM 27566874
DA 2020-07-08
ER

PT J
AU Glowacki, EM
   Lazard, AJ
   Wilcox, GB
   Mackert, M
   Bernhardt, JM
AF Glowacki, Elizabeth M.
   Lazard, Allison J.
   Wilcox, Gary B.
   Mackert, Michael
   Bernhardt, Jay M.
TI Identifying the public's concerns and the Centers for Disease Control
   and Prevention's reactions during a health crisis: An analysis of a Zika
   live Twitter chat
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Social media; Health communication; Health messaging
ID EBOLA
AB The arrival of the Zika virus in the United States caused much concern among the public because of its ease of transmission and serious consequences for pregnant women and their newborns. We conducted a text analysis to examine original tweets from the public and responses from the Centers for Disease Control and Prevention (CDC) during a live Twitter chat hosted by the CDC. Both the public and the CDC expressed concern about the spread of Zika virus, but the public showed more concern about the consequences it had for women and babies, whereas the CDC focused more on symptoms and education. (C) 2016 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Glowacki, Elizabeth M.; Wilcox, Gary B.; Mackert, Michael; Bernhardt, Jay M.] Univ Texas Austin, Moody Coll Commun, Ctr Hlth Commun, Austin, TX 78712 USA.
   [Glowacki, Elizabeth M.; Bernhardt, Jay M.] Univ Texas Austin, Moody Coll Commun, Dept Commun Studies, Austin, TX 78712 USA.
   [Lazard, Allison J.] Univ N Carolina, Sch Journalism & Mass Commun, Chapel Hill, NC USA.
   [Wilcox, Gary B.; Mackert, Michael; Bernhardt, Jay M.] Univ Texas Austin, Moody Coll Commun, Stan Richards Sch Advertising & Publ Relat, Austin, TX 78712 USA.
   [Mackert, Michael] Univ Texas Houston, Sch Publ Hlth, Hlth Sci Ctr Houston, Houston, TX USA.
EM glowacki@utexas.edu
RI amsalu, ribka/G-8780-2019
OI Glowacki, Elizabeth M./0000-0001-7870-3206
CR Bowerman Mary, 2016, US TODAY
   Centers for Disease Control and Prevention, 2016, AR WITH ZIK
   Centers for Disease Control and Prevention, 2016, QUEST ANSW ZIK VIR I
   Chakraborty G., 2013, TEXT MINING ANAL PRA
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Lazard AJ, 2015, AM J INFECT CONTROL, V43, P1109, DOI 10.1016/j.ajic.2015.05.025
   Prieto VM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086191
   Simon TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105159
   World Health Organization, 2016, ZIK VIR
   Yates D, 2011, INT J INFORM MANAGE, V31, P6, DOI 10.1016/j.ijinfomgt.2010.10.001
NR 10
TC 32
Z9 32
U1 7
U2 20
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD DEC 1
PY 2016
VL 44
IS 12
BP 1709
EP 1711
DI 10.1016/j.ajic.2016.05.025
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA EI6SH
UT WOS:000392626300058
PM 27544795
DA 2020-07-08
ER

PT J
AU Moghadam, SRJ
   Bayrami, S
   Moghadam, SJ
   Golrokhi, R
   Pahlaviani, FG
   SeyedAlinaghi, S
AF Moghadam, Saeed Reza Jamali
   Bayrami, Samaneh
   Moghadam, Sepideh Jamali
   Golrokhi, Raheleh
   Pahlaviani, Fatemeh Golsoorat
   SeyedAlinaghi, SeyedAhmad
TI Zika virus: A review of literature
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; CHIKUNGUNYA; OUTBREAK;
   AMERICA; PATIENT; DENGUE; STATES
AB Zika virus (ZIKV) has two lineages: African and Asian. Mosquito-borne flaviviruses are thought to replicate initially in dendritic cells and then spread to lymph nodes and the blood stream. Risk for infection through blood transfusion, sexual practices and perinatal transmission exists. The possible routes of perinatal transmission are during delivery, breastfeeding and by close contact between the mother and her newborn. Also, mucocutaneous exposures to the virus by infected blood or monkey bite, organ transplantation or hemodialysis are the other routes of ZIKV transmission. There are two types of ZIKV infection; Zika fever and congenital infection. Clinical presentation of Zika fever varies from asymptomatic infections to a self-limiting febrile disease with low grade fever, conjunctivitis, maculopapular rash, headache, retro-orbital pain and arthritis/arthralgia with periarticular edema, myalgia, vertigo, vomiting and asthenia. This clinical feature could be mistaken for dengue or chikungunya fevers. Microcephaly is the most important and frequently reported clinical picture of suspected congenital Zika syndrome. Laboratory tests are needed for diagnosis of ZIKV infection, because there is no known pathognomonic clinical, biochemical or radiological features. RT-PCR is the most well-liked assay. Serum samples are tested by immunoglobulin G ELISA with ZIKV antigen. Samples are also tested by immunoglobulin M ELISA. There is no certified vaccine or therapeutic medication. In asymptomatic or uncomplicated patients, treatment is not necessary.
C1 [Moghadam, Saeed Reza Jamali] Univ Tehran Med Sci, Ziaeian Hosp, Tehran, Iran.
   [Bayrami, Samaneh; Moghadam, Sepideh Jamali; Golrokhi, Raheleh; Pahlaviani, Fatemeh Golsoorat; SeyedAlinaghi, SeyedAhmad] Univ Tehran Med Sci, Iranian Inst Reduct High Risk Behav, IRCHA, Tehran, Iran.
RP SeyedAlinaghi, S (corresponding author), Imam Khomeini Hosp, IRCHA, Keshavarz Blvd, Tehran, Iran.
EM s.a.alinaghi@gmail.com
RI Pahlaviani, Fatemeh Golsoorat/X-1111-2019; SeyedAlinaghi,
   SeyedAhmad/M-2938-2017
OI SeyedAlinaghi, SeyedAhmad/0000-0003-3210-7905; Golsoorat Pahlaviani,
   Fatemeh/0000-0002-5792-295X
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 40
TC 11
Z9 11
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD DEC
PY 2016
VL 6
IS 12
BP 989
EP 994
DI 10.1016/j.apjtb.2016.09.007
PG 6
WC Tropical Medicine
SC Tropical Medicine
GA EF1WT
UT WOS:000390116500001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ma, WQ
   Li, SH
   Ma, SQ
   Jia, LN
   Zhang, FC
   Zhang, Y
   Zhang, JY
   Wong, G
   Zhang, SS
   Lu, XC
   Liu, M
   Yan, JH
   Li, W
   Qin, C
   Han, DS
   Qin, CF
   Wang, N
   Li, XD
   Gao, GF
AF Ma, Wenqiang
   Li, Shihua
   Ma, Shuoqian
   Jia, Lina
   Zhang, Fuchun
   Zhang, Yong
   Zhang, Jingyuan
   Wong, Gary
   Zhang, Shanshan
   Lu, Xuancheng
   Liu, Mei
   Yan, Jinghua
   Li, Wei
   Qin, Chuan
   Han, Daishu
   Qin, Chengfeng
   Wang, Na
   Li, Xiangdong
   Gao, George Fu
TI Zika Virus Causes Testis Damage and Leads to Male Infertility in Mice
SO CELL
LA English
DT Article
ID TESTICULAR PERITUBULAR CELLS; EPIDIDYMAL EPITHELIAL-CELLS; INNATE
   IMMUNE-RESPONSES; STEM LEYDIG-CELLS; SEXUAL TRANSMISSION; SERTOLI; PLZF;
   TRANSPLANTATION; OUTBREAK; PATTERN
AB Zika virus (ZIKV) persists in the semen of male patients, a first for flavivirus infection. Here, we demonstrate that ZIKV can induce inflammation in the testis and epididymidis, but not in the prostate or seminal vesicle, and can lead to damaged testes after 60 days post-infection in mice. ZIKV induces innate immune responses in Leydig, Sertoli, and epididymal epithelial cells, resulting in the production of pro-inflammatory cytokines/chemokines. However, ZIKV does not induce a rapid and abundant cytokine production in peritubular cell and spermatogonia, suggesting that these cells are vulnerable for ZIKV infection and could be the potential repositories for ZIKV. Our study demonstrates a correlation between ZIKV and testis infection/damage and suggests that ZIKV infection, under certain circumstances, can eventually lead to male infertility.
C1 [Ma, Wenqiang; Ma, Shuoqian; Jia, Lina; Zhang, Yong; Zhang, Jingyuan; Zhang, Shanshan; Wang, Na; Li, Xiangdong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.
   [Li, Shihua; Wong, Gary; Yan, Jinghua; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
   [Gao, George Fu] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.
   [Liu, Mei] Chinese Peoples Liberat Army Gen Hosp, Dept Pathol, Beijing 102628, Peoples R China.
   [Li, Wei] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China.
   [Qin, Chuan] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China.
   [Qin, Chuan] Peking Union Med Coll, Comparat Med Ctr, Key Lab Human Dis Comparat Med, Natl Hlth & Family Planning Commiss, Beijing 100021, Peoples R China.
   [Han, Daishu] Chinese Acad Med Sci, Inst Basic Med Sci, Sch Basic Med, Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing 100071, Peoples R China.
   [Qin, Chengfeng] State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Gao, George Fu] Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.
   [Gao, George Fu] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
   [Lu, Xuancheng] Chinese Ctr Dis Control & Prevent China CDC, Lab Anim Ctr, Beijing 102206, Peoples R China.
RP Li, XD (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China.; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing 100049, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
EM xiangdongli@cau.edu.cn; gaof@im.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
FU CAU Scientific Fund [2015SKLAB6-13]; Ministry of Science and Technology
   (MOST)Ministry of Science and Technology, China [2013ZX10004608,
   CAIJIAO(2016)273]; National Natural Science Foundation of China
   (NSFC)National Natural Science Foundation of China [31071316, 81290342];
   Zika Special Project of the MOST Reform and Development Project;
   National Key Plan for Scientific Research and Development of China
   [2016YFD0500300]; Task-Force of Zika Virus Research from the Chinese
   Academy of Sciences (CAS) [KJZD-EW-L15]; Banting Postdoctoral Fellowship
   from the Canadian Institutes of Health Research (CIHR)Canadian
   Institutes of Health Research (CIHR); President's International
   Fellowship Initiative from CAS; NSFC Innovative Research Group
   [81321063]
FX This work was supported by grants from the CAU Scientific Fund (No.
   2015SKLAB6-13), Ministry of Science and Technology (MOST,
   2013ZX10004608), the National Natural Science Foundation of China (NSFC,
   Grant No. 31071316 and 81290342), the Zika Special Project of the MOST
   Reform and Development Project, the National Key Plan for Scientific
   Research and Development of China (No. 2016YFD0500300), and the
   Task-Force of Zika Virus Research from the Chinese Academy of Sciences
   (CAS, No. KJZD-EW-L15) and MOST (No. CAIJIAO(2016)273). G.W. is the
   recipient of a Banting Postdoctoral Fellowship from the Canadian
   Institutes of Health Research (CIHR) and the President's International
   Fellowship Initiative from CAS. G.F.G. is a leading principal
   investigator of the NSFC Innovative Research Group (Grant No. 81321063).
CR Albrecht M, 2006, J CLIN ENDOCR METAB, V91, P1956, DOI 10.1210/jc.2005-2169
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11303, DOI 10.1073/pnas.91.24.11303
   Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366
   Buff S, 2005, THERIOGENOLOGY, V64, P1603, DOI 10.1016/j.theriogenology.2005.04.020
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764
   Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Flenkenthaler F, 2014, J PROTEOME RES, V13, P1259, DOI 10.1021/pr400769z
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kanatsu-Shinohara M, 2002, P NATL ACAD SCI USA, V99, P1383, DOI 10.1073/pnas.022646399
   Kim GJ, 2010, INT J DEV BIOL, V54, P867, DOI 10.1387/ijdb.092874gk
   KLINEFELTER GR, 1987, BIOL REPROD, V36, P769, DOI 10.1095/biolreprod36.3.769
   Landreh L, 2014, J CLIN ENDOCR METAB, V99, pE1227, DOI 10.1210/jc.2013-4199
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   MORI H, 1978, ANDROLOGIA, V10, P434
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ogawa T, 2000, NAT MED, V6, P29, DOI 10.1038/71496
   Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REID A, 1995, BLOOD, V86, P4544, DOI 10.1182/blood.V86.12.4544.bloodjournal86124544
   Shang T, 2011, ENDOCRINOLOGY, V152, P2827, DOI 10.1210/en.2011-0031
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170
   Stefanovic KB, 2009, AM FAM PHYSICIAN, V80, P1421
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TUNG PS, 1990, BIOL REPROD, V42, P351, DOI 10.1095/biolreprod42.2.351
   VERHOEVEN G, 1988, ENDOCRINOLOGY, V123, P2100, DOI 10.1210/endo-123-4-2100
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Yu WP, 2014, J CLIN INVEST, V124, P2709, DOI 10.1172/JCI59901
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhu WW, 2015, J IMMUNOL, V194, P4825, DOI 10.4049/jimmunol.1402706
NR 47
TC 167
Z9 176
U1 11
U2 104
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD DEC 1
PY 2016
VL 167
IS 6
BP 1511
EP +
DI 10.1016/j.cell.2016.11.016
PG 24
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EE3EN
UT WOS:000389470500014
PM 27884405
OA Bronze
DA 2020-07-08
ER

PT J
AU Wells, MF
   Salick, MR
   Wiskow, O
   Ho, DJ
   Worringer, KA
   Ihry, RJ
   Kommineni, S
   Bilican, B
   Klim, JR
   Hill, EJ
   Kane, LT
   Ye, CY
   Kaykas, A
   Eggan, K
AF Wells, Michael F.
   Salick, Max R.
   Wiskow, Ole
   Ho, Daniel J.
   Worringer, Kathleen A.
   Ihry, Robert J.
   Kommineni, Sravya
   Bilican, Bilada
   Klim, Joseph R.
   Hill, Ellen J.
   Kane, Liam T.
   Ye, Chaoyang
   Kaykas, Ajamete
   Eggan, Kevin
TI Genetic Ablation of AXL Does Not Protect Human Neural Progenitor Cells
   and Cerebral Organoids from Zika Virus Infection
SO CELL STEM CELL
LA English
DT Article
AB Zika virus (ZIKV) can cross the placental barrier, resulting in infection of the fetal brain and neurological defects including microcephaly. The cellular tropism of ZIKV and the identity of attachment factors used by the virus to gain access to key cell types involved in pathogenesis are under intense investigation. Initial studies suggested that ZIKV preferentially targets neural progenitor cells (NPCs), providing an explanation for the developmental phenotypes observed in some pregnancies. The AXL protein has been nominated as a key attachment factor for ZIKV in several cell types including NPCs. However, here we show that genetic ablation of AXL has no effect on ZIKV entry or ZIKV-mediated cell death in human induced pluripotent stem cell (iPSC)-derived NPCs or cerebral organoids. These findings call into question the utility of AXL inhibitors for preventing birth defects after infection and suggest that further studies of viral attachment factors in NPCs are needed.
C1 [Wells, Michael F.; Eggan, Kevin] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.
   [Wells, Michael F.; Wiskow, Ole; Klim, Joseph R.; Hill, Ellen J.; Kane, Liam T.; Eggan, Kevin] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.
   [Wells, Michael F.; Wiskow, Ole; Klim, Joseph R.; Hill, Ellen J.; Kane, Liam T.; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.
   [Salick, Max R.; Ho, Daniel J.; Worringer, Kathleen A.; Ihry, Robert J.; Kommineni, Sravya; Bilican, Bilada; Ye, Chaoyang; Kaykas, Ajamete] Novartis Inst BioMed Res, Dept Neurosci, Cambridge, MA 02139 USA.
RP Eggan, K (corresponding author), Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.; Eggan, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.; Eggan, K (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Kaykas, A (corresponding author), Novartis Inst BioMed Res, Dept Neurosci, Cambridge, MA 02139 USA.
EM ajamete.kaykas@novartis.com; eggan@mcb.harvard.edu
RI Eggan, Kevin/P-7119-2018
OI Worringer, Kathleen/0000-0001-7807-2344
FU Stanley Center for Psychiatric Research; Harvard Stem Cell Institute
FX We thank Maura E. Charlton and Sid Paula for their assistance in safely
   acquiring the ZIKV at the initiation of this project as well as Kiki
   Lilliehook for reviewing the manuscript. We thank Priscilla L. Yang and
   Dominique J. Burri of Harvard Medical School for their help with
   propagating and quantifying ZIKV. We would also like to thank Nathaniel
   D. Kirkpatrick for imaging assistance and Ricardo E. Dolmetsch and Don
   E. Ganem for their guidance. K.E. was supported by the Stanley Center
   for Psychiatric Research and the Harvard Stem Cell Institute.
CR Brasil P., 2016, N ENGL J ME IN PRESS
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Yao Z., CELL STEM C IN PRESS, V20
NR 24
TC 114
Z9 116
U1 2
U2 35
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD DEC 1
PY 2016
VL 19
IS 6
BP 703
EP 708
DI 10.1016/j.stem.2016.11.011
PG 6
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EE3GD
UT WOS:000389474900009
PM 27912091
OA Bronze
DA 2020-07-08
ER

PT J
AU Paul, LM
   Carlin, ER
   Jenkins, MM
   Tan, AL
   Barcellona, CM
   Nicholson, CO
   Michael, SF
   Isern, S
AF Paul, Lauren M.
   Carlin, Eric R.
   Jenkins, Meagan M.
   Tan, Amanda L.
   Barcellona, Carolyn M.
   Nicholson, Cindo O.
   Michael, Scott F.
   Isern, Sharon
TI Dengue virus antibodies enhance Zika virus infection
SO CLINICAL & TRANSLATIONAL IMMUNOLOGY
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; DEPENDENT ENHANCEMENT; FRENCH-POLYNESIA;
   TRANSMISSION; SERA; RESPONSES; OUTBREAK; EPITOPES; FEVER
AB For decades, human infections with Zika virus (ZIKV), a mosquito-transmitted flavivirus, were sporadic, associated with mild disease, and went underreported since symptoms were similar to other acute febrile diseases. Recent reports of severe disease associated with ZIKV have greatly heightened awareness. It is anticipated that ZIKV will continue to spread in the Americas and globally where competent Aedes mosquito vectors are found. Dengue virus (DENV), the most common mosquito-transmitted human flavivirus, is both well-established and the source of outbreaks in areas of recent ZIKV introduction. DENV and ZIKV are closely related, resulting in substantial antigenic overlap. Through antibody-dependent enhancement (ADE), anti-DENV antibodies can enhance the infectivity of DENV for certain classes of immune cells, causing increased viral production that correlates with severe disease outcomes. Similarly, ZIKV has been shown to undergo ADE in response to antibodies generated by other flaviviruses. We tested the neutralizing and enhancing potential of well-characterized broadly neutralizing human anti-DENV monoclonal antibodies (HMAbs) and human DENV immune sera against ZIKV using neutralization and ADE assays. We show that anti-DENV HMAbs, cross-react, do not neutralize, and greatly enhance ZIKV infection in vitro. DENV immune sera had varying degrees of neutralization against ZIKV and similarly enhanced ZIKV infection. Our results suggest that pre-existing DENV immunity may enhance ZIKV infection in vivo and may lead to increased disease severity. Understanding the interplay between ZIKV and DENV will be critical in informing public health responses and will be particularly valuable for ZIKV and DENV vaccine design and implementation strategies.
C1 [Paul, Lauren M.; Carlin, Eric R.; Jenkins, Meagan M.; Tan, Amanda L.; Barcellona, Carolyn M.; Nicholson, Cindo O.; Michael, Scott F.; Isern, Sharon] Florida Gulf Coast Univ, Coll Arts & Sci, Dept Biol Sci, 10501 FGCU Blvd South,Seidler Hall 304, Ft Myers, FL 33965 USA.
   [Carlin, Eric R.; Jenkins, Meagan M.] Univ Alabama Birmingham, Dept Grad & Biomed Sci, Birmingham, AL 35294 USA.
   [Nicholson, Cindo O.] Duke Univ, Sch Med, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
RP Isern, S (corresponding author), Florida Gulf Coast Univ, Coll Arts & Sci, Dept Biol Sci, 10501 FGCU Blvd South,Seidler Hall 304, Ft Myers, FL 33965 USA.
EM sisern@fgcu.edu
OI Jenkins, Meagan/0000-0003-1379-9176; Paul, Lauren/0000-0001-5503-7570
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [1R01AI099210-01-R1]
FX We thank Lydie Trautmann formerly at the Vaccine and Gene Therapy
   Institute of Florida for providing DENV negative control serum from
   Canada, John S. Schieffelin at Tulane Univeristy for providing HMAbs
   1.6D and D11C, Robert B. Tesh at the University of Texas at Galveston
   for providing virus strains through the World Reference Center for
   Emerging Viruses and Arboviruses, and the US Centers for Disease Control
   and Prevention for Zika strain PRVABC59. This work was supported in part
   by the National Institute of Allergy and Infectious Diseases grant no.
   1R01AI099210-01-R1.
CR Argolo AFLT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-254
   Barba-Spaeth G, 2016, NATURE, V539, DOI 10.1038/nature19780
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   FAGBAMI A H, 1986, African Journal of Medicine and Medical Sciences, V15, P103
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Muyanja E, 2014, J CLIN INVEST, V124, P3147, DOI 10.1172/JCI75429
   Nicholson CO, 2011, ANTIVIR RES, V89, P71, DOI 10.1016/j.antiviral.2010.11.008
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Paul L., 2016, BIORXIV
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schieffelin JS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-28
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 50
TC 89
Z9 92
U1 2
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2050-0068
J9 CLIN TRANSL IMMUNOL
JI Clin. Transl. Immunol.
PD DEC
PY 2016
VL 5
AR e117
DI 10.1038/cti.2016.72
PG 9
WC Immunology
SC Immunology
GA EG4HU
UT WOS:000391005300004
PM 28090318
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Musso, D
   Lanteri, MC
AF Musso, Didier
   Lanteri, Marion C.
TI Thoughts Around the Zika Virus Crisis
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Zika virus; outbreak; emergence; crisis
AB As a lot of reviews are available on Zika virus (ZIKV), in this short commentary, we will focus on the recent advances and gaps in knowledge regarding our understanding of ZIKV infections and on the reaction to the "ZIKV crisis."
C1 [Musso, Didier] Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, France.
   [Lanteri, Marion C.] Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
RP Musso, D (corresponding author), Inst Louis Malarde, POB 30, Papeete 98713, Tahiti, France.; Lanteri, MC (corresponding author), Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
EM dmusso@ilm.pf; mlanteri@bloodsystems.org
RI Musso, Didier/AAO-8178-2020; Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
NR 0
TC 3
Z9 3
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD DEC
PY 2016
VL 18
IS 12
AR 46
DI 10.1007/s11908-016-0551-8
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA ED3DM
UT WOS:000388729500008
PM 27832453
OA Green Published
DA 2020-07-08
ER

PT J
AU Eboigbodin, KE
   Brummer, M
   Ojalehto, T
   Hoser, M
AF Eboigbodin, Kevin E.
   Brummer, Mirko
   Ojalehto, Tuomas
   Hoser, Mark
TI Rapid molecular diagnostic test for Zika virus with low demands on
   sample preparation and instrumentation
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE Zika; Virus; Diagnostics; RNA; Isothermal; Amplification; Portable;
   Outbreak
ID PCR; ASSAY
AB Zika virus has only recently gained attention due to recent large outbreaks worldwide. An easy to use nucleic acid amplification test could play an important role in the early detection of the infection and patient management. Here, we report a rapid and robust isothermal nucleic acid amplification assay for the detection of Zika virus. The method is cost-effective and compatible with portable instrumentation, enabling near patient testing and field use. (C) 2016 The Authors. Published by Elsevier Inc.
C1 [Eboigbodin, Kevin E.; Brummer, Mirko; Ojalehto, Tuomas] Orion Diagnost Oy, Res & Dev, POB 83, FI-02101 Espoo, Finland.
   [Hoser, Mark] GeneForm Technol, Mol Biol, Broadstairs, Kent, England.
RP Eboigbodin, KE (corresponding author), Orion Diagnost Oy, Res & Dev, POB 83, FI-02101 Espoo, Finland.
EM kevin.eboigbodin@oriondiagnostica.fi
RI Eboigbodin, Kevin Efosa/I-9152-2018
OI Eboigbodin, Kevin Efosa/0000-0002-8262-8226
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   Driggers RW, NEW ENGLAND J MED
   Eboigbodin K, 2016, APPL MICROBIOL BIOT, V100, P5559, DOI 10.1007/s00253-016-7491-y
   Eboigbodin KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep20487
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Hoser MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112656
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Zanluca C, 2016, MICROBES INFECT
NR 11
TC 18
Z9 20
U1 0
U2 25
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD DEC
PY 2016
VL 86
IS 4
BP 369
EP 371
DI 10.1016/j.diagmicrobio.2016.08.027
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA EC3VP
UT WOS:000388055500009
PM 27645608
OA Other Gold
DA 2020-07-08
ER

PT J
AU Kumar, A
   Hou, SM
   Airo, AM
   Limonta, D
   Mancinelli, V
   Branton, W
   Power, C
   Hobman, TC
AF Kumar, Anil
   Hou, Shangmei
   Airo, Adriana M.
   Limonta, Daniel
   Mancinelli, Valeria
   Branton, William
   Power, Christopher
   Hobman, Tom C.
TI Zika virus inhibits type-I interferon production and downstream
   signaling
SO EMBO REPORTS
LA English
DT Article
DE flavivirus; interferon response; NS5; STAT2; Zika virus
ID SEXUAL TRANSMISSION; GAMMA-INTERFERON; ALPHA-INTERFERON; MOUSE MODEL;
   DENGUE; STAT2; INFECTION; BINDING; RNA
AB Zika virus is an emerging mosquito-borne pathogen that is associated with Guillain-Barre syndrome in adults and microcephaly and other neurological defects in newborns. Despite being declared an international emergency by the World Health Organization, comparatively little is known about its biology. Here, we investigate the strategies employed by the virus to suppress the host antiviral response. We observe that once established, Zika virus infection is impervious to interferon treatment suggesting that the virus deploys effective countermeasures to host cell defences. This is confirmed by experiments showing that Zika virus infection impairs the induction of type-I interferon as well as downstream interferon-stimulated genes. Multiple viral proteins affect these processes. Virus-mediated degradation of STAT2 acts to reduce type-I and type-III interferon-mediated signaling. Further, the NS5 of Zika virus binds to STAT2, and its expression is correlated with STAT2 degradation by the proteasome. Together, our findings provide key insights into how Zika virus blocks cellular defense systems. This in turn is important for understanding pathogenesis and may aid in designing antiviral therapies.
C1 [Kumar, Anil; Hou, Shangmei; Limonta, Daniel; Mancinelli, Valeria; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.
   [Airo, Adriana M.; Hobman, Tom C.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.
   [Branton, William; Power, Christopher] Univ Alberta, Dept Med, Edmonton, AB, Canada.
   [Hobman, Tom C.] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.
   [Hobman, Tom C.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
RP Hobman, TC (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
EM tom.hobman@ualberta.ca
RI ; Limonta, Daniel/A-8644-2012
OI Branton, William/0000-0002-3259-2544; Kumar, Anil/0000-0002-6179-4516;
   Hobman, Tom/0000-0002-5744-3545; Limonta, Daniel/0000-0002-5128-6542
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); Li Ka Shing Institute of Virology; Women &
   Children's Health Research Institute; Alberta Innovates-Health
   Solutions; CIHRCanadian Institutes of Health Research (CIHR); Alberta
   Innovates [201400474, 201400447]
FX The authors thank Eileen Reklow and Cheyneille Oliver for technical
   support. This work was funded by the grants from the Canadian Institutes
   of Health Research (CIHR), the Li Ka Shing Institute of Virology and the
   Women & Children's Health Research Institute to T.C.H. A.K. and D.L. are
   funded by postdoctoral fellowships from the Alberta Innovates-Health
   Solutions. A.A. is the recipient of a Doctoral scholarship from CIHR.
   T.C.H. and C.P. hold Canada Research Chair awards.
CR Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Prestwood TR, 2012, J VIROL, V86, P12561, DOI 10.1128/JVI.06743-11
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004
   Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Vivithanaporn P, 2016, AIDS, V30, P543, DOI 10.1097/QAD.0000000000000955
   Xu XD, 2014, INTERVIROLOGY, V57, DOI 10.1159/000357327
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 131
Z9 133
U1 2
U2 39
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD DEC
PY 2016
VL 17
IS 12
BP 1766
EP 1775
DI 10.15252/embr.201642627
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EE1GQ
UT WOS:000389329400014
PM 27797853
OA Green Published
DA 2020-07-08
ER

PT J
AU Nicastri, E
   Castilletti, C
   Balestra, P
   Galgani, S
   Ippolito, G
AF Nicastri, Emanuele
   Castilletti, Concetta
   Balestra, Pietro
   Galgani, Simonetta
   Ippolito, Giuseppe
TI Zika Virus Infection in the Central Nervous System and Female Genital
   Tract
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Nicastri, Emanuele; Castilletti, Concetta; Balestra, Pietro; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
   [Galgani, Simonetta] Azienda Osped San Camillo Forlanini, Rome, Italy.
RP Castilletti, C (corresponding author), Natl Inst Infect Dis INMI IRCCS, Via Portuense 292, I-00149 Rome, Italy.
EM concetta.castilletti@inmi.it
RI Ippolito, Giuseppe/J-7207-2017; Castilletti, Concetta/AAA-8408-2019;
   Castilletti, Concetta/B-6545-2016; nicastri, emanuele/K-7780-2016
OI Castilletti, Concetta/0000-0001-9819-236X; Castilletti,
   Concetta/0000-0001-9819-236X; nicastri, emanuele/0000-0002-5606-8712;
   Ippolito, Giuseppe/0000-0002-1076-2979
CR Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Li H, 2016, CELL STEM CELL
   Prisant N., 2016, LANCET INFECT DIS
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 7
TC 39
Z9 41
U1 0
U2 5
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD DEC
PY 2016
VL 22
IS 12
BP 2228
EP 2230
DI 10.3201/eid2212.161280
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA ED5SP
UT WOS:000388912900047
PM 27617352
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Benelli, G
AF Benelli, Giovanni
TI Green synthesized nanoparticles in the fight against mosquito-borne
   diseases and cancer-a brief review
SO ENZYME AND MICROBIAL TECHNOLOGY
LA English
DT Review
DE Aedes; Anopheles; Artemisinin; Chloroquine; Culex; Dengue; Malaria;
   Mosquito vector control; Plasmodium; Tumor Zika virus
ID VECTOR ANOPHELES-STEPHENSI; NONTARGET AQUATIC ORGANISMS;
   NECROSIS-FACTOR-ALPHA; AEGYPTI DIPTERA-CULICIDAE; SILVER NANOPARTICLES;
   PLASMODIUM-FALCIPARUM; DENGUE VIRUS; ZIKA VIRUS; IN-VITRO;
   ANTIPLASMODIAL ACTIVITY
AB Nanobiomedicine and parasitology are facing a number of key challenges, which mostly deal with the paucity of effective preventive and curative tools against mosquito-borne diseases and cancer. In this scenario, the employ of botanical and invertebrate extracts as reducing, stabilizing and capping agents for the synthesis of nanoparticles is advantageous over chemical and physical methods, since it is one pot, cheap, and does not require high pressure, energy, temperature, or the use of highly toxic chemicals. Considering the overlooked connection between mosquito vector activity and the spread of cancer in USA, this review focused on the current knowledge available about green synthesized nanoparticles with efficacy against mosquito-borne diseases and cancer. Green fabricated metal nanoparticles showed antiplasmodial activity that often encompasses the efficacy of currently marked drugs for malaria treatment. They have been also reported as growth inhibitors against dengue virus (serotype DEN-2), with moderate cytotoxicity on mammalian cells. However, this feature is strongly dependent to the botanical agents employed during nanosynthesis. In addition, green nanoparticles have been successfully used to reduce mosquito young instar populations in the field. The final section focuses on some issues for future research, with special reference to the chemical standardization of the botanical extracts used for nanosynthesis"and the potential effects on green fabricated nanoparticles on non-target organisms. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pontedera, Italy.
EM benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX The author is grateful to E. Marsili for helpful discussions on the
   topic. Two anonymous reviewers improved an earlier version of the
   manuscript. G. Benelli is sponsored by PROAPI (PRAF 2015) and University
   of Pisa, Department of Agriculture, Food and Environment (Grant ID:
   COFIN2015_22). Funders had no role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Adams Y, 2005, PARASITOL RES, V97, P290, DOI 10.1007/s00436-005-1426-3
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P491, DOI 10.1007/s00436-006-0185-0
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Asada H, 2007, J DERMATOL SCI, V45, P153, DOI 10.1016/j.jdermsci.2006.11.002
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   BANFIELD WG, 1965, SCIENCE, V148, P1239, DOI 10.1126/science.148.3674.1239
   BANFIELD WG, 1966, CANCER-AM CANCER SOC, V19, P1333, DOI 10.1002/1097-0142(196610)19:10<1333::AID-CNCR2820191002>3.0.CO;2-I
   Barik TK, 2008, PARASITOL RES, V103, P253, DOI 10.1007/s00436-008-0975-7
   Barik TK, 2012, PARASITOL RES, V111, P1075, DOI 10.1007/s00436-012-2934-6
   Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011
   Becker Norbert, 2012, P31
   Benelli G., 2016, Asian Pacific Journal of Tropical Disease, V6, P253, DOI 10.1016/S2222-1808(15)61025-8
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Callaway E, 2015, NATURE, V526, P174, DOI 10.1038/nature.2015.18507
   Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327
   Carlton JM, 2008, TRENDS PARASITOL, V24, P545, DOI 10.1016/j.pt.2008.09.003
   CBTRUS, 2008, STAT REP PRIM BRAIN, P1
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chaturvedi D, 2010, CHEM SOC REV, V39, P435, DOI 10.1039/b816679j
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Cohen J, 2011, PARASITOL RES MG, V2, P121, DOI 10.1007/978-3-642-21396-0_7
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412
   Efferth T, 2001, INT J ONCOL, V18, P767
   Espina LM, 2003, AM J TROP MED HYG, V68, P48, DOI 10.4269/ajtmh.2003.68.48
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   GOODSELL DS, 2004, BIONANOTECHNOLOGY LE
   Gopinath P, 2010, COLLOID SURFACE B, V77, P240, DOI 10.1016/j.colsurfb.2010.01.033
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, PARASITOL RES MG, V8, P99, DOI 10.1007/978-3-319-25292-6_7
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Heng MY, 2013, TRAC-TREND ANAL CHEM, V50, P1, DOI 10.1016/j.trac.2013.03.012
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   Kawa K, 2001, BLOOD, V98, P3173, DOI 10.1182/blood.V98.10.3173
   KILHAM L, 1955, AM J HYG, V61, P55, DOI 10.1093/oxfordjournals.aje.a119739
   KIRBY GC, 1989, BIOCHEM PHARMACOL, V38, P4367, DOI 10.1016/0006-2952(89)90644-8
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Kumar S, 2015, NANOMEDICINE-UK, V10, P2451, DOI [10.2217/NNM.15.112, 10.2217/nnm.15.112]
   Lehrer S, 2010, ANTICANCER RES, V30, P1371
   Lehrer S, 2010, MED HYPOTHESES, V74, P167, DOI 10.1016/j.mehy.2009.07.005
   Li XF, 2016, SCI CHINA LIFE SCI, V59, P440, DOI 10.1007/s11427-016-5020-y
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Majumder DD, 2006, IETE J RES, V52, P339
   MARIMUTHU S., 2011, PARASITOL RES, V10, P2212
   Mehlhorn H., 2016, PARASITOL RES MONOGR, V8
   Mehlhorn H., 2015, ENCY PARASITOLOGY, P893
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Mishra A, 2013, COLLOID SURFACE B, V111, P713, DOI 10.1016/j.colsurfb.2013.06.036
   Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008
   Murugan K, 2016, ENVIRON SCI POLLUT R, V23, P16671, DOI 10.1007/s11356-016-6832-9
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P1085, DOI 10.1007/s00436-015-4838-8
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Murugan K, 2015, PARASITOL RES, V114, P4087, DOI 10.1007/s00436-015-4638-1
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nethengwe M. F., 2012, Journal of Medicinal Plants Research, V6, P1255
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Pastula DM, 2016, J NEUROVIROL
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Rajakumar G, 2015, PARASITOL RES, V114, P1397, DOI 10.1007/s00436-015-4318-1
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rajasekharreddy P, 2014, MAT SCI ENG C-MATER, V39, P203, DOI 10.1016/j.msec.2014.03.003
   Raman N, 2012, SPECTROCHIM ACTA A, V96, P1031, DOI 10.1016/j.saa.2012.08.011
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Sanpui P, 2011, ACS APPL MATER INTER, V3, P218, DOI 10.1021/am100840c
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Shanthi K, 2015, RSC ADV, V5, P44998, DOI 10.1039/c5ra05803a
   Skarbinski Jacek, 2006, Morbidity and Mortality Weekly Report, V55, P23
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Suffness M, 1990, METHODS PLANT BIOCH, P71
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Sun RB, 2012, BIOMED ENVIRON SCI, V25, P495, DOI 10.3967/0895-3988.2012.05.001
   Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tokura Y, 2001, J AM ACAD DERMATOL, V45, P569, DOI 10.1067/mjd.2001.114751
   Tsuge I, 1999, CLIN EXP IMMUNOL, V115, P385
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   Usherwood EJ, 1996, J VIROL, V70, P6516, DOI 10.1128/JVI.70.9.6516-6518.1996
   WELSH JD, 1976, GASTROENTEROLOGY, V70, P392
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   WHO, 2015, WHO UPD ART RES
   World Health Organization, 2012, HDB INT VECT MAN
   Yen YT, 2008, J VIROL, V82, P12312, DOI 10.1128/JVI.00968-08
NR 108
TC 148
Z9 148
U1 9
U2 143
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0141-0229
EI 1879-0909
J9 ENZYME MICROB TECH
JI Enzyme Microb. Technol.
PD DEC
PY 2016
VL 95
SI SI
BP 58
EP 68
DI 10.1016/j.enzmictec.2016.08.022
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA ED9AD
UT WOS:000389161400006
PM 27866627
DA 2020-07-08
ER

PT J
AU Towers, S
   Brauer, F
   Castillo-Chavez, C
   Falconar, AKI
   Mubayi, A
   Romero-Vivas, CME
AF Towers, Sherry
   Brauer, Fred
   Castillo-Chavez, Carlos
   Falconar, Andrew K. I.
   Mubayi, Anuj
   Romero-Vivas, Claudia M. E.
TI Estimate of the reproduction number of the 2015 Zika virus outbreak in
   Barranquilla, Colombia, and estimation of the relative role of sexual
   transmission
SO EPIDEMICS
LA English
DT Article
DE Zika virus; Basic reproduction number; Mathematical model; Sexually
   transmitted infections; Arboviruses
ID DENGUE-FEVER; EPIDEMIC; DYNAMICS; DISEASE
AB BACKGROUND: In 2015, the Zika arbovirus (ZIKV) began circulating in the Americas, rapidly expanding its global geographic range in explosive outbreaks. Unusual among mosquito-borne diseases, ZIKV has been shown to also be sexually transmitted, although sustained autochthonous transmission due to sexual transmission alone has not been observed, indicating the reproduction number (R0) for sexual transmission alone is less than 1. Critical to the assessment of outbreak risk, estimation of the potential attack rates, and assessment of control measures, are estimates of the basic reproduction number, R0.
   METHODS: We estimated the R0 of the 2015 ZIKV outbreak in Barranquilla, Colombia, through an analysis of the exponential rise in clinically identified ZIKV cases (n=359 to the end of November, 2015).
   FINDINGS: The rate of exponential rise in cases was rho=0.076days(-1), with 95% CI [0.066,0.087] days(-1). We used a vector-borne disease model with additional direct transmission to estimate the R0; assuming the R0 of sexual transmission alone is less than 1, we estimated the total R0=3.8 [2.4,5.6], and that the fraction of cases due to sexual transmission was 0.23 [0.01,0.47] with 95% confidence.
   INTERPRETATION: This is among the first estimates of R0 for a ZIKV outbreak in the Americas, and also among the first quantifications of the relative impact of sexual transmission. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Towers, Sherry; Castillo-Chavez, Carlos; Mubayi, Anuj] Arizona State Univ, Tempe, AZ USA.
   [Brauer, Fred] Univ British Columbia, Vancouver, BC, Canada.
   [Falconar, Andrew K. I.; Romero-Vivas, Claudia M. E.] Univ Norte, Barranquilla, Atlantico, Colombia.
RP Towers, S (corresponding author), Arizona State Univ, Simon A Levin Math Computat & Modeling Sci Ctr, POB 873901, Tempe, AZ 85287 USA.
EM smtowers@asu.edu
RI Castillo-Chavez, Carlos/E-1412-2014
OI Castillo-Chavez, Carlos/0000-0002-1046-3901
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada [OGPIN 203901-99];
   Proyecto de Regalias [Convenio0103-2015-000039, 955869]; National
   Science FoundationNational Science Foundation (NSF) [DMS-1263374,
   DUE-1101782]; National Security AgencyNational Security Agency
   [H98230-14-1-0157]; Office of the President of ASU; Office of the
   Provost of ASU
FX The authors are grateful for the following sources of funding that
   supported these studies:r FB: Natural Sciences and Engineering Research
   Council of Canada, Grant OGPIN 203901-99;r AKIF, CMERV: Proyecto de
   Regalias, Convenio0103-2015-000039, Actividad MGA [955869];r CCC, ST,
   AM: National Science Foundation (DMS-1263374, DUE-1101782), National
   Security Agency (H98230-14-1-0157), the Office of the President of ASU,
   and the Office of the Provost of ASU.
CR Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brauer F., 2012, CAN APPL MATH Q, V20, P1
   Brauer F., 2016, SOME MODELS EPIDEMIC
   Cardona- Ospina J. A., 2015, T R SOC
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Chowell G, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-298
   Davidson A., 2016, MORBIDITY MORTALITY
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4107
   Falconar AKI, 2006, CLIN VACCINE IMMUNOL, V13, P1044, DOI 10.1128/CVI.00105-06
   Falconar Andrew K I, 2012, J Clin Med Res, V4, P33, DOI 10.4021/jocmr694w
   Fauci A. S., 2016, NEW ENGL J MED
   Fenichel EP, 2011, P NATL ACAD SCI USA, V108, P6306, DOI 10.1073/pnas.1011250108
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   GARDNER RH, 1983, UNCERTAINTY FORECAST, P245
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Lau JTF, 2005, PREV MED, V41, P454, DOI 10.1016/j.ypmed.2004.11.023
   Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180
   Majumder M. S., 2016, B WORLD HEALTH ORGAN, V1- 6
   Ministerio de la Proteccion Social, 2006, REGL SIST VIG SAL PU
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Plucinski MM, 2015, LANCET INFECT DIS, V15, P1017, DOI 10.1016/S1473-3099(15)00061-4
   Romero- Vivas C., 2006, ANN TROP MED PARA S1, V100
   Romero-Vivas CME, 2013, AM J TROP MED HYG, V88, P178, DOI 10.4269/ajtmh.2012.12-0232
   Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010
   Tognarelli J., 2015, ARCH VIROL, P1
   Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754
   World Health Organization, 2016, ZIK VIR FACTSH
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 34
TC 54
Z9 54
U1 5
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD DEC
PY 2016
VL 17
BP 50
EP 55
DI 10.1016/j.epidem.2016.10.003
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA EJ1CQ
UT WOS:000392948300007
PM 27846442
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Caprara, A
   Ridde, V
AF Caprara, Andrea
   Ridde, Valery
TI Zika: exposing anew the need for health promotion in Latin America
SO GLOBAL HEALTH PROMOTION
LA English
DT Editorial Material
C1 [Caprara, Andrea] Univ State Ceara, Fortaleza, Ceara, Brazil.
   [Ridde, Valery] Univ Montreal, Montreal, PQ H3C 3J7, Canada.
RP Ridde, V (corresponding author), Univ Montreal, Montreal, PQ H3C 3J7, Canada.
EM valery.ridde@umontreal.ca
RI Caprara, Andrea/I-4011-2013; Caprara, Andrea/F-8399-2012; Ridde,
   Valery/AAD-2736-2019; Caprara, Andrea/O-9522-2019
OI Caprara, Andrea/0000-0003-1972-8205; Caprara,
   Andrea/0000-0003-1972-8205; Ridde, Valery/0000-0001-9299-8266; Caprara,
   Andrea/0000-0003-1972-8205
CR Bouyer J, 2016, LANCET GLOB HEALTH, V4, pE364, DOI 10.1016/S2214-109X(16)00082-6
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Canadian Public Health Association (CPHA), 2015, GLOB CHANG PUBL HLTH
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   Charron DF, 2012, INSIGHT INNOV INT DE, P1, DOI 10.1007/978-1-4614-0517-7
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Frenz Patricia, 2013, Rev. perú. med. exp. salud publica, V30, P665
   Gilson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001079
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Ridde Valery, 2007, Promot Educ, V14, P63, DOI 10.1177/10253823070140021401
   *WHO, 2008, CLOS GAP GEN REP COM
   WHO, 1991, SUNDSV STAT SUPP ENV
   World Health Organization, 1986, OTT CHART HLTH PROM
   World Health Organization (WHO), 2000, MEX STAT HLTH RES
NR 16
TC 2
Z9 2
U1 0
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1757-9759
EI 1757-9767
J9 GLOB HEALTH PROMOT
JI Glob. Health Promot.
PD DEC
PY 2016
VL 23
IS 4
BP 3
EP 5
DI 10.1177/1757975916673964
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ED2WX
UT WOS:000388712000001
PM 27888265
OA Bronze
DA 2020-07-08
ER

PT J
AU Atif, M
   Azeem, M
   Sarwar, MR
   Bashir, A
AF Atif, Muhammad
   Azeem, Muhammad
   Sarwar, Muhammad Rehan
   Bashir, Arslan
TI Zika virus disease: a current review of the literature
SO INFECTION
LA English
DT Review
DE Zika virus; Zika fever; Mosquitoes; Epidemiology; Clinical
   manifestations; Pathogenesis; Treatment
ID WEST-NILE-VIRUS; INTERIM GUIDELINES; FRENCH-POLYNESIA; CLIMATE-CHANGE;
   UNITED-STATES; INFECTIOUS-DISEASES; DECEMBER 2013; DENGUE VIRUS;
   BREAST-MILK; TRANSMISSION
AB Background The massive pandemic of Zika virus (ZIKV) infection is spreading through South America, Central America, the Caribbean, and possibly the USA. It is the most recent of four surprising appearances of imperative arthropod-borne viral illnesses in the Western Hemisphere over the preceding 20 years.
   Objective The objective of this narrative review is to summarize the existing knowledge about the epidemiology, transmission, clinical manifestations, complications, replication, pathogenesis, diagnosis, and treatment and prevention of ZIKV infection.
   Methods We used electronic databases to identify relevant published data regarding ZIKV in BOOLEAN and MeSH searches.
   Conclusion This review concludes that the ZIKV predominantly circulates in arboreal mosquitoes (e.g., Aedes africanus) and wild primates. It rarely causes severe infection in humans, even in extremely enzootic regions. Currently, we do not have any efficacious drugs against ZIKV infection. However, there are virus-specific therapeutic targets, which may lead to the development of targeted anti-ZIKV drugs.
C1 [Atif, Muhammad; Azeem, Muhammad; Sarwar, Muhammad Rehan; Bashir, Arslan] Islamia Univ Bahawalpur, Dept Pharm, Punjab, Pakistan.
RP Sarwar, MR (corresponding author), Islamia Univ Bahawalpur, Dept Pharm, Punjab, Pakistan.
EM rehansarwaralvi@gmail.com; pharmacist_atif@yahoo.com;
   azeem634@hotmail.com; arslanbashir41@gmail.com
OI Sarwar, Muhammad Rehan/0000-0003-4312-9157
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bennett J.E., 2014, PRINCIPLES PRACTICE
   Bergquist R, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-3
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-28
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler CD, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-5
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carneiro LAM, 2016, MICROBES INFECT, V18, P169, DOI 10.1016/j.micinf.2015.12.006
   Centers for Disease Control and Prevention, 2016, ZIK VIR DIS US 2015
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Derraik JG, 2015, AUST NZ J PUBL HEAL, V39, P5, DOI 10.1111/1753-6405.12302
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2015, INFECTION, DOI [DOI 10.1007/S15010-016-0906-Y, 10.1007/s15010-016-0906-y]
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i383
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, 2016, INT GUID HEALTHC PRO
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Hofer U, 2016, NAT REV MICROBIOL, V14, P401, DOI 10.1038/nrmicro.2016.80
   Ingrid Rabe, 2016, ZIK VIR WHAT CLIN NE
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Majumder MS, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171009, DOI 10.2471/BLT.16.171009]
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR MORB MORTAL WKL, V65, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   MicrobeWiki, 2016, REPR CYCL ZIK VIR HO
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Organization WH, 2016, ZIK SIT REP NEUR SYN
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Schuler-Faccini L., 2015, MMWR MORB MORTAL WKL, V65, DOI 10.15585/mmwr.mm6503e2.
   Sexton DJ, 2016, ZIKA VIRUS INFECT
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2013, EUROSURVEILLANCE, V54, P54
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, 2012, GLOB REP RES INF DIS
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   World Health Organizaton, 2016, FACT SHEET MICR
   Xia S, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-27
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 100
TC 47
Z9 49
U1 2
U2 56
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0300-8126
EI 1439-0973
J9 INFECTION
JI Infection
PD DEC
PY 2016
VL 44
IS 6
BP 695
EP 705
DI 10.1007/s15010-016-0935-6
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA ED4NY
UT WOS:000388827600001
PM 27510169
OA Bronze
DA 2020-07-08
ER

PT J
AU Benelli, G
   Jeffries, CL
   Walker, T
AF Benelli, Giovanni
   Jeffries, Claire L.
   Walker, Thomas
TI Biological Control of Mosquito Vectors: Past, Present, and Future
SO INSECTS
LA English
DT Review
ID SYNTHESIZED SILVER NANOPARTICLES; AEDES-AEGYPTI DIPTERA; ASIAN TIGER
   MOSQUITO; STERILE INSECT TECHNIQUE; DENGUE VECTOR;
   CULEX-QUINQUEFASCIATUS; MALARIA VECTOR; MESOCYCLOPS-LONGISETUS;
   PREDATION EFFICIENCY; ANOPHELES-GAMBIAE
AB Mosquitoes represent the major arthropod vectors of human disease worldwide transmitting malaria, lymphatic filariasis, and arboviruses such as dengue virus and Zika virus. Unfortunately, no treatment (in the form of vaccines or drugs) is available for most of these diseases and vector control is still the main form of prevention. The limitations of traditional insecticide-based strategies, particularly the development of insecticide resistance, have resulted in significant efforts to develop alternative eco-friendly methods. Biocontrol strategies aim to be sustainable and target a range of different mosquito species to reduce the current reliance on insecticide-based mosquito control. In this review, we outline non-insecticide based strategies that have been implemented or are currently being tested. We also highlight the use of mosquito behavioural knowledge that can be exploited for control strategies.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, I-56124 Pisa, Italy.
   [Jeffries, Claire L.; Walker, Thomas] London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.
RP Walker, T (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, London WC1E 7HT, England.
EM benelli.giovanni@gmail.com; claire.jeffries@lshtm.ac.uk;
   thomas.walker@lshtm.ac.uk
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]; Wellcome Trust/Royal Society grant
   [101285/Z/13/Z]
FX We would like to thank Andrew G.S. Cuthbertson and EricW. Riddick for
   inviting this review. Giovanni Benelli is supported by PROAPI (PRAF
   2015) and the University of Pisa, Department of Agriculture, Food and
   Environment (Grant ID: COFIN2015_22). Thomas Walker and Claire Jeffries
   are supported by a Wellcome Trust/Royal Society grant (101285/Z/13/Z).
   Funders had no role in the study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aditya Gautam, 2006, Journal of Vector Borne Diseases, V43, P66
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amer A, 2006, PARASITOL RES, V99, P473, DOI 10.1007/s00436-006-0183-2
   Anbu P., 2015, NAT PROD RES, P1
   Armengol G, 2006, J ECON ENTOMOL, V99, P1590, DOI 10.1603/0022-0493-99.5.1590
   BAILEY PCE, 1989, AUST J ECOL, V14, P381, DOI 10.1111/j.1442-9993.1989.tb01448.x
   Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985
   Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   Becker N, 1997, PARASITOL TODAY, V13, P485, DOI 10.1016/S0169-4758(97)01154-X
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   Benelli G, 2014, J PEST SCI, V87, P385, DOI 10.1007/s10340-014-0577-3
   Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Bouyer J, 2016, LANCET GLOB HEALTH, V4, pE364, DOI 10.1016/S2214-109X(16)00082-6
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Boyer S, 2011, MED VET ENTOMOL, V25, P454, DOI 10.1111/j.1365-2915.2011.00962.x
   Brelsfoard CL, 2011, J MED ENTOMOL, V48, P1008, DOI 10.1603/ME10202
   Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38
   Brodman R, 2006, J FRESHWATER ECOL, V21, P467, DOI 10.1080/02705060.2006.9665024
   Burivong P, 2004, VIROLOGY, V329, P261, DOI 10.1016/j.virol.2004.08.032
   Cabrera M, 2007, J AM MOSQUITO CONTR, V23, P1, DOI 10.2987/8756-971X(2007)23[1:AAPMLB]2.0.CO;2
   Callaway E, 2015, NATURE, V526, P174, DOI 10.1038/nature.2015.18507
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cator LJ, 2011, ANIM BEHAV, V82, P627, DOI 10.1016/j.anbehav.2011.07.013
   Cator LJ, 2011, J MED ENTOMOL, V48, P941, DOI 10.1603/ME11019
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   Chandramohan B, 2016, PARASITOL RES MG, V8, P173, DOI 10.1007/978-3-319-25292-6_9
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x
   Chitra Thangadurai, 2013, Asian Pacific Journal of Tropical Disease, V3, P111, DOI 10.1016/S2222-1808(13)60054-7
   Chobu M, 2015, ACTA TROP, V142, P131, DOI 10.1016/j.actatropica.2014.11.012
   CLOAREC A, 1990, ANIM BEHAV, V40, P262, DOI 10.1016/S0003-3472(05)80921-2
   Connor ME, 1922, AM J PUBLIC HEALTH, V12, P193, DOI 10.2105/AJPH.12.3.193
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   Darbro JM, 2009, AM J TROP MED HYG, V80, P992, DOI 10.4269/ajtmh.2009.80.992
   DAS M K, 1991, Indian Journal of Malariology, V28, P171
   de Valdez MRW, 2010, J MED ENTOMOL, V47, P392, DOI 10.1603/ME09157
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8
   Diabate A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-184
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   FOCKS DA, 1985, J ECON ENTOMOL, V78, P622, DOI 10.1093/jee/78.3.622
   Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977
   Georghiou GP, 1997, APPL ENVIRON MICROB, V63, P1095, DOI 10.1128/AEM.63.3.1095-1101.1997
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Griffin LF, 2012, WETL ECOL MANAG, V20, P243, DOI 10.1007/s11273-012-9248-4
   Hales S, 2005, LANCET, V365, P551
   Hamady D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-206
   HARRINGTON RW, 1982, B MAR SCI, V32, P523
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Helinski MEH, 2011, J MED ENTOMOL, V48, P202, DOI 10.1603/ME10071
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1
   Hirunkanokpun S, 2008, AM J TROP MED HYG, V78, P784, DOI 10.4269/ajtmh.2008.78.784
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   IKESHOJI T, 1981, Medical Entomology and Zoology, V32, P7
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Jeffries CL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003576
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   KAHN MC, 1949, AM J TROP MED, V29, P811
   Kalimuthu K, 2014, HYDROBIOLOGIA, V741, P113, DOI 10.1007/s10750-013-1745-9
   Kamareddine L, 2012, TOXINS, V4, P748, DOI 10.3390/toxins4090748
   KANDA T, 1988, Tropical Biomedicine, V5, P37
   Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x
   Kay BH, 2010, AM J TROP MED HYG, V82, P822, DOI 10.4269/ajtmh.2010.09-0503
   Knols BGJ, 2010, FUTURE MICROBIOL, V5, P339, DOI 10.2217/FMB.10.11
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Kumar PM, 2012, PARASITOL RES, V111, P609, DOI 10.1007/s00436-012-2876-z
   Kumar R, 2006, ZOOL STUD, V45, P447
   Kweka EJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-128
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lacroix R, 2009, J MED ENTOMOL, V46, P1117, DOI 10.1603/033.046.0519
   Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Louca V, 2009, J MED ENTOMOL, V46, P546, DOI 10.1603/033.046.0320
   Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Manrique-Saide P, 1998, MED VET ENTOMOL, V12, P386, DOI 10.1046/j.1365-2915.1998.00126.x
   MARIAN MP, 1983, HYDROBIOLOGIA, V106, P59, DOI 10.1007/BF00016416
   MARTEN GG, 1989, J MED ENTOMOL, V26, P624, DOI 10.1093/jmedent/26.6.624
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Mehlorn H., 2015, ENCYCLOPEDIA OF PARA
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Mnyone LL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-246
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Nam VS, 2005, AM J TROP MED HYG, V72, P67, DOI 10.4269/ajtmh.2005.72.67
   Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   NOVAK RJ, 1985, J AM MOSQUITO CONTR, V1, P449
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Ohba SY, 2010, J MED ENTOMOL, V47, P783, DOI 10.1603/ME10051
   Oliva CF, 2014, ACTA TROP, V132, pS130, DOI 10.1016/j.actatropica.2013.11.019
   Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Mosimann ALP, 2011, MEM I OSWALDO CRUZ, V106, P285, DOI 10.1590/S0074-02762011000300006
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-91
   Paula AR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-8
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Philips TK, 1996, J INSECT BEHAV, V9, P739, DOI 10.1007/BF02213554
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Pitts RJ, 2014, ACTA TROP, V132, pS26, DOI 10.1016/j.actatropica.2013.09.005
   Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2
   Raghavendra K, 2008, INDIAN J MED RES, V128, P22
   Rai KS, 1999, ADV GENET, V41, P1, DOI 10.1016/S0065-2660(08)60149-2
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   RAWLINS SC, 1991, J AM MOSQUITO CONTR, V7, P7
   Rawlins SC, 1997, J AM MOSQUITO CONTR, V13, P18
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   ROBINSON AS, 1983, ANNU REV GENET, V17, P191, DOI 10.1146/annurev.ge.17.120183.001203
   Rupp HR, 1996, J AM MOSQUITO CONTR, V12, P155
   Schaper S, 1999, J AM MOSQUITO CONTR, V15, P510
   Schliekelman P, 2005, J ECON ENTOMOL, V98, P18, DOI 10.1603/0022-0493-98.1.18
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Scholte EJ, 2007, ACTA TROP, V102, P151, DOI 10.1016/j.actatropica.2007.04.011
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Shaalan EAS, 2007, J VECTOR ECOL, V32, P16, DOI 10.3376/1081-1710(2007)32[16:AMPSIT]2.0.CO;2
   Singh R. K., 2003, Journal of Communicable Diseases, V35, P96
   Sivaram A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-95
   Soumare MKF, 2011, J AM MOSQUITO CONTR, V27, P376, DOI 10.2987/11-6129.1
   South SH, 2008, J INSECT BEHAV, V21, P451, DOI 10.1007/s10905-008-9137-0
   South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991
   STEFFAN WA, 1981, ANNU REV ENTOMOL, V26, P159, DOI 10.1146/annurev.en.26.010181.001111
   Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   Van Dam AR, 2007, J AM MOSQUITO CONTR, V23, P430, DOI 10.2987/5620.1
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   VENKATESAN P, 1985, INDIAN J EXP BIOL, V23, P227
   Vreysen MJB, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002857
   Nam VS, 2012, AM J TROP MED HYG, V86, P850, DOI 10.4269/ajtmh.2012.11-0466
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walton WE, 2007, J AM MOSQUITO CONTR, V23, P184, DOI 10.2987/8756-971X(2007)23[184:LFIG]2.0.CO;2
   Wei W, 2006, AM J TROP MED HYG, V75, P1118, DOI 10.4269/ajtmh.2006.75.1118
   Weterings R, 2015, J VECTOR ECOL, V40, P230, DOI 10.1111/jvec.12158
   Wiwatanaratanabutr I, 2010, J AM MOSQUITO CONTR, V26, P265, DOI 10.2987/09-5937.1
   Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhang DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151864
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
   Zsemlye JL, 2005, MED VET ENTOMOL, V19, P276, DOI 10.1111/j.1365-2915.2005.00570.x
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 170
TC 81
Z9 82
U1 4
U2 27
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2016
VL 7
IS 4
AR UNSP 52
DI 10.3390/insects7040052
PG 18
WC Entomology
SC Entomology
GA EI1VS
UT WOS:000392274800006
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Day, JF
AF Day, Jonathan F.
TI Mosquito Oviposition Behavior and Vector Control
SO INSECTS
LA English
DT Review
DE mosquito oviposition; mosquito control; mosquito-borne disease
   transmission
AB The burden of gene transfer from one mosquito generation to the next falls on the female and her eggs. The selection of an oviposition site that guarantees egg and larval survival is a critical step in the reproductive process. The dangers associated with ephemeral aquatic habitats, lengthy droughts, freezing winters, and the absence of larval nutrition makes careful oviposition site selection by a female mosquito extremely important. Mosquito species exhibit a remarkable diversity of oviposition behaviors that ensure eggs are deposited into microenvironments conducive for successful larval development and the emergence of the next mosquito generation. An understanding of mosquito oviposition behavior is necessary for the development of surveillance and control opportunities directed against specific disease vectors. For example, Aedes aegypti Linnaeus is the vector of viruses causing important human diseases including yellow fever, dengue, chikungunya, and Zika. The preference of this species to oviposit in natural and artificial containers has facilitated the development of Ae. aegypti-specific surveillance and toxic oviposition traps designed to detect and control this important vector species in and around disease foci. A better understanding of the wide diversity of mosquito oviposition behavior will allow the development of new and innovative surveillance and control devices directed against other important mosquito vectors of human and animal disease.
C1 [Day, Jonathan F.] Univ Florida, Florida Med Entomol Lab, IFAS, 200 9th St SE, Vero Beach, FL 32962 USA.
RP Day, JF (corresponding author), Univ Florida, Florida Med Entomol Lab, IFAS, 200 9th St SE, Vero Beach, FL 32962 USA.
EM jfda@ufl.edu
FU Florida Department of Agriculture and Consumer Services
FX This work would not have been possible without the continued commitment
   and dedication to mosquito surveillance and control by personnel from
   all of the Florida mosquito control programs. Their willingness to
   conduct local and regional mosquito surveillance and to freely
   disseminate surveillance information is one of the reasons that Florida
   has internationally-recognized arboviral and mosquito surveillance
   programs. I thank Gregg Ross, Tim Hope, two anonymous reviewers, and the
   MDPI insects editorial staff for their helpful suggestions for the
   revision of this manuscript. This work was supported by several research
   contracts from the Florida Department of Agriculture and Consumer
   Services.
CR Allan SA, 1995, J CHEM ECOL, V21, P1847, DOI 10.1007/BF02033681
   ANDERSSON IH, 1987, MED VET ENTOMOL, V1, P59, DOI 10.1111/j.1365-2915.1987.tb00323.x
   APOSTOL BL, 1994, AM J TROP MED HYG, V51, P89, DOI 10.4269/ajtmh.1994.51.89
   AULT SK, 1994, AM J TROP MED HYG, V50, P35, DOI 10.4269/ajtmh.1994.50.35
   Barbosa RMR, 2010, J MED ENTOMOL, V47, P345, DOI 10.1603/ME09241
   Beament J., 1989, Journal of the Royal Army Medical Corps, V135, P49
   BEEHLER J, 1992, GREAT LAKES ENTOMOL, V25, P259
   BEIER JC, 1990, J AM MOSQUITO CONTR, V6, P105
   BELTON PETER, 1967, MOSQUITO NEWS, V27, P66
   BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153
   BENZON GL, 1988, J MED ENTOMOL, V25, P158, DOI 10.1093/jmedent/25.3.158
   BIDLINGMAYER WL, 1974, ANN ENTOMOL SOC AM, V67, P919, DOI 10.1093/aesa/67.6.919
   BIDLINGMAYER WL, 1979, B ENTOMOL RES, V69, P691, DOI 10.1017/S0007485300020228
   BIDLINGMAYER WL, 1975, ANN ENTOMOL SOC AM, V68, P51, DOI 10.1093/aesa/68.1.51
   BIDLINGMAYER WL, 1995, J AM MOSQUITO CONTR, V11, P295
   BIDLINGMAYER WL, 1974, J MED ENTOMOL, V11, P119, DOI 10.1093/jmedent/11.2.119
   BIRLEY MH, 1989, ANN TROP MED PARASIT, V83, P415, DOI 10.1080/00034983.1989.11812366
   Burkett-Cadena ND, 2007, J AM MOSQUITO CONTR, V23, P117, DOI 10.2987/8756-971X(2007)23[117:FCOBIT]2.0.CO;2
   Chadee Dave D., 1993, Journal of the Florida Mosquito Control Association, V64, P63
   Chaves LF, 2011, B ENTOMOL RES, V101, P633, DOI 10.1017/S0007485310000519
   Choo Y.-M., 2015, FRONT PHYSL
   Clements A. N., 1996, BIOL MOSQUITOES DEV, V1, P222
   CORBET PS, 1990, ANN TROP MED PARASIT, V84, P63, DOI 10.1080/00034983.1990.11812434
   CURTIS GA, 1985, J AM MOSQUITO CONTR, V1, P169
   CURTIS GA, 1981, ENVIRON ENTOMOL, V10, P180, DOI 10.1093/ee/10.2.180
   DAWSON GW, 1989, PESTIC SCI, V27, P277, DOI 10.1002/ps.2780270307
   Day Jonathan F., 1994, American Entomologist, V40, P162
   DETHIER VG, 1960, J ECON ENTOMOL, V53, P134, DOI 10.1093/jee/53.1.134
   DOW RP, 1970, ANN ENTOMOL SOC AM, V63, P995, DOI 10.1093/aesa/63.4.995
   Du YJ, 1999, J MED ENTOMOL, V36, P158, DOI 10.1093/jmedent/36.2.158
   Edgerly JS, 1998, J ANIM ECOL, V67, P805, DOI 10.1046/j.1365-2656.1998.00243.x
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   FOCKS DA, 1983, ENVIRON ENTOMOL, V12, P1073, DOI 10.1093/ee/12.4.1073
   GALINDO P, 1958, AM J TROP MED HYG, V7, P429, DOI 10.4269/ajtmh.1958.7.429
   GIBSON G, 1995, PHYSIOL ENTOMOL, V20, P224, DOI 10.1111/j.1365-3032.1995.tb00005.x
   GILLETT J. D., 1959, ANN TROP MED AND PARASITOL, V53, P35
   GILLETT J. D., 1959, ANN TROP MED AND PARASITOL, V53, P132
   GILLETT JD, 1961, ANN TROP MED PARASIT, V55, P427, DOI 10.1080/00034983.1961.11686070
   GILLETT JD, 1962, J INSECT PHYSIOL, V8, P665, DOI 10.1016/0022-1910(62)90021-5
   Gillies M. T., 1972, Zoological Journal of the Linnean Society, V51, P69
   HADDOW AJ, 1961, ANN TROP MED PARASIT, V55, P343, DOI 10.1080/00034983.1961.11686057
   HUDSON A, 1967, ANIM BEHAV, V15, P336, DOI 10.1016/0003-3472(67)90020-6
   HWANG YS, 1984, J CHEM ECOL, V10, P145, DOI 10.1007/BF00987651
   Iltis W. G., 1962, ANN ENTOMOL SOC AM, V25, P85
   IRVINGBELL RJ, 1991, TROP MED PARASITOL, V42, P63
   ISOE J, 1995, J AM MOSQUITO CONTR, V11, P39
   Isoe J, 1996, ENVIRON ENTOMOL, V25, P1383, DOI 10.1093/ee/25.6.1383
   Jackson M. L., 1958, SOIL CHEM ANAL, P240
   Kalpage D. S. P., 1973, ENVIRON ENTOMOL, V2, P729
   KENNEDY JOHN S., 1942, BULL ENT RES, V32, P279, DOI 10.1017/S0007485300017235
   KENNEDY JS, 1978, PHYSIOL ENTOMOL, V3, P91, DOI 10.1111/j.1365-3032.1978.tb00138.x
   KLOCKE JA, 1987, J CHEM ECOL, V13, P2131, DOI 10.1007/BF01012562
   KLOWDEN M J, 1990, Bulletin of the Society for Vector Ecology, V15, P59
   KNIGHT KENNETH L., 1962, MOSQUITO NEWS, V22, P247
   LINLEY JR, 1987, J MED ENTOMOL, V24, P637, DOI 10.1093/jmedent/24.6.637
   LOUNIBOS LP, 1978, ECOL ENTOMOL, V3, P299, DOI 10.1111/j.1365-2311.1978.tb00930.x
   LOUNIBOS LP, 1987, PHYSIOL ENTOMOL, V12, P435, DOI 10.1111/j.1365-3032.1987.tb00770.x
   LOUNIBOS LP, 1987, BIOTROPICA, V19, P83, DOI 10.2307/2388463
   LOUNIBOS LP, 1983, ECOL ENTOMOL, V8, P475, DOI 10.1111/j.1365-2311.1983.tb00526.x
   LOUNIBOS LP, 1989, ECOL ENTOMOL, V14, P413, DOI 10.1111/j.1365-2311.1989.tb00943.x
   LOWENBERGER CA, 1994, ENVIRON ENTOMOL, V23, P1269, DOI 10.1093/ee/23.5.1269
   MACAN TT, 1961, BIOL REV, V36, P151, DOI 10.1111/j.1469-185X.1961.tb01582.x
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   MAIRE A, 1985, J AM MOSQUITO CONTR, V1, P320
   MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821
   MEEK CL, 1986, J ENTOMOL SCI, V21, P185, DOI 10.18474/0749-8004-21.2.185
   O'GOWER A. K., 1963, ANIMAL BEHAVIOUR, V11, P189, DOI 10.1016/0003-3472(63)90028-9
   OKAZAWA T, 1991, J MED ENTOMOL, V28, P606, DOI 10.1093/jmedent/28.5.606
   OLSON JK, 1977, MOSQ NEWS, V37, P19
   OSGOOD CE, 1971, J ECON ENTOMOL, V64, P1038, DOI 10.1093/jee/64.5.1038
   PAPPAS LG, 1983, MOSQ NEWS, V43, P153
   PETRANKA JW, 1991, COPEIA, P234, DOI 10.2307/1446271
   Rapley LP, 2009, MED VET ENTOMOL, V23, P303, DOI 10.1111/j.1365-2915.2009.00834.x
   REITER P, 1983, MOSQ NEWS, V43, P496
   Ritchie SA, 2009, MED VET ENTOMOL, V23, P295, DOI 10.1111/j.1365-2915.2009.00833.x
   RITCHIE SA, 1994, J AM MOSQUITO CONTR, V10, P380
   Ritchie SA, 2003, J AM MOSQUITO CONTR, V19, P235
   ROBERTS DR, 1977, J MED ENTOMOL, V14, P129, DOI 10.1093/jmedent/14.1.129
   Barbosa RMR, 2011, MEM I OSWALDO CRUZ, V106, P451, DOI 10.1590/S0074-02762011000400011
   Russell PF, 1942, J EXP ZOOL, V91, P303, DOI 10.1002/jez.1400910211
   Russell RC, 1999, ECOL ENG, V12, P107, DOI 10.1016/S0925-8574(98)00057-3
   SHROYER DA, 1977, J MED ENTOMOL, V14, P121, DOI 10.1093/jmedent/14.1.121
   SILBERGLIED RE, 1979, ANNU REV ECOL SYST, V10, P373, DOI 10.1146/annurev.es.10.110179.002105
   Thavara U, 2004, J VECTOR ECOL, V29, P66
   Trexler JD, 1998, J MED ENTOMOL, V35, P967, DOI 10.1093/jmedent/35.6.967
   TRIMBLE RM, 1980, J MED ENTOMOL, V17, P509, DOI 10.1093/jmedent/17.6.509
   VANPLETZEN R, 1981, B ENTOMOL RES, V71, P71, DOI 10.1017/S000748530005104X
   WEBER RG, 1993, J INSECT BEHAV, V6, P343, DOI 10.1007/BF01048115
   WEBER RG, 1990, ENTOMOL NEWS, V101, P257
   WELLINGTON WG, 1974, CAN ENTOMOL, V106, P941, DOI 10.4039/Ent106941-9
   Williams CR, 2007, J MED ENTOMOL, V44, P256, DOI 10.1603/0022-2585(2007)44[256:IOABLO]2.0.CO;2
   Zahiri N, 1998, J MED ENTOMOL, V35, P782, DOI 10.1093/jmedent/35.5.782
   Zhang LY, 2008, ANN TROP MED PARASIT, V102, P399, DOI 10.1179/136485908X300878
NR 93
TC 41
Z9 42
U1 0
U2 16
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2016
VL 7
IS 4
AR 65
DI 10.3390/insects7040065
PG 22
WC Entomology
SC Entomology
GA EI1VS
UT WOS:000392274800019
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Du, YZ
   Nomura, Y
   Zhorov, BS
   Dong, K
AF Du, Yuzhe
   Nomura, Yoshiko
   Zhorov, Boris S.
   Dong, Ke
TI Sodium Channel Mutations and Pyrethroid Resistance in Aedes aegypti
SO INSECTS
LA English
DT Review
ID KNOCKDOWN-RESISTANCE; ANOPHELES-GAMBIAE; POINT MUTATIONS; WIDESPREAD
   DISTRIBUTION; INSECTICIDE RESISTANCE; MOLECULAR EVIDENCE;
   RECEPTOR-SITES; BINDING-SITES; 1ST DETECTION; GENE
AB Pyrethroid insecticides are widely used to control insect pests and human disease vectors. Voltage-gated sodium channels are the primary targets of pyrethroid insecticides. Mutations in the sodium channel have been shown to be responsible for pyrethroid resistance, known as knockdown resistance (kdr), in various insects including mosquitoes. In Aedes aegypti mosquitoes, the principal urban vectors of dengue, zika, and yellow fever viruses, multiple single nucleotide polymorphisms in the sodium channel gene have been found in pyrethroid-resistant populations and some of them have been functionally confirmed to be responsible for kdr in an in vitro expression system, Xenopus oocytes. This mini-review aims to provide an update on the identification and functional characterization of pyrethroid resistance-associated sodium channel mutations from Aedes aegypti. The collection of kdr mutations not only helped us develop molecular markers for resistance monitoring, but also provided valuable information for computational molecular modeling of pyrethroid receptor sites on the sodium channel.
C1 [Du, Yuzhe; Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol Genet & Neurosci Programs, E Lansing, MI 48824 USA.
   [Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.
   [Zhorov, Boris S.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg 194223, Russia.
   [Du, Yuzhe] USDA ARS, Biol Control Pest Res Unit, 59 Lee Rd, Stoneville, MS 38776 USA.
RP Dong, K (corresponding author), Michigan State Univ, Dept Entomol Genet & Neurosci Programs, E Lansing, MI 48824 USA.
EM duy@msu.edu; Nomuray@msu.edu; Boriszhorov@yahoo.com; dongk@cns.msu.edu
RI Zhorov, Boris/T-9892-2019; Zhorov, Boris S./V-8072-2019
OI Zhorov, Boris/0000-0002-3630-7114; 
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM 57440]
FX The project on the mechanism of knockdown resistance to pyrethroids in
   Aedes aegypti is supported by a grant from NIH (GM 57440) to Ke Dong and
   Boris S. Zhorov. We thank past and current lab members for their
   significant contributions to our research.
CR Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bona A. C., 2016, PARASITES VECTORS, V9
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   Chen H., 2016, INFECT DIS POVERTY
   Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011681
   Cornel A. J., 2016, F1000RES
   Dong K, 1997, INSECT BIOCHEM MOLEC, V27, P93, DOI 10.1016/S0965-1748(96)00082-3
   Dong K., 1998, NEUROTOXICOLOGY, V19, P581
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du YZ, 2016, J BIOL CHEM, V291, P4638, DOI 10.1074/jbc.M115.678672
   Du YZ, 2015, MOL PHARMACOL, V88, P273, DOI 10.1124/mol.115.098707
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Du Y, 2009, BIOCHEM J, V419, P377, DOI 10.1042/BJ20082082
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Elliott, 1977, SYNTHETIC LISSENDEN, P1
   Elliott M, 1977, SYNTHETIC PYRETHROID, P1
   Enayati AA, 2003, MED VET ENTOMOL, V17, P138, DOI 10.1046/j.1365-2915.2003.00418.x
   Chapadense FGG, 2015, REV SOC BRAS MED TRO, V48, P607, DOI 10.1590/0037-8682-0046-2015
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Head DJ, 1998, INSECT MOL BIOL, V7, P191, DOI 10.1046/j.1365-2583.1998.72061.x
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hodgdon HE, 2010, PEST MANAG SCI, V66, P1031, DOI 10.1002/ps.1979
   Hu ZN, 2011, INSECT BIOCHEM MOLEC, V41, P9, DOI 10.1016/j.ibmb.2010.09.005
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109
   Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P108, DOI 10.1016/j.pestbp.2006.10.001
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kim H, 2007, PESTIC BIOCHEM PHYS, V87, P54, DOI 10.1016/j.pestbp.2006.06.009
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Lee SH, 1999, INSECT BIOCHEM MOLEC, V29, P185, DOI 10.1016/S0965-1748(98)00122-2
   Li C., 2015, PARASITES VECTORS
   Liu ZQ, 2000, INSECT BIOCHEM MOLEC, V30, P991, DOI 10.1016/S0965-1748(00)00074-6
   Lol JC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-268
   Luleyap HU, 2002, J MED ENTOMOL, V39, P870, DOI 10.1603/0022-2585-39.6.870
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205
   Narahashi T, 1998, NEUROTOXICOLOGY, V19, P581
   Narahashi T, 1996, PHARMACOL TOXICOL, V79, P1, DOI 10.1111/j.1600-0773.1996.tb00234.x
   O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925
   Pang SC, 2015, TROP BIOMED, V32, P140
   Prapanthadara L., 2002, Dengue Bulletin, V26, P185
   Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004
   Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Silver K.S., 2014, VOLTAGE GATED SODIUM, V46, P389
   Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7
   Singh O. P., 2010, MALAR J
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soderlund D.M., 2005, P1
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453
   Srisawat R, 2012, SE ASIAN J TROP MED, V43, P1380
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591
   Tan WL, 2012, J MED ENTOMOL, V49, P1012, DOI 10.1603/ME11266
   Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057
   Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59
   Wang ZM, 2012, MED VET ENTOMOL, V26, P228, DOI 10.1111/j.1365-2915.2011.00985.x
   Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090
   Yanola J., 2008, P 2 INT C DENG DENG
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005
   Zhorov B. S., 2016, NEUROTOXICO IN PRESS
NR 79
TC 34
Z9 34
U1 2
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2016
VL 7
IS 4
AR 60
DI 10.3390/insects7040060
PG 11
WC Entomology
SC Entomology
GA EI1VS
UT WOS:000392274800014
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Severson, DW
   Behura, SK
AF Severson, David W.
   Behura, Susanta K.
TI Genome Investigations of Vector Competence in Aedes aegypti to Inform
   Novel Arbovirus Disease Control Approaches
SO INSECTS
LA English
DT Review
ID QUANTITATIVE TRAIT LOCI; MALARIA PARASITE SUSCEPTIBILITY; YELLOW-FEVER
   MOSQUITO; DENGUE-VIRUS; INNATE IMMUNITY; ORAL INFECTION;
   GENETIC-CONTROL; BODY-SIZE; TRANSCRIPTIONAL RESPONSE; INSECTICIDE
   RESISTANCE
AB Dengue (DENV), yellow fever, chikungunya, and Zika virus transmission to humans by a mosquito host is confounded by both intrinsic and extrinsic variables. Besides virulence factors of the individual arboviruses, likelihood of virus transmission is subject to variability in the genome of the primary mosquito vector, Aedes aegypti. The vectorial capacity of A. aegypti varies depending upon its density, biting rate, and survival rate, as well as its intrinsic ability to acquire, host and transmit a given arbovirus. This intrinsic ability is known as vector competence. Based on whole transcriptome analysis, several genes and pathways have been predicated to have an association with a susceptible or refractory response in A. aegypti to DENV infection. However, the functional genomics of vector competence of A. aegypti is not well understood, primarily due to lack of integrative approaches in genomic or transcriptomic studies. In this review, we focus on the present status of genomics studies of DENV vector competence in A. aegypti as limited information is available relative to the other arboviruses. We propose future areas of research needed to facilitate the integration of vector and virus genomics and environmental factors to work towards better understanding of vector competence and vectorial capacity in natural conditions.
C1 [Severson, David W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Severson, David W.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Behura, Susanta K.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.
RP Severson, DW (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Severson, DW (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
EM severson.1@nd.edu; behuras@missouri.edu
OI Severson, David/0000-0002-5798-3365
FU National Institutes of Health, National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R56-AI110721]
FX We dedicate this review to the memory of our colleague and dear friend
   Dave D. Chadee. This work was funded in part by a grant from the
   National Institutes of Health, National Institute of Allergy and
   Infectious Diseases (R56-AI110721) to David W. Severson.
CR Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Adelman ZN, 2002, MOL BIOCHEM PARASIT, V121, P1, DOI 10.1016/S0166-6851(02)00028-2
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey L, 2013, PATHOG GLOB HEALTH, V107, P170, DOI 10.1179/2047773213Y.0000000095
   Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886
   Arjona A, 2011, CELL MICROBIOL, V13, P1648, DOI 10.1111/j.1462-5822.2011.01649.x
   Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539
   Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030
   Baron O. L., 2008, J INSECT SCI, DOI [10.1673/031.010.410120572793, DOI 10.1673/031.010.410120572793]
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   Beerntsen BT, 1995, EXP PARASITOL, V81, P355, DOI 10.1006/expr.1995.1126
   Behura SK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2468-x
   Behura SK, 2014, MOL GENET GENOMICS, V289, P885, DOI 10.1007/s00438-014-0857-x
   Behura SK, 2014, FUNCT INTEGR GENOMIC, V14, P581, DOI 10.1007/s10142-014-0376-1
   Behura SK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-37
   Behura SK, 2012, INFECT GENET EVOL, V12, P1413, DOI 10.1016/j.meegid.2012.04.027
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bennett KE, 2005, GENETICS, V170, P185, DOI 10.1534/genetics.104.035634
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Black IV W. C., 2005, GENETICS VECTOR COMP, P415
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Black William C. IV, 2005, P187
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Bosio CF, 2000, GENETICS, V156, P687
   Bosio CF, 1998, AM J TROP MED HYG, V59, P965, DOI 10.4269/ajtmh.1998.59.965
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Bryant CE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120015
   Burt B., 2014, T R SOC B, DOI [10.1098/rstb.2014.0217, DOI 10.1098/RSTB.2014.0217]
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57
   Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488
   Chauhan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047350
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005
   Clem RJ, 2016, J GEN VIROL, V97, P1033, DOI 10.1099/jgv.0.000429
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   Dimopoulos G, 2001, CURR OPIN IMMUNOL, V13, P79, DOI 10.1016/S0952-7915(00)00186-2
   Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Failloux AB, 2002, J MOL EVOL, V55, P653, DOI 10.1007/s00239-002-2360-y
   Fansiri T, 2016, EVOL APPL, V9, P608, DOI 10.1111/eva.12360
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Fragkoudis R, 2009, J GEN VIROL, V90, P2061, DOI 10.1099/vir.0.013201-0
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Franz Alexander W E, 2014, Curr Trop Med Rep, V1, P21
   Gaye A, 2014, TROP MED INT HEALTH, V19, P1355, DOI 10.1111/tmi.12373
   Gomez-Machorro C, 2004, INSECT MOL BIOL, V13, P637, DOI 10.1111/j.0962-1075.2004.00522.x
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hemme RR, 2009, ACTA TROP, V112, P59, DOI 10.1016/j.actatropica.2009.06.008
   Jain B, 2014, MICROB PATHOGENESIS, V69-70, P45, DOI 10.1016/j.micpath.2014.03.004
   Kamimura Kiyoshi, 2002, Medical Entomology and Zoology, V53, P53
   KEIRANS JE, 1968, MOSQ NEWS, V28, P338
   Khoo CCH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-257
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Lambrechts L, 2012, J VIROL, V86, P1853, DOI 10.1128/JVI.06458-11
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lara-Ramirez EE, 2014, BIOMED RES INT, DOI 10.1155/2014/851425
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Lequime S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006111
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282
   Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x
   Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004
   Marques JT, 2016, CURR OPIN MICROBIOL, V32, P71, DOI 10.1016/j.mib.2016.05.002
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira LA, 2002, INT J PARASITOL, V32, P1599, DOI 10.1016/S0020-7519(02)00188-1
   Moreno-Garcia M, 2014, INFECT GENET EVOL, V24, P25, DOI 10.1016/j.meegid.2014.02.010
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   NASCI RS, 1991, J MED ENTOMOL, V28, P522, DOI 10.1093/jmedent/28.4.522
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Obbard DJ, 2014, CURR OPIN VIROL, V8, P73, DOI 10.1016/j.coviro.2014.07.002
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Paupy C, 2003, GENET RES, V82, P171, DOI 10.1017/S0016672303006463
   Prasad AN, 2013, VIRUSES-BASEL, V5, P3142, DOI 10.3390/v5123142
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Robinson AS, 2004, INSECT BIOCHEM MOLEC, V34, P113, DOI 10.1016/j.ibmb.2003.10.004
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Schneider JR, 2007, MED VET ENTOMOL, V21, P370, DOI 10.1111/j.1365-2915.2007.00699.x
   Schneider JR, 2011, INFECT GENET EVOL, V11, P11, DOI 10.1016/j.meegid.2010.10.019
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117
   Severson David W., 1994, Insect Molecular Biology, V3, P67, DOI 10.1111/j.1365-2583.1994.tb00153.x
   SEVERSON DW, 1995, GENETICS, V139, P1711
   Severson DW, 2001, ANNU REV ENTOMOL, V46, P183, DOI 10.1146/annurev.ento.46.1.183
   Shen SH, 2015, P NATL ACAD SCI USA, V112, P4749, DOI 10.1073/pnas.1502864112
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Smith DR, 2012, INSECT MOL BIOL, V21, P1, DOI 10.1111/j.1365-2583.2011.01098.x
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Steinert S, 2011, IMMUNOL REV, V240, P129, DOI 10.1111/j.1600-065X.2010.00985.x
   Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283
   Tabachnick WJ, 2016, CURR OPIN VIROL, V21, P124, DOI 10.1016/j.coviro.2016.09.008
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   TARDIEUX I, 1990, AM J TROP MED HYG, V43, P308, DOI 10.4269/ajtmh.1990.43.308
   Terenius O, 2008, CELL HOST MICROBE, V4, P417, DOI 10.1016/j.chom.2008.09.002
   THOMAS RE, 1993, J MED ENTOMOL, V30, P326, DOI 10.1093/jmedent/30.2.326
   Thomas SJ, 2015, VACCINE, V33, pD24, DOI 10.1016/j.vaccine.2015.05.095
   Timoshevskiy VA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002052
   Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1
   Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467
   Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wisser RJ, 2006, PHYTOPATHOLOGY, V96, P120, DOI 10.1094/PHYTO-96-0120
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yan G, 1997, EVOLUTION, V51, P441, DOI 10.2307/2411116
   Ye Y. H., 2016, EVOLUTION, DOI [10.1111/evo.1303927530960, DOI 10.1111/EVO.1303927530960]
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
   Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010
   Zhong DB, 2006, GENETICS, V173, P1337, DOI 10.1534/genetics.105.055178
NR 131
TC 17
Z9 18
U1 2
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2016
VL 7
IS 4
AR UNSP 58
DI 10.3390/insects7040058
PG 15
WC Entomology
SC Entomology
GA EI1VS
UT WOS:000392274800012
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tabachnick, WJ
AF Tabachnick, Walter J.
TI Research Contributing to Improvements in Controlling Florida's
   Mosquitoes and Mosquito-Borne Diseases
SO INSECTS
LA English
DT Review
AB Research on mosquitoes and mosquito-borne diseases has contributed to improvements in providing effective, efficient, and environmentally proper mosquito control. Florida has benefitted from several research accomplishments that have increased the state's mosquito control capabilities. Research with Florida's mosquitoes has resulted in the development of ecologically sound management of mosquito impoundments on Florida's east coast. This strategy, called Rotational Impoundment Management (RIM), has improved the ability to target the delivery of pesticides and has helped to reduce non-target effects and environmental damage. Research has led to the development of an arbovirus surveillance system which includes sentinel chicken surveillance, real time use of environmental contributing factors like meteorology and hydrology to target mosquito control, as well as public health efforts to mitigate disease outbreaks to areas with risk of disease. These research driven improvements have provided substantial benefits to all of Florida. More research is needed to meet the future challenges to reduce emerging pathogens like Zika virus and the consequences of environmental changes like global climate change that are likely to influence the effects of mosquito-borne pathogens on human health and well-being.
C1 [Tabachnick, Walter J.] Univ Florida, IFAS, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
RP Tabachnick, WJ (corresponding author), Univ Florida, IFAS, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
CR Alfonso-Sierra E, 2016, PATHOG GLOB HEALTH, V110, P14, DOI 10.1080/20477724.2016.1142057
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Barber J., FIELD MEASUREMENT DE
   Barber JAS, 2008, J AM MOSQUITO CONTR, V24, P177, DOI 10.2987/8756-971X(2008)24[177:CEDSDA]2.0.CO;2
   Barber JAS, 2007, J AM MOSQUITO CONTR, V23, P55, DOI 10.2987/8756-971X(2007)23[55:FTOMAP]2.0.CO;2
   Becker N., 2003, MOSQUITOES THEIR CON
   Benelli G, 2015, PARASITOL RES, V114, P2801, DOI 10.1007/s00436-015-4586-9
   BIDLINGMAYER WL, 1974, J MED ENTOMOL, V11, P119, DOI 10.1093/jmedent/11.2.119
   Bonds JAS, 2009, J AM MOSQUITO CONTR, V25, P474, DOI 10.2987/09-5882.1
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brockmeyer R.E. Jr, 1997, Wetlands Ecology and Management, V4, P93, DOI 10.1007/BF01876231
   Carlson D. B., 2016, COMMUNICATION
   CARLSON DB, 1988, J AM MOSQUITO CONTR, V4, P146
   CARLSON DB, 1991, J AM MOSQUITO CONTR, V7, P83
   CHAMBERLAIN RW, 1964, AM J TROP MED HYG, V13, P456, DOI 10.4269/ajtmh.1964.13.456
   Connelly CR, 2009, FLORIDA MOSQUITO CON
   Crosby M. C., 2006, AM PLAGUE UNTOLD STO
   Curtis GA, 1996, J AM MOSQUITO CONTR, V12, P368
   CURTIS GA, 1988, J AM MOSQUITO CONTR, V4, P345
   Day J. F., 2009, FLORIDA MOSQUITO CON, P131
   Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111
   Day JF, 2011, FLAVIVIRUS ENCEPHALI, P105
   Day JF, 2008, J MED ENTOMOL, V45, P458, DOI 10.1603/0022-2585(2008)45[458:UHCTFT]2.0.CO;2
   Day Jonathan F., 1994, American Entomologist, V40, P162
   Day JF, 2015, J MED ENTOMOL, V52, P743, DOI 10.1093/jme/tjv076
   Day JF, 2009, J MED ENTOMOL, V46, P1498, DOI 10.1603/033.046.0638
   DETINOVA TS, 1962, AGE GROUPING METHODS
   Dukes J, 2004, J AM MOSQUITO CONTR, V20, P27
   Dukes J, 2004, J AM MOSQUITO CONTR, V20, P36
   DUKES JC, 1990, J AM MOSQUITO CONTR, V6, P279
   Eldridge BF, 2012, MED ENTOMOLOGY TXB P
   Hester PG, 2001, J AM MOSQUITO CONTR, V17, P2
   Hoffmann WC, 2007, J AM MOSQUITO CONTR, V23, P321, DOI 10.2987/8756-971X(2007)23[321:COTAET]2.0.CO;2
   Hribar Lawrence J., 2013, Life-The Excitement of Biology, V1, P53, DOI 10.9784/LEB1(1)Hribar.04
   Knight RL, 2003, ECOL ENG, V21, P211, DOI 10.1016/j.ecoleng.2003.11.001
   Latham M., 2007, Outlooks on Pest Management, V18, P178, DOI 10.1564/18aug10
   Latham M., 2004, P INT C PEST APPL DR, P97
   Latham M. D., 2016, COMMUNICATION
   Latham M. D., 2008, ASPECTS APPL BIOL, V84, P281
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   LINLEY JR, 1988, J AM MOSQUITO CONTR, V4, P326
   Linthicum K., 2009, FLORIDA MOSQUITO CON, P193
   Marquardt W. C, 2004, BIOL DIS VECTORS
   MOORE JC, 1993, J AM MOSQUITO CONTR, V9, P138
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   MOUNT GA, 1970, MOSQ NEWS, V30, P70
   Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305
   Mount GA, 1996, J AM MOSQUITO CONTR, V12, P601
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Patterson Gordon, 2004, MOSQUITO WARS HIST M
   POLOVODOVA VP, 1949, MED PARAZITOL PARAZI, V18, P352
   PROVOST MW, 1976, B MAR SCI, V26, P558
   Qualls WA, 2010, J AM MOSQUITO CONTR, V26, P223, DOI 10.2987/09-5956.1
   RATHBURN CB, 1989, J AM MOSQUITO CONTR, V5, P173
   REEVES WC, 1990, EPIDEMIOLOGY CONTROL
   Reisen W.K., 1990, P254
   Rey J. R., MOSQUITO CONTROL IMP
   Rey JR, 2012, WETL ECOL MANAG, V20, P197, DOI 10.1007/s11273-011-9235-1
   Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2
   Shaman J, 2006, CLIMATIC CHANGE, V75, P495, DOI 10.1007/s10584-006-6340-x
   Smith J. P., 2009, WING BEATS, V20, P18
   Tabachnick W. J., 2014, Viral infections and global change, P21
   Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564
   Tabachnick W. J., 1998, Emerging infections., P411
   Tabachnick W. J., 2016, ANN REV VIR IN PRESS
   TABACHNICK WJ, 1995, PARASITOL TODAY, V11, P27, DOI 10.1016/0169-4758(95)80105-7
   Tabachnick WJ, 2003, J MED ENTOMOL, V40, P597, DOI 10.1603/0022-2585-40.5.597
   Wang SB, 2013, TRENDS BIOTECHNOL, V31, P185, DOI 10.1016/j.tibtech.2013.01.001
   Zarowiecki M, 2011, PARASITOLOGY, V138, P1723, DOI 10.1017/S003118201100062X
   Zhong H, 2004, J ECON ENTOMOL, V97, P1, DOI 10.1603/0022-0493-97.1.1
   Zhong H, 2010, ENVIRON ENTOMOL, V39, P1961, DOI 10.1603/EN10089
   Zhong H, 2003, J AM MOSQUITO CONTR, V19, P47
   Zhong H., 2007, ENCY PEST MANAGEMENT, V2, P4
NR 74
TC 3
Z9 3
U1 0
U2 7
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4450
J9 INSECTS
JI Insects
PD DEC
PY 2016
VL 7
IS 4
AR 50
DI 10.3390/insects7040050
PG 13
WC Entomology
SC Entomology
GA EI1VS
UT WOS:000392274800004
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mlacker, S
   Shafa, G
   Aldahan, AS
   Shah, VV
   Samarkandy, S
   Nouri, K
AF Mlacker, Stephanie
   Shafa, Golsa
   Aldahan, Adam S.
   Shah, Vidhi V.
   Samarkandy, Sahal
   Nouri, Keyvan
TI Origin of the Zika virus revealed: a historical journey across the world
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Article
DE disease control; tropical disease; viral disease
ID PUBLIC-HEALTH; INFECTION; OUTBREAK; EPIDEMIOLOGY; EMERGENCE; AMERICA;
   BIOLOGY
AB BackgroundZika virus (ZIKV) is an arbovirus within the Flaviviridae family, the recent spread of which has promoted public concern.
   MethodsThis study outlines the clinical features, potential for teratogenicity, diagnosis, and treatment of ZIKV infection.
   ResultsZika virus is transmitted through the bite of an infected Stegomyia (= Aedes) mosquito, blood transfusion, sexual intercourse, and perinatal routes. Infection has been characterized as mildly symptomatic. Symptoms include mild fever, headache, arthralgia, myalgia, non-purulent conjunctivitis, and a pruritic maculopapular rash. It is rarely life-threatening, but both Guillain-Barre syndrome and fetal microcephaly have been reported. ZIKV belongs to the same family as bovine viral diarrhea virus, which causes hydrocephalus and microcephaly in newborn calves, and hepatitis C virus, which can be vertically transmitted in human pregnancies, and hence there remains concern for potential similarities. Diagnostic methods include polymerase chain reaction performed in blood samples during infection, and in urine and saliva. Pregnant women undergo antibody testing for immunoglobulin M. Treatment involves supportive care, and acetaminophen and antihistamines to control symptoms.
   ConclusionsAlthough there was no evidence of the circulation of ZIKV in the Western hemisphere prior to 2014, the global spread of Stegomyia aegypti and increases in urban populations and international travel have fostered its evolution. Adherence to current guidelines for the prevention of ZIKV transmission is especially relevant in regions experiencing ongoing outbreaks. Concern for microcephaly in newborns warrants further investigation into the potential long-term effects of ZIKV infection, especially in relation to reproductive health and mother-fetus transmission.
C1 [Mlacker, Stephanie; Shafa, Golsa; Aldahan, Adam S.; Shah, Vidhi V.; Samarkandy, Sahal; Nouri, Keyvan] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, 1475 NW 12th Ave,Suite 2175, Miami, FL 33136 USA.
RP Mlacker, S (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, 1475 NW 12th Ave,Suite 2175, Miami, FL 33136 USA.
EM mlackerstephanie@gmail.com
CR Borchardt RA, 2016, JAAPA-J AM ACAD PHYS, V29, P48, DOI 10.1097/01.JAA.0000481413.11539.b1
   Burd I, 2016, J ASSIST REPROD GEN, V33, P439, DOI 10.1007/s10815-016-0687-3
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Dhimal M, 2015, J Nepal Health Res Counc, V13, P248
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lopes MH, 2016, REV ASSOC MED BRAS, V62, P4, DOI 10.1590/1806-9282.62.01.4
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
NR 22
TC 6
Z9 6
U1 1
U2 73
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD DEC
PY 2016
VL 55
IS 12
BP 1369
EP 1372
DI 10.1111/ijd.13399
PG 4
WC Dermatology
SC Dermatology
GA EB4PU
UT WOS:000387355500024
PM 27650823
DA 2020-07-08
ER

PT J
AU Wong, LP
   Alias, H
   Aghamohammadi, N
   Sam, IC
   AbuBakar, S
AF Wong, Li Ping
   Alias, Haridah
   Aghamohammadi, Nasrin
   Sam, I-Ching
   AbuBakar, Sazaly
TI The Self-Regulation Model of Illness: Comparison between Zika and Dengue
   and Its Application to Predict Mosquito Prevention Behaviours in
   Malaysia, a Dengue-Endemic Country
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Self-Regulation Model of Illness; Zika; dengue; mosquito prevention
ID VIRUS
AB Perceptions about illnesses may influence self-care and preventive health behaviours. Illness perceptions of the Zika virus (ZIKV) infection were investigated under the framework of the Self-Regulation Model of Illness. Illness perception differences between ZIKV and dengue fever were also examined. Lastly, associations between illness perceptions of ZIKV with mosquito prevention practices were studied. Samples were drawn from landline telephone numbers using computer-assisted telephone interviewing in Malaysia. A total of 567 respondents completed the survey between February 2015 and May 2016. The median and interquartile range (IQR) for the total six dimensions of illness perceptions score was higher for dengue (23.0 (IQR 17.0-28.0)) than ZIKV (20.0 (IRQ 11.0-28.0)), p < 0.001. Respondents who planned to have children (OR 1.670, 95% CI 1.035-2.694 vs. no intention to have children) and had friends or acquaintances who died of dengue (OR 2.372, 95% CI 1.300-4.327 vs. no friends who died of dengue) were more likely to have a higher total score for six illness perceptions for ZIKV compared to dengue. Multivariate analysis indicated that the best predictors for mosquito control practices after the ZIKV outbreak was declared a Public Health Emergency of International Concern, in descending order, were causes, control, timeline, and consequences dimensions of illness perception. Understanding the context in which a person perceives ZIKV may contribute to developing interventions that influence prevention behaviours.
C1 [Wong, Li Ping; Alias, Haridah; Aghamohammadi, Nasrin] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia.
   [Wong, Li Ping] Univ Malaya, Julius Ctr Univ Malaya JCUM, Kuala Lumpur 50603, Malaysia.
   [Aghamohammadi, Nasrin] Univ Malaya, Dept Social & Prevent Med, Ctr Occupat & Environm Hlth, Fac Med, Kuala Lumpur 50603, Malaysia.
   [Sam, I-Ching; AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
   [AbuBakar, Sazaly] Univ Malaya, Trop Infect Dis Res & Educ Ctr TIDREC, Kuala Lumpur 50603, Malaysia.
RP Wong, LP (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur 50603, Malaysia.; Wong, LP (corresponding author), Univ Malaya, Julius Ctr Univ Malaya JCUM, Kuala Lumpur 50603, Malaysia.
EM wonglp@ummc.edu.my; haridahalias@gmail.com; nasrin@ummc.edu.my;
   jicsam@um.edu.my; sazaly@um.edu.my
RI abubakar, sazaly/B-3957-2010; Sam, Jamal I-Ching/B-8688-2010; Wong, Li
   Ping/B-2782-2010; Aghamohammadi, Nasrin/L-5822-2013; Aghamohammadi,
   Nasrin/G-9392-2013; ALIAS, HARIDAH/A-8075-2017
OI abubakar, sazaly/0000-0002-9267-1420; Sam, Jamal
   I-Ching/0000-0002-1296-7898; Wong, Li Ping/0000-0002-0107-0532;
   Aghamohammadi, Nasrin/0000-0002-7063-1671; Aghamohammadi,
   Nasrin/0000-0002-7063-1671; ALIAS, HARIDAH/0000-0002-1830-4761
FU Ministry of Education [GCSUS-15SUS, UM.C/625/1/HIR/MOE/MED/02
   (E000013-20001)]
FX This study received financial supports from Grand Challenge-SUS
   (Sustainability Science) GCSUS-15SUS and High Impact Research Grant
   (UM.C/625/1/HIR/MOE/MED/02 (E000013-20001)) from the Ministry of
   Education.
CR Browning KK, 2009, CANCER NURS, V32, pE15, DOI 10.1097/NCC.0b013e3181a0238f
   Department of Statistics Malaysia, 2014, POP DISTR BAS DEM CH
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Lange LJ, 2006, J BEHAV MED, V29, P239, DOI 10.1007/s10865-006-9049-4
   Lemeshow S., 2004, APPL LOGISTIC REGRES
   LEVENTHAL H, 2003, SELF REGULATION HLTH, P42
   Leventhal H., 1997, PERCEPTIONS HLTH ILL, P19
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mo PKH, 2015, J HEALTH PSYCHOL, V20, P1523, DOI 10.1177/1359105313516031
   Mudin RN, 2015, INT MED J MALAYS, V14, P5
   Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536
   Petrie KJ, 1996, BRIT MED J, V312, P1191
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Reynolds NR, 2003, AIDS CARE, V15, P117, DOI 10.1080/0954012021000039815
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sam J.I.C., 2016, MED J MALAYS, V71, P68
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Streiner DI, 2008, HLTH MEASUREMENT SCA
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
NR 19
TC 4
Z9 4
U1 0
U2 12
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD DEC
PY 2016
VL 13
IS 12
AR 1210
DI 10.3390/ijerph13121210
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EE4KX
UT WOS:000389571900037
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Osterhaus, A
AF Osterhaus, A.
TI AIDS, Avian flu, SARS, MERS, Ebola, Zika ... what next?
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Osterhaus, A.] Artemis One Hlth Fdn, Hanover, DE USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 01.001
BP 4
EP 4
DI 10.1016/j.ijid.2016.11.013
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU van der Linden, V
AF van der Linden, V.
TI Congenital Zika Syndrome
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 02.002
BP 6
EP 6
DI 10.1016/j.ijid.2016.11.019
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400009
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Olival, K
   Wiens, K
   Rosenthal, C
   Willoughby, A
   Zambrana-Torrelio, C
   Ross, N
   Daszak, P
AF Olival, K.
   Wiens, K.
   Rosenthal, C.
   Willoughby, A.
   Zambrana-Torrelio, C.
   Ross, N.
   Daszak, P.
TI Identifying the next Zika: An analysis of zoonotic potential in
   Flaviviridae
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Olival, K.; Willoughby, A.; Ross, N.; Daszak, P.] EcoHlth Alliance, New York, NY USA.
   [Wiens, K.] NYU, New York, NY USA.
   [Rosenthal, C.] Trinity Coll, New York, NY USA.
   [Zambrana-Torrelio, C.] EcoHlth Alliance Org, New York, NY USA.
RI Zambrana-Torrelio, Carlos/AAH-3911-2020
OI Zambrana-Torrelio, Carlos/0000-0002-5614-7496; Ross,
   Noam/0000-0002-2136-0000
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 03.002
BP 7
EP 8
DI 10.1016/j.ijid.2016.11.023
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400013
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU van Kessel, CG
   Islam, Z
   Jacobs, B
   Kamga, S
   Reusken, C
   Mogling, R
   Islam, B
   Mohammed, D
   Koopmans, M
   Endtz, H
AF van Kessel, C. Geurts
   Islam, Z.
   Jacobs, B.
   Kamga, S.
   Reusken, C.
   Mogling, R.
   Islam, B.
   Mohammed, D.
   Koopmans, M.
   Endtz, H.
TI Guillain-Barre syndrome during an outbreak of Zika virus in Bangladesh:
   A case-control study
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [van Kessel, C. Geurts; Kamga, S.; Mogling, R.] Erasmus MC, Virosci, Rotterdam, Netherlands.
   [Islam, Z.; Islam, B.] ICDDR B, Dhaka, Bangladesh.
   [Jacobs, B.] Erasmus MC, Neurol & Immunol, Rotterdam, Netherlands.
   [Reusken, C.] Erasmus MC, Virosci, Rotterdam, Netherlands.
   [Mohammed, D.] Dhaka Med Coll Hosp, Dhaka, Bangladesh.
   [Koopmans, M.] Erasmus MC, Rotterdam, Netherlands.
   [Endtz, H.] Erasmus MC, Rotterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 08.001
BP 13
EP 13
DI 10.1016/j.ijid.2016.11.039
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400028
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Moni, M
   Lio, P
AF Moni, M.
   Lio, P.
TI Infectome, diseasome and comorbidities of Zika infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Moni, M.] Univ New South Wales, Garvan Inst Med Res, Sydney, NSW, Australia.
   [Lio, P.] Univ Cambridge, Comp Lab, Cambridge, England.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 08.002
BP 14
EP 14
DI 10.1016/j.ijid.2016.11.040
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400029
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hueston, L
AF Hueston, L.
TI Evaluation of the Euroimmun Zika Virus IgG and IgM ELISA kits
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Hueston, L.] Pathol West ICPMR, Westmead, NSW, Australia.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 08.004
BP 15
EP 15
DI 10.1016/j.ijid.2016.11.042
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400031
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Martelli, CMT
   Castanha, P
   Cortes, F
   Rodrigues, L
   Marques, ET
   Eder, M
AF Martelli, C. M. T.
   Castanha, P.
   Cortes, F.
   Rodrigues, L.
   Marques, E. T.
   Eder, M.
TI High levels of exposure of Zika and Dengue infections detected using
   plaque reduction neutralization assay in Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Martelli, C. M. T.] Ctr Pesquisa Aggeu Magalhaes Fiocruz, Saude Colet, Recife, PE, Brazil.
   [Castanha, P.] Fiocruz Pernambuco, Recife, PE, Brazil.
   [Cortes, F.] LSHTM, London, England.
   [Rodrigues, L.; Marques, E. T.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA.
   [Eder, M.] North West London Hosp NHS Trust, Infect & Trop Med, Harrow, Middx, England.
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
FU PAHO; Brazilian MoH; ERAES
FX PAHO, Brazilian MoH and ERAES.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 08.005
BP 15
EP 15
DI 10.1016/j.ijid.2016.11.043
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400032
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Boltz, D
   Curry, P
   Baker, R
AF Boltz, D.
   Curry, P.
   Baker, R.
TI Development of models for Zika virus infection in mice and Rhesus
   macaques using a contemporary virus strain
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Boltz, D.; Curry, P.; Baker, R.] IIT Res Inst, MMB, Chicago, IL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 08.009
BP 16
EP 16
DI 10.1016/j.ijid.2016.11.045
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400034
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Guirakhoo, F
   Domi, A
   McCurley, N
   Robinson, H
AF Guirakhoo, F.
   Domi, A.
   McCurley, N.
   Robinson, H.
TI Development of a Zika vaccine using a novel MVA-VLP platform
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Guirakhoo, F.] Geovax, RD, Melrose, MA USA.
   [Domi, A.; McCurley, N.; Robinson, H.] Geovax, R&D, Atlanta, GA USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 08.010
BP 16
EP 17
DI 10.1016/j.ijid.2016.11.046
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400035
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vairo, F
   Valle, S
   Mammone, A
   Castilletti, C
   Nicastri, E
   Puro, V
   Capobianchi, M
   Ippolito, G
   Scognamiglio, P
   Team, AS
AF Vairo, F.
   Valle, S.
   Mammone, A.
   Castilletti, C.
   Nicastri, E.
   Puro, V.
   Capobianchi, M.
   Ippolito, G.
   Scognamiglio, P.
   Team, A. Seresmi
TI Regional surveillance for arbovirus in Lazio Region, Italy during the
   ZIKV epidemic in Latin America
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Vairo, F.; Valle, S.; Mammone, A.; Puro, V.; Scognamiglio, P.; Team, A. Seresmi] Natl Inst Infect Dis L Spallanzani, SERESMI, Rome, Italy.
   [Castilletti, C.; Nicastri, E.; Capobianchi, M.; Ippolito, G.] Natl Inst Infect Dis INMI L Spallanzani, Rome, Italy.
RI Castilletti, Concetta/AAA-8408-2019; nicastri, emanuele/K-7780-2016;
   Castilletti, Concetta/B-6545-2016
OI Castilletti, Concetta/0000-0001-9819-236X; nicastri,
   emanuele/0000-0002-5606-8712; Castilletti, Concetta/0000-0001-9819-236X
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 08.006
BP 16
EP 16
DI 10.1016/j.ijid.2016.11.044
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400033
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Arafat, R
   Arnold, R
   Persse, D
AF Arafat, R.
   Arnold, R.
   Persse, D.
TI Preparing for Zika virus in Houston, Texas: A comprehensive, city-wide
   approach
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Arafat, R.; Arnold, R.] Houston Hlth Dept, Off Surveillance & Publ Hlth Preparedness, Houston, TX USA.
   [Persse, D.] HHD, Houston, TX USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.128
BP 72
EP 72
DI 10.1016/j.ijid.2016.11.182
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400167
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kyaw, WM
   Loke, HY
   Chow, A
   Chan, M
   Leo, YS
AF Kyaw, W. M.
   Loke, H. Y.
   Chow, A.
   Chan, M.
   Leo, Y. S.
TI Surveillance of Zika virus infection: The experience of an adult
   tertiary care hospital in Singapore
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Kyaw, W. M.; Loke, H. Y.; Chow, A.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore.
   [Chan, M.; Leo, Y. S.] Tan Tock Seng Hosp, Infect Dis, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.161
BP 81
EP 82
DI 10.1016/j.ijid.2016.11.206
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400191
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU O'connor, C
   Pereboom, M
   Walsh, A
   Mohammed, H
   Dunning, J
AF O'connor, C.
   Pereboom, M.
   Walsh, A.
   Mohammed, H.
   Dunning, J.
TI The risk of sustained sexual transmission of Zika virus infection in
   England, United Kingdom
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [O'connor, C.] Publ Hlth England, Emerging Infect & Zoonoses, London, England.
   [Pereboom, M.] Publ Hlth England, Field Epidemiol Serv, London, England.
   [Walsh, A.] Hlth Protect Agcy, Gastrointestinal Emerging & Zoonot Infect, London, England.
   [Mohammed, H.] Publ Hlth England, HIV & STI Dept, London, England.
   [Dunning, J.] Publ Hlth England, Virol Reference Dept, London, England.
RI Dunning, Jake/U-7181-2019
OI Dunning, Jake/0000-0002-4035-4562
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.181
BP 86
EP 87
DI 10.1016/j.ijid.2016.11.219
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400204
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Martinez, N
   Moro, Z
   Torres, J
AF Martinez, N.
   Moro, Z.
   Torres, J.
TI Microhematospermia in acute Zika virus infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Martinez, N.] Univ Cent Venezuela, Inst Trop Med, Caracas, Venezuela.
   [Moro, Z.] Venezuelan Inst Sci Res, Caracas, Venezuela.
   [Torres, J.] Trop Med Inst, Caracas, Venezuela.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.198
BP 92
EP 93
DI 10.1016/j.ijid.2016.11.233
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400218
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Steinhagen, K
   Schmidt-Chanasit, J
   Emmerich, P
   Lattwein, E
   Fraune, J
   Schlumberger, W
   Warnecke, JM
AF Steinhagen, K.
   Schmidt-Chanasit, J.
   Emmerich, P.
   Lattwein, E.
   Fraune, J.
   Schlumberger, W.
   Warnecke, J. M.
TI Anti-Zika virus IgA as putative indicator of acute infection in
   anti-Zika virus IgM-negative patients
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Steinhagen, K.; Lattwein, E.; Fraune, J.; Schlumberger, W.] EUROIMMUN AG, Inst Expt Immunol, Lubeck, Germany.
   [Schmidt-Chanasit, J.] WHO Collaborating Ctr Arbovirus & Haemorrhag Feve, Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Emmerich, P.] Partner Site Hamburg Lubeck Borstel, German Ctr Infect Res DZIF, Hamburg, Germany.
   [Warnecke, J. M.] Euroimmun AG, Infect Serol, Lubeck, Germany.
NR 0
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.201
BP 93
EP 94
DI 10.1016/j.ijid.2016.11.235
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400220
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Langerak, T
   Yang, H
   Codrington, J
   Alberga, H
   Jacobs, B
   van Kessel, CG
   Reusken, C
   Koopmans, M
   van Gorp, E
   Vreden, S
AF Langerak, T.
   Yang, H.
   Codrington, J.
   Alberga, H.
   Jacobs, B.
   van Kessel, C. Geurts
   Reusken, C.
   Koopmans, M.
   van Gorp, E.
   Vreden, S.
TI Three patients from Suriname with possibly Zika virus associated
   Guillain-Barre syndrome
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Langerak, T.; van Kessel, C. Geurts; Reusken, C.] Erasmus MC, Virosci, Rotterdam, Netherlands.
   [Yang, H.; Alberga, H.; Vreden, S.] Acad Hosp Paramaribo, Neurol, Paramaribo, Suriname.
   [Codrington, J.] Acad Hosp Paramaribo, Diagnost Lab, Paramaribo, Suriname.
   [Jacobs, B.] Erasmus MC, Neurol & Immunol, Rotterdam, Netherlands.
   [Koopmans, M.; van Gorp, E.] Erasmus MC, Rotterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.208
BP 96
EP 96
DI 10.1016/j.ijid.2016.11.241
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400226
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Huff, A
   Allen, T
   Whiting, KA
   Arnold, B
   Breit, N
   Miessler, A
AF Huff, A.
   Allen, T.
   Whiting, K. A.
   Arnold, B.
   Breit, N.
   Miessler, A.
TI FLIRT, a web application to predict the movement of infected travelers
   validated against the current zika virus epidemic
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Huff, A.] Michigan State Univ, Vet Med, New York, NY USA.
   [Allen, T.; Whiting, K. A.] EcoHlth Alliance, Res Technol, New York, NY USA.
   [Arnold, B.] EcoHlth Alliance, Res Technol, Malone, NY USA.
   [Breit, N.] EcoHlth Alliance, Res Technol, Taipei, Taiwan.
   [Miessler, A.] EcoHlth Alliance, Res Technol, Grass Valley, CA USA.
NR 0
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.214
BP 97
EP 98
DI 10.1016/j.ijid.2016.11.245
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400230
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Trojanek, M
   Rohacova, H
   Zelena, H
   Sojkova, N
   Karimova, Z
   Rudova, T
   Stejskal, F
AF Trojanek, M.
   Rohacova, H.
   Zelena, H.
   Sojkova, N.
   Karimova, Z.
   Rudova, T.
   Stejskal, F.
TI Zika virus infection in Czech travellers
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Trojanek, M.; Stejskal, F.] Charles Univ Prague, Fac Med 2, Dept Infect Dis, Prague, Czech Republic.
   [Rohacova, H.; Karimova, Z.; Rudova, T.] Hosp Bulovce, Dept Infect Parasit & Trop Dis, Prague, Czech Republic.
   [Zelena, H.] Inst Publ Hlth, Dept Virol, Ostrava, Czech Republic.
   [Sojkova, N.] Inst Publ Hlth, Dept Virol, Prague, Czech Republic.
RI Trojanek, Milan/AAK-7890-2020
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.213
BP 97
EP 97
DI 10.1016/j.ijid.2016.11.244
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400229
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Fortescue-Webb, DC
   Dimitrov, BD
AF Fortescue-Webb, D. C.
   Dimitrov, B. D.
TI Nowcasting incidence of emergent zika virus infection and its outbreaks
   using Google Trends data: Examples from Brazil and Colombia
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Fortescue-Webb, D. C.] Univ Southampton, Fac Med, Southampton, Hants, England.
   [Dimitrov, B. D.] Univ Southampton, Primary Care & Populat Sci, Southampton, Hants, England.
NR 0
TC 0
Z9 0
U1 2
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 20.001
BP 98
EP 98
DI 10.1016/j.ijid.2016.11.247
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400232
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Tesha, FE
AF Tesha, F. E.
TI Tools and methods employed by community health centers in the prevention
   and control of zika virus infections in Bahia, Brazil
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Tesha, F. E.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 19.215
BP 98
EP 98
DI 10.1016/j.ijid.2016.11.246
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400231
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Leidinger-Kaufmann, P
   Steimer, M
   Carman, W
AF Leidinger-Kaufmann, P.
   Steimer, M.
   Carman, W.
TI Fast track diagnostics Zika virus kit - A real-time PCR based
   diagnostics assay
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Leidinger-Kaufmann, P.; Steimer, M.; Carman, W.] Fast Track Diagnost, Esch Sur Alzette, Luxembourg.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 20.033
BP 109
EP 109
DI 10.1016/j.ijid.2016.11.273
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400258
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hou, YA
   Sridhar, R
   Chan, HC
   Chiu, L
   Lee, CK
   Tambyah, PA
   Fisher, DA
   Bagdasarian, N
AF Hou, Y. A.
   Sridhar, R.
   Chan, H. C.
   Chiu, L.
   Lee, C. K.
   Tambyah, P. A.
   Fisher, D. A.
   Bagdasarian, N.
TI The Zika outbreak: An overview of suspected Zika cases presenting at a
   tertiary hospital in Singapore
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Hou, Y. A.; Chiu, L.; Lee, C. K.; Bagdasarian, N.] Natl Univ Singapore Hosp, Singapore, Singapore.
   [Sridhar, R.] Natl Univ Hlth Syst, Med, Singapore, Singapore.
   [Chan, H. C.; Fisher, D. A.] NUH, Infect Dis, Singapore, Singapore.
   [Tambyah, P. A.] Natl Univ Hlth Syst, Div Infect Dis, Dept Med, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 20.077
BP 123
EP 123
DI 10.1016/j.ijid.2016.11.305
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400290
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Oeser, CC
   Heath, P
   Johnson, K
   Khalil, A
   Lynn, R
   Knight, M
   Ladhani, S
   Morgan, D
   O'brien, P
   Pebody, R
AF Oeser, C. C.
   Heath, P.
   Johnson, K.
   Khalil, A.
   Lynn, R.
   Knight, M.
   Ladhani, S.
   Morgan, D.
   O'brien, P.
   Pebody, R.
TI Congenital Zika Syndrome: Establishing obstetric and paediatric
   surveillance in the UK and ROI
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Oeser, C. C.] Publ Hlth England, London, England.
   [Heath, P.] St Georges Univ London, Paediat Infect Dis, London, England.
   [Johnson, K.] Leeds Teaching Hosp, Neonatol, Leeds, W Yorkshire, England.
   [Khalil, A.] St Georges Univ London, Fetal Med, London, England.
   [Lynn, R.] Royal Coll Paediat & Child Hlth, British Paediat Surveillance Unit, London, England.
   [Knight, M.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England.
   [Ladhani, S.] Publ Hlth England, Immunisat Hepatitis & Blood Safety, London, England.
   [Morgan, D.] Publ Hlth England, Gastrointestinal Emerging & Zoonot Infect, London, England.
   [O'brien, P.] Univ Coll London Hosp, Womens Hlth, London, England.
   [Pebody, R.] Publ Hlth England, Dept Resp Dis, London, England.
RI Knight, Marian/B-6225-2009; Khall, Asma/AAC-1459-2020
OI Khall, Asma/0000-0003-2802-7670; Heath, Paul/0000-0002-7540-7433
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 20.097
BP 130
EP 130
DI 10.1016/j.ijid.2016.11.321
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400306
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Castro, JS
   Torres, J
   Oletta, J
   Strauss, R
AF Castro, J. S.
   Torres, J.
   Oletta, J.
   Strauss, R.
TI Google trend tool as a predictor of Chikungunya and Zika epidemic in a
   enviroment with little epidemiological data, a Venezuelan case
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Castro, J. S.] Inst Med Trop, Infect Dis, Caracas, Venezuela.
   [Torres, J.] Trop Med Inst, Caracas, Venezuela.
   [Oletta, J.] Red Defendamos Epidemiol, Caracas, Venezuela.
   [Strauss, R.] Hsch Angew Wissensch Hamburg Fak Life Sci, Fak Serv Buro, Hamburg, Germany.
NR 0
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 20.106
BP 133
EP 134
DI 10.1016/j.ijid.2016.11.329
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400314
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Slathia, PS
   Sharma, P
AF Slathia, P. S.
   Sharma, P.
TI Epitiope based DNA vaccine design using epitopes predicted from Zika
   virus polyprotein
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Slathia, P. S.; Sharma, P.] Shri Mata Vaishno Devi Univ, Biotechnol, Jammu, J&K, India.
OI SLATHIA, PARVEZ SINGH/0000-0002-9064-041X
NR 0
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 20.173
BP 149
EP 149
DI 10.1016/j.ijid.2016.11.364
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400349
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kempster, S
   Margaretto, CS
   Morris, C
   Anderson, R
   Almond, N
AF Kempster, S.
   Margaretto, C. Santirso
   Morris, C.
   Anderson, R.
   Almond, N.
TI Standardisation of Zika virus nucleic acid testing
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Kempster, S.; Margaretto, C. Santirso; Morris, C.; Anderson, R.; Almond, N.] NIBSC, Virol, Potters Bar, Herts, England.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA 20.194
BP 155
EP 155
DI 10.1016/j.ijid.2016.11.378
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400363
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vielle, NJ
   Zumkehr, B
   Musso, D
   Summerfield, A
   Alves, M
AF Vielle, N. J.
   Zumkehr, B.
   Musso, D.
   Summerfield, A.
   Alves, M.
TI Life cycle of Zika virus in human dendritic cells
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Meeting Abstract
C1 [Vielle, N. J.; Zumkehr, B.; Summerfield, A.; Alves, M.] Inst Immunol & Virol, Immunol, Mittelhausern, Switzerland.
   [Musso, D.] Inst Louis Malarde, Emerging Infect Dis Unit, Papeete Tahiti, French Polynesi, France.
RI Musso, Didier/P-7809-2016
OI Musso, Didier/0000-0002-9226-0971
NR 0
TC 0
Z9 0
U1 2
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD DEC
PY 2016
VL 53
SU S
MA Zika
BP 163
EP 163
DI 10.1016/j.ijid.2016.11.398
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA VE8AG
UT WOS:000440378400383
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Melo, ASD
   Aguiar, RS
   Amorim, MMR
   Arruda, MB
   Melo, FD
   Ribeiro, STC
   Batista, AGM
   Ferreira, T
   dos Santos, MP
   Sampaio, VV
   Moura, SRM
   Rabello, LP
   Gonzaga, CE
   Malinger, G
   Ximenes, R
   de Oliveira-Szejnfeld, PS
   Tovar-Moll, F
   Chimelli, L
   Silveira, PP
   Delvechio, R
   Higa, L
   Campanati, L
   Nogueira, RMR
   Filippis, AMB
   Szejnfeld, J
   Voloch, CM
   Ferreira, OC
   Brindeiro, RM
   Tanuri, A
AF de Oliveira Melo, Adriana Suely
   Aguiar, Renato Santana
   Ramos Amorim, Melania Maria
   Arruda, Monica B.
   Melo, Fabiana de Oliveira
   Clementino Ribeiro, Suelem Tais
   Medeiros Batista, Alba Gean
   Ferreira, Thales
   dos Santos, Mayra Pereira
   Sampaio, Virginia Vilar
   Martins Moura, Sarah Rogeria
   Rabello, Luciana Portela
   Gonzaga, Clarissa Emanuelle
   Malinger, Gustavo
   Ximenes, Renato
   de Oliveira-Szejnfeld, Patricia Soares
   Tovar-Moll, Fernanda
   Chimelli, Leila
   Silveira, Paola Paz
   Delvechio, Rodrigo
   Higa, Luiza
   Campanati, Loraine
   Nogueira, Rita M. R.
   Bispo Filippis, Ana Maria
   Szejnfeld, Jacob
   Voloch, Carolina Moreira
   Ferreira, Orlando C., Jr.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Congenital Zika Virus Infection Beyond Neonatal Microcephaly
SO JAMA NEUROLOGY
LA English
DT Article
ID CYTOMEGALOVIRUS-INFECTION; DIAGNOSTIC-APPROACH; TRANSMISSION; CHILDREN
AB IMPORTANCE Recent studies have reported an increase in the number of fetuses and neonates with microcephaly whose mothers were infected with the Zika virus (ZIKV) during pregnancy. To our knowledge, most reports to date have focused on select aspects of the maternal or fetal infection and fetal effects.
   OBJECTIVE To describe the prenatal evolution and perinatal outcomes of 11 neonates who had developmental abnormalities and neurological damage associated with ZIKV infection in Brazil.
   DESIGN, SETTING, AND PARTICIPANTS We observed 11 infants with congenital ZIKV infection from gestation to 6 monthus in the state of Paraba, Brazil. Ten of 11 women included in this study presented with symptoms of ZIKV infection during the first half of pregnancy, and all 11 had laboratory evidence of the infection in several tissues by serology or polymerase chain reaction. Brain damage was confirmed through intrauterine ultrasonography and was complemented by magnetic resonance imaging. Histopathological analysis was performed on the placenta and brain tissue from infants who died. The ZIKV genome was investigated in several tissues and sequenced for further phylogenetic analysis.
   MAIN OUTCOMES AND MEASURES Description of the major lesions caused by ZIKV congenital infection.
   RESULTS Of the 11 infants, 7 (63.6%) were female, and the median (SD) maternal age at delivery was 25 (6) years. Three of 11 neonates died, giving a perinatal mortality rate of 27.3%. The median (SD) cephalic perimeter at birth was 31 (3) cm, a value lower than the limit to consider a microcephaly case. In all patients, neurological impairments were identified, including microcephaly, a reduction in cerebral volume, ventriculomegaly, cerebellar hypoplasia, lissencephaly with hydrocephalus, and fetal akinesia deformation sequence (ie, arthrogryposis). Results of limited testing for other causes of microcephaly, such as genetic disorders and viral and bacterial infections, were negative, and the ZIKV genome was found in both maternal and neonatal tissues (eg, amniotic fluid, cord blood, placenta, and brain). Phylogenetic analyses showed an intrahost virus variation with some polymorphisms in envelope genes associated with different tissues.
   CONCLUSIONS AND RELEVANCE Combined findings from clinical, laboratory, imaging, and pathological examinations provided a more complete picture of the severe damage and developmental abnormalities caused by ZIKV infection than has been previously reported. The term congenital Zika syndrome is preferable to refer to these cases, as microcephaly is just one of the clinical signs of this congenital malformation disorder.
C1 [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira; Clementino Ribeiro, Suelem Tais; dos Santos, Mayra Pereira] Inst Saude Elpidio de Almeida, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Clementino Ribeiro, Suelem Tais; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela] Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Medeiros Batista, Alba Gean; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela; Gonzaga, Clarissa Emanuelle] Hosp Municipal Pedro I, Campina Grande, Paraiba, Brazil.
   [Aguiar, Renato Santana; Arruda, Monica B.; Silveira, Paola Paz; Delvechio, Rodrigo; Higa, Luiza; Voloch, Carolina Moreira; Ferreira, Orlando C., Jr.; Brindeiro, Rodrigo M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Ramos Amorim, Melania Maria; Ferreira, Thales] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Div Ultrasound Obstet & Gynecol, Lis Matern Hosp, Tel Aviv Sourasky Med Ctr,Sackler Fac Med, Tel Aviv, Israel.
   [Ximenes, Renato] Fundacao Med Fetal Latino Amer, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fundacao Inst Pesquisa & Ensino Diagnost Imagem, Sao Paulo, Brazil.
   [Tovar-Moll, Fernanda; Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nogueira, Rita M. R.; Bispo Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imagem, Sao Paulo, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, CCS Bloco Sala 121, BR-21941902 Rio De Janeiro, Brazil.
EM atanuri1@gmail.com
RI Melo, Adriana S O/H-5650-2016; Campanati, Loraine/V-2632-2018; Amorim,
   Melania M/C-5807-2013; Ferreira, Thales Araujo/AAA-6252-2019; Higa,
   Luiza/W-2698-2019; Voloch, Carolina M/F-8874-2013; Aguiar, Renato
   S/G-3542-2015
OI Campanati, Loraine/0000-0001-9172-1951; Amorim, Melania
   M/0000-0003-1047-2514; Voloch, Carolina M/0000-0001-5182-4366; Aguiar,
   Renato S/0000-0001-5180-3717
FU Consellho Nacional de Desenvolvimento e Pesquisa; Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Prefeitura Municipal
   de Campina Grande
FX This study was supported by Consellho Nacional de Desenvolvimento e
   Pesquisa, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and
   Prefeitura Municipal de Campina Grande.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EURO SURVEILL, V19
   Bosnjak VM, 2011, COLLEGIUM ANTROPOL, V35, P229
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002
   Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003
   Kouame N, 2013, Diagn Interv Imaging, V94, P433, DOI 10.1016/j.diii.2013.01.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller-Oehring EM, 2010, NEUROPSYCHOLOGIA, V48, P1133, DOI 10.1016/j.neuropsychologia.2009.12.015
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Romaniello R, 2015, BRAIN DEV-JPN, V37, P273, DOI 10.1016/j.braindev.2014.06.002
   Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zucca C, 2003, NEUROLOGY, V61, P710, DOI 10.1212/WNL.61.5.710
NR 33
TC 172
Z9 172
U1 0
U2 47
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 1
PY 2016
VL 73
IS 12
BP 1407
EP 1416
DI 10.1001/jamaneurol.2016.3720
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA EG5ZB
UT WOS:000391122200011
PM 27695855
OA Bronze
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Ventura, LO
   Bravo, V
   Martins, TT
   Berrocal, AM
   Gois, AL
   Dias, JRD
   Araujo, L
   Escariao, P
   van der Linden, V
   Belfort, R
   Maia, M
AF Ventura, Camila V.
   Ventura, Liana O.
   Bravo-Filho, Vasco
   Martins, Thayze T.
   Berrocal, Audina M.
   Gois, Adriana L.
   de Oliveira Dias, Joao Rafael
   Araujo, Leandro
   Escariao, Paulo
   van der Linden, Vanessa
   Belfort, Rubens, Jr.
   Maia, Mauricio
TI Optical Coherence Tomography of Retinal Lesions in Infants With
   Congenital Zika Syndrome
SO JAMA OPHTHALMOLOGY
LA English
DT Article
ID VIRUS; OUTBREAK
AB IMPORTANCE Zika virus (ZIKV) can cause severe changes in the retina and choroid that may result in marked visual impairment in infants with congenital Zika syndrome (CZS), the term created for a variety of anomalies associated with intrauterine ZIKV infection.
   OBJECTIVE To evaluate the affected retinal layers in infants with CZS and associated retinal abnormalities using optical coherence tomography (OCT).
   DESIGN, SETTING, AND PARTICIPANTS This cross-sectional, consecutive case series included 8 infants (age range, 3.0-5.1 months) with CZS. Optical coherence tomographic images were obtained in the affected eyes of 7 infants with CZS who had undergone previous ophthalmologic examinations on March 17, 2016, and in 1 infant on January 1, 2016. An IgM antibody-capture enzyme-linked immunosorbent assay for ZIKV was performed on the cerebrospinal fluid samples of 7 of the 8 infants (88%), and other congenital infections were ruled out.
   MAIN OUTCOMES AND MEASURES Observation of retinal and choroidal findings in the OCT images.
   RESULTS Among the 8 infants included in the study (3 male; 5 female; mean [SD] age at examination, 4.1 [0.7] months), 7 who underwent cerebrospinal fluid analysis for ZIKV had positive findings for IgM antibodies. Eleven of the 16 eyes (69%) of the 8 infants had retinal alterations and OCT imaging was performed in 9 (82%) of them. Optical coherence tomography was also performed in 1 unaffected eye. The main OCT findings in the affected eyes included discontinuation of the ellipsoid zone and hyperreflectivity underlying the retinal pigment epithelium in 9 eyes (100%), retinal thinning in 8 eyes (89%), choroidal thinning in 7 eyes (78%), and colobomatouslike excavation involving the neurosensory retina, retinal pigment epithelium, and choroid in 4 eyes (44%).
   CONCLUSIONS AND RELEVANCE Zika virus can cause severe damage to the retina, including the internal and external layers, and the choroid. The colobomatouslike finding seen in the OCT images relate to the excavated chorioretinal scar observed clinically.
C1 [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco; Martins, Thayze T.; Gois, Adriana L.; Araujo, Leandro; Escariao, Paulo] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; Ventura, Liana O.; Bravo-Filho, Vasco; Martins, Thayze T.; Gois, Adriana L.; Araujo, Leandro; Escariao, Paulo] Pernambuco Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Camila V.; de Oliveira Dias, Joao Rafael; Belfort, Rubens, Jr.; Maia, Mauricio] Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
   [Ventura, Camila V.; Berrocal, Audina M.; de Oliveira Dias, Joao Rafael] Bascom Palmer Eye Inst, Miami, FL 33136 USA.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Dept Pediat Neurol, Recife, PE, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Dept Ophthalmol & Visual Sci, Paulista Sch Med, Rua Botucatu 831, BR-04023062 Sao Paulo, SP, Brazil.
EM clinbelf@uol.com.br
RI Ventura, Camila V/N-2654-2018; Maia, Mauricio/I-5892-2015; Ventura,
   Liana Vieira O/N-6151-2018; Filho, Vasco/N-6993-2018; Escariao,
   Paulo/N-3349-2018
OI Ventura, Camila V/0000-0002-2927-4684; Maia,
   Mauricio/0000-0002-7034-8091; Ventura, Liana Vieira
   O/0000-0001-6529-6883; Filho, Vasco/0000-0003-4460-3236; Escariao,
   Paulo/0000-0003-3710-9475; Martins, Thayze/0000-0002-8082-2623; Gois,
   Adriana/0000-0001-5542-1097
CR Brasil Ministerio da Saude, INF EP NO 32 MON CAS
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de
   World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053
   Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oh Joo Youn, 2007, Korean J Ophthalmol, V21, P175, DOI 10.3341/kjo.2007.21.3.175
   Optovue, RTVUE 100 OPT COH TO
   Optovue, AV OPT COH TOM BROCH
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217
   Sun Lisa L, 2012, Digit J Ophthalmol, V18, P1, DOI 10.5693/djo.02.2012.04.001
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Trevino R, 2014, OPTOMETRY VISION SCI, V91, pS71, DOI 10.1097/OPX.0000000000000181
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villegas VM, 2014, OSLI RETINA, V45, P222, DOI 10.3928/23258160-20140410-01
   World Health Organization, 2015, EP AL NEUR SYNDR CON
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 27
Z9 27
U1 0
U2 36
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD DEC 1
PY 2016
VL 134
IS 12
BP 1420
EP 1427
DI 10.1001/jamaophthalmol.2016.4283
PG 9
WC Ophthalmology
SC Ophthalmology
GA EF8SR
UT WOS:000390600300020
PM 27832267
DA 2020-07-08
ER

PT J
AU Padilla, C
   Pan, A
   Geller, A
   Zakowski, MI
AF Padilla, Cesar
   Pan, Aileen
   Geller, Andrew
   Zakowski, Mark I.
TI Zika virus: review and obstetric anesthetic clinical considerations
SO JOURNAL OF CLINICAL ANESTHESIA
LA English
DT Review
DE Zika virus; Guillain-Barre; Uteroplacental insufficiency; Anesthetic
   considerations; Transmission prevention
ID GUILLAIN-BARRE-SYNDROME; CYTOMEGALOVIRUS-INFECTION; UNITED-STATES;
   PREGNANCY; TRANSMISSION; DELIVERY; BRAZIL; LABOR; RNA
AB Study Objectives: To review the clinical and basic science literature regarding Zika viral illness and highlight relevant findings for obstetric anesthesiologists. This review provides a global review of Zika viral illness, transmission patterns, pathophysiology of disease, and anesthetic management of the parturient with Zika viral illness and associated comorbidities.
   Design: Systematic review.
   Setting: Large academic hospital.
   Subjects: None.
   Interventions: None.
   Measurements: None.
   Main Results: None.
   Conclusion: With the rapid spread of Zika virus and expected increase of spread in the summer of 2016, this review provides anesthesiologists with current recommendations, physiologic alterations, and anesthetic considerations in regard to the parturient with Zika viral illness and associated diseases. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Padilla, Cesar; Pan, Aileen; Geller, Andrew; Zakowski, Mark I.] Cedars Sinai Med Ctr, Dept Anesthesiol, 8700 Beverly Blvd 8211, Los Angeles, CA 90048 USA.
RP Zakowski, MI (corresponding author), Cedars Sinai Med Ctr, Dept Anesthesiol, 8700 Beverly Blvd 8211, Los Angeles, CA 90048 USA.
EM Mark.Zakowski@cshs.org
CR [Anonymous], 2016, ZIKA VIRUS SPREADS N
   Atlee J., 2007, COMPLICATIONS ANESTH
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, N ENGL J MED
   Brooks H, 2000, ANAESTHESIA, V55, P894, DOI 10.1046/j.1365-2044.2000.01367.x
   Canada PHAo, 2012, CAN IMM GUID 4
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, US ZIK PREGN REG OBS
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Chan LYS, 2004, ACTA OBSTET GYN SCAN, V83, P319, DOI 10.1111/j.0001-6349.2004.0473.x
   Chestnut DH, 2014, CHESTNUTS OBSTET ANE
   Culler LE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1549
   Daniel KL, 2016, MMWR-MORBID MORTAL W, V65, P352, DOI 10.15585/mmwr.mm6513e1
   de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Gernsheimer T, 2013, BLOOD, V121, P38, DOI 10.1182/blood-2012-08-448944
   Jiang GX, 1996, NEUROEPIDEMIOLOGY, V15, P192, DOI 10.1159/000109907
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Kindhauser MK, 2016, B WHO
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MCGRADY EM, 1987, ANAESTHESIA, V42, P899, DOI 10.1111/j.1365-2044.1987.tb04130.x
   Meaney-Delman D, 2016, OBSTET GYNECOL
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Ornoy A, 2007, ISR MED ASSOC J, V9, P398
   Pastula DM, 2016, J NEUROVIROL
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROCKEL A, 1994, J PERINAT MED, V22, P393, DOI 10.1515/jpme.1994.22.5.393
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shah ASG, 2013, EPIDURAL ANALGESIA M
   Simeone RM, 2016, MMWR MORB MORTAL WKL
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   Singh M, 2013, NEUROL INDIA, V61, P541, DOI 10.4103/0028-3886.121946
   Stewart RD, 2013, CASE REP INFECT DIS, DOI 10.1155/2013/351872
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Tabata T, 2012, AM J PATHOL, V181, P1540, DOI 10.1016/j.ajpath.2012.08.003
   Volquind D, 2013, REV BRAS ANESTESIOL, V63, P370, DOI [10.1016/j.bjane.2012.06.002, 10.1016/j.bjan.2012.06.002]
   Vox F, 2016, WHAT REAL THREAT DOE
   Waggoner JJ, 2016, J CLIN MICROBIOL
   World Health Organization, DIR GEN SUMM OUTC EM
   Zapata JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002858
NR 56
TC 3
Z9 3
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0952-8180
EI 1873-4529
J9 J CLIN ANESTH
JI J. Clin. Anesth.
PD DEC
PY 2016
VL 35
BP 136
EP 144
DI 10.1016/j.jclinane.2016.07.034
PG 9
WC Anesthesiology
SC Anesthesiology
GA EE7HD
UT WOS:000389785600021
PM 27871511
DA 2020-07-08
ER

PT J
AU Azevedo, RSS
   Araujo, MT
   Martins, AJ
   Oliveira, CS
   Nunes, BTD
   Cruza, ACR
   Nascimento, AGPAC
   Medeiros, RC
   Caldas, CAM
   Araujo, FC
   Quaresma, JAS
   Vasconcelos, BCB
   Queiroz, MGL
   da Rosa, EST
   Henriques, DF
   Silva, EVP
   Chiang, JO
   Martins, LC
   Medeiros, DBA
   Lima, JA
   Nunes, MRT
   Cardoso, JF
   Silva, SP
   Shi, PY
   Tesh, RB
   Rodrigues, SG
   Vasconcelos, PFC
AF Azevedo, Raimunda S. S.
   Araujo, Marialva T.
   Martins Filho, Arnaldo J.
   Oliveira, Consuelo S.
   Nunes, Bruno T. D.
   Cruza, Ana C. R.
   Nascimento, Ana G. P. A. C.
   Medeiros, Rita C.
   Caldas, Cezar A. M.
   Araujo, Fernando C.
   Quaresma, Juarez A. S.
   Vasconcelos, Barbara C. B.
   Queiroz, Maria G. L.
   da Rosa, Elizabeth S. Travassos
   Henriques, Daniele F.
   Silva, Eliana V. P.
   Chiang, Jannifer O.
   Martins, Livia C.
   Medeiros, Daniele B. A.
   Lima, Juliana A.
   Nunes, Marcio R. T.
   Cardoso, Jedson F.
   Silva, Sandro P.
   Shi, Pei-Yong
   Tesh, Robert B.
   Rodrigues, Sueli G.
   Vasconcelos, Pedro F. C.
TI Zika virus epidemic in Brazil. I. Fatal disease in adults: Clinical and
   laboratorial aspects
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Erythematous lupus; Evans syndrome; Autoimmune disorders;
   Immunohistochemistry; Histopathology
ID YELLOW-FEVER; HUMAN LIVER; WESTERN-HEMISPHERE; INFECTION; EMERGENCE;
   AMERICA; MICRONESIA; COLOMBIA
AB Background: Zika virus (ZIKV) was first detected in Brazil in May 2015 and the country experienced an explosive epidemic. However, recent studies indicate that the introduction of ZIKV occurred in late 2013. Cases of microcephaly and deaths associated with ZIKV infection were identified in Brazil in November, 2015.
   Objectives: To determine the etiology of three fatal adult cases.
   Study design: Here we report three fatal adult cases of ZIKV disease. ZIKV infection in these patients was confirmed by cells culture and/or real-time reverse transcriptase polymerase chain reaction (RT-qPCR) and by antigen detection using immunohistochemical assay. Samples of brain and other selected organ staken at autopsy from three patients were also analyzed by histopathological and immunohistologicalexamination.
   Results: The first patient, a 36-year-old man with lupus and receiving prednisone therapy, developed a fulminant ZIKV infection. At autopsy, RT-qPCR of blood and tissues was positivefor ZIKV RNA, and the virus was cultured from an organ homogenate. The second patient, a previously healthy female, 16 years of age, presented classic symptoms of Zika fever, but later developed severe thrombocytopenia, anemia and hemorrhagic manifestations and died. A blood sample taken on the seventh day of her illness was positive RT-PCR for ZIKV RNA and research in the serum was positive for antinuclear factor fine speckled (1/640), suggesting Evans syndrome (hemolytic anemia an autoimmune disorder with immune thrombocytopenic purpura) secondary to ZIKV infection. The third patient was a 20-year-old woman hospitalized with fever, pneumonia and hemorrhages, who died on 13 days after admission. Histopathological changes were observed in all viscera examined. ZIKV antigens were detected by immunohistochemistry in viscera specimens of patients 1 and 3. These three cases demonstrate other potential complications of ZIKV infection, in addition to microcephaly and Guillain-Barre syndrome (GBS), and they suggest that individuals with immune suppression and/or autoimmune disorders may be at higher risk of developing severe disease, if infected with ZIKV. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Azevedo, Raimunda S. S.; Oliveira, Consuelo S.; Nunes, Bruno T. D.; Cruza, Ana C. R.; da Rosa, Elizabeth S. Travassos; Henriques, Daniele F.; Silva, Eliana V. P.; Chiang, Jannifer O.; Martins, Livia C.; Medeiros, Daniele B. A.; Lima, Juliana A.; Nunes, Marcio R. T.; Cardoso, Jedson F.; Silva, Sandro P.; Rodrigues, Sueli G.; Vasconcelos, Pedro F. C.] Minist Saude, Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
   [Araujo, Marialva T.; Martins Filho, Arnaldo J.] Minist Saude, Inst Evandro Chagas, Secao Patol, Ananindeua, Para, Brazil.
   [Cruza, Ana C. R.; Quaresma, Juarez A. S.; Vasconcelos, Barbara C. B.; Vasconcelos, Pedro F. C.] Univ Estado Para, Dept Patol, Belem, Para, Brazil.
   [Nascimento, Ana G. P. A. C.] Univ Fed Maranhao, Sao Luis, Maranhao, Brazil.
   [Medeiros, Rita C.; Caldas, Cezar A. M.; Araujo, Fernando C.] Univ Fed Para, Hosp Univ Joao de Barros Barreto, Belem, Para, Brazil.
   [Queiroz, Maria G. L.] Secretaria Saude Publ Rio Grande do Norte, Lab Cent, Natal, RN, Brazil.
   [Shi, Pei-Yong; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Azevedo, Raimunda S. S.; Cardoso, Jedson F.] Inst Evandro Chagas, PPGV, Ananindeua, Para, Brazil.
RP Vasconcelos, PFC (corresponding author), Minist Saude, Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
EM raimundaazevedo@iec.pa.gov.br; marialvaaraujo@iec.pa.gov.br;
   arnaldofilho@iec.pa.gov.br; consuelooliveira@iec.pa.gov.br;
   brunonunes@iec.pa.gov.br; anacecilia@iec.pa.gov.br;
   ana.giselia@globo.com; ritaclosset@uol.com.br;
   cezar_caldas@yahoo.com.br; fernando.stm@hotmail.com;
   juarez.quaresma@gmail.com; barbaravasconcelos@globo.com;
   lacenrn@yahoo.com.br; elizabethsalbe@iec.pa.gov.br;
   danielehenriques@iec.pa.gov.br; elianapinto@iec.pa.gov.br;
   anniferchiang@iec.pa.gov.br; liviamartins@iec.pa.gov.br;
   danielemedeiros@iec.pa.gov.br; julianaabreulima@hotmail.com;
   marcionunesbrasil@yahoo.com.br; jedson.cardoso@gmail.com;
   spatroca@gmail.com; peshi@utmb.edu; rtesh@utmb.edu;
   suelirodrigues@iec.pa.gov.br; pedrovasconcelos@iec.pa.gov.br
RI QUARESMA, JUAREZ ANTONIO SIMOES/F-8390-2012; Filho, Arnaldo Jorge
   Martins/AAJ-2779-2020; Quaresma, Juarez AS/M-4190-2014; Vasconcelos,
   Pedro/AAH-3142-2019; Azevedo, Raimunda/T-4656-2019
OI QUARESMA, JUAREZ ANTONIO SIMOES/0000-0002-6267-9966; Filho, Arnaldo
   Jorge Martins/0000-0001-9153-1234; Quaresma, Juarez
   AS/0000-0002-6267-9966; Azevedo, Raimunda/0000-0003-1932-9976
FU Ministry of Health through the Evandro Chagas Institute official budget;
   CNPq (PFCV) [573739/2008-0, 301641/2010-2, 457664/2013-4]; CAPES Zika
   Fast-track; CNPq Zika fund; FINEP Zika andother aarboviruses fund;
   National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24 AT120992]
FX This study was partially supported by the Ministry of Health through the
   Evandro Chagas Institute official budget and by CNPq (PFCV by grants
   573739/2008-0, 301641/2010-2 and 457664/2013-4), CAPES Zika Fast-track,
   the CNPq Zika fund, and FINEP Zika andother aarboviruses fund; RBT is
   supported by the grant R24 AT120992 from National Institute of Health.
CR Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kleinschmidt-DeMasters BK, 2004, ARCH NEUROL-CHICAGO, V61, P1210, DOI 10.1001/archneur.61.8.1210
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Mateo R, 2006, AM J TROP MED HYG, V75, P356, DOI 10.4269/ajtmh.2006.75.356
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   P. A. H. O. PAHO, 2016, ZIK EP UPD 29 JUL 20
   Pagliari C, 2016, J CLIN VIROL, V75, P16, DOI 10.1016/j.jcv.2015.12.005
   Pagliari C, 2014, J MED VIROL, V86, P1193, DOI 10.1002/jmv.23758
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058
   Quaresma JAS, 2005, ACTA TROP, V94, P116, DOI 10.1016/j.actatropica.2005.03.003
   Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   VASCONCELOS PFD, 2015, REV PAN-AMAZ SAUDE, V6, P9, DOI DOI 10.5123/S2176-62232015000200001
NR 32
TC 44
Z9 46
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD DEC
PY 2016
VL 85
BP 56
EP 64
DI 10.1016/j.jcv.2016.10.024
PG 9
WC Virology
SC Virology
GA EC9HW
UT WOS:000388456400012
PM 27835759
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Han, M
   Hashemi, S
   Joo, SH
   Kim, T
AF Han, Mooyoung
   Hashemi, Shervin
   Joo, Sung Hee
   Kim, Tschungil
TI Novel integrated systems for controlling and prevention of
   mosquito-borne diseases caused by poor sanitation and improper water
   management
SO JOURNAL OF ENVIRONMENTAL CHEMICAL ENGINEERING
LA English
DT Article
DE Public health; Rainwater harvesting and management; Sustainable
   development goals; Sustainable water and sanitation management
AB Mosquito-borne diseases, as a threat to public health, are primarily caused by the lack of clean water access and poor sanitation. On the way to overcome these problems, the sixth goal of Sustainable Development Goals (SDG-6) is imperative to improve sanitation practices and access to clean water supplies in a safe and sustainable way. By considering weak points of current centralized water and sanitation systems on the way to achieve SDG-6, finding sustainable approaches as alternative to unrealistic, unreliable and uneconomical water supplies (e.g. dams, groundwater and bottled water) and dangerous sanitation practices such as open defecation is essential to protect the public's health against the recently spreading diseases such as Zika, Ebola, Malaria, etc. In this case, we developed novel integrated systems in which rainwater harvesting systems and waterless toilets, along with self-cleaning ponds. In this paper, suitable key elements and their roles in new water and sanitation management are introduced together with assessments of each key system identified for both public and residential zones. Comparisons with the current treatment plants by using economic analysis are discussed with reasonable parameters. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Han, Mooyoung; Hashemi, Shervin] Seoul Natl Univ, Dept Civil & Environm Engn, 1 Gwanak Ro, Seoul 08826, South Korea.
   [Joo, Sung Hee] Univ Miami, Dept Civil Architectural & Environm Engn, 1251 Mem Dr McArthur Engn Bldg, Coral Gables, FL 33146 USA.
   [Kim, Tschungil] Seoul Natl Univ, Integrated Res Inst Construct & Environm Engn, 1 Gwanak Ro, Seoul 08826, South Korea.
RP Han, M (corresponding author), Seoul Natl Univ, Dept Civil & Environm Engn, 1 Gwanak Ro, Seoul 08826, South Korea.
EM myhan@snu.ac.kr
RI Hashemi, Shervin/K-2450-2019
OI Hashemi, Shervin/0000-0001-6999-5235
FU Korea Ministry of Environment as Eco-Innovation project [413-111-008];
   Advanced Industrial Technology Development project [2014000150010]
FX This research was supported by Korea Ministry of Environment as
   Eco-Innovation project [grant number 413-111-008] and Advanced
   Industrial Technology Development project [grant number 2014000150010].
CR Amin MT, 2009, WATER RES, V43, P5225, DOI 10.1016/j.watres.2009.08.041
   Nguyen DC, 2014, J WATER SUPPLY RES T, V63, P578, DOI 10.2166/aqua.2014.087
   Han M., 2015, KR patent application, Patent No. 0051067
   Hashemi S., 2015, P 8 C INT FOR URB IN, P873, DOI [DOI 10.3390/IFOU-E013, 10.3390/ifou-e013]
   Hashemi S, 2016, J SCI FOOD AGR, V96, P4416, DOI 10.1002/jsfa.7652
   Hutton G, 2007, J WATER HEALTH, V5, P481, DOI 10.2166/wh.2007.009
   Kim Y., 2016, WATER SCI TECHNOL, V1
   Kim Y, 2016, DISASTER MED PUBLIC, V10, P281, DOI 10.1017/dmp.2015.166
   Mun JS, 2012, J ENVIRON MANAGE, V93, P147, DOI 10.1016/j.jenvman.2011.08.024
   Mwamila TB, 2015, WATER SCI TECH-W SUP, V15, P974, DOI 10.2166/ws.2015.053
   Nguyen Duc Kanh, 2013, Environmental Engineering Research, V18, P109
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   WHO, 2015, PROGR SAN DRINK WAT, P2015
NR 13
TC 10
Z9 10
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2213-3437
J9 J ENVIRON CHEM ENG
JI J. Environ. Chem. Eng.
PD DEC
PY 2016
VL 4
IS 4
BP 3718
EP 3723
DI 10.1016/j.jece.2016.08.013
PN A
PG 6
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA EH3VU
UT WOS:000391700900002
DA 2020-07-08
ER

PT J
AU Zhang, GM
   Etebari, K
   Asgari, S
AF Zhang, Guagmei
   Etebari, Kayvan
   Asgari, Sassan
TI Wolbachia suppresses cell fusing agent virus in mosquito cells
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
ID WEST NILE VIRUS; INSECT-SPECIFIC FLAVIVIRUSES; LIFE-SHORTENING
   WOLBACHIA; AEDES-AEGYPTI; CULEX FLAVIVIRUS; ANTIVIRAL PROTECTION;
   INFECTION; TRANSMISSION; POPULATION; DROSOPHILA
AB The genus Flavivirus contains a large number of positive-sense ssRNA viruses. While some are transmitted by mosquitoes or other arthropods and are pathogenic to humans and animals (e. g. dengue and Zika viruses), some are insect-specific and do not replicate in vertebrate cells. These are known as insect-specific flaviviruses (ISFs). Cell fusing agent virus (CFAV) was the first described ISF, which was detected in an Aedes aegypti cell line, Aag2. Here, we investigated the effect of Wolbachia, a widespread endosymbiont of many insect species, that is known to block replication of several pathogenic flaviviruses, on CFAV. Our results demonstrated that, in mosquito cells, Wolbachia vastly suppresses replication of CFAV, with significantly less CFAV viral interfering small RNAs produced in the cells. However, removal of Wolbachia with tetracycline led to increased CFAV replication. These results suggest that Wolbachia is also able to suppress an ISF.
C1 [Zhang, Guagmei; Etebari, Kayvan; Asgari, Sassan] Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld 4072, Australia.
RP Asgari, S (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Biol Sci, Brisbane, Qld 4072, Australia.
EM s.asgari@uq.edu.au
RI Asgari, Sassan/G-2678-2011; Etebari, Kayvan/C-6436-2008
OI Asgari, Sassan/0000-0001-7885-6544; Etebari, Kayvan/0000-0001-5213-6362
FU Australian Research Council grant (ARC)Australian Research Council
   [DP150101782]; National Health and Medical Research Council
   (NHMRC)National Health and Medical Research Council of Australia
   [APP1062983]
FX This project was funded by the Australian Research Council grant (ARC,
   DP150101782) and the National Health and Medical Research Council
   (NHMRC, APP1062983) to S. A.
CR Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Calzolari M, 2012, J GEN VIROL, V93, P1215, DOI 10.1099/vir.0.040485-0
   CAMMISAPARKS H, 1992, VIROLOGY, V189, P511, DOI 10.1016/0042-6822(92)90575-A
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0
   Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1
   Espinoza-Gomez F, 2011, ARCH VIROL, V156, P1263, DOI 10.1007/s00705-011-0967-2
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Goenaga S, 2014, J MED ENTOMOL, V51, P900, DOI 10.1603/ME13172
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hedges LM, 2012, APPL ENVIRON MICROB, V78, P6773, DOI 10.1128/AEM.01650-12
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x
   Johnson KN, 2015, CURR OPIN INSECT SCI, V8, P97, DOI 10.1016/j.cois.2015.01.008
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Khoo CCH, 2013, B ENTOMOL RES, V103, P251, DOI 10.1017/S0007485312000648
   Kihara Y, 2007, J VIROL METHODS, V146, P372, DOI 10.1016/j.jviromet.2007.07.008
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Lutomiah JJL, 2007, J INSECT SCI, V7
   Mayoral JG, 2014, P NATL ACAD SCI USA, V111, P18721, DOI 10.1073/pnas.1420131112
   Mayoral JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096107
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nasar F, 2015, VIROLOGY, V484, P51, DOI 10.1016/j.virol.2015.05.009
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Roby JA, 2012, MOLECULAR VIROLOGY AND CONTROL OF FLAVIVIRUSES, P21
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
NR 51
TC 19
Z9 19
U1 1
U2 20
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD DEC
PY 2016
VL 97
BP 3427
EP 3432
DI 10.1099/jgv.0.000653
PN 12
PG 6
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA EF9XF
UT WOS:000390684000032
PM 27902358
OA Bronze
DA 2020-07-08
ER

PT J
AU Elfiky, AA
AF Elfiky, Abdo A.
TI Zika viral polymerase inhibition using anti-HCV drugs both in market and
   under clinical trials
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE molecular modeling; Zika virus; polymerase; nucleotide inhibitors;
   IDX-184; protein-ligand docking
ID SERINE-PROTEASE; VIRUS OUTBREAK; HEPATITIS; SOFOSBUVIR; THERAPY
AB In the last few months, a new Zika virus (ZIKV) outbreak evolved in America. In accordance, World Health Organization (WHO) in February 2016 declared it as Public Health Emergency of International Concern (PHEIC). ZIKV infection was reported in more than 60 countries and the disease was spreading since 2007 but with little momentum. Many antiviral drugs are available in market or in laboratories under clinical trials, could affect ZIKV infection. In silico docking study were performed on the ZIKV polymerase to test some of Hepatitis C Virus (HCV) drugs (approved and in clinical trials). The results show potency of almost all of the studied compounds on ZIKV polymerase and hence inhibiting the propagation of the disease. In addition, the study suggested two nucleotide inhibitors (IDX-184 and MK0608) that may be tested as drugs against ZIKV infection. J. Med. Virol. 88:2044-2051, 2016. (c) 2016 Wiley Periodicals, Inc.
C1 [Elfiky, Abdo A.] Cairo Univ, Dept Biophys, Fac Sci, Giza 12613, Egypt.
RP Elfiky, AA (corresponding author), Cairo Univ, Dept Biophys, Fac Sci, Giza 12613, Egypt.
EM abdo@sci.cu.edu.eg
RI Mohamed, Abdo/H-3595-2019
OI Mohamed, Abdo/0000-0003-4600-6240
CR [Anonymous], PYMOL MOL GRAPH SYST
   Asselah T, 2014, J HEPATOL, V61, P435, DOI 10.1016/j.jhep.2014.04.042
   Bahgat MM, 2009, ARCH VIROL, V154, P1649, DOI 10.1007/s00705-009-0500-z
   Bellissent-Funel MC, 2016, CHEM REV, V116, P7673, DOI 10.1021/acs.chemrev.5b00664
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Das D, 2011, BIOORGAN MED CHEM, V19, P4690, DOI 10.1016/j.bmc.2011.06.079
   De Francesco R, 2003, ANTIVIR RES, V58, P1, DOI 10.1016/S0166-3542(03)00028-7
   De Francesco R, 2007, ADV DRUG DELIVER REV, V59, P1242, DOI 10.1016/j.addr.2007.04.016
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elfiky AA, HEPATITIS C IN PRESS
   Elfiky AA, 2016, MED CHEM RES, V25, P1005, DOI 10.1007/s00044-016-1533-y
   Elfiky AA, 2015, J COMPUT THEOR NANOS, V12, P376, DOI 10.1166/jctn.2015.3739
   Elfiky AA, 2013, PROTEIN J, V32, P75, DOI 10.1007/s10930-013-9462-9
   Genovese D, 2005, J CLIN MICROBIOL, V43, P1902, DOI 10.1128/JCM.43.4.1902-1909.2005
   Gonzalez-Grande R, 2016, WORLD J GASTROENTERO, V22, P1421, DOI 10.3748/wjg.v22.i4.1421
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AJW, 1964, B WID HLTH ORG, V31, P69
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemon SM, 2010, ANTIVIR RES, V86, P79, DOI 10.1016/j.antiviral.2010.02.003
   Love RA, 1996, CELL, V87, P331, DOI 10.1016/S0092-8674(00)81350-1
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Sacramento CQ, 2016, BIORXIV
   Saleh NA, 2015, J COMPUT THEOR NANOS, V12, P371, DOI 10.1166/jctn.2015.3738
   Saleh NA, 2014, J COMPUT THEOR NANOS, V11, P544, DOI 10.1166/jctn.2014.3392
   Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Summers KL, 2012, BIOCHEM BIOPH RES CO, V425, P485, DOI 10.1016/j.bbrc.2012.07.141
   Tong J, 2012, J ZHEJIANG UNIV-SC B, V13, P56, DOI 10.1631/jzus.B1100120
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Yan SQ, 2006, BIOORG MED CHEM LETT, V16, P5888, DOI 10.1016/j.bmcl.2006.08.056
   Yang PL, 2011, CURR OPIN VIROL, V1, P607, DOI 10.1016/j.coviro.2011.10.019
   Zumla A, 2016, INT J INFECT DIS, V45, P92, DOI 10.1016/j.ijid.2016.02.1007
NR 42
TC 36
Z9 36
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD DEC
PY 2016
VL 88
IS 12
BP 2044
EP 2051
DI 10.1002/jmv.24678
PG 8
WC Virology
SC Virology
GA DZ3DF
UT WOS:000385724000006
PM 27604059
DA 2020-07-08
ER

PT J
AU Sakkas, H
   Economou, V
   Papadopoulou, C
AF Sakkas, Hercules
   Economou, Vangelis
   Papadopoulou, Chrissanthy
TI Zika virus infection: Past and present of another emerging vector-borne
   disease
SO JOURNAL OF VECTOR BORNE DISEASES
LA English
DT Review
DE Aedes; Brazil; Flavivirus Polynesia; Yap; Zika virus
ID FRENCH-POLYNESIA; BRAZIL; AEDES; TRANSMISSION; MOSQUITOS; OUTBREAK;
   AMERICA; CHIKUNGUNYA; DENGUE; ISOLATIONS
AB Zika virus infection is an emerging mosquito-borne disease, first identified in Uganda in 1947. It is caused by the Zika arbovirus, and transmitted by the bites of infected mosquitoes of the genus Aedes. For almost half a century, the Zika virus was reported as the causative agent of sporadic human infections. In 2007, the Zika virus emerged outside Asia and Africa causing an epidemic on the Island of Yap in Micronesia. The manifestation of the newly acquired human infection varies from asymptomatic to self-limiting acute febrile illness with symptoms and clinical features similar to those caused by the Dengue virus ('Dengue-like syndrome'). The real-time PCR and serological methods have been successfully applied for the diagnosis of the disease. The treatment is symptomatic, since there is no specific antiviral treatment or a vaccine. During the recent outbreaks in French Polynesia and Brazil, incidents of Guillain-Barre syndrome and microcephaly were associated with Zika virus infection, giving rise to fears of further global spread of the virus. Prevention and vector control strategies have to be urgently implemented by national health authorities in order to contain future outbreaks in vulnerable populations. This review summarizes the existing information on Zika virus characteristics, pathogenesis and epidemiology, the available methods for the diagnosis of Zika virus infection and recent approaches for prevention and control.
C1 [Sakkas, Hercules; Papadopoulou, Chrissanthy] Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Microbiol, GR-45110 Ioannina, Greece.
   [Economou, Vangelis] Aristotle Univ Thessaloniki, Fac Vet Med, Sch Hlth Sci, Lab Hyg Foods Anim Origin, Thessaloniki, Greece.
RP Sakkas, H (corresponding author), Univ Ioannina, Fac Med, Sch Hlth Sci, Dept Microbiol, GR-45110 Ioannina, Greece.
EM isakkas@uoi.gr
RI Sakkas, Hercules/AAH-8344-2019; Papadopoulou, Chrissanthy/AAC-2390-2019
OI Papadopoulou, Chrissanthy/0000-0002-1628-1009
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Torjesen I, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i500
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang B, 2015, NANOMED-NANOTECHNOL, V11, P1745, DOI 10.1016/j.nano.2015.05.009
NR 48
TC 17
Z9 18
U1 2
U2 26
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0972-9062
J9 J VECTOR DIS
JI J. Vector Borne Dis.
PD DEC
PY 2016
VL 53
IS 4
BP 305
EP 311
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EJ3IC
UT WOS:000393104800002
PM 28035106
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Chen, RB
   Puri, V
   Fedorova, N
   Lin, D
   Hari, KL
   Jain, R
   Rodas, JD
   Das, SR
   Shabman, RS
   Weaver, SC
AF Chen, Rubing
   Puri, Vinita
   Fedorova, Nadia
   Lin, David
   Hari, Kumar L.
   Jain, Ravi
   Rodas, Juan David
   Das, Suman R.
   Shabman, Reed S.
   Weaver, Scott C.
TI Comprehensive Genome Scale Phylogenetic Study Provides New Insights on
   the Global Expansion of Chikungunya Virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID AEDES-ALBOPICTUS; GENETIC DIVERSITY; ZIKA VIRUS; INDIA; OUTBREAK;
   AEGYPTI; DETERMINANTS; TRANSMISSION; REEMERGENCE; PHILIPPINES
AB Since the India and Indian Ocean outbreaks of 2005 and 2006, the global distribution of chikungunya virus (CHIKV) and the locations of epidemics have dramatically shifted. First, the Indian Ocean lineage (IOL) caused sustained epidemics in India and has radiated to many other countries. Second, the Asian lineage has caused frequent outbreaks in the Pacific islands and in 2013 was introduced into the Caribbean, followed by rapid spread to nearly all of the neotropics. Further, CHIKV epidemics, as well as exported cases, have been reported in central Africa after a long period of perceived silence. To understand these changes and to anticipate the future of the virus, the exact distribution, genetic diversity, transmission routes, and future epidemic potential of CHIKV require further assessment. To do so, we conducted the most comprehensive phylogenetic analysis to date, examined CHIKV evolution and transmission, and explored distinct genetic factors associated with the emergence of the East/Central/South African (ECSA) lineage, the IOL, and the Asian lineage. Our results reveal contrasting evolutionary patterns among the lineages, with growing genetic diversities observed in each, and suggest that CHIKV will continue to be a major public health threat with the potential for further emergence and spread.
   IMPORTANCE
   Chikungunya fever is a reemerging infectious disease that is transmitted by Aedes mosquitoes and causes severe health and economic burdens in affected populations. Since the unprecedented Indian Ocean and Indian subcontinent outbreaks of 2005 and 2006, CHIKV has further expanded its geographic range, including to the Americas in 2013. Its evolution and transmission during and following these epidemics, as well as the recent evolution and spread of other lineages, require optimal assessment. Using newly obtained genome sequences, we provide a comprehensive update of the global distribution of CHIKV genetic diversity and analyze factors associated with recent outbreaks. These results provide a solid foundation for future evolutionary studies of CHIKV that can elucidate emergence mechanisms and also may help to predict future epidemics.
C1 [Chen, Rubing; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immunol, Galveston, TX 77555 USA.
   [Chen, Rubing; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Puri, Vinita; Fedorova, Nadia; Das, Suman R.; Shabman, Reed S.] J Craig Venter Inst, Rockville, MD USA.
   [Lin, David; Hari, Kumar L.; Jain, Ravi] CBio Inc, Fremont, CA USA.
   [Rodas, Juan David] Univ Antioquia, Medellin, Colombia.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immunol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Rodas, Juan David/AAM-6382-2020; Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556
FU Department of Homeland SecurityUnited States Department of Homeland
   Security (DHS) [HSHQDC-13-C-B0009]; HHS \ NIH \ National Institute of
   Allergy and Infectious Diseases (NIAID) [AI120942, AI121452,
   U19AI110819]
FX This work, including the efforts of David Lin, Kumar Hari, and Ravi
   Jain, was funded by Department of Homeland Security (HSHQDC-13-C-B0009).
   This work, including the efforts of Rubing Chen, was funded by
   Department of Homeland Security (HSHQDC-13-C-B0009). This work,
   including the efforts of Scott C. Weaver, was funded by Department of
   Homeland Security (HSHQDC-13-C-B0009). This work, including the efforts
   of Scott C. Weaver, was funded by HHS vertical bar NIH vertical bar
   National Institute of Allergy and Infectious Diseases (NIAID) (AI120942
   and AI121452). This work, including the efforts of Rubing Chen, was
   funded by HHS vertical bar NIH vertical bar National Institute of
   Allergy and Infectious Diseases (NIAID) (AI121452). This work, including
   the efforts of Vinita Puri and Nadia Fedorova, was funded by HHS
   vertical bar NIH vertical bar National Institute of Allergy and
   Infectious Diseases (NIAID) (U19AI110819). This work, including the
   efforts of Suman R. Das and Reed S. Shabman, was funded by HHS vertical
   bar NIH vertical bar National Institute of Allergy and Infectious
   Diseases (NIAID) (U19AI110819).
CR AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Chen RB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003591
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chua K B, 2010, Med J Malaysia, V65, P277
   Conteville LC, 2016, MEM I OSWALDO CRUZ, V111, P347, DOI 10.1590/0074-02760160004
   D'Ortenzio E, 2011, EMERG INFECT DIS, V17, P309, DOI 10.3201/eid1702.101056
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Galatas B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004281
   Galbraith SE, 2006, J GEN VIROL, V87, P937, DOI 10.1099/vir.0.81406-0
   Ganushkina LA, 2016, VECTOR-BORNE ZOONOT, V16, P58, DOI 10.1089/vbz.2014.1761
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Ho SYW, 2014, MOL ECOL, V23, P5947, DOI 10.1111/mec.12953
   Kaariainen L, 2002, PROG NUCLEIC ACID RE, V71, P187, DOI 10.1016/S0079-6603(02)71044-1
   Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar CVMN, 2016, ACTA VIROL, V60, P114, DOI 10.4149/av_2016_01_114
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LASTARZA MW, 1994, VIROLOGY, V202, P224, DOI 10.1006/viro.1994.1338
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Maha MS, 2015, EMERG INFECT DIS, V21, P379, DOI 10.3201/eid2102.141121
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Nitatpattana N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-183
   Noridah O, 2007, Med J Malaysia, V62, P323
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Parashar D, 2015, INDIAN J MED RES, V142, P111, DOI 10.4103/0971-5916.176639
   Paupy C, 2012, VECTOR-BORNE ZOONOT, V12, P167, DOI 10.1089/vbz.2011.0736
   Petersen Lyle R, 2016, F1000Res, V5, DOI 10.12688/f1000research.7171.1
   Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Posada David, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0605s00
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sam IC, 2009, J CLIN VIROL, V46, P180, DOI 10.1016/j.jcv.2009.07.016
   Saxton-Shaw KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001931
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Stockwell TB, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.01255-15
   Sumathy K, 2012, J MED VIROL, V84, P462, DOI 10.1002/jmv.23187
   Sy AK, 2016, EMERG INFECT DIS, V22, P887, DOI 10.3201/eid2205.151268
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Wang CL, 2016, AM J TROP MED HYG, V94, P400, DOI 10.4269/ajtmh.15-0497
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 72
TC 31
Z9 31
U1 0
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD DEC
PY 2016
VL 90
IS 23
BP 10600
EP 10611
DI 10.1128/JVI.01166-16
PG 12
WC Virology
SC Virology
GA EE8VL
UT WOS:000389904500014
PM 27654297
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Van Kerkhove, MD
   Reveiz, L
   Souza, JP
   Jaenisch, T
   Carson, G
   Broutet, N
AF Van Kerkhove, Maria D.
   Reveiz, Ludovic
   Souza, Joao Paulo
   Jaenisch, Thomas
   Carson, Gail
   Broutet, Nathalie
CA Working Grp ZIKV Harmonized Res
TI Harmonisation of Zika virus research protocols to address key public
   health concerns
SO LANCET GLOBAL HEALTH
LA English
DT Letter
C1 [Van Kerkhove, Maria D.] Inst Pasteur, Ctr Global Hlth, Paris, France.
   [Reveiz, Ludovic] Pan Amer Hlth Org, Knowledge Management Bioeth & Res Off, Washington, DC USA.
   [Souza, Joao Paulo; Broutet, Nathalie] WHO, Geneva, Switzerland.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
   [Jaenisch, Thomas] Int Res Consortium Dengue Risk Assessment Managem, Heidelberg, Germany.
   [Carson, Gail] Int Severe Acute Resp & Emerging Infect Consortiu, Oxford, England.
RP Van Kerkhove, MD (corresponding author), Inst Pasteur, Ctr Global Hlth, Paris, France.
EM Maria.Van-Kerkhove@pasteur.fr
RI Jaenisch, Thomas/H-3473-2017; Souza, Joao Paulo/G-1982-2010
OI Souza, Joao Paulo/0000-0002-2288-4244
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15001];
   World Health OrganizationWorld Health Organization [001]
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   CDC-Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control Rapid Risk Assessment, ZIK VIR EP AM POT AS
   Ministerio da Saude, DECL EM SAUD PUBL IM
   Pan American Health Organization, ZIK VIR INF
   Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI 10.1111/irv.12074
   WHO, WHO DIR GEN SUMM OUT
   WHO, GUILL BARR SYNDR EL
   World Health Organziation, 2005, 4 M EM COMM INT HLTH
NR 10
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD DEC
PY 2016
VL 4
IS 12
BP E911
EP E912
DI 10.1016/S2214-109X(16)30255-8
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EJ2FV
UT WOS:000393026400022
PM 27815145
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Brasil, P
   Nielsen-Saines, K
AF Brasil, Patricia
   Nielsen-Saines, Karin
TI More pieces to the microcephaly-Zika virus puzzle in Brazil
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Brasil, Patricia] Fiocruz RJ, BR-22010122 Rio De Janeiro, Brazil.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.
RP Brasil, P (corresponding author), Fiocruz RJ, BR-22010122 Rio De Janeiro, Brazil.
EM patricia.brasil@ini.fiocruz.br
CR Araujo TVB, 2016, LANCET INFECT DIS
   Brasil Ministerio da Satide, 2015, 12015 BARS MIN SAUD
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 11
TC 12
Z9 12
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1307
EP 1309
DI 10.1016/S1473-3099(16)30372-3
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800003
PM 27641776
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU de Araujo, TVB
   Rodrigues, LC
   Ximenes, RADA
   Miranda-Filho, DDB
   Montarroyos, UR
   de Melo, APL
   Valongueiro, S
   de Albuquerque, MDFPM
   Souza, WV
   Braga, C
   Filho, SPB
   Cordeiro, MT
   Vazquez, E
   Cruz, DDCS
   Henriques, CMP
   Bezerra, LCA
   Castanha, PMDS
   Dhalia, R
   Marques-Junior, ETA
   Martell, CMT
AF de Araujo, Thalia Velho Barreto
   Rodrigues, Laura Cunha
   Ximenes, Ricardo Arraes de Alencar
   Miranda-Filho, Democrito de Barros
   Montarroyos, Ulisses Ramos
   de Melo, Ana Paula Lopes
   Valongueiro, Sandra
   de Albuquerque, Maria de Fcitima Pessoa Militao
   Souza, Wayner Vieira
   Braga, Cynthia
   Filho, Sinval Pinto Brandao
   Cordeiro, Marli Tenorio
   Vazquez, Enrique
   Cruz, Danielle Di Cavalcanti Souza
   Henriques, Clciudio Maierovitch Pessanha
   Bezerra, Luciana Caroline Albuquerque
   Castanha, Priscila Mayrelle da Silva
   Dhalia, Rafael
   Marques-Junior, Ernesto Torres Azevedo
   Martelli, Celina Maria Turchi
TI Association between Zika virus infection and microcephaly in Brazil,
   January to May, 2016: preliminary report of a case-control study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID AMERICA; FETAL
AB Background The microcephaly epidemic, which started in Brazil in 2015, was declared a Public Health Emergency of International Concern by WHO in 2016. We report the preliminary results of a case-control study investigating the association between microcephaly and Zika virus infection during pregnancy.
   Methods We did this case-control study in eight public hospitals in Recife, Brazil. Cases were neonates with microcephaly. Two controls (neonates without microcephaly), matched by expected date of delivery and area of residence, were selected for each case. Serum samples of cases and controls and cerebrospinal fluid samples of cases were tested for Zika virus-specific IgM and by quantitative RT-PCR. Laboratory-confirmed Zika virus infection during pregnancy was defined as detection of Zika virus-specific IgM or a positive RT-PCR result in neonates. Maternal serum samples were tested by plaque reduction neutralisation assay for Zika virus and dengue virus. We estimated crude odds ratios (ORs) and 95% CIs using a median unbiased estimator for binary data in an unconditional logistic regression model. We estimated ORs separately for cases with and without radiological evidence of brain abnormalities.
   Findings Between Jan 15, 2016, and May 2, 2016, we prospectively recruited 32 cases and 62 controls. 24 (80%) of 30 mothers of cases had Zika virus infection compared with 39 (64%) of 61 mothers of controls (p=0.12). 13 (41%) of 32 cases and none of 62 controls had laboratory-confirmed Zika virus infection; crude overall OR 55.5 (95% CI 8.6-infinity); OR 113.3 (95% CI 14.5-infinity) for seven cases with brain abnormalities; and OR 24.7 (95% CI 2.9-infinity) for four cases without brain abnormalities.
   Interpretation Our data suggest that the microcephaly epidemic is a result of congenital Zika virus infection. We await further data from this ongoing study to assess other potential risk factors and to confirm the strength of association in a larger sample size.
C1 [de Araujo, Thalia Velho Barreto; Valongueiro, Sandra] Univ Fed Pernambuco, Dept Social Med, Recife, PE, Brazil.
   [Ximenes, Ricardo Arraes de Alencar] Univ Fed Pernambuco, Dept Trop Med, Recife, PE, Brazil.
   [de Melo, Ana Paula Lopes] Univ Fed Pernambuco, Dept Community Hlth, Vitoria De Santo Antao, Brazil.
   [Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Ximenes, Ricardo Arraes de Alencar; Miranda-Filho, Democrito de Barros; Montarroyos, Ulisses Ramos] Univ Pernambuco, Recife, PE, Brazil.
   [de Albuquerque, Maria de Fcitima Pessoa Militao; Souza, Wayner Vieira; Braga, Cynthia; Filho, Sinval Pinto Brandao; Cordeiro, Marli Tenorio; Castanha, Priscila Mayrelle da Silva; Marques-Junior, Ernesto Torres Azevedo; Martelli, Celina Maria Turchi] Res Ctr Aggeu Magalhaes CPqAM, Recife, PE, Brazil.
   [de Albuquerque, Maria de Fcitima Pessoa Militao; Filho, Sinval Pinto Brandao; Cordeiro, Marli Tenorio; Castanha, Priscila Mayrelle da Silva; Dhalia, Rafael; Marques-Junior, Ernesto Torres Azevedo; Martelli, Celina Maria Turchi] Oswaldo Cruz Fdn Fiocruz, Recife, PE, Brazil.
   [Vazquez, Enrique] Pan Amer Hlth Org, Brasilia, DF, Brazil.
   [Cruz, Danielle Di Cavalcanti Souza] Inst Materno Infantil Fernando Figueira, Recife, PE, Brazil.
   [Henriques, Clciudio Maierovitch Pessanha] Fiocruz Brasilia, Brasilia, DF, Brazil.
   [Bezerra, Luciana Caroline Albuquerque] Pernambuco State Hlth Dept, Recife, PE, Brazil.
   [Martelli, Celina Maria Turchi] Univ Fed Goias, Dept Community Hlth, Goiania, Go, Brazil.
RP de Araujo, TVB (corresponding author), Univ Fed Pernambuco, BR-50670901 Recife, PE, Brazil.
RI Souza, Wayner V/H-3798-2013; Marques, Ernesto T. A/L-4967-2013;
   Brandao-Filho, Sinval Pinto/AAP-4792-2020; Dhalia, Rafael/AAD-5432-2020;
   Braga, Maria Cynthia/A-8204-2013; Montarroyos, Ulisses/AAJ-7527-2020;
   CASTANHA, PRISCILA/G-1785-2012
OI Marques, Ernesto T. A/0000-0003-3826-9358; Brandao-Filho, Sinval
   Pinto/0000-0003-3768-2810; Braga, Maria Cynthia/0000-0002-7862-6455;
   Turchi Martelli, Celina Maria/0000-0002-2491-0688; Souza,
   Wayner/0000-0002-0939-9332; CASTANHA, PRISCILA/0000-0002-1220-5308
FU Brazilian Ministry of Health; Pan American Health Organization;
   Enhancing Research Activity in Epidemic Situations
FX Brazilian Ministry of Health, Pan American Health Organization, and
   Enhancing Research Activity in Epidemic Situations.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Brasil Ministerio da Satide, 2016, 32 BRAS MIN SAUD
   Brasil Ministerio da Saude, 2015, 12015 BRAS MIN SAUD
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   University of Calgary, FENT PRET GROWTH CHA
   WHO, 2016, SCREEN ASS MAN NEON
   WHO, 2016, WHOZIKVMOC163REV3WHO
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 39
TC 171
Z9 175
U1 2
U2 39
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD DEC
PY 2016
VL 16
IS 12
BP 1356
EP 1363
DI 10.1016/S1473-3099(16)30318-8
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA EC3YK
UT WOS:000388062800045
PM 27641777
OA Bronze
DA 2020-07-08
ER

PT J
AU Fernando, S
   Fernando, T
   Stefanik, M
   Eyer, L
   Ruzek, D
AF Fernando, Sandun
   Fernando, Teshan
   Stefanik, Michal
   Eyer, Ludek
   Ruzek, Daniel
TI An Approach for Zika Virus Inhibition Using Homology Structure of the
   Envelope Protein
SO MOLECULAR BIOTECHNOLOGY
LA English
DT Article
DE Zika virus; Homology model; Druggability; Drug discovery
ID DYNAMICS
AB To find an effective drug for Zika virus, it is important to understand how numerous proteins which are critical for the virus' structure and function interact with their counterparts. One approach to inhibiting the flavivirus is to deter its ability to bind onto glycoproteins; however, the crystal structures of envelope proteins of the ever-evolving viral strains that decipher glycosidic or drug-molecular interactions are not always available. To fill this gap, we are reporting a holistic, simulation-based approach to predict compounds that will inhibit ligand binding onto a structurally unresolved protein, in this case the Zika virus envelope protein (ZVEP), by developing a three-dimensional general structure and analyzing sites at which ligands and small drug-like molecules interact. By examining how glycan molecules and small-molecule probes interact with a freshly resolved ZVEP homology model, we report the susceptibility of ZVEP to inhibition via two small molecules, ZINC33683341 and ZINC49605556-by preferentially binding onto the primary receptor responsible for the virus' virulence. Antiviral activity was confirmed when ZINC33683341 was tested in cell culture. We anticipate the results to be a starting point for drug discovery targeting Zika virus and other emerging pathogens.
C1 [Fernando, Sandun; Fernando, Teshan] Texas A&M Univ, Biol Engn, 303C Scoates Hall,2117 TAMU, College Stn, TX 77843 USA.
   [Stefanik, Michal; Eyer, Ludek; Ruzek, Daniel] Vet Res Inst, Dept Virol, Brno 62100, Czech Republic.
   [Eyer, Ludek; Ruzek, Daniel] Czech Acad Sci, Ctr Biol, Inst Parasitol, Ceske Budejovice 37005, Czech Republic.
RP Fernando, S (corresponding author), Texas A&M Univ, Biol Engn, 303C Scoates Hall,2117 TAMU, College Stn, TX 77843 USA.
EM sfernando@tamu.edu
RI Eyer, Ludek/U-4883-2018; Ruzek, Daniel/G-9275-2014
OI Eyer, Ludek/0000-0001-7761-0702; Ruzek, Daniel/0000-0003-4655-2380;
   Fernando, Sandun/0000-0002-7692-2170
FU Czech Science FoundationGrant Agency of the Czech Republic [16-20054S]
FX Portions of this research were conducted with high-performance research
   computing resources provided by Texas A&M University
   (http://hprc.tamu.edu). Antiviral in vitro testing was supported by
   Czech Science Foundation (Project No. 16-20054S). The authors wish to
   thank Martin Palus for performing the statistical analysis.
CR Bakan A, 2013, BIOPHYS J, V104, p556A, DOI 10.1016/j.bpj.2012.11.3081
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   Talan J., 2016, NEUROL TODAY, V16, P1
   Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200
   Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 13
TC 17
Z9 17
U1 0
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1073-6085
EI 1559-0305
J9 MOL BIOTECHNOL
JI Mol. Biotechnol.
PD DEC
PY 2016
VL 58
IS 12
BP 801
EP 806
DI 10.1007/s12033-016-9979-1
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA EJ3PH
UT WOS:000393123600003
PM 27683255
OA Bronze
DA 2020-07-08
ER

PT J
AU Osuna, CE
   Lim, SY
   Deleage, C
   Griffin, BD
   Stein, D
   Schroeder, LT
   Omange, RW
   Best, K
   Luo, M
   Hraber, PT
   Andersen-Elyard, H
   Ojeda, EFC
   Huang, S
   Vanlandingham, DL
   Higgs, S
   Perelson, AS
   Estes, JD
   Safronetz, D
   Lewis, MG
   Whitney, JB
AF Osuna, Christa E.
   Lim, So-Yon
   Deleage, Claire
   Griffin, Bryan D.
   Stein, Derek
   Schroeder, Lukas T.
   Omange, Robert Were
   Best, Katharine
   Luo, Ma
   Hraber, Peter T.
   Andersen-Elyard, Hanne
   Ojeda, Erwing Fabian Cardozo
   Huang, Scott
   Vanlandingham, Dana L.
   Higgs, Stephen
   Perelson, Alan S.
   Estes, Jacob D.
   Safronetz, David
   Lewis, Mark G.
   Whitney, James B.
TI Zika viral dynamics and shedding in rhesus and cynomolgus macaques
SO NATURE MEDICINE
LA English
DT Article
ID NATURAL-KILLER-CELLS; WEST NILE VIRUS; SEXUAL TRANSMISSION; DENGUE
   VIRUS; INFECTION; BRAZIL; MOSQUITOS; OUTBREAK; SERUM; EXPRESSION
AB Infection with Zika virus has been associated with serious neurological complications and fetal abnormalities. However, the dynamics of viral infection, replication and shedding are poorly understood. Here we show that both rhesus and cynomolgus macaques are highly susceptible to infection by lineages of Zika virus that are closely related to, or are currently circulating in, the Americas. After subcutaneous viral inoculation, viral RNA was detected in blood plasma as early as 1 d after infection. Viral RNA was also detected in saliva, urine, cerebrospinal fluid (CSF) and semen, but transiently in vaginal secretions. Although viral RNA during primary infection was cleared from blood plasma and urine within 10 d, viral RNA was detectable in saliva and seminal fluids until the end of the study, 3 weeks after the resolution of viremia in the blood. The control of primary Zika virus infection in the blood was correlated with rapid innate and adaptive immune responses. We also identified Zika RNA in tissues, including the brain and male and female reproductive tissues, during early and late stages of infection. Re-infection of six animals 45 d after primary infection with a heterologous strain resulted in complete protection, which suggests that primary Zika virus infection elicits protective immunity. Early invasion of Zika virus into the nervous system of healthy animals and the extent and duration of shedding in saliva and semen underscore possible concern for additional neurologic complications and nonarthropod-mediated transmission in humans.
C1 [Osuna, Christa E.; Lim, So-Yon; Whitney, James B.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA.
   [Deleage, Claire; Estes, Jacob D.] Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA.
   [Griffin, Bryan D.; Stein, Derek; Schroeder, Lukas T.; Omange, Robert Were; Luo, Ma; Safronetz, David] Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Best, Katharine; Hraber, Peter T.; Ojeda, Erwing Fabian Cardozo; Perelson, Alan S.] Los Alamos Natl Lab, Los Alamos, NM USA.
   [Andersen-Elyard, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD USA.
   [Huang, Scott; Vanlandingham, Dana L.; Higgs, Stephen] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Whitney, James B.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.
RP Whitney, JB (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA USA.; Whitney, JB (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.
EM jwhitne2@bidmc.harvard.edu
RI Perelson, Alan S/Z-1959-2019; Omange, Were/F-1454-2016
OI Perelson, Alan S/0000-0002-2455-0002; Hraber, Peter/0000-0002-2920-4897;
   Omange, Were/0000-0002-0421-110X; Osuna, Christa/0000-0003-2761-2456;
   Elyard, Hanne/0000-0003-1103-9608; Cardozo Ojeda,
   Erwing/0000-0001-8690-9896
FU National Cancer Institute ( NIH Contract) [HHSN261200800001E]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [AI028433, OD0110995]; Public Health Agency of Canada
FX We thank B. Finneyfrock, Z. Pippin, A. Dodson and A. Cook for their
   expert animal husbandry and care, and J. Guedj for suggestions about the
   model simulations. CD38 antibodies were obtained from the NIH Nonhuman
   Primate Reagent Resource supported by HHSN272200900037C and OD010976.
   The data presented in this study are tabulated in the main paper and in
   the supplementary materials. This work was supported in part by federal
   funds from the National Cancer Institute ( NIH Contract
   HHSN261200800001E). The content of this publication does not necessarily
   reflect the views or policies of the Department of Health and Human
   Services, nor does the mention of trade names, commercial products or
   organizations imply endorsement by the US Government. A.S.P.
   acknowledges support from NIH grants AI028433 and OD0110995. D.S.
   acknowledges support from the Public Health Agency of Canada.
CR Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Banerjee S, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0130
   Barcellos C., 2016, EMERG INFECT DIS
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deleage Claire, 2016, Pathog Immun, V1, P68
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fukuhara M, 2013, J VIROL, V87, P701, DOI 10.1128/JVI.01453-12
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P146, DOI 10.4269/ajtmh.1976.25.146
   Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARRISON RM, 1980, J MED PRIMATOL, V9, P265
   Kuhrt D, 2011, J IMMUNOL METHODS, V363, P166, DOI 10.1016/j.jim.2010.09.017
   Kumar Y, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001887
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Millon P., 2015, EPIDEMIOLOGIE SYNDRO
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pandey N, 2015, ARCH VIROL, V160, P1463, DOI 10.1007/s00705-015-2410-6
   Peterson A.T., 2016, PLOS CURR
   Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29
   Prisant N., 2016, LANCET INFECT DIS
   Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Reeves RK, 2010, BLOOD, V115, P4439, DOI 10.1182/blood-2010-01-265595
   Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Webster RL, 2005, IMMUNOLOGY, V115, P206, DOI 10.1111/j.1365-2567.2005.02147.x
   Whitney JB, 2009, AIDS, V23, P1453, DOI 10.1097/QAD.0b013e32832b43d9
NR 54
TC 149
Z9 152
U1 5
U2 36
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD DEC
PY 2016
VL 22
IS 12
BP 1448
EP +
DI 10.1038/nm.4206
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA EE4CI
UT WOS:000389549000022
PM 27694931
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Patel, RV
   Shaeer, KM
   Patel, P
   Garmaza, A
   Wiangkham, K
   Franks, RB
   Pane, O
   Carris, NW
AF Patel, Radha V.
   Shaeer, Kristy M.
   Patel, Pooja
   Garmaza, Aleksey
   Wiangkham, Kornwalee
   Franks, Rachel B.
   Pane, Olivia
   Carris, Nicholas W.
TI EPA-Registered Repellents for Mosquitoes Transmitting Emerging Viral
   Disease
SO PHARMACOTHERAPY
LA English
DT Review
DE mosquito; repellent; West Nile virus; chikungunya; dengue; Zika; Aedes
   aegypti; Aedes albopictus; Culex species
ID PERSONAL PROTECTION STRATEGIES; 3 CLIMATIC REGIMENS; INSECT REPELLENTS;
   AEDES-ALBOPICTUS; FIELD-EVALUATION; N,N-DIETHYL-M-TOLUAMIDE DEET;
   ESSENTIAL OILS; CULEX-QUINQUEFASCIATUS; LABORATORY EVALUATION;
   COMPARATIVE EFFICACY
AB In many parts of the United States, mosquitoes were previously nuisance pests. However, they now represent a potential threat in the spread of viral diseases. The Aedes aegypti, Aedes albopictus, and Culex species mosquitoes are endemic to the United States and together may transmit a variety of viral diseases of growing concern, including West Nile virus, chikungunya, dengue fever, and Zika virus. The Centers for Disease Control and Prevention and the Environmental Protection Agency (EPA) recommend N, N-diethyl-meta-toluamide (DEET) as a first-line mosquito repellent, but for patients refusing to use DEET or other conventional repellents, guidance is limited to any EPA-registered product. Therefore, we conducted a systematic review of the literature to identify which EPA-registered personal mosquito repellent provides the best protection from A. aegypti, A. albopictus, and Culex spp. mosquitoes. We abstracted data from 62 published reports of EPA-registered mosquito repellents. The conventional repellent picaridin has the strongest data to support its use as a second-line agent, while IR3535 and oil of lemon eucalyptus are reasonably effective natural products. Citronella, catnip, and 2-undecanone offer limited protection or have limited data. These results can be used by pharmacists and other health care professionals to advise patients on the selection of an EPA-registered mosquito repellent. Regardless of the repellent chosen, it is vital for patients to follow all instructions/precautions in the product labeling to ensure safe and effective use.
C1 [Patel, Radha V.; Shaeer, Kristy M.; Patel, Pooja; Garmaza, Aleksey; Wiangkham, Kornwalee; Franks, Rachel B.; Pane, Olivia; Carris, Nicholas W.] Univ S Florida, Coll Pharm, Dept Pharmacotherapeut & Clin Res, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA.
   [Patel, Radha V.; Shaeer, Kristy M.; Franks, Rachel B.] Univ S Florida, Morsani Coll Med, Dept Internal Med, Tampa, FL USA.
   [Patel, Pooja; Pane, Olivia; Carris, Nicholas W.] Univ S Florida, Morsani Coll Med, Dept Family Med, Tampa, FL USA.
RP Shaeer, KM (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmacotherapeut & Clin Res, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA.; Shaeer, KM (corresponding author), Univ S Florida, Coll Med, Dept Pharmacotherapeut & Clin Res, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA.; Shaeer, KM (corresponding author), Univ S Florida, Dept Internal Med, 12901 Bruce B Downs Blvd,MDC 30, Tampa, FL 33612 USA.
EM kshaeer@health.usf.edu
RI Carris, Nicholas/D-5154-2017
OI Carris, Nicholas/0000-0001-8904-5034
CR Ali A, 2013, J MED ENTOMOL, V50, P1267, DOI 10.1603/ME12177
   Amer A, 2006, PARASITOL RES, V99, P478, DOI 10.1007/s00436-006-0184-1
   American Mosquito Control Association, 2016, MOSQ INF
   ANNIS B, 1991, J AM MOSQUITO CONTR, V7, P543
   [Anonymous], 2016, MOSQ BIT PREV US
   Barnard DR, 2004, J MED ENTOMOL, V41, P726, DOI 10.1603/0022-2585-41.4.726
   Carroll SP, 2006, J AM MOSQUITO CONTR, V22, P507, DOI 10.2987/8756-971X(2006)22[507:PARBMR]2.0.CO;2
   Centers for Disease Control and Prevention, 2014, W NIL VIR DIS CAS PR
   Centers for Disease Control and Prevention, 2014, DENG HOM PAG EP
   Centers for Disease Control and Prevention, 2016, CDCS DIV  VECT BON D
   Centers for Disease Control and Prevention, 2010, TRAV HLTH PRETR CONS
   Centers for Disease Control Prevention, 2016, AV BUG BIT
   Centers for Disease Control Prevention, 2015, INS REP US SAF
   Centres for Disease Control and Prevention, 2015, ZIK VIR DIS US
   Chen-Hussey V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-173
   Cilek JE, 2004, J AM MOSQUITO CONTR, V20, P299
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Frances SP, 1996, J AM MOSQUITO CONTR, V12, P331
   FRANCES SP, 1993, J AM MOSQUITO CONTR, V9, P474
   Frances SP, 2004, J MED ENTOMOL, V41, P414, DOI 10.1603/0022-2585-41.3.414
   GILBERT IH, 1970, J ECON ENTOMOL, V63, P1203, DOI 10.1093/jee/63.4.1203
   Goodyer LI, 2010, J TRAVEL MED, V17, P182, DOI 10.1111/j.1708-8305.2010.00402.x
   GUPTA RK, 1989, J AM MOSQUITO CONTR, V5, P176
   GUPTA RK, 1991, J AM MOSQUITO CONTR, V7, P490
   GUPTA RK, 1990, J MED ENTOMOL, V27, P494, DOI 10.1093/jmedent/27.4.494
   GUPTA RK, 1989, J AM MOSQUITO CONTR, V5, P52
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kim SI, 2012, J MED ENTOMOL, V49, P876, DOI 10.1603/ME11127
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   Naucke TJ, 2007, PARASITOL RES, V101, P169, DOI 10.1007/s00436-006-0450-2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Revay EE, 2013, ACTA TROP, V125, P226, DOI 10.1016/j.actatropica.2012.10.009
   Sadanandane C, 2001, INDIAN J MED RES, V113, P108
   SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247
   Semmler M, 2014, PARASITOL RES, V113, P185, DOI 10.1007/s00436-013-3641-7
   SHOLDT LL, 1988, J AM MOSQUITO CONTR, V4, P233
   Tawatsin A, 2001, J VECTOR ECOL, V26, P76
   Tawatsin A, 2006, J AM MOSQUITO CONTR, V22, P306, DOI 10.2987/8756-971X(2006)22[306:FEODRC]2.0.CO;2
   Thavara U, 2001, J AM MOSQUITO CONTR, V17, P190
   Theurkar S, 2014, WJPR, V3, P1961
   Thomas J, 2009, J MED ENTOMOL, V46, P1387, DOI 10.1603/033.046.0619
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Trongtokit Yuwadee, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P325
   Tuetun B, 2008, PARASITOL RES, V104, P107, DOI 10.1007/s00436-008-1167-1
   Tuetun B, 2005, TROP MED INT HEALTH, V10, P1190, DOI 10.1111/j.1365-3156.2005.01500.x
   United States Environmental Protection Agency, 2015, TIPS PREV MOSQ BIT
   United States Environmental Protection Agency, 2016, FIND INS REP IS RIGH
   Uzzan B, 2009, FUND CLIN PHARMACOL, V23, P589, DOI 10.1111/j.1472-8206.2009.00731.x
   Van Roey K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003326
   Webb CE, 2007, J AM MOSQUITO CONTR, V23, P351, DOI 10.2987/8756-971X(2007)23[351:ITEFTP]2.0.CO;2
   Webb CE, 2009, AUST NZ J PUBL HEAL, V33, P485, DOI 10.1111/j.1753-6405.2009.00435.x
   Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2
   Yang P, 2005, J VECTOR ECOL, V30, P231
   Yap HH, 1998, J VECTOR ECOL, V23, P62
NR 56
TC 8
Z9 8
U1 2
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0277-0008
EI 1875-9114
J9 PHARMACOTHERAPY
JI Pharmacotherapy
PD DEC
PY 2016
VL 36
IS 12
BP 1272
EP 1280
DI 10.1002/phar.1854
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EJ4QB
UT WOS:000393200800357
PM 27779781
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Dudley, DM
   Newman, CM
   Mohr, EL
   Gellerup, DD
   Breitbach, ME
   Buechler, CR
   Rasheed, MN
   Mohns, MS
   Weiler, AM
   Barry, GL
   Weisgrau, KL
   Eudailey, JA
   Rakasz, EG
   Vosler, LJ
   Post, J
   Capuano, S
   Golos, TG
   Permar, SR
   Osorio, JE
   Friedrich, TC
   O'Connor, SL
   O'Connor, DH
AF Aliota, Matthew T.
   Dudley, Dawn M.
   Newman, Christina M.
   Mohr, Emma L.
   Gellerup, Dane D.
   Breitbach, Meghan E.
   Buechler, Connor R.
   Rasheed, Mustafa N.
   Mohns, Mariel S.
   Weiler, Andrea M.
   Barry, Gabrielle L.
   Weisgrau, Kim L.
   Eudailey, Josh A.
   Rakasz, Eva G.
   Vosler, Logan J.
   Post, Jennifer
   Capuano, Saverio, III
   Golos, Thaddeus G.
   Permar, Sallie R.
   Osorio, Jorge E.
   Friedrich, Thomas C.
   O'Connor, Shelby L.
   O'Connor, David H.
TI Heterologous Protection against Asian Zika Virus Challenge in Rhesus
   Macaques
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BORNE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; 17D VACCINE STRAIN;
   JAPANESE-ENCEPHALITIS; ENVELOPE PROTEIN; NEUTRALIZING ANTIBODIES;
   MONOCLONAL-ANTIBODIES; FAR-EASTERN; PHYLOGENETIC ANALYSIS;
   SEQUENCE-ANALYSIS
AB Background
   Zika virus (ZIKV; Flaviviridae, Flavivirus) was declared a public health emergency of international concern by the World Health Organization (WHO) in February 2016, because of the evidence linking infection with ZIKV to neurological complications, such as Guillain-Barre Syndrome in adults and congenital birth defects including microcephaly in the developing fetus. Because development of a ZIKV vaccine is a top research priority and because the genetic and antigenic variability of many RNA viruses limits the effectiveness of vaccines, assessing whether immunity elicited against one ZIKV strain is sufficient to confer broad protection against all ZIKV strains is critical. Recently, in vitro studies demonstrated that ZIKV likely circulates as a single serotype. Here, we demonstrate that immunity elicited by African lineage ZIKV protects rhesus macaques against subsequent infection with Asian lineage ZIKV.
   Methodology/Principal Findings
   Using our recently developed rhesus macaque model of ZIKV infection, we report that the prototypical ZIKV strain MR766 productively infects macaques, and that immunity elicited by MR766 protects macaques against heterologous Asian ZIKV. Furthermore, using next generation deep sequencing, we found in vivo restoration of a putative N-linked glycosylation site upon replication in macaques that is absent in numerous MR766 strains that are widely being used by the research community. This reversion highlights the importance of carefully examining the sequence composition of all viral stocks as well as understanding how passage history may alter a virus from its original form.
   Conclusions/Significance
   An effective ZIKV vaccine is needed to prevent infection-associated fetal abnormalities. Macaques whose immune responses were primed by infection with East African ZIKV were completely protected from detectable viremia when subsequently rechallenged with heterologous Asian ZIKV. Therefore, these data suggest that immunogen selection is unlikely to adversely affect the breadth of vaccine protection, i.e., any Asian ZIKV immunogen that protects against homologous challenge will likely confer protection against all other Asian ZIKV strains.
C1 [Aliota, Matthew T.; Osorio, Jorge E.; Friedrich, Thomas C.] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI USA.
   [Dudley, Dawn M.; Newman, Christina M.; Breitbach, Meghan E.; Buechler, Connor R.; Rasheed, Mustafa N.; Mohns, Mariel S.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Mohr, Emma L.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA.
   [Gellerup, Dane D.; Weiler, Andrea M.; Barry, Gabrielle L.; Weisgrau, Kim L.; Rakasz, Eva G.; Vosler, Logan J.; Post, Jennifer; Capuano, Saverio, III; Golos, Thaddeus G.; Friedrich, Thomas C.; O'Connor, Shelby L.; O'Connor, David H.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Eudailey, Josh A.; Permar, Sallie R.] Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC USA.
   [Golos, Thaddeus G.] Univ Wisconsin Madison, Sch Vet Med, Dept Comparat Biosci, Madison, WI USA.
   [Golos, Thaddeus G.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Obstet, Madison, WI USA.
   [Golos, Thaddeus G.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Gynecol, Madison, WI USA.
   [Permar, Sallie R.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.; O'Connor, DH (corresponding author), Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
EM dhoconno@wisc.edu
RI Rakasz, Eva G/H-9197-2019
OI Friedrich, Thomas/0000-0001-9831-6895; Aliota,
   Matthew/0000-0002-6902-9149
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R01AI116382-01A1]; Office Of The
   Director, National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [P510D011106]; Research Facilities Improvement ProgramUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Research Resources (NCRR) [RR15459-01,
   RR020141-01]
FX This project would not have been possible without the support of a
   supplement to NIH grant 1R01AI116382-01A1. Research reported in this
   publication was also supported in part by the Office Of The Director,
   National Institutes of Health under Award Number P510D011106 to the
   Wisconsin National Primate Research Center, University of
   Wisconsin-Madison. This research was conducted at a facility constructed
   with support from Research Facilities Improvement Program grant numbers
   RR15459-01 and RR020141-01. The content is solely the responsibility of
   the authors and does not necessarily represent the official views of the
   National Institutes of Health. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Ali A, 1997, MICROBIOL IMMUNOL, V41, P241, DOI 10.1111/j.1348-0421.1997.tb01196.x
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Anderson KB, 2014, J INFECT DIS, V209, P360, DOI 10.1093/infdis/jit436
   BARRETT ADT, 1990, J GEN VIROL, V71, P13, DOI 10.1099/0022-1317-71-1-13
   BARRETT ADT, 1989, VACCINE, V7, P333, DOI 10.1016/0264-410X(89)90196-5
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beasley DWC, 2004, VACCINE, V22, P3722, DOI 10.1016/j.vaccine.2004.03.027
   Berthet FX, 1997, J GEN VIROL, V78, P2293, DOI 10.1099/0022-1317-78-9-2293
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CFD C, 2016, ALL COUNTR TERR ACT
   Chambers TJ, 1998, J GEN VIROL, V79, P2375, DOI 10.1099/0022-1317-79-10-2375
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chiba N, 1999, VACCINE, V17, P1532, DOI 10.1016/S0264-410X(98)00360-0
   CLARKE DH, 1960, J EXP MED, V111, P21, DOI 10.1084/jem.111.1.21
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Daffis S, 2005, VIROLOGY, V337, P262, DOI 10.1016/j.virol.2005.04.031
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Demina T. V., 2012, Voprosy Virusologii, V57, P13
   Demina TV, 2010, J MED VIROL, V82, P965, DOI 10.1002/jmv.21765
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fritz R, 2012, VACCINE, V30, P1165, DOI 10.1016/j.vaccine.2011.12.013
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gellerup DD, 2016, J VIROL, V90, P545, DOI 10.1128/JVI.02587-15
   Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   GUIRAKHOO F, 1993, VIROLOGY, V194, P219, DOI 10.1006/viro.1993.1252
   Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hayden E, 2016, NATURE
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   HOLZMANN H, 1992, VACCINE, V10, P345, DOI 10.1016/0264-410X(92)90376-U
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   HOTTA S, 1953, Acta Sch Med Univ Kioto, V31, P7
   Idris F, 2016, ARCH VIROL, V161, P1751, DOI 10.1007/s00705-016-2855-2
   Ishak H, 2001, MICROBIOL IMMUNOL, V45, P327, DOI 10.1111/j.1348-0421.2001.tb02627.x
   Jimenez RO, 2000, VACCINE, V19, P648, DOI 10.1016/S0264-410X(00)00247-4
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   KOBAYASHI Y, 1985, MICROBIOL IMMUNOL, V29, P1069, DOI 10.1111/j.1348-0421.1985.tb00897.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lauck M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-107
   LEDGER TN, 1992, BIOLOGICALS, V20, P117, DOI 10.1016/S1045-1056(05)80059-4
   Lee E, 1997, VIROLOGY, V232, P281, DOI 10.1006/viro.1997.8570
   Leonova GN, 2009, VACCINE, V27, P2899, DOI 10.1016/j.vaccine.2009.02.069
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Liu XY, 2011, VACCINE, V29, P2127, DOI 10.1016/j.vaccine.2010.12.108
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Moudy RM, 2011, AM J TROP MED HYG, V85, P374, DOI 10.4269/ajtmh.2011.10-0697
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Orlinger KK, 2011, J INFECT DIS, V203, P1556, DOI 10.1093/infdis/jir122
   Osuna CE, 2016, NAT MED
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Pomplun N, 2015, CYTOM PART A, V87A, P890, DOI 10.1002/cyto.a.22727
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Ryman KD, 1997, J GEN VIROL, V78, P1353, DOI 10.1099/0022-1317-78-6-1353
   SABIN AB, 1945, SCIENCE, V101, P640, DOI 10.1126/science.101.2634.640
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SCHLESINGER JJ, 1983, VIROLOGY, V125, P8, DOI 10.1016/0042-6822(83)90059-4
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Tsarev SA, 2000, VACCINE, V18, P36, DOI 10.1016/S0264-410X(00)00039-6
   Uchil PD, 2001, AM J TROP MED HYG, V65, P242, DOI 10.4269/ajtmh.2001.65.242
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   VORNDAM V, 1993, J GEN VIROL, V74, P2653, DOI 10.1099/0022-1317-74-12-2653
   Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika experimental science team, 2016, ZIK OP RES PORT
NR 92
TC 68
Z9 68
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005168
DI 10.1371/journal.pntd.0005168
PG 22
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100038
PM 27911897
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bouzid, M
   Brainard, J
   Hooper, L
   Hunter, PR
AF Bouzid, Maha
   Brainard, Julii
   Hooper, Lee
   Hunter, Paul R.
TI Public Health Interventions for Aedes Control in the Time of Zikavirus-
   A Meta-Review on Effectiveness of Vector Control Strategies
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; COMMUNITY EFFECTIVENESS; DENGUE-FEVER; INSECTICIDE; EFFICACY
AB Background
   There is renewed interest in effective measures to control Zika and dengue vectors. A synthesis of published literature with a focus on the quality of evidence is warranted to determine the effectiveness of vector control strategies.
   Methodology
   We conducted a meta-review assessing the effectiveness of any Aedes control measure. We searched Scopus and Medline for relevant reviews through to May 2016. Titles, abstracts and full texts were assessed independently for inclusion by two authors. Data extraction was performed in duplicate and validity of the evidence was assessed using GRADE criteria.
   Findings
   13 systematic reviews that investigated the effect of control measures on entomological parameters or disease incidence were included. Biological controls seem to achieve better reduction of entomological indices than chemical controls, while educational campaigns can reduce breeding habitats. Integrated vector control strategies may not always increase effectiveness. The efficacy of any control programme is dependent on local settings, intervention type, resources and study duration, which may partly explain the varying degree of success between studies. Nevertheless, the quality of evidence was mostly low to very low due to poor reporting of study design, observational methodologies, heterogeneity, and indirect outcomes, thus hindering an evidence-based recommendation.
   Conclusions
   The evidence for the effectiveness of Aedes control measures is mixed. Chemical control, which is commonly used, does not appear to be associated with sustainable reductions of mosquito populations over time. Indeed, by contributing to a false sense of security, chemical control may reduce the effectiveness of educational interventions aimed at encouraging local people to remove mosquito breeding sites. Better quality studies of the impact of vector control interventions on the incidence of human infections with Dengue or Zika are still needed.
C1 [Bouzid, Maha; Brainard, Julii; Hooper, Lee; Hunter, Paul R.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.
RP Hunter, PR (corresponding author), Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England.
EM paul.hunter@uea.ac.uk
RI Hunter, Paul R/A-7172-2008; Hunter, Paul/N-9021-2019; Hooper,
   Lee/D-2795-2009
OI Hunter, Paul R/0000-0002-5608-6144; Hunter, Paul/0000-0002-5608-6144;
   Hooper, Lee/0000-0002-7904-3331
FU RESPONSES project [244092]; National Institute for Health Research
   Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness
   and Response at Kings College London; Public Health England (PHE)
FX Research was partially funded by the RESPONSES project (Grant Agreement
   number 244092) and the National Institute for Health Research Health
   Protection Research Unit (NIHR HPRU) in Emergency Preparedness and
   Response at Kings College London in partnership with Public Health
   England (PHE). The views expressed are those of the author(s) and not
   necessarily those of the National Health Service, the NIHR, the
   Department of Health or PHE. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Al-Muhandis N, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001278
   Amaku M, 2014, B MATH BIOL, V76, P697, DOI 10.1007/s11538-014-9939-5
   Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521
   Becker L, COCHRANE HDB SYSTEMA
   Bouzid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062041
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Chan M, 2016, LANCET, V387, P2165, DOI 10.1016/S0140-6736(16)30620-1
   Das JK, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-24
   Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Toledo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119373
   Fletcher R., 2005, CLIN EPIDEMIOLOGY ES
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485
   Lima E. P., 2015, BMC PUBLIC HEALTH, V15, P1
   Maharajan MK, 2016, CLIN REV ALLERGY IMM
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Moher D, 2015, SYST REV-LONDON, V4, DOI 10.1186/2046-4053-4-1
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Parks W., 2004, PLANNING SOCIAL MOBI
   Sarrami-Foroushani P, 2015, CTS-CLIN TRANSL SCI, V8, P77, DOI 10.1111/cts.12188
   Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15
   Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Streiner DL, 1998, PDQ EPIDEMIOLOGY
   Tran TT, 2015, ACTA TROP, V141, P54, DOI 10.1016/j.actatropica.2014.10.006
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
   World Health Organisation, 2016, MOSQ CONTR CAN IT ST
   World Health Organization, 2014, WHO HDB GUID DEV
   2016, LANCET LONDON ENGLAN, V387, P96
NR 38
TC 17
Z9 17
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005176
DI 10.1371/journal.pntd.0005176
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100046
PM 27926934
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Funk, S
   Kucharski, AJ
   Camacho, A
   Eggo, RM
   Yakob, L
   Murray, LM
   Edmunds, WJ
AF Funk, Sebastian
   Kucharski, Adam J.
   Camacho, Anton
   Eggo, Rosalind M.
   Yakob, Laith
   Murray, Lawrence M.
   Edmunds, W. John
TI Comparative Analysis of Dengue and Zika Outbreaks Reveals Differences by
   Setting and Virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID FEDERATED STATES; AEDES-HENSILLI; YAP STATE; EPIDEMIC; TRANSMISSION;
   INFECTION; DISEASE; CHIKUNGUNYA; POPULATION
AB The pacific islands of Micronesia have experienced several outbreaks of mosquito-borne diseases over the past decade. In outbreaks on small islands, the susceptible population is usually well defined, and there is no co-circulation of pathogens. Because of this, analysing such outbreaks can be useful for understanding the transmission dynamics of the pathogens involved, and particularly so for yet understudied pathogens such as Zika virus. Here, we compared three outbreaks of dengue and Zika virus in two different island settings in Micronesia, the Yap Main Islands and Fais, using a mathematical model of transmission dynamics and making full use of commonalities in disease and setting between the outbreaks. We found that the estimated reproduction numbers for Zika and dengue were similar when considered in the same setting, but that, conversely, reproduction number for the same disease can vary considerably by setting. On the Yap Main Islands, we estimated a reproduction number of 8.0-16 (95% Credible Interval (CI)) for the dengue outbreak and 4.8-14 (95% CI) for the Zika outbreak, whereas for the dengue outbreak on Fais our estimate was 28-102 (95% CI). We further found that the proportion of cases of Zika reported was smaller (95% CI 1.4%-1.9%) than that of dengue (95% CI: 47%-61%). We confirmed these results in extensive sensitivity analysis. They suggest that models for dengue transmission can be useful for estimating the predicted dynamics of Zika transmission, but care must be taken when extrapolating findings from one setting to another.
C1 [Funk, Sebastian; Kucharski, Adam J.; Camacho, Anton; Eggo, Rosalind M.; Yakob, Laith; Edmunds, W. John] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Funk, Sebastian; Kucharski, Adam J.; Camacho, Anton; Eggo, Rosalind M.; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, London, England.
   [Murray, Lawrence M.] Univ Oxford, Dept Stat, Oxford, England.
RP Funk, S (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.; Funk, S (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
EM sebastian.funk@lshtm.ac.uk
RI Murray, Lawrence M/C-9770-2009; Yakob, Laith/AAD-4521-2019
OI Murray, Lawrence M/0000-0002-6567-6015; Yakob,
   Laith/0000-0001-8639-4511; Funk, Sebastian/0000-0002-2842-3406; Eggo,
   Rosalind M/0000-0002-0362-6717
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MR/K021680/1, MR/K021524/1, MR/J01432X/1]; Innovative Medicines
   Initiative 2 (IMI2) Joint Undertaking under grant agreement EBOVAC1
   [115854]; European UnionEuropean Union (EU); European Federation of
   Pharmaceutical Industries and Associations; Medical Research
   CouncilMedical Research Council UK (MRC) [MR/K021524/1, MC_PC_15097]
FX SF, AJK and AC were supported by fellowships from the UK Medical
   Research Council (SF: MR/K021680/1, AJK: MR/K021524/1, AC:
   MR/J01432X/1). RME was supported by the Innovative Medicines Initiative
   2 (IMI2) Joint Undertaking under grant agreement EBOVAC1 (grant 115854).
   The IMI2 is supported by the European Union Horizon 2020 Research and
   Innovation Programme and the European Federation of Pharmaceutical
   Industries and Associations. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau V. M., 2016, LANCET
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Champagne C, 2016, STRUCTURE VARIABILIT
   Champredon D, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2026
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   DYE C, 1986, T ROY SOC TROP MED H, V80, P69, DOI 10.1016/0035-9203(86)90199-9
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   European Centre for Disease Prevention and Control, 2015, ZIK VIR INF OUTBR BR
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S., 2016, RBI HELPERS RBI HELP
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hyman JM, 2013, MBE, V10, P1455
   Jacob PE, 2016, RBI R INTERFACE LIBB
   Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042
   Kahle D, 2016, GGMAP SPATIAL VISUAL
   Kindhauser MK, 2016, B WHO
   Kucharski AJ, 2016, TRANSMISSION DYNAMIC
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lessler J., 2016, TIMES KEY EVENTS COU
   Majumder MS, 2016, B WHO, DOI 10.2471/BLT.16.171009
   Mlakar J, 2016, N ENGL J MED
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Murray Lawrence M., 2013, BAYESIAN STATE SPACE
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   National Environmental Agency Singapore, 2016, LIF CYCL AED MOSQ
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Nilles E, 2012, AM SOC TROP MED HYG
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Nishiura H, 2010, MATH BIOSCI ENG, V7, P851, DOI 10.3934/mbe.2010.7.851
   Nukui Y, 2006, EMERG INFECT DIS, V12, P343, DOI 10.3201/eid1202.050733
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Paul L. M., 2016, DENGUE VIRUS ANTIBOD
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   R Core Team, 2015, R LANG ENV STAT COMP
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   Shinichi Noda, 2014, South Pacific Studies, V34, P117
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 34
Z9 34
U1 0
U2 13
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005173
DI 10.1371/journal.pntd.0005173
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100043
PM 27926933
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Langsjoen, RM
   Rubinstein, RJ
   Kautz, TF
   Auguste, AJ
   Erasmus, JH
   Kiaty-Figueroa, L
   Gerhardt, R
   Lin, D
   Hari, KL
   Jain, R
   Ruiz, N
   Muruato, AE
   Silfa, J
   Bido, F
   Dacso, M
   Weaver, SC
AF Langsjoen, Rose M.
   Rubinstein, Rebecca J.
   Kautz, Tiffany F.
   Auguste, Albert J.
   Erasmus, Jesse H.
   Kiaty-Figueroa, Liddy
   Gerhardt, Renessa
   Lin, David
   Hari, Kumar L.
   Jain, Ravi
   Ruiz, Nicolas
   Muruato, Antonio E.
   Silfa, Jael
   Bido, Franklin
   Dacso, Matthew
   Weaver, Scott C.
TI Molecular Virologic and Clinical Characteristics of a Chikungunya Fever
   Outbreak in La Romana, Dominican Republic, 2014
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID REUNION ISLAND; VIRUS-INFECTION; LABORATORY FEATURES; EPIDEMIC;
   MYOCARDITIS; ARTHRALGIA; DISEASE; DENGUE; INDIA
AB Since emerging in Saint Martin in 2013, chikungunya virus (CHIKV), an alphavirus transmitted by the Aedes aegypti mosquito, has infected approximately two million individuals in the Americas, with over 500,000 reported cases in the Dominican Republic (DR). CHIKV-infected patients typically present with a febrile syndrome including polyarthritis/polyarthralgia, and a macropapular rash, similar to those infected with dengue and Zika viruses, and malaria. Nevertheless, many Dominican cases are unconfirmed due to the unavailability and high cost of laboratory testing and the absence of specific treatment for CHIKV infection. To obtain a more accurate representation of chikungunya fever (CHIKF) clinical signs and symptoms, and confirm the viral lineage responsible for the DR CHIKV outbreak, we tested 194 serum samples for CHIKV RNA and IgM antibodies from patients seen in a hospital in La Romana, DR using quantitative RT-PCR and IgM capture ELISA, and performed retrospective chart reviews. RNA and antibodies were detected in 49% and 24.7% of participants, respectively. Sequencing revealed that the CHIKV strain responsible for the La Romana outbreak belonged to the Asian/American lineage and grouped phylogenetically with recent Mexican and Trinidadian isolates. Our study shows that, while CHIKV-infected individuals were infrequently diagnosed with CHIKF, uninfected patients were never falsely diagnosed with CHIKF. Participants testing positive for CHIKV RNA were more likely to present with arthralgia, although it was reported in just 20.0% of CHIKF+ individuals. High percentages of respiratory (19.6%) signs and symptoms, especially among children, were noted, though it was not possible to determine whether individuals infected with CHIKV were co-infected with other pathogens. These results suggest that CHIKV may have been underdiagnosed during this outbreak, and that CHIKF should be included in differential diagnoses of diverse undifferentiated febrile syndromes in the Americas.
C1 [Langsjoen, Rose M.; Rubinstein, Rebecca J.; Kautz, Tiffany F.; Auguste, Albert J.; Erasmus, Jesse H.; Muruato, Antonio E.; Dacso, Matthew; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Langsjoen, Rose M.; Rubinstein, Rebecca J.; Kautz, Tiffany F.; Auguste, Albert J.; Erasmus, Jesse H.; Muruato, Antonio E.; Dacso, Matthew; Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Langsjoen, Rose M.; Erasmus, Jesse H.] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.
   [Rubinstein, Rebecca J.; Kiaty-Figueroa, Liddy; Gerhardt, Renessa; Ruiz, Nicolas; Dacso, Matthew] Univ Texas Med Branch, Ctr Global Hlth Educ, Galveston, TX 77555 USA.
   [Kautz, Tiffany F.; Muruato, Antonio E.; Weaver, Scott C.] Univ Texas, Dept Microbiol & Immunol, Galveston, TX USA.
   [Auguste, Albert J.; Dacso, Matthew; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Lin, David; Hari, Kumar L.; Jain, Ravi] cBio Inc, Fremont, CA USA.
   [Silfa, Jael] Hosp Dr Francisco Gonzalvo, La Romana, Dominican Rep.
   [Bido, Franklin] Hosp Buen Samaritano, La Romana, Dominican Rep.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Weaver, SC (corresponding author), Univ Texas, Dept Microbiol & Immunol, Galveston, TX USA.; Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011; Erasmus, Jesse/J-8792-2019
OI Weaver, Scott C/0000-0001-8016-8556; Erasmus, Jesse/0000-0003-1612-2697;
   Auguste, Albert/0000-0001-9048-0041; Langsjoen, Rose/0000-0001-9008-425X
FU Institute for Human Infections and Immunity at the University of Texas
   Medical Branch; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [AI120942, NCATS CTSA UL1 TR001439]; Institute for Collaboration in
   Health at the University of Texas Medical Branch; Department of Homeland
   SecurityUnited States Department of Homeland Security (DHS)
   [HSHQDC-13-C-B0009]
FX This work was funded by the Institute for Human Infections and Immunity
   at the University of Texas Medical Branch (http://www.utmb.edu/ihii/),
   National Institutes of Health grant AI120942, and the Institute for
   Collaboration in Health at the University of Texas Medical Branch
   (http://www.utmb.edu/ccgh/education/). RML and JHE were supported by the
   National Institutes of Health NCATS CTSA UL1 TR001439. The genomes
   referenced in this publication were sequenced through funding provided
   by Department of Homeland Security through Contract No.
   HSHQDC-13-C-B0009 "Capturing Global Biodiversity of Pathogens by Whole
   Genome Sequencing." The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Angelini R, 2007, Euro Surveill, V12
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Cashat-Cruz Miguel, 2005, Semin Pediatr Infect Dis, V16, P84, DOI 10.1053/j.spid.2005.12.005
   CDC, 2015, 2015TABLE 062216 FIN
   Diaz-Quinonez JA, 2015, GENOME ANNOUNC, V3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255
   Horwood PF, 2013, EMERG INFECT DIS, V19, P1535, DOI 10.3201/eid1909.130130
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Mirabel M, 2007, INT J CARDIOL, V121, pE7, DOI 10.1016/j.ijcard.2007.04.153
   Nandha B, 2009, Indian J Public Health, V53, P209
   OBEYESEKERE I, 1972, BRIT HEART J, V34, P821
   Ozden S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000527
   Pimentel R, 2014, REV PANAM SALUD PUBL, V36, P336
   Powers AM, 2011, METHODS MOL BIOL, V665, P17, DOI 10.1007/978-1-60761-817-1_2
   Renault P, 2008, EMERG INFECT DIS, V14, P1327, DOI 10.3201/eid1408.080201
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Sankari T, 2008, LANCET INFECT DIS, V8, P3, DOI 10.1016/S1473-3099(07)70295-5
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Seyler T, 2010, T ROY SOC TROP MED H, V104, P133, DOI 10.1016/j.trstmh.2009.07.014
   Sheehan AM, 2013, HEMATOLOGY BASIC PRI, pe1
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Solet J. L., 2007, PLOS BIOL, V77, P727
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335
   Tsetsarkin KA, 2011, CURR OPIN VIROL, V1, P310, DOI 10.1016/j.coviro.2011.07.004
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Win MK, 2010, J CLIN VIROL, V49, P111, DOI 10.1016/j.jcv.2010.07.004
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
NR 49
TC 7
Z9 7
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD DEC
PY 2016
VL 10
IS 12
AR e0005189
DI 10.1371/journal.pntd.0005189
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0IX
UT WOS:000392158100056
PM 28030537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Asadi-Pooya, AA
AF Asadi-Pooya, Ali A.
TI Zika virus-associated seizures
SO SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
LA English
DT Letter
C1 [Asadi-Pooya, Ali A.] Thomas Jefferson Univ, Dept Neurol, Jefferson Comprehens Epilepsy Ctr, Philadelphia, PA 19107 USA.
   [Asadi-Pooya, Ali A.] Shiraz Univ Med Sci, Shiraz Med Sch, Neurosci Res Ctr, Shiraz, Iran.
RP Asadi-Pooya, AA (corresponding author), Thomas Jefferson Univ, Dept Neurol, Jefferson Comprehens Epilepsy Ctr, Philadelphia, PA 19107 USA.
EM aliasadipooya@yahoo.com
RI Asadi-Pooya, Ali/AAD-4353-2019
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Raze B, 2016, EUROSURVEILLANCE, V201621
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Valentine G, 2016, J PEDIAT INF DIS SOC, V5, P323, DOI 10.1093/jpids/piw037
NR 6
TC 7
Z9 7
U1 0
U2 3
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1059-1311
EI 1532-2688
J9 SEIZURE-EUR J EPILEP
JI Seizure
PD DEC
PY 2016
VL 43
BP 13
EP 13
DI 10.1016/j.seizure.2016.10.011
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EG9ZE
UT WOS:000391420200003
PM 27788398
DA 2020-07-08
ER

PT J
AU Delvecchio, R
   Higa, LM
   Pezzuto, P
   Valadao, AL
   Garcez, PP
   Monteiro, FL
   Loiola, EC
   Dias, AA
   Silva, FJM
   Aliota, MT
   Caine, EA
   Osorio, JE
   Bellio, M
   O'Connor, DH
   Rehen, S
   de Aguiar, RS
   Savarino, A
   Campanati, L
   Tanuri, A
AF Delvecchio, Rodrigo
   Higa, Luiza M.
   Pezzuto, Paula
   Valadao, Ana Luiza
   Garcez, Patricia P.
   Monteiro, Fabio L.
   Loiola, Erick C.
   Dias, Andre A.
   Silva, Fabio J. M.
   Aliota, Matthew T.
   Caine, Elizabeth A.
   Osorio, Jorge E.
   Bellio, Maria
   O'Connor, David H.
   Rehen, Stevens
   de Aguiar, Renato Santana
   Savarino, Andrea
   Campanati, Loraine
   Tanuri, Amilcar
TI Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus
   Infection in Different Cell Models
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; chloroquine; antiviral; microcephaly; neural stem cell
ID SEXUAL TRANSMISSION; MECHANISM; PREGNANCY; ENTRY; DRUG; REPLICATION;
   MICRONESIA; ORGANOIDS; EXPOSURE; MALARIA
AB Zika virus (ZIKV) infection in utero might lead to microcephaly and other congenital defects. Since no specific therapy is available thus far, there is an urgent need for the discovery of agents capable of inhibiting its viral replication and deleterious effects. Chloroquine is widely used as an antimalarial drug, anti-inflammatory agent, and it also shows antiviral activity against several viruses. Here we show that chloroquine exhibits antiviral activity against ZIKV in Vero cells, human brain microvascular endothelial cells, human neural stem cells, and mouse neurospheres. We demonstrate that chloroquine reduces the number of ZIKV-infected cells in vitro, and inhibits virus production and cell death promoted by ZIKV infection without cytotoxic effects. In addition, chloroquine treatment partially reveres morphological changes induced by ZIKV infection in mouse neurospheres.
C1 [Delvecchio, Rodrigo; Higa, Luiza M.; Pezzuto, Paula; Valadao, Ana Luiza; Monteiro, Fabio L.; de Aguiar, Renato Santana; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941902 Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Silva, Fabio J. M.; Rehen, Stevens; Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil.
   [Garcez, Patricia P.; Loiola, Erick C.; Rehen, Stevens] DOr Inst Res & Educ IDOR, BR-22281100 Rio De Janeiro, Brazil.
   [Dias, Andre A.; Bellio, Maria] Univ Fed Rio de Janeiro, Dept Immunol, BR-21941902 Rio De Janeiro, Brazil.
   [Aliota, Matthew T.; Caine, Elizabeth A.; Osorio, Jorge E.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
   [O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Savarino, Andrea] Ist Super Sanita, Deptartment Infect Dis, 299 Viale Regina Elena, I-00161 Rome, Italy.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, BR-21941902 Rio De Janeiro, Brazil.; Campanati, L (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21941902 Rio De Janeiro, Brazil.
EM digodelvecchio@gmail.com; luizahiga@gmail.com; paulapezzuto81@gmail.com;
   analuvaladao@gmail.com; ppgarcez@gmail.com; fabiolimonte@gmail.com;
   erickloiola@lance-ufrj.org; aadias2005@yahoo.com.br;
   fabiojms@icb.ufrj.br; mtaliota@wisc.edu; eacaine@wisc.edu;
   jorge.osorio@wisc.edu; mariabellioufrj@gmail.com; dhoconno@wisc.edu;
   srehen@lance-ufrj.org; santanarnt@gmail.com; ansavari@yahoo.com;
   lcampanati@gmail.com; atanuri@biologia.ufrj.br
RI Garcez, Patricia/F-8026-2012; Aguiar, Renato S/G-3542-2015; Campanati,
   Loraine/V-2632-2018; Rehen, Stevens K/J-5874-2012; Higa,
   Luiza/W-2698-2019; BELLIO, MARIA/N-8525-2018; Loiola, Erick/I-4106-2016
OI Garcez, Patricia/0000-0002-9107-1335; Aguiar, Renato
   S/0000-0001-5180-3717; Campanati, Loraine/0000-0001-9172-1951; Rehen,
   Stevens K/0000-0003-4216-9501; o'connor, david/0000-0003-2139-470X;
   Pezzuto, Paula/0000-0001-9570-8244; Aliota, Matthew/0000-0002-6902-9149;
   BELLIO, MARIA/0000-0002-3360-2740; Lima Monteiro, Fabio
   Luis/0000-0002-9107-6865; Savarino, Andrea/0000-0003-0983-3693; Loiola,
   Erick/0000-0002-7926-795X
FU Conselho Nacional de Desenvolvimento e Pesquisa (CNPq)National Council
   for Scientific and Technological Development (CNPq); Fundacao de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Departamento de Doencas Sexualmente Transmissiveis, AIDS e Hepatites
   Virais do Ministerio da Saude do Brasil
FX This work was supported by Conselho Nacional de Desenvolvimento e
   Pesquisa (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ), and Departamento de Doencas Sexualmente
   Transmissiveis, AIDS e Hepatites Virais do Ministerio da Saude do
   Brasil. The authors acknowledge Manoel Itamar for providing technical
   support.
CR [Anonymous], 2016, ZIK VIR MICR GUILL B
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Brasil P., 2016, ENGL J MED, DOI [10.1056/NEJMoa160241226943629, DOI 10.1056/NEJMOA160241226943629]
   Browning D., 2014, PHARM CHLOROQUINE HY, V35, P63
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campanati L., 2016, BIORXIV, V1, P25
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Diaz-Griffero F, 2002, J VIROL, V76, P12866, DOI 10.1128/JVI.76.24.12866-12876.2002
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dohgu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039565
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Farias K. J. S., 2013, WORLD J, V2013, DOI [10.1155/2013/28273423431254, DOI 10.1155/2013/28273423431254]
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Ferreira DF, 2000, J MED MICROBIOL, V49, P313, DOI 10.1099/0022-1317-49-4-313
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89
   GonzalezDunia D, 1998, J VIROL, V72, P783, DOI 10.1128/JVI.72.1.783-788.1998
   Harley CA, 2001, J VIROL, V75, P1236, DOI 10.1128/JVI.75.3.1236-1251.2001
   Helal GK, 2016, J MED VIROL, V88, P2170, DOI 10.1002/jmv.24575
   Keyaerts E, 2009, ANTIMICROB AGENTS CH, V53, P3416, DOI 10.1128/AAC.01509-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Law I, 2008, BRIT J CLIN PHARMACO, V65, P674, DOI 10.1111/j.1365-2125.2008.03111.x
   LEVY M, 1991, AM J PERINAT, V8, P174, DOI 10.1055/s-2007-999371
   MACKENZIE AH, 1983, AM J MED, V75, P40, DOI 10.1016/0002-9343(83)91269-X
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI [DOI 10.15585/MMWR.MM6506E1ER, 10.15585/mmwr.mm6506e1]
   Melo A. S., 2016, JAMA NEUROL, V1, DOI [10.1001/jamaneurol.2016.372027695855, DOI 10.1001/JAMANEUROL.2016.372027695855]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ooi EE, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-39
   PARKE AL, 1988, J RHEUMATOL, V15, P607
   Paulsen BD, 2012, CELL TRANSPLANT, V21, P1547, DOI 10.3727/096368911X600957
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Savarino A, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0178-0
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406
   Suen WW, 2014, VIRUSES-BASEL, V6, P2796, DOI 10.3390/v6072796
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TITUS EO, 1989, THER DRUG MONIT, V11, P369, DOI 10.1097/00007691-198911040-00001
   Tricou V., 2010, PLOS NEGLECT TROP D, V4, DOI [10.1371/journal.pntd.000078520706626, DOI 10.1371/JOURNAL.PNTD.000078520706626]
   TSAI WP, 1990, AIDS RES HUM RETROV, V6, P481, DOI 10.1089/aid.1990.6.481
   WOLFE MS, 1985, BRIT MED J, V290, P1466, DOI 10.1136/bmj.290.6480.1466
   Yan YP, 2013, STEM CELL TRANSL MED, V2, P1022, DOI [10.5966/sctm.2013-0080erratum, 10.5966/sctm.2013-0080]
   Yan YW, 2013, CELL RES, V23, P300, DOI 10.1038/cr.2012.165
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
NR 56
TC 86
Z9 90
U1 5
U2 15
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD DEC
PY 2016
VL 8
IS 12
AR 322
DI 10.3390/v8120322
PG 15
WC Virology
SC Virology
GA EI4SW
UT WOS:000392484600002
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alam, A
   Ali, S
   Ahamad, S
   Malik, MZ
   Ishrat, R
AF Alam, Aftab
   Ali, Shahnawaz
   Ahamad, Shahzaib
   Malik, Md. Zubbair
   Ishrat, Romana
TI From ZikV genome to vaccine: in silico approach for the epitope-based
   peptide vaccine against Zika virus envelope glycoprotein
SO IMMUNOLOGY
LA English
DT Article
DE artificial neural network; epitopes; Immune Epitope Database;
   immunogenomics; MHC class; Zika virus
ID T-CELL EPITOPES; CLASS-II; PREDICTION; DESIGN; ALIGNMENT; ANTIBODY;
   ELICITS; BINDING; HUMANS; SERVER
AB Zika virus (ZikV) has emerged as a potential threat to human health worldwide. A member of the Flaviviridae, ZikV is transmitted to humans by mosquitoes. It is related to other pathogenic vector-borne flaviviruses including dengue, West Nile and Japanese encephalitis viruses, but produces a comparatively mild disease in humans. As a result of its epidemic outbreak and the lack of potential medication, there is a need for improved vaccine/drugs. Computational techniques will provide further information about this virus. Comparative analysis of ZikV genomes should lead to the identification of the core characteristics that define a virus family, as well as its unique properties, while phylogenetic analysis will show the evolutionary relationships and provide clues about the protein's ancestry. Envelope glycoprotein of ZikV was obtained from a protein database and the most immunogenic epitope for T cells and B cells involved in cell-mediated immunity, whereas B cells are primarily responsible for humoral immunity. We mainly focused on MHC class I potential peptides. YRIMLSVHG, VLIFLSTAV and MMLELDPPF, GLDFSDLYY are the most potent peptides predicted as epitopes for CD4(+) and CD8(+) T cells, respectively, whereas MMLELDPPF and GLDFSDLYY had the highest pMHC-I immunogenicity score and these are further tested for interaction against the HLA molecules, using in silico docking techniques to verify the binding cleft epitope. However, this is an introductory approach to design an epitope-based peptide vaccine against ZikV; we hope that this model will be helpful in designing and predicting novel vaccine candidates.
C1 [Alam, Aftab; Ali, Shahnawaz; Malik, Md. Zubbair; Ishrat, Romana] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
   [Ahamad, Shahzaib] IFTM, Coll Engn & Technol, Dept Biotechnol, Moradabad, India.
RP Ishrat, R (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
EM rishrat@jmi.ac.in
RI ali, shahnawaz/K-5884-2015
OI ali, shahnawaz/0000-0002-7601-4762; Ahamad,
   Shahzaib/0000-0003-2009-7367; ALAM, AFTAB/0000-0002-6989-9398
FU ICMR-SRF PhD fellowship
FX The authors are grateful to the Centre for Interdisciplinary Research in
   Basic Sciences (CIRBSc), Jamia Millia Islamia-110025 for providing the
   research infrastructure and we gratefully acknowledge the IEDB team.
   Shahnwaz Ali and Md Zubbair Malik are supported by ICMR-SRF PhD
   fellowship.
CR Aftab ALAM, 2016, GLOB J, V5, P212
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Andersen PH, 2006, PROTEIN SCI, V15, P2558, DOI 10.1110/ps.062405906
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bourdette DN, 2005, MULT SCLER, V11, P552, DOI 10.1191/1352458505ms1225oa
   Brusic V, 2004, METHODS, V34, P436, DOI 10.1016/j.ymeth.2004.06.006
   Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361
   Buus S, 2003, TISSUE ANTIGENS, V62, P378, DOI 10.1034/j.1399-0039.2003.00112.x
   Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266
   Chiou SS, 2012, J GEN VIROL, V93, P1185, DOI 10.1099/vir.0.040238-0
   CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343
   CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fields BN, 2007, FIELDS VIROLOGY, P2
   Fraser CC, 2014, VACCINE, V32, P2896, DOI 10.1016/j.vaccine.2014.02.024
   Giguere S, 2013, J IMMUNOL METHODS, V400, P30, DOI 10.1016/j.jim.2013.10.003
   Hasan MA, 2013, BIOINFORM BIOL INSIG, V7, P347, DOI 10.4137/BBI.S13402
   Johansson MU, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-173
   KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768
   Khan MK, 2014, MOL IMMUNOL, V61, P16, DOI 10.1016/j.molimm.2014.04.009
   Knutson KL, 2001, J CLIN INVEST, V107, P477, DOI 10.1172/JCI11752
   KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M
   Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215
   Muh HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005861
   Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7
   Oyarzn P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-52
   PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013
   Patronov A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-32
   Petrovsky N, 2002, IMMUNOL CELL BIOL, V80, P248, DOI 10.1046/j.1440-1711.2002.01093.x
   Poland GA, 2009, PHARMACOGENOMICS, V10, P837, DOI 10.2217/PGS.09.25
   RINI JM, 1992, SCIENCE, V255, P959, DOI 10.1126/science.1546293
   ROEHRIG JT, 1983, VIROLOGY, V128, P118, DOI 10.1016/0042-6822(83)90323-9
   ROSE GD, 1985, ADV PROTEIN CHEM, V37, P1, DOI 10.1016/S0065-3233(08)60063-7
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schrodinger LLC, 2015, PYMOL MOL GRAPHICS S
   Shahsavandi S, 2015, VIROL SIN, V30, P200, DOI 10.1007/s12250-014-3504-0
   Tambunan USF, 2009, ONLINE J BIOL SCI, V9, P6
   Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419
   World Health Organization (WHO), ZIK SIT REP
   Xu X, 2016, COMPUTATIONAL ANAL Z
   Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213
NR 52
TC 35
Z9 37
U1 0
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0019-2805
EI 1365-2567
J9 IMMUNOLOGY
JI Immunology
PD DEC
PY 2016
VL 149
IS 4
BP 386
EP 399
DI 10.1111/imm.12656
PG 14
WC Immunology
SC Immunology
GA EB4RL
UT WOS:000387360700004
PM 27485738
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lamb, LE
   Bartolone, SN
   Kutluay, SB
   Robledo, D
   Porras, A
   Plata, M
   Chancellor, MB
AF Lamb, Laura E.
   Bartolone, Sarah N.
   Kutluay, Sebla B.
   Robledo, Daniela
   Porras, Alexandra
   Plata, Mauricio
   Chancellor, Michael B.
TI Advantage of urine based molecular diagnosis of Zika virus
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Review
DE Zika virus; Urine biomarker; Molecular diagnostic; Zika infection
ID WEST NILE VIRUS; DENGUE VIRUS; FRENCH-POLYNESIA; INTERIM GUIDELINES;
   UNITED-STATES; DECEMBER 2013; BLOOD SPOTS; SALIVA; INFECTION; GENOME
AB Zika virus (ZIKV) infection is an emerging global health concern, and diagnostic recommendations are currently developing based on new information. Several case or small sample size studies using both urine and blood samples suggest that ZIKV RNA can be detected at higher levels and for a longer time after onset of infection in urine compared to blood. We recommend that urine and serum collection for molecular testing be a standard part of evaluating patients for ZIKV infection, and that urine is a good alternative testing sample when blood collection is problematic.
C1 [Lamb, Laura E.; Bartolone, Sarah N.; Chancellor, Michael B.] William Beaumont Hosp, Dept Urol, 3811 West 13 Mile Rd,Suite 187, Royal Oak, MI 48073 USA.
   [Lamb, Laura E.; Chancellor, Michael B.] Oakland Univ, William Beaumont Sch Med, Dept Urol, Royal Oak, MI USA.
   [Kutluay, Sebla B.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Robledo, Daniela; Plata, Mauricio] Univ Hosp, Fdn Santa Fe Bogota, Dept Urol, Bogota, Colombia.
   [Robledo, Daniela; Plata, Mauricio] Univ Los Andes, Sch Med, Bogota, Colombia.
   [Porras, Alexandra] Univ Hosp, Fdn Santa Fe Bogota, Subdirecc Estudios Clin, Bogota, Colombia.
RP Lamb, LE (corresponding author), William Beaumont Hosp, Dept Urol, 3811 West 13 Mile Rd,Suite 187, Royal Oak, MI 48073 USA.; Lamb, LE (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Urol, Royal Oak, MI USA.
EM laura.lamb@beaumont.org
OI Porras-Ramirez, Alexandra/0000-0002-0800-1388; Bartolone,
   Sarah/0000-0001-9040-7055; Lamb, Laura/0000-0003-0386-4165; Plata,
   Mauricio/0000-0002-0129-945X
FU Maureen and Ronald Hirsch family philanthropic contribution
FX This study was funded in part by the Maureen and Ronald Hirsch family
   philanthropic contribution.
CR Anders KL, 2012, AM J TROP MED HYG, V87, P165, DOI 10.4269/ajtmh.2012.11-0713
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   [Anonymous], 2016, ZIK VIR POT COMPL
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L, 2014, J CLIN MICROBIOL, V52, P3411, DOI 10.1128/JCM.01328-14
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Chakravarti A, 2007, CURR MICROBIOL, V55, P461, DOI 10.1007/s00284-007-9040-5
   Chuansumrit A, 2011, DIAGN MICR INFEC DIS, V71, P467, DOI 10.1016/j.diagmicrobio.2011.08.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Elsana S, 1998, J MED VIROL, V55, P24, DOI 10.1002/(SICI)1096-9071(199805)55:1&lt;24::AID-JMV5&gt;3.0.CO;2-Q
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   FRERICHS RR, 1994, AIDS, V8, P885, DOI 10.1097/00002030-199407000-00004
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hearn P, 2014, AM J TROP MED HYG S1, V91, P62
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Interim Guidance for Zika Virus Testing of Urine-United States, 2016, MMWR MORB MORTAL WKL, V65, DOI 10.15585/mmwr.mm6518e1
   Joshi MS, 2002, CLIN DIAGN LAB IMMUN, V9, P840, DOI 10.1128/CDLI.9.4.840-845.2002
   Korhonen EM, 2015, EUROSURVEILLANCE, V21, P2016
   Korhonen EM, 2014, J CLIN VIROL, V61, P353, DOI 10.1016/j.jcv.2014.08.021
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Luo W, 2013, J CLIN VIROL, V58, pE113, DOI 10.1016/j.jcv.2013.08.017
   Ma XZ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-56
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NUMATA N, 1993, J MED VIROL, V41, P120, DOI 10.1002/jmv.1890410207
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Papa A, 2014, J MED VIROL, V86, P2142, DOI 10.1002/jmv.23949
   PERRY KR, 1992, J MED VIROL, V38, P265, DOI 10.1002/jmv.1890380407
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Schnirring L, 2015, ZIKA VIRUS SPREADS M
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Terada K, 2000, PEDIATR INFECT DIS J, V19, P104, DOI 10.1097/00006454-200002000-00003
   Vazquez S, 2007, INT J INFECT DIS, V11, P256, DOI 10.1016/j.ijid.2006.05.005
   Yap G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001046
NR 55
TC 9
Z9 9
U1 2
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
EI 1573-2584
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
PD DEC
PY 2016
VL 48
IS 12
BP 1961
EP 1966
DI 10.1007/s11255-016-1406-9
PG 6
WC Urology & Nephrology
SC Urology & Nephrology
GA EB7VW
UT WOS:000387600200004
PM 27567913
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Urine-based molecular diagnosis of Zika virus
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Wiwanitkit House, Bangkok 10160, Thailand.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Peoples R China.; Wiwanitkit, V (corresponding author), Dr DY Patil Univ, Pune, Maharashtra, India.; Wiwanitkit, V (corresponding author), Univ Nis, Fac Med, Nish, Serbia.; Wiwanitkit, V (corresponding author), Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.; Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Lamb LE, 2016, INT UROL NEPHROL, V48, P1961, DOI 10.1007/s11255-016-1406-9
NR 2
TC 2
Z9 2
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
EI 1573-2584
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
PD DEC
PY 2016
VL 48
IS 12
BP 2023
EP 2023
DI 10.1007/s11255-016-1417-6
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA EB7VW
UT WOS:000387600200010
PM 27650447
OA Bronze
DA 2020-07-08
ER

PT J
AU Lamb, LE
   Bartolone, SN
   Kutluay, SB
   Robledo, D
   Porras, A
   Plata, M
   Chancellor, MB
AF Lamb, Laura E.
   Bartolone, Sarah N.
   Kutluay, Sebla B.
   Robledo, Daniela
   Porras, Alexandra
   Plata, Mauricio
   Chancellor, Michael B.
TI Reply to the letter: Urine based molecular diagnosis of Zika virus by
   Viroj Wiwanitkit
SO INTERNATIONAL UROLOGY AND NEPHROLOGY
LA English
DT Letter
C1 [Lamb, Laura E.; Bartolone, Sarah N.; Chancellor, Michael B.] William Beaumont Hosp, Dept Urol, 3811 West 13 Mile Rd,Suite 187, Royal Oak, MI 48073 USA.
   [Lamb, Laura E.; Chancellor, Michael B.] Oakland Univ, William Beaumont Sch Med, Dept Urol, Royal Oak, MI USA.
   [Kutluay, Sebla B.] Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Robledo, Daniela; Plata, Mauricio] Univ Hosp, Fdn Santa Fe Bogota, Dept Urol, Bogota, DC, Colombia.
   [Robledo, Daniela; Plata, Mauricio] Univ Los Andes, Sch Med, Bogota, DC, Colombia.
   [Porras, Alexandra] Univ Hosp, Fdn Santa Fe Bogota, Subdirecc Estudios Clin, Bogota, DC, Colombia.
RP Lamb, LE (corresponding author), William Beaumont Hosp, Dept Urol, 3811 West 13 Mile Rd,Suite 187, Royal Oak, MI 48073 USA.; Lamb, LE (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Urol, Royal Oak, MI USA.
EM laura.lamb@beaumont.org
OI Bartolone, Sarah/0000-0001-9040-7055; Porras-Ramirez,
   Alexandra/0000-0002-0800-1388; Lamb, Laura/0000-0003-0386-4165; Plata,
   Mauricio/0000-0002-0129-945X
NR 0
TC 1
Z9 1
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-1623
EI 1573-2584
J9 INT UROL NEPHROL
JI Int. Urol. Nephrol.
PD DEC
PY 2016
VL 48
IS 12
BP 2025
EP 2025
DI 10.1007/s11255-016-1424-7
PG 1
WC Urology & Nephrology
SC Urology & Nephrology
GA EB7VW
UT WOS:000387600200011
PM 27687554
DA 2020-07-08
ER

PT J
AU Vancini, RL
   Andrade, MS
   Vancini-Campanharo, CR
   de Lira, CAB
AF Vancini, Rodrigo Luiz
   Andrade, Marilia Santos
   Vancini-Campanharo, Cassia Regina
   Barbosa de Lira, Claudio Andre
TI Zika Virus Infection, Summer Olympic and Paralympic Games in Rio 2016,
   and Sports Performance
SO JOURNAL OF HUMAN KINETICS
LA English
DT Letter
ID MUSCLE DYSFUNCTION; DENGUE; ELECTROMYOGRAPHY; BRAZIL
C1 [Vancini, Rodrigo Luiz] Univ Fed Espirito Santo UFES, Ctr Educ Fis & Desportos CEFD, Vitoria, ES, Brazil.
   [Andrade, Marilia Santos] Univ Fed Sao Paulo UNIFESP, Dept Fisiol, Sao Paulo, SP, Brazil.
   [Vancini-Campanharo, Cassia Regina] Univ Fed Sao Paulo UNIFESP, Escola Paulista Enfermagem, Sao Paulo, SP, Brazil.
   [Barbosa de Lira, Claudio Andre] Univ Fed Goias UFG, Fac Educ Fis & Danca, Setor Fisiol Humana & Exercicio, Ave Esperanca S-N,Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
RP de Lira, CAB (corresponding author), Univ Fed Goias UFG, Fac Educ Fis & Danca, Setor Fisiol Humana & Exercicio, Ave Esperanca S-N,Campus Samambaia, BR-74690900 Goiania, Go, Brazil.
EM andre.claudio@gmail.com
RI Lira, Claudio/A-5105-2012; Andrade, Marilia S/J-2333-2014; de Lira,
   Claudio/V-2480-2019
OI Lira, Claudio/0000-0001-5749-6877; Andrade, Marilia
   S/0000-0002-7004-4565; de Lira, Claudio/0000-0001-5749-6877
CR [Anonymous], 2016, GUARDIAN
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Kalita J, 2012, J CLIN NEUROPHYSIOL, V29, P468, DOI 10.1097/WNP.0b013e31826be029
   Misra UK, 2012, INFECTION, V40, P125, DOI 10.1007/s15010-011-0203-8
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Ross J., 2016, WHAT YOU NEED KNOW Z
   Turbeville SD, 2006, AM J SPORT MED, V34, P1860, DOI 10.1177/0363546505285385
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Washington Post, 2016, WASHINGTON POST
   World Health Organization, 2016, ZIK SIT REP ZIK POT
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 12
TC 0
Z9 0
U1 0
U2 11
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 1640-5544
EI 1899-7562
J9 J HUM KINET
JI J. Hum. Kinet.
PD DEC
PY 2016
VL 53
IS 1
BP 5
EP 7
DI 10.1515/hukin-2016-0005
PG 3
WC Sport Sciences
SC Sport Sciences
GA EB1KX
UT WOS:000387111600001
PM 28149405
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diaz-Quionez, JA
   Lopez-Martinez, I
   Torres-Longoria, B
   Vazquez-Pichardo, M
   Cruz-Ramirez, E
   Ramirez-Gonzalez, JE
   Ruiz-Matus, C
   Kuri-Morales, P
AF Alberto Diaz-Quionez, Jose
   Lopez-Martinez, Irma
   Torres-Longoria, Belem
   Vazquez-Pichardo, Mauricio
   Cruz-Ramirez, Edith
   Ernesto Ramirez-Gonzalez, Jose
   Ruiz-Matus, Cuitlahuac
   Kuri-Morales, Pablo
TI Evidence of the presence of the Zika virus in Mexico since early 2015
SO VIRUS GENES
LA English
DT Article
DE Zika virus; Mexico; RT-PCR; Retrospective analysis
AB To assess the possible circulation of Zika virus (ZIKV) prior to the first documented case in Mexico, we reanalyzed the stored samples from the states of Veracruz and Yucatan, which were originally collected to test for dengue (DENV) and chikungunya (CHIKV) but were negative for these viruses despite the symptomatology. The samples were originally collected between the 30 and 46 epidemiological weeks (EW) when the ZIKV was not yet declared as a Public Health Emergency of International Concern (PHEIC). From the total 4016 negative samples, a total of one hundred samples, 50 from Veracruz (CHIK- DENV-) and 50 from Yucatan (4 CHIK- DENV- and 46 CHIK- or DENV-), were tested for Zika virus by using RT-PCR. Results showed that in Veracruz and Yucatan, 20 % (10/50) and 70 % (35/50) were, respectively, ZIKV positive, indicating unequivocally the presence of ZIKV at least since July 2015. We also tested non-confirmed suspect measles cases from early 2015 for ZIKV by RT-PCR. Remarkably in 11 Mexican states, 86 % (18/21) were positive with the earlier symptoms onset as early as May 2015. Finally, RT-PCR analyses on RNA extracted from Aedes aegypti mosquitoes captured from January to March 2015 showed the presence of ZIKV, strongly suggesting that the vector was already carrying the virus at the start of 2015.
C1 [Alberto Diaz-Quionez, Jose; Lopez-Martinez, Irma; Torres-Longoria, Belem; Vazquez-Pichardo, Mauricio; Cruz-Ramirez, Edith; Ernesto Ramirez-Gonzalez, Jose] Dr Manuel Martinez Baez, Inst Diagnst & Referencia Epidemiol, Mexico City, DF, Mexico.
   [Alberto Diaz-Quionez, Jose; Kuri-Morales, Pablo] Univ Nacl Autonoma Mexico, Fac Med, Mexico City, DF, Mexico.
   [Ruiz-Matus, Cuitlahuac] Direcc Gen Epidemiol, Mexico City, DF, Mexico.
   [Kuri-Morales, Pablo] Subsecretaria Prevenc & Promoc Salud, Mexico City, DF, Mexico.
RP Diaz-Quionez, JA (corresponding author), Dr Manuel Martinez Baez, Inst Diagnst & Referencia Epidemiol, Mexico City, DF, Mexico.
EM alberto.diaz@salud.gob.mx
OI Diaz-Quinonez, Jose Alberto/0000-0002-3503-7079
FU CONACyT (Consejo Nacional de Ciencia y Tecnologia, Mexico)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [210399]
FX This study was partially funded by CONACyT (Consejo Nacional de Ciencia
   y Tecnologia, Mexico) Grant No. 210399.
CR Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Jimenez-Corona M. E., 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Keighley CL, 2015, CURR OPIN INFECT DIS, V28, P139, DOI 10.1097/QCO.0000000000000145
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
NR 7
TC 17
Z9 17
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD DEC
PY 2016
VL 52
IS 6
BP 855
EP 857
DI 10.1007/s11262-016-1384-0
PG 3
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA EB3LG
UT WOS:000387265600012
PM 27557815
DA 2020-07-08
ER

PT J
AU Champagne, C
   Salthouse, DG
   Paul, R
   Cao-Lormeau, VM
   Roche, B
   Cazelles, B
AF Champagne, Clara
   Salthouse, David Georges
   Paul, Richard
   Cao-Lormeau, Van-Mai
   Roche, Banjamin
   Cazelles, Bernard
TI Structure in the variability of the basic reproductive number (R-0) for
   Zika epidemics in the Pacific islands
SO ELIFE
LA English
DT Article
ID DISEASE TRANSMISSION; DENGUE TRANSMISSION; FRENCH-POLYNESIA;
   VIRUS-INFECTION; MOSQUITO-BORNE; AEDES-AEGYPTI; SOUTH-PACIFIC; MODELS;
   VECTOR; INSIGHTS
AB Before the outbreak that reached the Americas in 2015, Zika virus (ZIKV) circulated in Asia and the Pacific: these past epidemics can be highly informative on the key parameters driving virus transmission, such as the basic reproduction number (R-0). We compare two compartmental models with different mosquito representations, using surveillance and seroprevalence data for several ZIKV outbreaks in Pacific islands (Yap, Micronesia 2007, Tahiti and Moorea, French Polynesia 2013-2014, New Caledonia 2014). Models are estimated in a stochastic framework with recent Bayesian techniques. R0 for the Pacific ZIKV epidemics is estimated between 1.5 and 4.1, the smallest islands displaying higher and more variable values. This relatively low range of R0 suggests that intervention strategies developed for other flaviviruses should enable as, if not more effective control of ZIKV. Our study also highlights the importance of seroprevalence data for precise quantitative analysis of pathogen propagation, to design prevention and control strategies.
C1 [Champagne, Clara; Salthouse, David Georges; Cazelles, Bernard] CNRS, Ecole Normale Super, ENS, UMR 8197,IBENS, Paris, France.
   [Champagne, Clara] Univ Paris Saclay, CREST, ENSAE, Paris, France.
   [Paul, Richard] Inst Pasteur, Unite Genet Fonct Malad Infect, Dept Genomes & Genet, Paris, France.
   [Paul, Richard] CNRS, URA 3012, Paris, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
   [Roche, Banjamin; Cazelles, Bernard] UPMC, IRD, Int Ctr Math & Computat Modelling Complex Syst UM, Bondy, France.
RP Champagne, C; Cazelles, B (corresponding author), CNRS, Ecole Normale Super, ENS, UMR 8197,IBENS, Paris, France.; Champagne, C (corresponding author), Univ Paris Saclay, CREST, ENSAE, Paris, France.; Cazelles, B (corresponding author), UPMC, IRD, Int Ctr Math & Computat Modelling Complex Syst UM, Bondy, France.
EM champagn@biologie.ens.fr; cazelles@biologie.ens.fr
RI Cazelles, Bernard/B-1572-2013; Cao-Lormeau, Van-Mai/H-4879-2018
OI Cazelles, Bernard/0000-0002-7972-361X; Cao-Lormeau,
   Van-Mai/0000-0001-5606-7480
FU Centre National de la Recherche ScientifiqueCentre National de la
   Recherche Scientifique (CNRS); European CommissionEuropean Commission
   Joint Research Centre [282 348]
FX Centre National de la Recherche Scientifique Pepiniere
   interdisciplinaire Eco-Evo-Devo Clara Champagne David Georges Salthouse
   Bernard Cazelles; European Commission Seventh Framework Program [FP7
   2007-2013] for the DENFREE project under Grant Agreement 282 348 Clara
   Champagne David Georges Salthouse Richard Paul Van-Mai Cao-Lormeau
   Bernard Cazelles; The funders had no role in study design, data
   collection and interpretation, or the decision to submit the work for
   publication.
CR ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839
   Andrieu C, 2010, J R STAT SOC B, V72, P269, DOI 10.1111/j.1467-9868.2009.00736.x
   Aubry M, 2015, 64 ANN M AM SOC TROP
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carnell R, 2016, PACKAGE IHS 0 14
   Cazelles B, 2006, PLOS MED, V3, P1212, DOI 10.1371/journal.pmed.0030328
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CHSP, 2014, SURV DENG ZUK POL FR
   DASS, 2014, DIR AFF SAN SOC NOUV
   Daudens E, 2009, B EPIDEMIOLOGIQUE HE, V48-49-50, P499
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Doucet A, 2001, STAT ENG IN, P3
   Doucet A., 2011, TUTORIAL PARTICLE FI
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dureau J, 2013, SSM INF TIME SERIES
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Funk S, 2016, BIORXIV, DOI [10.1101/043265, DOI 10.1101/043265]
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   Insee, 2014, POP LEG REC POP 2012
   Insee, 2012, POP LEG REC POP 2012
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Laneri K, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000898
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599
   Mallet HP, 2015, B INFORM SANITAIRES, V13
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/s0034-89102003000400013
   Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pujol G., 2016, PACKAGE SENSITIVITY
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Roberts GO, 2009, J COMPUT GRAPH STAT, V18, P349, DOI 10.1198/jcgs.2009.06134
   Roy M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001979
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Telle O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146539
   Thompson RN, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004836
   Towers S, 2016, ESTIMATION REPRODUCT
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   World Health Organization, 2016, WHO STAT 1 M INT HLT
NR 60
TC 15
Z9 15
U1 1
U2 13
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD NOV 29
PY 2016
VL 5
AR e19874
DI 10.7554/eLife.19874.001
PG 34
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EJ7GD
UT WOS:000393388900001
PM 27897973
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Hombach, J
AF Hombach, Joachim
TI Developing a vaccine against Zika (vol 355, i5923, 2016)
SO BMJ-British Medical Journal
LA English
DT Correction
CR Hombach J, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5923
NR 1
TC 0
Z9 0
U1 0
U2 5
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD NOV 29
PY 2016
VL 355
AR i6424
DI 10.1136/bmj.i6424
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EE0ZA
UT WOS:000389308200009
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Samuel, GH
   Wiley, MR
   Badawi, A
   Adelman, ZN
   Myles, KM
AF Samuel, Glady Hazitha
   Wiley, Michael R.
   Badawi, Atif
   Adelman, Zach N.
   Myles, Kevin M.
TI Yellow fever virus capsid protein is a potent suppressor of RNA
   silencing that binds double-stranded RNA
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE yellow fever virus; flavivirus; capsid; Zika virus; RNA interference
ID DENGUE VIRUS; CORE PROTEIN; 3-DIMENSIONAL ARCHITECTURE; ANTIVIRAL
   IMMUNITY; SUBVIRAL PARTICLES; FLAVIVIRUS RNA; REPLICATION; MOSQUITO;
   SIRNA; INTERFERENCE
AB Mosquito-borne flaviviruses, including yellow fever virus (YFV), Zika virus (ZIKV), and West Nile virus (WNV), profoundly affect human health. The successful transmission of these viruses to a human host depends on the pathogen's ability to overcome a potentially sterilizing immune response in the vector mosquito. Similar to other invertebrate animals and plants, the mosquito's RNA silencing pathway comprises its primary antiviral defense. Although a diverse range of plant and insect viruses has been found to encode suppressors of RNA silencing, the mechanisms by which flaviviruses antagonize antiviral small RNA pathways in disease vectors are unknown. Here we describe a viral suppressor of RNA silencing (VSR) encoded by the prototype flavivirus, YFV. We show that the YFV capsid (YFC) protein inhibits RNA silencing in the mosquito Aedes aegypti by interfering with Dicer. This VSR activity appears to be broadly conserved in the C proteins of other medically important flaviviruses, including that of ZIKV. These results suggest that a molecular "arms race" between vector and pathogen underlies the continued existence of flaviviruses in nature.
C1 [Samuel, Glady Hazitha; Adelman, Zach N.; Myles, Kevin M.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Wiley, Michael R.; Badawi, Atif] Virginia Polytech Inst & State Univ, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.
   [Wiley, Michael R.] US Army, Med Res Inst Infect Dis, Ctr Genome Sci, Ft Detrick, MD 21702 USA.
RP Myles, KM (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
EM mylesk@tamu.edu
OI Adelman, Zach/0000-0001-5901-7171; Wiley, Michael/0000-0001-6688-007X
FU National Institute for Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [AI077726, AI103265, AI119081]
FX This work was supported by National Institute for Allergy and Infectious
   Diseases Grants AI077726, AI103265, and AI119081. The funding agency had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Adelman ZN, 2008, INSECT BIOCHEM MOLEC, V38, P705, DOI 10.1016/j.ibmb.2008.04.002
   Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001
   Allison SL, 2003, J VIROL, V77, P11357, DOI 10.1128/JVI.77.21.11357-11366.2003
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Billoir F, 2000, J GEN VIROL, V81, P2339, DOI 10.1099/0022-1317-81-9-2339
   Bornholdt ZA, 2006, NAT STRUCT MOL BIOL, V13, P559, DOI 10.1038/nsmb1099
   Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Cheng A, 2009, CELL RES, V19, P187, DOI 10.1038/cr.2008.288
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Garcia-Sastre A, 2002, MICROBES INFECT, V4, P647, DOI 10.1016/S1286-4579(02)01583-6
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Koonin EV, 2013, CURR OPIN VIROL, V3, P546, DOI 10.1016/j.coviro.2013.06.008
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205
   Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100
   Lindsey B, 2013, HUMAN CAPITALISM: HOW ECONOMIC GROWTH HAS MADE US SMARTER-AND MORE UNEQUAL, P6
   Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583
   Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325
   Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Marques JT, 2010, NAT STRUCT MOL BIOL, V17, P24, DOI 10.1038/nsmb.1735
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810
   O'Neal ST, 2014, VIRUSES-BASEL, V6, P4314, DOI 10.3390/v6114314
   Patkar CG, 2007, J VIROL, V81, P6471, DOI 10.1128/JVI.02120-06
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269
   Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003
   Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020
   Schalich J, 1996, J VIROL, V70, P4549, DOI 10.1128/JVI.70.7.4549-4557.1996
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312
   Szemiel AM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001823
   Teoh PG, 2014, J VIROL, V88, P7998, DOI 10.1128/JVI.00940-14
   Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057
   Valli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045957
   van Cleef KWR, 2014, NUCLEIC ACIDS RES, V42, P8732, DOI 10.1093/nar/gku528
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 55
TC 47
Z9 49
U1 2
U2 25
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 29
PY 2016
VL 113
IS 48
BP 13863
EP 13868
DI 10.1073/pnas.1600544113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ED4QR
UT WOS:000388835700086
PM 27849599
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wang, HJ
   Liu, SQ
   Zhang, B
   Wei, WQ
AF Wang, Hongju
   Liu, Siqing
   Zhang, Bo
   Wei, Wenqiang
TI Analysis of Synonymous Codon Usage Bias of Zika Virus and Its Adaption
   to the Hosts
SO PLOS ONE
LA English
DT Article
ID SELECTION; BIOLOGY; ADAPTATION; MUTATION; GENES; RNA
AB Zika virus (ZIKV) is a mosquito-borne virus (arbovirus) in the family Flaviviridae, and the symptoms caused by ZIKV infection in humans include rash, fever, arthralgia, myalgia, asthenia and conjunctivitis. Codon usage bias analysis can reveal much about the molecular evolution and host adaption of ZIKV. To gain insight into the evolutionary characteristics of ZIKV, we performed a comprehensive analysis on the codon usage pattern in 46 ZIKV strains by calculating the effective number of codons (ENc), codon adaptation index (CAI), relative synonymous codon usage (RSCU), and other indicators. The results indicate that the codon usage bias of ZIKV is relatively low. Several lines of evidence support the hypothesis that translational selection plays a role in shaping the codon usage pattern of ZIKV. The results from a correspondence analysis (CA) indicate that other factors, such as base composition, aromaticity, and hydrophobicity may also be involved in shaping the codon usage pattern of ZIKV. Additionally, the results from a comparative analysis of RSCU between ZIKV and its hosts suggest that ZIKV tends to evolve codon usage patterns that are comparable to those of its hosts. Moreover, selection pressure from Homo sapiens on the ZIKV RSCU patterns was found to be dominant compared with that from Aedes aegypti and Aedes albopictus. Taken together, both natural translational selection and mutation pressure are important for shaping the codon usage pattern of ZIKV. Our findings contribute to understanding the evolution of ZIKV and its adaption to its hosts.
C1 [Wang, Hongju; Wei, Wenqiang] Henan Univ, Sch Med, Kaifeng, Peoples R China.
   [Liu, Siqing; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.
RP Wei, WQ (corresponding author), Henan Univ, Sch Med, Kaifeng, Peoples R China.
EM weiwq168@163.com
OI Wei, Wenqiang/0000-0002-7453-123X
FU Plant Foundation for Young Scientists of Henan University
   [CX0000A40557]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31501701]
FX This work was supported by grants from the Plant Foundation for Young
   Scientists of Henan University (CX0000A40557) and the National Natural
   Science Foundation of China (31501701). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.; This work was supported by grants from
   the Plant Foundation for Young Scientists of Henan University
   (CX0000A40557), and the National Natural Science Foundation of China
   (31501701). We thank Yihui Yuan (Wuhan Institute of Virology, Chinese
   Academy of Sciences) for helpful discussions and editing of this
   manuscript.
CR Auewarakul P, 2005, VIRUS RES, V109, P33, DOI 10.1016/j.virusres.2004.10.004
   Babbitt GA, 2014, NUCLEIC ACIDS RES, V42, P10915, DOI 10.1093/nar/gku811
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BULMER M, 1991, GENETICS, V129, P897
   BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358
   Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272
   Chen Youhua, 2014, VirusDisease, V25, P285, DOI 10.1007/s13337-014-0191-2
   Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   Das S, 2006, VIRUS RES, V117, P227, DOI 10.1016/j.virusres.2005.10.007
   de Melo Freire C. C., 2015, SPREAD PANDEMIC ZIKA
   Doran TM, 2011, THESIS
   dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897
   Ermolaeva M D, 2001, Curr Issues Mol Biol, V3, P91
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hemert FV, 2015, VIROL J, V13, P1
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Jung SK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-340
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar N., 2016, PLOS ONE, V11
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lararamirez EE, 2014, BIOMED RES INT, V2014, P66
   Liu XS, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-68
   Ma YP, 2015, J FISH DIS, V38, P665, DOI 10.1111/jfd.12316
   Ma YP, 2014, ARCH VIROL, V159, P1841, DOI 10.1007/s00705-014-2000-z
   Ma YL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111950
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4
   Plotkin JB, 2006, J MOL EVOL, V63, P635, DOI 10.1007/s00239-005-0233-x
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1
   SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737
   SHARP PM, 1994, CURR OPIN GENET DEV, V4, P851, DOI 10.1016/0959-437X(94)90070-1
   Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Vicario S, 2006, BMC EVOL BIOL, V7, P1
   Wan XF, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-19
   Wang M, 2011, VIRUS GENES, V42, P245, DOI 10.1007/s11262-011-0574-z
   Wang M, 2011, ARCH VIROL, V156, P153, DOI 10.1007/s00705-010-0848-0
   Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Zeng ZY, 2014, J VIROL METHODS, V208, P102, DOI 10.1016/j.jviromet.2014.08.001
   Zhou JH, 2013, PLOS ONE, V8, P1175
NR 56
TC 7
Z9 7
U1 2
U2 25
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 28
PY 2016
VL 11
IS 11
AR e0166260
DI 10.1371/journal.pone.0166260
PG 22
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE3FE
UT WOS:000389472400020
PM 27893824
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kampen, H
   Jansen, S
   Schmidt-Chanasit, J
   Walther, D
AF Kampen, H.
   Jansen, S.
   Schmidt-Chanasit, J.
   Walther, D.
TI Indoor development of Aedes aegypti in Germany, 2016
SO EUROSURVEILLANCE
LA English
DT Article
ID REGION; DENGUE; VIRUS
AB In spring 2016, a German traveller returning from Martinique cultivated imported plant offsets in her home, and accidentally bred Aedes aegypti. Thirteen adult mosquito specimens submitted for identification and the traveller were tested for Zika, dengue and chikungunya virus infections, with negative results. The detection of Ae. aegypti by the 'Mueckenatlas' project demonstrates the value of this passive surveillance scheme for potential public health threats posed by invasive mosquitoes in Germany.
C1 [Kampen, H.] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany.
   [Jansen, S.; Schmidt-Chanasit, J.] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Walther, D.] Leibniz Ctr Agr Landscape Res, Muncheberg, Germany.
RP Kampen, H (corresponding author), Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Germany.
EM helge.kampen@fli.de
FU German Federal Ministry of Food and Agriculture (BMEL) through the
   Federal Office for Agriculture and Food (BLE) [2819104115, 2819104615]
FX The work was funded by the German Federal Ministry of Food and
   Agriculture (BMEL) through the Federal Office for Agriculture and Food
   (BLE), grant numbers 2819104115 and 2819104615.
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Almeida APG, 2007, EUROSURVEILLANCE, V12
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   ECDC, 2012, GUID SURV INV MOSQ E
   European Centre for Disease Prevention and Control (ECDC), 2016, ZIK VIR DIS EP PREP
   Ganushkina LA, 2016, VECTOR-BORNE ZOONOT, V16, P58, DOI 10.1089/vbz.2014.1761
   Ibanez-Justicia A, 2016, 20 E SOVE C OCT 3 7, P41
   Ibanez-Justicia A, 2014, J EUR MOSQ CONTROL A, V32, P9
   Jost H, 2010, J CLIN MICROBIOL, V48, P1900, DOI 10.1128/JCM.00037-10
   Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Tappe D, 2009, MED MICROBIOL IMMUN, V198, P271, DOI 10.1007/s00430-009-0122-9
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Yunicheva Yu. V., 2008, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P40
NR 22
TC 3
Z9 3
U1 0
U2 4
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD NOV 24
PY 2016
VL 21
IS 47
BP 7
EP 9
AR 30407
DI 10.2807/1560-7917.ES.2016.21.47.30407
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA EE1QW
UT WOS:000389358600002
PM 27918261
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ngoagouni, C
   Kamgang, B
   Brengues, C
   Yahouedo, G
   Paupy, C
   Nakoune, E
   Kazanji, M
   Chandre, F
AF Ngoagouni, Carine
   Kamgang, Basile
   Brengues, Cecile
   Yahouedo, Gildas
   Paupy, Christophe
   Nakoune, Emmanuel
   Kazanji, Mirdad
   Chandre, Fabrice
TI Susceptibility profile and metabolic mechanisms involved in Aedes
   aegypti and Aedes albopictus resistant to DDT and deltamethrin in the
   Central African Republic
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Arboviruses; Vectors; Insecticide
   resistance; Metabolic resistance; Central African Republic
ID GATED SODIUM-CHANNEL; INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE;
   PYRETHROID RESISTANCE; CHIKUNGUNYA-VIRUS; ANOPHELES-GAMBIAE; ZIKA VIRUS;
   MOLECULAR EVIDENCE; MOSQUITO VECTOR; AE. ALBOPICTUS
AB Background: Aedes aegypti and Ae. albopictus are the main epidemic vectors of dengue, chikungunya and Zika viruses worldwide. Their control during epidemics relies mainly on control of larvae and adults with insecticides. Unfortunately, loss of susceptibility of both species to several insecticide classes limits the efficacy of interventions. In Africa, where Aedes-borne viruses are of growing concern, few data are available on resistance to insecticides. To fill this gap, we assessed the susceptibility to insecticides of Ae. aegypti and Ae. albopictus populations in the Central African Republic (CAR) and studied the mechanisms of resistance.
   Methods: Immature stages were sampled between June and September 2014 in six locations in Bangui (the capital of CAR) for larval and adult bioassays according to WHO standard procedures. We also characterized DDT- and pyrethroid-resistant mosquitoes molecularly and biochemically, including tests for the activities of nonspecific esterases (alpha and beta), mixed-function oxidases, insensitive acetylcholinesterase and glutathione S-transferases.
   Results: Larval bioassays, carried out to determine the lethal concentrations (LC50 and LC95) and resistance ratios (RR50 and RR95), suggested that both vector species were susceptible to Bacillus thuringiensis var. israeliensis and to temephos. Bioassays of adults showed susceptibility to propoxur and fenitrothion, except for one Ae. albopictus population that was suspected to be resistant to fenithrothion. None of the Ae. aegypti populations was fully susceptible to DDT. Ae. albopictus presented a similar profile to Ae. aegypti but with a lower mortality rate (41%). Possible resistance to deltamethrin was observed among Ae. aegypti and Ae. albopictus, although some were susceptible. No kdr mutations were detected in either species; however, the activity of detoxifying enzymes was higher in most populations than in the susceptible Ae. aegypti strain, confirming decreased susceptibility to DDT and deltamethrin.
   Conclusion: These findings suggested that regular, continuous monitoring of resistance is necessary in order to select the most effective adulticides for arbovirus control in Bangui.
C1 [Ngoagouni, Carine; Nakoune, Emmanuel; Kazanji, Mirdad] Inst Pasteur, POB 923, Bangui, Cent Afr Republ.
   [Kamgang, Basile] Org Coordinat Endemies Afrique Cent, Liverpool Sch Trop Med, Res Unit, POB 288, Yaounde, Cameroon.
   [Brengues, Cecile; Yahouedo, Gildas; Paupy, Christophe; Chandre, Fabrice] Univ Montpellier, Lab Malad Infect & Vecteurs Ecol Genet Evolut & C, CNRS, Inst Rech Dev,Unite Mixte Rech 224 5290, Montpellier, France.
   [Kazanji, Mirdad] Inst Pasteur, BP 6010,23 Ave Pasteur, Cayenne 97306, French Guiana.
RP Ngoagouni, C (corresponding author), Inst Pasteur, POB 923, Bangui, Cent Afr Republ.
EM ngoagounic@yahoo.fr
RI Nakoune, Emmanuel/W-2710-2019; Chandre, Fabrice/Q-3429-2019; Paupy,
   Christophe/I-4847-2017
OI Paupy, Christophe/0000-0002-7122-2079; Yahouedo,
   Gildas/0000-0002-4056-325X; Kamgang, Basile/0000-0002-8883-4557;
   Chandre, Fabrice/0000-0002-1994-9705
FU Institute Pasteur de Bangui; International Network of Pasteur Institutes
   (Actions Concertees Inter-Pasteuriennes) - Institut Pasteur (Paris,
   France) [A12-12, A22-15]; Service de Cooperation et d'Action Culturelle
   de l'Ambassade de France a Bangui
FX This work was supported by the Institute Pasteur de Bangui, the
   International Network of Pasteur Institutes (Actions Concertees
   Inter-Pasteuriennes No. A12-12 and A22-15) financed by the Institut
   Pasteur (Paris, France) and by the Service de Cooperation et d'Action
   Culturelle de l'Ambassade de France a Bangui. The funders had no role in
   study design, data collection or analysis, decision to publish or
   preparation of the manuscript.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Ahmad Intan, 2007, Pakistan Journal of Biological Sciences, V10, P3688, DOI 10.3923/pjbs.2007.3688.3692
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Ayorinde A, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev045
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Carvalho Maria do Socorro Laurentino de, 2004, Rev. Saúde Pública, V38, P623, DOI 10.1590/S0034-89102004000500002
   Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x
   Cisse MBM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0847-4
   Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014
   Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042
   Diallo M, 2010, TROP MED INT HEALTH, V15, P1185, DOI 10.1111/j.1365-3156.2010.02594.x
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Enayati AA, 2003, MED VET ENTOMOL, V17, P138, DOI 10.1046/j.1365-2915.2003.00418.x
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631
   GINER M, 1999, WIN DL VERSION 2 0
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grigoraki L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003771
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Higgs S, 2015, INT HEALTH, V7, P1, DOI 10.1093/inthealth/ihu092
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2
   Jupp P.G., 1996, MOSQUITOES SO AFRICA
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Koffi AA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-68
   Labbe P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P363, DOI 10.1016/B978-0-12-384890-1.00014-5
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Mombouli JV, 2013, EMERG INFECT DIS, V19, P1542, DOI 10.3201/eid1909.130451
   Morlais I, 2004, AM J TROP MED HYG, V71, P795, DOI 10.4269/ajtmh.2004.71.795
   Mouchet J, 1972, WHOVBC72381
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Paeporn Pungasem, 2004, Tropical Biomedicine, V21, P145
   Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2
   Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   Scully C, 2016, BRIT DENT J, V220, P265, DOI 10.1038/sj.bdj.2016.182
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   WHO, 2016, WHOPES REC COMP FORM
   WHO, 2013, TEST PROC INREMO
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Yadouleton A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-60
NR 68
TC 16
Z9 17
U1 0
U2 30
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD NOV 24
PY 2016
VL 9
AR 599
DI 10.1186/s13071-016-1887-5
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EC7VT
UT WOS:000388349300001
PM 27881148
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Zhang, S
   Kostyuchenko, VA
   Ng, TS
   Lim, XN
   Ooi, JSG
   Lambert, S
   Tan, TY
   Widman, DG
   Shi, J
   Baric, RS
   Lok, SM
AF Zhang, Shuijun
   Kostyuchenko, Victor A.
   Thiam-Seng Ng
   Lim, Xin-Ni
   Ooi, Justin S. G.
   Lambert, Sebastian
   Ter Yong Tan
   Widman, Douglas G.
   Shi, Jian
   Baric, Ralph S.
   Lok, Shee-Mei
TI Neutralization mechanism of a highly potent antibody against Zika virus
SO NATURE COMMUNICATIONS
LA English
DT Article
ID DENGUE VIRUS; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; PROTEIN; IMAGES;
   ACQUISITION; RESOLUTION; ALGORITHM; SYSTEM
AB The rapid spread of Zika virus (ZIKV), which causes microcephaly and Guillain-Barre syndrome, signals an urgency to identify therapeutics. Recent efforts to rescreen dengue virus human antibodies for ZIKV cross-neutralization activity showed antibody C10 as one of the most potent. To investigate the ability of the antibody to block fusion, we determined the cryoEM structures of the C10-ZIKV complex at pH levels mimicking the extracellular (pH8.0), early (pH6.5) and late endosomal (pH5.0) environments. The 4.0 angstrom resolution pH8.0 complex structure shows that the antibody binds to E proteins residues at the intra-dimer interface, and the virus quaternary structure-dependent inter-dimer and inter-raft interfaces. At pH6.5, antibody C10 locks all virus surface E proteins, and at pH5.0, it locks the E protein raft structure, suggesting that it prevents the structural rearrangement of the E proteins during the fusion event-a vital step for infection. This suggests antibody C10 could be a good therapeutic candidate.
C1 [Zhang, Shuijun; Kostyuchenko, Victor A.; Thiam-Seng Ng; Lim, Xin-Ni; Ooi, Justin S. G.; Lambert, Sebastian; Ter Yong Tan; Lok, Shee-Mei] Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore.
   [Zhang, Shuijun; Kostyuchenko, Victor A.; Thiam-Seng Ng; Lim, Xin-Ni; Ooi, Justin S. G.; Lambert, Sebastian; Ter Yong Tan; Shi, Jian; Lok, Shee-Mei] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117557, Singapore.
   [Widman, Douglas G.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.
   [Shi, Jian] Natl Univ Singapore, Dept Biol Sci, CryoEM Unit, Singapore 117557, Singapore.
RP Lok, SM (corresponding author), Duke Natl Univ Singapore, Sch Med, Program Emerging Infect Dis, Singapore 169857, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117557, Singapore.; Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA.
EM rbaric@email.unc.edu; sheemei.lok@duke-nus.edu.sg
OI Widman, Douglas/0000-0002-3585-6373; Ooi, Justin/0000-0003-4899-8255;
   Lim, Xin-Ni/0000-0001-8117-3613; Lok, Shee-Mei/0000-0003-4631-8041
FU Singapore Ministry of Education Tier 3 grant [MOE2012-T3-1-008];
   National Research Foundation Investigatorship award [NRF-NRFI2016-01];
   Ministry of Health, Singapore; NIH AIDUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [AI100625, AI
   107731]
FX We thank the European Virus Archive for consenting to the use of the
   ZIKV H/PF/2013 strain and M.S. Diamond for sending the virus. The work
   is supported by Singapore Ministry of Education Tier 3 grant
   (MOE2012-T3-1-008), National Research Foundation Investigatorship award
   (NRF-NRFI2016-01) awarded to S-M.L and the Duke-NUS Signature Research
   Programme funded by the Ministry of Health, Singapore and NIH AID
   research grants AI100625 and AI 107731 awarded to R.S.B.
CR Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Li XM, 2015, J STRUCT BIOL, V192, P174, DOI 10.1016/j.jsb.2015.09.003
   Liu XG, 2007, J STRUCT BIOL, V160, P11, DOI 10.1016/j.jsb.2007.06.009
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mukherjee S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp318
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tsai CJ, 1996, J MOL BIOL, V260, P604, DOI 10.1006/jmbi.1996.0424
   Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
NR 31
TC 54
Z9 57
U1 1
U2 27
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 24
PY 2016
VL 7
AR 13679
DI 10.1038/ncomms13679
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ED3RC
UT WOS:000388765200001
PM 27882950
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Battaglia, V
   Gabrieli, P
   Brandini, S
   Capodiferro, MR
   Javier, PA
   Chen, XG
   Achilli, A
   Semino, O
   Gomulski, LM
   Malacrida, AR
   Gasperi, G
   Torroni, A
   Olivieri, A
AF Battaglia, Vincenza
   Gabrieli, Paolo
   Brandini, Stefania
   Capodiferro, Marco R.
   Javier, Pio A.
   Chen, Xiao-Guang
   Achilli, Alessandro
   Semino, Ornella
   Gomulski, Ludvik M.
   Malacrida, Anna R.
   Gasperi, Giuliano
   Torroni, Antonio
   Olivieri, Anna
TI The Worldwide Spread of the Tiger Mosquito as Revealed by Mitogenome
   Haplogroup Diversity
SO FRONTIERS IN GENETICS
LA English
DT Article
DE Aedes albopictus; tiger mosquito; mitochondrial DNA; mitogenomes;
   haplogroups
ID AEDES-ALBOPICTUS DIPTERA; INVASIVE MOSQUITOS; MITOCHONDRIAL GENOMES;
   POPULATION-GENETICS; CONTROL REGION; CULICIDAE; AEGYPTI; DENGUE;
   PHYLOGEOGRAPHY; IDENTIFICATION
AB In the last 40 years, the Asian tiger mosquito Aedes albopictus, indigenous to East Asia, has colonized every continent except Antarctica. Its spread is a major public health concern, given that this species is a competent vector for numerous arboviruses, including those causing dengue, chikungunya, West Nile, and the recently emerged Zika fever. To acquire more information on the ancestral source(s) of adventive populations and the overall diffusion process from its native range, we analyzed the mitogenome variation of 27 individuals from representative populations of Asia, the Americas, and Europe. Phylogenetic analyses revealed five haplogroups in Asia, but population surveys appear to indicate that only three of these (Al al, Al a2, and Al b) were involved in the recent worldwide spread. We also found out that a derived lineage (Al al al) within Al al, which is now common in Italy, most likely arose in North America from an ancestral Japanese source. These different genetic sources now coexist in many of the recently colonized areas, thus probably creating novel genomic combinations which might be one of the causes of the apparently growing ability of A. albopictus to expand its geographical range.
C1 [Battaglia, Vincenza; Gabrieli, Paolo; Brandini, Stefania; Capodiferro, Marco R.; Achilli, Alessandro; Semino, Ornella; Gomulski, Ludvik M.; Malacrida, Anna R.; Gasperi, Giuliano; Torroni, Antonio; Olivieri, Anna] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Pavia, Italy.
   [Javier, Pio A.] Univ Philippines Los Banos, Coll Agr, Crop Protect Cluster, Los Banos, Philippines.
   [Chen, Xiao-Guang] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Pathogen Biol, Guangzhou, Guangdong, Peoples R China.
RP Gasperi, G; Torroni, A; Olivieri, A (corresponding author), Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, Pavia, Italy.
EM giuliano.gasperi@unipv.it; antonio.torroni@unipv.it;
   anna.olivieri@unipv.it
RI Capodiferro, Marco/AAQ-4941-2020; Gasperi, Giuliano/Y-1894-2019;
   Gabrieli, Paolo/A-3206-2016; Battaglia, Vincenza/F-6950-2017; Torroni,
   Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; /I-9235-2012
OI Gasperi, Giuliano/0000-0001-6972-8591; Gabrieli,
   Paolo/0000-0002-4996-2468; Torroni, Antonio/0000-0002-4163-4478;
   Achilli, Alessandro/0000-0001-6871-3451; /0000-0002-3941-8098;
   Capodiferro, Marco Rosario/0000-0003-2494-5423; malacrida,
   anna/0000-0003-4566-8795
FU University of Pavia strategic theme "Toward a governance model for
   international migration: an interdisciplinary and diachronic
   perspective" (MIGRATING); EU-FP7 Research Infrastructures project
   (INFRAVEC)European Union (EU) [228421]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81420108024]; Italian Ministry of HealthMinistry of Health, Italy
   [RF-2010-2318965]; Italian Ministry of Education; University and
   Research: Progetti Futuro in Ricerca [RBFR126B8I]; Progetti Ricerca
   Interesse NazionaleMinistry of Education, Universities and Research
   (MIUR)Research Projects of National Relevance (PRIN) [2012JA4BTY];
   Department of Biology and Biotechnology, University of Pavia
FX This work was supported by the University of Pavia strategic theme
   "Toward a governance model for international migration: an
   interdisciplinary and diachronic perspective" (MIGRATING), the EU-FP7
   Research Infrastructures project (INFRAVEC) Grant 228421 (to GC), the
   National Natural Science Foundation of China (81420108024) (to X-GC),
   the Italian Ministry of Health (RF-2010-2318965) (to ARM), the Italian
   Ministry of Education, University and Research: Progetti Futuro in
   Ricerca 2012 (RBFR126B8I) (to AA and AO), and Progetti Ricerca Interesse
   Nazionale 2012 (2012JA4BTY) (to AA, AT, and OS). PG was supported by a
   fellowship from the Department of Biology and Biotechnology, University
   of Pavia.
CR Achilli A, 2008, CURR BIOL, V18, pR157, DOI 10.1016/j.cub.2008.01.019
   Achilli A, 2012, P NATL ACAD SCI USA, V109, P2449, DOI 10.1073/pnas.1111637109
   Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   Dritsou V, 2015, PATHOG GLOB HEALTH, V109, P207, DOI 10.1179/2047773215Y.0000000031
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duenas JCR, 2006, GENOME, V49, P931, DOI 10.1139/G06-053
   Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35
   Gubler D.J., 2006, NOVART FDN SYMP, V277, P16, DOI DOI 10.1002/0470058005.CH2
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   Higa Y, 2010, JPN J INFECT DIS, V63, P312
   KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257
   Khormi HM, 2014, GEOSPATIAL HEALTH, V8, P405, DOI 10.4081/gh.2014.29
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Nei M., 2000, MOL EVOLUTION PHYLOG
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83
   Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Romi R, 1997, J AM MOSQUITO CONTR, V13, P245
   Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Scholte EJ, 2009, EUROSURVEILLANCE, V14, P24
   Sumruayphol S, 2016, ACTA TROP, V159, P1, DOI 10.1016/j.actatropica.2016.03.010
   Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001
   Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x
   Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755
   Xu JW, 2011, MITOCHONDR DNA, V22, P155, DOI 10.3109/19401736.2011.636434
   Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088
   Zawani MKN, 2014, GENET MOL RES, V13, P8184, DOI 10.4238/2014.October.7.13
   Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7
   Zhang HD, 2016, MITOCHONDRIAL DNA A, V27, P2787, DOI 10.3109/19401736.2015.1053067
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
NR 58
TC 17
Z9 18
U1 0
U2 16
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD NOV 23
PY 2016
VL 7
AR 208
DI 10.3389/fgene.2016.00208
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA EW7GX
UT WOS:000402678900001
PM 27933090
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McCarthy, M
AF McCarthy, Michael
TI Zika related microcephaly may appear after birth, study finds
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR van der Linden V, 2016, MMWR MORB MORTAL WKL
NR 1
TC 0
Z9 0
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD NOV 23
PY 2016
VL 355
AR i6333
DI 10.1136/bmj.i6333
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA ED5UF
UT WOS:000388917100021
PM 27881434
OA Bronze
DA 2020-07-08
ER

PT J
AU Boubidi, SC
   Roiz, D
   Rossignol, M
   Chandre, F
   Benoit, R
   Raselli, M
   Tizon, C
   Cadiou, B
   Tounsi, R
   Lagneau, C
   Fontenille, D
   Reiter, P
AF Boubidi, Said C.
   Roiz, David
   Rossignol, Marie
   Chandre, Fabrice
   Benoit, Romain
   Raselli, Marc
   Tizon, Charles
   Cadiou, Bernard
   Tounsi, Reda
   Lagneau, Christophe
   Fontenille, Didier
   Reiter, Paul
TI Efficacy of ULV and thermal aerosols of deltamethrin for control of
   Aedes albopictus in nice, France
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes albopictus; ULV; Cold fogging; Thermal fogging; Vector control;
   Dengue; Deltamethrin
ID MOSQUITO-CONTROL; ZIKA VIRUS; DENGUE; AEGYPTI; POPULATIONS; CHIKUNGUNYA;
   TEMPERATE; CULICIDAE; EPIDEMICS; DIPTERA
AB Background: Ultra-low volume (ULV) insecticidal aerosols dispensed from vehicle-mounted cold-foggers are widely considered the method of choice for control of Aedes aegypti and Ae. albopictus during outbreaks of dengue and chikungunya and, more recently, Zika. Nevertheless, their effectiveness has been poorly studied, particularly in Europe. Nearly all published studies of ULV efficacy are bio-assays based on the mortality of caged mosquitoes. In our study we preferred to monitor the direct impact of treatments on the wild mosquito populations. This study was undertaken to evaluate the efficiency of the two widely used space spraying methods to control Ae. albopictus and Ae. aegypti.
   Methods: We determined the susceptibility of local Ae. albopictus to deltamethrin by two methods: topical application and the "WHO Tube Test". We used ovitraps baited with hay infusion and adult traps (B-G Sentinel) baited with a patented attractant to monitor the mosquitoes in four residential areas in Nice, southern France. The impact of deltamethrin applied from vehicle-mounted ULV fogging-machines was assessed by comparing trap results in treated vs untreated areas for 5 days before and 5 days after treatment. Four trials were conducted at the maximum permitted application rate (1 g.ha-1). We also made two small-scale tests of the impact of the same insecticide dispensed from a hand-held thermal fogger.
   Results: Susceptibility to the insecticide was high but there was no discernable change in the oviposition rate or the catch of adult female mosquitoes, nor was there any change in the parous rate. In contrast, hand-held thermal foggers were highly effective, with more than 90% reduction of both laid eggs and females.
   Conclusions: We believe that direct monitoring of the wild mosquito populations gives a realistic assessment of the impact of treatments and suggest that the lack of efficacy is due to lack of interaction between the target mosquitoes and the ULV aerosol. We discuss the factors that influence the effectiveness of both methods of spraying in the context of epidemic situations.
C1 [Boubidi, Said C.; Benoit, Romain; Raselli, Marc; Tizon, Charles; Cadiou, Bernard; Tounsi, Reda; Lagneau, Christophe] EID Mediterranee, Montpellier, France.
   [Boubidi, Said C.] Inst Pasteur, Serv Ecoepidemiol Parasitaire, Algiers, Algeria.
   [Roiz, David; Rossignol, Marie; Chandre, Fabrice; Fontenille, Didier] CNRS, IRD, UMR Mivegec, Montpellier, France.
   [Roiz, David; Rossignol, Marie; Chandre, Fabrice; Fontenille, Didier] Univ Montpellier, Montpellier, France.
   [Fontenille, Didier] Inst Pasteur Cambodge, Phnom Penh, Cambodia.
   [Reiter, Paul] Inst Pasteur, Unite Insectes & Malad Infect, Paris, France.
RP Boubidi, SC (corresponding author), EID Mediterranee, Montpellier, France.; Boubidi, SC (corresponding author), Inst Pasteur, Serv Ecoepidemiol Parasitaire, Algiers, Algeria.
EM saidboubidi@yahoo.fr
RI Roiz, David/F-2082-2011; Chandre, Fabrice/Q-3429-2019
OI Roiz, David/0000-0002-5819-3648; Chandre, Fabrice/0000-0002-1994-9705
FU European CommissionEuropean Commission Joint Research Centre [282589
   [32]]
FX The research was funded by the European Commission under the 7th
   Framework, Grant Agreement Number: 282589 [32].
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   ANDIS MD, 1987, J AM MOSQUITO CONTR, V3, P125
   Bengoa M, 2014, J AM MOSQUITO CONTR, V30, P42, DOI 10.2987/13-6378.1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Britch SC, 2010, J AM MOSQUITO CONTR, V26, P183, DOI 10.2987/09-5948.1
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Mount GA, 1998, J AM MOSQUITO CONTR, V14, P305
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   R Core Team, 2013, R LANG ENV STAT COMP
   REITER P, 1991, J AM MOSQUITO CONTR, V7, P52
   Reiter P, 2001, GUIDELINES ASSESSING
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Romi R, 2003, J AM MOSQUITO CONTR, V19, P419
   RUDNICK ALBERT, 1960, MOSQUITO NEWS, V20, P247
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Septfons A, 2015, B EPIDEMIOL HEBD, V13-14, P204
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wilder-Smith A, 2012, GLOB HLTH ACTION, V22, P17273
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2009, GUID EFF INS IND OUT, P51
   World Health Organization, 2006, 9 WHOPES WORK GROUP, P48
   World Health Organization, 2003, WHOCDSWHOPESGCDPP200, P43
   Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x
NR 32
TC 6
Z9 7
U1 0
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD NOV 23
PY 2016
VL 9
AR 597
DI 10.1186/s13071-016-1881-y
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EC7WA
UT WOS:000388350100001
PM 27881181
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rose, N
   Pinho-Nascimento, CA
   Ruggieri, A
   Favuzza, P
   Tamborrini, M
   Roth, H
   de Moraes, MTB
   Matile, H
   Janisch, T
   Pluschke, G
   Roltgen, K
AF Rose, Natalie
   Pinho-Nascimento, Carlos Augusto
   Ruggieri, Alessia
   Favuzza, Paola
   Tamborrini, Marco
   Roth, Hanna
   Baroni de Moraes, Marcia Terezinha
   Matile, Hugues
   Jaenisch, Thomas
   Pluschke, Gerd
   Roltgen, Katharina
TI Generation of monoclonal antibodies against native viral proteins using
   antigen-expressing mammalian cells for mouse immunization
SO BMC BIOTECHNOLOGY
LA English
DT Article
DE Dengue virus; NS1 protein; Mouse immunization; HEK cells; Transfection;
   Hybridoma technology; Monoclonal antibodies
ID VIRUS; DENGUE; BIOLOGY
AB Background: Due to their rising incidence and progressive geographical spread, infections with mosquito-borne viruses, such as dengue (DENV), chikungunya and zika virus, have developed into major public health challenges. Since all of these viruses may cause similar symptoms and can occur in concurrent epidemics, tools for their differential diagnosis and epidemiological monitoring are of urgent need.
   Results: Here we report the application of a novel strategy to rapidly generate monoclonal antibodies (mAbs) against native viral antigens, exemplified for the DENV nonstructural glycoprotein 1 (NS1). The described system is based on the immunization of mice with transfected mammalian cells expressing the target antigens in multiple displays on their cell surface and thereby presenting them efficiently to the host immune system in their native conformation. By applying this cell-based approach to the DENV NS1 protein of serotypes 1 (D1NS1) and 4 (D4NS1), we were able to rapidly generate panels of DENV NS1 serotype cross-reactive, as well as D1NS1-and D4NS1 serotype-specific mAbs. Our data show that the generated mAbs were capable of recognizing the endogenous NS1 protein in DENV-containing biological samples.
   Conclusion: The use of this novel immunization strategy, allows for a fast and efficient generation of hybridoma cell lines, producing mAbs against native viral antigens. Envisaged applications of the mAbs include the development of test platforms enabling a differentiation of the DENV serotypes and high resolution immunotyping for epidemiological studies.
C1 [Rose, Natalie; Favuzza, Paola; Tamborrini, Marco; Matile, Hugues; Pluschke, Gerd; Roltgen, Katharina] Swiss Trop & Publ Hlth Inst, Mol Immunol, Basel, Switzerland.
   [Rose, Natalie; Favuzza, Paola; Tamborrini, Marco; Matile, Hugues; Pluschke, Gerd; Roltgen, Katharina] Univ Basel, Basel, Switzerland.
   [Pinho-Nascimento, Carlos Augusto] Univ Fed Fluminense, Inst Biol, Mol Virol Lab, Niteroi, RJ, Brazil.
   [Ruggieri, Alessia; Roth, Hanna] Heidelberg Univ, Dept Infect Dis, Mol Virol, Heidelberg, Germany.
   [Baroni de Moraes, Marcia Terezinha] Fiocruz MS, Inst Oswaldo Cruz, Lab Comparat & Environm Virol, Rio De Janeiro, Brazil.
   [Jaenisch, Thomas] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany.
RP Roltgen, K (corresponding author), Swiss Trop & Publ Hlth Inst, Mol Immunol, Basel, Switzerland.; Roltgen, K (corresponding author), Univ Basel, Basel, Switzerland.
EM Katharina.roeltgen@unibas.ch
RI Jaenisch, Thomas/H-3473-2017
OI Ruggieri, Alessia/0000-0001-9981-3308; Favuzza,
   Paola/0000-0002-1394-927X; Pluschke, Gerd/0000-0003-1957-2925; Rose,
   Natalie/0000-0001-5102-4385
FU Swiss TPH; Brazilian National Council of Technological and Scientific
   Development (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX The laboratory work was financed by funds of the Swiss TPH. Carlos
   Augusto Pinho-Nascimento was supported by a stipend of the Brazilian
   National Council of Technological and Scientific Development (CNPq). The
   concept of the study was developed in cooperation with the Unisciencia
   foundation.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Aricescu AR, 2013, CURR OPIN STRUC BIOL, V23, P345, DOI 10.1016/j.sbi.2013.04.003
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Buss NAPS, 2012, CURR OPIN PHARMACOL, V12, P615, DOI 10.1016/j.coph.2012.08.001
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779
   Dreyer A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003477
   Dreyer AM, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-87
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fields B.N., 2013, FIELDS VIROLOGY
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Pluschke G, 1998, J IMMUNOL METHODS, V215, P27, DOI 10.1016/S0022-1759(98)00041-6
   Portolano N, 2014, JOVE-J VIS EXP, DOI 10.3791/51897
   Siddiqui MZ, 2010, INDIAN J PHARM SCI, V72, P12, DOI 10.4103/0250-474X.62229
   Sorensen HP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-27
   Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 27
TC 5
Z9 6
U1 0
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1472-6750
J9 BMC BIOTECHNOL
JI BMC Biotechnol.
PD NOV 22
PY 2016
VL 16
AR 83
DI 10.1186/s12896-016-0314-5
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EC8UE
UT WOS:000388417500001
PM 27876044
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Fisher, D
   Cutter, J
AF Fisher, Dale
   Cutter, Jeffery
TI The inevitable colonisation of Singapore by Zika virus
SO BMC MEDICINE
LA English
DT Editorial Material
AB Singapore is endemic for Dengue virus, with approximately 10,000 to 20,000 annual cases reported in recent years. In 2012, Chikungunya was introduced, although the numbers of cases reported is much fewer. The current Zika virus pandemic originating in Brazil represents a threat to all regions with Aedes mosquitoes, particularly those well connected by travellers. In this respect, it was felt inevitable that Singapore would eventually realise its third endemic flavivirus. In late August 2016, a primary care practitioner observed a cluster of geographically linked patients attending with fever and rash. This resulted in the first identification of locally transmitted Zika in Singapore on August 27, 2016. This prompted a robust response in an attempt to stop further spread, which continued for approximately 10 days until a large number of laboratory-confirmed cases were found as a result of active case finding. Surprisingly, the strain was later identified to be of Asian lineage and distinct from that originating in the Americas, prompting speculation over the epidemiology of this under recognised virus in Asia.
C1 [Fisher, Dale] Natl Univ Singapore Hosp, Div Infect Dis, Singapore, Singapore.
   [Fisher, Dale] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
   [Cutter, Jeffery] Minist Hlth, Communicable Dis Div, Singapore, Singapore.
RP Fisher, D (corresponding author), Natl Univ Singapore Hosp, Div Infect Dis, Singapore, Singapore.; Fisher, D (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.
EM mdcfda@nuhs.edu.sg
CR [Anonymous], 2000, EP NEWS B
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naish S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092524
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 7
TC 6
Z9 7
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD NOV 21
PY 2016
VL 14
AR 188
DI 10.1186/s12916-016-0737-9
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EC7QY
UT WOS:000388336600001
PM 27866470
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Glynn, RW
   Boland, M
AF Glynn, R. W.
   Boland, M.
CA HSE Port Hlth Grp
TI Ebola, Zika and the International Health Regulations - implications for
   Port Health Preparedness
SO GLOBALIZATION AND HEALTH
LA English
DT Article
DE International health regulations; IHR; Ebola; EVD; Port Health; Zika
AB Background: The outbreak of Ebola Virus Disease in West Africa in 2014-2015 was unprecedented in terms of its scale and consequence. This, together with the emergence of Zika virus as a Public Health Emergency of International Concern in 2016, has again highlighted the potential for disease to spread across international borders and provided an impetus for countries to review their Port Health preparedness. This report reviews the legislative framework and actions taken under this framework in advancing and improving Port Health preparedness in Ireland, in response to the declaration of the Public Health Emergency of International Concern for Ebola Virus Disease in August 2014.
   Findings: Infectious disease Shipping and Aircraft Regulations were brought into force in Ireland in 2008 and 2009, respectively. Preparatory actions taken under these and the International Health Regulations necessitated significant levels of cross disciplinary working with other organisations, both within and beyond traditional healthcare settings. Information packs on Ebola Virus Disease were prepared and distributed to airports, airlines, port authorities and shipping agents, and practical exercises were held at relevant sites. Agreements were put in place for contact tracing of passenger and crew on affected conveyances and protocols were established for the management of Medical Declarations of Health from ships coming from West Africa.
   Conclusions: The outbreak of Ebola Virus Disease in West Africa resulted in significant strengthening of Ireland's Port Health preparedness, while also highlighting the extent to which preparedness requires ongoing and sustained commitment from all stakeholders, both nationally and internationally, in ensuring that countries are ready when the next threat presents at their borders.
C1 [Glynn, R. W.; Boland, M.; HSE Port Hlth Grp] Dr Steevens Hosp, Dept Publ Hlth East, Steevens Lane, Dublin 8, Ireland.
RP Glynn, RW (corresponding author), Dr Steevens Hosp, Dept Publ Hlth East, Steevens Lane, Dublin 8, Ireland.
EM ronanglynn@doctors.net.uk
CR [Anonymous], 2014, EB EV MAN POINTS ENT
   [Anonymous], 2014, US GOV GLOB EM INF D
   [Anonymous], 2014, GUIN COUNTR MIN GUID
   Dzau VJ, 2016, N ENGL J MED
   Harris M, 2015, IT TAKES THREAT EB S, P16
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
NR 6
TC 3
Z9 3
U1 1
U2 8
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1744-8603
J9 GLOBALIZATION HEALTH
JI Global. Health
PD NOV 21
PY 2016
VL 12
AR 74
DI 10.1186/s12992-016-0173-9
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ED0MT
UT WOS:000388537300001
PM 27871327
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stoler, J
   Awandare, GA
AF Stoler, Justin
   Awandare, Gordon A.
TI Febrile illness diagnostics and the malaria-industrial complex: a
   socio-environmental perspective
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Fever; Malaria; Communicable disease; Diagnostics; Africa
ID DAR-ES-SALAAM; PLASMODIUM-FALCIPARUM; INFECTIOUS-DISEASES; SOUTHERN
   GHANA; HEALTH; DENGUE; FEVER; URBAN; ACCRA; SURVEILLANCE
AB Background: Global prioritization of single-disease eradication programs over improvements to basic diagnostic capacity in the Global South have left the world unprepared for epidemics of chikungunya, Ebola, Zika, and whatever lies on the horizon. The medical establishment is slowly realizing that in many parts of sub-Saharan Africa (SSA), particularly urban areas, up to a third of patients suffering from acute fever do not receive a correct diagnosis of their infection.
   Main body: Malaria is the most common diagnosis for febrile patients in low-resource health care settings, and malaria misdiagnosis has soared due to the institutionalization of malaria as the primary febrile illness of SSA by international development organizations and national malaria control programs. This has inadvertently created a "malaria-industrial complex" and historically obstructed our complete understanding of the continent's complex communicable disease epidemiology, which is currently dominated by a melange of undiagnosed febrile illnesses. We synthesize interdisciplinary literature from Ghana to highlight the complexity of communicable disease care in SSA from biomedical, social, and environmental perspectives, and suggest a way forward.
   Conclusion: A socio-environmental approach to acute febrile illness etiology, diagnostics, and management would lead to substantial health gains in Africa, including more efficient malaria control. Such an approach would also improve global preparedness for future epidemics of emerging pathogens such as chikungunya, Ebola, and Zika, all of which originated in SSA with limited baseline understanding of their epidemiology despite clinical recognition of these viruses for many decades. Impending ACT resistance, new vaccine delays, and climate change all beckon our attention to proper diagnosis of fevers in order to maximize limited health care resources.
C1 [Stoler, Justin] Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33124 USA.
   [Stoler, Justin] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Stoler, Justin] Univ Miami, Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.
   [Awandare, Gordon A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Ghana.
   [Awandare, Gordon A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Ghana.
RP Stoler, J (corresponding author), Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33124 USA.; Stoler, J (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.; Stoler, J (corresponding author), Univ Miami, Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA.
RI Awandare, Gordon/J-1392-2019
OI Awandare, Gordon/0000-0002-8793-3641
CR Adokiya MN, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1397-y
   Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x
   AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6
   Ahorlu CK, 1997, TROP MED INT HEALTH, V2, P488, DOI 10.1046/j.1365-3156.1997.d01-298.x
   Ahorlu CK, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-47
   Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1
   Andrus JK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-S1-S2
   Ansah EK, 2010, BMJ-BRIT MED J, P340
   Ansah EK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-258
   Apalayine GB, 1996, J INFORM SCI, V22, P367, DOI 10.1177/016555159602200505
   Appawu M, 2006, Ghana Med J, V40, P137
   Appiah-Darkwah I., 2011, International Journal of Tropical Medicine, V6, P61
   Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241
   Ayi I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-98
   Baba M.M., 2009, J AM SCI, V5, P129
   Bastiaens GJH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001590
   Bhatt S, 2015, NATURE
   Biritwum RB, 2000, ANN TROP MED PARASIT, V94, P771, DOI 10.1080/00034980020013037
   Bisoffi Z, 2013, LANCET GLOB HEALTH, V1, pE11, DOI 10.1016/S2214-109X(13)70013-5
   Bygbjerg IC, 2012, SCIENCE, V337, P1499, DOI 10.1126/science.1223466
   Campen R, 2011, BMJ-BRIT MED J, V342, pd2809
   Castro MC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000693
   Chandler CIR, 2008, HEALTH POLICY PLANN, V23, P170, DOI 10.1093/heapol/czm046
   Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53
   Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x
   Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154
   Chinery W.A., 1995, GHANA AFR J MED MED, V24, P179
   Chinery W. A., 1970, GHANA MED J, V9, P197
   Chinery W.A., 1999, GHANA J SCI, V39, P111
   CHINERY WA, 1984, J TROP MED HYG, V87, P75
   Chinery WA, 1991, GHANA J SCI, V31
   COLBOURNE M J, 1954, J Trop Med Hyg, V57, P203
   Crump JA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004040
   Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324
   D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482
   D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240
   D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252
   De La Cruz N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-61
   Dinko B, 2016, MALARIA WORLD J, V7, P1
   Donovan C, 2012, Ghana Med J, V46, P85
   Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08
   Dovlo D, 1998, HUMAN RESOURCES HLTH, V2, P1
   DOWNS W G, 1975, Bulletin of the New York Academy of Medicine, V51, P984
   Eisenhut Michael, 2013, J Travel Med, V20, P63, DOI 10.1111/j.1708-8305.2012.00664_1.x
   Fobil JN, 2012, J URBAN HEALTH, V89, P977, DOI 10.1007/s11524-012-9702-x
   Font F, 2001, TROP MED INT HEALTH, V6, P423, DOI 10.1046/j.1365-3156.2001.00727.x
   GARDINER C, 1984, B WORLD HEALTH ORGAN, V62, P607
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191
   Hoffman SJ, 2011, MALAR J, V10, DOI DOI 10.1186.
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Jankowska MM, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26492
   JSI Research and Training Institute, 2013, REP GHAN URB MAL STU
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Katz RL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-S1-S1
   Kiemde F, 2016, TROP MED INT HEALTH, V21, P943, DOI 10.1111/tmi.12722
   Klinkenberg E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-151
   KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1
   Koram KA, 2007, AM J TROP MED HYG, V77, P1
   Liu J, 2016, J CLIN MICROBIOL, V54, P49, DOI 10.1128/JCM.02257-15
   Malm K, 2012, P ANN M AM SOC TROP
   Marquez PV, 2013, CHALLENGE NONCOMMUNI
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66
   Nonvignon J, 2012, TROP MED INT HEALTH, V17, P951, DOI 10.1111/j.1365-3156.2012.03018.x
   O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7
   ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y
   OforiAdjei D, 1996, SOC SCI MED, V42, P1169, DOI 10.1016/0277-9536(95)00389-4
   Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373
   Oladosu OO, 2013, ISRN INFECT DIS, V2013, P1, DOI DOI 10.5402/2013/914675
   Opoku A.A., 2007, W AFR J APPL ECOL, V11, P81
   PATTERSON KD, 1979, SOC SCI MED-MED ANTH, V13, P251, DOI 10.1016/0160-7987(79)90023-1
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Perri-Moore Seneca, 2015, Glob Health Commun, V1, P41
   Phuong HL, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-275
   Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246
   Population Reference Bureau, 2014, WORLD POP DAT SHEET, P2014
   President's Malaria Initiative, 2014, GHAN MAL OP PLAN FY
   Rambaud-Althaus C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127674
   Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55
   Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE
   Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4
   Shao AF, 2015, BMC HEALTH SERV RES, V15, P1
   Shao AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132316
   Stoler J, 2015, AM J TROP MED HYG, V92, P497, DOI 10.4269/ajtmh.14-0678
   Stoler J, 2014, ACTA TROP, V134, P58, DOI 10.1016/j.actatropica.2014.02.017
   Stoler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067257
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29
   Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0
   UN-HABITAT, 2005, TRENDS SUBS AFR
   United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD URB PROSP 2010
   Van Dillen J, 2007, TROP DOCT, V37, P185, DOI 10.1258/004947507781524845
   Walker PGT, 2016, LANCET GLOB HEALTH, V4, pE474, DOI 10.1016/S2214-109X(16)30073-0
   Watts N, 2015, LANCET, V386, P1861, DOI 10.1016/S0140-6736(15)60854-6
   Weeks J. R., 2013, SPATIAL INEQUALITIES
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   WHO, 2010, GUID TREATM MAL
   Wilson P, 2012, GETTING BETTER VALUE
   Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119
   World Health Organization, 2015, GLOB TECHN STRAT MAL
   World Health Organization, 2015, WORLD MAL REP 2015
   World Health Organization, 1995, REP CONS KEY ISS DEN
   Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160
   Yeboah-Antwi K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000340
   Zinsstag J, 2011, PREV VET MED, V101, P148, DOI 10.1016/j.prevetmed.2010.07.003
   Zurovac D, 2006, ANN TROP MED PARASIT, V100, P283, DOI 10.1179/136485906X105633
NR 110
TC 6
Z9 6
U1 1
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 17
PY 2016
VL 16
AR 683
DI 10.1186/s12879-016-2025-x
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA ED7VE
UT WOS:000389078900001
PM 27855644
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xu, BY
   Low, SG
   Tan, RTH
   Vasanwala, FF
AF Xu, Bang Yu
   Low, Sher Guan
   Tan, Richard Tiong Heng
   Vasanwala, Farhad Fakhrudin
TI A case series of atypical presentation of Zika Virus infection in
   Singapore
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Case series; Case definition; Atypical presentation; Zika; Outbreak;
   Singapore
AB Background: The World Health Organization's and Centers for Disease Control and Prevention's definition of Zika infection are symptoms of fever, rash, joint pain, myalgia, headache and conjunctivitis. The diagnosis of Zika infection is based on the clinical history, physical examination and laboratory investigations which includes blood and urine Zika virus Polymerase Chain Reaction.
   Case presentation: Two patients presented with atypical presentation of Zika infection to Sengkang Health, Alexandra Hospital during the recent Zika outbreak in Singapore in August 2016. Madam A presented with isolated generalized rash with no fever, joint pain, myalgia, headache or conjunctivitis. Mr. B presented with isolated fever of 39.4 degrees C with no rash, joint pain, myalgia, headache or conjunctivitis. Both patients' blood Zika Polymerase Chain Reactions were positive at the time of presentation.
   Conclusion: The described case reports illustrated the challenges that our community Family Physicians faced in diagnosing patients infected with Zika virus. Coupled with the knowledge that most patients are asymptomatic, Family Physicians need to have a high index of clinical suspicion for early identification of patients infected with Zika virus, so as to institute timely treatment and appropriate measures to mitigate the outbreak of Zika infection in the community. Appropriate epidemiological measures such as ensuring prompt and thorough contact tracing of the cases are instrumental in the control of this public health problem.
C1 [Xu, Bang Yu; Low, Sher Guan; Tan, Richard Tiong Heng; Vasanwala, Farhad Fakhrudin] Alexandra Hosp, SingHealth, Sengkang Hlth, Dept Family Med, 378 Alexandra Rd, Singapore 159964, Singapore.
RP Xu, BY (corresponding author), Alexandra Hosp, SingHealth, Sengkang Hlth, Dept Family Med, 378 Alexandra Rd, Singapore 159964, Singapore.
EM xu.bangyu@skh.com.sg
OI Bang Yu, Xu/0000-0001-7547-4292
NR 0
TC 3
Z9 3
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 17
PY 2016
VL 16
AR 681
DI 10.1186/s12879-016-2032-y
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA ED7VB
UT WOS:000389078500001
PM 27855636
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Scata, M
   Di Stefano, A
   Lio, P
   La Corte, A
AF Scata, Marialisa
   Di Stefano, Alessandro
   Lio, Pietro
   La Corte, Aurelio
TI The Impact of Heterogeneity and Awareness in Modeling Epidemic Spreading
   on Multiplex Networks
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INTERPLAY; DISEASE
AB In the real world, dynamic processes involving human beings are not disjoint. To capture the real complexity of such dynamics, we propose a novel model of the coevolution of epidemic and awareness spreading processes on a multiplex network, also introducing a preventive isolation strategy. Our aim is to evaluate and quantify the joint impact of heterogeneity and awareness, under different socioeconomic conditions. Considering, as case study, an emerging public health threat, Zika virus, we introduce a data-driven analysis by exploiting multiple sources and different types of data, ranging from Big Five personality traits to Google Trends, related to different world countries where there is an ongoing epidemic outbreak. Our findings demonstrate how the proposed model allows delaying the epidemic outbreak and increasing the resilience of nodes, especially under critical economic conditions. Simulation results, using data-driven approach on Zika virus, which has a growing scientific research interest, are coherent with the proposed analytic model.
C1 [Scata, Marialisa; Di Stefano, Alessandro; La Corte, Aurelio] Catania Univ, Dipartimento Ingn Elettr Elettron & Informat, I-95125 Catania, Italy.
   [Lio, Pietro] Univ Cambridge, Comp Lab, Cambridge CB3 OFD, England.
RP Scata, M (corresponding author), Catania Univ, Dipartimento Ingn Elettr Elettron & Informat, I-95125 Catania, Italy.
EM lisa.scata@dieei.unict.it
RI La Corte, Aurelio/H-4519-2017; PAN, ZEQIANG/X-6341-2018; SCATA,
   Marialisa/AAM-4892-2020
OI SCATA, Marialisa/0000-0002-4785-0067; DI STEFANO,
   Alessandro/0000-0003-4905-3309; LaCorte, Aurelio/0000-0003-0370-7717;
   Lio, Pietro/0000-0002-0540-5053
FU Italian Ministry of UniversityMinistry of Education, Universities and
   Research (MIUR); MIUR "Programma Operativo Nazionale Ricerca e
   CompetitivitaMinistry of Education, Universities and Research (MIUR)
   [PON-03PE-00132-1]
FX This work was partially supported by the following Research Grant:
   Italian Ministry of University and Research MIUR "Programma Operativo
   Nazionale Ricerca e Competitivita 2007-2013" within the project
   "PON-03PE-00132-1" - Servify.
CR Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47
   Zuzek LGA, 2015, SCI REP-UK, V5, DOI 10.1038/srep12151
   ANDERSON R M, 1991
   Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804
   Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001
   Brauer F., 2001, MATH MODELS POPULATI, V40
   Buono C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092200
   Caldarelli G., 2007, SCALE FREE NETWORKS
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Catalano R, 2009, NEW ENGL J MED, V360, P749, DOI 10.1056/NEJMp0809122
   Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082
   Cobb J. S., COLOMBIA DECLARES EN
   Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028
   Crepey P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046131
   Cristelli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070726
   De Domenico M, 2013, PHYS REV X, V3, DOI 10.1103/PhysRevX.3.041022
   Di Stefano A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140646
   Dickison M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066109
   Diekmann O., 2012, MATH TOOLS UNDERSTAN
   Dorogovtsev S.N., 2013, EVOLUTION NETWORKS B
   Fan CJ, 2016, PHYSICA A, V461, P523, DOI 10.1016/j.physa.2016.06.050
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fleming-Dutra K. E., 2016, MMWR MORBIDITY MORTA, V65
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Granell C, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.012808
   Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701
   Guo Q., 2016, CHAOS AN INTERDISCIP, V26, DOI DOI 10.1063/1.4947420
   Heesterbeek J., 2000, MATH EPIDEMIOLOGY IN, V5
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581
   Kamp C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000984
   Keeling M. J., 2008, MODELING INFECT DIS
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li M., 2016, ARXIV160705382
   Massaro E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052817
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moni Mohammad Ali, 2014, J Clin Bioinforma, V4, P8, DOI 10.1186/2043-9113-4-8
   Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122
   Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128
   Orwat C, 2016, ACM SIGCOMM COMP COM, V46, P25, DOI 10.1145/2935634.2935640
   Pandey A, 2013, MATH BIOSCI, V246, P252, DOI 10.1016/j.mbs.2013.10.007
   Pastor-Satorras R, 2015, REV MOD PHYS, V87, P925, DOI 10.1103/RevModPhys.87.925
   Pecora LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5079
   Perkins A., 2016, 039610 BIORXIV
   Qu D, 2015, SCI REP-UK, V5, DOI 10.1038/srep07998
   Scata M, 2016, CHAOS SOLITON FRACT, V91, P17, DOI 10.1016/j.chaos.2016.04.018
   Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299
   Simon H. A., 1990, UTILITY PROBABILITY
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Stolerman LM, 2015, SIAM J APPL MATH, V75, P2581, DOI 10.1137/140996148
   Thangamani S., 2016, AM J TROPICAL MED HY, V16-0448
   Vespignani A, 2012, NAT PHYS, V8, P32
   Wang W., 2016, SCI REPORTS, V6
   Wang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05097
   Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104
   Wu QC, 2012, CHAOS, V22, DOI 10.1063/1.3673573
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Yang H., 2015, SCI REPORTS, V5
   Zhao DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112018
   Zhao DW, 2014, PHYS LETT A, V378, P770, DOI 10.1016/j.physleta.2014.01.014
   Zuzek LGA, 2015, J PHYS CONF SER, V640, DOI 10.1088/1742-6596/640/1/012007
NR 61
TC 14
Z9 14
U1 1
U2 19
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 16
PY 2016
VL 6
AR 37105
DI 10.1038/srep37105
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC6TR
UT WOS:000388270100001
PM 27848978
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Swale, DR
   Engers, DW
   Bollinger, SR
   Gross, A
   Inocente, EA
   Days, E
   Kanga, F
   Johnson, RM
   Yang, L
   Bloomquist, JR
   Hopkins, CR
   Piermarini, PM
   Denton, JS
AF Swale, Daniel R.
   Engers, Darren W.
   Bollinger, Sean R.
   Gross, Aaron
   Inocente, Edna Alfaro
   Days, Emily
   Kanga, Fariba
   Johnson, Reed M.
   Yang, Liu
   Bloomquist, Jeffrey R.
   Hopkins, Corey R.
   Piermarini, Peter M.
   Denton, Jerod S.
TI An insecticide resistance-breaking mosquitocide targeting inward
   rectifier potassium channels in vectors of Zika virus and malaria
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANOPHELES-GAMBIAE; AEDES-AEGYPTI; FUNCTIONAL-CHARACTERIZATION;
   PYRETHROID RESISTANCE; KIR CHANNELS; CARBAMATE; STRAIN; POPULATIONS;
   MECHANISMS; INHIBITOR
AB Insecticide resistance is a growing threat to mosquito control programs around the world, thus creating the need to discover novel target sites and target-specific compounds for insecticide development. Emerging evidence suggests that mosquito inward rectifier potassium (Kir) channels represent viable molecular targets for developing insecticides with new mechanisms of action. Here we describe the discovery and characterization of VU041, a submicromolar-affinity inhibitor of Anopheles (An.) gambiae and Aedes (Ae.) aegypti Kir1 channels that incapacitates adult female mosquitoes from representative insecticide-susceptible and -resistant strains of An. gambiae (G3 and Akron, respectively) and Ae. aegypti (Liverpool and Puerto Rico, respectively) following topical application. VU041 is selective for mosquito Kir channels over several mammalian orthologs, with the exception of Kir2.1, and is not lethal to honey bees. Medicinal chemistry was used to develop an analog, termed VU730, which retains activity toward mosquito Kir1 but is not active against Kir2.1 or other mammalian Kir channels. Thus, VU041 and VU730 are promising chemical scaffolds for developing new classes of insecticides to combat insecticide-resistant mosquitoes and the transmission of mosquito-borne diseases, such as Zika virus, without harmful effects on humans and beneficial insects.
C1 [Swale, Daniel R.; Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA.
   [Swale, Daniel R.] Louisiana State Univ, Ctr Agr, Dept Entomol, Baton Rouge, LA 70803 USA.
   [Engers, Darren W.; Bollinger, Sean R.; Hopkins, Corey R.; Denton, Jerod S.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.
   [Engers, Darren W.; Bollinger, Sean R.; Hopkins, Corey R.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA.
   [Gross, Aaron; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32610 USA.
   [Inocente, Edna Alfaro; Kanga, Fariba; Johnson, Reed M.; Yang, Liu; Piermarini, Peter M.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.
   [Days, Emily; Denton, Jerod S.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.
   [Hopkins, Corey R.] Vanderbilt Univ, Dept Chem, Box 1583, Nashville, TN 37235 USA.
   [Denton, Jerod S.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA.
RP Denton, JS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA.; Denton, JS (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.; Piermarini, PM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.; Denton, JS (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA.; Denton, JS (corresponding author), Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA.
EM piermarini.1@osu.edu; jerod.s.denton@vanderbilt.edu
RI Gross, Aaron/A-6994-2018; Johnson, Reed M./H-3742-2011
OI Gross, Aaron/0000-0001-7687-8133; Johnson, Reed M./0000-0002-2431-0180
FU Foundation for the National Institutes of Health through the
   Vector-Based Transmission of Control: Discovery Research (VCTR) program
   of the Grand Challenges in Global Health initiative; National Institute
   of Diabetes and Digestive and Kidney DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [1R01DK082884]
FX The authors thank Nuris Acosta (The Ohio State University), and the
   Vanderbilt High-Throughput Screening Center for technical assistance,
   and Dr. Julian F. Hillyer, (Vanderbilt University) for providing the
   Anopheles gambiae (G3 strain) that were used for toxicology experiments.
   Funded by a grant from the Foundation for the National Institutes of
   Health through the Vector-Based Transmission of Control: Discovery
   Research (VCTR) program of the Grand Challenges in Global Health
   initiative. This work was also supported in part by a grant from the
   National Institute of Diabetes and Digestive and Kidney Diseases
   (1R01DK082884; JSD).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167
   Beyenbach KW, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2015.1081861
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhave G, 2011, MOL PHARMACOL, V79, P42, DOI 10.1124/mol.110.066928
   Calkins TL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137084
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949
   Coast GM, 2009, J EXP BIOL, V212, P378, DOI 10.1242/jeb.024109
   Dahal GR, 2012, DEVELOPMENT, V139, P3653, DOI 10.1242/dev.078592
   Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2
   Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538
   Eleftherianos I, 2011, P NATL ACAD SCI USA, V108, P12024, DOI 10.1073/pnas.1108926108
   Foy BD, 2011, TRENDS PARASITOL, V27, P423, DOI 10.1016/j.pt.2011.05.007
   FUKUTO TR, 1990, ENVIRON HEALTH PERSP, V87, P245, DOI 10.2307/3431032
   Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009
   Lewis LM, 2009, MOL PHARMACOL, V76, P1094, DOI 10.1124/mol.109.059840
   Liu G., 2015, J NANOTECHNOL NANOME, V2, P1, DOI DOI 10.1186/S12943-015-0455-5
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Mutunga JM, 2015, PESTIC BIOCHEM PHYS, V121, P116, DOI 10.1016/j.pestbp.2015.03.001
   Pacey EK, 2014, J INSECT PHYSIOL, V61, P42, DOI 10.1016/j.jinsphys.2013.12.008
   Piermarini P. M., 2015, INSECT BIOCH MOL BIO
   Piermarini PM, 2013, INSECT BIOCHEM MOLEC, V43, P75, DOI 10.1016/j.ibmb.2012.09.009
   Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7
   Pridgeon JW, 2008, J MED ENTOMOL, V45, P82, DOI 10.1603/0022-2585(2008)45[82:SOAACQ]2.0.CO;2
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Raphemot R., 2014, MOL PHARM
   Raphemot R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110772
   Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002
   Raphemot R, 2013, ASSAY DRUG DEV TECHN, V11, P532, DOI 10.1089/adt.2013.544
   Raphemot R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064905
   Raphemot R, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00075
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105
   Rouhier MF, 2014, AM J PHYSIOL-REG I, V307, pR850, DOI 10.1152/ajpregu.00106.2014
   Rouhier MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100700
   Rouhier MF, 2014, INSECT BIOCHEM MOLEC, V48, P91, DOI 10.1016/j.ibmb.2014.03.003
   Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   WEBB JE, 1945, J EXP BIOL, V22, P8
   Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x
   Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260
   WILLIAMS JC, 1983, J COMP PHYSIOL, V153, P257, DOI 10.1007/BF00689629
   Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109
   Wong DM, 2013, CHEM-BIOL INTERACT, V203, P314, DOI 10.1016/j.cbi.2012.09.001
   Wong DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046712
   Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103
NR 52
TC 32
Z9 34
U1 1
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 16
PY 2016
VL 6
AR 36954
DI 10.1038/srep36954
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC5LZ
UT WOS:000388178200001
PM 27849039
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shao, Q
   Herrlinger, S
   Yang, SL
   Lai, F
   Moore, JM
   Brindley, MA
   Chen, JF
AF Shao, Qiang
   Herrlinger, Stephanie
   Yang, Si-Lu
   Lai, Fan
   Moore, Julie M.
   Brindley, Melinda A.
   Chen, Jian-Fu
TI Zika virus infection disrupts neurovascular development and results in
   postnatal microcephaly with brain damage
SO DEVELOPMENT
LA English
DT Article
DE ZIKV; Microcephaly; Blood-brain barrier (BBB); Astrogliosis; Microglial
   activation
ID CELL-MIGRATION; CYCLE; PERMEABILITY; INDUCTION; MICROGLIA; ORGANOIDS;
   PREGNANCY; HUMANS; INJURY; FOXG1
AB Zika virus (ZIKV) infection of pregnant women can result in fetal brain abnormalities. It has been established that ZIKV disrupts neural progenitor cells (NPCs) and leads to embryonic microcephaly. However, the fate of other cell types in the developing brain and their contributions to ZIKV-associated brain abnormalities remain largely unknown. Using intracerebral inoculation of embryonic mouse brains, we found that ZIKV infection leads to postnatal growth restriction including microcephaly. In addition to cell cycle arrest and apoptosis of NPCs, ZIKV infection causes massive neuronal death and axonal rarefaction, which phenocopy fetal brain abnormalities in humans. Importantly, ZIKV infection leads to abnormal vascular density and diameter in the developing brain, resulting in a leaky blood-brain barrier (BBB). Massive neuronal death and BBB leakage indicate brain damage, which is further supported by extensive microglial activation and astrogliosis in virally infected brains. Global gene analyses reveal dysregulation of genes associated with immune responses in virus-infected brains. Thus, our data suggest that ZIKV triggers a strong immune response and disrupts neurovascular development, resulting in postnatal microcephaly with extensive brain damage.
C1 [Shao, Qiang; Herrlinger, Stephanie; Yang, Si-Lu; Chen, Jian-Fu] Univ Georgia, Dept Genet, Dept Biochem & Mol Biol, Athens, GA 30602 USA.
   [Lai, Fan] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Human Genet, Miami, FL 33136 USA.
   [Moore, Julie M.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.
   [Moore, Julie M.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Dept Infect Dis, Dept Populat Hlth, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
RP Chen, JF (corresponding author), Univ Georgia, Dept Genet, Dept Biochem & Mol Biol, Athens, GA 30602 USA.
EM chen2014@uga.edu
RI Shao, Qiang/I-1359-2019
OI Shao, Qiang/0000-0001-5307-8264
FU Office of the Vice President for Research (OVPR) at University of
   Georgia; National Institutes of HealthUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R00HD073269,
   R01NS096176, R01NS097231, HD046860, AI111242]
FX This work was supported by funds from the Office of the Vice President
   for Research (OVPR) at University of Georgia; and by the National
   Institutes of Health [R00HD073269, R01NS096176 and R01NS097231 to J.C.;
   HD046860 and AI111242 to J.M.M.]. Deposited in PMC for release after 12
   months.
CR ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0
   Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Friedl J, 2002, BLOOD, V100, P1334, DOI 10.1182/blood.V100.4.1334.h81602001334_1334_1339
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Keller A, 2013, NAT GENET, V45, P1077, DOI 10.1038/ng.2723
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lu KT, 2005, J NEUROTRAUM, V22, P885, DOI 10.1089/neu.2005.22.885
   Manzini MC, 2011, CURR OPIN GENET DEV, V21, P333, DOI 10.1016/j.gde.2011.01.006
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miklossy J, 2005, ACTA NEUROPATHOL, V109, P643, DOI 10.1007/s00401-005-1007-7
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Nieto M, 2004, J COMP NEUROL, V479, P168, DOI 10.1002/cne.20322
   Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345
   Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036
   NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834
   Puhlmann M, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-37
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Siegenthaler JA, 2008, CEREB CORTEX, V18, P1865, DOI 10.1093/cercor/bhm209
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
NR 45
TC 75
Z9 76
U1 1
U2 15
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD NOV 15
PY 2016
VL 143
IS 22
BP 4127
EP 4136
DI 10.1242/dev.143768
PG 10
WC Developmental Biology
SC Developmental Biology
GA EJ8CY
UT WOS:000393453300005
PM 27729407
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI US Closer to Testing Engineered Mosquitoes That Could Fight Zika
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2016
VL 63
IS 10
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ED0TI
UT WOS:000388554500002
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI US Declares a Zika Public Health Emergency in Puerto Rico
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 15
PY 2016
VL 63
IS 10
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA ED0TI
UT WOS:000388554500001
DA 2020-07-08
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI Where Will Zika Spread?
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD NOV 15
PY 2016
VL 316
IS 19
BP 1956
EP 1956
DI 10.1001/jama.2016.16151
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB8XC
UT WOS:000387673800002
PM 27838728
DA 2020-07-08
ER

PT J
AU Wainberg, MA
   Lever, AML
AF Wainberg, Mark A.
   Lever, Andrew M. L.
TI HIV and Zika: When will we be able to end these epidemics?
SO RETROVIROLOGY
LA English
DT Editorial Material
ID INFECTION
C1 [Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ, Canada.
   [Lever, Andrew M. L.] Univ Cambridge, Cambridge, England.
RP Wainberg, MA (corresponding author), McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ, Canada.
EM mark.wainberg@mcgill.ca
CR Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243
   Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205
   Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273
   Wainberg MA, 2016, LANCET INFECT DIS, V16, P1215, DOI 10.1016/S1473-3099(16)30383-8
   Wainberg MA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0110-z
   Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541
NR 6
TC 0
Z9 0
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4690
J9 RETROVIROLOGY
JI Retrovirology
PD NOV 15
PY 2016
VL 13
AR 80
DI 10.1186/s12977-016-0315-4
PG 2
WC Virology
SC Virology
GA EC0WV
UT WOS:000387823200001
PM 27846847
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Cardiovascular complications of Zika virus infection
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Letter
DE Heart; Complication; Zika virus
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Inst Nat Med Sci Dev & Estab Project, Ctr Res & Dev, Suvannhabhumi Clin Training, Mueang Surin Dist, Surin Province, Thailand.
RP Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Inst Nat Med Sci Dev & Estab Project, Ctr Res & Dev, Suvannhabhumi Clin Training, Mueang Surin Dist, Surin Province, Thailand.
EM wviroj@yahoo.com
CR Joob B, 2016, ANATOL J CARDIOL, V16, P455, DOI 10.14744/AnatolJCardiol.2016.7140
   Krittanawong C, 2016, INT J CARDIOL, V221, P859, DOI 10.1016/j.ijcard.2016.06.293
   Wiwanitkit S., 2016, PAC J TROP MED, V9, P513
NR 3
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD NOV 15
PY 2016
VL 223
BP 53
EP 53
DI 10.1016/j.ijcard.2016.08.174
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB0LV
UT WOS:000387036200021
PM 27532234
DA 2020-07-08
ER

PT J
AU Phoo, WW
   Li, Y
   Zhang, ZZ
   Lee, MYQ
   Loh, YR
   Tan, YB
   Ng, EY
   Lescar, J
   Kang, CB
   Luo, DH
AF Phoo, Wint Wint
   Li, Yan
   Zhang, Zhenzhen
   Lee, Michelle Yueqi
   Loh, Ying Ru
   Tan, Yaw Bia
   Ng, Elizabeth Yihui
   Lescar, Julien
   Kang, CongBao
   Luo, Dahai
TI Structure of the NS2B-NS3 protease from Zika virus after self-cleavage
SO NATURE COMMUNICATIONS
LA English
DT Article
ID YELLOW-FEVER VIRUS; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; NS3 PROTEASES;
   DENGUE; PROTEINS; POLYPROTEIN; REFINEMENT; ASSIGNMENT; INTERFACE
AB The recent outbreak of Zika virus (ZIKV) infections in the Americas represents a serious threat to the global public health. The viral protease that processes viral polyproteins during infection appears as an attractive drug target. Here we report a crystal structure at 1.84 resolution of ZIKV non-structural protein NS2B-NS3 protease with the last four amino acids of the NS2B cofactor bound at the NS3 active site. This structure represents a post-proteolysis state of the enzyme during viral polyprotein processing and provides insights into peptide substrate recognition by the protease. Nuclear magnetic resonance (NMR) studies and protease activity assays unravel the protein dynamics upon binding the protease inhibitor BPTI in solution and confirm this finding. The structural and functional insights of the ZIKV protease presented here should advance our current understanding of flavivirus replication and accelerate structure-based antiviral drug discovery against ZIKV.
C1 [Phoo, Wint Wint; Zhang, Zhenzhen; Tan, Yaw Bia; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Phoo, Wint Wint; Lescar, Julien; Luo, Dahai] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 636921, Singapore.
   [Phoo, Wint Wint; Zhang, Zhenzhen; Tan, Yaw Bia; Lescar, Julien; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
   [Li, Yan; Lee, Michelle Yueqi; Loh, Ying Ru; Ng, Elizabeth Yihui; Kang, CongBao] ASTAR, Ctr Expt Therapeut, 31 Biopolis way,Nanos 03-01, Singapore 138669, Singapore.
RP Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 636921, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.; Kang, CB (corresponding author), ASTAR, Ctr Expt Therapeut, 31 Biopolis way,Nanos 03-01, Singapore 138669, Singapore.
EM cbkang@etc.a-star.edu.sg; luodahai@ntu.edu.sg
RI Kang, Congbao/AAP-7572-2020; Luo, Dahai/J-6022-2012; Li, Yan/G-4642-2013
OI Kang, Congbao/0000-0002-9886-9374; Luo, Dahai/0000-0001-7637-7275; Li,
   Yan/0000-0003-1963-839X; Tan, Yaw Bia/0000-0002-1491-2516
FU Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; National Medical Research
   CouncilMedical Research Council UK (MRC) [CBRG14May051]; A*STAR JCO
   grantAgency for Science Technology & Research (ASTAR)
   [1431AFG102/1331A028]
FX We thank Drs Liew Chong Wai and El Sahili Abbas from Nanyang
   Technological University in Singapore, scientists from Swiss Light
   Source beam-line PXIII for their help with diffraction data collection.
   We thank Dr Subhash Vasudevan from Duke-NUS graduate medical school in
   Singapore for critically reading our manuscript. We thank Shuang Liu and
   Dr Alvin Hung from Experimental Therapeutics Centre, Agency for Science,
   Technology and Research (A*STAR) in Singapore for the thermal shift
   assay. This work was supported by (1) a start-up grant to D.L. lab from
   Lee Kong Chian School of Medicine, Nanyang Technological University, (2)
   National Medical Research Council grant CBRG14May051 to J.L., (3) A*STAR
   JCO grant (1431AFG102/1331A028) to C.K.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   CHOI HK, 1991, NATURE, V354, P37, DOI 10.1038/354037a0
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   Evans PR, 2007, ACTA CRYSTALLOGR D, V63, P58, DOI 10.1107/S090744490604604X
   Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089
   Goff S. P., 2013, FIELDS VIROLOGY, P1424
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leon-Juarez M, 2016, VIROL J, V13, DOI 10.1186/s12985-015-0456-4
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Lin CW, 2006, VIRUS RES, V116, P106, DOI 10.1016/j.virusres.2005.09.002
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lorenz IC, 2006, NATURE, V442, P831, DOI 10.1038/nature04975
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Ramanathan MP, 2006, VIROLOGY, V345, P56, DOI 10.1016/j.virol.2005.08.043
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585
   Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
NR 50
TC 78
Z9 81
U1 0
U2 39
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 15
PY 2016
VL 7
AR 13410
DI 10.1038/ncomms13410
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC2RS
UT WOS:000387972200001
PM 27845325
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Goodfellow, FT
   Tesla, B
   Simchick, G
   Zhao, Q
   Hodge, T
   Brindley, MA
   Stice, SL
AF Goodfellow, Forrest T.
   Tesla, Blanka
   Simchick, Gregory
   Zhao, Qun
   Hodge, Thomas
   Brindley, Melinda A.
   Stice, Steven L.
TI Zika Virus Induced Mortality and Microcephaly in Chicken Embryos
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
DE Zika; microcephaly; embryo
ID INFECTION; MODEL
AB The explosive spread of the Zika virus (ZIKV) through South and Central America has been linked to an increase in congenital birth defects, specifically microcephaly. Representative rodent models for investigating infections include direct central nervous system (CNS) injections late in pregnancy and transplacental transmission in immunodeficient mice. Microcephaly in humans may be the result of infection occurring early in pregnancy, therefore recapitulating that the human course of ZIKV infection should include normal embryo exposed to ZIKV during the first trimester. In ovo development of the chicken embryo closely mirrors human fetal neurodevelopment and, as a comparative model, could provide key insights into both temporal and pathophysiological effects of ZIKV. Chick embryos were directly infected early and throughout incubation with ZIKV isolated from a Mexican mosquito in January 2016. High doses of virus caused embryonic lethality. In a subset of lower dosed embryos, replicating ZIKV was present in various organs, including the CNS, throughout development. Surviving ZIKV-infected embryos presented a microcephaly-like phenotype. Chick embryos were longitudinally monitored by magnetic resonance imaging that documented CNS structural malformations, including enlarged ventricles (30% increase) and stunted cortical growth (decreased telencephalon by 18%, brain stem by 32%, and total brain volume by 18%), on both embryonic day 15 (E15) and E20 of development. ZIKV-induced microcephaly was observed with inoculations of as few as 2-20 viral particles. The chick embryo model presented ZIKV embryonic lethal effects and progressive CNS damage similar to microcephaly.
C1 [Goodfellow, Forrest T.] Univ Georgia, Dept Anim & Dairy Sci, Coll Agr & Environm Sci, Interdisciplinary Toxicol Program,Regenerat Biosc, Athens, GA 30602 USA.
   [Tesla, Blanka; Hodge, Thomas] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA USA.
   [Simchick, Gregory; Zhao, Qun] Univ Georgia, Bioimaging Res Ctr, Athens, GA 30602 USA.
   [Simchick, Gregory; Zhao, Qun] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA.
   [Brindley, Melinda A.] Univ Georgia, Coll Vet Med, Dept Infect Dis, Populat Hlth,Ctr Vaccines & Immunol, Athens, GA 30602 USA.
   [Stice, Steven L.] Univ Georgia, Dept Anim & Dairy Sci, Coll Agr & Environm Sci, Regenerat Biosci Ctr, Athens, GA 30602 USA.
RP Brindley, MA (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Populat Hlth,Ctr Vaccines & Immunol, Athens, GA 30602 USA.
EM mbrindle@uga.edu
RI Zhao, Qun/C-3813-2011
OI Zhao, Qun/0000-0003-0784-1024; Simchick, Gregory/0000-0001-9326-7203
FU U.S. Environmental Protection Agency STAR grant [83555101]; National
   Science Foundation under the Science and Technology Center; National
   Center for Research ResourcesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [S10RR023706]
FX We thank Dr. Robert Beckstead and Dr. Jeanna Wilson of the UGA Poultry
   Science Department for assistance procuring embryonated broiler eggs.
   This work was supported, in part, by U.S. Environmental Protection
   Agency STAR grant (83555101), National Science Foundation under the
   Science and Technology Center, and grant S10RR023706 from the National
   Center for Research Resources.
CR Avakian AP, 2002, 51 W POULTR DIS C PU
   Barbosa T, 2013, 18 C WORLD VET POULT
   Boss A, 2008, J MAGN RESON IMAGING, V28, P1510, DOI 10.1002/jmri.21601
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Drake VJ, 2006, BIRTH DEFECTS RES A, V76, P66, DOI 10.1002/bdra.20202
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Iimura T, 2008, METHOD CELL BIOL, V87, P257, DOI 10.1016/S0091-679X(08)00213-6
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Slotkin TA, 2008, NEUROTOXICOL TERATOL, V30, P433, DOI 10.1016/j.ntt.2008.02.005
   TSAI HM, 1981, J COMP NEUROL, V198, P275, DOI 10.1002/cne.901980207
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Woodruff AM, 1931, AM J PATHOL, V7, P209
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhou Z, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0077-6
NR 31
TC 43
Z9 45
U1 0
U2 31
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD NOV 15
PY 2016
VL 25
IS 22
BP 1691
EP 1697
DI 10.1089/scd.2016.0231
PG 7
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA EB2VM
UT WOS:000387220700001
PM 27627457
OA Green Published
DA 2020-07-08
ER

PT J
AU Fleming, I
AF Fleming, Ingrid
TI Annexing AXL Endothelial Cell Infection by the Zika Virus
SO CIRCULATION RESEARCH
LA English
DT Editorial Material
DE Editorials; blood-borne pathogen; endothelial cell; microcephaly;
   receptor tyrosine kinase; vasculopathy
ID SARS CORONAVIRUS; GLYCOCALYX
C1 [Fleming, Ingrid] Goethe Univ, Ctr Mol Med, Inst Vasc Signalling, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
RP Fleming, I (corresponding author), Goethe Univ, Ctr Mol Med, Inst Vasc Signalling, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.
EM fleming@em.uni-frankfurt.de
RI Fleming, Ingrid/L-1225-2014
OI Fleming, Ingrid/0000-0003-1881-3635
CR Brown M, 2016, J CLIN PATHOL, V69, P391, DOI 10.1136/jclinpath-2016-203629
   Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hegermann J, 2016, HISTOCHEM CELL BIOL, V145, P41, DOI 10.1007/s00418-015-1378-3
   Kolarova H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/694312
   Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Rai S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0223-9
   Shi L, 2013, CIRC RES, V113, P1320, DOI 10.1161/CIRCRESAHA.113.301824
   Vythilingam I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01452
NR 15
TC 1
Z9 1
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD NOV 11
PY 2016
VL 119
IS 11
BP 1149
EP 1150
DI 10.1161/CIRCRESAHA.116.310001
PG 2
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Hematology
GA EC4NN
UT WOS:000388108900002
PM 28051775
DA 2020-07-08
ER

PT J
AU Lozier, M
   Adams, L
   Febo, MF
   Torres-Aponte, J
   Bello-Pagan, M
   Ryff, KR
   Munoz-Jordan, J
   Garcia, M
   Rivera, A
   Read, JS
   Waterman, SH
   Sharp, TM
   Rivera-Garcia, B
AF Lozier, Matthew
   Adams, Laura
   Febo, Mitchelle Flores
   Torres-Aponte, Jomil
   Bello-Pagan, Melissa
   Ryff, Kyle R.
   Munoz-Jordan, Jorge
   Garcia, Myriam
   Rivera, Aidsa
   Read, Jennifer S.
   Waterman, Stephen H.
   Sharp, Tyler M.
   Rivera-Garcia, Brenda
TI Incidence of Zika Virus Disease by Age and Sex - Puerto Rico, November
   1, 2015-October 20, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Editorial Material
ID TRANSMISSION
C1 [Lozier, Matthew; Adams, Laura; Febo, Mitchelle Flores; Munoz-Jordan, Jorge; Rivera, Aidsa; Read, Jennifer S.; Waterman, Stephen H.; Sharp, Tyler M.] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Febo, Mitchelle Flores; Torres-Aponte, Jomil; Bello-Pagan, Melissa; Ryff, Kyle R.; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
   [Garcia, Myriam] Puerto Rico Dept Hlth, Biol & Chem Emergencies Lab, Off Publ Hlth Preparedness & Response, San Juan, PR USA.
   [Garcia, Myriam] Puerto Rico Dept Hlth, Publ Hlth Lab, San Juan, PR USA.
RP Lozier, M (corresponding author), CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM mlozier@cdc.gov
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
   Sharp TM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002159
NR 10
TC 32
Z9 32
U1 0
U2 6
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD NOV 11
PY 2016
VL 65
IS 44
BP 1219
EP 1223
DI 10.15585/mmwr.mm6544a4
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EC3XJ
UT WOS:000388060100004
PM 27832051
OA Bronze
DA 2020-07-08
ER

PT J
AU Nicastri, E
   Pisapia, R
   Corpolongo, A
   Fusco, FM
   Cicalini, S
   Scognamiglio, P
   Castilletti, C
   Bordi, L
   Di Caro, A
   Capobianchi, MR
   Puro, V
   Ippolito, G
AF Nicastri, Emanuele
   Pisapia, Raffaella
   Corpolongo, Angela
   Fusco, Francesco Maria
   Cicalini, Stefania
   Scognamiglio, Paola
   Castilletti, Concetta
   Bordi, Licia
   Di Caro, Antonino
   Capobianchi, Maria Rosaria
   Puro, Vincenzo
   Ippolito, Giuseppe
TI Three cases of Zika virus imported in Italy: need for a clinical
   awareness and evidence-based knowledge
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Emerging or re-emerging diseases; Imported viral diseases;
   Pregnancy; Surveillance; Travel
AB Background: Since early 2015, a large epidemic of Zika Virus (ZIKV) is spreading across South and Central America. An association between congenital neurological malformations (mainly microcephaly), other neurological manifestations such as Guillain-Barre Syndrome, and ZIKV infection is suspected.
   Case presentation: Three confirmed cases of ZIKV in travelers returning from Brazil between May 2015 and January 2016 are described. All patients had mild symptoms with no neurological complications.
   Conclusions: An increasing awareness among clinicians about this emerging disease is advisable, both for the need to provide correct additional information to the patients and to travelers, with a special focus on pregnant women, and for the presence of the competent vector in Southern Europe.
C1 [Nicastri, Emanuele; Pisapia, Raffaella; Corpolongo, Angela; Fusco, Francesco Maria; Cicalini, Stefania; Scognamiglio, Paola; Castilletti, Concetta; Bordi, Licia; Di Caro, Antonino; Capobianchi, Maria Rosaria; Puro, Vincenzo; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Via Portuense 292, I-00149 Rome, Italy.
   [Puro, Vincenzo] Ist Nazl Malattie Infett Lazzaro Spallanzani, Via Portuense 292, I-00149 Rome, Italy.
RP Puro, V (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Via Portuense 292, I-00149 Rome, Italy.; Puro, V (corresponding author), Ist Nazl Malattie Infett Lazzaro Spallanzani, Via Portuense 292, I-00149 Rome, Italy.
EM vincenzo.puro@inmi.it
RI nicastri, emanuele/K-7780-2016; Castilletti, Concetta/B-6545-2016;
   Castilletti, Concetta/AAA-8408-2019; Di Caro, Antonino/K-6854-2016;
   Bordi, Licia/B-6827-2017; corpolongo, angela/AAC-5616-2020; Ippolito,
   Giuseppe/J-7207-2017
OI nicastri, emanuele/0000-0002-5606-8712; Castilletti,
   Concetta/0000-0001-9819-236X; Castilletti, Concetta/0000-0001-9819-236X;
   Di Caro, Antonino/0000-0001-6027-3009; Bordi, Licia/0000-0003-3962-3646;
   Ippolito, Giuseppe/0000-0002-1076-2979
FU Ministero della Salute, Italia-Ricerca Corrente, Istituti di Ricovero e
   Cura a Carattere ScientificoMinistry of Health, Italy
FX This work was supported by the Ministero della Salute, Italia-Ricerca
   Corrente, Istituti di Ricovero e Cura a Carattere Scientifico.
CR Arzuza-Ortega L, 2016, FATAL ZIKA VIRUS INF
   Besnard M, 2014, EURO SURVEILL, V19
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   CDC, AR ZIK
   CIDRAP, SEX TRANSM ZIK CONF
   Di Caro A, 2015, EUR J INTERN MED, V26, P451, DOI 10.1016/j.ejim.2015.03.005
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D., 2014, EURO SURVEILL, V19
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rubin EJ, 2016, NEW ENGL J MED
   Straetemans M, 2008, EURO SURVEILL, V13
   Tappe D, 2013, EURO SURVEILL, V19
NR 19
TC 6
Z9 6
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD NOV 11
PY 2016
VL 16
AR 669
DI 10.1186/s12879-016-1973-5
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EB9PT
UT WOS:000387728200002
PM 27835966
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, SF
   DeLalio, LJ
   Isakson, BE
   Wang, TT
AF Liu, Shufeng
   DeLalio, Leon J.
   Isakson, Brant E.
   Wang, Tony T.
TI AXL-Mediated Productive Infection of Human Endothelial Cells by Zika
   Virus
SO CIRCULATION RESEARCH
LA English
DT Article
DE axl receptor tyrosine kinase; blood; endothelial cells; infection; virus
   internalization; Zika virus
ID VERTICAL TRANSMISSION; SEXUAL TRANSMISSION; BREAST-CANCER; RECEPTOR;
   IDENTIFY; MODELS; KINASE; MICE
AB Rationale: The mosquito-borne Zika virus (ZIKV) is now recognized as a blood-borne pathogen, raising an important question about how the virus gets into human bloodstream. The imminent threat of the ZIKV epidemic to the global blood supply also demands novel therapeutics to stop virus transmission though transfusion.
   Objective: We intend to characterize ZIKV tropism for human endothelial cells (ECs) and provide potential targets for intervention.
   Methods and Results: We conducted immunostaining, plaque assay, and quantitative reverse transcription-polymerase chain reaction of ZIKV RNA to evaluate the possible infection of ECs by ZIKV. Both the African and the South American ZIKV strains readily infect human umbilical vein endothelial cells and human ECs derived from aortic and coronary artery, as well as the saphenous vein. Infected ECs released infectious progeny virus. Compared with the African strains, South American ZIKV isolates replicate faster in ECs and are partially cytopathic, suggesting enhanced virulence of these isolates. Flow cytometric analyses showed that the susceptibility of ECs positively correlated with the cell surface levels of tyrosine-protein kinase receptor UFO (AXL) receptor tyrosine kinase. Gain-and loss-of-function studies further revealed that AXL is required for ZIKV entry at a postbinding step. Finally, small-molecule inhibitors of the AXL kinase significantly reduced ZIKA infection of ECs.
   Conclusions: We identified EC as a key cell type for ZIKV infection. These data support the view of hematogenous dissemination of ZIKV and implicate AXL as a new target for antiviral therapy.
C1 [Liu, Shufeng; Wang, Tony T.] SRI Int, Discovery Biol, Ctr Infect Dis, Harrisonburg, VA USA.
   [DeLalio, Leon J.; Isakson, Brant E.] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Dept Mol Physiol & Biophys, Charlottesville, VA 22908 USA.
RP Wang, TT (corresponding author), 140 Res Dr, Harrisonburg, VA 22802 USA.
EM tony.wang@sri.com
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01DK088787,
   R01HL088554]
FX This study was sponsored by National Institutes of Health grant
   R01DK088787 (to T. Wang), R01HL088554 (B. E. Isakson). The funders had
   no role in study design, data collection, and interpretation, or the
   decision to submit the work for publication.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052
   Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Lohman AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8965
   McCormick KD, 2012, ANTIMICROB AGENTS CH, V56, P3399, DOI 10.1128/AAC.06425-11
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meyer AS, 2015, CELL SYST, V1, P25, DOI 10.1016/j.cels.2015.06.002
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Weksler BB, 2005, FASEB J, V19, P1872
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343
NR 30
TC 71
Z9 72
U1 1
U2 22
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7330
EI 1524-4571
J9 CIRC RES
JI Circ.Res.
PD NOV 11
PY 2016
VL 119
IS 11
BP 1183
EP +
DI 10.1161/CIRCRESAHA.116.309866
PG 20
WC Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular
   Disease
SC Cardiovascular System & Cardiology; Hematology
GA EC4NN
UT WOS:000388108900013
PM 27650556
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Ebi, KL
   Semenza, JC
   Rocklov, J
AF Ebi, Kristie L.
   Semenza, Jan C.
   Rocklov, Joacim
TI Current medical research funding and frameworks are insufficient to
   address the health risks of global environmental change
SO ENVIRONMENTAL HEALTH
LA English
DT Article
DE Climate change; Global change; Human health; Funding
ID CLIMATE-CHANGE; ZIKA VIRUS; ADAPTATION; IMPACTS; DISEASE
AB Background: Three major international agreements signed in 2015 are key milestones for transitioning to more sustainable and resilient societies: the UN 2030 Agenda for Sustainable Development; the Sendai Framework for Disaster Risk Reduction; and the Paris Agreement under the United Nations Framework Convention on Climate Change. Together, these agreements underscore the critical importance of understanding and managing the health risks of global changes, to ensure continued population health improvements in the face of significant social and environmental change over this century.
   Body: Funding priorities of major health institutions and organizations in the U.S. and Europe do not match research investments with needs to inform implementation of these international agreements. In the U.S., the National Institutes of Health commit 0.025 % of their annual research budget to climate change and health. The European Union Seventh Framework Programme committed 0.08 % of the total budget to climate change and health; the amount committed under Horizon 2020 was 0.04 % of the budget. Two issues apparently contributing to this mismatch are viewing climate change primarily as an environmental problem, and therefore the responsibility of other research streams; and narrowly framing research into managing the health risks of climate variability and change from the perspective of medicine and traditional public health. This reductionist, top-down perspective focuses on proximate, individual level risk factors. While highly successful in reducing disease burdens, this framing is insufficient to protect health and well-being over a century that will be characterized by profound social and environmental changes.
   Conclusions: International commitments in 2015 underscored the significant challenges societies will face this century from climate change and other global changes. However, the low priority placed on understanding and managing the associated health risks by national and international research institutions and organizations leaves populations poorly prepared to cope with changing health burdens. Risk-centered, systems approaches can facilitate understanding of the complex interactions and dependencies across environmental, social, and human systems. This understanding is needed to formulate effective interventions targeting socio-environmental factors that are as important for determining health burdens as are individual risk factors.
C1 [Ebi, Kristie L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Semenza, Jan C.] Stockholm Environm Inst, Linnegatan 87D, S-11523 Stockholm, Sweden.
   [Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.
RP Ebi, KL (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
EM krisebi@essllc.org
OI Rocklov, Joacim/0000-0003-4030-0449
CR Aitsi-Selmi A, 2016, PREHOSP DISASTER MED, V31, P74, DOI 10.1017/S1049023X15005531
   [Anonymous], 2016, OUR PLAN OUR HLTH
   [Anonymous], 2014, 3 HLTH PROGR 2014 20
   Bernard SM, 2001, ENVIRON HEALTH PERSP, V109, P177, DOI 10.2307/3435007
   Bolin B, 2007, HISTORY OF THE SCIENCE AND POLITICS OF CLIMATE CHANGE: THE ROLE OF THE INTERGOVERNMENTAL PANEL ON CLIMATE CHANGE, P1, DOI 10.1017/CBO9780511721731
   Burton I., 2005, ADAPTATION POLICY FR
   Charron DF, 2012, INSIGHT INNOV INT DE, P1, DOI 10.1007/978-1-4614-0517-7
   Ebi KL, 2013, PROTECTING HLTH CLIM
   Ebi K, 2011, HEALTH AFFAIR, V30, P924, DOI 10.1377/hlthaff.2011.0071
   Ebi KL, 2008, AM J PREV MED, V35, P501, DOI 10.1016/j.amepre.2008.08.018
   Ebi KL, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24154
   Ebi KL, 2014, INT J ENV RES PUB HE, V11, P30, DOI 10.3390/ijerph110100030
   Ebi KL, 2009, ENVIRON HEALTH PERSP, V117, P857, DOI 10.1289/ehp.0800088
   Field C. B., 2012, MANAGING RISKS EXTRE, P594, DOI DOI 10.1017/CBO9781139177245
   Field CB, 2012, MANAGING RISKS EXTRE
   Hess JJ, 2014, ENVIRON HEALTH PERSP, V122, P1177, DOI 10.1289/ehp.1307396
   Hess JJ, 2012, ENVIRON HEALTH PERSP, V120, P171, DOI 10.1289/ehp.1103515
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Jessup CM, 2013, ENVIRON HEALTH PERSP, V121, P399, DOI 10.1289/ehp.1104518
   KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X
   Marinucci GD, 2014, INT J ENV RES PUB HE, V11, P6433, DOI 10.3390/ijerph110606433
   MCMICHAEL AJ, 1993, PLANETARY OVERLOAD G
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6
   National Research Council, 1983, RISK ASS FED GOV MAN
   NIEHS, 2011, HUM HLTH IMPL CLIM C
   Obama B., 2013, EXECUTIVE ORDER PREP
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Semenza JC, 2007, HEALTH PROMOT PRACT, V8, P243, DOI 10.1177/1524839906289585
   Semenza JC, 2007, J URBAN HEALTH, V84, P8, DOI 10.1007/s11524-006-9124-8
   Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204.151073, 10.3201/eid2204]
   Semenza JC, 2011, ADV GLOB CHANGE RES, V42, P143, DOI 10.1007/978-94-007-0567-8_10
   Semenza JC, 1996, NEW ENGL J MED, V335, P84, DOI 10.1056/NEJM199607113350203
   Semenza JC, 2007, MACROSOCIAL DETERMIN, P443
   Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709
   United Nations, 2015, LAUNCH NEW SUST DEV
   Winslow CEA, 1920, SCIENCE, V51, P23, DOI 10.1126/science.51.1306.23
   World Health Organization, 2015, LESS LEARN HLTH AD C
NR 39
TC 11
Z9 11
U1 1
U2 29
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-069X
J9 ENVIRON HEALTH-GLOB
JI Environ. Health
PD NOV 11
PY 2016
VL 15
AR 108
DI 10.1186/s12940-016-0183-3
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EB5PX
UT WOS:000387433800001
PM 27835959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barba-Spaeth, G
   Dejnirattisai, W
   Rouvinski, A
   Vaney, MC
   Edits, IM
   Sharma, A
   Simon-Loriere, E
   Sakuntabhai, A
   Cao-Lormeau, VM
   Haouz, A
   England, P
   Stiasny, K
   Ongkolsapaya, JM
   Heinz, FX
   Screaton, GR
   Rey, FA
AF Barba-Spaeth, Giovanna
   Dejnirattisai, Wanwisa
   Rouvinski, Alexander
   Vaney, Marie-Christine
   Edits, Iris M.
   Sharma, Arvind
   Simon-Loriere, Etienne
   Sakuntabhai, Anavaj
   Cao-Lormeau, Van-Mai
   Haouz, Ahmed
   England, Patrick
   Stiasny, Karin
   Ongkolsapaya, Juthathip M.
   Heinz, Franz X.
   Screaton, Gavin R.
   Rey, Felix A.
TI Structural basis of potent Zika-dengue virus antibody
   cross-neutralization (vol 536, pg 48, 2016)
SO NATURE
LA English
DT Correction
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Rey,
   Felix/0000-0002-9953-7988; Barba Spaeth, Giovanna/0000-0003-2069-9501;
   Stiasny, Karin/0000-0002-1902-8674
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
NR 1
TC 8
Z9 8
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 10
PY 2016
VL 539
IS 7628
DI 10.1038/nature19780
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB4CZ
UT WOS:000387318500052
PM 27626374
OA Bronze
DA 2020-07-08
ER

PT J
AU Rodrigues, NCP
   Lino, VTS
   Daumas, RP
   Andrade, MKD
   O'Dwyer, G
   Monteiro, DLM
   Gerardi, A
   Fernandes, GHBV
   Ramos, JA
   Ferreira, CEG
   Leitelf, LD
AF Pinheiro Rodrigues, Nadia Cristina
   Saraiva Lino, Valeria Teresa
   Daumas, Regina Paiva
   de Noronha Andrade, Monica Kramer
   O'Dwyer, Gisele
   Maia Monteiro, Denise Leite
   Gerardi, Alyssa
   Barroso Viana Fernandes, Gabriel Henrique
   Sapienza Ramos, Jose Augusto
   Goncalves Ferreira, Carlos Eduardo
   Leite, Luri da Costa
TI Temporal and Spatial Evolution of Dengue Incidence in Brazil, 2001-2012
SO PLOS ONE
LA English
DT Article
ID AEDES-AEGYPTI; VIRUS TYPE-4; SAO-PAULO; STATE; CLIMATE
AB Background
   In Brazil, the incidence of dengue greatly increased in the last two decades and there are several factors impeding the control of the disease. The present study focused on describing the space-time evolution of dengue in Brazil from 2001 to 2012 and analyzing the relationship of the reported cases with socio-demographic and environmental factors.
   Methods
   The analytic units used in the preparation of thematic maps were municipalities. Statistical tests and multilevel regression models were used to evaluate the association between dengue incidence and the following factors: climate, diagnostic period, demographic density, percentage of people living in rural areas, Gross Domestic Product, Gini index, percentage of garbage collection and the rate of households with a sewage network.
   Results
   The largest accumulation of dengue cases in Brazil was concentrated on the Atlantic coast and in the interior part of Sao Paulo State. The risk of dengue in subtropical and tropical climates was 1.20-11 times lower than that observed in semi-arid climates. In 2009-2010 and 2011-2012, the risks were ten and six times higher than in 2003-2004, respectively.
   Conclusion
   Dengue is a common infection in the Brazilian population, with the largest accumulation of dengue cases concentrated on the Atlantic coast and in the interior area of Sao Paulo State.The high dengue rates observed in the Brazilian coastal region suggest that the cases imported from neighboring countries contribute to the spread of the disease in the country. Our results suggest that several socio-demographic and environmental factors resulted in the increase of dengue in the country over time. This is likely applicable to the occurrence of other arboviruses like Zika and chikungunya. To reverse the situation, Brazil must implement effective public policies that offer basic services such as garbage collection and sanitation networks as well as reduce vector populations.
C1 [Pinheiro Rodrigues, Nadia Cristina; Saraiva Lino, Valeria Teresa; Daumas, Regina Paiva; de Noronha Andrade, Monica Kramer; O'Dwyer, Gisele; Leite, Luri da Costa] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil.
   [Pinheiro Rodrigues, Nadia Cristina; Maia Monteiro, Denise Leite] Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil.
   [de Noronha Andrade, Monica Kramer] Vital Brazil Inst, Ctr Studies & Res Ageing, Rio De Janeiro, Brazil.
   [Gerardi, Alyssa] Georgetown Univ, Washington, DC USA.
   [Barroso Viana Fernandes, Gabriel Henrique; Sapienza Ramos, Jose Augusto; Goncalves Ferreira, Carlos Eduardo] Univ Estado Rio De Janeiro, Sch Geol, Rio De Janeiro, Brazil.
   [Pinheiro Rodrigues, Nadia Cristina] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Germano Sinval Faria, Rio De Janeiro, Brazil.
   [Pinheiro Rodrigues, Nadia Cristina] Univ Estado Rio de Janeiro, Fac Med, Dept Tecnol Informacao & Educ Saude, Rio De Janeiro, Brazil.
RP Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Germano Sinval Faria, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio de Janeiro, Fac Med, Dept Tecnol Informacao & Educ Saude, Rio De Janeiro, Brazil.
EM nadiacristinapr@gmail.com
RI DAUMAS, REGINA/M-9387-2013
OI DAUMAS, REGINA/0000-0002-8923-7711
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   [Anonymous], 2015, PLOS NEGLECTED TROPI
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285
   Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Bertolacci-Rocha LG, 2014, CAD SAUDE PUBLICA, V30, P1789, DOI 10.1590/0102-311X00003914
   Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009
   Chahad-Ehlers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052559
   Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164
   DATASUS, 2015, HLTH INF
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   FIOCRUZ FOC, 2016, AED AEG MOSQ PART HI
   FUNASA BHM, 2011, HIST PUBL HLTH CHRON
   Gelman A., 2007, DATA ANAL USING REGR
   Gentile C, 2013, MEM I OSWALDO CRUZ, V108, P80, DOI 10.1590/0074-0276130471
   Glasser CM, 2002, REV SAUDE PUBL, V36, P166, DOI 10.1590/s0034-89102002000200008
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   HM BHM, 2009, DENG BRAS INF EP 17
   HM BHM, 2012, EP B DENG EP SIT
   HM BHM, 2016, COMP PROB CAS DENG 2
   IBGE, 2010, SUBN CLUST TERR INF
   IBGE, 2015, IBGE MALH DIG
   IBGE BIoGaS, 2014, EST RES POP BRAZ FED
   IPEA, 2016, EC APPL RES
   Ismail Noriszura, 2007, CASUALTY ACTUARIAL S, V2007, P103
   Jacobi P., 2004, URBAN ENV IMPACTS RI
   Jaenisch Thomas, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2010.140487
   Mendonça Francisco de Assis, 2009, Soc. nat., V21, P257, DOI 10.1590/S1982-45132009000300003
   Muhamad M, 2010, INT J BIOL SCI, V6, P294
   Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001
   Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376
   Ribeiro AF, 2006, REV SAUDE PUBL, V40, P671, DOI 10.1590/s0034-89102006000500017
   RIPSA RIdIpS, 2012, IND DAD BAS BRAS 201
   Rocco Iray Maria, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P55, DOI 10.1590/S0036-46652001000100011
   Rolim Glauco de Souza, 2007, Bragantia, V66, P711, DOI 10.1590/S0006-87052007000400022
   Sampaio MdS, 2011, AN 15 S BRAS SENS RE, P8857
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Teixeira Maria Glória, 2012, Rev. Inst. Med. trop. S. Paulo, V54, P1, DOI 10.1590/S0036-46652012000700002
   The World Bank, 2006, EQ DEV
   UJVARI SC, 2003, REV INST MED TROP SP, V45, P212
   Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3
   World Health Organization, 2009, DENG GUID DIAGN TREA
NR 42
TC 11
Z9 11
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 10
PY 2016
VL 11
IS 11
AR e0165945
DI 10.1371/journal.pone.0165945
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB9ON
UT WOS:000387725000045
PM 27832129
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hombach, J
   Friede, M
   Moorphy, V
   Costello, A
   Kieny, MP
AF Hombach, Joachim
   Friede, Martin
   Moorphy, Vasee
   Costello, Anthony
   Kieny, Marie Paule
TI Developing a vaccine against Zika
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Editorial Material
C1 [Hombach, Joachim; Friede, Martin; Moorphy, Vasee] WHO, Initiat Vaccine Res, Geneva, Switzerland.
   [Costello, Anthony] WHO, Maternal Child & Adolescent Hlth, Geneva, Switzerland.
   [Kieny, Marie Paule] WHO, Hlth Syst & Innovat, Geneva, Switzerland.
RP Kieny, MP (corresponding author), WHO, Hlth Syst & Innovat, Geneva, Switzerland.
EM kienym@who.int
RI Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019
OI Kieny, Marie-Paule/0000-0002-5943-6488; Moorthy,
   Vasee/0000-0002-6535-2854
FU World Health OrganizationWorld Health Organization [001]
CR WHO, 2016, VACC PIP TRACK
   WHO, 2016, DES VACC EFF TRIAL P
   WHO, 2016, UN ZIK VIR VACC TARG
   World Health Organization, 2016, CURR ZIK PROD PIP
   World Health Organization, 2016, RES DEV BLUEPR ACT P
NR 5
TC 6
Z9 6
U1 2
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD NOV 10
PY 2016
VL 355
AR i5923
DI 10.1136/bmj.i5923
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EC3CV
UT WOS:000388003200005
PM 27834272
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Swaminathan, S
   Schlaberg, R
   Lewis, J
   Hanson, KE
   Couturier, MR
AF Swaminathan, Sankar
   Schlaberg, Robert
   Lewis, Julia
   Hanson, Kimberly E.
   Couturier, Marc R.
TI Fatal Zika Virus Infection with Secondary Nonsexual Transmission
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [Swaminathan, Sankar; Schlaberg, Robert; Lewis, Julia; Hanson, Kimberly E.; Couturier, Marc R.] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA.
RP Swaminathan, S (corresponding author), Univ Utah, Sch Med, Salt Lake City, UT 84112 USA.
EM sankar.swaminathan@hsc.utah.edu
FU NCATS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Advancing
   Translational Sciences (NCATS) [UL1 TR001067, KL2 TR001065]; NCI NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01
   CA081133]
CR Chen LH, 2004, CLIN INFECT DIS, V39, pE56, DOI 10.1086/423807
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Flygare S, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0969-1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Pan American Health Organization, CUM ZIK SUSP CONF CA
NR 5
TC 85
Z9 85
U1 0
U2 8
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD NOV 10
PY 2016
VL 375
IS 19
BP 1907
EP 1909
DI 10.1056/NEJMc1610613
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB6ZK
UT WOS:000387534200031
PM 27681699
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Barrett, ADT
AF Barrett, Alan D. T.
TI Zika vaccine candidates progress through nonclinical development and
   enter clinical trials
SO NPJ VACCINES
LA English
DT Article
ID STRUCTURAL BASIS; VIRUS; PROTECTION
C1 [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
RP Barrett, ADT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; Barrett, ADT (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.
EM abarrett@utmb.edu
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Goo L., 2016, MBIO, V6, P5
   Kim E., EBIOMEDICINE
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plotkin SA, 2016, CLIN MICROBIOL INFEC, V22, P294, DOI 10.1016/j.cmi.2016.03.001
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Van Gessel Y, 2011, VACCINE, V29, P5925, DOI 10.1016/j.vaccine.2011.06.062
   Vannice K. S., VACCINE IN PRESS
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 24
TC 10
Z9 10
U1 0
U2 1
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD NOV 10
PY 2016
VL 1
AR 16023
DI 10.1038/npjvaccines.2016.23
PG 2
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FK1SD
UT WOS:000413261900001
PM 29263861
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Muthumani, K
   Griffin, BD
   Agarwal, S
   Kudchodkar, SB
   Reuschel, EL
   Choi, H
   Kraynyak, KA
   Duperret, EK
   Keaton, AA
   Chung, C
   Kim, YK
   Booth, SA
   Racine, T
   Yan, J
   Morrow, MP
   Jiang, JJ
   Lee, B
   Ramos, S
   Broderick, KE
   Reed, CC
   Khan, AS
   Humeau, L
   Ugen, KE
   Park, YK
   Maslow, JN
   Sardesai, NY
   Kim, JJ
   Kobinger, GP
   Weiner, DB
AF Muthumani, Karuppiah
   Griffin, Bryan D.
   Agarwal, Sangya
   Kudchodkar, Sagar B.
   Reuschel, Emma L.
   Choi, Hyeree
   Kraynyak, Kimberly A.
   Duperret, Elizabeth K.
   Keaton, Amelia Anne
   Chung, Christopher
   Kim, Yinho K.
   Booth, Stephanie A.
   Racine, Trina
   Yan, Jian
   Morrow, Matthew P.
   Jiang, Jingjing
   Lee, Brian
   Ramos, Stephanie
   Broderick, Kate E.
   Reed, Charles C.
   Khan, Amir S.
   Humeau, Laurent
   Ugen, Kenneth E.
   Park, Young K.
   Maslow, Joel N.
   Sardesai, Niranjan Y.
   Kim, J. Joseph
   Kobinger, Gary P.
   Weiner, David B.
TI In vivo protection against ZIKV infection and pathogenesis through
   passive antibody transfer and active immunisation with a prMEnv DNA
   vaccine
SO NPJ VACCINES
LA English
DT Article
ID VIRUS CHALLENGE; RHESUS-MONKEYS; OUTBREAK; AMERICA; MICRONESIA; ANTIGEN;
   BRAZIL; MOUSE; MODEL
AB Significant concerns have been raised owing to the rapid global spread of infection and disease caused by the mosquito-borne Zika virus (ZIKV). Recent studies suggest that ZIKV can also be transmitted sexually, further increasing the exposure risk for this virus. Associated with this spread is a dramatic increase in cases of microcephaly and additional congenital abnormalities in infants of ZIKV-infected mothers, as well as a rise in the occurrence of Guillain Barre' syndrome in infected adults. Importantly, there are no licensed therapies or vaccines against ZIKV infection. In this study, we generate and evaluate the in vivo efficacy of a novel, synthetic, DNA vaccine targeting the pre-membrane+envelope proteins (prME) of ZIKV. Following initial in vitro development and evaluation studies of the plasmid construct, mice and non-human primates were immunised with this prME DNA-based immunogen through electroporation-mediated enhanced DNA delivery. Vaccinated animals were found to generate antigen-specific cellular and humoral immunity and neutralisation activity. In mice lacking receptors for interferon (IFN)- alpha/beta(designated IFNAR(-/-)) immunisation with this DNA vaccine induced, following in vivo viral challenge, 100% protection against infection-associated weight loss or death in addition to preventing viral pathology in brain tissue. In addition, passive transfer of non-human primate anti-ZIKV immune serum protected IFNAR(-/-) mice against subsequent viral challenge. This study in NHP and in a pathogenic mouse model supports the importance of immune responses targeting prME in ZIKV infection and suggests that additional research on this vaccine approach may have relevance for ZIKV control and disease prevention in humans.
C1 [Muthumani, Karuppiah; Agarwal, Sangya; Kudchodkar, Sagar B.; Reuschel, Emma L.; Choi, Hyeree; Duperret, Elizabeth K.; Chung, Christopher; Kim, Yinho K.; Weiner, David B.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Griffin, Bryan D.; Booth, Stephanie A.; Racine, Trina; Kobinger, Gary P.] Publ Hlth Agcy Canada, Special Pathogens Program, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada.
   [Griffin, Bryan D.; Booth, Stephanie A.; Racine, Trina; Kobinger, Gary P.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB R3E 0J9, Canada.
   [Kraynyak, Kimberly A.; Yan, Jian; Morrow, Matthew P.; Jiang, Jingjing; Lee, Brian; Ramos, Stephanie; Broderick, Kate E.; Reed, Charles C.; Khan, Amir S.; Humeau, Laurent; Sardesai, Niranjan Y.; Kim, J. Joseph] Inovio Pharmaceut Inc, Plymouth Meeting, PA USA.
   [Keaton, Amelia Anne] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.
   [Ugen, Kenneth E.] Univ S Florida, Dept Mol Med, Morsani Coll Med, Tampa, FL USA.
   [Park, Young K.; Maslow, Joel N.] GeneOne Life Sci Inc, Seoul, South Korea.
   [Kobinger, Gary P.] CHU Laval, Quebec City, PQ G1V 4G2, Canada.
RP Weiner, DB (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
EM dweiner@wistar.org
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065; Ramos,
   Stephanie/0000-0002-5326-4937; Sardesai, Niranjan/0000-0001-6920-1167
FU Intramural Research Program of National Institute of Allergy and
   Infectious Diseases of NIH [R01 AI092843]; Inovio Pharmaceuticals Inc.
   PA, USA; Gene One Life Science Inc, Seoul, Korea
FX We thank Dr Susan Weiss (University of Pennsylvania) and Dr Scott Weaver
   (University of Texas Medical Branch) for providing the Zika-MR766 virus.
   We thank animal caretakers of the PHAC for assistance with the mouse
   viral challenge studies. The research was conducted in compliance with
   the Animal Welfare Act and other federal statutes and regulations
   relating to animals and experiments involving animals and adheres to
   principles state in the Guide for the Care and Use of Laboratory
   Animals, National Research Council, 1996. The facilities where this
   research was conducted are fully accredited by the Association for
   Assessment and Accreditation of Laboratory Animal Care International. We
   thank Dr Mark Lewis at Bioqual, Inc. for the rhesus macaque vaccination
   studies. We also thank Wistar flow cytometry facilities core facilities
   for their support. This work was partially funded by the Intramural
   Research Program of the National Institute of Allergy and Infectious
   Diseases of NIH (R01 AI092843) to DBW. DBW and KM also note funding by
   Inovio Pharmaceuticals Inc. PA, USA and Gene One Life Science Inc,
   Seoul, Korea. DBW is the W.W. Smith Charitable Trust Professor in Cancer
   Research at the Wistar Institute.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Birbeck GL, 2016, NEUROLOGY, V86, P1272, DOI 10.1212/WNL.0000000000002553
   Broderick KE, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.1
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Check Hayden Erika, 2016, Nature, V530, P142, DOI 10.1038/530142a
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flingai S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12616
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   Hutnick NA, 2012, HUM GENE THER, V23, P943, DOI 10.1089/hum.2012.055
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muthumani K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7462
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372
   Trimble CL, 2015, LANCET, V386, P2078, DOI 10.1016/S0140-6736(15)00239-1
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 29
TC 66
Z9 69
U1 1
U2 3
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD NOV 10
PY 2016
VL 1
AR 16021
DI 10.1038/npjvaccines.2016.21
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA FK1SB
UT WOS:000413261600001
PM 29263859
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gokhale, NS
   McIntyre, ABR
   McFadden, MJ
   Roder, AE
   Kennedy, EM
   Gandara, JA
   Hopcraft, SE
   Quicke, KM
   Vazquez, C
   Willer, J
   Ilkayeva, OR
   Law, BA
   Holley, CL
   Garcia-Blanco, MA
   Evans, MJ
   Suthar, MS
   Bradrick, SS
   Mason, CE
   Horner, SM
AF Gokhale, Nandan S.
   McIntyre, Alexa B. R.
   McFadden, Michael J.
   Roder, Allison E.
   Kennedy, Edward M.
   Gandara, Jorge A.
   Hopcraft, Sharon E.
   Quicke, Kendra M.
   Vazquez, Christine
   Willer, Jason
   Ilkayeva, Olga R.
   Law, Brittany A.
   Holley, Christopher L.
   Garcia-Blanco, Mariano A.
   Evans, Matthew J.
   Suthar, Mehul S.
   Bradrick, Shelton S.
   Mason, Christopher E.
   Horner, Stacy M.
TI N6-Methyladenosine in Flaviviridae Viral RNA Genomes Regulates Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID HEPATITIS-C VIRUS; TRANSLATIONAL CONTROL; SEQUENCE SPECIFICITY;
   METHYLATION; N-6-METHYLADENOSINE; REVEALS; PROTEIN; NUCLEAR; SITES; M6A
AB The RNA modification N6-methyladenosine (m(6)A) post-transcriptionally regulates RNA function. The cellular machinery that controls m(6)A includes methyl-transferases and demethylases that add or remove this modification, as well as m(6)A-binding YTHDF proteins that promote the translation or degradation of m(6)A-modified mRNA. We demonstrate that m(6)A modulates infection by hepatitis C virus (HCV). Depletion of m(6)A methyltransferases or an m(6)A demethylase, respectively, increases or decreases infectious HCV particle production. During HCV infection, YTHDF proteins relocalize to lipid droplets, sites of viral assembly, and their depletion increases infectious viral particles. We further mapped m(6)A sites across the HCV genome and determined that inactivating m(6)A in one viral genomic region increases viral titer without affecting RNA replication. Additional mapping of m(6)A on the RNA genomes of other Flaviviridae, including dengue, Zika, yellow fever, and West Nile virus, identifies conserved regions modified by m(6)A. Altogether, this work identifies m(6)A as a conserved regulatory mark across Flaviviridae genomes.
C1 [Gokhale, Nandan S.; McFadden, Michael J.; Roder, Allison E.; Kennedy, Edward M.; Vazquez, Christine; Willer, Jason; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   [Law, Brittany A.; Holley, Christopher L.; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.
   [McIntyre, Alexa B. R.; Gandara, Jorge A.; Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10021 USA.
   [Hopcraft, Sharon E.; Evans, Matthew J.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Quicke, Kendra M.; Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA.
   [Quicke, Kendra M.; Suthar, Mehul S.] Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Ilkayeva, Olga R.] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27701 USA.
   [Garcia-Blanco, Mariano A.; Bradrick, Shelton S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA.
   [Mason, Christopher E.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10021 USA.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
   [McIntyre, Alexa B. R.] Tri Inst Program Computat Biol & Med, New York, NY 10065 USA.
RP Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Mason, CE (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10021 USA.; Mason, CE (corresponding author), Weill Cornell Med, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10021 USA.; Mason, CE (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10021 USA.
EM chm2042@med.cornell.edu; stacy.horner@duke.edu
RI Simal-Gandara, Jesus/A-9533-2009
OI Simal-Gandara, Jesus/0000-0001-9215-9737; Gokhale,
   Nandan/0000-0002-4459-4053; McFadden, Michael/0000-0003-0303-6968;
   Holley, Christopher/0000-0002-2870-3352; Horner,
   Stacy/0000-0002-9351-7409; McIntyre, Alexa/0000-0001-6965-6292
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI125416, 5P30AI064518,
   T32-CA009111, R25EB020393, R01NS076465, R01ES021006, R01AI089526,
   R01AI101431, R01DK0951250, U19AI083019, R56AI110516]; Duke Whitehead
   Scholarship; Ford Foundation; Tri-Institutional Training Program in
   Computational Biology and Medicine; STARR [I7-A765, I9-A9-071]; Irma T.
   Hirschl and Monique Weill-Caulier Charitable Trusts; Bert L. and N.
   Kuggie Vallee Foundation; World-Quant; Pershing Square Sohn Cancer
   Research Alliance; NASANational Aeronautics & Space Administration
   (NASA) [NNX14AH50G, 15-15Omni2-0063]; Bill and Melinda Gates
   FoundationGates Foundation [OPP1151054]; Alfred P. Sloan
   FoundationAlfred P. Sloan Foundation [G-2015-13964]; U-TX STARs Award;
   UTMB; Pew Charitable Trusts [USPHS-AI07647, ACS-RSG-12-176-01-MPC];
   Burroughs Wellcome FundBurroughs Wellcome Fund
FX We thank Dr. Lemon and Dr. Weeks (University of North Carolina- Chapel
   Hill) and Dr. Rice (Rockefeller University) for reagents; the Duke
   University Light Microscopy Core Facility; the Epigenomics Core Facility
   at Weill Cornell; and members of the S.M.H. and C.E.M. labs for
   discussion and reading of this manuscript. This work was supported by
   funds from the NIH: R01AI125416 (S.M.H. and C.E.M.); 5P30AI064518
   (S.M.H.); T32-CA009111 (A.E.R.); R25EB020393, R01NS076465, and
   R01ES021006 (C.E.M.); R01AI089526 and R01AI101431 (M.A.G.-B.);
   R01DK0951250 (M.J.E.); and U19AI083019 and R56AI110516 (M.S.S.).
   Additional funding sources were the Duke Whitehead Scholarship (S.M.H.),
   the Ford Foundation (C.V.), the Tri-Institutional Training Program in
   Computational Biology and Medicine (A.B.R.M.), STARR (I7-A765 and
   I9-A9-071; C.E.M.), the Irma T. Hirschl and Monique Weill-Caulier
   Charitable Trusts, the Bert L. and N. Kuggie Vallee Foundation,
   World-Quant, the Pershing Square Sohn Cancer Research Alliance, NASA
   (NNX14AH50G and 15-15Omni2-0063), the Bill and Melinda Gates Foundation
   (OPP1151054), and the Alfred P. Sloan Foundation (G-2015-13964), the
   U-TX STARs Award (M.A.G.-B.), UTMB (M.A.G.-B. and S.S.B.), Pew
   Charitable Trusts (USPHS-AI07647 and ACS-RSG-12-176-01-MPC; M.J.E.), and
   the Burroughs Wellcome Fund.
CR Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011
   Aligeti M, 2015, J VIROL, V89, P11523, DOI 10.1128/JVI.01185-15
   Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Bocharov G, 2004, J VIROL, V78, P2247, DOI 10.1128/JVI.78.5.2247-2254.2004
   Chatel-Chaix L, 2013, J VIROL, V87, P11704, DOI 10.1128/JVI.01474-13
   Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016
   DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021
   Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724
   Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009
   HARPER JE, 1990, NUCLEIC ACIDS RES, V18, P5735, DOI 10.1093/nar/18.19.5735
   Hopcraft SE, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00009-15
   Hopcraft SE, 2015, HEPATOLOGY, V62, P1059, DOI 10.1002/hep.27815
   Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   KANE SE, 1987, J BIOL CHEM, V262, P3422
   Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Li S, 2014, ANNU REV GENOM HUM G, V15, P127, DOI 10.1146/annurev-genom-090413-025405
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Mauger DM, 2015, P NATL ACAD SCI USA, V112, P3692, DOI 10.1073/pnas.1416266112
   Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012
   Meyer KD, 2014, NAT REV MOL CELL BIO, V15, P313, DOI 10.1038/nrm3785
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Pirakitikulr N, 2016, MOL CELL, V62, P111, DOI 10.1016/j.molcel.2016.01.024
   Poenisch M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004573
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rios-Marco P, 2016, SCI REP-UK, V6, DOI 10.1038/srep25729
   Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shimoike T, 1999, J VIROL, V73, P9718, DOI 10.1128/JVI.73.12.9718-9725.1999
   SOMMER S, 1976, NUCLEIC ACIDS RES, V3, P749, DOI 10.1093/nar/3.3.749
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilkins C, 2013, HEPATOLOGY, V57, P461, DOI 10.1002/hep.26066
   Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610
   Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115
   Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377
NR 58
TC 128
Z9 134
U1 5
U2 25
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 9
PY 2016
VL 20
IS 5
BP 654
EP 665
DI 10.1016/j.chom.2016.09.015
PG 12
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EE3FA
UT WOS:000389472000014
PM 27773535
OA Other Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Lichinchi, G
   Zhao, BS
   Wu, YA
   Lu, ZK
   Qin, Y
   He, C
   Rana, TM
AF Lichinchi, Gianluigi
   Zhao, Boxuan Simen
   Wu, Yinga
   Lu, Zhike
   Qin, Yue
   He, Chuan
   Rana, Tariq M.
TI Dynamics of Human and Viral RNA Methylation during Zika Virus Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID M(6)A RNA; DENGUE VIRUS; NUCLEAR-RNA; N6-METHYLADENOSINE; GENE; M6A;
   METHYLTRANSFERASE; METHYLOMES; SUBUNIT; BINDING
AB Infection with the flavivirus Zika (ZIKV) causes neurological, immunological, and developmental defects through incompletely understood mechanisms. We report that ZIKV infection affects viral and human RNAs by altering the topology and function of N6-adenosine methylation (m(6)A), a modification affecting RNA structure and function. m(6)A nucleosides are abundant in ZIKV RNA, with twelve m(6)A peaks identified across full-length ZIKV RNA. m(6)A in ZIKV RNA is controlled by host methyltransferases METTL3 and METTL14 and demethylases ALKBH5 and FTO, and knockdown of methyltransferases increases, while silencing demethylases decreases, ZIKV production. YTHDF family proteins, which regulate the stability of m(6)A- modified RNA, bind to ZIKV RNA, and their silencing increases ZIKV replication. Profiling of the m(6)A methylome of host mRNAs reveals that ZIKV infection alters m(6)A location in mRNAs, methylation motifs, and target genes modified by methyltransferases. Our results identify a mechanism by which ZIKV interacts with and alters host cell functions.
C1 [Lichinchi, Gianluigi; Wu, Yinga; Qin, Yue; Rana, Tariq M.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.
   [Lichinchi, Gianluigi; Wu, Yinga; Rana, Tariq M.] Sanford Burnham Prebys Med Discovery Inst, Program RNA Biol, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Lichinchi, Gianluigi; Wu, Yinga; Rana, Tariq M.] Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Zhao, Boxuan Simen; Lu, Zhike; He, Chuan] Univ Chicago, Dept Chem, Dept Biochem & Mol Biol, Inst Biophys Dynam, 5735 S Ellis Ave, Chicago, IL 60637 USA.
   [Zhao, Boxuan Simen; Lu, Zhike; He, Chuan] Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.
   [Rana, Tariq M.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
RP Rana, TM (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Rana, TM (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Program RNA Biol, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Rana, TM (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Grad Sch Biomed Sci, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Rana, TM (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
EM trana@ucsd.edu
RI Zhao, Boxuan/Q-2159-2019
OI Zhao, Boxuan/0000-0002-3729-4511
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA
FX We thank Steve Head and the staff of the Next Generation Sequencing core
   facility at UCSD for help with the HT-seq and data analysis. We thank
   Jason Dang for his help with preparation of the artwork and members of
   the T.M.R. lab for helpful discussions and advice. This work was
   supported in part by grants from the NIH. C.H. is an Investigator of the
   Howard Hughes Medical Institute (HHMI). B.S.Z. is an HHMI International
   Student Research Fellow.
CR Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019
   Bokar JA, 1997, RNA, V3, P1233
   Brasil P, 2016, N ENGL J MED
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1
   Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634
   Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724
   Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026
   Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234
   Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902
   Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]
   Yi CQ, 2011, ACCOUNTS CHEM RES, V44, P1380, DOI 10.1021/ar200057m
   Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08
   Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377
NR 49
TC 109
Z9 115
U1 5
U2 52
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD NOV 9
PY 2016
VL 20
IS 5
BP 666
EP 673
DI 10.1016/j.chom.2016.10.002
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EE3FA
UT WOS:000389472000015
PM 27773536
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Asad, S
   Hall-Mendelin, S
   Asgari, S
AF Asad, Sultan
   Hall-Mendelin, Sonja
   Asgari, Sassan
TI Downregulation of Aedes aegypti chromodomain helicase DNA binding
   protein 7/Kismet by Wolbachia and its effect on dengue virus replication
SO SCIENTIFIC REPORTS
LA English
DT Article
ID LIFE-SHORTENING WOLBACHIA; NUCLEAR-LOCALIZATION; GLOBAL DISTRIBUTION;
   CORE PROTEIN; ZIKA VIRUS; DROSOPHILA; CHD1; STRAIN; GENE; INFECTION
AB Dengue virus (DENV) is a mosquito-transmitted virus imposing a significant burden on human health around the world. Since current control strategies are not sufficient, there is an urgent need to find alternative methods to control DENV transmission. It has been demonstrated that introduction of Wolbachia pipientis in Aedes aegypti mosquitoes can impede DENV transmission with the mechanism(s) not fully understood. Recently, a number of studies have found the involvement of chromodomain DNA binding helicases in case of Human Immunodeficiency virus (HIV) and Influenza A virus infection. In this study, we have identified three chromodomain helicase DNA binding protein (CHD) genes in Ae. aegypti and looked at their response in the case of Wolbachia and DENV infections. Foremost amongst them we have found that AeCHD7/Kismet is significantly downregulated in the presence of Wolbachia infection only in female mosquitoes. Furthermore, AeCHD7 levels showed significant increase during DENV infection, and AeCHD7 depletion led to severe reduction in the replication of DENV. Our data have identified AeCHD7 as a novel Ae. aegypti host factor that is important for DENV replication, and Wolbachia downregulates it, which may contribute towards the mechanism(s) of limiting DENV replication.
C1 [Asad, Sultan; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
   [Hall-Mendelin, Sonja] Queensland Govt, Dept Hlth, Virol Serv, Brisbane, Qld, Australia.
   [Hall-Mendelin, Sonja] Queensland Govt, Dept Hlth, Publ & Environm Hlth Serv, Brisbane, Qld, Australia.
   [Hall-Mendelin, Sonja] Queensland Govt, Dept Hlth, Forens & Sci Serv, Brisbane, Qld, Australia.
RP Asgari, S (corresponding author), Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
EM s.asgari@uq.edu.au
RI Asgari, Sassan/G-2678-2011
OI Asgari, Sassan/0000-0001-7885-6544; Asad, Sultan/0000-0001-8627-6080
FU National Health Medical Research Council grant [APP1062983]; UQ
   International scholarship
FX We are thankful to Dr Karyn Johnson and Verna Hearne from UQ for
   providing D. melanogaster wMelPop-infected and tetracycline cured flies,
   Prof Paul Young from UQ for providing the anti-DENV antibody, and Dr
   Andrew van den Hurk from Queensland Health for providing Ae. aegypti
   eggs. Special thanks to Solomon-Osei-Amo (UQ) for critical reading of
   the manuscript. This project was supported by a National Health Medical
   Research Council grant (APP1062983) to S Asgari and a UQ International
   scholarship to S Asad.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Bugga L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059496
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Colpitts TM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024365
   Daubresse G, 1999, DEVELOPMENT, V126, P1175
   Diosa-Toro M, 2013, ADV VIRUS RES, V85, P91, DOI 10.1016/B978-0-12-408116-1.00004-5
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hopfner KP, 2012, CURR OPIN STRUC BIOL, V22, P225, DOI 10.1016/j.sbi.2012.02.007
   Hughes GL, 2014, INSECT MOL BIOL, V23, P141, DOI 10.1111/imb.12066
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Kageyama D, 2002, HEREDITY, V88, P444, DOI 10.1038/sj.hdy.6800077
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897
   Khattak S, 2002, GENE, V293, P107, DOI 10.1016/S0378-1119(02)00698-4
   Kleino A, 2005, EMBO J, V24, P3423, DOI 10.1038/sj.emboj.7600807
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcos-Villar L, 2016, J VIROL, V90, P3694, DOI 10.1128/JVI.00053-16
   Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012
   Mayoral JG, 2014, P NATL ACAD SCI USA, V111, P18721, DOI 10.1073/pnas.1420131112
   McDaniel IE, 2008, GENETICS, V178, P583, DOI 10.1534/genetics.107.079038
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Murawska M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002206
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Riparbelli MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030045
   Rodgers MJ, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-180
   Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713
   Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217
   Stokes DG, 1996, P NATL ACAD SCI USA, V93, P7137, DOI 10.1073/pnas.93.14.7137
   STOKES DG, 1995, MOL CELL BIOL, V15, P2745
   Tai HH, 2003, BIOCHEM BIOPH RES CO, V308, P170, DOI 10.1016/S0006-291X(03)01354-8
   Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Watterson D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22791
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m
   Ye YXH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066482
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 62
TC 2
Z9 2
U1 0
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 9
PY 2016
VL 6
AR 36850
DI 10.1038/srep36850
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC0AO
UT WOS:000387760000001
PM 27827425
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dinh, L
   Chowell, G
   Mizumoto, K
   Nishiura, H
AF Dinh, Linh
   Chowell, Gerardo
   Mizumoto, Kenji
   Nishiura, Hiroshi
TI Estimating the subcritical transmissibility of the Zika outbreak in the
   State of Florida, USA, 2016
SO THEORETICAL BIOLOGY AND MEDICAL MODELLING
LA English
DT Article
DE Prediction; Zika virus; Epidemic; Mathematical model; Basic reproduction
   number
ID EPIDEMIC
AB Background: Florida State has reported autochthonous transmission of Zika virus since late July 2016. Here we assessed the transmissibility associated with the outbreak and generated a short-term forecast.
   Methods: Time-dependent dynamics of imported cases reported in the state of Florida was approximated by a logistic growth equation. We estimated the reproduction number using the renewal equation in order to predict the incidence of local cases arising from both local and imported primary cases. Using a bootstrap method together with the logistic and renewal equations, a short-term forecast of local and imported cases was carried out.
   Results: The reproduction number was estimated at 0.16 (95 % Confidence Interval: 0.13, 0.19). Employing the logistic equation to capture a drastic decline in the number of imported cases expected through the course of 2016, together with the low estimate of the local reproduction number in Florida, the expected number of local reported cases was demonstrated to show an evident declining trend for the remainder of 2016.
   Conclusions: The risk of local transmission in the state of Florida is predicted to dramatically decline by the end of 2016.
C1 [Dinh, Linh; Chowell, Gerardo] Georgia State Univ, Sch Publ Hlth, 1 Pk Pl, Atlanta, GA 30303 USA.
   [Chowell, Gerardo] NIH, Div Int Epidemiol & Populat Studies, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
   [Mizumoto, Kenji; Nishiura, Hiroshi] Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.
   [Mizumoto, Kenji; Nishiura, Hiroshi] Japan Sci & Technol Agcy, CREST, 4-1-8,Honcho, Kawaguchi, Saitama 3320012, Japan.
RP Nishiura, H (corresponding author), Hokkaido Univ, Grad Sch Med, Kita Ku, Kita 15 Jo Nishi 7 Chome, Sapporo, Hokkaido 0608638, Japan.; Nishiura, H (corresponding author), Japan Sci & Technol Agcy, CREST, 4-1-8,Honcho, Kawaguchi, Saitama 3320012, Japan.
EM nishiurah@med.hokudai.ac.jp
OI Mizumoto, Kenji/0000-0002-2748-6560
FU Japan Agency for Medical Research and DevelopmentJapan Agency for
   Medical Research and Development (AMED); Japan Society for the Promotion
   of Science (JSPS) KAKENHI GrantMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16KT0130, 16
   K15356, 26700028]; Program for Advancing Strategic International
   Networks; Japan Science and Technology Agency (JST) CREST program;
   RISTEX program for Science of Science, Technology and Innovation Policy;
   NSFNational Science Foundation (NSF) [1414374]; UK Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BB/M008894/1]; NSF-IIS RAPID
   [1518939]; NSF: Small: Data Management for Real-Time Data Driven
   Epidemic simulation [1318788 III]; Division of International
   Epidemiology and Population Studies, The Fogarty International Center,
   US National Institutes of Health; Biotechnology and Biological Sciences
   Research CouncilBiotechnology and Biological Sciences Research Council
   (BBSRC) [BB/M008894/1]
FX HN received funding support from the Japan Agency for Medical Research
   and Development, the Japan Society for the Promotion of Science (JSPS)
   KAKENHI Grant Numbers 16KT0130, 16 K15356 and 26700028, Program for
   Advancing Strategic International Networks to Accelerate the Circulation
   of Talented Researchers, the Japan Science and Technology Agency (JST)
   CREST program and RISTEX program for Science of Science, Technology and
   Innovation Policy. GC acknowledges financial support from the NSF grant
   1414374 as part of the joint NSF-NIH-USDA Ecology and Evolution of
   Infectious Diseases program; UK Biotechnology and Biological Sciences
   Research Council grant BB/M008894/1, NSF-IIS RAPID award # 1518939, and
   NSF grant 1318788 III: Small: Data Management for Real-Time Data Driven
   Epidemic simulation, and the Division of International Epidemiology and
   Population Studies, The Fogarty International Center, US National
   Institutes of Health. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Chowell G, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0659
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Efron B., 1993, INTRO BOOTSTRAP
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Majumder MS, 2016, B WHO IN PRESS, DOI [10.2471/BLT.16.170860, DOI 10.2471/BLT.16.170860]
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   Omori R, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-2
   Robert MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161365
   Roberts MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017835
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
NR 12
TC 21
Z9 21
U1 1
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4682
J9 THEOR BIOL MED MODEL
JI Theor. Biol. Med. Model.
PD NOV 9
PY 2016
VL 13
AR 20
DI 10.1186/s12976-016-0046-1
PG 7
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA EC2EJ
UT WOS:000387922200001
PM 27829439
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hancock, PA
   White, VL
   Ritchie, SA
   Hoffmann, AA
   Godfray, HCJ
AF Hancock, Penelope A.
   White, Vanessa L.
   Ritchie, Scott A.
   Hoffmann, Ary A.
   Godfray, H. Charles J.
TI Predicting Wolbachia invasion dynamics in Aedes aegypti populations
   using models of density-dependent demographic traits
SO BMC BIOLOGY
LA English
DT Article
DE Wolbachia; Zika; Dengue; Mosquito; Aedes aegypti; Density-dependence;
   Bayesian statistical model; Invasion; Vector-borne disease; Fitness
ID DENGUE VECTOR MOSQUITO; BLOOD-FEEDING SUCCESS; WMELPOP-WOLBACHIA;
   BODY-SIZE; RESISTANCE; FIELD; COMPETITION; INFECTION; FEVER;
   ESTABLISHMENT
AB Background: Arbovirus transmission by the mosquito Aedes aegypti can be reduced by the introduction and establishment of the endosymbiotic bacteria Wolbachia in wild populations of the vector. Wolbachia spreads by increasing the fitness of its hosts relative to uninfected mosquitoes. However, mosquito fitness is also strongly affected by population size through density-dependent competition for limited food resources. We do not understand how this natural variation in fitness affects symbiont spread, which limits our ability to design successful control strategies.
   Results: We develop a mathematical model to predict A. aegypti-Wolbachia dynamics that incorporates larval density-dependent variation in important fitness components of infected and uninfected mosquitoes. Our model explains detailed features of the mosquito-Wolbachia dynamics observed in two independent experimental A. aegypti populations, allowing the combined effects on dynamics of multiple density-dependent fitness components to be characterized. We apply our model to investigate Wolbachia field release dynamics, and show how invasion outcomes can depend strongly on the severity of density-dependent competition at the release site. Specifically, the ratio of released relative to wild mosquitoes required to attain a target infection frequency (at the end of a release program) can vary by nearly an order of magnitude. The time taken for Wolbachia to become established following releases can differ by over 2 years. These effects depend on the relative fitness of field and insectary-reared mosquitoes.
   Conclusions: Models of Wolbachia invasion incorporating density-dependent demographic variation in the host population explain observed dynamics in experimental A. aegypti populations. These models predict strong effects of density-dependence on Wolbachia dynamics in field populations, and can assist in the effective use of Wolbachia to control the transmission of arboviruses such as dengue, chikungunya and zika.
C1 [Hancock, Penelope A.; Godfray, H. Charles J.] Univ Oxford, Dept Zool, South Pk Rd, Oxford OX1 3PS, England.
   [White, Vanessa L.; Hoffmann, Ary A.] Univ Melbourne, Sch Biosci, Bio Inst 21, Melbourne, Vic 3010, Australia.
   [Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Townsville, Qld 4878, Australia.
RP Hancock, PA (corresponding author), Univ Oxford, Dept Zool, South Pk Rd, Oxford OX1 3PS, England.
EM hancock.penelope@gmail.com
RI Hoffmann, Ary/R-2972-2019
OI Hoffmann, Ary/0000-0001-9497-7645
FU European CommunityEuropean Community (EC) [326551-WOLBACHIA-MOD]
FX This research was supported by a Marie Curie International Outgoing
   Fellowship within the 7th European Community Framework Programme (Grant
   no. 326551-WOLBACHIA-MOD). We thank Jane Lloyd, Gavin Omodei, Chris
   Paton and Mick Townsend for their generous help and support.
CR Barrera R, 1996, ECOL ENTOMOL, V21, P117, DOI 10.1111/j.1365-2311.1996.tb01178.x
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   Darbro JM, 2012, AM J TROP MED HYG, V86, P656, DOI 10.4269/ajtmh.2012.11-0455
   DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355
   Endersby NM, 2013, B ENTOMOL RES, V103, P269, DOI 10.1017/S0007485312000673
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Hancock PA, 2016, J APPL ECOL, V53, P785, DOI 10.1111/1365-2664.12620
   Hancock PA, 2011, AM NAT, V177, P323, DOI 10.1086/658121
   Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98
   Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Legros M, 2009, J MED ENTOMOL, V46, P409, DOI 10.1603/033.046.0301
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924
   Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walsh RK, 2013, AM J TROP MED HYG, V89, P68, DOI 10.4269/ajtmh.12-0378
   Williams CR, 2013, MED VET ENTOMOL, V27, P313, DOI 10.1111/j.1365-2915.2012.01051.x
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Yeap HL, 2016, HEREDITY, V116, P265, DOI 10.1038/hdy.2015.97
   Yeap HL, 2013, AM J TROP MED HYG, V89, P78, DOI 10.4269/ajtmh.12-0719
   Zhang XH, 2015, MATH BIOSCI, V269, P164, DOI 10.1016/j.mbs.2015.09.004
NR 38
TC 23
Z9 24
U1 0
U2 28
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD NOV 8
PY 2016
VL 14
AR 96
DI 10.1186/s12915-016-0319-5
PG 12
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EB7WN
UT WOS:000387601900001
PM 27825343
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Li, CX
   Bai, XF
   Meng, RZ
   Shaozhou, WL
   Zhang, QS
   Hua, RH
   Liu, JH
   Liu, M
   Zhang, Y
AF Li, Chenxi
   Bai, Xiaofei
   Meng, Runze
   Shaozhou, Wulin
   Zhang, Qingshan
   Hua, Ronghong
   Liu, Jyung-Hurng
   Liu, Ming
   Zhang, Yun
TI Identification of a New Broadly Cross-reactive Epitope within Domain III
   of the Duck Tembusu Virus E Protein
SO SCIENTIFIC REPORTS
LA English
DT Article
ID DENGUE VIRUS; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES;
   ENCEPHALITIS-VIRUS; FLAVIVIRUS; DETERMINANTS; SEQUENCE
AB In 2010, a pathogenic flavivirus termed duck Tembusu virus (DTMUV) caused widespread outbreak of egg-drop syndrome in domesticated ducks in China. Although the glycoprotein E of DTMUV is an important structural component of the virus, the B-cell epitopes of this protein remains uncharacterized. Using phage display and mutagenesis, we identified a minimal B-cell epitope, (EXE)-E-374/DPPFG(380), that mediates binding to a nonneutralizing monoclonal antibody. DTMUV-positive duck serum reacted with the epitope, and amino acid substitutions revealed the specific amino acids that are essential for antibody binding. Dot-blot assays of various flavivirus-positive sera indicated that EXE/DPPFG is a cross-reactive epitope in most flaviviruses, including Zika, West Nile, Yellow fever, dengue, and Japanese encephalitis viruses. These findings indicate that the epitope sequence is conserved among many strains of mosquito-borne flavivirus. Protein structure modeling revealed that the epitope is located in domain III of the DTMUV E protein. Together, these results provide new insights on the broad cross-reactivity of a B-cell binding site of the E protein of flaviviruses, which can be exploited as a diagnostic or therapeutic target for identifying, studying, or treating DTMUV and other flavivirus infections.
C1 [Li, Chenxi; Bai, Xiaofei; Meng, Runze; Shaozhou, Wulin; Zhang, Qingshan; Hua, Ronghong; Liu, Ming; Zhang, Yun] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China.
   [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung, Taiwan.
RP Liu, M; Zhang, Y (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150001, Peoples R China.
EM liuming04@126.com; yunzhang03@yahoo.com
RI Liu, Jyung-Hurng/C-1340-2010
OI Liu, Jyung-Hurng/0000-0002-7173-0372
FU China's Important Research and Developments Program [2016YFD0500106];
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [31670153]
FX This work was funded by China's Important Research and Developments
   Program (2016YFD0500106) and the Natural Science Foundation of China
   (31670153). Yun Zhang supervised and provided the funding for the study.
CR Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Bai XF, 2015, ARCH VIROL, V160, P757, DOI 10.1007/s00705-014-2312-z
   Bai XF, 2013, VIRUS GENES, V47, P478, DOI 10.1007/s11262-013-0966-3
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Burland T G, 2000, Methods Mol Biol, V132, P71
   Cao ZZ, 2011, EMERG INFECT DIS, V17, P1873, DOI 10.3201/eid1710.101890
   Chauhan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067008
   Chuang GY, 2012, BIOINFORMATICS, V28, P2249, DOI 10.1093/bioinformatics/bts426
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004
   Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053026
   Li YF, 2012, VIRUS RES, V163, P546, DOI 10.1016/j.virusres.2011.12.006
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu M, 2012, J CLIN MICROBIOL, V50, P2807, DOI 10.1128/JCM.00655-12
   Liu M, 2012, J VIROL, V86, P3398, DOI 10.1128/JVI.07086-11
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Smith SA, 2013, J INFECT DIS, V207, P1898, DOI 10.1093/infdis/jit119
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Wu XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118041
   Xue M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049842
   Yan PX, 2011, VIROLOGY, V417, P1, DOI 10.1016/j.virol.2011.06.003
NR 33
TC 8
Z9 9
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 8
PY 2016
VL 6
AR 36288
DI 10.1038/srep36288
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB3PI
UT WOS:000387277300001
PM 27824100
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Konongoi, L
   Ofula, V
   Nyunja, A
   Owaka, S
   Koka, H
   Makio, A
   Koskei, E
   Eyase, F
   Langat, D
   Schoepp, RJ
   Rossi, CA
   Njeru, I
   Coldren, R
   Sang, R
AF Konongoi, Limbaso
   Ofula, Victor
   Nyunja, Albert
   Owaka, Samuel
   Koka, Hellen
   Makio, Albina
   Koskei, Edith
   Eyase, Fredrick
   Langat, Daniel
   Schoepp, Randal J.
   Rossi, Cynthia Ann
   Njeru, Ian
   Coldren, Rodney
   Sang, Rosemary
TI Detection of dengue virus serotypes 1, 2 and 3 in selected regions of
   Kenya: 2011-2014
SO VIROLOGY JOURNAL
LA English
DT Article
DE Dengue; Serotypes 1, 2 and 3; Kenya
ID CHIKUNGUNYA VIRUS; HEMORRHAGIC-FEVER; FEBRILE PATIENTS; YELLOW-FEVER;
   INFECTIONS; DELHI
AB Background: Dengue fever, a mosquito-borne disease, is associated with illness of varying severity in countries in the tropics and sub tropics. Dengue cases continue to be detected more frequently and its geographic range continues to expand. We report the largest documented laboratory confirmed circulation of dengue virus in parts of Kenya since 1982.
   Methods: From September 2011 to December 2014, 868 samples from febrile patients were received from hospitals in Nairobi, northern and coastal Kenya. The immunoglobulin M enzyme linked immunosorbent assay (IgM ELISA) was used to test for the presence of IgM antibodies against dengue, yellow fever, West Nile and Zika. Reverse transcription polymerase chain reaction (RT-PCR) utilizing flavivirus family, yellow fever, West Nile, consensus and sero type dengue primers were used to detect acute arbovirus infections and determine the infecting serotypes. Representative samples of PCR positive samples for each of the three dengue serotypes detected were sequenced to confirm circulation of the various dengue serotypes.
   Results: Forty percent (345/ 868) of the samples tested positive for dengue by either IgM ELISA (14.6 %) or by RT-PCR (25.1 %). Three dengue serotypes 1-3 (DENV1-3) were detected by serotype specific RT-PCR and sequencing with their numbers varying from year to year and by region. The overall predominant serotype detected from 2011-2014 was DENV1 accounting for 44 % (96/218) of all the serotypes detected, followed by DENV2 accounting for 38.5 % (84/218) and then DENV3 which accounted for 17.4 % (38/218). Yellow fever, West Nile and Zika was not detected in any of the samples tested.
   Conclusion: From 2011-2014 serotypes 1, 2 and 3 were detected in the Northern and Coastal parts of Kenya. This confirmed the occurrence of cases and active circulation of dengue in parts of Kenya. These results have documented three circulating serotypes and highlight the need for the establishment of active dengue surveillance to continuously detect cases, circulating serotypes, and determine dengue fever disease burden in the country and region.
C1 [Konongoi, Limbaso; Sang, Rosemary] Kenya Govt Med Res Ctr, POB 54628-00200, Nairobi, Kenya.
   [Konongoi, Limbaso; Ofula, Victor; Nyunja, Albert; Owaka, Samuel; Koka, Hellen; Makio, Albina; Koskei, Edith; Eyase, Fredrick; Coldren, Rodney; Sang, Rosemary] US Army, Med Res Directorate, POB 606, Nairobi, Kenya.
   [Langat, Daniel; Njeru, Ian] Kenya Minist Hlth, Div Dis Surveillance & Response, POB 20781-00202, Nairobi, Kenya.
   [Schoepp, Randal J.; Rossi, Cynthia Ann] US Army, Med Res Inst Infect Dis, 1425 Porter St, Frederick, MD 21702 USA.
RP Konongoi, L (corresponding author), Kenya Govt Med Res Ctr, POB 54628-00200, Nairobi, Kenya.; Konongoi, L (corresponding author), US Army, Med Res Directorate, POB 606, Nairobi, Kenya.
EM Limbaso@gmail.com
RI Schoepp, Randal J./F-3330-2019; Schoepp, Randal/L-8578-2019
OI Schoepp, Randal J./0000-0002-5026-0404; Schoepp,
   Randal/0000-0002-5026-0404; Njeru, Ian/0000-0003-0610-3492
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Azhar EI, 2015, VIROL J, V11, DOI 10.1186/s12985-014-0235-7
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CAREY DE, 1971, LANCET, V1, P105
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Chang SF, 2010, J CLIN MICROBIOL, V48, P4586, DOI 10.1128/JCM.01228-10
   Chepkorir E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-435
   Sierra BDL, 2007, ARCH VIROL, V152, P533, DOI 10.1007/s00705-006-0869-x
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   GUBLER DJ, 1986, AM J TROP MED HYG, V35, P1280, DOI 10.4269/ajtmh.1986.35.1280
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1
   HYAMS KC, 1986, AM J TROP MED HYG, V35, P860, DOI 10.4269/ajtmh.1986.35.860
   Jelinek T, 2000, CLIN INFECT DIS, V31, P144, DOI 10.1086/313889
   JOHNSON BK, 1982, LANCET, V2, P208
   Kakkar M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8574
   Kanesa-thasan N, 1998, EMERG INFECT DIS, V4, P299, DOI 10.3201/eid0402.980220
   KOKERNOT RH, 1956, J IMMUNOL, V77, P313
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725
   Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371
   MELNICK JL, 1951, P SOC EXP BIOL MED, V77, P661, DOI 10.3181/00379727-77-18884
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nobuchi H, 1979, KANPO RINSHO, V26, P422
   Onyango CO, 2004, EMERG INFECT DIS, V10, P1064, DOI 10.3201/eid1006.030738
   Parreira R., 2014, Eurosurveillance, V19, P20730, DOI 10.2807/1560-7917.ES2014.19.10.20730
   Porter KR, 1993, AM J TROP MED HYG, V61, P600
   SABIN AB, 1950, BACTERIOL REV, V14, P225
   SABIN AB, 1945, SCIENCE, V101, P640, DOI 10.1126/science.101.2634.640
   SALUZZO JF, 1986, T ROY SOC TROP MED H, V80, P5, DOI 10.1016/0035-9203(86)90182-3
   Sang RC, 2007, SCI WORK GROUP M DEN, P50
   SHARP TW, 1995, AM J TROP MED HYG, V53, P89, DOI 10.4269/ajtmh.1995.53.89
   Singh P, 2012, EPIDEMIOL INFECT, V140, P1337, DOI 10.1017/S0950268811001671
   Sow A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1100-5
   Stokes A, 1928, J AMER MED ASSOC, V90, P253, DOI 10.1001/jama.1928.02690310005002
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
NR 49
TC 16
Z9 17
U1 0
U2 20
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD NOV 4
PY 2016
VL 13
AR 182
DI 10.1186/s12985-016-0641-0
PG 11
WC Virology
SC Virology
GA EB1CT
UT WOS:000387084700002
PM 27814732
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giri, R
   Kumar, D
   Sharma, N
   Uversky, VN
AF Giri, Rajanish
   Kumar, Deepak
   Sharma, Nitin
   Uversky, Vladimir N.
TI Intrinsically Disordered Side of the Zika Virus Proteome
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Zika virus; intrinsically disordered proteins (IDPs); intrinsically
   disordered protein regions (IDPRs); molecular machinery; viral proteome;
   cellular proteome
ID WEST-NILE-VIRUS; DENGUE VIRUS; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION;
   LIMITED PROTEOLYSIS; UNSTRUCTURED PROTEINS; SEGMENTAL MOBILITY; NS2B-NS3
   PROTEASE; ENVELOPE PROTEIN; DRUG DISCOVERY
AB Over the last few decades, concepts of protein intrinsic disorder have been implicated in different biological processes. Recent studies have suggested that intrinsically disordered proteins (IDPs) provide structural plasticity and functional diversity to viral proteins that are involved in rapid replication and immune evasion in host cells. In case of Zika virus, the roles of protein intrinsic disorder in mechanisms of pathogenesis are not completely understood. In this study, we have analyzed the prevalence of intrinsic disorder in Zika virus proteome (strain MR 766). Our analyses revealed that Zika virus polyprotein is enriched with intrinsically disordered protein regions (IDPRs) and this finding is consistent with previous reports on the involvement of IDPs in shell formation and virulence of the Flaviviridae family. We found abundant IDPRs in Capsid, NS2B, NS3, NS4A, and NS5 proteins that are involved in mature particle formation and replication. In our view, the intrinsic disorder-focused analysis of ZIKV proteins could be important for the development of disorder-based drugs.
C1 [Giri, Rajanish; Kumar, Deepak; Sharma, Nitin] Indian Inst Technol, Sch Basic Sci, Mandi, India.
   [Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.
   [Uversky, Vladimir N.] Univ S Florida, Byrd Alzheimers Res Inst, Morsani Coll Med, Tampa, FL 33620 USA.
   [Uversky, Vladimir N.] Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg, Russia.
RP Giri, R (corresponding author), Indian Inst Technol, Sch Basic Sci, Mandi, India.; Uversky, VN (corresponding author), Univ S Florida, Dept Mol Med, Tampa, FL 33620 USA.; Uversky, VN (corresponding author), Univ S Florida, Byrd Alzheimers Res Inst, Morsani Coll Med, Tampa, FL 33620 USA.; Uversky, VN (corresponding author), Russian Acad Sci, Inst Cytol, Lab Struct Dynam Stabil & Folding Prot, St Petersburg, Russia.
EM rajanishgiri@iitmandi.ac.in; vuversky@health.usf.edu
RI Uversky, Vladimir N./F-4515-2011; Giri, Rajanish/Q-6530-2018
OI Uversky, Vladimir N./0000-0002-4037-5857; Giri,
   Rajanish/0000-0002-2046-836X; Kumar, Deepak/0000-0001-8182-0016; Sharma,
   Nitin/0000-0002-8176-7056
FU DST grant, India [YSS/2015/000613]; IIT-Mandi, India; ICMR fellowship,
   India; MHRD fellowship, India
FX This work was partially supported by DST grant, India (YSS/2015/000613)
   to RG and IIT-Mandi, India to RG. DK is supported by ICMR fellowship and
   NS is supported by MHRD fellowship, both in India.
CR Ambadipudi S, 2016, EXPERT OPIN DRUG DIS, V11, P65, DOI 10.1517/17460441.2016.1107041
   Babu MM, 2011, CURR OPIN STRUC BIOL, V21, P432, DOI 10.1016/j.sbi.2011.03.011
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164
   Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273
   Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005
   Deng X, 2012, MOL BIOSYST, V8, P114, DOI 10.1039/c1mb05207a
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541
   Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071
   Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518
   Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25
   Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Fan X, 2014, MOL BIOSYST, V10, P1345, DOI 10.1039/c4mb00027g
   Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontana A, 2004, ACTA BIOCHIM POL, V51, P299
   FONTANA A, 1986, BIOCHEMISTRY-US, V25, P1847, DOI 10.1021/bi00356a001
   Gebhard LG, 2016, J VIROL, V90, P5451, DOI 10.1128/JVI.00206-16
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Goh GKM, 2016, MOL BIOSYST, V12, P1881, DOI 10.1039/c6mb00228e
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253
   Iakoucheva LM, 2001, PROTEIN SCI, V10, P560, DOI 10.1110/ps.29401
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Ivanyi-Nagy R, 2010, PROTEIN PEPTIDE LETT, V17, P1019, DOI 10.2174/092986610791498911
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Z, 2008, J MED CHEM, V51, P4660, DOI 10.1021/jm800412d
   Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519
   Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002
   Liu H, 2004, J MED VIROL, V72, P618, DOI 10.1002/jmv.20025
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mayhoub AS, 2011, J MED CHEM, V54, P1704, DOI 10.1021/jm1013538
   Meng FC, 2015, FEBS J, V282, P3368, DOI 10.1111/febs.13349
   Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   NOVOTNY J, 1987, FEBS LETT, V211, P185, DOI 10.1016/0014-5793(87)81433-3
   Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735
   Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e
   Pejaver V, 2014, PROTEIN SCI, V23, P1077, DOI 10.1002/pro.2494
   Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208
   Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886
   Peng ZL, 2012, CURR PROTEIN PEPT SC, V13, P6, DOI 10.2174/138920312799277938
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537
   Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3
   Salonen A, 2005, CURR TOP MICROBIOL, V285, P139
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924
   Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005
   Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261
   Uversky VN, 2012, EXPERT OPIN DRUG DIS, V7, P475, DOI 10.1517/17460441.2012.686489
   Uversky VN, 2010, EXPERT REV PROTEOMIC, V7, P543, DOI 10.1586/EPR.10.36
   Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017
   Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xue B, 2014, CHEM REV, V114, P6880, DOI 10.1021/cr4005692
   Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 89
TC 28
Z9 29
U1 0
U2 31
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD NOV 4
PY 2016
VL 6
AR 144
DI 10.3389/fcimb.2016.00144
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EA9IZ
UT WOS:000386958000001
PM 27867910
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Callaway, E
AF Callaway, Ewen
TI Infected mosquitoes fight Zika
SO NATURE
LA English
DT News Item
NR 0
TC 17
Z9 17
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD NOV 3
PY 2016
VL 539
IS 7627
BP 17
EP 17
DI 10.1038/nature.2016.20878
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EA5OJ
UT WOS:000386670100052
PM 27808208
OA Bronze
DA 2020-07-08
ER

PT J
AU Li, HD
   Saucedo-Cuevas, L
   Regla-Nava, JA
   Chai, GL
   Sheets, N
   Tang, W
   Terskikh, AV
   Shresta, S
   Gleeson, JG
AF Li, Hongda
   Saucedo-Cuevas, Laura
   Regla-Nava, Jose A.
   Chai, Guoliang
   Sheets, Nicholas
   Tang, William
   Terskikh, Alexey V.
   Shresta, Sujan
   Gleeson, Joseph G.
TI Zika Virus Infects Neural Progenitors in the Adult Mouse Brain and
   Alters Proliferation
SO CELL STEM CELL
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; HIPPOCAMPAL NEUROGENESIS; PATTERN SEPARATION;
   ALZHEIMERS-DISEASE; DENTATE GYRUS; MICE; ORGANOIDS; DENGUE; CELLS;
   PATHOGENESIS
AB Zika virus (ZIKV)-related neuropathology is an important global health concern. Several studies have shown that ZIKV can infect neural stem cells in the developing brain, but infection in the adult brain has not been examined. Two areas in the adult mouse brain contain neural stem cells: the subventricular zone of the anterior forebrain and the subgranular zone of the hippocampus. Here, using 6-week-old mice triply deficient in interferon regulatory factor (IRF) as a model, we show that blood-borne ZIKV administration can lead to pronounced evidence of ZIKV infection in these adult neural stem cells, leading to cell death and reduced proliferation. Our data therefore suggest that adult as well as fetal neural stem cells are vulnerable to ZIKV neuropathology. Thus, although ZIKV is considered a transient infection in adult humans without marked long-term effects, there may in fact be consequences of exposure in the adult brain.
C1 [Li, Hongda; Saucedo-Cuevas, Laura; Chai, Guoliang; Gleeson, Joseph G.] Rockefeller Univ, Howard Hughes Med Inst, Lab Pediat Brain Dis, New York, NY 10065 USA.
   [Li, Hongda; Saucedo-Cuevas, Laura; Chai, Guoliang; Gleeson, Joseph G.] Univ Calif San Diego, Rady Childrens Inst Genom Med, Dept Neurosci, La Jolla, CA 92093 USA.
   [Regla-Nava, Jose A.; Sheets, Nicholas; Tang, William; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Terskikh, Alexey V.] Sanford Burnham Prebys Discovery Inst, Del E Webb Ctr Neurosci Aging & Stem Cell Regener, La Jolla, CA 92037 USA.
RP Gleeson, JG (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Pediat Brain Dis, New York, NY 10065 USA.; Gleeson, JG (corresponding author), Univ Calif San Diego, Rady Childrens Inst Genom Med, Dept Neurosci, La Jolla, CA 92093 USA.; Shresta, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
EM sujan@lji.org; jogleeson@rockefeller.edu
RI Terskikh, Alexey/U-8407-2019; Li, Hongda/F-3034-2017
OI Li, Hongda/0000-0001-6754-5150; Regla-Nava, Jose
   Angel/0000-0002-5438-1369; Chai, Guoliang/0000-0001-9658-6381
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01NS041537, R01NS048453, R01NS052455,
   P01HD070494, P30NS047101, R01 AI116813]; Simons Foundation Autism
   Research Initiative (SFARI); Howard Hughes Medical InstituteHoward
   Hughes Medical Institute; California Institute of Regenerative
   MedicineCalifornia Institute for Regenerative Medicine; Druckenmiller
   Fellowship from New York Stem Cell Foundation
FX This work was supported by the NIH (R01NS041537, R01NS048453,
   R01NS052455, P01HD070494, and P30NS047101), the Simons Foundation Autism
   Research Initiative (SFARI), the Howard Hughes Medical Institute, and
   California Institute of Regenerative Medicine (J.G.G.); NIH R01 AI116813
   (S.S.); and a Druckenmiller Fellowship from New York Stem Cell
   Foundation (H.L). We thank Alysson Muotri and Charles Rice for
   discussions.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota M.T., 2016, PLOS NEGLECT TROP D, V10
   Araujo FMC, 2012, NEUROLOGY, V78, P736, DOI 10.1212/WNL.0b013e31824b94e9
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Demars M, 2010, J NEUROSCI RES, V88, P2103, DOI 10.1002/jnr.22387
   Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Kaneko N, 2006, NEUROPSYCHOPHARMACOL, V31, P2619, DOI 10.1038/sj.npp.1301137
   Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Luethy LN, 2016, VIROLOGY, V487, P1, DOI 10.1016/j.virol.2015.09.019
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Patricio P, 2013, MOL NEUROBIOL, V48, P84, DOI 10.1007/s12035-013-8422-x
   Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rodriguez JJ, 2011, CURR ALZHEIMER RES, V8, P707
   Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817
   Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103
   Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002
   Stolp HB, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00020
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zellweger RM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00151
NR 38
TC 131
Z9 131
U1 1
U2 43
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD NOV 3
PY 2016
VL 19
IS 5
BP 593
EP 598
DI 10.1016/j.stem.2016.08.005
PG 6
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EE3FX
UT WOS:000389474300009
PM 27545505
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Liang, QM
   Luo, ZF
   Zeng, JX
   Chen, WQ
   Foo, SS
   Lee, SA
   Ge, JN
   Wang, S
   Goldman, SA
   Zlokovic, BV
   Zhao, Z
   Jung, JU
AF Liang, Qiming
   Luo, Zhifei
   Zeng, Jianxiong
   Chen, Weiqiang
   Foo, Suan-Sin
   Lee, Shin-Ae
   Ge, Jianning
   Wang, Su
   Goldman, Steven A.
   Zlokovic, Berislav V.
   Zhao, Zhen
   Jung, Jae U.
TI Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human
   Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
SO CELL STEM CELL
LA English
DT Article
ID PROGENITOR CELLS; INFECTION; IDENTIFICATION; MUTATIONS; PREGNANCY;
   IMMUNITY; BIOLOGY; MODEL
AB The current widespread outbreak of Zika virus (ZIKV) infection has been linked to severe clinical birth defects, particularly microcephaly, warranting urgent study of the molecular mechanisms underlying ZIKV pathogenesis. Akt-mTOR signaling is one of the key cellular pathways essential for brain development and autophagy regulation. Here, we show that ZIKV infection of human fetal neural stem cells (fNSCs) causes inhibition of the Akt-mTOR pathway, leading to defective neurogenesis and aberrant activation of autophagy. By screening the three structural proteins and seven nonstructural proteins present in ZIKV, we found that two, NS4A and NS4B, cooperatively suppress the Akt-mTOR pathway and lead to cellular dysregulation. Corresponding proteins from the closely related dengue virus do not have the same effect on neurogenesis. Thus, our study highlights ZIKV NS4A and NS4B as candidate determinants of viral pathogenesis and identifies a mechanism of action for their effects, suggesting potential targets for anti-ZIKV therapeutic intervention.
C1 [Liang, Qiming; Zeng, Jianxiong; Chen, Weiqiang; Foo, Suan-Sin; Lee, Shin-Ae; Ge, Jianning; Jung, Jae U.] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
   [Luo, Zhifei; Zlokovic, Berislav V.; Zhao, Zhen] Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.
   [Luo, Zhifei; Zlokovic, Berislav V.; Zhao, Zhen] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.
   [Liang, Qiming] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai Inst Immunol, Shanghai 200025, Peoples R China.
   [Wang, Su; Goldman, Steven A.] Univ Rochester, Ctr Translat Neuromed, Rochester, NY 14642 USA.
   [Wang, Su; Goldman, Steven A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA.
   [Wang, Su; Goldman, Steven A.] Univ Copenhagen, Fac Hlth & Med Sci, DK-1165 Copenhagen, Denmark.
RP Liang, QM; Jung, JU (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.; Zhao, Z (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA.; Zhao, Z (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.; Liang, QM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai Inst Immunol, Shanghai 200025, Peoples R China.
EM liangqiming@shsmu.edu.cn; zzhao@usc.edu; jaeujung@med.usc.edu
OI Goldman, Steven/0000-0002-5498-4303; zhao, zhen/0000-0001-8967-5570
FU Hastings Foundation [CA200422, CA180779, DE023926, AI073099, AI116585,
   HL110609]; Fletcher Jones Foundation; National Research Foundation of
   KoreaNational Research Foundation of Korea [K20815000001]; Alzheimer's
   AssociationAlzheimer's Association [NIRG-15-363387]; Cure for
   Alzheimer's Fund; Program for Professor of Special Appointment (Eastern
   Scholar) at Shanghai Institutions of Higher learning;  [9R01NS090904];
   Novo Nordisk FondenNovo NordiskNovo Nordisk Foundation [NNF13OC0004260]
FX We specially thank Michael Diamond and Cecile Baronti for providing ZIKV
   strains MR766 and H/PF/2013. This work was partly supported by CA200422,
   CA180779, DE023926, AI073099, AI116585, HL110609, Hastings Foundation,
   Fletcher Jones Foundation, and GRL Program (K20815000001) from National
   Research Foundation of Korea (JUJ); NIRG-15-363387 from the Alzheimer's
   Association (Z.Z.); 9R01NS090904 (B.V.Z.); and the Cure for Alzheimer's
   Fund (B.V.Z. and Z.Z.). Q.L. is a Special Fellow of Leukemia & Lymphoma
   Society and is supported by the Program for Professor of Special
   Appointment (Eastern Scholar) at Shanghai Institutions of Higher
   learning.
CR Baek ST, 2015, NAT MED, V21, P1445, DOI 10.1038/nm.3982
   Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan CH, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-59
   Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Guo H, 2013, J NEUROSCI, V33, P6181, DOI 10.1523/JNEUROSCI.4491-12.2013
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee DY, 2015, EXP NEUROBIOL, V24, P177, DOI 10.5607/en.2015.24.3.177
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liang QM, 2015, J VIROL, V89, P5308, DOI 10.1128/JVI.00102-15
   Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009
   Liang QM, 2013, J VIROL, V87, P12499, DOI 10.1128/JVI.01898-13
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001
   Mirzaa GM, 2013, AM J MED GENET C, V163C, P122, DOI 10.1002/ajmg.c.31361
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nellist M, 2015, MOL GENET METAB, V114, P467, DOI 10.1016/j.ymgme.2014.11.018
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sir D, 2012, J BIOL CHEM, V287, P18036, DOI 10.1074/jbc.M111.320085
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wahane SD, 2014, J NEUROCHEM, V130, P255, DOI 10.1111/jnc.12718
   Wang S, 2010, J NEUROSCI, V30, P14635, DOI 10.1523/JNEUROSCI.1729-10.2010
   Williams LR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00170
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 45
TC 182
Z9 192
U1 4
U2 75
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD NOV 3
PY 2016
VL 19
IS 5
BP 663
EP 671
DI 10.1016/j.stem.2016.07.019
PG 9
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EE3FX
UT WOS:000389474300015
PM 27524440
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Li, C
   Xu, D
   Ye, Q
   Hong, S
   Jiang, YS
   Liu, XY
   Zhang, NN
   Shi, L
   Qin, CF
   Xu, ZH
AF Li, Cui
   Xu, Dan
   Ye, Qing
   Hong, Shuai
   Jiang, Yisheng
   Liu, Xinyi
   Zhang, Nana
   Shi, Lei
   Qin, Cheng-Feng
   Xu, Zhiheng
TI Zika Virus Disrupts Neural Progenitor Development and Leads to
   Microcephaly in Mice (vol 19, pg 120, 2016)
SO Cell Stem Cell
LA English
DT Correction
EM qincf@bmi.ac.cn; zhxu@genetics.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807
CR Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
NR 1
TC 82
Z9 86
U1 2
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD NOV 3
PY 2016
VL 19
IS 5
BP 672
EP 672
DI 10.1016/j.stem.2016.10.017
PG 1
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EE3FX
UT WOS:000389474300016
PM 27814481
OA Bronze
DA 2020-07-08
ER

PT J
AU Velez, ACG
   Diniz, SG
AF Gonzalez Velez, Ana Cristina
   Diniz, Simone G.
TI Inequality, Zika epidemics, and the lack of reproductive rights in Latin
   America
SO REPRODUCTIVE HEALTH MATTERS
LA English
DT Article
DE Zika epidemic; Latin America; Colombia
ID BRAZIL
AB It is well-documented that structural economic inequalities in Latin America are expressed through and reinforce existing gender gaps. This article aims to look at the relationship between structural inequalities and reproductive health in the case of the Zika epidemic. The consequences of the epidemic will continue to affect the same women whose access to comprehensive reproductive health services, including safe abortion, is restricted at best. (C) 2016 Reproductive Health Matters. Published by Elsevier BV. All rights reserved.
C1 [Gonzalez Velez, Ana Cristina] Fiocruz MS, Et Aplicada & Saude Colet PPGBIOS, Programa Pos Grad Bioet, Rio De Janeiro, RJ, Brazil.
   [Diniz, Simone G.] Univ Sao Paulo, Dept Maternal & Child Hlth, Sch Publ Hlth, Sao Paulo, Brazil.
RP Velez, ACG (corresponding author), Fiocruz MS, Et Aplicada & Saude Colet PPGBIOS, Programa Pos Grad Bioet, Rio De Janeiro, RJ, Brazil.
EM acgonzalezvelez@gmail.com
CR Diniz D., 2016, ZIKA VIRUS WOMEN, V32
   Diniz SG, 2012, REPROD HEALTH MATTER, V20, P94, DOI 10.1016/S0968-8080(12)40657-7
   Diniz SG, 2016, MIDWIFERY, V35, P22, DOI 10.1016/j.midw.2016.02.011
   ECLAC Division of Gender Affairs, 2016, EF FALT AUT FIS AUT
   Florez C. E., 2008, ESTADO SALUD SEXUAL
   Florez CE, 2006, FECUNDIADAD ADOLESCE
   Gonzalez Velez AC, MESA VIDA SALUD MUJE
   Gonzalez Velez AC, 2016, EXP M SANT CHIL IN
   Gonzalez Velez AC, 2015, GENDER GAPS MDGS OTH
   Sedgh G, ABORTION INCIDENCE 1
   Selgelid MJ, 2011, GLOBAL HEALTH AND GLOBAL HEALTH ETHICS, P89
   Yamin A., 2016, FEMINISM PSYCHOL MON
NR 12
TC 14
Z9 14
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0968-8080
EI 1460-9576
J9 REPROD HEALTH MATTER
JI Reprod. Health Matters
PD NOV
PY 2016
VL 24
IS 48
BP 57
EP 61
DI 10.1016/j.rhm.2016.11.008
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EV7KF
UT WOS:000401953600009
PM 28024678
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kading, RC
   Schountz, T
AF Kading, Rebekah C.
   Schountz, Tony
TI Flavivirus Infections of Bats: Potential Role in Zika Virus Ecology
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Review
ID ST-LOUIS ENCEPHALITIS; WEST-NILE-VIRUS; JAPANESE-B ENCEPHALITIS;
   FOREST-DISEASE VIRUS; INSECTIVOROUS BATS; EAST-AFRICA; NEW-YORK;
   CHIROPTERA; UGANDA; IDENTIFICATION
AB Understanding the vector and nonhuman vertebrate species contributing to Zika virus (ZIKAV) transmission is critical to understanding the ecology of this emerging arbovirus and its potential to establish in new geographic areas. This minireview summarizes what is known regarding the association of bats with flaviviruses (Flaviviridae: Flavivirus) with a particular emphasis on the potential role of bats in the sylvatic transmission of ZIKAV. Key research directions that remain to be addressed are also discussed.
C1 [Kading, Rebekah C.; Schountz, Tony] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Kading, Rebekah C.; Schountz, Tony] Colorado State Univ, 1692 Campus Delivery, Ft Collins, CO 80523 USA.
RP Kading, RC (corresponding author), Colorado State Univ, 1692 Campus Delivery, Ft Collins, CO 80523 USA.
EM rebekah.kading@colostate.edu; tony.schountz@colostate.edu
RI Kading, Rebekah/E-5633-2017; Schountz, Tony/I-2161-2017
OI Kading, Rebekah/0000-0002-4996-915X; 
CR ALLEN R, 1970, AM J TROP MED HYG, V19, P851, DOI 10.4269/ajtmh.1970.19.851
   BELL JF, 1964, AM J TROP MED HYG, V13, P607, DOI 10.4269/ajtmh.1964.13.607
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   BRES P, 1963, ANN I PASTEUR PARIS, V104, P705
   Bunde JM, 2006, J WILDLIFE DIS, V42, P455, DOI 10.7589/0090-3558-42.2.455
   BURNS KF, 1956, SCIENCE, V123, P227, DOI 10.1126/science.123.3189.227
   Butenko AM, 1996, MED PARAZITOL MOSK, V2, P40
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Crabtree MB, 2013, J WILDLIFE DIS, V49, P611, DOI 10.7589/2012-08-213
   Davis A, 2005, AM J TROP MED HYG, V73, P467, DOI 10.4269/ajtmh.2005.73.467
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   HERBOLD JR, 1983, AM J VET RES, V44, P1889
   Johnson HN, 1957, DIAGNOSTIC PROCEDURE
   Johnson HN, 1957, P 9 PAC SCI C BANGK, P39
   Kading RC, 2015, AM J TROP MED HYG, V93, P475, DOI 10.4269/ajtmh.15-0065
   Karabatsos N, 1985, INT CATALOGUE ARBOVI, p[1, 147]
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuno G, 2006, AM J TROP MED HYG, V75, P1165, DOI 10.4269/ajtmh.2006.75.1165
   LAMOTTE LC, 1958, AM J HYG, V67, P101, DOI 10.1093/oxfordjournals.aje.a119912
   Liu S, 2013, ARCH VIROL, V158, P2543, DOI 10.1007/s00705-013-1777-5
   Logue K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004512
   LUMSDEN WH, 1961, ANN TROP MED PARASIT, V55, P389, DOI 10.1080/00034983.1961.11686063
   LVOV DK, 1973, ARCH GES VIRUSFORSCH, V41, P170, DOI 10.1007/BF01252762
   Machain-Williams C, 2013, J WILDLIFE DIS, V49, P684, DOI 10.7589/2012-12-318
   Molaei G, 2006, AM J TROP MED HYG, V75, P1140, DOI 10.4269/ajtmh.2006.75.1140
   PAVRI KM, 1968, INDIAN J MED RES, V56, P1202
   Perea-Martinez L, 2013, COMP IMMUNOL MICROB, V36, P193, DOI 10.1016/j.cimid.2012.12.002
   Pilipski JD, 2004, J WILDLIFE DIS, V40, P335, DOI 10.7589/0090-3558-40.2.335
   PRICE JL, 1978, AM J TROP MED HYG, V27, P153, DOI 10.4269/ajtmh.1978.27.153
   RAJAGOPA.PK, 1969, INDIAN J MED RES, V57, P805
   Regan RL, 1955, T AM MICROSC SOC, V74, P77
   SALAUN JJ, 1974, ANN INST PASTEUR MIC, VA125, P485
   SHEPHERD R. C, 1964, ZOONOSES RES, V3, P125
   SIMPSON DIH, 1968, ANN TROP MED PARASIT, V62, P432, DOI 10.1080/00034983.1968.11686580
   SIMPSON DIH, 1968, ANN TROP MED PARASIT, V62, P422, DOI 10.1080/00034983.1968.11686579
   SULKIN SE, 1963, AM J TROP MED HYG, V12, P800, DOI 10.4269/ajtmh.1963.12.800
   SULKIN SE, 1964, AM J TROP MED HYG, V13, P475, DOI 10.4269/ajtmh.1964.13.475
   SULKIN SE, 1966, AM J TROP MED HYG, V15, P418, DOI 10.4269/ajtmh.1966.15.418
   Tajima S, 2005, VIROLOGY, V332, P38, DOI 10.1016/j.virol.2004.06.052
   Thompson NN, 2015, ZOONOSES PUBLIC HLTH, V62, P53, DOI 10.1111/zph.12118
   umsden WHR, 1957, E AFRICAN VIRUS RES, P22
   Williams MC, 1964, E AFRICAN VIRUS RES, P42
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
NR 45
TC 10
Z9 11
U1 2
U2 19
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 993
EP 996
DI 10.4269/ajtmh.16-0625
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600007
PM 27645783
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Thangamani, S
   Huang, J
   Hart, CE
   Guzman, H
   Tesh, RB
AF Thangamani, Saravanan
   Huang, Jing
   Hart, Charles E.
   Guzman, Hilda
   Tesh, Robert B.
TI Vertical Transmission of Zika Virus in Aedes aegypti Mosquitoes
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRANS-OVARIAL TRANSMISSION; LOUIS ENCEPHALITIS-VIRUS; YELLOW-FEVER
   VIRUS; DENGUE VIRUSES; TRANSOVARIAL TRANSMISSION; ALBOPICTUS; CULEX;
   MAINTENANCE; GENERATIONS; DISCOVERY
AB Previous experimental studies have demonstrated that a number of mosquito-borne flavivirus pathogens are vertically transmitted in their insect vectors, providing a mechanism for these arboviruses to persist during adverse climatic conditions or in the absence of a susceptible vertebrate host. In this study, designed to test whether Zika virus (ZIKV) could be vertically transmitted, female Aedes aegypti and Aedes albopictus were injected with ZIKV, and their F-1 adult progeny were tested for ZIKV infection. Six of 69 Ae. aegypti pools, comprised of a total of 1,738 F-1 adults, yielded ZIKV upon culture, giving a minimum filial infection rate of 1:290. In contrast, none of 803 F-1 Ae. albopictus adults (32 pools) yielded ZIKV. The MFIR for Ae. aegypti was comparable to MFIRs reported for other flaviviruses in mosquitoes, including dengue, Japanese encephalitis, yellow fever, West Nile, and St. Louis encephalitis viruses. The results suggest that vertical transmission may provide a potential mechanism for the virus to survive during adverse conditions.
C1 [Thangamani, Saravanan; Huang, Jing; Hart, Charles E.; Guzman, Hilda; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Thangamani, Saravanan; Huang, Jing; Hart, Charles E.; Guzman, Hilda; Tesh, Robert B.] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Tesh, RB (corresponding author), Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77555 USA.
EM rtesh@utmb.edu
RI Thangamani, Saravanan/E-7371-2010
OI Thangamani, Saravanan/0000-0002-4269-5993
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24 AI 120942]
FX This work was. supported in part by NIH grant R24 AI 120942.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125, DOI 10.4269/ajtmh.1980.29.125
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2015, VIRUSES-BASEL, V7, P4911, DOI 10.3390/v7092851
   Christophers S., 1960, AEDES AEGYPTI L YELL
   DUTARY BE, 1981, T ROY SOC TROP MED H, V75, P128, DOI 10.1016/0035-9203(81)90036-5
   Estrado-Franco JG, 1995, 42 PAN AM HLTH ORG
   FINE PEM, 1975, ANN NY ACAD SCI, V266, P173, DOI 10.1111/j.1749-6632.1975.tb35099.x
   FREIER JE, 1988, AM J TROP MED HYG, V39, P218, DOI 10.4269/ajtmh.1988.39.218
   HARDY JL, 1984, AM J TROP MED HYG, V33, P166, DOI 10.4269/ajtmh.1984.33.166
   HARDY JL, 1980, AM J TROP MED HYG, V29, P963, DOI 10.4269/ajtmh.1980.29.963
   Hermance ME, 2015, J VIROL, V89, P7852, DOI 10.1128/JVI.01056-15
   Higgs Stephen, 2005, P733
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   JOUSSET FX, 1981, ANN INST PASTEUR VIR, V132, P357, DOI 10.1016/S0769-2617(81)80006-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NAYAR JK, 1986, AM J TROP MED HYG, V35, P1296, DOI 10.4269/ajtmh.1986.35.1296
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035
   ROSEN L, 1989, AM J TROP MED HYG, V40, P548, DOI 10.4269/ajtmh.1989.40.548
   Seecof R, 1968, Curr Top Microbiol Immunol, V42, P59
   SHROYER DA, 1990, J AM MOSQUITO CONTR, V6, P312
   TESH RB, 1980, AM J TROP MED HYG, V29, P657, DOI 10.4269/ajtmh.1980.29.657
   TESH RB, 1980, AM J TROP MED HYG, V29, P1394, DOI 10.4269/ajtmh.1980.29.1394
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   Tesh RB, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P191
   THOMPSON WH, 1978, AM J TROP MED HYG, V27, P187, DOI 10.4269/ajtmh.1978.27.187
   TURELL MJ, 1982, AM J TROP MED HYG, V31, P1252, DOI 10.4269/ajtmh.1982.31.1252
   Vasilakis N, 2008, ADV VIRUS RES, V72, P1, DOI 10.1016/S0065-3527(08)00401-6
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
NR 35
TC 71
Z9 71
U1 0
U2 15
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1169
EP 1173
DI 10.4269/ajtmh.16-0448
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600038
PM 27573623
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lounibos, LP
AF Lounibos, L. Philip
TI Mosquito Vectors of Zika
SO AMERICAN SCIENTIST
LA English
DT Letter
C1 [Lounibos, L. Philip] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL USA.
RP Lounibos, LP (corresponding author), Univ Florida, Florida Med Entomol Lab, Vero Beach, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SIGMA XI-SCI RES SOC
PI RES TRIANGLE PK
PA PO BOX 13975, RES TRIANGLE PK, NC 27709 USA
SN 0003-0996
EI 1545-2786
J9 AM SCI
JI Am. Scientist
PD NOV-DEC
PY 2016
VL 104
IS 6
BP 323
EP 323
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EQ1MC
UT WOS:000397833200002
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Mosquito Vectors of Zika response
SO AMERICAN SCIENTIST
LA English
DT Letter
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SIGMA XI-SCI RES SOC
PI RES TRIANGLE PK
PA PO BOX 13975, RES TRIANGLE PK, NC 27709 USA
SN 0003-0996
EI 1545-2786
J9 AM SCI
JI Am. Scientist
PD NOV-DEC
PY 2016
VL 104
IS 6
BP 323
EP 323
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EQ1MC
UT WOS:000397833200003
DA 2020-07-08
ER

PT J
AU Gokce, A
   Ozer, A
   Bentli, R
   Tekedereli, I
AF Gokce, A.
   Ozer, A.
   Bentli, R.
   Tekedereli, I.
TI Knowledge level of medical students about Zika virus disease in Malatya,
   an eastern city of Turkey
SO EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Meeting Abstract
C1 [Gokce, A.; Ozer, A.] Inonu Univ, Fac Med, Dept Publ Hlth, Malatya, Turkey.
   [Bentli, R.] Inonu Univ, Fac Med, Dept Gen Internal Med, Malatya, Turkey.
   [Tekedereli, I.] Inonu Univ, Fac Med, Dept Med Biol & Genet, Malatya, Turkey.
EM aliozer91@hotmail.com
NR 0
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1101-1262
EI 1464-360X
J9 EUR J PUBLIC HEALTH
JI Eur. J. Public Health
PD NOV
PY 2016
VL 26
SU 1
BP 452
EP 452
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ER2CA
UT WOS:000398600404313
DA 2020-07-08
ER

PT J
AU Mani, RS
AF Mani, Reeta S.
TI Microcephaly not a reliable indicator of congenital Zika virus syndrome
   in infants
SO NATIONAL MEDICAL JOURNAL OF INDIA
LA English
DT Editorial Material
C1 [Mani, Reeta S.] Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bengaluru, Karnataka, India.
RP Mani, RS (corresponding author), Natl Inst Mental Hlth & Neurosci, Dept Neurovirol, Bengaluru, Karnataka, India.
EM drreeta@gmail.com
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   CDC-Centers for Disease Control and Prevention, CDC CONCL ZIK CAUS M
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   World Health Organization, ZIK VIR MICR GUILL B
NR 11
TC 2
Z9 2
U1 0
U2 4
PU ALL INDIA INST MEDICAL SCIENCES
PI NEW DELHI
PA ANSARI NAGAR, NEW DELHI 110 029, INDIA
SN 0970-258X
J9 NATL MED J INDIA
JI Natl. Med. J. India
PD NOV-DEC
PY 2016
VL 29
IS 6
BP 339
EP 340
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EP1WJ
UT WOS:000397174700006
PM 28327482
DA 2020-07-08
ER

PT J
AU Iqbal, MZ
   Tahir, M
   Lokanayagi, SS
   Rahul, R
   Chong, LW
   Kho, ZX
   Kumar, PS
AF Iqbal, M. Z.
   Tahir, M.
   Lokanayagi, S. S.
   Rahul, R.
   Chong, L. W.
   Kho, Z. X.
   Kumar, Sunil P.
TI KNOWLEDGE, ATTITUDE AND PERCEPTION OF ZIKA VIRUS AMONG HEALTHCARE
   STUDENTS OF MEDICINE, PHARMACY AND DENTISTRY OF AIMST UNIVERSITY
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Iqbal, M. Z.; Lokanayagi, S. S.; Chong, L. W.; Kho, Z. X.; Kumar, Sunil P.] AIMST Univ, Bedong, Kedah Darul Ama, Malaysia.
   [Tahir, M.] Univ Vet & Anim Sci Lahore, Lahore, Malaysia.
   [Rahul, R.] AIMST Univ, Fac Dent, Sungai Petani, Malaysia.
NR 0
TC 3
Z9 3
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD NOV
PY 2016
VL 19
IS 7
MA PHP256
BP A484
EP A484
DI 10.1016/j.jval.2016.09.798
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA EO3PI
UT WOS:000396606300751
OA Bronze
DA 2020-07-08
ER

PT J
AU Khan, MU
   Ahmad, A
   Arief, M
   Saleem, F
   Hassali, MA
   Bhagavathula, AS
AF Khan, M. U.
   Ahmad, A.
   Arief, M.
   Saleem, F.
   Hassali, M. A.
   Bhagavathula, A. S.
TI PUBLIC KNOWLEDGE AND ATTITUDES TOWARDS ZIKA VIRUS AND ITS PREVENTION IN
   MALAYSIA
SO VALUE IN HEALTH
LA English
DT Meeting Abstract
C1 [Khan, M. U.; Ahmad, A.; Arief, M.] UCSI Univ, Kuala Lumpur, Malaysia.
   [Saleem, F.; Hassali, M. A.] Univ Sains Malaysia, George Town, Malaysia.
   [Bhagavathula, A. S.] Univ Gondar, Gondar, Ethiopia.
RI Bhagavathula, Akshaya Srikanth/G-6649-2015
OI Bhagavathula, Akshaya Srikanth/0000-0002-0581-7808
NR 0
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1098-3015
EI 1524-4733
J9 VALUE HEALTH
JI Value Health
PD NOV
PY 2016
VL 19
IS 7
MA PIN94
BP A423
EP A423
DI 10.1016/j.jval.2016.09.445
PG 1
WC Economics; Health Care Sciences & Services; Health Policy & Services
SC Business & Economics; Health Care Sciences & Services
GA EO3PI
UT WOS:000396606300418
OA Bronze
DA 2020-07-08
ER

PT J
AU Mekala, HM
   Jayakumar, P
   Yeruva, RR
   Lippmann, S
AF Mekala, Hema Madhuri
   Jayakumar, Priyanga
   Yeruva, Rajashekar Reddy
   Lippmann, Steven
TI What can we do about the Zika virus in the United States?
SO JOURNAL OF FAMILY PRACTICE
LA English
DT Letter
CR Centers for Disease Control and Prevention, ZIK VIR ZIK IS YOUR
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   Ernst KC, 2015, EMERG INFECT DIS, V21, P320, DOI 10.3201/eid2102.141035
NR 4
TC 0
Z9 0
U1 0
U2 0
PU DOWDEN HEALTH MEDIA
PI MONTVALE
PA 110 SUMMIT AVE, MONTVALE, NJ 07645-1712 USA
SN 0094-3509
J9 J FAM PRACTICE
JI J. Fam. Pract.
PD NOV
PY 2016
VL 65
IS 11
BP 756
EP 757
PG 2
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA EK4IZ
UT WOS:000393891600011
PM 28087875
DA 2020-07-08
ER

PT J
AU Campos, AGD
   Lira, RPC
   Arantes, TEFE
AF de Moura Campos, Adriana Gondim
   Cavalcanti Lira, Rodrigo Pessoa
   Faria e Arantes, Tiago Eugenio
TI Optical coherence tomography of macular atrophy associated with
   microcephaly and presumed intrauterine Zika virus infection
SO ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
LA English
DT Article
DE Retina; Microcephaly; Zika virus; Tomography; optical coherence; Eye
   manifestations
AB This case report describes the retinal optical coherence tomography (OCT) findings in a microcephalic infant with macular atrophy presumably caused by intrauterine Zika virus infection. OCT demonstrated atrophy of the outer retinal layers and choriocapillaris, including the outer nuclear layer and ellipsoid zone, associated with retinal pigment epithelium hyper-reflectivity and increased OCT penetration into deeper layers of the choroid and sclera. A major concern associated with this infection is the apparent increased incidence of microcephaly in fetuses born to mothers infected with the Zika virus. It is becoming increasingly difficult to ignore the upsurge in congenital microcephaly observed in Brazil. Recently, ocular findings in infants with microcephaly associated with intrauterine Zika virus infection have been described. This is the first report of OCT imaging of macular atrophy in a child with presumed Zika virus infection-asso-ciated microcephaly.
C1 [de Moura Campos, Adriana Gondim] Univ Fed Pernambuco UFPE, Recife, PE, Brazil.
   [Cavalcanti Lira, Rodrigo Pessoa] Univ Estadual Campinas UNICAMP, Campinas, SP, Brazil.
   [Faria e Arantes, Tiago Eugenio] Univ Fed Sao Paulo UNIFESP, Sao Paulo, SP, Brazil.
RP Campos, AGD (corresponding author), Rua Neto Mendonca 230-1-402, BR-52050100 Recife, PE, Brazil.
EM adri.gondim@gmail.com
RI Lira, Rodrigo Pessoa Cavalcanti/G-9211-2012; Arantes, Tiago
   EF/I-3093-2013
OI Lira, Rodrigo Pessoa Cavalcanti/0000-0002-7274-1065; Arantes, Tiago
   EF/0000-0002-8122-3446
CR Brasil Ministerio da Saude, PROT VIG RESP OC MIC
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Garg S, 2009, RETINA-J RET VIT DIS, V29, P631, DOI 10.1097/IAE.0b013e318198d8de
   Goldenberg D, 2013, GRAEF ARCH CLIN EXP, V251, P2037, DOI 10.1007/s00417-013-2334-3
   Jones GE, 2014, EUR J HUM GENET, V22, P881, DOI 10.1038/ejhg.2013.263
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
NR 6
TC 12
Z9 12
U1 0
U2 24
PU CONSEL BRASIL OFTALMOLOGIA
PI SAO PAULO
PA ALAMEDA SANTOS 1343, 11 ANDAR CJ 1110, CERQUEIRA CESAR, SAO PAULO, SP
   00000, BRAZIL
SN 0004-2749
EI 1678-2925
J9 ARQ BRAS OFTALMOL
JI Arq. Bras. Oftalmol.
PD NOV-DEC
PY 2016
VL 79
IS 6
BP 400
EP 401
DI 10.5935/0004-2749.20160112
PG 2
WC Ophthalmology
SC Ophthalmology
GA EJ2EH
UT WOS:000393022300012
PM 28076569
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Quam, MB
   Wilder-Smith, A
AF Quam, Mikkel B.
   Wilder-Smith, Annelies
TI Estimated global exportations of Zika virus infections via travellers
   from Brazil from 2014 to 2015
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Zika; Brazil; air passengers; travel; exportation
ID DENGUE OUTBREAK; AIR-TRAVEL; IMPORTATIONS; ORIGIN
AB The ongoing Zika pandemic in Latin America illustrates a potential source for further globalized spread. Here, we assessed global travel-related Zika virus exportations from Brazil during the initial year of the epidemic. Similar to subsequent national notifications, we estimated 584-1786 exported Zika cases from Brazil occurred September 2014-August 2015.
C1 [Quam, Mikkel B.] Umea Univ, Epidemiol & Global Hlth, Umea, Sweden.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Wilder-Smith, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.; Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
EM anneliesws@gmail.com
RI Wilder-Smith, Annelies/F-8751-2015
CR Attaway DF, 2016, ACTA TROP, V158, P248, DOI 10.1016/j.actatropica.2016.02.018
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lopez LF, 2016, B MATH BIOL, V78, P185, DOI 10.1007/s11538-015-0135-z
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Quam M, 2014, LANCET, V383, P1632, DOI 10.1016/S0140-6736(14)60537-7
   Quam MB, 2016, AM J TROP MED HYG, V94, P409, DOI 10.4269/ajtmh.15-0468
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Quam MB, 2015, J TRAVEL MED, V22, P72, DOI 10.1111/jtm.12177
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Sessions OM, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.21822
   Tatem AJ, 2012, PARASITOLOGY, V139, P1816, DOI 10.1017/S0031182012000352
   Venturi G, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.10.30163
   Wilder-Smith A, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.8.20718
   Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P614, DOI 10.1016/j.apjtm.2016.04.017
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 23
TC 20
Z9 20
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD NOV
PY 2016
VL 23
IS 6
AR taw059
DI 10.1093/jtm/taw059
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA EJ2UE
UT WOS:000393066100005
PM 27601533
OA Bronze
DA 2020-07-08
ER

PT J
AU Cosme-Blanco, W
   Arroyo-Flores, E
   Nazario, S
AF Cosme-Blanco, W.
   Arroyo-Flores, E.
   Nazario, S.
TI ZIKA VIRUS INFECTION AS A TRIGGER OF ATOPIC DERMATITIS
SO ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
LA English
DT Meeting Abstract
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1081-1206
EI 1534-4436
J9 ANN ALLERG ASTHMA IM
JI Ann. Allergy Asthma Immunol.
PD NOV
PY 2016
VL 117
IS 5
SU S
MA O062
BP S20
EP S20
PG 1
WC Allergy; Immunology
SC Allergy; Immunology
GA EI9FV
UT WOS:000392814200063
DA 2020-07-08
ER

PT J
AU Trevathan, E
AF Trevathan, Edwin
TI Brain Malformation Surveillance in the Zikra Era
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Editorial Material
ID CONGENITAL HEART-DEFECTS; DEVELOPMENTAL-DISABILITIES; CORTICAL
   DEVELOPMENT; BIRTH-DEFECTS; UNITED-STATES; VIRUS; PREVALENCE;
   POPULATION; INFECTION; AUTISM
AB The current surveillance systems for congenital microcephaly are necessary to monitor the impact of Zika virus (ZIKV) on the developing human brain, as well as the ZIKV prevention efforts. However, these congenital microcephaly surveillance systems are insufficient. Abnormalities of neuronal differentiation, development and migration may occur among infants with normal head circumference who have intrauterine exposure to ZIKV. Therefore, surveillance for congenital microcephaly does not ascertain many of the infants seriously impacted by congenital ZIKV infection. Furthermore, many infants with normal head circumference and with malformations of the brain cortex do not have clinical manifestations of their congenital malformations until several months to many years after birth, when they present with clinical manifestations such as seizures/epilepsy, developmental delays with or without developmental regression, and/or motor impairment. In response to the ZIKV threat, public health surveillance systems must be enhanced to ascertain a wide variety of congenital brain malformations, as well as their clinical manifestations that lead to diagnostic brain imaging. (C) 2016 The Authors Birth Defects Research Part A: Clinical and Molecular Teratology Published by Wiley Periodicals, Inc.
C1 [Trevathan, Edwin] Vanderbilt Univ, Sch Med, Div Pediat Neurol, Dept Pediat,Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.
   [Trevathan, Edwin] Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN 37232 USA.
RP Trevathan, E (corresponding author), Vanderbilt Univ, Sch Med, Div Pediat Neurol, Dept Pediat,Vanderbilt Inst Global Hlth, Nashville, TN 37212 USA.; Trevathan, E (corresponding author), Monroe Carell Jr Childrens Hosp Vanderbilt, Nashville, TN 37232 USA.
OI Trevathan, Edwin/0000-0003-2370-5970
FU NICHD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [U54 HD083211]
CR Agopian AJ, 2012, BIRTH DEFECTS RES A, V94, P141, DOI 10.1002/bdra.22883
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Braun KVN, 2008, AUTISM RES, V1, P266, DOI 10.1002/aur.41
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, GUID TRAV TEST PREGN
   CHI JG, 1977, ANN NEUROL, V1, P86, DOI 10.1002/ana.410010109
   Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6503a1
   Correa Adolfo, 2007, Birth Defects Res A Clin Mol Teratol, V79, P65
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DeBaun MR, 2014, NEW ENGL J MED, V371, P699, DOI 10.1056/NEJMoa1401731
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gaitanis JN, 2013, PEDIATR NEUROL, V49, P79, DOI 10.1016/j.pediatrneurol.2012.12.024
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilboa SM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.005
   Glenn OA, 2012, RADIOLOGY, V263, P843, DOI 10.1148/radiol.12102492
   Guerrini R, 2010, J CLIN NEUROPHYSIOL, V27, P372, DOI 10.1097/WNP.0b013e3181fe0585
   Gupta P, 2016, J PEDIATR NEUROSCI, V11, P7, DOI 10.4103/1817-1745.181261
   Hahn M. B., 2016, J MED ENTOMOL
   Hartman RJ, 2011, PEDIATR CARDIOL, V32, P1147, DOI 10.1007/s00246-011-0034-5
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mai CT, 2012, BIRTH DEFECTS RES A, V94, P970, DOI 10.1002/bdra.23098
   Malik S, 2008, PEDIATRICS, V121, pE810, DOI 10.1542/peds.2007-1519
   Marelli AJ, 2014, CIRCULATION, V130, P749, DOI 10.1161/CIRCULATIONAHA.113.008396
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P1
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Soares de Oliveira-Szejnfeld P, 2016, RADIOLOGY, V281, P1
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   White AL, 2014, PEDIATR NEUROL, V50, P218, DOI 10.1016/j.pediatrneurol.2013.11.005
   Yeargin-Allsopp M, 2003, JAMA-J AM MED ASSOC, V289, P49, DOI 10.1001/jama.289.1.49
   YEARGINALLSOPP M, 1992, PEDIATRICS, V89, P624
NR 43
TC 5
Z9 5
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD NOV
PY 2016
VL 106
IS 11
SI SI
BP 869
EP 874
DI 10.1002/bdra.23582
PG 6
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EI9HC
UT WOS:000392817500002
PM 27891785
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cragan, JD
   Isenburg, JL
   Parker, SE
   Alverson, CJ
   Meyer, RE
   Stallings, EB
   Kirby, RS
   Lupo, PJ
   Liu, JS
   Seagroves, A
   Ethen, MK
   Cho, SJ
   Evans, M
   Liberman, RF
   Fornoff, J
   Browne, ML
   Rutkowski, RE
   Nance, AE
   Anderka, M
   Fox, DJ
   Steele, A
   Copeland, G
   Romitti, PA
   Mai, CT
AF Cragan, Janet D.
   Isenburg, Jennifer L.
   Parker, Samantha E.
   Alverson, C. J.
   Meyer, Robert E.
   Stallings, Erin B.
   Kirby, Russell S.
   Lupo, Philip J.
   Liu, Jennifer S.
   Seagroves, Amanda
   Ethen, Mary K.
   Cho, Sook Ja
   Evans, MaryAnn
   Liberman, Rebecca F.
   Fornoff, Jane
   Browne, Marilyn L.
   Rutkowski, Rachel E.
   Nance, Amy E.
   Anderka, Marlene
   Fox, Deborah J.
   Steele, Amy
   Copeland, Glenn
   Romitti, Paul A.
   Mai, Cara T.
CA Natl Birth Defects Prevention
TI Population-Based Microcephaly Surveillance in the United States, 2009 to
   2013: An Analysis of Potential Sources of Variation
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Article
DE microcephaly; surveillance; prevalence; head circumference
ID BIRTH-DEFECTS DATA; HEAD CIRCUMFERENCE; PREVALENCE; STANDARDS; PROGRAMS
AB Background: Congenital microcephaly has been linked to maternal Zika virus infection. However, ascertaining infants diagnosed with microcephaly can be challenging. Methods: Thirty birth defects surveillance programs provided data on infants diagnosed with microcephaly born 2009 to 2013. The pooled prevalence of microcephaly per 10,000 live births was estimated overall and by maternal/infant characteristics. Variation in prevalence was examined across case finding methods. Nine programs provided data on head circumference and conditions potentially contributing to microcephaly. Results: The pooled prevalence of microcephaly was 8.7 per 10,000 live births. Median prevalence (per 10,000 live births) was similar among programs using active (6.7) and passive (6.6) methods; the interdecile range of prevalence estimates was wider among programs using passive methods for all race/ethnicity categories except Hispanic. Prevalence (per 10,000 live births) was lowest among non-Hispanic Whites (6.5) and highest among nonHispanic Blacks and Hispanics (11.2 and 11.9, respectively); estimates followed a U-shaped distribution by maternal age with the highest prevalence among mothers <20 years (11.5) and > 40 years (13.2). For gestational age and birth weight, the highest prevalence was among infants <32 weeks gestation and infants <1500 gm. Case definitions varied; 41.8% of cases had an HC > the 1 0 t h percentile for sex and gestational age. Conclusion: Differences in methods, population distribution of maternal/infant characteristics, and case definitions for microcephaly can contribute to the wide range of observed prevalence estimates across individual birth defects surveillance programs. Addressing these factors in the setting of Zika virus infection can improve the quality of prevalence estimates. (C) 2016 Wiley Periodicals, Inc.
C1 [Cragan, Janet D.; Isenburg, Jennifer L.; Alverson, C. J.; Stallings, Erin B.; Liu, Jennifer S.; Seagroves, Amanda; Mai, Cara T.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Isenburg, Jennifer L.; Stallings, Erin B.; Seagroves, Amanda] Carter Consulting Inc, Atlanta, GA USA.
   [Parker, Samantha E.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Meyer, Robert E.] NC Div Publ Hlth, State Ctr Hlth Stat, Raleigh, NC USA.
   [Kirby, Russell S.; Rutkowski, Rachel E.] Univ S Florida, Dept Community & Family Hlth, Coll Publ Hlth, Tampa, FL USA.
   [Lupo, Philip J.] Baylor Coll Med, Dept Pediat, Sect Hematol Oncol, Houston, TX 77030 USA.
   [Liu, Jennifer S.] Leidos Holdings Inc, Reston, VA USA.
   [Ethen, Mary K.] Texas Dept State Hlth Serv, Birth Defects Epidemiol & Surveillance Branch, Austin, TX USA.
   [Cho, Sook Ja] Minnesota Dept Hlth, Div Community & Family Hlth, St Paul, MN USA.
   [Evans, MaryAnn] Oregon Publ Hlth Div, Oregon Birth Anomalies Surveillance Syst, Portland, OR USA.
   [Liberman, Rebecca F.] Massachusetts Dept Publ Hlth, Ctr Birth Defects Res & Prevent, Boston, MA USA.
   [Fornoff, Jane] Illinois Dept Publ Hlth, Div Epidemiol Studies, Springfield, IL 62761 USA.
   [Browne, Marilyn L.; Fox, Deborah J.] New York State Dept Hlth, Albany, NY USA.
   [Nance, Amy E.; Steele, Amy] Utah Dept Hlth, Utah Birth Defect Network, Div Family Hlth & Preparedness, Salt Lake City, UT 84116 USA.
   [Anderka, Marlene] Natl Birth Defects Prevent Network, Houston, TX USA.
   [Copeland, Glenn] Michigan Dept Hlth & Human Serv, Div Vital Records & Hlth Stat, Lansing, MI USA.
   [Romitti, Paul A.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA.
RP Cragan, JD (corresponding author), Ctr Dis Control & Prevent, MS E86,1600 Clifton Rd NE, Atlanta, GA 30329 USA.
EM jcragan@cdc.gov
RI Lupo, Philip/R-8314-2019; Kirby, Russell/E-8113-2018
OI Lupo, Philip/0000-0003-0978-5863; Kirby, Russell/0000-0002-3489-401X;
   Parker, Samantha/0000-0002-7193-077X
FU NCBDD CDC HHS [U01 DD001035]; Intramural CDC HHS [CC999999]
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Baxter PS, 2009, PEDIATRICS, V124, P590, DOI 10.1542/peds.2008-2784
   BRAY PF, 1969, J PEDIATR, V75, P303, DOI 10.1016/S0022-3476(69)80404-X
   Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.1093/biomet/26.4.404
   COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9
   Holden KR, 2014, DEV MED CHILD NEUROL, V56, P705, DOI 10.1111/dmcn.12449
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Mai CT, 2015, BIRTH DEFECTS RES A, V103, P972, DOI 10.1002/bdra.23461
   Mai CT, 2014, BIRTH DEFECTS RES A, V100, P895, DOI 10.1002/bdra.23329
   Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198
   Mason CA, 2005, BIRTH DEFECTS RES A, V73, P690, DOI 10.1002/bdra.20211
   OPITZ JM, 1990, J CRAN GENET DEV BIO, V10, P175
   Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RAYMOND GV, 1994, J CHILD NEUROL, V9, P63, DOI 10.1177/088307389400900116
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Steele A, 2016, BIRTH DEF A IN PRESS
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
NR 18
TC 25
Z9 26
U1 0
U2 4
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD NOV
PY 2016
VL 106
IS 11
SI SI
BP 972
EP 982
DI 10.1002/bdra.23587
PG 11
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EI9HC
UT WOS:000392817500014
PM 27891783
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Steele, A
   Johnson, J
   Nance, A
   Satterfield, R
   Alverson, CJ
   Mai, C
AF Steele, Amy
   Johnson, Jane
   Nance, Amy
   Satterfield, Robert
   Alverson, C. J.
   Mai, Cara
TI A Quality Assessment of Reporting Sources for Microcephaly in Utah, 2003
   to 2013
SO BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
LA English
DT Article
DE microcephaly; quality assessment; birth defects; Utah; hospital
   discharge data; reporting
ID BIRTH-DEFECTS SURVEILLANCE; CERTIFICATE; INFANT; BIAS
AB Background: Obtaining accurate microcephaly prevalence is important given the recent association between microcephaly and Zika virus. Assessing the quality of data sources can guide surveillance programs as they focus their data collection efforts. The Utah Birth Defect Network (UBDN) has monitored microcephaly by data sources since 2003. The objective of this study was to examine the impact of reporting sources for microcephaly surveillance. Methods: All reported cases of microcephaly among Utah mothers from 2003 to 2013 were clinically reviewed and confirmed. The UBDN database was linked to state vital records and hospital discharge data for analysis. Reporting sources were analyzed for positive predictive value and sensitivity. Results: Of the 477 reported cases of microcephaly, 251 (52.6%) were confirmed as true cases. The UBDN identified 94 additional cases that were reported to the surveillance system as another birth defect, but were ultimately determined to be true microcephaly cases. The prevalence for microcephaly based on the UBDN medical record abstraction and clinical review was 8.2 per 10,000 live births. Data sources varied in the number and accuracy of reporting, but a case was more likely to be a true case if identified from multiple sources than from a single source. Conclusion: While some reporting sources are more likely to identify possible and true microcephaly cases, maintaining a multiple source methodology allows for more complete case ascertainment. Surveillance programs should conduct periodic assessments of data sources to ensure their systems are capturing all possible birth defects cases. (C) 2016 Wiley Periodicals, Inc.
C1 [Steele, Amy; Satterfield, Robert] Utah Dept Hlth, Data Resources Program, Bur Maternal Child Hlth, Div Family Hlth & Preparedness, Salt Lake City, UT 84116 USA.
   [Johnson, Jane; Nance, Amy] Utah Dept Hlth, Utah Birth Defect Network, Bur Children Special Hlth Care Needs, Div Family Hlth & Preparedness, Salt Lake City, UT 84116 USA.
   [Alverson, C. J.; Mai, Cara] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
RP Steele, A (corresponding author), Utah Dept Hlth, 44 Med Dr, Salt Lake City, UT 84113 USA.
EM amysteele@utah.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA [1
   NU50DD004948-01-00]; Health Resources and Services Administration (HRSA)
   of the U.S. Department of Health and Human Services (HHS) [B04MC25374]
FX Supported in-part by a cooperative agreement (1 NU50DD004948-01-00)
   through the Centers for Disease Control and Prevention. The Utah Birth
   Defect Network is supported by the Health Resources and Services
   Administration (HRSA) of the U.S. Department of Health and Human
   Services (HHS) under grant number B04MC25374.
CR Boulet SL, 2011, PUBLIC HEALTH REP, V126, P186, DOI 10.1177/003335491112600209
   CALLIFDALEY FA, 1995, PUBLIC HEALTH REP, V110, P154
   Correa-Villasenor A, 2003, BIRTH DEFECTS RES A, V67, P610, DOI 10.1002/bdra.10110
   Feldkamp M, 2005, BIRTH DEFECTS RES A, V73, P693, DOI 10.1002/bdra.20212
   HEXTER AC, 1991, TERATOLOGY, V44, P177, DOI 10.1002/tera.1420440205
   Li J, 2013, BIRTH DEFECTS RES A, V97, P140, DOI 10.1002/bdra.23119
   Mai CT, 2015, PUBLIC HEALTH REP, V130, P722, DOI 10.1177/003335491513000621
   Tanner JP, 2010, BIRTH DEFECTS RES A, V88, P1017, DOI 10.1002/bdra.20718
   Watkins ML, 1996, AM J PUBLIC HEALTH, V86, P731, DOI 10.2105/AJPH.86.5.731
NR 9
TC 1
Z9 2
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1542-0752
EI 1542-0760
J9 BIRTH DEFECTS RES A
JI Birth Defects Res. Part A-Clin. Mol. Teratol.
PD NOV
PY 2016
VL 106
IS 11
SI SI
BP 983
EP 988
DI 10.1002/bdra.23593
PG 6
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA EI9HC
UT WOS:000392817500015
PM 27891786
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Rasic, G
   Filipovic, I
   Callahan, AG
   Stanford, D
   Chan, A
   Lam-Phua, SG
   Tan, CH
   Hoffmann, AA
AF Rasic, Gordana
   Filipovic, Igor
   Callahan, Ashley G.
   Stanford, Darren
   Chan, Abigail
   Lam-Phua, Sai Gek
   Tan, Cheong Huat
   Hoffmann, Ary Anthony
TI The queenslandensis and the type Form of the Dengue Fever Mosquito
   (Aedes aegypti L.) Are Genomically Indistinguishable
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WOLBACHIA INFECTION; GENETIC-STRUCTURE; COMPUTER-PROGRAM; MITOCHONDRIAL;
   VECTOR; SEQUENCES; PATTERNS; GENOMES; STRAIN
AB Background
   The mosquito Aedes aegypti (L.) is a major vector of viral diseases like dengue fever, Zika and chikungunya. Aedes aegypti exhibits high morphological and behavioral variation, some of which is thought to be of epidemiological significance. Globally distributed domestic Ae. aegypti have often been grouped into (i) the very pale variety queenslandensis and (ii) the type form. Because the two color forms co-occur across most of their range, there is interest in understanding how freely they interbreed. This knowledge is particularly important for control strategies that rely on mating compatibilities between the release and target mosquitoes, such as Wolbachia releases and SIT. To address this question, we analyzed nuclear and mitochondrial genome-wide variation in the co-occurring pale and type Ae. aegypti from northern Queensland (Australia) and Singapore.
   Methods/Findings
   We typed 74 individuals at a 1170 bp-long mitochondrial sequence and at 16,569 nuclear SNPs using a customized double-digest RAD sequencing. 11/29 genotyped individuals from Singapore and 11/45 from Queensland were identified as var. queenslandensis based on the diagnostic scaling patterns. We found 24 different mitochondrial haplotypes, seven of which were shared between the two forms. Multivariate genetic clustering based on nuclear SNPs corresponded to individuals' geographic location, not their color. Several family groups consisted of both forms and three queenslandensis individuals were Wolbachia infected, indicating previous breeding with the type form which has been used to introduce Wolbachia into Ae. aegypti populations.
   Conclusion
   Aedes aegypti queenslandensis are genomically indistinguishable from the type form, which points to these forms freely interbreeding at least in Australia and Singapore. Based on our findings, it is unlikely that the presence of very pale Ae. aegypti will affect the success of Aedes control programs based on Wolbachia-infected, sterile or RIDL mosquitoes.
C1 [Rasic, Gordana; Filipovic, Igor; Callahan, Ashley G.; Hoffmann, Ary Anthony] Univ Melbourne, Sch BioSci, Pest & Environm Adaptat Res Grp, Inst Bio21, Parkville, Vic, Australia.
   [Stanford, Darren] Monash Univ, Inst Vector Borne Dis, Clayton, Vic, Australia.
   [Chan, Abigail; Lam-Phua, Sai Gek; Tan, Cheong Huat] Natl Environm Agcy, Environm Hlth Inst, Environm Bldg, Singapore, Singapore.
RP Rasic, G (corresponding author), Univ Melbourne, Sch BioSci, Pest & Environm Adaptat Res Grp, Inst Bio21, Parkville, Vic, Australia.
EM rasic.gordana@gmail.com
RI Hoffmann, Ary/R-2972-2019; Rasic, Gordana/AAO-4360-2020
OI Hoffmann, Ary/0000-0001-9497-7645; Rasic, Gordana/0000-0002-3057-0093
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia; National Environment Agency, Singapore
FX This work is funded by the National Health and Medical Research Council
   and the National Environment Agency, Singapore. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354
   Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271
   Chan A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0569-4
   Chan M, 2016, LANCET, V387, P2165, DOI 10.1016/S0140-6736(16)30620-1
   Fansiri T, 2016, BIORXIV, DOI [10.1101/2003/01/01, DOI 10.1101/2003/01/01]
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hardy CM, 2016, MITOCHONDRIAL DNA A, V27, P2552, DOI 10.3109/19401736.2015.1038800
   Hardy CM, 2016, MITOCHONDRIAL DNA A, V27, P2024, DOI 10.3109/19401736.2014.974171
   Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x
   HILL. G. F., 1921, Annals of Tropical Medicine and Parasitology, V15, P91
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Howard L. O., 1912, MOSQUITOES N CENTRAL
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kress W John, 2012, Methods Mol Biol, V858, P3, DOI 10.1007/978-1-61779-591-6_1
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   Mayr E., 1963, ANIMAL SPECIES EVOLU
   MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x
   Moore M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002175
   Mori A, 2016, J HERED, V107, P438, DOI 10.1093/jhered/esw027
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Rasic G, 2015, EVOL APPL, V8, P901, DOI 10.1111/eva.12301
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446
   Tsuda Y, 2003, JPN SOC MED ENTOMOL, V54, P73, DOI DOI 10.7601/MEZ.54.73
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wasinpiyamongkol Ladawan, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 2, P131
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
NR 42
TC 4
Z9 4
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2016
VL 10
IS 11
AR e0005096
DI 10.1371/journal.pntd.0005096
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0HR
UT WOS:000392154400026
PM 27806047
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhou, PC
   Wang, J
   Zheng, YX
   Zhou, RR
   Fan, XG
AF Zhou, Pengcheng
   Wang, Juan
   Zheng, Yixiang
   Zhou, Rongrong
   Fan, Xue-Gong
TI Zika Virus May Affect the Universal Two-Child Policy: A New Challenge
   for China
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
C1 [Zhou, Pengcheng; Wang, Juan; Zheng, Yixiang; Zhou, Rongrong; Fan, Xue-Gong] Cent S Univ, Xiangya Hosp, Dept Infect Dis, Key Lab Viral Hepatitis Hunan Prov, Changsha, Hunan, Peoples R China.
RP Zhou, RR; Fan, XG (corresponding author), Cent S Univ, Xiangya Hosp, Dept Infect Dis, Key Lab Viral Hepatitis Hunan Prov, Changsha, Hunan, Peoples R China.
EM rr_xy1234@126.com; xgfan@hotmail.com
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bureau of Exit and Entry Administration of the Ministry of public security China, STAT DAT EX ENTR POP
   CDC, ZIK VIR TRANSM RISKS
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Health and Family Planning Commission of Guangdong Province, NEW IMP ZIK VIR INF
   Lai S, 2015, BMC MED, V13, P100, DOI DOI 10.1186/S12916-015-0336-1
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   National Health and Family Planning Commission of PRC, NAT SCHEM PREV CONTR
   National Health and Family Planning Commission of PRC, DIAGN TREATM PROT ZI
   The Central Committee of the Communist Party of China, B 5 PLEN SESS 18 CPC
   WHO, TECHN GUID ZIK VIR
   World Health Organization, 2016, ZIK SIT REP
NR 13
TC 1
Z9 3
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD NOV
PY 2016
VL 10
IS 11
AR e0004984
DI 10.1371/journal.pntd.0004984
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EI0HR
UT WOS:000392154400009
PM 27832058
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Custodio, KM
   de Oliveira, JG
   Moterle, D
   Zepon, KM
   Prophiro, JS
   Kanis, LA
AF Custodio, Kaue Muller
   de Oliveira, Joice Guilherme
   Moterle, Diego
   Zepon, Karine Modolon
   Prophiro, Josiane Somariva
   Kanis, Luiz Alberto
TI A biodegradable device for the controlled release of Piper nigrum
   (Piperaceae) standardized extract to control Aedes aegypti (Diptera,
   Culicidae) larvae
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Aedes aegypti; Larvicide; Controlled release; Piperine; Residual
   activity
ID INSECTICIDAL ACTIVITY; LARVICIDAL ACTIVITY; L. DIPTERA; DENGUE;
   RESISTANCE; ALBOPICTUS; STABILITY; TEMEPHOS; MALARIA; FRUITS
AB Introduction: The significant increase in dengue, Zika, and chikungunya and the resistance of the Aedes aegypti mosquito to major insecticides emphasize the importance of studying alternatives to control this vector. The aim of this study was to develop a controlled-release device containing Piper nigrum extract and to study its larvicidal activity against Aedes aegypti. Methods: Piper nigrum extract was produced by maceration, standardized in piperine, and incorporated into cotton threads, which were inserted into hydrogel cylinders manufactured by the extrusion of carrageenan and carob. The piperine content of the extract and thread reservoirs was quantified by chromatography. The release profile from the device was assessed in aqueous medium and the larvicidal and residual activities of the standardized extract as well as of the controlled-release device were examined in Aedes aegypti larvae. Results: The standardized extract contained 580mg/g of piperine and an LC50 value of 5.35ppm (24h) and the 3 cm thread reservoirs contained 13.83 +/- 1.81mg of piperine. The device showed zero-order release of piperine for 16 days. The P. nigrum extract (25ppm) showed maximum residual larvicidal activity for 10 days, decreasing progressively thereafter. The device had a residual larvicidal activity for up to 37 days. Conclusions: The device provided controlled release of Piper nigrum extract with residual activity for 37 days. The device is easy to manufacture and may represent an effective alternative for the control of Aedes aegypti larvae in small water containers.
C1 [Custodio, Kaue Muller; Moterle, Diego; Zepon, Karine Modolon; Kanis, Luiz Alberto] Univ Sul Santa Catarina, Programa Pos Grad Ciencias Saude, Grp Pesquisa Tecnol Farmaceut, Tubarao, SC, Brazil.
   [de Oliveira, Joice Guilherme; Prophiro, Josiane Somariva] Univ Sul Santa Catarina, Programa Pos Grad Ciencias Saude, Grp Pesquisa Imunoparasitol, Tubarao, SC, Brazil.
RP Kanis, LA (corresponding author), Univ Sul Santa Catarina, Programa Pos Grad Ciencias Saude, Grp Pesquisa Tecnol Farmaceut, Tubarao, SC, Brazil.
EM luizalbertokanis@gmail.com
RI ZEPON, KARINE MODOLON/P-1832-2016; Prophiro, Josiane
   Somariva/J-7086-2014
OI MODOLON ZEPON, KARINE/0000-0002-4209-9374
FU Brazilian National Council for Scientific and Technological Development
   [Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)]National Council for Scientific and Technological Development
   (CNPq); Institutional Scientific Initiation Scholarship Program
   [Programa Institucional de Bolsas de Iniciacao Cientifica (PIBIC)];
   University of Southern Santa Catarina [Universidade do Sul de Santa
   Catarina (UNISUL)]; Innovation and Entrepreneurship Agency of Unisul
   [(Agencia de Gestao, desenvolvimento cientifico, tecnologia e inovacao
   da Unisul (AGETEC)]
FX This study was financially supported by grants from the Brazilian
   National Council for Scientific and Technological Development [Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)], the
   Institutional Scientific Initiation Scholarship Program [Programa
   Institucional de Bolsas de Iniciacao Cientifica (PIBIC)], and the
   University of Southern Santa Catarina [Universidade do Sul de Santa
   Catarina (UNISUL)], Innovation and Entrepreneurship Agency of Unisul
   [(Agencia de Gestao, desenvolvimento cientifico, tecnologia e inovacao
   da Unisul (AGETEC)].
CR Badawy M.E., 2015, INT J MOSQ RES A, V2, P45
   Benelli G, 2014, PHARM ON LINE, V1, P44
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Chaithong U, 2006, J VECTOR ECOL, V31, P138, DOI 10.3376/1081-1710(2006)31[138:LEOPPO]2.0.CO;2
   de Morals SM, 2007, BIOCHEM SYST ECOL, V35, P670, DOI 10.1016/j.bse.2007.05.002
   George DR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-28
   Gulzar T, 2013, PHYTOCHEM LETT, V6, P219, DOI 10.1016/j.phytol.2013.01.006
   Hermann LL, 2015, J CLIN VIROL, V64, P153, DOI 10.1016/j.jcv.2014.08.031
   Jarvis AP, 1998, PESTIC SCI, V53, P217, DOI 10.1002/(SICI)1096-9063(199807)53:3&lt;217::AID-PS766&gt;3.0.CO;2-9
   Kanis LA, 2013, IND CROP PROD, V50, P816, DOI 10.1016/j.indcrop.2013.08.034
   Karunaratne SHPP, 2013, PESTIC BIOCHEM PHYS, V107, P98, DOI 10.1016/j.pestbp.2013.05.011
   Kotte SCB, 2014, ANAL METHODS-UK, V6, P8022, DOI [10.1039/c4ay01088d, 10.1039/C4AY01088D]
   Kuhne S, 2008, AGRONOMSKI GLASNIK, V4, P377
   Li L, 2014, CARBOHYD POLYM, V103, P1, DOI 10.1016/j.carbpol.2013.12.008
   Lija-Escaline J, 2015, PARASITOL RES, V114, P4239, DOI 10.1007/s00436-015-4662-1
   Lima EP, 2006, REV SOC BRAS MED TRO, V39, P259, DOI 10.1590/S0037-86822006000300006
   LIN SY, 1995, J CONTROL RELEASE, V33, P375, DOI 10.1016/0168-3659(94)00109-8
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mohan Rajeswary, 2014, Asian Pacific Journal of Tropical Disease, V4, pS449
   Nath DR, 2006, DEFENCE SCI J, V56, P507, DOI 10.14429/dsj.56.1916
   Park IK, 2002, J AGR FOOD CHEM, V50, P1866, DOI 10.1021/jf011457a
   Park IK, 2012, NAT PROD RES, V26, P2129, DOI 10.1080/14786419.2011.628178
   Patil S. G., 2015, WORLD J PHARM RES, V4, P324
   Prajapati VD, 2014, CARBOHYD POLYM, V105, P97, DOI 10.1016/j.carbpol.2014.01.067
   Prophiro JS, 2012, PARASITOL RES, V110, P713, DOI 10.1007/s00436-011-2547-5
   Prophiro JS, 2011, REV SOC BRAS MED TRO, V44, P300, DOI [10.1590/s0037-86822011005000025, 10.1590/S0037-86822011005000025]
   Rajani Chauhan, 2008, International Journal of Chemical Sciences, V6, P1726
   Campos EVR, 2015, AGRON SUSTAIN DEV, V35, P47, DOI 10.1007/s13593-014-0263-0
   Reegan AD, 2014, ACTA TROP, V139, P67, DOI 10.1016/j.actatropica.2014.07.002
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   da Silva MFR, 2016, EXP PARASITOL, V165, P64, DOI 10.1016/j.exppara.2016.03.017
   Roy A, 2014, CENT EUR J CHEM, V12, P453, DOI 10.2478/s11532-013-0405-2
   Saleh MS, 2013, AFR ENTOMOL, V21, P349
   Samuel M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1521-6
   Santana AI, 2016, PLANTA MED, V82, P986, DOI 10.1055/s-0042-108060
   Santiago VS, 2015, NAT PROD RES, V29, P441, DOI 10.1080/14786419.2014.947490
   Scott Ian M., 2008, Phytochemistry Reviews, V7, P65, DOI 10.1007/s11101-006-9058-5
   Siddiqui BS, 2004, NAT PROD RES, V18, P473, DOI 10.1080/14786410310001608028
   Simas NK, 2007, REV SOC BRAS MED TRO, V40, P405, DOI 10.1590/S0037-86822007000400006
   Singh A, 2008, ASIAN J CHEM, V20, P6007
   Pontes RJS, 2010, MEM I OSWALDO CRUZ, V105, P220, DOI 10.1590/S0074-02762010000200019
   Vasudevan K, 2009, J VECTOR DIS, V46, P153
   (WHO). World Health Organization, 2009, DENG GUID DIAGN TREA, P147
   Wood A., 1988, FLAVOUR FRAG J, V3, P55
   World Health Organization, 1981, WHOVBC81807
NR 45
TC 4
Z9 4
U1 0
U2 7
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD NOV-DEC
PY 2016
VL 49
IS 6
BP 687
EP 692
DI 10.1590/0037-8682-0340-2016
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EH4CU
UT WOS:000391719400004
PM 28001214
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wiwanitki, V
AF Wiwanitki, Viroj
TI Congenital Zika virus syndrome
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Letter
C1 [Wiwanitki, Viroj] Surin Rajabhat Univ, Surin, Thailand.
RP Wiwanitki, V (corresponding author), Surin Rajabhat Univ, Surin, Thailand.
EM wviroj@yahoo.com
CR Eickmann SH, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00047716
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
NR 3
TC 0
Z9 0
U1 0
U2 0
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD NOV
PY 2016
VL 32
IS 11
AR e00133116
DI 10.1590/0102-311X00133115
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EH0EU
UT WOS:000391436500013
PM 27982288
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Rao, GE
   Pallavi, K
   Nithya, PD
   Madhavi, BR
AF Rao, Eswara G.
   Pallavi, K.
   Nithya, Durga P.
   Madhavi, Radha B.
TI ZIKA VIRUS - A REVIEW ON PAST, PRESENT AND FUTURE SCENARIO
SO INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
LA English
DT Review
DE Zika virus; mosquito bite; diagnosis; treatment; vaccine; prevention
ID TRANSMISSION; OUTBREAK; STATES
AB Zika virus is transmitted to people through aedes mosquito bites. People with Zika virus disease usually have symptoms of mild fever, exanthema (skin rash), joint pain and conjunctivitis that normally last for 2-7 days. There is no specific treatment or vaccine currently available. The best form of prevention is protection against mosquito bites. The virus is known to circulate in Africa, the Americas, Asia and the Pacific. The present paper deals with various modes of transmission, symptoms, diagnosis and preventive measures. A brief discussion about the role of various departments for control and prevention of zika virus. The available means for treatment of zika virus were also indicated.
C1 [Rao, Eswara G.; Pallavi, K.; Nithya, Durga P.] Vignan Pharm Coll, Guntur 522213, Andhra Pradesh, India.
   [Madhavi, Radha B.] Acharya Nagarjuna Univ, Guntur 522510, Andhra Pradesh, India.
RP Rao, GE (corresponding author), Vignan Pharm Coll, Guntur 522213, Andhra Pradesh, India.
EM eswararaogondu@gmail.com
CR [Anonymous], 2016, CLIN EV DIS
   [Anonymous], 2016, CDC ZIK TRANSM
   [Anonymous], 2016, INDIAS BIOTECH MOMEN
   [Anonymous], 2012, DENG AED AEG MOSQ PD
   [Anonymous], 2016, ZIK VIR TRANSM RISKS
   [Anonymous], 2016, AED AEG HLTH TOP VEC
   [Anonymous], 2016, SYMPT DIAGN TREATM Z
   Antoine Enfissi, 2014, LANCET, P387
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bagla Pallava, 2016, BHARAT BIOTECH MADE
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2016, CASE CONTROL STUDY
   CDC, 2016, CDC CONCL ZIK CAUS M
   Chang Kuno G, 2016, ARCH VIROL, V152, P687
   Chung KW, 2016, DECLINING BLOOD COLL
   Cook, 2016, BBC NEWS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Food and Drug Administration, 2016, FDA ALL US INV TEST
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hayes Edward B, 2015, EMERG INFECT DIS, V15, P1347
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Knipe David M, 2007, FIELDS VIROLOGY, P1156
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti Robert S, 2016, EMERG INFECT DIS, V22, P5
   Lanciotti Robert S, 2015, EMERG INFECT DIS, P22
   Malone Robert W, 2016, PLOS NEGLECTED TROPI, V10
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Microcephaly Zika Virus, 2016, ZIK VIR MICR GUILL B
   Mitchell, 2016, ZIKA VIRUS SPREADS P
   Mitchell, 2016, PAHO STATEMENT ZIKA
   Molone, 2016, FACTBOX ZIKA VIRUS S
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oumar Faye, 2014, PLOS NEGLECTED TROPI, V8
   Rasmussen Sonja A., 2016, NEW ENGLAND J MED
   Reporter M. O., 2016, UK EXPERTS TEST VACC
   Reuters, 2016, BRAZ REP ZIK INF BLO
   Sarah Craig, 2016, MOSQUITOES CAPABLE C
   Siddiq, 2016, BHARAT BIOTECH SAYS
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sternberg, 2016, US NEWS WORLD REPORT
   Thomas DL, 2015, LOCAL TRANSMISSION
   US Department of Health and Human Services, 2016, HHS SHIPS BLOOD PROD
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization, 2016, WHO EXP PRIOR VACC D
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 52
TC 0
Z9 0
U1 0
U2 8
PU INT JOURNAL PHARMACEUTICAL SCIENCES & RESEARCH
PI HARYANA
PA 1117, SECTOR 12 A, PANCHKULA, HARYANA, 00000, INDIA
SN 0975-8232
J9 INT J PHARM SCI RES
JI Int. J. Pharm.l Sci. Res.
PD NOV
PY 2016
VL 7
IS 11
BP 4374
EP 4378
DI 10.13040/IJPSR.0975-8232.7(11).4374-78
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EG6ZJ
UT WOS:000391194500008
OA Other Gold
DA 2020-07-08
ER

PT J
AU Mossad, SB
AF Mossad, Sherif Beniameen
TI Influenza: Still more important than Zika virus in 2016-2017
SO CLEVELAND CLINIC JOURNAL OF MEDICINE
LA English
DT Review
ID LABORATORY-CONFIRMED INFLUENZA; PREGNANT-WOMEN; VACCINATION;
   ASSOCIATION; COHORT
AB Influenza kills and hospitalizes many people every year. Although the 2015-2016 influenza season was relatively mild, we should remain vigilant in our efforts to reduce the impact of future epidemics or pandemics by implementing universal influenza vaccination and early initiation of antiviral therapy for suspected cases. We don't expect influenza vaccine to prevent all cases of influenza, since immune response varies depending on age, underlying diseases, and immunosuppression.
C1 [Mossad, Sherif Beniameen] Cleveland Clin, Inst Med, Dept Infect Dis, Cleveland, OH 44106 USA.
   [Mossad, Sherif Beniameen] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Med, Cleveland, OH 44106 USA.
RP Mossad, SB (corresponding author), Cleveland Clin, Dept Infect Dis, G21,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM mossads@ccf.org
FU GlaxoSmithKlineGlaxoSmithKline; Oxford Immunotec
FX Dr. Mossad is the site principal investigator for multicenter studies
   funded by GlaxoSmithKline and Oxford Immunotec.
CR [Anonymous], 2016, HELIO CARDIOLOG 0525
   Baxter R, 2013, CLIN INFECT DIS, V57, P197, DOI 10.1093/cid/cit222
   Chen QX, 2015, J INFECT DIS, V211, P1045, DOI 10.1093/infdis/jiu578
   Davlin SL, 2016, MMWR-MORBID MORTAL W, V65, P567, DOI 10.15585/mmwr.mm6522a3
   Fuchs EL, 2016, PREV MED, V88, P8, DOI 10.1016/j.ypmed.2016.03.012
   Goodman K, 2015, J REPROD MED, V60, P471
   Grijalva CG, 2015, JAMA-J AM MED ASSOC, V314, P1488, DOI 10.1001/jama.2015.12160
   Havers FP, 2016, CLIN INFECT DIS
   Kashiwagi S, 2016, CLIN INFECT DIS, V63, P330, DOI 10.1093/cid/ciw255
   Kumar D, 2017, AM J TRANSPLANT, V17, P281, DOI 10.1111/ajt.13960
   Loeb M, 2016, ANN INTERN MED, V165, P617, DOI 10.7326/M16-0513
   MOSTOW S R, 1975, Cleveland Clinic Quarterly, V42, P63
   Oboho IK, 2016, J INFECT DIS, V214, P507, DOI 10.1093/infdis/jiw033
   Olsen SJ, 2016, CLIN INFECT DIS, V63, P487, DOI 10.1093/cid/ciw290
   Reber AJ, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv052
   Regan AK, 2016, CLIN INFECT DIS, V62, P1221, DOI 10.1093/cid/ciw082
   Russell ES, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw113
   Sasaki A, 2009, EMERG INFECT DIS, V15, P1841, DOI 10.3201/eid1511.090798
   Siegers JY, 2016, J INFECT DIS, V214, P516, DOI 10.1093/infdis/jiw123
   Tartof SY, 2016, ANN INTERN MED, V213, P1876
   Wright PF, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw108
   Zhong WM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw102
   Zurli V, 2016, J INFECT DIS, V213, P1876, DOI 10.1093/infdis/jiw048
NR 23
TC 2
Z9 2
U1 0
U2 6
PU CLEVELAND CLINIC
PI CLEVELAND
PA 9500 EUCLID AVE, CLEVELAND, OH 44106 USA
SN 0891-1150
EI 1939-2869
J9 CLEV CLIN J MED
JI Clevel. Clin. J. Med.
PD NOV
PY 2016
VL 83
IS 11
BP 836
EP 840
DI 10.3949/ccjm.83a.16105
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG3EG
UT WOS:000390926000011
PM 27824536
DA 2020-07-08
ER

PT J
AU Largent, EA
AF Largent, Emily A.
TI EBOLA and FDA: reviewing the response to the 2014 outbreak, to find
   lessons for the future
SO JOURNAL OF LAW AND THE BIOSCIENCES
LA English
DT Review
DE Ebola; ethics; food and drug law; public health
ID RESEARCH-AND-DEVELOPMENT; CLINICAL-RESEARCH; VIRUS DISEASE;
   ETHICAL-ISSUES; OFF-LABEL; DEVELOPING-COUNTRIES; NEGLECTED DISEASES;
   HEMORRHAGIC FEVERS; EXPERIMENTAL DRUGS; COMPASSIONATE USE
AB In 2014, West Africa confronted the most severe outbreak of Ebola virus disease (EVD) in history. At the onset of the outbreak-as now-there were no therapies approved by the U.S. Food and Drug Administration (FDA) for prevention of, post-exposure prophylaxis against, or treatment of EVD. As a result, the outbreak spurred interest in developing novel treatments, sparked calls to use experimental interventions in the field, and highlighted challenges to the standard approach to FDA approval of new drugs. Although the outbreak was geographically centered in West Africa, it show cased FDA's global role in drug development, approval, and access. FDA's response to EVD highlights the panoply of agency powers and demonstrates the flexibility of FDA's regulatory framework. This paper evaluates the strengths and weaknesses of FDA's response and makes policy recommendations regarding how FDA should respond to new and re-emerging public health threats. In particular, it argues that greater emphasis should be placed on drug development in interoutbreak periods and on assuring access to approved products. The current pandemic of Zika virus infection is but one example of an emerging health threat that will require FDA involvement in order to achieve a successful response.
C1 [Largent, Emily A.] Harvard Univ, Harvard Law Sch, Program Hlth Policy, Cambridge, MA 02138 USA.
RP Largent, EA (corresponding author), Harvard Univ, Harvard Law Sch, Program Hlth Policy, Cambridge, MA 02138 USA.
EM emily.a.largent@gmail.com
FU Wellcome TrustWellcome Trust
CR Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7
   Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209
   [Anonymous], 2014, EXP EB VACC LEAST 50
   [Anonymous], 2014, GUIDE GOOD CLIN PRAC, V22, P16
   [Anonymous], 2014, FACTSHEET UPDATE EBO
   Arnold Cameron G., 2014, BROWN J WORLD AFF, V21, P225
   Arnold Cameron G., 2014, BROWN J WORLD AFF, V21, P223
   Associated Press, 2014, CBS NEWS
   Avorn J, 2015, NEW ENGL J MED, V372, P2473, DOI 10.1056/NEJMp1506964
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Bains Ripudaman, 2014, BIOMED CENTRAL
   Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505
   Bansal Sarika, 2011, FORBES
   Bard Jennifer S., 2015, HOUS J INT L, V37, P32
   Bard Jennifer S., 2015, HOUS J INT L, V37, P1
   Bausch DG, 2008, ANTIVIR RES, V78, P150, DOI 10.1016/j.antiviral.2008.01.152
   Blehar MC, 2013, WOMEN HEALTH ISS, V23, pE39, DOI 10.1016/j.whi.2012.10.003
   Bogoch II, 2015, LANCET, V385, P29, DOI 10.1016/S0140-6736(14)61828-6
   Borio Luciana, EXAMINING MED PRODUC
   Borio Luciana, 2014, FDA WORKS MITIGATE W
   Boyd Lindsay M., 2014, FORBES
   BROWER JENNIFER, 2003, ACQUISITION DRUGS BI, V2
   Calain P, 2009, PUBLIC HLTH ETHICS
   Calma Justine, 2015, NOVA
   Caplan Arthur, 2014, NBC NEWS
   CARAFANO JAMES J., 2015, EBOLA OUTBREAK 2013, P22
   Carroll John, 2016, PRIORITY REV VOUCHER
   CDC, 2014, QUEST ANSW EXP TREAT
   Chan M, 2014, NEW ENGL J MED, V371, P1183, DOI 10.1056/NEJMp1409859
   CIOMS, 2015, INT ETH GUID BIOM RE
   Cohen IG, 2013, J LEGAL ANAL, V5, P221, DOI 10.1093/jla/lat001
   Cohen J, 2014, SCIENCE, V346, P289, DOI 10.1126/science.346.6207.289
   Cohen Jon, 2014, SCIENCE
   Cohen J, 2006, APPL HEALTH ECON HEA, V5, P177, DOI 10.2165/00148365-200605030-00004
   Coleman Carl H., 2016, J BIOSEC BIOSAFETY B, V7, P3
   Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs, 2012, ETH SCI ISS STUD SAF
   Cooper Helen, 2015, NY TIMES
   Cooper Helene, 2014, NY TIMES
   Cox E, 2014, NEW ENGL J MED, V371, P2350, DOI 10.1056/NEJMp1414145
   Daly Michael, 2014, DAILY BEAST
   Darrow JJ, 2015, NEW ENGL J MED, V372, P279, DOI 10.1056/NEJMhle1409465
   Dawson AJ, 2015, J MED ETHICS, V41, P107, DOI 10.1136/medethics-2014-102304
   del Rio C, 2014, ANN INTERN MED, V161, P746, DOI 10.7326/M14-1880
   DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012
   Dodd LE, 2016, J INFECT DIS, V213, P1906, DOI 10.1093/infdis/jiw061
   Dolgin E, 2013, NAT MED, V19, P118, DOI 10.1038/nm0213-118
   Dwyer Susan, 2014, ALJAZEERA AM    0813
   Editorial Board, 2015, NY TIMES
   Ekins Sean, 2015, FDA APPROVED DRUGS P
   Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701
   Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709
   Epatko Larisa, 2014, PBS NEWSHOUR    0908
   Evans BJ, 2015, FOOD DRUG LAW J, V70, P259
   Evans DK, 2015, LANCET GLOB HEALTH, V3, pE439, DOI 10.1016/S2214-109X(15)00065-0
   Farrar JJ, 2014, NEW ENGL J MED, V371, P1545, DOI 10.1056/NEJMe1411471
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494
   FDA, 2008, GUID IND TR IN PRESS
   FDA and WHO, 2014, MUT CONF ARR COMM NO
   Fink Doran L., 2015, APPROACHES DEMONSTRA, P3
   Folayan M, 2014, LANCET, V384, P1843, DOI 10.1016/S0140-6736(14)61605-6
   Folayan MO, 2015, JAMA-J AM MED ASSOC, V313, P421, DOI 10.1001/jama.2014.17256
   Fox M., 2014, NBC NEWS
   Fox M, 2015, NBC NEWS
   Frieden TR, 2014, NEW ENGL J MED, V371, P1177, DOI 10.1056/NEJMp1409903
   Gaffney Alexander, 2014, REGULATORY EXPLAINER
   Gaffney Alexander, 2014, US SENATE UNVEILS MA
   Gaffney Alexander, OBAMA SIGNS SPECIAL
   Gaffney Alexander, 2015, 100 HOURS 1 FDA DRAM
   Gaffney Alexander, 2015, RAPS
   GAO Highlights, 2016, RAR DIS TOO EARL GAU, P1
   Gatherer D, 2014, J GEN VIROL, V95, P1619, DOI 10.1099/vir.0.067199-0
   Gericke CA, 2005, J MED ETHICS, V31, P164, DOI 10.1136/jme.2003.007138
   Gibson S, 2015, J LAW BIOSCI, V2, P263, DOI 10.1093/jlb/lsv013
   Gimm G, 2015, AM J PUBLIC HEALTH, V105, pE8, DOI 10.2105/AJPH.2015.302576
   Goldschmidt Debra, 2015, CNN             0917
   Goodman JL, 2014, NEW ENGL J MED, V371, P1086, DOI 10.1056/NEJMp1409817
   GRABOWSKI H, 1988, HEALTH AFFAIR, V7, P102, DOI 10.1377/hlthaff.7.5.102
   Grabowski HG, 2015, HEALTH AFFAIR, V34, P302, DOI 10.1377/hlthaff.2014.1047
   Grabowski Henry G., 2015, HLTH AFF, V34, P308
   Grady Christine, 2005, Yale J Health Policy Law Ethics, V5, P425
   Greeley Brendan, 2014, BLOOMBERG BUSINESS W
   Grimm Gilbert, 2015, AM J PUBLIC HEALTH, V105, pe9
   Gronvalli GK, 2007, NAT BIOTECHNOL, V25, P1084, DOI 10.1038/nbt1007-1084
   H. H. S. DEP'T OF HEALTH AND HUMAN SERVICES, 1993, I REV BOARD GUID
   Hamming L., 2013, DUKE LAW TECHNOLOGY, V11, P390
   Hamming Lesley, 2013, DUKE L TECH REV, V11, P394
   Hampton T, 2014, JAMA-J AM MED ASSOC, V312, P987, DOI 10.1001/jama.2014.11170
   Hampton Tracy, 2014, JAMA
   Hantel A, 2015, ANN INTERN MED, V162, P141, DOI 10.7326/M14-2002
   Hayden E. C., 2014, NATURE
   HHS FDA, 2015, PROD DEV AN RUL GUID
   Hogan C., 2014, WASHINGTON POST
   Hotez PJ, 2016, ANNU REV MED, V67, P405, DOI 10.1146/annurev-med-051214-024241
   Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6
   ICMRA, 2016, INT COAL MED REG AUT
   INSTITUTE OF MEDICINE (IOM), 2010, PUBL HLTH EM MED COU
   International Coalition of Medicines Regulatory Authorities (ICMRA), 2014, INT COAL MED REG AUT
   IOM (Inst. Med.), 2012, BEST CARE LOWER COST
   Javitt Gail H., 2016, WHAT DOES FUTURE HOL
   Joffe S, 2014, JAMA-J AM MED ASSOC, V312, P1299, DOI 10.1001/jama.2014.12867
   Junod Suzanne White, 2008, FDA CLIN DRUG TRIALS
   Kalb Soma, IDE BASICS TRANSCRIP
   Kanters S, 2015, JAMA-J AM MED ASSOC, V313, P421, DOI [10.1001/jama.2014.17262, 10.1001/jama.2014.17259]
   Kesselheim AS, 2008, NEW ENGL J MED, V359, P1981, DOI 10.1056/NEJMp0806684
   King NMP, 2000, J LAW MED ETHICS, V28, P332, DOI 10.1111/j.1748-720X.2000.tb00685.x
   Lamontagne F, 2014, NEW ENGL J MED, V371, P1565, DOI 10.1056/NEJMp1411310
   Largent EA, 2016, J LAW BIOSCI, V3, P206, DOI 10.1093/jlb/lsw001
   Largent EA, 2013, HASTINGS CENT REP, V43, pS28, DOI 10.1002/hast.135
   Largent EA, 2012, HASTINGS CENT REP, V42, P27, DOI 10.1002/HAST.12
   Largent EA, 2011, HASTINGS CENT REP, V41, P37
   Largent EA, 2009, ARCH INTERN MED, V169, P1745, DOI 10.1001/archinternmed.2009.314
   Mackey T, 2011, U MICH J LAW REFORM, V45, P1
   Mackey Tim, 2011, U MICH J L REFORM, V45, P15
   MacNeil A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001546
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Marcus A., 2010, WALL STREET J
   Maron Dina Fine, 2014, SCI AM
   McLaughlin J., 2015, MOTHER JONES
   McNeil D., 2014, NY TIMES
   Meadows Michelle, 2006, FDA CONSUMER MAG JAN
   Miline Christopher-Paul, 2009, FOOD DRUG LAW J, V64, P737
   Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434
   Miller PB, 2003, KENNEDY INST ETHIC J, V13, P93, DOI 10.1353/ken.2003.0014
   Millman J, 2014, WASHINGTON POST
   Milne CP, 2009, FOOD DRUG LAW J, V64, P733
   Moe J, 2009, NEW ENGL J MED, V360, P837, DOI 10.1056/NEJMc086492
   Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7
   Mullin Rick, SCI AM
   National Institutes of Health, 2008, WHAT AR CLIN TRIAL P
   Noack R., 2015, WASHINGTON POST
   Oates M, 2005, NEW YORK U LAW REV, V80, P1272
   OFFICE OF INSPECTOR GENERAL HHS, 2001, OEI020000560, P7
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Onishi Norimitsu, 2015, NY TIMES
   ONISHI NORIMITSU, 2014, NY TIMES
   Oprea L, 2009, J MED ETHICS, V35, P310, DOI 10.1136/jme.2008.027078
   Orent Wendy, 2014, LOS ANGELES TIMES
   Pace C, 2003, CRIT CARE MED, V31, pS121, DOI 10.1097/01.CCM.0000054907.33928.48
   Parekh A, 2015, CLIN PHARMACOL THER, V97, P221, DOI 10.1002/cpt.42
   Pellerin Cheryl, DTRA MED COUNTERMEAS
   Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9
   Philips M, 2014, LANCET, V384, P1181, DOI 10.1016/S0140-6736(14)61606-8
   Phillips MI, 2013, EXPERT OPIN ORPHAN D, V1, P1, DOI 10.1517/21678707.2013.752128
   Phillips M. Ian, 2012, EXPERT OPINION ORPHA, V1, P2
   PhRMA, 2015, PROC NEW MED, P1
   PMLiVE, 2015, SAN PAYS 245M FDA PR
   Pollack A, 2014, NY TIMES
   PRESIDENTIAL COMMISSION FOR THE STUDY OF BIOETHICAL ISSUES, 2015, EB
   PRESIDENTIAL COMMISSION FOR THE STUDY OF BIOETHICAL ISSUES (PRESIDENTIAL COMMISSION), 2015, ETH EB PUBL HLTH PLA, P33
   Preston R., 1995, HOT ZONE TERRIFYING
   Prior A, 2014, WALL STREET J
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Quartey Kwei, 2014, FOREIGN POLICY FOCUS
   Rabourn Jess, 2016, CREATING LANDSCAPE P
   Reardon S, 2014, NATURE, V511, P520, DOI 10.1038/511520a
   RedHill Biopharma, 2016, REDHILL ANN RES COLL
   Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248
   Rid A, 2014, LANCET, V384, P1844, DOI 10.1016/S0140-6736(14)62236-4
   Rid A, 2014, LANCET, V384, P1896, DOI 10.1016/S0140-6736(14)61315-5
   Russek-Cohen E, 2016, CLIN TRIALS, V13, P105, DOI 10.1177/1740774515620613
   Sack K., 2014, NY TIMES
   Saville BR, 2016, CLIN TRIALS, V13, P358, DOI 10.1177/1740774515626362
   Schlanger Zoe, 2014, NEWSWEEK
   Schnirring Lisa, 2015, CIDRAP NEWS     0512
   Schultz William B., 1996, COMMUNICATION   0222
   Searcey D., 2016, NY TIMES
   Seay L., 2014, WASHINGTON POST
   Sem Daniel S., 2014, MARQ INTELL PROP L R, V18, p[143, 143]
   Senthilingham Meera, ARE WE READY NEXT GL
   Silverman E., 2015, WALL STREET J
   Skierritt John, 2015, WHO DRUG INFO, V29, P4
   Skierritt John, 2015, WHO DRUG INFORM, V29, P3
   Skwarecki Beth, 2014, ETHICAL DILEMMAS GIV
   SMADEL JE, 1953, AM J PUBLIC HEALTH, V43, P1327
   Stone Judy, 2014, FORBES
   Strauss S, 2014, NAT BIOTECHNOL, V32, P849, DOI 10.1038/nbt0914-849a
   Szabo L., 2016, US TODAY
   THE NAT'L COMM'N FOR THE PROTECTION OF HUMAN SUBJECTS OF BIOMEDICAL AND BEHAVIORAL RESEARCH, 1979, BELM REP ETH PRINC G
   Tomori O, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0359-7
   U.S. Centers for Disease Control and Prevention (CDC), 2014, QUEST ANSW EB
   United Nations Population Fund, 2015, EB SURV FAC STIGM UN
   WELLCOME TRUST & CENTER FOR INFECTIOUS DISEASE RESEARCH POLICY (CIDRAP) AT UNIVERSITY OF MINNESOTA, 2016, PLOTT COURS EB VACC
   Wendler D, 2004, AM J PUBLIC HEALTH, V94, P923, DOI 10.2105/AJPH.94.6.923
   Wendler D., 2012, STANFORD ENCY PHILOS
   WHO, 2014, EB VIR DIS W AFR UPD
   WHO, 2015, EB W AFR 12 MONTHS
   WHO, 2014, AN EV EXP EB THER
   WHO Ebola Response Team, 2014, NEW ENGL J MED, V371, P1482
   WILLIAMS ERIN D., 2005, FEDERAL PROTECION HU
   Wittich CM, 2012, MAYO CLIN PROC, V87, P982, DOI 10.1016/j.mayocp.2012.04.017
   World Health Organization, 2016, WHO EB SIT REP
   World Health Organization, 2014, EB VIR DIS GUIN
   World Health Organization (WHO), 2015, HLTH WORK EB INF GUI
NR 194
TC 8
Z9 8
U1 0
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2053-9711
J9 J LAW BIOSCI
JI J. Law Biosci.
PD NOV
PY 2016
VL 3
IS 3
BP 489
EP 537
DI 10.1093/jlb/lsw046
PG 49
WC Ethics; Law; Medical Ethics; Medicine, Legal
SC Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal
   Medicine
GA EG5TE
UT WOS:000391106400004
PM 28852537
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kennedy, RB
AF Kennedy, Richard B.
TI Pushing Forward With Zika Vaccines
SO EBIOMEDICINE
LA English
DT Editorial Material
DE Zika virus; Vaccine
ID VIRUS
C1 [Kennedy, Richard B.] Mayo Clin, Dept Gen Internal Med, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.
   [Kennedy, Richard B.] Mayo Clin, Mayo Vaccine Res Grp, Guggenheim 611D,200 First St SW, Rochester, MN 55905 USA.
RP Kennedy, RB (corresponding author), Mayo Clin, Dept Gen Internal Med, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.; Kennedy, RB (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Guggenheim 611D,200 First St SW, Rochester, MN 55905 USA.
EM kennedy.rick@mayo.edu
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
NR 10
TC 6
Z9 6
U1 1
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD NOV
PY 2016
VL 13
BP 29
EP 30
DI 10.1016/j.ebiom.2016.10.016
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EG0EU
UT WOS:000390704800015
PM 27751766
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Maestre, AM
   Fernandez-Sesma, A
AF Maestre, Ana M.
   Fernandez-Sesma, Ana
TI ZIKV Strains' Different Phenotypes in Human Neural Cells Could be a Hint
   for the Emergence of the New Clinical Neurological Outcomes
SO EBIOMEDICINE
LA English
DT Editorial Material
ID VIRUS; FETAL
C1 [Maestre, Ana M.; Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Fernandez-Sesma, Ana] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
RP Fernandez-Sesma, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
EM ana.sesma@mssm.edu
RI Merens, Ana Maestre/I-2445-2019
OI Merens, Ana Maestre/0000-0002-2494-0879
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI073450]
CR Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rodrigues LC, 2016, LANCET INFECT DIS
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD NOV
PY 2016
VL 13
BP 35
EP 36
DI 10.1016/j.ebiom.2016.10.021
PG 2
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EG0EU
UT WOS:000390704800018
PM 27765639
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, E
   Erdos, G
   Huang, SH
   Kenniston, T
   Falo, LD
   Gambotto, A
AF Kim, Eun
   Erdos, Geza
   Huang, Shaohua
   Kenniston, Thomas
   Falo, Louis D., Jr.
   Gambotto, Andrea
TI Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; ZIKV-E; Vaccine; Microneedles; Adenovirus
ID YELLOW-FEVER; MODEL; ANTIBODIES; INFECTION; EFFICACY; DISEASE; MICE
AB Since it emerged in Brazil in May 2015, the mosquito-borne Zika virus (ZIKV) has raised global concern due to its association with a significant rise in the number of infants born with microcephaly and neurological disorders such as Guillain-Barre syndrome. We developed prototype subunit and adenoviral-based Zika vaccines encoding the extracellular portion of the ZIKV envelope gene (E) fused to the T4 fibritin foldon trimerization domain (Efl). The subunit vaccine was delivered intradermally through carboxymethyl cellulose microneedle array (MNA). The immunogenicity of these two vaccines, named Ad5. ZIKV-Efl and ZIKV-rEfl, was tested in C57BL/6 mice. Prime/boost immunization regimen was associated with induction of a ZIKV-specific antibody response, which provided neutralizing immunity. Moreover, protection was evaluated in seven-day-old pups after virulent ZIKV intraperitoneal challenge. Pups born to mice immunizedwith Ad5. ZIKV-Eflwere all protected against lethal challenge infection without weight loss or neurological signs, while pups born to dams immunized with MNA-ZIKV-rEfl were partially protected (50%). No protection was seen in pups born to phosphate buffered saline-immunized mice. This study illustrates the preliminary efficacy of the E ZIKV antigen vaccination in controlling ZIKV infectivity, providing a promising candidate vaccine and antigen format for the prevention of Zika virus disease. (C) 2016 The Authors. Published by Elsevier B.V.
C1 [Kim, Eun; Huang, Shaohua; Kenniston, Thomas; Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA.
   [Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA.
   [Erdos, Geza; Falo, Louis D., Jr.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15261 USA.
   [Erdos, Geza; Falo, Louis D., Jr.] Univ Pittsburgh, Sch Med, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Gambotto, Andrea] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15261 USA.
RP Gambotto, A (corresponding author), Univ Pittsburgh, Sch Med, Div Infect Dis, Dept Surg & Med, W1148 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.
EM gambottoa@upmc.edu
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P50
   CA121973]
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Bediz B, 2014, PHARM RES-DORDR, V31, P117, DOI 10.1007/s11095-013-1137-x
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Gao WT, 2004, BIOTECHNOL PROGR, V20, P443, DOI 10.1021/bp0300467
   Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997
   Kim E, 2014, J VIROL, V88, P5100, DOI 10.1128/JVI.03194-13
   Korkmaz E, 2015, ACTA BIOMATER, V24, P96, DOI 10.1016/j.actbio.2015.05.036
   Larocca RA, 2016, NATURE
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303
   Mou H, 2013, J VIROL, V87, P9379, DOI 10.1128/JVI.01277-13
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Taylor TJ, 2016, VIROLOGY, V496, P186, DOI 10.1016/j.virol.2016.06.006
   Weldon WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041501
   Yoshii K, 2014, J VIROL, V88, P5406, DOI 10.1128/JVI.00421-14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 69
Z9 73
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD NOV
PY 2016
VL 13
BP 315
EP 320
DI 10.1016/j.ebiom.2016.09.028
PG 6
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EG0EU
UT WOS:000390704800045
PM 27717627
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khalid, M
   Khan, SA
   Ahmed, AA
AF Khalid, Muneeb
   Khan, Sohaib Ahmed
   Ahmed, Ammar Asif
TI Zika Virus in Pakistan: A Looming Adversity?
SO JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
LA English
DT Letter
C1 [Khalid, Muneeb; Khan, Sohaib Ahmed; Ahmed, Ammar Asif] Civil Hosp, Dept Cardiac Surg, Karachi, Pakistan.
RP Khalid, M (corresponding author), Civil Hosp, Dept Cardiac Surg, Karachi, Pakistan.
EM kmuneeb@hotmail.com
CR Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
NR 1
TC 0
Z9 0
U1 0
U2 1
PU COLL PHYSICIANS & SURGEONS PAKISTAN
PI KARACHI
PA SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN
SN 1022-386X
EI 1681-7168
J9 JCPSP-J COLL PHYSICI
JI JCPSP-J. Coll. Physicians Surg.
PD NOV
PY 2016
VL 26
IS 11
BP 943
EP 943
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF6EB
UT WOS:000390422700021
PM 27981937
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh RamBihariLal
   Shrivastava, Prateek Saurabh
   Ramasamy, Jegadeesh
TI Exploring the multiple dimensions in the control of Zika virus disease:
   Vector control, surveillance, clinical care, risk communication, travel,
   and promotion of research
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Shrivastava, Saurabh RamBihariLal; Shrivastava, Prateek Saurabh; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Kancheepuram 603108, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Kancheepuram 603108, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Bell BP, 2016, AM J PUBLIC HEALTH, V106, P589, DOI 10.2105/AJPH.2016.303124
   Lee J, 2016, J KOREAN MED SCI, V31, P331, DOI 10.3346/jkms.2016.31.3.331
   Lupton K., 2016, BR J NURS, V25, P198
   Lupton K., 2016, BR J NURS, V25, P200
   Rodrigues LC, 2016, AM J PUBLIC HEALTH, V106, P582, DOI 10.2105/AJPH.2016.303114
   World Health Organization, 2016, 2 M IHR EM COMM ZIK
NR 6
TC 1
Z9 1
U1 0
U2 20
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 377
EP 378
DI 10.4103/1755-6783.193930
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800001
DA 2020-07-08
ER

PT J
AU Shrivastava, SR
   Shrivastava, PS
   Ramasamy, J
AF Shrivastava, Saurabh R.
   Shrivastava, Prateek S.
   Ramasamy, Jegadeesh
TI Implementing strategic response framework for the control of Zika virus
   infection: World Health Organization
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Shrivastava, Saurabh R.; Shrivastava, Prateek S.; Ramasamy, Jegadeesh] Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Madras 603108, Tamil Nadu, India.
RP Shrivastava, SR (corresponding author), Shri Sathya Sai Med Coll & Res Inst, Dept Community Med, 3rd Floor,Thiruporur Guduvancherry Main Rd, Madras 603108, Tamil Nadu, India.
EM drshrishri2008@gmail.com
OI Shrivastava, Saurabh/0000-0001-6102-7475
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Elachola H, 2016, LANCET, V387, P630, DOI 10.1016/S0140-6736(16)00274-9
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   WHO, 2016, ZIK VIR MICR GUILL B, P1
NR 5
TC 0
Z9 0
U1 0
U2 4
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 408
EP 409
DI 10.4103/1755-6783.193943
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800015
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Zika virus infection among travelers departing from Thailand
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
   [Wiwanitkit, Viroj] Joseph Ayo Babalola Univ, Ikeji Arakeji, Osun State, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
RP Wiwanitkit, V (corresponding author), Wiwanitkit House, Bangkok 10160, Thailand.
EM wviroj@yahoo.com
CR Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 415
EP 415
DI 10.4103/1755-6783.193950
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800021
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI How about the rate of Zika virus infection among suspicious cases:
   Thailand's situation
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanit 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
RP Joob, B (corresponding author), Sanit 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 416
EP U156
DI 10.4103/1755-6783.193952
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800023
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Rate of false positive IgM in cases of Zika virus infection: Thailand's
   situation
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanit 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
RP Joob, B (corresponding author), Sanit 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 417
EP U138
DI 10.4103/1755-6783.193953
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800024
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Asymptomatic and polymerase chain reaction negative Zika virus
   infection: Are these big concerns
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2013, ANN TROP MED PUBLIC, V6, DOI 10.4103/1755-6783.140273
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 5
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 418
EP 418
DI 10.4103/1755-6783.193954
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800025
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Leukopenia is common in Zika virus infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Surin Rajabhat Univ, Surin, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Joseph Ayobabalola Univ, Ikeji Arakeji, Nigeria.
   [Wiwanitkit, Viroj] Dr DY Patil Med Univ, Pune, Maharashtra, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@hotmail.co.th
CR Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 6
TC 0
Z9 0
U1 0
U2 1
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 424
EP U150
DI 10.4103/1755-6783.193959
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800030
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Hemorrhagic presentation in Zika virus infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Dept Trop Med, Haikou, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 426
EP U154
DI 10.4103/1755-6783.193961
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800032
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Elevation of C-reactive protein in Zika virus infection
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 6
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 427
EP 427
DI 10.4103/1755-6783.193962
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800033
DA 2020-07-08
ER

PT J
AU Wiwanikit, S
   Wiwanikit, V
AF Wiwanikit, Somsri
   Wiwanikit, Viroj
TI Emerging Zika virus infection: Occurrence of the first clinical
   presentation in airplane
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanikit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanikit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Wiwanikit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
BP 432
EP U85
DI 10.4103/1755-6783.193967
PG 2
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800038
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Immunological evidence of Zika virus in Thailand: Further implication
   for rate of possible infected cases in province with reported case
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Fac Med, Haikou, Hainan, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Tuntaprasart Walairut, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P564
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
DI 10.4103/1755-6783.193931
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800006
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Does the basic "1-week illness period" for viral infection can be
   applied to the cases of Zika virus infection?
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Fac Med, Nish, Serbia.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 1
Z9 1
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
DI 10.4103/1755-6783.193955
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800026
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Imported case of Zika virus: Lessons learnt from Taiwan case
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Wiwanitkit, Somsri] Wiwanitkit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitkit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 3
TC 0
Z9 0
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
DI 10.4103/1755-6783.193974
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800045
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Platelet count in Zika virus infection: A summary on 26 cases
SO ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
NR 5
TC 1
Z9 1
U1 0
U2 0
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 1755-6783
EI 0974-6005
J9 ANN TROP MED PUBLIC
JI Ann. Trop. Med. Public Health
PD NOV-DEC
PY 2016
VL 9
IS 6
DI 10.4103/1755-6783.193963
PG 1
WC Tropical Medicine
SC Tropical Medicine
GA EE1OE
UT WOS:000389350800034
DA 2020-07-08
ER

PT J
AU Ponce-Garcia, G
   Del Rio-Galvan, S
   Barrera, R
   Saavedra-Rodriguez, K
   Villanueva-Segura, K
   Felix, G
   Amador, M
   Flores, AE
AF Ponce-Garcia, Gustavo
   Del Rio-Galvan, Samantha
   Barrera, Roberto
   Saavedra-Rodriguez, Karla
   Villanueva-Segura, Karina
   Felix, Gilberto
   Amador, Manuel
   Flores, Adriana E.
TI Knockdown Resistance Mutations in Aedes aegypti (Diptera: Culicidae)
   From Puerto Rico
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE permethrin resistance; kdr; Aedes aegypti; Puerto Rico
ID SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; PYRETHROID RESISTANCE; KDR
   MUTATIONS; POPULATIONS; MECHANISMS; STATE
AB Permethrin resistance is widespread in Aedes aegypti (L.), the main dengue, zika, and chikungunya virus vector in Latin America and the Caribbean. A common mechanism of resistance to pyrethroids-knockdown resistance (kdr)-is conferred through mutations in the insect's voltage-dependent sodium channel. In this mosquito, around 10 replacement substitutions in the voltage-gated sodium channel gene (vgsc) have been reported in pyrethroid-resistant strains. Two of these mutations, named Ile1,016 and Cys1,534, are widespread in mosquito populations from Latin America and the Caribbean. This study assessed the levels of permethrin resistance and the frequency of two kdr mutations in eight Ae. aegypti populations collected in Puerto Rico in 2013. Permethrin resistance factors ranged from 33-214-fold relative to the New Orleans reference strain. The frequency of kdr mutation Ile1,016 ranged from 0.65 to fixation (1.0), and for Cys1,534 frequencies varied from 0.8 to fixation. Alarmingly, two populations-Carolina and Caguas-reached fixation at both loci. Our results suggest that permethrin effectiveness for Ae. aegypti control is compromised in these collections from Puerto Rico.
C1 [Ponce-Garcia, Gustavo; Del Rio-Galvan, Samantha; Villanueva-Segura, Karina; Flores, Adriana E.] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza 66455, Nuevo Leon, Mexico.
   [Barrera, Roberto; Felix, Gilberto; Amador, Manuel] Ctr Dis Control & Prevent, Dengue Branch, Entomol & Ecol Act, San Juan, PR USA.
   [Saavedra-Rodriguez, Karla] Colorado State Univ, Lab Insect Genet Microbiol Immunol & Pathol, Ft Collins, CO 80521 USA.
RP Ponce-Garcia, G (corresponding author), Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza 66455, Nuevo Leon, Mexico.
EM gponcealfa@gmail.com; samdelriog@hotmail.com; amz9@cdc.gov;
   karlasaav@gmail.com; karinaypwm@gmail.com; ckn5@cdc.gov; maa4@cdc.gov;
   adriana.floressr@uanl.edu.mx
RI Flores, Adriana E./AAM-4478-2020; Flores, Adriana/J-1820-2012;
   Villanueva-Segura, Olga Karina/AAF-2131-2020
OI Flores, Adriana E./0000-0001-8554-8865; Flores,
   Adriana/0000-0001-8554-8865; Saavedra-Rodriguez,
   Karla/0000-0001-8511-3327; Ponce-Garcia, Gustavo/0000-0003-0654-006X
CR Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   BLACK WC, 1985, THEOR APPL GENET, V70, P484, DOI 10.1007/BF00305980
   Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   FLYNN A. D., 1964, MOSQUITO NEWS, V24, P118
   FOX I, 1980, MOSQ NEWS, V40, P280
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   HEMINGWAY J, 1989, B ENTOMOL RES, V79, P123, DOI 10.1017/S0007485300018630
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Lozano-Fuentes S, 2012, J AM MOSQUITO CONTR, V28, P59, DOI 10.2987/11-6192.1
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   Narahashi T, 2000, J PHARMACOL EXP THER, V294, P1
   Narahashi T, 1988, NEUROTOX, V88, P563
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   Sutherland D. J., 1987, Proceedings - Annual Meeting, New Jersey Mosquito Control Association, Inc., V74, P71
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 27
TC 15
Z9 14
U1 2
U2 12
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD NOV
PY 2016
VL 53
IS 6
BP 1410
EP 1414
DI 10.1093/jme/tjw115
PG 5
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA EF3IH
UT WOS:000390217500020
PM 27493252
DA 2020-07-08
ER

PT J
AU Masi, M
   Cala, A
   Tabanca, N
   Cimmino, A
   Green, IR
   Bloomquist, JR
   van Otterlo, WAL
   Macias, FA
   Evidente, A
AF Masi, Marco
   Cala, Antonio
   Tabanca, Nurhayat
   Cimmino, Alessio
   Green, Ivan R.
   Bloomquist, Jeffrey R.
   van Otterlo, Willem A. L.
   Macias, Francisco A.
   Evidente, Antonio
TI Alkaloids with Activity against the Zika Virus Vector Aedes aegypti
   (L.)-Crinsarnine and Sarniensinol, Two New Crinine and Mesembrine Type
   Alkaloids Isolated from the South African Plant Nerine sarniensis
SO MOLECULES
LA English
DT Article
DE Nerine sarniensis; Amaryllidaceae; mesembrine; crinine; crinsarnine;
   sarniensinol; bowdensine; Zika virus; Aedes aegypti
ID AMARYLLIDACEAE
AB Two new Amaryllidaceae alkaloids, belonging to the mesembrine-and crinine-types, named crinsarnine (1) and sarniensinol (2), were isolated from the dried bulbs of Nerine sarniensis together with bowdensine (3), sarniensine (4), hippadine (5) and 1-O-acetyl-lycorine (6). Crinsarnine (1) and sarniensinol (2) were characterized using spectroscopic and chiroptical methods as (1S,2S,4aR,10bS)-2,7-dimethoxy-1,2,3,4,4a, 6-hexahydro-5,11b-ethano[1,3]dioxolo-[4,5-j]phenanthridin-1-yl acetate and (6-(3aR,4Z,6S,7aS)-6-methoxy-1-methyl-2,3,3a, 6,7,7a-hexa-hydro-1H-indol-3a-yl)benzo [d][1,3]dioxol-5-yl)methanol, respectively. Furthermore, the complete spectroscopic characterization of bowdensine (3) is reported for the first time. Compounds 1-6 were evaluated against the Orlando reference strain of Aedes aegypti. None of compounds showed mortality against 1st instar Ae. aegypti larvae at the concentrations tested. In adult topical bioassays, only 1 displayed adulticidal activity with an LD50 = 2.29 +/- 0.049 mu g/mosquito. As regards the structure-activity relationship, the pretazettine and crinine scaffold in 2 and 4 and in 1 and 3 respectively, proved to be important for their activity, while the pyrrole[de]phenanthridine scaffold present in 5 and 6 was important for their reactivity. Among the pretazettine group compounds, opening of the B ring or the presence of a B ring lactone as well as the trans-stereochemistry of the A/B ring junction, appears to be important for activity, while in crinine-type alkaloids, the substituent at C-2 seems to play a role in their activity.
C1 [Masi, Marco; Cala, Antonio; Cimmino, Alessio; Evidente, Antonio] Univ Naples Federico II, Dept Chem Sci, Complesso Univ Monte S Angelo,Via Cintia 4, I-80126 Naples, Italy.
   [Cala, Antonio; Macias, Francisco A.] Univ Cadiz, Allelopathy Grp, Dept Organ Chem, Sch Sci,Inst Biomol INBIO, C Republ Saharaui 7, Cadiz 11510, Spain.
   [Tabanca, Nurhayat; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematol, Emerging Pathogens Inst, Gainesville, FL 32610 USA.
   [Tabanca, Nurhayat; van Otterlo, Willem A. L.] ARS, USDA, Subtrop Hort Res Stn, 13601 Old Cutler Rd, Miami, FL 33158 USA.
   [Green, Ivan R.] Univ Stellenbosch, Dept Chem & Polymer Sci, Private Bag X1, ZA-7602 Stellenbosch, South Africa.
RP Evidente, A (corresponding author), Univ Naples Federico II, Dept Chem Sci, Complesso Univ Monte S Angelo,Via Cintia 4, I-80126 Naples, Italy.
EM marco.masi@unina.it; antonio.cala@uca.es; ntabanca@ufl.edu@ufl.edu;
   alessio.cimmino@unina.it; irg@sun.ca.za; jbquist@epi.ufl.edu;
   wvo@sun.ca.za; famacias@uca.es; evidente@unina.it
RI Evidente, Antonio/N-9357-2013; Cimmino, Alessio/I-2121-2012; Macias,
   Francisco A./W-2568-2018; Peralta, Antonio Cala/Q-2000-2017; Masi,
   Marco/J-7742-2016
OI Evidente, Antonio/0000-0001-9110-1656; Cimmino,
   Alessio/0000-0002-1551-4237; Macias, Francisco A./0000-0001-8862-2864;
   Peralta, Antonio Cala/0000-0001-5714-4556; Masi,
   Marco/0000-0003-0609-8902
FU Deployed War-Fighter Protection Research Program via U.S. Department of
   Defense through the Armed Forces Pest Management Board; Research Unit of
   the University of Cadiz in the Researchers Training Program; Italian and
   South-African Ministry of Foreign Affairs Area: South Africa, Medicine
   and Health [ZA14MO06]; National Research Foundation-South Africa
   (NRF)National Research Foundation - South Africa; NRF; Stellenbosch
   University (Faculty of Science and University Research Office)
FX This study was partly funded by the Deployed War-Fighter Protection
   Research Program via grants from the U.S. Department of Defense through
   the Armed Forces Pest Management Board (to Jeffrey R. Bloomquist,
   Department of Entomology and Nematology, Emerging Pathogens Institute,
   University of Florida, Gainesville, FL 32610, USA). A.C. (Spain) thanks
   the financial support of the Research Unit of the University of Cadiz in
   the Researchers Training Program. We thank James J. Becnel, Alden S.
   Estep, Jessica Louton, (USDA-ARS, CMAVE, Gainesville, FL, USA) for
   mosquito bioassays. Part of the work was supported by grants from a
   bilateral project of the Italian and South-African Ministry of Foreign
   Affairs Area: South Africa, Medicine and Health Project number:
   ZA14MO06, titled: Bioactive metabolites from South-Africa plants with
   anticancer activity. This South African part of this project was
   overseen by the National Research Foundation-South Africa (NRF) and
   their support is gratefully acknowledged. Willem A. L. van Otterlo and
   Ivan R. Green acknowledge support from the NRF (Incentive funding
   grants) and Stellenbosch University (Faculty of Science and University
   Research Office). Martin Smit, curator of the Stellenbosch Botanical
   Garden is thanked for the allocation of space for the three living
   specimens of Nerine sarniensis. A.E. is associated to the Istituto di
   Chimica Biomolecolare del CNR, Pozzuoli, Italy.
CR Al-Massarani S., 2016, Natural Volatiles & Essential Oils, V3, P26
   Bastida J, 1998, STUD NAT PROD CHEM, V20, P323
   Benelli G, 2015, PARASITOL RES, V114, P3201, DOI 10.1007/s00436-015-4656-z
   Berger S., 2004, 200 MORE BASIC NMR E
   BOIT HG, 1954, CHEM BER-RECL, V87, P1704, DOI 10.1002/cber.19540871115
   Breitmaier E., 1987, CARBON 13 NMR SPECTR, P183
   De Azambuja Garcia G., 2016, PLOS ONE, V11
   Evidente A, 2009, PHYTOCHEM REV, V8, P449, DOI 10.1007/s11101-008-9119-z
   GHOSAL S, 1981, PHYTOCHEMISTRY, V20, P2003, DOI 10.1016/0031-9422(81)84053-8
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Houghton PJ, 2006, NAT PROD REP, V23, P181, DOI 10.1039/b508966m
   KOBAYASHI S, 1984, CHEM PHARM BULL, V32, P3015
   Kornienko A, 2008, CHEM REV, V108, P1982, DOI 10.1021/cr078198u
   Lamoral-Theys D, 2009, J MED CHEM, V52, P6244, DOI 10.1021/jm901031h
   LYLE RE, 1960, J AM CHEM SOC, V82, P2620, DOI 10.1021/ja01495a057
   Mann RS, 2012, MINI-REV ORG CHEM, V9, P185
   Masi M., 2016, FITOTERAPIA UNPUB
   Masi M, 2015, FITOTERAPIA, V102, P41, DOI 10.1016/j.fitote.2015.01.009
   Meerow A.W., 1998, FAMILIES GENERA VASC, V3, P83, DOI DOI 10.1007/978-3-662-03533-7_11
   Nair JJ, 2013, FOOD CHEM TOXICOL, V62, P262, DOI 10.1016/j.fct.2013.08.042
   Nair JJ, 2013, NAT PROD COMMUN, V8, P1335
   Nakanishi K., 1977, INFRARED ABSORPTION, P17
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Pham LH, 1999, PHYTOCHEMISTRY, V51, P327, DOI 10.1016/S0031-9422(98)00743-2
   Pretsch E., 2000, STRUCTURE DETERMINAT, P161
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   STERNHELL S, 1969, Q REV CHEM SOC, V23, P236, DOI 10.1039/qr9692300236
   Wagner J, 1996, TETRAHEDRON, V52, P6591, DOI 10.1016/0040-4020(96)00297-9
NR 28
TC 19
Z9 19
U1 2
U2 28
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD NOV
PY 2016
VL 21
IS 11
AR 1432
DI 10.3390/molecules21111432
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA EE9AO
UT WOS:000389918200016
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Johansson, MA
   Mier-Y-Teran-Romero, L
   Reefhuis, J
   Gilboa, SM
   Hills, SL
AF Johansson, Michael A.
   Mier-y-Teran-Romero, Luis
   Reefhuis, Jennita
   Gilboa, Suzanne M.
   Hills, Susan L.
TI Zika and the Risk of Microcephaly EDITORIAL COMMENT
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Editorial Material
C1 [Johansson, Michael A.; Mier-y-Teran-Romero, Luis; Hills, Susan L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA 30333 USA.
   [Reefhuis, Jennita; Gilboa, Suzanne M.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA.
   [Johansson, Michael A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
RP Johansson, MA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA 30333 USA.
OI Johansson, Michael/0000-0002-5090-7722
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7828
EI 1533-9866
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD NOV
PY 2016
VL 71
IS 11
BP 635
EP 636
DI 10.1097/OGX.0000000000000386
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EE0DY
UT WOS:000389245100001
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Pacheco, LD
   Saad, AF
   Hankins, GDV
   Chiosi, G
   Saade, G
AF Pacheco, Luis D.
   Saad, Antonio F.
   Hankins, Gary D. V.
   Chiosi, Giuseppe
   Saade, George
TI Guillain-Barre Syndrome in Pregnancy
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID ZIKA VIRUS; MANAGEMENT; METAANALYSIS; INFECTIONS; POSTPARTUM;
   NEUROPATHY; PROGNOSIS; FEATURES; USA
AB Guillain-Barre syndrome has been reported in pregnancy and is a potentially lethal condition. It affects the nervous system with acute onset of symmetric ascending weakness and may result in frank respiratory failure and autonomic dysfunction. Most patients recall symptoms of a respiratory or gastrointestinal illness in the weeks preceding the onset of weakness. Recent evidence suggests a potential role of the Zika virus as a trigger for the syndrome. The diagnosis of Guillain-Barre is clinical. Supportive measures include venous thromboembolism prophylaxis, aggressive physical therapy, pressure ulcer prevention, enteral nutrition, and respiratory support. The mainstay of management comprises plasmapheresis or administration of intravenous immunoglobulins. Affected patients must be closely monitored for development of respiratory failure and autonomic dysfunction. Treatment during pregnancy should follow the same principles as for nonpregnant individuals.
C1 Univ Texas Med Branch, Div Maternal Fetal Med, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.
   Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Pacheco, LD (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol & Anesthesiol, Div Maternal Fetal Med & Surg Crit Care, 301 Univ Blvd, Galveston, TX 77555 USA.
EM ldpachec@utmb.edu
RI Saad, Antonio/L-5374-2019
OI Saad, Antonio/0000-0003-0034-3567
CR Annane D, 1997, ANN NEUROL, V41, P298
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chalela JA, 2001, SEMIN NEUROL, V21, P399, DOI 10.1055/s-2001-19411
   Chan LYS, 2004, ACTA OBSTET GYN SCAN, V83, P319, DOI 10.1111/j.0001-6349.2004.0473.x
   Cheng Q, 1998, EPIDEMIOLOGY, V9, P601
   Clark AL, 1999, CLIN OBSTET GYNECOL, V42, P368, DOI 10.1097/00003081-199906000-00021
   Gasim T, 2011, J REPROD MED, V56, P163
   Guillain G, 1999, ANN MED INTERNE, V150, P24
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414
   HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512
   Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316
   Haskin JA, 1999, ANN PHARMACOTHER, V33, P800, DOI 10.1345/aph.18305
   Hiraga A, 2005, J NEUROL NEUROSUR PS, V76, P719, DOI 10.1136/jnnp.2004.051136
   Hughes RAC, 1997, LANCET, V349, P225
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6
   Jackson BR, 2014, EPIDEMIOL INFECT, V142, P1089, DOI 10.1017/S0950268813001908
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Lemos A, 2010, RESP MED, V104, P1638, DOI 10.1016/j.rmed.2010.05.020
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Luijckx GJ, 1997, LANCET, V349, P27, DOI 10.1016/S0140-6736(97)24001-8
   Mangar D, 2013, A A CASE REP, V1, P19, DOI 10.1097/ACC.0b013e318291d378
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Meenakshi-Sundaram S, 2014, ANN INDIAN ACAD NEUR, V17, P352, DOI 10.4103/0972-2327.138527
   Mori M, 2012, EXPERT REV NEUROTHER, V12, P39, DOI [10.1586/ern.11.182, 10.1586/ERN.11.182]
   NELSON LH, 1985, OBSTET GYNECOL, V65, pS25
   Radwan IAM, 2002, ANESTH ANALG, V94, P319, DOI 10.1097/00000539-200202000-00016
   Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2
   Rizk A, 2001, TRANSFUSION, V41, P264, DOI 10.1046/j.1537-2995.2001.41020264.x
   Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345
   Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Seneviratne U, 2000, POSTGRAD MED J, V76, P774, DOI 10.1136/pmj.76.902.774
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van Doorn Pieter A, 2013, Presse Med, V42, pe193, DOI 10.1016/j.lpm.2013.02.328
   Wiertlewski S, 2004, ANESTH ANALG, V98, P825
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 41
TC 5
Z9 5
U1 1
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD NOV
PY 2016
VL 128
IS 5
BP 1105
EP 1110
DI 10.1097/AOG.0000000000001716
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EE0GA
UT WOS:000389251000029
PM 27741183
DA 2020-07-08
ER

PT J
AU Millard, WB
AF Millard, William B.
TI Virology and Virality Confronting Zika in and Beyond the Emergency
   Department
SO ANNALS OF EMERGENCY MEDICINE
LA English
DT Editorial Material
ID MALE SEXUAL TRANSMISSION; VIRUS; MANAGEMENT; IDENTIFY; ISOLATE; INFORM
CR Alvarez Lizette, 2016, NY TIMES
   Brooks RB, 2016, MORB MORTAL WKLY REP
   Center for Biologics Evaluation and Research; US Food and Drug Administration, 2016, REV REC RED RISK ZIK
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, ZIK VIR DIG PRESS KI
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, ZIK VIR HEALTHC PROV
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Engber D., 2016, SLATE
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Florida Department of Agriculture and Consumer Services, MIAM DAD MOSQ TEST P
   Folkers KM, 2016, NEW YORK TIMES  0820
   Food and Drug Administration, FDA REL FIN ENV ASS
   Koenig KL, 2016, DISASTER MED PUBLIC
   Koenig KL, 2016, WEST J EMERG MED, V17, P238, DOI 10.5811/westjem.2016.3.30188
   Koenig KL, 2015, DISASTER MED PUBLIC, V9, P86, DOI 10.1017/dmp.2014.125
   Lyon J, 2016, JAMA-J AM MED ASSOC, V316, P1246, DOI 10.1001/jama.2016.11054
   Maron D. F., 2016, SCI AM
   Medscape, 2016, ZIK VIR RES CTR
   Mukherjee S, 2016, NEW YORKER
   National Academy of Medicine, 2016, RES PRIOR INF PUBL H
   National Institutes of Health, 2016, NIH BEG TEST INV ZIK
   Nutt C, 2016, SLATE
   Rodriguez A, N ENGL J MED
   Solo H, 2016, TWITTER POST    0721
   The New England Journal of Medicine, 2016, NEW ENGLAND J MED
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   World Health Organisation, ZIK VIR COMPL
   World Health Organization, 2016, ZIK SIT REP WHO
NR 31
TC 0
Z9 0
U1 0
U2 2
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-0644
J9 ANN EMERG MED
JI Ann. Emerg. Med.
PD NOV
PY 2016
VL 68
IS 5
BP 18A
EP 24A
DI 10.1016/j.annemergmed.2016.09.013
PG 7
WC Emergency Medicine
SC Emergency Medicine
GA EB3WD
UT WOS:000387298700002
OA Bronze
DA 2020-07-08
ER

PT J
AU Goertz, GP
   Fros, JJ
   Miesen, P
   Vogels, CBF
   van der Bent, ML
   Geertsema, C
   Koenraadt, CJM
   van Rij, RP
   van Oers, MM
   Pijlman, GP
AF Goertz, G. P.
   Fros, J. J.
   Miesen, P.
   Vogels, C. B. F.
   van der Bent, M. L.
   Geertsema, C.
   Koenraadt, C. J. M.
   van Rij, R. P.
   van Oers, M. M.
   Pijlman, G. P.
TI Noncoding Subgenomic Flavivirus RNA Is Processed by the Mosquito RNA
   Interference Machinery and Determines West Nile Virus Transmission by
   Culex pipiens Mosquitoes
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID ARBOVIRUS INFECTION; DENGUE; OUTBREAK; ENCEPHALITIS; SUPPRESSOR;
   IMMUNITY; STRAINS; KUNJIN; VECTOR; CELLS
AB Flaviviruses, such as Zika virus, yellow fever virus, dengue virus, and West Nile virus (WNV), are a serious concern for human health. Flaviviruses produce an abundant noncoding subgenomic flavivirus RNA (sfRNA) in infected cells. sfRNA results from stalling of the host 5'-3' exoribonuclease XRN1/Pacman on conserved RNA structures in the 3' untranslated region (UTR) of the viral genomic RNA. sfRNA production is conserved in insect-specific, mosquito-borne, and tick-borne flaviviruses and flaviviruses with no known vector, suggesting a pivotal role for sfRNA in the flavivirus life cycle. Here, we investigated the function of sfRNA during WNV infection of Culex pipiens mosquitoes and evaluated its role in determining vector competence. An sfRNA1-deficient WNV was generated that displayed growth kinetics similar to those of wild-type WNV in both RNA interference (RNAi)-competent and -compromised mosquito cell lines. Small-RNA deep sequencing of WNV-infected mosquitoes indicated an active small interfering RNA (siRNA)-based antiviral response for both the wild-type and sfRNA1-deficient viruses. Additionally, we provide the first evidence that sfRNA is an RNAi substrate in vivo. Two reproducible small-RNA hot spots within the 3' UTR/sfRNA of the wild-type virus mapped to RNA stem-loops SL-III and 3' SL, which stick out of the three-dimensional (3D) sfRNA structure model. Importantly, we demonstrate that sfRNA-deficient WNV displays significantly decreased infection and transmission rates in vivo when administered via the blood meal. Finally, we show that transmission and infection rates are not affected by sfRNA after intrathoracic injection, thereby identifying sfRNA as a key driver to overcome the mosquito midgut infection barrier. This is the first report to describe a key biological function of sfRNA for flavivirus infection of the arthropod vector, providing an explanation for the strict conservation of sfRNA production.
   IMPORTANCE
   Understanding the flavivirus transmission cycle is important to identify novel targets to interfere with disease and to aid development of virus control strategies. Flaviviruses produce an abundant noncoding viral RNA called sfRNA in both arthropod and mammalian cells. To evaluate the role of sfRNA in flavivirus transmission, we infected mosquitoes with the flavivirus West Nile virus and an sfRNA-deficient mutant West Nile virus. We demonstrate that sfRNA determines the infection and transmission rates of West Nile virus in Culex pipiens mosquitoes. Comparison of infection via the blood meal versus intrathoracic injection, which bypasses the midgut, revealed that sfRNA is important to overcome the mosquito midgut barrier. We also show that sfRNA is processed by the antiviral RNA interference machinery in mosquitoes. This is the first report to describe a pivotal biological function of sfRNA in arthropods. The results explain why sfRNA production is evolutionarily conserved.
C1 [Goertz, G. P.; Fros, J. J.; van der Bent, M. L.; Geertsema, C.; van Oers, M. M.; Pijlman, G. P.] Wageningen Univ, Virol Lab, Wageningen, Netherlands.
   [Fros, J. J.] Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Oxford, England.
   [Miesen, P.; van Rij, R. P.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Med Microbiol, Nijmegen, Netherlands.
   [Vogels, C. B. F.; Koenraadt, C. J. M.] Wageningen Univ, Entomol Lab, Wageningen, Netherlands.
RP Pijlman, GP (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.
EM gorben.pijlman@wur.nl
RI van der Bent, Leontien/L-6837-2015; Fros, Jelke/AAN-5110-2020; van der
   Bent, M. Leontien/AAQ-7354-2020; Van Rij, Ronald/I-7073-2012
OI van der Bent, Leontien/0000-0002-1274-6227; van der Bent, M.
   Leontien/0000-0002-1274-6227; Van Rij, Ronald/0000-0003-0221-4689; Fros,
   Jelke/0000-0002-3291-8401; Koenraadt, Constantianus/0000-0001-7861-8781;
   Vogels, Chantal/0000-0003-0027-6480; Goertz, Giel/0000-0002-8194-3574
FU European Commission (EC)European Commission Joint Research
   CentreEuropean Community (EC) [261466]; EC \ European Research Council
   (ERC) [615680]; European Community's Seventh Framework Programme (FP7
   VECTORIE project) [261466]; Radboud UMC; European Research Council under
   the European Union's Seventh Framework Programme (ERC)European Research
   Council (ERC) [615680]
FX This work, including the efforts of Gorben P. Pijlman, was funded by
   European Commission (EC) (261466). This work, including the efforts of
   Ronald P. Van Rij, was funded by EC vertical bar European Research
   Council (ERC) (615680).; This work was supported by the European
   Community's Seventh Framework Programme (FP7 VECTORIE project 261466), a
   Ph.D. fellowship from Radboud UMC to P.M., and a Consolidator Grant from
   the European Research Council under the European Union's Seventh
   Framework Programme (ERC grant 615680) to R.P.V.R.
CR ADAMS SC, 1995, VIROLOGY, V206, P49, DOI 10.1016/S0042-6822(95)80018-2
   Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737
   Bakonyi T, 2006, EMERG INFECT DIS, V12, P618
   Barzon L, 2013, VIRUSES-BASEL, V5, P2825, DOI 10.3390/v5112825
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Clem RJ, 2016, J GEN VIROL, V97, P1033, DOI 10.1099/jgv.0.000429
   Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525
   Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Fros JJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003956
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86
   Gortz GP, 2015, CELL HOST MICROBE, V18, P133, DOI 10.1016/j.chom.2015.07.009
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   HALL RA, 1991, IMMUNOL CELL BIOL, V69, P47, DOI 10.1038/icb.1991.7
   Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   Kakumani PK, 2015, BIOCHEM J, V471, P89, DOI 10.1042/BJ20150445
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092
   Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MAIN OM, 1977, J MED ENTOMOL, V14, P107, DOI 10.1093/jmedent/14.1.107
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schrodinger L. L. C., 2015, PYMOL MOL GRAPHICS S
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Silva P.F., 2011, THESIS
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Sullivan CS, 2007, METHOD ENZYMOL, V427, P3, DOI 10.1016/S0076-6879(07)27001-6
   Szentpali-Gavaller K, 2016, VIRUSES, V8, pE49
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   WHITFIELD SG, 1973, VIROLOGY, V56, P70, DOI 10.1016/0042-6822(73)90288-2
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 56
TC 55
Z9 55
U1 0
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2016
VL 90
IS 22
BP 10145
EP 10159
DI 10.1128/JVI.00930-16
PG 15
WC Virology
SC Virology
GA EC9MN
UT WOS:000388468800010
PM 27581979
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Hughes, RAC
   Cornblath, DR
   Willison, HJ
AF Hughes, Richard A. C.
   Cornblath, David R.
   Willison, Hugh J.
TI Guillain-Barr, syndrome in the 100 years since its description by
   Guillain, Barr, and Strohl
SO BRAIN
LA English
DT Editorial Material
DE Guillain-Barre syndrome; history; pathology; Zika virus; treatment
ID EXPERIMENTAL ALLERGIC NEURITIS; MOTOR AXONAL NEUROPATHY; ACUTE
   IDIOPATHIC POLYNEURITIS; MILLER FISHER SYNDROME; AUTOIMMUNE PERIPHERAL
   NEUROPATHY; BRAIN-STEM ENCEPHALITIS; NERVE CONDUCTION; NORTHERN CHINA;
   IGG ANTIBODY; POLYNEUROPATHY
AB In 1916, during the Battle of the Somme, Guillain, Barr, and Strohl described two soldiers with severe generalised weakness and loss of sensation. Hughes et al. mark the centenary of this first account of 'Guillain-Barr, syndrome' by examining its subtypes, pathophysiology and epidemiology, including recent Zika virus-associated epidemics.In 1916, during the Battle of the Somme, Guillain, Barr, and Strohl described two soldiers with severe generalised weakness and loss of sensation. Hughes et al. mark the centenary of this first account of 'Guillain-Barr, syndrome' by examining its subtypes, pathophysiology and epidemiology, including recent Zika virus-associated epidemics.
C1 [Hughes, Richard A. C.] UCL, Inst Neurol, London, England.
   [Cornblath, David R.] Johns Hopkins Univ, Meyer 6-181a,601 North Wolfe St, Baltimore, MD 21287 USA.
   [Willison, Hugh J.] Glasgow Biomed Res Ctr, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, 120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.
RP Hughes, RAC (corresponding author), UCL, Inst Neurol, London, England.
CR ALDIN AN, 1982, BRAIN, V105, P481, DOI 10.1093/brain/105.3.481
   [Anonymous], 1978, Ann Neurol, V3, P565
   Arnason B.G., 1984, PERIPHERAL NEUROPATH, V1, P2050
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001
   BANNISTER RG, 1962, J NEUROL NEUROSUR PS, V25, P321, DOI 10.1136/jnnp.25.4.321
   Boes CJ, 2014, J NEUROL, V261, P2264, DOI 10.1007/s00415-014-7326-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7
   CHIBA A, 1992, ANN NEUROL, V31, P677, DOI 10.1002/ana.410310619
   Dionne A, 2010, MUSCLE NERVE, V41, P202, DOI 10.1002/mus.21480
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   ERB W, 1875, ARCH PSYCHIAT NERVEN, V5, P792
   FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115
   FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gabriel CM, 1998, BRAIN, V121, P1895, DOI 10.1093/brain/121.10.1895
   Goodfellow JA, 2005, J NEUROSCI, V25, P1620, DOI 10.1523/JNEUROSCI.4279-04.2005
   GRIFFIN JW, 1995, BRAIN, V118, P577, DOI 10.1093/brain/118.3.577
   Griffin JW, 1996, J NEUROCYTOL, V25, P33, DOI 10.1007/BF02284784
   Guillain G, 1953, ANN MED, V54, P81
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   GUILOFF RJ, 1977, J NEUROL NEUROSUR PS, V40, P801, DOI 10.1136/jnnp.40.8.801
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414
   HAHN AF, 1993, MUSCLE NERVE, V16, P1174, DOI 10.1002/mus.880161106
   Halstead SK, 2004, BRAIN, V127, P2109, DOI 10.1093/brain/awh231
   HAYMAKER W, 1949, MEDICINE, V28, P59, DOI 10.1097/00005792-194902000-00003
   Holmes C, 1917, BRIT MED J, V1917, P37, DOI 10.1136/bmj.2.2950.37
   Horste GMZ, 2014, J IMMUNOL, V193, P2678, DOI 10.4049/jimmunol.1400367
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   ILYAS AA, 1988, ANN NEUROL, V23, P440, DOI 10.1002/ana.410230503
   Ito M, 2008, J NEUROL, V255, P674, DOI 10.1007/s00415-008-0775-0
   KADLUBOWSKI M, 1979, NATURE, V277, P140, DOI 10.1038/277140a0
   Krucke W., 1955, HDB SPEZIELLEN PAT 5, V13, P164
   LAMPERT PW, 1969, LAB INVEST, V20, P127
   Landry O, 1859, GAZETTE HEBDOMADAIRE, V6, P472
   LANGMUIR AD, 1984, AM J EPIDEMIOL, V119, P841, DOI 10.1093/oxfordjournals.aje.a113809
   LININGTON C, 1992, EUR J IMMUNOL, V22, P1813, DOI 10.1002/eji.1830220721
   LININGTON C, 1984, J IMMUNOL, V133, P1946
   Liu JX, 2009, INVEST OPHTH VIS SCI, V50, P3226, DOI 10.1167/iovs.08-3333
   Louvet C, 2009, J EXP MED, V206, P507, DOI 10.1084/jem.20082113
   Makowska A, 2008, J NEUROL NEUROSUR PS, V79, P664, DOI 10.1136/jnnp.2007.123943
   Mathey EK, 2015, J NEUROL NEUROSUR PS, V86, P973, DOI 10.1136/jnnp-2014-309697
   MCCOMBE PA, 1987, BRAIN, V110, P1617
   McGonigal R, 2010, BRAIN, V133, P1944, DOI 10.1093/brain/awq119
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P
   MCLEOD JG, 1981, ANN NEUROL, V9, P20, DOI 10.1002/ana.410090705
   Miller James A L, 2014, J Neuromuscul Dis, V1, P191
   MILNER P, 1987, J NEUROL SCI, V79, P275, DOI 10.1016/0022-510X(87)90235-8
   Odaka M, 2001, J NEUROL NEUROSUR PS, V70, P50, DOI 10.1136/jnnp.70.1.50
   PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704
   PRINEAS JW, 1972, LAB INVEST, V26, P133
   Quincke HI, 1891, BERL KLIN WOCHENSCHR, V28, P929
   Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Su MA, 2012, J IMMUNOL, V188, P4906, DOI 10.4049/jimmunol.1200493
   Susuki K, 2003, ANN NEUROL, V54, P383, DOI 10.1002/ana.33333
   Umapathi T, 2012, J NEUROL NEUROSUR PS, V83, P941, DOI 10.1136/jnnp-2012-303079
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   van den Berg B, 2016, GLASG INFL NEUR CONS, P55
   van den Berg B, 2013, NEUROLOGY, V80, P1650, DOI 10.1212/WNL.0b013e3182904fcc
   van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8
   WAKSMAN BH, 1955, J EXP MED, V102, P213, DOI 10.1084/jem.102.2.213
   WAKSMAN BH, 1956, J NEUROPATH EXP NEUR, V15, P293, DOI 10.1097/00005072-195607000-00005
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   Westphal C., 1875, ARCH PSYCHIAT NERVEN, V4, P803
   Wiederholt HM, 1964, P MAYO CLIN, V49, P427
   Willison HJ, 2016, GBS100 CELEBRATING C, P1
   Willison HJ, 2008, J NEUROIMMUNOL, V201, P172, DOI 10.1016/j.jneuroim.2008.05.028
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Willison Hugh J, 2012, J Peripher Nerv Syst, V17 Suppl 3, P3, DOI 10.1111/j.1529-8027.2012.00423.x
   YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771
NR 75
TC 8
Z9 8
U1 0
U2 12
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
EI 1460-2156
J9 BRAIN
JI Brain
PD NOV
PY 2016
VL 139
BP 3041
EP 3047
DI 10.1093/brain/aww247
PN 11
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ED0WV
UT WOS:000388564400029
PM 29106487
OA Bronze
DA 2020-07-08
ER

PT J
AU He, TJ
   Kaplan, S
   Kamboj, M
   Tang, YW
AF He, Taojun
   Kaplan, Samuel
   Kamboj, Mini
   Tang, Yi-Wei
TI Laboratory Diagnosis of Central Nervous System Infection
SO CURRENT INFECTIOUS DISEASE REPORTS
LA English
DT Review
DE Central nervous system infections; Meningitis; Encephalitis; Laboratory
   diagnosis; Microscopic morphology; Rapid antigen testing; Culture;
   Serology; Molecular methods; Pan-omic techniques
ID HERPES-SIMPLEX-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; QUANTITATIVE
   PROTEOMIC ANALYSIS; ISOTHERMAL AMPLIFICATION ASSAY; CEREBROSPINAL-FLUID;
   TUBERCULOUS MENINGITIS; CRYPTOCOCCAL MENINGITIS; ASEPTIC-MENINGITIS;
   ZIKA-VIRUS; PCR ASSAY
AB Central nervous system (CNS) infections are potentially life threatening if not diagnosed and treated early. The initial clinical presentations of many CNS infections are nonspecific, making a definitive etiologic diagnosis challenging. Nucleic acid in vitro amplification-based molecular methods are increasingly being applied for routine microbial detection. These methods are a vast improvement over conventional techniques with the advantage of rapid turnaround and higher sensitivity and specificity. Additionally, molecular methods performed on cerebrospinal fluid samples are considered the new gold standard for diagnosis of CNS infection caused by pathogens, which are otherwise difficult to detect. Commercial diagnostic platforms offer various monoplex and multiplex PCR assays for convenient testing of targets that cause similar clinical illness. Pan-omic molecular platforms possess potential for use in this area. Although molecular methods are predicted to be widely used in diagnosing and monitoring CNS infections, results generated by these methods need to be carefully interpreted in combination with clinical findings. This review summarizes the currently available armamentarium of molecular assays for diagnosis of central nervous system infections, their application, and future approaches.
C1 [He, Taojun] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Lab Med, Shenzhen 518033, Guangdong, Peoples R China.
   [He, Taojun; Kaplan, Samuel; Kamboj, Mini; Tang, Yi-Wei] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.
   [Kamboj, Mini; Tang, Yi-Wei] Cornell Univ, Weill Med Coll, 1300 York Ave, New York, NY 10065 USA.
RP Tang, YW (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.; Tang, YW (corresponding author), Cornell Univ, Weill Med Coll, 1300 York Ave, New York, NY 10065 USA.
EM tangy@mskcc.org
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30
   CA008748]
CR Antinori S, 2005, J CLIN MICROBIOL, V43, P5828, DOI 10.1128/JCM.43.11.5828-5829.2005
   Bahr NC, 2015, INT J TUBERC LUNG D, V19, P1209, DOI 10.5588/ijtld.15.0253
   Bahr NC, 2016, CLIN INFECT DIS, V62, P1133, DOI 10.1093/cid/ciw083
   Bale JF, 2015, PEDIATR NEUROL, V53, P3, DOI 10.1016/j.pediatrneurol.2015.03.013
   Bloch KC, 2016, MOL MICROBIOLOGY DIA, P287
   Boving MK, 2009, J CLIN MICROBIOL, V47, P908, DOI 10.1128/JCM.01966-08
   Brown JR, 2015, CLIN INFECT DIS, V60, P881, DOI 10.1093/cid/ciu940
   Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578
   Capaul SE, 2005, J CLIN VIROL, V32, P236, DOI 10.1016/j.jcv.2004.08.006
   Cassol E, 2014, AIDS, V28, P1579, DOI 10.1097/QAD.0000000000000303
   Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10
   Chabierski S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-246
   Conca N, 2016, REV CHIL PEDIATR-CHI, V87, P24, DOI 10.1016/j.rchipe.2015.07.024
   Deng JR, 2015, J VIROL METHODS, V213, P98, DOI 10.1016/j.jviromet.2014.12.006
   Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814
   Dheda K, 2013, RESPIROLOGY, V18, P217, DOI 10.1111/resp.12022
   Dickens Alex M, 2015, AIDS, V29, P559, DOI 10.1097/QAD.0000000000000580
   Dunbar SA, 1998, J CLIN MICROBIOL, V36, P1617, DOI 10.1128/JCM.36.6.1617-1620.1998
   Emmadi R, 2011, J MOL DIAGN, V13, P583, DOI 10.1016/j.jmoldx.2011.05.011
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6
   Ginocchio CC, 2005, J CLIN MICROBIOL, V43, P2616, DOI 10.1128/JCM.43.6.2616-2623.2005
   Gitman MR, 2013, J CLIN MICROBIOL, V51, P3765, DOI 10.1128/JCM.01413-13
   Giulieri SG, 2015, J CLIN VIROL, V62, P58, DOI 10.1016/j.jcv.2014.11.001
   Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841
   Goldberg B, 2015, MBIO, V6, DOI 10.1128/mBio.01888-15
   Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044630
   Han SH, 2016, J MED VIROL, V88, P175, DOI 10.1002/jmv.24316
   Haughey NJ, 2013, J NEUROIMMUNE PHARM, V8, P1136, DOI 10.1007/s11481-013-9506-0
   Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010
   Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613
   Ji Shujuan, 2015, Zhonghua Yi Xue Za Zhi, V95, P3733
   Jin Dahee, 2015, Korean J Pediatr, V58, P446, DOI 10.3345/kjp.2015.58.11.446
   Kaplan JE, 2015, JAIDS-J ACQ IMM DEF, V68, pS331, DOI 10.1097/QAI.0000000000000484
   Kelley VA, 2001, CLIN CHEM, V47, P1559
   Kelly C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-145
   Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042954
   Kim DW, 2011, J CLIN MICROBIOL, V49, P3621, DOI 10.1128/JCM.00515-11
   Ku LC, 2015, CLIN PERINATOL, V42, P29, DOI 10.1016/j.clp.2014.10.004
   Kuroda Hiroshi, 2015, Brain Nerve, V67, P931, DOI 10.11477/mf.1416200232
   Kuypers J, 2015, J CLIN VIROL, V62, P103, DOI 10.1016/j.jcv.2014.11.003
   Launes C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.04.021
   Lee D, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01548
   Liermann K, 2014, J VIROL METHODS, V199, P29, DOI 10.1016/j.jviromet.2014.01.001
   Lipkin WI, 2015, BRAIN PATHOL, V25, P600, DOI 10.1111/bpa.12277
   Lu Hong-Zhou, 2002, Curr Infect Dis Rep, V4, P339, DOI 10.1007/s11908-002-0027-x
   Lyons JL, 2015, J CLIN MICROBIOL, V53, P319, DOI 10.1128/JCM.02301-14
   Marchetti O, 2012, BONE MARROW TRANSPL, V47, P846, DOI 10.1038/bmt.2011.178
   Marcos MA, 2001, LANCET, V357, P1499, DOI 10.1016/S0140-6736(00)04658-4
   McAllister SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118529
   McHugh MP, 2015, J MED MICROBIOL, V64, P1321, DOI 10.1099/jmm.0.000154
   Meyer T, 2014, J CLIN MICROBIOL, V52, P1751, DOI 10.1128/JCM.00469-14
   Mishra AK, 2014, EUR J CLIN MICROBIOL, V33, P2083, DOI 10.1007/s10096-014-2166-z
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moayedi Ali Reza, 2015, Electron Physician, V7, P1609, DOI 10.19082/1609
   Mu J, 2015, BIOCHEM BIOPH RES CO, V466, P689, DOI 10.1016/j.bbrc.2015.08.036
   MUSHER DM, 1973, ANN INTERN MED, V79, P603, DOI 10.7326/0003-4819-79-4-603
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912
   Nhu NTQ, 2014, J CLIN MICROBIOL, V52, P226, DOI 10.1128/JCM.01834-13
   Huy NT, 2012, FEMS MICROBIOL LETT, V337, P25, DOI 10.1111/1574-6968.12002
   Nolte FS, 2011, J CLIN MICROBIOL, V49, P528, DOI 10.1128/JCM.01570-10
   Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9
   Ohkusu Kiyofumi, 2015, Brain Nerve, V67, P799, DOI 10.11477/mf.1416200220
   Palmiere C, 2015, J FORENSIC LEG MED, V30, P21, DOI 10.1016/j.jflm.2014.12.012
   Panackal AA, 2016, MBIO, V7, DOI 10.1128/mBio.01906-15
   Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536
   Peng XL, 2016, FEBS LETT, V590, P509, DOI 10.1002/1873-3468.12072
   Polage CR, 2006, CLIN INFECT DIS, V43, P1578, DOI 10.1086/509581
   Rajasingham R, 2015, AM J TROP MED HYG, V92, P274, DOI 10.4269/ajtmh.14-0452
   Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680
   Rhein J, 2016, DIAGN MICR INFEC DIS, V84, P268, DOI 10.1016/j.diagmicrobio.2015.11.017
   ROWLEY AH, 1990, LANCET, V335, P440, DOI 10.1016/0140-6736(90)90667-T
   Salvatore C. M., 2015, J PEDIAT INFECT DIS
   Shaker OG, 2015, CLIN NEUROL NEUROSUR, V129, P67, DOI 10.1016/j.clineuro.2014.12.004
   Shawahna R, 2015, CURR DRUG METAB, V16, P105, DOI 10.2174/138920021602150713114715
   Solomons RS, 2015, INT J TUBERC LUNG D, V19, P74, DOI 10.5588/ijtld.14.0394
   Song F, 2014, IRISH J MED SCI, V183, P85, DOI 10.1007/s11845-013-0980-4
   Silva BDS, 2014, MEM I OSWALDO CRUZ, V109, P29, DOI [10.1590/0074-0276140140, 10.1590/0074-02760140140]
   Steingart KR, 2012, INDIAN J MED RES, V135, P695
   Storch GA, 2000, CLIN INFECT DIS, V31, P739, DOI 10.1086/314015
   Swanson PA, 2015, CURR OPIN VIROL, V11, P44, DOI 10.1016/j.coviro.2014.12.009
   Tang Yi-Wei, 2007, Expert Opin Med Diagn, V1, P489, DOI 10.1517/17530059.1.4.489
   Thounaojam MC, 2014, J VIROL, V88, P4798, DOI 10.1128/JVI.02979-13
   Tuddenham S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1028-3
   TYLER KL, 2004, HERPES J IHMF, V11, P57
   Ubukata Kimiko, 2013, Rinsho Shinkeigaku, V53, P1184
   Varatharaj A, 2016, BRAIN BEHAV IMMUN
   Venkatesan A, 2015, CURR OPIN NEUROL, V28, P277, DOI 10.1097/WCO.0000000000000199
   Whitley Richard J, 2015, Continuum (Minneap Minn), V21, P1704, DOI 10.1212/CON.0000000000000243
   Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   Wootton SH, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0137-1
   Yang YT, 2015, INT J MOL MED, V35, P1323, DOI 10.3892/ijmm.2015.2131
   Zhu B, 2015, J IMMUNOL, V195, P2251, DOI 10.4049/jimmunol.1500370
NR 96
TC 10
Z9 11
U1 0
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1523-3847
EI 1534-3146
J9 CURR INFECT DIS REP
JI Curr. Infect. Dis. Rep.
PD NOV
PY 2016
VL 18
IS 11
AR 35
DI 10.1007/s11908-016-0545-6
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA ED3DI
UT WOS:000388729100003
PM 27686677
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Dikhit, MR
   Ansari, MY
   Vijaymahantesh
   Kalyani
   Mansuri, R
   Sahoo, BR
   Dehury, B
   Amit, A
   Topno, RK
   Sahoo, GC
   Ali, V
   Bimal, S
   Das, P
AF Dikhit, Manas R.
   Ansari, Md. Yousuf
   Vijaymahantesh
   Kalyani
   Mansuri, Rani
   Sahoo, Bikash R.
   Dehury, Budheswar
   Amit, Ajay
   Topno, Roshan K.
   Sahoo, Ganesh C.
   Ali, Vahab
   Bimal, Sanjiva
   Das, Pradeep
TI Computational prediction and analysis of potential antigenic CTL
   epitopes in Zika virus: A first step towards vaccine development
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Zika virus; ZIKV; Epitope; Epitope mapping; CD8+T cell; MHC class I;
   Immunoinformatics
ID WEST-NILE-VIRUS; T-CELL RESPONSE; DENGUE HEMORRHAGIC-FEVER;
   NONSTRUCTURAL PROTEINS; PEPTIDE BINDING; JAPANESE ENCEPHALITIS;
   LYMPHOCYTE RESPONSES; IDENTIFICATION; INFECTION; NS3
AB The Zika virus disease is an Aedesmosquito-borne disease caused by the ZIKA virus. The unavailability of vaccines or proper chemotherapeutic treatment emphasizes the need for the development of preventive and therapeutic vaccines. T cell specific epitopes have been used as vaccine candidates to generate desired immune responses against a variety of viral pathogens. Herein, the immune-informatics approach was used for the screening of potential major histocompatibility complex class I restricted epitopes, which may be competent to generate a cellmediated immune response in humans. A total of 63 epitopes were identified, which revealed a comprehensive binding affinity to the 42 different human leukocyte antigen class I supertypes: A01, A02, A08, A23, A24, A25, A26, A29, A30, A32, A66, A68, A69, A80, B07, B08, B14, B15, B27, B35, B39, B40, B42, B45, B46, B48, B51, B53, B54, B57, B58, B83, C12, C03, C04, C05, C06, C07, C08, C12, C14, and C15, andwhich had no homologs in humans. By combining the human leukocyte antigen binding specificity and population coverage, nine promiscuous epitopes located in Capsid 1 Protein (MVLAILAFL(P1)), Envelop Protein (RLKGVSYSL (P2) and RLITANPVI (P3)), NS2A (AILAALTPL (P4)), NS4B (LLVAHYMYL (P5) and LVAHYMYLI (P6)) and NS5 (SLINGVVRL (P7), ALNTFTNLV (P8) and YLSTQVRYL (P9)) were shortlisted. Most of these consensus epitopes revealed 100% conservancy in all Zika virus strains andwere very less conserved against the human proteome. The combination of the selected epitopes accounted for an optimal coverage in the worldwide population (N99%) independent of ethnicity. Structural analysis of these selected epitopes by the PatchDock web server showed their preferential mode of presentation to the T cell receptor. All these results recommended the possibility of a combined epitope vaccine strategy and can therefore be further investigated for their immunological relevance and usefulness as vaccine candidates. (C) 2016 Elsevier B. V. All rights reserved.
C1 [Dikhit, Manas R.; Ansari, Md. Yousuf; Mansuri, Rani; Dehury, Budheswar; Sahoo, Ganesh C.] Rajendra Mem Res Inst Med Sci, Dept Bioinformat, Patna 800007, Bihar, India.
   [Vijaymahantesh; Amit, Ajay; Bimal, Sanjiva] Rajendra Mem Res Inst Med Sci, Dept Immunol, Patna 800007, Bihar, India.
   [Ansari, Md. Yousuf; Vijaymahantesh; Mansuri, Rani] Natl Inst Pharmaceut Educ & Res, Dept Pharmacoinformat & Biotechnol, Hajipur 844102, India.
   [Kalyani] Rajendra Mem Res Inst Med Sci, Div Virol, Patna 800007, Bihar, India.
   [Sahoo, Bikash R.] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan.
   [Topno, Roshan K.] Rajendra Mem Res Inst Med Sci, Dept Epidemiol, Patna 800007, Bihar, India.
   [Ali, Vahab] Rajendra Mem Res Inst Med Sci, Dept Clin Biochem, Patna 800007, Bihar, India.
   [Das, Pradeep] Rajendra Mem Res Inst Med Sci, Dept Mol Biol, Patna 800007, Bihar, India.
RP Das, P (corresponding author), Rajendra Mem Res Inst Med Sci, Dept Mol Biol, Patna 800007, Bihar, India.
EM drpradeep.das@gmail.com
RI Sahoo, Bikash Ranjan/H-7399-2012; Ansari, Yousuf/F-6045-2014; Idrees,
   Muhammad/K-6032-2012; DEHURY, BUDHESWAR/G-9330-2017
OI Sahoo, Bikash Ranjan/0000-0002-3683-1178; Ansari,
   Yousuf/0000-0001-6365-7104; Idrees, Muhammad/0000-0002-3081-7631;
   DEHURY, BUDHESWAR/0000-0002-9726-8454
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amit A., 2016, J BIOMOL STRUCT DYN, P1
   Ansari MY, 2012, INT J BIOL MACROMOL, V50, P637, DOI 10.1016/j.ijbiomac.2012.01.010
   Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07
   Armengol E, 2002, J GEN VIROL, V83, P551, DOI 10.1099/0022-1317-83-3-551
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Bhasin M, 2004, PROTEIN SCI, V13, P596, DOI 10.1110/ps.03373104
   Brinton MA, 1998, CLIN DIAGN VIROL, V10, P129, DOI 10.1016/S0928-0197(98)00039-7
   CAMENGA DL, 1974, J INFECT DIS, V130, P634, DOI 10.1093/infdis/130.6.634
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Cauchemez S, 2016, LANCET
   CHARRON D, 1997, P 12 INT HIST WORKSH
   CLAYTON J, 1997, GENETIC DIVERSITY HL, V1, P665
   Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255
   Comber J. D., 2015, J NANOMED BIOTHERAPE
   De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115343
   de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142
   Dikhit MR, 2015, INFECT GENET EVOL, V36, P369, DOI 10.1016/j.meegid.2015.10.012
   Doytchinova IA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-131
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gagnon SJ, 1996, J VIROL, V70, P141, DOI 10.1128/JVI.70.1.141-147.1996
   Gomez I, 2003, VIRAL IMMUNOL, V16, P407, DOI 10.1089/088282403322396190
   Gomez-Nunez M, 2006, LEUKEMIA RES, V30, P1293, DOI 10.1016/j.leukres.2006.02.010
   Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512
   Kaabinejadian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066298
   Kar RK, 2013, BIOMED RES INT, DOI 10.1155/2013/609289
   Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626
   KESSON AM, 1987, J GEN VIROL, V68, P2001, DOI 10.1099/0022-1317-68-7-2001
   Kim Y., 2012, NUCLEIC ACIDS RES
   King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012
   Kolaskar AS, 1999, VIROLOGY, V261, P31, DOI 10.1006/viro.1999.9859
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   KUTUBUDDIN M, 1991, MOL IMMUNOL, V28, P149, DOI 10.1016/0161-5890(91)90098-5
   LIU Y, 1989, J GEN VIROL, V70, P565, DOI 10.1099/0022-1317-70-3-565
   LOBIGS M, 1994, VIROLOGY, V202, P195, DOI 10.1006/viro.1994.1335
   Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320
   Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202
   Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186
   Mathew A, 1996, J CLIN INVEST, V98, P1684, DOI 10.1172/JCI118964
   McMurry J, 2005, TUBERCULOSIS, V85, P95, DOI 10.1016/j.tube.2004.09.005
   McMurtrey CP, 2008, P NATL ACAD SCI USA, V105, P2981, DOI 10.1073/pnas.0711874105
   Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Ramirez-Zamora M, 2009, REV NEUROLOGIA, V48, P292, DOI 10.33588/rn.4806.2008560
   RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063
   Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7
   Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996
   Schiewe AJ, 2007, J MOL GRAPH MODEL, V26, P667, DOI 10.1016/j.jmgm.2007.03.017
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Schuler M. M., 2007, SYFPEITHI IMMUNOINFO, P75
   Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594
   Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Sieker F, 2009, CURR PROTEIN PEPT SC, V10, P286, DOI 10.2174/138920309788452191
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Soares de Araujo JS, 2016, B WHO
   Testa JS, 2012, J INFECT DIS, V205, P647, DOI 10.1093/infdis/jir814
   Thomas SJ, 2009, VACCINE, V27, P355, DOI 10.1016/j.vaccine.2008.10.086
   Trost BM, 2007, J AM CHEM SOC, V129, P12396, DOI 10.1021/ja075335w
   van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432
   Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524
   Wang Y, 2006, J GEN VIROL, V87, P3599, DOI 10.1099/vir.0.81306-0
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
NR 67
TC 26
Z9 28
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD NOV
PY 2016
VL 45
BP 187
EP 197
DI 10.1016/j.meegid.2016.08.037
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA ED0ZY
UT WOS:000388574400026
PM 27590716
DA 2020-07-08
ER

PT J
AU Moore, KS
AF Moore, Karen S.
TI Assessing Nurse Practitioner Knowledge of Zika Virus
SO JNP-JOURNAL FOR NURSE PRACTITIONERS
LA English
DT Article
DE knowledge; nurse practitioner; Zika
ID HEALTH-CARE STUDENTS; WORKERS KNOWLEDGE; TRANSMISSION; COLOMBIA; CITIES
AB Zika virus infection is a rapidly evolving disease currently spreading in the Americas and the Caribbean. It is important to assess the current level of Zika virus infection knowledge in nurse practitioners (NPs) to identify gaps that may impact patient and community health. The aim of this study was to assess the level of NP knowledge about Zika virus infection using a 13-question survey that was created and administered via paper/pencil to a convenience sample of 559 NPs. Variables included age of NP, years in NP practice, territory of NP practice, and type of NP specialty. Additional educational interventions are needed to address the knowledge deficits identified.
C1 [Moore, Karen S.] St Louis Univ, Sch Nursing, St Louis, MO 63103 USA.
RP Moore, KS (corresponding author), St Louis Univ, Sch Nursing, St Louis, MO 63103 USA.
EM kmoore71@slu.edu
CR Center for Infectious Disease Research and Policy, US
   Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022
   Grills A, 2016, MMWR-MORBID MORTAL W, V65, P711, DOI 10.15585/mmwr.mm6528e1
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Jamieson D, 2016, 10 QUESTIONS ZIKA CD
   Kuehnert MJ, 2016, MMWR MORB MORTAL WKL, V65
   Betancourt-Trejos ML, 2016, TRAVEL MED INFECT DI, V14, P283, DOI 10.1016/j.tmaid.2016.03.017
   National Institutes of Health, ZIK VIR VACC RES
   Sabogal-Roman JA, 2016, TRAVEL MED INFECT DI, V14, P52, DOI 10.1016/j.tmaid.2015.12.003
   US Centers for Disease Control and Prevention, UN PREGN PREV
   US Centers for Disease Control and Prevention, ZIK VIR HEALTHC PROV
   US Centers for Disease Control and Prevention, MOSQ CONTR
   US Centers for Disease Control and Prevention, ZIK PREGN
   US Centers for Disease Control and Prevention, ZIK VIR PUERT RIC
   US Centers for Disease Control and Prevention, AR RISK LOC ACQ VECT
   US Centers for Disease Control and Prevention, WOM THEIR PARTN
   US Centers for Disease Control and Prevention, COMM RES
   US Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, REC DON SCREEN DEF P
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   WHO, WHO ZIK APP
NR 20
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1555-4155
EI 1878-058X
J9 JNP-J NURSE PRACT
JI JNP-J. Nurse Pract.
PD NOV-DEC
PY 2016
VL 12
IS 10
BP 697
EP +
DI 10.1016/j.nurpra.2016.09.012
PG 11
WC Nursing
SC Nursing
GA ED2UG
UT WOS:000388704500025
OA Bronze
DA 2020-07-08
ER

PT J
AU Casas, J
   Lazzari, C
   Insausti, T
   Launois, P
   Fouque, F
AF Casas, Jerome
   Lazzari, Claudio
   Insausti, Teresita
   Launois, Pascal
   Fouque, Florence
TI Mapping of courses on vector biology and vector-borne diseases systems:
   time for a worldwide effort
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE teaching; expertise; entomology; MOOCs; vector control; insect control;
   crisis management
ID ZIKA VIRUS; ENTOMOLOGY; DISCIPLINE; SCIENCE; FUTURE
AB Major emergency efforts are being mounted for each vector-borne disease epidemiological crisis anew, while knowledge about the biology of arthropods vectors is dwindling slowly but continuously, as is the number of field entomologists. The discrepancy between the rates of production of knowledge and its use and need for solving crises is widening, in particular due to the highly differing time spans of the two concurrent processes. A worldwide web based search using multiple key words and search engines of onsite and online courses in English, Spanish, Portuguese, French, Italian and German concerned with the biology of vectors identified over 140 courses. They are geographically and thematically scattered, the vast majority of them are on-site, with very few courses using the latest massive open online course (MOOC) powerfulness. Over two third of them is given in English and Western Africa is particularity poorly represented. The taxonomic groups covered are highly unbalanced towards mosquitoes. A worldwide unique portal to guide students of all grades and levels of expertise, in particular those in remote locations, is badly needed. This is the objective a new activity supported by the Special Programme for Research and Training in Tropical Diseases (TDR).
C1 [Casas, Jerome; Lazzari, Claudio; Insausti, Teresita] Univ Tours, Inst Rech Biol Insectes, UMR, CNRS, Tours, France.
   [Launois, Pascal; Fouque, Florence] World Hlth Org, Res & Training Trop Dis, Geneva, Switzerland.
RP Casas, J (corresponding author), Univ Tours, Inst Rech Biol Insectes, UMR, CNRS, Tours, France.
EM jerome.casas@univ-tours.fr
RI Lazzari, Claudio/H-6286-2019; Casas, Jerome/D-9620-2011; Lazzari,
   Claudio R/D-2869-2009
OI Lazzari, Claudio/0000-0003-3703-0302; Casas, Jerome/0000-0003-1666-295X;
   Lazzari, Claudio R/0000-0003-3703-0302
FU World Health OrganizationWorld Health Organization [001]
CR Butler D, 2016, NATURE, V532, P155, DOI 10.1038/532155a
   Cuisance D, 2004, COMP IMMUNOL MICROB, V27, P377, DOI 10.1016/j.cimid.2004.03.007
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Daly Howell V., 1995, American Entomologist, V41, P55
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Lambrechts L, 2009, TROP MED INT HEALTH, V14, P1505, DOI 10.1111/j.1365-3156.2009.02401.x
   Leather Simon R., 2009, Biologist (London), V56, P10
   Loxdale HD, 2016, ENTOMOL EXP APPL, V159, P121, DOI 10.1111/eea.12421
   Mullens BA, 2015, VET ITAL, V51, P313, DOI 10.12834/VetIt.560.2675.1
   Pandey Anuja, 2015, WHO South East Asia J Public Health, V4, P92, DOI 10.4103/2224-3151.206627
   Reisen WK, 2014, INFECT GENET EVOL, V28, P573, DOI 10.1016/j.meegid.2013.11.025
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   World Health Organ-ization (WHO), 2016, PROGR REP DEV WHO HL
NR 13
TC 1
Z9 1
U1 0
U2 22
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD NOV
PY 2016
VL 111
IS 11
BP 717
EP 719
DI 10.1590/0074-02760160295
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA ED1QX
UT WOS:000388621100010
PM 27759770
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rajah, MM
   Pardy, RD
   Condotta, SA
   Richer, MJ
   Sagan, SM
AF Rajah, Maaran M.
   Pardy, Ryan D.
   Condotta, Stephanie A.
   Richer, Martin J.
   Sagan, Selena M.
TI Zika Virus: Emergence, Phylogenetics, Challenges, and Opportunities
SO ACS INFECTIOUS DISEASES
LA English
DT Review
DE Zika virus; Guillain-Barre syndrome; fetal microcephaly
ID GENOMIC CHARACTERIZATION; CROSS-REACTIVITY; DENGUE VIRUSES;
   BIRTH-DEFECTS; INFECTION; MODEL; TRANSMISSION; CHIKUNGUNYA; OUTBREAK;
   INHIBITORS
AB Zika virus (ZIKV) is an emerging arthropod borne pathogen that has recently gained notoriety due to its rapid and ongoing geographic expansion and its novel association with neurological complications. Reports of ZIKV-associated Guillain-Barre syndrome as well as fetal microcephaly place emphasis on the need to develop preventative measures and therapeutics to combat ZIKV infection. Thus, it is imperative that models to study ZIKV replication and pathogenesis and the immune response are developed in conjunction with integrated vector control strategies to mount an efficient response to the pandemic. This paper summarizes the current state of knowledge on ZIKV, including the clinical features, phylogenetic analyses, pathogenesis, and the immune response to infection. Potential challenges in developing diagnostic tools, treatment, and prevention strategies are also discussed.
C1 [Rajah, Maaran M.; Pardy, Ryan D.; Condotta, Stephanie A.; Richer, Martin J.; Sagan, Selena M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada.
   [Richer, Martin J.; Sagan, Selena M.] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ H3A 2B4, Canada.
RP Sagan, SM (corresponding author), McGill Univ, 3775 Univ St,Room 608, Montreal, PQ H3A 2B4, Canada.; Richer, MJ (corresponding author), McGill Univ, 3775 Univ St,Room 406A, Montreal, PQ H3A 2B4, Canada.
EM martin.j.richer@mcgill.ca; selena.sagan@mcgill.ca
OI Pardy, Ryan/0000-0002-0024-8888; Sagan, Selena/0000-0002-8484-3632
FU McGill University; Fonds de Recherche du Quebec Nature et Technologies;
   Fonds de Recherche du Quebec Sante - Chercheurs-Boursiers Junior 1;
   McGill University Faculty of Medicine Max E. Binz Fellowship; Natural
   Sciences and Engineering Research Council of Canada (NSERC) Canada
   Graduate Scholarship - Masters (CGS-M)Natural Sciences and Engineering
   Research Council of Canada
FX This work was supported by start-up funds from McGill University (S.M.S.
   and M.J.R.) as well as operating funds from the Fonds de Recherche du
   Quebec Nature et Technologies (S.M.S.). S.M.S. is a Tier II Canada
   Research Chair in RNA Biology and Viral Infections. M.J.R. received
   salary support from the Fonds de Recherche du Quebec Sante -
   Chercheurs-Boursiers Junior 1. M.M.R. thanks the McGill University
   Faculty of Medicine Max E. Binz Fellowship for graduate training. R.D.P.
   thanks the Natural Sciences and Engineering Research Council of Canada
   (NSERC) Canada Graduate Scholarship - Masters (CGS-M) for graduate
   support.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bargielowski I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020699
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Curtis Z, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003999
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hunter P, 2016, EMBO REP, V17, P1370, DOI 10.15252/embr.201643233
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Kawiecki A. B., 2016, J INFECT DIS
   Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Subbaraman N, 2011, NAT BIOTECHNOL, V29, P9, DOI 10.1038/nbt0111-9a
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Waltz E, 2016, NAT BIOTECHNOL, V34, P221, DOI 10.1038/nbt0316-221
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 100
TC 18
Z9 18
U1 1
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD NOV
PY 2016
VL 2
IS 11
BP 763
EP 772
DI 10.1021/acsinfecdis.6b00161
PG 10
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA EC5GL
UT WOS:000388161300004
PM 27704772
DA 2020-07-08
ER

PT J
AU de Araujo, JSS
   Regis, CT
   Gomes, RGS
   Tavares, TR
   dos Santos, CR
   Assuncao, PM
   Nobrega, RV
   Pinto, DDA
   Bezerra, BVD
   Mattos, SD
AF Soares de Araujo, Juliana Sousa
   Regis, Claudio Teixeira
   Silva Gomes, Renata Grigorio
   Tavares, Thiago Ribeiro
   dos Santos, Cicera Rocha
   Assuncao, Patricia Melo
   Nobrega, Renata Valeria
   Alves Pinto, Diana de Fatima
   Dantas Bezerra, Bruno Vinicius
   Mattos, Sandra da Silva
TI Microcephaly in north-east Brazil: a retrospective study on neonates
   born between 2012 and 2015
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID ZIKA VIRUS; CHILD
AB Objective To assess the number of children born with microcephaly in the State of Paraiba, north-east Brazil.
   Methods We contacted 21 maternity centres belonging to a paediatric cardiology network, with access to information regarding more than 100 000 neonates born between 1 January 2012 and 31 December 2015. For 10% of these neonates, nurses were requested to retrieve head circumference measurements data from delivery-room books. We used three separate criteria to classify whether a neonate had microcephaly: (i) the Brazilian Ministry of Health proposed criterion: term neonates (gestational age >= 37 weeks) with a head circumference of less than 32 cm; (ii) Fenton curves: neonates with a head circumference of less than 3 standard deviation for age and gender; or (iii) the proportionality criterion: neonates with a head circumference of less than ((height/2))+10)+/- 2.
   Findings Between 1 and 31 December 2015, nurses obtained data for 16 208 neonates. Depending on which criterion we used, the number of neonates with microcephaly varied from 678 to 1272 (4.2-8.2%).Two per cent (316) ofthe neonates fulfilled all three criteria. We observed temporal fluctuations of microcephaly prevalence from late 2012.
   Conclusion The numbers of microcephaly reported here are much higher than the 6.4 per 10 000 live births reported by the Brazilian live birth information system.The results raise questions about the notification system, the appropriateness of the diagnostic criteria and future implications for the affected children and their families. More studies are needed to understand the epidemiology and the implications for the Brazilian health system.
C1 [Soares de Araujo, Juliana Sousa; Regis, Claudio Teixeira; Silva Gomes, Renata Grigorio; Tavares, Thiago Ribeiro; dos Santos, Cicera Rocha; Assuncao, Patricia Melo; Nobrega, Renata Valeria; Alves Pinto, Diana de Fatima; Dantas Bezerra, Bruno Vinicius; Mattos, Sandra da Silva] Heart Circle Royal Portuguese Hosp, Ave Agamenon Magalhaes 2760, BR-52010902 Recife, PE, Brazil.
RP Mattos, SD (corresponding author), Heart Circle Royal Portuguese Hosp, Ave Agamenon Magalhaes 2760, BR-52010902 Recife, PE, Brazil.
EM ssmattos@cardiol.br
CR [Anonymous], 2016, FACTS MICR
   [Anonymous], 2016, EUROCAT PREV DAT TAB
   [Anonymous], 2016, 13 CTR OP EM SAUD PU
   [Anonymous], 2015, PROT VIG RESP OC MIC
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Cauchemez S, 2016, LANCET
   Geraedts EJ, 2011, HORM RES PAEDIAT, V75, P213, DOI 10.1159/000321192
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Graf WD, 2010, NEUROLOGY, V74, P1080, DOI 10.1212/WNL.0b013e3181d5e077
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Krauss MJ, 2003, AM J OBSTET GYNECOL, V188, P1484, DOI 10.1067/mob.2003.452
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mattos SD, 2015, B WORLD HEALTH ORGAN, V93, P881, DOI 10.2471/BLT.14.148874
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Natale V, 2014, BMJ OPEN, V8, P4, DOI DOI 10.1136/BMJ0PEN-2013-003735
   Oehler E., 2014, Eurosurveillance, V19, P20720
NR 17
TC 29
Z9 31
U1 0
U2 13
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD NOV
PY 2016
VL 94
IS 11
BP 835
EP 840
DI 10.2471/BLT.16.170639
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EC3XP
UT WOS:000388060700010
PM 27821886
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Florida Travel Warning Issued for Pregnant Women After More Zika Cases
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2016
VL 63
IS 9
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC2WY
UT WOS:000387986200001
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI China's "Mosquito Factory" Aims to Wipe Out Zika, Other Diseases
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 2
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2016
VL 63
IS 9
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC2WY
UT WOS:000387986200003
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI US Health Researchers Test Zika Vaccine as Funds Run Low
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2016
VL 63
IS 9
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC2WY
UT WOS:000387986200002
DA 2020-07-08
ER

PT J
AU Cunha, BA
   Apostolopoulou, A
   Sivarajah, T
   Klein, NC
AF Cunha, Burke A.
   Apostolopoulou, Anna
   Sivarajah, Thulashie
   Klein, Natalie C.
TI Facial Puffiness in a Returning Traveler From Puerto Rico: Chikungunya,
   Dengue Fever, or Zika Virus?
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
ID MANIFESTATIONS
C1 [Cunha, Burke A.; Apostolopoulou, Anna; Sivarajah, Thulashie; Klein, Natalie C.] Winthrop Univ Hosp, Div Infect Dis, 222 Stn Plaza N Ste 432, Mineola, NY 11501 USA.
   [Cunha, Burke A.; Apostolopoulou, Anna; Sivarajah, Thulashie; Klein, Natalie C.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA.
RP Cunha, BA (corresponding author), Winthrop Univ Hosp, Div Infect Dis, 222 Stn Plaza N Ste 432, Mineola, NY 11501 USA.
EM bacunha@winthrop.org
CR Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Cunha BA, 2015, INFECT CHEMOTHER, V47, P123, DOI 10.3947/ic.2015.47.2.123
   Padbidri V. S., 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P699
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prashant Soma, 2009, Indian J Dermatol, V54, P128, DOI 10.4103/0019-5154.53186
   Riyaz N, 2010, INDIAN J DERMATOL VE, V76, P671, DOI 10.4103/0378-6323.72466
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Vairo F, 2016, EMERG INFECT DIS, V22, P895, DOI 10.3201/eid2205.151462
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
NR 10
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2016
VL 63
IS 9
BP 1264
EP U139
DI 10.1093/cid/ciw536
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC2WY
UT WOS:000387986200024
PM 27567120
DA 2020-07-08
ER

PT J
AU Rezza, G
AF Rezza, Giovanni
TI Vaccines against chikungunya, Zika and other emerging Aedes
   mosquito-borne viruses: unblocking existing bottlenecks
SO FUTURE VIROLOGY
LA English
DT Review
DE arbovirus; chikungunya; neglected infections; vaccine; viral disease;
   Yellow fever; Zika
ID TETRAVALENT DENGUE VACCINE; PROTECTIVE IMMUNITY; NEUTRALIZING
   ANTIBODIES; DNA VACCINE; LIVE; RECOMBINANT; CANDIDATE; STRAIN;
   IMMUNOGENICITY; CHALLENGE
AB The emergence of Aedes mosquito-borne viral diseases is a global public health challenge. Since mosquito control programs are not highly efficient for outbreak containment, vaccines are essential to limit disease burden. Besides yellow fever vaccines, a vaccine against dengue is now available, while research on vaccines against Zika has just started. Several vaccine candidates against chikungunya are undergoing preclinical studies, and few of them have been tested in Phase II trials. To overcome hurdles and speed-up the development of vaccines against these viral diseases, several actions should be planned: first, the 'animal rule' could be considered for regulatory purposes; second, public-private partnership should be stimulated; third, countries, international organizations and donors commitment should be strengthened, and potential markets identified.
C1 [Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, Viale Regina Elena 299, I-00142 Rome, Italy.
RP Rezza, G (corresponding author), Ist Super Sanita, Dept Infect Dis, Viale Regina Elena 299, I-00142 Rome, Italy.
EM Giovanni.rezza@iss.it
RI rezza, giovanni/D-4393-2016
OI rezza, giovanni/0000-0003-0268-6790
CR Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Andre F E, 2002, Dev Biol (Basel), V110, P25
   Bao HH, 2013, VIRAL IMMUNOL, V26, P75, DOI 10.1089/vim.2012.0061
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Butler D, 2007, NATURE, V449, P158, DOI 10.1038/449158a
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Center for Disease research and Policy, WHO CIT 2 MONTH WIND
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chattopadhyay A, 2013, J VIROL, V87, P395, DOI 10.1128/JVI.01860-12
   Chitradevi STS, 2013, VACCINE, V31, P2035, DOI 10.1016/j.vaccine.2013.02.045
   Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059
   Cohen J, 2016, SCIENCE, V351, P543, DOI 10.1126/science.351.6273.543
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dengue Rezza G., 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917, DOI 10.2807/1560-7917]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   European Centers for Disease Prevention and Control (ECDC), 2016, PRZEGL EPIDEMIOL, V70
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Gessner BD, 2016, VACCINE, V34, P2397, DOI 10.1016/j.vaccine.2016.03.017
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Hallengard D, 2014, J VIROL, V88, P13333, DOI 10.1128/JVI.01926-14
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   HARRISON VR, 1971, J IMMUNOL, V107, P643
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoke CH, 2012, VACCINE, V30, P6713, DOI 10.1016/j.vaccine.2012.08.025
   Khan M, 2012, VIRUS RES, V167, P236, DOI 10.1016/j.virusres.2012.05.004
   Kramer RM, 2013, J PHARM SCI-US, V102, P4305, DOI 10.1002/jps.23749
   Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4
   Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   McClain DJ, 1998, J INFECT DIS, V177, P634, DOI 10.1086/514240
   Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124
   Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/erv.12.6, 10.1586/ERV.12.6]
   Morse SS, 1996, EMERGING VIRUSES
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   PEDERSEN CE, 1972, AM J EPIDEMIOL, V95, P490, DOI 10.1093/oxfordjournals.aje.a121416
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Piper A, 2013, J VIROL, V87, P6748, DOI 10.1128/JVI.03357-12
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Powers AM, 2014, LANCET, V384, P2008, DOI 10.1016/S0140-6736(14)61290-3
   Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rezza G, 2015, PATHOG GLOB HEALTH, V109, P170, DOI 10.1179/2047773215Y.0000000017
   Rezza G, 2014, PATHOG GLOB HEALTH, V108, P349, DOI 10.1179/2047773214Y.0000000163
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Salmona M, 2015, VACCINE, V33, P5432, DOI 10.1016/j.vaccine.2015.08.055
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Stock NK, 2012, VACCINE, V30, P989, DOI 10.1016/j.vaccine.2011.12.057
   Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062
   Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114
   TURELL MJ, 1992, AM J TROP MED HYG, V47, P98, DOI 10.4269/ajtmh.1992.47.98
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054
   Wang EY, 2011, J VIROL, V85, P9249, DOI 10.1128/JVI.00844-11
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   *WHO, 2006, WKLY EPIDEMIOL REC, V81, P105
   WHO, YELL FEV VACC BOOST
   World Health Organization, 2016, IMM VACC BIOL
   World Health Organization, DENG SEV DENG
   World Health Organization. WHO statement on the first meeting of the International Health Regulations, 2005, WHO 1 M INT HLTH REG
   Zuckerman AJ, 2005, PRINCIPLE PRACTICE C
NR 78
TC 2
Z9 2
U1 0
U2 10
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD NOV
PY 2016
VL 11
IS 11
BP 723
EP 730
DI 10.2217/fvl-2016-0067
PG 8
WC Virology
SC Virology
GA EC5WD
UT WOS:000388207100004
DA 2020-07-08
ER

PT J
AU Harville, EW
   Althabe, FA
   Breart, G
   Buekens, P
AF Harville, Emily W.
   Althabe, Fernando A.
   Breart, Gerard
   Buekens, Pierre
TI The Difficult Design of Epidemiologic Studies on Zika Virus and
   Pregnancy
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Editorial Material
C1 [Harville, Emily W.; Althabe, Fernando A.; Breart, Gerard; Buekens, Pierre] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA.
   [Althabe, Fernando A.] IECS, Buenos Aires, DF, Argentina.
   [Breart, Gerard] INSERM, U1153, Paris, France.
RP Harville, EW (corresponding author), Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, Tidewater 2012,1440 Canal St, New Orleans, LA 70112 USA.
EM harville@tulane.edu
OI breart, gerard/0000-0003-3142-9128
CR [Anonymous], 2016, WEEKLY EPIDEMIOLOGIC, V91, P73
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   BHUSHAN V, 1991, J CLIN EPIDEMIOL, V44, P1027, DOI 10.1016/0895-4356(91)90004-S
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarris I, 2012, ULTRASOUND OBST GYN, V39, P266, DOI 10.1002/uog.10082
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2011, UNS AB GLOB REG EST
NR 10
TC 2
Z9 2
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD NOV
PY 2016
VL 30
IS 6
BP 531
EP 532
DI 10.1111/ppe.12312
PG 2
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA EC9IO
UT WOS:000388458500002
PM 27766638
DA 2020-07-08
ER

PT J
AU Jayakumar, P
   Brar, K
   Lippmann, S
AF Jayakumar, Priyanga
   Brar, Kanwarjeet
   Lippmann, Steven
TI Best Zika Virus Detection: Saliva, Serum, or Urine?
SO SOUTHERN MEDICAL JOURNAL
LA English
DT Letter
ID UNIFORM; ATTIRE
C1 [Jayakumar, Priyanga; Brar, Kanwarjeet; Lippmann, Steven] Univ Louisville, Sch Med, Dept Psychiat, Louisville, KY 40292 USA.
RP Jayakumar, P (corresponding author), Univ Louisville, Sch Med, Dept Psychiat, Louisville, KY 40292 USA.
CR Berkin NL, 2001, AM J INFECT CONTROL, V29, P58
   Bianchi MT, 2008, J GEN INTERN MED, V23, P641, DOI 10.1007/s11606-008-0546-8
   Callahan BC, 2016, SOUTH MED J, V109, P326, DOI 10.14423/SMJ.0000000000000455
   Hartmans C HS, 2014, PRIMARY HLTH CARE, V3, P145
   WIlson JA, 2007, J HOSP INFECT, V66, P301, DOI 10.1016/j.jhin.2007.03.026
NR 5
TC 3
Z9 3
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0038-4348
EI 1541-8243
J9 SOUTH MED J
JI South.Med.J.
PD NOV
PY 2016
VL 109
IS 11
BP 697
EP 697
DI 10.14423/SMJ.0000000000000550
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EC0IE
UT WOS:000387782500005
PM 27812710
DA 2020-07-08
ER

PT J
AU Kochakarn, T
   Kotanan, N
   Kumpornsin, K
   Loesbanluechai, D
   Thammasatta, M
   Auewarakul, P
   Wilairat, P
   Chookajorn, T
AF Kochakarn, Theerarat
   Kotanan, Namfon
   Kumpornsin, Krittikorn
   Loesbanluechai, Duangkamon
   Thammasatta, Monta
   Auewarakul, Prasert
   Wilairat, Prapon
   Chookajorn, Thanat
TI Comparative genome analysis between Southeast,Asian and South American
   Zika viruses
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Phylogenetic analysis; Protein structure; Southeast Asia; Dengue virus;
   Zika virus
ID DENGUE VIRUS; ENVELOPE PROTEIN; INFECTION; NS1; MATURATION; MOSQUITOS;
   GLYCOPROTEIN; INSIGHTS; THAILAND; CELLS
AB Objective: To understand the cause for the differences between potentially mild Southeast Asian and the more pathogenic ZIKV in South America. Methods: A comparative genomic analysis was performed to determine putative causations stemming from ZIKV. Results: Phylogenctic analyses integrating geographical and time factors revealed that Southeast Asian ZIKV might not be the direct source of South American outbreaks as previously speculated. Amino acid residues unique to South American ZIKV isolates at the envelope, pr and NS1 proteins are listed and shown in the structural context. These unique residues on external viral proteins are not found in Southeast Asian ZIKV and could be responsible for the ongoing outbreak either via an intrinsic property of the virus or interactions with human immunity. Only a selected few primer/probe sets currently in clinical use were identified of being capable of detecting ZIKV strains worldwide. The envelope proteins of dengue virus (DENV) and ZIKV also showed a remarkable degree of similarity especially at the surface residues. Conclusions: findings that may help explain the cross-reactivity of DENY antibodies to ZIKV. Thus, major caveats must be exercised in using existing diagnostic tools for ZIKV.
C1 [Kochakarn, Theerarat; Kotanan, Namfon; Kumpornsin, Krittikorn; Chookajorn, Thanat] Mahidol Univ, Fac Trop Med, Ctr Excellence Malaria Res, Genom & Evolutionary Med Unit, Bangkok, Thailand.
   [Kochakarn, Theerarat; Wilairat, Prapon] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand.
   [Loesbanluechai, Duangkamon] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Clin Microscopy, Bangkok, Thailand.
   [Thammasatta, Monta] Natl Sci & Technol Dev Agcy, Pathum Thani, Thailand.
   [Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Dept Microbiol, Fac Med, Bangkok, Thailand.
RP Chookajorn, T (corresponding author), Mahidol Univ, Fac Trop Med, Ctr Excellence Malaria Res, Genom & Evolutionary Med Unit, Bangkok, Thailand.
EM thanat.cho@mahidol.edu
OI Chookajorn, Thanat/0000-0003-2876-6203
FU Thailand Research Fund-Mahidol University [RSA5880062]; Office of the
   Higher Education Commission; Mahidol University under the National
   Research Universities Initiative; Royal Golden Jubilee Ph.D.
   ProgramThailand Research Fund (TRF) [PHD/0204/2552]
FX This work in the Chookajorn laboratory is supported by Thailand Research
   Fund-Mahidol University (RSA5880062) and by the Office of the Higher
   Education Commission and Mahidol University under the National Research
   Universities Initiative. TK is supported by the Royal Golden Jubilee
   Ph.D. Program (Grant No. PHD/0204/2552).
CR Akey DL, 2015, BIOESSAYS, V37, P489, DOI 10.1002/bies.201400182
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Corbel V, 2013, TRENDS PARASITOL, V29, P623, DOI 10.1016/j.pt.2013.09.007
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2012, PAEDIATR INT CHILD H, V32, P5, DOI 10.1179/2046904712Z.00000000045
   Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633
   Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lee JWM, 2006, J BIOL CHEM, V281, P1352, DOI 10.1074/jbc.M506614200
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Luca VC, 2013, J VIROL, V87, P818, DOI 10.1128/JVI.01950-12
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Rodrigues JPGLM, 2012, NUCLEIC ACIDS RES, V40, pW323, DOI 10.1093/nar/gks376
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Scheuermann RH, 2016, NATURE, V531, P173, DOI 10.1038/531173a
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang Q, 2012, J BIOL CHEM, V287, P40525, DOI 10.1074/jbc.M112.384446
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 60
TC 8
Z9 8
U1 0
U2 11
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD NOV
PY 2016
VL 9
IS 11
BP 1026
EP 1032
DI 10.1016/j.apjtm.2016.10.002
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EB8IV
UT WOS:000387635600004
PM 27890363
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Wiwanitkit, S
   Wiwanitkit, V
AF Wiwanitkit, Somsri
   Wiwanitkit, Viroj
TI Based on the risk of dengue virus transmission via blood transfusion:
   What about the risk in case of Zika virus?
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
DE Zika virus; Blood; Transfusion; Transmission
AB The risk of dengue virus transmission via blood transfusion is confirmed. As a similar virus, the risk for the case of Zika virus should be mentioned. Here, the authors calculated for the risk of Zika virus transmission via blood transmission referring to the previous data on the risk in case of dengue virus.
C1 [Wiwanitkit, Somsri] Wiwanitit House, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou 571199, Hainan, Peoples R China.
RP Wiwanitkit, S (corresponding author), Wiwanitit House, Bangkok, Thailand.
EM somsriwiwan@hotmail.com
CR Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Dias LL, 2012, TRANSFUSION, V52, P1667, DOI 10.1111/j.1537-2995.2012.03729.x
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Mangwana Sadhana, 2015, Asian J Transfus Sci, V9, P177, DOI 10.4103/0973-6247.154253
   Matos D, 2016, TRANSFUSION, V56, P215, DOI 10.1111/trf.13288
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit S, 2015, J ACUTE DIS, V4, P277, DOI 10.1016/j.joad.2015.06.004
   Wiwanitkit V, 2009, J INFECT DEV COUNTR, V304, P51
NR 10
TC 2
Z9 4
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1995-7645
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD NOV
PY 2016
VL 9
IS 11
BP 1099
EP 1100
DI 10.1016/j.apjtm.2016.10.004
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA EB8IV
UT WOS:000387635600017
PM 27890376
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Kadaikunnan, S
   Alharbi, NS
   Benelli, G
AF Govindarajan, Marimuthu
   Kadaikunnan, Shine
   Alharbi, Naiyf S.
   Benelli, Giovanni
TI Acute toxicity and repellent activity of the Origanum scabrum Boiss. &
   Heldr. (Lamiaceae) essential oil against four mosquito vectors of public
   health importance and its biosafety on non-target aquatic organisms
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Botanical insecticides; Repellent; Anopheles stephensi; Aedes aegypti;
   Culex quinquefasciatus; Culex tritaeniorhynchus; Non-target organisms
ID SYNTHESIZED SILVER NANOPARTICLES; PIPIENS-MOLESTUS DIPTERA; PLANT
   ESSENTIAL OILS; AEDES-AEGYPTI; LARVICIDAL ACTIVITY;
   CHEMICAL-COMPOSITION; CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI;
   MEDIATED SYNTHESIS; VETERINARY IMPORTANCE
AB The recent outbreaks of dengue, chikungunya, and Zika virus highlighted the pivotal importance of mosquito vector control in tropical and subtropical areas worldwide. However, mosquito control is facing hot challenges, mainly due to the rapid development of pesticide resistance in Culicidae and the limited success of biocontrol programs on Aedes mosquitoes. In this framework, screening botanicals for their mosquitocidal potential may offer effective and eco-friendly tools in the fight against mosquitoes. In the present study, the essential oil (EO) obtained from the medicinal plant Origanum scabrum was analyzed by GC-MS and evaluated for its mosquitocidal and repellent activities towards Anopheles stephensi, Aedes aegypti, Culex quinquefasciatus, and Culex tritaeniorhynchus. GC-MS analysis showed a total of 28 compounds, representing 97.1 % of the EO. The major constituents were carvacrol (48.2 %) and thymol (16.6 %). The EO was toxic effect to the A. stephensi, A. aegypti, C. quinquefasciatus, and C. tritaeniorhynchus larvae, with LC50 of 61.65, 67.13, 72.45, and 78.87 mu g/ml, respectively. Complete ovicidal activity was observed at 160, 200, 240, and 280 mu g/ml, respectively. Against adult mosquitoes, LD50 were 122.38, 134.39, 144.53, and 158.87 mu g/ml, respectively. In repellency assays, the EOs tested at 1.0, 2.5, and 5.0 mg/cm(2) concentration of O. scabrum gave 100 % protection from mosquito bites up to 210, 180, 150, and 120 min, respectively. From an eco-toxicological point of view, the EO was tested on three non-target mosquito predators, Gambusia affinis, Diplonychus indicus, and Anisops bouvieri, with LC50 ranging from 4162 to 12,425 mu g/ml. Overall, the EO from O. scabrum may be considered as a low-cost and eco-friendly source of phytochemicals to develop novel repellents against Culicidae.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Kadaikunnan, Shine; Alharbi, Naiyf S.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@gmail.com; benelli.giovanni@gmail.com
RI /L-2836-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019; Benelli,
   Giovanni/A-9100-2013; Alharbi, Naiyf S/B-9402-2019
OI /0000-0001-7018-5379; GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931;
   Benelli, Giovanni/0000-0001-8971-6010; 
FU Deanship of Scientific Research at King Saud UniversityDeanship of
   Scientific Research at King Saud University [PRG-1437-36]
FX Prof. P. Garrigues and two anonymous reviewers kindly improved an
   earlier version of the manuscript. The authors extend their sincere
   appreciations to the Deanship of Scientific Research at King Saud
   University for funding this Prolific Research Group (PRG-1437-36). The
   authors would like to thank Professor and Head of the Department of
   Zoology, Annamalai University, for the laboratory provisions granted.
CR Abu-Lafi S, 2008, BIORESOURCE TECHNOL, V99, P3914, DOI 10.1016/j.biortech.2007.07.042
   Aligiannis N, 2001, J AGR FOOD CHEM, V49, P4168, DOI 10.1021/jf001494m
   Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   Ansari MA, 2000, BIORESOURCE TECHNOL, V73, P207, DOI 10.1016/S0960-8524(99)00180-7
   Araujo ECC, 2003, J AGR FOOD CHEM, V51, P3760, DOI 10.1021/jf021074s
   Benelli G, 2017, J KING SAUD UNIV SCI, V29, P424, DOI 10.1016/j.jksus.2016.08.006
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P2545, DOI 10.1007/s00436-016-5095-1
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P1011, DOI 10.1007/s00436-014-4267-0
   Benelli G, 2015, PARASITOL RES, V114, P227, DOI 10.1007/s00436-014-4183-3
   Calmasur O, 2006, IND CROP PROD, V23, P140, DOI 10.1016/j.indcrop.2005.05.003
   Cavalcanti ESB, 2004, MEM I OSWALDO CRUZ, V99, P541, DOI 10.1590/S0074-02762004000500015
   Cetin H, 2006, J VECTOR ECOL, V31, P118, DOI 10.3376/1081-1710(2006)31[118:ASOTLA]2.0.CO;2
   Cetin H, 2011, PARASITOL RES, V108, P943, DOI 10.1007/s00436-010-2136-z
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Cheng SS, 2003, BIORESOURCE TECHNOL, V89, P99, DOI 10.1016/S0960-8524(03)00008-7
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   de Paula JP, 2003, J ETHNOPHARMACOL, V88, P253, DOI 10.1016/S0378-8741(03)00233-2
   DEO P G, 1988, International Pest Control, V30, P118
   Dev V, 2004, AM J TROP MED HYG, V71, P451, DOI 10.4269/ajtmh.2004.71.451
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   El-Akhal Eouad, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P746
   El-Akhal F, 2016, INT J PHARM PHARM SC, V8, P372
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gbolade AA, 2008, J ESSENT OIL BEAR PL, V11, P148, DOI 10.1080/0972060X.2008.10643611
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   de Lima GPG, 2013, PARASITOL RES, V112, P1953, DOI 10.1007/s00436-013-3351-1
   Govindarajan M, 2008, PARASITOL RES, V102, P289, DOI 10.1007/s00436-007-0761-y
   Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Govindarajan M., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P43, DOI 10.1016/S2221-1691(11)60066-X
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, RES VET SCI, V104, P77, DOI 10.1016/j.rvsc.2015.11.011
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2015, PARASITOL RES, V114, P601, DOI 10.1007/s00436-014-4222-0
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P691, DOI 10.1016/S1995-7645(10)60167-8
   Ifantis TM, 2012, BIOCHEM SYST ECOL, V44, P289, DOI 10.1016/j.bse.2012.06.014
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Isman MB, 2001, FITOTERAPIA, V72, P65, DOI 10.1016/S0367-326X(00)00253-7
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   Jitendra Sharma, 2014, Annals of Biological Research, V5, P50
   Kulkarni RR, 2013, J PEST SCI, V86, P713, DOI 10.1007/s10340-013-0502-1
   Kweka EJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-277
   Lahlou M, 2001, THERAPIE, V56, P193
   Lima MAA, 2011, AFR J BIOTECHNOL, V10, P11716
   Liu ZL, 2012, PARASITOL RES, V111, P991, DOI 10.1007/s00436-012-2923-9
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Mehlhorn H., 2008, ENCY PARASITOLOGY
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Pavela R, 2017, J PEST SCI, V90, P369, DOI 10.1007/s10340-016-0763-6
   Pavela R, 2015, PARASITOL RES, V114, P3835, DOI 10.1007/s00436-015-4614-9
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavela R, 2014, PLANT PROTECT SCI, V50, P36, DOI 10.17221/48/2013-PPS
   Pavela R, 2009, IND CROP PROD, V30, P311, DOI 10.1016/j.indcrop.2009.06.005
   PERICH MJ, 1995, J AM MOSQUITO CONTR, V11, P307
   Pitarokili D, 2011, PARASITOL RES, V109, P425, DOI 10.1007/s00436-011-2271-1
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Rajkumar S, 2004, J ETHNOPHARMACOL, V90, P87, DOI 10.1016/j.jep.2003.09.030
   Sakthivadivel M, 2015, J MED PLANT STU, V3, P1
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Su TY, 1998, J AM MOSQUITO CONTR, V14, P204
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Tawatsin A, 2001, J VECTOR ECOL, V26, P76
   Traboulsi AF, 2005, PEST MANAG SCI, V61, P597, DOI 10.1002/ps.1017
   Traboulsi AF, 2002, PEST MANAG SCI, V58, P491, DOI 10.1002/ps.486
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   WHO, 2005, WHOCDSWHOPESGCDPP13
   WHO (World Health Organization), 1981, WHOVBC81806
   Yildirim E, 2005, FRESEN ENVIRON BULL, V14, P23
   Zein S, 2011, J MED PLANTS RES, V5, P379
NR 84
TC 24
Z9 25
U1 0
U2 22
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD NOV
PY 2016
VL 23
IS 22
BP 23228
EP 23238
DI 10.1007/s11356-016-7568-2
PG 11
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EB7WW
UT WOS:000387602800090
PM 27604128
OA Bronze
DA 2020-07-08
ER

PT J
AU Katz, BZ
AF Katz, Ben Z.
TI Zika Virus Is More Like Rubella Than Human Immunodeficiency Virus
SO JAMA PEDIATRICS
LA English
DT Letter
C1 Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.
   Ann & Robert H Lurie Childrens Hosp Chicago, Div Infect Dis, Chicago, IL 60611 USA.
RP Katz, BZ (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Ann & Robert H Lurie Childrens Hosp Chicago, 225 E Chicago Ave, Chicago, IL 60611 USA.
EM bkatz@northwestern.edu
CR Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Hotez PJ, 2016, JAMA PEDIATR, V170, P787, DOI 10.1001/jamapediatrics.2016.1465
   MARION RW, 1986, AM J DIS CHILD, V140, P638, DOI 10.1001/archpedi.1986.02140210036020
NR 3
TC 1
Z9 1
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD NOV
PY 2016
VL 170
IS 11
BP 1115
EP 1116
DI 10.1001/jamapediatrics.2016.2750
PG 19
WC Pediatrics
SC Pediatrics
GA EC4KM
UT WOS:000388097900028
PM 27617787
DA 2020-07-08
ER

PT J
AU Hotez, PJ
AF Hotez, Peter J.
TI Zika Virus Is More Like Rubella Than Human Immunodeficiency Virus Reply
SO JAMA PEDIATRICS
LA English
DT Letter
C1 [Hotez, Peter J.] Baylor Coll Med, Pediat & Mol Virol, Houston, TX 77030 USA.
   [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA.
RP Hotez, PJ (corresponding author), Baylor Coll Med, Sect Pediat Trop Med, 1 Baylor Plaza,MS 320, Houston, TX 77030 USA.
EM hotez@bcm.edu
CR Franca GVA, 2016, LANCET, VS0140- 6736, P30902
   Johansson MA, 2016, NEW ENGL J MED, V375
NR 2
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD NOV
PY 2016
VL 170
IS 11
BP 1116
EP 1116
DI 10.1001/jamapediatrics.2016.2753
PG 1
WC Pediatrics
SC Pediatrics
GA EC4KM
UT WOS:000388097900029
PM 27617894
DA 2020-07-08
ER

PT J
AU van den Hurk, AF
AF van den Hurk, Andrew F.
TI Dengue and the introduction of mosquito-transmitted viruses into
   Australia
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
AB Dengue virus outbreaks involving 100s of cases periodically occur in north Queensland, the area of Australia where the primary mosquito vector, Aedes aegypti, occurs. This article summarises the ecology, history, current situation and control of dengue virus transmission in Australia and examines the threat posed by newly emergent arboviruses, such as Zika and chikungunya viruses.
C1 [van den Hurk, Andrew F.] Publ Hlth Virol Forens & Sci Serv, Dept Hlth Queensland Govt, POB 594, Archerfield, Qld 4108, Australia.
RP van den Hurk, AF (corresponding author), Publ Hlth Virol Forens & Sci Serv, Dept Hlth Queensland Govt, POB 594, Archerfield, Qld 4108, Australia.
EM andrew.vandenhurk@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019
OI van den Hurk, Andrew/0000-0001-6262-831X
NR 0
TC 0
Z9 0
U1 0
U2 5
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD NOV
PY 2016
VL 37
IS 4
BP 167
EP 169
DI 10.1071/MA16056
PG 3
WC Microbiology
SC Microbiology
GA EC0RO
UT WOS:000387808600005
DA 2020-07-08
ER

PT J
AU Rawlinson, W
AF Rawlinson, William
TI Pregnancy, the placenta and Zika virus (ZIKV) infection
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
ID TRANSMISSION; MICE
AB Zika virus (ZIKV) infections have been recognised in Africa and Asia since 1940. The virus is in the family Flaviviridae and genus Flavivirus, along with Dengue, Japanese encephalitis virus, Tick borne encephalitis, West Nile virus, and Yellow fever virus. These viruses share biological characteristics of an envelope, icosahedral nucleocapsid, and a non-segmented, positive sense, single-strand RNA genome of similar to 10kb encoding three structural proteins (capsid C premembrane/membrane PrM/M, envelope E), and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). ZIKV has three known genotypes; the West African (Nigerian cluster), East African (MR766 prototype cluster), and Asian strains. Virus sequencing from the most recent South American outbreak suggests this virus is related to the 2013 French Polynesian isolates of Asian lineage.
C1 [Rawlinson, William] Prince Wales Hosp, SEALS Pathol, Serol & Virol Div, Level 4,Clin Sci Bldg, Randwick, NSW 2031, Australia.
RP Rawlinson, W (corresponding author), Prince Wales Hosp, SEALS Pathol, Serol & Virol Div, Level 4,Clin Sci Bldg, Randwick, NSW 2031, Australia.
EM w.rawlinson@unsw.edu.au
CR Araujo T. V. B., 2016, LANCET INFECT DIS
   Bastgos L., 2016, 055475 BIORXIV, DOI 10.1101/055475
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Colt S., 2016, B WORLD HEALTH ORGAN, V2, DOI [10.2471/BLT.16.176677, DOI 10.2471/BLT.16.176677]
   Dontigny L, 2008, J OBSTET GYNAECOL CA, V30, P152, DOI 10.1016/S1701-2163(16)32740-2
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Hamilton ST, 2013, J GEN VIROL, V94, P2495, DOI 10.1099/vir.0.052878-0
   Hamilton ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052899
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Scott GM, 2012, J INFECT DIS, V205, P1305, DOI 10.1093/infdis/jis186
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Van Zuylen WJ, 2016, J VIROL, V90, P1108, DOI 10.1128/JVI.02588-15
NR 22
TC 1
Z9 1
U1 0
U2 10
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD NOV
PY 2016
VL 37
IS 4
BP 170
EP 172
DI 10.1071/MA16057
PG 3
WC Microbiology
SC Microbiology
GA EC0RO
UT WOS:000387808600006
DA 2020-07-08
ER

PT J
AU Gatherer, D
AF Gatherer, Derek
TI The voyages of Zika virus
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
AB The announcement in May this year from the World Health Organization, that the Zika virus outbreak that began in October 2015 in the Cape Verde Islands off the west coast of Africa was an American variant of Zika virus, confirmed that Zika has now circumnavigated the world.
C1 [Gatherer, Derek] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YG, England.
RP Gatherer, D (corresponding author), Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YG, England.
EM d.gatherer@lancaster.ac.uk
NR 0
TC 0
Z9 0
U1 0
U2 4
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD NOV
PY 2016
VL 37
IS 4
BP 206
EP 207
DI 10.1071/MA16067
PG 2
WC Microbiology
SC Microbiology
GA EC0RO
UT WOS:000387808600016
OA Bronze
DA 2020-07-08
ER

PT J
AU Sahar, S
   Eleazar, E
   Hugo, J
   Naranatt, P
   Tabb, M
AF Sahar, S.
   Eleazar, E.
   Hugo, J.
   Naranatt, P.
   Tabb, M.
TI DiaSorin Molecular's Zika Virus Primer Pair: Specific Detection of Asian
   and African Lineages and Compatible Multiplexing with Chikungunya Primer
   Pair
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Meeting of the Association-for-Molecular-Pathology
CY NOV 10-12, 2016
CL Charlotte, NC
SP Assoc Mol Pathol
C1 [Sahar, S.; Eleazar, E.; Hugo, J.; Naranatt, P.; Tabb, M.] Diasorin Mol LLC, Cypress, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2016
VL 18
IS 6
MA ID37
BP 977
EP 977
PG 1
WC Pathology
SC Pathology
GA EB2OF
UT WOS:000387201000184
DA 2020-07-08
ER

PT J
AU Ching, J
   Yang, K
   Li, S
AF Ching, J.
   Yang, K.
   Li, S.
TI Clinical Study Involving POC Screening of Returning Travelers for Zika
   Virus at the Border
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Meeting of the Association-for-Molecular-Pathology
CY NOV 10-12, 2016
CL Charlotte, NC
SP Assoc Mol Pathol
C1 [Ching, J.] Coyote Biosci, Campbell, CA USA.
   [Yang, K.; Li, S.] Coyote Biosci, Beijing, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2016
VL 18
IS 6
MA ID58
BP 982
EP 982
PG 1
WC Pathology
SC Pathology
GA EB2OF
UT WOS:000387201000204
DA 2020-07-08
ER

PT J
AU Battersby, T
   Chmura, A
   Hao, S
   Huang, H
   Kritikos, G
   Lal, A
   Malhotra, R
   Miller, A
   Monga, D
   Mosner, J
   Patel, A
   Wagner, C
AF Battersby, T.
   Chmura, A.
   Hao, S.
   Huang, H.
   Kritikos, G.
   Lal, A.
   Malhotra, R.
   Miller, A.
   Monga, D.
   Mosner, J.
   Patel, A.
   Wagner, C.
TI Analytical Sensitivity and Specificity of the VERSANT Zika RNA 1.0 Assay
   (kPCR)
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Meeting of the Association-for-Molecular-Pathology
CY NOV 10-12, 2016
CL Charlotte, NC
SP Assoc Mol Pathol
C1 [Battersby, T.; Hao, S.; Huang, H.; Kritikos, G.; Lal, A.; Malhotra, R.; Miller, A.; Monga, D.; Mosner, J.; Patel, A.; Wagner, C.] Siemens Healthcare, Berkeley, CA USA.
   [Chmura, A.] Siemens Mol Diagnost, Berkeley, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2016
VL 18
IS 6
MA ID72
BP 985
EP 985
PG 1
WC Pathology
SC Pathology
GA EB2OF
UT WOS:000387201000218
DA 2020-07-08
ER

PT J
AU DeFrancesco, L
AF DeFrancesco, Laura
TI Zika pipeline progresses
SO NATURE BIOTECHNOLOGY
LA English
DT News Item
CR 2016, NAT MED, V22, P1101
   2014, NAT BIOTECHNOL, V32, P849
   2016, CELL, V165, P1238
   2016, SCIENCE, V354, P237
   2016, NATURE, V536, P474
NR 5
TC 1
Z9 1
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD NOV
PY 2016
VL 34
IS 11
BP 1084
EP 1086
DI 10.1038/nbt1116-1084b
PG 4
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA EB6PG
UT WOS:000387506500007
PM 27824828
DA 2020-07-08
ER

PT J
AU Omole, O
   Folaranmi, T
AF Omole, Oluwatosin
   Folaranmi, Temitope
TI Zika virus in Africa: revitalising the discourse of health systems
SO PERSPECTIVES IN PUBLIC HEALTH
LA English
DT Editorial Material
C1 [Omole, Oluwatosin] Howard Univ Hosp, Dept Community & Family Med, Washington, DC 20059 USA.
   [Folaranmi, Temitope] Afe Babalola Univ, OGEES Inst, Ado Ekiti, Nigeria.
RP Omole, O (corresponding author), Howard Univ Hosp, Dept Community & Family Med, Washington, DC 20059 USA.
CR Hirschler B., INSIGHT MOSQUITOES R
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Soyombo F., PLUNDER W AFRICA EBO
   US Centers for Disease Control and Prevention, ZIK VIR CAP VERD
NR 5
TC 2
Z9 2
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1757-9139
EI 1757-9147
J9 PERSPECT PUBLIC HEAL
JI Perspect. Public Health
PD NOV
PY 2016
VL 136
IS 6
BP 333
EP 334
DI 10.1177/1757913916663141
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EB4FP
UT WOS:000387325900016
PM 27811226
DA 2020-07-08
ER

PT J
AU Barcellos, C
   Xavier, DR
   Pavao, AL
   Boccolini, CS
   Pina, MF
   Pedroso, M
   Romero, D
   Romao, AR
AF Barcellos, Christovam
   Xavier, Diego Ricardo
   Pavao, Ana Luiza
   Boccolini, Crittiano Siqueira
   Pina, Maria Fatima
   Pedroso, Marcel
   Romero, Dalia
   Romao, Anselmo Rocha
TI Increased Hospitalizations for Neuropathies as Indicators of Zika Virus
   Infection, according to Health Information System Data, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB Evidence is increasing that Zika virus can cause extensive damage to the central nervous system, affecting both fetuses and adults. We sought to identify traces of possible Clinical manifestations of nervous system diseases among the registers of hospital admissions recorded in the Brazilian Unified Health System. Time series Of several diagnoses from the International Classification of Diseases, 10th Revision; were analyzed by using control diagrams, during January 2008 February 2016. Beginning in mid-2014, We observed an unprecedented and Significant rise in the hospitalization rate for congenital malformation of the nervous system, Gullain-Barre syndrome, encephalitis; Myelitis, and encephalomyelitis. These conditions are compatible with viral infection and inflammation-associated manifestations and may have been due to the entrance of Zika virus into Brazil. These findings show the necessity of adequately diagnosing and treating suspected cases of Zika virus Wee fiat and also that health surveillance systems can be improved by using routine data.
C1 [Barcellos, Christovam; Xavier, Diego Ricardo; Pavao, Ana Luiza; Boccolini, Crittiano Siqueira; Pina, Maria Fatima; Pedroso, Marcel; Romero, Dalia; Romao, Anselmo Rocha] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Pina, Maria Fatima] Univ Porto, Inst Invest & Inovacao Saude, Oporto, Portugal.
RP Barcellos, C (corresponding author), LIS ICICT Fiocruz, Av Brasil 4365, BR-21045900 Rio De Janeiro, RJ, Brazil.
EM xris@fiocruz.br
RI Pedroso, Marcel/AAG-2318-2020; Barcellos, Christovam/G-6856-2012; Pina,
   Maria de Fatima/N-7574-2014
OI Pedroso, Marcel/0000-0002-7323-2107; Barcellos,
   Christovam/0000-0002-1161-2753; Romero M., Dalia E./0000-0002-2643-9797;
   Pina, Maria de Fatima/0000-0002-1521-7865
FU Brazilian Ministry of Health; Health Situation Analysis Department;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [404160/2013-1]
FX We are thankful for the support of the Brazilian Ministry of Health,
   namely, the Health Situation Analysis Department. We also are grateful
   for the inspiring ideas from Paulo Sabroza, as well as the advice from
   Laura Machado and the anonymous reviewers of the Emerging Infectious
   Diseases journal.; The authors received partial support from the
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, project
   404160/2013-1.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Guerra FAR, 2008, CAD SAUDE PUBLICA, V24, P438, DOI [10.1590/S0102-311X2008000200023, 10.1590/S0102-311X2008000100014]
   Gutierrez APA, 2014, WEATHER CLIM EXTREME, V3, P95, DOI 10.1016/j.wace.2.013.12.001
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Mahecha M. P., 2016, IMMUNOL RES
   Mallet HP, 2015, B INFORM SANITAIRES, V20-21, P367
   Ministerio da Saude, 2015, DENG CHIG ZIC SIT EP
   Ministerio da Saude, 2015, PROT VIG CAS MAN NEU
   Ministerio da Saude (Brazil), 2016, PROT VIG RESP OC MIC
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oliveira Evangelina X G de, 2004, Cad Saude Publica, V20, P386
   Pan American Health Organization World Health Organization, 2015, EP AL
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Rufino R, 2016, CIENC SAUDE COLETIVA, V21, P777, DOI 10.1590/1413-81232015213.17002015
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Secretaria de Estado de Saude Publica do Estado do Rio Grande do Norte (SESAP-RN), 2015, SINDR EX ESCL
   Secretaria de Saude do Estado da Bahia (SESAB-BA), 2015, 0315 SESABBA
   Secretaria Estadual de Saude de Pernambuco, 0415 SECR EST SAUD P
   Toledo J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004284
   Viana Dione Viero, 2013, Rev. bras. epidemiol., V16, P240, DOI 10.1590/S1415-790X2013000200002
   World Health Organization, ZIK VIR POT COMPL
NR 29
TC 22
Z9 23
U1 0
U2 13
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2016
VL 22
IS 11
BP 1894
EP 1899
DI 10.3201/eid2211.160901
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EA3XS
UT WOS:000386543200004
PM 27603576
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Merel, S
   Snyder, SA
AF Merel, Sylvain
   Snyder, Shane A.
TI Critical assessment of the ubiquitous occurrence and fate of the insect
   repellent N,N-diethyl-m-toluamide in water
SO ENVIRONMENT INTERNATIONAL
LA English
DT Review
DE DEET; Diethyltoluamide; Insect repellent; Water treatment; Mass
   spectrometry; Water contamination; Analytical interference
ID PERSONAL CARE PRODUCTS; ORGANIC WASTE-WATER; ENDOCRINE DISRUPTING
   COMPOUNDS; SOLID-PHASE EXTRACTION; CHROMATOGRAPHY MASS-SPECTROMETRY;
   PRESSURE CHEMICAL-IONIZATION; ANODIC FENTON TREATMENT;
   GREAT-BARRIER-REEF; DRINKING-WATER; EMERGING CONTAMINANTS
AB The insect repellent diethyltoluamide (DEET) is among the most frequently detected organic chemical contaminants in water across a wide range of geographies from around the world. These observations are raising critical questions and increasing concerns regarding potential environmental relevance, particularly when the emergence of severe neurological conditions attributed to the Zika virus has increased the use of insect repellents. After dermal application, DEET is washed from the skin when bathing and enters the municipal sewer system before discharge into the environment. Mainly measured by gas chromatography or liquid chromatography coupled to mass spectrometry (GC-MS or LC-MS), more than 200 peer-reviewed publications have already reported concentrations of DEET ranging ng/L to mg/L in several water matrices from North America, Europe, Asia, Oceania, and more recently Africa and South America. While conventional wastewater treatment technology has limited capacity of removal, advanced technologies are capable of better attenuation and could lower the environmental discharge of organic contaminants, including DEET. For instance, adsorption on activated carbon, desalinating membrane processes (nanofiltration and reverse osmosis), ozonation, and advanced oxidation processes can achieve 50% to essentially 100% DEET attenuation. Despite the abundant literature on the topic, the ubiquity of DEET in the environment still raises questions due to the apparent lack of obvious spatio-temporal trends in concentrations measured in surface water, which does not fit the expected usage pattern of insect repellents. Moreover, two recent studies showed discrepancies between the concentrations obtained by GC-MS and LC-MS analyses. While the occurrence of DEET in the environment is well established, the concentrations reported should be interpreted cautiously, considering the disparities in methodologies applied and occurrence patterns observed. Therefore, this manuscript provides a critical overview of the origin of DEET in the environment, the relevant analytical methods, the occurrence reported in peer-reviewed literature, and the attenuation efficacy of water treatment processes. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Merel, Sylvain; Snyder, Shane A.] Univ Arizona, Dept Chem & Environm Engn, 1133 James E Rogers Way, Tucson, AZ 85721 USA.
   [Merel, Sylvain] Eberhard Karls Univ Tubingen, Ctr Appl Geosci, Environm Analyt Chem, 12 Holderlinstr, D-72074 Tubingen, Germany.
RP Merel, S; Snyder, SA (corresponding author), Univ Arizona, Dept Chem & Environm Engn, 1133 James E Rogers Way, Tucson, AZ 85721 USA.; Merel, S (corresponding author), Eberhard Karls Univ Tubingen, Ctr Appl Geosci, Environm Analyt Chem, 12 Holderlinstr, D-72074 Tubingen, Germany.
EM sylvain.merel@uni-tuebingen.de; snyders2@email.arizona.edu
RI Snyder, Shane/A-3302-2011
OI Snyder, Shane/0000-0003-2709-9840; Merel, Sylvain/0000-0002-9587-2981
FU DEET Task Force of the Consumer Specialty Products Association; Water &
   Energy Sustainable Technology (WEST) Center at the University of
   Arizona; Agilent Technologies
FX This study was funded in part by the DEET Task Force of the Consumer
   Specialty Products Association and in part by the Water & Energy
   Sustainable Technology (WEST) Center at the University of Arizona. The
   authors wish to thank Agilent Technologies for their support related to
   mass spectrometric analyses conducted in the Snyder Research
   Laboratories at the University of Arizona.
CR Acero JL, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2404-8
   Acero JL, 2013, CHEM ENG J, V219, P43, DOI 10.1016/j.cej.2012.12.067
   Adams WA, 2009, J PHOTOCH PHOTOBIO A, V202, P28, DOI 10.1016/j.jphotochem.2008.11.003
   Alidina M, 2014, SCI TOTAL ENVIRON, V478, P152, DOI 10.1016/j.scitotenv.2014.01.093
   Allinson M, 2012, WATER SCI TECHNOL, V66, P768, DOI 10.2166/wst.2012.242
   Almeida C, 2014, TALANTA, V120, P126, DOI 10.1016/j.talanta.2013.11.031
   Alturki A, 2012, BIORESOURCE TECHNOL, V113, P201, DOI 10.1016/j.biortech.2012.01.082
   Alturki AA, 2010, J MEMBRANE SCI, V365, P206, DOI 10.1016/j.memsci.2010.09.008
   Alvarez DA, 2005, CHEMOSPHERE, V61, P610, DOI 10.1016/j.chemosphere.2005.03.023
   Alvarez D, 2014, SCI TOTAL ENVIRON, V484, P322, DOI 10.1016/j.scitotenv.2013.07.128
   Alvarez DA, 2014, MAR POLLUT BULL, V81, P347, DOI 10.1016/j.marpolbul.2013.04.022
   Alvarez DA, 2012, CHEMOSPHERE, V88, P605, DOI 10.1016/j.chemosphere.2012.03.040
   Antonopoulou M, 2015, J ENVIRON CHEM ENG, V3, P3005, DOI 10.1016/j.jece.2015.02.020
   Antonopoulou M, 2014, GLOBAL NEST J, V16, P507
   Antonopoulou M, 2013, CHEM ENG J, V231, P314, DOI 10.1016/j.cej.2013.06.123
   Antonopoulou M, 2013, CLEAN-SOIL AIR WATER, V41, P593, DOI 10.1002/clen.201200405
   Anumol T, 2016, ENVIRON INT, V92-93, P33, DOI 10.1016/j.envint.2016.03.022
   Anumol T, 2015, ENVIRON SCI-WAT RES, V1, P632, DOI [10.1039/c5ew00080g, 10.1039/C5EW00080G]
   Anumol T, 2015, WATER RES, V76, P76, DOI 10.1016/j.watres.2015.02.019
   Anumol T, 2015, TALANTA, V132, P77, DOI 10.1016/j.talanta.2014.08.011
   Anumol T, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-104
   Aronson D, 2012, INTEGR ENVIRON ASSES, V8, P135, DOI 10.1002/ieam.271
   Baderna D, 2011, ENVIRON RES, V111, P603, DOI 10.1016/j.envres.2011.01.015
   Balducci C, 2012, ENVIRON SCI POLLUT R, V19, P1875, DOI 10.1007/s11356-012-0815-2
   Barber LB, 2007, AQUAT TOXICOL, V82, P36, DOI 10.1016/j.aquatox.2007.01.003
   Barber LB, 2013, ENVIRON SCI TECHNOL, V47, P2177, DOI 10.1021/es303720g
   Bargar TA, 2013, MAR POLLUT BULL, V70, P281, DOI 10.1016/j.marpolbul.2013.03.001
   Barnes KK, 2008, SCI TOTAL ENVIRON, V402, P192, DOI 10.1016/j.scitotenv.2008.04.028
   Barnes KK, 2004, GROUND WATER MONIT R, V24, P119, DOI 10.1111/j.1745-6592.2004.tb00720.x
   Bartelt-Hunt SL, 2009, ENVIRON POLLUT, V157, P786, DOI 10.1016/j.envpol.2008.11.025
   Bellona C, 2007, WATER RES, V41, P3948, DOI 10.1016/j.watres.2007.05.027
   Bellona C, 2012, SEP PURIF TECHNOL, V85, P69, DOI 10.1016/j.seppur.2011.09.046
   Bellona C, 2010, SEP PURIF TECHNOL, V74, P44, DOI 10.1016/j.seppur.2010.05.006
   Benbow TJ, 2008, ORG GEOCHEM, V39, P1690, DOI 10.1016/j.orggeochem.2008.08.008
   Benotti MJ, 2009, WATER RES, V43, P1513, DOI 10.1016/j.watres.2008.12.049
   Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a
   Bernhard M, 2006, WATER RES, V40, P3419, DOI 10.1016/j.watres.2006.07.011
   Bernot MJ, 2013, SCI TOTAL ENVIRON, V445, P219, DOI 10.1016/j.scitotenv.2012.12.039
   Bidwell JR, 2010, ARCH ENVIRON CON TOX, V58, P286, DOI 10.1007/s00244-009-9388-6
   Bisceglia KJ, 2010, J CHROMATOGR A, V1217, P558, DOI 10.1016/j.chroma.2009.11.062
   Blanset DL, 2007, HUM ECOL RISK ASSESS, V13, P615, DOI 10.1080/10807030701341209
   Calza P, 2013, J PHOTOCH PHOTOBIO A, V271, P99, DOI 10.1016/j.jphotochem.2013.08.001
   Calza P, 2011, SCI TOTAL ENVIRON, V409, P3894, DOI 10.1016/j.scitotenv.2011.06.006
   Campos D, 2016, CHEMOSPHERE, V149, P177, DOI 10.1016/j.chemosphere.2016.01.098
   Celano R, 2014, J CHROMATOGR A, V1355, P26, DOI 10.1016/j.chroma.2014.06.009
   Chapman H, 2003, WATER SCI TECHNOL, V47, P151
   Chari BP, 2012, WATER RES, V46, P4814, DOI 10.1016/j.watres.2012.06.017
   Chen TH, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4511-9
   Chen TS, 2014, J TAIWAN INST CHEM E, V45, P2615, DOI 10.1016/j.jtice.2014.06.020
   Chen ZF, 2014, WATER RES, V58, P269, DOI 10.1016/j.watres.2014.03.072
   Chen ZF, 2012, ANAL BIOANAL CHEM, V404, P3175, DOI 10.1007/s00216-012-6444-2
   Cheng Y, 2006, ENVIRON SCI TECHNOL, V40, P5846, DOI 10.1021/es0603857
   Clarke BO, 2015, CHEMOSPHERE, V127, P269, DOI 10.1016/j.chemosphere.2015.02.030
   Coes AL, 2014, SCI TOTAL ENVIRON, V473, P731, DOI 10.1016/j.scitotenv.2013.12.082
   Comerton AM, 2008, J MEMBRANE SCI, V313, P323, DOI 10.1016/j.memsci.2008.01.021
   Comerton AM, 2007, J MEMBRANE SCI, V303, P267, DOI 10.1016/j.memsci.2007.07.025
   Cordy GE, 2004, GROUND WATER MONIT R, V24, P58, DOI 10.1111/j.1745-6592.2004.tb00713.x
   Corwin CJ, 2010, ENVIRON SCI TECHNOL, V44, P5403, DOI 10.1021/es9037462
   Costanzo SD, 2007, SCI TOTAL ENVIRON, V384, P214, DOI 10.1016/j.scitotenv.2007.05.036
   Dai G, 2015, CHEMOSPHERE, V119, P1033, DOI 10.1016/j.chemosphere.2014.08.056
   Dall'Osto M, 2007, SCI TOTAL ENVIRON, V384, P120, DOI 10.1016/j.scitotenv.2007.05.041
   De Geronimo E, 2014, CHEMOSPHERE, V107, P423, DOI 10.1016/j.chemosphere.2014.01.039
   Del Rosario KL, 2014, SCI TOTAL ENVIRON, V487, P216, DOI 10.1016/j.scitotenv.2014.03.135
   Deroux JM, 1996, TALANTA, V43, P365, DOI 10.1016/0039-9140(95)01815-8
   Dickenson ERV, 2011, WATER RES, V45, P1199, DOI 10.1016/j.watres.2010.11.012
   Dickenson ERV, 2009, ENVIRON SCI TECHNOL, V43, P6242, DOI 10.1021/es803696y
   Dong BF, 2015, SCI TOTAL ENVIRON, V518, P479, DOI 10.1016/j.scitotenv.2015.02.074
   Dsikowitzky L, 2004, CHEMOSPHERE, V57, P1275, DOI 10.1016/j.chemosphere.2004.08.052
   Dsikowitzky L, 2014, ENVIRON CHEM LETT, V12, P407, DOI 10.1007/s10311-014-0462-6
   Dsikowitzky L, 2015, J HAZARD MATER, V300, P254, DOI 10.1016/j.jhazmat.2015.07.001
   Dsikowitzky L, 2011, MAR POLLUT BULL, V62, P851, DOI 10.1016/j.marpolbul.2011.02.023
   Eggen T, 2010, SCI TOTAL ENVIRON, V408, P5147, DOI 10.1016/j.scitotenv.2010.07.049
   EPA, 2013, INS REP US EFF
   EPA, 1998, DEET RER EL DEC FACT
   Escher BI, 2013, ENVIRON SCI TECHNOL, V47, P7002, DOI 10.1021/es304793h
   Fairbairn DJ, 2015, SCI TOTAL ENVIRON, V505, P896, DOI 10.1016/j.scitotenv.2014.10.046
   Farhat A, 2015, ENVIRON SCI TECHNOL, V49, P14326, DOI 10.1021/acs.est.5b02705
   Ferguson PJ, 2013, SCI TOTAL ENVIRON, V458, P187, DOI 10.1016/j.scitotenv.2013.04.024
   Ferrer I, 2007, J CHROMATOGR A, V1175, P24, DOI 10.1016/j.chroma.2007.09.092
   Focazio MJ, 2008, SCI TOTAL ENVIRON, V402, P201, DOI 10.1016/j.scitotenv.2008.02.021
   Fox JT, 2010, ENVIRON SCI TECHNOL, V44, P8835, DOI 10.1021/es1019367
   FRANKE S, 1995, FRESEN J ANAL CHEM, V353, P39, DOI 10.1007/BF00322888
   French VA, 2015, SCI TOTAL ENVIRON, V536, P639, DOI 10.1016/j.scitotenv.2015.07.114
   Fujioka T, 2015, DESALINATION, V368, P69, DOI 10.1016/j.desal.2014.06.011
   Fujioka T, 2014, SEP PURIF TECHNOL, V136, P258, DOI 10.1016/j.seppur.2014.08.039
   Garcia-Ac A, 2009, J CHROMATOGR A, V1216, P8518, DOI 10.1016/j.chroma.2009.10.015
   Garcia-Segura S, 2015, J HAZARD MATER, V283, P551, DOI 10.1016/j.jhazmat.2014.10.003
   Geerdink RB, 1999, J CHROMATOGR A, V863, P147, DOI 10.1016/S0021-9673(99)00898-5
   Gerrity D, 2012, WATER RES, V46, P6257, DOI 10.1016/j.watres.2012.08.037
   Gerrity D, 2011, WATER RES, V45, P5399, DOI 10.1016/j.watres.2011.07.020
   Gerrity D, 2011, WATER RES, V45, P2155, DOI 10.1016/j.watres.2010.12.031
   Glassmeyer ST, 2005, ENVIRON SCI TECHNOL, V39, P5157, DOI 10.1021/es048120k
   Gomez MJ, 2010, J CHROMATOGR A, V1217, P7038, DOI 10.1016/j.chroma.2010.08.070
   Gomez MJ, 2009, J CHROMATOGR A, V1216, P4071, DOI 10.1016/j.chroma.2009.02.085
   Haggard BE, 2006, J ENVIRON QUAL, V35, P1078, DOI 10.2134/jeq2005.0248dup
   Hanamoto S, 2013, ENVIRON SCI TECHNOL, V47, P13571, DOI 10.1021/es4035478
   Hawker DW, 2011, WATER RES, V45, P768, DOI 10.1016/j.watres.2010.08.053
   Heeb F, 2012, ENVIRON SCI TECHNOL, V46, P8680, DOI 10.1021/es301912q
   Helbling DE, 2010, ENVIRON SCI TECHNOL, V44, P6628, DOI 10.1021/es101035b
   Helbling DE, 2010, ENVIRON SCI TECHNOL, V44, P6621, DOI 10.1021/es100970m
   HENDRIKS AJ, 1994, WATER RES, V28, P581, DOI 10.1016/0043-1354(94)90009-4
   Hernandez F, 2015, J HAZARD MATER, V282, P86, DOI 10.1016/j.jhazmat.2014.08.006
   Hollender J, 2009, ENVIRON SCI TECHNOL, V43, P7862, DOI 10.1021/es9014629
   Holloway RW, 2014, ENVIRON SCI TECHNOL, V48, P10859, DOI 10.1021/es501051b
   Hope BK, 2012, SCI TOTAL ENVIRON, V417, P263, DOI 10.1016/j.scitotenv.2011.12.028
   Huang HO, 2011, DESALINATION, V281, P446, DOI 10.1016/j.desal.2011.08.018
   Huang KL, 2015, J ENVIRON SCI HEAL A, V50, P931, DOI 10.1080/10934529.2015.1030286
   Hunt RJ, 2010, ENVIRON SCI TECHNOL, V44, P7956, DOI 10.1021/es100698m
   Hyland KC, 2012, WATER RES, V46, P1958, DOI 10.1016/j.watres.2012.01.012
   Benitez FJ, 2013, OZONE-SCI ENG, V35, P263, DOI 10.1080/01919512.2013.794107
   Benitez FJ, 2013, WATER RES, V47, P870, DOI 10.1016/j.watres.2012.11.016
   Benitez FJ, 2013, J ENVIRON SCI HEAL A, V48, P120, DOI 10.1080/10934529.2012.707864
   Jernberg J, 2013, SCI TOTAL ENVIRON, V450, P1, DOI 10.1016/j.scitotenv.2013.02.006
   Jernberg J, 2013, TALANTA, V103, P384, DOI 10.1016/j.talanta.2012.10.084
   Gomez MJ, 2012, SCI TOTAL ENVIRON, V420, P134, DOI 10.1016/j.scitotenv.2012.01.029
   Karpuzcu ME, 2014, ENVIRON SCI-PROC IMP, V16, P2390, DOI [10.1039/C4EM00324A, 10.1039/c4em00324a]
   Katz BG, 2008, ENVIRON GEOL, V55, P801, DOI 10.1007/s00254-007-1033-y
   Katz BG, 2009, SCI TOTAL ENVIRON, V407, P2872, DOI 10.1016/j.scitotenv.2009.01.022
   Kennedy K, 2012, MAR POLLUT BULL, V64, P1495, DOI 10.1016/j.marpolbul.2012.05.014
   Kim IH, 2008, WATER SCI TECHNOL, V57, P195, DOI 10.2166/wst.2008.808
   Kim I, 2009, CHEMOSPHERE, V77, P518, DOI 10.1016/j.chemosphere.2009.07.041
   Kim I, 2009, J HAZARD MATER, V166, P1134, DOI 10.1016/j.jhazmat.2008.12.020
   Kim I, 2009, ENVIRON INT, V35, P793, DOI 10.1016/j.envint.2009.01.003
   Kim SD, 2007, WATER RES, V41, P1013, DOI 10.1016/j.watres.2006.06.034
   Kitchen LW, 2009, J VECTOR ECOL, V34, P50, DOI [10.1111/j.1948-7134.2009.00007.x, 10.3376/038.034.0107]
   Klosterhaus SL, 2013, ENVIRON INT, V54, P92, DOI 10.1016/j.envint.2013.01.009
   Knepper TP, 2004, WATER SCI TECHNOL, V50, P301
   Kolpin DW, 2013, SCI TOTAL ENVIRON, V443, P700, DOI 10.1016/j.scitotenv.2012.09.063
   Kolpin DW, 2004, SCI TOTAL ENVIRON, V328, P119, DOI 10.1016/j.scitotenv.2004.01.015
   Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j
   Kuroda K, 2012, ENVIRON SCI TECHNOL, V46, P1455, DOI 10.1021/es202059g
   Langford KH, 2008, J ENVIRON MONITOR, V10, P894, DOI 10.1039/b806198j
   Lapworth DJ, 2015, ENVIRON POLLUT, V203, P214, DOI 10.1016/j.envpol.2015.02.030
   Laws BV, 2011, SCI TOTAL ENVIRON, V409, P1087, DOI 10.1016/j.scitotenv.2010.11.021
   Leblebici ME, 2015, CHEM ENG PROCESS, V97, P106, DOI 10.1016/j.cep.2015.09.009
   Lee CO, 2012, WATER RES, V46, P1005, DOI 10.1016/j.watres.2011.11.069
   Lee CJ, 2006, SCI TOTAL ENVIRON, V371, P258, DOI 10.1016/j.scitotenv.2006.07.023
   Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006
   Lee Y, 2013, ENVIRON SCI TECHNOL, V47, P5872, DOI 10.1021/es400781r
   Lei HX, 2007, WATER RES, V41, P4051, DOI 10.1016/j.watres.2007.05.010
   Leusch FDL, 2014, WATER RES, V49, P300, DOI 10.1016/j.watres.2013.11.030
   Li W, 2013, J HAZARD MATER, V244, P698, DOI 10.1016/j.jhazmat.2012.10.064
   Li W, 2012, WATER RES, V46, P403, DOI 10.1016/j.watres.2011.11.002
   Liu WR, 2015, ENVIRON POLLUT, V200, P53, DOI 10.1016/j.envpol.2015.02.013
   Loos R, 2013, WATER RES, V47, P6475, DOI 10.1016/j.watres.2013.08.024
   Loos R, 2013, ANAL BIOANAL CHEM, V405, P5875, DOI 10.1007/s00216-013-6944-8
   Loos R, 2010, WATER RES, V44, P4115, DOI 10.1016/j.watres.2010.05.032
   Lopez B, 2015, SCI TOTAL ENVIRON, V518, P562, DOI 10.1016/j.scitotenv.2015.01.110
   Fernandez RL, 2014, SEP PURIF TECHNOL, V127, P131, DOI 10.1016/j.seppur.2014.02.031
   Loraine GA, 2006, ENVIRON SCI TECHNOL, V40, P687, DOI 10.1021/es051380x
   Magnusson M, 2013, WATER RES, V47, P5211, DOI 10.1016/j.watres.2013.06.003
   Margot J, 2013, SCI TOTAL ENVIRON, V461, P480, DOI 10.1016/j.scitotenv.2013.05.034
   Masoner JR, 2014, ENVIRON SCI-PROC IMP, V16, P2335, DOI 10.1039/c4em00124a
   Masten SJ, 2001, CHEMOSPHERE, V44, P457, DOI 10.1016/S0045-6535(00)00296-4
   Medana C, 2011, J MASS SPECTROM, V46, P24, DOI 10.1002/jms.1866
   Mena E, 2015, CATAL TODAY, V252, P100, DOI 10.1016/j.cattod.2014.09.022
   Merel S, 2015, CHEMOSPHERE, V127, P238, DOI 10.1016/j.chemosphere.2015.02.025
   Merel S, 2015, J HAZARD MATER, V282, P75, DOI 10.1016/j.jhazmat.2014.09.008
   Merel S, 2013, TOXICON, V76, P118, DOI 10.1016/j.toxicon.2013.09.008
   MEYER MR, 2015, Patent No. 156311
   Monsalvo VM, 2014, WATER RES, V49, P103, DOI 10.1016/j.watres.2013.11.026
   Moschet C, 2014, ENVIRON SCI TECHNOL, V48, P5423, DOI 10.1021/es500371t
   Moschet C, 2013, ENVIRON SCI TECHNOL, V47, P7028, DOI 10.1021/es304484w
   Muller A, 2011, CHEMOSPHERE, V85, P1211, DOI 10.1016/j.chemosphere.2011.07.009
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nakada N, 2007, WATER SCI TECHNOL, V56, P133, DOI 10.2166/wst.2007.801
   Nakada N, 2010, WATER SCI TECHNOL, V61, P1739, DOI 10.2166/wst.2010.100
   Nakada N, 2008, ENVIRON SCI TECHNOL, V42, P6347, DOI 10.1021/es7030856
   Nakada N, 2007, WATER RES, V41, P4373, DOI 10.1016/j.watres.2007.06.038
   Nakada N, 2006, WATER RES, V40, P3297, DOI 10.1016/j.watres.2006.06.039
   Nanaboina V, 2010, ENVIRON SCI TECHNOL, V44, P6130, DOI 10.1021/es1005175
   Nanny MA, 2002, WATER RES, V36, P1572, DOI 10.1016/S0043-1354(01)00359-1
   Narumiya M, 2013, J HAZARD MATER, V260, P305, DOI 10.1016/j.jhazmat.2013.05.032
   Neale PA, 2015, ENVIRON SCI TECHNOL, V49, P14614, DOI 10.1021/acs.est.5b04083
   Nelson ED, 2011, ENVIRON SCI TECHNOL, V45, P1228, DOI 10.1021/es102452f
   Tran NH, 2014, ENVIRON SCI POLLUT R, V21, P4727, DOI 10.1007/s11356-013-2428-9
   Tran NH, 2013, BIORESOURCE TECHNOL, V147, P667, DOI 10.1016/j.biortech.2013.08.113
   Tran NH, 2013, TALANTA, V113, P82, DOI 10.1016/j.talanta.2013.03.072
   Okuda T, 2008, WATER SCI TECHNOL, V57, P65, DOI 10.2166/wst.2008.822
   OMAN C, 1993, ENVIRON POLLUT, V80, P265, DOI 10.1016/0269-7491(93)90047-R
   Oppenheimer J, 2011, WATER RES, V45, P4019, DOI 10.1016/j.watres.2011.05.014
   Oros DR, 2003, MAR POLLUT BULL, V46, P1102, DOI 10.1016/S0025-326X(03)00248-0
   Oulton R, 2015, ENVIRON SCI TECHNOL, V49, P3687, DOI 10.1021/es505430v
   Padhye LP, 2014, WATER RES, V51, P266, DOI 10.1016/j.watres.2013.10.070
   PAN, 2014, CAL DEET US STAT 201
   Paxeus N, 2000, WATER SCI TECHNOL, V42, P323
   Peller JR, 2011, J WATER SUPPLY RES T, V60, P69, DOI 10.2166/aqua.2011.024
   Pennetier C, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-81
   PEREIRA WE, 1993, ENVIRON SCI TECHNOL, V27, P1542, DOI 10.1021/es00045a008
   Phan HV, 2015, INT BIODETER BIODEGR, V102, P40, DOI 10.1016/j.ibiod.2015.02.010
   Phillips PJ, 2015, SCI TOTAL ENVIRON, V512, P43, DOI 10.1016/j.scitotenv.2014.12.067
   Pintado-Herrera MG, 2014, ANAL CHIM ACTA, V851, P1, DOI 10.1016/j.aca.2014.05.030
   Pisarenko AN, 2012, WATER RES, V46, P316, DOI 10.1016/j.watres.2011.10.021
   Pitarch E, 2010, ANAL BIOANAL CHEM, V397, P2763, DOI 10.1007/s00216-010-3692-x
   Portoles T, 2014, J CHROMATOGR A, V1339, P145, DOI 10.1016/j.chroma.2014.03.001
   Portoles T, 2011, J CHROMATOGR A, V1218, P303, DOI 10.1016/j.chroma.2010.11.010
   Qi WD, 2014, SCI TOTAL ENVIRON, V472, P789, DOI 10.1016/j.scitotenv.2013.11.019
   Qi WX, 2015, CHEMOSPHERE, V119, P1054, DOI 10.1016/j.chemosphere.2014.09.027
   Quednow K, 2009, ENVIRON SCI POLLUT R, V16, P630, DOI 10.1007/s11356-009-0169-6
   Rasmussen JJ, 2011, ECOL ENG, V37, P1990, DOI 10.1016/j.ecoleng.2011.08.016
   Rattier M, 2014, WATER RES, V54, P89, DOI 10.1016/j.watres.2014.01.030
   Reemtsma T, 2006, ENVIRON SCI TECHNOL, V40, P5451, DOI 10.1021/es060908a
   Regnery J, 2015, CHEMOSPHERE, V127, P136, DOI 10.1016/j.chemosphere.2014.12.076
   Reinhold D, 2010, CHEMOSPHERE, V80, P687, DOI 10.1016/j.chemosphere.2010.05.045
   Reungoat J, 2011, WATER RES, V45, P2751, DOI 10.1016/j.watres.2011.02.013
   Reungoat J, 2010, WATER RES, V44, P625, DOI 10.1016/j.watres.2009.09.048
   Rivera-Cancel G, 2007, APPL ENVIRON MICROB, V73, P3105, DOI 10.1128/AEM.02765-06
   Robles-Molina J, 2014, SCI TOTAL ENVIRON, V479, P247, DOI [10.1016/j.scitotenv2014.01.121, 10.1016/j.scitotenv.2014.01.121]
   Rodil R, 2008, J CHROMATOGR A, V1178, P9, DOI 10.1016/j.chroma.2007.11.051
   Rodil R, 2012, CHEMOSPHERE, V86, P1040, DOI 10.1016/j.chemosphere.2011.11.053
   Rodil R, 2009, J CHROMATOGR A, V1216, P2958, DOI 10.1016/j.chroma.2008.09.041
   Rodriguez-Alvarez T, 2015, SCI TOTAL ENVIRON, V536, P91, DOI 10.1016/j.scitotenv.2015.07.016
   Rossner A, 2009, WATER RES, V43, P3787, DOI 10.1016/j.watres.2009.06.009
   Ruff M, 2015, WATER RES, V87, P145, DOI 10.1016/j.watres.2015.09.017
   Ryu J, 2014, ENVIRON MONIT ASSESS, V186, P3239, DOI 10.1007/s10661-013-3613-5
   Ryu J, 2011, KSCE J CIV ENG, V15, P57, DOI 10.1007/s12205-011-0913-6
   Sandstrom MW, 2005, ENVIRON TOXICOL CHEM, V24, P1029, DOI 10.1897/04-297R.1
   Schaider LA, 2014, SCI TOTAL ENVIRON, V468, P384, DOI 10.1016/j.scitotenv.2013.08.067
   Schoenig G.P., 2001, HDB PESTICIDE TOXICO
   Schwarzbauer J, 2005, WATER RES, V39, P4735, DOI 10.1016/j.watres.2005.09.029
   Schwarzbauer J, 2002, WATER RES, V36, P2275, DOI 10.1016/S0043-1354(01)00452-3
   Schwarzbauer J, 2006, ORG GEOCHEM, V37, P2026, DOI 10.1016/j.orggeochem.2006.08.008
   Schwarzbauer J, 2010, ENVIRON SCI POLLUT R, V17, P934, DOI 10.1007/s11356-009-0269-3
   Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P1811, DOI 10.1021/es4044374
   Sengupta A, 2014, ENVIRON TOXICOL CHEM, V33, P350, DOI 10.1002/etc.2457
   Seo J, 2005, ARCH ENVIRON CON TOX, V48, P323, DOI 10.1007/s00244-004-0029-9
   Sgroi M., 2016, J HAZARD MA IN PRESS
   Shahmansouri A, 2013, SEP PURIF TECHNOL, V118, P627, DOI 10.1016/j.seppur.2013.07.050
   Simon A, 2013, J MEMBRANE SCI, V447, P153, DOI 10.1016/j.memsci.2013.07.013
   Singh SP, 2010, ECOTOXICOLOGY, V19, P338, DOI 10.1007/s10646-009-0416-0
   Smital T, 2011, ECOTOX ENVIRON SAFE, V74, P844, DOI 10.1016/j.ecoenv.2010.11.010
   Smith R, 2012, MAR POLLUT BULL, V65, P117, DOI 10.1016/j.marpolbul.2011.08.010
   Snyder SA, 2007, DESALINATION, V202, P156, DOI 10.1016/j.desal.2005.12.052
   Snyder SA, 2006, OZONE-SCI ENG, V28, P445, DOI 10.1080/01919510601039726
   Song WH, 2009, WATER RES, V43, P635, DOI 10.1016/j.watres.2008.11.018
   Sorensen JPR, 2015, WATER RES, V72, P51, DOI 10.1016/j.watres.2014.08.002
   Stackelberg PE, 2007, SCI TOTAL ENVIRON, V377, P255, DOI 10.1016/j.scitotenv.2007.01.095
   Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015
   Steinle-Darling E, 2010, ENVIRON SCI TECHNOL, V44, P2592, DOI 10.1021/es902846m
   Stevens-Garmon J, 2011, WATER RES, V45, P3417, DOI 10.1016/j.watres.2011.03.056
   Stiles R, 2008, ENVIRON SCI TECHNOL, V42, P2976, DOI 10.1021/es071804i
   Stuart M, 2012, SCI TOTAL ENVIRON, V416, P1, DOI 10.1016/j.scitotenv.2011.11.072
   Stuart ME, 2014, SCI TOTAL ENVIRON, V468, P564, DOI 10.1016/j.scitotenv.2013.08.042
   Sudhakaran S, 2013, CHEMOSPHERE, V92, P731, DOI 10.1016/j.chemosphere.2013.04.021
   Sudhakaran S, 2013, SCI TOTAL ENVIRON, V442, P478, DOI 10.1016/j.scitotenv.2012.09.076
   Sudhakaran S, 2012, CHEMOSPHERE, V87, P144, DOI 10.1016/j.chemosphere.2011.12.006
   Sui Q, 2011, ENVIRON SCI TECHNOL, V45, P3341, DOI 10.1021/es200248d
   Sui Q, 2010, WATER RES, V44, P417, DOI 10.1016/j.watres.2009.07.010
   Sui Q, 2009, CHINESE SCI BULL, V54, P4633, DOI 10.1007/s11434-009-0413-y
   Sun J, 2015, ECOTOX ENVIRON SAFE, V117, P132, DOI 10.1016/j.ecoenv.2015.03.032
   Tadkaew N, 2011, WATER RES, V45, P2439, DOI 10.1016/j.watres.2011.01.023
   Tanoue R, 2015, ENVIRON SCI TECHNOL, V49, P11649, DOI 10.1021/acs.est.5b02478
   Tay KS, 2009, CHEMOSPHERE, V76, P1296, DOI 10.1016/j.chemosphere.2009.06.007
   Teerlink J, 2012, WATER RES, V46, P5174, DOI 10.1016/j.watres.2012.06.024
   ter Laak TL, 2012, SCI TOTAL ENVIRON, V427, P308, DOI 10.1016/j.scitotenv.2012.04.013
   Terzic S, 2008, SCI TOTAL ENVIRON, V399, P66, DOI 10.1016/j.scitotenv.2008.03.003
   Trenholm RA, 2008, J CHROMATOGR A, V1190, P253, DOI 10.1016/j.chroma.2008.02.032
   Trenholm RA, 2006, CHEMOSPHERE, V65, P1990, DOI 10.1016/j.chemosphere.2006.07.004
   USGS, 2015, NAT FIELD MAN COLL W
   Vanderford BJ, 2011, ANAL BIOANAL CHEM, V399, P2227, DOI 10.1007/s00216-010-4608-5
   Veach AM, 2011, SCI TOTAL ENVIRON, V409, P4553, DOI 10.1016/j.scitotenv.2011.07.022
   Vidal-Dorsch DE, 2013, ENVIRON SCI TECHNOL, V47, P11268, DOI 10.1021/es401942n
   Vidal-Dorsch DE, 2013, AQUAT TOXICOL, V140, P174, DOI 10.1016/j.aquatox.2013.05.017
   Wang B, 2015, ENVIRON POLLUT, V202, P153, DOI 10.1016/j.envpol.2015.03.030
   Wang CT, 2013, ANAL BIOANAL CHEM, V405, P5925, DOI 10.1007/s00216-013-6799-z
   Wang CT, 2012, J MASS SPECTROM, V47, P1255, DOI 10.1002/jms.3051
   Wang D, 2014, ENVIRON SCI POLLUT R, V21, P4276, DOI 10.1007/s11356-013-2363-9
   Wang Z, 2015, ENVIRON POLLUT, V204, P223, DOI 10.1016/j.envpol.2015.04.021
   Wauhob TJ, 2007, MAR POLLUT BULL, V54, P1116, DOI 10.1016/j.marpolbul.2007.05.003
   Weigel S, 2002, SCI TOTAL ENVIRON, V295, P131, DOI 10.1016/S0048-9697(02)00064-5
   Weigel S, 2004, J CHROMATOGR A, V1023, P183, DOI 10.1016/j.chroma.2003.10.036
   Weigel S, 2004, CHEMOSPHERE, V56, P583, DOI 10.1016/j.chemosphere.2004.04.015
   Weigel S, 2001, J CHROMATOGR A, V912, P151, DOI 10.1016/S0021-9673(01)00529-5
   Wert EC, 2011, WATER RES, V45, P5191, DOI 10.1016/j.watres.2011.07.021
   Wert EC, 2009, WATER RES, V43, P1005, DOI 10.1016/j.watres.2008.11.050
   Westerhoff P, 2005, ENVIRON SCI TECHNOL, V39, P6649, DOI 10.1021/es0484799
   Westerhoff P, 2009, WATER RES, V43, P3992, DOI 10.1016/j.watres.2009.04.010
   Wickramasekara S, 2012, ANAL CHIM ACTA, V717, P77, DOI 10.1016/j.aca.2011.12.019
   Wijekoon KC, 2015, BIORESOURCE TECHNOL, V189, P391, DOI 10.1016/j.biortech.2015.04.034
   WINDHEUSER JJ, 1982, J PHARM SCI-US, V71, P1211, DOI 10.1002/jps.2600711107
   Wode F, 2015, WATER RES, V69, P274, DOI 10.1016/j.watres.2014.11.034
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Writer JH, 2010, SCI TOTAL ENVIRON, V409, P100, DOI 10.1016/j.scitotenv.2010.07.018
   Wu XQ, 2014, ENVIRON SCI TECHNOL, V48, P11286, DOI 10.1021/es502868k
   Wu YY, 2011, PROCESS SAF ENVIRON, V89, P112, DOI 10.1016/j.psep.2010.10.005
   Xue WC, 2010, WATER RES, V44, P5999, DOI 10.1016/j.watres.2010.07.052
   Yang X, 2011, WATER RES, V45, P5218, DOI 10.1016/j.watres.2011.07.026
   Yoon MK, 2013, CHEMOSPHERE, V93, P2055, DOI 10.1016/j.chemosphere.2013.07.038
   Yoon Y, 2006, J MEMBRANE SCI, V270, P88, DOI 10.1016/j.memsci.2005.06.045
   Yoon Y, 2007, DESALINATION, V202, P16, DOI 10.1016/j.desal.2005.12.033
   Yoon Y, 2010, SCI TOTAL ENVIRON, V408, P636, DOI 10.1016/j.scitotenv.2009.10.049
   You LH, 2015, SCI TOTAL ENVIRON, V536, P955, DOI 10.1016/j.scitotenv.2015.06.041
   Yu HW, 2015, WATER RES, V81, P250, DOI 10.1016/j.watres.2015.05.064
   Zenobio JE, 2015, CHEMOSPHERE, V120, P750, DOI 10.1016/j.chemosphere.2014.10.050
   Zhang HC, 2007, J AGR FOOD CHEM, V55, P4073, DOI 10.1021/jf070104u
   Zhang HC, 2006, ENVIRON SCI TECHNOL, V40, P4488, DOI 10.1021/es060515b
   Zhang NS, 2015, ECOTOX ENVIRON SAFE, V122, P417, DOI 10.1016/j.ecoenv.2015.09.004
   Zhu SC, 2014, ENVIRON SCI POLLUT R, V21, P1466, DOI 10.1007/s11356-013-2025-y
   Zhu SC, 2013, ECOTOX ENVIRON SAFE, V96, P154, DOI 10.1016/j.ecoenv.2013.06.033
NR 299
TC 18
Z9 18
U1 3
U2 75
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0160-4120
EI 1873-6750
J9 ENVIRON INT
JI Environ. Int.
PD NOV
PY 2016
VL 96
BP 98
EP 117
DI 10.1016/j.envint.2016.09.004
PG 20
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA EA9AU
UT WOS:000386933300013
PM 27639850
DA 2020-07-08
ER

PT J
AU Schmidt, CW
AF Schmidt, Charles W.
TI Zika in the United States: How Are We Preparing? (vol 124, pg A157,
   2016)
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Correction
CR Schmidt CW, 2016, ENVIRON HEALTH PERSP, V124, pA157, DOI 10.1289/ehp.124-A157
NR 1
TC 0
Z9 0
U1 0
U2 0
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD NOV
PY 2016
VL 124
IS 11
BP A198
EP A198
DI 10.1289/EHP1096
PG 1
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA EA8UF
UT WOS:000386913800004
PM 27801647
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hampton, T
AF Hampton, Tracy
TI DNA Vaccine Protects Monkeys Against Zika Virus Infection
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 1
Z9 1
U1 0
U2 8
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD NOV 1
PY 2016
VL 316
IS 17
BP 1755
EP 1755
DI 10.1001/jama.2016.15862
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EA4GP
UT WOS:000386569300005
PM 27802535
DA 2020-07-08
ER

PT J
AU Graham, DM
AF Graham, Dustin M.
TI DNA vaccine for zika
SO LAB ANIMAL
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0093-7355
EI 1548-4475
J9 LAB ANIMAL
JI Lab Anim.
PD NOV
PY 2016
VL 45
IS 11
BP 412
EP 412
PG 1
WC Veterinary Sciences
SC Veterinary Sciences
GA EA3ZI
UT WOS:000386547400005
DA 2020-07-08
ER

PT J
AU Younger, DS
AF Younger, David S.
TI Epidemiology of Zika Virus
SO NEUROLOGIC CLINICS
LA English
DT Article
DE Zika virus; Public health; Neuroepidemiology
ID TRANSMISSION; ISLAND; INFECTION; OUTBREAK; STATES; BRAZIL
AB Zika virus is an arbovirus belonging to the Flaviviridae family known to cause mild clinical symptoms similar to those of dengue and chikungunya. Zika is transmitted by different species of Aedes mosquitoes. Nonhuman primates and possibly rodents play a role as reservoirs. Direct interhuman transmission has also been reported. Human cases have been reported in Africa and Asia, Easter Island, the insular Pacific region, and Brazil. Its clinical profile is that of a dengue-like febrile illness, but recently associated Guillain-Barre syndrome and microcephaly have appeared. There is neither a vaccine nor prophylactic medications available to prevent Zika virus infection.
C1 [Younger, David S.] NYU, Dept Neurol, Div Neuroepidemiol, Sch Med, New York, NY 10016 USA.
   [Younger, David S.] NYU, Coll Global Publ Hlth, New York, NY 10003 USA.
   [Younger, David S.] 333 East 34th St,1J, New York, NY 10016 USA.
RP Younger, DS (corresponding author), NYU, Dept Neurol, Div Neuroepidemiol, Sch Med, New York, NY 10016 USA.; Younger, DS (corresponding author), NYU, Coll Global Publ Hlth, New York, NY 10003 USA.; Younger, DS (corresponding author), 333 East 34th St,1J, New York, NY 10016 USA.
EM david.younger@nyumc.org
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P973
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2014, EUROSURVEILLANCE, V19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Salvador FS, 2016, TRAVEL MED INFECT DI, V14, P49, DOI 10.1016/j.tmaid.2015.10.004
   Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 31
TC 13
Z9 15
U1 0
U2 43
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0733-8619
EI 1557-9875
J9 NEUROL CLIN
JI Neurol. Clin.
PD NOV
PY 2016
VL 34
IS 4
BP 1049
EP +
DI 10.1016/j.ncl.2016.06.008
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EA3YK
UT WOS:000386545000017
PM 27719988
DA 2020-07-08
ER

PT J
AU Mohammadi, D
AF Mohammadi, Dara
TI DNA vaccine for Zika
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2016
VL 16
IS 11
BP 1234
EP 1234
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DZ5PP
UT WOS:000385914300032
DA 2020-07-08
ER

PT J
AU Goddard, J
AF Goddard, Jerome
TI Essential Facts About Mosquito Control and Zika Virus
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Review
DE Mosquito control; Mosquito vectors; Protection methods; Zika virus
ID WEST-NILE-VIRUS; AEDES-ALBOPICTUS; TRANSMISSION; MISSISSIPPI
AB The threat to persons living in the southern United States from Zika virus (ZIKV) is both significant and ongoing. Although there are several modes of transmission of ZIKV to humans, mosquito transmission is the primary avenue by which persons become infected. Only 2 mosquito species are likely able to transmit ZIKV to humans in the United States, and information about their biology and control is important to physicians and public health officials. This article discusses ZIKV mosquito vector ecology and control, with emphasis on source reduction and personal protection. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Goddard, Jerome] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, 100 Old Hwy 12, Starkville, MS 39762 USA.
RP Goddard, J (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, 100 Old Hwy 12, Starkville, MS 39762 USA.
EM jgoddard@entomology.msstate.edu
CR CARPENTER SJ, 1955, MOSQUITOES N AM
   Cope SE, 1996, WING BEATS, V7, P14
   Crosby MC, 2006, THE AM PLAGUE
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Goddard J, 2002, INFECT MED, V19, P542
   Goddard J, 2008, INFECT MED, V25, P134
   Goddard J, 2007, P ENTOMOL SOC WASH, V109, P684
   Goddard Jerome, 2016, J Miss State Med Assoc, V57, P138
   Goddard J, 2010, J VECTOR ECOL, V35, P79, DOI 10.1111/j.1948-7134.2010.00032.x
   Harrison BA, 2016, PUBLICATION W CAROLI
   Hataway K, 2011, J MISS ACAD SCI, V56, P223
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Mississippi State Department of Health, MOSQ REP TYP REC
   POWELL KE, 1976, SOUTHERN MED J, V69, P1121, DOI 10.1097/00007611-197609000-00005
   RAI KS, 1991, ANNU REV ENTOMOL, V36, P459, DOI 10.1146/annurev.en.36.010191.002331
NR 15
TC 3
Z9 3
U1 0
U2 46
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD NOV
PY 2016
VL 129
IS 11
BP 1149
EP 1152
DI 10.1016/j.amjmed.2016.07.021
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA EA1ES
UT WOS:000386335900026
PM 27555094
OA Bronze
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Zika Virus in Returning Travelers
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Letter
ID INFECTION
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Univ Nis, Nish, Serbia.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
CR Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Huang ASE, 2016, J FORMOS MED ASSOC, V115, P223, DOI 10.1016/j.jfma.2016.03.002
   Meltzer E, 2016, AM J MED
NR 4
TC 0
Z9 0
U1 0
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD NOV
PY 2016
VL 129
IS 11
BP E295
EP E295
DI 10.1016/j.amjmed.2016.06.036
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA EA1ES
UT WOS:000386335900012
PM 27770843
OA Bronze
DA 2020-07-08
ER

PT J
AU Trujillo-Ocampo, A
   Cazares-Raga, FE
   Celestino-Montes, A
   Cortes-Martinez, L
   Rodriguez, MH
   Hernandez-Hernandez, FD
AF Trujillo-Ocampo, Abel
   Elena Cazares-Raga, Febe
   Celestino-Montes, Antonio
   Cortes-Martinez, Leticia
   Rodriguez, Mario H.
   de la Cruz Hernandez-Hernandez, Fidel
TI IDENTIFICATION AND EXPRESSION ANALYSIS OF TWO 14-3-3 PROTEINS IN THE
   MOSQUITO Aedes aegypti, AN IMPORTANT ARBOVIRUSES VECTOR
SO ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Article
DE 14-3-3; Aedes aegypti; RNA; proteins; expression
ID CELLULAR-METABOLISM; STRUCTURAL BASIS; BOMBYX-MORI; EXOENZYME-S;
   IN-VIVO; DROSOPHILA; PHOSPHORYLATION; 14-3-3-PROTEINS; BINDING;
   14-3-3-EPSILON
AB The 14-3-3 proteins are evolutionarily conserved acidic proteins that form a family with several isoforms in many cell types of plants and animals. In invertebrates, including dipteran and lepidopteran insects, only two isoforms have been reported. 14-3-3 proteins are scaffold molecules that form homo-or heterodimeric complexes, acting as molecular adaptors mediating phosphorylation-dependent interactions with signaling molecules involved in immunity, cell differentiation, cell cycle, proliferation, apoptosis, and cancer. Here, we describe the presence of two isoforms of 14-3-3 in the mosquito Aedes aegypti, the main vector of dengue, yellow fever, chikungunya, and zika viruses. Both isoforms have the conserved characteristics of the family: two protein signatures (PS1 and PS2), an annexin domain, three serine residues, targets for phosphorylation (positions 58, 184, and 233), necessary for their function, and nine alpha helix-forming segments. By sequence alignment and phylogenetic analysis, we found that the molecules correspond to epsilon and zeta isoforms (Aeae14-3-3 epsilon and Aeae14-3-3 zeta). The messengers and protein products were present in all stages of the mosquito life cycle and all the tissues analyzed, with a small predominance of Aeae14-3-3 zeta except in the midgut and ovaries of adult females. The 14-3-3 proteins in female midgut epithelial cells were located in the cytoplasm. Our results may provide insights to further investigate the functions of these proteins in mosquitoes. (C) 2016 Wiley Periodicals, Inc.
C1 [Trujillo-Ocampo, Abel; Elena Cazares-Raga, Febe; Celestino-Montes, Antonio; Cortes-Martinez, Leticia; de la Cruz Hernandez-Hernandez, Fidel] Inst Politecn Nacl, Dept Infect & Patogenesis Mol, Ctr Invest & Estudios Avanzados, Av IPN 2508, Mexico City, DF, Mexico.
   [Rodriguez, Mario H.] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
RP Hernandez-Hernandez, FD (corresponding author), Inst Politecn Nacl, Dept Infect & Patogenesis Mol, Ctr Invest & Estudios Avanzados, Av IPN 2508, Mexico City, DF, Mexico.
EM cruzcruz@cinvestav.mx
RI Hernandez-Hernandez, Fidel/I-5193-2012
OI Hernandez-Hernandez, Fidel/0000-0002-7276-7513
FU Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)Consejo
   Nacional de Ciencia y Tecnologia (CONACyT) [180514, 83866]
FX Grant sponsor: Consejo Nacional de Ciencia y Tecnologia (CONACyT,
   Mexico); Grant numbers: 180514; 83866.
CR Acevedo SF, 2007, GENETICS, V177, P239, DOI 10.1534/genetics.107.072280
   AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B
   Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005
   Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003
   Alexander RD, 2006, PROTEOMICS, V6, P1886, DOI 10.1002/pmic.200500548
   Bustad HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049671
   Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127
   Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6
   Corpet F, 1999, NUCLEIC ACIDS RES, V27, P263, DOI 10.1093/nar/27.1.263
   de Boer AH, 2013, PROTOPLASMA, V250, P425, DOI 10.1007/s00709-012-0437-z
   Ferl RJ, 2002, GENOME BIOL, V3
   Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617
   Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774
   GALLAGHER SR, 2007, CURR PROTOC CELL BIO, pCH6
   Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102
   Gonzalez-Calixto C, 2015, J PROTEOMICS, V119, P45, DOI 10.1016/j.jprot.2014.11.019
   Henriksson ML, 2002, EUR J BIOCHEM, V269, P4921, DOI 10.1046/j.1432-1033.2002.03191.x
   Ito T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977721
   Kaeodee M, 2011, COMP BIOCHEM PHYS B, V159, P244, DOI 10.1016/j.cbpb.2011.05.004
   Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879
   Kim Sun Am, 2009, Entomological Research, V39, P129, DOI 10.1111/j.1748-5967.2009.00214.x
   Kjarland E, 2006, CURR PHARM BIOTECHNO, V7, P217, DOI 10.2174/138920106777549777
   Kockel L, 1997, GENE DEV, V11, P1140, DOI 10.1101/gad.11.9.1140
   Kong LY, 2007, BBA-GEN SUBJECTS, V1770, P1598, DOI 10.1016/j.bbagen.2007.08.005
   Lalle M, 2012, J PROTEOME RES, V11, P2666, DOI 10.1021/pr3000199
   Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966
   Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021
   LIU D, 1995, NATURE, V376, P191, DOI 10.1038/376191a0
   Ma SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140182
   Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m
   Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3
   Nielsen MD, 2008, AGING CELL, V7, P688, DOI 10.1111/j.1474-9726.2008.00420.x
   Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001
   Olayioye MA, 2003, J BIOL CHEM, V278, P32929, DOI 10.1074/jbc.M302910200
   Pauly B, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-31
   Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008
   Rosenquist M, 2001, PLANT PHYSIOL, V127, P142, DOI 10.1104/pp.127.1.142
   ROTH D, 1993, FEBS LETT, V320, P207, DOI 10.1016/0014-5793(93)80587-K
   Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/BJ20031797
   Shandala T, 2011, J CELL SCI, V124, P2165, DOI 10.1242/jcs.080598
   Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X
   Su TT, 2001, J CELL SCI, V114, P3445
   Tabunoki H, 2008, NEUROSCI RES, V61, P271, DOI 10.1016/j.neures.2008.03.007
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wang WF, 1997, J MOL BIOL, V268, P619, DOI 10.1006/jmbi.1997.1002
   Waterman MJF, 1998, NAT GENET, V19, P175, DOI 10.1038/542
   Xiao Bing, 1995, Nature (London), V376, P188
   Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0
   Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229
   Yoo JY, 2011, ARCH INSECT BIOCHEM, V76, P114, DOI 10.1002/arch.20409
   Zhou Y, 2003, J BIOL CHEM, V278, P10073, DOI 10.1074/jbc.M211907200
NR 51
TC 2
Z9 2
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0739-4462
EI 1520-6327
J9 ARCH INSECT BIOCHEM
JI Arch. Insect Biochem. Physiol.
PD NOV
PY 2016
VL 93
IS 3
BP 143
EP 159
DI 10.1002/arch.21348
PG 17
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA EA1NV
UT WOS:000386359900003
PM 27592842
DA 2020-07-08
ER

PT J
AU Leyser, M
   de Camargo, OK
   Matta, APC
   Vasconcelos, MM
   Nascimento, OJM
AF Leyser, Marcio
   de Camargo, Olaf Kraus
   Matta, Andre P. C.
   Vasconcelos, Marcio Moacyr
   Nascimento, Osvaldo J. M.
TI The International Classification of Functioning framework in
   Zika-related disabilities
SO EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
LA English
DT Letter
ID CHILDHOOD
C1 [Leyser, Marcio; Matta, Andre P. C.; Vasconcelos, Marcio Moacyr; Nascimento, Osvaldo J. M.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Niteroi, RJ, Brazil.
   [de Camargo, Olaf Kraus] McMaster Univ, Hamilton, ON, Canada.
RP Leyser, M (corresponding author), Antonio Pedro Univ Hosp, NeuroUPC, R Marques Parana,303-5th Floor Ctr, BR-24033900 Niteroi, RJ, Brazil.
EM marcioley@hotmail.com
RI Leyser, Marcio/Z-4422-2019; de Camargo, Olaf Kraus/G-8419-2011
OI de Camargo, Olaf Kraus/0000-0002-7927-7189; Leyser,
   Marcio/0000-0002-2929-8416
CR DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Kraus de Camargo O., 2016, BRAZ J MED HUM HLTH, V4, P29
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Rosenbaum P, 2012, CHILD CARE HLTH DEV, V38, P457, DOI 10.1111/j.1365-2214.2011.01338.x
   Rosenbaum P, 2009, NEUROPEDIATRICS, V40, P56, DOI 10.1055/s-0029-1234104
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 7
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1090-3798
EI 1532-2130
J9 EUR J PAEDIATR NEURO
JI Eur. J. Paediatr. Neurol.
PD NOV
PY 2016
VL 20
IS 6
BP 946
EP 947
DI 10.1016/j.ejpn.2016.08.001
PG 2
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA EA1BC
UT WOS:000386322300021
PM 27558313
DA 2020-07-08
ER

PT J
AU Truong, L
   Gonnerman, G
   Simonich, MT
   Tanguay, RL
AF Truong, Lisa
   Gonnerman, Greg
   Simonich, Michael T.
   Tanguay, Robert L.
TI Assessment of the developmental and neurotoxicity of the mosquito
   control larvicide, pyriproxyfen, using embryonic zebrafish
SO ENVIRONMENTAL POLLUTION
LA English
DT Article
DE Pyriproxyfen; Zika; Development; Morphology defects; Neurotoxicology;
   Behavior; Zebrafish
ID THROUGHPUT
AB In 2014, as an attempt to address the Zika health crisis by controlling the mosquito population, Brazil took the unprecedented action of applying a chemical larvicide, pyriproxyfen, to drinking water sources. The World Health Organization has established an acceptable daily intake of pyriproxyfen to be 100 mu g per kg of body weight per day, but studies have demonstrated that at elevated doses (>5000 mg/kg), there are adverse effects in mice, rats and dogs. To better understand the potential developmental toxicity of pyriproxyfen, we utilized the embryonic zebrafish. Our results demonstrate that the concentration resulting in 50% of animals presenting adverse morphological effects (EC50), including craniofacial defects, was 5.2 mu M for daily renewal exposure, and above this concentration, adverse behavioral effects were also observed in animals that followed a static exposure regimen. Thus, zebrafish data suggest that the developmental toxicity of pyriproxyfen may not be limited to insects. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Sinnhuber Aquat Res Lab, 28645 East Highway 34, Corvallis, OR 97333 USA.
   Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA.
RP Tanguay, RL (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Sinnhuber Aquat Res Lab, 28645 East Highway 34, Corvallis, OR 97333 USA.
EM Lisa.truong@oregonstate.edu; Gman@oregonstate.edu;
   mtsimonich@oregonstate.edu; Robert.tanguay@oregonstate.edu
OI Truong, Lisa/0000-0003-1751-4617
FU NIEHS grant [P30 ES000210]; Environmental Protection Agency STAR Grant
   [R835168]
FX We would like to thank members of the Tanguay laboratory, SARL for
   assistance with fish husbandry. This work was supported by NIEHS grant
   P30 ES000210 and Environmental Protection Agency STAR Grant # R835168 to
   RLT.
CR [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Dix DJ, 2007, TOXICOL SCI, V95, P5, DOI 10.1093/toxsci/kfl103
   Fourrier J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132985
   Government B., 2014, OR TECN UT LARV PYR
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kokel David, 2008, Briefings in Functional Genomics & Proteomics, V7, P483, DOI 10.1093/bfgp/eln040
   Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235
   Mandrell D, 2012, JALA-J LAB AUTOM, V17, P66, DOI 10.1177/2211068211432197
   OECD, TEST NO 236 FISH EMB
   Organization W.H., 2007, WAT QUAL GUID
   Padilla S, 2012, REPROD TOXICOL, V33, P174, DOI 10.1016/j.reprotox.2011.10.018
   Raftery TD, 2014, ENVIRON SCI TECHNOL, V48, P804, DOI 10.1021/es404322p
   Reif DM, 2016, ARCH TOXICOL, V90, P1459, DOI 10.1007/s00204-015-1554-1
   [Safety I.P.o.C. Sciences N.I.o.H.], 1999, PEST RES FOOD PYR
   Truong L, 2016, REPROD TOXICOL, V65, P139, DOI 10.1016/j.reprotox.2016.05.015
   Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16
   *WHO, 2008, GUID DRINK WAT QUAL
   Zhang GZ, 2016, REPROD TOXICOL, V62, P92, DOI 10.1016/j.reprotox.2016.04.012
NR 19
TC 21
Z9 21
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0269-7491
EI 1873-6424
J9 ENVIRON POLLUT
JI Environ. Pollut.
PD NOV
PY 2016
VL 218
BP 1089
EP 1093
DI 10.1016/j.envpol.2016.08.061
PG 5
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DZ1JZ
UT WOS:000385596000118
PM 27593350
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Mounce, BC
   Cesaro, T
   Moratorio, G
   Hooikaas, PJ
   Yakovleva, A
   Werneke, SW
   Smith, EC
   Poirier, EZ
   Simon-Loriere, E
   Prot, M
   Tamietti, C
   Vitry, S
   Volle, R
   Khou, C
   Frenkiel, MP
   Sakuntabhai, A
   Delpeyroux, F
   Pardigon, N
   Flamand, M
   Barba-Spaeth, G
   Lafon, M
   Denison, MR
   Albert, ML
   Vignuzzi, M
AF Mounce, Bryan C.
   Cesaro, Teresa
   Moratorio, Gonzalo
   Hooikaas, Peter Jan
   Yakovleva, Anna
   Werneke, Scott W.
   Smith, Everett Clinton
   Poirier, Enzo Z.
   Simon-Loriere, Etienne
   Prot, Matthieu
   Tamietti, Carole
   Vitry, Sandrine
   Volle, Romain
   Khou, Cecile
   Frenkiel, Marie-Pascale
   Sakuntabhai, Anavaj
   Delpeyroux, Francis
   Pardigon, Nathalie
   Flamand, Marie
   Barba-Spaeth, Giovanna
   Lafon, Monique
   Denison, Mark R.
   Albert, Matthew L.
   Vignuzzi, Marco
TI Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy
   against RNA Viruses
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID RESPIRATORY SYNDROME CORONAVIRUS; ALPHA-DIFLUOROMETHYLORNITHINE;
   MAMMALIAN-CELLS; SPERMIDINE; DEPLETION; DRUG; EFLORNITHINE; REPLICATION;
   TRANSLATION; INFECTION
AB RNA viruses present an extraordinary threat to human health, given their sudden and unpredictable appearance, the potential for rapid spread among the human population, and their ability to evolve resistance to antiviral therapies. The recent emergence of chikungunya virus, Zika virus, and Ebola virus highlights the struggles to contain outbreaks. A significant hurdle is the availability of antivirals to treat the infected or protect at-risk populations. While several compounds show promise in vitro and in vivo, these outbreaks underscore the need to accelerate drug discovery. The replication of several viruses has been described to rely on host polyamines, small and abundant positively charged molecules found in the cell. Here, we describe the antiviral effects of two molecules that alter polyamine levels: difluoromethylornithine (DFMO; also called eflornithine), which is a suicide inhibitor of ornithine decarboxylase 1 (ODC1), and diethylnorspermine (DENSpm), an activator of spermidine/spermine N-1-acetyltransferase (SAT1). We show that reducing polyamine levels has a negative effect on diverse RNA viruses, including several viruses involved in recent outbreaks, in vitro and in vivo. These findings highlight the importance of the polyamine biosynthetic pathway to viral replication, as well as its potential as a target in the development of further antivirals or currently available molecules, such as DFMO.
C1 [Mounce, Bryan C.; Cesaro, Teresa; Moratorio, Gonzalo; Hooikaas, Peter Jan; Yakovleva, Anna; Poirier, Enzo Z.; Vignuzzi, Marco] Inst Pasteur, Viral Populat & Pathogenesis Unit, Paris, France.
   [Werneke, Scott W.; Albert, Matthew L.] Inst Pasteur, Lab Dendrit Cell Biol, Paris, France.
   [Werneke, Scott W.; Albert, Matthew L.] INSERM, U818, Paris, France.
   [Smith, Everett Clinton; Denison, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA.
   [Poirier, Enzo Z.] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France.
   [Simon-Loriere, Etienne; Prot, Matthieu] Inst Pasteur, Unite Genet Fonct Malad Infect, Paris, France.
   [Tamietti, Carole; Flamand, Marie; Barba-Spaeth, Giovanna] Inst Pasteur, Unite Virol Struct, Paris, France.
   [Vitry, Sandrine; Lafon, Monique] Inst Pasteur, Unite NeuroImmunol Virale, Paris, France.
   [Volle, Romain; Delpeyroux, Francis] Inst Pasteur, Unite Biol Virus Enter, Paris, France.
   [Volle, Romain; Delpeyroux, Francis] INSERM, U994, Paris, France.
   [Khou, Cecile; Frenkiel, Marie-Pascale; Pardigon, Nathalie] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infect, Paris, France.
   [Denison, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.
RP Vignuzzi, M (corresponding author), Inst Pasteur, Viral Populat & Pathogenesis Unit, Paris, France.
EM marco.vignuzzi@pasteur.fr
RI Delpeyroux, Francis/H-8838-2016; Denison, Mark/O-7258-2018
OI Delpeyroux, Francis/0000-0002-4895-823X; Denison,
   Mark/0000-0003-2655-0900; Poirier, Enzo/0000-0001-9795-2144; Vitry,
   Sandrine/0000-0003-4693-7694; , Etienne/0000-0001-8420-7743; Barba
   Spaeth, Giovanna/0000-0003-2069-9501; Mounce, Bryan/0000-0003-1710-5362;
   Lafon, Monique/0000-0002-4423-7996; Hooikaas, Peter
   Jan/0000-0001-9849-9193; Vignuzzi, Marco/0000-0002-4400-771X
FU Laboratoire d'Excellence via Integrative Biology of Emerging Infectious
   Diseases [ANR-10-LABX-62-IBEID]; Equipe FRM from the French Fondation
   pour la Recherche Medicale [DEQ20150331759]; Institut Pasteur Defeat
   Dengue Program; Erasmus+ Unipharma-Graduates Program; Amgen Scholars
   Program at Institut Pasteur; Het Weerstandfonds; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI108197, U19 AI109680]; Institut Pasteur Programme
   Transversal de Recherche [ZPTR484]; Fondation Total [S-CM15010-05B];
   Roux Howard Cantarini postdoctoral fellowship; Seventh Framework
   ProgrammeEuropean Union (EU) [278433-PREDEMICS]; Ministry of Defense,
   Direction Generale de l'Armement
FX This work was funded by the Laboratoire d'Excellence via Integrative
   Biology of Emerging Infectious Diseases (grant no. ANR-10-LABX-62-IBEID
   to B.C.M. and M.V.), Equipe FRM DEQ20150331759 from the French Fondation
   pour la Recherche Medicale (to M.V.), Institut Pasteur Defeat Dengue
   Program (to B.C.M. and M.V.), Erasmus+ Unipharma-Graduates Program (to
   T.C.), Amgen Scholars Program at Institut Pasteur (to A.Y.), Het
   Weerstandfonds (to P.J.H), NIH (grant no. R01AI108197 to M.R.D.), NIH
   (grant no. U19 AI109680 to M.R.D.), Institut Pasteur Programme
   Transversal de Recherche (grant no. ZPTR484 to F.D.), Fondation Total
   (grant no. S-CM15010-05B to F.D.), Roux Howard Cantarini postdoctoral
   fellowship (to R.V.), Seventh Framework Programme (grant no.
   278433-PREDEMICS to N.P.), and Ministry of Defense, Direction Generale
   de l'Armement (to C.K.).
CR Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   BACCHI CJ, 1980, SCIENCE, V210, P332, DOI 10.1126/science.6775372
   BARDOCZ S, 1995, TRENDS FOOD SCI TECH, V6, P341, DOI 10.1016/S0924-2244(00)89169-4
   Beaucourt S, 2014, CURR OPIN VIROL, V8, P10, DOI 10.1016/j.coviro.2014.04.011
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Carbone PP, 2000, CLIN CANCER RES, V6, P3850
   Casero RA, 2009, J MED CHEM, V52, P4551, DOI 10.1021/jm900187v
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   Council for International Organization of Medical Sciences and the International Council for Laboratory Animal Science, 2012, INT GUID PRINC BIOM
   CREAVEN PJ, 1993, CANCER EPIDEM BIOMAR, V2, P243
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   FUKUMA I, 1975, J VIROL, V16, P222, DOI 10.1128/JVI.16.2.222-227.1975
   GIBSON W, 1971, P NATL ACAD SCI USA, V68, P2818, DOI 10.1073/pnas.68.11.2818
   HOMMA Y, 1987, CANCER RES, V47, P6176
   HUGGINS JW, 1989, REV INFECT DIS, V11, pS750
   Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601
   Johansen LM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005471
   Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419
   LANZER W, 1975, J VIROL, V16, P1254, DOI 10.1128/JVI.16.5.1254-1264.1975
   Law GL, 2013, CURR OPIN IMMUNOL, V25, P588, DOI 10.1016/j.coi.2013.08.004
   Liang JJ, 2009, VACCINE, V27, P2746, DOI 10.1016/j.vaccine.2009.03.007
   Lightfoot HL, 2014, NUCLEIC ACIDS RES, V42, P11275, DOI 10.1093/nar/gku837
   Madhubala R., 1998, POLYAMINE PROTOCOLS, P131
   Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110
   METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050
   Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020
   MILORD F, 1992, LANCET, V340, P652, DOI 10.1016/0140-6736(92)92180-N
   Mounce BC, 2016, CELL HOST MICROBE, V20, P167, DOI 10.1016/j.chom.2016.06.011
   PEPIN J, 1987, LANCET, V2, P1431, DOI 10.1016/S0140-6736(87)91131-7
   POHJANPELTO P, 1988, LIFE SCI, V42, P2011, DOI 10.1016/0024-3205(88)90501-2
   ROMIJN JC, 1987, CANCER CHEMOTH PHARM, V19, P30, DOI 10.1007/BF00296251
   Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110
   Simarro PP, 2012, PARASITOLOGY, V139, P842, DOI 10.1017/S0031182012000169
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wolf JE, 2007, INT J DERMATOL, V46, P94, DOI 10.1111/j.1365-4632.2006.03079.x
NR 35
TC 24
Z9 25
U1 3
U2 45
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2016
VL 90
IS 21
BP 9683
EP 9692
DI 10.1128/JVI.01347-16
PG 10
WC Virology
SC Virology
GA DZ0JW
UT WOS:000385525700012
PM 27535047
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Goorhuis, A
   Grobusch, MP
AF Goorhuis, Abraham
   Grobusch, Martin P.
TI Zika virus: who's next?
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID CHIKUNGUNYA; DENGUE; STATES
C1 [Goorhuis, Abraham; Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop Med & Travel Med,Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
RP Goorhuis, A (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop Med & Travel Med,Div Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM a.goorhuis@amc.uva.nl
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Bogoch II, 2016, LANCET INFECT DIS
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2015, INFECTION, DOI [DOI 10.1007/S15010-016-0906-Y, 10.1007/s15010-016-0906-y]
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Li JD, 2016, EMERG INFECT DIS, V22, P1133, DOI 10.3201/eid2206.160273
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Reuters, GUIN BISS CONF 3 CAS
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
NR 11
TC 3
Z9 3
U1 0
U2 114
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2016
VL 16
IS 11
BP 1204
EP 1205
DI 10.1016/S1473-3099(16)30316-4
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DZ5PP
UT WOS:000385914300002
PM 27593583
OA Bronze
DA 2020-07-08
ER

PT J
AU Aldo, P
   You, Y
   Szigeti, K
   Horvath, TL
   Lindenbach, B
   Mor, G
AF Aldo, Paulomi
   You, Yuan
   Szigeti, Klara
   Horvath, Tamas L.
   Lindenbach, Brett
   Mor, Gil
TI HSV-2 enhances ZIKV infection of the placenta and induces apoptosis in
   first-trimester trophoblast cells
SO AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE co-infection; fetal viral infection; HSV-1/2; pika virus; placenta;
   pregnancy
ID SIMPLEX-VIRUS INFECTION; PREGNANCY; DISEASE; HERPES; REPLICATION;
   IMMUNITY; TYRO3; SEROPREVALENCE; RECEPTORS; DIAGNOSIS
AB Problem: Zika virus (ZIKV) has gained public concern for its association with microcephaly in infants born to ZIKV-infected mothers. To reach the fetus the virus must overcome the defense mechanisms provided by trophoblast cells. Additionally, in the first trimester, the integrity of the placenta is critical for fetal protection as damage to differentiating trophoblast can affect placental formation and function. We sought to investigate the effect of ZIKV infection on trophoblast cells and the factors that might increase the risk for ZIKV infection during pregnancy.
   Methods: First-trimester human trophoblast cells, Swan 7.1, were infected with ZIKV, herpes simplex virus-2 (HSV-2), and yellow fiver (YFV). C57BL/6 pregnant mice were infected with HSV-2, ZIKV, or coinfection. Placental viral titers were determined by RT-PCR.
   Results: ZIKV infection induces apoptosis in first-trimester trophoblasts and prevents differentiation of these cells. Furthermore, HSV-2 infection enhances placental sensitivity to ZIKV by enhancing the expression of TAM receptors, which facilitate ZIKV cell entry.
   Conclusion: These findings may explain the mechanism by which ZIKV breaches the placental barrier to access the fetus. Furthermore, our results suggest that patients with HSV-2 infection are at a higher risk for the teratogenic effects induced by ZIKV.
C1 [Aldo, Paulomi; You, Yuan; Horvath, Tamas L.; Mor, Gil] Yale Univ, Sch Med, Div Reprod Sci, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.
   [Szigeti, Klara; Horvath, Tamas L.] Yale Univ, Dept Comparat Med, Sch Med, New Haven, CT USA.
   [Lindenbach, Brett] Yale Univ, Dept Microbial Pathogenesis, Sch Med, New Haven, CT USA.
RP Mor, G (corresponding author), Yale Univ, Sch Med, Div Reprod Sci, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.
EM gil.mor@yale.edu
FU NIAID/NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R56AI124356-01]
FX This work was funded in part by NIAID/NIH grant #: 1R56AI124356-01.
CR Aldo PB, 2014, AM J REPROD IMMUNOL, V72, P270, DOI 10.1111/aji.12288
   Aldo PB, 2010, AM J REPROD IMMUNOL, V64, P27, DOI 10.1111/j.1600-0897.2010.00817.x
   Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871
   Anzivino E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-40
   Bakaletz LO, 2004, NAT REV MICROBIOL, V2, P552, DOI 10.1038/nrmicro928
   Baptista T, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2194
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   Brett-Major DM, 2016, J ROY COLL PHYS EDIN, V46, P3, DOI 10.4997/JRCPE.2016.102
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chan PY, 2016, SCIENCE, V352, P99, DOI 10.1126/science.aaf1358
   Clemens SAC, 2010, REV SAUDE PUBL, V44, P726, DOI [10.1590/S0034-89102010000400017, 10.1590/s0034-89102010000400017]
   Desselberger U, 1998, INTERVIROLOGY, V41, P185, DOI 10.1159/000024934
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686
   Geyer AI, 2013, CYTOKINE, V64, P152, DOI 10.1016/j.cyto.2013.07.010
   Hajishengallis G, 2011, NAT REV IMMUNOL, V11, P187, DOI 10.1038/nri2918
   Harding-Esch EM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000573
   Henriquez SA, 2009, NEUROIMMUNOMODULAT, V16, P122, DOI 10.1159/000180267
   Holmberg JC, 2012, AM J REPROD IMMUNOL, V67, P169, DOI 10.1111/j.1600-0897.2011.01095.x
   Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09
   Ishihara N, 2000, ENDOCR J, V47, P317, DOI 10.1507/endocrj.47.317
   Kawana K, 1996, INT J GYNECOL OBSTET, V55, P165, DOI 10.1016/S0020-7292(96)02732-4
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Pazos M, 2012, IMMUNOL RES, V54, P254, DOI 10.1007/s12026-012-8303-9
   Pereira VSS, 2012, EUR J OBSTET GYN R B, V161, P190, DOI 10.1016/j.ejogrb.2011.12.006
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501
   Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661
   Rothlin CV, 2015, ANNU REV IMMUNOL, V33, P355, DOI 10.1146/annurev-immunol-032414-112103
   Rothlin CV, 2014, INFLAMM BOWEL DIS, V20, P1472, DOI 10.1097/MIB.0000000000000050
   Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001
   SMITH H, 1982, PHILOS T ROY SOC B, V297, P551, DOI 10.1098/rstb.1982.0060
   Smith PD, 2009, J AM COLL HEALTH, V57, P389, DOI 10.3200/JACH.57.4.389-394
   Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007
   Tabata T, 2012, AM J PATHOL, V181, P1540, DOI 10.1016/j.ajpath.2012.08.003
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964
NR 47
TC 24
Z9 24
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1046-7408
EI 1600-0897
J9 AM J REPROD IMMUNOL
JI Am. J. Reprod. Immunol.
PD NOV
PY 2016
VL 76
IS 5
BP 348
EP 357
DI 10.1111/aji.12578
PG 10
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA EB4LG
UT WOS:000387342700002
PM 27613665
OA Bronze
DA 2020-07-08
ER

PT J
AU do Rosario, MS
   de Jesus, PAP
   Vasilakis, N
   Farias, DS
   Novaes, MAC
   Rodrigues, SG
   Martins, LC
   Vasconcelos, PFD
   Ko, AI
   Alcantara, LCJ
   de Siqueira, IC
AF do Rosario, Mateus Santana
   Pereira de Jesus, Pedro Antonio
   Vasilakis, Nikos
   Farias, Daniel Santana
   Caires Novaes, Marco Antonio
   Rodrigues, Sueli Guerreiro
   Martins, Livia Caricio
   da Costa Vasconcelos, Pedro Fernando
   Ko, Albert Icksang
   Junior Alcantara, Luiz Carlos
   de Siqueira, Isadora Cristina
TI Case Report: Guillain-Barre Syndrome after Zika Virus Infection in
   Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID DENGUE; OUTBREAK; BAHIA
AB Zika virus (ZIKV) is an emerging flavivirus, which has caused a widespread outbreak in the Americas. Shortly after its introduction in 2015, a cluster of cases with Guillain Barre syndrome was detected in Brazil. Herein, we describe two cases from the city of Salvador, who developed ascending paresis after an acute exanthematous illness. The patients were admitted to the intensive care unit with tetraparesis and cranial nerve palsy, which resolved after intravenous administration of human immunoglobulin. Serological evaluation detected IgM-specific ZIKV antibodies. In regions of Zika virus transmission, health-care workers must be aware of the potential severe neurological complications associated with ZIKV infection and be prepared to provide prompt diagnosis, treatment, and supportive care.
C1 [do Rosario, Mateus Santana; Pereira de Jesus, Pedro Antonio; Farias, Daniel Santana] Secretaria Estadual Saude Bahia, Hosp Geral Roberto Santos, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Ctr Biodefense & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Fundacao Monte Tabor, Hosp Salo Rafael, Salvador, BA, Brazil.
   [Rodrigues, Sueli Guerreiro; Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas SVS MS, Secao Arbovirol & Febres Hemorrag, Ananindeua, Brazil.
   [Ko, Albert Icksang] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA.
   [Junior Alcantara, Luiz Carlos; de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil.
   [do Rosario, Mateus Santana] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas, Salvador, BA, Brazil.
   [Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Caires Novaes, Marco Antonio] Hosp Sao Rafael, Fundacao Monte Tabor, Salvador, BA, Brazil.
   [Martins, Livia Caricio; da Costa Vasconcelos, Pedro Fernando] Evandro Chagas Inst, Dept Arbovirol & Hemorrhag Fevers, Belem, Para, Brazil.
RP de Siqueira, IC (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Gongalo Moniz, R Waldemar Falcao 121, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@bahia.fiocruz.br
RI Ko, Albert Icksang/P-2343-2015; de Siqueira, Isadora
   Cristina/R-9953-2016; Vasconcelos, Pedro/AAH-3142-2019
OI Ko, Albert Icksang/0000-0001-9023-2339; de Siqueira, Isadora
   Cristina/0000-0002-2520-4099; Jesus, Pedro Antonio/0000-0003-1211-2272;
   do Rosario, Mateus/0000-0001-7404-6392; Alcantara,
   Luiz/0000-0002-6769-9931
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R24AI120942]
FX We are grateful to Marcia Weber for the laboratorial technical
   assistance, Fernanda Washington de M. Lima and Daniel Moura for
   assistance in the serological diagnosis, and the physicians and nurses
   involved in the patient's clinical treatment. We also thank Bruno B.
   Andrade for the critical review of the manuscript. This work was
   supported in part by the NIH grant R24AI120942 to Nikos Vasilakis.
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos GS, 2015, JPN J INFECT DIS, V68, P45, DOI 10.7883/yoken.JJID.2014.063
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   DVIS/CIEVS, 2015, INF EP DOENC EX MAT
   Garg RK, 2015, NEUROL INDIA, V63, P497, DOI 10.4103/0028-3886.161990
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 45
Z9 45
U1 0
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1157
EP 1160
DI 10.4269/ajtmh.16-0306
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600035
PM 27645785
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Fabrizius, RG
   Anderson, K
   Hendel-Paterson, B
   Kaiser, RM
   Maalim, S
   Walker, PF
AF Fabrizius, Ryan G.
   Anderson, Kathryn
   Hendel-Paterson, Brett
   Kaiser, Robyn M.
   Maalim, Salahudin
   Walker, Patricia F.
TI Case Report: Guillain-Barre Syndrome Associated with Zika Virus
   Infection in a Traveler Returning from Guyana
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID SEROLOGICAL SURVEY; ARBOVIRUSES; POPULATION; SOUTHEAST; URINE; GABON;
   FEVER; CARE
AB Zika virus (ZIKV) is a mosquito-borne flavivirus with a significant public health impact highlighted by the ongoing epidemic in the Americas. We describe a 44-year-old male presenting to our tropical medicine center with complaints of fever, headache, joint pain, and rash after recent travel to Guyana. The patient subsequently developed gait imbalance and lower extremity weakness with clinical examination, cerebrospinal fluid studies, and magnetic resonance imaging of the spine consistent with a diagnosis of Guillain-Barre syndrome (GBS). ZIKV infection was confirmed via detection of ZIKV RNA in urine by polymerase chain reaction. The patient was treated with intravenous immunoglobulin and experienced near-complete neurologic recovery, reporting ongoing mild paresthesia up to 2 months later. This case highlights the diagnostic challenges posed by ZIKV and underscores the need for clinician awareness of the potential for neurological complications such as GBS with ZIKV infection.
C1 [Fabrizius, Ryan G.; Anderson, Kathryn; Hendel-Paterson, Brett; Maalim, Salahudin; Walker, Patricia F.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.
   [Anderson, Kathryn] Walter Reed Army Inst Res, Armed Forces Res Inst Med Sci, US Army Med Directorate, Dept Virol, Bangkok, Thailand.
   [Hendel-Paterson, Brett; Kaiser, Robyn M.; Maalim, Salahudin; Walker, Patricia F.] HealthPartners Med Grp, St Paul, MN USA.
   [Hendel-Paterson, Brett; Maalim, Salahudin; Walker, Patricia F.] HealthPartners Med Grp, Travel & Trop Med Ctr, St Paul, MN USA.
   [Kaiser, Robyn M.] HealthPartners Med Grp, Infect Dis, St Paul, MN USA.
RP Walker, PF (corresponding author), HealthPartners Ctr Int Hlth, 451 North Dunlap St, St Paul, MN 55104 USA.
EM patricia.f.walker@healthpartners.com
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bui YG, 2011, J TRAVEL MED, V18, P373, DOI 10.1111/j.1708-8305.2011.00556.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, ZIK VIR DIS US 2015
   CDC, 2016, ALL COUNTR TERR ACT
   CDC, 2015, ARB DIS NEUR NONN 20
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Food and Drug Administration (FDA), 2016, EM US AUTH ZIK VIR E
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kang JH, 2010, CLIN INFECT DIS, V51, P525, DOI 10.1086/655136
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LaRocque RC, 2013, AM J TROP MED HYG, V88, P376, DOI 10.4269/ajtmh.2012.12-0460
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Ministerio da Saude (Brazil), 2015, MIN SAUD DIV NOV DAD
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization (PAHO)/World Health Organization (WHO)-Regional Office for the Americas, 2015, EP AL ZIK VIR INF 7
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roze B, 2016, EUROSURVEILLANCE, V21, P1
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
NR 36
TC 13
Z9 13
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1161
EP 1165
DI 10.4269/ajtmh.16-0397
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600036
PM 27807296
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Norman, FF
   Chamorro, S
   Vazquez, A
   Sanchez-Seco, MP
   Perez-Molina, JA
   Monge-Maillo, B
   Vivancos, MJ
   Rodriguez-Dominguez, M
   Galan, JC
   de Ory, F
   Lopez-Velez, R
AF Norman, Francesca F.
   Chamorro, Sandra
   Vazquez, Ana
   Sanchez-Seco, Maria-Paz
   Perez-Molina, Jose-Antonio
   Monge-Maillo, Begona
   Vivancos, Maria-Jesus
   Rodriguez-Dominguez, Mario
   Galan, Juan-Carlos
   de Ory, Fernando
   Lopez-Velez, Rogelio
TI Case Report: Sequential Chikungunya and Zika Virus Infections in a
   Traveler from Honduras
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRANSMISSION; SPAIN
AB Zika virus (ZIKV) and chikungunya virus (CHIKV) are currently circulating in overlapping areas in the American continents and may both be transmitted by Aedes spp. mosquitoes. The first documented case, to the authors' knowledge, of sequential CHIKV and ZIKV infections diagnosed in a nonendemic area in a returning traveler is reported. The implications for heightened clinical surveillance for these infections and specific patient recommendations are emphasized.
C1 [Norman, Francesca F.; Chamorro, Sandra; Perez-Molina, Jose-Antonio; Monge-Maillo, Begona; Vivancos, Maria-Jesus; Rodriguez-Dominguez, Mario; Galan, Juan-Carlos; Lopez-Velez, Rogelio] Ramon & Cajal Hosp, IRYCIS, Madrid, Spain.
   [Vazquez, Ana; Sanchez-Seco, Maria-Paz; de Ory, Fernando] Inst Salud Carlos III, CiberEsp, Natl Microbiol Ctr, Madrid, Spain.
   [Norman, Francesca F.; Chamorro, Sandra; Vivancos, Maria-Jesus] Hosp Univ Ramon y Cajal, Dept Infect Dis, IRYCIS, Trop Med, Madrid, Spain.
   [Sanchez-Seco, Maria-Paz] Inst Salud Carlos III, Alert & Emergency Unit, Madrid, Spain.
   [Perez-Molina, Jose-Antonio; Monge-Maillo, Begona; Lopez-Velez, Rogelio] Ramon & Cajal Hosp, Dept Infect Dis, IRYCIS, Trop Med, Madrid, Spain.
   [Rodriguez-Dominguez, Mario; Galan, Juan-Carlos] Hosp Univ Ramon y Cajal, IRYCIS, Dept Microbiol, Madrid, Spain.
RP Norman, FF (corresponding author), Ramon & Cajal Hosp, Dept Infect Dis, Natl Referral Unit Trop Dis, Ctra Colmenar Km 9-1, E-28034 Madrid, Spain.
EM ffnorman@gmail.com
RI Vazquez, Ana/H-4911-2013
OI Vazquez, Ana/0000-0002-9872-3316; Perez-Molina, Jose
   Antonio/0000-0001-8735-4124; SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704
FU Spanish Ministry of Science and InnovationSpanish Government; Institute
   de Salud Carlos III within the Network of Tropical Diseases Research
   RICET [RD06/0021/0020]
FX This work was supported by the Spanish Ministry of Science and
   Innovation and the Institute de Salud Carlos III within the Network of
   Tropical Diseases Research RICET [RD06/0021/0020].
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Figuerola J, 2008, VET MICROBIOL, V132, P39, DOI 10.1016/j.vetmic.2008.04.023
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Vazquez A, 2012, VECTOR-BORNE ZOONOT, V12, P223, DOI 10.1089/vbz.2011.0687
   World Health Organization, 2016, MOSQ BORN DIS
NR 9
TC 13
Z9 13
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2016
VL 95
IS 5
BP 1166
EP 1168
DI 10.4269/ajtmh.16-0426
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VC
UT WOS:000400206600037
PM 27601517
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Pinheiro, TJ
   Guimaraes, LF
   Silva, MTT
   Soares, CN
AF Pinheiro, Talys J.
   Guimaraes, Luis F.
   Silva, Marcus Tulius T.
   Soares, Cristiane N.
TI Neurological manifestations of Chikungunya and Zika infections
SO ARQUIVOS DE NEURO-PSIQUIATRIA
LA English
DT Review
DE Guillain-Barre syndrome; Zika virus; Chikungunya virus
ID POLYMERASE CHAIN-REACTION; VIRUS-INFECTION; RAPID DETECTION; DECEMBER
   2013; OUTBREAK; FEVER; BRAZIL; QUANTIFICATION; COMPLICATIONS; MICRONESIA
AB The epidemics of Chikungunya virus (CHIKV) and Zika virus (ZIKV) infections have been considered the most important epidemiological occurrences in the Americas. The clinical picture of CHIKV infection is characterized by high fever, exanthema, myalgia, headaches, and arthralgia. Besides the typical clinical picture of CHIKV, atypical manifestations of neurological complications have been reported: meningo-encephalitis, meningoencephalo-myeloradiculitis, myeloradiculitis, myelitis, myeloneuropathy, Guillain-Barre syndrome and others. The diagnosis is based on clinical, epidemiological, and laboratory criteria. The most common symptoms of ZIKV infection are skin rash (mostly maculopapular), fever, arthralgia, myalgia, headache, and conjunctivitis. Some epidemics that have recently occurred in French Polynesia and Brazil, reported the most severe conditions, with involvement of the nervous system (Guillain-Barre syndrome, transverse myelitis, microcephaly and meningitis). The treatment for ZIKV and CHIKV infections are symptomatic and the management for neurological complications depends on the type of affliction. Intravenous immunoglobulin, plasmapheresis, and corticosteroid pulse therapy are options.
C1 [Pinheiro, Talys J.; Guimaraes, Luis F.; Soares, Cristiane N.] Hosp Servidores Estado, Serv Neurol, Rio De Janeiro, RJ, Brazil.
   [Silva, Marcus Tulius T.] Fundacao Oswaldo Cruz, Lab Pesquisa Clin Doencas Neuroinfecciosas, Inst Nacl Doencas Infecciosas Evandro Chagas, Rio De Janeiro, RJ, Brazil.
RP Soares, CN (corresponding author), Rua Santa Clara,50 Sala 1217, BR-22060000 Rio De Janeiro, RJ, Brazil.
EM crist_nsoares@yahoo.com.br
RI Silva, Marcus Tulius/AAM-1077-2020
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bhavana K, 2008, INT J PEDIATR OTORHI, V72, P257, DOI 10.1016/j.ijporl.2007.09.022
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carbajo AE, 2015, MEM I OSWALDO CRUZ, V110, P259, DOI 10.1590/0074-02760150005
   Carletti F, 2007, AM J TROP MED HYG, V77, P521, DOI 10.4269/ajtmh.2007.77.521
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Casolari S, 2008, SCAND J INFECT DIS, V40, P995, DOI 10.1080/00365540802419055
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chandak NH, 2008, BMC P S1, V2, P11, DOI [10.1186/1753-6561-2-s1-p11, DOI 10.1186/1753-6561-2-S1-P11]
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Azevedo RDD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049006219
   Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Domingo C, 2011, J CLIN MICROBIOL, V49, P760, DOI 10.1128/JCM.01775-10
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fraisier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091397
   Garg M, 2014, ANN EMERG MED, V64, P552, DOI 10.1016/j.annemergmed.2014.08.002
   Gauri L A, 2012, J Assoc Physicians India, V60, P68
   Gutierrez-Saravia E, 2015, J PEDIAT INF DIS SOC, V4, P1, DOI 10.1093/jpids/piv002
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Ho PS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-13
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kalita J, 2013, INFECTION, V41, P727, DOI 10.1007/s15010-013-0406-2
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Ministerio da Saude (BR), 2015, MICR MIN SAUD DIV B
   Ministerio da Saude - CIEVS Nacional, NOT INF 07 2015 EV S
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oehler E, 2011, Med Trop (Mars), V71, P203
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization - PAHO, 2016, CAS CHIK FEV AM 2016
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Polynesie Francaise, SURV DENG ZIK POL FR
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wadia R. S., 2007, Annals of the Indian Academy of Neurology, V10, P198
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 60
TC 27
Z9 30
U1 0
U2 17
PU ASSOC ARQUIVOS NEURO- PSIQUIATRIA
PI SAO PAULO SP
PA PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL
SN 0004-282X
EI 1678-4227
J9 ARQ NEURO-PSIQUIAT
JI Arq. Neuro-Psiquiatr.
PD NOV
PY 2016
VL 74
IS 11
BP 937
EP 943
DI 10.1590/0004-282X20160138
PG 7
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA ED1BS
UT WOS:000388579300013
PM 27901259
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Baca-Carrasco, D
   Velasco-Hernandez, JX
AF Baca-Carrasco, David
   Velasco-Hernandez, Jorge X.
TI Sex, Mosquitoes and Epidemics: An Evaluation of Zika Disease Dynamics
SO BULLETIN OF MATHEMATICAL BIOLOGY
LA English
DT Article
DE ZIKA virus; Sexual transmission; Migration; Basic reproductive number
ID VIRUS OUTBREAK; TRANSMISSION; AMERICA; STATES; BRAZIL
AB Since the first major outbreak reported on the island Yap in 2007, the Zika virus spread has alerted the scientific community worldwide. Zika is an arbovirus transmitted by Aedes mosquitoes; particularly in Central and South America, the main vector is the same mosquito that transmits dengue and chikungunya, Aedes aegypti. Seeking to understand the dynamics of spread of the Zika, in this paper, three mathematical models are presented, in which vector transmission of the virus, sexual contact transmission and migration are considered. Numerical analysis of these models allows us to have a clear view of the effects of sexual transmission and migration in the spread of the virus, showing that sexual transmission influences the magnitude of the outbreaks and migration generates outbreaks over time, each of lower intensity than the previous.
C1 [Baca-Carrasco, David; Velasco-Hernandez, Jorge X.] UNAM, Inst Matemat, Campus Juriquilla,Blvd Juriquilla 3001, Juriquilla 76230, Queretaro, Mexico.
RP Baca-Carrasco, D (corresponding author), UNAM, Inst Matemat, Campus Juriquilla,Blvd Juriquilla 3001, Juriquilla 76230, Queretaro, Mexico.
EM davidbaca@im.unam.mx; jx.velasco@im.unam.mx
RI Velasco-Hernandez, Jorge/A-5391-2008
OI Velasco-Hernandez, Jorge/0000-0002-5604-7719; Baca-Carrasco,
   David/0000-0001-7006-3953
FU PAPIIT (UNAM)Programa de Apoyo a Proyectos de Investigacion e Innovacion
   Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico [IA101215];
   CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT);
   UNAMUniversidad Nacional Autonoma de Mexico; UNISON
FX JXVH acknowledges support form PAPIIT (UNAM) Grant IA101215. DBC
   acknowledges support from CONACyT, UNAM and UNISON.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Olmos D, 2015, J DIFFER EQU DYN SYS, DOI [10.1007/s12591-015-0257-7, DOI 10.1007/S12591-015-0257-7]
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Prisant N., 2016, LANCET INFECT DIS
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 23
TC 19
Z9 19
U1 0
U2 43
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0092-8240
EI 1522-9602
J9 B MATH BIOL
JI Bull. Math. Biol.
PD NOV
PY 2016
VL 78
IS 11
BP 2228
EP 2242
DI 10.1007/s11538-016-0219-4
PG 15
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA EB4LO
UT WOS:000387343500005
PM 27743310
DA 2020-07-08
ER

PT J
AU Lessler, J
   Ott, CT
   Carcelen, AC
   Konikoff, JM
   Williamson, J
   Bi, QF
   Kucirka, LM
   Cummings, DAT
   Reich, NG
   Chaisson, LH
AF Lessler, Justin
   Ott, Cassandra T.
   Carcelen, Andrea C.
   Konikoff, Jacob M.
   Williamson, Joe
   Bi, Qifang
   Kucirka, Lauren M.
   Cummings, Derek A. T.
   Reich, Nicholas G.
   Chaisson, Lelia H.
TI Times to key events in Zika virus infection and implications for blood
   donation: a systematic review
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID INCUBATION PERIODS; FRENCH-POLYNESIA; VIRAL-INFECTIONS; DECEMBER 2013;
   OUTBREAK; TRANSMISSION; TRAVEL
AB Objective To estimate the timing of key events in the natural history of Zika virus infection.
   Methods In February 2016, we searched PubMed, Scopus and the Web of Science for publications containing the term Zika. By pooling data, we estimated the incubation period, the time to seroconversion and the duration of viral shedding. We estimated the risk of Zika virus contaminated blood donations.
   Findings We identified 20 articles on 25 patients with Zika virus infection. The median incubation period for the infection was estimated to be 5.9 days (95% credible interval, Crl: 4.4-7.6), With 95% of people who developed symptoms doing so within 11.2 days (95% Crl: 7.6-18.0) after infection. On average, seroconversion occurred 9.1 days (95% Crl: 7.0-11.6) after infection. The virus was detectable in blood for 9.9 days (95% Crl: 6.9-21.4) on average. Without screening, the estimated risk that a blood donation would come from an infected individual increased by approximately 1 in 10 000 for every 1 per 100 000 person days increase in the incidence of Zika virus infection. Symptom-based screening may reduce this rate by 7% (relative risk, RR: 0.93; 95% Crl: 0.89-0.99) and antibody screening, by 29% (RR: 0.71; 95% Crl: 0.28-0.88).
   Conclusion Neither symptom- nor antibody-based screening for Zika virus infection substantially reduced the risk that blood donations would be contaminated by the virus. Polymerase chain reaction testing should be considered for identifying blood safe for use in pregnant women in high-incidence areas.
C1 [Lessler, Justin; Ott, Cassandra T.; Carcelen, Andrea C.; Konikoff, Jacob M.; Williamson, Joe; Bi, Qifang; Chaisson, Lelia H.] Johns Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA.
   [Kucirka, Lauren M.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA.
   [Cummings, Derek A. T.] Univ Florida, Gainesville, FL USA.
   [Reich, Nicholas G.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.
RP Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 North Wolfe St, Baltimore, MD 21205 USA.
EM justin@jhu.edu
RI Reich, Nicholas/L-1168-2019
OI Reich, Nicholas/0000-0003-3503-9899
FU Department of Epidemiology; Office of Public Health Practice and
   Training at Johns Hopkins Bloomberg School of Public Health
FX The study was funded by the Department of Epidemiology and the Office of
   Public Health Practice and Training at Johns Hopkins Bloomberg School of
   Public Health.
CR [Anonymous], 2016, REC DON SCREEN DEF P
   [Anonymous], 2016, CUM ZIK SUSP CONF CA
   [Anonymous], 2016, NEW BLOOD DON RUL PR
   [Anonymous], 2016, PROT VIG RESP OC MIC
   [Anonymous], 2016, ZIKALITREVIEW
   [Anonymous], 2016, SYMPT TEST TREATM AT
   [Anonymous], 2016, FACTSH HLTH PROF
   [Anonymous], 2016, WHOZIKVHS161
   [Anonymous], 2016, NOT TECN QUE DEF CRI
   Azman AS, 2013, J INFECTION, V66, P432, DOI 10.1016/j.jinf.2012.11.013
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boadle A., 2016, BRAZIL REPORTS ZIKA
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lee RM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-446
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lessler J, 2010, INFECT CONT HOSP EP, V31, P809, DOI 10.1086/655023
   Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089
   Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Plummer M., 2016, JAGS JUST ANOTHER GI
   R_Foundation, 2016, R PROJECT STAT COMPU
   Reich NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019496
   Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   SARTWELL PE, 1950, AM J HYG, V51, P310, DOI 10.1093/oxfordjournals.aje.a119397
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Vasquez AM, 2016, MMWR-MORBID MORTAL W, V65, P375, DOI 10.15585/mmwr.mm6514e1
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   WHO, 2016, FACT SHEET
   WHO, 2016, GEN SUMM OUTC EM COM
   World Health Organization, 2016, SITUATION REPORT
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 52
TC 45
Z9 45
U1 0
U2 9
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD NOV
PY 2016
VL 94
IS 11
BP 841
EP 849
DI 10.2471/BLT.16.174540
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EC3XP
UT WOS:000388060700011
PM 27821887
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Chen, X
   Yang, KL
   Wu, C
   Chen, C
   Hu, C
   Buzovetsky, O
   Wang, ZF
   Ji, XY
   Xiong, Y
   Yang, HT
AF Chen, Xia
   Yang, Kailin
   Wu, Chen
   Chen, Cheng
   Hu, Can
   Buzovetsky, Olga
   Wang, Zefang
   Ji, Xiaoyun
   Xiong, Yong
   Yang, Haitao
TI Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease
SO CELL RESEARCH
LA English
DT Letter
ID WEST-NILE-VIRUS; CRYSTAL-STRUCTURE; NS3 PROTEASES; DENGUE; CLEAVAGE
C1 [Chen, Xia; Wu, Chen; Chen, Cheng; Hu, Can; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Chen, Xia; Hu, Can; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Yang, Kailin] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA.
   [Buzovetsky, Olga; Xiong, Yong] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.
   [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
RP Yang, HT (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.; Ji, XY (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
EM xiaoyun.ji@nju.edu.cn; yanght@tju.edu.cn
RI ; Yang, Kailin/L-2205-2013
OI Ji, Xiaoyun/0000-0002-0801-8825; Yang, Kailin/0000-0001-5968-6738
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32 GM007223]
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
NR 15
TC 40
Z9 45
U1 2
U2 34
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD NOV
PY 2016
VL 26
IS 11
BP 1260
EP 1263
DI 10.1038/cr.2016.116
PG 4
WC Cell Biology
SC Cell Biology
GA EC1RO
UT WOS:000387885300012
PM 27752039
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Sharp, TM
   Munoz-Jordan, J
   Perez-Padilla, J
   Bello-Pagan, MI
   Rivera, A
   Pastula, DM
   Salinas, JL
   Mendez, JHM
   Mendez, M
   Powers, AM
   Waterman, S
   Rivera-Garcia, B
AF Sharp, Tyler M.
   Munoz-Jordan, Jorge
   Perez-Padilla, Janice
   Bello-Pagan, Melissa I.
   Rivera, Aidsa
   Pastula, Daniel M.
   Salinas, Jorge L.
   Mendez, Jose H. Martinez
   Mendez, Mnica
   Powers, Ann M.
   Waterman, Stephen
   Rivera-Garcia, Brenda
TI Zika Virus Infection Associated With Severe Thrombocytopenia
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika virus; thrombocytopenia; fatal; Puerto Rico
ID FEVER
AB We report two patients that developed severe thrombocytopenia after Zika virus ( ZIKV) infection. The first patient had 1000 platelets/mu L and died after multiple hemorrhages. The second patient had 2000 platelets/mu L, had melena and ecchymoses, and recovered after receiving intravenous immunoglobulin. ZIKV may be associated with immune-mediated severe thrombocytopenia.
C1 [Sharp, Tyler M.; Munoz-Jordan, Jorge; Perez-Padilla, Janice; Rivera, Aidsa; Waterman, Stephen] Ctr Dis Control & Prevent, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Pastula, Daniel M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA.
   [Salinas, Jorge L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, San Juan, PR USA.
   [Powers, Ann M.] Ctr Dis Control & Prevent, Arboviral Dis Branch, San Juan, PR USA.
   [Bello-Pagan, Melissa I.; Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Mendez, Jose H. Martinez] San Juan City Hosp, San Juan, PR USA.
   [Mendez, Mnica] Hosp HIMA San Pablo, Bayamon, PR USA.
   [Pastula, Daniel M.] Univ Colorado, Denver, CO 80202 USA.
RP Sharp, TM (corresponding author), Ctr Dis Control & Prevent, Dengue Branch, 1324 Calle Canada, San Juan, PR 00920 USA.
EM tsharp@cdc.gov
RI Pastula, Daniel M./M-1325-2019
OI Pastula, Daniel M./0000-0001-9342-4459
FU Intramural CDC HHS [CC999999]
CR [Anonymous], 2016, MMWR MORB MORTAL WKL, V65, P474
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Azeredo EL, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/313842
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Pan American Health Organization, COUNTR TERR AUT TRAN
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ruzek D, 2010, LANCET, V376, P2104, DOI 10.1016/S0140-6736(10)61120-8
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 14
TC 40
Z9 40
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2016
VL 63
IS 9
BP 1198
EP 1201
DI 10.1093/cid/ciw476
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC2WY
UT WOS:000387986200013
PM 27418575
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Matheron, S
   d'Ortenzio, E
   Leparc-Goffart, I
   Hubert, B
   de Lamballerie, X
   Yazdanpanah, Y
AF Matheron, Sophie
   d'Ortenzio, Eric
   Leparc-Goffart, Isabelle
   Hubert, Bruno
   de Lamballerie, Xavier
   Yazdanpanah, Yazdan
TI Long-Lasting Persistence of Zika Virus in Semen
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Letter
ID SEXUAL TRANSMISSION
C1 [Matheron, Sophie; Yazdanpanah, Yazdan] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France.
   [Matheron, Sophie; d'Ortenzio, Eric; Yazdanpanah, Yazdan] INSERM, UMR 1137, Paris, France.
   [Matheron, Sophie; Yazdanpanah, Yazdan] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.
   [Leparc-Goffart, Isabelle] Ctr Natl Reference Arboviroses, Inst Rech Biomed Armees, Marseille, France.
   [Hubert, Bruno] Sante Publ France, St Maurice, France.
   [de Lamballerie, Xavier] Univ Aix Marseille, UMR 190, Inst Rech Dev, INSERM 1207,Ecole Hautes Etud Sante Publ, Marseille, France.
RP Matheron, S (corresponding author), CHU Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, 46 Rue Henri Huchard, F-75018 Paris, France.
EM sophie.matheron@aphp.fr
RI Matheron, Sophie/D-7420-2017
OI Matheron, Sophie/0000-0001-7879-6553; D'Ortenzio,
   Eric/0000-0002-4527-6209; Hubert, Bruno/0000-0003-3640-718X
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   World Health Organization, 2016, WHOZIKVMOC161
NR 5
TC 53
Z9 54
U1 0
U2 10
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD NOV 1
PY 2016
VL 63
IS 9
DI 10.1093/cid/ciw509
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC2WY
UT WOS:000387986200023
PM 27470244
OA Bronze
DA 2020-07-08
ER

PT J
AU da Silva, MB
   dos Santos, RCR
   da Cunha, AM
   Valentini, A
   Pessoa, ODL
   Caetano, EWS
   Freire, VN
AF Bezerra da Silva, M.
   dos Santos, R. C. R.
   da Cunha, A. M.
   Valentini, A.
   Pessoa, O. D. L.
   Caetano, E. W. S.
   Freire, V. N.
TI Structural, Electronic, and Optical Properties of Bulk Boric Acid 2A and
   3T Polymorphs: Experiment and Density Functional Theory Calculations
SO CRYSTAL GROWTH & DESIGN
LA English
DT Article
ID GROUND-STATE; APPROXIMATION; DIFFRACTION; ABSORPTION; MOLECULES;
   CRYSTALS; SPECTRA; MALARIA; GAS; DFT
AB Boric acid (H3BO3) is being used effectively nowadays in traps/baits for the management of Aedes aegypti L. and Aedes albopictus Skuse species of mosquitos, which are the main spreading vectors for diseases like malaria, dengue, and zika worldwide. Due to its renewed importance, we have studied in this work the structural, electronic, and optical properties of its molecular triclinic H3BO3-2A and trigonal H3BO3-3T polymorphs within the framework of density functional theory (DFT) at the local density and generalized gradient levels of calculations, LDA and GGA, respectively, improving and extending previously published theoretical results on triclinic boric acid structural properties. In addition, the optical absorption of the 2A polymorph was measured in this work for the sake of comparison with our DFT estimate. In comparison to published X-ray diffraction data, unit cell deviations as small as Delta a similar to -0.13 angstrom (-0.12 angstrom), Delta b similar to -0.13 angstrom (-0.12 angstrom), Delta c similar to 0.18 angstrom (-0.31 angstrom), and interplanar distance deviation Delta d similar to -0.11 angstrom (-0.10 angstrom) for H3BO3-2A (H3BO3-3T) were obtained using a Tkatchenko and Scheffler dispersion corrected GGA functional. The properties of the polymorphs are shown to be ruled by an interplay between in-plane hydrogen bonds and interplanar van der Waals interactions. However, the molecular stacking pattern, AB for H3BO3-2A and ABC for H(3)BO3(-)3T, does not lead to significantly distinct electronic and optical properties. Both polymorphs are suggested to be insulators with indirect bang gaps of about 6.26 +/- 0.01 eV, which is in close agreement with the 5.98 eV indirect band gap we have measured for triclinic boric acid by optical absorption. Notably the usual DFT gap underestimation is not observed due to the extra shrinking of the unit cell caused by the inclusion of van der Waals forces in the geometry optimization. The complex dielectric function and optical absorption of both boric acid polymorphs were characterized as well.
C1 [Bezerra da Silva, M.; Freire, V. N.] Univ Fed Ceara, Dept Fis, Caixa Postal 6030, BR-60440900 Fortaleza, CE, Brazil.
   [dos Santos, R. C. R.; da Cunha, A. M.; Valentini, A.; Freire, V. N.] Univ Fed Ceara, Dept Quim Analit & Fisicoquim, BR-60440554 Fortaleza, CE, Brazil.
   [Pessoa, O. D. L.] Univ Fed Ceara, Dept Quim Organ & Inorgan, BR-60021970 Fortaleza, CE, Brazil.
   [Caetano, E. W. S.] DEMEL, Inst Fed Educ Ciencia & Tecnol Ceara, Campus Fortaleza, BR-60040531 Fortaleza, CE, Brazil.
RP Caetano, EWS (corresponding author), DEMEL, Inst Fed Educ Ciencia & Tecnol Ceara, Campus Fortaleza, BR-60040531 Fortaleza, CE, Brazil.
EM ewcaetano@gmail.com
RI Caetano, Ewerton WS/A-2284-2015; BEZERRA DA SILVA,
   MAURICELIO/M-8997-2017; Freire, Valder/D-1136-2013; Santos, Regina C.
   R./N-1418-2018; Valentini, Antoninho/N-1358-2018
OI Caetano, Ewerton WS/0000-0002-1021-6927; BEZERRA DA SILVA,
   MAURICELIO/0000-0001-7941-3956; Freire, Valder/0000-0001-7867-3908;
   Santos, Regina C. R./0000-0002-6943-366X; Valentini,
   Antoninho/0000-0002-7019-6155
FU Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq); CNPqNational Council
   for Scientific and Technological Development (CNPq) [307843/2013-0]
FX V. N. F., A. Valentim, and O. D. L. Pessoa are senior researchers from
   the Brazilian National Research Council (CNPq), and would like to
   acknowledge the financial support received during the development of
   this work. E. W. S. C. received financial support from CNPq through the
   project 307843/2013-0.
CR ANDREWS L, 1992, J CHEM PHYS, V97, P7203, DOI 10.1063/1.463545
   BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Beran GJO, 2016, CHEM REV, V116, P5567, DOI 10.1021/acs.chemrev.5b00648
   Berland K, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/6/066501
   Bhami LC, 2015, J VECTOR DIS, V52, P147
   Bhimanapati GR, 2015, ACS NANO, V9, P11509, DOI 10.1021/acsnano.5b05556
   BONACCOR.R, 1970, J CHEM PHYS, V52, P5270, DOI 10.1063/1.1672775
   Caetano EWS, 2005, AIP CONF PROC, V772, P1095
   Candido JR, 2011, CHEM PHYS LETT, V512, P208, DOI 10.1016/j.cplett.2011.07.028
   CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566
   Costa SN, 2013, CRYST GROWTH DES, V13, P2793, DOI 10.1021/cg400111w
   COWLEY JM, 1953, ACTA CRYSTALLOGR, V6, P522, DOI 10.1107/S0365110X53001423
   CRAVEN BM, 1966, ACTA CRYSTALLOGR, V20, P214, DOI 10.1107/S0365110X66000446
   da Silva JG, 2013, CHEM PHYS LETT, V587, P20, DOI 10.1016/j.cplett.2013.09.051
   Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015
   DORSET DL, 1992, ACTA CRYSTALLOGR A, V48, P562, DOI 10.1107/S010876739200206X
   FAN HY, 1956, REP PROG PHYS, V19, P107, DOI 10.1088/0034-4885/19/1/304
   Flores MZS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115104
   FOSTER JP, 1980, J AM CHEM SOC, V102, P7211, DOI 10.1021/ja00544a007
   Fox A. M., 2001, OPTICAL PROPERTIES S, P58, DOI DOI 10.1119/1.1691372
   GAJHEDE M, 1986, ACTA CRYSTALLOGR B, V42, P545, DOI 10.1107/S0108768186097720
   Gao SP, 2012, SOLID STATE COMMUN, V152, P1817, DOI 10.1016/j.ssc.2012.07.022
   Gao SP, 2012, COMP MATER SCI, V61, P266, DOI 10.1016/j.commatsci.2012.04.039
   Grimme S, 2016, CHEM REV, V116, P5105, DOI 10.1021/acs.chemrev.5b00533
   Harabor A, 2014, J THERM ANAL CALORIM, V118, P1375, DOI 10.1007/s10973-014-4169-5
   HIRSHFELD FL, 1977, THEOR CHIM ACTA, V44, P129, DOI 10.1007/BF00549096
   Housecroft C. E., 2005, INORG CHEM, P905
   Jolly W. L., 1991, MODERN INORGANIC CHE, P635
   Jones RO, 2015, REV MOD PHYS, V87, P897, DOI 10.1103/RevModPhys.87.897
   Klimes J, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754130
   KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   LIN JS, 1993, PHYS REV B, V47, P4174, DOI 10.1103/PhysRevB.47.4174
   Maia FF, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3584680
   MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188
   MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   PARR RG, 1984, J AM CHEM SOC, V106, P4049, DOI 10.1021/ja00326a036
   PERDEW JP, 1992, PHYS REV B, V45, P13244, DOI 10.1103/PhysRevB.45.13244
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048
   Pfrommer BG, 1997, J COMPUT PHYS, V131, P233, DOI 10.1006/jcph.1996.5612
   Pribram-Jones A, 2015, ANNU REV PHYS CHEM, V66, P283, DOI 10.1146/annurev-physchem-040214-121420
   Qualls WA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0819-8
   Roy RK, 1999, J CHEM PHYS, V110, P8236, DOI 10.1063/1.478792
   Segall MD, 2002, J PHYS-CONDENS MAT, V14, P2717, DOI 10.1088/0953-8984/14/11/301
   Shuvalov RR, 2003, ACTA CRYSTALLOGR C, V59, pI47, DOI 10.1107/S0108270103009685
   Silva AM, 2015, J PHYS CHEM A, V119, P11791, DOI 10.1021/acs.jpca.5b08784
   Silva AM, 2013, CRYST GROWTH DES, V13, P4844, DOI 10.1021/cg401016v
   Silva AM, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.195201
   Tkatchenko A, 2015, ADV FUNCT MATER, V25, P2054, DOI 10.1002/adfm.201403029
   Tkatchenko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.073005
   Zachariasen WH, 1934, Z KRISTALLOGR, V88, P150
   ZACHARIASEN WH, 1954, ACTA CRYSTALLOGR, V7, P305, DOI 10.1107/S0365110X54000886
   ZAKI K, 1995, CHEM PHYS LETT, V236, P184, DOI 10.1016/0009-2614(95)00172-Z
   Zanatta G, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4869179
   Zapol P, 2000, J CHEM PHYS, V113, P3338, DOI 10.1063/1.1286220
   Zhu T, 2014, J PHYS CHEM C, V118, P11385, DOI 10.1021/jp412462m
NR 60
TC 4
Z9 4
U1 2
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1528-7483
EI 1528-7505
J9 CRYST GROWTH DES
JI Cryst. Growth Des.
PD NOV
PY 2016
VL 16
IS 11
BP 6631
EP 6640
DI 10.1021/acs.cgd.6b01297
PG 10
WC Chemistry, Multidisciplinary; Crystallography; Materials Science,
   Multidisciplinary
SC Chemistry; Crystallography; Materials Science
GA EB1FI
UT WOS:000387094600060
DA 2020-07-08
ER

PT J
AU da Silva, AAM
   Ganz, JSS
   Sousa, PD
   Doriqui, MJR
   Ribeiro, MRC
   Branco, MDFC
   Queiroz, RCD
   Pacheco, MDT
   da Costa, FRV
   Silva, FD
   Simoes, VMF
   Pacheco, MAB
   Lamy, F
   Lamy, ZC
   Alves, MTSSDE
AF Moura da Silva, Antonio Augusto
   Santos Ganz, Jucelia Sousa
   Sousa, Patricia da Silva
   Rodovalho Doriqui, Maria Juliana
   Costa Ribeiro, Marizelia Rodrigues
   Freitas Carvalho Branco, Maria dos Remedios
   de Sousa Queiroz, Rejane Christine
   Torres Pacheco, Maria de Jesus
   Vieira da Costa, Flavia Regina
   Silva, Francelena de Sousa
   Ferreira Simoes, Vanda Maria
   Barbosa Pacheco, Marcos Antonio
   Lamy-Filho, Fernando
   Lamy, Zeni Carvaiho
   Seabra Soares de Britto e Alves, Maria Teresa
TI Early Growth and Neurologic Outcomes of Infants with Probable Congenital
   Zika Virus Syndrome
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID BRAIN; INFECTION; BRAZIL
AB We report the early growth and neurologic findings of 48 infants in Brazil diagnosed with probable congenital Zika virus syndrome and followed to age 1-8 months. Most of these infants had microcephaly (86.7%) and craniofacial disproportion (95.8%). The clinical pattern included poor head growth with increasingly negative z-scores, pyramidal/extrapyramidal symptoms, and epilepsy.
C1 [Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Postgrad Program Publ Hlth, Sao Luis, Maranhao, Brazil.
   [Costa Ribeiro, Marizelia Rodrigues; Freitas Carvalho Branco, Maria dos Remedios; de Sousa Queiroz, Rejane Christine; Torres Pacheco, Maria de Jesus; Ferreira Simoes, Vanda Maria; Lamy-Filho, Fernando; Lamy, Zeni Carvaiho; Seabra Soares de Britto e Alves, Maria Teresa] Univ Fed Maranhao, Sao Luis, Maranhao, Brazil.
   [Santos Ganz, Jucelia Sousa; Sousa, Patricia da Silva; Rodovalho Doriqui, Maria Juliana; Vieira da Costa, Flavia Regina; Silva, Francelena de Sousa; Barbosa Pacheco, Marcos Antonio] State Dept Hlth Maranhao, Sao Luis, Maranhao, Brazil.
RP da Silva, AAM (corresponding author), Univ Fed Maranhao, Programa Posgrad Saude Colet, Rua Barao de Itapary 155, BR-65020070 Sao Luis, Maranhao, Brazil.
EM aamouradasilva@gmail.com
RI Lamy, Zeni Carvalho/AAP-6494-2020; Silva, Antonio A M/B-5410-2009;
   FILHO, FERNANDO LAMY/I-3633-2013; Simoes, Vanda Maria
   Ferreira/M-4126-2016
OI Silva, Antonio A M/0000-0003-4968-5138; Simoes, Vanda Maria
   Ferreira/0000-0001-8351-1348; Freitas Carvalho Branco, Maria dos
   Remedios/0000-0002-3537-0840; Queiroz, Rejane/0000-0003-4019-2011
FU Maranhao State Health Department; Brazil's National Research Council
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Maranhao State Research Foundation (FAPEMA)
FX We are thankful for the support of the Maranhao State Health
   Department.; The authors received partial support from Brazil's National
   Research Council (CNPq) (scholarship to A.S.) and the Maranhao State
   Research Foundation (FAPEMA) (scholarships to R.Q., V.S., Z.L., and
   M.A.).
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Brasil P, 2016, NEW ENGL J MED
   Brazilian Ministry of Health, SURV RESP PROT OCC M
   Brazilian Ministry of Health, 2016, EP B MON CAS DENG CH
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Franca GV, 2016, LANCET
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 14
TC 78
Z9 78
U1 0
U2 25
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2016
VL 22
IS 11
BP 1953
EP 1956
DI 10.3201/eid2211.160956
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EA3XS
UT WOS:000386543200014
PM 27767931
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lednicky, J
   De Rochars, VMB
   Elbadry, M
   Loeb, J
   Telisma, T
   Chavannes, S
   Anilis, G
   Cella, E
   Ciccozzi, M
   Okech, B
   Salemi, M
   Morris, JG
AF Lednicky, John
   De Rochars, Valery Madsen Beau
   Elbadry, Maha
   Loeb, Julia
   Telisma, Taina
   Chavannes, Sonese
   Anilis, Gina
   Cella, Eleonora
   Ciccozzi, Massinno
   Okech, Bernard
   Salemi, Marco
   Morris, J. Glenn, Jr.
TI Mayaro Virus in Child with Acute Febrile Illness, Haiti, 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ALPHAVIRUSES; AMERICA; DISEASE
AB Mayaro virus has been associated with small outbreaks in northern South America. We isolated this virus from a child with acute febrile illness in rural Haiti, confirming its role as a cause of mosquitoborne illness in the Caribbean region. The clinical presentation can mimic that of chikungunya, dengue, and Zika virus infections.
C1 [Lednicky, John] Univ Florida, Coll Publ Hlth & Hlth Profess, Environm & Global Hlth, Gainesville, FL USA.
   [De Rochars, Valery Madsen Beau; Elbadry, Maha; Loeb, Julia; Cella, Eleonora; Okech, Bernard; Salemi, Marco; Morris, J. Glenn, Jr.] Univ Florida, Gainesville, FL USA.
   [Telisma, Taina; Chavannes, Sonese; Anilis, Gina] Christianville Fdn Sch Clin, Gressier, Haiti.
   [Cella, Eleonora; Ciccozzi, Massinno] Ist Super Sanita, Rome, Italy.
RP Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, 2055 Mowry Rd,POB 100009, Gainesville, FL 32610 USA.
EM jgmorris@epi.ufl.edu
RI Cella, Eleonora/J-9961-2016; Elbadry, Maha Adel/AAH-4444-2020; Lednicky,
   John A/C-5678-2012; ciccozzi, massimo/C-6484-2016
OI Cella, Eleonora/0000-0002-7870-9744; Elbadry, Maha
   Adel/0000-0002-6089-4523; ciccozzi, massimo/0000-0003-3866-9239
FU Emerging Pathogens Institute, University of FloridaUniversity of Florida
FX This study was conducted with use of internal funds from the Emerging
   Pathogens Institute, University of Florida.
CR ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   De Rochars VEMB, 2015, AM J TROP MED HYG, V92, P752, DOI 10.4269/ajtmh.14-0059
   El Badry M, 2016, PEDIAT INFECT DIS J
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Llagonne-Barets M, 2016, J CLIN VIROL, V77, P66, DOI 10.1016/j.jcv.2016.02.013
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   Navarrete-Espinosa Joel, 2006, Rev Med Inst Mex Seguro Soc, V44, P347
   Powers AM, 2001, J VIROL, V75, P10118, DOI 10.1128/JVI.75.21.10118-10131.2001
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   SMITH GC, 1991, J AM MOSQUITO CONTR, V7, P89
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Tesh RB, 1999, CLIN INFECT DIS, V28, P67, DOI 10.1086/515070
NR 13
TC 59
Z9 59
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2016
VL 22
IS 11
BP 2000
EP 2002
DI 10.3201/eid2211.161015
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EA3XS
UT WOS:000386543200027
PM 27767924
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Edwards, T
   Signor, LDC
   Williams, C
   Donis, E
   Cuevas, LE
   Adams, ER
AF Edwards, Thomas
   Castillo Signor, Leticia del Carmen
   Williams, Christopher
   Donis, Evelin
   Cuevas, Luis E.
   Adams, Emily R.
TI Co-infections with Chikungunya and Dengue Viruses, Guatemala, 2015
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ZIKA
AB We screened serum samples referred to the national reference laboratory in Guatemala that were positive for chikungunya or dengue viruses in June 2015. Co-infection with both viruses was detected by reverse transcription PCR in 46 (32%) of 144 samples. Specimens should be tested for both arboviruses to detect co-infections.
C1 [Edwards, Thomas] Univ Liverpool Liverpool Sch Trop Med, Res Ctr Drugs & Diagnost, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
   [Williams, Christopher; Cuevas, Luis E.; Adams, Emily R.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Castillo Signor, Leticia del Carmen; Donis, Evelin] Lab Nacl Salud Guatemala, Villa Nueva, Guatemala.
RP Edwards, T (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Res Ctr Drugs & Diagnost, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.
EM thomas.edwardg@lstmed.ac.uk
RI ; Cuevas, Luis E./I-3697-2015
OI Adams, Emily/0000-0002-0816-2835; Edwards, Thomas/0000-0003-4058-4461;
   Cuevas, Luis E./0000-0002-6581-0587
FU Medical Research Council Confidence in Concept award [MC-PC_14111];
   Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15089]
FX This study was supported by a Medical Research Council Confidence in
   Concept award (MC-PC_14111).
CR Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Bhooshan S, 2015, INT J HEALTHCARE BIO, V03, P117
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Pan American Health Organization, 2015, NUMB REP CAS CHIK FE
   Pan American Health Organization, 2016, NUMB REP CAS DENG SE
   Pan American Health Organization, 2016, ZIK VIR ZIKV SURV AM
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wilson M. E., 2002, Dengue Bulletin, V26, P44
NR 13
TC 18
Z9 19
U1 0
U2 2
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD NOV
PY 2016
VL 22
IS 11
BP 2003
EP 2005
DI 10.3201/eid2211.161017
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA EA3XS
UT WOS:000386543200028
PM 27767914
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Jasti, AK
   Selmi, C
   Sarmiento-Monroy, JC
   Vega, DA
   Anaya, JM
   Gershwin, ME
AF Jasti, Anil K.
   Selmi, Carlo
   Sarmiento-Monroy, Juan C.
   Vega, Daniel A.
   Anaya, Juan-Manuel
   Gershwin, M. Eric
TI Guillain-Barre syndrome: causes, immunopathogenic mechanisms and
   treatment
SO EXPERT REVIEW OF CLINICAL IMMUNOLOGY
LA English
DT Review
DE Molecular mimicry; immune tolerance; autoimmune neuropathy;
   Guillain-Barre; infection and immunity
ID MOTOR AXONAL NEUROPATHY; ZIKA VIRUS; CAMPYLOBACTER-JEJUNI;
   FISHER-SYNDROME; NEUROLOGICAL MANIFESTATIONS; INTRAVENOUS
   IMMUNOGLOBULIN; CYTOMEGALOVIRUS-INFECTION; DENGUE INFECTION;
   ELECTRODIAGNOSTIC CRITERIA; INFLUENZA VACCINATION
AB Introduction: Guillain-Barre syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month. The etiology and pathogenesis remain largely enigmatic and the syndrome results in death or severe disability in 9-17% of cases despite immunotherapy.Areas covered: In terms of etiology, Guillain-Barre syndrome is linked to Campylobacter infection but less than 0.1% of infections result in the syndrome. In terms of pathogenesis, activated macrophages and T cells and serum antibodies against gangliosides are observed but their significance is unclear.Expert commentary: Guillain-Barre syndrome is a heterogeneous condition with numerous subtypes and recent data point towards the role of ganglioside epitopes by immunohistochemical methods. Ultimately, the syndrome results from a permissive genetic background on which environmental factors, including infections, vaccination and the influence of aging, lead to disease.
C1 [Jasti, Anil K.; Gershwin, M. Eric] Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
   [Selmi, Carlo] Humanitas Res Hosp, Rheumatol & Clin Immunol, Milan, Italy.
   [Selmi, Carlo] Univ Milan, BIOMETRA Dept, Milan, Italy.
   [Sarmiento-Monroy, Juan C.; Anaya, Juan-Manuel] Univ Rosario, Ctr Autoimmune Dis Res CREA, Bogota, Colombia.
   [Vega, Daniel A.] Univ Rosario, Hosp Univ Mayor, Intens Care Unit, Mederi, Bogota, Colombia.
RP Gershwin, ME (corresponding author), Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Sch Med, 451 Hlth Sci Dr,Suite 6510, Davis, CA 95616 USA.
EM megershwin@ucdavis.edu
RI Anaya, Juan-Manuel/J-1960-2016
OI Anaya, Juan-Manuel/0000-0002-6444-1249; Sarmiento-Monroy, Juan
   Camilo/0000-0002-8426-7268; Selmi, Carlo/0000-0002-0323-0376
CR Adutler-Lieber S, 2014, J AUTOIMMUN, V54, P100, DOI 10.1016/j.jaut.2014.05.003
   Aharoni R, 2014, J AUTOIMMUN, V54, P81, DOI 10.1016/j.jaut.2014.05.005
   Aladro-Benito Y, 2002, REV NEUROLOGIA, V35, P705
   Alhefzi M, 2016, TRANSPL INFECT DIS, V18, P288, DOI 10.1111/tid.12516
   Anaya JM, 2013, AUTOIMMUNITY BENCH B
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004
   Annane D, 1997, ANN NEUROL, V41, P298
   Asahina M, 2002, ACTA NEUROL SCAND, V105, P44, DOI 10.1034/j.1600-0404.2002.00099.x
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001
   ASBURY AK, 1981, ANN NEUROL, V9, P1, DOI 10.1002/ana.410090703
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003
   BEGHI E, 1985, ARCH NEUROL-CHICAGO, V42, P1053, DOI 10.1001/archneur.1985.04060100035016
   Ben-Nun A, 2014, J AUTOIMMUN, V54, P33, DOI 10.1016/j.jaut.2014.06.004
   Berciano J, 2000, NEUROLOGY, V55, P552, DOI 10.1212/WNL.55.4.552
   BERCIANO J, 1993, MUSCLE NERVE, V16, P744, DOI 10.1002/mus.880160709
   BERGER JR, 1987, ANN NEUROL, V22, P393, DOI 10.1002/ana.410220322
   Bitan M, 2004, CLIN INFECT DIS, V39, P1076, DOI 10.1086/424015
   Bogdanos DP, 2012, J AUTOIMMUN, V38, pJ156, DOI 10.1016/j.jaut.2011.11.003
   Bogliun G, 2004, ACTA NEUROL SCAND, V110, P100, DOI 10.1111/j.1600-0404.2004.00272.x
   Brannagan TH, 2003, J NEUROL SCI, V208, P39, DOI 10.1016/S0022-510X(02)00418-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Chalela JA, 2001, SEMIN NEUROL, V21, P399, DOI 10.1055/s-2001-19411
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chaudhary SC, 2011, BMJ CASE REP, V2011
   Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026
   Cheng Q, 2000, EUR J NEUROL, V7, P11, DOI 10.1046/j.1468-1331.2000.00006.x
   CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911
   Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0
   CORNBLATH DR, 1987, ANN NEUROL, V21, P32, DOI 10.1002/ana.410210107
   Cortese A, 2012, J NEUROL SCI, V312, P173, DOI 10.1016/j.jns.2011.08.047
   Cuadrado JI, 2004, NEUROL SCI, V25, P57, DOI 10.1007/s10072-004-0231-6
   Cuadrado JI, 2001, EUR NEUROL, V46, P83, DOI 10.1159/000050769
   D'Amico F, 2014, CLIN REV ALLERG IMMU, V47, P334, DOI 10.1007/s12016-013-8392-9
   DALAKAS MC, 1988, ANN NEUROL, V23, pS38, DOI 10.1002/ana.410230713
   Deceuninck G, 2008, CAN J NEUROL SCI, V35, P472, DOI 10.1017/S0317167100009136
   Derksen A, 2014, MUSCLE NERVE, V50, P780, DOI 10.1002/mus.24226
   Drenthen J, 2011, J NEUROL NEUROSUR PS, V82, P300, DOI 10.1136/jnnp.2010.226639
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Esack A, 1999, W INDIAN MED J, V48, P36
   FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gallardo E, 2015, CLIN NEUROPHYSIOL, V126, P810, DOI 10.1016/j.clinph.2014.06.051
   Garcia-Rivera EJ, 2009, P R HEALTH SCI J, V28, P114
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GERVAIX A, 1993, EUR J PEDIATR, V152, P613, DOI 10.1007/BF01954093
   Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200
   Goncalves E, 2011, REV INST MED TROP SP, V53, P223, DOI 10.1590/S0036-46652011000400009
   Gong Y, 2002, BRAIN, V125, P2491, DOI 10.1093/brain/awf258
   Govoni V, 2003, J NEUROL SCI, V216, P99, DOI 10.1016/S0022-510X(03)00215-6
   Grimaldi-Bensouda L, 2011, AM J EPIDEMIOL, V174, P326, DOI 10.1093/aje/kwr072
   Grimm A, 2016, CLIN NEUROPHYSIOL, V127, P1657, DOI 10.1016/j.clinph.2015.06.032
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414
   HAYMAKER W, 1949, MEDICINE, V28, P59, DOI 10.1097/00005792-194902000-00003
   Hira HS, 2012, J NEUROSCI RURAL PRA, V3, P36, DOI 10.4103/0976-3147.91928
   Hiraga A, 2003, NEUROLOGY, V61, P471, DOI 10.1212/01.WNL.0000081231.08914.A1
   Hiraga A, 2007, J NEUROL SCI, V258, P148, DOI 10.1016/j.jns.2007.02.029
   Ho TW, 1999, ANN NEUROL, V45, P168, DOI 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6
   Hollenbach JA, 2015, J AUTOIMMUN, V64, P13, DOI 10.1016/j.jaut.2015.06.010
   Houliston RS, 2007, BIOCHEMISTRY-US, V46, P8164, DOI 10.1021/bi700685s
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793
   Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004
   Incesu TK, 2013, CLIN NEUROPHYSIOL, V124, P197, DOI 10.1016/j.clinph.2012.07.004
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735
   Islam Z, 2011, EMERG INFECT DIS, V17, P1317, DOI [10.3201/eid1707.101999, 10.3201/eid1707.102031]
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Ito M, 2008, J NEUROL, V255, P674, DOI 10.1007/s00415-008-0775-0
   Jackson ST, 2008, W INDIAN MED J, V57, P373
   Jacobs BC, 2003, BRAIN, V126, P2220, DOI 10.1093/brain/awg235
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   Jenkinson WE, 2015, J AUTOIMMUN, V63, P13, DOI 10.1016/j.jaut.2015.06.008
   Kaida K, 2004, ANN NEUROL, V56, P567, DOI 10.1002/ana.20222
   KANDA T, 1989, J NEUROL NEUROSUR PS, V52, P857, DOI 10.1136/jnnp.52.7.857
   Kang JH, 2010, CLIN INFECT DIS, V51, P525, DOI 10.1086/655136
   Karussis D, 2014, J AUTOIMMUN, V48-49, P134, DOI 10.1016/j.jaut.2014.01.022
   Kennedy M, 2013, NEUROL INT, V5, P20, DOI 10.4081/ni.2013.e7
   Khan FY, 2007, CLIN NEUROL NEUROSUR, V109, P452, DOI 10.1016/j.clineuro.2007.02.003
   Kim SH, 2016, KOREAN J INTERN MED
   KLEMOLA E, 1967, ACTA MED SCAND, V181, P603
   Koga M, 2005, J NEUROL NEUROSUR PS, V76, P1736, DOI 10.1136/jnnp.2005.065359
   Koga M, 2002, J NEUROL NEUROSUR PS, V72, P767, DOI 10.1136/jnnp.72.6.767
   Koike H, 2003, ANN NEUROL, V54, P19, DOI 10.1002/ana.10550
   Koike H, 2013, J NEUROL NEUROSUR PS, V84, P98, DOI 10.1136/jnnp-2012-302833
   Kokubun N, 2012, J NEUROL SCI, V319, P164, DOI 10.1016/j.jns.2012.05.001
   Kuitwaard K, 2009, ANN NEUROL, V66, P597, DOI 10.1002/ana.21737
   Kumar Sudhir, 2005, Neurol India, V53, P250
   Kusunoki S, 2001, NEUROLOGY, V57, P736, DOI 10.1212/WNL.57.4.736
   Kusunoki S, 1999, MUSCLE NERVE, V22, P1071, DOI 10.1002/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0
   Kutlesa M, 2010, NEUROCRIT CARE, V13, P98, DOI 10.1007/s12028-010-9365-y
   Kuwabara S, 2004, NEUROLOGY, V63, P529, DOI 10.1212/01.WNL.0000133205.05169.04
   Kuwabara S, 2011, J NEUROL NEUROSUR PS, V82, P1174, DOI 10.1136/jnnp.2010.210708
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Ladhani S.N., 2016, ARCH DIS CHILD
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Li S, 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/740947
   Liu JX, 2009, INVEST OPHTH VIS SCI, V50, P3226, DOI 10.1167/iovs.08-3333
   Lu QJ, 2010, AUTOIMMUN REV, V9, P627, DOI 10.1016/j.autrev.2010.05.011
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Luigetti M, 2015, CLIN NEUROL NEUROSUR, V135, P6, DOI 10.1016/j.clineuro.2015.05.001
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   MCKHANN, 1985, NEUROLOGY, V35, P1096
   Meda F, 2011, CELL MOL IMMUNOL, V8, P226, DOI 10.1038/cmi.2010.78
   Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789
   Miller FW, 2012, J AUTOIMMUN, V39, P253, DOI 10.1016/j.jaut.2012.05.001
   Mitchell MM, 2011, EPIGENETICS-US, V6, P95, DOI 10.4161/epi.6.1.13405
   Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x
   Mori K, 2002, NEUROLOGY, V58, P979, DOI 10.1212/WNL.58.6.979
   Mori M, 2000, BRAIN, V123, P2171, DOI 10.1093/brain/123.10.2171
   Mori M, 2001, NEUROLOGY, V56, P1104, DOI 10.1212/WNL.56.8.1104
   Mori M, 2007, NEUROLOGY, V68, P1144, DOI 10.1212/01.wnl.0000258673.31824.61
   Musso D, 2014, EUROSURVEILLANCE, V19, P14, DOI DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd
   Nafissi Shahriar, 2013, Acta Med Iran, V51, P372
   Nagashima T, 2007, ARCH NEUROL-CHICAGO, V64, P1519, DOI 10.1001/archneur.64.10.1519
   NAGER F, 1963, SCHWEIZ MED WSCHR, V93, P1030
   NAHATA MC, 1961, J INDIAN MED ASSOC, V37, P134
   Netto AB, 2011, ANN INDIAN ACAD NEUR, V14, P262, DOI 10.4103/0972-2327.91942
   Nyati KK, 2011, ARCH NEUROL-CHICAGO, V68, P445, DOI 10.1001/archneurol.2011.51
   Nyati KK, 2013, BIOMED RES INT, DOI 10.1155/2013/852195
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Oehler E, 2011, Med Trop (Mars), V71, P203
   Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074
   OSUNTOKUN BO, 1972, ARCH NEUROL-CHICAGO, V27, P7, DOI 10.1001/archneur.1972.00490130009002
   Palma-da Cunha-Matta A, 2004, REV NEUROLOGIA, V39, P233
   Parry O, 1997, ACTA NEUROL SCAND, V96, P218, DOI 10.1111/j.1600-0404.1997.tb00272.x
   PIETTE AM, 1986, LANCET, V1, P852
   Piliero PJ, 2003, CLIN INFECT DIS, V36, pE111, DOI 10.1086/368311
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Polkey MI, 1999, J NEUROL NEUROSUR PS, V66, P5, DOI 10.1136/jnnp.66.1.5
   PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704
   Pritchard J, 2007, J NEUROIMMUNOL, V183, P232, DOI 10.1016/j.jneuroim.2006.12.002
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Ralapanawa Dissanayake Mudiyanselage Priyantha Udaya Kumara, 2015, BMC Res Notes, V8, P729, DOI 10.1186/s13104-015-1672-0
   Rho Young Il, 2014, Korean J Pediatr, V57, P457, DOI 10.3345/kjp.2014.57.10.457
   Rocha MSG, 2004, ARQ NEURO-PSIQUIAT, V62, P33, DOI 10.1590/S0004-282X2004000100006
   Rogatsky I, 2014, AUTOIMMUNITY, V47, P242, DOI 10.3109/08916934.2013.853050
   Saariaho AH, 2015, J AUTOIMMUN, V63, P68, DOI 10.1016/j.jaut.2015.07.006
   Saito Y, 2014, CLIN REV ALLERG IMMU, V47, P128, DOI 10.1007/s12016-013-8401-z
   SAMANTRAY SK, 1977, MED J AUSTRALIA, V2, P84, DOI 10.5694/j.1326-5377.1977.tb99056.x
   Santos NQ, 2004, ARQ NEURO-PSIQUIAT, V62, P144, DOI 10.1590/S0004-282X2004000100025
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Schwartz M, 2014, J AUTOIMMUN, V54, P8, DOI 10.1016/j.jaut.2014.08.002
   SEDANO MJ, 1994, ACTA NEUROL SCAND, V89, P287
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Selmi C, 2012, CLIN EXP IMMUNOL, V169, P253, DOI 10.1111/j.1365-2249.2012.04621.x
   Selmi C, 2012, J AUTOIMMUN, V39, P249, DOI 10.1016/j.jaut.2012.07.011
   Selmi C, 2012, J AUTOIMMUN, V39, P272, DOI 10.1016/j.jaut.2012.05.007
   Selmi C, 2012, J AUTOIMMUN, V39, P34, DOI 10.1016/j.jaut.2011.11.005
   Selmi C, 2009, TRENDS IMMUNOL, V30, P415, DOI 10.1016/j.it.2009.05.006
   Selmi C, 2008, BEST PRACT RES CL RH, V22, P913, DOI 10.1016/j.berh.2008.09.002
   Shahrizaila N, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/829129
   Sharma MB, 2011, J INFECT DEV COUNTR, V5, P459, DOI 10.3855/jidc.1508
   Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371
   Simpson BS, 2009, EUR J NEUROL, V16, pE81, DOI 10.1111/j.1468-1331.2009.02569.x
   Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Soares CN, 2008, ARQ NEURO-PSIQUIAT, V66, P234, DOI 10.1590/S0004-282X2008000200018
   SORVILLO FJ, 1991, J ACQ IMMUN DEF SYND, V4, P598
   Souayah N, 2007, J NEUROIMMUNOL, V188, P143, DOI 10.1016/j.jneuroim.2007.05.020
   Spagnoli C, 2016, EUR J PAEDIATR NEURO, V20, P168, DOI 10.1016/j.ejpn.2015.11.004
   Steinman L, 2014, J AUTOIMMUN, V54, P1, DOI 10.1016/j.jaut.2014.08.001
   Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310
   Sulekha C, 2004, Indian Pediatr, V41, P948
   Susuki K, 2004, NEUROLOGY, V62, P949, DOI 10.1212/01.WNL.0000115123.42929.FD
   Taheraghdam A, 2014, IRAN J NEUROL, V13, P7
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294
   Tatarelli P, 2016, INT J NEUROSCI, V126, P478, DOI 10.3109/00207454.2015.1033621
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Tsuda M, 2010, J AUTOIMMUN, V35, P265, DOI 10.1016/j.jaut.2010.06.017
   Uncini A, 2012, CLIN NEUROPHYSIOL, V123, P1487, DOI 10.1016/j.clinph.2012.01.025
   Uncini A, 2012, MUSCLE NERVE, V45, P464, DOI 10.1002/mus.22298
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Van Den Bergh PYK, 2004, MUSCLE NERVE, V29, P565, DOI 10.1002/mus.20022
   van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X
   VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705
   Vega D, 2008, ACTA COLOMB CUID INT, V8, P219
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Wagner Jeffrey C, 2007, J Clin Neuromuscul Dis, V9, P303
   Wakerley Benjamin R, 2015, Pract Neurol, V15, P90, DOI 10.1136/practneurol-2014-000937
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   Wang Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/564098
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Williams CJ, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.4.30119
   Willison HJ, 2005, J PERIPHER NERV SYST, V10, P94, DOI 10.1111/j.1085-9489.2005.0010202.x
   Willison HJ, 2016, LANCET
   Winer JB, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/793024
   WINNER SJ, 1990, Q J MED, V77, P1297, DOI 10.1093/qjmed/77.3.1297
   Wise J, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1242
   Wong AHY, 2015, J PERIPHER NERV SYST, V20, P47, DOI 10.1111/jns.12104
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
   Yuki N, 1998, J NEUROL SCI, V154, P14, DOI 10.1016/S0022-510X(97)00174-3
   Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012
   Yuki N, 1996, J NEUROIMMUNOL, V71, P155, DOI 10.1016/S0165-5728(96)00142-7
   YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771
   YUKI N, 1990, NEUROLOGY, V40, P1900, DOI 10.1212/WNL.40.12.1900
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Yuki N, 2012, J NEUROL, V259, P1181, DOI 10.1007/s00415-011-6330-4
   Yuki N, 2012, J NEUROL NEUROSUR PS, V83, P116, DOI 10.1136/jnnp.2010.227777
   Zan H, 2014, AUTOIMMUNITY, V47, P213, DOI 10.3109/08916934.2014.915393
   Zhang G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133520
   Zhang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027067
   Zhang G, 2011, J NEUROSCI, V31, P1664, DOI 10.1523/JNEUROSCI.3829-10.2011
NR 219
TC 22
Z9 22
U1 1
U2 33
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1744-666X
EI 1744-8409
J9 EXPERT REV CLIN IMMU
JI Expert Rev. Clin. Immunol.
PD NOV
PY 2016
VL 12
IS 11
BP 1175
EP 1189
DI 10.1080/1744666X.2016.1193006
PG 15
WC Immunology
SC Immunology
GA EA7DK
UT WOS:000386788800005
PM 27292311
DA 2020-07-08
ER

PT J
AU Demir, T
   Kilic, S
AF Demir, Tulin
   Kilic, Selcuk
TI Zika virus: a new arboviral public health problem
SO FOLIA MICROBIOLOGICA
LA English
DT Article
ID BRAZIL; TRANSMISSION
AB Zika virus (ZIKV) is a single-stranded RNA virus in the Flaviviridae family and transmitted to human through infected mosquitos (Aedes aegypti and Aedes albopictus). Virus is closely related with other flaviviruses; dengue virus, yellow fever virus, West Nile virus, and Japanese encephalitis virus phylogenetically. Due to the possible relationship between virus and clinical features including microcephaly, ventricule, and eye deformities, Guillain-Barre syndrome increases the interest on this virus gradually. Along with the vector-borne transmission, exposure via blood transfusion and sexual contact are further concerns. Since December 2015, CDC reported 440.000-1.300.000 possible cases in Brazil and as of 19 January 2016, El Salvador, Venezuela, Colombia, Brazil, Surinam, French Guana, Honduras, Mexico, and Panama are the countries with active epidemic. CDC recommends ZIKV screening for all pregnants including asymptomatic cases those living in the active epidemic areas. Recently, virus is detected in the USA and most European countries including UK, Netherlands, Denmark, Switzerland, and Italy as a travel-associated infection. Owing to the changing world with increased capabilities for transportation globally, this vector-borne infection represents a valuable marker for the ability of spreading of any infection from its original area that it was first seen. In this review, we summarized the up-to-date data and reports in terms of the importance of the ZIKV infection in the public health.
C1 [Demir, Tulin; Kilic, Selcuk] Publ Hlth Inst Turkey, Natl Reference Labs Microbiol, Ankara, Turkey.
RP Demir, T (corresponding author), Publ Hlth Inst Turkey, Natl Reference Labs Microbiol, Ankara, Turkey.
EM drtulin@yahoo.com; mdskilic2003@yahoo.com
OI demir, tulin/0000-0003-2708-2838
CR [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   ECDC, 2016, COMM DIS THREAT REP
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organisation (PAHO), 2015, ZIKV SURV AM INT GUI
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 16
TC 9
Z9 9
U1 0
U2 48
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0015-5632
EI 1874-9356
J9 FOLIA MICROBIOL
JI Folia Microbiol.
PD NOV
PY 2016
VL 61
IS 6
BP 523
EP 527
DI 10.1007/s12223-016-0467-6
PG 5
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA EA1KT
UT WOS:000386351700010
PM 27469112
OA Bronze
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Albini, TA
   Berrocal, AM
AF Ventura, Camila V.
   Albini, Thomas A.
   Berrocal, Audina M.
TI First Locally Transmitted Zika Virus Cases Identified in the United
   States
SO JAMA OPHTHALMOLOGY
LA English
DT Editorial Material
C1 [Ventura, Camila V.; Albini, Thomas A.; Berrocal, Audina M.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, 900 NW 17th Ave, Miami, FL 33136 USA.
   [Ventura, Camila V.] Altino Ventura Fdn, Recife, PE, Brazil.
RP Albini, TA (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, 900 NW 17th Ave, Miami, FL 33136 USA.
EM talbini@med.miami.edu
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684; Albini,
   Thomas/0000-0003-2199-9047
CR Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, ADV PEOPL LIV TRAV S
   Centers for Disease Control and Prevention (CDC), ZIK VIR INF CLIN
   Centre for Disease Control and Prevention, TYP ZIK VIR TESTS
   Florida State Government. Gov, GOV SOCTT FLOR CALLS
   Florida State Government. Gov, GOV SCOTT LIK MOSQ B
NR 6
TC 5
Z9 5
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD NOV 1
PY 2016
VL 134
IS 11
BP 1219
EP 1220
DI 10.1001/jamaophthalmol.2016.3623
PG 2
WC Ophthalmology
SC Ophthalmology
GA EC6GY
UT WOS:000388235700005
PM 27685812
DA 2020-07-08
ER

PT J
AU Sun, JF
   Wu, D
   Zhong, HJ
   Guan, DW
   Zhang, H
   Tan, QQ
   Ke, CW
AF Sun, Jiufeng
   Wu, De
   Zhong, Haojie
   Guan, Dawei
   Zhang, Huan
   Tan, Qiqi
   Ke, Changwen
TI Presence of Zika Virus in Conjunctival Fluid
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Sun, Jiufeng] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [Wu, De; Zhong, Haojie; Guan, Dawei; Zhang, Huan; Tan, Qiqi; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 510300, Guangdong, Peoples R China.
RP Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 510300, Guangdong, Peoples R China.
EM kecw1965@aliyun.com
OI sun, jiufeng/0000-0003-1047-929X
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P946, DOI 10.1001/jamaophthalmol.2016.1307
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
NR 6
TC 30
Z9 30
U1 0
U2 4
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD NOV 1
PY 2016
VL 134
IS 11
BP 1330
EP 1332
DI 10.1001/jamaophthalmol.2016.3417
PG 3
WC Ophthalmology
SC Ophthalmology
GA EC6GY
UT WOS:000388235700030
PM 27632055
DA 2020-07-08
ER

PT J
AU Abushouk, AI
   Negida, A
   Ahmed, H
AF Abushouk, Abdelrahman Ibrahim
   Negida, Ahmed
   Ahmed, Hussien
TI An updated review of Zika virus
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Review
DE Zika virus; Epidemic; Public health; Microcephaly
ID SEXUAL TRANSMISSION; PREGNANT-WOMEN; UNITED-STATES; INFECTION; OUTBREAK;
   VACCINE; URINE; AEDES; ALBOPICTUS; BIOLOGY
AB The current outbreak of Zika virus (ZIKV) in South America is one of the most serious public health emergencies since the Ebola outbreak of West Africa [2014]. ZIKV belongs to the flaviviridae family and has two lineages (Asian and African). The virus was first discovered in Uganda [1947] and the first human infection was identified in Nigeria [1952]. The current epidemic is the third of its type after that of Yap Island, Micronesia [2007] and French Polynesia [2013]. Phylogenetic studies revealed that the current strain shares about 99.7% of nucleotides and 99.9% of amino acids with the strain of French Polynesia epidemic [2013], suggesting that it has spread across the Pacific Ocean to invade South America. Aedes Aegypti mosquito is the main vector for ZIKV and there are some reports describing possible sexual and maternal to fetal transmission. ZIKV infection is known to be self-limited. However, recent reports suggested that it can be associated with neurological manifestations as Guillan-Barre Syndrome and microcephaly in the newborn population. Currently, vector control seems to be the most effective available preventive measure against ZIKV spread. The development of broad spectrum antivirals and ZIKV vaccines should be a priority of future research. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Abushouk, Abdelrahman Ibrahim] Ain Shams Univ, Fac Med, Postal Code 11566, Cairo, Egypt.
   [Abushouk, Abdelrahman Ibrahim] NovaMed Med Res Assoc, Cairo, Egypt.
   [Negida, Ahmed; Ahmed, Hussien] Med Res Grp Egypt, Cairo, Egypt.
   [Negida, Ahmed; Ahmed, Hussien] Zagazig Univ, Fac Med, Zagazig, El Sharkia, Egypt.
   [Negida, Ahmed; Ahmed, Hussien] Zagazig Univ, Student Res Unit, Zagazig, El Sharkia, Egypt.
RP Abushouk, AI (corresponding author), Ain Shams Univ, Fac Med, Postal Code 11566, Cairo, Egypt.
EM abdelrahman.abushouk@med.asu.edu.eg
RI Abushouk, Abdelrahman Ibrahim/I-9229-2018; amsalu, ribka/G-8780-2019;
   Negida, Ahmed/C-6376-2015
OI Abushouk, Abdelrahman Ibrahim/0000-0003-1399-6487; Negida,
   Ahmed/0000-0001-5363-6369; Ahmed, Hussien/0000-0001-7101-837X
CR Barzon L., 2016, EUROSURVEILLANCE B E, V21, P10
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Corman V. M., 2016, B WHO IN PRESS
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   De Oliveira W. K., 2016, MMWR MORB MORTAL WKL, V65
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deng Yichu, 2016, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V28, P106, DOI 10.3760/cma.j.issn.2095-4352.2016.02.005
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A. P., 2016, VACCINE DEV ZIKA VIR
   Dyer O., 2016, BR MED J, V3588
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, N ENGL J MED
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. De Melo, 2015, BIORXIV COLD SPRING, P32839
   Fulginiti V. A., 1982, AM ACAD PEDIAT, V69, P810
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1086
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lipsitch M, 2016, SCIENCE, V353, P1094, DOI 10.1126/science.aai8126
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1180
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T., 2016, MMWR MORB MORTAL WKL, V65
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2015, MMWR MORB MORTAL WKL, V65
   Pacheco O., 2016, NEW ENGL J MED
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schuler-Faccini L., 2015, MMWR MORB MORTAL WKL, V65, DOI 10.15585/mmwr.mm6503e2.
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Soares de Araujo JS, 2016, B WHO
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Turmel P. A. Jean Marie, 2016, LANCET, V6736, P30775, DOI DOI 10.1016/S0140-6736(16)30775-9
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WHO, 2016, ZIK VIR FACT SHEET
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, WHO EXP PRIOR VACC D
NR 63
TC 46
Z9 49
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD NOV
PY 2016
VL 84
BP 53
EP 58
DI 10.1016/j.jcv.2016.09.012
PG 6
WC Virology
SC Virology
GA EC9HU
UT WOS:000388456200011
PM 27721110
DA 2020-07-08
ER

PT J
AU Guerbois, M
   Fernandez-Salas, I
   Azar, SR
   Danis-Lozano, R
   Alpuche-Aranda, CM
   Leal, G
   Garcia-Malo, IR
   Diaz-Gonzalez, EE
   Casas-Martinez, M
   Rossi, SL
   Del Rio-Galvan, SL
   Sanchez-Casas, RM
   Roundy, CM
   Wood, TG
   Widen, SG
   Vasilakis, N
   Weaver, SC
AF Guerbois, Mathilde
   Fernandez-Salas, Ildefonso
   Azar, Sasha R.
   Danis-Lozano, Rogelio
   Alpuche-Aranda, Celia M.
   Leal, Grace
   Garcia-Malo, Iliana R.
   Diaz-Gonzalez, Esteban E.
   Casas-Martinez, Mauricio
   Rossi, Shannan L.
   Del Rio-Galvan, Samanta L.
   Sanchez-Casas, Rosa M.
   Roundy, Christopher M.
   Wood, Thomas G.
   Widen, Steven G.
   Vasilakis, Nikos
   Weaver, Scott C.
TI Outbreak of Zika Virus Infection, Chiapas State, Mexico, 2015, and First
   Confirmed Transmission by Aedes aegypti Mosquitoes in the Americas
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; flavivirus; arbovirus; mosquito; transmission
ID CHIKUNGUNYA VIRUS; POTENTIAL VECTOR; SEQUENCE DATA; DENGUE; MICRONESIA;
   ALBOPICTUS; SINGAPORE; EPIDEMIC
AB Background. After decades of obscurity, Zika virus (ZIKV) has spread through the Americas since 2015 accompanied by congenital microcephaly and Guillain-Barre syndrome. Although these epidemics presumably involve transmission by Aedes aegypti, no direct evidence of vector involvement has been reported, prompting speculation that other mosquitoes such as Culex quinquefasciatus could be involved.
   Methods.aEuro integral We detected an outbreak of ZIKV infection in southern Mexico in late 2015. Sera from suspected ZIKV-infected patients were analyzed for viral RNA and antibodies. Mosquitoes were collected in and around patient homes and tested for ZIKV.
   Results.aEuro integral Of 119 suspected ZIKV-infected patients, 25 (21%) were confirmed by RT-PCR of serum collected 1-8 days after the onset of signs and symptoms including rash, arthralgia, headache, pruritus, myalgia, and fever. Of 796 mosquitoes collected, A. aegypti yielded ZIKV detection by RT-PCR in 15 of 55 pools (27.3%). No ZIKV was detected in C. quinquefasciatus. ZIKV sequences derived from sera and mosquitoes showed a monophyletic relationship suggestive of a point source introduction from Guatemala.
   Conclusions.aEuro integral These results demonstrate the continued, rapid northward progression of ZIKV into North America with typically mild disease manifestations, and implicate A. aegypti for the first time as a principal vector in North America.
C1 [Guerbois, Mathilde; Azar, Sasha R.; Leal, Grace; Rossi, Shannan L.; Roundy, Christopher M.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Guerbois, Mathilde; Azar, Sasha R.; Leal, Grace; Rossi, Shannan L.; Roundy, Christopher M.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Guerbois, Mathilde; Azar, Sasha R.; Leal, Grace; Rossi, Shannan L.; Roundy, Christopher M.; Vasilakis, Nikos; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
   [Wood, Thomas G.; Widen, Steven G.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Fernandez-Salas, Ildefonso; Danis-Lozano, Rogelio; Garcia-Malo, Iliana R.; Casas-Martinez, Mauricio] Inst Nacl Salud Publ, Ctr Reg Salud Publ, Tapachula, Mexico.
   [Alpuche-Aranda, Celia M.] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
   [Diaz-Gonzalez, Esteban E.; Sanchez-Casas, Rosa M.] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Mexico.
   [Diaz-Gonzalez, Esteban E.; Del Rio-Galvan, Samanta L.] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza, Mexico.
   [Sanchez-Casas, Rosa M.] Univ Autonoma Nuevo Leon, Fac Med Vet & Zootecnia, Escobedo, Mexico.
RP Weaver, SC (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA.
EM sweaver@utmb.edu
RI Weaver, Scott C/D-6490-2011
OI Weaver, Scott C/0000-0001-8016-8556; Diaz Gonzalez, Esteban
   Eduardo/0000-0001-6124-3282; SANCHEZ CASAS, ROSA
   MARIA/0000-0002-2626-7227
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI120942]
FX This work was supported by the National Institutes of Health
   (grantAI120942).
CR Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Beaty B, 1995, DIAGNOSTIC PROCEDURE, P189
   Besnard M, 2016, EUROSURVEILLANCE, V21, P1
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V22, P913
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Erasmus JH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004119
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MILLER BR, 1989, TROP MED PARASITOL, V40, P396
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108
   Sistema Nacional de Vigilancia Epidemiologica, 2016, B EPIDEMIOLOGICO SEM, V33, P14
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zika virus disease, 2016, WHOZIKVSUR161
NR 37
TC 100
Z9 105
U1 0
U2 15
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 1
PY 2016
VL 214
IS 9
BP 1349
EP 1356
DI 10.1093/infdis/jiw302
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC3EH
UT WOS:000388007700012
PM 27436433
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Kawiecki, AB
   Christofferson, RC
AF Kawiecki, Anna B.
   Christofferson, Rebecca C.
TI Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2
   Replication In Vitro
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; plaque reduction neutralization test (PRNT); dengue; antibody;
   enhancement; antibody dependent enhancement
ID CROSS-REACTIVITY; INFECTION; PROTECTION; DISEASE
AB Zika virus has emerged in the Americas, where dengue virus is endemic. Among the 4 serotypes of dengue virus, antibody-dependent enhancement is thought to enhance viral replication and disease severity. Reports suggest that anti-dengue virus antibody may enhance Zika virus replication. We investigated whether Zika virus antibodies enhance dengue virus replication, by exposing C57Bl/6 mice to Zika virus. Polyclonal serum was verified for strong Zika virus-neutralizing, dengue virus-subneutralizing capacity. Then we determined the enhancement capabilities of Zika virus-immune serum for dengue virus in vitro. We showed that Zika virus antibodies have the ability to enhance dengue virus infections, which is important, because in many Zika virus-affected areas, dengue virus is expected to remain endemic.
C1 [Kawiecki, Anna B.; Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobioloigcal Sci, Baton Rouge, LA 70803 USA.
RP Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Skip Bertman Dr, Baton Rouge, LA 70803 USA.
EM rcarri1@lsu.edu
CR Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   Christofferson RC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-127
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953
   Mangada MNM, 1998, VIROLOGY, V244, P458, DOI 10.1006/viro.1998.9093
   MORENS DM, 1991, AM J TROP MED HYG, V45, P644, DOI 10.4269/ajtmh.1991.45.644
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   WHO, 2007, GUID PLAQ RED NEUTR
NR 14
TC 64
Z9 69
U1 0
U2 14
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD NOV 1
PY 2016
VL 214
IS 9
BP 1357
EP 1360
DI 10.1093/infdis/jiw377
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA EC3EH
UT WOS:000388007700013
PM 27521359
OA Bronze
DA 2020-07-08
ER

PT J
AU Hindupur, A
   Evans, J
   Maity, C
   Raines, S
   Loeffler, B
   Elagin, S
   Stepnev, V
AF Hindupur, A.
   Evans, J.
   Maity, C.
   Raines, S.
   Loeffler, B.
   Elagin, S.
   Stepnev, V.
TI Detection of Zika Virus by Reverse Transcription Coupled Loop Mediated
   Isothermal Amplification (RT-LAMP) Using Meridian M-Prep Method
SO JOURNAL OF MOLECULAR DIAGNOSTICS
LA English
DT Meeting Abstract
CT Meeting of the Association-for-Molecular-Pathology
CY NOV 10-12, 2016
CL Charlotte, NC
SP Assoc Mol Pathol
C1 [Hindupur, A.; Evans, J.; Maity, C.; Raines, S.; Loeffler, B.; Elagin, S.; Stepnev, V.] Meridian Biosci, Cincinnati, OH USA.
NR 0
TC 1
Z9 1
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1525-1578
EI 1943-7811
J9 J MOL DIAGN
JI J. Mol. Diagn.
PD NOV
PY 2016
VL 18
IS 6
MA ID23
BP 973
EP 974
PG 2
WC Pathology
SC Pathology
GA EB2OF
UT WOS:000387201000170
DA 2020-07-08
ER

PT J
AU Conde, JN
   da Silva, EM
   Allonso, D
   Coelho, DR
   Andrade, ID
   de Medeiros, LN
   Menezes, JL
   Barbosa, AS
   Mohana-Borges, R
AF Conde, Jonas Nascimento
   da Silva, Emiliana Mandarano
   Allonso, Diego
   Coelho, Diego Rodrigues
   Andrade, Iamara da Silva
   de Medeiros, Luciano Neves
   Menezes, Joice Lima
   Barbosa, Angela Silva
   Mohana-Borges, Ronaldo
TI Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through
   Interaction with Vitronectin and Terminal Complement Proteins
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID PLASMINOGEN-ACTIVATOR INHIBITOR-1; HEPARIN-BINDING DOMAINS;
   HEMORRHAGIC-FEVER; ESCHERICHIA-COLI; RNA REPLICATION; FACTOR-H; REVEALS;
   IDENTIFICATION; GLYCOPROTEIN; PURIFICATION
AB Dengue virus (DENV) infects millions of people worldwide and is a major public health problem. DENV nonstructural protein 1 (NS1) is a conserved glycoprotein that associates with membranes and is also secreted into the plasma in DENV-infected patients. The present study describes a novel mechanism by which NS1 inhibits the terminal complement pathway. We first identified the terminal complement regulator vitronectin (VN) as a novel DENV2 NS1 binding partner by using a yeast two-hybrid system. This interaction was further assessed by enzyme-linked immunosorbent assay (ELISA) and surface plasmon resonance (SPR) assay. The NS1-VN complex was also detected in plasmas from DENV-infected patients, suggesting that this interaction occurs during DENV infection. We also demonstrated that the DENV2 NS1 protein, either by itself or by interacting with VN, hinders the formation of the membrane attack complex (MAC) and C9 polymerization. Finally, we showed that DENV2, West Nile virus (WNV), and Zika virus (ZIKV) NS1 proteins produced in mammalian cells inhibited C9 polymerization. Taken together, our results points to a role for NS1 as a terminal pathway inhibitor of the complement system.
C1 [Conde, Jonas Nascimento; da Silva, Emiliana Mandarano; Allonso, Diego; Coelho, Diego Rodrigues; Andrade, Iamara da Silva; Menezes, Joice Lima; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
   [de Medeiros, Luciano Neves] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Biol Mol & Bioquim Prot, Rio De Janeiro, RJ, Brazil.
   [Barbosa, Angela Silva] Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil.
   [Andrade, Iamara da Silva] Fac Educ Tecnol Estado Rio De Janeiro FAETERJ FAE, Paracambi, RJ, Brazil.
RP Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil.
EM mohana@biof.ufrj.br
RI Barbosa, Angela S/I-3518-2013; Nascimento conde, Jonas/D-4481-2019;
   Allonso, Diego/Y-3446-2018; Borges, Ronaldo S Mohana/C-5575-2013
OI Barbosa, Angela S/0000-0002-6458-9489; Allonso,
   Diego/0000-0002-1410-480X; 
FU International Centre for Genetic Engineering and Biotechnology (ICGEB)
   [CRP/BRA15-02]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do
   Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [475104/2012-9]
FX This work, including the efforts of Ronaldo Mohana-Borges, was funded by
   International Centre for Genetic Engineering and Biotechnology (ICGEB)
   (CRP/BRA15-02). This work, including the efforts of Ronaldo
   Mohana-Borges, was funded by Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa do Estado do Rio de Janeiro (FAPERJ) (475104/2012-9).
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Allonso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113634
   Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bozzini S, 1998, J MED VIROL, V54, P44, DOI 10.1002/(SICI)1096-9071(199801)54:1&lt;44::AID-JMV7&gt;3.0.CO;2-P
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911
   da Silva LB, 2015, INFECT IMMUN, V83, P888, DOI 10.1128/IAI.02844-14
   DECLERCK PJ, 1988, J BIOL CHEM, V263, P15454
   Djamiatun K, 2011, J TROP PEDIATRICS, V57, P424, DOI 10.1093/tropej/fmq122
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hallstrom T, 2009, J IMMUNOL, V183, P2593, DOI 10.4049/jimmunol.0803226
   Hansen M, 2001, EUR J BIOCHEM, V268, P6274, DOI 10.1046/j.0014-2956.2001.02582.x
   Huang YP, 2005, WORLD J GASTROENTERO, V11, P5659, DOI 10.3748/wjg.v11.i36.5659
   Kohler S, 2015, THROMB HAEMOSTASIS, V113, P125, DOI 10.1160/TH14-06-0561
   KOST C, 1992, J BIOL CHEM, V267, P12098
   LANE DA, 1987, J BIOL CHEM, V262, P16343
   LAWRENCE D, 1989, EUR J BIOCHEM, V186, P523, DOI 10.1111/j.1432-1033.1989.tb15238.x
   Liang OD, 1997, BIOCHEM BIOPH RES CO, V234, P445, DOI 10.1006/bbrc.1997.6663
   Liang OD, 1997, FEBS LETT, V407, P169, DOI 10.1016/S0014-5793(97)00330-X
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mairuhu ATA, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-17
   MILIS L, 1993, CLIN EXP IMMUNOL, V92, P114
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   PODACK ER, 1984, ACTA PATH MICRO IM C, V92, P89
   PREISSNER KT, 1990, BIOCHEM BIOPH RES CO, V168, P966, DOI 10.1016/0006-291X(90)91123-A
   Schar CR, 2008, J BIOL CHEM, V283, P28487, DOI 10.1074/jbc.M804257200
   SHEEHAN M, 1995, CLIN EXP IMMUNOL, V101, P136
   Shyu HW, 2010, THROMB HAEMOSTASIS, V104, P1219, DOI 10.1160/TH10-05-0302
   Silva EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057514
   Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x
   SU HR, 1994, INT ARCH ALLERGY IMM, V105, P238, DOI 10.1159/000236763
   Su YC, 2013, MOL MICROBIOL, V87, P1245, DOI 10.1111/mmi.12164
   Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003
   Wills BA, 2002, CLIN INFECT DIS, V35, P277, DOI 10.1086/341410
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xu D, 2001, PROTEINS, V44, P312, DOI 10.1002/prot.1096
   YASUMITSU H, 1993, IN VITRO CELL DEV-AN, V29A, P403
   Zhang ZF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001225
   Zhou AW, 2001, J BIOL CHEM, V276, P27541, DOI 10.1074/jbc.M102594200
NR 48
TC 20
Z9 20
U1 1
U2 30
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD NOV
PY 2016
VL 90
IS 21
BP 9570
EP 9581
DI 10.1128/JVI.00912-16
PG 12
WC Virology
SC Virology
GA DZ0JW
UT WOS:000385525700002
PM 27512066
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Visseaux, B
   Mortier, E
   Houhou-Fidouh, N
   Brichler, S
   Collin, G
   Larrouy, L
   Charpentier, C
   Descamps, D
AF Visseaux, Benoit
   Mortier, Emmanuel
   Houhou-Fidouh, Nadhira
   Brichler, Segolene
   Collin, Gilles
   Larrouy, Lucile
   Charpentier, Charlotte
   Descamps, Diane
TI Zika virus in the female genital tract
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID SEXUAL TRANSMISSION
C1 [Visseaux, Benoit; Houhou-Fidouh, Nadhira; Collin, Gilles; Larrouy, Lucile; Charpentier, Charlotte; Descamps, Diane] Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat, AP HP,IAME,UMR 1137,INSERM,Lab Virol, Paris, France.
   [Mortier, Emmanuel] Hop Louis Mourier, AP HP, Serv Med Interne, Colombes, France.
   [Brichler, Segolene] Univ Paris 13, Hop Avicenne, AP HP, Serv Bacteriol Virol & Hyg, Paris, France.
RP Visseaux, B (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Hop Bichat, AP HP,IAME,UMR 1137,INSERM,Lab Virol, Paris, France.
EM benoit.visseaux@aphp.fr
RI BRICHLER, Segolene/R-7039-2018
OI BRICHLER, Segolene/0000-0002-7336-7730
CR Brooks JT., 2016, MMWR-MORBID MORTAL W, P65
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Nicastri E, 2016, EUROSURVEILLANCE, V11, P21, DOI DOI 10.2807/1560-7917
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
NR 6
TC 27
Z9 27
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2016
VL 16
IS 11
BP 1220
EP 1220
DI 10.1016/S1473-3099(16)30387-5
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DZ5PP
UT WOS:000385914300013
PM 27788975
OA Bronze
DA 2020-07-08
ER

PT J
AU Bogoch, II
   Brady, OJ
   Kraemer, MUG
   German, M
   Creatore, MI
   Brent, S
   Watts, AG
   Hay, SI
   Kulkarni, MA
   Brownstein, JS
   Khan, K
AF Bogoch, Isaac I.
   Brady, Oliver J.
   Kraemer, Moritz U. G.
   German, Matthew
   Creatore, Maria I.
   Brent, Shannon
   Watts, Alexander G.
   Hay, Simon I.
   Kulkarni, Manisha A.
   Brownstein, John S.
   Khan, Kamran
TI Potential for Zika virus introduction and transmission in resource
   -limited countries in Africa and the Asia-Pacific region: a modelling
   study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; OUTBREAK; STATES; FEVER; CHINA
AB Background As the epidemic of Zika virus expands in the Americas, countries across Africa and the Asia-Pacific region are becoming increasingly susceptible to the importation and possible local spread of the virus. To support public health readiness, we aim to identify regions and times where the potential health, economic, and social effects from Zika virus are greatest, focusing on resource-limited countries in Africa and the Asia-Pacific region.
   Methods Our model combined transportation network analysis, ecological modelling of mosquito occurrences, and vector competence for flavivirus transmission, using data from the International Air Transport Association, entomological observations from Zika's primary vector species, and climate conditions using WorldClim. We overlaid monthly flows of airline travellers arriving to Africa and the Asia-Pacific region from areas of the Americas suitable for year-round transmission of Zika virus with monthly maps of climatic suitability for mosquito-borne transmission of Zika virus within Africa and the Asia-Pacific region.
   Findings An estimated 2.6 billion people live in areas of Africa and the Asia-Pacific region where the presence of competent mosquito vectors and suitable climatic conditions could support local transmission of Zika virus. Countries with large volumes of travellers arriving from Zika virus-affected areas of the Americas and large populations at risk of mosquito-borne Zika virus infection include India (67 422 travellers arriving per year; 1.2 billion residents in potential Zika transmission areas), China (238 415 travellers; 242 million residents), Indonesia (13 865 travellers; 197 million residents), Philippines (35 635 travellers; 70 million residents), and Thailand (29 241 travellers; 59 million residents).
   Interpretation Many countries across Africa and the Asia-Pacific region are vulnerable to Zika virus. Strategic use of available health and human resources is essential to prevent or mitigate the health, economic, and social consequences of Zika virus, especially in resource-limited countries.
   Funding Canadian Institutes of Health Research and the US Centers for Disease Control and Prevention.
C1 [Bogoch, Isaac I.; Khan, Kamran] Univ Toronto, Div Infect Dis, Dept Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada.
   [Bogoch, Isaac I.] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada.
   [Brady, Oliver J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Brady, Oliver J.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, SEEG, Oxford OX1 2JD, England.
   [German, Matthew; Creatore, Maria I.; Watts, Alexander G.; Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.
   [Creatore, Maria I.; Brent, Shannon] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Hay, Simon I.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
   [Hay, Simon I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Kulkarni, Manisha A.] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.
   [Brownstein, John S.] Harvard Med Sch, Childrens Hosp Boston, Boston, MA USA.
RP Khan, K (corresponding author), St Michaels Hosp, Toronto, ON M5B 1W8, Canada.
EM khank@smh.ca
RI Hay, Simon I/F-8967-2015
OI Hay, Simon I/0000-0002-0611-7272
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR); US Centers for Disease Control and PreventionUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA
FX Canadian Institutes of Health Research and the US Centers for Disease
   Control and Prevention.
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Huang XY, 2014, BIOMED ENVIRON SCI, V27, P894, DOI 10.3967/bes2014.125
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   ProMED-mail, 2015, UND ILLN BRAZ 02 ZIK
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   The World Bank, HLTH EXP PER CAP CUR
   US Centers for Disease Control and Prevention, ZIK VIR
   WHO, YELL FEV ANG
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   WordlClim, WORLDCLIM GLOB CLIM
   Zhang FC, 2014, INT J INFECT DIS, V27, P4, DOI 10.1016/j.ijid.2014.03.1392
NR 38
TC 93
Z9 97
U1 0
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD NOV
PY 2016
VL 16
IS 11
BP 1237
EP 1245
DI 10.1016/S1473-3099(16)30270-5
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DZ5PP
UT WOS:000385914300036
PM 27593584
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Zammarchi, L
   Spinicci, M
   Bartoloni, A
AF Zammarchi, Lorenzo
   Spinicci, Michele
   Bartoloni, Alessandro
TI Zika Virus: a Review from the Virus Basics to Proposed Management
   Strategies
SO MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
LA English
DT Review
ID MALE SEXUAL TRANSMISSION; UPDATE INTERIM GUIDANCE; UNITED-STATES; DENGUE
   VIRUS; INFECTION; CHIKUNGUNYA; EMERGENCE; PREGNANCY; OUTBREAK; EXPOSURE
AB This review aims to summarize the body of knowledge available on Zika virus to date. A comprehensive review of the scientific literature on Zika virus was performed with the aim to stress relevant aspects for healthcare professionals in the non-endemic areas. For several years, the Zika virus infection was considered an extremely rare exotic disease with poor clinical relevance. However, Zika virus has recently gained the attention of the scientific community and public opinion since the virus spread to the Pacific islands and the South America in an unprecedented epidemic, and additionally due to the definitive evidence that the infection could be complicated by Guillain-Barre syndrome, passed through vertical transmission, and result in central nervous system abnormalities (including microcephaly) of the fetus. Studies and scientific evidence on the complications associated with Zika virus infection are growing day by day. It is advisable that the healthcare professionals working in non-endemic areas maintain full awareness on this issue in order to practice proper management of the imported cases of Zika virus infection.
C1 [Zammarchi, Lorenzo; Spinicci, Michele; Bartoloni, Alessandro] Univ Firenze, Dipartimento Med Sperimentale & Clin, Florence, Italy.
   [Zammarchi, Lorenzo; Bartoloni, Alessandro] Azienda Osped Univ Careggi, SOD Malattie Infett & Trop, Florence, Italy.
RP Bartoloni, A (corresponding author), Univ Firenze, Dipartimento Med Sperimentale & Clin, Florence, Italy.; Bartoloni, A (corresponding author), Azienda Osped Univ Careggi, SOD Malattie Infett & Trop, Florence, Italy.
EM alessandro.bartoloni@unifi.it
RI BARTOLONI, ALESSANDRO/K-3403-2018
OI BARTOLONI, ALESSANDRO/0000-0001-9758-1523; ZAMMARCHI,
   Lorenzo/0000-0003-0892-8404
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Barzon L., 2016, EURO SURVEILL, V21
   Baud D, 2016, LANCET INFECT DIS
   Besnard M, 2014, EURO SURVEILL, V19
   Bocanegra C, 2016, CLIN MICROBIOL INFEC
   Brasil P, 2016, N ENGL J MED
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, REC MAN REP ZIK VIR
   Centers for Disease Control and Prevention, 2016, GUID TRAV VIS FRIEND
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delisle E, 2015, EURO SURVEILL, V20
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Di Luca M, 2016, EURO SURVEILL, V21
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP PREP
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP RAP R
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   European Centre for Disease Prevention and Control, 2016, INT GUID HEALTHC PRO
   European Centre for Disease Prevention and Control, 2016, PROP CAS DEF SURV ZI
   European Centre for Disease Prevention and Control, 2016, ZIK VIR SAF SUBST HU
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Freour T., 2016, EURO SURVEILL, V21
   Gjenero-Margan I, 2011, EURO SURVEILL, V16
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Huzly D, 2016, EURO SURVEILL, V21
   Johansson M.A., 2016, N ENGL J MED
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lessler J, 2016, B WHO
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL
   Lustig Y, 2016, EURO SURVEILL, V21
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magurano F, 2015, VECTOR-BORNE ZOONOT, V15, P258, DOI 10.1089/vbz.2014.1724
   Mallet H. P., 2015, B INFORM SANITAIRES
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Martins KAO, 2016, VACCINE, V34, P3711, DOI 10.1016/j.vaccine.2016.06.012
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ministero della Salute, 2016, 001720016062016DGPRE
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Outbreak news, 2015, WKLY EPIDEMIOL REC, V90, P409
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prisant N., 2016, LANCET INFECT DIS
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Roze B, 2016, EURO SURVEILL, P21
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Succo T, 2016, EURO SURVEILL, V21
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, DIS OUTBREAK NE 0208
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, WHOZIKVMOC161
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Wylie BJ, 2016, OBSTET GYNECOL
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 98
TC 7
Z9 9
U1 0
U2 7
PU PAGEPRESS PUBL
PI PAVIA
PA MEDITGROUP, VIA G BELLI, 4, PAVIA, 27100, ITALY
SN 2035-3006
J9 MEDITERR J HEMATOL I
JI Med. J. Hematol. Infect. Dis.
PD NOV 1
PY 2016
VL 8
AR e2016056
DI 10.4084/MJHID.2016.056
PG 10
WC Hematology; Infectious Diseases
SC Hematology; Infectious Diseases
GA EC6IF
UT WOS:000388239000003
PM 27872736
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Waldorf, KMA
   Stencel-Baerenwald, JE
   Kapur, RP
   Studholme, C
   Boldenow, E
   Vornhagen, J
   Baldessari, A
   Dighe, MK
   Thiel, J
   Merillat, S
   Armistead, B
   Tisoncik-Go, J
   Green, RR
   Davis, MA
   Dewey, EC
   Fairgrieve, MR
   Gatenby, JC
   Richards, T
   Garden, GA
   Diamond, MS
   Juul, SE
   Grant, RF
   Kuller, L
   Shaw, DWW
   Ogle, J
   Gough, GM
   Lee', W
   English, C
   Hevner, RF
   Dobyns, WB
   Gale, M
   Rajagopa, L
AF Waldorf, Kristina M. Adams
   Stencel-Baerenwald, Jennifer E.
   Kapur, Raj P.
   Studholme, Colin
   Boldenow, Erica
   Vornhagen, Jay
   Baldessari, Audrey
   Dighe, Manjiri K.
   Thiel, Jeff
   Merillat, Sean
   Armistead, Blair
   Tisoncik-Go, Jennifer
   Green, Richard R.
   Davis, Michael A.
   Dewey, Elyse C.
   Fairgrieve, Marian R.
   Gatenby, J. Christopher
   Richards, Todd
   Garden, Gwenn A.
   Diamond, Michael S.
   Juul, Sandra E.
   Grant, Richard F.
   Kuller, LaRene
   Shaw, Dennis W. W.
   Ogle, Jason
   Gough, G. Michael
   Lee', Wonsok
   English, Chris
   Hevner, Robert F.
   Dobyns, William B.
   Gale, Michael, Jr.
   Rajagopa, Lakshmi
TI Fetal brain lesions after sub-cutaneous inoculation of Zika virus in a
   pregnant nonhuman primate
SO NATURE MEDICINE
LA English
DT Article
ID ENCEPHALITIS; INFECTION; MACAQUE; DAMAGE; CELLS
AB We describe the development of fetal brain lesions after Zika virus (ZIKV) inoculation in a pregnant pigtail macaque. Periventricular lesions developed within 10 d and evolved asymmetrically in the occipital-parietal lobes. Fetal autopsy revealed ZIKV in the brain and significant cerebral white matter hypoplasia, periventricular white matter gliosis, and axonal and ependymal injury. Our observation of ZIKV-associated fetal brain lesions in a nonhuman primate provides a model for therapeutic evaluation.
C1 [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA.
   [Stencel-Baerenwald, Jennifer E.; Tisoncik-Go, Jennifer; Green, Richard R.; Davis, Michael A.; Dewey, Elyse C.; Fairgrieve, Marian R.; Gale, Michael, Jr.] Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.
   [Kapur, Raj P.; Garden, Gwenn A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA.
   [Kapur, Raj P.] Seattle Childrens Hosp, Dept Pathol, Seattle, WA USA.
   [Studholme, Colin; Boldenow, Erica; Juul, Sandra E.; Dobyns, William B.; Rajagopa, Lakshmi] Univ Washington, Dept Pediat, Seattle, WA 98195 USA.
   [Studholme, Colin] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Studholme, Colin; Dighe, Manjiri K.; Thiel, Jeff; Gatenby, J. Christopher; Richards, Todd; Shaw, Dennis W. W.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA.
   [Boldenow, Erica; Vornhagen, Jay; Merillat, Sean; Armistead, Blair; Rajagopa, Lakshmi] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.
   [Armistead, Blair; Rajagopa, Lakshmi] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Baldessari, Audrey; Grant, Richard F.; Kuller, LaRene; Ogle, Jason; Gough, G. Michael; Lee', Wonsok; English, Chris] Washington Natl Primate Res Ctr, Seattle, WA USA.
   [Garden, Gwenn A.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA.
   [Shaw, Dennis W. W.] Seattle Childrens Hosp, Dept Radiol, Seattle, WA USA.
   [Hevner, Robert F.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA.
   [Hevner, Robert F.; Dobyns, William B.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA USA.
   [Boldenow, Erica] Calvin Coll, Dept Biol, Grand Rapids, MI 49506 USA.
RP Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Gale, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.; Gale, M (corresponding author), Univ Washington, Ctr Innate Immun & Immune Dis, Seattle, WA 98195 USA.; Rajagopa, L (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Rajagopa, L (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA USA.; Rajagopa, L (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
EM adamsk@uw.edu; mgale@uw.edu; lakshmi.rajagopal@seattlechildrens.org
RI Dobyns, William/AAI-2768-2020; Vornahgen, Jay/AAI-1887-2019; Diamond,
   Michael/AAH-1733-2019
OI Dobyns, William/0000-0002-7681-2844; Diamond,
   Michael/0000-0002-8791-3165; Garden, Gwenn/0000-0002-8753-6515; Gale,
   Michael/0000-0002-6332-7436
FU University of Washington Department of Obstetrics and Gynecology; US
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01AI100989,
   AI104002, AI083019, R01EB017133, R01NS055064, R01NS061957]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [T32 HD007233, T32 AI07509]; Office of Research
   Infrastructure Programs (ORIP) of the NIH [P51OD010425]
FX We thank the Seattle Genomics Core Laboratory of the Washington National
   Primate Research Center Systems Biology Division for sequence analysis
   and the Center for Innate Immunity and Immune Disease immuno-informatics
   core group for bioinformatics support. We would like to acknowledge J.
   Hamanishi for technical assistance with preparation of the figures and
   L. Brandao (neuroradiologist at the Clinica Felippe Mattoso) for
   providing images and clinical information from a child with congenital
   ZIKV syndrome. We thank R. Tesh (University of Texas Medical Branch at
   Galveston-World Reference Center for Emerging Viruses and Arboviruses)
   for providing viral seed stocks. We thank A. Powers (US Centers for
   Disease Control and Prevention) for technical guidance for the qPCR
   experiments and C. Hughes for administrative assistance. We also thank
   M.-T. Little for technical editing. This work was supported by funding
   from the University of Washington Department of Obstetrics and
   Gynecology (K.M.A.W.) and the US National Institutes of Health (NIH)
   (grant no. R01AI100989 (L.R. and K.M.A.W.), AI104002 (M.G.), AI083019
   (M.G.), R01EB017133 (C.S.), R01NS055064 (C.S.) and R01NS061957 (C.S)).
   The NIH training grants T32 HD007233 and T32 AI07509 provided support
   for E.B. and respectively. This project was also supported by the Office
   of Research Infrastructure Programs (ORIP) of the NIH through grant no.
   P51OD010425 to the Washington National Primate Research Center (A.B.,
   R.F.G., L.K., J.O., G.M.G., W.L. and C.E.). The content of this paper is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the US National Institutes of Health or
   other funders. The funders had no role in study design, data collection
   and analysis, the decision to publish or preparation of the manuscript.
CR Brasil R, 2016, N ENGL J MED
   Bruce AG, 2013, J VIROL, V87, P13676, DOI 10.1128/JVI.02331-13
   CONRAD S, 1995, AM J PRIMATOL, V36, P15, DOI 10.1002/ajp.1350360103
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   HADDAD J, 1990, NEUROPEDIATRICS, V21, P215, DOI 10.1055/s-2008-1071500
   Lennartsson F, 2014, INVEST OPHTH VIS SCI, V55, P8278, DOI 10.1167/iovs.14-14913
   Leonard JR, 2000, AM J ROENTGENOL, V174, P1651, DOI 10.2214/ajr.174.6.1741651
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Nakgoi K, 2014, AM J PRIMATOL, V76, P97, DOI 10.1002/ajp.22213
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Putaporntip C, 2010, MOL ECOL, V19, P3466, DOI 10.1111/j.1365-294X.2010.04756.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sourisseau M, 2013, GASTROENTEROLOGY, V145, P966, DOI 10.1053/j.gastro.2013.07.026
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Waldorf KMA, 2011, BJOG-INT J OBSTET GY, V118, P136, DOI 10.1111/j.1471-0528.2010.02728.x
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 19
TC 137
Z9 137
U1 0
U2 19
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD NOV
PY 2016
VL 22
IS 11
BP 1256
EP 1259
DI 10.1038/nm.4193
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA EB3XK
UT WOS:000387302300017
PM 27618651
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Coyne, CB
   Lazear, HM
AF Coyne, Carolyn B.
   Lazear, Helen M.
TI Zika virus - reigniting the TORCH
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID MALE SEXUAL TRANSMISSION; UPDATE INTERIM GUIDANCE; TO-CHILD
   TRANSMISSION; PLACENTAL-TRANSFER; UNITED-STATES; ANIMAL-MODELS; GLOBAL
   BURDEN; 1ST TRIMESTER; INFECTION; DENGUE
AB The recent association between Zika virus (ZIKV) infection during pregnancy and fetal microcephaly has led to a renewed interest in the mechanisms by which vertically transmitted microorganisms reach the fetus and cause congenital disease. In this Opinion article, we provide an overview of the structure and cellular composition of the human placenta and of the mechanisms by which traditional 'TORCH' pathogens (Toxoplasma gondii, other, rubella virus, cytomegalovirus and herpes simplex virus) access the fetal compartment. Based on our current understanding of ZIKV pathogenesis and the developmental defects that are caused by fetal ZIKV infection, ZIKV should be considered a TORCH pathogen and future research and public health measures should be planned and implemented accordingly.
C1 [Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.
   [Coyne, Carolyn B.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.
   [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
RP Coyne, CB (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA.; Coyne, CB (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15213 USA.
EM coynec2@pitt.edu; helen.lazear@med.unc.edu
OI Lazear, Helen/0000-0002-8649-4579
FU US National Institutes of Health (NIH)United States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [R01-AI081759,
   NIH R01-HD075665]; Burroughs Wellcome Investigators in the Pathogenesis
   of Infectious Disease AwardBurroughs Wellcome Fund; University of North
   Carolina Department of Microbiology and Immunology; Lineberger
   Comprehensive Cancer Center
FX The authors apologize to those whose work was not covered in detail
   owing to space restrictions and for inaccuracies or omissions resulting
   from the remarkably rapid pace of discovery in the Zika virus field. The
   authors thank Y. Sadovsky for helpful discussions in relation to this
   manuscript. C.B.C is supported by the US National Institutes of Health
   (NIH; grants R01-AI081759 and NIH R01-HD075665), and the Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease Award.
   H.M.L is supported by start-up funds from the University of North
   Carolina Department of Microbiology and Immunology and the Lineberger
   Comprehensive Cancer Center.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bayer A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.060
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2016, EURO SURVEILL
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, N ENGL J MED
   BRIGHT NA, 1995, J HISTOCHEM CYTOCHEM, V43, P933, DOI 10.1177/43.9.7642966
   Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DANCIS J, 1961, AM J OBSTET GYNECOL, V82, P167, DOI 10.1016/S0002-9378(16)36111-7
   Dang J., 2016, CELL STEM CELL
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FOIDART JM, 1992, INT J DEV BIOL, V36, P451
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GV, 2016, LANCET
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GARTY BZ, 1994, CLIN DIAGN LAB IMMUN, V1, P667, DOI 10.1128/CDLI.1.6.667-669.1994
   GUSDON JP, 1969, AM J OBSTET GYNECOL, V103, P895, DOI 10.1016/S0002-9378(16)34434-9
   Guttmacher Institute, 2015, FACTS AB LAT AM CAR
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   HUSTIN J, 1987, AM J OBSTET GYNECOL, V157, P162, DOI 10.1016/S0002-9378(87)80371-X
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   KINNEY JS, 1988, CLIN PERINATOL, V15, P727
   Lambert N, 2015, LANCET, V385, P2297, DOI 10.1016/S0140-6736(14)60539-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liotta G, 2015, INT J ENV RES PUB HE, V12, P13224, DOI 10.3390/ijerph121013224
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Maltepe E, 2010, J CLIN INVEST, V120, P1016, DOI 10.1172/JCI41211
   Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Martines R. B., 2016, LANCET
   McConkey CA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501462
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NAHMIAS AJ, 1971, AM J OBSTET GYNECOL, V110, P825, DOI 10.1016/0002-9378(71)90580-1
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pacheco O, 2016, N ENGL J MED
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Perez S, 2016, EUROSURVEILLANCE, V21, P1, DOI 10.2807/1560-7917.ES.2016.21.24.30261
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Plotkin SA, 2001, VACCINE, V19, P3311, DOI 10.1016/S0264-410X(01)00073-1
   Prisant N., 2016, LANCET INFECT DIS
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robbins JR, 2012, INFECT IMMUN, V80, P418, DOI 10.1128/IAI.05899-11
   Robbins JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000732
   Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186
   Schleiss MR, 2013, FUTURE VIROL, V8, P1161, DOI 10.2217/fvl.13.106
   Schmidt A, 2015, J REPROD IMMUNOL, V108, P65, DOI 10.1016/j.jri.2015.03.001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K., 2016, SCIENCE
   Stevens J, 2014, J INFECTION, V69, pS56, DOI 10.1016/j.jinf.2014.07.018
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   US National Institutes of Health, 2016, NIH LAUNCH LARG STUD
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212
   World Health Organization, 2016, ZIK SIT REP
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeldovich VB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003821
NR 105
TC 123
Z9 127
U1 2
U2 50
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD NOV
PY 2016
VL 14
IS 11
BP 707
EP 715
DI 10.1038/nrmicro.2016.125
PG 9
WC Microbiology
SC Microbiology
GA EA0ZF
UT WOS:000386317400010
PM 27573577
OA Bronze
DA 2020-07-08
ER

PT J
AU Wylie, BJ
   Hauptman, M
   Woolf, AD
   Goldman, RH
AF Wylie, Blair J.
   Hauptman, Marissa
   Woolf, Alan D.
   Goldman, Rose H.
TI Insect Repellants During Pregnancy in the Era of the Zika Virus
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID PERMETHRIN; REPELLENTS; SAFETY; DEET; EFFICACY; EXPOSURE; NEUROTOXICITY;
   ABSORPTION; UNIFORMS; AEDES
AB Health care providers must be equipped to provide appropriate advice to reproductive-aged patients for protection against the potentially devastating consequences of prenatal Zika virus exposure. The goal of this commentary is to summarize what is known about the safety and toxicity of N,N-diethyl-meta-toluamide (DEET) as a topical insect repellant and the pyrethroid permethrin for treatment of fabric, endorsed in the fight against Zika virus. Reviews assessing the safety and toxicity of DEET conducted by the U.S. Environmental Protection Agency and the Canadian Pest Management Regulatory Agency conclude that DEET has low acute toxicity and does not appear to pose a significant health concern to humans when used as directed. Some experimental animal and limited epidemiologic data suggest that prenatal pyrethroid exposure may adversely affect learning and behavior, but this level of evidence pales in comparison to the known risks of Zika virus to the fetal brain. The available evidence has led to the strong recommendation by the Centers for Disease Control and Prevention for use of these products by pregnant women as personal protection against mosquito bites in the fight against Zika virus infection. This message has been affirmed by our obstetrics and gynecology professional organizations. Because Zika virus is unlikely to be the last disease requiring vector control, those with environmental health expertise must continue to join with infectious disease specialists to communicate the potential vulnerability of our youngest (fetuses, infants, and young children) to vector-borne disease, both to the disease itself and to the strategies employed to mitigate the spread of such disease.
C1 Harvard Med Sch, Massachusetts Gen Hosp, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA.
   Boston Childrens Hosp, Boston, MA USA.
   Cambridge Hlth Alliance, Cambridge, MA USA.
RP Wylie, BJ (corresponding author), Mass Gen Hosp, Dept Obstet & Gynecol, Div Maternal Fetal Med, 55 Fruit St, Boston, MA 02114 USA.
EM bwylie@mgh.harvard.edu
FU American Academy of Pediatrics (AAP); Agency for Toxic Substances and
   Disease Registry (ATSDR) [FAIN: 1U61TS000237-02]; U.S. Environmental
   Protection Agency (EPA)United States Environmental Protection Agency
   [DW-75-95877701]; National Institute of Environmental Health
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Environmental
   Health Sciences (NIEHS) [NIH K23 ES021471]
FX Supported by the American Academy of Pediatrics (AAP) and funded (in
   part) by the cooperative agreement FAIN: 1U61TS000237-02 from the Agency
   for Toxic Substances and Disease Registry (ATSDR). The U.S.
   Environmental Protection Agency (EPA) supports the PEHSU by providing
   partial funding to the Agency for Toxic Substances and Diseases Registry
   (ATSDR) under Inter- Agency Agreement number DW-75-95877701. Neither EPA
   nor ATSDR endorse the purchase of any commercial products or services
   mentioned in PEHSU publications. Blair J. Wylie is supported by the
   National Institute of Environmental Health Sciences (NIH K23 ES021471).
CR American College of Obstetricians and Gynecologists, PRACT ADV ZIK VIR
   [Anonymous], 1989, MMWR MORB MORTAL WKL, V38, P678
   BUESCHER MD, 1983, MOSQ NEWS, V43, P364
   Centers for Disease Control and Prevention, TICKS LYM DIS
   Centers for Disease Control and Prevention, ZIK VIR PREGN
   Centers for Disease Control and Prevention, DENG AED AEG MOSQ
   Centers for Disease Control and Prevention, W NIL VIR INS REP US
   Dugas J, 2010, OCCUP ENVIRON MED, V67, P196, DOI 10.1136/oem.2009.047373
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Horton MK, 2011, PEDIATRICS, V127, pE699, DOI 10.1542/peds.2010-0133
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kegel P, 2014, OCCUP ENVIRON MED, V71, P112, DOI 10.1136/oemed-2012-101279
   Kennedy D, 2005, AM J PERINAT, V22, P87, DOI 10.1055/s-2005-837736
   Koren G, 2003, CAN MED ASSOC J, V169, P209
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   McGready R, 2001, AM J TROP MED HYG, V65, P285, DOI 10.4269/ajtmh.2001.65.285
   MotherToBaby, FACT SHEET DEET N N
   MotherToBaby, FACT SHEET INS REP
   Mytton OT, 2007, BJOG-INT J OBSTET GY, V114, P582, DOI 10.1111/j.1471-0528.2007.01290.x
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Proctor SP, 2014, J EXPO SCI ENV EPID, V24, P572, DOI 10.1038/jes.2013.65
   SCHAEFER C, 1992, REPROD TOXICOL, V6, P175, DOI 10.1016/0890-6238(92)90120-I
   Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   Submission Coordination and Documentation Division, 2002, RRD200201 SUBM COORD
   Sudakin DL, 2003, J TOXICOL-CLIN TOXIC, V41, P831, DOI 10.1081/CLT-120025348
   Tomalik-Scharte D, 2005, EUR J CLIN PHARMACOL, V61, P399, DOI 10.1007/s00228-005-0932-7
   United States Environmental Protection Agency, REG REV PROP INT DEC
   United States Environmental Protection Agency, 2007, RER EL DEC PERM
   United States Environmental Protection Agency, NEW PEST FACT SHEET
   US Environmental Protection Agency, 2009, 738F09001 EPA
   (US EPA) United State Environmental Protection Agency, 1998, RER EL DEC RED DEET
   US. Food and Drug Administration, PERM OV
   VANDERRHEE HJ, 1989, ACTA DERM-VENEREOL, V69, P170
   World Health Organization, 2002, BREASTF MAT MED REC
NR 35
TC 23
Z9 23
U1 1
U2 31
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD NOV
PY 2016
VL 128
IS 5
BP 1111
EP 1115
DI 10.1097/AOG.0000000000001685
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EE0GA
UT WOS:000389251000030
PM 27548647
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Parke, DW
   Almeida, DRP
   Albini, TA
   Ventura, CV
   Berrocal, AM
   Mittra, RA
AF Parke, D. Wilkin, III
   Almeida, David R. P.
   Albini, Thomas A.
   Ventura, Camila V.
   Berrocal, Audina M.
   Mittra, Robert A.
TI Serologically Confirmed Zika-Related Unilateral Acute Maculopathy in an
   Adult
SO OPHTHALMOLOGY
LA English
DT Article
ID VIRUS
C1 [Parke, D. Wilkin, III; Almeida, David R. P.; Mittra, Robert A.] VitreoRetinal Surg, Minneapolis, MN USA.
   [Albini, Thomas A.; Ventura, Camila V.; Berrocal, Audina M.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.
RP Parke, DW (corresponding author), 7760 France Ave South,Suite 310, Minneapolis, MN 55435 USA.
EM wilkinparke@gmail.com
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684; Albini,
   Thomas/0000-0003-2199-9047
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   YANNUZZI LA, 1991, ARCH OPHTHALMOL-CHIC, V109, P1411, DOI 10.1001/archopht.1991.01080100091049
NR 5
TC 27
Z9 27
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0161-6420
EI 1549-4713
J9 OPHTHALMOLOGY
JI Ophthalmology
PD NOV
PY 2016
VL 123
IS 11
BP 2432
EP 2433
DI 10.1016/j.ophtha.2016.06.039
PG 2
WC Ophthalmology
SC Ophthalmology
GA EE3QK
UT WOS:000389509500029
PM 27474145
DA 2020-07-08
ER

PT J
AU Manangeeswaran, M
   Ireland, DDC
   Verthelyi, D
AF Manangeeswaran, Mohanraj
   Ireland, Derek D. C.
   Verthelyi, Daniela
TI Zika (PRVABC59) Infection Is Associated with T cell Infiltration and
   Neurodegeneration in CNS of Immunocompetent Neonatal C57Bl/6 Mice
SO PLOS PATHOGENS
LA English
DT Article
ID VIRUS-INFECTION; ALPHAVIRUS ENCEPHALOMYELITIS; MOUSE MODEL; ARENAVIRUS;
   BRAIN; INTERLEUKIN-10; PATHOGENICITY; ENCEPHALITIS; ORGANOIDS; PREGNANCY
AB The recent spread of Zika virus (ZIKV) and its association with increased rates of Guillain Barre and other neurological disorders as well as congenital defects that include microcephaly has created an urgent need to develop animal models to examine the pathogenesis of the disease and explore the efficacy of potential therapeutics and vaccines. Recently developed infection models for ZIKV utilize mice defective in interferon responses. In this study we establish and characterize a new model of peripheral ZIKV infection using immunocompetent neonatal C57BL/6 mice and compare its clinical progression, virus distribution, immune response, and neuropathology with that of C57BL/6-IFNAR KO mice. We show that while ZIKV infected IFNAR KO mice develop bilateral hind limb paralysis and die 5-6 days post-infection (dpi), immunocompetent B6 WT mice develop signs of neurological disease including unsteady gait, kinetic tremors, severe ataxia and seizures by 13 dpi that subside gradually over 2 weeks. Immunohistochemistry show viral antigen predominantly in cerebellum at the peak of the disease in both models. However, whereas IFNAR KO mice showed infiltration by neutrophils and macrophages and higher expression of IL-1, IL-6 and Cox2, B6 WT mice show a cellular infiltration in the CNS composed predominantly of T cells, particularly CD8+ T cells, and increased mRNA expression levels of IFNg, GzmB and Prf1 at peak of disease. Lastly, the CNS of B6 WT mice shows evidence of neurodegeneration predominantly in the cerebellum that are less prominent in mice lacking the IFN response possibly due to the difference in cellular infiltrates and rapid progression of the disease in that model. The development of the B6 WT model of ZIKV infection will provide insight into the immunopathology of the virus and facilitate assessments of possible therapeutics and vaccines.
C1 [Manangeeswaran, Mohanraj; Ireland, Derek D. C.; Verthelyi, Daniela] US FDA, Div Biotechnol Review & Res 3, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.
RP Verthelyi, D (corresponding author), US FDA, Div Biotechnol Review & Res 3, Off Biotechnol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.
EM Daniela.Verthelyi@fda.hhs.gov
OI Verthelyi, Daniela/0000-0002-5450-3071; Ireland,
   Derek/0000-0001-5829-4206
FU FDA Medical Countermeasures Initiative
FX This work was partly funded by the FDA Medical Countermeasures
   Initiative. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   AMSTEY MS, 1976, AM J OBSTET GYNECOL, V125, P40, DOI 10.1016/0002-9378(76)90888-7
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Borrow P, 2010, VIRUSES-BASEL, V2, P2443, DOI 10.3390/v2112443
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang TH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000493
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Herz J, 2015, J EXP MED, V212, P1153, DOI 10.1084/jem.20142047
   Hofer U, 2016, NAT REV MICROBIOL, V14, P401, DOI 10.1038/nrmicro.2016.80
   Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005
   Ireland DDC, 2016, CELL MOL IMMUNOL
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909
   Kulcsar KA, 2016, J NEUROIMMUNOL, V295, P60, DOI 10.1016/j.jneuroim.2016.04.010
   Kulcsar KA, 2014, P NATL ACAD SCI USA, V111, P16053, DOI 10.1073/pnas.1418966111
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear Helen M, CELL HOST MICROBE
   Li H, 2016, CELL STEM CELL
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LUSTIG S, 1988, J VIROL, V62, P2329, DOI 10.1128/JVI.62.7.2329-2336.1988
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miner Jonathan J, 2016, CELL REPORTS
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nazmi A, 2011, J NEUROIMMUNE PHARM, V6, P420, DOI 10.1007/s11481-011-9271-x
   Paploski I. A., 2016, EMERG INFECT DIS, V22
   Pedras-Vasconcelos JA, 2008, J IMMUNOL, V180, P8231, DOI 10.4049/jimmunol.180.12.8231
   Pedras-Vasconcelos JA, 2006, J IMMUNOL, V176, P4940, DOI 10.4049/jimmunol.176.8.4940
   Pletnikov MV, 2003, CEREBELLUM, V2, P62
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Wang Y, 2003, J VIROL, V77, P13323, DOI 10.1128/JVi.77.24.13323-13334.2003
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   WHO, 2016, ZUJ SIT REP
   WHO, 2016, ON YEAR ZIK OUTBR OB, P2
   Winkelmann E. R., 2016, F1000RES, V5
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhao L, 2011, J VIROL, V85, P10058, DOI 10.1128/JVI.05075-11
NR 52
TC 71
Z9 72
U1 0
U2 14
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD NOV
PY 2016
VL 12
IS 11
AR e1006004
DI 10.1371/journal.ppat.1006004
PG 20
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EI0VO
UT WOS:000392193200033
PM 27855206
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oza, KS
   Kumbhar, VS
   Kamat, RK
AF Oza, Kavita S.
   Kumbhar, V. S.
   Kamat, R. K.
TI Zika Virus Awareness: A Text Mining Approach
SO RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES
LA English
DT Article
DE Zika virus; text mining; word cloud; Google; Bing; YouTube
AB Bunches of uproar is made about Zika infection all through the world in the last decade. The present paper reports a text mining based approach to explore the public awareness about this virus in India. Data set for the present investigation is created using keywords which have been used by different search engines. The above mentioned dataset is pre-processed for further analysis. Text mining approach is used to analyze these datasets to find frequently used search keyword. The framework developed is useful for adopting the preventive measures in the public health policy regarding such deadly viruses.
C1 [Oza, Kavita S.; Kumbhar, V. S.] Shivaji Univ, Dept Comp Sci, Kolhapur, Maharashtra, India.
   [Kamat, R. K.] Shivaji Univ, Dept Elect, Kolhapur, Maharashtra, India.
RP Oza, KS (corresponding author), Shivaji Univ, Dept Comp Sci, Kolhapur, Maharashtra, India.
CR Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Patel Rashmi, LANCET, V383, pS16
   Poland CM, 2011, VACCINE, V29, P6145, DOI 10.1016/j.vaccine.2011.07.131
   R Core Team, 2016, R LANG ENV STAT COMP
NR 8
TC 0
Z9 0
U1 0
U2 2
PU RJPBCS RESEARCH JOURNAL PHARMACEUTICAL, BIOLOGICAL & CHEMICAL SCIENCES
PI PRODDATUR
PA RJPBCS RESEARCH JOURNAL PHARMACEUTICAL, BIOLOGICAL & CHEMICAL SCIENCES,
   PRODDATUR, 00000, INDIA
SN 0975-8585
J9 RES J PHARM BIOL CHE
JI Res. J. Pharm. Biol. Chem. Sci.
PD NOV-DEC
PY 2016
VL 7
IS 6
BP 1942
EP 1947
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG9YF
UT WOS:000410795300262
DA 2020-07-08
ER

PT J
AU Simulundu, E
   Mweene, AS
   Changula, K
   Monze, M
   Chizema, E
   Mwaba, P
   Takada, A
   Ippolito, G
   Kasolo, F
   Zumla, A
   Bates, M
AF Simulundu, Edgar
   Mweene, Aaron S.
   Changula, Katendi
   Monze, Mwaka
   Chizema, Elizabeth
   Mwaba, Peter
   Takada, Ayato
   Ippolito, Guiseppe
   Kasolo, Francis
   Zumla, Alimuddin
   Bates, Matthew
TI Lujo viral hemorrhagic fever: considering diagnostic capacity and
   preparedness in the wake of recent Ebola and Zika virus outbreaks
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE Arenaviridae; diagnostic capacity; Ebola virus disease; lessons; Lujo
   virus; Mammarenavirus; preparedness; viral hemorrhagic fever; Zika virus
ID WEST-AFRICA; NEW-WORLD; ARENAVIRUS; DISEASE; LASSA; INFECTION; ZAMBIA;
   SURVEILLANCE; PERSISTENCE
AB Lujo virus is a novel Old World arenavirus identified in Southern Africa in 2008 as the cause of a viral hemorrhagic fever (VHF) characterized by nosocomial transmission with a high case fatality rate of 80% (4/5 cases). Whereas this outbreak was limited, the unprecedented Ebola virus disease outbreak in West Africa, and recent Zika virus disease epidemic in the Americas, has brought into acute focus the need for preparedness to respond to rare but potentially highly pathogenic outbreaks of zoonotic or arthropod-borne viral infections. A key determinant for effective control of a VHF outbreak is the time between primary infection and diagnosis of the index case. Here, we review the Lujo VHF outbreak of 2008 and discuss how preparatory measures with respect to developing diagnostic capacity might be effectively embedded into existing national disease control networks, such as those for human immunodeficiency virus, tuberculosis, and malaria.
C1 [Simulundu, Edgar; Mweene, Aaron S.; Changula, Katendi; Takada, Ayato] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka, Zambia.
   [Monze, Mwaka] Univ Teaching Hosp, Lusaka, Zambia.
   [Monze, Mwaka] Natl Virol Reference Lab, Lusaka, Zambia.
   [Chizema, Elizabeth; Mwaba, Peter] Minist Hlth, Lusaka, Zambia.
   [Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan.
   [Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido, Japan.
   [Ippolito, Guiseppe] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Rome, Italy.
   [Kasolo, Francis] WHO Afr, WHO, Brazzaville, Rep Congo.
   [Zumla, Alimuddin; Bates, Matthew] UCL, Div Infect & Immun, Dept Infect, London, England.
   [Zumla, Alimuddin; Bates, Matthew] Univ Teaching Hosp, Univ Zambia Univ Coll London Res & Training Prog, Lusaka, Zambia.
   [Bates, Matthew] Univ Teaching Hosp, HerpeZ, Lusaka, Zambia.
RP Bates, M (corresponding author), Univ Teaching Hosp, UNZA UCLMS Res & Training Programme, Lusaka RW1X, Zambia.
EM matthew.bates@ucl.ac.uk
RI Mwaba, Peter/V-6017-2019; Simulundu, Edgar/H-7331-2019; Ippolito,
   Giuseppe/J-7207-2017
OI Simulundu, Edgar/0000-0001-9423-0816; Bates,
   Matthew/0000-0003-0464-1529; Ippolito, Giuseppe/0000-0002-1076-2979;
   Changula, Katendi/0000-0003-2182-4319; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735
FU World Health OrganizationWorld Health Organization [001]
CR Abraham J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000358
   [Anonymous], 1977, LANCET, V1, P581
   [Anonymous], 2006, ICTVDB UNIVERSAL VIR
   [Anonymous], 2015, EBOLA OUTBREAKS 2000
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Bellan SE, 2014, LANCET, V384, P1499, DOI 10.1016/S0140-6736(14)61839-0
   Branch SP, 2016, VIR HEM FEV FACT SHE
   Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455
   Burke J, 1978, B WORLD HEALTH ORGAN, V56, P271
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Cheng BYH, 2013, JOVE-J VIS EXP, DOI 10.3791/50662
   Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12
   Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410
   Emonet SF, 2009, INFECT GENET EVOL, V9, P417, DOI 10.1016/j.meegid.2009.03.005
   Gostin LO, 2015, LANCET, V385, P1902, DOI 10.1016/S0140-6736(15)60644-4
   Gryseels S, 2015, VIROLOGY, V476, P249, DOI 10.1016/j.virol.2014.12.011
   Gulland A, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4336
   Hayden EC, 2015, NATURE, V521, P137, DOI 10.1038/521137a
   Heinrich N, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001557
   Ippolito G, 2015, LANCET INFECT DIS, V15, P1254, DOI 10.1016/S1473-3099(15)00236-4
   Ippolito G, 2015, INFECT DIS REP, V7, P38, DOI 10.4081/idr.2015.5957
   Ishii A, 2012, J GEN VIROL, V93, P2247, DOI 10.1099/vir.0.044099-0
   Ishii A, 2011, EMERG INFECT DIS, V17, P1921, DOI 10.3201/eid1710.10452
   Klempa B, 2013, TROP MED INT HEALTH, V18, P366, DOI 10.1111/tmi.12045
   Koma T, 2016, J VIROL, V90, P1290, DOI 10.1128/JVI.02615-15
   LaBeaud AD, 2008, EMERG INFECT DIS, V14, P1240, DOI 10.3201/eid1408.080082
   Leroy EM, 2000, LANCET, V355, P2210, DOI 10.1016/S0140-6736(00)02405-3
   Manguvo Angellar, 2015, Pan Afr Med J, V22 Suppl 1, P9, DOI 10.11694/pamj.supp.2015.22.1.6190
   Manning JT, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01037
   MARTINI GA, 1973, POSTGRAD MED J, V49, P542, DOI 10.1136/pgmj.49.574.542
   McLay L, 2014, J GEN VIROL, V95, P1, DOI 10.1099/vir.0.057000-0
   Ogawa H, 2011, J VIROL METHODS, V171, P310, DOI 10.1016/j.jviromet.2010.11.010
   Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Peterson AT, 2004, EMERG INFECT DIS, V10, P2073, DOI 10.3201/eid1012.040346
   Peterson AT, 2004, EMERG INFECT DIS, V10, P40, DOI 10.3201/eid1001.030125
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Racsa LD, 2016, CLIN INFECT DIS, V62, P214, DOI 10.1093/cid/civ792
   Radoshitzky SR, 2007, NATURE, V446, P92, DOI 10.1038/nature05539
   Radoshitzky SR, 2015, ARCH VIROL, V160, P1851, DOI 10.1007/s00705-015-2418-y
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Rosenberg R, 2015, CELL MOL LIFE SCI, V72, P1115, DOI 10.1007/s00018-014-1785-y
   Sayler KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115769
   Schoepp RJ, 2014, EMERG INFECT DIS, V20, P1176, DOI 10.3201/eid2007.131265
   Sevilla N, 2000, J EXP MED, V192, P1249, DOI 10.1084/jem.192.9.1249
   Sewlall NH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003233
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11
   Stenglein MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004900
   Tomori O, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0359-7
   WHO, 2016, EB SIT REP
   WHO, 2015, EM GUID US EB IN VIT
   WHO, 2016, SAF COLL BLOOD SAMPL
   Wilson MR, 2014, HAND CLINIC, V123, P671, DOI 10.1016/B978-0-444-53488-0.00033-X
NR 54
TC 2
Z9 2
U1 2
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD NOV
PY 2016
VL 26
IS 6
BP 446
EP 454
DI 10.1002/rmv.1903
PG 9
WC Virology
SC Virology
GA EC0OE
UT WOS:000387799700005
PM 27593704
OA Green Published
DA 2020-07-08
ER

PT J
AU Cheng, FX
   Murray, JL
   Rubin, DH
AF Cheng, Feixiong
   Murray, James L.
   Rubin, Donald H.
TI Drug Repurposing: New Treatments for Zika Virus infection?
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Editorial Material
ID INHIBITORS; TARGETS
AB To date, no antiviral agents have been approved for treating Zika virus (ZIKV) infection. Two recent drug-repurposing studies published in Cell Host & Microbe and Nature Medicine demonstrated that screening FDA-approved drugs for antiviral activity is a promising strategy for identifying therapeutics with novel activity against ZIKV infection.
C1 [Cheng, Feixiong] Northeastern Univ, Ctr Complex Networks Res, Boston, MA 02115 USA.
   [Cheng, Feixiong] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA.
   [Murray, James L.] GeneTAG Technol Inc, Atlanta, GA 30340 USA.
   [Rubin, Donald H.] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37232 USA.
   [Rubin, Donald H.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.
   [Rubin, Donald H.] VA Tennessee Valley Healthcare Syst, Res Med, Nashville, TN 37212 USA.
RP Cheng, FX (corresponding author), Northeastern Univ, Ctr Complex Networks Res, Boston, MA 02115 USA.; Cheng, FX (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA.
EM fxcheng1988@gmail.com
OI Cheng, Feixiong/0000-0002-1736-2847
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Cheng FX, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005074
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Laxminarayan R, 2016, SCIENCE, V353, P874, DOI 10.1126/science.aaf9286
   Nosengo N, 2016, NATURE, V534, P314, DOI 10.1038/534314a
   Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758
   Satoh K, 2016, CLIN CANCER RES, V22, P3458, DOI 10.1158/1078-0432.CCR-15-2256
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 9
TC 25
Z9 25
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD NOV
PY 2016
VL 22
IS 11
BP 919
EP 921
DI 10.1016/j.molmed.2016.09.006
PG 3
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA EK8RF
UT WOS:000394190600001
PM 27692879
DA 2020-07-08
ER

PT J
AU Patterson, J
   Sammon, M
   Garg, M
AF Patterson, Jessica
   Sammon, Maura
   Garg, Manish
TI Dengue, Zika and Chikungunya: Emerging Arboviruses in the New World
SO WESTERN JOURNAL OF EMERGENCY MEDICINE
LA English
DT Review
ID VIRUS; OUTBREAK; FEVER; FEATURES; AMERICA; FLORIDA; STATES; ISLAND;
   AREA; WEST
AB The arboviruses that cause dengue, chikungunya, and Zika illnesses have rapidly expanded across the globe in recent years, with large-scale outbreaks occurring in Western Hemisphere territories in close proximity to the United States (U.S.). In March 2016, the Centers for Disease Control and Protection (CDC) expanded its vector surveillance maps for A. aegypti and A. albopictus, the mosquito vectors for these arboviruses. They have now been shown to inhabit a larger portion of the U.S., including the heavily populated northeast corridor. Emergency physicians need to further familiarize themselves with these diseases, which have classically been considered only in returning travelers but may soon be encountered in the U.S. even in the absence of travel. In this paper, we discuss the presentation and treatment of dengue, Zika, and chikungunya, as well as special challenges presented to the emergency physician in evaluating a patient with a suspected arbovirus infection.
C1 [Sammon, Maura] Temple Univ Hosp & Med Sch, Jones Hall Room 1005,Pk Ave & Ontario St, Philadelphia, PA 19140 USA.
   [Sammon, Maura] Sch Med, Dept Emergency Med, Jones Hall Room 1005,Pk Ave & Ontario St, Philadelphia, PA 19140 USA.
RP Sammon, M (corresponding author), Temple Univ Hosp & Med Sch, Jones Hall Room 1005,Pk Ave & Ontario St, Philadelphia, PA 19140 USA.; Sammon, M (corresponding author), Sch Med, Dept Emergency Med, Jones Hall Room 1005,Pk Ave & Ontario St, Philadelphia, PA 19140 USA.
EM maura.sammon@tuhs.temple.edu
CR Anez G, 2013, BIOMED RES INT, DOI 10.1155/2013/678645
   [Anonymous], DENG SERV DENG FACT
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003
   Bouquillard E, 2009, ANN RHEUM DIS, V68, P1505, DOI 10.1136/ard.2008.097626
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   CDC, 2016, REV DIAGN TEST ZIK C
   Centers for Disease Control and Protection, DENG VIR INF 2015 CA
   Centers for Disease Control and Protection, DENG CAS MAN
   Centers for Disease Control and Protection, PREVENTION
   Centers for Disease Control and Protection, CLIN GUID DENG VIR
   Centers for Disease Control and Protection, DENG EP
   Centers for Disease Control and Protection, 2016, EST RANG AED AEG AED
   Centers for Disease Control and Protection, 2015, ZIK VIR DIS US
   Centers for Disease Control and Protection, CHIK INF HEALTHC PRO
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Garg M, 2014, ANN EMERG MED, V64, P552, DOI 10.1016/j.annemergmed.2014.08.002
   Gregory CJ, 2010, AM J TROP MED HYG, V82, P922, DOI 10.4269/ajtmh.2010.09-0552
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2010, VIRUSES-BASEL, V2, P2649, DOI 10.3390/v2122649
   Halsey ES, 2013, AM J TROP MED HYG, V89, P99, DOI 10.4269/ajtmh.13-0103
   Hills SL, 2016, MMWR MORB MORTAL WKL, V65
   Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676
   Itoda I, 2006, AM J TROP MED HYG, V75, P470, DOI 10.4269/ajtmh.2006.75.470
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kaur P, 2014, INT J APP BASIC MED, V4, P8, DOI DOI 10.4103/2229-516X.140708
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Kondekar S, 2006, J POSTGRAD MED, V52, P307
   Londono-Renteria B, 2015, AM J TROP MED HYG, V93, P869, DOI 10.4269/ajtmh.15-0130
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Oster AM, 2015, MMWR MORB MORTAL WKL, V65
   Pan American Health Organization, CHIK INT MAP
   Pan American Health Organization, 2015, REP CHIK VIR TRANSM
   Panpanich R, 2007, EVID BASED CHILD HLT, V2, P1064
   Petersen EE, 2016, MMWR MORB MORTAL WKL, V65
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rasmussen S, N ENGL J MED
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   U. S. Centers for Disease Control and Prevention, ZIK VIR HLTH CAR PRO
   U. S. Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   U. S. Centers for Disease Control and Prevention, 1 FEM TO MAL SEX TRA
   U. S. Centers for Disease Control and Prevention, ZIK AND PREGN
   U. S. Centers for Disease Control and Protection, CHIK GEOGR DISTR
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   World Health Organization, GUID CLIN MAN CHIK F
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization (WHO), ZIK SIT REP
NR 61
TC 93
Z9 97
U1 0
U2 7
PU WESTJEM
PI ORANGE
PA C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01,
   ORANGE, CA 92868 USA
SN 1936-900X
EI 1936-9018
J9 WEST J EMERG MED
JI West. J. Emerg. Med.
PD NOV
PY 2016
VL 17
IS 6
BP 671
EP 679
DI 10.5811/westjem.2016.9.30904
PG 9
WC Emergency Medicine
SC Emergency Medicine
GA EL1ER
UT WOS:000394363800001
PM 27833670
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hermann, T
AF Hermann, Thomas
TI Small molecules targeting viral RNA
SO WILEY INTERDISCIPLINARY REVIEWS-RNA
LA English
DT Article
ID HEPATITIS-C VIRUS; RIBOSOME-ENTRY SITE; BINDING SMALL MOLECULES; TAR
   RNA; AMINOGLYCOSIDE ANTIBIOTICS; CONFORMATIONAL PLASTICITY; HERPESVIRUS
   VFLIP; SARS-CORONAVIRUS; LIGAND-BINDING; NONCODING RNAS
AB Highly conserved noncoding RNA (ncRNA) elements in viral genomes and transcripts offer new opportunities to expand the repertoire of drug targets for the development of antiinfective therapy. Ligands binding to ncRNA architectures are able to affect interactions, structural stability or conformational changes and thereby block processes essential for viral replication. Proof of concept for targeting functional RNA by small molecule inhibitors has been demonstrated for multiple viruses with RNA genomes. Strategies to identify antiviral compounds as inhibitors of ncRNA are increasingly emphasizing consideration of drug-like properties of candidate molecules emerging from screening and ligand design. Recent efforts of antiviral lead discovery for RNA targets have provided drug-like small molecules that inhibit viral replication and include inhibitors of human immunodeficiency virus (HIV), hepatitis C virus (HCV), severe respiratory syndrome coronavirus (SARS CoV), and influenza A virus. While target selectivity remains a challenge for the discovery of useful RNA-binding compounds, a better understanding is emerging of properties that define RNA targets amenable for inhibition by small molecule ligands. Insight from successful approaches of targeting viral ncRNA in HIV, HCV, SARS CoV, and influenza A will provide a basis for the future exploration of RNA targets for therapeutic intervention in other viral pathogens which create urgent, unmet medical needs. Viruses for which targeting ncRNA components in the genome or transcripts may be promising include insect-borne flaviviruses (Dengue, Zika, and West Nile) and filoviruses (Ebola and Marburg).
C1 [Hermann, Thomas] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.
   [Hermann, Thomas] Univ Calif San Diego, Ctr Drug Discovery Innovat, San Diego, CA 92103 USA.
RP Hermann, T (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Hermann, T (corresponding author), Univ Calif San Diego, Ctr Drug Discovery Innovat, San Diego, CA 92103 USA.
EM tch@ucsd.edu
RI Hermann, Thomas/L-4311-2019
OI Hermann, Thomas/0000-0002-9855-1593
CR Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798
   Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48
   Bieleski L, 2004, J GEN VIROL, V85, P615, DOI 10.1099/vir.0.19733-0
   Bieleski L, 2001, J VIROL, V75, P1864, DOI 10.1128/JVI.75.4.1864-1869.2001
   Blond A, 2014, CHEMMEDCHEM, V9, P1982, DOI 10.1002/cmdc.201402259
   Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268
   Boerneke MA, 2015, RNA BIOL, V12, P780, DOI 10.1080/15476286.2015.1054592
   Boerneke MA, 2014, P NATL ACAD SCI USA, V111, P15952, DOI 10.1073/pnas.1414678111
   Bottini A, 2015, CHEM BIOL DRUG DES, V86, P663, DOI 10.1111/cbdd.12534
   Bradford S, 2012, CHEM COMMUN, V48, P3118, DOI 10.1039/c2cc17377h
   Bradford SS, 2014, CHEMMEDCHEM, V9, P1275, DOI 10.1002/cmdc.201400070
   Brakier-Gingras L, 2012, EXPERT OPIN THER TAR, V16, P249, DOI 10.1517/14728222.2012.665879
   Branilovic MG, 2014, MOL BIOSYST, V10, P3272, DOI 10.1039/c4mb00469h
   Brauburger K, 2016, J VIROL, V90, P1898, DOI 10.1128/JVI.02341-15
   Cao F, 2014, J VIRAL HEPATITIS, V21, P882, DOI 10.1111/jvh.12225
   Carnevali M, 2010, CHEMBIOCHEM, V11, P1364, DOI 10.1002/cbic.201000177
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman RL, 2002, ANTIVIR RES, V54, P149, DOI 10.1016/S0166-3542(01)00222-4
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Conrad NK, 2016, VIRUS RES, V212, P53, DOI 10.1016/j.virusres.2015.06.012
   Crary SM, 2003, VIROLOGY, V306, P210, DOI 10.1016/S0042-6822(02)00014-4
   CUNDLIFFE E, 1987, BIOCHIMIE, V69, P863, DOI 10.1016/0300-9084(87)90213-6
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   Desiraju GR, 2005, CHEM COMMUN, P2995, DOI 10.1039/b504372g
   Dibrov SM, 2007, ANGEW CHEM INT EDIT, V46, P226, DOI 10.1002/anie.200603807
   Dibrov SM, 2014, J MED CHEM, V57, P1694, DOI 10.1021/jm401312n
   Dibrov SM, 2012, P NATL ACAD SCI USA, V109, P5223, DOI 10.1073/pnas.1118699109
   Ding K, 2014, BIOORG MED CHEM LETT, V24, P3113, DOI 10.1016/j.bmcl.2014.05.009
   Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126
   Disney MD, 2014, ORG BIOMOL CHEM, V12, P1029, DOI 10.1039/c3ob42023j
   Disney MD, 2004, CHEM-EUR J, V10, P3308, DOI 10.1002/chem.200306017
   Duca M, 2010, CHEM COMMUN, V46, P6162, DOI 10.1039/c0cc00645a
   Enterlein S, 2009, J VIROL, V83, P4508, DOI 10.1128/JVI.02429-08
   Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467
   Feng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072798
   Feng H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027862
   Flick R, 1996, RNA, V2, P1046
   FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994
   Gale EF, 1981, MOL BASIS ANTIBIOTIC
   Gallego J, 2002, BIOCHEM SOC T, V30, P140, DOI 10.1042/BST0300140
   Gallego J, 2001, ACCOUNTS CHEM RES, V34, P836, DOI 10.1021/ar000118k
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gilbert SD, 2009, STRUCTURE, V17, P857, DOI 10.1016/j.str.2009.04.009
   Guan LR, 2012, ACS CHEM BIOL, V7, P73, DOI 10.1021/cb200447r
   Guasparri I, 2004, J EXP MED, V199, P993, DOI 10.1084/jem.20031467
   Hashem Y, 2009, METHODS, V47, P187, DOI 10.1016/j.ymeth.2008.09.020
   Henriksen NM, 2014, J CHEM INF MODEL, V54, P1758, DOI 10.1021/ci500132c
   Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x
   Hermann T, 2005, CURR OPIN STRUC BIOL, V15, P355, DOI 10.1016/j.sbi.2005.05.001
   Hermann T, 1998, CURR OPIN BIOTECH, V9, P66, DOI 10.1016/S0958-1669(98)80086-4
   Hermann T, 2003, BIOPOLYMERS, V70, P4, DOI 10.1002/bip.10410
   Hermann T, 1998, J MOL BIOL, V276, P903, DOI 10.1006/jmbi.1997.1590
   Hermann T, 1998, STRUCTURE, V6, P1303, DOI 10.1016/S0969-2126(98)00130-0
   Hermann T, 2000, ANGEW CHEM INT EDIT, V39, P1891
   Horowitz S, 2012, J BIOL CHEM, V287, P41576, DOI 10.1074/jbc.R112.418574
   Howe JA, 2015, NATURE, V526, P672, DOI 10.1038/nature15542
   Inoue R, 2015, BIOORGAN MED CHEM, V23, P2139, DOI 10.1016/j.bmc.2015.03.001
   Jefferson EA, 2004, BIOORG MED CHEM LETT, V14, P5139, DOI 10.1016/j.bmcl.2004.07.066
   Joly JP, 2014, CHEM-EUR J, V20, P2071, DOI 10.1002/chem.201303664
   Jones SA, 2012, J VIROL, V86, P5134, DOI 10.1128/JVI.07137-11
   Jubin R, 2001, CURR OPIN MOL THER, V3, P278
   Jubin Ronald, 2003, Curr Opin Investig Drugs, V4, P162
   Kim H, 2012, MOL BIOSYST, V8, P2857, DOI 10.1039/c2mb25333j
   Kramvis A, 1998, J VIRAL HEPATITIS, V5, P357, DOI 10.1046/j.1365-2893.1998.00124.x
   Kumar S, 2016, ORG BIOMOL CHEM, V14, P2052, DOI 10.1039/c5ob02016f
   Le Grice SFJ, 2015, CURR TOP MICROBIOL, V389, P147, DOI 10.1007/82_2015_434
   Lee MK, 2014, CHEM COMMUN, V50, P368, DOI 10.1039/c3cc46973e
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Low W, 2001, J VIROL, V75, P2938, DOI 10.1128/JVI.75.6.2938-2945.2001
   Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001
   Matzner D, 2015, J MED CHEM, V58, P3275, DOI 10.1021/jm500868e
   McCoy LS, 2011, WIRES RNA, V2, P209, DOI 10.1002/wrna.60
   Mei HY, 1997, BIOORGAN MED CHEM, V5, P1173, DOI 10.1016/S0968-0896(97)00064-3
   Mei HY, 1998, BIOCHEMISTRY-US, V37, P14204, DOI 10.1021/bi981308u
   MEI HY, 1995, BIOORG MED CHEM LETT, V5, P2755, DOI 10.1016/0960-894X(95)00467-8
   Mitton-Fry RM, 2010, SCIENCE, V330, P1244, DOI 10.1126/science.1195858
   Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722
   Mousseau G, 2015, CURR TOP MICROBIOL, V389, P121, DOI 10.1007/82_2015_435
   Muhlberger E, 2007, FUTURE VIROL, V2, P205, DOI 10.2217/17460794.2.2.205
   Neumann G, 2009, VIRUS RES, V144, P1, DOI 10.1016/j.virusres.2009.02.005
   Noble E, 2011, J BIOL CHEM, V286, P22965, DOI 10.1074/jbc.M111.239509
   Othman Z, 2014, RNA, V20, P1803, DOI 10.1261/rna.045328.114
   Park SJ, 2011, J AM CHEM SOC, V133, P10094, DOI 10.1021/ja1098325
   Park WKC, 1996, J AM CHEM SOC, V118, P10150, DOI 10.1021/ja9612817
   Parker MA, 2011, MOLECULES, V16, P281, DOI 10.3390/molecules16010281
   Parsons J, 2009, NAT CHEM BIOL, V5, P823, DOI 10.1038/nchembio.217
   Pearson ND, 1997, CHEM BIOL, V4, P409, DOI 10.1016/S1074-5521(97)90192-7
   Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008
   Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172
   Prado S, 2016, BIOCHEM PHARMACOL, V107, P14, DOI 10.1016/j.bcp.2016.02.007
   Ranjan N, 2013, BIOORG MED CHEM LETT, V23, P5689, DOI 10.1016/j.bmcl.2013.08.014
   Ratmeyer L, 1996, BIOCHEMISTRY-US, V35, P13689, DOI 10.1021/bi960954v
   Ritchie DB, 2014, J AM CHEM SOC, V136, P2196, DOI 10.1021/ja410344b
   Ritchie DB, 2012, P NATL ACAD SCI USA, V109, P16167, DOI 10.1073/pnas.1204114109
   Ross MJ, 2015, DALTON T, V44, P20972, DOI 10.1039/c5dt02837j
   Rynearson KD, 2014, BIOORG MED CHEM LETT, V24, P3521, DOI 10.1016/j.bmcl.2014.05.088
   Seth PP, 2005, J MED CHEM, V48, P7099, DOI 10.1021/jm050815o
   Shaw KJ, 2011, ANN NY ACAD SCI, V1241, P48, DOI 10.1111/j.1749-6632.2011.06330.x
   Shortridge MD, 2015, CURR OPIN STRUC BIOL, V30, P79, DOI 10.1016/j.sbi.2015.01.008
   Shuck-Lee D, 2008, ANTIMICROB AGENTS CH, V52, P3169, DOI 10.1128/AAC.00274-08
   Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044
   Su MC, 2005, NUCLEIC ACIDS RES, V33, P4265, DOI 10.1093/nar/gki731
   Sztuba-Solinska J, 2014, J AM CHEM SOC, V136, P8402, DOI 10.1021/ja502754f
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Tan SL, 2002, NAT REV DRUG DISCOV, V1, P867, DOI 10.1038/nrd937
   Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546
   Tor Y, 1998, CHEM BIOL, V5, pR277, DOI 10.1016/S1074-5521(98)90286-1
   Tycowski KT, 2012, CELL REP, V2, P26, DOI 10.1016/j.celrep.2012.05.020
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Wang SH, 1998, BIOCHEMISTRY-US, V37, P5549, DOI 10.1021/bi972808a
   Wang WY, 2000, BIOORG MED CHEM LETT, V10, P1151, DOI 10.1016/S0960-894X(00)00217-1
   Watanabe Kenatarou, 2007, Nucleic Acids Symp Ser (Oxf), P209
   Weik M, 2005, J VIROL, V79, P10660, DOI 10.1128/JVI.79.16.10660-10671.2005
   Weik M, 2002, J VIROL, V76, P8532, DOI 10.1128/JVI.76.17.8532-8539.2002
   Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080
   ZAPP ML, 1993, CELL, V74, P969, DOI 10.1016/0092-8674(93)90720-B
   Zeiger M, 2014, BIOORG MED CHEM LETT, V24, P5576, DOI 10.1016/j.bmcl.2014.11.004
   Zhou S, 2013, BIOORGAN MED CHEM, V21, P6139, DOI 10.1016/j.bmc.2013.03.054
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 119
TC 47
Z9 47
U1 7
U2 52
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7004
EI 1757-7012
J9 WIRES RNA
JI Wiley Interdiscip. Rev.-RNA
PD NOV-DEC
PY 2016
VL 7
IS 6
BP 726
EP 743
DI 10.1002/wrna.1373
PG 18
WC Cell Biology
SC Cell Biology
GA DZ4QH
UT WOS:000385843200001
PM 27307213
OA Green Published
DA 2020-07-08
ER

PT J
AU Govindarajan, M
   Benelli, G
AF Govindarajan, Marimuthu
   Benelli, Giovanni
TI Eco-friendly larvicides from Indian plants: Effectiveness of lavandulyl
   acetate and bicyclogermacrene on malaria, dengue and Japanese
   encephalitis mosquito vectors
SO ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
LA English
DT Article
DE Apiaceae; Heracleum sprengelianum; Mosquitoes; Biosafety; Non-target
   effects; Gambusia affair
ID ESSENTIAL OILS; CHEMICAL-COMPOSITION; ANTICONVULSANT ACTIVITY;
   VETERINARY IMPORTANCE; LABORATORY EVALUATION; AEDES-ALBOPICTUS; LARVAE
   DIPTERA; NANOPARTICLES; L.; REPELLENTS
AB Mosquitoes (Diptera: Culicidae) are a key threat for millions of people and animals worldwide, since they act as vectors for devastating pathogens and parasites, including malaria, dengue, Japanese encephalitis, filiariasis and Zika virus. Mosquito young instars are usually targeted using organophosphates, insect growth regulators and microbial agents. Indoor residual spraying and insecticide-treated bed nets are also employed. However, these chemicals have negative effects on human health and the environment and induce resistance in a number of vectors. In this scenario, newer and safer tools have been recently implemented to enhance mosquito control. The concrete potential of screening plant species as sources of metabolites for entomological and parasitological purposes is worthy of attention, as recently elucidated by the Y. Tu's example. Here we investigated the toxicity of Heracleum sprengelianum (Apiaceae) leaf essential oil and its major compounds toward third instar larvae of the malaria vector Anopheles subpictus, the arbovirus vector Aedes albopictus and the Japanese encephalitis vector Culex tritaeniorhynchus. GC-MS analysis showed that EO major components were lavandulyl acetate (17.8%) and bicyclogermacrene (12.9%). The EO was toxic to A. subpictus, A. albopictus, and C tritaeniorhynchus, with LC50 of 33.4, 375 and 40.9 mu g/ml, respectively. Lavandulyl acetate was more toxic to mosquito larvae if compared to bicyclogermacrene. Their LC50 were 4.17 and 10.3 mu g/ml for A. subpictus, 4.60 and 11.1 mu g/ml for A. albopictus, 5.11 and 12.5 mu g/ml for C tritaeniorhynchus. Notably, the EO and its major compounds were safer to three non-target mosquito predators, Anisops bouvieri, Diplonychus indicus and Gambusia affinis, with LC50 ranging from 206 to 4219 mu g/ml. Overall, this study highlights that H. sprengelianum EO is a promising source of eco-friendly larvicides against three important mosquito vectors with moderate toxicity against non-target aquatic organisms. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Insect Behav Grp, Via Borghetto 80, I-56124 Pisa, Italy.
EM drgovind1979@ginail.com; benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013; Donders, A.R.T./L-4277-2015; Tack, Cees
   J/A-2368-2014
OI Benelli, Giovanni/0000-0001-8971-6010; Donders,
   A.R.T./0000-0002-0484-1419; Govindarajan, Marimuthu/0000-0002-4662-8931
FU PROAPI (PRAF); University of Pisa, Department of Agriculture, Food and
   Environment [COFIN2015_22]
FX Prof. K. Kannan and two anonymous reviewers improved an earlier version
   of our manuscript. The authors would like to thank Professor and Head,
   Department of Zoology, Annamalai University for the laboratory
   facilities provided. We also acknowledge the cooperation of staff
   members of the VCRC (ICMR), Pondicherry. G. Benelli is supported by
   PROAPI (PRAF 2015) and University of Pisa, Department of Agriculture,
   Food and Environment (Grant ID: COFIN2015_22). Funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ali A, 2015, J MED ENTOMOL, V52, P93, DOI 10.1093/jme/tju014
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   DEO P G, 1988, International Pest Control, V30, P118
   Doi M, 2004, ACTA CRYSTALLOGR C, V60, pO833, DOI 10.1107/S0108270104024291
   Ebadollahi A., 2011, International Journal of Biological Chemistry, V5, P266, DOI 10.3923/ijbc.2011.266.290
   Evergetis E, 2009, PARASITOL RES, V105, P117, DOI 10.1007/s00436-009-1370-8
   Evergetis E, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P613
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   George V, 2001, J ESSENT OIL RES, V13, P80, DOI 10.1080/10412905.2001.9699618
   Govindarajan M, 2013, EXP PARASITOL, V134, P7, DOI 10.1016/j.exppara.2013.01.018
   Govindarajan M, 2012, PARASITOL RES, V110, P2023, DOI 10.1007/s00436-011-2731-7
   Govindarajan M., 2016, J CLUST SCI
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2015, PARASITOL RES, V114, P601, DOI 10.1007/s00436-014-4222-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Heywood V.H., 1971, BOT J LINN SOC, V64, P438
   Iscan G, 2003, Z NATURFORSCH C, V58, P195
   John AJ, 2007, J ESSENT OIL RES, V19, P358, DOI 10.1080/10412905.2007.9699304
   Karuppusamy S, 2011, IRAN J PHARM RES, V10, P769
   Koodalingam A, 2011, ACTA TROP, V118, P27, DOI 10.1016/j.actatropica.2011.01.003
   Kreutzweiser DP, 1997, ECOTOX ENVIRON SAFE, V36, P109, DOI 10.1006/eesa.1996.1485
   Kumar S, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00147
   Lee S, 2003, J STORED PROD RES, V39, P77, DOI 10.1016/S0022-474X(02)00020-6
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Mills C, 2004, J PHARM PHARMACOL, V56, P375, DOI 10.1211/0022357022773
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nayar M.P., 1996, BIODIVERSITY HOT SPO
   Niu XM, 2004, PLANTA MED, V70, P578, DOI 10.1055/s-2004-827164
   PAPAGEORGIOU VP, 1985, J NAT PROD, V48, P851, DOI 10.1021/np50041a034
   Pavela R, 2005, FITOTERAPIA, V76, P691, DOI 10.1016/j.fitote.2005.06.001
   Pavela R., 2016, J PEST SCI
   Pavela R, 2008, PARASITOL RES, V102, P555, DOI 10.1007/s00436-007-0821-3
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2016, EXP PARASITOL, V165, P51, DOI 10.1016/j.exppara.2016.03.016
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pimenov MG, 2004, TURK J BOT, V28, P139
   Pushpanathan T, 2006, TROP BIOMED, V23, P208
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Sayyah M, 2005, J ETHNOPHARMACOL, V98, P209, DOI 10.1016/j.jep.2004.12.026
   Sedaghat MM, 2011, IRAN J ARTHROPOD-BOR, V5, P51
   Sefidkon F, 2004, J ESSENT OIL RES, V16, P296, DOI 10.1080/10412905.2004.9698725
   Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586
   SILVA L.L., 2015, Rev. bras. plantas med., V17, P215, DOI 10.1590/1983-084X/13_034
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Tabanca N, 2016, REC NAT PROD, V10, P311
   Taniguchi M, 2005, CHEM PHARM BULL, V53, P701, DOI 10.1248/cpb.53.701
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Tosun F, 2008, FOOD CHEM, V107, P990, DOI 10.1016/j.foodchem.2007.08.085
   WHO, 2012, GLOB PLAN INS RES MA
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Zoubiri S, 2014, J SAUDI CHEM SOC, V18, P925, DOI 10.1016/j.jscs.2011.11.015
   Zoubiri S, 2011, FOOD CHEM, V129, P179, DOI 10.1016/j.foodchem.2011.04.033
NR 59
TC 34
Z9 34
U1 2
U2 59
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-6513
EI 1090-2414
J9 ECOTOX ENVIRON SAFE
JI Ecotox. Environ. Safe.
PD NOV
PY 2016
VL 133
BP 395
EP 402
DI 10.1016/j.ecoenv.2016.07.035
PG 8
WC Environmental Sciences; Toxicology
SC Environmental Sciences & Ecology; Toxicology
GA DX5DA
UT WOS:000384398800046
PM 27504617
DA 2020-07-08
ER

PT J
AU Alderdice, F
   de Souza, MD
AF Alderdice, Fiona
   de Souza, Maria de Lourdes
TI Integrated reproductive health: the Zika virus
SO JOURNAL OF REPRODUCTIVE AND INFANT PSYCHOLOGY
LA English
DT Editorial Material
C1 [Alderdice, Fiona] Queens Univ Belfast, Sch Nursing & Midwifery, Perinatal Hlth & Well Being, Belfast BT7 1NN, Antrim, North Ireland.
   [de Souza, Maria de Lourdes] Univ Fed Santa Catarina, Woman Hlth & Publ Hlth, BR-88040900 Florianopolis, SC, Brazil.
   [de Souza, Maria de Lourdes] Univ Fed Santa Catarina, Repensul Inst, BR-88040900 Florianopolis, SC, Brazil.
RP Alderdice, F (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Perinatal Hlth & Well Being, Belfast BT7 1NN, Antrim, North Ireland.
EM f.a.alderdice@qub.ac.uk; lourdesr@repensul.ufsc.br
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P., 2016, NEW ENGLAND J MED
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharpe M, 2014, LANCET, V384, P1099, DOI 10.1016/S0140-6736(14)61231-9
   WHO World Health Organization, 2016, MICR
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
NR 6
TC 0
Z9 0
U1 0
U2 43
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0264-6838
EI 1469-672X
J9 J REPROD INFANT PSYC
JI J. Reprod. Infant Psychol.
PD NOV
PY 2016
VL 34
IS 5
BP 429
EP 430
DI 10.1080/02646838.2016.1230369
PG 2
WC Psychology, Multidisciplinary
SC Psychology
GA DX8ZT
UT WOS:000384682600001
OA Bronze
DA 2020-07-08
ER

PT J
AU Calvo, EP
   Sanchez-Quete, F
   Duran, S
   Sandoval, I
   Castellanos, JE
AF Calvo, Eliana P.
   Sanchez-Quete, Fernando
   Duran, Sandra
   Sandoval, Isabel
   Castellanos, Jaime E.
TI Easy and inexpensive molecular detection of dengue, chikungunya and zika
   viruses in febrile patients
SO ACTA TROPICA
LA English
DT Article
DE Arbovirus; Chikungunya; Dengue; Zika; Detection; Nested PCR
ID POLYMERASE CHAIN-REACTION; RT-PCR ASSAY; CLINICAL-SAMPLES; RAPID
   DETECTION; REUNION ISLAND; INFECTION; AMERICA; STEP; QUANTIFICATION;
   PERFORMANCE
AB Dengue (DENV), chikungunya (CHIKV) and zika (ZIKV) are arthropod-borne viruses (arboviruses) sharing a common vector, the mosquito Aedes aegypti. At initial stages, patients infected with these viruses have similar clinical manifestations, however, the outcomes and clinical management of these diseases are different, for this reason early and accurate identification of the causative virus is necessary. This paper reports the development of a rapid and specific nested-PCR for detection of DENV, CHIKV and ZIKV infection in the same sample. A set of six outer primers targeting the C-preM, E1, and E gene respectively was used in a multiplex one-step RT-PCR assay, followed by the second round of amplification with specific inner primers for each virus. The specificity of the present assay was validated with positive and negative serum samples for viruses and supernatants of infected cells. The assay was tested using clinical samples from febrile patients. In these samples, we detected mono and dual infections and a case of triple co-infection DENV-CHIKV-ZIKV. This assay might be a useful and an inexpensive tool for detection of these infections in regions where these arboviruses co-circulate. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Calvo, Eliana P.; Sanchez-Quete, Fernando; Duran, Sandra; Sandoval, Isabel; Castellanos, Jaime E.] Univ El Bosque, Lab Virol, Ave Cra 9 131 A-02,Edificio D, Bogota, DC, Colombia.
   [Sanchez-Quete, Fernando; Castellanos, Jaime E.] Univ Nacl Colombia, Grp Patogenesis Infecciosa, Bogota, Colombia.
RP Calvo, EP (corresponding author), Univ El Bosque, Lab Virol, Ave Cra 9 131 A-02,Edificio D, Bogota, DC, Colombia.
EM calvoeliana@unbosque.edu.co
RI Castellanos, Jaime/W-2635-2019; Sandoval, Isabel-Sofia/V-2680-2018
OI Castellanos, Jaime/0000-0003-1596-8383; Duran Cristiano, Sandra
   Carolina/0000-0002-5366-8552; Calvo, Eliana/0000-0002-9135-0748
FU Vicerrectoria de investigaciones, Universidad El Bosque;
   ColcienciasDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [360-2011]; Programa Red de Investigacion
   Multidisciplinaria para la prevencion y control de Enfermedades
   Transmitidas por Vectores
FX Vicerrectoria de investigaciones, Universidad El Bosque. Colciencias
   360-2011. Programa Red de Investigacion Multidisciplinaria para la
   prevencion y control de Enfermedades Transmitidas por Vectores.
CR Ali UH, 2010, TROP BIOMED, V27, P611
   [Anonymous], 2016, SEMANA EPIDEMIOLOGIC
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvo E. P., 2016, BIOMEDICA S1, V36
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Castellanos J. E., 2014, REV FAC MED UNAL, V62, P455, DOI DOI 10.15446/REVFACMED.V62N4.45593
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Dash PK, 2008, DIAGN MICR INFEC DIS, V62, P52, DOI 10.1016/j.diagmicrobio.2008.05.002
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ho PS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-13
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Magalhaes BML, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003239
   Mishra B, 2011, DIAGN MICR INFEC DIS, V71, P118, DOI 10.1016/j.diagmicrobio.2011.06.020
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   PAHO, 2014, SEMANA EPIDEMIOLOGIC
   PAHO, 2016, EPIDEMIOLOGICAL WEEK
   PAHO, 2016, SEMANA EPIDEMIOLOGIC
   PAHO/WHO, 2015, EP AL NEUR SYNDR CON
   Panning M, 2009, J CLIN MICROBIOL, V47, P3014, DOI 10.1128/JCM.01024-09
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Prat CM, 2014, EMERG INFECT DIS, V20, P2129, DOI 10.3201/eid2012.141269
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ridde V, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0120-2
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yap G, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000753
NR 49
TC 20
Z9 22
U1 2
U2 157
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD NOV
PY 2016
VL 163
BP 32
EP 37
DI 10.1016/j.actatropica.2016.07.021
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DW3FO
UT WOS:000383527700007
PM 27477452
DA 2020-07-08
ER

PT J
AU Mccoy, M
AF Mccoy, Michael
TI Heat Biologics eyes Zika vaccine
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD OCT 31
PY 2016
VL 94
IS 43
BP 13
EP 13
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA EA3YO
UT WOS:000386545400033
DA 2020-07-08
ER

PT J
AU Madad, SS
   Masci, J
   Cagliuso, NV
   Allen, M
AF Madad, Syra S.
   Masci, Joseph
   Cagliuso, Nicholas V., Sr.
   Allen, Machelle
TI Preparedness for Zika Virus Disease - New York City, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; UNITED-STATES
C1 [Madad, Syra S.; Cagliuso, Nicholas V., Sr.] New York City Hlth Hosp, Emergency Management, New York, NY 10013 USA.
   [Masci, Joseph] New York City Hlth Hosp Elmhurst, Elmhurst, NY USA.
   [Allen, Machelle] New York City Hlth Hosp, Cent Off, New York, NY USA.
RP Madad, SS (corresponding author), New York City Hlth Hosp, Emergency Management, New York, NY 10013 USA.
EM syra.madad@nychhc.org
CR CDC, 2016, GUID US LAB TEST ZIK
   CDC, 2016, ZIK VIR CAS COUNTS U
   Centers for Disease Control, 2016, ZIK VIR DIS ZIK VIR
   New York City Department of Health and Mental Hygiene, 2016, ZIK VIR INF PROV
   New York City Department of Health and Mental Hygiene, 2016, 2016 HLTH AL
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
NR 7
TC 12
Z9 12
U1 0
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD OCT 28
PY 2016
VL 65
IS 42
BP 1161
EP 1165
DI 10.15585/mmwr.mm6542a2
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EA5EZ
UT WOS:000386643500002
PM 27787490
OA Bronze
DA 2020-07-08
ER

PT J
AU Liu, H
   Shen, L
   Zhang, XL
   Li, XL
   Liang, GD
   Ji, HF
AF Liu, Hong
   Shen, Liang
   Zhang, Xiao-Lin
   Li, Xiao-Long
   Liang, Guo-Dong
   Ji, Hong-Fang
TI From discovery to outbreak: the genetic evolution of the emerging Zika
   virus
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID EMERGENCE
C1 [Liu, Hong; Shen, Liang; Zhang, Xiao-Lin; Ji, Hong-Fang] Shandong Univ Technol, Sch Life Sci, Shandong Prov Res Ctr Bioinformat Engn & Tech, Zibo 255049, Shandong, Peoples R China.
   [Li, Xiao-Long; Liang, Guo-Dong] Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.
   [Li, Xiao-Long; Liang, Guo-Dong] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.
RP Ji, HF (corresponding author), Shandong Univ Technol, Sch Life Sci, Shandong Prov Res Ctr Bioinformat Engn & Tech, Zibo 255049, Shandong, Peoples R China.; Liang, GD (corresponding author), Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.; Liang, GD (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.
EM gdliang@hotmail.com; jhf@sdut.edu.cn
CR Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   [Anonymous], 2016, ZIK VIR POT COMPL
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684
   Pan XL, 2011, J VIROL, V85, P9847, DOI 10.1128/JVI.00825-11
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 14
TC 7
Z9 8
U1 0
U2 43
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD OCT 26
PY 2016
VL 5
AR e111
DI 10.1038/emi.2016.109
PG 3
WC Immunology; Microbiology
SC Immunology; Microbiology
GA EA7ZY
UT WOS:000386853500001
PM 27780969
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abbasi, J
AF Abbasi, Jennifer
TI Repurposing Drugs to Treat Zika
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD OCT 25
PY 2016
VL 316
IS 16
BP 1636
EP 1636
DI 10.1001/jama.2016.14757
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ8GB
UT WOS:000386107800004
PM 27784079
DA 2020-07-08
ER

PT J
AU Tang, B
   Xiao, YN
   Wu, JH
AF Tang, Biao
   Xiao, Yanni
   Wu, Jianhong
TI Implication of vaccination against dengue for Zika outbreak
SO SCIENTIFIC REPORTS
LA English
DT Article
ID VIRUS-INFECTION; TRANSMISSION DYNAMICS; MATHEMATICAL-ANALYSIS;
   REPRODUCTION NUMBER; COINFECTION MODEL; DISEASE-MODELS; EPIDEMIC; FEVER;
   AGE; DETERMINANTS
AB Zika virus co-circulates with dengue in tropical and sub-tropical regions. Cases of co-infection by dengue and Zika have been reported, the implication of this co-infection for an integrated intervention program for controlling both dengue and Zika must be addressed urgently. Here, we formulate a mathematical model to describe the transmission dynamics of co-infection of dengue and Zika with particular focus on the effects of Zika outbreak by vaccination against dengue among human hosts. Our analysis determines specific conditions under which vaccination against dengue can significantly increase the Zika outbreak peak, and speed up the Zika outbreak peak timing. Our results call for further study about the co-infection to direct an integrated control to balance the benefits for dengue control and the damages of Zika outbreak.
C1 [Tang, Biao; Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Peoples R China.
   [Tang, Biao; Wu, Jianhong] York Univ, York Inst Hlth Res, Ctr Dis Modelling, Toronto, ON M3J 1P3, Canada.
RP Xiao, YN (corresponding author), Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Peoples R China.
EM yxiao@mail.xjtu.edu.cn
RI Tang, Biao/N-4129-2019
OI Tang, Biao/0000-0002-0418-5773
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [11571273, 11631012]; Fundamental Research
   Funds for the Central UniversitiesFundamental Research Funds for the
   Central Universities [08143042]; Canada Research Chair ProgramCanada
   Research Chairs; Natural Sciences and Engineering Research Council of
   CanadaNatural Sciences and Engineering Research Council of Canada;
   International Development Research Center (Ottawa, Canada) [104519-010]
FX This project was supported by the National Natural Science Foundation of
   China (NSFC, 11571273, 11631012(YX)), by the Fundamental Research Funds
   for the Central Universities (08143042 (YX)), by the Canada Research
   Chair Program, the Natural Sciences and Engineering Research Council of
   Canada (JW), and the International Development Research Center (Ottawa,
   Canada, 104519-010).
CR Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Bhunu CP, 2009, ACTA BIOTHEOR, V57, P361, DOI 10.1007/s10441-009-9080-2
   Bianco S, 2011, B MATH BIOL, V73, P248, DOI 10.1007/s11538-010-9541-4
   Bianco S, 2009, CHAOS, V19, DOI 10.1063/1.3270261
   Billings L, 2008, MATH BIOSCI, V211, P265, DOI 10.1016/j.mbs.2007.08.004
   Billings L, 2007, J THEOR BIOL, V246, P18, DOI 10.1016/j.jtbi.2006.12.023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carvalho ARM, 2014, BIOSYSTEMS, V124, P46, DOI 10.1016/j.biosystems.2014.08.004
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Derouich M, 2006, APPL MATH COMPUT, V177, P528, DOI 10.1016/j.amc.2005.11.031
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diekmann O., 2000, MATH EPIDEMIOLOGY IN
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Esteva L, 2003, J MATH BIOL, V46, P31, DOI 10.1007/s00285-002-0168-4
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   Feng ZL, 1997, J MATH BIOL, V35, P523, DOI 10.1007/s002850050064
   Funk S., 2016, BIORXIV
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gao DZ, 2016, J MATH ANAL APPL, V442, P171, DOI 10.1016/j.jmaa.2016.04.039
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2016, TRAVEL MED INFECT DI, V14, P378, DOI 10.1016/j.tmaid.2016.06.005
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hu K, 2013, J THEOR BIOL, V319, P62, DOI 10.1016/j.jtbi.2012.11.021
   Kapitanov G, 2015, MATH BIOSCI ENG, V12, P23, DOI 10.3934/mbe.2015.12.23
   Kautner I, 1997, J PEDIATR-US, V131, P516, DOI 10.1016/S0022-3476(97)70054-4
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Knerer G, 2015, HEALTH CARE MANAG SC, V18, P205, DOI 10.1007/s10729-013-9263-x
   Kouri G, 1998, EMERG INFECT DIS, V4, P89
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lourenco J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000894
   Martcheva M, 2006, SIAM J APPL MATH, V66, P843, DOI 10.1137/040619272
   Martcheva M, 2007, MATH BIOSCI, V207, P58, DOI 10.1016/j.mbs.2006.09.010
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/s0034-89102003000400013
   Merler S, 2008, J THEOR BIOL, V254, P499, DOI 10.1016/j.jtbi.2008.06.004
   Moreno V., 2016, ARXIV160300442V3
   Moualeu DP, 2011, J BIOL SYST, V19, P683, DOI 10.1142/S0218339011004159
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   Nuraini N, 2007, B MALAYS MATH SCI SO, V30, P143
   Osorio JE, 2016, EXPERT REV VACCINES, V15, P497, DOI 10.1586/14760584.2016.1128328
   Packer A, 2014, MATH BIOSCI, V247, P38, DOI 10.1016/j.mbs.2013.10.004
   Paul L., 2016, BIORXIV
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pinto CMA, 2014, APPL MATH COMPUT, V242, P36, DOI 10.1016/j.amc.2014.05.061
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Prosper O, 2011, MATH BIOSCI ENG, V8, P141, DOI 10.3934/mbe.2011.8.141
   Qesmi R, 2011, SIAM J APPL MATH, V71, P1509, DOI 10.1137/10079690X
   Rupnow MFT, 2000, EMERG INFECT DIS, V6, P228, DOI 10.3201/eid0603.000302
   Sharomi O, 2008, MATH BIOSCI ENG, V5, P145
   Sierra B, 2010, CELL IMMUNOL, V262, P134, DOI 10.1016/j.cellimm.2010.02.005
   Silva CJ, 2015, DISCRETE CONT DYN-A, V35, P4639, DOI 10.3934/dcds.2015.35.4639
   Sriprom M, 2007, MATH COMPUT MODEL, V45, P1053, DOI 10.1016/j.mcm.2006.09.011
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Wichmann O, 2004, TROP MED INT HEALTH, V9, P1022, DOI 10.1111/j.1365-3156.2004.01295.x
   Wikramaratna PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012347
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 71
TC 16
Z9 16
U1 1
U2 76
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 24
PY 2016
VL 6
AR 35623
DI 10.1038/srep35623
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ5RK
UT WOS:000385919000001
PM 27774987
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shukla, S
   Hong, SY
   Chung, SH
   Kim, M
AF Shukla, Shruti
   Hong, Sung-Yong
   Chung, Soo Hyun
   Kim, Myunghee
TI Rapid Detection Strategies for the Global Threat of Zika Virus: Current
   State, New Hypotheses, and Limitations
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE detection; diagnosis; immunoassay; liposome; PCR; Zika; virus
ID YELLOW-FEVER-VIRUS; ENCAPSULATED MAGNETIC BEADS;
   LINKED-IMMUNOSORBENT-ASSAY; GAS PLASMA TECHNOLOGY; HEPATITIS-A-VIRUS;
   DENGUE VIRUS; ENTERIC VIRUSES; REAL-TIME; ENVELOPE GLYCOPROTEIN;
   ENVIRONMENTAL-SAMPLES
AB The current scenario regarding the widespread Zika virus (ZIKV) has resulted in numerous diagnostic studies, specifically in South America and in locations where there is frequent entry of travelers returning from ZIKV-affected areas, including pregnant women with or without clinical symptoms of ZIKV infection. The World Health Organization, WHO, announced that millions of cases of ZIKV are likely to occur in the USA in the near future. This situation has created an alarming public health emergency of international concern requiring the detection of this life-threatening viral candidate due to increased cases of newborn microcephaly associated with ZIKV infection. Hence, this review reports possible methods and strategies for the fast and reliable detection of ZIKV with particular emphasis on current updates, knowledge, and new hypotheses that might be helpful for medical professionals in poor and developing countries that urgently need to address this problem. In particular, we emphasize liposome-based biosensors. Although these biosensors are currently among the less popular tools for human disease detection, they have become useful tools for the screening and detection of pathogenic bacteria, fungi, and viruses because of their versatile advantageous features compared to other sensing devices. This review summarizes the currently available methods employed for the rapid detection of ZIKV and suggests an innovative approach involving the application of a liposome-based hypothesis for the development of new strategies for ZIKV detection and their use as effective biomedicinal tools.
C1 [Shukla, Shruti; Kim, Myunghee] Yeungnam Univ, Dept Food Sci & Technol, Gyongsan, South Korea.
   [Hong, Sung-Yong; Chung, Soo Hyun] Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Seoul, South Korea.
RP Kim, M (corresponding author), Yeungnam Univ, Dept Food Sci & Technol, Gyongsan, South Korea.
EM foodtech@ynu.ac.kr
RI amsalu, ribka/G-8780-2019; shukla, shruti/M-7538-2016; Kim,
   Myunghee/AAP-8425-2020
FU Basic Science Research Program through the National Research Foundation,
   Republic of Korea (NRF) - Ministry of Education [NRF-
   2014R1A2A1A11053211]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation, Republic of Korea (NRF),
   funded by the Ministry of Education (NRF- 2014R1A2A1A11053211).
CR Abd El Wahed A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129682
   Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001
   Adungo F, 2016, CLIN VACCINE IMMUNOL, V23, P689, DOI 10.1128/CVI.00209-16
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   [Anonymous], 2016, WHO SIT REP NEUR SYN
   Baeumner AJ, 2004, ANAL BIOANAL CHEM, V380, P15, DOI 10.1007/s00216-004-2726-7
   Baeumner AJ, 2002, ANAL CHEM, V74, P1442, DOI 10.1021/ac015675e
   Balamurugan S, 2008, ANAL CHEM, V80, P9630, DOI 10.1021/ac8009559
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Butot S, 2007, APPL ENVIRON MICROB, V73, P5104, DOI 10.1128/AEM.00450-07
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Chen ZongYuan, 2016, Journal of AIDS and Clinical Research, V7, P540
   Connelly JT, 2012, ANAL BIOANAL CHEM, V402, P315, DOI 10.1007/s00216-011-5381-9
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   DIGOUTTE JP, 1992, RES VIROLOGY, V143, P417, DOI 10.1016/S0923-2516(06)80135-4
   ECDC, 2016, EP UPD OUTBR ZIK VIR
   Edwards KA, 2010, ANAL BIOANAL CHEM, V398, P2645, DOI 10.1007/s00216-010-3920-4
   Erdogan S, 2008, J MAGN RESON IMAGING, V27, P574, DOI 10.1002/jmri.21202
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Esch MB, 2001, ANAL CHEM, V73, P3162, DOI 10.1021/ac010012i
   Euroimmun, 2016, SER DIAGN ZIK VIR IN
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Feng B, 2010, BIOMATERIALS, V31, P4139, DOI 10.1016/j.biomaterials.2010.01.086
   Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   Hamza IA, 2011, INT J HYG ENVIR HEAL, V214, P424, DOI 10.1016/j.ijheh.2011.07.014
   Hartley HA, 2003, ANAL BIOANAL CHEM, V376, P319, DOI 10.1007/s00216-003-1939-5
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoenen T, 2016, EMERG INFECT DIS, V22, P331, DOI 10.3201/eid2202.151796
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kallen B., 2014, EPIDEMIOLOGY HUMAN C, P27
   Kelser EA, 2016, MICROBES INFECT, V18, P163, DOI 10.1016/j.micinf.2015.12.003
   Kilianski A, 2016, EMERG INFECT DIS, V22, P1448, DOI 10.3201/eid2208.160270
   Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111
   Kow CY, 2001, J MED ENTOMOL, V38, P475, DOI 10.1603/0022-2585-38.4.475
   Kwallah AO, 2013, J VIROL METHODS, V193, P23, DOI 10.1016/j.jviromet.2013.05.004
   Lanciotti R. S., 2011, EMERG INFECT DIS, V17, P5, DOI [10.3201/eid1705.101939, DOI 10.3201/EID1705.101939]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lehtinen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041410
   Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   NOVOTNY J, 1992, ACTA VIROL, V36, P483
   Nunes MRT, 2011, J VIROL METHODS, V174, P29, DOI 10.1016/j.jviromet.2011.02.025
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0
   Pan American Health Organization [PAHO], 2016, COUNTR TERR ZIK AUT
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Poplawska M, 2014, CARBON, V74, P180, DOI 10.1016/j.carbon.2014.03.022
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Reynolds KA, 2001, CAN J MICROBIOL, V47, P153, DOI 10.1139/cjm-47-2-153
   Rodriguez RA, 2009, APPL ENVIRON MICROB, V75, P297, DOI 10.1128/AEM.01150-08
   Roth WK, 1999, LANCET, V353, P359, DOI 10.1016/S0140-6736(98)06318-1
   Rutjes SA, 2005, APPL ENVIRON MICROB, V71, P3734, DOI 10.1128/AEM.71.7.3734-3740.2005
   Safarikova M., 2001, MAGN ELECT SEP, V10, P223, DOI DOI 10.1155/2001/57434
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sajja Hari Krishna, 2009, Curr Drug Discov Technol, V6, P43
   Sakudo A, 2016, MOL MED REP, V14, P697, DOI 10.3892/mmr.2016.5330
   Sakudo A, 2015, BIOORG MED CHEM LETT, V25, P1012, DOI 10.1016/j.bmcl.2015.01.031
   Sanchez G, 2007, LETT APPL MICROBIOL, V45, P1, DOI 10.1111/j.1472-765X.2007.02140.x
   Saraswati TE, 2011, DIAM RELAT MATER, V20, P359, DOI 10.1016/j.diamond.2011.01.027
   Saraswati TE, 2012, CARBON, V50, P1253, DOI 10.1016/j.carbon.2011.10.044
   Seifi M., 2012, OVERVIEW REAL TIME P
   Shin J, 2008, J MICROBIOL BIOTECHN, V18, P1689
   Shukla S, 2016, BIOSENS BIOELECTRON, V77, P986, DOI 10.1016/j.bios.2015.10.077
   Shukla S, 2012, EUR FOOD RES TECHNOL, V234, P53, DOI 10.1007/s00217-011-1606-6
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sofou S, 2008, EXPERT OPIN DRUG DEL, V5, P189, DOI 10.1517/17425247.5.2.189
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Tombelli S, 2005, BIOSENS BIOELECTRON, V20, P2424, DOI 10.1016/j.bios.2004.11.006
   Torchilin Vladimir P., 2000, Current Pharmaceutical Biotechnology, V1, P183, DOI 10.2174/1389201003378960
   Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110
   Vazquez Y, 2009, MABS-AUSTIN, V1, P157, DOI 10.4161/mabs.1.2.7908
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00766
   Weng KC, 2008, NANO LETT, V8, P2851, DOI 10.1021/nl801488u
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zaytseva NV, 2004, ANAL BIOANAL CHEM, V380, P46, DOI 10.1007/s00216-004-2724-9
   Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149
NR 98
TC 18
Z9 18
U1 0
U2 26
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 24
PY 2016
VL 7
AR 1685
DI 10.3389/fmicb.2016.01685
PG 15
WC Microbiology
SC Microbiology
GA ED1VL
UT WOS:000388632900001
PM 27822207
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lindqvist, R
   Mundt, F
   Gilthorpe, JD
   Wolfel, S
   Gekara, NO
   Kroger, A
   Overby, AK
AF Lindqvist, Richard
   Mundt, Filip
   Gilthorpe, Jonathan D.
   Woelfel, Silke
   Gekara, Nelson O.
   Kroeger, Andrea
   Overby, Anna K.
TI Fast type I interferon response protects astrocytes from flavivirus
   infection and virus-induced cytopathic effects
SO JOURNAL OF NEUROINFLAMMATION
LA English
DT Article
DE Astrocytes; Interferon; TBEV; Flavivirus; Viperin
ID WEST-NILE-VIRUS; TICK-BORNE ENCEPHALITIS; IMMUNE-RESPONSE; JAPANESE
   ENCEPHALITIS; ANTIVIRAL RESPONSE; DIFFERENTIAL GENE; INNATE IMMUNITY;
   BETA INTERFERON; OLFACTORY-BULB; STRANDED-RNA
AB Background: Neurotropic flaviviruses such as tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV), West Nile virus (WNV), and Zika virus (ZIKV) are causative agents of severe brain-related diseases including meningitis, encephalitis, and microcephaly. We have previously shown that local type I interferon response within the central nervous system (CNS) is involved in the protection of mice against tick-borne flavivirus infection. However, the cells responsible for mounting this protective response are not defined.
   Methods: Primary astrocytes were isolated from wild-type (WT) and interferon alpha receptor knock out (IFNAR(-/-)) mice and infected with neurotropic flaviviruses. Viral replication and spread, IFN induction and response, and cellular viability were analyzed. Transcriptional levels in primary astrocytes treated with interferon or supernatant from virus-infected cells were analyzed by RNA sequencing and evaluated by different bioinformatics tools.
   Results: Here, we show that astrocytes control viral replication of different TBEV strains, JEV, WNV, and ZIKV. In contrast to fibroblast, astrocytes mount a rapid interferon response and restrict viral spread. Furthermore, basal expression levels of key interferon-stimulated genes are high in astrocytes compared to mouse embryonic fibroblasts. Bioinformatic analysis of RNA-sequencing data reveals that astrocytes have established a basal antiviral state which contributes to the rapid viral recognition and upregulation of interferons. The most highly upregulated pathways in neighboring cells were linked to type I interferon response and innate immunity. The restriction in viral growth was dependent on interferon signaling, since loss of the interferon receptor, or its blockade in wild-type cells, resulted in high viral replication and virus-induced cytopathic effects. Astrocyte supernatant from TBEV-infected cells can restrict TBEV growth in astrocytes already 6 h post infection, the effect on neurons is highly reinforced, and astrocyte supernatant from 3 h post infection is already protective.
   Conclusions: These findings suggest that the combination of an intrinsic constitutive antiviral response and the fast induction of type I IFN production by astrocytes play an important role in self-protection of astrocytes and suppression of flavivirus replication in the CNS.
C1 [Lindqvist, Richard; Overby, Anna K.] Umea Univ, Dept Clin Microbiol, Virol, S-90185 Umea, Sweden.
   [Lindqvist, Richard; Overby, Anna K.] Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.
   [Mundt, Filip] Broad Inst MIT & Harvard, Prote & Biomarkers, 415 Main St,5033-A, Cambridge, MA 02142 USA.
   [Gilthorpe, Jonathan D.] Umea Univ, Dept Pharmacol & Clin Neurosci, S-90187 Umea, Sweden.
   [Woelfel, Silke] Bundeswehr Inst Microbiol, Neuherbergstr 11, D-80937 Munich, Germany.
   [Gekara, Nelson O.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.
   [Kroeger, Andrea] Helmholtz Ctr Infect Res, Innate Immun & Infect, Inhoffen Str 7, D-38124 Braunschweig, Germany.
   [Kroeger, Andrea] Univ Magdeburg, Inst Med Microbiol, Leipziger Str 44, D-39120 Magdeburg, Germany.
RP Overby, AK (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, S-90185 Umea, Sweden.; Overby, AK (corresponding author), Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.
EM anna.overby@umu.se
RI Gekara, Nelson/AAG-7944-2020; Gekara, Nelson/P-9208-2019
OI Gekara, Nelson O./0000-0002-1269-8288; Gilthorpe,
   Jonathan/0000-0002-6884-4774
FU Kempe Foundations; Laboratory for Molecular Medicine Sweden (MIMS); Umea
   Center for Microbial Research (UCMR); Swedish Foundation for
   International Cooperation in Research and Higher Education (STINT),
   Swedish Research Council
FX This work was supported by the Kempe Foundations, the Laboratory for
   Molecular Medicine Sweden (MIMS), the Umea Center for Microbial Research
   (UCMR) and Linneus Support, and the Swedish Foundation for International
   Cooperation in Research and Higher Education (STINT), Swedish Research
   Council (AKO).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Aoki K, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-105
   Aschner M, 2000, NEUROTOXICOLOGY, V21, P1101
   BARRETT ADT, 1984, J VIROL METHODS, V8, P349, DOI 10.1016/0166-0934(84)90072-7
   Beasley DWC, 2011, IMMUNOTHERAPY-UK, V3, P269, DOI 10.2217/IMT.10.93
   Bossi Philippe, 2004, Euro Surveill, V9, pE21
   Butchi NB, 2010, GLIA, V58, P650, DOI 10.1002/glia.20952
   Cargnelutti JF, 2011, BRAZ J MICROBIOL, V42, P1160
   Chang CY, 2015, GLIA, V63, P1915, DOI 10.1002/glia.22857
   Cho H, 2013, J VIROL, V87, P8363, DOI 10.1128/JVI.01097-13
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13
   Crotta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003773
   Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468
   De Miranda J, 2009, FASEB J, V23, P1064, DOI 10.1096/fj.08-121434
   Detje CN, 2015, J VIROL, V89, P2731, DOI 10.1128/JVI.02044-14
   Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596
   Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006
   Diniz JAP, 2006, AM J TROP MED HYG, V75, P691, DOI 10.4269/ajtmh.2006.75.691
   Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010
   Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195
   Dunning CJ, 2016, ACS CHEM NEUROSCI, V7, P161, DOI 10.1021/acschemneuro.5b00262
   Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005
   Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506
   German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008
   Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133
   Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105
   Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harris MG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04422
   HORISBERGER MA, 1987, J GEN VIROL, V68, P945, DOI 10.1099/0022-1317-68-3-945
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200
   Kallfass C, 2012, J VIROL, V86, P11223, DOI 10.1128/JVI.01093-12
   KIMELBERG HK, 1979, BRAIN RES, V173, P111
   Kolokoltsova OA, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-126
   KORNYEY S, 1978, ACTA NEUROPATHOL, V43, P179
   Kurhade C, 2016, J NEUROINFLAMM, P13
   Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9
   Kuri T, 2009, J GEN VIROL, V90, P2686, DOI 10.1099/vir.0.013599-0
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2011, J VIROL, V85, P7186, DOI 10.1128/JVI.00396-11
   LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348
   Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277
   LOTHMAN EW, 1975, J PHYSIOL-LONDON, V252, P115, DOI 10.1113/jphysiol.1975.sp011137
   Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9
   Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0
   MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400
   Metz P, 2012, HEPATOLOGY, V56, P2082, DOI 10.1002/hep.25908
   MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221
   Nair S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003999
   NIEDRIG M, 1994, ACTA VIROL, V38, P141
   Overby AK, 2011, VIRULENCE, V2, P238, DOI 10.4161/viru.2.3.16162
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Perler L, 1999, J IMMUNOL METHODS, V222, P189, DOI 10.1016/S0022-1759(98)00198-7
   Pfefferkorn C, 2016, J VIROL, V90, P2031, DOI 10.1128/JVI.02979-15
   Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604
   Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219
   Pozner RG, 2008, NEUROSCI LETT, V445, P31, DOI 10.1016/j.neulet.2008.08.059
   Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893
   Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735
   Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462
   Schildge S, 2013, JOVE-J VIS EXP, Ve50079, P1
   Schoneboom BA, 1999, J NEUROVIROL, V5, P342, DOI 10.3109/13550289909029475
   Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3
   Seng LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109023
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007
   Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x
   Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080
   Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004
   Tiroumourougane SV, 2002, POSTGRAD MED J, V78, P205, DOI 10.1136/pmj.78.918.205
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241
   van Marle G, 2007, J VIROL, V81, P10933, DOI 10.1128/JVI.02422-06
   Weber E, 2014, J VIROL, V88, P12202, DOI 10.1128/JVI.01215-14
   Yousef H, 2015, ONCOTARGET, V6, P11959, DOI 10.18632/oncotarget.3851
NR 86
TC 48
Z9 51
U1 2
U2 20
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-2094
J9 J NEUROINFLAMM
JI J. Neuroinflamm.
PD OCT 24
PY 2016
VL 13
AR 277
DI 10.1186/s12974-016-0748-7
PG 15
WC Immunology; Neurosciences
SC Immunology; Neurosciences & Neurology
GA DZ6NQ
UT WOS:000385979600001
PM 27776548
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Healy, JM
   Burgess, MC
   Chen, TH
   Hancock, WT
   Toews, KAE
   Anesi, MS
   Tulafono, RT
   Mataia, MA
   Sili, B
   Solaita, J
   Whelen, AC
   Sciulli, R
   Gose, RB
   Uluiviti, V
   Hennessey, M
   Utu, F
   Nua, MT
   Fischer, M
AF Healy, Jessica M.
   Burgess, M. Catherine
   Chen, Tai-Ho
   Hancock, W. Thane
   Toews, Karrie-Ann E.
   Anesi, Magele Scott
   Tulafono, Ray T., Jr.
   Mataia, Mary Aseta
   Sili, Benjamin
   Solaita, Jacqueline
   Whelen, A. Christian
   Sciulli, Rebecca
   Gose, Remedios B.
   Uluiviti, Vasiti
   Hennessey, Morgan
   Utu, Fara
   Nua, Motusa Tuileama
   Fischer, Marc
TI Outbreak of Zika Virus Disease - American Samoa, 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Healy, Jessica M.; Hennessey, Morgan] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Healy, Jessica M.] Cty San Diego Hlth & Human Serv Agcy, Epidemiol & Immunizat Serv Branch, San Diego, CA USA.
   [Healy, Jessica M.; Chen, Tai-Ho] CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Burgess, M. Catherine; Hancock, W. Thane; Toews, Karrie-Ann E.] CDC, Div State & Local Readiness, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Anesi, Magele Scott; Mataia, Mary Aseta; Sili, Benjamin; Solaita, Jacqueline; Utu, Fara; Nua, Motusa Tuileama] Amer Samoa Govt, Dept Hlth, Utulei, AS USA.
   [Tulafono, Ray T., Jr.] Lyndon B Johnson Trop Med Ctr, Pago Pago, AS USA.
   [Whelen, A. Christian; Sciulli, Rebecca; Gose, Remedios B.] Hawaii Dept Hlth State Labs Div, Honolulu, HI USA.
   [Uluiviti, Vasiti] Pacific Isl Hlth Officers Assoc, Honolulu, HI USA.
   [Hennessey, Morgan; Fischer, Marc] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Healy, JM (corresponding author), CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.; Healy, JM (corresponding author), Cty San Diego Hlth & Human Serv Agcy, Epidemiol & Immunizat Serv Branch, San Diego, CA USA.; Healy, JM (corresponding author), CDC, Div Global Migrat & Quarantine, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM jhealy@cdc.gov
CR Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Centers for Disease Control, 2016, ZIK VIR DIS ZIK VIR
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 3
TC 7
Z9 7
U1 0
U2 3
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD OCT 21
PY 2016
VL 65
IS 41
BP 1146
EP 1147
DI 10.15585/mmwr.mm6541a4
PG 2
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EA5EX
UT WOS:000386643300005
PM 27764076
OA Bronze
DA 2020-07-08
ER

PT J
AU Frontera, JA
   da Silva, IRF
AF Frontera, Jennifer A.
   da Silva, Ivan R. F.
TI Zika Getting on Your Nerves? The Association with the Guillain-Barre
   Syndrome
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID GUIDELINES
C1 [Frontera, Jennifer A.] Cleveland Clin, Neurol Inst, Cerebrovasc Ctr, Cleveland, OH 44106 USA.
   [da Silva, Ivan R. F.] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [da Silva, Ivan R. F.] Amer Med City, Neurocrit Care Dept, Rio De Janeiro, Brazil.
RP Frontera, JA (corresponding author), Cleveland Clin, Neurol Inst, Cerebrovasc Ctr, Cleveland, OH 44106 USA.
CR [Anonymous], 2016, UPD INT ZIK VIR CLIN
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   da Silva IR, 2016, NEUROLOGY
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   World Health Organization, 2016, LAB TEST ZIK VIR INF
NR 11
TC 8
Z9 8
U1 0
U2 0
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD OCT 20
PY 2016
VL 375
IS 16
BP 1581
EP 1582
DI 10.1056/NEJMe1611840
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EJ3HF
UT WOS:000393102500012
PM 27705077
DA 2020-07-08
ER

PT J
AU Narasimhan, SD
AF Narasimhan, Sri Devi
TI Fighting Infection in a Globalized World
SO CELL
LA English
DT Editorial Material
ID ZIKA VIRUS; NONHUMAN-PRIMATES; STRUCTURAL BASIS; PROTECTION; DISEASE
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dowd K.A., 2016, SCIENCE
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Sullivan NJ, 2003, NATURE, V424, P681, DOI 10.1038/nature01876
   Wec AZ, 2016, SCIENCE
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 10
TC 1
Z9 1
U1 0
U2 46
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD OCT 20
PY 2016
VL 167
IS 3
BP 583
EP 585
DI 10.1016/j.cell.2016.10.012
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EA1HW
UT WOS:000386344100001
PM 27768877
OA Bronze
DA 2020-07-08
ER

PT J
AU Pierson, TC
   Graham, BS
AF Pierson, Theodore C.
   Graham, Barney S.
TI Zika Virus: Immunity and Vaccine Development
SO CELL
LA English
DT Review
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; ANTIBODY-DEPENDENT
   ENHANCEMENT; CD8(+) T-CELLS; DENGUE VIRUS; ENVELOPE PROTEIN; STRUCTURAL
   BASIS; NEUTRALIZING ANTIBODY; CROSS-REACTIVITY; SURFACE-PROTEINS
AB The emergence of Zika virus in the Americas and Caribbean created an urgent need for vaccines to reduce transmission and prevent disease, particularly the devastating neurodevelopmental defects that occur in utero. Rapid advances in Zika immunity and the development of vaccine candidates provide cautious optimism that preventive measures are possible.
C1 [Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Graham, Barney S.] NIAID, Viral Pathogenesis Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM piersontc@mail.nih.gov
RI Graham, Barney S./AAC-5898-2019
OI Graham, Barney S./0000-0001-8112-0853
FU intramural research program of the Division of Intramural Research,
   NIAID, NIH; intramural research program of the Vaccine Research Center,
   NIAID, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID)
FX This work was supported by the intramural research programs of the
   Division of Intramural Research and the Vaccine Research Center, NIAID,
   NIH. We thank Michael Diamond and Steve Whitehead for their comments on
   the manuscript. We apologize for the many instances in which the
   important work of others is not cited due to formatting constraints. Dr.
   Pierson and Dr. Graham are inventors on patents for ZIKV vaccine
   candidates.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beck AS, 2015, EXPERT REV VACCINES, V14, P1479, DOI 10.1586/14760584.2015.1083430
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   BUKOWSKI JF, 1989, J VIROL, V63, P5086, DOI 10.1128/JVI.63.12.5086-5091.1989
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Jampol LM, 2016, JAMA OPHTHALMOL
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2014, ANNU REV VIROL, V1, P375, DOI 10.1146/annurev-virology-031413-085453
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Quicke KM, 2013, VIRUSES-BASEL, V5, P2643, DOI 10.3390/v5112643
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang T, 2013, VIRUSES-BASEL, V5, P2298, DOI 10.3390/v5092298
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 83
TC 66
Z9 70
U1 0
U2 115
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD OCT 20
PY 2016
VL 167
IS 3
BP 625
EP 631
DI 10.1016/j.cell.2016.09.020
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EA1HW
UT WOS:000386344100011
PM 27693357
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Fajardo, A
   Cristina, J
   Moreno, P
AF Fajardo, Alvaro
   Cristina, Juan
   Moreno, Pilar
TI Emergence and Spreading Potential of Zika Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE ZIKV; emerging infectious diseases; genetic variability ZIKV; molecular
   evolution; spreading potential; ZIKV
ID MALE SEXUAL TRANSMISSION; WEST-NILE-VIRUS; DENGUE VIRUS; YELLOW-FEVER;
   BIOLOGICAL TRANSMISSION; INFECTION; OUTBREAK; VECTOR; SUSCEPTIBILITY;
   ARBOVIRUSES
AB Zika virus (ZIKV) is an arthropod-borne Flavivirus (family Flaviviridae) closely related to dengue, yellow fever and West Nile viruses. ZIKV remained neglected, confined to enzootic transmission cycles in Africa and Asia, until the first significant outbreak was reported in Micronesia in 2007. Subsequent epidemics of growing incidence occurred in French Polynesia and other South Pacific Islands, and recently, in the Americas. The latter and currently ongoing outbreak of unprecedented incidence revealed the association of ZIKV infection with the occurrence of severe congenital malformations and neurological diseases, leading to a widespread concern about its potential to pose a global public health threat. Serological and molecular data suggest that the genetic and geographic diversification of ZIKV may be greatly underestimated. Here we discuss several ecological and epidemiological aspects, together with the evolutionary processes that may have driven the emergence and abrupt spread of ZIKV in the Americas.
C1 [Fajardo, Alvaro; Cristina, Juan; Moreno, Pilar] Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Montevideo, Uruguay.
RP Moreno, P (corresponding author), Univ Republica, Fac Ciencias, Ctr Invest Nucl, Lab Virol Mol, Montevideo, Uruguay.
EM pmoreno@cin.edu.uy
OI Moreno, Pilar/0000-0001-6155-7206
FU Comision Sectorial de Investigacion Cientifica (CSIC), UdelaR,
   UruguayConsejo Superior de Investigaciones Cientificas (CSIC); Agencia
   Nacional de Investigacion e Innovacion (ANII); Programa de Desarrollo de
   las Ciencias Basicas (PEDECIBA)
FX This work was supported by: Comision Sectorial de Investigacion
   Cientifica (CSIC), UdelaR, Uruguay; Agencia Nacional de Investigacion e
   Innovacion (ANII); and Programa de Desarrollo de las Ciencias Basicas
   (PEDECIBA).
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bennett SN, 2010, MOL BIOL EVOL, V27, P811, DOI 10.1093/molbev/msp285
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EURO SURVEILL, V19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Cristina J, 2016, VIRUS RES, V223, P147, DOI 10.1016/j.virusres.2016.06.022
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fajardo A, 2016, J MED VIROL, V88, P1672, DOI 10.1002/jmv.24596
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hughes BW, 2016, EBIOMEDICINE, V10, P65, DOI 10.1016/j.ebiom.2016.06.026
   Kaddumukasa A. M., 2015, AFR J BIOTECHNOL, V14, P1418, DOI DOI 10.5897/AJB2015.14474
   Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1
   Korhonen E., 2016, EURO SURVEILL, V21
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lord JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004074
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nhan TX, 2015, VIROLOGIE, V19, P225, DOI 10.1684/vir.2015.0622
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO, 2016, ZIK ACT EP REG OPS A
   Paul L. M., 2016, COLD SPRING HARB LAB, DOI [10.1101/050112, DOI 10.1101/050112]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Russell PK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004589
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2013, EURO SURVEILL, V19
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
NR 109
TC 20
Z9 21
U1 2
U2 31
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD OCT 20
PY 2016
VL 7
AR 1667
DI 10.3389/fmicb.2015.01667
PG 8
WC Microbiology
SC Microbiology
GA ED0MM
UT WOS:000388536600001
PM 27812357
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Parra, B
   Lizarazo, J
   Jimenez-Arango, JA
   Zea-Vera, AF
   Gonzalez-Manrique, G
   Vargas, J
   Angarita, JA
   Zuniga, G
   Lopez-Gonzalez, R
   Beltran, CL
   Rizcala, KH
   Morales, MT
   Pacheco, O
   Ospina, ML
   Kumar, A
   Cornblath, DR
   Munoz, LS
   Osorio, L
   Barreras, P
   Pardo, CA
AF Parra, Beatriz
   Lizarazo, Jairo
   Jimenez-Arango, Jorge A.
   Zea-Vera, Andres F.
   Gonzalez-Manrique, Guillermo
   Vargas, Jose
   Angarita, Jorge A.
   Zuniga, Gonzalo
   Lopez-Gonzalez, Reydmar
   Beltran, Cindy L.
   Rizcala, Karen H.
   Morales, Maria T.
   Pacheco, Oscar
   Ospina, Martha L.
   Kumar, Anupama
   Cornblath, David R.
   Munoz, Laura S.
   Osorio, Lyda
   Barreras, Paula
   Pardo, Carlos A.
TI Guillain-Barre Syndrome Associated with Zika Virus Infection in Colombia
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
AB BACKGROUND
   Zika virus (ZIKV) infection has been linked to the Guillain-Barre syndrome. From November 2015 through March 2016, clusters of cases of the Guillain-Barre syndrome were observed during the outbreak of ZIKV infection in Colombia. We characterized the clinical features of cases of Guillain-Barre syndrome in the context of this ZIKV infection outbreak and investigated their relationship with ZIKV infection.
   METHODS
   A total of 68 patients with the Guillain-Barre syndrome at six Colombian hospitals were evaluated clinically, and virologic studies were completed for 42 of the patients. We performed reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assays for ZIKV in blood, cerebrospinal fluid, and urine, as well as antiflavivirus antibody assays.
   RESULTS
   A total of 66 patients (97%) had symptoms compatible with ZIKV infection before the onset of the Guillain-Barre syndrome. The median period between the onset of symptoms of ZIKV infection and symptoms of the Guillain-Barre syndrome was 7 days (inter-quartile range, 3 to 10). Among the 68 patients with the Guillain-Barre syndrome, 50% were found to have bilateral facial paralysis on examination. Among 46 patients in whom nerve-conduction studies and electromyography were performed, the results in 36 patients (78%) were consistent with the acute inflammatory demyelinating polyneuropathy subtype of the Guillain-Barre syndrome. Among the 42 patients who had samples tested for ZIKV by RT-PCR, the results were positive in 17 patients (40%). Most of the positive RT-PCR results were in urine samples (in 16 of the 17 patients with positive RT-PCR results), although 3 samples of cerebrospinal fluid were also positive. In 18 of 42 patients (43%) with the Guillain-Barre syndrome who underwent laboratory testing, the presence of ZIKV infection was supported by clinical and immunologic findings. In 20 of these 42 patients (48%), the Guillain-Barre syndrome had a parainfectious onset. All patients tested were negative for dengue virus infection as assessed by RT-PCR.
   CONCLUSIONS
   The evidence of ZIKV infection documented by RT-PCR among patients with the Guillain-Barre syndrome during the outbreak of ZIKV infection in Colombia lends support to the role of the infection in the development of the Guillain-Barre syndrome. (Funded by the Bart McLean Fund for Neuroimmunology Research and others.)
C1 [Parra, Beatriz; Zea-Vera, Andres F.] Univ Valle, Dept Microbiol, Cali, Colombia.
   [Zea-Vera, Andres F.; Zuniga, Gonzalo] Univ Valle, Dept Internal Med, Hosp Univ Valle, Cali, Colombia.
   [Osorio, Lyda] Univ Valle, Escuela Salud Publ, Cali, Colombia.
   [Lizarazo, Jairo] Univ Pamplona, Hosp Univ Erasmo Meoz, Cucuta, Colombia.
   [Jimenez-Arango, Jorge A.; Lopez-Gonzalez, Reydmar] Univ Antioquia, Clin Leon 13, Neuroclin, Medellin, Colombia.
   [Gonzalez-Manrique, Guillermo; Beltran, Cindy L.] Univ Surcolombiana, Hosp Univ Neiva, Neiva, Colombia.
   [Angarita, Jorge A.] Clin Medilaser, Neiva, Colombia.
   [Vargas, Jose; Rizcala, Karen H.; Morales, Maria T.] Clin La Misericordia Int, Barranquilla, Colombia.
   [Pacheco, Oscar; Ospina, Martha L.] Inst Nacl Salud, Bogota, Colombia.
   [Kumar, Anupama; Cornblath, David R.; Munoz, Laura S.; Barreras, Paula; Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Pardo, Carlos A.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
RP Pardo, CA (corresponding author), Johns Hopkins Univ, Sch Med, 600 N Wolfe St,627 Pathol Bldg, Baltimore, MD 21287 USA.
EM cpardov1@jhmi.edu
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335; Lizarazo,
   Jairo/0000-0003-4062-147X; Osorio, Lyda/0000-0002-5121-4741; Pacheco
   Garcia, Oscar Eduardo/0000-0001-5939-6407; Munoz Arcos, Laura
   Sofia/0000-0002-0229-9056; Zea-Vera, Andres Felipe/0000-0001-9127-3677
FU Bart McLean Fund for Neuroimmunology Research; Johns Hopkins Project
   Restore; VIREM, Virology Laboratory Fund, Department of Microbiology,
   Universidad del Valle
FX Supported by the Bart McLean Fund for Neuroimmunology Research; Johns
   Hopkins Project Restore; and VIREM, Virology Laboratory Fund, Department
   of Microbiology, Universidad del Valle.
CR [Anonymous], 2016, ZIK CAS DEF
   [Anonymous], 2016, SEM EP NUM 12 2016
   [Anonymous], 2015, MINS CONF PRIM NUEV
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gonzalez M Guillermo, 2015, Acta Neurol Colomb., V31, P54
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Hadden RDM, 2001, NEUROLOGY, V56, P758, DOI 10.1212/WNL.56.6.758
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976
   KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Suryapranata FST, 2016, AM J TROP MED HYG, V94, P1380, DOI 10.4269/ajtmh.15-0070
   Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 26
TC 237
Z9 251
U1 0
U2 29
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD OCT 20
PY 2016
VL 375
IS 16
BP 1513
EP 1523
DI 10.1056/NEJMoa1605564
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA EJ3HF
UT WOS:000393102500004
PM 27705091
OA Bronze
DA 2020-07-08
ER

PT J
AU dos Santos, T
   Rodriguez, A
   Almiron, M
   Sanhueza, A
   Ramon, P
   de Oliveira, WK
   Coelho, GE
   Badaro, R
   Cortez, J
   Ospina, M
   Pimentel, R
   Masis, R
   Hernandez, F
   Lara, B
   Montoya, R
   Jubithana, B
   Melchor, A
   Alvarez, A
   Aldighieri, S
   Dye, C
   Espinal, MA
AF dos Santos, Thais
   Rodriguez, Angel
   Almiron, Maria
   Sanhueza, Antonio
   Ramon, Pilar
   de Oliveira, Wanderson K.
   Coelho, Giovanini E.
   Badaro, Roberto
   Cortez, Juan
   Ospina, Martha
   Pimentel, Raquel
   Masis, Rolando
   Hernandez, Franklin
   Lara, Bredy
   Montoya, Romeo
   Jubithana, Beatrix
   Melchor, Angel
   Alvarez, Angel
   Aldighieri, Sylvain
   Dye, Christopher
   Espinal, Marcos A.
TI Zika Virus and the Guillain-Barre Syndrome - Case Series from Seven
   Countries
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
C1 [dos Santos, Thais; Rodriguez, Angel; Almiron, Maria; Sanhueza, Antonio; Ramon, Pilar; Cortez, Juan; Hernandez, Franklin; Montoya, Romeo; Alvarez, Angel; Aldighieri, Sylvain; Espinal, Marcos A.] Pan Amer Hlth Org, Washington, DC 20037 USA.
   [de Oliveira, Wanderson K.; Coelho, Giovanini E.] Minist Hlth, Brasilia, DF, Brazil.
   [Badaro, Roberto] Univ Fed Bahia, Salvador, BA, Brazil.
   [Ospina, Martha] Minist Hlth, Bogota, Colombia.
   [Pimentel, Raquel] Minist Hlth, Santo Domingo, Dominican Rep.
   [Masis, Rolando] Minist Hlth, San Salvador, El Salvador.
   [Lara, Bredy] Minist Hlth, Tegucigalpa, Honduras.
   [Jubithana, Beatrix] Minist Hlth, Paramaribo, Suriname.
   [Melchor, Angel] Minist Hlth, Caracas, Venezuela.
   [Dye, Christopher] WHO, Geneva, Switzerland.
RP Espinal, MA (corresponding author), Pan Amer Hlth Org, Washington, DC 20037 USA.
EM espinalm@paho.org
RI Oliveira, Wanderson/AAF-5182-2019
OI Oliveira, Wanderson/0000-0002-9662-1930; Dye,
   Christopher/0000-0002-2957-1793
FU World Health OrganizationWorld Health Organization [001]
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   RAVI V, 1994, ACTA NEUROL SCAND, V90, P67
   Sejvar JJ, 2005, EMERG INFECT DIS, V11, P1021, DOI 10.3201/eid1107.040991
NR 5
TC 160
Z9 163
U1 2
U2 12
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD OCT 20
PY 2016
VL 375
IS 16
BP 1598
EP 1601
DI 10.1056/NEJMc1609015
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA EJ3HF
UT WOS:000393102500029
PM 27579558
OA Bronze
DA 2020-07-08
ER

PT J
AU El Costa, H
   Gouilly, J
   Mansuy, JM
   Chen, Q
   Levy, C
   Cartron, G
   Veas, F
   Al-Daccak, R
   Izopet, J
   Jabrane-Ferrat, N
AF El Costa, Hicham
   Gouilly, Jordi
   Mansuy, Jean-Michel
   Chen, Qian
   Levy, Claude
   Cartron, Geraldine
   Veas, Francisco
   Al-Daccak, Reem
   Izopet, Jacques
   Jabrane-Ferrat, Nabila
TI ZIKA virus reveals broad tissue and cell tropism during the first
   trimester of pregnancy
SO SCIENTIFIC REPORTS
LA English
DT Article
ID INFECTION; PATHOGENESIS; REPLICATION; ROLES; BIRTH
AB The outbreak of the Zika Virus (ZIKV) and its association with fetal abnormalities have raised worldwide concern. However, the cellular tropism and the mechanisms of ZIKV transmission to the fetus during early pregnancy are still largely unknown. Therefore, we ex vivo modeled the ZIKV transmission at the maternal-fetal interface using organ culture from first trimester pregnancy samples. Here, we provide evidence that ZIKV strain circulating in Brazil infects and damages tissue architecture of the maternal decidua basalis, the fetal placenta and umbilical cord. We also show that ZIKV replicates differentially in a wide range of maternal and fetal cells, including decidual fibroblasts and macrophages, trophoblasts, Hofbauer cells as well as umbilical cord mesenchymal stem cells. The striking cellular tropism of ZIKV and its cytopathic-induced tissue injury during the first trimester of pregnancy could provide an explanation for the irreversible congenital damages.
C1 [El Costa, Hicham; Gouilly, Jordi; Chen, Qian; Izopet, Jacques; Jabrane-Ferrat, Nabila] Univ Toulouse 3, CNRS UMR5282, CPTP, INSERM U1043, F-31024 Toulouse, France.
   [El Costa, Hicham; Mansuy, Jean-Michel; Izopet, Jacques] CHU Toulouse, IFB, Virol Lab, F-31059 Toulouse, France.
   [Levy, Claude] Clin Sarrus Teinturiers, Serv Gynecol Obstet, F-31300 Toulouse, France.
   [Cartron, Geraldine] CHU Toulouse, Serv Gynecol Obstet, F-31059 Toulouse, France.
   [Veas, Francisco] Univ Montpellier, Fac Pharm, IRD, UMR Minist Def, F-34094 Montpellier, France.
   [Al-Daccak, Reem] Univ Paris Diderot, INSERM UMRS976, Hop St Louis, F-75010 Paris, France.
RP Jabrane-Ferrat, N (corresponding author), Univ Toulouse 3, CNRS UMR5282, CPTP, INSERM U1043, F-31024 Toulouse, France.
EM nabila.jabrane-ferrat@inserm.fr
RI Jabrane-Ferrat, Nabila/K-1224-2014; Al-Daccak, Reem/L-8804-2018
OI Jabrane-Ferrat, Nabila/0000-0003-4809-7836; IZOPET,
   JACQUES/0000-0002-8462-3234; CHEN, Qian/0000-0002-7771-2802; Al-Daccak,
   Reem/0000-0002-6146-2845; Gouilly, Jordi/0000-0001-8684-7429; EL COSTA,
   Hicham/0000-0001-8889-9759
FU INSERM and CNRS; Chinese Scholarship CouncilChina Scholarship Council;
   ANRSANRSFrench National Research Agency (ANR)
FX The authors thank E. Bahraoui, N. Espagnolle, J. Aziza and T. Al Saati
   for critical discussions. We also thank MDs from Paule de Viguier and
   Sarrus-Teinturiers hospitals for participating in the study, V. Calmes
   for ensuring the collection of clinical material. We are grateful for
   help from the CPTP (Cell Imaging and Flow Cytometry) and UMS-US006 (
   Histopathology) core facilities. English language proofreading was
   performed by D. McCarthy (English@Work). The work was supported by the
   INSERM and CNRS (N.J.-F., J.I.), ANRS (J.I., J.G.) and the "Chinese
   Scholarship Council" (Q.C.).
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Binder M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003561
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   El Costa H, 2016, MUCOSAL IMMUNOL, V9, P634, DOI 10.1038/mi.2015.87
   El Costa H, 2008, J IMMUNOL, V181, P3009, DOI 10.4049/jimmunol.181.5.3009
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jabrane-Ferrat N, 2014, IMMUNOLOGY, V141, P490, DOI 10.1111/imm.12218
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123
   Kwon A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23544
   Lash GE, 2016, J LEUKOCYTE BIOL, V100, P315, DOI 10.1189/jlb.1A0815-351R
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lunghi L, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-6
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marmotti A, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/326813
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038
   Schang Luis M, 2003, Prog Cell Cycle Res, V5, P103
   Siewiera J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003257
   Smith SK, 2000, HUM REPROD, V15, P59
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang ZH, 2011, ANN NY ACAD SCI, V1221, P103, DOI 10.1111/j.1749-6632.2010.05932.x
NR 31
TC 72
Z9 72
U1 2
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 19
PY 2016
VL 6
AR 35296
DI 10.1038/srep35296
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ8UI
UT WOS:000386146900001
PM 27759009
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Friedrich, MJ
AF Friedrich, M. J.
TI Congenital Brain Abnormalities From Zika Infection
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD OCT 18
PY 2016
VL 316
IS 15
BP 1537
EP 1537
DI 10.1001/jama.2016.14955
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ0KM
UT WOS:000385527600005
PM 27755638
DA 2020-07-08
ER

PT J
AU LaRocque, RL
   Ryan, ET
AF LaRocque, Regina L.
   Ryan, Edward T.
TI Personal Actions to Minimize Mosquito-Borne Illnesses, Including Zika
   Virus
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Editorial Material
C1 [LaRocque, Regina L.; Ryan, Edward T.] Massachusetts Gen Hosp, Div Infect Dis, Jackson 504,55 Fruit St, Boston, MA 02114 USA.
   Harvard Univ, Boston, MA 02115 USA.
RP Ryan, ET (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Jackson 504,55 Fruit St, Boston, MA 02114 USA.
EM etryan@mgh.harvard.edu
FU NCEZID CDC HHS [U01 CK000175, U01 CK000490]
CR Anderson KB, 2016, ANN INTERN MED, V165, P175, DOI 10.7326/M16-0617
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
NR 5
TC 6
Z9 6
U1 0
U2 1
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD OCT 18
PY 2016
VL 165
IS 8
BP 589
EP +
DI 10.7326/M16-1397
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ6BM
UT WOS:000385946600020
PM 27399646
DA 2020-07-08
ER

PT J
AU Ndeffo-Mbah, ML
   Parpia, AS
   Galvani, AP
AF Ndeffo-Mbah, Martial L.
   Parpia, Alyssa S.
   Galvani, Alison P.
TI Mitigating Prenatal Zika Virus Infection in the Americas
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Article
ID DENGUE HEMORRHAGIC-FEVER; AEDES-AEGYPTI DIPTERA; SEXUAL TRANSMISSION;
   RELEASE-RECAPTURE; CULICIDAE; AGE; POPULATION; STRATEGIES; MOSQUITOS;
   DYNAMICS
AB Background: Because of the risk for Zika virus infection in the Americas and the links between infection and microcephaly, other serious neurologic conditions, and fetal death, health ministries across the region have advised women to delay pregnancy. However, the effectiveness of this policy in reducing prenatal Zika virus infection has yet to be quantified.
   Objective: To evaluate the effectiveness of pregnancy-delay policies on the incidence and prevalence of prenatal Zika virus infection.
   Design: Vector-borne Zika virus transmission model fitted to epidemiologic data from 2015 to 2016 on Zika virus infection in Colombia.
   Setting: Colombia, August 2015 to July 2017.
   Patients: Population of Colombia, stratified by sex, age, and pregnancy status.
   Intervention: Recommendations to delay pregnancy by 3, 6, 9, 12, or 24 months, at different levels of adherence.
   Measurements: Weekly and cumulative incidence of prenatal infections and microcephaly cases.
   Results: With 50% adherence to recommendations to delay pregnancy by 9 to 24 months, the cumulative incidence of prenatal Zika virus infections is likely to decrease by 17% to 44%, whereas recommendations to delay pregnancy by 6 or fewer months are likely to increase prenatal infections by 2% to 7%. This paradoxical exacerbation of prenatal Zika virus exposure is due to an elevated risk for pregnancies to shift toward the peak of the outbreak.
   Limitation: Sexual transmission was not explicitly accounted for in the model because of limited data but was implicitly subsumed within the overall transmission rate, which was calibrated to observed incidence.
   Conclusion: Pregnancy delays can have a substantial effect on reducing cases of microcephaly but risks exacerbating the Zika virus outbreak if the duration is not sufficient. Duration of the delay, population adherence, and the timing of initiation of the intervention must be carefully considered.
C1 [Ndeffo-Mbah, Martial L.; Parpia, Alyssa S.; Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, 135 Coll St,Suite 200, New Haven, CT 06510 USA.
   Yale Univ, New Haven, CT USA.
RP Ndeffo-Mbah, ML (corresponding author), Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, 135 Coll St,Suite 200, New Haven, CT 06510 USA.
EM Martial.Ndeffo-Mbah@yale.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01 GM087719, U01
   GM105627]
FX By the National Institutes of Health (grants U01 GM087719 and U01
   GM105627).
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Blumel JE, 2006, MENOPAUSE, V13, P706, DOI 10.1097/01.gme.0000227338.73738.2d
   Bongaarts J, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0058-9
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brasil P, 2016, N ENGL J MED
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eskenazi B, 2003, HUM REPROD, V18, P447, DOI 10.1093/humrep/deg107
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hallett TB, 2009, EPIDEMICS-NETH, V1, P108, DOI 10.1016/j.epidem.2009.03.001
   Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Instituto Nacional de Salud, 2016, B EP SEM
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kindhauser MK, 2016, B WHO
   Lardeux F, 2001, MED VET ENTOMOL, V15, P167, DOI 10.1046/j.0269-283x.2001.00305.x
   Lessler J, 2016, B WHO
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   Majumder MS, 2016, B WHO, DOI 10.2471/BLT.16.171009
   Mallet HP, 2015, BISES B INFORM SANIT, P1
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   McNeil DG Jr, 2016, NY TIMES, pD1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Pan American Health Organization; World Health Organization, 2016, SUSP CONF ZIK CAS RE
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SAWYER W. A., 1931, JOUR PREV MED, V5, P413
   Schuck-Paim C., 2016, PLOS CURR OUTBREAKS
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Stykes J, 2011, FP1104 NAT CTR FAM M
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   UN (United Nations), 2015, ESAPWP241 UN
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
NR 55
TC 11
Z9 11
U1 0
U2 6
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD OCT 18
PY 2016
VL 165
IS 8
BP 551
EP +
DI 10.7326/M16-0919
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ6BM
UT WOS:000385946600015
PM 27454076
DA 2020-07-08
ER

PT J
AU Dyer, O
AF Dyer, Owen
TI Zika virus is set to spread through Asia, WHO says
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT News Item
CR Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   TANURI A, JAMA NEUROLOGY
   World Health Organization, 2016, ZIK RISK ASS W PAC R
NR 5
TC 6
Z9 6
U1 0
U2 20
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD OCT 17
PY 2016
VL 355
AR i5577
DI 10.1136/bmj.i5577
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ8KK
UT WOS:000386119100011
PM 27754830
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Xu, XY
   Song, H
   Qi, JX
   Liu, YQ
   Wang, HY
   Su, C
   Shi, Y
   Gao, GF
AF Xu, Xiaoying
   Song, Hao
   Qi, Jianxun
   Liu, Yuqian
   Wang, Haiyuan
   Su, Chao
   Shi, Yi
   Gao, George F.
TI Contribution of intertwined loop to membrane association revealed by
   Zika virus full-length NS1 structure
SO EMBO JOURNAL
LA English
DT Article
DE crystal structure; membrane association; NS1; Zika virus
ID NONSTRUCTURAL PROTEIN NS1; DENGUE VIRUS; SEXUAL TRANSMISSION;
   ANTIBODIES; MORTALITY; ENHANCE; BINDING; CELLS
AB The association of Zika virus (ZIKV) infections with microcephaly and neurological diseases has highlighted an emerging public health concern. Here, we report the crystal structure of the full-length ZIKV nonstructural protein 1 (NS1), a major host-interaction molecule that functions in flaviviral replication, pathogenesis, and immune evasion. Of note, a long intertwined loop is observed in the wing domain of ZIKV NS1, and forms a hydrophobic "spike", which can contribute to cellular membrane association. For different flaviviruses, the amino acid sequences of the "spike" are variable but their common characteristic is either hydrophobic or positively charged, which is a beneficial feature for membrane binding. Comparative studies with West Nile and Dengue virus NS1 structures reveal conserved features, but diversified electrostatic characteristics on both inner and outer faces. Our results suggest different mechanisms of flavivirus pathogenesis and should be considered during the development of diagnostic tools.
C1 [Xu, Xiaoying; Gao, George F.] Univ Sci & Technol China, Sch Life Sci, Hefei, Peoples R China.
   [Xu, Xiaoying; Song, Hao; Qi, Jianxun; Liu, Yuqian; Wang, Haiyuan; Su, Chao; Shi, Yi; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Song, Hao; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.
   [Qi, Jianxun; Shi, Yi; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Liu, Yuqian] Anhui Univ, Inst Hlth Sci, Hefei, Peoples R China.
   [Wang, Haiyuan] Guangxi Univ, Coll Anim Sci & Technol, Nanning, Peoples R China.
   [Su, Chao] China Agr Univ, Coll Vet Med, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Gao, GF (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Shi, Y; Gao, GF (corresponding author), Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
EM shiyi@im.ac.cn; gaof@im.ac.cn
OI Song, Hao/0000-0002-2811-0370
FU Emergency Task-Force Project of the National Natural Science Foundation
   of China (NSFC)National Natural Science Foundation of China [81641001];
   China Ministry of Science and Technology (MOST) National 973 Project
   [2014CB542503]; Task-Force of Zika Virus Research from the Chinese
   Academy of Sciences (CAS); National Key Plan for Scientific Research and
   Development of China [2016YFD0500300]; Zika Special Project of the MOST
   Reform and Development Project; Strategic Priority Research Program of
   the Chinese Academy of SciencesChinese Academy of Sciences
   [XDB08020100]; Excellent Young Scientist Program from the NSFC
   [81622031]; Excellent Young Scientist Program of the Chinese Academy of
   Sciences; Youth Innovation Promotion Association CAS [2015078]; NSFC
   Innovative Research Group [81321063]
FX This work was supported by the Emergency Task-Force Project (Grant No.
   81641001) of the National Natural Science Foundation of China (NSFC),
   the China Ministry of Science and Technology (MOST) National 973 Project
   (Grant No. 2014CB542503), the Task-Force of Zika Virus Research from the
   Chinese Academy of Sciences (CAS), the National Key Plan for Scientific
   Research and Development of China (2016YFD0500300), Zika Special Project
   of the MOST Reform and Development Project, and Strategic Priority
   Research Program of the Chinese Academy of Sciences (XDB08020100). We
   thank the staff of beamline BL17U at Shanghai Synchrotron Radiation
   Facility, for assistance during data collection. Y.S. is supported by
   the Excellent Young Scientist Program from the NSFC (No. 81622031), the
   Excellent Young Scientist Program of the Chinese Academy of Sciences and
   the Youth Innovation Promotion Association CAS (2015078). G.F.G. is
   supported partly as a leading principal investigator of the NSFC
   Innovative Research Group (Grant No. 81321063).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   Avirutnan P, 2007, PLOS PATHOG, V3, P1798, DOI 10.1371/journal.ppat.0030183
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   BRANDT WE, 1970, J IMMUNOL, V105, P1565
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Brown WC, 2011, PROTEIN EXPRES PURIF, V77, P34, DOI 10.1016/j.pep.2011.01.007
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cheng HJ, 2009, EXP BIOL MED, V234, P63, DOI 10.3181/0805-RM-147
   Chuang YC, 2014, J VIROL, V88, P13759, DOI 10.1128/JVI.02166-14
   Chuang YC, 2011, J IMMUNOL, V187, P6483, DOI 10.4049/jimmunol.1102218
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Muller DA, 2012, J GEN VIROL, V93, P771, DOI 10.1099/vir.0.039321-0
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471
   RUSSELL PK, 1970, J IMMUNOL, V105, P838
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Song H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005411
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun DS, 2007, J THROMB HAEMOST, V5, P2291, DOI 10.1111/j.1538-7836.2007.02754.x
   Sun DS, 2015, J IMMUNOL, V195, P2743, DOI 10.4049/jimmunol.1500136
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Yin Y, 2013, VIRAL IMMUNOL, V26, P185, DOI 10.1089/vim.2012.0063
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 53
TC 60
Z9 66
U1 1
U2 102
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD OCT 17
PY 2016
VL 35
IS 20
BP 2170
EP 2178
DI 10.15252/embj.201695290
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA DZ2YC
UT WOS:000385708000002
PM 27578809
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Florida Tests More Than 200 Residents in Zika Probe
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2016
VL 63
IS 8
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DZ7KN
UT WOS:000386044400001
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Suspected Female-to-Male Sexual Transmission of Zika Virus-New York
   City, 2016
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 4
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2016
VL 63
IS 8
BP I
EP I
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DZ7KN
UT WOS:000386044400002
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Utah Reports Zika Infection in Person Who Cared for Patient With Virus
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 15
PY 2016
VL 63
IS 8
BP I
EP II
PG 2
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DZ7KN
UT WOS:000386044400003
DA 2020-07-08
ER

PT J
AU Krittanawong, C
   Zhang, HJ
   Sun, T
AF Krittanawong, Chayakrit
   Zhang, HongJu
   Sun, Tao
TI Cardiovascular complications after Zika virus infection
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Letter
DE Public health; Zika virus; Zika outbreak
ID DENGUE
C1 [Krittanawong, Chayakrit] Cleveland Clin, Inst Heart & Vasc, Dept Cardiovasc Med, Cleveland, OH 44106 USA.
   [Zhang, HongJu; Sun, Tao] Mayo Clin, Dept Med, Div Cardiovasc Dis, Rochester, MN USA.
RP Krittanawong, C (corresponding author), Cleveland Clin, Inst Heart & Vasc, 9500,Euclid Ave,Desk J3-4 WT, Cleveland, OH 44106 USA.
EM Krittac@ccf.org
CR Kushawaha Anurag, 2009, Cases J, V2, P7147, DOI 10.1186/1757-1626-2-7147
   Miranda CH, 2013, CLIN INFECT DIS, V57, P812, DOI 10.1093/cid/cit403
   OBEYESEKERE I, 1972, BRIT HEART J, V34, P821
   Qanitha A., 2015, EUR HEART J ACUTE S5, V4, pS39
   Weerakoon Kosala Gad, 2011, BMC Res Notes, V4, P268, DOI 10.1186/1756-0500-4-268
NR 5
TC 8
Z9 8
U1 0
U2 19
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD OCT 15
PY 2016
VL 221
BP 859
EP 859
DI 10.1016/j.ijcard.2016.06.293
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DX9DA
UT WOS:000384692600164
PM 27434361
DA 2020-07-08
ER

PT J
AU Medina, MT
   England, JD
   Lorenzana, I
   Medina-Montoya, M
   Alvarado, D
   De Bastos, M
   Fontiveros, S
   Sierra, M
   Contreras, F
AF Medina, Marco T.
   England, John D.
   Lorenzana, Ivette
   Medina-Montoya, Marco
   Alvarado, Diego
   De Bastos, Mario
   Fontiveros, Santiago
   Sierra, Manuel
   Contreras, Francis
TI Zika virus associated with sensory polyneuropathy
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Zika virus; Polyneuropathy; Small fiber sensory neuropathy
C1 [Medina, Marco T.; Medina-Montoya, Marco; Alvarado, Diego; Sierra, Manuel] Natl Autonomous Univ Honduras, Fac Med Sci, Tegucigalpa, Honduras.
   [Medina, Marco T.; England, John D.] World Federat Neurol WFN Zika Work Grp, London, England.
   [England, John D.] LSUHSC Sch Med, Dept Neurol, New Orleans, LA USA.
   [Lorenzana, Ivette] Natl Autonomous Univ Honduras, Fac Sci, Sch Microbiol, Tegucigalpa, Honduras.
   [De Bastos, Mario; Fontiveros, Santiago] Venezuelan World Federat Neurol WFN Chapter, Caracas, Venezuela.
   [Contreras, Francis] Minist Hlth, Tegucigalpa, Honduras.
RP Medina, MT (corresponding author), Natl Autonomous Univ Honduras, Fac Med Sci, Tegucigalpa, Honduras.
EM marcotmedina@yahoo.com
RI Sierra-Castaner, Manuel/AAL-8845-2020; Garzon-Alvarado,
   Diego/AAD-6607-2019
OI Sierra-Castaner, Manuel/0000-0002-8752-6448; Medina, Marco
   Tulio/0000-0003-0469-054X
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   White M. K., 2016, ANN NEUROL
NR 7
TC 18
Z9 18
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD OCT 15
PY 2016
VL 369
BP 271
EP 272
DI 10.1016/j.jns.2016.08.044
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DY1NF
UT WOS:000384861000051
PM 27653905
DA 2020-07-08
ER

PT J
AU Zhang, FR
   Hammack, C
   Ogden, SC
   Cheng, YC
   Lee, EM
   Wen, ZX
   Qian, XY
   Nguyen, HN
   Li, YJ
   Yao, B
   Xu, M
   Xu, TL
   Chen, L
   Wang, ZQ
   Feng, H
   Huang, WK
   Yoon, KJ
   Shan, C
   Huang, LX
   Qin, ZH
   Christian, KM
   Shi, PY
   Xu, MJ
   Xia, MH
   Zheng, W
   Wu, H
   Song, HJ
   Tang, HL
   Ming, GL
   Jin, P
AF Zhang, Feiran
   Hammack, Christy
   Ogden, Sarah C.
   Cheng, Yichen
   Lee, Emily M.
   Wen, Zhexing
   Qian, Xuyu
   Ha Nam Nguyen
   Li, Yujing
   Yao, Bing
   Xu, Miao
   Xu, Tianlei
   Chen, Li
   Wang, Zhiqin
   Feng, Hao
   Huang, Wei-Kai
   Yoon, Ki-jun
   Shan, Chao
   Huang, Luoxiu
   Qin, Zhaohui
   Christian, Kimberly M.
   Shi, Pei-Yong
   Xu, Mingjiang
   Xia, Menghang
   Zheng, Wei
   Wu, Hao
   Song, Hongjun
   Tang, Hengli
   Ming, Guo-Li
   Jin, Peng
TI Molecular signatures associated with ZIKV exposure in human cortical
   neural progenitors
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID VIRUS-INFECTION; PROTECTS MICE; GENE; EXPRESSION; P53; INHIBITOR;
   BIOINFORMATICS; SCHIZOPHRENIA; TRANSMISSION; ACTIVATION
AB Zika virus (ZIKV) infection causes microcephaly and has been linked to other brain abnormalities. How ZIKV impairs brain development and function is unclear. Here we systematically profiled transcriptomes of human neural progenitor cells exposed to Asian ZIKV(C), African ZIKV(M), and dengue virus (DENV). In contrast to the robust global transcriptome changes induced by DENV, ZIKV has a more selective and larger impact on expression of genes involved in DNA replication and repair. While overall expression profiles are similar, ZIKV(C), but not ZIKV(M), induces upregulation of viral response genes and TP53. P53 inhibitors can block the apoptosis induced by both ZIKV(C) and ZIKV(M) in hNPCs, with higher potency against ZIKV(C)-induced apoptosis. Our analyses reveal virus- and strain-specific molecular signatures associated with ZIKV infection. These datasets will help to investigate ZIKV-host interactions and identify neurovirulence determinants of ZIKV.
C1 [Zhang, Feiran; Li, Yujing; Yao, Bing; Wang, Zhiqin; Huang, Luoxiu; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.
   [Hammack, Christy; Ogden, Sarah C.; Cheng, Yichen; Lee, Emily M.; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
   [Wen, Zhexing; Qian, Xuyu; Ha Nam Nguyen; Huang, Wei-Kai; Yoon, Ki-jun; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.
   [Wen, Zhexing; Ha Nam Nguyen; Yoon, Ki-jun; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   [Qian, Xuyu] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21205 USA.
   [Xu, Miao; Xia, Menghang; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA.
   [Xu, Tianlei; Chen, Li; Feng, Hao; Qin, Zhaohui; Wu, Hao] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.
   [Huang, Wei-Kai] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Dept Pharmacol & Toxicol, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Xu, Mingjiang] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.
   [Song, Hongjun; Ming, Guo-Li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.
   [Ming, Guo-Li] Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21205 USA.
RP Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Song, HJ; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Dept Psychiat & Behav Sci, Sch Med, Baltimore, MD 21205 USA.
EM shongju1@jhmi.edu; tang@bio.fsu.edu; gming1@jhmi.edu; peng.jin@emory.edu
RI xu, miao/U-1176-2017; Wen, Zhexing/L-1228-2018; Zheng, Wei/J-8889-2014;
   Wu, Hao/H-3899-2017; Li, Yujing/AAJ-1411-2020; Qin, Zhaohui/Q-3133-2019;
   Wu, Hao/AAG-8660-2020; Yoon, Ki-Jun/S-8170-2018; Qian, Xuyu/C-1240-2017
OI Wen, Zhexing/0000-0002-1518-3845; Zheng, Wei/0000-0003-1034-0757; Wu,
   Hao/0000-0003-1269-7354; Li, Yujing/0000-0002-4363-2484; Qin,
   Zhaohui/0000-0002-1583-146X; Wu, Hao/0000-0003-1269-7354; Qian,
   Xuyu/0000-0001-5944-3816; Ming, Guo-li/0000-0002-2517-6075; Xu,
   Tianlei/0000-0001-9382-6917; Yao, Bing/0000-0002-3205-8130; Chen,
   Li/0000-0001-9372-5606; Yoon, Ki-Jun/0000-0003-2985-2541; Zhang,
   Feiran/0000-0001-6222-6177; Feng, Hao/0000-0003-2243-9949
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI119530,
   AI111250, NS048271, NS095348, NS047344, MH087874, NS079625]; Maryland
   Stem Cell Research Fund; start-up fund; College of Arts and Sciences and
   Department of Biological Science at Florida State University seed fund;
   Emory Genetics Discovery Fund; Emory Integrated Genomics Core (EIGC);
   Emory University School of Medicine; National Center for Advancing
   Translational Sciences of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Center for Advancing Translational Sciences (NCATS)
   [UL1TR000454]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA
FX National Institutes of Health (NIH) [AI119530 and AI111250 to H.T.,
   NS048271 and NS095348 to G-L.M., NS047344 and MH087874 to H.S., NS079625
   to P.J.]; Maryland Stem Cell Research Fund (to H.S. and Z.W.); start-up
   fund (to H.S. and G-L.M.); College of Arts and Sciences and Department
   of Biological Science at Florida State University seed fund (to H.T.);
   Emory Genetics Discovery Fund (to P.J.). This study was supported in
   part by the Emory Integrated Genomics Core (EIGC), which is subsidized
   by the Emory University School of Medicine and is one of the Emory
   Integrated Core Facilities. Additional support was provided by the
   National Center for Advancing Translational Sciences of the National
   Institutes of Health under Award Number UL1TR000454. The content is
   solely the responsibility of the authors and does not necessarily
   reflect the official views of the National Institutes of Health. Funding
   for open access charge: NIH.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhuvanakantham R, 2010, MICROBES INFECT, V12, P615, DOI 10.1016/j.micinf.2010.04.005
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06
   Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duncan R, 2000, VIROLOGY, V275, P20, DOI 10.1006/viro.2000.0467
   Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Megyeri K, 1999, VIROLOGY, V259, P74, DOI 10.1006/viro.1999.9757
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montojo Jason, 2014, F1000Res, V3, P153, DOI 10.12688/f1000research.4572.1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200
   Onlamoon N, 2010, BLOOD, V115, P1823, DOI 10.1182/blood-2009-09-242990
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pham AM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002465
   Pietrancosta N, 2006, J MED CHEM, V49, P3645, DOI 10.1021/jm060318n
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Srikiatkhachorn A, 2007, J VIROL, V81, P1592, DOI 10.1128/JVI.01642-06
   Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472
   Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033
   Wu-Hsieh BA, 2009, ANN NY ACAD SCI, V1171, pE42, DOI 10.1111/j.1749-6632.2009.05053.x
   Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003
NR 51
TC 72
Z9 72
U1 1
U2 25
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT 14
PY 2016
VL 44
IS 18
BP 8610
EP 8620
DI 10.1093/nar/gkw765
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EA9ET
UT WOS:000386945000012
PM 27580721
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dowd, KA
   Ko, SY
   Morabito, KM
   Yang, ES
   Pelc, RS
   DeMaso, CR
   Castilho, LR
   Abbink, P
   Boyd, M
   Nityanandam, R
   Gordon, DN
   Gallagher, JR
   Chen, XJ
   Todd, JP
   Tsybovsky, Y
   Harris, A
   Huang, YJS
   Higgs, S
   Vanlandingham, DL
   Andersen, H
   Lewis, MG
   De La Barrera, R
   Eckels, KH
   Jarman, RG
   Nason, MC
   Barouch, DH
   Roederer, M
   Kong, WP
   Mascola, JR
   Pierson, TC
   Graham, BS
AF Dowd, Kimberly A.
   Ko, Sung-Youl
   Morabito, Kaitlyn M.
   Yang, Eun Sung
   Pelc, Rebecca S.
   DeMaso, Christina R.
   Castilho, Leda R.
   Abbink, Peter
   Boyd, Michael
   Nityanandam, Ramya
   Gordon, David N.
   Gallagher, John Robert
   Chen, Xuejun
   Todd, John-Paul
   Tsybovsky, Yaroslav
   Harris, Audray
   Huang, Yan-Jang S.
   Higgs, Stephen
   Vanlandingham, Dana L.
   Andersen, Hanne
   Lewis, Mark G.
   De La Barrera, Rafael
   Eckels, Kenneth H.
   Jarman, Richard G.
   Nason, Martha C.
   Barouch, Dan H.
   Roederer, Mario
   Kong, Wing-Pui
   Mascola, John R.
   Pierson, Theodore C.
   Graham, Barney S.
TI Rapid development of a DNA vaccine for Zika virus
SO SCIENCE
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; TICK-BORNE ENCEPHALITIS; DENGUE VIRUS;
   CANDIDATE VACCINE; HEALTHY-ADULTS; ANTIBODY; NEUTRALIZATION;
   PREMEMBRANE; PROTECTION; CHALLENGE
AB Zika virus (ZIKV) was identified as a cause of congenital disease during the explosive outbreak in the Americas and Caribbean that began in 2015. Because of the ongoing fetal risk from endemic disease and travel-related exposures, a vaccine to prevent viremia in women of childbearing age and their partners is imperative. We found that vaccination with DNA expressing the premembrane and envelope proteins of ZIKV was immunogenic in mice and nonhuman primates, and protection against viremia after ZIKV challenge correlated with serum neutralizing activity. These data not only indicate that DNA vaccination could be a successful approach to protect against ZIKV infection, but also suggest a protective threshold of vaccine induced neutralizing activity that prevents viremia after acute infection.
C1 [Dowd, Kimberly A.; Pelc, Rebecca S.; DeMaso, Christina R.; Gordon, David N.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Ko, Sung-Youl; Morabito, Kaitlyn M.; Yang, Eun Sung; Castilho, Leda R.; Chen, Xuejun; Todd, John-Paul; Roederer, Mario; Kong, Wing-Pui; Mascola, John R.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Castilho, Leda R.] Univ Fed Rio de Janeiro, COPPE, Chem Engn Program, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Rio De Janeiro, Brazil.
   [Abbink, Peter; Boyd, Michael; Nityanandam, Ramya; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Gallagher, John Robert; Harris, Audray] NIAID, Struct Informat Unit, Infect Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Tsybovsky, Yaroslav] Frederick Natl Lab Canc Res, Electron Microscopy Lab, Canc Res Technol Program, Frederick, MD 21702 USA.
   [Huang, Yan-Jang S.; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
   [Andersen, Hanne; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA.
   [De La Barrera, Rafael; Eckels, Kenneth H.] Walter Reed Army Inst Res, Translat Med Branch, Silver Spring, MD 20910 USA.
   [Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20852 USA.
RP Pierson, TC (corresponding author), NIAID, Viral Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Graham, BS (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM piersontc@niaid.nih.gov; bgraham@mail.nih.gov
RI Barouch, Dan/Y-3918-2019; Castilho, Leda/I-8939-2014; Graham, Barney
   S./AAC-5898-2019
OI Graham, Barney S./0000-0001-8112-0853; Elyard,
   Hanne/0000-0003-1103-9608; Pelc, Rebecca/0000-0001-5080-4945; Morabito,
   Kaitlyn/0000-0002-4849-4690; Nason, Martha/0000-0002-0110-881X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [VRC5283, VRC5288, VRC8400, VRC8111,
   VRC4974]; National Institute of Allergy and Infectious DiseasesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID); Department of Diagnostic Medicine and Pathobiology,
   College of Veterinary Medicine, Kansas State University; Frederick
   National Laboratory for Cancer Research, NIH [HHSN261200800001E]; Leidos
   Biomedical Research
FX We thank A. Fauci, H. Marston, J. Ledgerwood, S. Whitehead, N. Michael,
   and M. Crank for scientific advice and comments; J. Stein and M. Young
   for coordinating collaborations; A. Cook and A. Dodson for the macaque
   work; K. Leung, L. Wang, W. Shi, K. Foulds, M. Donaldson, B. Fisher, A.
   Creanga, D. Scorpio, and B. Dekosky for laboratory and animal study
   support; M. Diamond for ZIKV-specific antibodies provided before
   publication; N. Bourne and A. Barrett for scientific advice and murine
   experiments; E. Moseley for serological assays; T. Pato for scientific
   discussion on the purification of SVPs; B. Hartman for help with figure
   optimization; R. Larocca and A. Badamchi-Zadeh for murine experiments;
   and N. Mercado for shipping and coordination. The data are tabulated in
   the main paper and in the supplementary materials. The opinions or
   assertions contained herein are the private views of the authors and are
   not to be construed as reflecting the official views of the U.S. Army or
   Department of Defense. VRC5283, VRC5288, VRC8400, VRC8111, and VRC4974
   are available from NIH under a material transfer agreement. ZIKV strain
   PRVABC59 challenge stock is available from Kansas State University under
   a material transfer agreement. A patent application describing candidate
   ZIKV vaccines has been filed with the following authors listed as
   inventors: B.S.G., T.C.P., W.-P. K., S.-Y.K., K. A. D., E.S.Y., R.S.P.,
   C.R.D., L.R.C., and J. R. M. This work was supported by intramural
   funding from the National Institute of Allergy and Infectious Diseases;
   startup funding from the Department of Diagnostic Medicine and
   Pathobiology, College of Veterinary Medicine, Kansas State University
   (to D.L.V.); and federal funds from the Frederick National Laboratory
   for Cancer Research, NIH, under contract HHSN261200800001E with Leidos
   Biomedical Research (Y.T.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Arora U, 2013, VACCINE, V31, P873, DOI 10.1016/j.vaccine.2012.12.016
   Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Chang GJJ, 2001, ANN NY ACAD SCI, V951, P272
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   KONISHI E, 1993, J VIROL, V67, P1672, DOI 10.1128/JVI.67.3.1672-1675.1993
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Ledgerwood JE, 2009, HUM VACCINES, V5, P623, DOI 10.4161/hv.8627
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   OKUNO Y, 1978, BIKEN J, V21, P137
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
   Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 24
TC 194
Z9 202
U1 8
U2 93
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD OCT 14
PY 2016
VL 354
IS 6309
BP 237
EP 240
DI 10.1126/science.aai9137
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EC0UN
UT WOS:000387816500047
PM 27708058
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Dallmeier, K
   Neyts, J
AF Dallmeier, Kai
   Neyts, Johan
TI Zika and Other Emerging Viruses: Aiming at the Right Target
SO CELL HOST & MICROBE
LA English
DT Editorial Material
C1 [Dallmeier, Kai; Neyts, Johan] Univ Leuven KU Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.
RP Neyts, J (corresponding author), Univ Leuven KU Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, B-3000 Leuven, Belgium.
EM johan.neyts@kuleuven.be
RI Neyts, Johan/U-8267-2017
OI Neyts, Johan/0000-0002-0033-7514
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Debing Y, 2015, CURR OPIN INFECT DIS, V28, P596, DOI 10.1097/QCO.0000000000000212
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Sacramento CQ, 2016, BIORXIV
   Xu M., 2016, NAT MED
NR 10
TC 4
Z9 4
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD OCT 12
PY 2016
VL 20
IS 4
BP 420
EP 422
DI 10.1016/j.chom.2016.09.011
PG 3
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EE3EV
UT WOS:000389471300007
PM 27736642
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Butt, AM
   Nasrullah, I
   Qamar, R
   Tong, YG
AF Butt, Azeem Mehmood
   Nasrullah, Izza
   Qamar, Raheel
   Tong, Yigang
TI Evolution of codon usage in Zika virus genomes is host and vector
   specific
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
DE codon usage; evolution; mutation pressure; natural selection; Zika virus
ID NUCLEOTIDE COMPOSITION; ESCHERICHIA-COLI; ADAPTATION INDEX; BIAS;
   PATTERNS; RECOMBINATION; SELECTION; OUTBREAK; DENGUE; GENES
AB The codon usage patterns of viruses reflect the evolutionary changes that allow them to optimize their survival and adapt their fitness to the external environment and, most importantly, their hosts. Here we report the genotype-specific codon usage patterns of Zika virus (ZIKV) strains from the current and previous outbreaks. Several genotype-specific and common codon usage traits were noted in the ZIKV coding sequences, indicating their independent evolutionary origins from a common ancestor. The overall influence of natural selection was more profound than that of mutation pressure, acting on a specific set of viral genes in the Asian-genotype ZIKV strains from the recent outbreak. An interplay between codon adaptation and deoptimization may have allowed the virus to adapt to multiple host and vectors and is reported for the first time in ZIKV genomes. Combining our codon analysis with geographical data on Aedes populations in the Americas suggested that ZIKV has evolved host-and vector-specific codon usage patterns to maintain successful replication and transmission chains within multiple hosts and vectors.
C1 [Butt, Azeem Mehmood; Nasrullah, Izza; Qamar, Raheel] COMSATS Inst Informat Technol, Dept Biosci, Genom Lab, Islamabad 45550, Pakistan.
   [Tong, Yigang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
RP Qamar, R (corresponding author), COMSATS Inst Informat Technol, Dept Biosci, Genom Lab, Islamabad 45550, Pakistan.; Tong, YG (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM raheel_qamar@comsats.edu.pk; tong.yigang@gmail.com
RI Butt, Azeem Mehmood/B-6249-2014
OI Butt, Azeem Mehmood/0000-0001-5897-6848; Tong,
   Yigang/0000-0002-8503-8045
FU China Mega-Project on Infectious Disease Prevention [2013ZX10004-605]
FX This research was supported by a grant from the China Mega-Project on
   Infectious Disease Prevention (NO 2013ZX10004-605).
CR Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216
   Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carbone A, 2003, BIOINFORMATICS, V19, P2005, DOI 10.1093/bioinformatics/btg272
   Chen YH, 2014, SAUDI J BIOL SCI, V21, P311, DOI 10.1016/j.sjbs.2013.12.004
   Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384
   Cristina J, 2015, VIRUS RES, V196, P87, DOI 10.1016/j.virusres.2014.11.005
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freire CCM, 2015, BIORXIV
   GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, pR49, DOI 10.1093/nar/8.1.197-c
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   Hu JS, 2011, INFECT GENET EVOL, V11, P2098, DOI 10.1016/j.meegid.2011.08.025
   Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Liu XD, 2010, ARCH VIROL, V155, P685, DOI 10.1007/s00705-010-0631-2
   Liu YS, 2011, INFECT GENET EVOL, V11, P1168, DOI 10.1016/j.meegid.2011.02.018
   Ma JJ, 2013, J ANIM VET ADV, V12, P88
   Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698
   MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Puigbo Pere, 2010, BMC Res Notes, V3, P87, DOI 10.1186/1756-0500-3-87
   Puigbo P, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-38
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Sanchez G, 2003, J VIROL, V77, P452, DOI 10.1128/JVI.77.1.452-459.2003
   Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1
   SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207
   SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948
   SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0
   SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653
   SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Zhou JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077239
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 54
TC 55
Z9 55
U1 1
U2 99
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD OCT 12
PY 2016
VL 5
AR e107
DI 10.1038/emi.2016.106
PG 14
WC Immunology; Microbiology
SC Immunology; Microbiology
GA DY7EZ
UT WOS:000385293700001
PM 27729643
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bayless, NL
   Greenberg, RS
   Swigut, T
   Wysocka, J
   Blish, CA
AF Bayless, Nicholas L.
   Greenberg, Rachel S.
   Swigut, Tomek
   Wysocka, Joanna
   Blish, Catherine A.
TI Zika Virus Infection Induces Cranial Neural Crest Cells to Produce
   Cytokines at Levels Detrimental for Neurogenesis
SO CELL HOST & MICROBE
LA English
DT Article
ID BRAIN; FACE
AB Zika virus (ZIKV) infection during pregnancy is linked to microcephaly, which is attributed to infection of developing brain structures. ZIKV infects neural progenitor cells in vitro, though its effects on other developmentally relevant stem cell populations, including cranial neural crest cells (CNCCs), have not been assessed. CNCCs give rise to most cranial bones and exert paracrine effects on the developing brain. Here, we report that CNCCs are productively infected by ZIKV, but not by the related dengue virus. ZIKV-infected CNCCs undergo limited apoptosis but secrete cytokines that promote death and drive aberrant differentiation of neural progenitor cultures. Addition of two such cytokines, LIF or VEGF, at levels comparable to those secreted by ZIKV-infected CNCCs is sufficient to recapitulate premature neuronal differentiation and apoptotic death of neural progenitors. Thus, our results suggest that CNCC infection by ZIKV may contribute to associated embryopathies through signaling crosstalk between developing face and brain structures.
C1 [Bayless, Nicholas L.; Blish, Catherine A.] Stanford Univ, Stanford Sch Med, Stanford Immunol, Stanford, CA 94305 USA.
   [Greenberg, Rachel S.; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Stanford Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.
   [Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Stanford Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.
   [Wysocka, Joanna] Stanford Univ, Howard Hughes Med Inst, Stanford Sch Med, Stanford, CA 94305 USA.
   [Wysocka, Joanna] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Sch Med, Stanford, CA 94305 USA.
   [Blish, Catherine A.] Stanford Univ, Dept Med, Stanford Sch Med, Stanford, CA 94305 USA.
RP Blish, CA (corresponding author), Stanford Univ, Stanford Sch Med, Stanford Immunol, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Stanford Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Stanford Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford Sch Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Sch Med, Stanford, CA 94305 USA.; Blish, CA (corresponding author), Stanford Univ, Dept Med, Stanford Sch Med, Stanford, CA 94305 USA.
EM wysocka@stanford.edu; cblish@stanford.edu
OI Swigut, Tomek/0000-0002-7649-6781; Blish, Catherine/0000-0001-6946-7627
FU Tasha and John Morgridge Endowed Faculty Scholar (C.A.B.) in Pediatric
   Translational Medicine from Stanford Child Health Research Institute and
   Stanford University School of Medicine, NIH Director's New Innovator
   Award [1DP2AI112193]; NIDCR U01 [DE024430]; March of Dimes Birth Defects
   FoundationMarch of Dimes; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute; NIDCRUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Dental & Craniofacial Research (NIDCR) [1F31DE025534]; Stanford
   Graduate FellowshipStanford University; NICHDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [1F31HD089675]; Stanford Systems Biology Seed Grant
FX We particularly thank Dr. Sara Prescott for her assistance with scoring
   neurosphere images. We thank Dr. Yael Rosenberg-Hasson in the Stanford
   Human Immune Monitoring Center for assistance with the Luminex assay. We
   thank Dr. Michael Diamond for protocols and reagents, Dr. Cecile Baronti
   for the H/PF/2013 ZIKV strain, and Dr. Karim Majzoub for assistance in
   establishing viral stocks for ZIKV. We thank Bo Gu for assistance with
   the apoptosis analysis and Dr. Hannah Long for assistance with cell
   culture. We thank Julia McKechnie and Dr. Laura Simpson for growing DENV
   stocks. This work was supported by the following funding sources: Tasha
   and John Morgridge Endowed Faculty Scholar (C.A.B.) in Pediatric
   Translational Medicine from Stanford Child Health Research Institute and
   Stanford University School of Medicine, NIH Director's New Innovator
   Award to C.A.B. (1DP2AI112193), NIDCR U01 (DE024430), March of Dimes
   Birth Defects Foundation, and Howard Hughes Medical Institute grants to
   J.W. R.S.G. is supported by a Ruth L. Kirschstein NRSA F31 award from
   NIDCR (1F31DE025534), and N.L.B is supported by the Stanford Graduate
   Fellowship and a Ruth L. Kirschstein NRSA F31 award from NICHD
   (1F31HD089675). This work was also supported by a Stanford Systems
   Biology Seed Grant (2016-2017) to N.L.B. and R.S.G.
CR Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733
   Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006
   Brasil P, 2016, N ENGL J MED
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kuznetsova T, 2015, J AM SOC HYPERTENS, V9, P975, DOI 10.1016/j.jash.2015.10.003
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023
   Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348
   Marcucio R, 2015, CURR TOP DEV BIOL, V115, P299, DOI 10.1016/bs.ctdb.2015.09.001
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Simamura E, 2010, ENDOCRINOLOGY, V151, P1853, DOI 10.1210/en.2009-0985
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 17
TC 52
Z9 52
U1 0
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD OCT 12
PY 2016
VL 20
IS 4
BP 423
EP 428
DI 10.1016/j.chom.2016.09.006
PG 6
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA EE3EV
UT WOS:000389471300008
PM 27693308
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Frieden, TR
   Schuchat, A
   Petersen, LR
AF Frieden, Thomas R.
   Schuchat, Anne
   Petersen, Lyle R.
TI Zika Virus 6 Months Later
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT Editorial Material
C1 [Frieden, Thomas R.; Schuchat, Anne; Petersen, Lyle R.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.
RP Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.
EM tfrieden@cdc.gov
OI Frieden, Thomas/0000-0002-4759-2256
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Centers for Disease Control and Prevention, 2016, ZIK VIR
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 6
TC 26
Z9 26
U1 0
U2 18
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD OCT 11
PY 2016
VL 316
IS 14
BP 1443
EP 1444
DI 10.1001/jama.2016.11941
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA DY1TC
UT WOS:000384876300011
PM 27532277
OA Bronze
DA 2020-07-08
ER

PT J
AU Siu, R
   Bukhari, W
   Todd, A
   Gunn, W
   Huang, QS
   Timmings, P
AF Siu, Ronald
   Bukhari, Wajih
   Todd, Angela
   Gunn, Wendy
   Huang, Qiu Sue
   Timmings, Paul
TI ACUTE ZIKA INFECTION WITH CONCURRENT ONSET OF GUILLAIN-BARRE SYNDROME
SO NEUROLOGY
LA English
DT Editorial Material
C1 [Siu, Ronald; Bukhari, Wajih; Timmings, Paul] Waikato Hosp, Dept Neurol, Hamilton, New Zealand.
   [Todd, Angela; Gunn, Wendy; Huang, Qiu Sue] Inst Environm Sci & Res, Arbovirus Reference Lab, Wellington, New Zealand.
RP Siu, R; Timmings, P (corresponding author), Waikato Hosp, Dept Neurol, Hamilton, New Zealand.
EM ronaldsiu@alumni.unimelb.edu.au; paul.timmings@xtra.co.nz
OI Huang, Q. Sue/0000-0002-3923-5195; Siu, Ronald/0000-0003-0348-6678
CR Ahmed S, 2000, NEUROLOGY, V55, P144, DOI 10.1212/WNL.55.1.144
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   Esack A, 1999, W INDIAN MED J, V48, P36
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lim SM, 2011, VIRUSES-BASEL, V3, P811, DOI 10.3390/v3060811
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
NR 7
TC 25
Z9 25
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD OCT 11
PY 2016
VL 87
IS 15
BP 1623
EP 1624
DI 10.1212/WNL.0000000000003038
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EI1HU
UT WOS:000392228600022
PM 27466468
OA Bronze
DA 2020-07-08
ER

PT J
AU da Silva, IRF
   Frontera, JA
   do Nascimento, OJM
AF Ferreira da Silva, Ivan Rocha
   Frontera, Jennifer Ann
   Moreira do Nascimento, Osvaldo Jose
TI NEWS FROM THE BATTLEFRONT: ZIKA VIRUS-ASSOCIATED GUILLAIN-BARRE SYNDROME
   IN BRAZIL
SO NEUROLOGY
LA English
DT Editorial Material
C1 [Ferreira da Silva, Ivan Rocha; Moreira do Nascimento, Osvaldo Jose] Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
   [Ferreira da Silva, Ivan Rocha] Amer Med City, Neurocrit Care Unit, Rio De Janeiro, Brazil.
   [Frontera, Jennifer Ann] Cleveland Clin Fdn, Neurocrit Care Dept, 9500 Euclid Ave, Cleveland, OH 44195 USA.
RP do Nascimento, OJM (corresponding author), Univ Fed Fluminense, Dept Neurol, Niteroi, RJ, Brazil.
EM osvaldo_nascimento@hotmail.com
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chai SJ, 2013, AM J PREV MED, V45, P190, DOI 10.1016/j.amepre.2013.03.014
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   Tracey LE, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.1.20999
NR 5
TC 9
Z9 10
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD OCT 11
PY 2016
VL 87
IS 15
BP E180
EP E181
DI 10.1212/WNL.0000000000003024
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EI1HU
UT WOS:000392228600005
PM 27421544
OA Bronze
DA 2020-07-08
ER

PT J
AU Melo, CFOR
   de Oliveira, DN
   Lima, ED
   Guerreiro, TM
   Esteves, CZ
   Beck, RM
   Padilla, MA
   Milanez, GP
   Arns, CW
   Proenca-Modena, JL
   Souza-Neto, JA
   Catharino, RR
AF Odir Rodrigues Melo, Carlos Fernando
   de Oliveira, Diogo Noin
   Lima, Estela de Oliveira
   Guerreiro, Tatiane Melina
   Esteves, Cibele Zanardi
   Beck, Raissa Marques
   Padilla, Marina Aiello
   Milanez, Guilherme Paier
   Arns, Clarice Weis
   Proenca-Modena, Jose Luiz
   Souza-Neto, Jayme Augusto
   Catharino, Rodrigo Ramos
TI A Lipidomics Approach in the Characterization of Zika-Infected Mosquito
   Cells: Potential Targets for Breaking the Transmission Cycle
SO PLOS ONE
LA English
DT Article
ID C VIRUS-INFECTION; DENGUE VIRUS; PHOSPHATIDYLSERINE RECEPTORS;
   SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLETHANOLAMINE; APOPTOSIS;
   PHOSPHATIDYLCHOLINE; REPLICATION; ENTRY; ASYMMETRY
AB Recent outbreaks of Zika virus in Oceania and Latin America, accompanied by unexpected clinical complications, made this infection a global public health concern. This virus has tropism to neural tissue, leading to microcephaly in newborns in a significant proportion of infected mothers. The clinical relevance of this infection, the difficulty to perform accurate diagnosis and the small amount of data in literature indicate the necessity of studies on Zika infection in order to characterize new biomarkers of this infection and to establish new targets for viral control in vertebrates and invertebrate vectors. Thus, this study aims at establishing a lipidomics profile of infected mosquito cells compared to a control group to define potential targets for viral control in mosquitoes. Thirteen lipids were elected as specific markers for Zika virus infection (Brazilian strain), which were identified as putatively linked to the intracellular mechanism of viral replication and/or cell recognition. Our findings bring biochemical information that may translate into useful targets for breaking the transmission cycle.
C1 [Odir Rodrigues Melo, Carlos Fernando; de Oliveira, Diogo Noin; Lima, Estela de Oliveira; Guerreiro, Tatiane Melina; Esteves, Cibele Zanardi; Catharino, Rodrigo Ramos] Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, BR-13083877 Campinas, SP, Brazil.
   [Beck, Raissa Marques; Padilla, Marina Aiello; Arns, Clarice Weis] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Anim Viruses Lab, BR-13083862 Campinas, SP, Brazil.
   [Milanez, Guilherme Paier; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut & Bioagents, Emerging Viruses Study Lab, BR-13083862 Campinas, SP, Brazil.
   [Souza-Neto, Jayme Augusto] Sao Paulo State Univ, UNESP Inst Biotechnol, Vector Funct Genom & Microbiol Lab, Alameda Tecomarias S-N, BR-18607440 Botucatu, SP, Brazil.
   [Souza-Neto, Jayme Augusto] Sao Paulo State Univ, Fac Agron Sci, Dept Bioproc & Biotechnol, Rua Jose Barbosa 1780, BR-18610307 Botucatu, SP, Brazil.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Pharmaceut Sci, Innovare Biomarkers Lab, BR-13083877 Campinas, SP, Brazil.
EM rrc@fcm.unicamp.br
RI Modena, Jose Luiz Proenca/C-8231-2014; Lima, Estela/W-5105-2019;
   Souza-Neto, Jayme A/E-7841-2010; de Oliveira, Diogo Noin/C-3939-2013;
   Milanez, Guilherme/G-6457-2016; Catharino, Rodrigo/G-1487-2013; Arns,
   Clarice/F-2762-2015
OI Modena, Jose Luiz Proenca/0000-0002-4996-3153; Lima,
   Estela/0000-0003-0479-0364; Souza-Neto, Jayme A/0000-0001-9281-894X; de
   Oliveira, Diogo Noin/0000-0002-2725-476X; Milanez,
   Guilherme/0000-0002-8599-1098; Catharino, Rodrigo/0000-0001-7219-2644;
   Melo, Carlos/0000-0003-0334-1065; Arns, Clarice/0000-0002-7308-460X
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Sao Paulo
   Research Foundation)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2011/50400-0, 2015/06809-1, 2014/00084-2, 2014/00302-0,
   2013/11343-6]; CPAES; CNPqNational Council for Scientific and
   Technological Development (CNPq)
FX We acknowledge funding from Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP - Sao Paulo Research Foundation), under the following
   grant numbers: 2011/50400-0 and 2015/06809-1 for RRC, 2014/00084-2 for
   DNO, 2014/00302-0 for CZE, 2013/11343-6 for JASN) JANS is a FAPESP Young
   Investigator. We also thank CPAES and CNPq for the fellowships for
   CFORM, EOL and TMG. the funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amemiya F, 2008, J INFECT DIS, V197, P361, DOI 10.1086/525287
   Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459
   Barathan M, 2015, APOPTOSIS, V20, P466, DOI 10.1007/s10495-014-1084-y
   Boumann HA, 2004, FEBS LETT, V569, P173, DOI 10.1016/j.febslet.2004.05.043
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brunner M, 2004, CURR ORG CHEM, V8, P1629, DOI 10.2174/1385272043369638
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Carocci M, 2015, ANTIMICROB AGENTS CH, V59, P85, DOI 10.1128/AAC.04177-14
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   de Oliveira DN, 2013, MATERIALS, V6, P1000, DOI 10.3390/ma6031000
   Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   GLIEDMAN JB, 1975, J VIROL, V16, P913, DOI 10.1128/JVI.16.4.913-926.1975
   Hematian Ali, 2016, Osong Public Health Res Perspect, V7, P77, DOI 10.1016/j.phrp.2015.11.011
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee SH, 2013, CELL DEATH DIFFER, V20, P64, DOI 10.1038/cdd.2012.93
   Liang TB, 2016, J AM COLL SURGEONS, V222, P269, DOI 10.1016/j.jamcollsurg.2015.12.009
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Maulik N, 1998, AM J PHYSIOL-HEART C, V274, pH242
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885
   Soulages JL, 2015, INSECT BIOCHEM MOLEC, V62, P194, DOI 10.1016/j.ibmb.2014.09.007
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347
   To KKW, 2015, J INFECTION, V70, P433, DOI 10.1016/j.jinf.2015.02.011
   TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062
   Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085
   Verkleij A, 1984, CIBA FDN S
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
   Zhang JT, 2016, P NATL ACAD SCI USA, V113, pE1064, DOI 10.1073/pnas.1519730113
   ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991
   Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121
NR 48
TC 16
Z9 16
U1 0
U2 15
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 10
PY 2016
VL 11
IS 10
AR e0164377
DI 10.1371/journal.pone.0164377
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DZ0CF
UT WOS:000385504100050
PM 27723844
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Argolo, AFLDE
   Feres, VCD
   Cordeiro, MT
   da Silveira, LA
   Guilarde, AO
   Marques, ETD
   de Souza, WV
   Martelli, CMT
AF Lopes de Teive e Argolo, Angela Ferreira
   de Rezende Feres, Valeria Christina
   Cordeiro, Marli Tenorio
   da Silveira, Lucimeire Antonelli
   Guilarde, Adriana Oliveira
   de Azevedo Marques, Ernesto Torres, Jr.
   de Souza, Wayner Vieira
   Turchi Martelli, Celina Maria
TI High frequency of pre-existing neutralizing antibody responses in
   patients with dengue during an outbreak in Central Brazil
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus; Neutralizing antibody; Dengue fever; Brazil
ID PLAQUE-REDUCTION NEUTRALIZATION; POLYMERASE CHAIN-REACTION; ORIGINAL
   ANTIGENIC SIN; VIRUS-INFECTIONS; SEROTYPES; ASSAY
AB Background: This study aims to identify dengue neutralizing antibody response in patients with dengue from a well-characterized cohort during an outbreak in central Brazil, 2012-2013.
   Methods: We analyzed paired samples from 40 patients with severe dengue and 20 patients with dengue. Eligibility criteria were: IgM, NS1Ag and/or RT-PCR positivity and positive IgG result. Plaque reduction neutralization test (PRNT50) from DENV-1 to DENV-4 was performed to identify serotype-specific NAbs response. An infecting serotype was defined as >= 4-fold increase in DENV NAbs in paired samples. Monotypic response was classified as PRNT50 >= 1/20 to only one DENV serotype, and multitypic response was considered to be PRNT50 >= 1/20 to two or more serotypes simultaneously.
   Results: Patients were mainly adults. Virological dengue infection was confirmed by RT-PCR: DENV-4 (n = 14) and DENV-1 (n = 10). Forty-four out of 60 (73.3 %) patients had NAbs to DENV-4, DENV-1(68.3 %), DENV-2 (68.3 %) and DENV-3 (61.6 %) respectively. Fifteen percent of the cases presented monotypic response, whereas 85 % had multitypic response. DENV-4 infected-patients presented the greatest difference in PRNT50 titers compared with other serotypes. Pre-existing DENV NAbs was not correlated with disease severity. This was the first time that DENV-4 was implicated in an epidemic in the region.
   Conclusion: Our data indicates high exposure of multiple DENV serotypes in all age groups in the pre-dengue vaccine era and also previous to Zika virus introduction in Brazil.
C1 [Lopes de Teive e Argolo, Angela Ferreira; da Silveira, Lucimeire Antonelli; Guilarde, Adriana Oliveira; Turchi Martelli, Celina Maria] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Rua 235,St Univ, BR-74605050 Goiania, Go, Brazil.
   [Lopes de Teive e Argolo, Angela Ferreira] Secretaria Estadual Saude Goias LACEN GO, Publ Hlth Lab, Av Contorno 3-556, BR-74853120 Goiania, Go, Brazil.
   [de Rezende Feres, Valeria Christina] Univ Fed Goias, Coll Pharm, Av Univ, BR-74605220 Goiania, Go, Brazil.
   [Cordeiro, Marli Tenorio; de Azevedo Marques, Ernesto Torres, Jr.; de Souza, Wayner Vieira; Turchi Martelli, Celina Maria] Fundacao Oswaldo, Ctr Pesquisas Aggeu Magalhaes, Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
   [de Azevedo Marques, Ernesto Torres, Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Ctr Vaccine Res, Pittsburgh, PA USA.
RP Argolo, AFLDE (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Rua 235,St Univ, BR-74605050 Goiania, Go, Brazil.; Argolo, AFLDE (corresponding author), Secretaria Estadual Saude Goias LACEN GO, Publ Hlth Lab, Av Contorno 3-556, BR-74853120 Goiania, Go, Brazil.
EM angelafarmaceutica@hotmail.com
RI Souza, Wayner V/H-3798-2013; Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358; Souza,
   Wayner/0000-0002-0939-9332; Lopes, Angela/0000-0002-7261-2079; Turchi
   Martelli, Celina Maria/0000-0002-2491-0688
FU Fundacao de Amparo a Pesquisa em Goias [FAPEG]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq]National Council for
   Scientific and Technological Development (CNPq) [PRONEX-REDE DENGUE
   73/2009, 201210267000729]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [306489/2010-4, 305281/2010-0]
FX This work was supported by the Fundacao de Amparo a Pesquisa em Goias
   [FAPEG] and Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico [CNPq] [PRONEX-REDE DENGUE 73/2009 # 201210267000729].
   C.M.T.M. and W.V.S. received research scholarships [CNPq numbers
   306489/2010-4, 305281/2010-0].
CR Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brazilian Institute of Geography and Statistics (IBGE), IBGE STAT SER
   Brazilian Ministry of Health, 2014, DENG CAS BRAZ MAJ RE
   Brazilian Ministry of Health, 2011, HLTH BRAZ 2010 HLTH, P157
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Corbett KS, 2015, J INFECT DIS, V211, P590, DOI 10.1093/infdis/jiu481
   Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   Santos Cecília Luiza Simões dos, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P11, DOI 10.1590/S0036-46652003000100003
   GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170, DOI 10.4269/ajtmh.1985.34.170
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   LAILLE M, 1991, J MED VIROL, V34, P51, DOI 10.1002/jmv.1890340109
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Pan American Health Organization/World Health Organization, 2014, COMM DIS HLTH AN HLT
   Rainwater Lovett K, 2012, BMC INFECT DIS, V12, P233
   Feres VCR, 2006, J CLIN VIROL, V37, P179, DOI 10.1016/j.jcv.2006.07.004
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Salje H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002952
   Secretariat of Health of Goias, 2013, DENG B GOIAS 2013
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, pe2520, DOI [10.1371/journal.pntd.0002520, DOI 10.1371/J0URNAL.PNTD.0002520]
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   van Panhuis WG, 2010, J INFECT DIS, V202, P1002, DOI 10.1086/656141
   VinodKumar CS, 2013, J INFECT PUBLIC HEAL, V6, P302, DOI 10.1016/j.jiph.2013.01.004
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   WHO, 2007, GUID PLAQ RED NEUTR
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN, P1
NR 35
TC 2
Z9 2
U1 0
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD OCT 7
PY 2016
VL 16
AR 546
DI 10.1186/s12879-016-1867-6
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DY9HM
UT WOS:000385444500003
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Petersen, EE
   Meaney-Delman, D
   Neblett-Fanfair, R
   Havers, F
   Oduyebo, T
   Hills, SL
   Rabe, IB
   Lambert, A
   Abercrombie, J
   Martin, SW
   Gould, CV
   Oussayef, N
   Polen, KND
   Kuehnert, MJ
   Pillai, SK
   Petersen, LR
   Honein, MA
   Jamieson, DJ
   Brooks, JT
AF Petersen, Emily E.
   Meaney-Delman, Dana
   Neblett-Fanfair, Robyn
   Havers, Fiona
   Oduyebo, Titilope
   Hills, Susan L.
   Rabe, Ingrid B.
   Lambert, Amy
   Abercrombie, Julia
   Martin, Stacey W.
   Gould, Carolyn V.
   Oussayef, Nadia
   Polen, Kara N. D.
   Kuehnert, Matthew J.
   Pillai, Satish K.
   Petersen, Lyle R.
   Honein, Margaret A.
   Jamieson, Denise J.
   Brooks, John T.
TI Update: Interim Guidance for Preconception Counseling and Prevention of
   Sexual Transmission of Zika Virus for Persons with Possible Zika Virus
   Exposure - United States, September 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
ID SEMEN; INFECTION; RNA; PERSISTENCE; EPIDEMIC; DISEASE; WOMEN
C1 [Petersen, Emily E.; Meaney-Delman, Dana; Neblett-Fanfair, Robyn; Havers, Fiona; Oduyebo, Titilope; Hills, Susan L.; Rabe, Ingrid B.; Lambert, Amy; Abercrombie, Julia; Martin, Stacey W.; Gould, Carolyn V.; Oussayef, Nadia; Polen, Kara N. D.; Kuehnert, Matthew J.; Pillai, Satish K.; Petersen, Lyle R.; Honein, Margaret A.; Jamieson, Denise J.; Brooks, John T.] CDC, Zika Response, Atlanta, GA 30333 USA.
RP Petersen, EE (corresponding author), CDC, Zika Response, Atlanta, GA 30333 USA.
EM zikamch@cdc.gov
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   CDC, 2016, CDC UPD GUID TRAV TE
   CDC, 2016, EFF FAM PLANN METH
   CDC, 2016, GUID US LAB TEST ZIK
   CDC, 2016, PREC COUNS WOM MEN L
   Curtis KM, 2016, MMWR RECOMM REP, V65
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   ENDERS G, 1988, LANCET, V1, P1445
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huits B, 2016, B WHO
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S., 2016, CLIN INFECT DIS
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nunoue T, 2002, PEDIATR INFECT DIS J, V21, P1133, DOI 10.1097/00006454-200212000-00009
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Revello MG, 2002, J INFECT DIS, V186, P553, DOI 10.1086/341831
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 42
TC 0
Z9 0
U1 1
U2 141
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD OCT 7
PY 2016
VL 65
IS 39
BP 33
EP 37
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DZ6SV
UT WOS:000385993100006
DA 2020-07-08
ER

PT J
AU Goodman, AB
   Dziuban, EJ
   Powell, K
   Bitsko, RH
   Langley, G
   Lindsey, N
   Franks, JL
   Russell, K
   Dasgupta, S
   Barfield, WD
   Odom, E
   Kahn, E
   Martin, S
   Fischer, M
   Staples, JE
AF Goodman, Alyson B.
   Dziuban, Eric J.
   Powell, Krista
   Bitsko, Rebecca H.
   Langley, Gayle
   Lindsey, Nicole
   Franks, Jessica L.
   Russell, Kate
   Dasgupta, Sharoda
   Barfield, Wanda D.
   Odom, Erika
   Kahn, Emily
   Martin, Stacey
   Fischer, Marc
   Staples, J. Erin
TI Characteristics of Children Aged < 18 Years with Zika Virus Disease
   Acquired Postnatally - US States, January 2015-July 2016
SO MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
LA English
DT Article
C1 [Goodman, Alyson B.] CDC, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Dziuban, Eric J.; Bitsko, Rebecca H.; Franks, Jessica L.] CDC, Div Human Dev & Disabil, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Powell, Krista] CDC, Div TB Eliminat, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Langley, Gayle] CDC, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Lindsey, Nicole; Martin, Stacey; Fischer, Marc; Staples, J. Erin] CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   [Russell, Kate; Dasgupta, Sharoda] CDC, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   [Russell, Kate] CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   [Dasgupta, Sharoda] CDC, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.
   [Barfield, Wanda D.] CDC, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Odom, Erika] CDC, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Kahn, Emily] CDC, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Staples, JE (corresponding author), CDC, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
EM estaples@cdc.gov
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pacheco O, 2016, N ENGL J MED
   Petersen E. E., 2016, MMWR MORB MORTAL WKL, P65
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sharp TM, 2016, CLIN INFECT DIS
NR 10
TC 1
Z9 1
U1 0
U2 46
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 0149-2195
EI 1545-861X
J9 MMWR-MORBID MORTAL W
JI MMWR-Morb. Mortal. Wkly. Rep.
PD OCT 7
PY 2016
VL 65
IS 39
BP 38
EP 41
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DZ6SV
UT WOS:000385993100007
DA 2020-07-08
ER

PT J
AU Huang, WC
   Abraham, R
   Shim, BS
   Choe, H
   Page, DT
AF Huang, Wen-Chin
   Abraham, Rachy
   Shim, Byoung-Shik
   Choe, Hyeryun
   Page, Damon T.
TI Zika virus infection during the period of maximal brain growth causes
   microcephaly and corticospinal neuron apoptosis in wild type mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID POSTNATAL-DEVELOPMENT; IN-VIVO; ORGANOIDS
AB Zika virus (ZIKV) infection in pregnant women has been established as a cause of microcephaly in newborns. Here we test the hypothesis that neurodevelopmental stages when the brain is undergoing rapid growth are particularly vulnerable to the effects of ZIKV infection. We injected ZIKV intracranially into wild type C57BL/6 mice at two different time points: early postnatal development, when the brain is growing at its maximal rate, and at weaning, when the brain has largely reached adult size. Both time points showed widespread immunoreactivity for ZIKV and cleaved caspase 3 (CC3, a marker of apoptosis) throughout the brain. However, in early postnatal ZIKV injected mice, some brain areas and cell types display particularly large increases in apoptosis that we did not observe in older animals. Corticospinal pyramidal neurons, a cell type implicated in human microcephaly associated with ZIKV infection, are an example of one such cell type. Proliferating cells in the ventricular zone stem cell compartment are also depleted. These findings are consistent with the hypothesis that periods of rapid brain growth are especially susceptible to neurodevelopmental effects of ZIKV infection, and establish a valuable model to investigate mechanisms underlying neurodevelopmental effects of ZIKV infection and explore candidate therapeutics.
C1 [Huang, Wen-Chin; Page, Damon T.] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.
   [Huang, Wen-Chin; Page, Damon T.] Scripps Res Inst, Doctoral Program Chem & Biol Sci, Jupiter, FL 33458 USA.
   [Abraham, Rachy; Shim, Byoung-Shik; Choe, Hyeryun] Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA.
RP Page, DT (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA.; Page, DT (corresponding author), Scripps Res Inst, Doctoral Program Chem & Biol Sci, Jupiter, FL 33458 USA.; Choe, H (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, Jupiter, FL 33458 USA.
EM HChoe@scripps.edu; paged@scripps.edu
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI110692]
FX This work was supported by NIH/NIAID grant R01 AI110692 (HC) and gift
   funds from Ms. Nancy Lurie Marks (DTP). We are grateful to Dr. Michael
   Farzan for helpful comments on this manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen YJ, 2015, J NEUROSCI, V35, P10252, DOI 10.1523/JNEUROSCI.5272-14.2015
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tramontin AD, 2003, CEREB CORTEX, V13, P580, DOI 10.1093/cercor/13.6.580
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
NR 26
TC 44
Z9 45
U1 0
U2 82
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD OCT 7
PY 2016
VL 6
AR 34793
DI 10.1038/srep34793
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DY1DZ
UT WOS:000384836400001
PM 27713505
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Munoz, AG
   Thomson, MC
   Goddard, L
   Aldighieri, S
AF Munoz, Angel G.
   Thomson, Madeleine C.
   Goddard, Lisa
   Aldighieri, Sylvain
TI Analyzing climate variations at multiple timescales can guide Zika virus
   response measures
SO GIGASCIENCE
LA English
DT Article
DE Zika virus; Epidemic; Climate; Climate change; Decadal; Inter-annual; El
   Nino; Brazil; Drought; Vector control
ID DENGUE; RISK; AMERICA
AB Background: The emergence of Zika virus (ZIKV) in Latin America and the Caribbean in 2014-2016 occurred during a period of severe drought and unusually high temperatures, conditions that have been associated with the 2015-2016 El Nino event, and/or climate change; however, no quantitative assessment has been made to date. Analysis of related flaviviruses transmitted by the same vectors suggests that ZIKV dynamics are sensitive to climate seasonality and longer-term variability and trends. A better understanding of the climate conditions conducive to the 2014-2016 epidemic may permit the development of climate-informed short and long-term strategies for ZIKV prevention and control.
   Results: Using a novel timescale-decomposition methodology, we demonstrate that the extreme climate anomalies observed in most parts of South America during the current epidemic are not caused exclusively by El Nino or climate change, but by a combination of climate signals acting at multiple timescales. In Brazil, the dry conditions present in 2013-2015 are primarily explained by year-to-year variability superimposed on decadal variability, but with little contribution of long-term trends. In contrast, the warm temperatures of 2014-2015 resulted from the compound effect of climate change, decadal and year-to-year climate variability.
   Conclusions: ZIKV response strategies made in Brazil during the drought concurrent with the 2015-2016 El Nino event, may require revision in light of the likely return of rainfall associated with the borderline La Nina event expected in 2016-2017. Temperatures are likely to remain warm given the importance of long term and decadal scale climate signals.
C1 [Munoz, Angel G.] Princeton Univ, Geophys Fluid Dynam Lab, Atmospher & Ocean Sci, Forrestal Campus Forrestal Rd 201, Princeton, NJ 08544 USA.
   [Munoz, Angel G.; Thomson, Madeleine C.; Goddard, Lisa] Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, New York, NY USA.
   [Munoz, Angel G.] Univ Zulia, Ctr Modelado Cient, Latin Amer Observ Climate Events, Maracaibo, Venezuela.
   [Thomson, Madeleine C.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA.
   [Thomson, Madeleine C.] World Hlth Org Collaborating Ctr Early Warning Sy, New York, NY USA.
   [Aldighieri, Sylvain] Pan Amer Hlth Org, Int Hlth Regulat Epidem Alert & Response, Washington, DC USA.
   [Aldighieri, Sylvain] Pan Amer Hlth Org, Water Borne Dis Communicable Dis & Hlth Anal Dept, Washington, DC USA.
RP Munoz, AG (corresponding author), Princeton Univ, Geophys Fluid Dynam Lab, Atmospher & Ocean Sci, Forrestal Campus Forrestal Rd 201, Princeton, NJ 08544 USA.; Munoz, AG (corresponding author), Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, New York, NY USA.; Munoz, AG (corresponding author), Univ Zulia, Ctr Modelado Cient, Latin Amer Observ Climate Events, Maracaibo, Venezuela.
EM angel.g.munoz@noaa.gov
FU National Oceanic and Atmospheric Administration Oceanic and Atmospheric
   Research under National Earth System Prediction Capability
FX AGM was supported by National Oceanic and Atmospheric Administration
   Oceanic and Atmospheric Research, under the auspices of the National
   Earth System Prediction Capability.
CR Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Campbell KM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003957
   Chen MY, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009132
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gardner LM, 2016, LANCET INFECT DIS, V16, P522, DOI 10.1016/S1473-3099(16)00176-6
   Greene AM, 2011, EOS T AM GEOPHYS UN, V92, P397, DOI DOI 10.1029/2011EO450001
   Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Kelly-Hope L, 2008, ADV GLOB CHANGE RES, V30, P31, DOI 10.1007/978-1-4020-6877-5_3
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Metz B., 2007, CONTRIBUTION WORKING
   Munoz A G, 2016, GIGASCIENCE DATABASE
   Munoz AG, 2016, 201601 IRI COL U AC, DOI [10.7916/D8X34XHV, DOI 10.7916/D8X34XHV]
   Munoz AG, 2016, 2016 HLTH CLIM C
   NOAA, 2015, STAT CLIM GLOB AN 20
   NOAA, 2016, STAT CLIM GLOB AN 20
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Schneider MC, 2012, INT J ENV RES PUB HE, V9, P3883, DOI 10.3390/ijerph9113883
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Trewin BJ, 2013, INT HEALTH, V5, P251, DOI 10.1093/inthealth/iht023
   van den Dool H, 2008, J GEOPHYS RES, V113
NR 25
TC 15
Z9 15
U1 0
U2 44
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2047-217X
J9 GIGASCIENCE
JI GigaScience
PD OCT 6
PY 2016
VL 5
AR 41
DI 10.1186/s13742-016-0146-1
PG 6
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA DY6TT
UT WOS:000385261900001
PM 27716414
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Basu, R
   Tumban, E
AF Basu, Rupsa
   Tumban, Ebenezer
TI Zika Virus on a Spreading Spree: what we now know that was unknown in
   the 1950's
SO VIROLOGY JOURNAL
LA English
DT Review
DE Zika virus; Sexual transmission; Neurological development; Microcephaly;
   Antibody-dependent enhancement
ID SEXUAL TRANSMISSION; CROSS-REACTIVITY; DENGUE VIRUS; INFECTION;
   OUTBREAK; MOSQUITO; BRAIN; STATE
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that is transmitted through the bite of Aedes spp mosquitoes and less predominantly, through sexual intercourse. Prior to 2007, ZIKV was associated with only sporadic human infections with minimal or no clinical manifestations. Recently the virus has caused disease outbreaks from the Pacific Islands, the Americas, and off the coast of West Africa with approximately 1.62 million people suspected to be infected in more than 60 countries around the globe. The recent ZIKV outbreaks have been associated with guillain-barre syndrome, congenital syndrome (microcephaly, congenital central nervous system anomalies), miscarriages, and even death. This review summarizes the path of ZIKV outbreak within the last decade, highlights three novel modes of ZIKV transmission associated with recent outbreaks, and points to the hallmarks of congenital syndrome. The review concludes with a summary of challenges facing ZIKV research especially the control of ZIKV infection in the wake of most recent data showing that anti-dengue virus antibodies enhance ZIKV infection.
C1 [Basu, Rupsa; Tumban, Ebenezer] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.
RP Tumban, E (corresponding author), Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA.
EM etumban@mtu.edu
RI Basu, Rupsa/V-2531-2019
OI Basu, Rupsa/0000-0002-6336-0842
FU Michigan Technological University
FX Start-up fund from Michigan Technological University.
CR Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Fokam E B, 2010, East Afr Med J, V87, P262
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pacheco O, 2016, N ENGL J MED
   Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 49
TC 14
Z9 14
U1 0
U2 136
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD OCT 6
PY 2016
VL 13
AR 165
DI 10.1186/s12985-016-0623-2
PG 9
WC Virology
SC Virology
GA DX9RW
UT WOS:000384733800002
PM 27716242
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Baud, D
   Gerardin, P
   Merriam, A
   Alves, MP
   Musso, D
   Genton, B
   Panchaud, A
AF Baud, David
   Gerardin, Patrick
   Merriam, Audrey
   Alves, Marco P.
   Musso, Didier
   Genton, Blaise
   Panchaud, Alice
TI MICROCEPHALY IN EUROPE Harness shared data in international Zika
   registry
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Letter
C1 [Baud, David] Univ Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, CH-1011 Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.
   [Baud, David] Univ Hosp, Lausanne, Switzerland.
   [Gerardin, Patrick] Univ La Reunion, Pole Femme Mere Enfant, Ctr Invest Clin,U1187,IRD 249,CHU Reunion, INSERM,CIC1410,UM 134,PIMIT,CNRS 9192,INSERM, St Pierre, Reunion, France.
   [Merriam, Audrey] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, New York, NY USA.
   [Alves, Marco P.] Univ Bern, Dept Infect Dis & Pathobiol, Inst Virol & Immunol, CH-3012 Bern, Switzerland.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, France.
   [Genton, Blaise] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland.
   [Genton, Blaise] Univ Lausanne Hosp, Dept Ambulatory Care, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Hosp, Swiss Teratogen Informat Serv, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Hosp, Div Clin Pharmacol, CH-1011 Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva & Lausanne, Sch Pharmaceut Sci, Geneva, Switzerland.
   [Panchaud, Alice] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
RP Baud, D (corresponding author), Univ Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, CH-1011 Lausanne, Switzerland.; Baud, D (corresponding author), Univ Lausanne, Fac Biol & Med, Inst Microbiol, Lausanne, Switzerland.; Baud, D (corresponding author), Univ Hosp, Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Panchaud, Alice/S-6535-2019; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020
OI Panchaud, Alice/0000-0001-6086-2401; Musso, Didier/0000-0002-9226-0971;
   Musso, Didier/0000-0002-9226-0971; Baud, David/0000-0001-9914-6496
CR Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
NR 3
TC 3
Z9 3
U1 1
U2 107
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD OCT 5
PY 2016
VL 355
AR i5319
DI 10.1136/bmj.i5319
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA DZ4UH
UT WOS:000385855300008
PM 27707728
OA Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Wu, J
   Huang, DY
   Ma, JT
   Ma, YH
   Hu, YF
AF Wu, Jing
   Huang, Da-Yong
   Ma, Jun-Tao
   Ma, Ying-Hua
   Hu, Yi-Fei
TI Available Evidence of Association between Zika Virus and Microcephaly
SO CHINESE MEDICAL JOURNAL
LA English
DT Review
DE Microcephaly; Pregnant Woman; Zika Virus
ID MATERNAL NUTRITIONAL-STATUS; SEXUAL TRANSMISSION; CHIKUNGUNYA VIRUS;
   FRENCH-POLYNESIA; INFECTION; INFANTS; BRAZIL; BRAIN; BIRTH; OUTBREAK
AB Objective: To clarify the possible association between the Zika virus (ZIKV) and microcephaly and understand where we are in terms of research and the debate on the causation between mild maternal clinical features and severe fetal microcephaly.
   Data Sources: We did a comprehensive literature review with the keywords "zika" and/or "microcephaly" from inception to May 27, 2016, with PubMed.
   Study Selection: Studies were included and analyzed if they met all of the following criteria: "probable or confirmed infant microcephaly" and "probable or confirmed ZJKV infection among mothers or infants".
   Results: We emphasize the diagnosis of ZIKV infection, including maternal clinical manifestations, maternal and fetal laboratory confirmation, and possible autopsy if need. Other confounders that may lead to microcephaly should be excluded from the study. We presented the results from clinical manifestations of ZIKV infection, testing methods evolving but the mechanism of microcephaly uncertain, flexible definition challenging the diagnosis of microcephaly, and limited causal reference on pregnant women. We made analog comparison of severe acute respiratory syndrome and chikungunya virus in terms of DNA mutation and global movement to provide further research recommendation. The chance of catch-up growth may decrease the number of pervious "diagnosed" microcephaly.
   Conclusions: There are some evidence available through mice models and direct isolation of ZIKV in affected pregnancies on kindly causal relationship but not convincible enough. We analyzed and presented the weakness or limitation of published reports with the desire to shed light to further study directions.
C1 [Wu, Jing] Open Univ China, Sch Agroforestry & Med, Beijing 100039, Peoples R China.
   [Huang, Da-Yong] Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, Beijing 100050, Peoples R China.
   [Ma, Jun-Tao] Chinese Peoples Liberat Army, Med Lib, Dept Reader Serv, Beijing 100039, Peoples R China.
   [Ma, Ying-Hua] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100191, Peoples R China.
   [Hu, Yi-Fei] Capital Med Univ, Sch Publ Hlth, Dept Child Adolescent Hlth & Maternal Hlth, Beijing 100069, Peoples R China.
RP Hu, YF (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Child Adolescent Hlth & Maternal Hlth, Beijing 100069, Peoples R China.
EM huyifei@ccmu.edu.cn
OI Huang, Dayong/0000-0001-9449-8484
FU Presidential Fund of Capital Medical University
FX This work was supported by the grant from 2016 Presidential Fund of
   Capital Medical University.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Adu-Afarwuah S, 2015, AM J CLIN NUTR, V101, P835, DOI 10.3945/ajcn.114.091546
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bispo A, 2016, B WORLD HEALTH ORGAN, V94, P165, DOI 10.2471/BLT.16.030316
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   He JF, 2004, SCIENCE, V303, P1666, DOI 10.1126/science.1092002
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   Hu B, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0422-1
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kline MW, 2016, JAMA PEDIATR, V170, P309, DOI 10.1001/jamapediatrics.2016.0429
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Logan I., 2015, BIORXIV, DOI 10.1101/016428
   Logan IS, 2016, ZOOL RES, V37, P110, DOI 10.13918/j.issn.2095-8137.2016.2.110
   Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mont'alvao A, 2016, YOUTH LABOR MARKET P
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Morgan C, 2014, PEDIATRICS, V133, pE120, DOI 10.1542/peds.2013-2207
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Pan American Health Organization World Health Organization, 2016, INCR MICR NE BRAZ 20
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shrinet J, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-100
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   STEIN Z, 1975, PEDIATR RES, V9, P70, DOI 10.1203/00006450-197509020-00003
   Thame M, 1997, EUR J CLIN NUTR, V51, P134, DOI 10.1038/sj.ejcn.1600357
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, 2016, ZIK VIR MICR GUIL BA
   Young MF, 2015, EUR J OBSTET GYN R B, V194, P223, DOI 10.1016/j.ejogrb.2015.09.018
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang X, 2013, VIROL J, V10, DOI [10.1186/1743-422X-10-194, 10.1186/1743-422X-10-174]
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 76
TC 6
Z9 6
U1 0
U2 81
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0366-6999
EI 2542-5641
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD OCT 5
PY 2016
VL 129
IS 19
BP 2347
EP 2356
DI 10.4103/0366-6999.190672
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX4LP
UT WOS:000384353100013
PM 27647195
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Steffler, LM
   Dolabella, SS
   Ribolla, PEM
   Dreyer, CS
   Araujo, ED
   Oliveira, RG
   Martins, WFS
   La Corte, R
AF Steffler, Lizandra Makowski
   Dolabella, Silvio Santana
   Martins Ribolla, Paulo Eduardo
   Dreyer, Carine Spenassatto
   Araujo, Edilson Divino
   Oliveira, Rosane Gomes
   Silva Martins, Walter Fabricio
   La Corte, Roseli
TI Genetic variability and spatial distribution in small geographic scale
   of Aedes aegypti (Diptera: Culicidae) under different climatic
   conditions in Northeastern Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE ISSR-PCR; Single nucleotide polymorphism; Entomological surveillance;
   Vector control; Zika; Dengue; Chikungunya; Arboviruses
ID YELLOW-FEVER MOSQUITO; POPULATION-GENETICS; DNA VARIATION;
   MICROSATELLITE; SELECTION; MARKERS; VECTOR; DENGUE; RESISTANCE;
   DIVERSITY
AB Background: The study of the genetic structure of Aedes aegypti is essential to understanding their population dynamics as well as for the analysis of factors responsible for their resistance and ecological adaptation. The use of molecular markers in identifying differences amongst populations of Ae. aegypti in different geographical areas as well as the temporal variation of the vector populations has contributed to the improvement of vector control strategies. The present study aims to determine the genetic variability of Ae. aegypti populations in a small geographical area (state of Sergipe, Northeastern Brazil) by means of inter-simple sequence repeat (ISSR) and single nucleotide polymorphism (SNP) molecular markers.
   Results: ISSR markers revealed a more heterogeneous pattern of genetic diversity among the populations with an expected heterozygosity (HE) ranging from 0.261 +/- 0.03 to 0.120 +/- 0.032, while a similar trend was detected through SNPs across populations with an HE between 0.375 +/- 0.054 and 0.269 +/- 0.042. The population's genetic differentiation assessed with ISSR and SNP markers indicated a very low structuring among the populations with the highest diversity observed within the populations 72 % (ISSR) and 92 % (SNP). Clustering analysis also suggested little variation among populations: the seven populations were grouped into only three ISSR clusters and a single panmictic group based on SNP markers. The present study identified a close relationship between the populations, which probably results mainly from passive gene flow between mosquitoes from distinct geographic regions, influenced by humans commuting along roads.
   Conclusions: There was an intense migration of mosquitos across municipalities, leading to a potential increase in risk of arbovirus and insecticide resistance associated-alleles spreading between mosquito populations.
C1 [Steffler, Lizandra Makowski; Dolabella, Silvio Santana; La Corte, Roseli] Univ Fed Sergipe, Programa Posgrad Biol Parasitaria, Ave Mal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Dolabella, Silvio Santana; La Corte, Roseli] Univ Fed Sergipe, Dept Morfol, Ave Mal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Martins Ribolla, Paulo Eduardo; Dreyer, Carine Spenassatto] Univ Estadual Julio de Mesquita Filho, Dept Parasitol, Rubiao Jr,CP 510, BR-18618900 Botucatu, SP, Brazil.
   [Araujo, Edilson Divino] Univ Fed Sergipe, Dept Biol, Ave Mal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Araujo, Edilson Divino; Oliveira, Rosane Gomes] Univ Fed Sergipe, Programa Posgrad Biotecnol, Rede Nordeste Biotecnol, Ave Mal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
   [Silva Martins, Walter Fabricio] Univ Estadual Paraiba, Dept Biol CCBS, R Baraunas 351, BR-58429500 Campina Grande, Paraiba, Brazil.
RP La Corte, R (corresponding author), Univ Fed Sergipe, Programa Posgrad Biol Parasitaria, Ave Mal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.; La Corte, R (corresponding author), Univ Fed Sergipe, Dept Morfol, Ave Mal Rondon S-N, BR-49100000 Sao Cristovao, Sergipe, Brazil.
EM rlacorte@ufs.br
RI Santos, Roseli LC/F-1735-2015; Ribolla, Paulo/AAH-3354-2020; Dolabella,
   Silvio/X-4351-2019; Ribolla, Paulo EM/B-9122-2012; Araujo,
   Edilson/H-9742-2013
OI Ribolla, Paulo EM/0000-0001-8735-6090; Santana Dolabella,
   Silvio/0000-0001-5576-3214; Araujo, Edilson/0000-0001-6443-3444
FU FAPITEC
FX This project was carried out with resources from 1. Conselho Nacional de
   Pesquisa e Desenvolvimento (CNPq) and Fundacao de Apoio a Pesquisa e
   Inovacao Tecnologica do Estado de Sergipe (FAPITEC) - Edital 73/2009
   Pronex Rede Dengue, 2. Conselho de Aperfeicoamento de Pessoal do Ensino
   Superior (CAPES) - Edital 32/2010 Parasitologia Basica and 3.
   CAPES/FAPITEC - Edital 06/2012 PROMOB and masters' grant (FAPITEC) to
   Lizandra Makowski Steffler.
CR Aizoun Nazaire, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P239, DOI 10.1016/S2221-1691(14)60238-0
   Ayres C, 2002, MEM I OSWALDO CRUZ, V97, P871, DOI 10.1590/S0074-02762002000600022
   Beserra EB, 2009, IHERINGIA SER ZOOL, V99, P142, DOI 10.1590/S0073-47212009000200004
   Bracco JE, 2007, MEM I OSWALDO CRUZ, V102, P573, DOI 10.1590/S0074-02762007005000062
   Castro Jr. Francisco P. de, 2013, Iheringia, Sér. Zool., V103, P118, DOI 10.1590/S0073-47212013000200006
   Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015
   Clemons A, 2010, COLD SPRING HARB PRO, V5, DOI [10.1101/pdb.emo141, DOI 10.1101/PDB.EMO141.]
   Damal K, 2013, AM J TROP MED HYG, V89, P482, DOI 10.4269/ajtmh.13-0102
   Paploski IAD, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1705-0
   Paduan KD, 2006, GENET MOL BIOL, V29, P391, DOI 10.1590/S1415-47572006000200030
   Endersby NM, 2009, J MED ENTOMOL, V46, P1074, DOI 10.1603/033.046.0514
   Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367
   Hickner PV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013062
   Hiragi C, 2009, NEOTROP ENTOMOL, V38, P542, DOI 10.1590/S1519-566X2009000400018
   Huber K, 2001, MOL ECOL NOTES, V1, P219, DOI 10.1046/j.1471-8278.2001.00077.x
   INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA (IBGE), EST
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129
   Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109
   Labbe P, 2009, GENETICS, V182, P303, DOI 10.1534/genetics.109.101444
   Lima RS, 2009, GENET MOL BIOL, V32, P414, DOI 10.1590/S1415-47572009005000036
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lovin DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-590
   Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021
   Marteis LS, 2013, CAD SAUDE PUBLICA, V29, P369
   Morlais I, 2003, INSECT MOL BIOL, V12, P631, DOI 10.1046/j.1365-2583.2003.00449.x
   Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420
   Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913
   Olson-Manning CF, 2012, NAT REV GENET, V13, P867, DOI 10.1038/nrg3322
   Omondi E. O., 2016, Advances in Bioscience and Biotechnology, V7, P188, DOI 10.4236/abb.2016.73017
   Paduan KS, 2009, MOL ECOL RESOUR, V9, P114, DOI 10.1111/j.1755-0998.2008.02282.x
   Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460
   Pritchard JK, 2000, GENETICS, V155, P945
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   Ravel S, 2002, ACTA TROP, V82, P39, DOI 10.1016/S0001-706X(02)00028-1
   Rose CJ, 2011, MOL BIOL EVOL, V28, P1835, DOI 10.1093/molbev/msr006
   Schlotterer C, 2003, TRENDS GENET, V19, P32, DOI 10.1016/S0168-9525(02)00012-4
   Slotman MA, 2007, MOL ECOL NOTES, V7, P168, DOI 10.1111/j.1471-8286.2006.01533.x
   Soliani C, 2010, MED VET ENTOMOL, V24, P316, DOI 10.1111/j.1365-2915.2010.00890.x
   Souza-Santos R, 2000, Cad Saude Publica, V16, P31, DOI 10.1590/S0102-311X2000000100004
   Turner TL, 2007, MOL BIOL EVOL, V24, P2132, DOI 10.1093/molbev/msm143
   Urdaneta-Marquez L, 2008, AM J TROP MED HYG, V78, P479, DOI 10.4269/ajtmh.2008.78.479
   Valenca MA, 2013, NEOTROP ENTOMOL, V42, P311, DOI 10.1007/s13744-013-0118-4
   Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526
NR 44
TC 3
Z9 3
U1 1
U2 46
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD OCT 4
PY 2016
VL 9
AR 530
DI 10.1186/s13071-016-1814-9
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DY1IA
UT WOS:000384846900002
PM 27716392
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jarvis, L
AF Jarvis, Lisa
TI Sanofi's Zika vaccine gets funding
SO CHEMICAL & ENGINEERING NEWS
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2347
EI 1520-605X
J9 CHEM ENG NEWS
JI Chem. Eng. News
PD OCT 3
PY 2016
VL 94
IS 39
BP 18
EP 18
PG 1
WC Chemistry, Multidisciplinary; Engineering, Chemical
SC Chemistry; Engineering
GA DX6RO
UT WOS:000384511000029
DA 2020-07-08
ER

PT J
AU de Souza, MDB
   Raupp, V
   Sobrinho, F
   Menezes, M
   Panaino, TR
   Tamm, MA
   Mancebo, ACA
   Costa, ALR
   Antunes, RA
AF de Souza, Maria do Carmo B.
   Raupp, Veronica
   Sobrinho, Fernanda
   Menezes, Mariana
   Panaino, Tatiana R.
   Tamm, Maria A.
   Mancebo, Ana C. A.
   Costa, Ana L. R.
   Antunes, Roberto A.
TI Zika virus and Assisted Reproductive Technology: to test or not to test,
   that is the question. Is it an unnecessary cost? The first two months of
   mandatory testing in an outbreak area in Rio de Janeiro, Brazil
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Article
DE Zika virus; immunology; in vitro fertilization
AB Objective: Infection by the Zika virus is a Public Health Emergency of International Concern as defined by the World Health Organization. Resolution no. 72, issued by the Collegiate Board of the Brazilian Health Surveillance Agency (ANVISA) on March 30, 2016, made ZKV testing mandatory prior to procedures involving germ cells and tissues. This paper aims to discuss the aforementioned Resolution from the standpoint of evidence and cost-effectiveness of the measures taken within the first two months of mandatory testing.
   Methods: The medical staff at the clinic looked into the steps needed to comply with the new rules and checked laboratories in the city to perform the tests with their lead times and costs, health insurance refunds, data maintenance capabilities, how to contact patients, decision-making processes in ongoing cases, deadlines for implementation, in addition to exchanging ideas with other clinics and gathering information from the guidelines being produced. A SWOT analysis was performed.
   Results: A total of 152 tests were performed within the first two months of mandatory testing, in five different clinical situations: one previously symptomatic woman with a negative PCR test before starting the cycle; two asymptomatic women had positive IgM (1.3%) and negative PCR tests on days 25 and 60; one husband enrolled as a suspect with a negative RT-PCR on day 13 and another untested suspected case; a couple decided to have their oocytes cryopreserved because the husband's test result was not available on pickup day. The mean cost of USD 200 per couple is equivalent to 1.2 day of the stimulation protocol. The staff worked more efficiently and was able to respond promptly to the increased demand for ZKV testing; however, the tests failed to reassure patients of the safety of the procedure and increased costs.
   Conclusion: The testing requirement for asymptomatic patients prior to ART should be reviewed.
C1 [de Souza, Maria do Carmo B.; Panaino, Tatiana R.; Tamm, Maria A.; Mancebo, Ana C. A.; Costa, Ana L. R.; Antunes, Roberto A.] Fertipraxis Ctr Reprod Humana, Rio De Janeiro, RJ, Brazil.
   [Raupp, Veronica; Sobrinho, Fernanda; Menezes, Mariana] Hosp Fed Lagoa, Rio De Janeiro, RJ, Brazil.
RP de Souza, MDB (corresponding author), Fertipraxis Ctr Reprod Humana, Rio De Janeiro, RJ, Brazil.
EM mariadocarmo@fertipraxis.com.br
CR ABHH-Associacao Brasileira de Hematologia Hemoter-apia e Terapia Celular, PAR TECN TRANSF SANG
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   ANVISA RDC 72 de 30 de marco de 2016, 2016, 72 ANVISA RDC
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministerio da Saude-Brazil, ZIK SINT
   Ministerio da Saude-Brazil, 2016, PLAN NAC ENFR MICR
   Musso D, 2013, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Vigilancia Epidemiologica. SMS, 2016, VIG EP
NR 12
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD OCT-DEC
PY 2016
VL 20
IS 4
BP 195
EP 199
DI 10.5935/1518-0557.20160038
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FA2CZ
UT WOS:000405249600002
PM 28050952
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI In times of Zika: getting pregnant or delaying plans
SO JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Surindra Rajabhat Univ, Surin, Thailand.
RP Wiwanitkit, V (corresponding author), Surindra Rajabhat Univ, Surin, Thailand.
EM wviroj@yahoo.com
CR de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
NR 1
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA
PI RIBEIRAO
PA SOC BRASILEIRA REPRODUCAO ASSISTIDA-SBRA, RIBEIRAO, 00000, BRAZIL
SN 1517-5693
EI 1518-0557
J9 J BRAS REPROD ASSIST
JI J. Bras. Reprod. Assist.
PD OCT-DEC
PY 2016
VL 20
IS 4
BP 259
EP 259
DI 10.5935/1518-0557.20160051
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FA2CZ
UT WOS:000405249600015
PM 28050965
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Skrove, JL
   Salhab, J
   Colella, DM
   Michel, G
   Sobrado, J
   Almeida, M
AF Skrove, Jamie L.
   Salhab, Joseph
   Colella, Dominic M.
   Michel, George, Jr.
   Sobrado, Javier
   Almeida, Mario
TI Zika Virus: A Rare Case with Presenting Symptoms of Gastroenteritis and
   Transaminitis with Subsequent Progression to Guillain-Barre Syndrome
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Meeting Abstract
CT 81st Annual Scientific Meeting of the
   American-College-of-Gastroenterology
CY OCT 21-26, 2016
CL Las Vegas, NV
SP Amer Coll Gastroenterol
C1 [Skrove, Jamie L.; Salhab, Joseph; Colella, Dominic M.] Nova Southeastern Univ, Larkin Hosp, South Miami, FL USA.
   [Michel, George, Jr.] Univ Miami, Miami, FL USA.
   [Sobrado, Javier] Nova Southeastern Univ, Larkin Hosp, Miami, FL USA.
   [Almeida, Mario] Baptist Hlth South Florida, Miami, FL USA.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD OCT
PY 2016
VL 111
SU 1
MA 2043
BP S975
EP S976
DI 10.14309/00000434-201610001-02043
PG 2
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA EN1IV
UT WOS:000395764603341
DA 2020-07-08
ER

PT J
AU Veilleux, C
   Eugenin, E
AF Veilleux, Courtney
   Eugenin, Eliseo
TI Characterization of Zika virus infection in Human Astrocytes
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT 14th International Symposium on NeuroVirology
CY OCT 25-28, 2016
CL Toronto, CANADA
C1 Rutgers State Univ, PHRI, Newark, NJ USA.
   Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA.
EM cav103@njms.rutgers.edu
NR 0
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD OCT
PY 2016
VL 22
SU 1
MA P162
BP S78
EP S79
PG 2
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA EK7GH
UT WOS:000394093700163
DA 2020-07-08
ER

PT J
AU Ventura, CV
   Fernandez, MP
   Gonzalez, IA
   Rivera-Hernandez, DM
   Lopez-Alberola, R
   Peinado, M
   Floren, AA
   Rodriguez, PA
   Williams, BK
   Muns, GD
   Rodriguez, AJ
   Negron, C
   Fallas, B
   Berrocal, AM
AF Ventura, Camila V.
   Fernandez, Maria Paula
   Gonzalez, Ivan A.
   Rivera-Hernandez, Delia M.
   Lopez-Alberola, Roberto
   Peinado, Maria
   Floren, Angelica A.
   Rodriguez, Patricia A.
   Williams, Basil K., Jr.
   Muns, Gabriela de la Vega
   Rodriguez, Ana J.
   Negron, Catherin
   Fallas, Brenda
   Berrocal, Audina M.
TI First Travel-Associated Congenital Zika Syndrome in the US: Ocular and
   Neurological Findings in the Absence of Microcephaly
SO OPHTHALMIC SURGERY LASERS & IMAGING RETINA
LA English
DT Article
ID VIRUS
AB A 6-day-old female baby with known diagnosis of congenital Zika infection was referred for ophthalmologic examination. The mother (37 years old) was referred for a pruritic rash, conjunctival hyperemia, and malaise at 12 weeks of gestation while still living in Venezuela. Upon arrival to Miami, Zika virus (ZIKV) exposure was confirmed during prenatal screening. At birth, due to the known exposure, a complete congenital ZIKV workup was performed, including brain ultrasound and MRI, which disclosed calcifications in the frontal lobe. Fundus examination revealed a hypopigmented retinal lesion in the left eye that was documented with retinal imaging.
C1 [Ventura, Camila V.; Fernandez, Maria Paula; Williams, Basil K., Jr.; Negron, Catherin] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.
   [Ventura, Camila V.] Altino Ventura Fdn, Recife, PE, Brazil.
   [Ventura, Camila V.] Univ Fed Sao Paulo, Paulista Sch Med, Dept Ophthalmol & Visual Sci, Sao Paulo, Brazil.
   [Gonzalez, Ivan A.; Rivera-Hernandez, Delia M.; Rodriguez, Patricia A.] Univ Miami, Jackson Mem Hosp, Miller Sch Med, Dept Pediat,Div Pediat Infect Dis, Miami, FL 33136 USA.
   [Lopez-Alberola, Roberto] Univ Miami, Jackson Mem Hosp, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA.
   [Peinado, Maria; Floren, Angelica A.; Rodriguez, Ana J.] Univ Miami, Jackson Mem Hosp, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA.
   [Muns, Gabriela de la Vega] Univ Miami, Jackson Mem Hosp, Miller Sch Med, Dept Neuroradiol, Miami, FL 33136 USA.
RP Berrocal, AM (corresponding author), Bascom Palmer Eye Inst, 900 NW 17th Ave, Miami, FL 33136 USA.
EM aberrocal@med.miami.edu
RI Ventura, Camila V/N-2654-2018
OI Ventura, Camila V/0000-0002-2927-4684
CR Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   De Fatima Vasco Aragao M, 2016, BMJ-BRIT MED J, V353, pi901
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Florida State Government. Gov, MOSQ BORN ZIK CAS ST
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Leal MC, 2016, BRAZ J OTORHINOLARYN
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   WHO, WHO DIR GEN SUMM OUT
   World Health Organization (WHO), EP AL NEUR SYNDR CON
NR 16
TC 18
Z9 18
U1 0
U2 13
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 2325-8160
EI 2325-8179
J9 OSLI RETINA
JI Ophthalmic Surg. Lasers Imag. Retin.
PD OCT
PY 2016
VL 47
IS 10
BP 952
EP 955
DI 10.3928/23258160-20161004-09
PG 4
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA EJ3HT
UT WOS:000393103900009
PM 27759862
DA 2020-07-08
ER

PT J
AU Di Guardo, G
AF Di Guardo, Giovanni
TI Zika virus: issues of concern
SO NEW MICROBIOLOGICA
LA English
DT Letter
ID INFECTION
C1 [Di Guardo, Giovanni] Univ Teramo, Fac Vet Med, I-64100 Teramo, Italy.
RP Di Guardo, G (corresponding author), Univ Teramo, Fac Vet Med, I-64100 Teramo, Italy.
EM gdiguardo@unite.it
CR Bonnan M, 2015, J NEUROIMMUNOL, V285, P41, DOI 10.1016/j.jneuroim.2015.05.015
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99
   Hayden EC, 2016, NATURE, V530, P142
   Klein L, 2015, CELL, V163, P794, DOI 10.1016/j.cell.2015.10.057
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629
NR 8
TC 0
Z9 0
U1 0
U2 1
PU EDIZIONI INT SRL
PI MILANO
PA VIA SPADOLINI 7, MILANO, 20141, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD OCT
PY 2016
VL 39
IS 4
BP 317
EP 317
PG 1
WC Microbiology
SC Microbiology
GA EI4NB
UT WOS:000392469400016
PM 27551728
DA 2020-07-08
ER

PT J
AU Mishra, B
   Behera, B
AF Mishra, B.
   Behera, B.
TI The mysterious Zika virus: Adding to the tropical flavivirus mayhem
SO JOURNAL OF POSTGRADUATE MEDICINE
LA English
DT Review
DE Aedes aegypti; chikungunya; dengue; microcephaly; Zika virus
ID INTERIM GUIDELINES; FRENCH-POLYNESIA; UNITED-STATES; TRANSMISSION;
   OUTBREAK; BRAZIL; CHIKUNGUNYA; INFECTIONS; DENGUE
AB Until now, known as the demure cousin of dengue virus (DENV) inhabiting Africa, Zika virus (ZIKV) has reinvented itself to cause explosive epidemics captivating the Western hemisphere. The outbreak causing potential for ZIKV was realized when it made its way from Africa to Yap Island Micronesia in 2007, and in French Polynesia in 2013. From there, it moved on to Brazil in 2015. Now ZIKV has infected people in more than 33 countries in Central and South America and the Caribbean. Moreover the epidemiological and subsequent virological association with microcephaly cases in Brazil has prompted the World Health Organization to declare a public health emergency of International Concern. ZIKV shares not only its vector Aedes aegypti with dengue and chikungunya but also the geographic distribution and clinical features, which makes the laboratory confirmation mandatory for definitive diagnosis. The serological cross-reactivity with other Flavivirus, particularly with DENV makes laboratory confirmation challenging and will place additional burden on health systems to establish molecular diagnostic facilities. The evidence of additional nonvector modes of transmission, such as perinatal, sexual as well as transfusion has made preventative strategies more difficult. As ZIKV disease continues to mystify us with several unanswered questions, it calls for coordinated effort of global scientific community to address the ever growing arboviral threat to mankind.
C1 [Mishra, B.; Behera, B.] All India Inst Med Sci, Dept Microbiol, Bhubaneswar, Odisha, India.
RP Mishra, B (corresponding author), All India Inst Med Sci, Dept Microbiol, Bhubaneswar, Odisha, India.
EM bm_mishra@hotmail.com
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G., 2016, LANCET INFECT DIS
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cecilia Dayaraj, 2014, WHO South East Asia J Public Health, V3, P22, DOI 10.4103/2224-3151.206879
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2016, J INFECT DIS
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Moulin E, 2016, New Microbes New Infect, V11, P6, DOI 10.1016/j.nmni.2016.02.003
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV AM
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 31
TC 7
Z9 7
U1 0
U2 2
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0022-3859
EI 0972-2823
J9 J POSTGRAD MED
JI J. Postgrad. Med.
PD OCT-DEC
PY 2016
VL 62
IS 4
BP 249
EP 254
DI 10.4103/0022-3859.191006
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA EG6BY
UT WOS:000391130000008
PM 27763483
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martin-Acebes, MA
   Vazquez-Calvo, A
   Saiz, JC
AF Martin-Acebes, Miguel A.
   Vazquez-Calvo, Angela
   Saiz, Juan-Carlos
TI Lipids and flaviviruses, present and future perspectives for the control
   of dengue, Zika, and West Nile viruses
SO PROGRESS IN LIPID RESEARCH
LA English
DT Review
DE Flavivirus; West Nile virus; Dengue virus; Zika virus; Infection; Lipid
ID HEPATITIS-C VIRUS; NF-KAPPA-B; INNATE IMMUNE-RESPONSES; FATTY-ACID
   SYNTHASE; JAPANESE ENCEPHALITIS; 3-DIMENSIONAL ARCHITECTURE; REPLICATION
   SITES; MEMBRANE-FUSION; SPHINGOLIPID METABOLISM; NONSTRUCTURAL PROTEINS
AB Flaviviruses are emerging arthropod-borne pathogens that cause life-threatening diseases such as yellow fever, dengue, West Nile encephalitis, tick-borne encephalitis, Kyasanur Forest disease, tick-borne encephalitis, or Zika disease. This viral genus groups >50 viral species of small enveloped plus strand RNA virus that are phylogenetically closely related to hepatitis C virus. Importantly, the flavivirus life cycle is intimately associated to host cell lipids. Along this line, flaviviruses rearrange intracellular membranes from the endoplasmic-reticulurn of the infected cells to develop adequate platforms for viral replication and particle biogenesis. Moreover, flaviviruses dramatically orchestrate a profound reorganization of the host cell lipid metabolism to create a favorable environment for viral multiplication. Consistently, recent work has shown the importance of specific lipid classes in flavivirus infections. For instances, fatty acid synthesis is linked to viral replication, phosphatidylserine and phosphatidylethanolamine are involved on the entry of flaviviruses, sphingolipids (ceramide and sphingomyelin) play a key role on virus assembly and.pathogenesis, and cholesterol is essential for innate immunity evasion in flavivirus-infected cells. Here, we revise the current knowledge on the interactions of the flaviviruses with the cellular lipid metabolism to identify potential targets for future antiviral development aimed to combat these relevant health-threatening pathogens. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Martin-Acebes, Miguel A.; Vazquez-Calvo, Angela; Saiz, Juan-Carlos] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Carretera A Coruna Km 7-5, Madrid 28040, Spain.
RP Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Carretera A Coruna Km 7-5, Madrid 28040, Spain.
EM martin.mangel@inia.es
RI Martin-Acebes, Miguel A./L-2258-2014; Vazquez-Calvo, Angela/G-8795-2015
OI Martin-Acebes, Miguel A./0000-0001-6015-3613; Saiz,
   Juan-Carlos/0000-0001-8269-5544; Vazquez-Calvo,
   Angela/0000-0003-3172-2762
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [AGL2014-56518-JIN]; INIAInstituto de Investigacion Agropecuaria (INIA)
   [E-RTA2013-0013, ZIKA-BIO-2016-1]; Autonomous Community of Madrid
   [S2013/ABI-2906]; MINECO
FX This work was supported by grants AGL2014-56518-JIN (to MAMA) from the
   Spanish Ministry of Economy and Competitiveness (MINECO), E-RTA2013-0013
   (to JC-S) and ZIKA-BIO-2016-1 (to J-CS) from INIA, and S2013/ABI-2906,
   PLATESA (to J-CS) from the Autonomous Community of Madrid. Angela
   Vazquez-Calvo was supported by a "Juan de la Cierva Incorporacion"
   fellowship from MINECO.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Asturias FJ, 2005, NAT STRUCT MOL BIOL, V12, P225, DOI 10.1038/nsmb899
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Biswas HH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003904
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Boslem E, 2013, J BIOL CHEM, V288, P26569, DOI 10.1074/jbc.M113.489310
   Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060
   Callens N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005476
   Calvert JK, 2015, J INTERF CYTOK RES, V35, P654, DOI 10.1089/jir.2014.0195
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Carocci M, 2015, ANTIMICROB AGENTS CH, V59, P85, DOI 10.1128/AAC.04177-14
   Carr JM, 2013, J GEN VIROL, V94, P2437, DOI 10.1099/vir.0.055616-0
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Chang YS, 1999, J VIROL, V73, P6257, DOI 10.1128/JVI.73.8.6257-6264.1999
   Chen CL, 2013, J IMMUNOL, V191, P1744, DOI 10.4049/jimmunol.1201976
   Chen CJ, 2011, NEUROCHEM INT, V58, P924, DOI 10.1016/j.neuint.2011.02.022
   Clarke JN, 2016, J GEN VIROL, V97, P95, DOI 10.1099/jgv.0.000334
   Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Das S, 2010, J NEUROCHEM, V115, P537, DOI 10.1111/j.1471-4159.2010.06951.x
   Devignot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011671
   Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719
   Diwaker D, 2015, VIRAL IMMUNOL, V28, P153, DOI 10.1089/vim.2014.0095
   Duran A, 2015, ARCH VIROL, V160, P1687, DOI 10.1007/s00705-015-2433-z
   Faustino AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10592
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Filipe A, 2015, TRENDS MOL MED, V21, P34, DOI 10.1016/j.molmed.2014.11.003
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Fu Q, 2015, J MED ENTOMOL, V52, P1124, DOI 10.1093/jme/tjv101
   Garavito RM, 2003, ANNU REV BIOPH BIOM, V32, P183, DOI 10.1146/annurev.biophys.32.110601.141906
   Cordero JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090704
   Gault CR, 2010, ADV EXP MED BIOL, V688, P1
   Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Goni FM, 2005, BIOCHEM SOC SYMP, V72, P177, DOI 10.1042/bss0720177
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harak C, 2015, VIROLOGY, V479, P418, DOI 10.1016/j.virol.2015.02.029
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860
   Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0
   Hoenen A, 2014, VIROLOGY, V448, P104, DOI 10.1016/j.virol.2013.10.005
   Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Ishikawa T, 2014, VACCINE REV SUCCESSF
   Jan JT, 2000, J VIROL, V74, P8680, DOI 10.1128/JVI.74.18.8680-8691.2000
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Jeffries CL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003576
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005
   Kimura T, 2016, PROG LIPID RES, V62, P75, DOI 10.1016/j.plipres.2016.02.001
   Kiran SK, 2015, EMERG INFECT DIS, V21, P146, DOI 10.3201/eid2101.141227
   Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006
   Kok WM, 2016, EXPERT OPIN DRUG DIS
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lanteri MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092134
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Leon-Juarez M, 2016, VIROL J, V13, DOI 10.1186/s12985-015-0456-4
   Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820
   Lorizate M, 2009, J BIOL CHEM, V284, P22238, DOI 10.1074/jbc.M109.029256
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Martin-Acebes M., 2013, LIPID METABOLISM, P291
   Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892
   Martinez-Seara H, 2008, BIOPHYS J, V95, P3295, DOI 10.1529/biophysj.108.138123
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Menzel N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002829
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917
   Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Modis Y, 2013, ADV EXP MED BIOL, V790, P150, DOI 10.1007/978-1-4614-7651-1_8
   Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0
   Molloy JC, 2016, APPL ENV MICROBIOL
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0
   Nour AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003585
   Opie LH, 2015, TRENDS CARDIOVAS MED, V25, P216, DOI 10.1016/j.tcm.2014.10.002
   Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607
   Puerta-Guardo H, 2010, J GEN VIROL, V91, P394, DOI 10.1099/vir.0.015420-0
   Reddy T, 2016, STRUCTURE, V24, P375, DOI 10.1016/j.str.2015.12.011
   Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631
   Saiz JC, 2016, FRONT MICROBIOL
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021
   Schneider-Schaulies J, 2015, BIOL CHEM, V396, P585, DOI 10.1515/hsz-2014-0273
   Silva BM, 2011, ARCH VIROL, V156, P1275, DOI 10.1007/s00705-011-0969-0
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sirohi D, 2016, SCIENCE
   Smith S, 2003, PROG LIPID RES, V42, P289, DOI 10.1016/S0163-7827(02)00067-X
   Sot J, 2006, BIOPHYS J, V90, P903, DOI 10.1529/biophysj.105.067710
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   Stiasny K, 2004, J VIROL, V78, P8536, DOI 10.1128/JVI.78.16.8536-8542.2004
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   STIASNY K, 2009, AMINO ACIDS
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14
   Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09
   Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z
   Teoh PG, 2014, J VIROL, V88, P7998, DOI 10.1128/JVI.00940-14
   Tong L, 2006, J CELL BIOCHEM, V99, P1476, DOI 10.1002/jcb.21077
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   Uchida L, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020046
   Umashankar M, 2008, J VIROL, V82, P9245, DOI 10.1128/JVI.00975-08
   Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539
   Vazquez-Calvo A, 2012, VIRUS RES
   Vazquez-Calvo A, 2011, J VIROL, V85, P1267, DOI 10.1128/JVI.01717-10
   Verma S, 2011, J GEN VIROL, V92, P507, DOI 10.1099/vir.0.026716-0
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430
   Wang CW., 2015, BIOCH BIOPHYS ACTA
   Waugh MG, 2011, J LIPID RES, V52, P2148, DOI 10.1194/jlr.M017814
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39
   Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
   Zhu YZ, 2012, J GEN VIROL, V93, P61, DOI 10.1099/vir.0.034637-0
NR 184
TC 41
Z9 45
U1 1
U2 28
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0163-7827
EI 1873-2194
J9 PROG LIPID RES
JI Prog. Lipid Res.
PD OCT
PY 2016
VL 64
BP 123
EP 137
DI 10.1016/j.plipres.2016.09.005
PG 15
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA EF7FM
UT WOS:000390495500008
PM 27702593
DA 2020-07-08
ER

PT J
AU Lysaght, T
   Lee, TL
   Watson, S
   Lederman, Z
   Bailey, M
   Tambyah, PA
AF Lysaght, Tamra
   Lee, Tsung-Ling
   Watson, Sangeetha
   Lederman, Zohar
   Bailey, Michele
   Tambyah, Paul Anantharajah
TI Zika in Singapore: insights from One Health and social medicine
SO SINGAPORE MEDICAL JOURNAL
LA English
DT Editorial Material
ID AEDES-AEGYPTI; WORKERS
C1 [Lysaght, Tamra; Lee, Tsung-Ling; Watson, Sangeetha; Lederman, Zohar] Natl Univ Singapore, Ctr Biomed Eth, Singapore, Singapore.
   [Bailey, Michele] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore.
   [Tambyah, Paul Anantharajah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
RP Lysaght, T (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Biomed Eth, Clin Res Ctr, Level 2 Block MD11,10 Med Dr, Singapore 117576, Singapore.
EM tlysaght@nus.edu.sg
RI Lee, Tsung-Ling/V-8583-2019
CR [Anonymous], ZIK AND AN
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Capps B, 2015, BIOETHICS, V29, P588, DOI 10.1111/bioe.12145
   Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1
   Degeling C, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2617-1
   Koh F, STRAITS TIMES
   Koou SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0471-0
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Liew C, 2004, MED VET ENTOMOL, V18, P351, DOI 10.1111/j.0269-283X.2004.00517.x
   Mo Y, 2016, BRIT MED BULL, V119, P25, DOI 10.1093/bmb/ldw023
   Wong ML, 2012, J URBAN HEALTH, V89, P1031, DOI 10.1007/s11524-012-9723-5
   Wong ML, 2005, SEX TRANSM DIS, V32, P439, DOI 10.1097/01.olq.0000168279.05452.ad
NR 12
TC 9
Z9 9
U1 0
U2 3
PU SINGAPORE MEDICAL ASSOC
PI SINGAPORE
PA LEVEL 2 ALUMNI MEDICAL CENTRE, 2 COLLEGE RD, SINGAPORE 169850, SINGAPORE
SN 0037-5675
J9 SINGAP MED J
JI Singap. Med. J.
PD OCT
PY 2016
VL 57
IS 10
BP 528
EP 529
DI 10.11622/smedj.2016161
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA EF4OJ
UT WOS:000390309200002
PM 27640519
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU El-Sabaawi, RW
   Frauendorf, TC
   Marques, PS
   Mackenzie, RA
   Manna, LR
   Mazzoni, R
   Phillip, DAT
   Warbanski, ML
   Zandona, E
AF El-Sabaawi, Rana W.
   Frauendorf, Therese C.
   Marques, Piata S.
   Mackenzie, Richard A.
   Manna, Luisa R.
   Mazzoni, Rosana
   Phillip, Dawn A. T.
   Warbanski, Misha L.
   Zandona, Eugenia
TI Biodiversity and ecosystem risks arising from using guppies to control
   mosquitoes
SO BIOLOGY LETTERS
LA English
DT Article
DE dengue; ecosystem service; invasion; malaria; Zika
ID LIFE-HISTORY EVOLUTION; POECILIA-RETICULATA; LARVAE; WATER; ADAPTATION;
   SPREAD; FISH
AB Deploying mosquito predators such as the guppy (Poecilia reticulata) into bodies of water where mosquitoes breed is a common strategy for limiting the spread of disease-carrying mosquitoes. Here, we draw on studies from epidemiology, conservation, ecology and evolution to show that the evidence for the effectiveness of guppies in controlling mosquitoes is weak, that the chances of accidental guppy introduction into local ecosystems are large, and that guppies can easily establish populations and damage these aquatic ecosystems. We highlight several knowledge and implementation gaps, and urge that this approach is either abandoned in favour of more effective strategies or that it is used much more rigorously. Controlling mosquitoes does not need to come at the expense of freshwater biodiversity.
C1 [El-Sabaawi, Rana W.; Frauendorf, Therese C.; Marques, Piata S.; Warbanski, Misha L.] Univ Victoria, Dept Biol, Stn CSC, POB 1700, Victoria, BC V8W 2Y2, Canada.
   [Mackenzie, Richard A.] USDA Forest Serv, Inst Pacific Isl, Pacific Southwest Res Stn, Hilo, HI 96720 USA.
   [Manna, Luisa R.; Mazzoni, Rosana; Zandona, Eugenia] Univ Estado Rio de Janeiro, Dept Ecol, Rua Sao Francisco Xavier 524, BR-20550900 Rio De Janeiro, Brazil.
   [Phillip, Dawn A. T.] Univ West Indies, Dept Life Sci, St Augustine, Trinidad Tobago.
RP El-Sabaawi, RW (corresponding author), Univ Victoria, Dept Biol, Stn CSC, POB 1700, Victoria, BC V8W 2Y2, Canada.
EM rana@uvic.ca
RI Mazzoni, Rosana/B-3461-2013; Manna, Luisa R/E-9780-2015; Mazzoni,
   Rosana/O-7241-2015; Zandona, Eugenia/B-3449-2013
OI Mazzoni, Rosana/0000-0001-8780-7779; Zandona,
   Eugenia/0000-0003-4754-5326
FU IDRC/AUCC; CNPqNational Council for Scientific and Technological
   Development (CNPq); Science without Borders (CAPES) fellowship;
   University of Victoria
FX We have received no funding for this study. Past and ongoing work on
   guppies in our groups has been funded by a number of sources (IDRC/AUCC,
   CNPq, etc) that are acknowledged in the primary papers we cite in this
   article. PSM is supported by a Science without Borders (CAPES)
   fellowship. TCF is supported by funding from the University of Victoria.
CR [Anonymous], 2016, REUTERS         0218
   [Anonymous], 2015, O GLOBO         1209
   [Anonymous], 2013, EXPRESS TRIBUNE 0916
   Azevedo-Santos VM, 2016, SCIENCE, V351, P675, DOI 10.1126/science.351.6274.675
   Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Collins SM, 2016, ECOLOGY, V97, P3154, DOI 10.1002/ecy.1530
   Deacon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024416
   Dua VK, 2007, J AM MOSQUITO CONTR, V23, P481, DOI 10.2987/5560.1
   Ehlman SM, 2015, J COMP PHYSIOL A, V201, P1125, DOI 10.1007/s00359-015-1041-4
   El-Sabaawi RW, 2015, FRESHWATER BIOL, V60, P590, DOI 10.1111/fwb.12507
   Elias M, 1995, Bangladesh Med Res Counc Bull, V21, P81
   FONT WF, 1994, J PARASITOL, V80, P682, DOI 10.2307/3283246
   Gagne RB, 2015, FRESHWATER BIOL, V60, P311, DOI 10.1111/fwb.12491
   Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Hawaii State Department of Health, 2015, CONTR MOSQ BREED RAI
   Holitzki TM, 2013, ECOL APPL, V23, P1367, DOI 10.1890/12-0529.1
   Kusumawathie PHD, 2008, ASIA-PAC J PUBLIC HE, V20, P56, DOI 10.1177/1010539507308507
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lawal M, 2013, W AFRICAN J APPL ECO, V20, P1
   Lee R., 2014, TECH TIMES
   Lopez-Sepulcre A, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1116
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Magurran A. E., 2005, EVOLUTIONARY ECOLOGY
   Manna Barnali, 2008, Journal of Vector Borne Diseases, V45, P200
   Mendonsa K., 2013, TIMES INDIA
   Murias A., 2015, GUPPY FISH STOCKED C
   Pyke GH, 2008, ANNU REV ECOL EVOL S, V39, P171, DOI 10.1146/annurev.ecolsys.39.110707.173451
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reeve AJ., 2015, PHENOTYPIC PLASTICIT
   Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934
   Rolshausen G, 2015, EVOL APPL, V8, P854, DOI 10.1111/eva.12289
   Saleeza SNR, 2014, SE ASIAN J TROP MED, V45, P299
   Sandipan Gupta, 2013, Bioscience Discovery, V4, P89
   van Driesche R, 2016, BIOL CONTROL CONSERV
   Walsh MR, 2011, EVOLUTION, V65, P1021, DOI 10.1111/j.1558-5646.2010.01188.x
   Walsh MR, 2011, FUNCT ECOL, V25, P227, DOI 10.1111/j.1365-2435.2010.01786.x
   Walsh MR, 2010, EVOLUTION, V64, P1583, DOI 10.1111/j.1558-5646.2009.00922.x
   Warbanski M, ECOL EVOL
   Widianarko B, 2000, ECOTOX ENVIRON SAFE, V46, P101, DOI 10.1006/eesa.1999.1879
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yamamoto M. N., 2000, HAWAIIS NATIVE EXOTI
   Zandona E, 2011, FUNCT ECOL, V25, P964, DOI 10.1111/j.1365-2435.2011.01865.x
NR 44
TC 16
Z9 16
U1 1
U2 55
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1744-9561
EI 1744-957X
J9 BIOL LETTERS
JI Biol. Lett.
PD OCT 1
PY 2016
VL 12
IS 10
AR 20160590
DI 10.1098/rsbl.2016.0590
PG 4
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA EE5HM
UT WOS:000389636800011
PM 28120806
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wang, JN
   Ling, F
AF Wang, Jin-Na
   Ling, Feng
TI Zika Virus Infection and Microcephaly: Evidence for a Causal Link
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Review
DE Zika virus (ZIKV); microcephaly; pregnancy; fetus
ID PREGNANCY; OUTBREAK; BRAZIL; AMERICA; BRAIN
AB Zika virus (ZIKV) is a flavivirus related to the Dengue, yellow fever and West Nile viruses. Since the explosive outbreaks of ZIKV in Latin America in 2015, a sudden increase in the number of microcephaly cases has been observed in infants of women who were pregnant when they contracted the virus. The severity of this condition raises grave concerns, and extensive studies on the possible link between ZIKV infection and microcephaly have been conducted. There is substantial evidence suggesting that there is a causal link between ZIKV and microcephaly, however, future studies are warranted to solidify this association. To summarize the most recent evidence on this issue and provide perspectives for future studies, we reviewed the literature to identify existing evidence of the causal link between ZIKV infection and microcephaly within research related to the epidemics, laboratory diagnosis, and possible mechanisms.
C1 [Wang, Jin-Na; Ling, Feng] Zhejiang Prov Ctr Dis Control & Prevent, 3399 Binsheng Rd, Hangzhou 310051, Zhejiang, Peoples R China.
RP Ling, F (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, 3399 Binsheng Rd, Hangzhou 310051, Zhejiang, Peoples R China.
EM jnwang@cdc.zj.cn; fengl@cdc.zj.cn
RI amsalu, ribka/G-8780-2019
FU Medicine and Health Care in Zhejiang Province Science and Technology
   Plan [2016KYA062]
FX The study was sponsored by "Medicine and Health Care in Zhejiang
   Province Science and Technology Plan" (Grant number: 2016KYA062).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Alvarado-Socarras JL, 2016, ULTRASOUND OBST GYN, V47, P525, DOI 10.1002/uog.15885
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, N ENGL J MED
   Bullerdiek J, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0240-1
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), 2016, INT GUID PREV SEX TA
   Centers for Disease Control and Prevention (CDC), 2016, TRAV HLTH NOT
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Dang J., 2016, CELL STEM CELL
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Flores MS, 2016, CLEV CLIN J MED, V83, P1, DOI 10.3949/ccjm.83a.16027
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization, 2015, EP AL INCR MICR NE B
   Pan American Health Organization World Health Organization, 2015, NEUR SYNDR CONG MALF
   Paploski I. A., 2016, EMERG INFECT DIS, V22
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sahai I, 2014, NEW ENGL J MED, V371, P847, DOI 10.1056/NEJMcpc1400833
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WHO, ZIK VIR
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization (WHO), 2016, WOM CONT MICR ZIK VI
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M., 2016, NAT MED
NR 55
TC 11
Z9 11
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD OCT
PY 2016
VL 13
IS 10
AR 1031
DI 10.3390/ijerph13101031
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA EE4KF
UT WOS:000389570100098
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU White, MK
   Wollebo, HS
   Beckham, JD
   Tyler, KL
   Khalili, K
AF White, Martyn K.
   Wollebo, Hassen S.
   Beckham, J. David
   Tyler, Kenneth L.
   Khalili, Kamel
TI Zika Virus: An Emergent Neuropathological Agent
SO ANNALS OF NEUROLOGY
LA English
DT Review
ID WEST NILE VIRUS; GUILLAIN-BARRE-SYNDROME; YELLOW-FEVER; SEXUAL
   TRANSMISSION; JAMESTOWN CANYON; MACACUS RHESUS; INFECTION; AMERICA;
   DISEASE; BRAZIL
AB The emergence of Zika virus in the Americas has followed a pattern that is familiar from earlier epidemics of other viruses, where a new disease is introduced into a human population and then spreads rapidly with important public health consequences. In the case of Zika virus, an accumulating body of recent evidence implicates the virus in the etiology of serious pathologies of the human nervous system, that is, the occurrence of microcephaly in neonates and Guillain-Barre syndrome in adults. Zika virus is an arbovirus (arthropod-borne virus) and a member of the family Flaviviridae, genus Flavivirus. Zika virions are enveloped and icosahedral, and contain a nonsegmented, single-stranded, positive-sense RNA genome, which encodes 3 structural and 7 nonstructural proteins that are expressed as a single polyprotein that undergoes cleavage. Zika genomic RNA replicates in the cytoplasm of infected host cells. Zika virus was first detected in 1947 in the blood of a febrile monkey in Uganda's Zika Forest and in crushed suspensions of the Aedes mosquito, which is one of the vectors for Zika virus. The virus remained obscure, with a few human cases confined to Africa and Asia. There are two lineages of the Zika virus, African and Asian, with the Asian strain causing outbreaks in Micronesia in 2007 and French Polynesia in 2013-2014. From here, the virus spread to Brazil with the first report of autochthonous Zika transmission in the Americas in March 2015. The rapid advance of the virus in the Americas and its likely association with microcephaly and Guillain-Barre syndrome make Zika an urgent public health concern.
C1 [White, Martyn K.; Wollebo, Hassen S.; Khalili, Kamel] Temple Univ, Dept Neurosci, Ctr Neurovirol, Comprehens NeuroAIDS Ctr,Lewis Katz Sch Med, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.
   [Beckham, J. David; Tyler, Kenneth L.] Univ Colorado, Div Infect Dis, Dept Med, Anschutz Med Campus, Aurora, CO USA.
   [Beckham, J. David; Tyler, Kenneth L.] Univ Colorado, Dept Neurol, Anschutz Med Campus, Aurora, CO USA.
   [Tyler, Kenneth L.] Univ Colorado, Dept Microbiol & Immunol, Anschutz Med Campus, Aurora, CO USA.
RP Khalili, K (corresponding author), Temple Univ, Dept Neurosci, Ctr Neurovirol, Comprehens NeuroAIDS Ctr,Lewis Katz Sch Med, 3500 N Broad St,7th Floor, Philadelphia, PA 19140 USA.
EM kamel.khalili@temple.edu
RI Tyler, Kenneth L./J-2420-2019
OI Tyler, Kenneth L./0000-0003-3294-5888; Wollebo,
   Hassen/0000-0003-2285-3496
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R33 AI101064, T32 AI052066]
CR [Anonymous], 2013, Wkly Epidemiol Rec, V88, P285
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Beasley DWC, 2015, ANTIVIR RES, V115, P48, DOI 10.1016/j.antiviral.2014.12.010
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Chambers TJ, 2003, FLAVIVIRUSES DETECTI, P376
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   CLEAVES GR, 1981, VIROLOGY, V111, P73, DOI 10.1016/0042-6822(81)90654-1
   CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalrymple NA, 2014, CURR OPIN VIROL, V7, P134, DOI 10.1016/j.coviro.2014.06.006
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   GOLLINS SW, 1985, J GEN VIROL, V66, P1969, DOI 10.1099/0022-1317-66-9-1969
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hidari Kazuya I P J, 2011, Trop Med Health, V39, P37, DOI 10.2149/tmh.2011-S03
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huzly D, 2016, EUROSURVEILLANCE, P21
   Kaiser R, 2008, INFECT DIS CLIN N AM, V22, P561, DOI 10.1016/j.idc.2008.03.013
   Kashima Simone, 2016, Rev. Bras. Hematol. Hemoter., V38, P90, DOI 10.1016/j.bjhh.2016.01.002
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kleinman S, 2015, CURR OPIN HEMATOL, V22, P547, DOI 10.1097/MOH.0000000000000186
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mathis C, 1928, CR HEBD ACAD SCI, V186, P604
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, EUROSURVEILLANCE, P19
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nain M, 2016, REV MED VIROL, V26, P129, DOI 10.1002/rmv.1868
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Pastula DM, 2015, AM J TROP MED HYG, V93, P384, DOI 10.4269/ajtmh.15-0196
   Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sellards AW, 1928, BRIT MED J, V1928, P713, DOI 10.1136/bmj.1.3512.713
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stein RA, 2016, INT J CLIN PRACT, V70, P182, DOI 10.1111/ijcp.12792
   Stokes A, 1928, J AMER MED ASSOC, V90, P253, DOI 10.1001/jama.1928.02690310005002
   STOKES ADRIAN, 1928, AMER JOUR TROP MED, V8, P103
   Suss J, 2008, EUROSURVEILLANCE, P13
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vermehren J, 2011, EUR J MED RES, V16, P303, DOI 10.1186/2047-783X-16-7-303
   Vogel G, 2016, SCIENCE, V351, P110, DOI 10.1126/science.351.6269.110
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WENGLER G, 1981, VIROLOGY, V113, P544, DOI 10.1016/0042-6822(81)90182-3
   Yacoub S, 2016, F1000RES, V5, P5
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 102
TC 30
Z9 33
U1 2
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2016
VL 80
IS 4
BP 479
EP 489
DI 10.1002/ana.24748
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ED0XZ
UT WOS:000388568700001
PM 27464346
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Barreras, P
   Munoz, L
   Parra, B
   Lizarazo, J
   Jimenez-Arango, JA
   Zea-Vera, AF
   Gonzalez-Manrique, G
   Vargas, J
   Angarita, JA
   Zuniga, G
   Lopez-Gonzalez, R
   Beltran, CL
   Rizcala, KH
   Morales, MT
   Kumar, A
   Cornblath, DR
   Osorio, L
   Pardo, CA
AF Barreras, Paula
   Munoz, Laura
   Parra, Beatriz
   Lizarazo, Jairo
   Jimenez-Arango, Jorge A.
   Zea-Vera, Andres F.
   Gonzalez-Manrique, Guillermo
   Vargas, Jose
   Angarita, Jorge A.
   Zuniga, Gonzalo
   Lopez-Gonzalez, Reydmar
   Beltran, Cindy L.
   Rizcala, Karen H.
   Morales, Maria T.
   Kumar, Anupama
   Cornblath, David R.
   Osorio, Lyda
   Pardo, Carlos A.
TI Spectrum of Zika Virus Associated Neurological Disease in Colombia
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 141st Annual Meeting of the American-Neurological-Association
CY OCT 16-18, 2016
CL Baltimore, MD
SP Amer Neurol Assoc
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335
NR 0
TC 0
Z9 0
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2016
VL 80
SU 20
SI SI
MA M315WIP
BP S237
EP S238
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ED0YK
UT WOS:000388569900494
DA 2020-07-08
ER

PT J
AU Barreras, P
   Pamies, D
   Kumar, A
   Munoz, LS
   Parra, B
   Abreu, C
   Gamma, L
   Hogberg, H
   Hartung, T
   Pardo, CA
AF Barreras, Paula
   Pamies, David
   Kumar, Anupama
   Munoz, Laura S.
   Parra, Beatriz
   Abreu, Celina
   Gamma, Lucio
   Hogberg, Helena
   Hartung, Thomas
   Pardo, Carlos A.
TI An iPSC Derived Human Minibrain to Study Zika Virus Associated
   Neurological Disease
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 141st Annual Meeting of the American-Neurological-Association
CY OCT 16-18, 2016
CL Baltimore, MD
SP Amer Neurol Assoc
RI Pardo, Carlos A./A-5192-2008
OI Pardo, Carlos A./0000-0002-4128-5335
NR 0
TC 0
Z9 0
U1 1
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2016
VL 80
SU 20
SI SI
MA M316WIP
BP S238
EP S238
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ED0YK
UT WOS:000388569900495
DA 2020-07-08
ER

PT J
AU Luciano, CA
   Arias-Berrios, JE
   Deliz, B
   Carlo, JR
   Alfonso, G
   Rivera-Garcia, B
AF Luciano, Carlos A.
   Arias-Berrios, Jose E.
   Deliz, Brenda
   Carlo, Jose R.
   Alfonso, Gishlaine
   Rivera-Garcia, Brenda
TI Guillain-Barre Syndrome and Zika Virus: Epidemiological Surveillance in
   Puerto Rico
SO ANNALS OF NEUROLOGY
LA English
DT Meeting Abstract
CT 141st Annual Meeting of the American-Neurological-Association
CY OCT 16-18, 2016
CL Baltimore, MD
SP Amer Neurol Assoc
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD OCT
PY 2016
VL 80
SU 20
SI SI
MA M332WIP
BP S242
EP S242
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA ED0YK
UT WOS:000388569900511
DA 2020-07-08
ER

PT J
AU Brunoni, D
   Blascovi-Assis, SM
   Osorio, AAC
   Seabra, AG
   Amato, CADLH
   Teixeira, MCTV
   da Rocha, MM
   Carreiro, LRR
AF Brunoni, Decio
   Blascovi-Assis, Silvana Maria
   Caldas Osorio, Ana Alexandra
   Seabra, Alessandra Gotuzo
   de la Higuera Amato, Cibelle Albuquerque
   Triguero Veloz Teixeira, Maria Cristina
   da Rocha, Marina Monzani
   Rodrigues Carreiro, Luiz Renato
TI Microcephaly and other Zika virus related events: the impact on
   children, families and health teams
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Public Health; Microcephaly; Health care
ID INFECTION; BRAZIL; BRAIN
AB The present study aimed to present an overview of recent national and international research on the Zika virus (ZIKV), as well as to explore possible action plans focused on children, their families and the health teams involved. Therefore, the study proposes the implementation of tracking systems in order to identify, describe and characterize the potential correlates of prenatal exposure to ZIKV, divided into three lines of action: 1. Diagnostic and etiological evaluation as well as screening of developmental problems in children confirmed or suspected of prenatal ZIKV infection. 2. Investigation of the emotional impact, quality of life, coping strategies and support network of the affected children and their families. 3. Training of multidisciplinary teams to conduct assessments and intervention programs throughout these children's development, especially in the first three years of life. In conclusion, the recent ZIKV outbreak in Brazil and several other Latin American countries places a significant burden on the health care systems: to understand the real meaning of a potential new teratogen; to unravel the pathogenic mechanisms of ZIKV, particularly in a prevention perspective; and to recognize the broad spectrum of clinical manifestations in order to devise intervention programs.
C1 [Brunoni, Decio; Blascovi-Assis, Silvana Maria; Caldas Osorio, Ana Alexandra; Seabra, Alessandra Gotuzo; de la Higuera Amato, Cibelle Albuquerque; Triguero Veloz Teixeira, Maria Cristina; da Rocha, Marina Monzani; Rodrigues Carreiro, Luiz Renato] Univ Presbiteriana Mackenzie, Programa Posgrad Disturbios Desenvolvimento, R Consolacao 930, BR-01302907 Sao Paulo, SP, Brazil.
RP Brunoni, D (corresponding author), Univ Presbiteriana Mackenzie, Programa Posgrad Disturbios Desenvolvimento, R Consolacao 930, BR-01302907 Sao Paulo, SP, Brazil.
EM disturbios.pos@mackenzie.br
RI Blascovi-Assis, Silvana M/C-9386-2014; Rocha, Marina M/E-4207-2013;
   Carreiro, Luiz Renato R/C-6829-2012
OI Blascovi-Assis, Silvana M/0000-0002-5437-891X; Rocha, Marina
   M/0000-0003-4995-7906; Osorio, Ana/0000-0002-1692-4609; Seabra,
   Alessandra/0000-0002-8373-7897; Rodrigues Carreiro, Luiz
   Renato/0000-0001-8249-1832
CR Alcantud F, 2015, REV ESPANOLA DISCAPA, V3, P107
   Brasil. Ministerio da Saude (MS), 2016, MON CAS MICR BRAS
   Brasil. Ministerio da Saude (MS), 2015, PROT AT SAUD RESP OC
   Carreiro LRR, 2014, ORIENTACOES PROMOCAO, P45
   Cernach MCSP, 2013, GENETICA MED, P97
   Favero-Nunes MA, 2010, PSICOL-REFLEX CRIT, V23, P208, DOI 10.1590/S0102-79722010000200003
   Horton R., 2016, LANCET, V387, P633
   Latin American Network of Congenital Malformations, 2015, MICR ECLAMC BRAS
   Martin MAF, 2014, CADERNOS GRADUACAO D, V14, P62
   Martin MAF, 2014, ORIENTACOES PROMOCAO, P19
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tsang TW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2542
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2015, LANCET
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 20
TC 11
Z9 16
U1 1
U2 11
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD OCT
PY 2016
VL 21
IS 10
BP 3296
EP 3301
DI 10.1590/1413-812320152110.16832016
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EC9LU
UT WOS:000388466900032
PM 27783802
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Torres, JR
   Murillo, J
   Bofill, L
AF Torres, Jaime R.
   Murillo, Jorge
   Bofill, Lina
TI The ever changing landscape of Zika virus infection. Learning on the fly
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
ID SEXUAL TRANSMISSION; FRENCH-POLYNESIA; DENGUE; CHIKUNGUNYA; OUTBREAK;
   DISEASE; SEMEN; DENV; RNA
C1 [Torres, Jaime R.] Cent Univ Venezuela, Luis Razetti Sch Med, Caracas, Venezuela.
   [Torres, Jaime R.] Trop Med Inst, Caracas, Venezuela.
   [Murillo, Jorge] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA.
   [Murillo, Jorge] Baptist Hlth Syst South Florida, Miami, FL USA.
   [Bofill, Lina] Florida Int Univ, Global Hlth Consortium, Miami, FL USA.
   [Bofill, Lina] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL USA.
RP Torres, JR (corresponding author), Cent Univ Venezuela, Inst Trop Med, Caracas, Venezuela.
EM torresj@post.com
CR [Anonymous], 2016, ZIK VIR EM US AUTH
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brooks RB, 2016, MMWR MORB MORTAL WKL
   Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen Joseph C., INFECT HUMAN UTERINE
   Chughtai AA, 2016, EPIDEMIOL INFECT, V144, P1652, DOI 10.1017/S0950268816000054
   Coelho FC, SEXUAL TRANSMISSION
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   European Center for Disease Prevention and Control, 2016, ZIK VIR DIS EP POT A
   European Center for Disease Prevention and Control, 2015, BRAZ PAC REG 25 MAY
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huits R.M.H.G., 2016, B WHO
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Machado-Alba Jorge Enrique, DIAGNOSIS NEUROLOGIC
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   PAHO/WHO, 2016, ZIK SUSP CONF CAS RE
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rodriguez-Morales Alfonso J., MAPPING ZIKA MUNICIP
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Torres Jaime R., MICROHEMATOSPERMIA A
   Vetter P., 2016, J INFECT DIS
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   World Health Organization, 2016, DIR GEN SUMM OUTC EM
   Zambrano H, 2016, AM J TROP MED HYG
NR 40
TC 5
Z9 5
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2016
VL 51
BP 123
EP 126
DI 10.1016/j.ijid.2016.09.001
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EC7NK
UT WOS:000388326700029
PM 27599795
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Torres, JR
   Martinez, N
   Moros, Z
AF Torres, Jaime R.
   Martinez, Nahir
   Moros, Zoila
TI Microhematospermia in acute Zika virus infection
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Letter
ID SEXUAL TRANSMISSION
C1 [Torres, Jaime R.] Cent Univ Venezuela, Inst Trop Med, Infect Dis Sect, Caracas, Venezuela.
   [Martinez, Nahir] Cent Univ Venezuela, Inst Trop Med, Virol Sect, Caracas, Venezuela.
   [Moros, Zoila] Venezuelan Inst Sci Res IVIC, Ctr Microbiol & Cellular Biol, Lab Virus Biol, Caracas, Venezuela.
RP Torres, JR (corresponding author), Cent Univ Venezuela, Inst Trop Med, Infect Dis Sect, Caracas, Venezuela.
EM torresj@iname.com
CR D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Huits R.M.H.G., 2016, B WHO
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
NR 5
TC 12
Z9 13
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2016
VL 51
BP 127
EP 127
DI 10.1016/j.ijid.2016.08.025
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA EC7NK
UT WOS:000388326700030
PM 27639453
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Machado-Alba, JE
   Machado-Duque, ME
   Gaviria-Mendoza, A
   Orozco-Giraldo, V
AF Enrique Machado-Alba, Jorge
   Machado-Duque, Manuel E.
   Gaviria-Mendoza, Andres
   Orozco-Giraldo, Viviana
TI Diagnosis of neurological disorders and the Zika virus epidemic in
   Colombia 2014-2016
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Guillain-Barre syndrome; Pharmacoepidemiology; Colombia
   (MeSH)
C1 [Enrique Machado-Alba, Jorge; Machado-Duque, Manuel E.; Gaviria-Mendoza, Andres; Orozco-Giraldo, Viviana] Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Calle 105 14-140, Pereira 660003, Risaralda, Colombia.
RP Machado-Alba, JE (corresponding author), Univ Tecnol Pereira Audifarma SA, Grp Invest Farmacoepidemiol & Farmacovigilancia, Calle 105 14-140, Pereira 660003, Risaralda, Colombia.
EM machado@utp.edu.co
OI Gaviria-Mendoza, Andres/0000-0003-2500-7658; Machado-Duque, Manuel
   E/0000-0001-8458-0986
CR Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Instituto Nacional de Salud Colombia, 2016, B EP SEM ZIK SEM EP
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 7
TC 9
Z9 11
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2016
VL 51
BP 133
EP 134
DI 10.1016/j.ijid.2016.09.010
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA EC7NK
UT WOS:000388326700032
PM 27637419
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dai, LP
   Wang, QH
   Qi, JX
   Shi, Y
   Yan, JH
   Gao, GF
AF Dai, Lianpan
   Wang, Qihui
   Qi, Jianxun
   Shi, Yi
   Yan, Jinghua
   Gao, George F.
TI Molecular Basis of Antibody-Mediated Neutralization and Protection
   Against Flavivirus
SO IUBMB LIFE
LA English
DT Review
DE flavivirus; antibodies; structural basis; neutralization; protection
ID WEST-NILE-VIRUS; BORNE ENCEPHALITIS-VIRUS; RECEPTOR-BINDING SITE;
   FC-GAMMA-RECEPTOR; CROSS-REACTIVE ANTIBODIES; CD8(+) T-CELLS; DENGUE
   VIRUS; ZIKA VIRUS; MONOCLONAL-ANTIBODY; DOMAIN-III
AB Antibody-mediated humoral immunity plays a pivotal role in flavivirus control. Neutralizing antibodies targeting viral envelope (E) protein, provide protection against flaviviruses in vivo but can also promote virus infection by antibody-dependent enhancement when antibodies are weakly neutralizing or in subneutralizing concentrations. The molecular basis for antibody-mediated virus neutralization can be revealed by structural studies of monoclonal antibodies complexed with the E protein or virion. In addition, the flavivirus non-structural protein NS1 can also induce host antibody production, and some of these antibodies can provide protection against virus challenge. In this review, we summarize the known structures of flavivirus neutralizing or protective antibodies bound to their epitopes and describe the underlying molecular mechanisms. (C) 2016 IUBMB Life, 68(10):783-791, 2016
C1 [Dai, Lianpan; Shi, Yi; Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.
   [Wang, Qihui; Yan, Jinghua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Microbial Physiol & Metab Engn, Beijing, Peoples R China.
   [Wang, Qihui; Shi, Yi; Yan, Jinghua; Gao, George F.] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.
   [Qi, Jianxun; Shi, Yi; Yan, Jinghua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Shi, Yi; Gao, George F.] Chinese Acad Sci, Ctr Influenza Res & Early Warning CASCIRE, Beijing, Peoples R China.
   [Shi, Yi; Yan, Jinghua; Gao, George F.] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Gao, George F.] Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.
RP Dai, LP (corresponding author), Chinese Acad Sci, Beijing Inst Life Sci, RNIH, Beijing 100101, Peoples R China.; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol CASPMI, Beijing 100101, Peoples R China.
EM dailp@biols.ac.cn; gaof@im.ac.cn
FU Task-Force of Zika Virus Research from the Chinese Academy of Sciences
   (CAS); Emergency Task-Force Project of the National Natural Science
   Foundation of China (NSFC) [81641001]; Zika Special Project of the
   National Infectious Disease Control ST Grand Project; Chinese Academy of
   SciencesChinese Academy of Sciences [XDB08020100]; National Key Plan for
   Scientific Research and Development of China [YFD0500300]; Chinese
   Academy of SciencesChinese Academy of Sciences; Youth Innovation
   Promotion Association CAS [2015078]; NSFC Innovative Research Group
   [81321063]
FX This work was supported by the Task-Force of Zika Virus Research from
   the Chinese Academy of Sciences (CAS), the Emergency Task-Force Project
   (Grant No. 81641001) of the National Natural Science Foundation of China
   (NSFC), the Zika Special Project of the National Infectious Disease
   Control S&T Grand Project, the Strategic Priority Research Program of
   the Chinese Academy of Sciences (XDB08020100), and National Key Plan for
   Scientific Research and Development of China, 2016 (YFD0500300). Y.S. is
   supported by the Excellent Young Scientist Program of the Chinese
   Academy of Sciences and the Youth Innovation Promotion Association CAS
   (Grant No. 2015078). G.F.G. is a leading principal investigator of the
   NSFC Innovative Research Group (Grant No. 81321063). The authors thank
   Gary Wong for his help in the English-editing of this manuscript.
CR ALLISON SL, 1995, J VIROL, V69, P695, DOI 10.1128/JVI.69.2.695-700.1995
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beaumier CM, 2009, VIRAL IMMUNOL, V22, P215, DOI 10.1089/vim.2008.0089
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001
   Chen Y, 2009, IUBMB LIFE, V61, P579, DOI 10.1002/iub.208
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Kaltenbock A, 2003, RECEPTOR CHANNEL, V9, P93, DOI 10.1080/10606820308251
   Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107
   Kaufmann B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000672
   Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103
   Knipe D. M., 2013, FIELDS VIRIOLOGY, P768
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Long GL, 2003, EUR J BIOCHEM, V270, P4059, DOI 10.1046/j.1432-1033.2003.03793.x
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   PRESTA M, 1992, BIOCHEM BIOPH RES CO, V185, P1098, DOI 10.1016/0006-291X(92)91739-D
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Shrestha B, 2004, J VIROL, V78, P8312, DOI 10.1128/jvi.78.15.8312-8321.2004
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stiasny K, 2004, J VIROL, V78, P3178, DOI 10.1128/JVI.78.6.3178-3183.2004
   Stiasny K, 1996, J VIROL, V70, P8142, DOI 10.1128/JVI.70.11.8142-8147.1996
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XZ, 2015, J VIROL, V89, P743, DOI 10.1128/JVI.02411-14
NR 65
TC 24
Z9 24
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD OCT
PY 2016
VL 68
IS 10
BP 783
EP 791
DI 10.1002/iub.1556
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EC9CE
UT WOS:000388440500001
PM 27604155
OA Bronze
DA 2020-07-08
ER

PT J
AU Bai, JPF
AF Bai, Jane P. F.
TI Pharmacodynamics and Systems Pharmacology Approaches to Repurposing
   Drugs in the Wake of Global Health Burden
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE global health; big data; pharmacodynamics; systems pharmacology
ID CANCER; MORTALITY; METFORMIN; ASSOCIATION; EXPRESSION
AB There are emergent needs for cost-effective treatment worldwide, for which repurposing to develop a drug with existing marketing approval of disease(s) for new disease(s) is a valid option. Although strategic mining of electronic health records has produced real-world evidences to inform drug repurposing, using omics data (drug and disease), knowledge base of protein interactions, and database of transcription factors have been explored. Structured integration of all the existing data under the framework of drug repurposing will facilitate decision making. The ability to foresee the need to integrate new data types produced by emergent technologies and to enable data connectivity in the context of human biology and targeted diseases, as well as to use the existing crucial quality data of all approved drugs will catapult the number of drugs being successfully repurposed. However, translational pharmacodynamics databases for modeling information across human biology in the context of host factors are lacking and are critically needed for drug repurposing to improve global public health, especially for the efforts to combat neglected tropic diseases as well as emergent infectious diseases such as Zika or Ebola virus. Published by Elsevier Inc. on behalf of the American Pharmacists Association.
C1 [Bai, Jane P. F.] US FDA, Off Clin Pharmacol, Ctr Drug Res & Evaluat, Silver Spring, MD 20993 USA.
RP Bai, JPF (corresponding author), US FDA, Off Clin Pharmacol, Ctr Drug Res & Evaluat, Silver Spring, MD 20993 USA.
EM jane.bai@fda.hhs.gov
CR Andersson JA, 2016, ANTIMICROB AGENTS CH, V60, P3717, DOI 10.1128/AAC.00326-16
   [Anonymous], 2015, GLOBAL HLTH TOPICS C
   Bai JPF, 2016, J PHARM SCI-US, V105, P476, DOI 10.1002/jps.24696
   Baur DM, 2011, METABOLISM, V60, P1363, DOI 10.1016/j.metabol.2010.09.012
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Boolell M, 1996, BRIT J UROL, V78, P257, DOI 10.1046/j.1464-410X.1996.10220.x
   Borkar DS, 2015, AM J OPHTHALMOL, V159, P707, DOI 10.1016/j.ajo.2015.01.009
   Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620
   Centers for Disease Control and Prevention, 1996, UPD INFL ACT WORLDW
   Crockett SD, 2014, DIGEST DIS SCI, V59, P1535, DOI 10.1007/s10620-014-3040-7
   Crockett SD, 2012, INFLAMM BOWEL DIS, V18, P1048, DOI 10.1002/ibd.21822
   Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6
   Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313
   Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648
   Food and Drug Administration, 2016, SEARCH ORPH DRUG DES
   Gignoux E, 2016, NEW ENGL J MED, V374, P23, DOI 10.1056/NEJMoa1504605
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hur J, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.11
   Jiang PF, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-13
   Kim CH, 2015, P NATL ACAD SCI USA, V112, P8756, DOI 10.1073/pnas.1509742112
   Melas IN, 2015, INTEGR BIOL-UK, V7, P904, DOI 10.1039/c4ib00294f
   Paik H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08580
   Perera-Lecoin M, 2014, VIRUSES-BASEL, V6, P69, DOI 10.3390/v6010069
   Prieto AL, 2000, J COMP NEUROL, V425, P295
   Pruefer D, 2002, CIRCULATION, V106, P2104, DOI 10.1161/01.CIR.0000034048.38910.91
   Rybniker J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8659
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318
   TORIUMI DM, 1988, ARCH OTOLARYNGOL, V114, P918
   Vissers PAJ, 2015, BREAST CANCER RES TR, V150, P427, DOI 10.1007/s10549-015-3331-5
   World Health Organization, 2016, HLTH 2015 MDGS SDGS
   Xu H, 2015, J AM MED INFORM ASSN, V22, P179, DOI 10.1136/amiajnl-2014-002649
NR 32
TC 6
Z9 7
U1 0
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD OCT
PY 2016
VL 105
IS 10
BP 3007
EP 3012
DI 10.1016/j.xphs.2016.07.004
PG 6
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA EC6ST
UT WOS:000388267700002
PM 27522921
OA Green Published
DA 2020-07-08
ER

PT J
AU Liu, ZY
   Li, XF
   Jiang, T
   Deng, YQ
   Ye, Q
   Zhao, H
   Yu, JY
   Qin, CF
AF Liu, Zhong-Yu
   Li, Xiao-Feng
   Jiang, Tao
   Deng, Yong-Qiang
   Ye, Qing
   Zhao, Hui
   Yu, Jiu-Yang
   Qin, Cheng-Feng
TI Viral RNA switch mediates the dynamic control of flavivirus replicase
   recruitment by genome cyclization
SO ELIFE
LA English
DT Article
ID DENGUE-VIRUS GENOME; DE-NOVO SYNTHESIS; PACKAGING SIGNAL; CODING REGION;
   IN-VITRO; UNTRANSLATED REGION; SECONDARY STRUCTURE; ENCEPHALITIS-VIRUS;
   CRYSTAL-STRUCTURE; STRAND RNA
AB Viral replicase recruitment and long-range RNA interactions are essential for RNA virus replication, yet the mechanism of their interplay remains elusive. Flaviviruses include numerous important human pathogens, e.g., dengue virus (DENV) and Zika virus (ZIKV). Here, we revealed a highly conserved, conformation-tunable cis-acting element named 5?-UAR-flanking stem (UFS) in the flavivirus genomic 5 ' terminus. We demonstrated that the UFS was critical for efficient NS5 recruitment and viral RNA synthesis in different flaviviruses. Interestingly, stabilization of the DENV UFS impaired both genome cyclization and vRNA replication. Moreover, the UFS unwound in response to genome cyclization, leading to the decreased affinity of NS5 for the viral 5 ' end. Thus, we propose that the UFS is switched by genome cyclization to regulate dynamic RdRp binding for vRNA replication. This study demonstrates that the UFS enables communication between flavivirus genome cyclization and RdRp recruitment, highlighting the presence of switch-like mechanisms among RNA viruses.
C1 [Liu, Zhong-Yu; Li, Xiao-Feng; Jiang, Tao; Deng, Yong-Qiang; Ye, Qing; Zhao, Hui; Yu, Jiu-Yang; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.
   [Liu, Zhong-Yu; Li, Xiao-Feng; Jiang, Tao; Deng, Yong-Qiang; Qin, Cheng-Feng] State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, Beijing, Peoples R China.; Qin, CF (corresponding author), State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
EM qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926;
   Liu, Zhong-Yu/0000-0001-7385-5681
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31270196, 31000083, 30972613, 2012CB518904,
   81522025]; Academy of Medical SciencesAcademy of Medical Sciences (AMS)
   [81661130162]; National Key Research and Development Project of China
   [2016YFD0500304]
FX National Natural Science Foundation of China 31270196 Cheng-Feng Qin;
   National Natural Science Foundation of China 31000083 Xiao-Feng Li;
   National Natural Science Foundation of China 30972613 Cheng-Feng Qin;
   National Natural Science Foundation of China National Basic Research
   Program of China, 2012CB518904 Cheng-Feng Qin; National Natural Science
   Foundation of China Excellent Young Scientist Program, 81522025
   Cheng-Feng Qin; Academy of Medical Sciences Newton Advanced Fellowship,
   81661130162 Cheng-Feng Qin; National Key Research and Development
   Project of China 2016YFD0500304 Cheng-Feng Qin; The funders had no role
   in study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Athavale SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054384
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   CHU PWG, 1985, VIROLOGY, V140, P68, DOI 10.1016/0042-6822(85)90446-5
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gong S, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4905214
   Goto H, 2013, J VIROL, V87, P11316, DOI 10.1128/JVI.01301-13
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112
   Keane SC, 2015, SCIENCE, V348, P917, DOI 10.1126/science.aaa9266
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Kieft JS, 2008, TRENDS BIOCHEM SCI, V33, P274, DOI 10.1016/j.tibs.2008.04.007
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Leija-Martinez N, 2014, NUCLEIC ACIDS RES, V42, P13963, DOI 10.1093/nar/gku1249
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Liu Y, 2009, BBA-GENE REGUL MECH, V1789, P495, DOI 10.1016/j.bbagrm.2009.09.007
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Meyer IM, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-10
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morales L, 2013, J VIROL, V87, P11579, DOI 10.1128/JVI.01836-13
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288
   Niyomrattanakit P, 2015, ANTIVIR RES, V119, P36, DOI 10.1016/j.antiviral.2015.04.007
   Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003
   Perdrizet GA, 2012, P NATL ACAD SCI USA, V109, P3323, DOI 10.1073/pnas.1113086109
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rouha H, 2011, VIROLOGY, V417, P79, DOI 10.1016/j.virol.2011.05.008
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shetty S, 2013, NUCLEIC ACIDS RES, V41, P2526, DOI 10.1093/nar/gks1318
   Simon AE, 2013, ANNU REV MICROBIOL, V67, P21, DOI 10.1146/annurev-micro-092412-155609
   Souii A, 2015, CURR MICROBIOL, V71, P387, DOI 10.1007/s00284-015-0866-y
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Tsetsarkin KA, 2016, NUCLEIC ACIDS RES, V44, P3330, DOI 10.1093/nar/gkw061
   Uchida L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07395
   Uchil PD, 2003, VIROLOGY, V307, P358, DOI 10.1016/S0042-6822(02)00130-7
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Vogt DA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000936
   Wang LY, 2011, J VIROL, V85, P7954, DOI 10.1128/JVI.00339-11
   Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249
   Wu BD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003363
   Wu BD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000323
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yoffe AM, 2011, NUCLEIC ACIDS RES, V39, P292, DOI 10.1093/nar/gkq642
   You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714
   Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 76
TC 9
Z9 9
U1 0
U2 18
PU ELIFE SCIENCES PUBLICATIONS LTD
PI CAMBRIDGE
PA SHERATON HOUSE, CASTLE PARK, CAMBRIDGE, CB3 0AX, ENGLAND
SN 2050-084X
J9 ELIFE
JI eLife
PD OCT 1
PY 2016
VL 5
AR e17636
DI 10.7554/eLife.17636
PG 27
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA EC2SZ
UT WOS:000387975600001
PM 27692070
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kriebs, JM
AF Kriebs, Jan M.
TI Zika Virus and Its Impact on Pregnancy
SO JOURNAL OF PERINATAL & NEONATAL NURSING
LA English
DT Editorial Material
ID UPDATE INTERIM GUIDANCE; SEXUAL TRANSMISSION; UNITED-STATES
C1 [Kriebs, Jan M.] Philadelphia Univ, Midwifery Inst, Philadelphia, PA 19144 USA.
   [Kriebs, Jan M.] Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA.
RP Kriebs, JM (corresponding author), Philadelphia Univ, Midwifery Inst, Philadelphia, PA 19144 USA.; Kriebs, JM (corresponding author), Univ Maryland, Sch Med, Dept Obstet Gynecol & Reprod Sci, Baltimore, MD 21201 USA.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK VIR
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Centers for Disease Control and Prevention, ZIK CAS REP US
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D., 2014, EURO SURVEILL, V19
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Prisant N, LANCET INFECT DIS
   Rossole N., GULF STATES ARE NEXT
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
NR 27
TC 0
Z9 0
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0893-2190
EI 1550-5073
J9 J PERINAT NEONAT NUR
JI J. Perinat. Neonatal Nurs.
PD OCT-DEC
PY 2016
VL 30
IS 4
BP 280
EP 283
DI 10.1097/JPN.0000000000000217
PG 4
WC Nursing; Obstetrics & Gynecology; Pediatrics
SC Nursing; Obstetrics & Gynecology; Pediatrics
GA EC1MX
UT WOS:000387871000004
PM 27776026
DA 2020-07-08
ER

PT J
AU Meaney-Delman, D
   Oduyebo, T
   Polen, KND
   White, JL
   Bingham, AM
   Slavinski, SA
   Heberlein-Larson, L
   St George, K
   Rakeman, JL
   Hills, S
   Olson, CK
   Adamski, A
   Barlow, LC
   Lee, EH
   Likos, AM
   Munoz, JL
   Petersen, EE
   Dufort, EM
   Dean, AB
   Cortese, MM
   Santiago, GA
   Bhatnagar, J
   Powers, AM
   Zaki, S
   Petersen, LR
   Jamieson, DJ
   Honein, MA
AF Meaney-Delman, Dana
   Oduyebo, Titilope
   Polen, Kara N. D.
   White, Jennifer L.
   Bingham, Andrea M.
   Slavinski, Sally A.
   Heberlein-Larson, Lea
   St George, Kirsten
   Rakeman, Jennifer L.
   Hills, Susan
   Olson, Christine K.
   Adamski, Alys
   Barlow, Lauren Culver
   Lee, Ellen H.
   Likos, Anna M.
   Munoz, Jorge L.
   Petersen, Emily E.
   Dufort, Elizabeth M.
   Dean, Amy B.
   Cortese, Margaret M.
   Santiago, Gilberto A.
   Bhatnagar, Julu
   Powers, Ann M.
   Zaki, Sherif
   Petersen, Lyle R.
   Jamieson, Denise J.
   Honein, Margaret A.
CA US Zika Pregnancy Registry Prolong
TI Prolonged Detection of Zika Virus RNA in Pregnant Women
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID UNITED-STATES; INFECTION; ANTIBODY; FETAL
AB OBJECTIVE:Zika virus infection during pregnancy is a cause of microcephaly and other fetal brain abnormalities. Reports indicate that the duration of detectable viral RNA in serum after symptom onset is brief. In a recent case report involving a severely affected fetus, Zika virus RNA was detected in maternal serum 10 weeks after symptom onset, longer than the duration of RNA detection in serum previously reported. This report summarizes the clinical and laboratory characteristics of pregnant women with prolonged detection of Zika virus RNA in serum that were reported to the U.S. Zika Pregnancy Registry.METHODS:Data were obtained from the U.S. Zika Pregnancy Registry, an enhanced surveillance system of pregnant women with laboratory evidence of confirmed or possible Zika virus infection. For this case series, we defined prolonged detection of Zika virus RNA as Zika virus RNA detection in serum by real-time reverse transcription-polymerase chain reaction (RT-PCR) 14 or more days after symptom onset or, for women not reporting signs or symptoms consistent with Zika virus disease (asymptomatic), 21 or more days after last possible exposure to Zika virus.RESULTS:Prolonged Zika virus RNA detection in serum was identified in four symptomatic pregnant women up to 46 days after symptom onset and in one asymptomatic pregnant woman 53 days postexposure. Among the five pregnancies, one pregnancy had evidence of fetal Zika virus infection confirmed by histopathologic examination of fetal tissue, three pregnancies resulted in live births of apparently healthy neonates with no reported abnormalities, and one pregnancy is ongoing.CONCLUSION:Zika virus RNA was detected in the serum of five pregnant women beyond the previously estimated timeframe. Additional real-time RT-PCR testing of pregnant women might provide more data about prolonged detection of Zika virus RNA and the possible diagnostic, epidemiologic, and clinical implications for pregnant women.
C1 Ctr Dis Control & Prevent, Off Director, Atlanta, GA 30333 USA.
   Ctr Dis Control & Prevent, Div Vector Borne Dis, Atlanta, GA 30333 USA.
   Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
   Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.
   Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.
   New York State Dept Hlth, Bur Communicable Dis Control, Wadsworth Ctr, Albany, NY 12237 USA.
   New York State Dept Hlth, Viral Dis Lab, Wadsworth Ctr, Albany, NY 12237 USA.
   New York State Dept Hlth, Viral Encephalitis Lab Viral Dis, Wadsworth Ctr, Albany, NY 12237 USA.
   New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, Div Dis Control, New York, NY USA.
   New York City Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA.
   New York State Dept Hlth & Mental Hyg, New York, NY USA.
   Suffolk Cty Dept Hlth Serv, New York, NY USA.
   Florida Dept Hlth, Bur Epidemiol, Tallahassee, FL USA.
   Florida Dept Hlth, Div Dis Control & Hlth Protect, Tallahassee, FL USA.
RP Meaney-Delman, D (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, 1600 Clifton Rd,Mailstop C-12, Atlanta, GA 30333 USA.
EM vmo0@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201
CR [Anonymous], 2016, MMWR MORB MORTAL WKL
   [Anonymous], 2016, ZIK OP RES PORT
   [Anonymous], 2016, MEM REV DIAGN TEST Z
   [Anonymous], 2016, N ENGL J MED    0615
   [Anonymous], 2016, N ENGL J MED
   [Anonymous], 2016, CLIN MICROBIOL  0406
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Cell-free DNA, 2015, OBSTET GYNECOL, V126, pe31
   Dauner AL, 2015, AM J TROP MED HYG, V93, P46, DOI 10.4269/ajtmh.15-0110
   Dawe GS, 2007, CELL ADHES MIGR, V1, P19, DOI 10.4161/cam.1.1.4082
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Granovsky MO, 1998, PEDIATRICS, V102, P355, DOI 10.1542/peds.102.2.355
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Krain LJ, 2014, AM J TROP MED HYG, V90, P365, DOI 10.4269/ajtmh.13-0265
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines R. B., 2016, LANCET
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Oduyebo T, 2016, MMWR MORB MORTAL WKL
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   van de Nieuwenhof HP, 2009, CANCER EPIDEM BIOMAR, V18, P2061, DOI 10.1158/1055-9965.EPI-09-0209
NR 26
TC 72
Z9 72
U1 1
U2 17
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD OCT
PY 2016
VL 128
IS 4
BP 724
EP 730
DI 10.1097/AOG.0000000000001625
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DX6VT
UT WOS:000384523600007
PM 27479770
DA 2020-07-08
ER

PT J
AU Koenig, KL
AF Koenig, Kristi L.
TI Quarantine for Zika Virus? Where is the Science?
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Editorial Material
DE Zika; quarantine; Ebola; isolation; health policy
ID EBOLA
AB In January 2016, the World Health Organization warned that Zika virus is spreading explosively in the Americas and that up to 4 million infections could be present worldwide within a year. Soon thereafter, some politicians and authors publicly advocated for quarantine of travelers returning from regions where mosquitoes carrying Zika virus are prevalent. The public health tool of quarantine can be used to prevent the spread of infection by restricting the movement of persons who have been exposed to a deadly disease that can be transmitted from person to person before symptom onset. With 80% of Zika virus infections being asymptomatic, no rapid test being available to detect the virus, and primary transmission being via the bites of certain mosquitoes, application of quarantine in this setting is not scientifically sound or practically feasible. Rather, public health interventions should focus on preventing bites from infected mosquitoes, counseling pregnant women on the risks of fetal microcephaly and other birth defects, and identifying patients with signs and symptoms of Guillain-Barre syndrome. As was seen in the Ebola virus disease outbreak of 2014, non-evidence-based factors can influence policy decisions. Public health experts must ensure that policy makers are informed that quarantine is not a scientifically sound approach for the control of Zika virus. (Disaster Med Public Health Preparedness. 2016;0:1-3)
C1 [Koenig, Kristi L.] Univ Calif Irvine, Ctr Disaster Med Sci, Orange, CA 92668 USA.
RP Koenig, KL (corresponding author), UC Irvine Med Ctr, Dept Emergency Med, Ctr Disaster Med Sci, 333 City Blvd West,Suite 640,Rt 128-01, Orange, CA 92868 USA.
EM kkoenig@uci.edu
RI amsalu, ribka/G-8780-2019
CR Barbisch D, 2015, DISASTER MED PUBLIC, V9, P547, DOI 10.1017/dmp.2015.38
   Fink S, NY TIMES
   Koenig KL, 2015, ANN EMERG MED, V65, P330, DOI 10.1016/j.annemergmed.2014.12.003
   World Health Organisation, 2005, IHR 2005 EM COMM ZIK
NR 4
TC 2
Z9 2
U1 0
U2 5
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD OCT
PY 2016
VL 10
IS 5
BP 704
EP 706
DI 10.1017/dmp.2016.56
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EB6GH
UT WOS:000387479200003
PM 27032458
OA Bronze
DA 2020-07-08
ER

PT J
AU Hodge, JG
   Corbett, A
   Repka, A
   Judd, PJ
AF Hodge, James G., Jr.
   Corbett, Alicia
   Repka, Ashley
   Judd, P. J.
TI Zika Virus and Global Implications for Reproductive Health Reforms
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
C1 [Hodge, James G., Jr.; Corbett, Alicia; Repka, Ashley; Judd, P. J.] Arizona State Univ, Sandra Day OConnor Coll Law, Tempe, AZ USA.
RP Hodge, JG (corresponding author), ASU Sandra Day OConnor Coll Law, Ross Blakeley Lib, Publ Hlth Law & Eth, Room 318,POB 877906, Tempe, AZ 85287 USA.
EM james.hodge.1@asu.edu
CR AHMED AZAM, NY TIMES
   Barchfield J., BOSTON GLOBE
   Brown L, HEAD UN WOMEN EXPAND
   Guttmacher Institute, FACTS AB LAT AM CAR
   Kates A, ZIKA VIRUS CHALLENGE
   Katz JM, DILEMMA ZIKA PREGNAN
   McNeil Jr Donald, NY TIMES
   Rocca FX, WALL STREET J
NR 8
TC 5
Z9 5
U1 0
U2 3
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD OCT
PY 2016
VL 10
IS 5
BP 713
EP 715
DI 10.1017/dmp.2016.34
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EB6GH
UT WOS:000387479200005
PM 26957316
OA Bronze
DA 2020-07-08
ER

PT J
AU Xie, XP
   Zou, J
   Shan, C
   Yang, YJ
   Kum, DB
   Dallmeier, K
   Neyts, J
   Shi, PY
AF Xie, Xuping
   Zou, Jing
   Shan, Chao
   Yang, Yujiao
   Kum, Dieudonne Buh
   Dallmeier, Kai
   Neyts, Johan
   Shi, Pei-Yong
TI Zika Virus Replicons for Drug Discovery
SO EBIOMEDICINE
LA English
DT Article
DE Zika; Drug discovery; Replicon; Flavivirus
ID WEST-NILE-VIRUS; DENGUE VIRUS; 3'-UNTRANSLATED REGION; SUBGENOMIC
   REPLICONS; RNA REPLICATION; IN-VITRO; CONSTRUCTION; TRANSLATION;
   ELEMENTS; INHIBITOR
AB The current epidemic of Zika virus (ZIKV) has underscored the urgency to establish experimental systems for studying viral replication and pathogenesis, and countermeasure development. Here we report two ZIKV replicon systems: a luciferase replicon that can differentiate between viral translation and RNA synthesis; and a stable luciferase replicon carrying cell line that can be used to screen and characterize inhibitors of viral replication. The transient replicon was used to evaluate the effect of an NS5 polymerase mutation on viral RNA synthesis and to analyze a known ZIKV inhibitor. The replicon cell line was developed into a 96-well format for antiviral testing. Compare with virus infection-based assay, the replicon cell line allows antiviral screening without using infectious virus. Collectively, the replicon systems have provided critical tools for both basic and translational research. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Xie, Xuping; Zou, Jing; Shan, Chao; Yang, Yujiao; Kum, Dieudonne Buh; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Yang, Yujiao] Southwest Univ, Coll Anim Sci & Technol, Chongqing, Peoples R China.
   [Kum, Dieudonne Buh; Dallmeier, Kai; Neyts, Johan] Univ Leuven, Lab Virol & Chemotherapy, Rega Inst Med Res, Leuven, Belgium.
RP Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
EM peshi@utmb.edu
RI Neyts, Johan/U-8267-2017; Xie, Xuping/AAD-7406-2019
OI Neyts, Johan/0000-0002-0033-7514; Kum, Dieudonne
   Buh/0000-0001-8251-8230; Shan, Chao/0000-0002-3953-3782
FU Novartis Institutes for BioMedical Research; University of Texas Medical
   Branch startup award; University of Texas STARs Award; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI087856]
FX X.X. was awarded with a postdoctoral fellowship from Novartis Institutes
   for BioMedical Research. P.Y.S. was supported by University of Texas
   Medical Branch startup award, University of Texas STARs Award, and NIH
   grant R01AI087856.
CR Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972
   Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Gehrke R, 2003, J VIROL, V77, P8924, DOI 10.1128/JVI.77.16.8924-8933.2003
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   Jones CT, 2005, VIROLOGY, V331, P247, DOI 10.1016/j.virol.2004.10.034
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Lo MK, 2003, J VIROL, V77, P12901, DOI 10.1128/JVI.77.23.12901-12906.2003
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   Puig-Basagoiti F, 2006, ANTIMICROB AGENTS CH, V50, P1320, DOI 10.1128/AAC.50.4.1320-1329.2006
   Qing M, 2010, ANTIVIR RES, V86, P163, DOI 10.1016/j.antiviral.2010.02.313
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shi Pei-Yong, 2002, Curr Opin Investig Drugs, V3, P1567
   Shi PY, 2002, VIROLOGY, V296, P219, DOI 10.1006/viro.2002.1453
   Wang QY, 2011, ANTIMICROB AGENTS CH, V55, P4072, DOI 10.1128/AAC.00620-11
   Xie XP, 2014, VIROLOGY, V450, P250, DOI 10.1016/j.virol.2013.12.025
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
NR 26
TC 36
Z9 36
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD OCT
PY 2016
VL 12
BP 156
EP 160
DI 10.1016/j.ebiom.2016.09.013
PG 5
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EA8IM
UT WOS:000386878500031
PM 27658737
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Legros, M
   Otero, M
   Aznar, VR
   Solari, H
   Gould, F
   Lloyd, AL
AF Legros, Mathieu
   Otero, Marcelo
   Romeo Aznar, Victoria
   Solari, Hernan
   Gould, Fred
   Lloyd, Alun L.
TI Comparison of two detailed models of Aedes aegypti population dynamics
SO ECOSPHERE
LA English
DT Article
DE Aedes aegypti; model comparison; mosquito-borne diseases; population
   dynamics; spatial model; vector control
ID TETRAVALENT DENGUE VACCINE; YELLOW-FEVER MOSQUITO; HEMORRHAGIC-FEVER;
   DIPTERA; SYSTEMS; CULICIDAE; EFFICACY
AB The success of control programs for mosquito-borne diseases can be enhanced by crucial information provided by models of the mosquito populations. Models, however, can differ in their structure, complexity, and biological assumptions, and these differences impact their predictions. Unfortunately, it is typically difficult to determine why two complex models make different predictions because we lack structured side-by-side comparisons of models using comparable parameterization. Here, we present a detailed comparison of two complex, spatially explicit, stochastic models of the population dynamics of Aedes aegypti, the main vector of dengue, yellow fever, chikungunya, and Zika viruses. Both models describe the mosquito's biological and ecological characteristics, but differ in complexity and specific assumptions. We compare the predictions of these models in two selected climatic settings: a tropical and weakly seasonal climate in Iquitos, Peru, and a temperate and strongly seasonal climate in Buenos Aires, Argentina. Both models were calibrated to operate at identical average densities in unperturbed conditions in both settings, by adjusting parameters regulating densities in each model (number of larval development sites and amount of nutritional resources). We show that the models differ in their sensitivity to environmental conditions (temperature and rainfall) and trace differences to specific model assumptions. Temporal dynamics of the Ae. aegypti populations predicted by the two models differ more markedly under strongly seasonal Buenos Aires conditions. We use both models to simulate killing of larvae and/or adults with insecticides in selected areas. We show that predictions of population recovery by the models differ substantially, an effect likely related to model assumptions regarding larval development and (direct or delayed) density dependence. Our methodical comparison provides important guidance for model improvement by identifying key areas of Ae. aegypti ecology that substantially affect model predictions, and revealing the impact of model assumptions on population dynamics predictions in unperturbed and perturbed conditions.
C1 [Legros, Mathieu; Gould, Fred] North Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.
   [Legros, Mathieu] Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland.
   [Otero, Marcelo; Romeo Aznar, Victoria; Solari, Hernan] Univ Buenos Aires, Fac Ciencias Exactas 7 Nat, Dept Fis, Pabellon 1,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.
   [Otero, Marcelo; Romeo Aznar, Victoria; Solari, Hernan] IFIBA CONICET, Pabellon 1,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.
   [Gould, Fred; Lloyd, Alun L.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.
   [Lloyd, Alun L.] North Carolina State Univ, Dept Math & Biomath, Grad Program, Raleigh, NC 27695 USA.
RP Lloyd, AL (corresponding author), NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA.; Lloyd, AL (corresponding author), North Carolina State Univ, Dept Math & Biomath, Grad Program, Raleigh, NC 27695 USA.
EM alun_lloyd@ncsu.edu
RI Legros, Mathieu/E-6767-2011; Lloyd, Alun/AAN-6639-2020; Solari,
   Hernan/AAH-5267-2020; Lloyd, Alun L/H-4944-2012; Solari,
   Hernan/AAF-8511-2020
OI Legros, Mathieu/0000-0003-3807-8594; Lloyd, Alun/0000-0002-6389-6321;
   Solari, Hernan/0000-0003-4287-1878; Otero, Marcelo/0000-0001-6963-4333
FU Research and Policy for Infectious Disease Dynamics (RAPIDD) program of
   the Science and Technology Directory, Department of Homeland Security;
   Fogarty International Center, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Fogarty International Center (FIC); Universidad de Buenos
   AiresUniversity of Buenos Aires [UBACYT 20020100100734, UBACYT
   20020110100205, UBACYT 20020130100361BA]; National Institutes for
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01-AI54954, R01-AI091980,
   P01-AI098670]; National Science FoundationNational Science Foundation
   (NSF) [RTG/DMS-1246991]
FX We acknowledge the support of the Research and Policy for Infectious
   Disease Dynamics (RAPIDD) program of the Science and Technology
   Directory, Department of Homeland Security, and Fogarty International
   Center, National Institutes of Health. This work was also supported by
   grants from the Universidad de Buenos Aires (UBACYT 20020100100734,
   UBACYT 20020110100205, and UBACYT 20020130100361BA; MO, VRA, and HS),
   the National Institutes for Health (R01-AI54954, R01-AI091980, and
   P01-AI098670; ML, FG, and ALL) and the National Science Foundation
   (RTG/DMS-1246991; ALL).
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Arrivillaga J, 2004, J VECTOR ECOL, V29, P11
   BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burks A.W., 1946, PHILOS SCI, V1, P301, DOI DOI 10.1086/286904
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499
   DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355
   Ekpereonne E, 2010, TROP MED INT HEALTH, V15, P619, DOI DOI 10.1111/J.1365-3156.2010.02489.X
   Ellis AM, 2011, AM J TROP MED HYG, V85, P257, DOI 10.4269/ajtmh.2011.10-0516
   Feller W, 1940, T AM MATH SOC, V48, P488, DOI 10.2307/1990095
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   GILPIN ME, 1979, FORTS ZOOL, V25, P355
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Horsfall WR, 1955, MOSQUITOES THEIR BIO
   Legros M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022701
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Naksathit AT, 1998, J AM MOSQUITO CONTR, V14, P148
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Peirce C. S., 1931, COLLECTED PAPERS
   Aznar VR, 2015, J THEOR BIOL, V365, P311, DOI 10.1016/j.jtbi.2014.10.016
   Aznar VR, 2013, ECOL MODEL, V253, P44, DOI 10.1016/j.ecolmodel.2012.12.004
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X
   Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870
   SOUTHWOOD T R E, 1972, Bulletin of the World Health Organization, V46, P211
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Walsh RK, 2013, AM J TROP MED HYG, V89, P68, DOI 10.4269/ajtmh.12-0378
   Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830
NR 39
TC 8
Z9 8
U1 1
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2150-8925
J9 ECOSPHERE
JI Ecosphere
PD OCT
PY 2016
VL 7
IS 10
AR e01515
DI 10.1002/ecs2.1515
PG 19
WC Ecology
SC Environmental Sciences & Ecology
GA EB2TU
UT WOS:000387216300048
PM 28462011
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Fu, XL
   Wang, LF
   Fang, B
   Ma, RR
   Zheng, Y
   Huang, S
   Zhou, P
   Cao, ZX
   Tian, J
   Li, SJ
   Zhang, GH
AF Fu, Xinliang
   Wang, Lifang
   Fang, Bo
   Ma, Ruirui
   Zheng, Yun
   Huang, San
   Zhou, Pei
   Cao, Zongxi
   Tian, Jin
   Li, Shoujun
   Zhang, Guihong
TI Import of Rift Valley fever to China: a potential new threat?
SO VIROLOGICA SINICA
LA English
DT Editorial Material
ID ZIKA VIRUS; VERTICAL TRANSMISSION; SAUDI-ARABIA; EAST-AFRICA; KENYA;
   IDENTIFICATION; EMERGENCE; DISEASE; MERS
C1 [Fu, Xinliang; Wang, Lifang; Fang, Bo; Ma, Ruirui; Zheng, Yun; Huang, San; Zhou, Pei; Li, Shoujun; Zhang, Guihong] South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.
   [Tian, Jin] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150009, Peoples R China.
   [Cao, Zongxi] Hainan Acad Agr Sci, Inst Anim Husb & Vet Med, Haikou 571100, Peoples R China.
   [Fu, Xinliang; Fang, Bo; Zhang, Guihong] Key Lab Zoonosis Prevent & Control Guangdong Prov, Guangzhou 510642, Guangdong, Peoples R China.
   [Fu, Xinliang; Wang, Lifang; Fang, Bo; Zheng, Yun; Huang, San; Zhou, Pei; Li, Shoujun; Zhang, Guihong] Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou 510642, Guangdong, Peoples R China.
RP Zhang, GH (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou 510642, Guangdong, Peoples R China.; Tian, J (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150009, Peoples R China.; Zhang, GH (corresponding author), Key Lab Zoonosis Prevent & Control Guangdong Prov, Guangzhou 510642, Guangdong, Peoples R China.; Zhang, GH (corresponding author), Guangdong Prov Key Lab Prevent & Control Severe C, Guangzhou 510642, Guangdong, Peoples R China.
EM tj6049345@126.com; guihongzh@scau.edu.cn
OI fu, xinliang/0000-0002-7741-7387
CR Adam I, 2008, J MED VIROL, V80, P929, DOI 10.1002/jmv.21132
   Anyangu AS, 2010, AM J TROP MED HYG, V83, P14, DOI 10.4269/ajtmh.2010.09-0293
   Arishi HM, 2006, ANN TROP PAEDIATR, V26, P251, DOI 10.1179/146532806X120363
   Baba M, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.57
   Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P261
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Daubney R, 1931, J PATHOL BACTERIOL, V34, P545, DOI 10.1002/path.1700340418
   DAVIES FG, 1980, T ROY SOC TROP MED H, V74, P815, DOI 10.1016/0035-9203(80)90213-8
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Himeidan YE, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00169
   Islam R, 2015, VIROL SIN, V30, P326, DOI 10.1007/s12250-015-3624-1
   Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747
   Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020
   Maurice D, 2015, VIROL SIN, V30, P470, DOI 10.1007/s12250-015-3663-7
   MEEGAN JM, 1979, T ROY SOC TROP MED H, V73, P618, DOI 10.1016/0035-9203(79)90004-X
   MUNDEL B., 1951, S AFRICAN MED JOUR, V25, P797
   Murithi RM, 2011, EPIDEMIOL INFECT, V139, P372, DOI 10.1017/S0950268810001020
   Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195
   Sindato Calvin, 2011, Tanzan J Health Res, V13, P305
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Su S, 2016, J INFECTION, V73, P289, DOI 10.1016/j.jinf.2016.06.004
   Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003
   Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5
   SWANEPOEL R, 1979, CENT AFR J MED, V25, P1
   Wang LF, 2016, J INFECTION, V73, P377, DOI 10.1016/j.jinf.2016.07.003
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Wong G, 2015, CELL HOST MICROBE, V18, P398, DOI 10.1016/j.chom.2015.09.013
   Woods CW, 2002, EMERG INFECT DIS, V8, P138, DOI 10.3201/eid0802.010023
   Xu X, 2016, EMBO J
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zhou HD, 2016, VIROL SIN, V31, P357, DOI 10.1007/s12250-016-3821-6
NR 31
TC 1
Z9 1
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD OCT
PY 2016
VL 31
IS 5
BP 454
EP 456
DI 10.1007/s12250-016-3876-4
PG 3
WC Virology
SC Virology
GA EB7ME
UT WOS:000387570900011
PM 27822717
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Garcia-Blanco, MA
   Vasudevan, SG
   Bradrick, SS
   Nicchitta, C
AF Garcia-Blanco, Mariano A.
   Vasudevan, Subhash G.
   Bradrick, Shelton S.
   Nicchitta, Christopher
TI Flavivirus RNA transactions from viral entry to genome replication
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Dengue genomic RNA; Dengue RNA translation; Dengue RNA replication;
   Dengue RNA structure
ID DENGUE VIRUS-REPLICATION; CORE PROTEIN; ZIKA VIRUS;
   NUCLEAR-LOCALIZATION; CAPSID PROTEIN; CODING REGION; TRANSLATION;
   POLYMERASE; INFECTION; RIBOSOMES
AB Upon release of the similar to 11 kb single-stranded positive polarity dengue virus genomic RNA (gRNA) into the cytoplasm of an infected cell, it serves as the template for translation of the viral polyprotein, which is cleaved into three structural and seven non-structural proteins. The structural organization of the viral replication complex and RNA is not known but it is increasingly becoming evident that the viral gRNA and replication intermediates adopt unique structural features and localize to discrete regions in the infected cell. Both structure and location play multiple roles ranging from evasion of innate immune response to recruitment of viral and host proteins for translation and replication of the message. This review visits the various transactions that the viral gRNA undergoes between entry and RNA synthesis with the view that some of these events may be targeted by antiviral compounds. This article forms part of a symposium on flavivirus drug discovery in Antiviral Research. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Garcia-Blanco, Mariano A.; Vasudevan, Subhash G.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Garcia-Blanco, Mariano A.; Bradrick, Shelton S.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Nicchitta, Christopher] Duke Univ, Dept Cell Biol, Durham, NC USA.
RP Garcia-Blanco, MA; Vasudevan, SG (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
EM maragarc@utmb.edu; subhash.vasudevan@duke-nus.edu.sg
OI Garcia-Blanco, Mariano/0000-0001-8538-1997
FU Texas STARs Award Program of the University of Texas System; University
   of Texas Medical Branch startup funds; Agency for Science, Technology
   and Research, SingaporeAgency for Science Technology & Research (ASTAR);
   Ministry of Health, Singapore
FX MGB acknowledges support from the Texas STARs Award Program of the
   University of Texas System. MGB and SB acknowledge support from the
   University of Texas Medical Branch startup funds. MGB and SV acknowledge
   support of the Research Signature Programme in Emerging Infectious
   Diseases at Duke-NUS Medical School provided by the Agency for Science,
   Technology and Research, Singapore and the Ministry of Health,
   Singapore.
CR Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chan CYY, 2015, FUTURE MICROBIOL, V10, P2017, DOI 10.2217/fmb.15.105
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead S.B., 2016, AM J TROP MED HYG
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   Herold J, 2001, MOL CELL, V7, P581, DOI 10.1016/S1097-2765(01)00205-2
   Hinnebusch AG, 2009, GENE DEV, V23, P891, DOI 10.1101/gad.1800509
   Hodge K, 2016, J BIOL CHEM, V291, P17437, DOI 10.1074/jbc.M116.724013
   Howe MK, 2016, ANTIVIR RES, V130, P81, DOI 10.1016/j.antiviral.2016.03.017
   Jagannathan S, 2014, RNA, V20, P1489, DOI 10.1261/rna.045526.114
   Kim YG, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-59
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   MAURACHER CA, 1991, VIROLOGY, V181, P773, DOI 10.1016/0042-6822(91)90916-Y
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   Nawa M, 1997, MICROBIOL IMMUNOL, V41, P537, DOI 10.1111/j.1348-0421.1997.tb01889.x
   Netsawang J, 2010, VIRUS RES, V147, P275, DOI 10.1016/j.virusres.2009.11.012
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   SINGH I, 1992, J VIROL, V66, P7049, DOI 10.1128/JVI.66.12.7049-7058.1992
   Sung C, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P293, DOI 10.1079/9781845939649.0293
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
NR 53
TC 28
Z9 28
U1 4
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD OCT
PY 2016
VL 134
BP 244
EP 249
DI 10.1016/j.antiviral.2016.09.010
PG 6
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA EA9SA
UT WOS:000386983800027
PM 27666184
DA 2020-07-08
ER

PT J
AU Gruba, N
   Martinez, JIR
   Grzywa, R
   Wysocka, M
   Skorenski, M
   Burmistrz, M
   Lecka, M
   Lesner, A
   Sienczyk, M
   Pyrc, K
AF Gruba, Natalia
   Martinez, Jose Ignacio Rodriguez
   Grzywa, Renata
   Wysocka, Magdalena
   Skorenski, Marcin
   Burmistrz, Michal
   Lecka, Maria
   Lesner, Adam
   Sienczyk, Marcin
   Pyrc, Krzysztof
TI Substrate profiling of Zika virus NS2B-NS3 protease
SO FEBS LETTERS
LA English
DT Article
DE combinatorial chemistry; NS2B-NS3 protease; substrate library; substrate
   mapping; Zika virus
ID DENGUE VIRUS; NS3 PROTEASE; NS2B/NS3 PROTEASE; SERINE-PROTEASE; LIGAND
   DOCKING; AMINO-ACIDS; DRUG DESIGN; SPECIFICITY; INHIBITORS; PROSPECTS
AB Zika virus (ZIKV), isolated from macaques in Uganda in 1947, was not considered to be a dangerous human pathogen. However, this view has recently changed as ZIKV infections are now associated with serious pathological disorders including microcephaly and Guillain-Barre syndrome. Similar to other viruses in the Flaviviridae family, ZIKV expresses the serine protease NS3 which is responsible for viral protein processing and replication. Herein, we report the expression of an active NS3(pro) domain fused with the NS2B cofactor (NS2B(LN)NS3(pro)) in a prokaryotic expression system and profile its specificity for synthesized FRET-type substrate libraries. Our findings pave way for screening potential intracellular substrates of NS3 and for developing specific inhibitors of this ZIKV protease.
C1 [Gruba, Natalia; Wysocka, Magdalena; Lesner, Adam] Univ Gdansk, Fac Chem, Dept Biochem, Wita Stwosza 63, PL-80952 Gdansk, Poland.
   [Martinez, Jose Ignacio Rodriguez; Burmistrz, Michal; Pyrc, Krzysztof] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland.
   [Grzywa, Renata; Skorenski, Marcin; Lecka, Maria; Sienczyk, Marcin] Wroclaw Univ Sci & Technol, Fac Chem, Div Med Chem & Microbiol, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.
   [Burmistrz, Michal; Pyrc, Krzysztof] Jagiellonian Univ, Malopolska Ctr Biotechnol, Krakow, Poland.
RP Lesner, A (corresponding author), Univ Gdansk, Fac Chem, Dept Biochem, Wita Stwosza 63, PL-80952 Gdansk, Poland.; Sienczyk, M (corresponding author), Wroclaw Univ Sci & Technol, Fac Chem, Div Med Chem & Microbiol, Wybrzeze Wyspianskiego 27, PL-50370 Wroclaw, Poland.; Pyrc, K (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Gronostajowa 7, PL-30387 Krakow, Poland.
EM adam.lesner@ug.edu.pl; marcin.sienczyk@pwr.edu.pl; k.a.pyrc@uj.edu.pl
RI Lesner, Adam/M-2732-2019; Burmistrz, Michal/AAQ-1027-2020
OI Lesner, Adam/0000-0001-8335-3431; Pyrc, Krzysztof/0000-0002-3867-7688;
   Gruba, Natalia/0000-0003-3281-9945; Rodriguez Martinez, Jose
   Ignacio/0000-0002-3379-9686; Wysocka, Magdalena/0000-0003-2216-5597
FU Ministry of Science and Higher Education Iuventus Plus Programme [IP2012
   0556 72]; National Science Center [UMO-657 2012/07/E/NZ6/01712];
   European UnionEuropean Union (EU) [POIG.02.01.00-12-064/08]; Ministry of
   Science and Higher Education of the Republic of PolandMinistry of
   Science and Higher Education, Poland
FX The study was partially supported by Ministry of Science and Higher
   Education Iuventus Plus Programme (IP2012 0556 72) to MSi and by
   National Science Center (UMO-657 2012/07/E/NZ6/01712) to KP. KP would
   like to acknowledge networking contribution by the COST Action CM1407
   'Challenging organic syntheses inspired by nature - from natural
   products chemistry to drug discovery'. The authors thank Dr Keri
   Csencsits-Smith (University of Texas at Houston) for critical reading of
   the manuscript. MSi and RG thank Polish Ministry of Science and Higher
   Education for Subsidiary Founds (S50129/Z0313). The Faculty of
   Biochemistry, Biophysics and Biotechnology of the Jagiellonian
   University is a beneficiary of the structural funds from the European
   Union (grant No: POIG.02.01.00-12-064/08 'Molecular biotechnology for
   health'). Faculty of Biochemistry, Biophysics and Biotechnology of the
   Jagiellonian University is a partner of the Leading National Research
   Center supported by the Ministry of Science and Higher Education of the
   Republic of Poland. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Ang MJY, 2014, PEPTIDES, V52, P49, DOI 10.1016/j.peptides.2013.12.002
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chappell KJ, 2008, CURR MED CHEM, V15, P2771, DOI 10.2174/092986708786242804
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hojo K, 2000, CHEM PHARM BULL, V48, P1740
   HOUGHTEN RA, 1991, NATURE, V354, P84, DOI 10.1038/354084a0
   Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Lima AB, 2015, BIOORGAN MED CHEM, V23, P5748, DOI 10.1016/j.bmc.2015.07.012
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Niyomrattanakit P, 2006, BIOCHEM J, V397, P203, DOI 10.1042/BJ20051767
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Ramanathan MP, 2006, VIROLOGY, V345, P56, DOI 10.1016/j.virol.2005.08.043
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Shafee N, 2003, J GEN VIROL, V84, P2191, DOI 10.1099/vir.0.19022-0
   Skorenski M, 2013, CURR PHARM DESIGN, V19, P1126
   SOLE NA, 1992, J ORG CHEM, V57, P5399, DOI 10.1021/jo00046a022
   ten Brink T, 2010, J COMPUT AID MOL DES, V24, P935, DOI 10.1007/s10822-010-9385-x
   Timiri AK, 2016, EUR J MED CHEM, V117, P125, DOI 10.1016/j.ejmech.2016.04.008
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wysocka M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22856
   Yilmaz NK, 2016, TRENDS MICROBIOL, V24, P547, DOI 10.1016/j.tim.2016.03.010
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yusof R, 2000, J BIOL CHEM, V275, P9963, DOI 10.1074/jbc.275.14.9963
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 41
TC 23
Z9 24
U1 2
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD OCT
PY 2016
VL 590
IS 20
BP 3459
EP 3468
DI 10.1002/1873-3468.12443
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA EA8FF
UT WOS:000386870000001
PM 27714789
DA 2020-07-08
ER

PT J
AU Rasool, N
   Odel, JG
AF Rasool, Nailyn
   Odel, Jeffrey G.
TI Similarities in the Retinal Appearance of Patients With Zika Virus
   Compared With Cobalamin C Deficiency
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [Rasool, Nailyn; Odel, Jeffrey G.] Columbia Univ, Dept Ophthalmol, 635 W 165th St, New York, NY 10032 USA.
RP Odel, JG (corresponding author), Columbia Univ, Dept Ophthalmol, 635 W 165th St, New York, NY 10032 USA.
EM odel1@aol.com
CR Bonafede L, 2015, INVEST OPHTH VIS SCI, V56, P7875, DOI 10.1167/iovs.15-17857
   Brooks BP, 2016, OPHTHALMOLOGY, V123, P571, DOI 10.1016/j.ophtha.2015.10.041
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Martinelli D, 2011, J INHERIT METAB DIS, V34, P127, DOI 10.1007/s10545-010-9161-z
   Weisfeld-Adams JD, 2010, MOL GENET METAB, V99, P116, DOI 10.1016/j.ymgme.2009.09.008
NR 5
TC 3
Z9 3
U1 0
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD OCT 1
PY 2016
VL 134
IS 10
BP 1200
EP 1201
DI 10.1001/jamaophthalmol.2016.2398
PG 3
WC Ophthalmology
SC Ophthalmology
GA EA3FO
UT WOS:000386486900034
PM 27490307
DA 2020-07-08
ER

PT J
AU Dias, JRD
   Freitas, BD
   Belfort, R
AF de Oliveira Dias, Joao Rafael
   Freitas, Bruno de Paula
   Belfort, Rubens, Jr.
TI Similarities in the Retinal Appearance of Patients With Zika Virus
   Compared With Cobalamin C Deficiency Reply
SO JAMA OPHTHALMOLOGY
LA English
DT Letter
C1 [de Oliveira Dias, Joao Rafael; Belfort, Rubens, Jr.] Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 821,First Floor, BR-04023062 Sao Paulo, Brazil.
   [Freitas, Bruno de Paula] Hosp Geral Roberto Santos, Dept Ophthalmol, Salvador, BA, Brazil.
RP Belfort, R (corresponding author), Univ Fed Sao Paulo, Vis Inst, Dept Ophthalmol, Paulista Med Sch, Rua Botucatu 821,First Floor, BR-04023062 Sao Paulo, Brazil.
EM prof.belfort@clinicabelfort.com.br
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6165
EI 2168-6173
J9 JAMA OPHTHALMOL
JI JAMA Ophthalmol.
PD OCT 1
PY 2016
VL 134
IS 10
BP 1201
EP 1201
DI 10.1001/jamaophthalmol.2016.2404
PG 1
WC Ophthalmology
SC Ophthalmology
GA EA3FO
UT WOS:000386486900036
PM 27490445
DA 2020-07-08
ER

PT J
AU Metz, SW
   Tian, SM
   Hoekstra, G
   Yi, XW
   Stone, M
   Horvath, K
   Miley, MJ
   DeSimone, J
   Luft, CJ
   de Silva, AM
AF Metz, Stefan W.
   Tian, Shaomin
   Hoekstra, Gabriel
   Yi, Xianwen
   Stone, Michelle
   Horvath, Katie
   Miley, Michael J.
   DeSimone, Joseph
   Luft, Chris J.
   de Silva, Aravinda M.
TI Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust
   Serotype-Specific Neutralizing Antibody Responses
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DENGUE VIRUS TYPE-2; MONOCLONAL-ANTIBODIES; PLGA MICROPARTICLES; GLOBAL
   DISTRIBUTION; PRINT PARTICLES; NEXT-GENERATION; DELIVERY; VACCINE;
   ANTIGEN; CELLS
AB Dengue virus (DENV) is the causative agent of dengue fever and dengue hemorrhagic fever. The virus is endemic in over 120 countries, causing over 350 million infections per year. Dengue vaccine development is challenging because of the need to induce simultaneous protection against four antigenically distinct DENV serotypes and evidence that, under some conditions, vaccination can enhance disease due to specific immunity to the virus. While several live-attenuated tetravalent dengue virus vaccines display partial efficacy, it has been challenging to induce balanced protective immunity to all 4 serotypes. Instead of using whole-virus formulations, we are exploring the potentials for a particulate subunit vaccine, based on DENV E-protein displayed on nanoparticles that have been precisely molded using Particle Replication in Non-wetting Template (PRINT) technology. Here we describe immunization studies with a DENV2-nanoparticle vaccine candidate. The ectodomain of DENV2-E protein was expressed as a secreted recombinant protein (sRecE), purified and adsorbed to poly (lactic-co-glycolic acid) (PLGA) nanoparticles of different sizes and shape. We show that PRINT nanoparticle adsorbed sRecE without any adjuvant induces higher IgG titers and a more potent DENV2-specific neutralizing antibody response compared to the soluble sRecE protein alone. Antigen trafficking indicate that PRINT nanoparticle display of sRecE prolongs the bio-availability of the antigen in the draining lymph nodes by creating an antigen depot. Our results demonstrate that PRINT nanoparticles are a promising platform for delivering subunit vaccines against flaviviruses such as dengue and Zika.
C1 [Metz, Stefan W.; Tian, Shaomin; Hoekstra, Gabriel; de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.
   [Yi, Xianwen; DeSimone, Joseph; Luft, Chris J.] Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27514 USA.
   [Miley, Michael J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA.
   [DeSimone, Joseph; Luft, Chris J.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27514 USA.
   [DeSimone, Joseph] Univ N Carolina, Dept Chem, Chapel Hill, NC USA.
   [DeSimone, Joseph] North Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC USA.
   [DeSimone, Joseph] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, 1275 York Ave, New York, NY 10021 USA.
   [Stone, Michelle; Horvath, Katie] Liquidia Technol, Res Triangle Pk, NC USA.
RP de Silva, AM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27514 USA.; Luft, CJ (corresponding author), Univ N Carolina, Lineberger Comprehens Ctr, Chapel Hill, NC 27514 USA.; Luft, CJ (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27514 USA.
EM jluft@email.unc.edu; deSilva@med.unc.edu
RI Metz, Stefan/J-1974-2019
OI Metz, Stefan/0000-0002-9249-2844
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [U19
   AI109784-01]
FX This study was funded by US National Institutes of Health grant U19
   AI109784-01. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Arvizo RR, 2012, CHEM SOC REV, V41, P2943, DOI 10.1039/c2cs15355f
   Astrom C, 2012, ECOHEALTH, V9, P448, DOI 10.1007/s10393-012-0808-0
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Ehrenfried LM, 2008, J MATER SCI-MATER M, V19, P459, DOI 10.1007/s10856-006-0061-6
   Enlow EM, 2011, NANO LETT, V11, P808, DOI 10.1021/nl104117p
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Galloway AL, 2013, NANOMED-NANOTECHNOL, V9, P523, DOI 10.1016/j.nano.2012.11.001
   Guzman MG, 2003, AM J TROP MED HYG, V69, P129, DOI 10.4269/ajtmh.2003.69.129
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Halstead SB, 2016, VACCINE IN PRESS, DOI [10.1016/j.vaccine.2016.02.004, DOI 10.1016/j.vaccine.2016.02.004]
   Hasan W, 2012, NANO LETT, V12, P287, DOI 10.1021/nl2035354
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   Holgado MA, 2008, INT J PHARMACEUT, V358, P27, DOI 10.1016/j.ijpharm.2008.02.012
   Kelly EP, 2000, VACCINE, V18, P2549, DOI 10.1016/S0264-410X(00)00032-3
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Liggins RT, 2001, INT J PHARM, V222, P19, DOI 10.1016/S0378-5173(01)00690-1
   Madaan A., 2014, J BIOL METHODS, V1, pe1, DOI DOI 10.14440/JBM.2014.12
   Mamo T, 2012, VACCINE, V30, P6609, DOI 10.1016/j.vaccine.2012.08.023
   Maynor BW, 2005, ABSTR PAP AM CHEM S, V230, pU4049
   Merkel TJ, 2012, J CONTROL RELEASE, V162, P37, DOI 10.1016/j.jconrel.2012.06.009
   Metz SW, 2013, VACCINE, V31, P6092, DOI 10.1016/j.vaccine.2013.09.045
   Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353
   Metz SW, 2011, J INVERTEBR PATHOL, V107, pS16, DOI 10.1016/j.jip.2011.05.002
   Mueller SN, 2015, MOL PHARMACEUT, V12, P1356, DOI 10.1021/mp500589c
   Oster CG, 2005, J MICROENCAPSUL, V22, P235, DOI 10.1080/02652040500100295
   Patel PA, 2011, J BIOMED NANOTECHNOL, V7, P632, DOI 10.1166/jbn.2011.1332
   Petros RA, 2008, J AM CHEM SOC, V130, P5008, DOI 10.1021/ja801436j
   Pitcher TJ, 2015, J GEN VIROL, V96, P288, DOI 10.1099/vir.0.070813-0
   Reddy ST, 2006, TRENDS IMMUNOL, V27, P573, DOI 10.1016/j.it.2006.10.005
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Schiller JT, 2015, J INFECT DIS, V211, P1373, DOI 10.1093/infdis/jiu648
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Storni T, 2005, ADV DRUG DELIVER REV, V57, P333, DOI 10.1016/j.addr.2004.09.008
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Tan M, 2014, CURR OPIN VIROL, V6, P24, DOI 10.1016/j.coviro.2014.02.009
   Thomas SJ, 2011, CURR OPIN INFECT DIS, V24, P442, DOI 10.1097/QCO.0b013e32834a1b0b
   Tiwari S, 2011, INT J PHARMACEUT, V413, P211, DOI 10.1016/j.ijpharm.2011.04.029
   Wan SW, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-37
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilder-Smith Annelies, 2010, Curr Infect Dis Rep, V12, P157, DOI 10.1007/s11908-010-0102-7
   Zazo H, 2016, J CONTROL RELEASE, V224, P86, DOI 10.1016/j.jconrel.2016.01.008
   Zhang NR, 2015, VIRUS RES, V202, P151, DOI 10.1016/j.virusres.2014.11.013
   Zhou Y, 2013, VIROLOGY, V439, P57, DOI 10.1016/j.virol.2013.01.022
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
NR 51
TC 16
Z9 16
U1 0
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005071
DI 10.1371/journal.pntd.0005071
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200051
PM 27764114
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reller, ME
   de Silva, AM
   Miles, JJ
   Jadi, RS
   Broadwater, A
   Walker, K
   Woods, C
   Mayorga, O
   Matute, A
AF Reller, Megan E.
   de Silva, Aravinda M.
   Miles, Jeremy J.
   Jadi, Ramesh S.
   Broadwater, Anne
   Walker, Katie
   Woods, Christopher
   Mayorga, Orlando
   Matute, Armando
TI Unsuspected Dengue as a Cause of Acute Febrile Illness in Children and
   Adults in Western Nicaragua
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LINKED-IMMUNOSORBENT-ASSAY; VIRUS-INFECTION; ZIKA VIRUS; EPIDEMIC;
   ANTIBODIES; AMERICA
AB Background
   Dengue is an emerging infectious disease of global significance. Suspected dengue, especially in children in Nicaragua's heavily-urbanized capital of Managua, has been well documented, but unsuspected dengue among children and adults with undifferentitated fever has not.
   Methodology/Principal Findings
   To prospectively study dengue in semi-urban and rural western Nicaragua, we obtained epidemiologic and clinical data as well as acute and convalescent sera (2 to 4 weeks after onset of illness) from a convenience sample (enrollment Monday to Saturday daytime to early evening) of consecutively enrolled patients (n = 740) aged >= 1 years presenting with acute febrile illness. We tested paired sera for dengue IgG and IgM and serotyped dengue virus using reverse transcriptase-PCR. Among 740 febrile patients enrolled, 90% had paired sera. We found 470 (63.5%) were seropositive for dengue at enrollment. The dengue seroprevalance increased with age and reached > 90% in people over the age of 20 years. We identified acute dengue (serotypes 1 and 2) in 38 (5.1%) patients. Only 8.1% (3/37) of confirmed cases were suspected clinically.
   Conclusions/Significance
   Dengue is an important and largely unrecognized cause of fever in rural western Nicaragua. Since Zika virus is transmitted by the same vector and has been associated with severe congenital infections, the population we studied is at particular risk for being devastated by the Zika epidemic that has now reached Central America.
C1 [Reller, Megan E.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA.
   [Reller, Megan E.; Woods, Christopher] Hubert Yeargan Ctr Global Hlth, Durham, NC 27710 USA.
   [de Silva, Aravinda M.; Jadi, Ramesh S.; Broadwater, Anne; Walker, Katie] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Miles, Jeremy J.] Duke Univ, Sch Med, Durham, NC USA.
   [Woods, Christopher] Duke Univ, Sch Med, Dept Med, Div Infect Dis, Durham, NC 27706 USA.
   [Mayorga, Orlando; Matute, Armando] Univ Nacl Autonoma Nicaragua, Hosp Escuela Oscar Danilo Rosales Arguello, Leon, Nicaragua.
RP Reller, ME (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA.; Reller, ME (corresponding author), Hubert Yeargan Ctr Global Hlth, Durham, NC 27710 USA.
EM megan.reller@duke.edu
CR Olano VA, 2015, J AM MOSQUITO CONTR, V31, P212, DOI 10.2987/moco-31-03-212-222.1
   Balmaseda A, 2006, AM J TROP MED HYG, V74, P449, DOI 10.4269/ajtmh.2006.74.449
   Balmaseda A, 1999, AM J TROP MED HYG, V61, P893, DOI 10.4269/ajtmh.1999.61.893
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   CHUNGUE E, 1989, T ROY SOC TROP MED H, V83, P708, DOI 10.1016/0035-9203(89)90404-5
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485
   de Paula Freitas B, 2016, JAMA OPHTHA IN PRESS
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Gregory CJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001400
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   Gutierrez G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001394
   Guzman Maria G., 1996, Boletin de la Oficina Sanitaria Panamericana, V121, P102
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Harris E, 2000, AM J TROP MED HYG, V63, P5, DOI 10.4269/ajtmh.2000.63.5
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Khun S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-262
   KOURI G, 1991, REV I MED TROP, V33, P365, DOI 10.1590/S0036-46651991000500005
   KUNO G, 1987, AM J TROP MED HYG, V36, P153, DOI 10.4269/ajtmh.1987.36.153
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Maillo BM, 2008, EMERG INFECT DIS, V14, P1171, DOI 10.3201/eid1407.071496
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Overgaard HJ, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-182
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Reller ME, 2012, EMERG INFECT DIS, V18, P256, DOI 10.3201/eid1802.110962
   Seng CM, 2009, TROP MED INT HEALTH, V14, P1233, DOI 10.1111/j.1365-3156.2009.02368.x
   Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4338
   Thai KTD, 2010, J INFECTION, V60, P229, DOI 10.1016/j.jinf.2010.01.003
NR 32
TC 4
Z9 4
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005026
DI 10.1371/journal.pntd.0005026
PG 14
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200019
PM 27792777
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sikulu-Lord, MT
   Milali, MP
   Henry, M
   Wirtz, RA
   Hugo, LE
   Dowell, FE
   Devine, GJ
AF Sikulu-Lord, Maggy T.
   Milali, Masabho P.
   Henry, Michael
   Wirtz, Robert A.
   Hugo, Leon E.
   Dowell, Floyd E.
   Devine, Gregor J.
TI Near-Infrared Spectroscopy, a Rapid Method for Predicting the Age of
   Male and Female Wild-Type and Wolbachia Infected Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MOSQUITO AGE; CUTICULAR HYDROCARBONS; CHIKUNGUNYA; CULICIDAE; DIPTERA;
   DENGUE; VIRUS
AB Estimating the age distribution of mosquito populations is crucial for assessing their capacity to transmit disease and for evaluating the efficacy of available vector control programs. This study reports on the capacity of the near-infrared spectroscopy (NIRS) technique to rapidly predict the ages of the principal dengue and Zika vector, Aedes aegypti. The age of wild-type males and females, and males and females infected with wMel and wMelPop strains of Wolbachia pipientis were characterized using this method. Calibrations were developed using spectra collected from their heads and thoraces using partial least squares (PLS) regression. A highly significant correlation was found between the true and predicted ages of mosquitoes. The coefficients of determination for wild-type females and males across all age groups were R-2 = 0.84 and 0.78, respectively. The coefficients of determination for the age of wMel and wMelPop infected females were 0.71 and 0.80, respectively (P<0.001 in both instances). The age of wild-type female Ae. aegypti could be identified as < or >= 8 days old with an accuracy of 91% (N = 501), whereas female Ae. aegypti infected with wMel and wMelPop were differentiated into the two age groups with an accuracy of 83% (N = 284) and 78% (N = 229), respectively. Our results also indicate NIRS can distinguish between young and old male wild-type, wMel and wMelPop infected Ae. aegypti with accuracies of 87% (N = 253), 83% (N = 277) and 78% (N = 234), respectively. We have demonstrated the potential of NIRS as a predictor of the age of female and male wild-type and Wolbachia infected Ae. aegypti mosquitoes under laboratory conditions. After field validation, the tool has the potential to offer a cheap and rapid alternative for surveillance of dengue and Zika vector control programs.
C1 [Sikulu-Lord, Maggy T.; Hugo, Leon E.; Devine, Gregor J.] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.
   [Sikulu-Lord, Maggy T.; Milali, Masabho P.; Henry, Michael] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.
   [Wirtz, Robert A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Dowell, Floyd E.] ARS, Stored Prod Insect & Engn Res Unit, Ctr Grain & Anim Hlth Res, USDA, Manhattan, KS USA.
RP Sikulu-Lord, MT (corresponding author), QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.; Sikulu-Lord, MT (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.
EM maggy.sikulu@qimrberghofer.edu.au
RI Sikulu-Lord, Maggy/L-8158-2017; Hugo, R. Leon E/O-3013-2018; Devine,
   Gregor J/H-1141-2014
OI Sikulu-Lord, Maggy/0000-0002-9346-2970; Hugo, R. Leon
   E/0000-0002-6767-9850; Devine, Gregor J/0000-0001-6312-0390; Henry,
   Michael/0000-0002-0608-9339
FU Grand Challenges Canada Stars for Global Health - Government of Canada
   [0439-01]
FX This study was supported by Grand Challenges Canada Stars for Global
   Health funded by the Government of Canada (grant 0439-01) awarded to
   MTSL. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Aliota MT, 2016, SCI REPORTS, V6
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Control ECfDPa, 2015, ZIK VIR EP AM POT AS
   Cook PE, 2007, NAT PROTOC, V2, P2796, DOI 10.1038/nprot.2007.396
   Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103
   Desena ML, 1999, J MED ENTOMOL, V36, P811, DOI 10.1093/jmedent/36.6.811
   Desena ML, 1999, J MED ENTOMOL, V36, P824, DOI 10.1093/jmedent/36.6.824
   DETINOVA T S, 1962, Monogr Ser World Health Organ, V47, P13
   Dowell FE, 2011, AM J TROP MED HYG, V85, P1093, DOI 10.4269/ajtmh.2011.11-0438
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Ferguson HM, 2005, TRENDS ECOL EVOL, V20, P202, DOI 10.1016/j.tree.2005.02.003
   Galizi H, 2014, NAT COMMUN, V5, DOI [10.1038/396, DOI 10.10.8/NCOMMS4977]
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hugo LE, 2008, J MED ENTOMOL, V45, P353, DOI 10.1603/0022-2585(2008)45[353:EOMAGT]2.0.CO;2
   Hugo LE, 2006, AM J TROP MED HYG, V74, P462, DOI 10.4269/ajtmh.2006.74.462
   Hugo LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058656
   Huho BJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-62
   Liebman K, 2015, AM J TROP MED HYG, V92, P1070, DOI 10.4269/ajtmh.14-0790
   MAHMOOD F, 1994, MED VET ENTOMOL, V8, P31, DOI 10.1111/j.1365-2915.1994.tb00380.x
   Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192
   Mayagaya VS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0661-4
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Ntamatungiro AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-298
   POLOVODOVA VP, 1949, MED PARAZITOL PARAZI, V18, P352
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   SCHULE P. A., 1928, American Journal of Tropical Medicine, V8, P203
   Scott TW, 2002, SCIENCE, V298, P117, DOI 10.1126/science.298.5591.117
   Sikulu M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-186
   Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49
   Sikulu MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090657
   Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759
   Tabachnick WJ, 2003, J MED ENTOMOL, V40, P597, DOI 10.1603/0022-2585-40.5.597
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization [WHO], 2016, MOSQ CONTR CAN IT ST
NR 41
TC 11
Z9 11
U1 0
U2 21
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005040
DI 10.1371/journal.pntd.0005040
PG 11
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200028
PM 27768689
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI France's Sanofi Partners US Army to Speed up Zika Vaccine
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD OCT 1
PY 2016
VL 63
IS 7
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA DZ7JL
UT WOS:000386041100005
DA 2020-07-08
ER

PT J
AU Darko, R
   Mashburn, JL
AF Darko, Richmond
   Mashburn, Jessica L.
TI Zika Virus Disease: Case Report and Review of Literature
SO PEDIATRIC EMERGENCY CARE
LA English
DT Review
DE Zika; virus; microcephaly; epidemic; Aedes; mosquito; global; public;
   health
ID SEXUAL TRANSMISSION; BRAZIL; INFECTION; MOSQUITOS; AMERICA; HISTORY
AB Zika virus (ZIKV) infection and its associated complications have become a significant public health concern. Zika virus is a Flavivirus, and is transmitted to humans by Aedes species mosquitoes. In May 2015, the World Health Organization reported the first locally acquired transmission of ZIKV in Brazil, the first case in the Western Hemisphere. There have also been reports of increased incidence of microcephaly and other neurologic complications associated with ZIKV infection, as well as a 20-fold increase in the incidence of Guillain-Barre Syndrome during ZIKV outbreaks. In light of the clusters of microcephaly and neurologic manifestations in areas of ZIKV transmission, the World Health Organization declared ZIKV and associated complications an international public health emergency. The clinical presentations of ZIKV disease resemble many common infections, making the diagnosis of ZIKV disease a clinical challenge. Patients with ZIKV infection may have other coinfections that can distract clinicians from suspecting ZIKV disease in their patients. Complications from ZIKV, although uncommon, may be severe. Therefore, it is important for health care providers to remain alert and up to date in the efforts to control this emerging global health crisis. It is critical for physicians and other providers to know the growing list of countries and territories on the US Centers for Disease Control and Prevention list of nations with endemic ZIKV disease and to work closely with local health departments to prevent spread. In this article, we present a case of ZIKV disease in a pediatric patient and review of the current literature.
C1 [Darko, Richmond; Mashburn, Jessica L.] Nicklaus Childrens Hosp, Div Pediat Hosp Med, Pediat Urgent Care Med, Miami, FL USA.
RP Darko, R (corresponding author), Nicklaus Childrens Hosp, Urgent Care Ctr, 3100 SW 62nd Ave, Miami, FL 33155 USA.
EM rdarko@gmail.com
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   CDC, REC MAN REP ZIK VIR
   CDC, ALL COUNTR TERR ACT
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Flores MS, 2016, CLEV CLIN J MED, V83, P1, DOI 10.3949/ccjm.83a.16027
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Maharajan MK, 2016, CLIN REV ALLERGY IMM
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   US Food and Drug Administration, 2016, REC DON SCREEN DEF P
   WHO, 2016, PREGN MAN CONT ZIK V
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 28
TC 3
Z9 3
U1 0
U2 62
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0749-5161
EI 1535-1815
J9 PEDIATR EMERG CARE
JI Pediatr. Emerg. Care
PD OCT
PY 2016
VL 32
IS 10
BP 705
EP 709
DI 10.1097/PEC.0000000000000932
PG 5
WC Emergency Medicine; Pediatrics
SC Emergency Medicine; Pediatrics
GA EA1FM
UT WOS:000386337900013
PM 27749669
DA 2020-07-08
ER

PT J
AU Haddow, AD
   Woodall, JP
AF Haddow, Andrew D.
   Woodall, John P.
TI Distinguishing between Zika and Spondweni viruses
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Editorial Material
C1 [Haddow, Andrew D.] US Army, Med Res Inst Infect Dis, Dept Entomol, Ft Detrick, MD 21702 USA.
   [Woodall, John P.] ProMED Mail, Int Soc Infect Dis, Brookline, MA USA.
RP Haddow, AD (corresponding author), US Army, Med Res Inst Infect Dis, Dept Entomol, Ft Detrick, MD 21702 USA.
EM andrew.d.haddow.ctr@mail.mil
RI Haddow, Andrew D/C-5902-2008
OI Haddow, Andrew D/0000-0002-8957-2608
NR 0
TC 21
Z9 23
U1 0
U2 5
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD OCT
PY 2016
VL 94
IS 10
BP 711
EP 711
DI 10.2471/BLT.16.181503
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DZ5OY
UT WOS:000385912600002
PM 27843157
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU de Andrade, PP
   Aragao, FJL
   Colli, W
   Dellagostin, OA
   Finardi, F
   Hirata, MH
   Lira-Neto, AD
   de Melo, MA
   Nepomuceno, AL
   da Nobrega, FG
   de Sousa, GD
   Valicente, FH
   Zanettini, MHB
AF de Andrade, Paulo Paes
   Lima Aragao, Francisco Jose
   Colli, Walter
   Dellagostin, Odir Antonio
   Finardi-Filho, Flavio
   Hirata, Mario Hiroyuki
   Lira-Neto, Amaro de Castro
   de Melo, Marcia Almeida
   Nepomuceno, Alexandre Lima
   da Nobrega, Francisco Gorgonio
   de Sousa, Gutemberg Delfino
   Valicente, Fernando Hercos
   Bodanese Zanettini, Maria Helena
TI Use of transgenic Aedes aegypti in Brazil: risk perception and
   assessment
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID ZIKA VIRUS; HORIZONTAL TRANSFERS; GENETIC-CONTROL; TRANSPOSONS;
   INVERTEBRATE; SUPPRESSION; VERTEBRATE; FLY
AB The OX513A strain of Aedes aegypti, which was developed by the British company Oxitec, expresses a self-limiting transgene that prevents larvae from developing to adulthood. In April 2014, the Brazilian National Technical Commission on Biosafety completed a risk assessment of OX513A and concluded that the strain did not present new biological risks to humans or the environment and could be released in Brazil. At that point, Brazil became the first country to approve the unconstrained release of a genetically modified mosquito. During the assessment, the commission produced a comprehensive list of and systematically analysed the perceived hazards. Such hazards included the potential survival to adulthood of immature stages carrying the transgene should the transgene fail to be expressed or be turned off by exposure to sufficient environmental tetracycline. Other perceived hazards included the potential allergenicity and/or toxicity of the proteins expressed by the gene, the potential for gene flow or increased transmission of human pathogens and the occupation of vacant breeding sites by other vector species. The Zika epidemic both elevated the perceived importance of Ae. aegypti as a vector among policy-makers and regulators as well as the general public - and increased concerns over the release of males of the OX513A strain. We have therefore reassessed the potential hazards. We found that release of the transgenic mosquitoes would still be both safe and of great potential value in the control of diseases spread by Ae. aegypti, such as chikungunya, dengue and Zika.
C1 [de Andrade, Paulo Paes] Univ Fed Pernambuco, Dept Genet, Ave Moraes Rego S-S, BR-50670901 Recife, PE, Brazil.
   [Lima Aragao, Francisco Jose; Nepomuceno, Alexandre Lima; Valicente, Fernando Hercos] EMBRAPA, Brasilia, DF, Brazil.
   [Colli, Walter; Finardi-Filho, Flavio; Hirata, Mario Hiroyuki; da Nobrega, Francisco Gorgonio] Univ Sao Paulo, Sao Paulo, Brazil.
   [Dellagostin, Odir Antonio] Univ Fed Pelotas, Pelotas, Brazil.
   [Lira-Neto, Amaro de Castro] Inst Agron Pernambuco IPA, Recife, PE, Brazil.
   [de Melo, Marcia Almeida] Univ Fed Campina Grande, Patos de Minas, Brazil.
   [de Sousa, Gutemberg Delfino] Fac Anhanguera, Brasilia, DF, Brazil.
   [Bodanese Zanettini, Maria Helena] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
RP de Andrade, PP (corresponding author), Univ Fed Pernambuco, Dept Genet, Ave Moraes Rego S-S, BR-50670901 Recife, PE, Brazil.
EM andrade@ufpe.br
RI Hirata, Mario Hiroyuki/C-9718-2013; Aragao, Francisco J.L./E-6962-2013;
   Colli, Walter/G-1188-2012; Dellagostin, Odir/C-2331-2009
OI Hirata, Mario Hiroyuki/0000-0002-9521-7979; Colli,
   Walter/0000-0001-7305-4673; Dellagostin, Odir/0000-0003-2803-4088
CR Alphey L, 2002, INSECT BIOCHEM MOLEC, V32, P1243, DOI 10.1016/S0965-1748(02)00087-5
   Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2150
   [Anonymous], 2016, B EPIDEMIOL, V47, P1, DOI DOI 10.1080/03740463.2015.1069049
   [Anonymous], 2012, 6 M C PART CONV BIOD
   [Anonymous], 2012, PROGR NAC CONTR DENG
   [Anonymous], 2016, STERILE INSECT TECHN
   [Anonymous], 2014, GUID FRAM TESST GEN
   [Anonymous], 2016, PREL FIND NO SIGN IM
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Wilke ABB, 2012, REV INST MED TROP SP, V54, P287, DOI 10.1590/S0036-46652012000500009
   Campbell H, 2001, RURAL SOCIOL, V11, P211
   Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Conko G, 2016, NAT BIOTECHNOL, V34, P493, DOI 10.1038/nbt.3568
   Crisp A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0607-3
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dame DA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S2
   Enkerlin W, 2015, FLA ENTOMOL, V98, P665, DOI 10.1653/024.098.0242
   Escobar H., 2016, MOSQUITOS TRANSGENIC
   Gilbert C, 2010, NATURE, V464, P1347, DOI 10.1038/nature08939
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Gorman K, 2016, PEST MANAG SCI, V72, P618, DOI 10.1002/ps.4151
   Goyal P, 2011, GMO BIOSAF RES
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Joy TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046946
   Kieny MP, 2016, KIEN MP WHO RES DEV
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lee H. L., 2009, Dengue Bulletin, V33, P103
   LINDQUIST DA, 1992, MED VET ENTOMOL, V6, P2, DOI 10.1111/j.1365-2915.1992.tb00027.x
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Smyth Stuart J, 2014, GM Crops Food, V5, P170, DOI 10.4161/21645698.2014.945880
   Sousa GD, 2013, BRAZILIAN GMO REGULA
   Tang Z, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-014-0033-1
   Vilella-Vila M, 2008, J SOCIO-ECON, V37, P2095, DOI DOI 10.1016/J.SOCEC.2008.04.006
   Vreysen MJB, 2011, AGRON SUSTAIN DEV, V31, P233, DOI 10.1051/agro/2010009
   WHO, 2016, ZIK SIT REP NEUR SYN
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   Zhang HH, 2014, GENOME BIOL EVOL, V6, P1375, DOI 10.1093/gbe/evu112
NR 46
TC 12
Z9 12
U1 0
U2 124
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD OCT
PY 2016
VL 94
IS 10
BP 766
EP 771
DI 10.2471/BLT.16.173377
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DZ5OY
UT WOS:000385912600017
PM 27843167
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Fajardo, A
   Sonora, M
   Moreno, P
   Moratorio, G
   Cristina, J
AF Fajardo, Alvaro
   Sonora, Martin
   Moreno, Pilar
   Moratorio, Gonzalo
   Cristina, Juan
TI Bayesian Coalescent Inference Reveals High Evolutionary Rates and
   Diversification of Zika Virus Populations
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Zika; coalescent; bayesian; evolution; microcephaly
ID TRANSMISSION; INFECTION; OUTBREAK; AMERICA; SPREAD
AB Zika virus (ZIKV) is a member of the family Flaviviridae. In 2015, ZIKV triggered an epidemic in Brazil and spread across Latin America. By May of 2016, the World Health Organization warns over spread of ZIKV beyond this region. Detailed studies on the mode of evolution of ZIKV strains are extremely important for our understanding of the emergence and spread of ZIKV populations. In order to gain insight into these matters, a Bayesian coalescent Markov Chain Monte Carlo analysis of complete genome sequences of recently isolated ZIKV strains was performed. The results of these studies revealed a mean rate of evolution of 1.20 x 10(-3) nucleotide substitutions per site per year (s/s/y) for ZIKV strains enrolled in this study. Several variants isolated in China are grouped together with all strains isolated in Latin America. Another genetic group composed exclusively by Chinese strains were also observed, suggesting the co-circulation of different genetic lineages in China. These findings indicate a high level of diversification of ZIKV populations. Strains isolated from microcephaly cases do not share amino acid substitutions, suggesting that other factors besides viral genetic differences may play a role for the proposed pathogenesis caused by ZIKV infection. (C) 2016 Wiley Periodicals, Inc.
C1 [Fajardo, Alvaro; Sonora, Martin; Moreno, Pilar; Moratorio, Gonzalo; Cristina, Juan] Univ Republica, Fac Ciencias, CIN, Mol Virol Lab, Igua 4225, Montevideo 11400, Uruguay.
   [Moratorio, Gonzalo] Inst Pasteur, Viral Populat & Pathogenesis Lab, Paris, France.
RP Cristina, J (corresponding author), Univ Republica, Fac Ciencias, CIN, Mol Virol Lab, Igua 4225, Montevideo 11400, Uruguay.
EM cristina@cin.edu.uy
OI Moreno, Pilar/0000-0001-6155-7206
FU Agencia Nacional de Investigacion e Innovacion (ANII); PEDECIBA;
   Comision Sectorial de Investigacion Cientifica (CSIC)Consejo Superior de
   Investigaciones Cientificas (CSIC); Grupos I+D program
FX Grant sponsor: Agencia Nacional de Investigacion e Innovacion (ANII);
   Grant sponsor: PEDECIBA; Grant sponsor: Comision Sectorial de
   Investigacion Cientifica (CSIC); Grant sponsor: Grupos I+D program
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Massad E, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.31669
   Meyer AG, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev006
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
NR 24
TC 8
Z9 8
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD OCT
PY 2016
VL 88
IS 10
BP 1672
EP 1676
DI 10.1002/jmv.24596
PG 5
WC Virology
SC Virology
GA DZ3BZ
UT WOS:000385720200005
PM 27278855
DA 2020-07-08
ER

PT J
AU Wiwanitkit, V
AF Wiwanitkit, Viroj
TI Comment on "Imaging of congenital Zika virus infection: the route to
   identification of prognostic factors"
SO PRENATAL DIAGNOSIS
LA English
DT Letter
C1 [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Peoples R China.
RP Wiwanitkit, V (corresponding author), Hainan Med Univ, Haikou, Peoples R China.
EM wviroj@yahoo.com
CR Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 2
TC 0
Z9 0
U1 0
U2 144
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0197-3851
EI 1097-0223
J9 PRENATAL DIAG
JI Prenat. Diagn.
PD OCT
PY 2016
VL 36
IS 10
BP 987
EP 987
DI 10.1002/pd.4913
PG 1
WC Genetics & Heredity; Obstetrics & Gynecology
SC Genetics & Heredity; Obstetrics & Gynecology
GA DZ5PW
UT WOS:000385915000015
PM 27747912
DA 2020-07-08
ER

PT J
AU Nunes, AT
   Brito, NF
   Oliveira, DS
   Araujo, GDT
   Nogueira, FCS
   Domont, GB
   Moreira, MF
   Moreira, LM
   Soares, MR
   Melo, ACA
AF Nunes, Alessandra T.
   Brito, Nathalia F.
   Oliveira, Daniele S.
   Araujo, Gabriel D. T.
   Nogueira, Fabio Cesar S.
   Domont, Gilberto B.
   Moreira, Monica F.
   Moreira, Leandro M.
   Soares, Marcia R.
   Melo, Ana C. A.
TI Comparative proteome analysis reveals that blood and sugar meals induce
   differential protein expression in Aedes aegypti female heads
SO PROTEOMICS
LA English
DT Article
DE Aedes aegypti; Animal proteomics; Blood meals; Heads; LC-MS; MS; Sugar
   meals
ID ALBOPICTUS DIPTERA; ANOPHELES-GAMBIAE; MOSQUITO; CULICIDAE; SURVIVAL;
   VIRUS; INFECTION; VECTOR; SIZE
AB Aedes aegypti females ingest sugar or blood to obtain the nutrients needed to maintain cellular homeostasis. During human blood ingestion, female mosquitoes may transmit different viruses such as dengue, yellow fever and, more recently, zika and chikungunya. Here, we report changes in protein expression in the heads of adult female Ae. aegypti mosquitoes in response to the ingestion of blood or sugar. Proteins extracted from the heads of Ae. aegypti fed exclusively on blood (BF) or sugar (SF) were trypsin hydrolyzed (off-gel) and analyzed by the reverse-phase nano-liquid chromatography coupled with hybrid mass spectrometry. A total of 1139 proteins were identified in female heads, representing 7.4% of the predicted proteins in Ae. aegypti genome (total = 15 419 active genes). Gene ontology annotation and categories showed that, in this insect, the head was rich in proteins involved in the metabolic process, proton transport, organelle, macromolecular complex, structural molecule activity, antioxidant activity, and catalytic activity. Our report is the first indicating that many of the annotated genes are translated into functional proteins in heads of adult female Ae. aegypti. Interestingly, we identified 8.7 times more exclusively expressed proteins involved in signal transduction, replication-transcription-translation (5.5 x), and transport (2.9 x) activity in BF than in SF groups. This paper discusses the protein profile of Ae. aegypti female heads and its implications for blood ingestion and carbohydrate intake.
C1 [Nunes, Alessandra T.; Brito, Nathalia F.; Oliveira, Daniele S.; Moreira, Monica F.; Soares, Marcia R.; Melo, Ana C. A.] Univ Fed Rio de Janeiro, Inst Quim, BR-21941909 Rio De Janeiro, Brazil.
   [Araujo, Gabriel D. T.; Nogueira, Fabio Cesar S.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Inst Chem, Prote Unit, Rio De Janeiro, Brazil.
   [Moreira, Monica F.; Melo, Ana C. A.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, Brazil.
   [Moreira, Leandro M.] Univ Fed Ouro Preto, Inst Ciencias Exatas & Biol, Ouro Preto, Brazil.
RP Melo, ACA (corresponding author), Univ Fed Rio de Janeiro, Inst Quim, BR-21941909 Rio De Janeiro, Brazil.
EM anamelo@iq.ufrj.br
RI Melo, Ana C A/Y-9734-2019; Nogueira, FCS/G-9580-2011; Moreira, Monica
   F./J-4507-2016; Melo, Ana C. A./V-6533-2019; Melo, Ana C A/K-1048-2013
OI Melo, Ana C A/0000-0003-0686-7089; Nogueira, FCS/0000-0001-5507-7142;
   Moreira, Monica F./0000-0002-3720-415X; Melo, Ana C
   A/0000-0003-0686-7089
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Instituto
   Nacional de Ciencia e Tecnologia em Entomologia Molecular (CNPq-EM);
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research Support of
   the State of Rio de Janeiro (FAPERJ) [E-26/111.559/2010,
   E-26/111.697/2013, E-26/010.001582/2014, E-26/110.334/2014]; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
FX This study was supported by Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Instituto Nacional de Ciencia e Tecnologia em
   Entomologia Molecular (CNPq-EM), Fundacao Carlos Chagas Filho de Amparo
   a Pesquisa do Estado do Rio de Janeiro (FAPERJ) -
   (Grants#E-26/111.559/2010; E-26/111.697/2013; E-26/010.001582/2014;
   E-26/110.334/2014) and Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES). The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript. No additional external funding was received for this study.
CR Biron DG, 2005, INT J PARASITOL, V35, P1385, DOI 10.1016/j.ijpara.2005.05.015
   Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82
   Briegel H, 2001, J VECTOR ECOL, V26, P21
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chisenhall DM, 2014, AM J TROP MED HYG, V90, P431, DOI 10.4269/ajtmh.13-0412
   Clements A.N., 1992, BIOL MOSQUITOES DEV
   CONSOLI R A G B, 1982, Revista Brasileira de Biologia, V42, P303
   Costero A, 1998, J AM MOSQUITO CONTR, V14, P234
   Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566
   Davey K, 2007, J INSECT PHYSIOL, V53, P208, DOI 10.1016/j.jinsphys.2006.10.002
   DHADIALLA TS, 1990, J BIOL CHEM, V265, P9924
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Hugo LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058656
   Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Matthews BJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2239-0
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Saboia-Vahia L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-290
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Siju KP, 2014, J COMP NEUROL, V522, P592, DOI 10.1002/cne.23434
   Sikulu MT, 2015, J PROTEOMICS, V126, P234, DOI 10.1016/j.jprot.2015.06.008
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Thangamani S, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-34
   Xue RD, 2008, EXP PARASITOL, V119, P225, DOI 10.1016/j.exppara.2008.01.007
   Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222
   Zhou GL, 2004, INSECT BIOCHEM MOLEC, V34, P919, DOI 10.1016/j.ibmb.2004.05.009
NR 28
TC 4
Z9 4
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD OCT
PY 2016
VL 16
IS 19
SI SI
BP 2582
EP 2586
DI 10.1002/pmic.201600126
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DZ4FT
UT WOS:000385814700007
PM 27343150
DA 2020-07-08
ER

PT J
AU Durbin, AP
AF Durbin, Anna P.
TI Dengue Antibody and Zika: Friend or Foe?
SO TRENDS IN IMMUNOLOGY
LA English
DT Editorial Material
ID ENHANCEMENT; INFECTION; POTENT
C1 [Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD 21205 USA.
RP Durbin, AP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Immunizat Res, Baltimore, MD 21205 USA.
EM adurbin1@jhu.edu
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Dejnirattisai W., 2016, NAT IMMUNOT
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   HALSTEAD SB, 1976, P SOC EXP BIOL MED, V151, P136, DOI 10.3181/00379727-151-39160
   HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
NR 10
TC 26
Z9 28
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
EI 1471-4981
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD OCT
PY 2016
VL 37
IS 10
BP 635
EP 636
DI 10.1016/j.it.2016.08.006
PG 2
WC Immunology
SC Immunology
GA DY7PQ
UT WOS:000385322100001
PM 27599407
OA Bronze
DA 2020-07-08
ER

PT J
AU Huang, YJS
   Ayers, VB
   Lyons, AC
   Unlu, I
   Alto, BW
   Cohnstaedt, LW
   Higgs, S
   Vanlandingham, DL
AF Huang, Yan-Jang S.
   Ayers, Victoria B.
   Lyons, Amy C.
   Unlu, Isik
   Alto, Barry W.
   Cohnstaedt, Lee W.
   Higgs, Stephen
   Vanlandingham, Dana L.
TI Culex Species Mosquitoes and Zika Virus
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Culex species mosquitoes; refractoriness; Zika virus
ID AEDES-ALBOPICTUS; ISOLATIONS; AEGYPTI; THREAT; IMPACT
AB Recent reports of Zika virus (ZIKV) isolates from Culex species mosquitoes have resulted in concern regarding a lack of knowledge on the number of competent vector species for ZIKV transmission in the new world. Although observations in the field have demonstrated that ZIKV isolation can be made from Culex species mosquitoes, the detection of ZIKV in these mosquitoes is not proof of their involvement in a ZIKV transmission cycle. Detection may be due to recent feeding on a viremic vertebrate, and is not indicative of replication in the mosquito. In this study, susceptibility of recently colonized Culex species mosquitoes was investigated. The results showed a high degree of refractoriness among members of Culex pipiens complex to ZIKV even when exposed to high-titer bloodmeals. Our finding suggests that the likelihood of Culex species mosquitoes serving as secondary vectors for ZIKV is very low, therefore vector control strategies for ZIKV should remain focused on Aedes species mosquitoes. Our demonstration that Culex quinquefasciatus from Vero Beach, FL, is refractory to infection with ZIKV is especially important and timely. Based on our data, we would conclude that the autochthonous cases of Zika in Florida are not due to transmission by C. quinquefasciatus, and so control efforts should focus on other species, logically Aedes aegypti and Aedes albopictus.
C1 [Huang, Yan-Jang S.; Ayers, Victoria B.; Lyons, Amy C.; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.
   [Huang, Yan-Jang S.; Ayers, Victoria B.; Lyons, Amy C.; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.
   [Unlu, Isik] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.
   [Unlu, Isik] Mercer Cty Mosquito Control, Trenton, NJ USA.
   [Alto, Barry W.] Univ Florida, Florida Med Entomol Lab, Vero Beach, FL USA.
   [Cohnstaedt, Lee W.] ARS, Arthropod Borne Anim Dis Res Unit, USDA, Manhattan, KS USA.
RP Vanlandingham, DL (corresponding author), Kansas State Univ, Dept Diagnost Med Pathobiol, K-221 Mosier Hall, Manhattan, KS 66506 USA.
EM dlvanlan@vet.ksu.edu
FU Department of Diagnostic Medicine/Pathobiology, College of Veterinary
   Medicine, Kansas State University
FX The authors would like to thank Christopher Clarkston, Ryan Dajczak,
   Susan Hettenbach, Brittany Hilfiker, Nick Indelicato, Sara Ortiz, Sydney
   Rathjen, and Kathryn Ryan for their technical assistance. The research
   is supported by the startup fund of the Department of Diagnostic
   Medicine/Pathobiology, College of Veterinary Medicine, Kansas State
   University (PI: D.L.V.). The funding body has no role in the design of
   the study, collection, analysis, and interpretation of data or writing
   of the article.
CR Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   HADDOW A. J., 1964, BULL WORLD HEALTH ORGAN, V31, P57
   Higgs S, 2006, AM J TROP MED HYG, V75, P986, DOI 10.4269/ajtmh.2006.75.986
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P709, DOI 10.1089/vbz.2015.1821
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Moraes P, 2016, TELEGRAPH
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Palmisano CT, 2005, J AM MOSQUITO CONTR, V21, P33, DOI 10.2987/8756-971X(2005)21[33:IOWNVO]2.0.CO;2
   Phillips D., 2016, WASHINGTON POST
   Vanlandingham DL, 2016, J MED ENTOMOL, P1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 22
TC 45
Z9 46
U1 0
U2 122
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 673
EP 676
DI 10.1089/vbz.2016.2058
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA DY8QO
UT WOS:000385395100008
PM 27556838
DA 2020-07-08
ER

PT J
AU Gibbens, N
AF Gibbens, Nigel
TI Vectorborne diseases: no respecters of borders
SO VETERINARY RECORD
LA English
DT Article
AB Vectorborne diseases have been very much in the news in 2016, with, for example, the outbreak of Zika virus resulting in a number of high-profile athletes withdrawing from this year's Olympic Games in Brazil. In the UK, the threat of bluetongue virus arriving by windborne midges from France remains real. In his latest update for Veterinary Record, Nigel Gibbens, the UK's Chief Veterinary Officer, discusses why a collaborative approach is needed to combat such diseases and their vectors
C1 [Gibbens, Nigel] Defra, Nobel House,17 Smith Sq, London SW1P 3JR, England.
RP Gibbens, N (corresponding author), Defra, Nobel House,17 Smith Sq, London SW1P 3JR, England.
NR 0
TC 1
Z9 1
U1 0
U2 6
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0042-4900
EI 2042-7670
J9 VET REC
JI Vet. Rec.
PD OCT
PY 2016
VL 179
IS 13
BP 321
EP U18
DI 10.1136/vr.i5200
PG 2
WC Veterinary Sciences
SC Veterinary Sciences
GA DZ6FH
UT WOS:000385956500009
PM 27687267
DA 2020-07-08
ER

PT J
AU Becic, T
   Paez, D
   Abdel-Wahab, M
AF Becic, Taric
   Paez, Diana
   Abdel-Wahab, May
TI International Atomic Energy Agency: Supporting Member States to Combat
   Zika Virus Outbreaks Through its Human Health Programme
SO ATW-INTERNATIONAL JOURNAL FOR NUCLEAR POWER
LA English
DT Article
ID ARBOVIRUSES; INFECTIONS; MOSQUITOS
AB The International Atomic Energy Agency's Human Health Programme The International Atomic Energy Agency (IAEA) was founded in 1957 as part of efforts to establish an international body to regulate and promote the peaceful uses of nuclear technology. The IAEA is an independent, intergovernmental science and technology based organization within the United Nations family and serves as the global focal point for nuclear cooperation worldwide. As of May 2016, there are 168 Member States (MS). With its MS and multiple partners across the globe, the /AEA works to promote the safe, secure and peaceful use of nuclear technologies worldwide. The Mission of the IAEA is to accelerate and enlarge the contribution of atomic energy to peace, health and prosperity globally, whilst being guided by interests and needs of MS. The IAEA is comprised of a total of 6 Departments Safeguards, Safety and Security, Technical Cooperation, Nuclear Energy, Management, and Nuclear Sciences and Applications. The Division of Human Health is part of the Department of Nuclear Sciences and Applications. The role of this Division is to strengthen the capabilities of MS to address the needs related to the prevention, diagnosis and treatment of health problems through the application of nuclear techniques.
C1 [Becic, Taric; Paez, Diana; Abdel-Wahab, May] IAEA, Dept Nucl Sci & Applicat, Div Human Hlth, POB 100, A-1400 Vienna, Austria.
RP Becic, T (corresponding author), IAEA, Dept Nucl Sci & Applicat, Div Human Hlth, POB 100, A-1400 Vienna, Austria.
CR BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kraemer, 2015, ALBOPICTUS ELIFE, V4
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Musso D., 2014, EURO SURVEILL, V19
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   SALUZZO JF, 1981, B SOC PATHOL EXOT, V74, P490
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 32
TC 0
Z9 0
U1 0
U2 9
PU INFORUM VERLAGS-VERWALTUNGSGESELLSCHAFT MBH
PI BERLIN
PA ATW-ADVERTISING-SUBSCRIPTIONS, ROBERT-KOCH-PLATZ 4, BERLIN, 10115,
   GERMANY
SN 1431-5254
J9 ATW-INT J NUCL POWER
JI ATW-Int. J. Nucl. Power
PD OCT
PY 2016
VL 61
IS 10
BP 585
EP 588
PG 4
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA DX6UN
UT WOS:000384518700002
DA 2020-07-08
ER

PT J
AU Huntington, MK
   Allison, J
   Nair, D
AF Huntington, Mark K.
   Allison, Jay
   Nair, Dilip
TI Emerging Vector-Borne Diseases
SO AMERICAN FAMILY PHYSICIAN
LA English
DT Article
ID UPDATE INTERIM GUIDELINES; MALE SEXUAL TRANSMISSION; ZIKA
   VIRUS-INFECTION; WEST NILE VIRUS; UNITED-STATES; PREVENTION; FEVER;
   CHIKUNGUNYA; GUIDANCE
AB Several mosquito-borne viral infections have recently emerged in North America; West Nile virus is the most common in the United States. Although West Nile virus generally causes a self-limited, flulike febrile illness, a serious neuroinvasive form may occur. Dengue is the most common vector-borne viral disease worldwide, and it has been a significant public health threat in the United States since 2009. Known as breakbone fever for its severe myalgias and arthralgias, dengue may cause a hemorrhagic syndrome. Chikungunya also causes flulike febrile illness and disabling arthralgias. Although meningoencephalitis may occur with chikungunya, bleeding is uncommon. Symptoms of Zika virus infection are similar to those of dengue, but milder. Zika virus increases the risk of fetal brain abnormalities, including microcephaly, if a pregnant woman is infected. Zika virus is spread through Aedes albopictus mosquito bites, is transmitted sexually, and may rarely spread nonsexually from person to person. Diagnosis of these vector borne infections is clinical and serologic, and treatment is supportive. Other, well-established vector-borne diseases are also important. Ehrlichiosis is a tick-borne bacterial disease that presents as a nonspecific syndrome of fever, headache, malaise, and myalgias. It is diagnosed via blood smear testing, with confirmatory serology. Ehrlichiosis is treated with doxycycline. Rickettsial infections are transmitted by fleas, mites, and ticks, and severity ranges from mild to life threatening. Rocky Mountain spotted fever, the most significant rickettsial infection, is primarily a clinical diagnosis that presents as fever, headache, myalgias, petechial rash, and tick exposure. Doxycycline is effective for rickettsial infections if administered promptly. Vector avoidance strategies are critical to the prevention of all of these infections. Copyright 2016 American Academy of Family Physicians.)
C1 [Huntington, Mark K.; Allison, Jay] Univ South Dakota, Sanford Sch Med, Sioux Falls Family Med Residency Program, Sioux Falls, SD USA.
   [Huntington, Mark K.; Allison, Jay] Univ South Dakota, Sanford Sch Med, Dept Family Med, Sioux Falls, SD USA.
   [Nair, Dilip] Marshall Univ, Joan C Edwards Sch Med, Dept Family & Community Hlth, Huntington, WV USA.
RP Huntington, MK (corresponding author), Univ South Dakota, Sanford Sch Med, Ctr Family Med, 1115 E 12th St, Sioux Falls, SD 57105 USA.
EM mark.huntington@usd.edu
RI amsalu, ribka/G-8780-2019; Huntington, Mark K/U-8445-2019
OI Huntington, Mark K/0000-0001-6009-0464
CR Adams Deborah, 2015, MMWR Morb Mortal Wkly Rep, V62, P1, DOI 10.15585/mmwr.mm6253a1
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Buckingham SC, 2015, J INFECTION, V71, pS88, DOI 10.1016/j.jinf.2015.04.009
   Centers for Disease Control and Prevention, CHIK VIR GEOGR DISTR
   Centers for Disease Control and Prevention, 2016, PREGN WOM PROT YOURS
   Centers for Disease Control and Prevention, ADV PEOPL LIV TRAV W
   Centers for Disease Control and Prevention, 2016, ALL COUNTR TERR ACT
   Chen LF, 2008, INFECT DIS CLIN N AM, V22, P415, DOI 10.1016/j.idc.2008.03.008
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Drexler NA, 2016, AM J TROP MED HYG, V94, P26, DOI 10.4269/ajtmh.15-0472
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Ganguly S., 2008, Journal of Vector Borne Diseases, V45, P273
   Heitman KN, 2016, AM J TROP MED HYG, V94, P52, DOI 10.4269/ajtmh.15-0540
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Johnson BA, 2012, AM FAM PHYSICIAN, V85, P973
   Johnston D, 2016, MMWR-MORBID MORTAL W, V65, P34, DOI 10.15585/mmwr.mm6502a4
   Lee VJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001786
   Lengeler C, 2004, COCHRANE DB SYST REV, pCD000363
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pacheco O, N ENGL J MED
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Vora Neil, 2008, Medscape J Med, V10, P238
   Walker DH, 2016, AM J TROP MED HYG, V94, P3, DOI 10.4269/ajtmh.15-0762
   WHO, DENGUE
   Woodhall D, 2014, AM FAM PHYSICIAN, V89, P803
   World Health Organisation, 2008, GUID CLIN MAN CHIK F
   World Health Organization, 2016, VECT BORN DIS
   Wright WF, 2012, AM FAM PHYSICIAN, V85, P1086
   Yates J, 2015, AM FAM PHYSICIAN, V91, P754
NR 38
TC 5
Z9 5
U1 0
U2 76
PU AMER ACAD FAMILY PHYSICIANS
PI KANSAS CITY
PA 8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797 USA
SN 0002-838X
EI 1532-0650
J9 AM FAM PHYSICIAN
JI Am. Fam. Physician
PD OCT 1
PY 2016
VL 94
IS 7
BP 551
EP 557
PG 7
WC Primary Health Care; Medicine, General & Internal
SC General & Internal Medicine
GA DX9IX
UT WOS:000384708300012
PM 27929218
DA 2020-07-08
ER

PT J
AU Poretti, A
   Huisman, TAGM
AF Poretti, A.
   Huisman, T. A. G. M.
TI Neuroimaging Findings in Congenital Zika Syndrome
SO AMERICAN JOURNAL OF NEURORADIOLOGY
LA English
DT Editorial Material
ID VIRUS; INFECTION
OI Poretti, Andrea/0000-0002-9594-3858; Huisman, Thierry
   A.G.M./0000-0003-2302-6724
CR Araujo AQ, 2016, BRAIN
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Horovitz DDG, 2016, NEUROLOGY, V87, P118, DOI 10.1212/WNL.0000000000002814
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 14
TC 5
Z9 5
U1 0
U2 48
PU AMER SOC NEURORADIOLOGY
PI DENVILLE
PA PO BOX 3000, DENVILLE, NJ 07834-9349 USA
SN 0195-6108
EI 1936-959X
J9 AM J NEURORADIOL
JI Am. J. Neuroradiol.
PD OCT
PY 2016
VL 37
IS 10
BP 1764
EP 1765
DI 10.3174/ajnr.A4924
PG 2
WC Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA DW9MR
UT WOS:000383984600007
PM 27492074
OA Other Gold
DA 2020-07-08
ER

PT J
AU Hoda, SA
AF Hoda, Syed A.
TI More Than Just a Pain in the Neck: Occupational Hazards of Pathologists
SO AMERICAN JOURNAL OF SURGICAL PATHOLOGY
LA English
DT Editorial Material
ID RADIOACTIVE SEED LOCALIZATION; WIRE LOCALIZATION; FORENSIC-PATHOLOGISTS;
   ZIKA VIRUS; BREAST; PLACENTA; OUTCOMES; RISK
C1 [Hoda, Syed A.] Weill Cornell Med Coll, Dept Pathol, 525 East 68th St,Starr 1031C, New York, NY 10065 USA.
   [Hoda, Syed A.] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA.
RP Hoda, SA (corresponding author), Weill Cornell Med Coll, Dept Pathol, 525 East 68th St,Starr 1031C, New York, NY 10065 USA.
EM sahoda@med.cornell.edu
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Al-Hilli Z, 2015, ANN SURG ONCOL, V22, P3350, DOI 10.1245/s10434-015-4749-z
   ANDRION A, 1994, PATHOL RES PRACT, V190, P1214, DOI 10.1016/S0344-0338(11)80453-X
   Belay ED, 2013, INFECT CONT HOSP EP, V34, P1272, DOI 10.1086/673986
   Bloomquist EV, 2016, BREAST J, V22, P151, DOI 10.1111/tbj.12564
   Fritzsche FR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1054
   Ganczak Maria, 2003, Polish Journal of Pathology, V54, P143
   Giesbrandt J, 2013, Pract Radiat Oncol, V3, pS20, DOI 10.1016/j.prro.2013.01.069
   Gilcrease MZ, 2016, AM J SURG PATHOL
   Gobardhan PD, 2013, ANN ONCOL, V24, P668, DOI 10.1093/annonc/mds475
   Graham RPD, 2012, AM J SURG PATHOL, V36, P1718, DOI 10.1097/PAS.0b013e318265c37f
   Hutchins KD, 2001, ARCH PATHOL LAB MED, V125, P790
   Jain G, 2014, INT J OCCUP MED ENV, V27, P591, DOI 10.2478/s13382-014-0288-2
   Lann MA, 2010, AM J FOREN MED PATH, V31, P7, DOI 10.1097/PAF.0b013e3181c6be92
   Loving VA, 2014, AM J ROENTGENOL, V202, P1383, DOI 10.2214/AJR.13.11368
   Mattioli Stefano, 2015, Handb Clin Neurol, V131, P427, DOI 10.1016/B978-0-444-62627-1.00022-6
   Nolte KB, 2003, INFECT CONT HOSP EP, V24, P772, DOI 10.1086/502131
   Roy D.R., 1999, OFFICIAL J AM ASS OC, V47, P199
   Sadovsky Y, 2016, PLACENTA, V40, pA1, DOI 10.1016/j.placenta.2016.03.008
   Sharek D, 2015, AM J ROENTGENOL, V204, P872, DOI 10.2214/AJR.14.12743
   Sung JS, 2013, EUR J RADIOL, V82, P1453, DOI 10.1016/j.ejrad.2013.04.008
NR 21
TC 0
Z9 0
U1 1
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0147-5185
EI 1532-0979
J9 AM J SURG PATHOL
JI Am. J. Surg. Pathol.
PD OCT
PY 2016
VL 40
IS 10
BP 1303
EP 1304
DI 10.1097/PAS.0000000000000701
PG 2
WC Pathology; Surgery
SC Pathology; Surgery
GA DX1HX
UT WOS:000384118600001
PM 27627743
DA 2020-07-08
ER

PT J
AU Harrower, J
   Kiedrzynski, T
   Baker, S
   Upton, A
   Rahnama, F
   Sherwood, J
   Huang, QS
   Todd, A
   Pulford, D
AF Harrower, Jay
   Kiedrzynski, Tomasz
   Baker, Simon
   Upton, Arlo
   Rahnama, Fahimeh
   Sherwood, Jill
   Huang, Q. Sue
   Todd, Angela
   Pulford, David
TI Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand,
   2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Harrower, Jay; Baker, Simon] Auckland Reg Publ Hlth Serv, Auckland, New Zealand.
   [Kiedrzynski, Tomasz] Minist Hlth, Wellington, New Zealand.
   [Upton, Arlo] Labtests & Northland Pathol Lab, Whangarei, New Zealand.
   [Rahnama, Fahimeh] Auckland Dist Hlth Board, Auckland, New Zealand.
   [Sherwood, Jill; Huang, Q. Sue; Todd, Angela] Inst Environm Sci & Res Ltd, Wallaceville, New Zealand.
   [Pulford, David] Minist Primary Ind, Wallaceville, New Zealand.
RP Harrower, J (corresponding author), Auckland Reg Publ Hlth Serv, Greenlane Clin Ctr, Cornwall Complex,Bldg 15,Level 2,Rm 247, Auckland, New Zealand.
EM jay.harrower@kinect.co.nz
OI Pulford, David/0000-0001-5955-2991; Huang, Q. Sue/0000-0002-3923-5195
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
NR 9
TC 50
Z9 50
U1 0
U2 32
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2016
VL 22
IS 10
BP 1855
EP 1857
DI 10.3201/eid2210.160951
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DX4YQ
UT WOS:000384387400036
PM 27454745
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cabral-Castro, MJ
   Peralta, RHS
   Cavalcanti, MG
   Puccioni-Sohler, M
   Carvalho, VL
   Vasconcelos, PFD
   Peralta, JM
AF Cabral-Castro, Mauro Jorge
   Saramago Peralta, Regina Helena
   Cavalcanti, Marta Guimaraes
   Puccioni-Sohler, Marzia
   Carvalho, Valeria Lima
   da Costa Vasconcelos, Pedro Fernando
   Peralta, Jose Mauro
TI A Luminex-based single DNA fragment amplification assay as a practical
   tool for detecting and serotyping dengue virus
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Dengue virus; Early diagnosis; Molecular diagnosis; Polymerase chain
   reaction; RT-PCR/Luminex assay
ID IDENTIFICATION; MULTIPLEX; SURVEILLANCE; CIRCULATION; TECHNOLOGY;
   ANTIBODIES; DIAGNOSIS; FEVER
AB Dengue is a mosquito-borne viral infection that can evolve from subclinical to severe forms of disease. Early recognition during initial primary and secondary infections correlates with a reduced case-fatality rate in susceptible groups. The aim of this study was to standardize a DNA hybridization assay based on the Luminex technology for detecting and serotyping dengue virus (DENV). Reference DENVs representing the four different serotypes were used as controls to standardize the test. For validation, 16 DENV isolates obtained from a reference laboratory were analyzed in a double-blind manner to validate the test. Sixty blood samples from patients suspected of having dengue fever were used to evaluate the methodology after the validation step, and the results were compared with the reference semi-nested RT-PCR. Additionally, five human samples of each Zika and Chikungunya confirmed patients were used for specificity analysis. The Luminex-based assay correctly identified all 16 DENV isolates. In the evaluation step, the results of the RT-PCR/Luminex assay showed a concordance of 86.7% with those of the semi-nested RT-PCR. None of other virus infection samples was amplified. This is the first description of a hybridization assay that can discriminate the four DENV serotypes using probes against a single DENV sequence. The results indicated that the RT-PCR/Luminex DENV assay designed and evaluated in this study is a valuable additional tool for the early and rapid detection and serotyping of DENV, which could, in the future, be applied to new targets such as the Zika and Chikungunya viruses. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Cabral-Castro, Mauro Jorge; Cavalcanti, Marta Guimaraes; Peralta, Jose Mauro] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.
   [Saramago Peralta, Regina Helena] Univ Fed Fluminense, Fac Med, Dept Patol, Niteroi, RJ, Brazil.
   [Cavalcanti, Marta Guimaraes] Univ Fed Rio de Janeiro, Dept Doencas Infecciosas & Parasitarias, Hosp Univ Clementine Fraga Filho, Rio De Janeiro, RJ, Brazil.
   [Puccioni-Sohler, Marzia] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, Lab Liquido Cefalorraqueano, Rio De Janeiro, RJ, Brazil.
   [Carvalho, Valeria Lima; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Ananindeua, Para, Brazil.
RP Peralta, JM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol CCS, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM peralta@micro.ufrj.br
RI Vasconcelos, Pedro/AAH-3142-2019; Cabral-Castro, Mauro Jorge/L-8868-2016
OI Cabral-Castro, Mauro Jorge/0000-0002-1755-999X
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   BrazilNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Supeiror
   (CAPES), Brazil; Fundacao de Amparo a Pesquisa Carlos Chagas Filho, Rio
   de Janeiro, Brazil
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq), Brazil and the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Supeiror (CAPES), Brazil and
   Fundacao de Amparo a Pesquisa Carlos Chagas Filho, Rio de Janeiro,
   Brazil.
CR Anderson NW, 2014, DIAGN MICR INFEC DIS, V79, P194, DOI 10.1016/j.diagmicrobio.2014.02.001
   Appanna R, 2012, AM J TROP MED HYG, V87, P936, DOI 10.4269/ajtmh.2012.11-0606
   Binnicker MJ, 2013, J CLIN MICROBIOL, V51, P3749, DOI 10.1128/JCM.02005-13
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Santos HLC, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-69
   da Silva Voorham Julia M, 2014, Ned Tijdschr Geneeskd, V158, pA7946
   De Simone TS, 2004, T ROY SOC TROP MED H, V98, P553, DOI 10.1016/j.trstmh.2003.09.003
   DIAZ MR, 2007, MICROBE, V2, P74
   Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023
   Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07
   Fulton RJ, 1997, CLIN CHEM, V43, P1749
   Gray J, 2014, EPIDEMIOL INFECT, V142, P1, DOI 10.1017/S0950268813002367
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332
   Munro SB, 2013, J CLIN MICROBIOL, V51, P1124, DOI 10.1128/JCM.03113-12
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Naiser T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218301
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Pickering JW, 2002, AM J CLIN PATHOL, V117, P589
   Prabhakar U, 2002, J IMMUNOL METHODS, V260, P207, DOI 10.1016/S0022-1759(01)00543-9
   Pride MW, 2012, CLIN VACCINE IMMUNOL, V19, P1131, DOI 10.1128/CVI.00064-12
   Rowe EK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002777
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   Sasmono RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103815
   Shu PY, 2004, CLIN DIAGN LAB IMMUN, V11, P642, DOI 10.1128/CDLI.11.4.642-650.2004
   Smith PL, 1998, CLIN CHEM, V44, P2054
   Wang SM, 2010, J CLIN MICROBIOL, V48, P2793, DOI 10.1128/JCM.02142-09
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Wessels E, 2014, CLIN MICROBIOL INFEC, V20, pO182, DOI 10.1111/1469-0691.12364
   Wootton SH, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0137-1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wu W, 2014, VIRUS RES, V187, P84, DOI 10.1016/j.virusres.2013.12.037
   Zhang L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1064
NR 37
TC 6
Z9 6
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD OCT
PY 2016
VL 236
BP 18
EP 24
DI 10.1016/j.jviromet.2016.07.003
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA DW8YR
UT WOS:000383941900004
PM 27393681
OA Bronze
DA 2020-07-08
ER

PT J
AU Xu, MY
   Liu, SQ
   Deng, CL
   Zhang, QY
   Zhang, B
AF Xu, Ming-Yue
   Liu, Si Qing
   Deng, Cheng-Lin
   Zhang, Qiu-Yan
   Zhang, Bo
TI Detection of Zika virus by SYBR green one-step real-time RT-PCR
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika virus; Real-time RT-PCR; SYBR green
ID FEVER VIRUS; DENGUE; TRANSMISSION; NS2B; RNA
AB The ongoing Zika virus (ZIKV) outbreak has rapidly spread to new areas of Americas, which were the first transmissions outside its traditional endemic areas in Africa and Asia. Due to the link with newborn defects and neurological disorder, numerous infected cases throughout the world and various mosquito vectors, the virus has been considered to be an international public health emergency. In the present study, we developed a SYBR Green based one-step real-time RT-PCR assay for rapid detection of ZIKV. Our results revealed that the real-time assay is highly specific and sensitive in detection of ZIKV in cell samples. Importantly, the replication of ZIKV at different time points in infected cells could be rapidly monitored by the real-time RT-PCR assay. Specifically, the real-time RT-PCR showed acceptable performance in measurement of infectious ZIKV RNA. This assay could detect ZIKV at a titer as low as 1 PFU/mL. The real-time RT-PCR assay could be a useful tool for further virology surveillance and diagnosis of ZIKV. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Xu, Ming-Yue; Liu, Si Qing; Deng, Cheng-Lin; Zhang, Qiu-Yan; Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
   [Xu, Ming-Yue; Zhang, Qiu-Yan] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Zhang, B (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
EM zhangbo@wh.iov.cn
FU National Basic Research Program of ChinaNational Basic Research Program
   of China [2012CB518904]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81572003]
FX This work was supported by the National Basic Research Program of China
   (Grants 2012CB518904) and the National Natural Science Foundation of
   China (Grant No. 81572003). We are grateful to the Core Facility and
   Technical Support, Wuhan Institute of Virology and Wuhan Key Laboratory
   on Emerging Infectious Diseases and Biosafety for helpful supports
   during the course of the work.
CR Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fayzulin R, 2006, VIROLOGY, V351, P196, DOI 10.1016/j.virol.2006.02.036
   Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guillaume V, 2004, J VIROL METHODS, V120, P229, DOI 10.1016/j.jviromet.2004.05.018
   Houng HSH, 2000, J VIROL METHODS, V86, P1, DOI 10.1016/S0166-0934(99)00166-4
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li XD, 2016, J VIROL, V90, P5735, DOI 10.1128/JVI.00340-16
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Shin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074582
   Yoshii K., 2011, VIRUS RES, V155, P61
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 26
TC 23
Z9 27
U1 1
U2 84
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD OCT
PY 2016
VL 236
BP 93
EP 97
DI 10.1016/j.jviromet.2016.07.014
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA DW8YR
UT WOS:000383941900015
PM 27444120
DA 2020-07-08
ER

PT J
AU Saenz, C
AF Saenz, Carla
TI Zika virus: ethics preparedness for old and new challenges
SO LANCET GLOBAL HEALTH
LA English
DT Letter
C1 [Saenz, Carla] Pan Amer Hlth Org, Reg Program Bioeth, Off Knowledge Management Bioeth & Res, Washington, DC 20037 USA.
RP Saenz, C (corresponding author), Pan Amer Hlth Org, Reg Program Bioeth, Off Knowledge Management Bioeth & Res, Washington, DC 20037 USA.
EM saenzcar@paho.org
CR [Anonymous], 2016, LANCET GLOB HEALTH, V4, pE427, DOI 10.1016/S2214-109X(16)30109-7
   Global Forum on Bioethics in Research, 2015, M REP EM EP INF EXP
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Pan American Health Organization, 2016, ZIK ETH CONS ETH GUI
   Pan American Health Organization, REG MAK COMM ACC MOD
   Pan American Health Organization Directing Council, 2012, 28 PAN AM SAN C 64 S
NR 6
TC 8
Z9 8
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD OCT
PY 2016
VL 4
IS 10
BP E686
EP E686
DI 10.1016/S2214-109X(16)30222-4
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA DW7RE
UT WOS:000383848000013
PM 27633426
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Makhluf, H
   Kim, K
   Shresta, S
AF Makhluf, Huda
   Kim, Kenneth
   Shresta, Sujan
TI Novel strategies for discovering inhibitors of Dengue and Zika fever
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Editorial Material
DE Dengue virus; Zika virus and antivirals
ID VIRUS-INFECTION; MOUSE MODELS; INFLUENZA; THERAPY; HIV
C1 [Makhluf, Huda; Kim, Kenneth; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Ctr Infect Dis, La Jolla, CA USA.
   [Makhluf, Huda] Natl Univ, Dept Math & Nat Sci, La Jolla, CA USA.
RP Makhluf, H (corresponding author), Natl Univ, 11255 North Torrey Pines Rd, La Jolla, CA 92037 USA.
EM hmakhluf@nu.edu
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burel JG, 2016, TRENDS IMMUNOL, V37, P53, DOI 10.1016/j.it.2015.11.006
   De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010
   Deligny C, 2014, J CLIN VIROL, V61, P442, DOI 10.1016/j.jcv.2014.08.011
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Pheng S, 2013, ANTIVIR RES, V100, P500, DOI [10.1016/j.antivira1.2013.09.013, DOI 10.1016/J.ANTIVIRA1.2013.09.013]
   Pinto AK, 2015, MBIO, V6, DOI 10.1128/mBio.01316-15
   Plummer E, 2015, J VIROL, V89, P5592, DOI 10.1128/JVI.00028-15
   Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007
   Warfield KL, 2015, VIRUSES-BASEL, V7, P2404, DOI 10.3390/v7052404
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Wyles DL, 2013, J INFECT DIS, V207, pS33, DOI 10.1093/infdis/jis761
NR 14
TC 4
Z9 4
U1 0
U2 29
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1746-0441
EI 1746-045X
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PD OCT
PY 2016
VL 11
IS 10
BP 921
EP 923
DI 10.1080/17460441.2016.1212013
PG 3
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DW8VQ
UT WOS:000383934000002
PM 27401601
OA Bronze
DA 2020-07-08
ER

PT J
AU Cinnamon, J
   Jones, SK
   Adger, WN
AF Cinnamon, Jonathan
   Jones, Sarah K.
   Adger, W. Neil
TI Evidence and future potential of mobile phone data for disease disaster
   management
SO GEOFORUM
LA English
DT Article
DE Mobile phone; Call detail records; SMS; Disaster; Disease; Big data
ID BIG DATA; GEOGRAPHIC INFORMATION; CRISIS; POPULATION; MALARIA; TIME;
   SURVEILLANCE; HEALTH; TOOL
AB Global health threats such as the recent Ebola and Zika virus outbreaks require rapid and robust responses to prevent, reduce and recover from disease dispersion. As part of broader big data and digital humanitarianism discourses, there is an emerging interest in data produced through mobile phone communications for enhancing the data environment in such circumstances. This paper assembles user perspectives and critically examines existing evidence and future potential of mobile phone data derived from call detail records (CDRs) and two-way short message service (SMS) platforms, for managing and responding to humanitarian disasters caused by communicable disease outbreaks. We undertake a scoping review of relevant literature and in-depth interviews with key informants to ascertain the: (i) information that can be gathered from CDRs or SMS data; (ii) phase(s) in the disease disaster management cycle when mobile data may be useful; (iii) value added over conventional approaches to data collection and transfer; (iv) barriers and enablers to use of mobile data in disaster contexts; and (v) the social and ethical challenges. Based on this evidence we develop a typology of mobile phone data sources, types, and end-uses, and a decision-tree for mobile data use, designed to enable effective use of mobile data for disease disaster management. We show that mobile data holds great potential for improving the quality, quantity and timing of selected information required for disaster management, but that testing and evaluation of the benefits, constraints and limitations of mobile data use in a wider range of mobile-user and disaster contexts is needed to fully understand its utility, validity, and limitations. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Cinnamon, Jonathan; Adger, W. Neil] Univ Exeter, Dept Geog, Coll Life & Environm Sci, Exeter, Devon, England.
   [Jones, Sarah K.] Kings Coll London, Dept Geog, London WC2R 2LS, England.
RP Cinnamon, J (corresponding author), Univ Exeter, Dept Geog, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England.
EM j.cinnamon@exeter.ac.uk
RI Adger, Neil/F-7676-2010
OI Adger, Neil/0000-0003-4244-2854; Jones, Sarah/0000-0002-9422-5563;
   Jones, Sarah/0000-0003-2265-3603
FU UK Department for International Development (DFID); Natural Environment
   Research Council (NERC)NERC Natural Environment Research Council;
   Economic and Social Research Council (ESRC)Economic & Social Research
   Council (ESRC)
FX A portion of this research was funded as part of the Science for
   Humanitarian Emergencies and Resilience (SHEAR) programme, by the UK
   Department for International Development (DFID), the Natural Environment
   Research Council (NERC) and the Economic and Social Research Council
   (ESRC). Thank you to the interview participants for sharing their
   practical insight and perspectives, and to the four reviewers for
   suggestions that improved the manuscript.
CR Ahas R, 2015, INT J GEOGR INF SCI, V29, P2017, DOI 10.1080/13658816.2015.1063151
   Ahas R, 2014, J URBAN TECHNOL, V21, P1, DOI 10.1080/10630732.2014.913420
   Alexander D. E, 2002, PRINCIPLES EMERGENCY
   Anderson C., 2008, WIRED MAG
   Anderson M., 2014, GUARDIAN
   [Anonymous], 2014, ECONOMIST
   [Anonymous], 2014, GUARDIAN
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Asiimwe C, 2011, AM J TROP MED HYG, V85, P26, DOI 10.4269/ajtmh.2011.10-0528
   Asokan GV, 2015, J EPIDEMIOL GLOB HEA, V5, P311, DOI 10.1016/j.jegh.2015.02.001
   Aubrecht C, 2015, NAT HAZARDS, P1
   Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923
   Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083
   Bharti N, 2015, INT HEALTH, V7, P90, DOI 10.1093/inthealth/ihv003
   Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878
   Buckee CO, 2013, TRAVEL MED INFECT DI, V11, P15, DOI 10.1016/j.tmaid.2012.12.003
   Burns R, 2015, GEOJOURNAL, V80, P477, DOI 10.1007/s10708-014-9599-x
   Burns R, 2014, GEOFORUM, V53, P51, DOI 10.1016/j.geoforum.2014.02.002
   Buscher M., 2014, INT J INF SYST CRISI, V6
   Buscher M., 2013, P 10 INT ISCRAM C BA
   Cecaj A, 2016, J AMB INTEL HUM COMP, V7, P83, DOI 10.1007/s12652-015-0303-x
   Center for Global Development, 2014, DEL DAT REV SUBS AFR
   Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5
   Cinnamon J, 2013, GEOJOURNAL, V78, P657, DOI 10.1007/s10708-012-9458-6
   Crawford K, 2015, GEOJOURNAL, V80, P491, DOI 10.1007/s10708-014-9597-z
   Custers B., 2016, INT DATA PRIVACY LAW
   de Montjoye Y.A., 2014, ISS TECHNOL INNO NOV, P1
   Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111
   Douglass RW, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0040-6
   Doyle J, 2014, J URBAN TECHNOL, V21, P109, DOI 10.1080/10630732.2014.888904
   Fadiya SO, 2014, PROCEDIA ENGINEER, V78, P88, DOI 10.1016/j.proeng.2014.07.043
   FCS, 2012, UK STAND CDRS
   Gao S, 2013, T GIS, V17, P463, DOI 10.1111/tgis.12042
   Gilpin L., 2014, ALGORITHM DETECTED E
   Goodchild MF, 2010, INT J DIGIT EARTH, V3, P231, DOI 10.1080/17538941003759255
   Griffin G.F., 2014, GEOMATICA, V68, P265, DOI DOI 10.5623/CIG2014-402
   GSMA, 2015, MOB EC 2015
   GSMA, 2014, GSMA GUID PROT PRIV
   GSMA, 2013, COD COND GUID US SMS
   Haggerty KD, 2000, BRIT J SOCIOL, V51, P605
   Hern Alex., 2014, GUARDIAN
   Hey A.J.G., 2009, 4 PARADIGM DATA INTE
   Higgins A., 2014, FIGHTING EBOLA LIBER
   Jacobsen K., 2014, CHRISTIAN SCI MONITO
   Jarv O, 2014, TRANSPORT RES C-EMER, V38, P122, DOI 10.1016/j.trc.2013.11.003
   KENNEDY H, 2015, BIG DATA SOC, V2
   KHAN H., 2008, MANAGEMENT MARKETING, VVI, P43
   Kitchin R, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714528481
   Kitchin R, 2014, GEOJOURNAL, V79, P1, DOI 10.1007/s10708-013-9516-8
   Kitchin Rob, 2013, DIALOGUES HUMAN GEOG, V3, P262, DOI DOI 10.1177/2043820613513388
   Koch T., 2016, CAN GEOGR
   Leszczynski A, 2015, ENVIRON PLANN D, V33, P965, DOI 10.1177/0263775815595814
   Leung Y, 2016, INT J GEOGR INF SCI, V30, P1336, DOI 10.1080/13658816.2015.1130830
   Lydersen K., 2014, HALT EBOLAS SPREAD
   Lyon D., 2003, SURVEILLANCE SOCIAL
   LYON DAVID, 2007, SURVEILLANCE STUDIES
   Macharia K, 2015, AFRICA IS BIG DATA S
   Madianou M., 2015, INT J COMMUN, V9, P19
   MapAction, 2016, GETT HELP ITS NEED M
   Mayer Jonathan, 2014, METAPHONE SENSITIVIT
   McDonald S. M., 2016, EBOLA BIG DATA DISAS
   Meier P., 2015, DIGITAL HUMANITARIAN
   Miller HJ, 2015, GEOJOURNAL, V80, P449, DOI 10.1007/s10708-014-9602-6
   Miller HJ, 2010, J REGIONAL SCI, V50, P181, DOI 10.1111/j.1467-9787.2009.00641.x
   Muah S., 2014, TECH SECTOR CAN HELP
   Mushayi W., 2015, MAKING SCH SAFER SIE
   O'Donovan J, 2015, LANCET GLOB HEALTH, V3, pE22, DOI 10.1016/S2214-109X(14)70357-2
   Oliver N., 2013, GUARDIAN
   Pew Research Center, 2015, CELL PHON AFR COMM L
   Pu C., 2013, BIG DAT DIS MAN JST
   Revere Debra, 2014, BMC Res Notes, V7, P514, DOI 10.1186/1756-0500-7-514
   Roche S, 2013, GEOJOURNAL, V78, P21, DOI 10.1007/s10708-011-9423-9
   Scepanovic S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124160
   Shacklett M., 2015, FIGHTING EBOLA HOLIS
   Shanley LA, 2013, PHOTOGRAMM ENG REM S, V79, P865
   Shelton T, 2014, GEOFORUM, V52, P167, DOI 10.1016/j.geoforum.2014.01.006
   Tatem AJ, 2014, INT HEALTH, V6, P5, DOI 10.1093/inthealth/ihu006
   Tatem AJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-52
   Tatem AJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-287
   Taylor L., 2015, ENV PLANN D
   Taylor L, 2015, GEOFORUM, V64, P229, DOI 10.1016/j.geoforum.2015.07.002
   Thatcher J., 2016, ENV PLANN D
   Thompson S, 2006, INT J EMERG MANAG, V3, P250, DOI 10.1504/IJEM.2006.011295
   Townsend A. M., 2013, SMART CITIES BIG DAT
   Tracey LE, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.1.20999
   Trad Mohamad-Ali, 2015, F1000Res, V4, P43, DOI 10.12688/f1000research.6105.1
   United Nations International Strategy for Disaster Reduction, 2009, UNISDR TERM DIS RISK
   Vayena E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003904
   Voigt S, 2007, IEEE T GEOSCI REMOTE, V45, P1520, DOI 10.1109/TGRS.2007.895830
   Wesolowski Amy, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.0177e7fcf52217b8b634376e2f3efc5e
   Wesolowski A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05678
   Whitford HM, 2012, J AM MED INFORM ASSN, V19, P744, DOI 10.1136/amiajnl-2011-000785
   Wood DM, 2013, GEOFORUM, V49, P317, DOI 10.1016/j.geoforum.2013.07.001
   Xu Y, 2016, ANN AM ASSOC GEOGR, V106, P489, DOI 10.1080/00045608.2015.1120147
   Yang CH, 2009, B WORLD HEALTH ORGAN, V87, P619, DOI 10.2471/BLT.08.060905
   Young SD, 2015, PREV MED, V70, P17, DOI 10.1016/j.ypmed.2014.11.002
   Zhong SR, 2016, ANN AM ASSOC GEOGR, V106, P480, DOI 10.1080/00045608.2015.1113113
   Zook M, 2010, WORLD MED HEALTH POL, V2, P7, DOI 10.2202/1948-4682.1069
   Zoomers A, 2016, GEOFORUM, V69, P147, DOI 10.1016/j.geoforum.2015.11.017
   Zwitter A, 2014, BIG DATA SOC, V1, DOI 10.1177/2053951714559253
NR 100
TC 16
Z9 17
U1 7
U2 51
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0016-7185
EI 1872-9398
J9 GEOFORUM
JI Geoforum
PD OCT
PY 2016
VL 75
BP 253
EP 264
DI 10.1016/j.geoforum.2016.07.019
PG 12
WC Geography
SC Geography
GA DW8ZJ
UT WOS:000383943700027
PM 32287362
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Gadea, G
   Bos, S
   Krejbich-Trotot, P
   Clain, E
   Viranaicken, W
   El-Kalamouni, C
   Mavingui, P
   Despres, P
AF Gadea, Gilles
   Bos, Sandra
   Krejbich-Trotot, Pascale
   Clain, Elodie
   Viranaicken, Wildriss
   El-Kalamouni, Chaker
   Mavingui, Patrick
   Despres, Philippe
TI A robust method for the rapid generation of recombinant Zika virus
   expressing the GFP reporter gene
SO VIROLOGY
LA English
DT Article
DE Arbovirus; Emerging disease; Flavivirus; Zika virus; Molecular clones;
   Recombinant virus; GFP reporter
ID WEST-NILE-VIRUS; DENGUE VIRUS; CHIKUNGUNYA; LUCIFERASE; EMERGENCE
AB Zika virus (ZIKV) infection is a major public health problem with severe human congenital and neurological anomalies. The screening of anti-ZIKV compounds and neutralizing antibodies needs reliable and rapid virus-based assays. Here, we described a convenient method leading to the rapid production of molecular clones of ZIKV. To generate a molecular clone of ZIKV strain MR766(NIID), the viral genome was directly assembled into Vero cells after introduction of four overlapping synthetic fragments that cover the full-length genomic RNA sequence. Such strategy has allowed the production of a recombinant ZIKV expressing the GFP reporter gene that is stable over two culturing rounds on Vero cells. Our data demonstrate that the ZIKV reporter virus is a very reliable GFP-based tool for analyzing viral growth and measuring the neutralizing antibody as well as rapid screening of antiviral effect of different classes of inhibitors. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Gadea, Gilles; Bos, Sandra; Krejbich-Trotot, Pascale; Clain, Elodie; Viranaicken, Wildriss; El-Kalamouni, Chaker; Mavingui, Patrick; Despres, Philippe] Univ La Reunion, CNRS UMR 9192, Plateforme Technol CYROI,INSERM U1187, IRD UMR 249,Unite Mixte Proc Infectieux Insulaire, F-97490 St Clotilde, Reunion, France.
RP Despres, P (corresponding author), Univ La Reunion, CNRS UMR 9192, Plateforme Technol CYROI,INSERM U1187, IRD UMR 249,Unite Mixte Proc Infectieux Insulaire, F-97490 St Clotilde, Reunion, France.
EM philippe.despres@univ-reunion.fr
RI Gilles, Gadea/M-9966-2015
OI Gilles, Gadea/0000-0001-6325-4866; El Kalamouni,
   Chaker/0000-0003-4673-6614; BOS, Sandra/0000-0001-5036-0336; Krejbich
   Trotot, Pascale/0000-0001-7329-1716
FU grant ZIKAVAx from the INSERM-transfert, France; grant DIRED from the
   Conseil General de La Reunion, France
FX We are grateful to ML. Gougeon, M. de Wispelaere, M. Roche, and E.
   Frumence, for helpful discussion and assistance during the course of
   this work. This research was supported in part by the grant ZIKAVAx from
   the INSERM-transfert, France. EC is supported by a grant DIRED from the
   Conseil General de La Reunion, France.
CR Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Brehin AC, 2008, VIROLOGY, V371, P185, DOI 10.1016/j.virol.2007.09.028
   Cao-Lormeau M., 2016, LANCET
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   de Wispelaere M, 2015, J VIROL, V89, P5862, DOI 10.1128/JVI.00358-15
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gatherer D, 2015, J GEN VIROL
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Mertens E, 2010, VIROLOGY, V399, P176, DOI 10.1016/j.virol.2009.12.036
   Musso D., 2016, CLIN MICROBIOL REV
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Quick K. M., 2016, CELL HOST MICROBE
   Ren LZ, 2016, APPL BIOCHEM BIOTECH, V178, P1567, DOI 10.1007/s12010-015-1968-5
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Shan C, 2016, CELL HOST MICROBE
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zhang PT, 2016, VIRUS RES, V211, P17, DOI 10.1016/j.virusres.2015.09.015
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 24
TC 44
Z9 44
U1 0
U2 45
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD OCT
PY 2016
VL 497
BP 157
EP 162
DI 10.1016/j.virol.2016.07.015
PG 6
WC Virology
SC Virology
GA DW8RC
UT WOS:000383922200016
PM 27471954
OA Bronze
DA 2020-07-08
ER

PT J
AU Yakob, L
   Kucharski, A
   Hue, S
   Edmunds, WJ
AF Yakob, Laith
   Kucharski, Adam
   Hue, Stephane
   Edmunds, W. John
TI Low risk of a sexually-transmitted Zika virus outbreak
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID EPIDEMIC AREA; APRIL 2016; TRANSMISSION; SEMEN
C1 [Yakob, Laith] London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, London WC1E 7HT, England.
   [Kucharski, Adam; Hue, Stephane; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.
RP Yakob, L (corresponding author), London Sch Hyg & Trop Med, Dept Dis Control, Fac Infect & Trop Dis, London WC1E 7HT, England.
EM laith.yakob@lshtm.ac.uk
RI Yakob, Laith/AAD-4521-2019
OI Yakob, Laith/0000-0001-8639-4511; Hue, Stephane/0000-0002-8580-6905
CR D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   ECDC, 2016, HLTH TOP ZIK VIR INF
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0
   Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
NR 12
TC 33
Z9 33
U1 0
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1100
EP 1102
DI 10.1016/S1473-3099(16)30324-3
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000015
PM 27676337
OA Bronze
DA 2020-07-08
ER

PT J
AU Arsuaga, M
   Bujalance, SG
   Diaz-Menendez, M
   Vazquez, A
   Arribas, JR
AF Arsuaga, Marta
   Garcia Bujalance, Silvia
   Diaz-Menendez, Marta
   Vazquez, Ana
   Arribas, Jose R.
TI Probable sexual transmission of Zika virus from a vasectomised man
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Arsuaga, Marta; Diaz-Menendez, Marta; Arribas, Jose R.] Hosp Univ La Paz IdiPAZ, Dept Internal Med, Madrid 28046, Spain.
   [Garcia Bujalance, Silvia] Hosp Univ La Paz IdiPAZ, Dept Microbiol, Madrid 28046, Spain.
   [Arribas, Jose R.] Hosp Univ La Paz IdiPAZ, Infect Dis Unit, Madrid 28046, Spain.
   [Vazquez, Ana] Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Arbovirus & Imported Viral Dis, Madrid, Spain.
RP Arribas, JR (corresponding author), Hosp Univ La Paz IdiPAZ, Dept Internal Med, Madrid 28046, Spain.; Arribas, JR (corresponding author), Hosp Univ La Paz IdiPAZ, Infect Dis Unit, Madrid 28046, Spain.
EM joser.arribas@salud.madrid.org
RI Vazquez, Ana/H-4911-2013
OI Vazquez, Ana/0000-0002-9872-3316
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
NR 3
TC 80
Z9 82
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1107
EP 1107
DI 10.1016/S1473-3099(16)30320-6
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000020
PM 27676342
OA Bronze
DA 2020-07-08
ER

PT J
AU Fleming, AM
   Ding, Y
   Alenko, A
   Burrows, CJ
AF Fleming, Aaron M.
   Ding, Yun
   Alenko, Anton
   Burrows, Cynthia J.
TI Zika Virus Genomic RNA Possesses Conserved G-Quadruplexes Characteristic
   of the Flaviviridae Family
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; G-quadruplex; RNA genome structure; Flaviviridae
ID DNA; SEQUENCES; HELICASE; STABILITY; MECHANISM; PROMOTER; CELLS
AB Zika virus has emerged as a global concern because neither a vaccine nor antiviral compounds targeting it exist. A structure for the positive-sense RNA genome has not been established, leading us to look for potential G-quadruplex sequences (PQS) in the genome. The analysis identified >60 PQSs in the Zika genome. To minimize the PQS population, conserved sequences in the Flaviviridae family were found by sequence alignment, identifying seven PQSs in the prM, E, NS1, NS3, and NS5 genes. Next, alignment of 78 Zika strain genomes identified a unique PQS near the end of the 3'-UTR. Structural studies on the G-quadruplex sequences found four of the conserved Zika virus sequences to adopt stable, parallel-stranded folds that bind a G-quadruplex-specific compound, and one that was studied caused polymerase stalling when folded to a G-quadruplex. Targeting these PQSs with G-quadruplex binding molecules validated in previous clinical trials may represent a new approach for inhibiting viral replication.
C1 [Fleming, Aaron M.; Ding, Yun; Alenko, Anton; Burrows, Cynthia J.] Univ Utah, Dept Chem, 315 South 1400 East, Salt Lake City, UT 84112 USA.
RP Fleming, AM; Burrows, CJ (corresponding author), Univ Utah, Dept Chem, 315 South 1400 East, Salt Lake City, UT 84112 USA.
EM afleming@chem.utah.edu; burrows@chem.utah.edu
OI Ding, Yun/0000-0002-6624-0934
FU National Cancer InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01 CA090689]; NCI Cancer Support Grant [P30 CA042014]
FX We are deeply appreciative of the National Cancer Institute (R01
   CA090689) for partial financial support of this work. We thank Dr. Peter
   Flynn (University of Utah) for help with NMR experiments. The
   oligonucleotides were provided by the DNA/Peptide core facility at the
   University of Utah, which is supported in part by NCI Cancer Support
   Grant (P30 CA042014).
CR Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428
   Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006
   Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]
   Bryan TM, 2010, METHODS MOL BIOL, V608, P1, DOI 10.1007/978-1-59745-363-9_1
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen MC, 2015, NUCLEIC ACIDS RES, V43, P2223, DOI 10.1093/nar/gkv051
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   de la Faverie AR, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku111
   Fleming AM, 2015, ACS CENTRAL SCI, V1, P226, DOI 10.1021/acscentsci.5b00202
   Gray RD, 2008, NUCLEIC ACIDS RES, V36, P4191, DOI 10.1093/nar/gkn379
   Guedin A, 2010, NUCLEIC ACIDS RES, V38, P7858, DOI 10.1093/nar/gkq639
   HALFORD B, 2016, CHEM ENG NEWS, V94, P33
   Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957
   Honda T, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00021
   Horsburgh BC, 1996, CELL, V86, P949, DOI 10.1016/S0092-8674(00)80170-1
   Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043
   Karsisiotis AI, 2011, ANGEW CHEM INT EDIT, V50, P10645, DOI 10.1002/anie.201105193
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/NCHEMBIO.1479, 10.1038/nchembio.1479]
   Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711
   Perrone R, 2014, J ANTIMICROB CHEMOTH, V69, P3248, DOI 10.1093/jac/dku280
   Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862
   Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tuesuwan B, 2008, BIOCHEMISTRY-US, V47, P1896, DOI 10.1021/bi701747d
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z
   Zhang DH, 2010, BIOCHEMISTRY-US, V49, P4554, DOI 10.1021/bi1002822
NR 38
TC 40
Z9 41
U1 0
U2 125
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD OCT
PY 2016
VL 2
IS 10
BP 674
EP 681
DI 10.1021/acsinfecdis.6b00109
PG 8
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA DZ2TE
UT WOS:000385693700003
PM 27737553
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Meltzer, E
   Leshem, E
   Lustig, Y
   Gottesman, G
   Schwartz, E
AF Meltzer, Eyal
   Leshem, Eyal
   Lustig, Yaniv
   Gottesman, Giora
   Schwartz, Eli
TI The Clinical Spectrum of Zika Virus in Returning Travelers
SO AMERICAN JOURNAL OF MEDICINE
LA English
DT Article
DE Arboviruses; Israel; Travel; Zika virus
ID DENGUE-FEVER; INFECTION; TRANSMISSION; OUTBREAK
AB INTRODUCTION: The clinical spectrum of Zika virus had, to date, been described in small series from endemic/epidemic countries and is not well established.
   METHODS: We describe the clinical manifestations of laboratory-proven Zika virus infection in Israeli travelers during December 2015-February 2016, and review all published cases of travel-related Zika virus.
   RESULTS: During the study period, 8 returning Israeli travelers were diagnosed with Zika virus infection. In addition, 41 published cases were included, mostly from Latin America to Europe and North America. Overall, 65.3% were diagnosed by polymerase chain reaction. Rash was the most frequent symptom, present in 95.7% of cases, followed by fever and arthralgia. Conjunctivitis was present in 53.1%; however, only 40.3% presented with a triad of conjunctivitis, fever, and rash. Less frequent symptoms included dysgeusia and nightmares, which, together with arthralgia, persisted for several weeks in some travelers.
   CONCLUSIONS: Zika virus clinical picture in travelers is diverse. Prolonged symptoms may occur. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Meltzer, Eyal; Leshem, Eyal; Schwartz, Eli] Chaim Sheba Med Ctr, Ctr Geog Med, IL-52621 Tel Hashomer, Israel.
   [Meltzer, Eyal; Leshem, Eyal; Schwartz, Eli] Chaim Sheba Med Ctr, Dept Med C, IL-52621 Tel Hashomer, Israel.
   [Meltzer, Eyal; Leshem, Eyal; Gottesman, Giora; Schwartz, Eli] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel.
   [Lustig, Yaniv] Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Tel Hashomer, Israel.
   [Gottesman, Giora] Meir Med Ctr, Pediat Infect Dis Unit, Kefar Sava, Israel.
RP Schwartz, E (corresponding author), Chaim Sheba Med Ctr, Ctr Geog Med, IL-52621 Tel Hashomer, Israel.; Schwartz, E (corresponding author), Chaim Sheba Med Ctr, Dept Med C, IL-52621 Tel Hashomer, Israel.
EM elischwa@post.tau.ac.il
OI Leshem, Eyal/0000-0003-1267-6131
CR Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chalupa P, 2001, Bratisl Lek Listy, V102, P322
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Goorhuis A, 2016, TRAVEL MED INFECT DI, V14, P13, DOI 10.1016/j.tmaid.2016.01.008
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Korhonen E., 2016, EURO SURVEILL, V21
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Macesic N, 2015, CLIN INFECT DIS, V61, P1445, DOI 10.1093/cid/civ401
   Macesis N, 2015, CLIN INFECT DIS, V61, P1485
   Maria AT, 2016, EURO SURVEILL, V21
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Rafiei N, 2016, MED J AUSTRALIA, V204, P186, DOI 10.5694/mja15.01275
   Schwartz E, 1996, AM J MED, V101, P516, DOI 10.1016/S0002-9343(96)00278-1
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Tavakolipoor P, 2016, TRAVEL MED INFECT DI, V14, P39, DOI 10.1016/j.tmaid.2016.01.007
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Venturi G, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.10.30163
   Venturi G, 2016, EURO SURVEILL, V21
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 36
TC 21
Z9 21
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9343
EI 1555-7162
J9 AM J MED
JI Am. J. Med.
PD OCT
PY 2016
VL 129
IS 10
BP 1126
EP 1130
DI 10.1016/j.amjmed.2016.04.034
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA EA1EA
UT WOS:000386334100044
PM 27260832
OA Bronze
DA 2020-07-08
ER

PT J
AU Zambrano, H
   Waggoner, JJ
   Almeida, C
   Rivera, L
   Benjamin, JQ
   Pinsky, BA
AF Zambrano, Hector
   Waggoner, Jesse J.
   Almeida, Cristina
   Rivera, Lisette
   Quintana Benjamin, Juan
   Pinsky, Benjamin A.
TI Case Report: Zika Virus and Chikungunya Virus CoInfections: A Series of
   Three Cases from a Single Center in Ecuador
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB Zika virus (ZIKV) and chikungunya virus (CHIKV) cocirculate throughout much of the tropical Western Hemisphere; however, few cases of coinfection with these two pathogens have been reported. Herein, we describe three cases of ZIKV CHIKV coinfection detected at a single center in Ecuador: a patient who developed symptoms on postoperative day 5 from an orthopedic procedure, a woman who had traveled to Ecuador for fertility treatment, and a woman who was admitted for Guillain Barre syndrome and had ZIKV and CHIKV detected in serum and cerebrospinal fluid. All cases were diagnosed using a multiplex real-time reverse transcription polymerase chain reaction, and ZIKV viremia was detected as late as 16 days after symptom onset. These cases demonstrate the varied clinical presentation of ZIKV CHIKV coinfections as well as the importance of multiplexed arboviral testing for these pathogens.
C1 [Zambrano, Hector; Almeida, Cristina; Rivera, Lisette] Hosp Luis Vernaza, Lab Biol Mol, Loja 700 & Escobedo, Guayaquil 090313, Ecuador.
   [Waggoner, Jesse J.; Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA USA.
   [Quintana Benjamin, Juan] Hosp Luis Vernaza, Dept Neurol, Guayaquil, Ecuador.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA.
RP Zambrano, H (corresponding author), Hosp Luis Vernaza, Lab Biol Mol, Loja 700 & Escobedo, Guayaquil 090313, Ecuador.
EM hzambrano@jbgye.org.ec
OI Pinsky, Benjamin/0000-0001-8751-4810
FU National Institute of Allergy and Infectious Diseases (NIAID) of the
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [K08AI110528]; Robert
   E. Shope International Fellowship in Infectious Diseases from the
   American Society of Tropical Medicine and Hygiene
FX This research was supported by the National Institute of Allergy and
   Infectious Diseases (NIAID) of the National Institutes of Health (NIH)
   grant K08AI110528 (Jesse J. Waggoner) and the Robert E. Shope
   International Fellowship in Infectious Diseases from the American
   Society of Tropical Medicine and Hygiene.
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 14
TC 31
Z9 31
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD OCT
PY 2016
VL 95
IS 4
BP 894
EP 896
DI 10.4269/ajtmh.16-0323
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA ET3VB
UT WOS:000400206500035
PM 27402518
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Gebre, Y
   Forbes, N
   Gebre, T
AF Gebre, Yitades
   Forbes, Nikkiah
   Gebre, Teshome
TI Zika virus infection, transmission, associated neurological disorders
   and birth abnormalities: A review of progress in research, priorities
   and knowledge gaps
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
ID WEST-NILE-VIRUS; UNITED-STATES; SEXUAL TRANSMISSION; INTERIM GUIDELINES;
   PREGNANT-WOMEN; MASS GATHERINGS; BREAST-MILK; DENGUE; BRAZIL; AMERICA
AB On February 1, 2016, the World Health Organization declared that the cluster of microcephaly cases and other neurological disorders constitute public health emergency of international concern. Furthermore, few studies demonstrated that there was an increased evidence of causal relationship of Zika virus (ZIKAV) infection and microcephaly, birth abnormalities and neurological disorders such as Guillain-Barre syndrome. ZIKAV transmission occurs mainly by the bite of infected mosquitos (Aedes species), but there are also reports that infections could occur via the placenta, breast milk, saliva, blood transfusion and sex. This article reviews the global efforts, progress in scientific research to understand the pathogenesis of ZIKAV infection & disease, clinical presentations, congenital transmission and autoimmune neurological disorders. The paper further explores the knowledge gaps, future priority research agenda for strategic response including vector control and prevention. We conducted a systematic literature review to synthesise available evidence on ZIKAV infection and its vector and host interaction from electronic databases.
C1 [Gebre, Yitades] World Hlth Org, Pan Amer Hlth Org, Country Off, Paramaribo, Suriname.
   [Forbes, Nikkiah] Minist Hlth, Natl HIV AIDS & Infect Dis Programme, Nassau, Bahamas.
   [Gebre, Teshome] Task Force Global Hlth, Int Trachoma Initiat, POB 10001, Addis Ababa, Ethiopia.
RP Gebre, T (corresponding author), Task Force Global Hlth, Int Trachoma Initiat, POB 10001, Addis Ababa, Ethiopia.
EM tgebre@taskforce.org
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2016, ZIK VIR INF
   [Anonymous], 2016, ZIK VIR SYMPT TEST T
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Besnard M, 2014, EURO SURVEILL
   Brasil P, 2016, N ENG J MED
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, TRAV HLTH TRAV HLTH
   Centers for Disease Control and Prevention, 2016, EM PREP RESP REC MAN
   Centers for Disease Control and Prevention, 2016, CDC ENC FOLL GUID PR
   Centers for Disease Control and Prevention, 2016, HLTH CAR PROV CLIN E
   Centers for Disease Control and Prevention, 2012, CDC ADDS COUNTR INT
   Centers for Disease Control and Prevention, 2016, TRANSM RISKS
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Dallas County Health and Human Services, 2016, DCHHS REP 1 ZIK VIR
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   dos Santos CND, 2016, TRENDS PARASITOL, V32, P508, DOI 10.1016/j.pt.2016.03.008
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2014, RAP RISK ASS ZIK VIR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Goldstein DA, 2016, JAMA OPTHALMOL
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kindhauser MK, 2016, B WHO
   Kleber de Oliveira W, 2016, MMWR-MORBID MORTAL W, V65, P242
   Kutsuna S, 2014, EURO SURVEILL
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Malone RW, 2016, BIORXIV
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministry of Health-Manatu Hauora, 2016, ZIK VIR
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EURO SURVEILL, V19
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oehler E, 2014, EURO SURVEILL
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Pan American Health Organization, 2016, EP AL NEUR SYNDR CON
   Pan American Health Organization, 2016, QUEST ANSW ZIK PREGN
   Pan American Health Organization World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pan American Health Organization World Health Organization Regional Office for the Americas, 2016, ZIK VIR INF ZIK FEV
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Reddy UM, 2014, J ULTRAS MED, V33, P745, DOI 10.7863/ultra.33.5.745
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roth A, 2014, EURO SURVEILL
   Roze B, 2016, EURO SURVEILL
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Terzian ACB, 2015, AM J TROP MED HYG, V92, P401, DOI 10.4269/ajtmh.14-0417
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Venturi G, 2016, EURO SURVEILL
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, ZIK VIR OUTBR GLOB R
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   WORLD HEALTH ORGANIZATION, 2016, ZIK VIR DIS
   World Health Organization, 2016, CURR ZIK PROD PIP
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, ZIK VIR
   World Health Organization, 2016, BREASTF CONT ZIK VIR
   World Health Organization, 2016, EM HIST ZIK VIR
   World Health Organization [WHO], 2016, MOSQ CONTR CAN IT ST
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 115
TC 9
Z9 9
U1 0
U2 8
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD OCT
PY 2016
VL 6
IS 10
BP 815
EP 824
DI 10.1016/j.apjtb.2016.08.008
PG 10
WC Tropical Medicine
SC Tropical Medicine
GA DW9MT
UT WOS:000383984800001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU El Ghouzzi, V
   Bianchi, FT
   Molineris, I
   Mounce, BC
   Berto, GE
   Rak, M
   Lebon, S
   Aubry, L
   Tocco, C
   Gai, M
   Chiotto, AMA
   Sgro, F
   Pallavicini, G
   Simon-Loriere, E
   Passemard, S
   Vignuzzi, M
   Gressens, P
   Di Cunto, F
AF El Ghouzzi, Vincent
   Bianchi, Federico T.
   Molineris, Ivan
   Mounce, Bryan C.
   Berto, Gaia E.
   Rak, Malgorzata
   Lebon, Sophie
   Aubry, Laetitia
   Tocco, Chiara
   Gai, Marta
   Chiotto, Alessandra M. A.
   Sgro, Francesco
   Pallavicini, Gianmarco
   Simon-Loriere, Etienne
   Passemard, Sandrine
   Vignuzzi, Marco
   Gressens, Pierre
   Di Cunto, Ferdinando
TI ZIKA virus elicits P53 activation and genotoxic stress in human neural
   progenitors similar to mutations involved in severe forms of genetic
   microcephaly and p53
SO CELL DEATH & DISEASE
LA English
DT Article
ID PLURIPOTENT STEM-CELLS; CITRON KINASE CONTROLS; DNA-DAMAGE RESPONSE;
   NUCLEAR-LOCALIZATION; INFECTION; EXPRESSION; GROWTH; APOPTOSIS; CORTEX;
   PHOSPHORYLATION
AB Epidemiological evidence from the current outbreak of Zika virus (ZIKV) and recent studies in animal models indicate a strong causal link between ZIKV and microcephaly. ZIKV infection induces cell-cycle arrest and apoptosis in proliferating neural progenitors. However, the mechanisms leading to these phenotypes are still largely obscure. In this report, we explored the possible similarities between transcriptional responses induced by ZIKV in human neural progenitors and those elicited by three different genetic mutations leading to severe forms of microcephaly in mice. We found that the strongest similarity between all these conditions is the activation of common P53 downstream genes. In agreement with these observations, we report that ZIKV infection increases total P53 levels and nuclear accumulation, as well as P53 Ser15 phosphorylation, correlated with genotoxic stress and apoptosis induction. Interestingly, increased P53 activation and apoptosis are induced not only in cells expressing high levels of viral antigens but also in cells showing low or undetectable levels of the same proteins. These results indicate that P53 activation is an early and specific event in ZIKV-infected cells, which could result from cell-autonomous and/or non-cellautonomous mechanisms. Moreover, we highlight a small group of P53 effector proteins that could act as critical mediators, not only in ZIKV-induced microcephaly but also in many genetic microcephaly syndromes.
C1 [El Ghouzzi, Vincent; Rak, Malgorzata; Lebon, Sophie; Passemard, Sandrine; Gressens, Pierre] Unv Paris Diderot, Sorbonne Paris Cite, INSERM, PROTECT, Paris, France.
   [Bianchi, Federico T.; Molineris, Ivan; Berto, Gaia E.; Tocco, Chiara; Gai, Marta; Chiotto, Alessandra M. A.; Sgro, Francesco; Pallavicini, Gianmarco; Gressens, Pierre; Di Cunto, Ferdinando] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Via Nizza 52, I-10126 Turin, Italy.
   [Mounce, Bryan C.; Vignuzzi, Marco] Inst Pasteur, Viral Populat & Pathogenesis Unit, UMR 3569, CNRS, Paris, France.
   [Aubry, Laetitia] UEVE UMR 861, I Stem, AFM, Evry, France.
   [Simon-Loriere, Etienne] Inst Pasteur, Funct Genet Infect Dis Unit, F-75724 Paris, France.
   [Simon-Loriere, Etienne] CNRS URA3012, F-75015 Paris, France.
   [Passemard, Sandrine] Hop Robert Debre, Dept Genet, Paris, France.
   [Gressens, Pierre] Kings Coll London, Ctr Dev Brain, London, England.
   [Di Cunto, Ferdinando] Neurosci Inst Turin, Turin, Italy.
RP Bianchi, FT; Gressens, P (corresponding author), Univ Turin, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Via Nizza 52, I-10126 Turin, Italy.
EM ferdinando.dicunto@unito.it; pierre.gressens@inserm.fr
RI Pallavicini, Gianmarco/AAQ-3254-2020; gressens, pierre/M-7557-2017
OI Pallavicini, Gianmarco/0000-0002-7735-3010; gressens,
   pierre/0000-0002-0909-4221; , Etienne/0000-0001-8420-7743; Mounce,
   Bryan/0000-0003-1710-5362; Vignuzzi, Marco/0000-0002-4400-771X; El
   Ghouzzi, Vincent/0000-0001-5894-8978; Bianchi, Federico
   Tommaso/0000-0002-8385-3310; Aubry, Laetitia/0000-0001-8152-6036; di
   cunto, ferdinando/0000-0001-9367-6357; Molineris,
   Ivan/0000-0003-2102-0804
FU French Government's Investissement d'Avenir program, Laboratoire
   d'Excellence 'Integrative Biology of Emerging Infectious Diseases'French
   National Research Agency (ANR) [ANR-10-LABX-62-IBEID]; ERA-NET grant
   from the E-Rare [ANR-13-RARE-0007-01]; CEFIPRA [4903-2]; INSERMInstitut
   National de la Sante et de la Recherche Medicale (Inserm); Universite
   Paris Diderot; ERA-NET Neuron Microkin [ANR-15-NEUR-0003-01]; PRC
   MicroGol [ANR-16-CE16-00025-01]; Telethon FoundationFondazione Telethon
   [GGP12095, GGP13081]; Associazione Italiana per la Ricerca sul Cancro
   (AIRC)Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG17527];
   EPIGEN consortium
FX We are grateful to Dr Hongjun Song, Johns Hopkins University, for
   discussing unpublished data. BCM and MV were supported by the French
   Government's Investissement d'Avenir program, Laboratoire d'Excellence
   'Integrative Biology of Emerging Infectious Diseases' (Grant No.
   ANR-10-LABX-62-IBEID). PG is supported by: ERA-NET grant from the E-Rare
   call 2013, no. ANR-13-RARE-0007-01; 'CEFIPRA', Grant no. 4903-2; INSERM;
   Universite Paris Diderot; ERA-NET Neuron Microkin, no.
   ANR-15-NEUR-0003-01 and PRC MicroGol, no ANR-16-CE16-00025-01. FDC is
   supported by: Telethon Foundation Grant Nos. GGP12095 and GGP13081 (to
   FDC); Associazione Italiana per la Ricerca sul Cancro (AIRC), Grant No.
   IG17527; EPIGEN consortium.
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Arboleda VA, 2015, AM J HUM GENET, V96, P498, DOI 10.1016/j.ajhg.2015.01.017
   Barbelanne M, 2014, BIOMED RES INT, DOI 10.1155/2014/547986
   Bassi ZI, 2013, P NATL ACAD SCI USA, V110, P9782, DOI 10.1073/pnas.1301328110
   Boissart C, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.71
   Breuss M, 2016, DEVELOPMENT, V143, P1126, DOI 10.1242/dev.131516
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008
   Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gai M, 2011, MOL BIOL CELL, V22, P3768, DOI 10.1091/mbc.E10-12-0952
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GINSBERG D, 1991, MOL CELL BIOL, V11, P582, DOI 10.1128/MCB.11.1.582
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   Hirsch M, 2009, BIOCHEM BIOPH RES CO, V388, P181, DOI 10.1016/j.bbrc.2009.07.073
   Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Karlsborn T, 2014, RNA BIOL, V11, P1519, DOI 10.4161/15476286.2014.992276
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039
   Lopez I, 2015, CELL CYCLE, V14, P3373, DOI 10.1080/15384101.2015.1090066
   Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Mahmood S, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-39
   Marjanovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8676
   McMahon JJ, 2016, INT J DEV NEUROSCI
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015
   Nasirudeen AMA, 2008, MICROBES INFECT, V10, P1124, DOI 10.1016/j.micinf.2008.06.005
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007
   Pollock A, 2014, CELL REP, V7, P1184, DOI 10.1016/j.celrep.2014.04.003
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qu LK, 2004, GENE DEV, V18, P261, DOI 10.1101/gad.1165804
   Rivas C, 2010, VIRUSES-BASEL, V2, P298, DOI 10.3390/v2010298
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002
   Sarkisian MR, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-08-j0001.2002
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Seah C, 2008, J NEUROSCI, V28, P12570, DOI 10.1523/JNEUROSCI.4048-08.2008
   Sgro F, 2016, CELL DEATH DIFFER, V23, P801, DOI 10.1038/cdd.2015.142
   SHAULSKY G, 1991, ONCOGENE, V6, P2055
   Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X
   Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taura M, 2008, MOL CELL BIOL, V28, P6557, DOI 10.1128/MCB.01202-08
   Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061
   WAY HJ, 1976, J GEN VIROL, V30, P123, DOI 10.1099/0022-1317-30-1-123
   Wei PC, 2016, CELL, V164, P644, DOI 10.1016/j.cell.2015.12.039
   Williams SE, 2015, DEVELOPMENT, V142, P3921, DOI 10.1242/dev.124271
   Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Yoon CH, 2009, P NATL ACAD SCI USA, V106, P7852, DOI 10.1073/pnas.0812148106
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
NR 74
TC 37
Z9 37
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD OCT
PY 2016
VL 7
AR e2440
DI 10.1038/cddis.2016.266
PG 10
WC Cell Biology
SC Cell Biology
GA EB4QU
UT WOS:000387358800005
PM 27787521
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Calvet, GA
   dos Santos, FB
   Sequeira, PC
AF Calvet, Guilherme Amaral
   dos Santos, Flavia Barreto
   Sequeira, Patricia Carvalho
TI Zika virus infection: epidemiology, clinical manifestations and
   diagnosis
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE Guillain-Barre syndrome; microcephaly; sexual transmission; Zika virus
ID RT-PCR
AB Purpose of reviewZika virus (ZIKV) is an arbovirus previously believed to cause only a mild and self-limiting illness. Recently, it has emerged as a new public health threat that caused a large outbreak in French Polynesia in 2013-2014 and since 2015 an explosive outbreak in Brazil, with an increase in severe congenital malformations (microcephaly) and neurological complications, mainly Guillain-Barre syndrome (GBS). Since then, it has spread through the Americas. On 1 February 2016, the WHO declared the ZIKV epidemic in Brazil a Public Health Emergency of International Concern. We reviewed the epidemiology of ZIKV infection, clinical presentations and diagnosis. We highlighted the clinical features and nonvector borne transmission of the virus.Recent findingsAssociation between ZIKV infection and severe foetal outcomes, including microcephaly and other birth defects; increased rate of GBS and other neurological complications due to the ongoing ZIKV outbreak; increased evidence to date of ZIKV being the only arbovirus linked to sexual transmission; the challenge of ZIKV diagnosis; and the need for a specific point-of care test in epidemic scenarios.SummaryThe findings illustrate the emergence of a viral disease with the identification of new associated disorders, new modes of transmission, including maternal-foetal and sexual transmission.
C1 [Calvet, Guilherme Amaral] Fundacao Oswaldo Cruz, Acute Febrile Illnesses Lab, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, Brazil.
   [dos Santos, Flavia Barreto; Sequeira, Patricia Carvalho] Fundacao Oswaldo Cruz, Flavivirus Lab, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
RP Calvet, GA (corresponding author), Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Lab Pesquisa Clin Doencas Febris Agudas, Ave Brasil 4365, BR-21045360 Rio De Janeiro, Brazil.
EM guilherme.calvet@ini.fiocruz.br
RI Calvet, Guilherme/G-6959-2013
OI Calvet, Guilherme/0000-0002-3545-5238
CR Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   CHOW VTK, 1993, ARCH VIROL, V133, P157, DOI 10.1007/BF01309751
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fang MY, 1997, MICROBIOL IMMUNOL, V41, P209, DOI 10.1111/j.1348-0421.1997.tb01192.x
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gaunt MW, 2005, J VIROL METHODS, V128, P113, DOI 10.1016/j.jviromet.2005.04.006
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
NR 21
TC 47
Z9 47
U1 2
U2 138
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 2016
VL 29
IS 5
BP 459
EP 466
DI 10.1097/QCO.0000000000000301
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA DW8QC
UT WOS:000383919600005
PM 27496713
DA 2020-07-08
ER

PT J
AU Fernandez-Salas, I
   Diaz-Gonzalez, EE
   Lopez-Gatell, H
   Alpuche-Aranda, C
AF Fernandez-Salas, Ildefonso
   Diaz-Gonzalez, Esteban E.
   Lopez-Gatell, Hugo
   Alpuche-Aranda, Celia
TI Chikugunya and zika virus dissemination in the Americas: different
   arboviruses reflecting the same spreading routes and poor vector-control
   policies
SO CURRENT OPINION IN INFECTIOUS DISEASES
LA English
DT Review
DE chikungunya; emergence; transcontinental movement; zika
ID CHIKUNGUNYA CHRONIC ARTHRALGIA; AEDES-AEGYPTI; SEXUAL TRANSMISSION;
   DENGUE VIRUSES; UNITED-STATES; 1ST REPORT; INFECTIONS; TRAVELERS;
   OUTBREAK; FEVER
AB Purpose of reviewThis review gathers the most recent investigations about chikungunya and zika viruses in America and would help in creating new research approaches.Recent findingsClinical descriptions of chikungunya fever have been performed in the American outbreak observing that fever, polyarthalgia, myalgia and rash are the most common symptoms in the acute phase, while chronic arthralgia has persisted in 37-90% of small cohorts. The Asian origin of American strains of chikungunya virus (CHIKV) and zika virus (ZIKV) evidences a dissemination route in common and both are being transmitted by Aedes aegypti. Regarding zika fever, the association of congenital malformations with previous ZIKV exposure of pregnant women and potential sexual transmission of ZIKV are the most important discoveries in the New World.SummaryMassive outbreaks of chikungunya fever in 2014 and then followed by zika fever epidemics of lower magnitude in the next year throughout the American continent have their origins in Asia but may have used Pacific Islands as a path of dissemination. Reports of chronic arthralgia have been little described in the continent and more research is needed to measure the economic and health impact in patients who contracted CHIKV before. On the contrary, zika is menacing newborns' health because of its link with congenital microcephaly and sexual health by prolonged presence of viral particles in semen and urine.
C1 [Fernandez-Salas, Ildefonso] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, 19 Poniente S-N Entre 4 Norte & 6 Norte, Tapachula 30700, Chiapas, Mexico.
   [Diaz-Gonzalez, Esteban E.] Univ Autonoma Nuevo Leon, Ctr Invest & Desarrollo Ciencias Salud, Monterrey, Nuevo Leon, Mexico.
   [Diaz-Gonzalez, Esteban E.] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza, Nuevo Leon, Mexico.
   [Lopez-Gatell, Hugo; Alpuche-Aranda, Celia] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.
RP Fernandez-Salas, I (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, 19 Poniente S-N Entre 4 Norte & 6 Norte, Tapachula 30700, Chiapas, Mexico.
EM ildefonso.fernandez@insp.mx
RI amsalu, ribka/G-8780-2019
OI Diaz Gonzalez, Esteban Eduardo/0000-0001-6124-3282
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carter D, 2014, AM J NURS, V114, P18, DOI 10.1097/01.NAJ.0000453741.11196.d4
   Cassadou S, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.13.20752
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Centro Nacional de Programas Preventivos y Control de Enfermedades, 2014, DECL EM EP EE 2 2014
   Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087
   Comision Nacional para la Vigilancia Epidemiologica, 2015, INF VIR ZIK SINDR NE
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Espinosa N., 2016, OPEN J MED MICROBIOL, V6, P23
   FAGBAMI A, 1977, TROP GEOGR MED, V29, P187
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gibney KB, 2011, CLIN INFECT DIS, V52, pE121, DOI 10.1093/cid/ciq214
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546
   Kendrick K, 2014, MMWR-MORBID MORTAL W, V63, P1137
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lanciotti RS, 2014, EMERG INFECT DIS, V20, P1400, DOI 10.3201/eid2008.140268
   Lindsey NP, 2015, AM J TROP MED HYG, V92, P82, DOI 10.4269/ajtmh.14-0442
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mattar S, 2015, J INFECT DEV COUNTR, V9, P1126, DOI 10.3855/jidc.6670
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monaghan AJ, 2016, PLOS CURR
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Morosini FC, 2016, BRAZILIAN APPROACH S
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Musso D, 2016, LANCET INFECT DIS, V16, P620, DOI 10.1016/S1473-3099(16)00096-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Noel H, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.28.20855
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pan American Health Organization, 2015, CUM ZIK SUSP CONF CA
   Pan American Health Organization, 2016, CHIK STAT DAT
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.28.20856
   PEERS RR, 1972, CAN J MICROBIOL, V18, P741, DOI 10.1139/m72-118
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pinnock FH, 2012, CARIBBEAN MARITIME T
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Requena-Mendez A, 2014, EUROSURVEILLANCE, V19, P5, DOI 10.2807/1560-7917.ES2014.19.28.20853
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rodriguez-Morales AJ, 2016, CLIN RHEUMATOL, V35, P831, DOI 10.1007/s10067-015-3041-8
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P58, DOI 10.1016/j.tmaid.2015.09.001
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Servicio Metereologico Nacional, 2016, SERV MET NAC REP AN
   Sistema IBGE de Recuperacao Automatica, EM INT SEX 2 CONT PA
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1952, J IMMUNOL, V68, P441
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vergara Y, 2016, TVN NOTICIAS
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zeana C, 2016, TRAVEL MED INFECT DI, V14, P21, DOI 10.1016/j.tmaid.2016.01.009
NR 75
TC 6
Z9 8
U1 0
U2 60
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0951-7375
EI 1473-6527
J9 CURR OPIN INFECT DIS
JI Curr. Opin. Infect. Dis.
PD OCT
PY 2016
VL 29
IS 5
BP 467
EP 475
DI 10.1097/QCO.0000000000000304
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA DW8QC
UT WOS:000383919600006
PM 27472289
DA 2020-07-08
ER

PT J
AU Alejo-Cancho, I
   Torner, N
   Oliveira, I
   Martinez, A
   Munoz, J
   Jane, M
   Gascon, J
   Requena-Mendez, A
   Vilella, A
   Marcos, MA
   Pinazo, MJ
   Gonzalo, V
   Rodriguez, N
   Martinez, MJ
AF Alejo-Cancho, Izaskun
   Torner, Nuria
   Oliveira, Ines
   Martinez, Ana
   Munoz, Jose
   Jane, Mireia
   Gascon, Joaquim
   Requena-Mendez, Ana
   Vilella, Anna
   Angeles Marcos, Ma.
   Jesus Pinazo, Maria
   Gonzalo, Veronica
   Rodriguez, Natalia
   Martinez, Miguel J.
TI Twenty-four cases of imported zika virus infections diagnosed by
   molecular methods
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
AB Zika virus is an emerging fiavivirus widely spreading through Latin America. Molecular diagnosis of the infection can be performed using serum, urine and saliva samples, although a well-defined diagnostic algorithm is not yet established. We describe a series of 24 cases of imported zika virus infection into Catalonia (northeastern Spain). Based on our findings, testing of paired serum and urine samples is recommended. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Alejo-Cancho, Izaskun; Angeles Marcos, Ma.; Gonzalo, Veronica; Martinez, Miguel J.] Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain.
   [Torner, Nuria; Martinez, Ana; Jane, Mireia] Publ Hlth Agcy Catalonia, Generalitat Catalonia, Barcelona, Spain.
   [Oliveira, Ines; Munoz, Jose; Gascon, Joaquim; Requena-Mendez, Ana; Vilella, Anna; Angeles Marcos, Ma.; Jesus Pinazo, Maria; Rodriguez, Natalia; Martinez, Miguel J.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
   [Vilella, Anna] Univ Barcelona, Hosp Clin, Dept Publ Hlth, Barcelona, Spain.
RP Martinez, MJ (corresponding author), Hosp Clin Barcelona, Dept Clin Microbiol, Barcelona, Spain.; Martinez, MJ (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.
EM myoldi@clinic.ub.es
RI , Nuria/AAG-8951-2019; Gutierrez, Jose Munoz/X-5917-2018; Gascon,
   Joaquim/M-3598-2015; Mendez, Ana Requena/U-5158-2018; Gutierrez, Jose
   Munoz/AAH-6954-2020; Pinazo, Maria Jesus M/X-6093-2018; Oliveira Souto,
   Ines/L-2947-2017
OI , Nuria/0000-0003-0143-5295; Gutierrez, Jose Munoz/0000-0002-0945-1735;
   Gascon, Joaquim/0000-0002-5045-1585; Mendez, Ana
   Requena/0000-0002-4422-241X; Gutierrez, Jose Munoz/0000-0002-0945-1735;
   Pinazo, Maria Jesus M/0000-0002-4237-1075; Alejo Cancho,
   Izaskun/0000-0003-2488-7139; Fernandez, Ivette/0000-0001-5179-0477;
   marcos, maria angeles/0000-0001-8250-3311; Oliveira Souto,
   Ines/0000-0001-6018-5797; Martinez, Miguel Julian/0000-0002-0682-1075
CR Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Cao-Lormeau V, 2016, LANCET IN PRESS
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2016, INT GUID HEALTHC PRO
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Levanov I, 2016, ZIKA VIRUS INFECT PR, P1
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Rasmussen SA, 2016, ZIKA VIRUS BIRTH DEF, P1
   [Unit P Wellcome T], 1973, T ROYAL SOC, V67, P174
NR 14
TC 3
Z9 4
U1 2
U2 58
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD OCT
PY 2016
VL 86
IS 2
BP 160
EP 162
DI 10.1016/j.diagmicrobio.2016.07.016
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA DX5BS
UT WOS:000384395400009
PM 27492132
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Vest, KG
AF Vest, Kelly G.
TI Zika Virus: A Basic Overview of an Emerging Arboviral Infection in the
   Western Hemisphere
SO DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS
LA English
DT Article
DE Zika virus; arbovirus; epidemic
ID FRENCH-POLYNESIA; TRANSMISSION; OUTBREAK; BRAZIL; TRAVELERS; STATES
AB Since February 2015, Zika virus has spread throughout the Western Hemisphere, starting in Brazil. As of March 2016, autochthonous transmission has been reported in at least 31 countries or territories. For countries in the Americas, the spread of Zika virus, a previously unfamiliar disease, follows similar emerging infection introductions of West Nile virus and Chikungunya virus and their spread throughout the American continents and the Caribbean nations. The Pan American Health Organization and the World Health Organization have issued alerts and a Public Health Emergency of International Concern announcement related to the recent cluster of microcephaly cases and other neurological disorders in Brazil that are temporally associated with Zika virus, which highlights the possible adverse impact of viral infection. This article provides an overview of the Zika virus infection and presents the historical background of the virus, a description of the pathogen, the epidemiology and clinical spectrum of Zika virus infection, diagnosis and treatment approaches, and prevention and control measures. Understanding what is known about the virus and its clinical presentation will assist in prevention, detection, and response measures to reduce and control the spread of the virus throughout the Western Hemisphere. (Disaster Med Public Health Preparedness. 2016;page 1 of 6)
C1 [Vest, Kelly G.] Uniformed Serv Univ Hlth Sci, Ctr Global Hlth Engagement, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.
RP Vest, KG (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Global Hlth Engagement, 11300 Rockville Pike,Suite 707, Rockville, MD 20852 USA.
EM kvest@cdham.org
CR *AM ASS BLOOD BANK, 2016, ASS B 16 04, V1604
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boadle A., 2016, BRAZIL REPORTS ZIKA
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, REV DIAGN TEST ZIK C
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Paula Freitas B, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GUBLER DJ, 1991, HUNTERS TROPICAL MED, V1, P981
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hong SK, 2014, EMERG INFECT DIS, V20, P1089, DOI 10.3201/eid2006.131508
   *INT SOC INF DIS, 2015, UND ILLN BRAZ NE RIO
   JAMPOL LM, JAMA OPHTHALMOL
   Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MANSUY JM, LANCET INFECT DIS
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   McNeil Jr Donald G., 2016, NY TIMES
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   MECHARLES S, LANCET
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   SMITH DW, ZIKA VIRUS GUILLAIN
   TANG H, 2016, CELL STEM CELL, V18
   *US I MED, 1992, EM INF MICR THREATS
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WHO, 2016, ZIK SIT REP NEUR SYN
   Willison HJ, LANCET
NR 46
TC 10
Z9 10
U1 1
U2 16
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1935-7893
EI 1938-744X
J9 DISASTER MED PUBLIC
JI Dis. Med. Public Health Prep.
PD OCT
PY 2016
VL 10
IS 5
BP 707
EP 712
DI 10.1017/dmp.2016.43
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EB6GH
UT WOS:000387479200004
PM 27021935
OA Bronze
DA 2020-07-08
ER

PT J
AU Simonin, Y
   Loustalot, F
   Desmetz, C
   Foulongne, V
   Constant, O
   Fournier-Wirth, C
   Leon, F
   Moles, JP
   Goubaud, A
   Lemaitre, JM
   Maquart, M
   Leparc-Goffart, I
   Briant, L
   Nagot, N
   Van de Perre, P
   Salinas, S
AF Simonin, Yannick
   Loustalot, Fabien
   Desmetz, Caroline
   Foulongne, Vincent
   Constant, Orianne
   Fournier-Wirth, Chantal
   Leon, Fanny
   Moles, Jean-Pierre
   Goubaud, Aurelien
   Lemaitre, Jean-Marc
   Maquart, Marianne
   Leparc-Goffart, Isabelle
   Briant, Laurence
   Nagot, Nicolas
   Van de Perre, Philippe
   Salinas, Sara
TI Zika Virus Strains Potentially Display Different Infectious Profiles in
   Human Neural Cells
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; Lineages; Neural stem cells; Astrocytes
ID WEST-NILE-VIRUS; ENVELOPE PROTEIN GLYCOSYLATION; FLAVIVIRUSES;
   PHENOTYPE; REGION
AB The recent Zika virus (ZIKV) epidemic has highlighted the poor knowledge on its physiopathology. Recent studies showed that ZIKV of the Asian lineage, responsible for this international outbreak, causes neuropathology in vitro and in vivo. However, two African lineages exist and the virus is currently found circulating in Africa. The original African strain was also suggested to be neurovirulent but its laboratory usage has been criticized due to its multiple passages. In this study, we compared the French Polynesian (Asian) ZIKV strain to an African strain isolated in Central African Republic and show a difference in infectivity and cellular response between both strains in human neural stem cells and astrocytes. Consistently, this African strain led to a higher infection rate and viral production, as well as stronger cell death and anti-viral response. Our results highlight the need to better characterize the physiopathology and predict neurological impairment associated with African ZIKV. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Simonin, Yannick; Loustalot, Fabien; Foulongne, Vincent; Constant, Orianne; Fournier-Wirth, Chantal; Leon, Fanny; Moles, Jean-Pierre; Nagot, Nicolas; Van de Perre, Philippe; Salinas, Sara] Univ Montpellier, INSERM, UMR 1058, Etab Francais Sang Pathogenesis & Control Chron I, Montpellier, France.
   [Simonin, Yannick; Desmetz, Caroline] Univ Montpellier, Montpellier, France.
   [Foulongne, Vincent; Nagot, Nicolas; Van de Perre, Philippe] CHU Montpellier, Montpellier, France.
   [Fournier-Wirth, Chantal; Leon, Fanny] Etab Francais Sang, Montpellier, France.
   [Goubaud, Aurelien; Lemaitre, Jean-Marc] Univ Montpellier, CHU Montpellier, INSERM, Inst Med Regeneratr & Biotherapies,U1183, Montpellier, France.
   [Goubaud, Aurelien; Lemaitre, Jean-Marc] Infrastruct Natl INGESTEM, Plateforme CHU SAFE IPS, Montpellier, France.
   [Maquart, Marianne; Leparc-Goffart, Isabelle] Ctr Natl Reference Arbovirus, Inst Rech Biomed Armees, Marseille, France.
   [Briant, Laurence] Univ Montpellier, CNRS, Ctr Etudes Agents Pathogenes & Biotechnol Sante, FRE3689, Montpellier, France.
RP Simonin, Y (corresponding author), Univ Montpellier, INSERM, UMR 1058, Etab Francais Sang Pathogenesis & Control Chron I, Montpellier, France.
EM yannick.simonin@umontpellier.fr; sara.salinas@inserm.fr
RI Moles, Jean-Pierre/M-2286-2017; Salinas, Sara/O-1150-2019; Desmetz,
   Caroline/N-4892-2016; LEMAITRE, Jean-Marc/I-4989-2016; Salinas,
   Sara/O-1856-2013; Van de Perre, Philippe/B-9692-2008
OI Moles, Jean-Pierre/0000-0002-6863-6350; Salinas,
   Sara/0000-0003-4492-2093; Desmetz, Caroline/0000-0002-8530-6011;
   Salinas, Sara/0000-0003-4492-2093; Van de Perre,
   Philippe/0000-0002-3912-0427; simonin, yannick/0000-0002-3475-1369;
   Briant, Laurence/0000-0002-1995-3501; LEMAITRE,
   Jean-Marc/0000-0002-6492-5219
FU REACTing through the ITMOs I3M and Neurosciences and La Region
   Languedoc-Roussillon [LR 0001146]
FX This work was funded by REACTing through the ITMOs I3M and Neurosciences
   and La Region Languedoc-Roussillon (LR 0001146).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Baraka V, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00110
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372
   Bell T.M., 1971, ARCH GES VIRUSFORSCH, P193
   Besnard M, 2016, EURO SURVEILL, V21
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S., 2016, LANCET, V6736, P1
   COES, 2016, 10 COES
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   ECDC, 2015, ZIK VIR EP AM POT AS
   Fazakerley JK, 2002, J VIROL, V76, P392, DOI 10.1128/JVI.76.1.392-396.2002
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Furr SR, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00201
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gong Z., 2016, TRENDS MICROBIOL, Vxx
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Johansson M.A., 2016, N ENGL J MED
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   KAWANO H, 1993, J VIROL, V67, P6567, DOI 10.1128/JVI.67.11.6567-6575.1993
   King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012
   Kostyuchenko V.A., 2016, NATURE
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee KX, 2016, J NANOMATER, V2016, DOI 10.1155/2016/8489094
   Li H., 2016, CELL STEM CELL, P1
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meda N, 2016, LANCET, V388, P337, DOI 10.1016/S0140-6736(16)31103-5
   Meersman K, 2016, EURO SURVEILL, V21
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Molofsky AV, 2015, GLIA, V63, P1320, DOI 10.1002/glia.22836
   Musso D, 2016, CLIN MICROBIOL INFEC, V22, P494, DOI 10.1016/j.cmi.2016.03.032
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nowakowski A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4956063
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Retallack H., 2016, ZIKA VIRUS HUMAN PLA
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Xu M., 2016, NAT MED
NR 54
TC 72
Z9 72
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD OCT
PY 2016
VL 12
BP 161
EP 169
DI 10.1016/j.ebiom.2016.09.020
PG 9
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EA8IM
UT WOS:000386878500032
PM 27688094
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, XF
   Dong, HL
   Huang, XY
   Qiu, YF
   Wang, HJ
   Deng, YQ
   Zhang, NN
   Ye, Q
   Zhao, H
   Liu, ZY
   Fan, H
   An, XP
   Sun, SH
   Gao, B
   Fa, YZ
   Tong, YG
   Zhang, FC
   Gao, GF
   Cao, WC
   Shi, PY
   Qin, CF
AF Li, Xiao-Feng
   Dong, Hao-Long
   Huang, Xing-Yao
   Qiu, Ye-Feng
   Wang, Hong-Jiang
   Deng, Yong-Qiang
   Zhang, Na-Na
   Ye, Qing
   Zhao, Hui
   Liu, Zhong-Yu
   Fan, Hang
   An, Xiao-Ping
   Sun, Shi-Hui
   Gao, Bo
   Fa, Yun-Zhi
   Tong, Yi-Gang
   Zhang, Fu-Chun
   Gao, George F.
   Cao, Wu-Chun
   Shi, Pei-Yong
   Qin, Cheng-Feng
TI Characterization of a 2016 Clinical Isolate of Zika Virus in Non-human
   Primates
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus; Non-human primate model; Target organ; Lacrimal fluid
ID ASIAN-LINEAGE; SEXUAL TRANSMISSION; INFECTION; MICE; PREGNANCY; BIOLOGY;
   MODELS; STATES; URINE; CELLS
AB Animal models are critical to understand disease and to develop countermeasures for the ongoing epidemics of Zika virus (ZIKV). Here we report a non-human primate model using a 2016 contemporary clinical isolate of ZIKV. Upon subcutaneous inoculation, rhesus macaques developed fever and viremia, with robust excretion of ZIKV RNA in urine, saliva, and lacrimal fluid. Necropsy of two infected animals revealed that systematic infections involving central nervous system and visceral organs were established at the acute phrase. ZIKV initially targeted the intestinal tracts, spleen, and parotid glands, and retained in spleen and lymph nodes till 10 days post infection. ZIKV-specific immune responses were readily induced in all inoculated animals. The non-human primate model described here provides a valuable platform to study ZIKV pathogenesis and to evaluate vaccine and therapeutics. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
C1 [Li, Xiao-Feng; Dong, Hao-Long; Huang, Xing-Yao; Wang, Hong-Jiang; Deng, Yong-Qiang; Zhang, Na-Na; Ye, Qing; Zhao, Hui; Liu, Zhong-Yu; Fan, Hang; An, Xiao-Ping; Sun, Shi-Hui; Gao, Bo; Tong, Yi-Gang; Cao, Wu-Chun; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Qiu, Ye-Feng; Fa, Yun-Zhi] Acad Mil Med Sci, Lab Anim Ctr, Beijing 100071, Peoples R China.
   [Zhang, Na-Na; Qin, Cheng-Feng] Guangxi Med Univ, Xining 530021, Peoples R China.
   [Zhang, Fu-Chun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Wang, Hong-Jiang] 306th Hosp PLA, Dept Infect Control, Beijing 100101, Peoples R China.
RP Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Qin, CF (corresponding author), Guangxi Med Univ, Xining 530021, Peoples R China.
EM qincf@bmi.ac.cn
RI Qin, Cheng-Feng/I-6839-2019
OI Qin, Cheng-Feng/0000-0002-0632-2807; huang, xingyao/0000-0002-3917-8100;
   Tong, Yigang/0000-0002-8503-8045; Liu, Zhong-Yu/0000-0001-7385-5681
FU State Key Laboratory of Pathogen and Biosecurity [SKLPBS1601]; Guangzhou
   Science and Technology Program for Public Wellbeing [201508020263,
   2014Y2-00550]; Beijing Nova ProgramBeijing Municipal Science &
   Technology Commission [2016110, 2010B041]; National Key Research and
   Development Project of China [2016YFD0500304]; Excellent Young Scientist
   Program from the NSFC of ChinaNational Natural Science Foundation of
   China [81522025]; Newton Advanced Fellowship from the Academy of Medical
   Sciences, UK; NSFC of ChinaNational Natural Science Foundation of China
   [81661130162]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI087856];
   Pan-American Health Organization and World Health Organization
FX We thank the veterinarians from Laboratory Animal Center, Academy of
   Military Medical Science, for their excellent technical support; and
   Drs. Jing An, Zhiheng Xu, Xia Jia, and Bo Zhang for helpful discussion.
   This work was supported by the State Key Laboratory of Pathogen and
   Biosecurity (no. SKLPBS1601), the Guangzhou Science and Technology
   Program for Public Wellbeing (no. 201508020263, and no. 2014Y2-00550),
   the Beijing Nova Program (no. 2016110, and no. 2010B041), and the
   National Key Research and Development Project of China (no.
   2016YFD0500304). CFQ was supported by the Excellent Young Scientist
   Program from the NSFC of China (no. 81522025) and the Newton Advanced
   Fellowship from the Academy of Medical Sciences, UK and the NSFC of
   China (No. 81661130162). PYS was partially supported by NIH grant
   AI087856, and a grant from Pan-American Health Organization and World
   Health Organization. All authors declared no conflicts of interest.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barzon L., 2016, EURO SURVEILL, V21
   Boonsriroj H, 2016, J VET MED SCI, V78, P35, DOI 10.1292/jvms.15-0308
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira J, 2016, CLIN INFECT DIS, V63, P141, DOI 10.1093/cid/ciw211
   Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Roze B, 2016, EURO SURVEILL, P21
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 43
TC 76
Z9 76
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD OCT
PY 2016
VL 12
BP 170
EP 177
DI 10.1016/j.ebiom.2016.09.022
PG 8
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA EA8IM
UT WOS:000386878500033
PM 27693104
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Naccache, SN
   Theze, J
   Sardi, SI
   Somasekar, S
   Greninger, AL
   Bandeira, AC
   Campos, GS
   Tauro, LB
   Faria, NR
   Pybus, OG
   Chiu, CY
AF Naccache, Samia N.
   Theze, Julien
   Sardi, Silvia I.
   Somasekar, Sneha
   Greninger, Alexander L.
   Bandeira, Antonio C.
   Campos, Gubio S.
   Tauro, Laura B.
   Faria, Nuno R.
   Pybus, Oliver G.
   Chiu, Charles Y.
TI Distinct Zika Virus Lineage in Salvador, Bahia, Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID OUTBREAK
AB Sequencing of isolates from patients in Bahia, Brazil, where most Zika virus cases in Brazil have been reported, resulted in 11 whole and partial Zika virus genomes. Phylogenetic analyses revealed a well-supported Bahia-specific Zika virus lineage, which indicates sustained Zika virus circulation in Salvador, Bahia's capital city, since mid-2014.
C1 [Naccache, Samia N.; Somasekar, Sneha; Chiu, Charles Y.] Univ Calif San Francisco, San Francisco, CA 94143 USA.
   [Naccache, Samia N.; Somasekar, Sneha; Chiu, Charles Y.] Univ Calif San Francisco, Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.
   [Theze, Julien; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Oxford, England.
   [Sardi, Silvia I.; Campos, Gubio S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Greninger, Alexander L.] Univ Washington, Seattle, WA 98195 USA.
   [Bandeira, Antonio C.] Hosp Alianca, Salvador, BA, Brazil.
   [Tauro, Laura B.] Fundacao Oswaldo Cruz, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   [Faria, Nuno R.] Evandro Chagas Inst, Ananindeua, Brazil.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, UCSF China Basin, 185 Berry St,Box 0134, San Francisco, CA 94107 USA.
EM charles.chiu@ucsf.edu
RI Faria, Nuno/I-2975-2012; Pybus, Oliver g/B-2640-2012; sardi, silvia
   ines/P-9349-2016
OI Faria, Nuno/0000-0001-8839-2798; Pybus, Oliver g/0000-0002-8797-2667;
   sardi, silvia ines/0000-0002-2002-8436; Greninger,
   Alexander/0000-0002-7443-0527
FU Fundacao de Amparo a Pesquisa do Estado da Bahia; European Research
   Council under the European Union's Seventh Framework Program (FP7)/ERC
   [614725-PATHPHYLODYN]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01-HL105704, R21-AI120977]; Abbott Laboratories, Inc.Abbott
   Laboratories; American people through the United States Agency for
   International Development Emerging Pandemic Threats Program-2
   PREDICT-2United States Agency for International Development (USAID)
   [AID-OAA-A-14-00102]
FX This study was supported in part by Fundacao de Amparo a Pesquisa do
   Estado da Bahia, the European Research Council under the European
   Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement
   no. 614725-PATHPHYLODYN, National Institutes of Health grants
   R01-HL105704 and R21-AI120977 (C.Y.C.), and a viral discovery award from
   Abbott Laboratories, Inc. (C.Y.C.). This study was made possible by the
   generous support of the American people through the United States Agency
   for International Development Emerging Pandemic Threats Program-2
   PREDICT-2 (Cooperative Agreement No. AID-OAA-A-14-00102).
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chiu CY, 2015, EMERG INFECT DIS, V21, P1409, DOI 10.3201/eid2108.150458
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Sardi SI, 2016, J CLIN MICROBIOL IN
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 15
TC 26
Z9 27
U1 0
U2 23
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2016
VL 22
IS 10
BP 1788
EP 1792
DI 10.3201/eid2210.160663
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DX4YQ
UT WOS:000384387400013
PM 27448188
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aliota, MT
   Peinado, SA
   Osorio, JE
   Bartholomay, LC
AF Aliota, Matthew T.
   Peinado, Stephen A.
   Osorio, Jorge E.
   Bartholomay, Lyric C.
TI Culex pipiens and Aedes triseriatus Mosquito Susceptibility to Zika
   Virus
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
C1 [Aliota, Matthew T.; Peinado, Stephen A.; Osorio, Jorge E.; Bartholomay, Lyric C.] Univ Wisconsin, Madison, WI USA.
RP Aliota, MT (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, 1656 Linden Dr, Madison, WI 53706 USA.
EM mtaliota@wisc.edu
OI Aliota, Matthew/0000-0002-6902-9149
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32 AI007414, R21 AI117413]
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Erickson SM, 2006, J MED ENTOMOL, V43, P966, DOI 10.1603/0022-2585(2006)43[966:TPOATD]2.0.CO;2
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
NR 10
TC 57
Z9 59
U1 1
U2 36
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD OCT
PY 2016
VL 22
IS 10
BP 1857
EP 1859
DI 10.3201/eid2210.161082
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA DX4YQ
UT WOS:000384387400037
PM 27434194
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, B
   Hou, Y
   Wang, JJ
   Kokoza, VA
   Saha, TT
   Wang, XL
   Lin, L
   Zou, Z
   Raikhel, AS
AF Zhao, Bo
   Hou, Yuan
   Wang, Jianjun
   Kokoza, Vladimir A.
   Saha, Tusar T.
   Wang, Xue-Li
   Lin, Ling
   Zou, Zhen
   Raikhel, Alexander S.
TI Determination of juvenile hormone titers by means of LC-MS/MS/MS and a
   juvenile hormone-responsive Ga14/UAS system in Aedes aegypti mosquitoes
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Juvenile hormone; Early trypsin; Methoprene-tolerant; Mosquito; Hormone
   action; Transgenesis
ID EARLY TRYPSIN; METHOPRENE-TOLERANT; GENE-EXPRESSION; MASS-SPECTROMETRY;
   YELLOW-FEVER; ZIKA VIRUS; MIDGUT; RECEPTOR; ACID; HETERODIMER
AB In anautogenous mosquitoes, juvenile hormone III (JH) plays an essential role in female post-eclosion (PE) development, preparing them for subsequent blood feeding and egg growth. We re-examined the JH titer during the reproductive cycle of female Aedes aegypti mosquitoes. Using liquid chromatography coupled with triple tandem mass spectrometry (LC-MS/MS/MS), we have shown that it reaches its peak at 48-54 h PE in the female hemolymph and at 72 h PE in whole body extracts. This method represents an effective assay for determination of JH titers. The 2.1-kb 5' promoter region of the Early Trypsin (ET) gene, which is specifically expressed in the female midgut under the control of JH during the PE phase, was utilized to genetically engineer the Ae. aegypti mosquito line with the ET-Gal4 activator. We then established the ET-GAL4 > UAS-enhanced green fluorescent protein (EGFP) system in Ae. aegypti. In ET-Gal4 > UAS-EGFP female mosquitoes, the intensity of the midgut-specific EGFP signal was observed to correspond to the ET gene transcript level and follow the JH titer during the PE phase. The EGFP signal and the EGFP transcript level were significantly diminished in midguts of transgenic female mosquitoes after RNA interference depletion of the JH receptor Methoprene-tolerant (Met), providing evidence of the control of ET gene expression by Met. Topical JH application caused premature enhancement of the EGFP signal and the EGFP transcript level in midguts of newly eclosed ET-Gal4 > UAS-EGFP female mosquitoes, in which endogenous JH titer is still low. Hence, this novel ET-Gal4 > UAS system permits JH-dependent gene overexpression in the midgut of Ae. aegypti female mosquitoes prior to a blood meal. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Zhao, Bo; Wang, Jianjun; Kokoza, Vladimir A.; Saha, Tusar T.; Lin, Ling; Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.
   [Hou, Yuan; Wang, Xue-Li; Zou, Zhen] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.
   [Hou, Yuan; Wang, Xue-Li; Zou, Zhen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Wang, Jianjun] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China.
   [Raikhel, Alexander S.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA.
RP Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.; Zou, Z (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.
EM zouzhen@ioz.ac.cn; alexander.raikhel@ucr.edu
RI zou, zhen/C-6134-2016
OI zou, zhen/0000-0003-3550-7656
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI036959];
   Strategic Priority Research Program of Chinese Academy of Sciences
   [XDB11030600]; National Science Foundation of ChinaNational Natural
   Science Foundation of China [31472008, L1524009]
FX This work was supported by National Institutes of Health Grant R01
   AI036959, Strategic Priority Research Program of the Chinese Academy of
   Sciences (No. XDB11030600) and the National Science Foundation of China
   (No. 31472008, L1524009).
CR Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Bian GW, 2008, INSECT BIOCHEM MOLEC, V38, P190, DOI 10.1016/j.ibmb.2007.10.008
   Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003
   Brandon MC, 2008, INSECT BIOCHEM MOLEC, V38, P916, DOI 10.1016/j.ibmb.2008.07.003
   Chen Z, 2007, INSECT BIOCHEM MOLEC, V37, P799, DOI 10.1016/j.ibmb.2007.05.019
   Clements A.N., 1992, BIOL MOSQUITOES DEV
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GWADZ RW, 1973, J INSECT PHYSIOL, V19, P1441, DOI 10.1016/0022-1910(73)90174-1
   HAGEDORN HH, 1979, NATURE, V282, P92, DOI 10.1038/282092a0
   Hernandez-Martinez S, 2015, J INSECT PHYSIOL, V72, P22, DOI 10.1016/j.jinsphys.2014.11.003
   Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110
   Hou Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005309
   Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008
   Kokoza VA, 2011, INSECT BIOCHEM MOLEC, V41, P637, DOI 10.1016/j.ibmb.2011.04.004
   Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021
   Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108
   Lynd A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031552
   Noriega FG, 1997, INSECT MOL BIOL, V6, P63, DOI 10.1046/j.1365-2583.1997.00154.x
   Noriega FG, 1996, INSECT MOL BIOL, V5, P25, DOI 10.1111/j.1365-2583.1996.tb00037.x
   Noriega FG, 1996, INSECT BIOCHEM MOLEC, V26, P119, DOI 10.1016/0965-1748(95)00068-2
   Noriega FG, 1999, INSECT BIOCHEM MOLEC, V29, P243, DOI 10.1016/S0965-1748(98)00132-5
   Raikhel A.S., 2005, COMPREHENSIVE MOL IN, P433
   RAIKHEL AS, 1985, GEN COMP ENDOCR, V57, P422, DOI 10.1016/0016-6480(85)90224-2
   RAIKHEL AS, 1990, GEN COMP ENDOCR, V77, P423, DOI 10.1016/0016-6480(90)90233-C
   Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002
   ROSSIGNOL PA, 1982, J MED ENTOMOL, V19, P719, DOI 10.1093/jmedent/19.6.719
   Saha TT, 2016, P NATL ACAD SCI USA, V113, pE735, DOI 10.1073/pnas.1523838113
   SHAPIRO AB, 1986, J INSECT PHYSIOL, V32, P867, DOI 10.1016/0022-1910(86)90102-2
   Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109
   Tsetsarkin KA, 2016, CURR OPIN VIROL, V16, P143, DOI 10.1016/j.coviro.2016.02.007
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x
   Zhao B, 2014, INSECT BIOCHEM MOLEC, V54, P1, DOI 10.1016/j.ibmb.2014.08.001
   Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100
   Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110
   Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011
NR 38
TC 10
Z9 11
U1 1
U2 32
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD OCT
PY 2016
VL 77
BP 69
EP 77
DI 10.1016/j.ibmb.2016.08.003
PG 9
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA DY7PN
UT WOS:000385321700007
PM 27530057
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Coelho, FC
   Durovni, B
   Saraceni, V
   Lemos, C
   Codeco, CT
   Camargo, S
   de Carvalho, LM
   Bastos, L
   Arduini, D
   Villela, DAM
   Armstrong, M
AF Coelho, Flavio Codeco
   Durovni, Betina
   Saraceni, Valeria
   Lemos, Cristina
   Codeco, Claudia Torres
   Camargo, Sabrina
   de Carvalho, Luiz Max
   Bastos, Leonardo
   Arduini, Denise
   Villela, Daniel A. M.
   Armstrong, Margaret
TI Higher incidence of Zika in adult women than adult men in Rio de Janeiro
   suggests a significant contribution of sexual transmission from men to
   women
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Sexual transmission; Dengue; Age-adjusted incidence
ID POTENTIAL VECTOR; VIRUS; DENGUE
AB Objectives: The recent emergence of Zika in Brazil and its association with an increased rate of congenital malformations has raised concerns over its impact on the birth rate in the country. Using data on the incidence of Zika in 2015-2016 and dengue in 2013 and 2015-2016 for the city of Rio de Janeiro (population 6.4 million), a massive increase of Zika in women compared to men was documented.
   Methods: The age-adjusted incidence was compared between men and women. A negative binomial Poisson generalized linear model was fitted to the Zika incidence data to determine the significance of sexual transmission statistically.
   Results: Even after correcting for the bias due to the systematic testing of pregnant women for Zika, there were found to be 90% more registered cases per 100 000 women than men in the sexually active age group (15-65 years); this was not the case for age groups < 15 years and > 65 years. Assuming that infected men transmit the disease to women in their semen, but that the converse is not true, some extra incidence in women is to be expected. An alternate hypothesis would be that women visit doctors more often than men. To test this, the incidence of dengue fever was compared in men and women in 2015 and in 2013 (before Zika reached Rio de Janeiro): in both years, women were 30% more likely to be reported with dengue.
   Conclusion: Women in the sexually active age group are far more likely to get Zika than men (+ 90% increase); sexual transmission is the most probable cause. Women in the 15-65 years age group are also 30% more likely to be reported with dengue than men, which is probably due to women being more careful with their health. (C) 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Coelho, Flavio Codeco; Camargo, Sabrina; Armstrong, Margaret] Fundacao Getulio Vargas, Praia Botafogo 190, Rio De Janeiro, Brazil.
   [Durovni, Betina; Saraceni, Valeria; Lemos, Cristina; Arduini, Denise] Secretaria Municipal Saude, Rio De Janeiro, Brazil.
   [Codeco, Claudia Torres; de Carvalho, Luiz Max; Bastos, Leonardo; Villela, Daniel A. M.] Fundacao Oswaldo Cruz, Programa Comp Cient, Rio De Janeiro, Brazil.
   [de Carvalho, Luiz Max] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.
   [Armstrong, Margaret] PSL Res Univ, MINES Paristech, CERNA Ctr Ind Econ, I3,CNRS UMR 9217, Paris, France.
RP Coelho, FC (corresponding author), Fundacao Getulio Vargas, Praia Botafogo 190, Rio De Janeiro, Brazil.
EM fccoelho@fgv.br
RI Villela, Daniel/AAG-6445-2019; Coelho, Flavio Codeco/L-1089-2018;
   Camargo, Sabrina/J-3745-2013; amsalu, ribka/G-8780-2019; Carvalho, Luiz
   Max/AAC-8266-2020; Carvalho, Luiz Max/J-6446-2014; Bastos, Leonardo
   Soares/AAD-5335-2019; Camargo, Sabrina/AAH-4857-2020; Coelho,
   Flavio/L-1089-2018
OI Villela, Daniel/0000-0001-8371-2959; Coelho, Flavio
   Codeco/0000-0003-0635-8989; Camargo, Sabrina/0000-0002-0237-3535;
   Carvalho, Luiz Max/0000-0001-5736-5578; Carvalho, Luiz
   Max/0000-0001-5736-5578; Bastos, Leonardo Soares/0000-0002-1406-0122;
   Camargo, Sabrina/0000-0002-0237-3535; Coelho, Flavio/0000-0003-3868-4391
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Kassam A, 2015, GUARDIAN
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 14
TC 71
Z9 73
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2016
VL 51
BP 128
EP 132
DI 10.1016/j.ijid.2016.08.023
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA EC7NK
UT WOS:000388326700031
PM 27664930
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Villamil-Gomez, WE
   Rodriguez-Morales, AJ
   Uribe-Garcia, AM
   Gonzalez-Arismendy, E
   Castellanos, JE
   Calvo, EP
   Alvarez-Mon, M
   Musso, D
AF Villamil-Gomez, Wilmer E.
   Rodriguez-Morales, Alfonso J.
   Maria Uribe-Garcia, Ana
   Gonzalez-Arismendy, Edgardo
   Castellanos, Jaime E.
   Calvo, Eliana P.
   Alvarez-Mon, Melchor
   Musso, Didier
TI Zika, dengue, and chikungunya co-infection in a pregnant woman from
   Colombia
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Chikungunya; Zika; Co-infection; Pregnancy
ID VIRUS
AB The clinical findings of a pregnant woman from Colombia with a triple co-infection caused by dengue, chikungunya, and Zika viruses are described. Weekly obstetric ultrasounds from 14.6 to 29 weeks of gestation were normal. She remains under follow-up and management according to the standard guidelines for the management of Zika virus-infected pregnant women. (C) 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Villamil-Gomez, Wilmer E.; Rodriguez-Morales, Alfonso J.] Hosp Univ Sincelejo, Grp Invest Enfermedades Infecciosas & Control Inf, Sincelejo, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Atlantico, Univ Cartagena, Doctorate Trop Med Program, Bolivar, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
   [Maria Uribe-Garcia, Ana; Gonzalez-Arismendy, Edgardo] Dept Gynecol, Clin Santa Maria, Sincelejo, Sucre, Colombia.
   [Castellanos, Jaime E.; Calvo, Eliana P.] Univ El Bosque, Grp Virol, Bogota, DC, Colombia.
   [Alvarez-Mon, Melchor] Alcala Univ, Univ Hosp Prncipe Asturias, Dept Immune Syst Dis & Oncol, Madrid, Spain.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Papeete, France.
RP Castellanos, JE (corresponding author), Univ El Bosque, Grp Virol, Bogota, DC, Colombia.
EM castellanosjaime@unbosque.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016; Musso, Didier/AAO-8178-2020;
   Castellanos, Jaime/W-2635-2019; amsalu, ribka/G-8780-2019; Musso,
   Didier/P-7809-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Musso,
   Didier/0000-0002-9226-0971; Castellanos, Jaime/0000-0003-1596-8383;
   Musso, Didier/0000-0002-9226-0971; Calvo, Eliana/0000-0002-9135-0748
FU Hospital Universitario de Sincelejo; Universidad El Bosque; Universidad
   Tecnologica de Pereira
FX This work was supported by the Hospital Universitario de Sincelejo,
   Universidad El Bosque, and Universidad Tecnologica de Pereira.
   Universidad El Bosque was responsible for the publication fees.
CR Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Mercado M, 2016, EURO SURVEILL, P21
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan American Health Organization, 2016, ALG DET ZIK VIR
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Roze B, 2016, EURO SURVEILL, P21
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   World Health Organization, 2016, WHOZIKVLAB161
NR 12
TC 52
Z9 55
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2016
VL 51
BP 135
EP 138
DI 10.1016/j.ijid.2016.07.017
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA EC7NK
UT WOS:000388326700033
PM 27497951
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Chen, JC
   Wang, ZG
   Huang, H
   Weitz, SH
   Wang, A
   Qiu, XL
   Baumeister, MA
   Uzgiris, A
AF Chen, Joseph C.
   Wang, Zuguang
   Huang, Hong
   Weitz, Sara H.
   Wang, Aprilgate
   Qiu, Xiaolei
   Baumeister, Mark A.
   Uzgiris, Arejas
TI Infection of human uterine fibroblasts by Zika virus in vitro:
   implications for viral transmission in women
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Uterine fibroblasts; Heterosexual transmission; Viral
   detection; Women's health
ID EMERGENCE; CELLS
C1 [Chen, Joseph C.; Wang, Zuguang; Huang, Hong; Weitz, Sara H.; Wang, Aprilgate; Qiu, Xiaolei; Baumeister, Mark A.; Uzgiris, Arejas] Siemens Healthcare Diagnost Inc, 725 Potter St, Berkeley, CA 94710 USA.
RP Chen, JC; Uzgiris, A (corresponding author), Siemens Healthcare Diagnost Inc, 725 Potter St, Berkeley, CA 94710 USA.
EM joseph.chen@siemens.com; arejas.uzgiris@siemens.com
OI Wang, Zuguang/0000-0003-3259-1282
FU Siemens Healthcare Diagnostics Inc.
FX There are no conflicts of interest. This work was supported in whole by
   Siemens Healthcare Diagnostics Inc.
CR Aplin JD, 2008, ENDOMETRIUM MOL CELL
   Brasil P, 2016, N ENGL J MED
   Chen JC, 2016, FERTIL STERIL, V105, P501, DOI 10.1016/j.fertnstert.2015.10.011
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
NR 9
TC 14
Z9 14
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD OCT
PY 2016
VL 51
BP 139
EP 140
DI 10.1016/j.ijid.2016.07.015
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA EC7NK
UT WOS:000388326700034
PM 27495006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ellington, SR
   Devine, O
   Bertolli, J
   Quinones, AM
   Shapiro-Mendoza, CK
   Perez-Padilla, J
   Rivera-Garcia, B
   Simeone, RM
   Jamieson, DJ
   Valencia-Prado, M
   Gilboa, SM
   Honein, MA
   Johansson, MA
AF Ellington, Sascha R.
   Devine, Owen
   Bertolli, Jeanne
   Quinones, Alma Martinez
   Shapiro-Mendoza, Carrie K.
   Perez-Padilla, Janice
   Rivera-Garcia, Brenda
   Simeone, Regina M.
   Jamieson, Denise J.
   Valencia-Prado, Miguel
   Gilboa, Suzanne M.
   Honein, Margaret A.
   Johansson, Michael A.
TI Estimating the Number of Pregnant Women Infected With Zika Virus and
   Expected Infants With Microcephaly Following the Zika Virus Outbreak in
   Puerto Rico, 2016
SO JAMA PEDIATRICS
LA English
DT Article
ID AEDES-AEGYPTI; CHIKUNGUNYA VIRUS; INTERIM GUIDANCE; UNITED-STATES;
   FOLIC-ACID; TRANSMISSION; COMMUNITIES; PREVENTION; DISPERSAL; DEFECTS
AB IMPORTANCE Zika virus (ZIKV) infection during pregnancy is a cause of congenital microcephaly and severe fetal brain defects, and it has been associated with other adverse pregnancy and birth outcomes.
   OBJECTIVE To estimate the number of pregnant women infected with ZIKV in Puerto Rico and the number of associated congenital microcephaly cases.
   DESIGN, SETTING, AND PARTICIPANTS We conducted a modeling study from April to July 2016. Using parameters derived from published reports, outcomes were modeled probabilistically using Monte Carlo simulation. We used uncertainty distributions to reflect the limited information available for parameter values. Given the high level of uncertainty in model parameters, interquartile ranges (IQRs) are presented as primary results. Outcomes were modeled for pregnant women in Puerto Rico, which currently has more confirmed ZIKV cases than any other US location.
   EXPOSURE Zika virus infection in pregnant women.
   MAIN OUTCOMES AND MEASURES Number of pregnant women infected with ZIKV and number of congenital microcephaly cases.
   RESULTS We estimated an IQR of 5900 to 10 300 pregnant women (median, 7800) might be infected during the initial ZIKV outbreak in Puerto Rico. Of these, an IQR of 100 to 270 infants (median, 180) may be born with microcephaly due to congenital ZIKV infection from mid-2016 to mid-2017. In the absence of a ZIKV outbreak, an IQR of 9 to 16 cases (median, 12) of congenital microcephaly are expected in Puerto Rico per year.
   CONCLUSIONS AND RELEVANCE The estimate of 5900 to 10 300 pregnant women that might be infected with ZIKV provides an estimate for the number of infants that could potentially have ZIKV-associated adverse outcomes. Including baseline cases of microcephaly, we estimated that an IQR of 110 to 290 total cases of congenital microcephaly, mostly attributable to ZIKV infection, could occur from mid-2016 to mid-2017 in the absence of effective interventions. The primary limitation in this analysis is uncertainty in model parameters. Multivariate sensitivity analyses indicated that the cumulative incidence of ZIKV infection and risk of microcephaly given maternal infection in the first trimester were the primary drivers of both magnitude and uncertainty in the estimated number of microcephaly cases. Increased information on these parameters would lead to more precise estimates. Nonetheless, the results underscore the need for urgent actions being undertaken in Puerto Rico to prevent congenital ZIKV infection and prepare for affected infants.
C1 [Ellington, Sascha R.; Devine, Owen; Bertolli, Jeanne; Shapiro-Mendoza, Carrie K.; Perez-Padilla, Janice; Simeone, Regina M.; Jamieson, Denise J.; Gilboa, Suzanne M.; Honein, Margaret A.; Johansson, Michael A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Ellington, Sascha R.] Univ Georgia, Athens, GA 30602 USA.
   [Devine, Owen] Carter Consulting Inc, Atlanta, GA USA.
   [Quinones, Alma Martinez; Rivera-Garcia, Brenda; Valencia-Prado, Miguel] Puerto Rico Dept Hlth, San Juan, PR USA.
RP Ellington, SR (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, MS F74,Chamblee Campus,4770 Buford Hwy, Atlanta, GA 30341 USA.
EM sellington@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Jamieson,
   Denise/0000-0003-2597-1201; Johansson, Michael/0000-0002-5090-7722
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, CDC HLTH ADV REC MAN
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P326, DOI 10.15585/mmwr.mm6512a3
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estado Libre Asociado De Puerto Rico Departamento de Salud, 2016, INF SEM ENF ARB
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Grosse SD, 2016, AM J PREV MED, V50, pS74, DOI 10.1016/j.amepre.2015.10.012
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   LIKOSKY WH, 1973, AM J EPIDEMIOL, V97, P264, DOI 10.1093/oxfordjournals.aje.a121508
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   National Center for Health Statistics, BIRTH DAT FIL
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   US Census Bureau, 2010, NAT STAT PUERT RIC C
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   WATERMAN SH, 1985, AM J TROP MED HYG, V34, P625, DOI 10.4269/ajtmh.1985.34.625
   Yi YN, 2011, EUR J PEDIATR, V170, P1391, DOI 10.1007/s00431-011-1492-8
NR 43
TC 31
Z9 31
U1 0
U2 14
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD OCT
PY 2016
VL 170
IS 10
BP 940
EP 945
DI 10.1001/jamapediatrics.2016.2974
PG 6
WC Pediatrics
SC Pediatrics
GA DZ2AB
UT WOS:000385643000012
PM 27544075
DA 2020-07-08
ER

PT J
AU Chraibi, S
   Najioullah, F
   Bourdin, C
   Pegliasco, J
   Deligny, C
   Resiere, D
   Meniane, JC
AF Chraibi, Samy
   Najioullah, Fatiha
   Bourdin, Carole
   Pegliasco, Jean
   Deligny, Christophe
   Resiere, Dabor
   Meniane, Jean-Come
TI Two cases of thrombocytopenic purpura at onset of Zika virus infection
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika; Thrombocytopenia
AB We report here two cases of thrombocytopenic purpura at onset of Zika virus infection. A 26-year-old woman and a 21-year-old man had thrombocytopenia above 5 x 10(9) platelets/L. Hemorrhagic symptoms were mucosal and subcutaneous bleeding and gross hematuria and they reported episode of conjunctivitis. In both cases blood and bone marrow analysis suggested thrombocytopenic purpura, blood PCR tests for Dengue (DENV), Chikungunya (CHIKV) and Zika virus (ZIKV) were negative. In both cases urinary PCR for ZIKV was positive, Prednisolone yielded early remission. Only three similar cases have been reported so far. In the Caribbean, DENV is also epidemic and responsible for severe thrombocytopenia. Coinfections can occur. Our report underlines the need to include a ZIKV assay in the diagnostic work-up of thrombocytopenic purpura in epidemic areas. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Chraibi, Samy; Pegliasco, Jean; Meniane, Jean-Come] Univ Hosp Martinique, Dept Clin Hematol, Fort De France, Martinique, France.
   [Najioullah, Fatiha] Univ Hosp Martinique, Virol Lab, Fort De France, Martinique, France.
   [Bourdin, Carole] Univ Hosp Martinique, Hematol Lab, Fort De France, Martinique, France.
   [Deligny, Christophe] Univ Hosp Martinique, Internal Med Dept 3C 5D, Fort De France, Martinique, France.
   [Resiere, Dabor] Univ Hosp Martinique, Dept Intens Care, Fort De France, Martinique, France.
   [Chraibi, Samy; Najioullah, Fatiha; Bourdin, Carole; Pegliasco, Jean; Deligny, Christophe; Resiere, Dabor; Meniane, Jean-Come] Univ Hosp Pierre Zobda Quitman, Fort De France, Martinique, France.
RP Meniane, JC (corresponding author), Univ Hosp Pierre Zobda Quitman, Unit Clin Hematol, POB 632, Fort De France 97261, Martinique, France.
EM jean-Come.Meniane@chu-fortdefrance.fr
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau V. M., 2016, LANCET
   Carteaux G, 2016, N ENGL J MED
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   SHARP TM, 2016, CLIN INFECT DIS, pIW476
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 11
TC 15
Z9 15
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD OCT
PY 2016
VL 83
BP 61
EP +
DI 10.1016/j.jcv.2016.08.299
PG 2
WC Virology
SC Virology
GA DZ7DY
UT WOS:000386026000013
PM 27596376
OA Bronze
DA 2020-07-08
ER

PT J
AU Soares, CN
   Brasil, P
   Carrera, RM
   Sequeira, P
   De Filippis, AB
   Borges, VA
   Theophilo, F
   Ellul, MA
   Solomon, T
AF Soares, Cristiane N.
   Brasil, Patricia
   Carrera, Raquel Medialdea
   Sequeira, Patricia
   De Filippis, Ana Bispo
   Borges, Vitor A.
   Theophilo, Fernando
   Ellul, Mark A.
   Solomon, Tom
TI Fatal encephalitis associated with Zika virus infection in an adult
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; Encephalitis; Neurological manifestations
AB Background: Zika virus (ZIKV) was first identified in the Americas in 2015, when an outbreak of an exanthematous illness occurred in Brazil. Subsequentely, there was an increase of microcephaly cases, suggesting an association between ZIKV and this neurological complication. Currently, ZIKV has been recognised as causing a wide range of neurological complications including Guillain Barre syndrome, and myelitis.
   Objectives: In this report, we describe the first fatal case of encephalitis in a 47 years old non pregnant woman, infected during the Brazilian zika epidemic of 2016.
   Study design: The diagnosis of encephalitis was determined by the presence of a disturbed level of consciousness and focal neurological signs during an exanthemous viral infection.
   Results: CSF analysis supported the diagnosis of viral encephalitis, revealing lymphocytic pleocytosis, a high protein concentration, and the presence of IgM zika antibodies. RT-PCR analysis for ZIKV was positive in the urine. A brain computed tomography showed massive brain swelling. Our case differs from previous reports, because her neurological picture developed rapidly and in a very aggressive manner leading to brain death after eleven days of admission.
   Conclusion: In endemic areas, ZIKV should be considered as an aetiological agent in cases of encephalitis, and clinicians should be aware of its potential severity. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Soares, Cristiane N.] Hosp Fed Serv Estado, Neurol Serv, Rua Sacadura Cabral 176, Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, Brazil.
   [Sequeira, Patricia; De Filippis, Ana Bispo] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Borges, Vitor A.; Theophilo, Fernando] Hosp Badim, Rio De Janeiro, Brazil.
   [Ellul, Mark A.; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Carrera, Raquel Medialdea; Ellul, Mark A.; Solomon, Tom] Univ Liverpool, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Ellul, Mark A.; Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.
RP Soares, CN (corresponding author), Hosp Fed Serv Estado, Neurol Serv, Rua Sacadura Cabral 176, Rio De Janeiro, RJ, Brazil.
EM crist_nsoares@yahoo.com.br
OI Solomon, Tom/0000-0001-7266-6547; Ellul, Mark/0000-0002-6115-8245;
   Medialdea-Carrera, Raquel/0000-0002-0371-5138
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [484735/2013-6]; Fundacao de Amparo a Pesquisa no Estado do Rio de
   Janeiro-FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/010.001558/2014]; Medical
   Research CouncilMedical Research Council UK (MRC) [MC_PC_15101];
   National Institute for Health ResearchNational Institute for Health
   Research (NIHR) [2259, NF-SI-0514-10177, RP-PG-0108-10048]
FX The laboratory essay was supported by the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico - CNPq (grant no.
   484735/2013-6) and Fundacao de Amparo a Pesquisa no Estado do Rio de
   Janeiro-FAPERJ (grant no. E-26/010.001558/2014). These funding sources
   had no other role. The corresponding author had full access to the data
   and made the final decision to publish the manuscript.
CR Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
NR 12
TC 69
Z9 71
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD OCT
PY 2016
VL 83
BP 63
EP 65
DI 10.1016/j.jcv.2016.08.297
PG 3
WC Virology
SC Virology
GA DZ7DY
UT WOS:000386026000014
PM 27598870
OA Green Published
DA 2020-07-08
ER

PT J
AU Pabbaraju, K
   Wong, S
   Gill, K
   Fonseca, K
   Tipples, GA
   Tellier, R
AF Pabbaraju, Kanti
   Wong, Sallene
   Gill, Kara
   Fonseca, Kevin
   Tipples, Graham A.
   Tellier, Raymond
TI Simultaneous detection of Zika, Chikungunya and Dengue viruses by a
   multiplex real-time RT-PCR assay
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Arbovirus; Zika; Chikungunya; Dengue; Multiplex real-time RT-PCR;
   Molecular diagnosis
ID URINE; TRAVELER; AMERICA; SALIVA; SERUM; RNA
AB Background: In the recent past, arboviruses such as Chikungunya (CHIKV) and Zika (ZIKV) have increased their area of endemicity and presented as an emerging global public health threat.
   Objectives: To design an assay for the simultaneous detection of ZIKV, CHIKV and Dengue (DENV) 1-4 from patients with symptoms of arboviral infection. This would be advantageous because of the similar clinical presentation typically encountered with these viruses and their co-circulation in endemic areas.
   Study design: In this study we have developed and validated a triplex real time reverse transcription PCR assay using hydrolysis probes targeting the non-structural 5 (NS5) region of ZIKV, non-structural protein 4 (nsP4) from CHIKV and 3' untranslated region (3'UTR) of DENV 1-4.
   Results and conclusions: The 95% LOD by the triplex assay was 15 copies/reaction for DENV-1 and less than 10 copies/reaction for all other viruses. The triplex assay was 100% specific and did not amplify any of the other viruses tested. The assay was reproducible and adaptable to testing different specimen types including serum, plasma, urine, placental tissue, brain tissue and amniotic fluid. This assay can be easily implemented for diagnostic testing of patient samples, even in a high throughput laboratory. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Pabbaraju, Kanti; Wong, Sallene; Gill, Kara; Fonseca, Kevin; Tipples, Graham A.; Tellier, Raymond] Prov Lab Publ Hlth, 3030 Hosp Dr, Calgary, AB T2N 4W4, Canada.
   [Fonseca, Kevin; Tellier, Raymond] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada.
   [Tipples, Graham A.] Univ Alberta, Dept Pathol & Lab Med, Edmonton, AB, Canada.
RP Pabbaraju, K (corresponding author), Prov Lab Publ Hlth, 3030 Hosp Dr, Calgary, AB T2N 4W4, Canada.
EM kanti.pabbaraju@ahs.ca; sallene.wong@ahs.ca; kara.gill2@ahs.ca;
   kevin.fonseca@ahs.ca; graham.tipples@ahs.ca; raymond.tellier@ahs.ca
FU Provincial Laboratory for Public Health of Alberta
FX The authors would like to thank Michael Drebot and David Safronetz
   (National Microbiology Laboratory, Winnipeg, Canada) for providing
   control viruses. We would also like to thank the technologists from the
   Molecular Diagnostics and Virology departments for their excellent
   technical help. This work was supported by the Provincial Laboratory for
   Public Health of Alberta.
CR Ayers M, 2006, J VIROL METHODS, V135, P235, DOI 10.1016/j.jviromet.2006.03.009
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   *CONTR ECFDPA, 2015, ZIK VIR INF OUTBR BR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman A, 2010, INT J ANTIMICROB AG, V36, pS40, DOI 10.1016/j.ijantimicag.2010.06.018
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   JOHANSSON MA, 2016, N ENGL J MED, V25
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EURO SURVEILL, V21
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   MIRANDA HA, 2016, OPHTHALMOLOGY
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nelson J, 2014, J CLIN MICROBIOL, V52, P3459, DOI 10.1128/JCM.01288-14
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Poloni TR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-22
   Prince HE, 2015, CLIN VACCINE IMMUNOL, V22, P291, DOI 10.1128/CVI.00720-14
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Saha K, 2013, J VIROL METHODS, V193, P521, DOI 10.1016/j.jviromet.2013.07.029
   VILLAMILGOMEZ WE, 2016, J INFECT PUBLIC HLTH, V3
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Whitehorn J, 2011, VACCINE, V29, P7221, DOI 10.1016/j.vaccine.2011.07.022
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   2016, TRIOPL REAL TIM RT P
NR 39
TC 49
Z9 51
U1 4
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD OCT
PY 2016
VL 83
BP 66
EP 71
DI 10.1016/j.jcv.2016.09.001
PG 6
WC Virology
SC Virology
GA DZ7DY
UT WOS:000386026000015
PM 27614319
DA 2020-07-08
ER

PT J
AU da Silva, SR
   Gao, SJ
AF da Silva, Suzane Ramos
   Gao, Shou-Jiang
TI Zika Virus Update II: Recent Development of Animal Models-Proofs of
   Association With Human Pathogenesis
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Zika virus; animal model; pathology
AB Three recent studies in pregnant mice and one ongoing study in rhesus macaques evaluating the effect of ZIKV infection have provided important information about maternal-fetus transmission and ZIKV-related pathogenesis, confirming a causal role of ZIKV in neurological problems observed in humans. Here, we present an update of these works published in the past few weeks. (C) 2016 Wiley Periodicals, Inc.
C1 [da Silva, Suzane Ramos; Gao, Shou-Jiang] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
RP da Silva, SR; Gao, SJ (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA.
EM ramosdas@usc.edu; shoujiag@usc.edu
RI Gao, Shou-Jiang/B-8641-2012
OI Ramos da Silva, Suzane/0000-0002-0768-8421; Gao,
   Shou-Jiang/0000-0001-6194-1742
FU NCI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01
   CA096512]
CR Cugola F. R., 2016, NATURE
   da Silva SR, 2016, J MED VIROL
   Dudley DM, 2016, BIORXIV
   Li C, 2016, CELL STEM CELL
   Miner J, 2016, CELL
   Rossi SL, 2016, AM J TROP MED HYG
NR 6
TC 7
Z9 7
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD OCT
PY 2016
VL 88
IS 10
BP 1657
EP 1658
DI 10.1002/jmv.24582
PG 2
WC Virology
SC Virology
GA DZ3BZ
UT WOS:000385720200003
PM 27208545
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Adiga, R
AF Adiga, Rama
TI Phylogenetic Analysis of the NS5 Gene of Zika Virus
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE Zika; ZIKV; phylogenetic; NS5; mutation; Latin American
ID OUTBREAK
AB ZIKV infection has become a global threat spreading across 31 countries in Central America, South America, and the Caribbean. However, little information is available about the molecular epidemiology of ZIKV. Shared mutation of a threonine residue to alanine at the same position in the C terminal of NS5 sequences was observed in sequences from Colombia, Mexico, Panama, and Martinique. The sequences in the phylogenetic tree fell within the same cluster. Based on shared mutation the presence of a Latin American genotype was proposed. Comparison of African and Asian lineages yielded R29N, N273S, H383Q, and P391S mutation. The study highlights that mutation of amino acids at NS5 may contribute to neutropism of ZIKV. (C) 2016 Wiley Periodicals, Inc.
C1 [Adiga, Rama] Nitte Univ, Div Bioinformat & Computat Genom, Nitte Univ Ctr Sci Educ & Res NUCSER, Paneer Campus, Mangalore 5750018, India.
RP Adiga, R (corresponding author), Nitte Univ, Div Bioinformat & Computat Genom, Nitte Univ Ctr Sci Educ & Res NUCSER, Paneer Campus, Mangalore 5750018, India.
EM rama_adiga@nitte.edu.in
CR Diaz-Quinonez JA, 2016, EMERG INFECT DIS, V22, P937, DOI 10.3201/eid2205.160190
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang YJ, 2016, PROTEIN CELL, V7, P461, DOI 10.1007/s13238-016-0274-5
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 20
TC 11
Z9 11
U1 0
U2 69
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD OCT
PY 2016
VL 88
IS 10
BP 1821
EP 1826
DI 10.1002/jmv.24615
PG 6
WC Virology
SC Virology
GA DZ3BZ
UT WOS:000385720200024
PM 27335310
DA 2020-07-08
ER

PT J
AU Gostin, LO
   Hodge, JG
AF Gostin, Lawrence O.
   Hodge, James G., Jr.
TI Zika virus and global health security
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
C1 [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.
   [Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Phoenix, AZ USA.
RP Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.
EM gostin@law.georgetown.edu
OI Gostin, Lawrence/0000-0001-5286-4044
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   [Anonymous], 2016, BBC NEWS
   Belson Ken, 2016, NY TIMES
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Hodge JG, 2016, US NEWS WORLD REP
   Lewis JT, 2016, WALL STREET J
   Pan American Health Organization World Health Organization, REG ZIK EP UPD AM
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Pestano AV, 2016, POLL 88 PERCENT AM N
   Tavernise S, 2016, NY TIMES
   Whitefield M., 2016, MIAMI HERALD
   WHO, WHO DIR GEN ADDR HIG
   WHO, CONT FUND EM INC ALL
   WHO, ZIK RESP FUND
   World Bank, WORLD BANK PROV 150
   World Bank Group, SHORT TERM EC COSTS
   Zagorskey JL, 2016, SCI AM
NR 17
TC 12
Z9 12
U1 1
U2 134
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1099
EP 1100
DI 10.1016/S1473-3099(16)30332-2
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000014
PM 27676336
OA Bronze
DA 2020-07-08
ER

PT J
AU Mansuy, JM
   Suberbielle, E
   Chapuy-Regaud, S
   Mengelle, C
   Bujan, L
   Marchou, B
   Delobel, P
   Gonzalez-Dunia, D
   Malnou, CE
   Izopet, J
   Martin-Blondel, G
AF Mansuy, Jean Michel
   Suberbielle, Elsa
   Chapuy-Regaud, Sabine
   Mengelle, Catherine
   Bujan, Louis
   Marchou, Bruno
   Delobel, Pierre
   Gonzalez-Dunia, Daniel
   Malnou, Cecile E.
   Izopet, Jacques
   Martin-Blondel, Guillaume
TI Zika virus in semen and spermatozoa
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Mansuy, Jean Michel; Chapuy-Regaud, Sabine; Mengelle, Catherine; Izopet, Jacques] CHU Toulouse, Lab Virol, Inst Federatif Biol, F-31059 Toulouse, France.
   [Suberbielle, Elsa; Chapuy-Regaud, Sabine; Delobel, Pierre; Gonzalez-Dunia, Daniel; Malnou, Cecile E.; Izopet, Jacques; Martin-Blondel, Guillaume] Univ Toulouse, CNRS, INSERM, Ctr Physiopathol Toulouse Purpan,UPS, Toulouse, France.
   [Marchou, Bruno; Delobel, Pierre; Martin-Blondel, Guillaume] CHU Toulouse, Serv Malad Infect & Trop, Toulouse, France.
   [Bujan, Louis] Univ Toulouse, Human Fertil Res Grp, CECOS, Ctr Hosp Univ Paule de Viguier,UPS, Toulouse, France.
RP Mansuy, JM (corresponding author), CHU Toulouse, Lab Virol, Inst Federatif Biol, F-31059 Toulouse, France.
EM mansuy.jm@chu-toulouse.fr
RI Suberbielle, Elsa/K-5416-2014; Delobel, Pierre/Q-6028-2019; MALNOU,
   Cecile/O-9970-2019; MALNOU, Cecile E/K-1569-2014; Dunia,
   Daniel/K-1090-2014; Martin-Blondel, Guillaume/K-6762-2014
OI Suberbielle, Elsa/0000-0002-4554-471X; Delobel,
   Pierre/0000-0002-2874-3581; MALNOU, Cecile/0000-0002-1223-0247; MALNOU,
   Cecile E/0000-0002-1223-0247; Dunia, Daniel/0000-0002-2837-7120;
   Martin-Blondel, Guillaume/0000-0002-8363-7028; Bujan,
   Louis/0000-0003-1540-0536; MARCHOU, Bruno/0000-0002-0673-2945; IZOPET,
   JACQUES/0000-0002-8462-3234
CR Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Sow MS, 2016, J INFECT DIS, V214, P1475, DOI 10.1093/infdis/jiw078
NR 5
TC 92
Z9 93
U1 0
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1106
EP 1107
DI 10.1016/S1473-3099(16)30336-X
PG 2
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000019
PM 27676340
OA Bronze
DA 2020-07-08
ER

PT J
AU Purpura, LJ
   Choi, MJ
   Rollin, PE
AF Purpura, Lawrence J.
   Choi, Mary J.
   Rollin, Pierre E.
TI Zika virus in semen: lessons from Ebola
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Purpura, Lawrence J.; Choi, Mary J.; Rollin, Pierre E.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.
RP Purpura, LJ (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.
EM yxp0@cdc.gov
OI Rollin, Pierre/0000-0002-4608-2641; Purpura,
   Lawrence/0000-0002-2900-6022
CR Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Rodriguez LL, 1999, J INFECT DIS, V179, pS170, DOI 10.1086/514291
   Soka M, 2016, LANCET GLOBAL HLTH
   WHO, 2016, INT ADV SEX TRANSM E
NR 7
TC 6
Z9 6
U1 0
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1107
EP 1108
DI 10.1016/S1473-3099(16)30330-9
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000021
PM 27676341
OA Bronze
DA 2020-07-08
ER

PT J
AU Musso, D
   Baud, D
   Freedman, DO
AF Musso, Didier
   Baud, David
   Freedman, David O.
TI Should testing of donors be restricted to active Zika virus areas?
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
C1 [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Tahiti, France.
   [Baud, David] Univ Lausanne Hosp, Maternofetal & Obstet Res Unit, Dept Femme Mere Enfant, Matern, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne, Inst Microbiol, Fac Biol & Med, Lausanne, Switzerland.
   [Baud, David] Univ Lausanne Hosp, Lausanne, Switzerland.
   [Freedman, David O.] Univ Alabama Birmingham, Div Infect Dis, William C Gorgas Ctr Geog Med, Birmingham, AL USA.
RP Musso, D (corresponding author), Inst Louis Malarde, Unit Emerging Infect Dis, F-98713 Tahiti, France.
EM dmusso@ilm.pf
RI Musso, Didier/P-7809-2016; Musso, Didier/AAO-8178-2020
OI Musso, Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971;
   Baud, David/0000-0001-9914-6496; Freedman, David O./0000-0002-5642-5257
CR Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rafiei N, 2016, MED J AUST, V204, P186
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 5
TC 5
Z9 5
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD OCT
PY 2016
VL 16
IS 10
BP 1108
EP +
DI 10.1016/S1473-3099(16)30337-1
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA DW2JP
UT WOS:000383469000022
PM 27676343
OA Bronze
DA 2020-07-08
ER

PT J
AU Ferreira-de-Brito, A
   Ribeiro, IP
   de Miranda, RM
   Fernandes, RS
   Campos, SS
   da Silva, KAB
   de Castro, MG
   Bonaldo, MC
   Brasil, P
   Lourenco-de-Oliveira, R
AF Ferreira-de-Brito, Anielly
   Ribeiro, Ieda P.
   de Miranda, Rafaella Moraes
   Fernandes, Rosilainy Surubi
   Campos, Stephanie Silva
   Barbosa da Silva, Keli Antunes
   de Castro, Marcia Goncalves
   Bonaldo, Myrna C.
   Brasil, Patricia
   Lourenco-de-Oliveira, Ricardo
TI First detection of natural infection of Aedes aegypti with Zika virus in
   Brazil and throughout South America
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article
DE Zika; Aedes aegypti; natural infection; Culex quinquefasciatus; Aedes
   albopictus
ID MOSQUITOS; TRANSMISSION; ISOLATIONS; STATES; FEVER
AB Zika virus (ZIKV) has caused a major epidemic in Brazil and several other American countries. ZIKV is an arbovirus whose natural vectors during epidemics have been poorly determined. In this study, 1,683 mosquitoes collected in the vicinity of ZIKV suspected cases in Rio de Janeiro, Brazil, from June 2015 to May 2016 were screened for natural infection by using molecular methods. Three pools of Aedes aegypti were found with the ZIKV genome, one of which had only one male. This finding supports the occurrence of vertical and/or venereal transmission of ZIKV in Ae. aegypti in nature. None of the examined Ae. albopictus and Culex quinquefasciatus was positive. This is the first report of natural infection by ZIKV in mosquitoes in Brazil and other South American countries. So far, Ae. aegypti is the only confirmed vector of ZIKV during the ongoing Pan-American epidemics.
C1 [Ferreira-de-Brito, Anielly; de Miranda, Rafaella Moraes; Fernandes, Rosilainy Surubi; Campos, Stephanie Silva; Barbosa da Silva, Keli Antunes; de Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
   [Ribeiro, Ieda P.; Bonaldo, Myrna C.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Brasil, Patricia] Inst Nacl Infectol, Lab Pesquisa Clin Doencas Febris Agudas, Rio De Janeiro, RJ, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, Rio De Janeiro, RJ, Brazil.
EM lourenco@ioc.fiocruz.br
OI Castro, Maria Graciela/0000-0003-2237-2756; Ribeiro, Ivonizete
   Pires/0000-0003-0737-5430
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U01 AI115595]
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Juliano SA, 2014, MEM I OSWALDO CRUZ, V109, P1070, DOI 10.1590/0074-02760140455
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lourenco-de-Oliveira R, 2015, ORG DENGUE TEORIAS P, P127
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO/WHO - Pan American Health Organization/World Health Organization, 2016, ZIK VIR DET AED ALB
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 27
TC 88
Z9 93
U1 0
U2 19
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD OCT
PY 2016
VL 111
IS 10
BP 655
EP 658
DI 10.1590/0074-02760160332
PG 4
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DZ0FY
UT WOS:000385514100009
PM 27706382
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xu, M
   Lee, EM
   Wen, ZX
   Cheng, YC
   Huang, WK
   Qian, XY
   Julia, TCW
   Kouznetsova, J
   Ogden, SC
   Hammack, C
   Jacob, F
   Nguyen, HN
   Itkin, M
   Hanna, C
   Shinn, P
   Allen, C
   Michael, SG
   Simeonov, A
   Huang, WW
   Christian, KM
   Goate, A
   Brennand, KJ
   Huang, RL
   Xia, MH
   Ming, GL
   Zheng, W
   Song, HJ
   Tang, HL
AF Xu, Miao
   Lee, Emily M.
   Wen, Zhexing
   Cheng, Yichen
   Huang, Wei-Kai
   Qian, Xuyu
   Julia, T. C. W.
   Kouznetsova, Jennifer
   Ogden, Sarah C.
   Hammack, Christy
   Jacob, Fadi
   Ha Nam Nguyen
   Itkin, Misha
   Hanna, Catherine
   Shinn, Paul
   Allen, Chase
   Michael, Samuel G.
   Simeonov, Anton
   Huang, Wenwei
   Christian, Kimberly M.
   Goate, Alison
   Brennand, Kristen J.
   Huang, Ruili
   Xia, Menghang
   Ming, Guo-li
   Zheng, Wei
   Song, Hongjun
   Tang, Hengli
TI Identification of small-molecule inhibitors of Zika virus infection and
   induced neural cell death via a drug repurposing screen
SO NATURE MEDICINE
LA English
DT Article
ID SEXUAL TRANSMISSION; CDK9 INHIBITORS; REPLICATION; ORGANOIDS; THERAPY;
   BIOLOGY; MODEL
AB In response to the current global health emergency posed by the Zika virus (ZIKV) outbreak and its link to microcephaly and other neurological conditions, we performed a drug repurposing screen of similar to 6,000 compounds that included approved drugs, clinical trial drug candidates and pharmacologically active compounds; we identified compounds that either inhibit ZIKV infection or suppress infection-induced caspase-3 activity in different neural cells. A pan-caspase inhibitor, emricasan, inhibited ZIKV-induced increases in caspase-3 activity and protected human cortical neural progenitors in both monolayer and three-dimensional organoid cultures. Ten structurally unrelated inhibitors of cyclin-dependent kinases inhibited ZIKV replication. Niclosamide, a category B anthelmintic drug approved by the US Food and Drug Administration, also inhibited ZIKV replication. Finally, combination treatments using one compound from each category (neuroprotective and antiviral) further increased protection of human neural progenitors and astrocytes from ZIKV-induced cell death. Our results demonstrate the efficacy of this screening strategy and identify lead compounds for anti-ZIKV drug development.
C1 [Xu, Miao; Kouznetsova, Jennifer; Itkin, Misha; Shinn, Paul; Michael, Samuel G.; Simeonov, Anton; Huang, Wenwei; Huang, Ruili; Xia, Menghang; Zheng, Wei] NIH, Natl Ctr Adv Translat, Bldg 10, Bethesda, MD 20892 USA.
   [Xu, Miao] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China.
   [Lee, Emily M.; Cheng, Yichen; Ogden, Sarah C.; Hammack, Christy; Hanna, Catherine; Allen, Chase; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA.
   [Wen, Zhexing] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.
   [Wen, Zhexing; Huang, Wei-Kai; Qian, Xuyu; Jacob, Fadi; Ha Nam Nguyen; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.
   [Huang, Wei-Kai] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Qian, Xuyu; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21218 USA.
   [Julia, T. C. W.; Goate, Alison] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.
   [Jacob, Fadi; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.
   [Ha Nam Nguyen; Christian, Kimberly M.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Brennand, Kristen J.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.
   [Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.
   [Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21218 USA.
RP Zheng, W (corresponding author), NIH, Natl Ctr Adv Translat, Bldg 10, Bethesda, MD 20892 USA.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21218 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Biomed Engn Grad Program, Baltimore, MD 21218 USA.; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA.; Ming, GL; Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Kavli Neurosci Discovery Inst, Baltimore, MD 21218 USA.
EM gming1@jhmi.edu; wzheng@mail.nih.gov; shongju1@jhmi.edu;
   tang@bio.fsu.edu
RI xu, miao/U-1176-2017; Qian, Xuyu/C-1240-2017; Brennand,
   Kristen/J-8704-2012; Zheng, Wei/J-8889-2014; Wen, Zhexing/L-1228-2018
OI Qian, Xuyu/0000-0001-5944-3816; Brennand, Kristen/0000-0003-0993-5956;
   Zheng, Wei/0000-0003-1034-0757; Wen, Zhexing/0000-0002-1518-3845; Jacob,
   Fadi/0000-0002-0094-8454; Ming, Guo-li/0000-0002-2517-6075; Goate,
   Alison/0000-0002-0576-2472
FU Intramural Research Program of the National Center for Advancing
   Translational Sciences, National Institutes of Health (NIH); Florida
   State University; Emory University; Brain and Behavior Research
   Foundation; New York Stem Cell Foundation; Maryland Stem Cell Research
   Fund; Simons Foundation Autism Research Initiative [308988]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [NS048271, NS095348, MH105128, NS047344, NS097206,
   MH106434, MH101454, MH106056, AG005138, AG046170, AI119530]
FX We thank R. Tesh and P.-Y. Shi (University of Texas Medical Branch) and
   the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA)
   for the FSS-13025 isolate of ZIKV, and D. Meckes (Florida State
   University) for the glioblastoma SNB-19 cell line. We also thank L. Liu
   and Y. Cai for technical support. This work was supported by the
   Intramural Research Program of the National Center for Advancing
   Translational Sciences, National Institutes of Health (NIH) (W.Z.), ZIKV
   seed funding from Florida State University (H.T.), a start-up fund from
   Emory University (Z.W.), the Brain and Behavior Research Foundation
   (K.J.B.), the New York Stem Cell Foundation (K.J.B.), the Maryland Stem
   Cell Research Fund (G.M. and H.S.), the Simons Foundation Autism
   Research Initiative (award no. 308988; H.S.), and partially by NIH
   grants NS048271 (G.M.), NS095348 (G.M.), MH105128 (G.M.), NS047344
   (H.S.), NS097206 (H.S.), MH106434 (H.S.), MH101454 (K.J.B.), MH106056
   (K.J.B.), AG005138 (K.J.B.), AG046170 (K.J.B.) and AI119530 (H.T.).
CR Abbink P, 2016, SCIENCE
   Al-Hadiya Badraddin M H, 2005, Profiles Drug Subst Excip Relat Methodol, V32, P67, DOI 10.1016/S0099-5428(05)32002-8
   ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Badia R, 2016, J ANTIMICROB CHEMOTH, V71, P387, DOI 10.1093/jac/dkv363
   Barreyro FJ, 2015, LIVER INT, V35, P953, DOI 10.1111/liv.12570
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Brasil P, 2016, N ENGL J MED
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen CZ, 2011, ANTIMICROB AGENTS CH, V55, P667, DOI 10.1128/AAC.00618-10
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Debnath A, 2012, NAT MED, V18, P956, DOI 10.1038/nm.2758
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Fontes C. A., 2016, NEURORADIOLOGY
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Haddad JJ, 2013, RECENT PATENTS INFLA, V7, P229, DOI 10.2174/1872213X113079990017
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hoglen NC, 2004, J PHARMACOL EXP THER, V309, P634, DOI 10.1124/jpet.103.062034
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Khanim FL, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.38
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Larocca RA, 2016, NATURE
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nemeth G, 2011, CURR MED CHEM, V18, P342, DOI 10.2174/092986711794839188
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Okamoto M, 2015, ANTIVIR RES, V123, P1, DOI 10.1016/j.antiviral.2015.08.012
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pfizer Inc, 2015, IBR PALB CAPS PRESCR
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Schang Luis M., 2006, Antiviral Chemistry & Chemotherapy, V17, P293
   Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x
   Sun W, 2016, DRUG DISCOV TODAY, V21, P1189, DOI 10.1016/j.drudis.2016.05.015
   Sun W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03743
   Sun W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070506
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Van Duyne R, 2013, J MOL BIOL, V425, P812, DOI 10.1016/j.jmb.2012.12.005
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yamamoto M, 2014, J CLIN INVEST, V124, P3479, DOI 10.1172/JCI73805
   Yang YM, 2013, CELL STEM CELL, V12, P713, DOI 10.1016/j.stem.2013.04.003
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhang JJ, 2010, J VIROL, V84, P12619, DOI 10.1128/JVI.01696-10
NR 59
TC 287
Z9 292
U1 17
U2 195
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD OCT
PY 2016
VL 22
IS 10
BP 1101
EP 1107
DI 10.1038/nm.4184
PG 7
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA DY1RQ
UT WOS:000384872500013
PM 27571349
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Macciocchi, D
   Lanini, S
   Vairo, F
   Zumla, A
   Figueiredo, LTM
   Lauria, FN
   Strada, G
   Brouqui, P
   Puro, V
   Krishna, S
   Kremsner, P
   Scognamiglio, P
   Kohler, C
   Nicastri, E
   Di Caro, A
   Cieri, RM
   Ioannidis, JPA
   Kobinger, G
   Burattini, MN
   Ippolito, G
AF Macciocchi, Daniele
   Lanini, Simone
   Vairo, Francesco
   Zumla, Alimuddin
   Moraes Figueiredo, Luiz Tadeu
   Lauria, Francesco Nicola
   Strada, Gino
   Brouqui, Philippe
   Puro, Vincenzo
   Krishna, Sanjeev
   Kremsner, Peter
   Scognamiglio, Paola
   Kohler, Carsten
   Nicastri, Emanuele
   Di Caro, Antonino
   Cieri, Rodolfo Maria
   Ioannidis, John P. A.
   Kobinger, Gary
   Burattini, Marcelo Nascimento
   Ippolito, Giuseppe
TI Short-term economic impact of the Zika virus outbreak
SO NEW MICROBIOLOGICA
LA English
DT Article
DE Zika Virus Infection; Disease Outbreaks; Latin America; Economics;
   Behavioral
ID HEALTH; AMERICA
AB Zika virus (ZIKV) is mainly transmitted by mosquitoes bites. However, transmission by sexual contacts has been reported in 11 non endemic countries. The rapid spread of ZIKV in Latin American and Caribbean Countries (LCR), person-to-person transmission and perceived risk on people's well being can affect the emerging economies of LCR which historically dependent on truism. Here we present an analysis on economic outputs for assessing the current impact of ZIKV on markets. Our analysis show an unexpected resilience of LCR markets to international alerts. This positive response represents an opportunity to scale-up interventions for preventing the further spreading of the ZIKV epidemic.
C1 [Macciocchi, Daniele] Univ Utah, David Eccles Sch Business, Salt Lake City, UT USA.
   [Lanini, Simone; Vairo, Francesco; Lauria, Francesco Nicola; Puro, Vincenzo; Scognamiglio, Paola; Nicastri, Emanuele; Di Caro, Antonino; Ippolito, Giuseppe] Lazzaro Spallanzani Natl Inst Infect Dis IRCCS, Rome, Italy.
   [Zumla, Alimuddin; Krishna, Sanjeev] UCL, Div Infect & Immun, London, England.
   [Zumla, Alimuddin] UCL Hosp Natl Hlth Serv Fdn Trust, UK Natl Inst Hlth Res Biomed Res Ctr, London, England.
   [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, FMRP, CPV, Ribeirao Preto, SP, Brazil.
   [Strada, Gino] Emergency NGO, Milan, Italy.
   [Brouqui, Philippe] Inst Hosp Univ Mediterranee, Serv Malad Infect & Trop, Marseille, France.
   [Kremsner, Peter; Kohler, Carsten] Univ Klinikum Tubingen, Inst Tropenmed, Tubingen, Germany.
   [Kremsner, Peter; Kohler, Carsten] Ctr Rech Med Lambarene, Lambarene, Gabon.
   [Lanini, Simone; Vairo, Francesco; Zumla, Alimuddin; Di Caro, Antonino; Cieri, Rodolfo Maria; Kobinger, Gary; Ippolito, Giuseppe] Int Publ Hlth Crisis Grp, Rome, Italy.
   [Ioannidis, John P. A.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA.
   [Kobinger, Gary] Quebec Laval Univ, Infect Dis Res Ctr, Fac Med, Dept Microbiol & Immunol, Quebec City, PQ, Canada.
   [Burattini, Marcelo Nascimento] Univ Sao Paulo, Sch Med, Sao Paulo, SP, Brazil.
   [Burattini, Marcelo Nascimento] LIM01 HCFMUSP, Sao Paulo, SP, Brazil.
RP Lanini, S (corresponding author), Lazzaro Spallanzani Natl Inst Infect Dis IRCCS, Rome, Italy.; Lanini, S (corresponding author), Int Publ Hlth Crisis Grp, Rome, Italy.
EM simone.lanini@inmi.it
RI Brouqui, Philippe/P-5771-2016; nicastri, emanuele/K-7780-2016; Di Caro,
   Antonino/K-6854-2016; Ippolito, Giuseppe/J-7207-2017; Burattini, Marcelo
   N/J-9272-2014; Lanini, Simone/C-7523-2012
OI nicastri, emanuele/0000-0002-5606-8712; Di Caro,
   Antonino/0000-0001-6027-3009; Burattini, Marcelo N/0000-0002-5407-6890;
   Ippolito, Giuseppe/0000-0002-1076-2979; Lanini,
   Simone/0000-0002-6743-4001; Zumla, Professor Sir
   Alimuddin/0000-0002-5111-5735
FU Italian Ministry of Health (Ricerca Corrente)Ministry of Health, Italy
FX the Italian Ministry of Health (Ricerca Corrente).
CR Attaran A, 2016, COMMUNICATION
   Gostin L. O, 2016, JAMA-J AM MED ASSOC, V15, P2395
   Hoyt K, 2016, NAT BIOTECHNOL, V34, P384, DOI 10.1038/nbt.3532
   Ippolito G, 2015, NEW MICROBIOL, V38, P1
   Kieny MP, 2016, LANCET, V387, P1509, DOI 10.1016/S0140-6736(16)00686-3
   Liuzzi G, 2016, EUR J INTERN MED, P30091
   Liuzzi G, 2016, NEW MICROBIOL, V39, P83
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, LANCET INFECT DIS, V16, P771, DOI 10.1016/S1473-3099(16)30074-3
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Turrini F, 2016, NEW MICROBIOL, V39, P86
   WHO, 2016, WHO ZIK SIT REP 11 A
   WHO, 2016, WHO ZIK SIT REP 10 M
   World Bank, 2016, SHORT TERM EC COSTS
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, 1 M INT HLTH REG 200
   Zumla A, 2016, INT J INFECT DIS, V47, P1, DOI 10.1016/j.ijid.2016.06.010
   Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012
NR 20
TC 9
Z9 9
U1 0
U2 7
PU EDIZIONI INT SRL
PI PAVIA
PA DIV EDIMES, EDIZIONI MEDICO SCIENTIFICHE PAVIA, VIA RIVIERA, PAVIA,
   39-27100, ITALY
SN 1121-7138
J9 NEW MICROBIOL
JI New Microbiol.
PD OCT
PY 2016
VL 39
IS 4
BP 287
EP 289
PG 3
WC Microbiology
SC Microbiology
GA EI4NB
UT WOS:000392469400007
PM 28004846
DA 2020-07-08
ER

PT J
AU Smith, LB
   Kasai, S
   Scott, JG
AF Smith, Leticia B.
   Kasai, Shinji
   Scott, Jeffrey G.
TI Pyrethroid resistance in Aedes aegypti and Aedes albopictus: Important
   mosquito vectors of human diseases
SO PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Review
DE Aedes; Mosquito; Insecticide resistance; Voltage sensitive sodium
   channel; Cytochrome P450 monooxygenases
ID SODIUM-CHANNEL GENE; MEDIATED PERMETHRIN RESISTANCE; HUMAN-BODY LOUSE;
   INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE; CROSS-RESISTANCE; POINT
   MUTATIONS; DETOXIFICATION GENES; KDR MUTATIONS; HOUSE-FLY
AB Aedes aegypti and A. albopictus mosquitoes are vectors of important human disease viruses, including dengue, yellow fever, chikungunya and Zika. Pyrethroid insecticides are widely used to control adult Aedes mosquitoes, especially during disease outbreaks. Herein, we review the status of pyrethroid resistance in A. aegypti and A. albopictus, mechanisms of resistance, fitness costs associated with resistance alleles and provide suggestions for future research. The widespread use of pyrethroids has given rise to many populations with varying levels of resistance worldwide, albeit with substantial geographical variation. In adult A. aegypti and A. albopictus, resistance levels are generally lower in Asia, Africa and the USA, and higher in Latin America, although there are exceptions. Susceptible populations still exist in several areas of the world, particularly in Asia and South America. Resistance to pyrethroids in larvae is also geographically widespread. The two major mechanisms of pyrethroid resistance are increased detoxification due to P450-monooxygenases, and mutations in the voltage sensitive sodium channel (Vssc) gene. Several P450s have been putatively associated with insecticide resistance, but the specific P450s involved are not fully elucidated. Pyrethroid resistance can be due to single mutations or combinations of mutations in Vssc. The presence of multiple Vssc mutations can lead to extremely high levels of resistance. Suggestions for future research needs are presented. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Smith, Leticia B.; Scott, Jeffrey G.] Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.
   [Kasai, Shinji] Natl Inst Infect Dis, Dept Med Entomol, Shinjuku Ku, 1-23-1 Toyama, Tokyo, Japan.
RP Scott, JG (corresponding author), Cornell Univ, Dept Entomol, 6134 Comstock Hall, Ithaca, NY 14853 USA.
CR Agosin M., 1985, COMPREHENSIVE INSECT, P647
   Aguirre-Obando OA, 2015, ZOOLOGIA-CURITIBA, V32, P14, DOI 10.1590/S1984-46702015000100003
   AHMAD S, 1986, J CHEM ECOL, V12, P533, DOI 10.1007/BF01020571
   Akiner MM, 2009, J PESTIC SCI, V34, P259, DOI 10.1584/jpestics.G09-28
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Alvarez LC, 2013, J MED ENTOMOL, V50, P1031, DOI 10.1603/ME12254
   Amichot M, 2004, EUR J BIOCHEM, V271, P1250, DOI 10.1111/j.1432-1033.2004.04025.x
   Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Basio R. G., 1974, PHILIPP J BIOL, V3, P155
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410
   BROWN A. W. A., 1971, Insecticide resistance in arthropods.
   Campos J, 2001, REV SAUDE PUBL, V35, P232, DOI 10.1590/S0034-89102001000300003
   CARTER SW, 1989, PESTIC SCI, V27, P361, DOI 10.1002/ps.2780270405
   Chan HH, 2011, TROP BIOMED, V28, P464
   Chan HH, 2013, J MED ENTOMOL, V50, P362, DOI 10.1603/ME12182
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x
   Conde M, 2015, BIOMEDICA, V35, P43, DOI [10.7705/biomedica.v35i1.2367, 10.1590/S0120-41572015000100007]
   CRAMPTON JM, 1994, ANN TROP MED PARASIT, V88, P3, DOI 10.1080/00034983.1994.11812828
   Curtis CF, 2000, SCIENCE, V290, P1508, DOI 10.1126/science.290.5496.1508
   D'Antonio M., 2001, MOSQUITO NATURAL HIS
   Macoris MDD, 2007, MEM I OSWALDO CRUZ, V102, P895, DOI 10.1590/S0074-02762007000800001
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Enserink M, 2015, SCIENCE, V350, P1012, DOI 10.1126/science.350.6264.1012
   Estrada-Franco J. G., 1995, BIOL DIS RELATIONSHI
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Festucci-Buselli RA, 2005, INSECT MOL BIOL, V14, P69, DOI 10.1111/j.1365-2583.2005.00532.x
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   GAMMON DW, 1981, PESTIC BIOCHEM PHYS, V15, P181, DOI 10.1016/0048-3575(81)90084-5
   Chapadense FGG, 2015, REV SOC BRAS MED TRO, V48, P607, DOI 10.1590/0037-8682-0046-2015
   Gatherer D, 2015, J GEN VIROL
   Georghiou G.P., 1986, FACTORS INFLUENCING, P157
   GEORGHIOU GP, 1991, OCCURRENCE RESISTANC
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GRATZ NG, 1994, AM J TROP MED HYG, V50, P11
   GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571
   GUBLER DJ, 1970, MOSQ NEWS, V30, P201
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Guengerich FP, 1997, CHEM-BIOL INTERACT, V106, P161, DOI 10.1016/S0009-2797(97)00068-9
   GUENGERICH FP, 1995, CYTOCHROME P, V450, P473
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hardstone MC, 2007, PESTIC BIOCHEM PHYS, V89, P175, DOI 10.1016/j.pestbp.2007.06.006
   Hardstone MC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-42
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   HEMINGWAY J, 1989, B ENTOMOL RES, V79, P123, DOI 10.1017/S0007485300018630
   Hien DS., 1975, ACTA PARASITOL POL, V23, P395
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   HODGSON E, 1983, INSECT BIOCHEM, V13, P237, DOI 10.1016/0020-1790(83)90044-6
   HODGSON E, 1985, COMPREHENSIVE INSECT, V11, P647
   Ibrahim SS, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005618
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379
   JIRAKANJANAKIT N, 2007, J EC ENTOMOL, V100
   Kalra N. L., 1997, Dengue Bulletin, V21, P84
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111195
   Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000391
   Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107
   Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395
   KLOWDEN MJ, 1992, J MED ENTOMOL, V29, P467, DOI 10.1093/jmedent/29.3.467
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Krogstad DJ, 1996, EPIDEMIOL REV, V18, P77, DOI 10.1093/oxfordjournals.epirev.a017918
   KULKARNI AP, 1980, PHARMACOL THERAPEUT, V8, P379, DOI 10.1016/0163-7258(80)90054-6
   Kumar S, 2009, TROP BIOMED, V26, P155
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x
   Lee Si Hyeock, 2002, Invertebrate Neuroscience, V4, P125, DOI 10.1007/s10158-001-0014-1
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Lin YH, 2013, PESTIC BIOCHEM PHYS, V107, P266, DOI 10.1016/j.pestbp.2013.08.004
   Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946
   LIU N, 1995, PESTIC BIOCHEM PHYS, V52, P116, DOI 10.1006/pest.1995.1036
   Liu N, 1996, BIOCHEM GENET, V34, P133, DOI 10.1007/BF00553609
   Liu N, 1998, INSECT BIOCHEM MOLEC, V28, P531, DOI 10.1016/S0965-1748(98)00039-3
   LIU N, 1995, EXPERIENTIA, V51, P164, DOI 10.1007/BF01929363
   Luna JED, 2004, REV SAUDE PUBL, V38, P842, DOI [10.1590/S0034-89102004000600013, 10.1590/s0034-89102004000600013]
   LUND AE, 1981, J PHARMACOL EXP THER, V219, P464
   LUND AE, 1983, PESTIC BIOCHEM PHYS, V20, P203, DOI 10.1016/0048-3575(83)90025-1
   LUND AE, 1981, NEUROTOXICOLOGY, V2, P213
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315
   Milani R., 1957, Rivista di Parassitologia Roma, V18, P199
   Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205
   MONATH TP, 1986, ANN INTERN MED, V105, P449, DOI 10.7326/0003-4819-105-3-449
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Muthusamy R., 2014, International Journal of Mosquito Research, V1, P1
   Muthusamy R, 2015, ACTA TROP, V148, P137, DOI 10.1016/j.actatropica.2015.04.026
   NARAHASHI T, 1976, PESTIC SCI, V7, P267, DOI 10.1002/ps.2780070310
   NAWROCKI SJ, 1987, J AM MOSQUITO CONTR, V3, P314
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   NRC, 1986, PEST RES STRAT TACT, P1
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pang SC, 2015, TROP BIOMED, V32, P140
   Ping LT, 2001, J AM MOSQUITO CONTR, V17, P144
   PLAPP FW, 1968, J ECON ENTOMOL, V61, P761, DOI 10.1093/jee/61.3.761
   Plernsub S, 2013, TROP BIOMED, V30, P621
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2
   Poupardin R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002743
   Qiu XH, 2013, PEST MANAG SCI, V69, P930, DOI 10.1002/ps.3454
   Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004
   Ranson H, 2010, TROPIKA NET J, V1, P1
   Reid WR, 2014, J MED ENTOMOL, V51, P605, DOI 10.1603/ME13228
   Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Rodhain Francois, 1997, P45
   Rodriguez MM, 2002, J MED ENTOMOL, V39, P882, DOI 10.1603/0022-2585-39.6.882
   Rodriguez MM, 2001, J MED ENTOMOL, V38, P623, DOI 10.1603/0022-2585-38.5.623
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x
   Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924
   Saavedra-Rodriguez K, 2015, AM J TROP MED HYG, V92, P201, DOI 10.4269/ajtmh.14-0277
   SAVAGE HM, 1993, J MED ENTOMOL, V30, P27, DOI 10.1093/jmedent/30.1.27
   SCHLIESSMANN DJ, 1974, MOSQ NEWS, V34, P1
   Scott J. G., 1990, PESTICIDE RESISTANCE, P39
   Scott JG, 2015, PESTIC BIOCHEM PHYS, V120, P68, DOI 10.1016/j.pestbp.2014.12.018
   Scott Jeffrey G., 2008, P117
   Scott JG, 1998, COMP BIOCHEM PHYS C, V121, P147, DOI 10.1016/S0742-8413(98)10035-X
   Scott JG, 2004, PESTIC BIOCHEM PHYS, V78, P171, DOI 10.1016/j.pestbp.2004.01.002
   Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7
   SCOTT JG, 1983, PESTIC BIOCHEM PHYS, V19, P141, DOI 10.1016/0048-3575(83)90133-5
   SCOTT JG, 1988, ISI ATLAS-PHARMACOL, V2, P125
   Shetty V, 2013, PEST MANAG SCI, V69, P257, DOI 10.1002/ps.3383
   Sivan A, 2015, PARASITOL RES, V114, P4693, DOI 10.1007/s00436-015-4717-3
   Soderlund DM, 2012, ARCH TOXICOL, V86, P165, DOI 10.1007/s00204-011-0726-x
   Srisawat R, 2012, SE ASIAN J TROP MED, V43, P1380
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Sun H, 2016, INSECT MOL BIOL, V25, P126, DOI 10.1111/imb.12206
   Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9
   Thanispong K, 2008, J PESTIC SCI, V33, P351, DOI 10.1584/jpestics.G08-12
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vais H, 2001, PEST MANAG SCI, V57, P877, DOI 10.1002/ps.392
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wan-Norafikah O, 2010, J ASIA-PAC ENTOMOL, V13, P175, DOI 10.1016/j.aspen.2010.03.003
   WANG Kian-chang, 1962, Acta Entomologica Sinica, V11, P357
   Whalon M E., 2015, ARTHROPOD PESTICIDE
   WHO, 2006, PEST THEIR APPL CONT
   WHO, 2012, DENGUE B
   WHO, 2009, DENG GUID DIAGN TRET
   Wilkinson C. F., 1983, Pest resistance to pesticides, P175
   WILKINSON CF, 1985, ACS SYM SER, V276, P161
   Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   World Health Organization (WHO), 1976, WHO TECH RPT SER, P77
   World Health Organization (WHO), 2012, DENG SEV DENG
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005
NR 183
TC 108
Z9 116
U1 4
U2 76
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0048-3575
EI 1095-9939
J9 PESTIC BIOCHEM PHYS
JI Pest. Biochem. Physiol.
PD OCT
PY 2016
VL 133
BP 1
EP 12
DI 10.1016/j.pestbp.2016.03.005
PG 12
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA DZ5OV
UT WOS:000385912300001
PM 27742355
DA 2020-07-08
ER

PT J
AU Althaus, CL
   Low, N
AF Althaus, Christian L.
   Low, Nicola
TI How Relevant Is Sexual Transmission of Zika Virus?
SO PLOS MEDICINE
LA English
DT Editorial Material
C1 [Althaus, Christian L.; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
RP Low, N (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
EM nicola.low@ispm.unthe.ch
RI Low, Nicola/H-4718-2019
OI Low, Nicola/0000-0003-4817-8986
CR Abbate JL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004676
   Centers for Disease Control and Prevention, ZIK VIR TRANSM RISKS
   Fingerhuth SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005611
   Folkers KM, 2016, NY TIMES
   Funk S, 2016, BIORXIV043265
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Krauer F, 2016, BIORXIV073098
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   McBride Folkers K, 2016, ZIKA IS STD WHY ARE
   McKenna M., 2016, NATL GEOGRAPHIC
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Towers S, 2016, ARXIV160601422V1
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, PREV SEX TRANS ZIK V
NR 15
TC 38
Z9 39
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD OCT
PY 2016
VL 13
IS 10
AR e1002157
DI 10.1371/journal.pmed.1002157
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB8QN
UT WOS:000387656000021
PM 27780196
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Donald, CL
   Brennan, B
   Cumberworth, SL
   Rezelj, VV
   Clark, JJ
   Cordeiro, MT
   Franca, RFD
   Pena, LJ
   Wilkie, GS
   Filipe, AD
   Davis, C
   Hughes, J
   Varjak, M
   Selinger, M
   Zuvanov, L
   Owsianka, AM
   Patel, AH
   McLauchlan, J
   Lindenbach, BD
   Fall, G
   Sall, AA
   Biek, R
   Rehwinkel, J
   Schnettler, E
   Kohl, A
AF Donald, Claire L.
   Brennan, Benjamin
   Cumberworth, Stephanie L.
   Rezelj, Veronica V.
   Clark, Jordan J.
   Cordeiro, Marli T.
   de Oliveira Franca, Rafael Freitas
   Pena, Lindomar J.
   Wilkie, Gavin S.
   Filipe, Ana Da Silva
   Davis, Christopher
   Hughes, Joseph
   Varjak, Margus
   Selinger, Martin
   Zuvanov, Luiza
   Owsianka, Ania M.
   Patel, Arvind H.
   McLauchlan, John
   Lindenbach, Brett D.
   Fall, Gamou
   Sall, Amadou A.
   Biek, Roman
   Rehwinkel, Jan
   Schnettler, Esther
   Kohl, Alain
TI Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika
   Virus from Recife, Brazil
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RNA INTERFERENCE; DENGUE; INFECTION; COINFECTION; ACTIVATION; RESPONSES;
   ALIGNMENT; HISTORY; BAHIA; STATE
AB Background
   The outbreak of Zika virus (ZIKV) in the Americas has transformed a previously obscure mosquito-transmitted arbovirus of the Flaviviridae family into a major public health concern. Little is currently known about the evolution and biology of ZIKV and the factors that contribute to the associated pathogenesis. Determining genomic sequences of clinical viral isolates and characterization of elements within these are an important prerequisite to advance our understanding of viral replicative processes and virus-host interactions.
   Methodology/Principal findings
   We obtained a ZIKV isolate from a patient who presented with classical ZIKV-associated symptoms, and used high throughput sequencing and other molecular biology approaches to determine its full genome sequence, including non-coding regions. Genome regions were characterized and compared to the sequences of other isolates where available. Furthermore, we identified a subgenomic flavivirus RNA (sfRNA) in ZIKV-infected cells that has antagonist activity against RIG-I induced type I interferon induction, with a lesser effect on MDA-5 mediated action.
   Conclusions/Significance
   The full-length genome sequence including non-coding regions of a South American ZIKV isolate from a patient with classical symptoms will support efforts to develop genetic tools for this virus. Detection of sfRNA that counteracts interferon responses is likely to be important for further understanding of pathogenesis and virus-host interactions.
C1 [Donald, Claire L.; Brennan, Benjamin; Cumberworth, Stephanie L.; Rezelj, Veronica V.; Clark, Jordan J.; Wilkie, Gavin S.; Filipe, Ana Da Silva; Davis, Christopher; Hughes, Joseph; Varjak, Margus; Zuvanov, Luiza; Owsianka, Ania M.; Patel, Arvind H.; McLauchlan, John; Schnettler, Esther; Kohl, Alain] Univ Glasgow, MRC, Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Cordeiro, Marli T.; de Oliveira Franca, Rafael Freitas; Pena, Lindomar J.] Fundacao Oswaldo Cruz PE, Ctr Pesquisas Aggeu Magalhaes, Dept Virol, Campus UFPE Cidade Univ, Recife, PE, Brazil.
   [Selinger, Martin] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.
   [Selinger, Martin] Acad Sci Czech Republ, Ctr Biol, Inst Parasitol, Ceske Budejovice, Czech Republic.
   [Lindenbach, Brett D.] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Fall, Gamou; Sall, Amadou A.] Inst Pasteur, Pole Virol, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal.
   [Biek, Roman] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.
   [Rehwinkel, Jan] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford, England.
   [Rehwinkel, Jan] Univ Oxford, Radcliffe Dept Med, Oxford, England.
   [Schnettler, Esther] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
RP Kohl, A (corresponding author), Univ Glasgow, MRC, Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.
EM alain.kohl@glasgow.ac.uk
RI Hughes, Joseph/B-7711-2009; Brennan, Benjamin/AAJ-9850-2020; Zuvanov,
   Luiza/AAF-2582-2020; Donald, Claire/AAC-7556-2019; Selinger,
   Martin/U-7604-2018
OI Hughes, Joseph/0000-0003-2556-2563; Brennan,
   Benjamin/0000-0003-4707-726X; Donald, Claire/0000-0002-4370-0707;
   Selinger, Martin/0000-0002-5420-9702; Varjak,
   Margus/0000-0003-2608-5148; Rehwinkel, Jan/0000-0003-3841-835X; Biek,
   Roman/0000-0003-3471-5357; Zuvanov, Luiza/0000-0003-0132-4894; Freitas
   de Oliveira Franca, Rafael/0000-0002-1846-6007; Clark,
   Jordan/0000-0003-1790-7883
FU UK Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014, MR/N017552/1]; FACEPE (Fundacao de Amparo a Ciencia e
   Tecnologia de Pernambuco) [APQ-0044-2.11/16]; Czech Science Foundation
   (GACR)Grant Agency of the Czech Republic [15-03044S]; Czech Research
   Infrastructure for Systems Biology (C4SYS) [LM2015055]; Biotechnology
   and Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [1518059]; Medical Research
   CouncilMedical Research Council UK (MRC) [MC_UU_12014/8, MR/N017552/1,
   MC_UU_12010/8, G0801822]
FX This study was funded by the UK Medical Research Council [(MC_UU_12014)
   (AK, ES, AHP, JM) and (MR/N017552/1) (AK, ES)], and FACEPE (Fundacao de
   Amparo a Ciencia e Tecnologia de Pernambuco, APQ-0044-2.11/16) (RFdOF,
   LJP). MS is supported by the Czech Science Foundation (GACR) [15-03044S]
   and the Czech Research Infrastructure for Systems Biology (C4SYS)
   [LM2015055]. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Brennan B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003922
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Carlos TS, 2009, J GEN VIROL, V90, P2147, DOI 10.1099/vir.0.012047-0
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   Diamond MS, 2012, TRENDS IMMUNOL, V33, P522, DOI 10.1016/j.it.2012.05.008
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grant A, CELL HOST M IN PRESS
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Oehler E, 2014, EURO SURVEILL, V19
   Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200
   Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087
   Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 65
TC 73
Z9 74
U1 2
U2 29
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD OCT
PY 2016
VL 10
IS 10
AR e0005048
DI 10.1371/journal.pntd.0005048
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA EA5QH
UT WOS:000386676200035
PM 27706161
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

EF